PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hernandez-Perez, S; Cabrera, E; Salido, E; Lim, M; Reid, L; Lakhani, SR; Khanna, KK; Saunus, JM; Freire, R				Hernandez-Perez, S.; Cabrera, E.; Salido, E.; Lim, M.; Reid, L.; Lakhani, S. R.; Khanna, K. K.; Saunus, J. M.; Freire, R.			DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer	ONCOGENE			English	Article							DNA-REPLICATION; DEUBIQUITINATING ENZYMES; SUMO DEUBIQUITINASE; STEM-CELLS; CDT1; P53; STABILIZATION; EXPRESSION; STABILITY; TRANSFORMATION	Correct control of DNA replication is crucial to maintain genomic stability in dividing cells. Inappropriate re-licensing of replicated origins is associated with chromosomal instability (CIN), a hallmark of cancer progression that at the same time provides potential opportunities for therapeutic intervention. Geminin is a critical inhibitor of the DNA replication licensing factor Cdt1. To properly achieve its functions, Geminin levels are tightly regulated through the cell cycle by ubiquitin-dependent proteasomal degradation, but the de-ubiquitinating enzymes ( DUBs) involved had not been identified. Here we report that DUB3 and USP7 control human Geminin. Overexpression of either DUB3 or USP7 increases Geminin levels through reduced ubiquitination. Conversely, depletion of DUB3 or USP7 reduces Geminin levels, and DUB3 knockdown increases re-replication events, analogous to the effect of Geminin depletion. In exploring potential clinical implications, we found that USP7 and Geminin are strongly correlated in a cohort of invasive breast cancers (P < 1.01E - 08). As expected, Geminin expression is highly prognostic. Interestingly, we found a non-monotonic relationship between USP7 and breast cancer-specific survival, with both very low or high levels of USP7 associated with poor outcome, independent of estrogen receptor status. Altogether, our data identify DUB3 and USP7 as factors that regulate DNA replication by controlling Geminin protein stability, and suggest that USP7 may be involved in Geminin dysregulation during breast cancer progression.	[Hernandez-Perez, S.; Cabrera, E.; Salido, E.; Freire, R.] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Ofra S-N, San Cristobal la Laguna 38320, Tenerife, Spain; [Lim, M.; Reid, L.; Lakhani, S. R.; Saunus, J. M.] Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia; [Lim, M.; Reid, L.; Saunus, J. M.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Lakhani, S. R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Herston, Qld, Australia; [Lakhani, S. R.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Khanna, K. K.] QIMR Berghofer Inst Med Res, Signal Transduct Lab, Brisbane, Qld, Australia	Universidad de la Laguna; University of Queensland; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; QIMR Berghofer Medical Research Institute	Freire, R (corresponding author), Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Ofra S-N, San Cristobal la Laguna 38320, Tenerife, Spain.; Saunus, JM (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia.	j.saunus@uq.edu.au; rfreire@ull.edu.es	Cabrera, Elisa/GPX-3455-2022; Freire, Raimundo/Q-7660-2019; Saunus, Jodi M/C-6657-2011; Lakhani, Sunil R/I-1970-2018; Saunus, Jodi/AAE-5291-2020; Salido, Eduardo/I-2232-2015	Freire, Raimundo/0000-0003-4473-8894; Saunus, Jodi M/0000-0002-4604-4709; Lakhani, Sunil R/0000-0003-4067-2760; Saunus, Jodi/0000-0002-4604-4709; Salido, Eduardo/0000-0001-9599-9854; Khanna, Kum Kum/0000-0001-8650-5381; Lim, Malcolm/0000-0003-3691-4368	Instituto de Salud Carlos III [BA15/00092]; Spanish Ministry of Economy and Competitiveness [SAF2013-49149-R, BFU2014-51672-REDC]; Fundacion CajaCanarias [AP2015/008]; Australian National Health and Medical Research (NHMRC program grant) [APP1017028]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion CajaCanarias; Australian National Health and Medical Research (NHMRC program grant)(National Health and Medical Research Council (NHMRC) of Australia)	We are grateful to V Smits for critical reading of the manuscript, J Moreira, E Lam, M van Vugt for sending cell lines and A Bravo for logistic help. This work was supported by grants from Instituto de Salud Carlos III (BA15/00092), the Spanish Ministry of Economy and Competitiveness (SAF2013-49149-R, BFU2014-51672-REDC), Fundacion CajaCanarias (AP2015/008) to RF and the Australian National Health and Medical Research (NHMRC program grant to SRL and KKK (APP1017028)).	Al-Ejeh F, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.41; Alonso-de Vega I, 2014, CELL CYCLE, V13, P3921, DOI 10.4161/15384101.2014.973324; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Cabrera E, 2017, ONCOGENE, V36, P678, DOI 10.1038/onc.2016.239; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen H, 2013, MOL CELL BIOL, V33, P1139, DOI 10.1128/MCB.01191-12; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; Epping MT, 2011, NAT CELL BIOL, V13, P102, DOI 10.1038/ncb2142; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Field S, 2016, INT J CANCER, V138, P1959, DOI 10.1002/ijc.29946; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Gonzalez MA, 2004, J PATHOL, V204, P121, DOI 10.1002/path.1625; Hernandez-Perez S, 2016, MOL ONCOL, V10, P1196, DOI 10.1016/j.molonc.2016.05.008; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Perez-Castro AJ, 2012, J CELL SCI, V125, P1152, DOI 10.1242/jcs.091124; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Junankar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7548; Kessler BM, 2014, EXPERT OPIN THER PAT, V24, P597, DOI 10.1517/13543776.2014.882320; Lecona E, 2016, NAT STRUCT MOL BIOL, V23, P270, DOI 10.1038/nsmb.3185; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Maire V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063712, 10.1371/journal.pone.0077372]; Martin Y, 2015, ONCOGENE, V34, P1058, DOI 10.1038/onc.2014.38; McClurg UL, 2015, ONCOTARGET, V6, P9657, DOI 10.18632/oncotarget.3922; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; Qian J, 2015, ONCOGENE, V34, P4791, DOI 10.1038/onc.2014.394; Rajan SS, 2014, BREAST CANCER RES TR, V143, P91, DOI 10.1007/s10549-013-2786-5; Refolio E, 2011, J CELL SCI, V124, P2488, DOI 10.1242/jcs.081711; Rialland M, 2002, J CELL SCI, V115, P1435; Rivlin N, 2014, P NATL ACAD SCI USA, V111, P7006, DOI 10.1073/pnas.1320428111; Delgado-Diaz MR, 2014, MOL ONCOL, V8, P884, DOI 10.1016/j.molonc.2014.03.003; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Smits VAJ, 2016, BIOESSAYS, V38, P863, DOI 10.1002/bies.201600096; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Srihari S, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0086-1; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Wang Q, 2016, J CLIN INVEST, V126, P2205, DOI 10.1172/JCI85747; Yagi T, 2016, BREAST CANCER-TOKYO, V23, P224, DOI 10.1007/s12282-014-0556-9; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zlatanou A, 2016, ONCOGENE, V35, P965, DOI 10.1038/onc.2015.149	51	11	11	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 17	2017	36	33					4802	4809		10.1038/onc.2017.21	http://dx.doi.org/10.1038/onc.2017.21			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD7JM	28288134				2022-12-26	WOS:000407702400012
J	Zayed, MA; Wei, XC; Park, KM; Belaygorod, L; Naim, UM; Harvey, J; Yin, L; Blumer, K; Semenkovich, CF				Zayed, Mohamed A.; Wei, Xiachao; Park, Kyoung-mi; Belaygorod, Larisa; Naim, Uzma; Harvey, Joseph; Yin, Li; Blumer, Kendall; Semenkovich, Clay F.			N-Acetylcysteine accelerates amputation stump healing in the setting of diabetes	FASEB JOURNAL			English	Article						NAC; peripheral arterial disease; G alpha q; arterial perfusion	ENDOTHELIAL-CELL APOPTOSIS; NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; PROTEIN PALMITOYLATION; LOWER-EXTREMITY; INSULIN-RESISTANCE; ACYL TRANSFERASES; MICE; ANGIOGENESIS; EXPRESSION	Over 60% of lower extremity amputations are performed in patients with diabetes and peripheral arterial disease, and at least 25% require subsequent reamputation due to poor surgical site healing. The mechanisms underlying poor amputation stump healing in the setting of diabetes are not understood. N-acetylcysteine (NAC) is known to promote endothelial cell function and angiogenesis and may have therapeutic benefits in the setting of diabetes. We tested the hypothesis that NAC alters the vascular milieu to improve healing of amputation stumps in diabetes using a novel in vivo murine hindlimb ischemia-amputation model. Amputation stump tissue perfusion and healing were evaluated in C57BL/6J adult mice with streptozotocin-induced diabetes. Compared with controls, mice treated with daily NAC demonstrated improved postamputation stump healing, perfusion, adductor muscle neovascularization, and decreased muscle fiber damage. Additionally, NAC stimulated HUVEC migration and proliferation in a phospholipase C beta-dependent fashion and decreased G alpha q palmitoylation. Similarly, NAC treatment also decreased Gaq palmitoylation in ischemic and nonischemic hindlimbs in vivo. In summary, we demonstrate that NAC accelerates healing of amputation stumps in the setting of diabetes and ischemia. The underlying mechanism appears to involve a previously unrecognized effect of NAC on Gaq palmitoylation and phospholipase C beta-mediated signaling in endothelial cells.	[Zayed, Mohamed A.; Park, Kyoung-mi; Belaygorod, Larisa; Naim, Uzma] Washington Univ, Sch Med, Dept Surg, Sect Vasc Surg, St Louis, MO 63110 USA; [Wei, Xiachao; Yin, Li; Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Harvey, Joseph; Blumer, Kendall; Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Zayed, Mohamed A.] St Louis Vet Affairs Hlth Care Syst, Dept Surg, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zayed, MA (corresponding author), Washington Univ, Sch Med, Vasc & Endovasc Surg, Campus Box 8109 Surg,660 South Euclid Ave, St Louis, MO 63110 USA.	zayedm@wustl.edu		Park, Kyoung-Mi/0000-0001-7548-8432	Vascular Cures Foundation; Society for Vascular Surgery Foundation; Washington University Diabetes Research Center [P30 DK020579]; U. S. Department of Veterans Affairs [VA-STL-151-16-01]; U. S. National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases [DK076729, DK101392, DK056341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL132060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007120, P30DK020579, P30DK056341, R01DK101392, R01DK076729] Funding Source: NIH RePORTER	Vascular Cures Foundation; Society for Vascular Surgery Foundation; Washington University Diabetes Research Center; U. S. Department of Veterans Affairs(US Department of Veterans Affairs); U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Vascular Cures Foundation Wylie Scholar Award (to M.A.Z.), Society for Vascular Surgery Foundation Research Seed Grant (to M.A.Z.), Washington University Diabetes Research Center grant (P30 DK020579), the U. S. Department of Veterans Affairs (VA-STL-151-16-01), and U. S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK076729, DK101392, and DK056341. The authors thank Dr. Sangeeta Adak, Dr. Larry Spears, and Malik Darwech (all from Washington University) for their scientific and technical input; the Washington University Diabetes Models Phenotyping Core for assistance with murine morphometric studies; and Dr. Luis Sanchez and Dr. Timothy Eberlein (all from Washington University) for institutional support.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Al Suleimani YM, 2016, PHYSIOL RES, V65, P53, DOI 10.33549/physiolres.932962; AMMON HPT, 1992, ARZNEIMITTEL-FORSCH, V42-1, P642; Atkins KB, 2000, J APPL TOXICOL, V21, pS125; Burgoyne JR, 2012, FASEB J, V26, P832, DOI 10.1096/fj.11-189415; Chen JM, 2011, J CLIN INVEST, V121, P593, DOI 10.1172/JCI41062; Dillingham TR, 2005, ARCH PHYS MED REHAB, V86, P480, DOI 10.1016/j.apmr.2004.06.072; Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042; EBSKOV B, 1980, PROSTHET ORTHOT INT, V4, P77; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Ho E, 1999, FASEB J, V13, P1845, DOI 10.1096/fasebj.13.13.1845; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Ismael MA, 2008, EUR J PHARMACOL, V589, P66, DOI 10.1016/j.ejphar.2008.05.006; Kanade Rajani, 2007, Int Wound J, V4, P344; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kim H, 2000, FREE RADICAL BIO MED, V29, P674, DOI 10.1016/S0891-5849(00)00368-3; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Lasram MM, 2015, CLIN BIOCHEM, V48, P1200, DOI 10.1016/j.clinbiochem.2015.04.017; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Marin EP, 2012, CIRC RES, V110, P1336, DOI 10.1161/CIRCRESAHA.112.269514; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Pieper GM, 1998, J CARDIOVASC PHARM, V32, P101, DOI 10.1097/00005344-199807000-00016; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PRESCOTT LF, 1977, LANCET, V2, P432; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; SHEFFNER AL, 1964, AM REV RESPIR DIS, V90, P721; Shih RH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-104; Sivaraj KK, 2015, CARDIOVASC RES, V108, P171, DOI 10.1093/cvr/cvv216; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Victor VM, 2003, FREE RADICAL RES, V37, P919, DOI 10.1080/1071576031000148727; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Wang SP, 2015, J CLIN INVEST, V125, P3077, DOI 10.1172/JCI81067; Wang TT, 2013, FREE RADICAL BIO MED, V63, P291, DOI 10.1016/j.freeradbiomed.2013.05.043; Wanivenhaus F, 2016, ORTHOPEDICS, V39, pE149, DOI 10.3928/01477447-20151222-14; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Xia ZY, 2006, EUR J PHARMACOL, V550, P134, DOI 10.1016/j.ejphar.2006.08.044; Zayed M, 2014, ANN VASC SURG, V28, P1157, DOI 10.1016/j.avsg.2013.11.008; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586	49	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2686	2695		10.1096/fj.201601348R	http://dx.doi.org/10.1096/fj.201601348R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28280002	Green Published			2022-12-26	WOS:000401553400038
J	Liu, XY; Jiang, JW; Zhang, K; Long, EP; Cui, JT; Zhu, MM; An, YY; Zhang, J; Liu, ZZ; Lin, ZL; Li, XY; Chen, JJ; Cao, QZ; Li, J; Wu, XH; Wang, DN; Lin, HT				Liu, Xiyang; Jiang, Jiewei; Zhang, Kai; Long, Erping; Cui, Jiangtao; Zhu, Mingmin; An, Yingying; Zhang, Jia; Liu, Zhenzhen; Lin, Zhuoling; Li, Xiaoyan; Chen, Jingjing; Cao, Qianzhong; Li, Jing; Wu, Xiaohang; Wang, Dongni; Lin, Haotian			Localization and diagnosis framework for pediatric cataracts based on slit-lamp images using deep features of a convolutional neural network	PLOS ONE			English	Article								Slit-lamp images play an essential role for diagnosis of pediatric cataracts. We present a computer vision-based framework for the automatic localization and diagnosis of slit-lamp images by identifying the lens region of interest (ROI) and employing a deep learning convolutional neural network (CNN). First, three grading degrees for slit-lamp images are proposed in conjunction with three leading ophthalmologists. The lens ROI is located in an automated manner in the original image using two successive applications of Candy detection and the Hough transform, which are cropped, resized to a fixed size and used to form pediatric cataract datasets. These datasets are fed into the CNN to extract high-level features and implement automatic classification and grading. To demonstrate the performance and effectiveness of the deep features extracted in the CNN, we investigate the features combined with support vector machine (SVM) and softmax classifier and compare these with the traditional representative methods. The qualitative and quantitative experimental results demonstrate that our proposed method offers exceptional mean accuracy, sensitivity and specificity: classification (97.07%, 97.28%, and 96.83%) and a three-degree grading area (89.02%, 86.63%, and 90.75%), density (92.68%, 91.05%, and 93.94%) and location (89.28%, 82.70%, and 93.08%). Finally, we developed and deployed a potential automatic diagnostic software for ophthalmologists and patients in clinical applications to implement the validated model.	[Liu, Xiyang; Jiang, Jiewei; Zhang, Kai; Cui, Jiangtao; An, Yingying; Zhang, Jia] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Liu, Xiyang] Xidian Univ, Sch Software, Xian, Peoples R China; [Long, Erping; Liu, Zhenzhen; Lin, Zhuoling; Li, Xiaoyan; Chen, Jingjing; Cao, Qianzhong; Li, Jing; Wu, Xiaohang; Wang, Dongni; Lin, Haotian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhu, Mingmin] Xidian Univ, Sch Math & Stat, Xian, Peoples R China	Xidian University; Xidian University; Sun Yat Sen University; Xidian University	Liu, XY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.; Liu, XY (corresponding author), Xidian Univ, Sch Software, Xian, Peoples R China.; Lin, HT (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	xyliu@xidian.edu.cn; gddlht@gmail.com	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	liu, zhenzhen/0000-0002-4853-2474; Long, Erping/0000-0002-3502-5596; Zhang, Kai/0000-0001-9054-288X; Lin, Haotian/0000-0003-4672-9721	NSFC [91546101, 11401454]; Guangdong Provincial Natural Science Foundation [YQ2015006, 2014A030306030, 2014TQ01R573, 20136020400003]; Natural Science Foundation of Guangzhou City [2014J2200060]; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University [2015ykzd11, 2015QN01]; Fundamental Research Funds for the Central Universities [BDZ011401, JB151005]; Novel Technology Research of Universities Cooperation Project; State Key Laboratory of Satellite Navigation System and Equipment Technology [KX152600027]; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of Guangzhou City; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Novel Technology Research of Universities Cooperation Project; State Key Laboratory of Satellite Navigation System and Equipment Technology; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	This study was funded by the NSFC (91546101,11401454); the Guangdong Provincial Natural Science Foundation (YQ2015006, 2014A030306030, 2014TQ01R573, 20136020400003); the Natural Science Foundation of Guangzhou City (2014J2200060); the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University (2015ykzd11, 2015QN01); the Fundamental Research Funds for the Central Universities (BDZ011401, JB151005); the Novel Technology Research of Universities Cooperation Project, the State Key Laboratory of Satellite Navigation System and Equipment Technology (KX152600027); and the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya L, 2003, SURV OPHTHALMOL, V48, P125, DOI 10.1016/S0039-6257(02)00462-9; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; BROWN NAP, 1987, EYE-T OPHTH SOC UK, V1, P234, DOI 10.1038/eye.1987.43; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chiu SJ, 2012, INVEST OPHTH VIS SCI, V53, P53, DOI 10.1167/iovs.11-7640; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Daugman J, 2007, IEEE T SYST MAN CY B, V37, P1167, DOI 10.1109/TSMCB.2007.903540; Essock EA, 2005, INVEST OPHTH VIS SCI, V46, P2838, DOI 10.1167/iovs.04-1156; Fan SH, 2003, LECT NOTES COMPUT SC, V2878, P592; Guo LY, 2015, COMPUT IND, V69, P72, DOI 10.1016/j.compind.2014.09.005; Hihn J, 2016, AEROSP CONF PROC; Huang W, 2011, IEEE T MED IMAGING, V30, P94, DOI 10.1109/TMI.2010.2062197; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Jiao Z, 2016, NEUROCOMPUTING; Kang MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155781; Kawaguchi T, 2003, PATTERN RECOGN, V36, P549, DOI 10.1016/S0031-3203(02)00066-3; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lambert SR, 2015, J AAPOS, V19, P393, DOI [10.1016/j.jaapos.2015.01.013, 10.1016/j.jaapos.2015.05.008]; Li HQ, 2010, IEEE T BIO-MED ENG, V57, P1690, DOI 10.1109/TBME.2010.2041454; Lin DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142298; Lin H., 2015, SCIENCE, V349, P6252; Liu ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39808; Marc RE, 2013, PROG RETIN EYE RES, V37, P141, DOI 10.1016/j.preteyeres.2013.08.002; Martonyi Csaba L, 2007, SLIT LAMP EXAMINATIO; Masek L, 2003, RECOGNITION HUMAN IR, P2; Medsinge Anagha, 2015, Clin Ophthalmol, V9, P77, DOI 10.2147/OPTH.S59009; Nair V., 2010, P 27 INT C INT C MAC, P807; Resnikoff S, 2012, INDIAN J OPHTHALMOL, V60, P387, DOI 10.4103/0301-4738.100532; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Shin KY, 2012, PATTERN RECOGN LETT, V33, P991, DOI 10.1016/j.patrec.2011.08.016; Singh A, 2016, COMPUT METH PROG BIO, V124, P108, DOI 10.1016/j.cmpb.2015.10.010; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; WEST SK, 1988, INVEST OPHTH VIS SCI, V29, P73; Wildes RP, 1994, APPL COMP VIS 1994 P; Wu XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28564; Ypsilantis PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137036; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang ZQ, 2014, J INSECT SCI, V14, DOI 10.1673/031.014.114	41	43	47	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0168606	10.1371/journal.pone.0168606	http://dx.doi.org/10.1371/journal.pone.0168606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306716	Green Published, Green Submitted, gold			2022-12-26	WOS:000396710300001
J	Kao, SC; Tsai, HI; Cheng, CW; Lin, TW; Chen, CC; Lin, CS				Kao, Sheng-Chin; Tsai, Hsin-I; Cheng, Chih-Wen; Lin, Ta-Wei; Chen, Chien-Chuan; Lin, Chia-Shiang			The association between frequent alcohol drinking and opioid consumption after abdominal surgery: A retrospective analysis	PLOS ONE			English	Article							CHRONIC ETHANOL-CONSUMPTION; POSTOPERATIVE NAUSEA; RISK-FACTORS; NEUROPATHIC PAIN; SPINAL-CORD; RECEPTOR; REDUCTION; INTENSITY; TRIAL	Aims It is perceived that patients with a history of frequent alcohol consumption require more opi-oids for postoperative pain control and experience less postoperative nausea and vomiting than patients without such a history. However, there is scarce evidence supporting this notion. The aim of this study was to assess association between frequent alcohol consump-tion and opioid requirement for postoperative pain control and occurrence of postoperative nausea and vomiting. Methods The medical records for 4143 patients using intravenous patient-control analgesia with opioids after abdominal surgery between January 2010 and September 2013 were obtained, and associations were sought between the cumulative opioid consumption (in intravenous morphine equivalence) per body weight (mg/kg) in the first 2 days after abdominal operation and several demographic and clinical variables by multiple regres-sion analysis. The association between the occurrence of postoperative nausea and vomiting and several demographic and clinical variables was also sought by multiple logistic regression analysis. Results Frequent alcohol drinking, among other previously reported factors, was associated with increased opioid consumption for postoperative pain control (p < 0.001). The estimate effect of frequent alcohol drinking was 0.117 mg/kg. Frequent alcohol drinking was also associ-ated with decreased risks of postoperative nausea (odds ratio = 0.59, p = 0.003) and vomiting (odds ratio = 0.49, p = 0.026). Conclusions Frequent alcohol drinking was associated with increased opioid consumption for postoperative pain control and decreased risks of postoperative nausea and vomiting after abdominal surgery.	[Kao, Sheng-Chin; Chen, Chien-Chuan; Lin, Chia-Shiang] Mackay Mem Hosp, Dept Anesthesiol, Taipei, Taiwan; [Kao, Sheng-Chin] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Tsai, Hsin-I; Cheng, Chih-Wen] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Lin, Ta-Wei] Natl Yang Ming Univ Hosp, Dept Anesthesiol, Yilan City, Yilan County, Taiwan	Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Lin, CS (corresponding author), Mackay Mem Hosp, Dept Anesthesiol, Taipei, Taiwan.	seancslin@gmail.com		Kao, Sheng-Chin/0000-0003-1035-7815				Apfel CC, 2012, BRIT J ANAESTH, V109, P742, DOI 10.1093/bja/aes276; Apfel CC, 2002, BRIT J ANAESTH, V88, P659, DOI 10.1093/bja/88.5.659; Aydogan MS, 2013, J ANESTH, V27, P569, DOI 10.1007/s00540-013-1565-0; Brettner F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146746; Campbell VC, 2007, ALCOHOL CLIN EXP RES, V31, P1435, DOI 10.1111/j.1530-0277.2007.00432.x; Chung KC, 2014, PAIN MED, V15, P225, DOI 10.1111/pme.12299; Fletcher D, 2014, BRIT J ANAESTH, V112, P991, DOI 10.1093/bja/aeu137; Gan TJ, 2006, ANESTH ANALG, V102, P1884, DOI 10.1213/01.ANE.0000219597.16143.4D; Gatch MB, 2009, CURR DRUG ABUSE REV, V2, P41; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; He L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019372; Hwang IC, 2014, ANESTHESIOLOGY, V121, P825, DOI 10.1097/ALN.0000000000000405; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Koike H, 2006, CURR OPIN NEUROL, V19, P481, DOI 10.1097/01.wco.0000245371.89941.eb; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; Miyoshi K, 2007, EUR J PHARMACOL, V562, P208, DOI 10.1016/j.ejphar.2007.01.091; MOGIL JS, 1993, BRAIN RES, V602, P126, DOI 10.1016/0006-8993(93)90251-H; Morino R, 2013, J ANESTH, V27, P18, DOI 10.1007/s00540-012-1468-5; Morisot N, 2016, GENES BRAIN BEHAV; Narita M, 2007, NEUROSCIENCE, V144, P777, DOI 10.1016/j.neuroscience.2006.10.028; Narita M, 2007, LIFE SCI, V80, P852, DOI 10.1016/j.lfs.2006.11.015; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Ryu Junnosuke, 1993, Bulletin Hospital for Joint Diseases, V53, P35; Shaheen PE, 2009, J PAIN SYMPTOM MANAG, V38, P409, DOI 10.1016/j.jpainsymman.2009.06.004; Smith HS, 2014, EUR J PHARMACOL, V722, P67, DOI 10.1016/j.ejphar.2013.09.074; Stadler M, 2003, ANESTHESIOLOGY, V98, P46, DOI 10.1097/00000542-200301000-00011; Treskatsch S, 2014, EUR J ANAESTH, V31, P41, DOI 10.1097/01.EJA.0000434967.03790.0e; Wang H, 2002, REGION ANESTH PAIN M, V27, P139, DOI 10.1053/rapm.2002.29253; Weingarten TN, 2011, OBES SURG, V21, P1407, DOI 10.1007/s11695-010-0217-9; Wu CL, 2011, LANCET, V377, P2215, DOI 10.1016/S0140-6736(11)60245-6; Yoshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116885	31	4	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171275	10.1371/journal.pone.0171275	http://dx.doi.org/10.1371/journal.pone.0171275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301483	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300011
J	Matsuyama, R; Miura, F; Nishiura, H				Matsuyama, Ryota; Miura, Fuminari; Nishiura, Hiroshi			The transmissibility of noroviruses: Statistical modeling of outbreak events with known route of transmission in Japan	PLOS ONE			English	Article							GASTROENTERITIS OUTBREAKS; EMERGENCE; VARIANT; EVOLUTION; STRAIN; IMMUNITY; IMPACT; VIRUS	In Japan, the fraction of norovirus outbreaks attributable to human-to-human transmission has increased with time, and the timing of the increased fraction has coincided with the increase in the observed fraction of genogroup II genotype 4 (GII.4). The present study aimed to estimate the time-dependent changes in the transmissibility of noroviruses. The effective reproduction number (R-y), for year y, was estimated by analyzing the time series surveillance data for outbreak events from 2000 to 2016. R-y was estimated by using the fraction of outbreak events that were attributable to human-to-human transmission and by employing three different statistical models that are considered to mechanistically capture the possible data-generating process in different ways. The R-y estimates ranged from 0.14 to 4.15 in value, revealing an overall increasing trend (p< 0.05 for all three models). The proportion of outbreaks caused by GII and GII.4 viruses among the total events also increased with time, and positive correlations were identified between transmissibility and these proportions. Parametric modeling of R-y indicated that the time-dependent patterns of R-y were better described by a step function plus linear trend rather than the step function alone that reflects the widespread use of reverse transcriptase PCR (RT-PCR) in and after 2007 for laboratory diagnosis. Accordingly, we conclude that norovirus transmissibility has increased over the past 16 years in Japan. The change is at least partially explained by the time-dependent domination of the contagious GII genogroup (e.g., GII.4), indicating that noroviruses better fitted to humans have selectively caused the human-to-human transmissions, thereby altering the epidemiology of this pathogen.	[Matsuyama, Ryota; Miura, Fuminari; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido, Japan; [Matsuyama, Ryota; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, 4-1-8 Honcho, Kawaguchi, Saitama, Japan; [Miura, Fuminari] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan	Hokkaido University; Japan Science & Technology Agency (JST); University of Tokyo	Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido, Japan.; Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, 4-1-8 Honcho, Kawaguchi, Saitama, Japan.	nishiurah@med.hokudai.ac.jp	Matsuyama, Ryota/AAX-8909-2021; Matsuyama, Ryota/AAF-5208-2021; Matsuyama, Ryota/ABH-7126-2020	Matsuyama, Ryota/0000-0002-7296-0129; Miura, Fuminari/0000-0001-8235-757X	Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science (JSPS) KAKENHI [16KT0130, 16K15356, 26700028]; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers; Japan Science and Technology Agency (JST); JSPS [16H06581]; Grants-in-Aid for Scientific Research [16KT0130, 26700028] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HN received funding support from the Japan Agency for Medical Research and Development, the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant numbers 16KT0130, 16K15356 and 26700028), the Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers, the Japan Science and Technology Agency (JST) CREST program and RISTEX program for Science of Science, Technology and Innovation Policy. RM also received funding support from JSPS KAKENHI (Grant number 16H06581). The funders played no roles in the study design, data collection and analysis, decision to publish, or manuscript preparation.	[Anonymous], EURO SURVEILL; Bitler EJ, 2013, EPIDEMIOL INFECT, V141, P1563, DOI 10.1017/S095026881300006X; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399; Chan MCW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10061; Chan-It W, 2012, J MED VIROL, V84, P1089, DOI 10.1002/jmv.23309; de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178; Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370; Dey SK, 2011, CLIN LAB, V57, P193; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Gao ZY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1315-z; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Harris T. E., 1963, THEORY BRANCHING PRO; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Heijne JCM, 2009, EMERG INFECT DIS, V15, P24, DOI [10.3201/1501.080299, 10.3201/eid1501.080299]; Infectious Disease Surveillance Center National Institute of Infectious Diseases, 2014, IASR, V35, P161; Kumazaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142568; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999; Nishiura H, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-30; Nishiura H, 2012, J THEOR BIOL, V294, P48, DOI 10.1016/j.jtbi.2011.10.039; Sakon N, 2015, J INFECT DIS, V211, P879, DOI 10.1093/infdis/jiu496; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Simmons K, 2013, EMERG INFECT DIS, V19, P1260, DOI 10.3201/eid1908.130472; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Vanderpas J, 2009, J HOSP INFECT, V71, P214, DOI 10.1016/j.jhin.2008.11.024; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Verhoef L, 2015, EMERG INFECT DIS, V21, P592, DOI 10.3201/eid2104.141073; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173996	10.1371/journal.pone.0173996	http://dx.doi.org/10.1371/journal.pone.0173996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296972	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700087
J	Kaya, B; Goceri, E; Becker, A; Elder, B; Puduvalli, V; Winter, J; Gurcan, M; Otero, JJ				Kaya, Behiye; Goceri, Evgin; Becker, Aline; Elder, Brad; Puduvalli, Vinay; Winter, Jessica; Gurcan, Metin; Otero, Jose Javier			Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; GLIOBLASTOMA; BRAIN; AUTOFLUORESCENCE; PATHOLOGY	Multiplexed immunofluorescent testing has not entered into diagnostic neuropathology due to the presence of several technical barriers, amongst which includes autofluorescence. This study presents the implementation of a methodology capable of overcoming the visual challenges of fluorescent microscopy for diagnostic neuropathology by using automated digital image analysis, with long term goal of providing unbiased quantitative analyses of multiplexed biomarkers for solid tissue neuropathology. In this study, we validated PTBP1, a putative biomarker for glioma, and tested the extent to which immunofluorescent microscopy combined with automated and unbiased image analysis would permit the utility of PTBP1 as a biomarker to distinguish diagnostically challenging surgical biopsies. As a paradigm, we utilized second resections from patients diagnosed either with reactive brain changes (pseudoprogression) and recurrent glioblastoma (true progression). Our image analysis workflow was capable of removing background autofluorescence and permitted quantification of DAPI-PTBP1 positive cells. PTBP1-positive nuclei, and the mean intensity value of PTBP1 signal in cells. Traditional pathological interpretation was unable to distinguish between groups due to unacceptably high discordance rates amongst expert neuropathologists. Our data demonstrated that recurrent glioblastoma showed more DAPI-PTBP1 positive cells and a higher mean intensity value of PTBP1 signal compared to resections from second surgeries that showed only reactive gliosis. Our work demonstrates the potential of utilizing automated image analysis to overcome the challenges of implementing fluorescent microscopy in diagnostic neuropathology.	[Kaya, Behiye; Otero, Jose Javier] Ohio State Univ, Coll Med, Dept Pathol, Div Neuropathol, Columbus, OH 43210 USA; [Goceri, Evgin] Akdeniz Univ, Fac Engn, Dept Comp Engn, Antalya, Turkey; [Becker, Aline] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Elder, Brad] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Puduvalli, Vinay] Ohio State Univ, Wexner Med Ctr, Div Neurooncol, Columbus, OH 43210 USA; [Winter, Jessica] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Winter, Jessica] Ohio State Univ, William G Lowie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Gurcan, Metin] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Akdeniz University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Otero, JJ (corresponding author), Ohio State Univ, Coll Med, Dept Pathol, Div Neuropathol, Columbus, OH 43210 USA.; Gurcan, M (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	Metin.Gurcan@osumc.edu; jose.otero@osumc.edu	Becker, Aline/AAD-2209-2021; Winter, Jessica O./AAO-5773-2020; Otero, Jose/AAI-4891-2020	Winter, Jessica O./0000-0002-5370-0137; Otero, Jose/0000-0003-0680-4520; Gurcan, Metin/0000-0002-2421-8229	Pelotonia Foundation Idea Grant; NIH/NHLBI [1R01HL132355-01A1]; NIH/NIBIB [R21EB017539]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB017539] Funding Source: NIH RePORTER	Pelotonia Foundation Idea Grant; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	JO, JW, BE, VP, and MG acknowledge Pelotonia Foundation Idea Grant. JO acknowledges support from NIH/NHLBI for 1R01HL132355-01A1 and NIH/NIBIB R21EB017539.	Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Cheung HC, 2006, MODERN PATHOL, V19, P1034, DOI 10.1038/modpathol.3800635; Fauzi MFA, 2015, J NEURO-ONCOL, V124, P393, DOI 10.1007/s11060-015-1872-4; Ferrarese R, 2014, J CLIN INVEST, V124, P2861, DOI 10.1172/JCI68836; Fitzgibbons PL, 2014, ARCH PATHOL LAB MED, V138, P1432, DOI 10.5858/arpa.2013-0610-CP; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Khandelwal S, 2007, J BIOSCIENCES, V32, P1139, DOI 10.1007/s12038-007-0115-z; Kim JH, 2012, AM J SURG PATHOL, V36, P620, DOI 10.1097/PAS.0b013e318246040c; Lillevali K, 2001, MECH DEVELOP, V101, P217, DOI 10.1016/S0925-4773(00)00566-9; McCutcheon IE, 2004, NEURO-ONCOLOGY, V6, P9, DOI 10.1215/S1152851703000279; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1677, DOI 10.1093/jnci/djt282; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Schulte A, 2013, NEURO-ONCOLOGY, V15, P1289, DOI 10.1093/neuonc/not093; Spitzer N, 2011, J NEUROSCI METH, V197, P48, DOI 10.1016/j.jneumeth.2011.01.029; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; Webster JD, 2014, VET PATHOL, V51, P211, DOI 10.1177/0300985813503570; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	21	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0170991	10.1371/journal.pone.0170991	http://dx.doi.org/10.1371/journal.pone.0170991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282372	Green Published, gold			2022-12-26	WOS:000396091800002
J	Te, ALD; Higa, S; Chung, FP; Lin, CY; Lo, MT; Liu, CA; Lin, C; Chang, YC; Chang, SL; Lo, LW; Hu, YF; Tuan, TC; Chao, TF; Liao, JN; Chang, YT; Lin, CH; Hung, Y; Yamada, S; Pan, KL; Lin, YJ; Chen, SA				Te, Abigail Louise D.; Higa, Satoshi; Chung, Fa-Po; Lin, Chin-Yu; Lo, Men-Tzung; Liu, Che-An; Lin, Chen; Chang, Yi-Chung; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jonan; Chang, Yao-Ting; Lin, Chung-Hsing; Hung, Yuan; Yamada, Shinya; Pan, Kuo-Li; Lin, Yenn-Jiang; Chen, Shih-Ann			The use of a novel signal analysis to identify the origin of idiopathic right ventricular outflow tract ventricular tachycardia during sinus rhythm: Simultaneous amplitude frequency electrogram transformation mapping	PLOS ONE			English	Article							CATHETER ABLATION; ELECTROPHYSIOLOGIC CHARACTERISTICS; SUBSTRATE-MODIFICATION; SITE; ARRHYTHMIAS; CARDIOMYOPATHY; ACTIVATION	Introduction The signal characteristics of intracardiac bipolar electrograms at the origin of idiopathic RVOT-VT during sinus rhythm remain unclear. Objective The study sought to develop a novel real-time/online technique, simultaneous amplitude frequency electrogram transformation (SAFE-T), to quantify and localize the diseased ventricular substrate in idiopathic RVOT-VT. Methods We retrospectively investigated the intracardiac bipolar recordings in 70 consecutive patients (26% male, mean age 42 +/- 12 years) who underwent successful radiofrequency catheter ablation of idiopathic RVOT-VT. We quantified the extent of the frequency fraction of ventricular potentials during sinus rhythm or ventricular pacing using a novel formula, the product of instantaneous amplitude and frequency, and showed that in a 3D geometry as an online SAFE-T map. Results The characteristics of the HHT spectra of electrograms derived from VT origins demonstrated high frequency components (>70 Hz), which were independent of the rhythm. The density of the abnormal potentials at the VT origins were higher (VT origins, 7.5 +/- 2.3 sites/cm(2) vs. surrounding myocardium, 1.5 +/- 1.3 sites/cm(2), p<0.001), and were significantly decreased after ablation (0.7 +/- 0.6 sites/cm(2), p<0.001). A small region of abnormal potentials were observed in the VT origins (mean area of 1.5 +/- 0.8 cm(2)). The SAFE-T maps predicted the VT origins with 92% sensitivity, 78% specificity with optimal cut-off value of >3.0 Hz.mV. Conclusion The online SAFE-T map was feasible for quantifying the diseased ventricular substrate, irrespective of the rhythm of activation, and can be used to identify the optimal ablation targets for idiopathic RVOT-VT. We found a limited region of abnormal potentials where the RVOT-VT origins were successfully ablated.	[Te, Abigail Louise D.; Chung, Fa-Po; Lin, Chin-Yu; Liu, Che-An; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jonan; Chang, Yao-Ting; Lin, Chung-Hsing; Hung, Yuan; Yamada, Shinya; Pan, Kuo-Li; Lin, Yenn-Jiang; Chen, Shih-Ann] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Higa, Satoshi] Makiminato Cent Hosp, Cardiac Electrophysiol & Pacing Lab, Div Cardiovasc Med, Urasoe, Okinawa, Japan; [Chung, Fa-Po; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jonan; Lin, Yenn-Jiang; Chen, Shih-Ann] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Lo, Men-Tzung; Lin, Chen; Chang, Yi-Chung] Natl Cent Univ, Res Ctr Adapt Data Anal, Jhongli, Taiwan; [Lo, Men-Tzung; Lin, Chen; Chang, Yi-Chung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Jhongli, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; National Central University	Lin, YJ (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.; Lin, YJ (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.	linyennjiang@gmail.com	huang, yuting/T-4341-2019; Hu, Yu-Feng/V-1401-2019; Wang, Pa-Chun/AAD-4094-2019	Hu, Yu-Feng/0000-0001-5715-2070; Te, Abigail Louise/0000-0002-7461-2793; Chang, Shu-chuan/0000-0002-7087-0744; HIGA, SATOSHI/0000-0002-5735-6249; Lin, Chin-Yu/0000-0003-3282-7523; Lin, Chen/0000-0001-6261-8509; Hung, Yuan/0000-0002-2199-8338	Ministry of Science and Technology of Taiwan [MOST 104-2314-B-010-063-MY2]; Grant of Taipei Veterans General Hospital [V105C-122]; Joint foundation of Taipei Veterans General Hospital; National Taiwan University Hospital [105AC-D710, VGHUST105-G7-4-1]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Grant of Taipei Veterans General Hospital(Taipei Veterans General Hospital); Joint foundation of Taipei Veterans General Hospital; National Taiwan University Hospital(National Taiwan University)	This work was supported by Ministry of Science and Technology of Taiwan support for National Yang-Ming University (MOST 104-2314-B-010-063-MY2); Grant of Taipei Veterans General Hospital (V105C-122); Joint foundation of Taipei Veterans General Hospital and National Taiwan University Hospital (105AC-D710, VGHUST105-G7-4-1).	Azegami K, 2005, J CARDIOVASC ELECTR, V16, P823, DOI 10.1111/j.1540-8167.2005.50041.x; Bogun F, 2006, J AM COLL CARDIOL, V47, P2013, DOI 10.1016/j.jacc.2005.12.062; BUXTON AE, 1983, CIRCULATION, V68, P917, DOI 10.1161/01.CIR.68.5.917; Campos B, 2015, HEART RHYTHM, V12, P95, DOI 10.1016/j.hrthm.2014.10.002; Chung FP, 2015, J CARDIOL, V65, P441, DOI 10.1016/j.jjcc.2014.12.023; Chung FP, 2014, HEART RHYTHM, V11, P1760, DOI 10.1016/j.hrthm.2014.06.011; Corrado D, 2008, J AM COLL CARDIOL, V51, P731, DOI 10.1016/j.jacc.2007.11.027; Deneke T, 2005, Z KARDIOL, V94, P453, DOI 10.1007/s00392-005-0240-3; Do VBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140167; Fisher WG, 1997, PACE, V20, P2188, DOI 10.1111/j.1540-8159.1997.tb04235.x; Flemming MA, 1999, AM J CARDIOL, V84, P1266, DOI 10.1016/S0002-9149(99)00546-9; Friedman PA, 2002, J AM COLL CARDIOL, V39, P1808, DOI 10.1016/S0735-1097(02)01864-8; Furushima H, 2012, J INTERV CARD ELECTR, V33, P135, DOI 10.1007/s10840-011-9623-8; Higa S, 2004, CIRCULATION, V109, P84, DOI 10.1161/01.CIR.0000109481.73788.2E; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216; Kuteszko R, 2015, EUROPACE, V17, P1428, DOI 10.1093/europace/euu392; Lee SH, 2002, PACE, V25, P1346, DOI 10.1046/j.1460-9592.2002.01346.x; LERMAN BB, 1995, CIRCULATION, V92, P421, DOI 10.1161/01.CIR.92.3.421; Lin Chin-Yu, 2016, JACC Clin Electrophysiol, V2, P459, DOI 10.1016/j.jacep.2016.01.013; Lin CY, 2016, HEART RHYTHM, V13, P111, DOI 10.1016/j.hrthm.2015.08.030; LIN JL, 1991, CIRCULATION, V84, P1319, DOI 10.1161/01.CIR.84.3.1319; Lu YY, 2014, J CELL MOL MED, V18, P1540, DOI 10.1111/jcmm.12329; Man KC, 1997, J CARDIOVASC ELECTR, V8, P974, DOI 10.1111/j.1540-8167.1997.tb00619.x; MORET L, 1993, REV EPIDEMIOL SANTE, V41, P179; O'Donnell D, 2003, EUR HEART J, V24, P801, DOI 10.1016/S0195-668X(02)00654-1; Pachon JC, 2004, EUROPACE, V6, P590, DOI 10.1016/j.eupc.2004.08.005; Sacher F, 2015, J CARDIOVASC ELECTR, V26, P464, DOI 10.1111/jce.12565; Sorgente A, 2016, HEART RHYTHM, V13, P519, DOI 10.1016/j.hrthm.2015.11.005; Tsai CF, 1997, INT J CARDIOL, V62, P143, DOI 10.1016/S0167-5273(97)00198-8	30	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173189	10.1371/journal.pone.0173189	http://dx.doi.org/10.1371/journal.pone.0173189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282453	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800018
J	Dale, AG; Frank, SD				Dale, Adam G.; Frank, Steven D.			Warming and drought combine to increase pest insect fitness on urban trees	PLOS ONE			English	Article							CLIMATE-CHANGE; GLOBAL CHANGE; TEMPERATURE; ECOLOGY; SCALE; CONSEQUENCES; HOMOPTERA; HERBIVORY; NITROGEN; PLANTS	Urban habitats are characterized by impervious surfaces, which increase temperatures and reduce water availability to plants. The effects of these conditions on herbivorous insects are not well understood, but may provide insight into future conditions. Three primary hypotheses have been proposed to explain why multiple herbivorous arthropods are more abundant and damaging in cities, and support has been found for each. First, less complex vegetation may reduce biological control of pests. Second, plant stress can increase plant quality for pests. And third, urban warming can directly increase pest fitness and abundance. These hypotheses are not mutually exclusive, and the effects of temperature and plant stress are particularly related. Thus, we test the hypothesis that urban warming and drought stress combine to increase the fitness and abundance of the scale insect, Melanaspis tenebricosa, an urban tree pest that is more abundant in urban than rural areas of the southeastern U.S. We did this by manipulating drought stress across an existing mosaic of urban warming. We found support for the additive effect of temperature and drought stress such that female embryo production and body size increased with temperature and was greater on drought stressed than watered trees. This study provides further evidence that drivers of pest insect outbreaks act in concert, rather than independently, and calls for more research that manipulates multiple abiotic factors related to urbanization and climate change to predict their effects on ecological interactions. As cities expand and the climate changes, warmer temperatures and drought conditions may become more widespread in the native range of this pest. These changes have direct physiological benefits for M. tenebricosa, and potentially other pests, that may increase their fitness and abundance in urban and natural forests.	[Dale, Adam G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Frank, Steven D.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA	State University System of Florida; University of Florida; University of North Carolina; North Carolina State University	Dale, AG (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	agdale@ufl.edu			United States Geological Survey [G11AC20471, G13AC00405, G15AP00153]; Southeast Climate Science Center; National Institute of Food and Agriculture, U.S. Department of Agriculture [2013-02476]	United States Geological Survey(United States Geological Survey); Southeast Climate Science Center; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Raleigh Parks, Recreation, and Cultural Resources provided tree maps and approved this study. The project described in this publication was supported by Cooperative Agreement no. G11AC20471, G13AC00405, and G15AP00153 from the United States Geological Survey. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the Southeast Climate Science Center or the USGS. This manuscript is submitted for publication with the understanding that the United States Government is authorized to reproduce and distribute reprints for governmental purposes. Funding for this work was also provided by a Southeast Climate Science Center graduate fellowship awarded to Adam Dale. This research was also supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2013-02476 to SDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, ROCK MOUNT RES STAT; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BEARDSLEY JW, 1975, ANNU REV ENTOMOL, V20, P47, DOI 10.1146/annurev.en.20.010175.000403; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; CHRISTENSEN NL, 1977, AM MIDL NAT, V97, P176, DOI 10.2307/2424693; Climate Office NC, 2016, N CAR 1971 2000 CLIM; Cregg B. M., 2001, Journal of Arboriculture, V27, P8; Dale Adam G., 2016, Arboriculture & Urban Forestry, V42, P181; Dale AG, 2014, ECOL APPL, V24, P1596, DOI 10.1890/13-1961.1; Dale AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102996; Dale AG, 2015, EFFECTS URBAN WARMIN; Donovan GH, 2013, AM J PREV MED, V44, P139, DOI 10.1016/j.amepre.2012.09.066; Frank SD, 2013, J INTEGR PEST MANAG, V4, DOI 10.1603/IPM12007; George K, 2007, ATMOS ENVIRON, V41, P7654, DOI 10.1016/j.atmosenv.2007.08.018; Graves William R., 1994, Journal of Arboriculture, V20, P24; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2015, FUNCT ECOL, V29, P863, DOI 10.1111/1365-2435.12488; Herms DA, 2002, ENVIRON ENTOMOL, V31, P923, DOI 10.1603/0046-225X-31.6.923; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Jochner S, 2013, TREE PHYSIOL, V33, P1256, DOI 10.1093/treephys/tpt079; Johnson DM, 2011, TREE PHYSIOL, V31, P659, DOI 10.1093/treephys/tpr050; KIM HH, 1992, INT J REMOTE SENS, V13, P2319, DOI 10.1080/01431169208904271; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Koricheva J, 1998, ANN REV ENTOMOLOGY, V1998; Kozlov MV, 2015, GLOBAL CHANGE BIOL, V21, P106, DOI 10.1111/gcb.12682; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; MCCLURE MS, 1980, ECOLOGY, V61, P72, DOI 10.2307/1937157; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meineke E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1574; Meineke EK, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0586; Meineke EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059687; Metcalf ZP, 1922, NC AGR EXPT STATION, V21, P1; METCALF ZP, 1912, J E MITCHELL SCI SOC, V28, P88; Mullaney J, 2015, LANDSCAPE URBAN PLAN, V134, P157, DOI 10.1016/j.landurbplan.2014.10.013; Nowak DJ, 2013, ENVIRON POLLUT, V178, P229, DOI 10.1016/j.envpol.2013.03.019; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; OKE TR, 1989, PHILOS T ROY SOC B, V324, P335, DOI 10.1098/rstb.1989.0051; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Raupp Michael J., 2006, Arboriculture & Urban Forestry, V32, P297; Robinet C, 2012, BIOL INVASIONS, V14, P1557, DOI 10.1007/s10530-011-9979-9; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; SCHAFFER B, 1990, OECOLOGIA, V84, P468, DOI 10.1007/BF00328162; Scherber C, 2013, ECOL EVOL, V3, P1449, DOI 10.1002/ece3.564; Shrewsbury PM, 2000, ENVIRON ENTOMOL, V29, P919, DOI 10.1603/0046-225X-29.5.919; Speight MR, 1998, ECOLOGY, V79, P1503, DOI 10.1890/0012-9658(1998)079[1503:HCSPRH]2.0.CO;2; Sperry Chad E., 2001, Journal of Arboriculture, V27, P263; Tooker JF, 2000, ENVIRON ENTOMOL, V29, P1305, DOI 10.1603/0046-225X-29.6.1305; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Yasuda S., 1983, J SERICULTURAL SCI J, V52, P106; Youngsteadt E, 2015, GLOBAL CHANGE BIOL, V21, P97, DOI 10.1111/gcb.12692; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	59	74	78	6	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173844	10.1371/journal.pone.0173844	http://dx.doi.org/10.1371/journal.pone.0173844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278206	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900039
J	Sawadogo, SP; Niang, A; Bilgo, E; Millogo, A; Maiga, H; Dabire, RK; Tripet, F; Diabate, A				Sawadogo, Simon Peguedwinde; Niang, Abdoulaye; Bilgo, Etienne; Millogo, Azize; Maiga, Hamidou; Dabire, Roch K.; Tripet, Frederic; Diabate, Abdoulaye			Targeting male mosquito swarms to control malaria vector density	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; MATING-BEHAVIOR; INSECTICIDE RESISTANCE; BURKINA-FASO; AREA; SYMPATRY; COLUZZII; SUCCESS	Malaria control programs are being jeopardized by the spread of insecticide resistance in mosquito vector populations. It has been estimated that the spread of resistance could lead to an additional 120000 deaths per year, and interfere with the prospects for sustained control or the feasibility of achieving malaria elimination. Another complication for the development of resistance management strategies is that, in addition to insecticide resistance, mosquito behavior evolves in a manner that diminishes the impact of LLINs and IRS. Mosquitoes may circumvent LLIN and IRS control through preferential feeding and resting outside human houses and/or being active earlier in the evening before people go to sleep. Recent developments in our understanding of mosquito swarming suggest that new tools targeting mosquito swarms can be designed to cut down the high reproductive rate of malaria vectors. Targeting swarms of major malaria vectors may provide an effective control method to counteract behavioral resistance developed by mosquitoes. Here, we evaluated the impact of systematic spraying of swarms of Anopheles gambiae s.l. using a mixed carbamate and pyrethroid aerosol. The impact of this intervention on vector density, female insemination rates and the age structure of males was measured. We showed that the resulting mass killing of swarming males and some mate-seeking females resulted in a dramatic 80% decrease in population size compared to a control population. A significant decrease in female insemination rate and a significant shift in the age structure of the male population towards younger males incapable of mating were observed. This paradigm-shift study therefore demonstrates that targeting primarily males rather than females, can have a drastic impact on mosquito population.	[Sawadogo, Simon Peguedwinde; Niang, Abdoulaye; Bilgo, Etienne; Maiga, Hamidou; Dabire, Roch K.; Diabate, Abdoulaye] IRSS, Dept Med Biol & Publ Hlth, Bobo Dioulasso, Burkina Faso; [Millogo, Azize] Inst Sci Soc INSS, Deparment Populat Sci, Ouagadougou, Burkina Faso; [Tripet, Frederic] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele, Staffs, England	Keele University	Sawadogo, SP (corresponding author), IRSS, Dept Med Biol & Publ Hlth, Bobo Dioulasso, Burkina Faso.	sawsimp2005@yahoo.fr	MILLOGO, Abdoul Azize/CAI-1274-2022; MAIGA, Hamidou/AAR-3023-2020; Dabire, Roch Kounbobr/ABF-3525-2020; Tripet, Frederic/M-6693-2015	MILLOGO, Abdoul Azize/0000-0003-3301-9149; MAIGA, Hamidou/0000-0001-8662-4700; Sawadogo, Simon Peguedwinde/0000-0002-9414-4659; Niang, Abdoulaye/0000-0003-3196-3064; Tripet, Frederic/0000-0002-7939-0712; DIABATE, Abdoulaye/0000-0002-9666-9395	Medical Research Concil/DFID; UK Medical Research Council (MRC); Department for International Development (DFID) under the MRC/DFID Concordat agreement [G1001336/1, 97014]; Medical Research Council [G1001336] Funding Source: researchfish; MRC [G1001336] Funding Source: UKRI	Medical Research Concil/DFID; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This Study was suppoorted by the Medical Research Concil/DFID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the populations of the study sites for their sincere cooperation during mosquito sampling. This work was funded by the UK Medical Research Council (MRC) and Department for International Development (DFID) under the MRC/DFID Concordat agreement (Grant Reference No: G1001336/1, Grant ID: 97014 to Abdoulaye Diabate and Frederic Trip et).	[Anonymous], GLOBAL STRATEGIC PLA; Assogba BS, 2014, ACTA TROP, V132, pS53, DOI 10.1016/j.actatropica.2013.09.006; Wilke ABB, 2012, REV INST MED TROP SP, V54, P287, DOI 10.1590/S0036-46652012000500009; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; CHARLWOOD JD, 1979, PHYSIOL ENTOMOL, V4, P111, DOI 10.1111/j.1365-3032.1979.tb00185.x; Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x; CHARLWOOD JD, 1980, PHYSIOL ENTOMOL, V5, P315, DOI 10.1111/j.1365-3032.1980.tb00241.x; Dabire KR, 2014, ACTA TROP, V132, pS35, DOI 10.1016/j.actatropica.2013.12.012; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8; Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; MARCHAND RP, 1984, NETH J ZOOL, V34, P367, DOI 10.1163/002829684X00209; Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Oliva CF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-135; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Sawadogo PS, 2014, ACTA TROP, V132, pS42, DOI 10.1016/j.actatropica.2013.12.011; Shutt B, 2010, MED VET ENTOMOL, V24, P91, DOI 10.1111/j.1365-2915.2009.00849.x; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Health Organization, 2015, WORLD MAL REP 2015	29	27	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173273	10.1371/journal.pone.0173273	http://dx.doi.org/10.1371/journal.pone.0173273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278212	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000396087900064
J	Li, B; Xu, WW; Han, L; Chan, KT; Tsao, SW; Lee, NPY; Law, S; Xu, LY; Li, EM; Chan, KW; Qin, YR; Guan, XY; He, QY; Cheung, ALM				Li, B.; Xu, W. W.; Han, L.; Chan, K. T.; Tsao, S. W.; Lee, N. P. Y.; Law, S.; Xu, L. Y.; Li, E. M.; Chan, K. W.; Qin, Y. R.; Guan, X. Y.; He, Q. Y.; Cheung, A. L. M.			MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; FACTOR EXPRESSION; PROGNOSTIC VALUE; ANGIOGENESIS; ACTIVATION; CHEMORESISTANCE; METASTASIS; ADENOVIRUS; CARCINOMA	Esophageal cancer is one of the most lethal cancers worldwide with poor survival and limited therapeutic options. The discovery of microRNAs created a new milestone in cancer research. miR-377 is located in chromosome region 14q32, which is frequently deleted in esophageal squamous cell carcinoma (ESCC), but the biological functions, clinical significance and therapeutic implication of miR-377 in ESCC are largely unknown. In this study, we found that miR-377 expression was significantly downregulated in tumor tissue and serum of patients with ESCC. Both tumor tissue and serum miR-377 expression levels were positively correlated with patient survival. Higher serum miR-377 expression was inversely associated with pathologic tumor stage, distant metastasis, residual tumor status and chemoradiotherapy resistance. The roles of miR-377 in suppressing tumor initiation and progression, and the underlying molecular mechanisms were investigated. Results of in vitro and in vivo experiments showed that miR-377 overexpression inhibited the initiation, growth and angiogenesis of ESCC tumors as well as metastatic colonization of ESCC cells, whereas silencing of miR-377 had opposite effects. Mechanistically, miR-377 regulated CD133 and VEGF by directly binding to their 3' untranslated region. Moreover, systemic delivery of formulated miR-377 mimic not only suppressed tumor growth in nude mice but also blocked tumor angiogenesis and metastasis of ESCC cells to the lungs without overt toxicity to mice. Collectively, our study established that miR-377 plays a functional and significant role in suppressing tumor initiation and progression, and may represent a promising non-invasive diagnostic and prognostic biomarker and therapeutic strategy for patients with ESCC.	[Li, B.; Xu, W. W.; Han, L.; Tsao, S. W.; Cheung, A. L. M.] Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Li, B.; Xu, W. W.; Han, L.; Cheung, A. L. M.] Univ Hong Kong, Shenzhen Inst Res & Innovat HKU SIRI, Shenzhen, Peoples R China; [Li, B.; Tsao, S. W.; Lee, N. P. Y.; Law, S.; Chan, K. W.; Guan, X. Y.; Cheung, A. L. M.] Univ Hong Kong, Ctr Canc Res, Pokfulam, Peoples R China; [Chan, K. T.; Lee, N. P. Y.; Law, S.] Univ Hong Kong, Dept Surg, Pokfulam, Peoples R China; [Xu, L. Y.; Li, E. M.] Shantou Univ Med Coll, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou, Peoples R China; [Chan, K. W.] Univ Hong Kong, Dept Pathol, Pokfulam, Peoples R China; [Qin, Y. R.] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou, Peoples R China; [Guan, X. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Pokfulam, Peoples R China; [He, Q. Y.] Jinan Univ, Coll Life Sci & Technol, 601 West Huangpu Blvd, Guangzhou, Guangdong, Peoples R China; [Li, B.] Jinan Univ, Coll Life Sci & Technol, 601 West Huangpu Blvd, Guangzhou 510632, Guangdong, Peoples R China; [Xu, W. W.] Jinan Univ, Inst Tumor Pharmacol, Coll Pharm, 601 West Huangpu Blvd, Guangzhou 510632, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Zhengzhou University; University of Hong Kong; Jinan University; Jinan University; Jinan University	Cheung, ALM (corresponding author), Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	lmcheung@hku.hk	He, Qing-Yu/H-7078-2014; Law, Simon/C-4324-2009; /C-4230-2009; /A-3639-2009	He, Qing-Yu/0000-0003-0503-9492; Law, Simon/0000-0002-6518-5806; /0000-0003-3217-1456; /0000-0003-1874-9805	Research Grants Council of the Hong Kong SAR, China [HKU 763111M, HKU 17103814]; CRCG [201111159198, 201211159003]; National Natural Science Foundation of China [81472790]; University of Hong Kong SRT Cancer research program	Research Grants Council of the Hong Kong SAR, China(Hong Kong Research Grants Council); CRCG; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong SRT Cancer research program	We thank Professor Yutaka Shimada (University of Toyama, Toyama, Japan) and DSMZ for the KYSE cell lines; Prof G Srivastava, Department of Pathology, University of Hong Kong for the HKESC-1 cell line; Dr Hitoshi Kawamata (Dokkyo University School of Medicine, Tochigi, Japan) for the T.Tn cell line; and Mr. Yiwei Xu (Shantou University Medical College, Shantou, Guangdong, China) for collection of patient serum. We also thank Prof Quan Chen (Institute of Zoology, Chinese Academy of Sciences, Beijing, China) for CD133-knockdown and control plasmids as well as virus packaging plasmids, Prof Gregory M. Vercellotti (University of Minnesota Medical School, Minneapolis, MN) for miR-377-expressing constructs, and Dr Anna CM Tsang (School of Biomedical Sciences, University of Hong Kong) for help in flow cytometry. Flow cytometry and cell sorting were performed and analyzed using equipment maintained by the University of Hong Kong Li Ka Shing Faculty of Medicine Faculty Core Facility. This work recieves Grant Support from Research Grants Council of the Hong Kong SAR, China (GRF Project Nos. HKU 763111M and HKU 17103814); The University of Hong Kong SRT Cancer research program and CRCG (Project Nos. 201111159198, 201211159003); National Natural Science Foundation of China (Project No. 81472790). The study sponsors are not involved in study design, or collection, analysis, interpretation of data.	Anson Donald S, 2004, Genet Vaccines Ther, V2, P9, DOI 10.1186/1479-0556-2-9; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Ceppi P, 2014, ONCOGENE, V33, P269, DOI 10.1038/onc.2013.55; Chen ML, 2012, CANCER EPIDEM BIOMAR, V21, P1126, DOI 10.1158/1055-9965.EPI-12-0020; Chen YC, 2015, ADV DRUG DELIVER REV, V81, P128, DOI 10.1016/j.addr.2014.05.009; Cheung A., 2015, GASTROINTEST CANC TA, V5, P79; Dong L, 2010, NEUROSCI LETT, V484, P210, DOI 10.1016/j.neulet.2010.08.057; Ebert G, 2011, GASTROENTEROLOGY, V141, P696, DOI 10.1053/j.gastro.2011.05.001; El-Khattouti A, 2015, CANCER LETT, V357, P83, DOI 10.1016/j.canlet.2014.10.043; Fang YX, 2014, ONCOGENE, V33, P135, DOI 10.1038/onc.2013.54; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hang D, 2012, DIS ESOPHAGUS, V25, P638, DOI 10.1111/j.1442-2050.2011.01298.x; Hu YC, 2000, CANCER GENET CYTOGEN, V118, P112, DOI 10.1016/S0165-4608(99)00193-4; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Ihara Y, 2002, CANCER GENET CYTOGEN, V135, P177, DOI 10.1016/S0165-4608(01)00654-9; Jooss K, 2003, GENE THER, V10, P955, DOI 10.1038/sj.gt.3302037; Kawamata H, 2003, CANCER SCI, V94, P699, DOI 10.1111/j.1349-7006.2003.tb01505.x; Kohlhapp FJ, 2015, ONCOGENE, V34, P5857, DOI 10.1038/onc.2015.89; Li B, 2007, CARCINOGENESIS, V28, P2313, DOI 10.1093/carcin/bgm152; Li B, 2014, CLIN CANCER RES, V20, P2651, DOI 10.1158/1078-0432.CCR-13-2735; Li B, 2009, MOL CANCER THER, V8, P2635, DOI 10.1158/1535-7163.MCT-09-0162; Lu CL, 2015, J THORAC CARDIOV SUR, V150, P386, DOI 10.1016/j.jtcvs.2015.05.030; Lu J, 2017, ONCOGENE, V36, P231, DOI 10.1038/onc.2016.194; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nakajima TE, 2012, CANCER SCI, V103, P233, DOI 10.1111/j.1349-7006.2011.02142.x; Okamoto K, 2016, ONCOL REP, V36, P3333, DOI 10.3892/or.2016.5133; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Peng J, 2013, J BUON, V18, P398; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Song JH, 2012, GASTROENTEROLOGY, V143, P35, DOI 10.1053/j.gastro.2012.05.003; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun X, 2014, ONCOGENE, V33, P4967, DOI [10.1038/onc.2013.492, 10.1038/onc.2014.224]; Tang KH, 2013, CANCER RES, V73, P2322, DOI 10.1158/0008-5472.CAN-12-2991; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; Tong DKH, 2010, ANN SURG ONCOL, V17, P2184, DOI 10.1245/s10434-010-0995-2; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Uchino K, 2013, JPN J CLIN ONCOL, V43, P596, DOI 10.1093/jjco/hyt052; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Won C, 2015, HEPATOLOGY, V62, P1160, DOI 10.1002/hep.27968; Xu WW, 2015, ONCOTARGET, V6, P1790, DOI 10.18632/oncotarget.2781; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zhao JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021419	54	109	115	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 13	2017	36	28					3986	4000		10.1038/onc.2017.29	http://dx.doi.org/10.1038/onc.2017.29			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FA3YD	28288140	Green Published, hybrid			2022-12-26	WOS:000405379900005
J	Neverisky, DL; Abbott, GW				Neverisky, Daniel L.; Abbott, Geoffrey W.			KCNQ-SMIT complex formation facilitates ion channel-solute transporter cross talk	FASEB JOURNAL			English	Article						myo-inositol; PIP2; sciatic nerve; SMIT1; SMIT2	I-KS; K+ CHANNEL; PIP2; FORM; IDENTIFICATION; DISRUPTION; ACTIVATION; K(V)LQT1; PROTEINS	Voltage-gated potassium channels formed by KCNQ2 and KCNQ3 are essential for normal neuronal excitability. KCNQ2/3 channel activity is augmented in vivo by phosphatidylinositol 4,5-bisphosphate (PIP2), which is generated from myo-inositol, an osmolyte transported into cells by sodium-dependent myo-inositol transporters (SMITs). Here, we discovered that KCNQ2/3 channels isoform-specifically colocalize with SMIT1 and SMIT2 at sciatic nerve nodes of Ranvier and in axon initial segments, and form channel transporter complexes in vitro and in vivo. KCNQ2/3 coexpression protected SMIT1 activity from the otherwise inhibitory effects of cellular depolarization imposed by elevating extracellular [K+], and KCNQ2 was required for potentiation of SMIT activity by myo-inositol preincubation. Cytoskeletal disruption, which speeds PIP2 dispersion, attenuated potentiation of KCNQ2/3 currents by SMIT1-mediated myo-inositol uptake, suggesting close channel transporter juxtaposition ensures KCNQ2/3 exposure to locally high myo-inositol-derived PIP2 concentrations. Thus, KCNQ2/3-SMIT1/2 coassembly permits cross talk via physical interaction, and may also be required for optimal, reciprocal indirect regulation via membrane potential and PIP2, especially within the specialized architecture of axons. Neverisky, D. L., Abbott, G. W. KCNQ-SMIT complex formation facilitates ion channel-solute transporter cross talk.	[Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Room 360,Med Surge 2, Irvine, CA 92697 USA; Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Room 360,Med Surge 2, Irvine, CA 92697 USA.	abbottg@uci.edu		Neverisky, Dan/0000-0002-5459-1032	U.S. National Institutes of Health, National Institute of General Medical Sciences [GM115189]; American Heart Association [14PRE20040013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115189] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge the generous gifts of GFP-tagged wild-type KCNQ2 cDNA from N. Hoshi (University of California, Irvine), SMIT2 cDNA from M. Coady (GEPROM, Universite de Montreal, Montreal, QC, Canada), and Slc5a3<SUP>-/-</SUP> mice from G. Berry (Harvard Medical School, Boston, MA, USA). This work was funded by the U.S. National Institutes of Health, National Institute of General Medical Sciences (GM115189 to G.W.A.) and American Heart Association (Predoctoral Fellowship 14PRE20040013 to D.L.N.).	Abbott GW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005025; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BERRY GT, 1995, GENOMICS, V25, P507, DOI 10.1016/0888-7543(95)80052-N; Berry GT, 2003, J BIOL CHEM, V278, P18297, DOI 10.1074/jbc.M213176200; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Dai GC, 2016, P NATL ACAD SCI USA, V113, pE3290, DOI 10.1073/pnas.1606348113; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Kim KS, 2016, BIOPHYS J, V110, P1089, DOI 10.1016/j.bpj.2016.01.006; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Mistry AC, 2016, BIOCHEM J, V473, P3237, DOI 10.1042/BCJ20160312; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Park JY, 2016, CURR BIOL, V26, P1965, DOI 10.1016/j.cub.2016.05.076; Purtell K, 2012, FASEB J, V26, P3252, DOI 10.1096/fj.12-206110; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Shcheynikov Nikolay, 2006, Novartis Found Symp, V273, P177; Singh H, 2016, NEUROSCIENCE, V317, P76, DOI 10.1016/j.neuroscience.2015.12.058; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang QS, 2013, P NATL ACAD SCI USA, V110, P20093, DOI 10.1073/pnas.1312483110	32	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2828	2838		10.1096/fj.201601334R	http://dx.doi.org/10.1096/fj.201601334R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28283543	Green Submitted, Green Published			2022-12-26	WOS:000405931000010
J	Hutchings, ML; Alpha-Cobb, CJ; Hiller, DA; Berro, J; Strobel, SA				Hutchings, Michelle L.; Alpha-Cobb, Cambria J.; Hiller, David A.; Berro, Julien; Strobel, Scott A.			Mycofumigation through production of the volatile DNA-methylating agent N-methyl-N-nitrosoisobutyramide by fungi in the genus Muscodor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; DNA methylation; fungi; gas chromatography-mass spectrometry (GC-MS); mycotoxin; toxicity; N-nitroso compounds; endophyte; mycofumigation; volatile organic compounds	ANTIBIOTIC-PRODUCING FUNGUS; DOUBLE-STRANDED DNA; ESCHERICHIA-COLI; ENDOPHYTIC FUNGUS; ORGANIC-COMPOUNDS; SECONDARY METABOLITES; NORTHEASTERN HIMALAYAS; ADAPTIVE RESPONSE; ALBUS; DAMAGE	Antagonistic microorganisms produce antimicrobials to inhibit the growth of competitors. Although water-soluble antimicrobials are limited to proximal interactions via aqueous diffusion, volatile antimicrobials are able to act at a distance and diffuse through heterogeneous environments. Here, we identify the mechanism of action of Muscodor albus, an endophytic fungus known for its volatile antimicrobial activity toward a wide range of human and plant pathogens and its potential use in mycofumigation. Proposed uses of the Muscodor species include protecting crops, produce, and building materials from undesired fungal or bacterial growth. By analyzing a collection of Muscodor isolates with varying toxicity, we demonstrate that the volatile mycotoxin, N-methyl-N-nitrosoisobutyramide, is the dominant factor in Muscodor toxicity and acts primarily through DNA methylation. Additionally, Muscodor isolates exhibit higher resistance to DNA methylation compared with other fungi. This work contributes to the evaluation of Muscodor isolates as potential mycofumigants, provides insight into chemical strategies that organisms use to manipulate their environment, and provokes questions regarding the mechanisms of resistance used to tolerate constitutive, long-term exposure to DNA methylation.	[Hutchings, Michelle L.] Yale Univ, Inst Chem Biol, Dept Chem, West Haven, CT 06516 USA; [Alpha-Cobb, Cambria J.; Hiller, David A.; Strobel, Scott A.] Yale Univ, Inst Chem Biol, Dept Mol Biophys & Biochem, 600 West Campus Dr,Mol Innovat Ctr Rm 214A, West Haven, CT 06516 USA; [Berro, Julien] Yale Univ, Nanobiol Inst, Dept Mol Biophys & Biochem, West Haven, CT 06516 USA	Yale University; Yale University; Yale University	Strobel, SA (corresponding author), Yale Univ, Inst Chem Biol, Dept Mol Biophys & Biochem, 600 West Campus Dr,Mol Innovat Ctr Rm 214A, West Haven, CT 06516 USA.	scott.strobel@yale.edu		Berro, Julien/0000-0002-9560-8646	Office of Assistant Secretary of Defense for Research and Engineering; National Security Science and Engineering Faculty Fellowship [N0024-09-1-0070]; Environmental Protection Agency Science to Achieve Results Graduate Fellowship [FP91761001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	Office of Assistant Secretary of Defense for Research and Engineering; National Security Science and Engineering Faculty Fellowship; Environmental Protection Agency Science to Achieve Results Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of Assistant Secretary of Defense for Research and Engineering, National Security Science and Engineering Faculty Fellowship Grant N0024-09-1-0070 (to S. A. S.) and Environmental Protection Agency Science to Achieve Results Graduate Fellowship FP91761001 (to M. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alpha CJ, 2015, APPL ENVIRON MICROB, V81, P1147, DOI 10.1128/AEM.03294-14; Atmosukarto I, 2005, PLANT SCI, V169, P854, DOI 10.1016/j.plantsci.2005.06.002; Banerjee D., 2010, Mycology - An International Journal on Fungal Biology, V1, P179, DOI 10.1080/21501203.2010.506204; Banerjee D, 2014, INDIAN J MICROBIOL, V54, P27, DOI 10.1007/s12088-013-0400-5; Bascom-Slack CA, 2012, SCIENCE, V338, P485, DOI 10.1126/science.1215227; Belenky P, 2013, CELL REP, V3, P350, DOI 10.1016/j.celrep.2012.12.021; Bolzan AD, 2002, MUTAT RES-REV MUTAT, V512, P121, DOI 10.1016/S1383-5742(02)00044-3; Chen JY, 2008, NUCLEIC ACIDS RES, V36, P3781, DOI 10.1093/nar/gkn302; Corcuff R, 2011, FUNGAL BIOL-UK, V115, P220, DOI 10.1016/j.funbio.2010.12.005; Cotsonas King A., 2009, CURR PROTOC PHARM; Daisy BH, 2002, MICROBIOL-SGM, V148, P3737, DOI 10.1099/00221287-148-11-3737; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; DENNIS C, 1971, T BRIT MYCOL SOC, V57, P41, DOI 10.1016/S0007-1536(71)80078-5; DOLAN ME, 1988, CARCINOGENESIS, V9, P2139, DOI 10.1093/carcin/9.11.2139; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5; Elsner M, 2000, DIABETOLOGIA, V43, P1528, DOI 10.1007/s001250051564; Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0; Fernando WGD, 2005, SOIL BIOL BIOCHEM, V37, P955, DOI 10.1016/j.soilbio.2004.10.021; Fialho MB, 2010, WORLD J MICROB BIOT, V26, P925, DOI 10.1007/s11274-009-0255-4; Goates BJ, 2011, EUR J PLANT PATHOL, V131, P403, DOI 10.1007/s10658-011-9817-z; Gonzalez MC, 2009, MYCOTAXON, V110, P363, DOI 10.5248/110.363; Grzesiuk E, 2001, MUTAT RES-FUND MOL M, V480, P77, DOI 10.1016/S0027-5107(01)00171-3; Hebels DGAJ, 2010, TOXICOL SCI, V116, P194, DOI 10.1093/toxsci/kfq121; Hollis T, 2000, MUTAT RES-DNA REPAIR, V460, P201, DOI 10.1016/S0921-8777(00)00027-6; Humphris SN, 2002, FEMS MICROBIOL LETT, V210, P215, DOI 10.1016/S0378-1097(02)00604-3; Hung R, 2015, APPL MICROBIOL BIOT, V99, P3395, DOI 10.1007/s00253-015-6494-4; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Jiang DY, 1997, J BACTERIOL, V179, P3773, DOI 10.1128/jb.179.11.3773-3782.1997; Jimenez J. I., 2012, US Patent, Patent No. 20120058058; Karran P., 1988, NUCL ACIDS MOL BIOL, P188; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; Krajaejun T, 2012, SE ASIAN J TROP MED, V43, P1474; Kudalkar P, 2012, MYCOSCIENCE, V53, P319, DOI 10.1007/s10267-011-0165-9; Lacey LA, 2009, J ECON ENTOMOL, V102, P43, DOI 10.1603/029.102.0107; Lijinsky W., 1992, CHEM BIOL N NITROSO; Masoud W, 2005, YEAST, V22, P1133, DOI 10.1002/yea.1304; Mercier J, 2005, BIOL CONTROL, V32, P401, DOI 10.1016/j.biocontrol.2004.12.002; Mercier J, 2007, CAN J MICROBIOL, V53, P404, DOI 10.1139/W06-124; Mercier J, 2009, BIOCONTROL, V54, P797, DOI 10.1007/s10526-009-9223-z; Meshram V, 2014, MYCOTAXON, V128, P93, DOI 10.5248/128.93; Meshram Vineet, 2013, Mycology, V4, P196, DOI 10.1080/21501203.2013.877990; Mitchell AM, 2008, FUNGAL DIVERS, V31, P37; Mitchell AM, 2010, MICROBIOL-SGM, V156, P270, DOI 10.1099/mic.0.032540-0; MONTESANO R, 1980, J TOXICOL ENV HEALTH, V6, P1001, DOI 10.1080/15287398009529922; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; O'Hanlon KA, 2012, NUCLEIC ACIDS RES, V40, P7806, DOI 10.1093/nar/gks522; Pletsa V, 1999, CANCER LETT, V135, P21; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Riga E, 2008, BIOL CONTROL, V45, P380, DOI 10.1016/j.biocontrol.2008.01.002; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Saxena S, 2015, ANN MICROBIOL, V65, P47, DOI 10.1007/s13213-014-0834-y; Saxena S, 2014, SYDOWIA, V66, P55; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Shaw JJ, 2015, APPL MICROBIOL BIOT, V99, P3715, DOI 10.1007/s00253-014-6206-5; SINGARAM S, 1979, J ANTIBIOT, V32, P379, DOI 10.7164/antibiotics.32.379; Siri-udom S, 2016, ANN MICROBIOL, V66, P437, DOI 10.1007/s13213-015-1126-x; Smith SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003052; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Strobel G, 2011, PHYTOCHEM REV, V10, P165, DOI 10.1007/s11101-010-9163-3; Strobel GA, 2007, MICROBIOL-SGM, V153, P2613, DOI 10.1099/mic.0.2007/008912-0; Suwannarach N, 2015, BIOL CONTROL, V90, P25, DOI 10.1016/j.biocontrol.2015.05.008; Suwannarach N, 2013, ANN MICROBIOL, V63, P1341, DOI 10.1007/s13213-012-0593-6; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; TAKAHASHI K, 1987, BIOCHEM BIOPH RES CO, V144, P447, DOI 10.1016/S0006-291X(87)80530-2; Tyc O, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00567; United Nations Environment Programme, 2014, ENV EFF OZ DEPL ITS, DOI [10.1002/9780470670590.wbeog931, DOI 10.1002/9780470670590.WBEOG931]; Wheatley RE, 2002, ANTON LEEUW INT J G, V81, P357, DOI 10.1023/A:1020592802234; Wu YP, 2013, ANAL CHEM, V85, P6908, DOI 10.1021/ac401346x; WURDEMAN RL, 1993, NUCLEIC ACIDS RES, V21, P4975, DOI 10.1093/nar/21.21.4975; Yuan J, 2012, APPL ENVIRON MICROB, V78, P5942, DOI 10.1128/AEM.01357-12; Zhang CL, 2010, FUNGAL BIOL-UK, V114, P797, DOI 10.1016/j.funbio.2010.07.006	73	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7358	7371		10.1074/jbc.M117.779009	http://dx.doi.org/10.1074/jbc.M117.779009			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28283571	Green Published, hybrid			2022-12-26	WOS:000400761300008
J	Alvarez-Davila, E; Cayuela, L; Gonzalez-Caro, S; Aldana, AM; Stevenson, PR; Phillips, O; Cogollo, A; Penuela, MC; von Hildebrand, P; Jimenez, E; Melo, O; Londono-Vega, AC; Mendoza, I; Velasquez, O; Fernandez, F; Serna, M; Velazquez-Rua, C; Benitez, D; Rey-Benayas, JAM				Alvarez-Davila, Esteban; Cayuela, Luis; Gonzalez-Caro, Sebastian; Aldana, Ana M.; Stevenson, Pablo R.; Phillips, Oliver; Cogollo, Alvaro; Penuela, Maria C.; von Hildebrand, Patricio; Jimenez, Eliana; Melo, Omar; Londono-Vega, Ana Catalina; Mendoza, Irina; Velasquez, Oswaldo; Fernandez, Fernando; Serna, Marcela; Velazquez-Rua, Cesar; Benitez, Doris; Rey-Benayas, Jose A. M.			Forest biomass density across large climate gradients in northern South America is related to water availability but not with temperature	PLOS ONE			English	Article							ABOVEGROUND LIVE BIOMASS; ELEVATIONAL TRANSECT; CARBON-DENSITY; GROWTH; PRODUCTIVITY; COVARIATION; PATTERNS; STOCKS	Understanding and predicting the likely response of ecosystems to climate change are crucial challenges for ecology and for conservation biology. Nowhere is this challenge greater than in the tropics as these forests store more than half the total atmospheric carbon stock in their biomass. Biomass is determined by the balance between biomass inputs (i.e., growth) and outputs (mortality). We can expect therefore that conditions that favor high growth rates, such as abundant water supply, warmth, and nutrient-rich soils will tend to correlate with high biomass stocks. Our main objective is to describe the patterns of above ground biomass (AGB) stocks across major tropical forests across climatic gradients in Northwestern South America. We gathered data from 200 plots across the region, at elevations ranging between 0 to 3400 m. We estimated AGB based on allometric equations and values for stem density, basal area, and wood density weighted by basal area at the plot level. We used two groups of climatic variables, namely mean annual temperature and actual evapotranspiration as surrogates of environmental energy, and annual precipitation, precipitation seasonality, and water availability as surrogates of water availability. We found that AGB is more closely related to water availability variables than to energy variables. In northwest South America, water availability influences carbon stocks principally by determining stand structure, i.e. basal area. When water deficits increase in tropical forests we can expect negative impact on biomass and hence carbon storage.	[Alvarez-Davila, Esteban; Rey-Benayas, Jose A. M.] Univ Alcala, Dept Ciencias Vida, Alcala De Henares, Spain; [Alvarez-Davila, Esteban; Mendoza, Irina; Velazquez-Rua, Cesar] Fdn Convida, Grp Serv Ecosistem & Cambio Climat, Medellin, Colombia; [Alvarez-Davila, Esteban] Univ Nacl Abierta & Distancia, Escuela Ciencias Agr Pecuarias & Medio Ambiente, Medellin, Colombia; [Cayuela, Luis] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Escuela Super Ciencias Expt & Tecnol, Dept 1, Madrid, Spain; [Gonzalez-Caro, Sebastian; Cogollo, Alvaro; Benitez, Doris] Jardin Bot Medellin, Herbario JAUM, Medellin, Colombia; [Aldana, Ana M.; Stevenson, Pablo R.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Phillips, Oliver] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Penuela, Maria C.] Univ Reg Amazon, Napo, Ecuador; [von Hildebrand, Patricio] Fdn Puerto Rastrojo, Bogota, Colombia; [Jimenez, Eliana] Univ Nacl Colombia, Grp Ecol Ecosistemas Terr Trop, Bogota, Colombia; [Melo, Omar; Fernandez, Fernando] Univ Tolima, Fac Ingn Forestal, Ibague, Colombia; [Velasquez, Oswaldo] Univ Nacl Colombia, Fac Ciencias Agron, Medellin, Colombia; [Serna, Marcela] Inst Univ Tecnol Antioquia, Fac Ingn, Medellin, Colombia	Universidad de Alcala; Universidad Rey Juan Carlos; Universidad de los Andes (Colombia); University of Leeds; Universidad Nacional de Colombia; Universidad del Tolima; Universidad Nacional de Colombia	Alvarez-Davila, E (corresponding author), Univ Alcala, Dept Ciencias Vida, Alcala De Henares, Spain.; Alvarez-Davila, E (corresponding author), Fdn Convida, Grp Serv Ecosistem & Cambio Climat, Medellin, Colombia.; Alvarez-Davila, E (corresponding author), Univ Nacl Abierta & Distancia, Escuela Ciencias Agr Pecuarias & Medio Ambiente, Medellin, Colombia.	esalvarez3000@gmail.com	Phillips, Oliver/A-1523-2011; Gonzalez-Caro, Sebastian/T-3532-2019; Cayuela, Luis/K-7255-2015; Aldana, Ana/AAW-1784-2021; Mendoza, Inés/T-4733-2017; Alvarez-Davila, Esteban/AAP-4231-2020	Phillips, Oliver/0000-0002-8993-6168; Cayuela, Luis/0000-0003-3562-2662; Aldana, Ana/0000-0003-3439-6245; Mendoza, Inés/0000-0002-8266-2598; Alvarez-Davila, Esteban/0000-0001-9032-0099; Serna Gonzalez, Marcela/0000-0001-6729-403X; Penuela Mora, Maria Cristina/0000-0002-9611-1359; Jimenez, Eliana M./0000-0002-8610-1771	Medellin Botanical Garden of Medellin; Leeds University (UK); Gordon and Betty Moore Foundation [1656, 3000]; Natural Environment Research Council (NERC Urgency Grant) [NE/D01025X/1]; European Research Council [291585]; Royal Society [CH160091]; ERC [291585]; Royal Society Wolfson Research Merit Award [WM120076]; "Universidad Nacional Abierta y a Distancia" from Colombia (UNAD); "Fundacion Convida" from Medellin, Colombia; Natural Environment Research Council [NE/B504630/1, NE/B503384/1, NE/I02982X/1] Funding Source: researchfish; NERC [NE/I02982X/1] Funding Source: UKRI	Medellin Botanical Garden of Medellin; Leeds University (UK); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Natural Environment Research Council (NERC Urgency Grant)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); ERC(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); "Universidad Nacional Abierta y a Distancia" from Colombia (UNAD); "Fundacion Convida" from Medellin, Colombia; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Colciencias partially financed the data analysis, through agreement 393 of 2011 with the Medellin Botanical Garden of Medellin and the support of the Leeds University (UK). The work of RAINFOR and ForestPlots in Colombia has been supported by grants to OLP from the Gordon and Betty Moore Foundation (grant numbers 1656 and 3000), the Natural Environment Research Council (NERC Urgency Grant, 'Assessing the impacts of the recent Amazonian drought', NE/D01025X/1), the European Research Council ('Tropical Forests in the Changing Earth System', T-FORCES, project number 291585), and most recently in 2016-2017 the Royal Society (Global Challenge Research Award 'Sensitivity of tropical Forest Services to Climate Changes', project number CH160091). OLP is supported by an ERC Advanced Grant (291585) and a Royal Society Wolfson Research Merit Award (WM120076). EAD is supported by "Universidad Nacional Abierta y a Distancia" from Colombia (UNAD) and "Fundacion Convida" from Medellin, Colombia.	Aldana AM, 2017, FOREST ECOL MANAG, V389, P86, DOI 10.1016/j.foreco.2016.12.023; Alvarez E, 2012, FOREST ECOL MANAG, V267, P297, DOI 10.1016/j.foreco.2011.12.013; Alves LF, 2010, FOREST ECOL MANAG, V260, P679, DOI 10.1016/j.foreco.2010.05.023; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Asner GP, 2014, REMOTE SENS ENVIRON, V140, P614, DOI 10.1016/j.rse.2013.09.023; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Banin L, 2014, J ECOL, V102, P1025, DOI 10.1111/1365-2745.12263; Baraloto C, 2011, GLOBAL CHANGE BIOL, V17, P2677, DOI 10.1111/j.1365-2486.2011.02432.x; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Carvalhais N, 2014, NATURE, V514, P213, DOI 10.1038/nature13731; Chambers J. M., 1991, STAT MODELS S; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Culmsee H, 2010, J BIOGEOGR, V37, P960, DOI 10.1111/j.1365-2699.2009.02269.x; Detto M, 2013, PLOS ONE, P8; DeWalt SJ, 2004, BIOTROPICA, V36, P7, DOI 10.1646/02115; Diaz D, 2011, FOREST CARBON MARKET, P93; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; Gloor M, 2013, GEOPHYS RES LETT, V40, P1729, DOI 10.1002/grl.50377; Hijmans R. J., 2016, PACKAGE RASTER CRAN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kates L, 2012, PROTO PROTOTYPE OBJE, P1; Keeling HC, 2007, GLOBAL ECOL BIOGEOGR, V16, P618, DOI 10.1111/j.1466-8238.2007.00314.x; Leuschner C, 2007, BASIC APPL ECOL, V8, P219, DOI 10.1016/j.baae.2006.02.004; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Marvin DC, 2014, AMAZONIAN LANDSCAPES; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; Mevik B., 2015, PARTIAL LEAST SQUARE; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pinheiro J., 2013, R PACKAGE3, P1; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2014, P NATL ACAD SCI USA, V111, P13721, DOI 10.1073/pnas.1216053111; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Selmants PC, 2014, GLOB CHANG BIOL; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Unger M, 2012, OECOLOGIA, V170, P263, DOI 10.1007/s00442-012-2295-y; Vallejo-Joyas M. I., 2005, METODOS ESTUDIOS ECO, V1; Venables W.N., 2003, MODERN APPL STAT S T, P111, DOI [10.1198/tech.2003.s33, DOI 10.1198/TECH.2003.S33]; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Zanne A.E., 2009, DRYAD DATA REPOS, DOI [10.5061/dryad.234, DOI 10.5061/DRYAD.234]; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	56	50	52	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171072	10.1371/journal.pone.0171072	http://dx.doi.org/10.1371/journal.pone.0171072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301482	Green Published, gold			2022-12-26	WOS:000396318300008
J	Corado, ADG; Bello, G; Leao, RAC; Granja, F; Naveca, FG				Guerra Corado, Andre de Lima; Bello, Gonzalo; Carvalho Leao, Renato Augusto; Granja, Fabiana; Naveca, Felipe Gomes			HIV-1 genetic diversity and antiretroviral drug resistance among individuals from Roraima state, northern Brazil	PLOS ONE			English	Article							SUBTYPE-C; TREATMENT-NAIVE; MUTATIONS; PREVALENCE; SURVEILLANCE; AMAZONAS; THERAPY; NETWORK	The HIV-1 epidemic in Brazil has spread towards the Northern country region, but little is known about HIV-1 subtypes and prevalence of HIV strains with resistance mutations to antiretrovirals in some of the Northern states. HIV-1 protease (PR) and reverse transcriptase (RT) sequences were obtained from 73 treatment-naive and -experienced subjects followed between 2013 and 2014 at a public health reference unit from Roraima, the northernmost Brazilian state. The most prevalent HIV-1 clade observed in the study population was the subtype B (91%), followed by subtype C (9%). Among 12 HIV-1 strains from treatment-naive patients, only one had a transmitted drug resistance mutation for NNRTI. Among 59 treatment-experienced patients, 12 (20%) harbored HIV-1 strains with acquired drug resistance mutations (ADRM) that reduce the susceptibility to two classes of antiretroviral drugs (NRTI and NNRTI or NRTI and PI), and five (8%) harbored HIV-1 strains with ADRM that reduced susceptibility to only one class of antiretroviral drugs (NNRTI or PI). No patients harboring HIV strains with reduced susceptibility to all three classes of antiretroviral drugs were detected. A substantial fraction of treatment-experienced patients with (63%) and without (70%) ADRM had undetectable plasma viral loads (<40 copies/ml) at the time of sampling. Among treatment-experienced with plasma viral loads above 2,000 copies/ml, 44% displayed no ADRM. This data showed that the HIV-1 epidemic in Roraima displayed a much lower level of genetic diversity and a lower prevalence of ADRM than that described in other Brazilian states.	[Guerra Corado, Andre de Lima; Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas Maria Deane, Manaus, Amazonas, Brazil; [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS Imunol Mol, Rio De Janeiro, Brazil; [Carvalho Leao, Renato Augusto] LACEN RR, Lab Cent Saude Publ Roraima, Roraima, Brazil; [Granja, Fabiana] Univ Fed Roraima UFRR, Lab Biol Mol, Roraima, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Roraima	Corado, ADG; Naveca, FG (corresponding author), Fiocruz MS, Inst Leonidas Maria Deane, Manaus, Amazonas, Brazil.	andrecorado@gmail.com; felipe.naveca@fiocruz.br	Naveca, Felipe/H-1130-2012; Granja, Fabiana/AAS-5763-2021; Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Naveca, Felipe/0000-0002-2888-1060; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Fundacao Oswaldo Cruz/ILMD - POM	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Fundacao Oswaldo Cruz/ILMD - POM	ALGC was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br), financial supported was provided by Fundacao Oswaldo Cruz/ILMD (www.amazonia.fiocruz.br) - POM 2014-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bahia Fabianna, 2004, Braz J Infect Dis, V8, P281; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Brazilian, 2015, AIDS EP B; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014; Cunha LKH, 2012, BRAZ J MED BIOL RES, V45, P104, DOI 10.1590/S0100-879X2012007500003; da Costa CM, 2016, AIDS RES HUM RETROV, V32, P918, DOI [10.1089/aid.2016.0044, 10.1089/AID.2016.0044]; Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Delgado E, 2001, AIDS RES HUM RETROV, V17, P753, DOI 10.1089/088922201750237022; Diaz RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139677; Diniz A.M.A., 2005, CAD GEOGRAFIA, V15, P23; Divino F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162112; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hacker MA, 2007, CAD SAUDE PUBLICA, V23, pS345, DOI 10.1590/S0102-311X2007001500003; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lopes CAF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/738528; Macedo O, 2012, REV PAN-AMAZ SAUDE, V3, P11, DOI [10.5123/S2176-62232012000200002, DOI 10.5123/S2176-62232012000200002]; Machado LFA, 2009, AIDS RES HUM RETROV, V25, P961, DOI 10.1089/aid.2009.0027; Toledo PV, 2010, BRAZ J INFECT DIS, V14, P360, DOI 10.1590/S1413-86702010000400009; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Rangel HR, 2009, MEM I OSWALDO CRUZ, V104, P522, DOI 10.1590/S0074-02762009000300020; Saad FF, 2010, INT J MOL MED, V26, P585, DOI 10.3892/ijmm_00000503; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Silva LD, 2016, AIDS RES HUM RETROV, V32, P373, DOI [10.1089/aid.2015.0280, 10.1089/AID.2015.0280]; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Tanuri A, 2002, J CLIN VIROL, V25, P39, DOI 10.1016/S1386-6532(01)00249-9; Cardoso LPV, 2009, AIDS RES HUM RETROV, V25, P943, DOI 10.1089/aid.2009.0060	35	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173894	10.1371/journal.pone.0173894	http://dx.doi.org/10.1371/journal.pone.0173894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301548	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300090
J	Hayward, CPM; Liang, MG; Tasneem, S; Soomro, A; Waye, JS; Paterson, AD; Rivard, GE; Wilson, MD				Hayward, Catherine P. M.; Liang, Minggao; Tasneem, Subia; Soomro, Asim; Waye, John S.; Paterson, Andrew D.; Rivard, Georges E.; Wilson, Michael D.			The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes	PLOS ONE			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; EXPRESSION; PATHWAY; DEGRADATION; MEMBRANE; THROMBUS; RECEPTOR; CONTAIN; GENE	Quebec Platelet disorder (QPD) is a unique bleeding disorder that markedly increases urokinase plasminogen activator (uPA) in megakaryocytes and platelets but not in plasma or urine. The cause is tandem duplication of a 78 kb region of chromosome 10 containing PLAU (the uPA gene) and C10orf55, a gene of unknown function. QPD increases uPA in platelets and megakaryocytes >100 fold, far more than expected for a gene duplication. To investigate the tissue-specific effect that PLAU duplication has on gene expression and transcript structure in QPD, we tested if QPD leads to: 1) overexpression of normal or unique PLAU transcripts; 2) increased uPA in leukocytes; 3) altered levels of C10orf55 mRNA and/or protein in megakaryocytes and leukocytes; and 4) global changes in megakaryocyte gene expression. Primary cells and cultured megakaryocytes from donors were prepared for quantitative reverse polymerase chain reaction analyses, RNA-seq and protein expression analyses. Rapidly isolated blood leukocytes from QPD subjects showed only a 3.9 fold increase in PLAU transcript levels, in keeping with the normal to minimally increased uPA in affinity purified, QPD leukocytes. All subjects had more uPA in granulocytes than monocytes and minimal uPA in lymphocytes. QPD leukocytes expressed PLAU alleles in proportions consistent with an extra copy of PLAU on the disease chromosome, unlike QPD megakaryocytes. QPD PLAU transcripts were consistent with reference gene models, with a much higher proportion of reads originating from the disease chromosome in megakaryocytes than granulocytes. QPD and control megakaryocytes contained minimal reads for C10orf55, and C10orf55 protein was not increased in QPD megakaryocytes or platelets. Finally, our QPD megakaryocyte transcriptome analysis revealed a global down regulation of the interferon type 1 pathway. We suggest that the low endogenous levels of uPA in blood are actively regulated, and that the regulatory mechanisms are disrupted in QPD in a megakaryocyte-specific manner.	[Hayward, Catherine P. M.; Tasneem, Subia; Soomro, Asim; Waye, John S.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Hayward, Catherine P. M.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Hayward, Catherine P. M.; Waye, John S.] Hamilton Reg Lab Med Program, Hamilton, ON, Canada; [Liang, Minggao; Paterson, Andrew D.; Wilson, Michael D.] Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada; [Liang, Minggao; Wilson, Michael D.] Univ Toronto, Mol Genet, Toronto, ON, Canada; [Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Paterson, Andrew D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Rivard, Georges E.] Ctr Hosp Univ St Justine, Hematol Oncol, Montreal, PQ, Canada; [Wilson, Michael D.] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hayward, CPM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.; Hayward, CPM (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Hayward, CPM (corresponding author), Hamilton Reg Lab Med Program, Hamilton, ON, Canada.; Wilson, MD (corresponding author), Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada.; Wilson, MD (corresponding author), Univ Toronto, Mol Genet, Toronto, ON, Canada.; Wilson, MD (corresponding author), Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada.	haywrdc@mcmaster.ca; michael.wilson@sickids.ca	Wilson, Michael D/K-6294-2014; Paterson, Andrew/AAQ-7511-2020; Paterson, Andrew D/A-4088-2011	Wilson, Michael D/0000-0002-4015-3066; Paterson, Andrew/0000-0002-9169-118X; Paterson, Andrew D/0000-0002-9169-118X; Hayward, Catherine/0000-0002-2843-0817	Canadian Institutes of Health Research [MOP 97942]; Heart and Stroke Foundation of Canada [7486]; Heart and Stroke Foundation of Ontario; Bayer Canada; Natural Sciences and Engineering Research Council of Canada [436194-2013]; Restracomp trainee scholarship; Canada Research Chairs; Faculty of Health Sciences, McMaster University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Bayer Canada(Bayer AG); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Restracomp trainee scholarship; Canada Research Chairs(Canada Research ChairsCGIAR); Faculty of Health Sciences, McMaster University	Canadian Institutes of Health Research (grant MOP 97942, CPMH, ADP, JSW), Heart and Stroke Foundation of Canada (bridge grant 7486, MDW), Heart and Stroke Foundation of Ontario (Career Investigator Award, CPMH), Bayer Canada (GER), Natural Sciences and Engineering Research Council of Canada (grant 436194-2013, MDW), Restracomp trainee scholarship (ML), Canada Research Chairs (CPM, ADP, MDW) and funding from the Faculty of Health Sciences, McMaster University (CPMH).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509; Chen L, 2014, SCIENCE, V345; Dejouvencel T, 2010, BLOOD, V115, P2048, DOI 10.1182/blood-2009-06-228817; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Diamandis M, 2006, J THROMB HAEMOST, V4, P1086, DOI 10.1111/j.1538-7836.2006.01877.x; Diamandis M, 2009, BLOOD, V113, P1543, DOI 10.1182/blood-2008-08-175216; Diarnandis M, 2008, BLOOD COAGUL FIBRIN, V19, P463, DOI 10.1097/MBC.0b013e328304e099; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dumler I, 1999, J BIOL CHEM, V274, P24059, DOI 10.1074/jbc.274.34.24059; Ervin AL, 2001, BLOOD COAGUL FIBRIN, V12, P415, DOI 10.1097/00001721-200109000-00001; GRAU E, 1989, THROMB RES, V53, P145, DOI 10.1016/0049-3848(89)90375-7; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hartley SW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw501; Hayward CPM, 2011, EXPERT REV HEMATOL, V4, P137, DOI [10.1586/EHM.11.5, 10.1586/ehm.11.5]; Hayward CPM, 1997, BRIT J HAEMATOL, V97, P497, DOI 10.1046/j.1365-2141.1997.862903.x; Hayward CPM, 1997, BLOOD, V89, P1243, DOI 10.1182/blood.V89.4.1243; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kahr WHA, 2001, BLOOD, V98, P257, DOI 10.1182/blood.V98.2.257; Koshelnick Y, 1997, J BIOL CHEM, V272, P28563, DOI 10.1074/jbc.272.45.28563; Kufrin D, 2003, BLOOD, V102, P926, DOI 10.1182/blood-2003-01-0054; Loehlin DW, 2016, P NATL ACAD SCI US; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madsen JGS, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1365; Matsunoshita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016234; Maynard DM, 2007, J THROMB HAEMOST, V5, P1945, DOI 10.1111/j.1538-7836.2007.02690.x; McKay H, 2004, BLOOD, V104, P159, DOI 10.1182/blood-2003-11-4077; Moir E, 2001, BRIT J HAEMATOL, V113, P72, DOI 10.1046/j.1365-2141.2001.02696.x; Mutch NJ, 2002, THROMB HAEMOSTASIS, V88, P996; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Paterson AD, 2010, BLOOD, V115, P1264, DOI 10.1182/blood-2009-07-233965; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PLESNER T, 1994, BLOOD, V83, P808; Psaila B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0939-7; Rainen L, 2002, CLIN CHEM, V48, P1883; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; RINDER HM, 1991, BLOOD, V78, P1760; Schmidt SF, 2015, GENOME RES, V25, P1281, DOI 10.1101/gr.188300.114; Sheth PM, 2003, THROMB HAEMOSTASIS, V90, P293, DOI 10.1160/TH02-12-0323; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; STEPHENS RW, 1984, EUR J BIOCHEM, V139, P253, DOI 10.1111/j.1432-1033.1984.tb08001.x; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Teruel-Montoya R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102259; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Vadivel K, 2014, J BIOL CHEM, V289, P31647, DOI 10.1074/jbc.M114.569665; Van der Auwera GA, CALLING VARIANTS RNA; Veljkovic DK, 2009, BLOOD, V113, P1535, DOI 10.1182/blood-2008-08-172338	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173991	10.1371/journal.pone.0173991	http://dx.doi.org/10.1371/journal.pone.0173991			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301587	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300107
J	Kong, P; Richardson, P; Hong, CX				Kong, Ping; Richardson, Patricia; Hong, Chuanxue			Diversity and community structure of cyanobacteria and other microbes in recycling irrigation reservoirs	PLOS ONE			English	Article							IDENTIFICATION; SURVIVAL; ECOLOGY; STRESS; BLOOMS; WATER; LAKES	Recycling irrigation reservoirs (RIRs) are emerging aquatic environments of global significance to crop production, water conservation and environmental sustainability. This study characterized the diversity and population structure of cyanobacteria and other detected microbes in water samples from eight RIRs and one adjacent runoff-free stream at three ornamental crop nurseries in eastern (VA1 and VA3) and central (VA2) Virginia after cloning and sequencing the 16S rRNA gene targeting cyanobacteria and chloroplast of eukaryotic phytoplankton. VA1 and VA2 utilize a multi-reservoir recycling irrigation system with runoff channeled to a sedimentation reservoir which then overflows into transition and retention reservoirs where water was pumped for irrigation. VA3 has a single sedimentation reservoir which was also used for irrigation. A total of 208 operational taxonomic units (OTU) were identified from clone libraries of the water samples. Among them, 53 OTUs (358 clones) were cyanobacteria comprising at least 12 genera dominated by Synechococcus species; 59 OTUs (387 clones) were eukaryotic phytoplankton including green algae and diatoms; and 96 were other bacteria (111 clones). Overall, cyanobacteria were dominant in sedimentation reservoirs, while eukaryotic phytoplankton and other bacteria were dominant in transition/ retention reservoirs and the stream, respectively. These results are direct evidence demonstrating the negative impact of nutrient-rich horticultural runoff, if not contained, on natural water resources. They also help in understanding the dynamics of water quality in RIRs and have practical implications. Although both single-and multi-reservoir recycling irrigation systems reduce the environmental footprint of horticultural production, the former is expected to have more cyanobacterial blooming, and consequently water quality issues, than the latter. Thus, a multi-reservoir recycling irrigation system should be preferred where feasible.	[Kong, Ping; Richardson, Patricia; Hong, Chuanxue] Virginia Tech, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA	Virginia Polytechnic Institute & State University	Kong, P (corresponding author), Virginia Tech, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA.	pkong@vt.edu			Specialty Crop Research Initiative (SCRI) [2010-51181-21140]; Hatch Program of the United States USDA National Institute of Food and the Agriculture; Virginia Agricultural Experiment Station	Specialty Crop Research Initiative (SCRI); Hatch Program of the United States USDA National Institute of Food and the Agriculture; Virginia Agricultural Experiment Station	This study was supported in part by the Specialty Crop Research Initiative (SCRI, Agreement #: 2010-51181-21140), the Hatch Program of the United States USDA National Institute of Food and the Agriculture Virginia Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2009, ISME J, V3, P31, DOI 10.1038/ismej.2008.78; Argo WR, 2002, UNDERSTANDING PH MAN; Barranguet C, 2005, EUR J PHYCOL, V40, P1, DOI 10.1080/09670260400009882; Bruno L, 2012, J APPL MICROBIOL, V113, P1052, DOI 10.1111/j.1365-2672.2012.05416.x; Burja AM, 2001, FEMS MICROBIOL LETT, V202, P195, DOI 10.1016/S0378-1097(01)00306-8; Buttner C., 2014, BIOL DETECTION MANAG; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; GLOVER HE, 1981, ARCH MICROBIOL, V129, P42, DOI 10.1007/BF00417177; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holdren JP, 2008, SCIENCE, V319, P424, DOI 10.1126/science.1153386; Hong CX, 2009, IRRIGATION SCI, V27, P485, DOI 10.1007/s00271-009-0161-4; Hong CX, 2005, CRIT REV PLANT SCI, V24, P189, DOI 10.1080/07352680591005838; Kaiser J., 2005, SCIENCE, V308, P195; Katsiapi M, 2013, FUND APPL LIMNOL, V182, P219, DOI 10.1127/1863-9135/2013/0362; Kim SG, 2006, APPL ENVIRON MICROB, V72, P3252, DOI 10.1128/AEM.72.5.3252-3258.2006; Kong P, 2012, PLANT PATHOL, V61, P1179, DOI 10.1111/j.1365-3059.2012.02614.x; Kong P, 2014, BIOL DETECTION MANAG, P333; Kong P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-124; Kong P, 2012, FEMS MICROBIOL LETT, V332, P54, DOI 10.1111/j.1574-6968.2012.02574.x; Kong P, 2009, APPL ENVIRON MICROB, V75, P4307, DOI 10.1128/AEM.00119-09; Leao PN, 2012, NAT PROD REP, V29, P372, DOI 10.1039/c2np00075j; Lindstrom ES, 2000, MICROBIAL ECOL, V40, P104; Lindstrom ES, 2001, MICROBIAL ECOL, V42, P598, DOI 10.1007/s00248-001-0031-y; Marshall HG, 2013, VIRGINIA J SCI, V64, P1; Nedelcu AM, 2001, J MOL EVOL, V53, P670, DOI 10.1007/s002390010254; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Okamoto N, 2005, SCIENCE, V310, P287, DOI 10.1126/science.1116125; Oksanen J, 2015, PACKAGE VEGAN COMMUN, P2; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; R Core Team, 2021, R LANGUAGE ENV STAT; Rozon RM, 2013, FRESHWATER BIOL, V58, P2648, DOI 10.1111/fwb.12241; Sahin U, 2005, J ENVIRON MANAGE, V76, P338, DOI 10.1016/j.jenvman.2005.02.003; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Singh Y, 2014, J BIOSCIENCES, V39, P643, DOI 10.1007/s12038-014-9458-4; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Whitton B.A., 2000, ECOLOGY CYANOBACTERI; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11	42	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173903	10.1371/journal.pone.0173903	http://dx.doi.org/10.1371/journal.pone.0173903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301562	gold, Green Submitted, Green Published			2022-12-26	WOS:000396318300092
J	Liu, CL; Xi, Y; Li, M; Jiao, Q; Zhang, HZ; Yang, QC; Yao, WW				Liu, Chenglei; Xi, Yan; Li, Mei; Jiao, Qiong; Zhang, Huizhen; Yang, Qingcheng; Yao, Weiwu			Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients	PLOS ONE			English	Article							CHEMOTHERAPY; EXPERIENCE; MRI	Background Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor survival. There are many confusing issues concerning the imaging feature that can facilitate early diagnosis and the factors that might be related to outcomes. Methods Twenty-three patients with dedifferentiated chondrosarcoma confirmed by pathology were retrospectively reviewed from 2008 to 2015. The patients' clinical information, images from radiographs (n = 17), CT (n = 19), and MRI (n = 17), histological features, treatment and prognosis were analyzed. Results There were 12 males and 11 females, and the mean age was 50.39 years old. Fourteen cases affected the axial bone (pelvis, spine), and 9 cases involved the appendicular bone. Seven (41.17%), 9 (47.36), and 12 (66.66%) lesions showed a biphasic nature on radiograph, CT and MRI, respectively. Of the lesions, 17.39% (4/23) were accompanied by pathological fractures. Histologically, the cartilage component was considered histological Grade1 in 12 patients and Grade 2 in 11 patients. The dedifferentiated component showed features of osteosarcoma in 8 cases, malignant fibrous histiocytoma in3 cases, myofibroblastic sarcoma in 1 case and spindle cell sarcoma in 11cases. Twenty-two cases were treated with surgical resection, and 17 cases achieved adequate (wide or radical) surgical margin. In 8 cases, surgery was combined with adjuvant chemotherapy. The overall median survival time was nine months; 17.4% of patients survived to five years. Conclusion Axial bone location, lung metastasis at diagnosis, inadequate surgical margin, incorrect diagnosis before surgery and pathological fractures was related to poorer outcome. Pre- or postoperative chemotherapy had no definitively effect on improved survival.	[Liu, Chenglei; Xi, Yan; Li, Mei; Yao, Weiwu] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Radiol, Shanghai, Peoples R China; [Jiao, Qiong; Zhang, Huizhen] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Pathol, Shanghai, Peoples R China; [Yang, Qingcheng] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthoped, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yao, WW (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Radiol, Shanghai, Peoples R China.	yaoweiwuhuan@163.com	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022		Scientific Research Plan Project of Shanghai [16511101100];  [2016YFC0106802]	Scientific Research Plan Project of Shanghai; 	This research was supported by the Scientific Research Plan Project of Shanghai (Grant # 16511101100, Funding Institution: Shanghai Science and Technology, url: http://www.stcsm.gov.cn/) and the Major Project Fund of Minister of Science and Technology (Grant # 2016YFC0106802, Funding Institution: Ministry of Science and Technology of the People's Republic of China, URL: http://www.most.gov.cn/). All external funding was secured by WY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergh P, 2001, CANCER-AM CANCER SOC, V91, P1201, DOI 10.1002/1097-0142(20010401)91:7<1201::AID-CNCR1120>3.0.CO;2-W; Bruns J, 2005, J CANCER RES CLIN, V131, P333, DOI 10.1007/s00432-004-0648-6; CHMELEVSKY D, 1988, RADIAT ENVIRON BIOPH, V27, P103, DOI 10.1007/BF01214600; DAHLIN DC, 1971, CANCER, V28, P461, DOI 10.1002/1097-0142(197108)28:2<461::AID-CNCR2820280227>3.0.CO;2-U; DALY PJ, 1989, ORTHOPEDICS, V12, P763; DELANGE EE, 1986, RADIOLOGY, V161, P489, DOI 10.1148/radiology.161.2.3763920; Dickey ID, 2004, J BONE JOINT SURG AM, V86A, P2412, DOI 10.2106/00004623-200411000-00008; Eustace S, 1997, CLIN IMAG, V21, P170, DOI 10.1016/S0899-7071(96)00016-2; FRASSICA FJ, 1986, J BONE JOINT SURG AM, V68A, P1197, DOI 10.2106/00004623-198668080-00008; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Grimer RJ, 2007, EUR J CANCER, V43, P2060, DOI 10.1016/j.ejca.2007.06.016; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; JOHNSON S, 1986, CANCER, V58, P278, DOI 10.1002/1097-0142(19860715)58:2<278::AID-CNCR2820580213>3.0.CO;2-6; Littrell LA, 2004, RADIOGRAPHICS, V24, P1397, DOI 10.1148/rg.245045009; MacSweeney F, 2003, SKELETAL RADIOL, V32, P671, DOI 10.1007/s00256-003-0706-1; Malchenko Sergey, 2012, Sarcoma, V2012, P820254, DOI 10.1155/2012/820254; Masciocchi C, 1998, EUR J RADIOL, V27, pS86, DOI 10.1016/S0720-048X(98)00048-5; MERCURI M, 1995, SKELETAL RADIOL, V24, P409, DOI 10.1007/BF00941235; Milchgrub S, 2002, TUMOURS SOFT TISSUE, P252; Mitchell AD, 2000, J BONE JOINT SURG BR, V82B, P55, DOI 10.1302/0301-620X.82B1.9020; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Nota Sjoerd P. F. T., 2015, Sarcoma, V2015, P623746, DOI 10.1155/2015/623746; Obid P, 2015, GLOB SPINE J, V5, pE74, DOI 10.1055/s-0035-1546953; Saifuddin A, 2004, CLIN RADIOL, V59, P268, DOI 10.1016/j.crad.2003.08.009; Sopta J, 2008, J CANCER RES CLIN, V134, P147, DOI 10.1007/s00432-007-0262-5; Staals EL, 2006, CANCER-AM CANCER SOC, V106, P2682, DOI 10.1002/cncr.21936; Yokota K, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-38	27	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173665	10.1371/journal.pone.0173665	http://dx.doi.org/10.1371/journal.pone.0173665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301537	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300058
J	Murtaza, G; Mermer, P; Goldenberg, A; Pfeil, U; Paddenberg, R; Weissmann, N; Lochnit, G; Kummer, W				Murtaza, Ghulam; Mermer, Petra; Goldenberg, Anna; Pfeil, Uwe; Paddenberg, Renate; Weissmann, Nobert; Lochnit, Guenter; Kummer, Wolfgang			TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries	PLOS ONE			English	Article							DOMAIN K+ CHANNEL; SMOOTH-MUSCLE-CELLS; OXYGEN; HYPERTENSION; RAT; KCNK3; MICE; MODULATION; EXPRESSION; ANTIBODIES	The two-pore domain potassium channel KCNK3 (TASK-1) is expressed in rat and human pulmonary artery smooth muscle cells. There, it is associated with hypoxia-induced signalling, and its dysfunction is linked to pathogenesis of human pulmonary hypertension. We here aimed to determine its role in hypoxic pulmonary vasoconstriction (HPV) in the mouse, and hence the suitability of this model for further mechanistic investigations, using appropriate inhibitors and TASK-1 knockout (KO) mice. RT-PCR revealed expression of TASK-1 mRNA in murine lungs and pre-acinar pulmonary arteries. Protein localization by immunohistochemistry and western blot was unreliable since all antibodies produced labelling also in TASK-1 KO organs/tissues. HPV was investigated by videomorphometric analysis of intra-(inner diameter: 25-40 mu m) and pre-acinar pulmonary arteries (inner diameter: 41-60 mu m). HPV persisted in TASK-1 KO intra-acinar arteries. Pre-acinar arteries developed initial HPV, but the response faded earlier (after 30 min) in KO vessels. This HPV pattern was grossly mimicked by the TASK-1 inhibitor anandamide in wild-type vessels. Hypoxia-provoked rise in pulmonary arterial pressure (PAP) in isolated ventilated lungs was affected neither by TASK-1 gene deficiency nor by the TASK-1 inhibitor A293. TASK-1 is dispensable for initiating HPV of murine intra-pulmonary arteries, but participates in sustained HPV specifically in pre-acinar arteries. This does not translate into abnormal rise in PAP. While there is compelling evidence that TASK-1 is involved in the pathogenesis of pulmonary arterial hypertension in humans, the mouse does not appear to serve as a suitable model to study the underlying molecular mechanisms.	[Murtaza, Ghulam; Mermer, Petra; Goldenberg, Anna; Pfeil, Uwe; Paddenberg, Renate; Kummer, Wolfgang] Justus Liebig Univ, Inst Anat & Cell Biol, Giessen, Germany; [Weissmann, Nobert] Justus Liebig Univ, Univ Giessen & Marburg Lung Ctr, Giessen, Germany; [Weissmann, Nobert; Kummer, Wolfgang] Justus Liebig Univ, German Ctr Lung Res Excellence Cluster Cardiopulm, Giessen, Germany; [Lochnit, Guenter] Justus Liebig Univ, Inst Biochem, Fac Med, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Murtaza, G (corresponding author), Justus Liebig Univ, Inst Anat & Cell Biol, Giessen, Germany.	gmurtazay@yahoo.com		Weissmann, Norbert/0000-0003-2675-3871; Kummer, Wolfgang/0000-0002-3946-0683				Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Decher N, 2011, CELL PHYSIOL BIOCHEM, V28, P77, DOI 10.1159/000331715; Donner BC, 2011, BASIC RES CARDIOL, V106, P75, DOI 10.1007/s00395-010-0128-x; Girerd B, 2016, EUR RESPIR J, V47, P541, DOI 10.1183/13993003.00717-2015; Graham V, 2006, DEV DYNAM, V235, P143, DOI 10.1002/dvdy.20558; Gurney AM, 2003, CIRC RES, V93, P957, DOI 10.1161/01.RES.0000099883.68414.61; Jeffery TK, 2001, PHARMACOL THERAPEUT, V92, P1, DOI 10.1016/S0163-7258(01)00157-7; Johnson RP, 2004, AM J PHYSIOL-CELL PH, V286, pC391, DOI 10.1152/ajpcell.00401.2003; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Krasteva G, 2007, INT J BIOCHEM CELL B, V39, P615, DOI 10.1016/j.biocel.2006.10.019; Kummer Wolfgang, 2011, Proc Am Thorac Soc, V8, P471, DOI 10.1513/pats.201101-013MW; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YM, 2006, CELL SIGNAL, V18, P499, DOI 10.1016/j.cellsig.2005.05.025; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Manoury B, 2009, BRIT J PHARMACOL, V158, P848, DOI 10.1111/j.1476-5381.2009.00353.x; Manoury B, 2011, J PHYSIOL-LONDON, V589, P3231, DOI 10.1113/jphysiol.2011.206748; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Navas Tejedor P, 2016, CLIN GENET; Olschewski A, 2006, CIRC RES, V98, P1072, DOI 10.1161/01.RES.0000219677.12988.e9; Paddenberg R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-93; Paddenberg R, 2014, JOVE-J VIS EXP, DOI 10.3791/50970; Paddenberg R, 2012, CARDIOVASC RES, V93, P702, DOI 10.1093/cvr/cvr359; Pandit LM, 2014, HYPERTENSION, V64, P1260, DOI 10.1161/HYPERTENSIONAHA.114.03406; Papreck JR, 2012, PFLUG ARCH EUR J PHY, V464, P471, DOI 10.1007/s00424-012-1159-y; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Putzke C, 2007, CARDIOVASC RES, V75, P59, DOI 10.1016/j.cardiores.2007.02.025; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Rommel FR, 2015, J HISTOCHEM CYTOCHEM, V63, P329, DOI 10.1369/0022155415575028; Tabuchi A, 2008, J APPL PHYSIOL, V104, P338, DOI 10.1152/japplphysiol.00348.2007; Timm T, 2016, PARASITOL RES; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Turner PJ, 2013, J PHYSIOL-LONDON, V591, P5977, DOI 10.1113/jphysiol.2013.262022; Weissmann N, 2004, RESP PHYSIOL NEUROBI, V139, P191, DOI 10.1016/j.resp.2003.10.003	40	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174071	10.1371/journal.pone.0174071	http://dx.doi.org/10.1371/journal.pone.0174071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301582	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300122
J	Krzemien, KM; Beckers, M; Quack, S; Michaelis, J				Krzemien, Katarzyna M.; Beckers, Maximilian; Quack, Salina; Michaelis, Jens			Atomic force microscopy of chromatin arrays reveal non-monotonic salt dependence of array compaction in solution	PLOS ONE			English	Article							NUCLEOSOME CORE PARTICLE; HIGHER-ORDER; HISTONE; DNA; FIBER; VISUALIZATION; ORGANIZATION; CHROMOSOMES; ELASTICITY; TRANSITION	Compaction of DNA in chromatin is a hallmark of the eukaryotic cell and unravelling its structure is required for an understanding of DNA involving processes. Despite strong experimental efforts, many questions concerning the DNA packing are open. In particular, it is heavily debated whether an ordered structure referred to as the "30 nm fibre" exist in vivo. Scanning probe microscopy has become a cutting edge technology for the high-resolution imaging of DNA-protein complexes. Here, we perform high-resolution atomic force microscopy of non-cross-linked chromatin arrays in liquid, under different salt conditions. A statistical analysis of the data reveals that array compaction is salt dependent in a non-monotonic fashion. A simple physical model can qualitatively explain the observed findings due to the opposing effects of salt dependent stiffening of DNA, nucleosome stability and histone-histone interactions. While for different salt concentrations different compaction states are observed, our data do not provide support for the existence of regular chromatin fibres. Our studies add new insights into chromatin structure, and with that contribute to a further understanding of the DNA condensation.	[Krzemien, Katarzyna M.; Beckers, Maximilian; Quack, Salina; Michaelis, Jens] Univ Ulm, Inst Biophys, Ulm, Germany; [Beckers, Maximilian] EMBL, Struct & Computat Biol Unit, Heidelberg, Germany	Ulm University; European Molecular Biology Laboratory (EMBL)	Michaelis, J (corresponding author), Univ Ulm, Inst Biophys, Ulm, Germany.	jens.michaelis@uni-ulm.de		Michaelis, Jens/0000-0002-2739-4172; Beckers, Maximilian/0000-0001-5988-1322	European Research Council	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Starting Grant "Remodelling", JM (https://erc.europa.eu/funding-and-grants/funding-schemes/starting-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitaya T, 2007, BIOMACROMOLECULES, V8, P273, DOI 10.1021/bm060634j; Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Bash RC, 2001, J BIOL CHEM, V276, P48362, DOI 10.1074/jbc.M104916200; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Bian Q, 2012, CURR OPIN CELL BIOL, V24, P359, DOI 10.1016/j.ceb.2012.03.003; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P5951, DOI 10.1093/nar/gks267; Bollobas B., 1998, MODERN GRAPH THEORY; Bussiek M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng137; Bussiek M, 2005, J MOL BIOL, V345, P695, DOI 10.1016/j.jmb.2004.11.016; Bustamante C, 1997, METHODS, V12, P73, DOI 10.1006/meth.1997.0449; Cano S, 2006, EUR BIOPHYS J BIOPHY, V35, P495, DOI 10.1007/s00249-006-0057-7; d'Erme M, 2001, BIOCHEMISTRY-US, V40, P10947, DOI 10.1021/bi002742a; Di Cerbo V, 2014, ELIFE, V3, DOI 10.7554/eLife.01632; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Elbel T, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/6/064105; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Gansen A, 2015, NUCLEIC ACIDS RES, V43, P1433, DOI 10.1093/nar/gku1354; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Hansen JC, 2012, EMBO J, V31, P1621, DOI 10.1038/emboj.2012.66; Hazan NP, 2015, BIOPHYS J, V109, P1676, DOI 10.1016/j.bpj.2015.07.004; Hizume K, 2009, ULTRAMICROSCOPY, V109, P868, DOI 10.1016/j.ultramic.2009.03.014; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104029; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088411; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Korolev N, 2012, SOFT MATTER, V8, P9322, DOI 10.1039/c2sm25662b; Korolev N, 2012, BIOCHEM BIOPH RES CO, V418, P205, DOI 10.1016/j.bbrc.2011.12.112; Korolev N, 2010, BIOPHYS J, V99, P1896, DOI 10.1016/j.bpj.2010.07.017; Lee C. Y., 1961, IRE T ELECTRON COMPU, P346, DOI DOI 10.1109/TEC.1961.5219222; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Lyubchenko YL, 2016, CRITICAL REV EUKARYO, V26; Maeshima K, 2016, EMBO J, V35, P1115, DOI 10.15252/embj.201592660; Menshikova Irina, 2011, Int J Biochem Mol Biol, V2, P129; Nazarov I, 2016, BIOCHIMIE, V121, P5, DOI 10.1016/j.biochi.2015.11.010; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; SEN D, 1986, BIOCHEMISTRY-US, V25, P1495, DOI 10.1021/bi00355a004; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Soille P, 2004, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-05088-0; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Toth K, 2013, CYTOM PART A, V83, P839, DOI 10.1002/cyto.a.22320; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Vergani L, 2002, PROTEIN EXPRES PURIF, V24, P420, DOI 10.1006/prep.2001.1601; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang H, 2004, BIOPHYS J, V87, P1964, DOI 10.1529/biophysj.104.042606; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wei SJ, 2015, NUCLEIC ACIDS RES, V43, pE111, DOI 10.1093/nar/gkv549; Wenner JR, 2002, BIOPHYS J, V82, P3160, DOI 10.1016/S0006-3495(02)75658-0; WIDOM J, 1986, J MOL BIOL, V190, P411, DOI 10.1016/0022-2836(86)90012-4; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Wu CY, 2016, FEBS LETT, V590, P935, DOI 10.1002/1873-3468.12128; Zhu P, 2016, CURR OPIN STRUC BIOL, V36, P106, DOI 10.1016/j.sbi.2016.01.013	69	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173459	10.1371/journal.pone.0173459	http://dx.doi.org/10.1371/journal.pone.0173459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296908	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700038
J	Woods, AL; Garvican-Lewis, LA; Lundy, B; Rice, AJ; Thompson, KG				Woods, Amy L.; Garvican-Lewis, Laura A.; Lundy, Bronwen; Rice, Anthony J.; Thompson, Kevin G.			New approaches to determine fatigue in elite athletes during intensified training: Resting metabolic rate and pacing profile	PLOS ONE			English	Article							INDIRECT CALORIMETRY; ENERGY HOMEOSTASIS; BODY-COMPOSITION; CONSENSUS STATEMENT; PHYSICAL-ACTIVITY; EXERCISE; STRESS; LEPTIN; EXPENDITURE; RESISTANCE	Background Elite rowers complete a high volume of training across a number of modalities to prepare for competition, including periods of intensified load, which may lead to fatigue and short-term performance decrements. As yet, the influence of substantial fatigue on resting metabolic rate (RMR) and exercise regulation (pacing), and their subsequent utility as monitoring parameters, has not been explicitly investigated in elite endurance athletes. Method Ten National-level rowers completed a four-week period of intensified training. RMR, body composition and energy intake were assessed PRE and POST the four-week period using indirect calorimetry, Dual-Energy X-Ray Densitometry (DXA), and three-day food diary, respectively. On-water rowing performance and pacing strategy was evaluated from 5 km time trials. Wellness was assessed weekly using the Multicomponent Training Distress Scale (MTDS). Results Significant decreases in absolute (mean +/- SD of difference, p-value: -466 +/- 488 kj.day(-1), p = 0.01) and relative RMR (-8.0 +/- 8.1 klkg.FFM-1, p = 0.01) were observed. Significant reductions in body mass (-1.6 +/- 1.3 kg, p = 0.003) and fat mass (-2.2 +/- 1.2 kg, p = 0.0001) were detected, while energy intake was unchanged. On -water 5 km rowing performance worsened (p < 0.05) and an altered pacing strategy was evident. Fatigue and total mood disturbance significantly increased across the cycle (p < 0.05), and trends were observed for reduced vigour and increased sleep disturbance (p < 0.1). Conclusion Four weeks of heavy training decreased RMR and body composition variables in elite rowers and induced substantial fatigue, likely related to an imbalance between energy intake and output. This study demonstrates that highly experienced athletes do not necessarily select the correct energy intake during periods of intensified training, and this can be assessed by reductions in RMR and body composition. The shortfall in energy availability likely affected recovery from training and altered 5 km time trial pacing strategy, resulting in reduced performance.	[Woods, Amy L.; Garvican-Lewis, Laura A.; Thompson, Kevin G.] Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia; [Woods, Amy L.; Garvican-Lewis, Laura A.; Lundy, Bronwen; Rice, Anthony J.] Australian Inst Sport, Bruce, ACT, Australia; [Garvican-Lewis, Laura A.] Australian Catholic Univ, Mary Mackillop Inst Hlth Res, Melbourne, Vic, Australia	University of Canberra; Australian Institute of Sport; Australian Catholic University	Woods, AL (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia.; Woods, AL (corresponding author), Australian Inst Sport, Bruce, ACT, Australia.	u3095542@uni.canberra.edu.au		Thompson, Kevin/0000-0003-3985-1622				Akbulut G, 2012, TURK FIZ TIP REHAB D, V58, P1, DOI 10.4274/tftr.88156; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; [Anonymous], J SPORTS SCI; [Anonymous], OVERTRAINING SPORT; BINGHAM SA, 1989, BRIT J NUTR, V61, P155, DOI 10.1079/BJN19890106; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BROEDER CE, 1992, AM J CLIN NUTR, V55, P802, DOI 10.1093/ajcn/55.4.802; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P139, DOI 10.1007/s00421-006-0255-0; de Koning JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015863; Desgorces FD, 2004, EUR J APPL PHYSIOL, V91, P677, DOI 10.1007/s00421-003-1030-0; Dolezal BA, 2000, MED SCI SPORT EXER, V32, P1202, DOI 10.1097/00005768-200007000-00003; Donahoo WT, 2004, CURR OPIN CLIN NUTR, V7, P599, DOI 10.1097/00075197-200411000-00003; Drenowatz C, 2013, EUR J SPORT SCI, V13, P422, DOI 10.1080/17461391.2011.635707; Garland SW, 2005, BRIT J SPORT MED, V39, P39, DOI 10.1136/bjsm.2003.010801; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Gleeson M, 2000, INT J SPORTS MED, V21, pS44, DOI 10.1055/s-2000-1451; Halson Shona L, 2014, Sports Med, V44 Suppl 2, pS139, DOI 10.1007/s40279-014-0253-z; Halson SL, 2004, SPORTS MED, V34, P967, DOI 10.2165/00007256-200434140-00003; Haugen HA, 2007, NUTR CLIN PRACT, V22, P377, DOI 10.1177/0115426507022004377; Henry CJK, 2003, BRIT J NUTR, V89, P811, DOI 10.1079/BJN2003839; Ihle R, 2004, J BONE MINER RES, V19, P1231, DOI 10.1359/JBMR.040410; Joy Elizabeth A, 2005, Curr Sports Med Rep, V4, P323; Jurimae J, 2011, METABOLISM, V60, P335, DOI 10.1016/j.metabol.2010.02.009; Jurimae J, 2004, J SCI MED SPORT, V7, P335, DOI 10.1016/S1440-2440(04)80028-8; Jurimae J, 2003, EUR J APPL PHYSIOL, V90, P533, DOI 10.1007/s00421-003-0879-2; Kelly B, 2013, EUR J APPL PHYSIOL, V113, P3039, DOI 10.1007/s00421-013-2741-5; Kentta G, 2006, EUR J SPORT SCI, V6, P245, DOI 10.1080/17461390601012652; Laforgia J, 2006, J SPORT SCI, V24, P1247, DOI 10.1080/02640410600552064; LaForgia J, 1999, EUR J CLIN NUTR, V53, P126, DOI 10.1038/sj.ejcn.1600689; Lee MG, 2009, MED SCI SPORT EXER, V41, P1444, DOI 10.1249/MSS.0b013e31819bd617; LENNON D, 1985, INT J OBESITY, V9, P39; Maestu J, 2005, SPORTS MED, V35, P597; Main L, 2009, EUR J SPORT SCI, V9, P195, DOI 10.1080/17461390902818260; Matarese LE, 1997, J AM DIET ASSOC, V97, pS154, DOI 10.1016/S0002-8223(97)00754-2; McMurray RG, 2005, SPORTS MED, V35, P393, DOI 10.2165/00007256-200535050-00003; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Melin A, 2015, SCAND J MED SCI SPOR, V25, P610, DOI 10.1111/sms.12261; Meuret J., 2007, PAPER 2461; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; POEHLMAN ET, 1989, MED SCI SPORT EXER, V21, P515; Popovic V, 2005, HORM METAB RES, V37, P533, DOI 10.1055/s-2005-870418; Potteiger JA, 2008, INT J SPORT NUTR EXE, V18, P79, DOI 10.1123/ijsnem.18.1.79; Ramson R, 2008, EUR J APPL PHYSIOL, V104, P839, DOI 10.1007/s00421-008-0839-y; Rauch HGL, 2005, BRIT J SPORT MED, V39, P34, DOI 10.1136/bjsm.2003.010645; Renfree A, 2014, SPORTS MED, V44, P147, DOI 10.1007/s40279-013-0107-0; Saris WHM, 2001, CAN J APPL PHYSIOL, V26, pS167, DOI 10.1139/h2001-051; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Tenforde AS, 2016, SPORTS MED, V46, P171, DOI 10.1007/s40279-015-0411-y; Thompson KG, 2015, PACING INDIVIDUAL ST; Tran J, 2015, J SPORT SCI, V33, P268, DOI 10.1080/02640414.2014.942686; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309; Vogler Andrew J, 2010, Int J Sports Physiol Perform, V5, P342; WESTERTERP KR, 1994, EUR J APPL PHYSIOL O, V69, P203, DOI 10.1007/BF01094789; Woods A, 2016, INTERNATIONAL JOURNA; Woods AL, 2016, INT J SPORT NUTR EXE, V26, P454, DOI 10.1123/ijsnem.2015-0315	56	44	44	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173807	10.1371/journal.pone.0173807	http://dx.doi.org/10.1371/journal.pone.0173807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296943	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700066
J	Song, YN; Dong, S; Wei, B; Liu, P; Zhang, YY; Su, SB				Song, Ya-Nan; Dong, Shu; Wei, Bin; Liu, Ping; Zhang, Yong-Yu; Su, Shi-Bing			Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data	PLOS ONE			English	Article							AMINO-ACID; ALDEHYDE DEHYDROGENASES; CARBON-TETRACHLORIDE; ENERGY-METABOLISM; GLYCOLYSIS; DISEASE; FIBROGENESIS; ACTIVATION; PROFILES; PATHWAY	Aims To investigate mechanisms and altered pathways of gypenoside against carbon tetrachloride (CCl4)-induced liver fibrosis based on integrative analysis of proteomics and metabolomics data. Methods CCl4-induced liver fibrosis rats were administrated gypenoside. The anti-fibrosis effects were evaluated by histomorphology and liver hydroxyproline (Hyp) content. Protein profiling and metabolite profiling of rats liver tissues were examined by isobaric tags for relative and absolute quantitation (iTRAQ) approach and gas chromatography-mass spectrometer (GCMS) technology. Altered pathways and pivotal proteins and metabolites were searched by integrative analysis of proteomics and metabolomics data. The levels of some key proteins in altered pathways were determined by western blot. Results Histopathological changes and Hyp content in gypenoside group had significant improvements (P<0.05). Compared to liver fibrosis model group, we found 301 up-regulated and 296 down-regulated proteins, and 9 up-regulated and 8 down-regulated metabolites in gypenoside group. According to integrative analysis, some important pathways were found, including glycolysis or gluconeogenesis, fructose and mannose metabolism, glycine, serine and threonine metabolism, lysine degradation, arginine and proline metabolism, glutathione metabolism, and sulfur metabolism. Furthermore, the levels of ALDH1B1, ALDH2 and ALDH7A1 were found increased and restored to normal levels after gypenoside treated (P<0.05). Conclusions Gypenoside inhibited CCl4-induced liver fibrosis, which may be involved in the alteration of glycolysis metabolism and the protection against the damage of aldehydes and lipid peroxidation by up-regulating ALDH.	[Song, Ya-Nan; Dong, Shu; Wei, Bin; Su, Shi-Bing] Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med Complex Syst, Shanghai, Peoples R China; [Liu, Ping] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Educ Commiss, E Inst Tradit Chinese Internal Med, Shanghai, Peoples R China; [Zhang, Yong-Yu] Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med & Syst Biol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai Municipal Education Commission (SHMEC); Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Su, SB (corresponding author), Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med & Syst Biol, Shanghai, Peoples R China.	dryyz@sina.com; shibingsu07@163.com			Key Program of National Natural Science Foundation of China [81330084]; National Science and Technology Major Project of China [2009ZX09311-003]; E-institutes of Shanghai Municipal Education Commission [E03008]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; E-institutes of Shanghai Municipal Education Commission	This work was supported by Key Program of National Natural Science Foundation of China (81330084), National Science and Technology Major Project of China (2009ZX09311-003), and E-institutes of Shanghai Municipal Education Commission (E03008).	Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cao W, 2015, TOXICOL LETT, V232, P233, DOI 10.1016/j.toxlet.2014.11.009; Chen JC, 2000, AM J CHINESE MED, V28, P175, DOI 10.1142/S0192415X00000222; Dong S, 2016, J TOXICOL SCI, V41, P561, DOI 10.2131/jts.41.561; Fang HL, 2008, CLIN NUTR, V27, P900, DOI 10.1016/j.clnu.2008.08.004; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Holecek M, 2015, NUTRITION, V31, P14, DOI 10.1016/j.nut.2014.03.016; Hu YY, 1997, CHINESE J INTEGRATED, V7, P87; Hu YY, 1997, CHINESE J INTEGRATED, V7, P92; Huang THW, 2006, J BIOMED SCI, V13, P535, DOI 10.1007/s11373-006-9076-8; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Jeong DW, 2004, BIOCHEM BIOPH RES CO, V313, P984, DOI 10.1016/j.bbrc.2003.12.033; Jiang Y, 2014, J ETHNOPHARMACOL, V158, P230, DOI 10.1016/j.jep.2014.10.028; Karthikeyan S, 2015, BIOCHEMICAL AND BIOP; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Meierhofer D, 2014, J PROTEOME RES; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014; Qin RA, 2012, ARCH PHARM RES, V35, P1241, DOI 10.1007/s12272-012-0715-5; Ruan Z, 2014, AMINO ACIDS, V46, P2219, DOI 10.1007/s00726-014-1762-7; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Song YN, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/626320; Song YN, 2015, PROTEOMICS CLINICAL; Su SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13668; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Wang XJ, 2013, MOL CELL PROTEOMICS, V12, P1226, DOI 10.1074/mcp.M112.021683; Zhang FT, 2015, SCI REP-UK, V5, DOI 10.1038/srep10298; Zhao J, 2014, EXP THER MED, V7, P1388, DOI 10.3892/etm.2014.1569	31	31	33	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173598	10.1371/journal.pone.0173598	http://dx.doi.org/10.1371/journal.pone.0173598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291813	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700033
J	Egashira, A; Morita, M; Kumagai, R; Taguchi, K; Ueda, M; Yamaguchi, S; Yamamoto, M; Minami, K; Ikeda, Y; Toh, Y				Egashira, Akinori; Morita, Masaru; Kumagai, Reiko; Taguchi, Ken-ichi; Ueda, Masanobu; Yamaguchi, Shohei; Yamamoto, Manabu; Minami, Kazuhito; Ikeda, Yasuharu; Toh, Yasushi			Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases	PLOS ONE			English	Article							SMALL-CELL CARCINOMA; CANCER; PDGFRA; KIT; P53	Background Neuroendocrine carcinoma (NEC) of the esophagus is a rare and highly aggressive disease but the biological features are poorly understood. The objective of this study was to analyze the clinicopathological and immunohistochemical features of NEC of the esophagus. Methods Fourteen patients diagnosed with NEC of the esophagus from 1998 to 2013 were included in this study. Clinicopathologic features, therapeutic outcomes and immunohistochemical results were analyzed. Results Eleven out of 14 cases showed protruding or localized type with or without ulceration. Only three patients were negative for both lymph node and organ metastasis and seven cases were positive for metastases to distant organs and/or distant lymph nodes. Of the six patients with limited disease (LD), three patients were treated by surgery. Three patients with LD and seven patients with extensive disease (ED) were initially treated with chemotherapy, except for one who underwent concurrent chemo-radiotherapy due to passage disturbance. The median survival of patients with LD was 8.5 months, whereas that of patients with LD was 17 months. Among the 14 cases, 12 cases (83.3%), 13 cases (91.7%) and 12 cases (83.3%) showed positive immunostaining for choromogranin A, synaptophysin and CD56, respectively. Nine of 14 cases (64.2%) presented positive staining for c-kit and most (8/9, 88%) simultaneously showed p53 protein abnormality. Two cases were negative for c-kit and p53, and positive for CK20. Conclusion Consistent with previous reports, the prognosis of NEC of esophagus is dismal. From the results of immunohistochemical study, NEC of esophagus might be divided into two categories due to the staining positivity of c-kit and p53. This study provides new insight into the biology of NEC of the esophagus.	[Egashira, Akinori; Morita, Masaru; Yamaguchi, Shohei; Yamamoto, Manabu; Minami, Kazuhito; Ikeda, Yasuharu; Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; [Kumagai, Reiko; Taguchi, Ken-ichi] Kyushu Natl Canc Ctr, Dept Canc Pathol, Fukuoka, Japan; [Ueda, Masanobu] Kyushu Natl Canc Ctr, Dept Radiol, Fukuoka, Japan; [Egashira, Akinori] Natl Kyushu Med Ctr, Dept Surg Gastroenterol, Fukuoka, Japan		Egashira, A (corresponding author), Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Fukuoka, Japan.; Egashira, A (corresponding author), Natl Kyushu Med Ctr, Dept Surg Gastroenterol, Fukuoka, Japan.	egashira.a@kyumed.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K10126]; Grants-in-Aid for Scientific Research [15K10125, 15K10126] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K10126). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asayama M, 2011, CANCER CHEMOTH PHARM, V68, P1325, DOI 10.1007/s00280-011-1619-7; Egashira A, 2011, J SURG ONCOL, V104, P169, DOI 10.1002/jso.21920; Harmse JL, 1999, J PATHOL, V189, P176, DOI 10.1002/(SICI)1096-9896(199910)189:2<176::AID-PATH416>3.0.CO;2-U; Hou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069259; Huang Q, 2013, AM J SURG PATHOL, V37, P467, DOI 10.1097/PAS.0b013e31826d2639; Kukar M, 2013, ANN SURG ONCOL; MCKEOWN F, 1952, J PATHOL BACTERIOL, V64, P889, DOI 10.1002/path.1700640420; Micke P, 2002, LUNG CANCER, V37, P271, DOI 10.1016/S0169-5002(02)00072-7; Onuki N, 1999, CANCER, V85, P600, DOI 10.1002/(SICI)1097-0142(19990201)85:3<600::AID-CNCR10>3.0.CO;2-W; Rice TW, 2009, ESOPHAGUS ESOPHAGAST; Sadanaga N, 2009, ESOPHAGUS-TOKYO, V6, P161, DOI 10.1007/s10388-009-0197-9; Schmid M, 1997, VIRCHOWS ARCH, V430, P233, DOI 10.1007/BF01324807; Situ DR, 2013, ANN THORAC SURG, V95, P1057, DOI 10.1016/j.athoracsur.2012.11.014; Tanaka T, 2010, DIS ESOPHAGUS, V23, P502, DOI 10.1111/j.1442-2050.2009.01045.x; Terada T, 2013, INT J CLIN EXP PATHO, V6, P485; Terada T, 2011, INT J CLIN EXP PATHO, V4, P718; Theise ND, 2010, NEUROENDOCRINE NEOPL; U.I.U.A. Cancer, 2009, TNM CLASSIFICATION M; Yun JP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-38	19	31	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173501	10.1371/journal.pone.0173501	http://dx.doi.org/10.1371/journal.pone.0173501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288180	Green Published, gold, Green Submitted			2022-12-26	WOS:000396092400017
J	Karajamaki, AJ; Kettunen, O; Lepojarvi, S; Koivurova, OP; Kesaniemi, YA; Huikuri, H; Ukkola, O				Karajamaki, Aki Juhani; Kettunen, Olli; Lepojarvi, Samuli; Koivurova, Olli-Pekka; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi			Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; FIBROSIS; INFLAMMATION; DISEASE; ACTIVATION; GALECTIN-3; HYPERCOAGULABILITY; MECHANISMS; NAFLD	Background Chronic liver injury from different etiologies drives liver fibrosis. However, little is known about the associated factors, systemic factors in particular. Recently, non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation have been shown to be associated with each other. Thereby, we aimed to study the association between atrial fibrillation and liver stiffness. Study Extensive clinical measurements including echocardiography of the heart, transient elastography (TE) of the liver and the presence of atrial fibrillation were determined in elderly Finnish study subjects (n = 76, mean age 73 years) from OPERA (Oulu Project Elucidating the Risk of Atherosclerosis) study cohort. Half of the study subjects had non-alcoholic fatty liver disease, whereas others did not have any known hepatic morbidity. The present study was cross-sectional by nature. Results The subjects with atrial fibrillation had higher TE values (with atrial fibrillation TE = 9.3kPa, without atrial fibrillation TE = 6.3kPa, p = 0.018). When the cohort was divided to four subgroups (those without NAFLD or atrial fibrillation, with NAFLD but without atrial fibrillation, with both conditions, and with atrial fibrillation but without NAFLD), the TE value was the highest in the subjects with both conditions (5.3kPa, 7.4kPa, 10.8kPa and 7.8kPa, respectively, p = 0.019). Moreover, the higher the TE value, the more prevalent atrial fibrillation was (the atrial fibrillation prevalence by tertiles of TE 27% / 36% / 77%, p = 0.001). Likewise, the greater the TE value, the greater the left atrial diameter, a collateral of atrial fibrillation (left atrial diameters by tertiles of TE 39mm / 45mm / 48mm, p<0.001) was. All these p-values for continuous variables remained statistically significant even after adjustment for common clinically relevant risk factors. Conclusions There is an association between atrial fibrillation and liver stiffness. This novel association may have multiple explanations and mechanistic links, which are discussed here and need further studies, prospective studies in particular.	[Karajamaki, Aki Juhani; Lepojarvi, Samuli; Koivurova, Olli-Pekka; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi] Oulu Univ Hosp, Res Unit Internal Med, Med Res Ctr Oulu, Oulu, Finland; [Karajamaki, Aki Juhani; Lepojarvi, Samuli; Koivurova, Olli-Pekka; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi] Univ Oulu, Oulu, Finland; [Karajamaki, Aki Juhani; Kettunen, Olli; Koivurova, Olli-Pekka] Oulu Univ Hosp, Dept Internal Med, Abdominal Ctr, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Karajamaki, AJ (corresponding author), Oulu Univ Hosp, Res Unit Internal Med, Med Res Ctr Oulu, Oulu, Finland.; Karajamaki, AJ (corresponding author), Univ Oulu, Oulu, Finland.; Karajamaki, AJ (corresponding author), Oulu Univ Hosp, Dept Internal Med, Abdominal Ctr, Oulu, Finland.	aki.karajamaki@vshp.fi			Medical Association of Vaasa, Vaasa, Finland; Finnish Foundation for Cardiovascular Research	Medical Association of Vaasa, Vaasa, Finland; Finnish Foundation for Cardiovascular Research	AJK was granted from the Medical Association of Vaasa, Vaasa, Finland. The study was funded by the Finnish Foundation for Cardiovascular Research.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Anstee QM, 2008, J THROMB HAEMOST, V6, P1336, DOI 10.1111/j.1538-7836.2008.03015.x; Anstee QM, 2011, CLIN RES HEPATOL GAS, V35, P526, DOI 10.1016/j.clinre.2011.03.011; Atta HM, 2015, WORLD J GASTROENTERO, V21, P5138, DOI 10.3748/wjg.v21.i17.5138; Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fu RB, 2011, EUROPACE, V13, P31, DOI 10.1093/europace/euq346; Gonzalez-Reimers E, 2016, WORLD J GASTROENTERO, V22, P4427, DOI 10.3748/wjg.v22.i18.4427; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Gurses KM, 2015, AM J CARDIOL, V115, P647, DOI 10.1016/j.amjcard.2014.12.021; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Ho JE, 2014, AM HEART J, V167, P729, DOI 10.1016/j.ahj.2014.02.009; Iredale JP, 2014, GASTROENTEROLOGY, V146, P1160, DOI 10.1053/j.gastro.2014.03.019; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Joseph P, 2016, INT J CARDIOVAS IMAG, V32, P113, DOI 10.1007/s10554-015-0766-z; Kallergis EM, 2008, HEART, V94, P200, DOI 10.1136/hrt.2006.108688; Karajamaki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981; Kornej J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123574; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li LC, 2014, J PHARMACOL EXP THER, V351, P336, DOI 10.1124/jpet.114.218370; Liang S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00017; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lippi G, 2015, CLIN BIOCHEM, V48, P818, DOI 10.1016/j.clinbiochem.2015.04.021; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Patel P, 2010, J CARDIOVASC ELECTR, V21, P1064, DOI 10.1111/j.1540-8167.2010.01774.x; Pavlov CS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010542.pub2; Petta S, 2011, ALIMENT PHARM THER, V33, P1350, DOI 10.1111/j.1365-2036.2011.04668.x; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Rullier A, 2008, AM J PHYSIOL-GASTR L, V294, pG226, DOI 10.1152/ajpgi.00444.2007; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Spronk HMH, 2017, EUR HEART J, V38, P38, DOI 10.1093/eurheartj/ehw119; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Tripodi A, 2011, J THROMB HAEMOST, V9, P1713, DOI 10.1111/j.1538-7836.2011.04429.x; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Wijesurendra RS, 2015, CARDIOVASC RES, V105, P238, DOI 10.1093/cvr/cvv001; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00140	53	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173855	10.1371/journal.pone.0173855	http://dx.doi.org/10.1371/journal.pone.0173855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288202	Green Submitted, Green Published, gold			2022-12-26	WOS:000396092400039
J	Shang, Y; Sikorski, J; Bonkowski, M; Fiore-Donno, AM; Kandeler, E; Marhan, S; Boeddinghaus, RS; Solly, EF; Schrumpf, M; Schoning, I; Wubet, T; Buscot, F; Overmann, J				Shang, Yu; Sikorski, Johannes; Bonkowski, Michael; Fiore-Donno, Anna-Maria; Kandeler, Ellen; Marhan, Sven; Boeddinghaus, Runa S.; Solly, Emily F.; Schrumpf, Marion; Schoening, Ingo; Wubet, Tesfaye; Buscot, Francois; Overmann, Joerg			Inferring interactions in complex microbial communities from nucleotide sequence data and environmental parameters	PLOS ONE			English	Article							DIVERSITY; SOIL; BIODIVERSITY; NETWORKS	Interactions occur between two or more organisms affecting each other. Interactions are decisive for the ecology of the organisms. Without direct experimental evidence the analysis of interactions is difficult. Correlation analyses that are based on co-occurrences are often used to approximate interaction. Here, we present a new mathematical model to estimate the interaction strengths between taxa, based on changes in their relative abundances across environmental gradients.	[Shang, Yu; Sikorski, Johannes; Overmann, Joerg] Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38124 Braunschweig, Germany; [Bonkowski, Michael; Fiore-Donno, Anna-Maria] Univ Cologne, Dept Terr Ecol, Inst Zool, Zulpicher Str 47b, D-50674 Cologne, Germany; [Kandeler, Ellen; Marhan, Sven; Boeddinghaus, Runa S.] Univ Hohenheim, Inst Soil Sci & Land Evaluat, Soil Biol Sect 310b, Emil Wolff Str 27, D-70593 Stuttgart, Germany; [Solly, Emily F.; Schrumpf, Marion; Schoening, Ingo] Max Planck Inst Biogeochem, Hans Knoll Str 10, D-07745 Jena, Germany; [Wubet, Tesfaye; Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Theodor Lieser Str 4, D-06120 Halle, Germany; [Sikorski, Johannes; Wubet, Tesfaye; Buscot, Francois; Overmann, Joerg] German Ctr Integrat Biodivers Res IDiv Jena Halle, Deutsch Pl 5e, D-04103 Leipzig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Cologne; University Hohenheim; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Shang, Y (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38124 Braunschweig, Germany.	yus14@dsmz.de	Bonkowski, Michael/C-3700-2013; Schöning, Ingo/D-3341-2009; Schrumpf, Marion/C-1671-2013; Buscot, Francois/A-4125-2016; Sikorski, Johannes/AAD-9775-2019; Sikorski, Johannes/AAX-1960-2020; Wubet, Tesfaye/C-6241-2012	Bonkowski, Michael/0000-0003-2656-1183; Schöning, Ingo/0000-0002-9830-5026; Buscot, Francois/0000-0002-2364-0006; Sikorski, Johannes/0000-0002-1890-5540; Wubet, Tesfaye/0000-0001-8572-4486; Solly, Emily/0000-0002-3157-1805; Schrumpf, Marion/0000-0003-4219-4125; Fiore-Donno, Anna Maria/0000-0001-6265-1907; Kandeler, Ellen/0000-0002-2854-0012	Deutsche Forschungsgemeinschaft (DFG) [OV 20/21-1, OV 20/22-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work has been (partly) funded by the Deutsche Forschungsgemeinschaft (DFG) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (Grants No. OV 20/21-1, 22-1 http://gepris.dfg.de/gepris/projekt/252263987). J.O. received the funding. Field work permits were issued by the responsible state environmental offices of Baden-Wurttemberg, Thuringen, and Brandenburg (according to 72 BbgNatSchG).	[Anonymous], 2015, BIORXIV; Ban YG, 2015, BIOINFORMATICS, V31, P3322, DOI 10.1093/bioinformatics/btv364; Biswas S, 2015, LECT N BIOINFORMAT, V9029, P32, DOI 10.1007/978-3-319-16706-0_6; Bodelier PLE, 2013, ISME J, V7, P2214, DOI 10.1038/ismej.2013.99; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bucci V, 2014, J MOL BIOL, V426, P3907, DOI 10.1016/j.jmb.2014.03.017; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Crowther TW, 2014, GLOBAL CHANGE BIOL, V20, P2983, DOI 10.1111/gcb.12565; Daniel B, 2011, NUMERICAL ECOLOGY R; Draper N.R., 1998, APPL REGRESSION ANAL; Ellis S, 2000, IEE CONF PUBL, P1, DOI 10.1049/cp:20000093; Everitt B. S., 2002, CAMBRIDGE DICT STAT; Fang HY, 2015, BIOINFORMATICS, V31, P3172, DOI 10.1093/bioinformatics/btv349; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fiore-Donno AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19068; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Goldmann K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01300; Golub GH., 2013, MATRIX COMPUTATIONS; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Hazewinkel M., 2001, ENCY MATH; Hoppener-Ogawa S, 2009, ISME J, V3, P190, DOI 10.1038/ismej.2008.97; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; Huber PJ, 2009, WILEY SERIES PROBABI; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jansen F, 2013, J VEG SCI, V24, P1108, DOI 10.1111/jvs.12050; Jousset A, 2008, FUNCT ECOL, V22, P714, DOI 10.1111/j.1365-2435.2008.01411.x; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Levine UY, 2011, ISME J, V5, P1683, DOI 10.1038/ismej.2011.40; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MERCHUK JC, 1995, BIOTECHNOL BIOENG, V45, P91, DOI 10.1002/bit.260450113; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007; Pankaj M, 2014, PLOS ONE, V9; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Power DA, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0094-1; Regan KM, 2014, SOIL BIOL BIOCHEM, V71, P21, DOI 10.1016/j.soilbio.2013.12.024; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmidt R, 2015, ISME J, V9, P2329, DOI 10.1038/ismej.2015.42; Solly EF, 2014, PLANT SOIL, V382, P203, DOI 10.1007/s11104-014-2151-4; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Thompson F., 2013, PROKARYOTES PROKARYO, P149, DOI DOI 10.1007/978-3-642-30194-0; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tveit AT, 2015, P NATL ACAD SCI USA, V112, pE2507, DOI 10.1073/pnas.1420797112; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wust PK, 2016, APPL ENVIRON MICROB	59	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173765	10.1371/journal.pone.0173765	http://dx.doi.org/10.1371/journal.pone.0173765			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288199	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000396092400037
J	Domsch, K; Acs, A; Obermeier, C; Nguyen, HT; Reim, I				Domsch, Katrin; Acs, Andreas; Obermeier, Claudia; Nguyen, Hanh T.; Reim, Ingolf			Identification of the essential protein domains for Mib2 function during the development of the Drosophila larval musculature and adult flight muscles	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; MIND BOMB; MYOBLAST FUSION; SOMATIC MUSCULATURE; MELANOGASTER; DELTA; ZEBRAFISH; MORPHOGENESIS; ACTIVATION; MYOGENESIS	The proper differentiation and maintenance of myofibers is fundamental to a functional musculature. Disruption of numerous mostly structural factors leads to perturbations of these processes. Among the limited number of known regulatory factors for these processes is Mind bomb2 (Mib2), a muscle-associated E3 ubiquitin ligase, which was previously established to be required for maintaining the integrity of larval muscles. In this study, we have examined the mechanistic aspects of Mib2 function by performing a detailed functional dissection of the Mib2 protein. We show that the ankyrin repeats, in its entirety, and the hitherto uncharacterized Mib-specific domains (MIB), are important for the major function of Mib2 in skeletal and visceral muscles in the Drosophila embryo. Furthermore, we characterize novel mib2 alleles that have arisen from a forward genetic screen aimed at identifying regulators of myogenesis. Two of these alleles are viable, but flightless hypomorphic mib2 mutants, and harbor missense mutations in the MIB domain and RING finger, respectively. Functional analysis of these new alleles, including in vivo imaging, demonstrates that Mib2 plays an additional important role in the development of adult thorax muscles, particularly in maintaining the larval templates for the dorsal longitudinal indirect flight muscles during metamorphosis.	[Domsch, Katrin; Acs, Andreas; Obermeier, Claudia; Nguyen, Hanh T.; Reim, Ingolf] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Div Dev Biol, Erlangen, Germany; [Domsch, Katrin] Heidelberg Univ, COS Heidelberg, Heidelberg, Germany; [Acs, Andreas] Friedrich Alexander Univ Erlangen Nurnberg, Ctr Mol Med, Div Genet, Erlangen, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Reim, I (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Div Dev Biol, Erlangen, Germany.	ingolf.reim@fau.de	Reim, Ingolf/H-7873-2017	Reim, Ingolf/0000-0001-8069-5532; Domsch, Katrin/0000-0003-1040-4474	Deutsche Forschungemeinschaft [NG 92/1-1, RE 2985/1-1]; Friedrich-Alexander University of Erlangen-Nurnberg; Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU)	Deutsche Forschungemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander University of Erlangen-Nurnberg; Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU)	This research was supported by grants (NG 92/1-1 to HTN and RE 2985/1-1 to IR) from the Deutsche Forschungemeinschaft (www.dfg.de). KD received additional support provided by the "Fakultatsfrauenpreis" from the Friedrich-Alexander University of Erlangen-Nurnberg (www.fau.de). The authors acknowledge support by the Deutsche Forschungsgemeinschaft and Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU) within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anant S, 1998, DEVELOPMENT, V125, P1361; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BATE M, 1993, DEV DROSOPHILA METAN, V2, P1013; Bernard F, 2006, DEV BIOL, V295, P164, DOI 10.1016/j.ydbio.2006.03.022; Bloor JW, 2001, DEV BIOL, V239, P215, DOI 10.1006/dbio.2001.0452; Cajanek L, 2015, J CELL SCI, V128, P1674, DOI 10.1242/jcs.166496; Carrasco-Rando M, 2008, DEVELOPMENT, V135, P849, DOI 10.1242/dev.015529; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Chen WB, 2004, DEV BIOL, V267, P361, DOI 10.1016/j.ydbio.2003.11.010; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; COSTELLO WJ, 1986, DEV BIOL, V118, P247, DOI 10.1016/0012-1606(86)90092-8; CURRIE DA, 1991, DEVELOPMENT, V113, P91; Daskalaki A, 2011, J CELL BIOL, V195, P1017, DOI 10.1083/jcb.201105166; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; Dobi KC, 2015, WIRES DEV BIOL, V4, P357, DOI 10.1002/wdev.182; Domsch K, 2013, J CELL SCI, V126, P3314, DOI 10.1242/jcs.122366; Dutta D, 2004, DEVELOPMENT, V131, P3761, DOI 10.1242/dev.01249; Dutta D, 2006, MOL B INT U, P125, DOI 10.1007/0-387-32963-3_11; Fernandes JJ, 1996, DEV BIOL, V176, P166, DOI 10.1006/dbio.1996.0125; Gildor B, 2012, DEVELOPMENT, V139, P4040, DOI 10.1242/dev.077495; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hollfelder D, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-26; HOMYK T, 1988, GENETICS, V119, P105; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; KIMURA K, 1990, J NEUROSCI, V10, P403; Kocherlakota KS, 2008, GENETICS, V178, P1371, DOI 10.1534/genetics.107.083808; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; LEE JC, 1995, P NATL ACAD SCI USA, V92, P10344, DOI 10.1073/pnas.92.22.10344; McMillan BJ, 2015, MOL CELL, V57, P912, DOI 10.1016/j.molcel.2015.01.019; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; Mertz J, 2015, MOL CELL PROTEOMICS, V14, P1898, DOI 10.1074/mcp.M114.045898; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Michelet X, 2010, BIOL CELL, V102, P191, DOI 10.1042/BC20090145; Mikami S, 2015, BIOL OPEN, V4, P1576, DOI 10.1242/bio.014225; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nguyen HT, 2007, J CELL BIOL, V179, P219, DOI 10.1083/jcb.200708135; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Popichenko D, 2013, DEVELOPMENT, V140, P3156, DOI 10.1242/dev.094466; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Schulman VK, 2015, WIRES DEV BIOL, V4, P313, DOI 10.1002/wdev.180; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Tixier V, 2010, EXP CELL RES, V316, P3019, DOI 10.1016/j.yexcr.2010.07.013; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; VOLK T, 1994, DEVELOPMENT, V120, P59; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Weitkunat M, 2014, METHODS, V68, P2, DOI 10.1016/j.ymeth.2014.02.037; Weitkunat M, 2014, CURR BIOL, V24, P705, DOI 10.1016/j.cub.2014.02.032; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034	57	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173733	10.1371/journal.pone.0173733	http://dx.doi.org/10.1371/journal.pone.0173733			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282454	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800074
J	Pitti, A; Gaussier, P; Quoy, M				Pitti, Alexandre; Gaussier, Philippe; Quoy, Mathias			Iterative free-energy optimization for recurrent neural networks (INFERNO)	PLOS ONE			English	Article							BASAL GANGLIA; DECISION-MAKING; SERIAL ORDER; GAIN-FIELD; MODEL; BEHAVIOR; DYNAMICS; REPRESENTATION; ORGANIZATION; SEQUENCES	The intra-parietal lobe coupled with the Basal Ganglia forms a working memory that demonstrates strong planning capabilities for generating robust yet flexible neuronal sequences. Neurocomputational models however, often fails to control long range neural synchrony in recurrent spiking networks due to spontaneous activity. As a novel framework based on the free-energy principle, we propose to see the problem of spikes' synchrony as an optimization problem of the neurons sub-threshold activity for the generation of long neuronal chains. Using a stochastic gradient descent, a reinforcement signal (presumably dopaminergic) evaluates the quality of one input vector to move the recurrent neural network to a desired activity; depending on the error made, this input vector is strengthened to hill-climb the gradient or elicited to search for another solution. This vector can be learned then by one associative memory as a model of the basal-ganglia to control the recurrent neural network. Experiments on habit learning and on sequence retrieving demonstrate the capabilities of the dual system to generate very long and precise spatio-temporal sequences, above two hundred iterations. Its features are applied then to the sequential planning of arm movements. In line with neurobiological theories, we discuss its relevance for modeling the cortico-basal working memory to initiate flexible goal-directed neuronal chains of causation and its relation to novel architectures such as Deep Networks, Neural Turing Machines and the Free-Energy Principle.	[Pitti, Alexandre; Gaussier, Philippe; Quoy, Mathias] Univ Cergy Pontoise, ENSEA, CNRS UMR 8051, ETIS Lab, Paris, Cergy Pontoise, France	CY Cergy Paris Universite	Pitti, A (corresponding author), Univ Cergy Pontoise, ENSEA, CNRS UMR 8051, ETIS Lab, Paris, Cergy Pontoise, France.	alexandre.pitti@u-cergy.fr	Pitti, Alex/GYV-0908-2022	Pitti, Alex/0000-0002-6541-578X	EQUIPEX-ROBOTEX (CNRS); chaire d'excellence CNRS-UCP; project Labex MME-DII [ANR11-LBX-0023-01]	EQUIPEX-ROBOTEX (CNRS); chaire d'excellence CNRS-UCP; project Labex MME-DII	This work was partially funded by EQUIPEX-ROBOTEX (CNRS), chaire d'excellence CNRS-UCP and project Labex MME-DII (ANR11-LBX-0023-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Souheil Hanoune and Karl Friston as well as the reviewers for interesting comments and fruitful feedback on anterior versions of the paper. This work was partially funded by EQUIPEX-ROBOTEX (CNRS), chaire d'excellence CNRS-UCP and project Labex MME-DII (ANR11-LBX-0023-01).	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barto A.G., 1997, ADV PSYCHOL, V121, P358; Benedek M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22959; Blohm G, 2009, NEURON, V64, P598, DOI 10.1016/j.neuron.2009.11.022; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; BURNOD Y, 1992, J NEUROSCI, V12, P1435; Buschman TJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0471; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Chersi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027652; Clark A., 2015, SURFING UNCERTAINTY, VReprint; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dehaene S, 2015, NEURON, V88, P2, DOI 10.1016/j.neuron.2015.09.019; den Ouden HEM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00548; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Diederich A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00697; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Friston Karl, 2012, Front Neurorobot, V6, P11, DOI 10.3389/fnbot.2012.00011; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Friston KJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00130; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gershman SJ, 2014, J EXP PSYCHOL GEN, V143, P182, DOI 10.1037/a0030844; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Graves A, 2014, 1410541V2 ARXIV; Graves A, 2016, NATURE, V538, P471, DOI 10.1038/nature20101; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Guthrie M, 2013, J NEUROPHYSIOL, V109, P3025, DOI 10.1152/jn.00026.2013; Hawkins J, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00023; Hinaut X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052946; Hirel J, 2013, NEURAL NETWORKS, V43, P8, DOI 10.1016/j.neunet.2013.01.023; Humphries MD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00009; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; JAEGER D, 1993, EXP BRAIN RES, V95, P51; KANEKO K, 2000, COMPLEX SYSTEMS CHAO; Kelso S., 1995, DYNAMIC PATTERNS SEL; Khamassi M, 2005, ADAPT BEHAV, V13, P131, DOI 10.1177/105971230501300205; Koechlin E, 2016, CURR OPIN NEUROBIOL, V37, P1, DOI 10.1016/j.conb.2015.11.004; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kuniyoshi Y, 2011, P INT JOINT C NEUR N, P1; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maass W, 2016, CURR OPIN BEHAV SCI, V11, P81, DOI 10.1016/j.cobeha.2016.06.003; Mannella F, 2015, BIOL CYBERN, V109, P575, DOI 10.1007/s00422-015-0662-6; Miller E, 2015, DIALOGUES CLIN NEURO, V15, P411; Orban G, 2011, CURR OPIN NEUROBIOL, V21, P629, DOI 10.1016/j.conb.2011.05.026; Pezzulo G, 2016, TRENDS COGN SCI, V20, P414, DOI 10.1016/j.tics.2016.03.013; Pezzulo G, 2014, TRENDS COGN SCI, V18, P647, DOI 10.1016/j.tics.2014.06.011; Pitti A, 2008, EUR PHYS J B, V63, P239, DOI 10.1140/epjb/e2008-00238-2; Pitti A, 2009, NEURAL NETWORKS, V22, P144, DOI 10.1016/j.neunet.2009.01.007; Pitti A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00771; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Poldrack RA, 2002, ANNU REV NEUROSCI, V25, P563; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rabinovich MI, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00024; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rolfe J, 2013, 3775V4 ARXIV; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Rueckert E, 2016, SCI REP-UK, V6, DOI 10.1038/srep21142; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Sandamirskaya Y, 2010, NEURAL NETWORKS, V23, P1164, DOI 10.1016/j.neunet.2010.07.012; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Spratling MW, 2016, COGN PROCESS, V17, P279, DOI 10.1007/s10339-016-0765-6; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Tani J, 2004, NEURAL NETWORKS, V17, P1273, DOI 10.1016/j.neunet.2004.05.007; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Topalidou M, 2015, RESCIENCE; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; Tsuda I., 1991, WORLD FEATURE, V31, P105; Tsuda Ichiro, 2004, Journal of Integrative Neuroscience, V3, P159, DOI 10.1142/S021963520400049X; Tsuda I, 2015, CURR OPIN NEUROBIOL, V31, P67, DOI 10.1016/j.conb.2014.08.011; van Hateren JH, 2015, BIOL CYBERN, V109, P33, DOI 10.1007/s00422-014-0622-6; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; Varona P, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0475; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Zylberberg A, 2013, PAP PHYS-LA PLATA, V5, DOI 10.4279/PIP.050006; Zylberberg A, 2011, TRENDS COGN SCI, V15, P293, DOI 10.1016/j.tics.2011.05.007	98	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173684	10.1371/journal.pone.0173684	http://dx.doi.org/10.1371/journal.pone.0173684			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282439	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800068
J	Tian, DD; Jiang, R; Chen, XJ; Ye, Q				Tian, Dan-dan; Jiang, Rong; Chen, Xue-jun; Ye, Qing			Meteorological factors on the incidence of MP and RSV pneumonia in children	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-INFECTIONS; HOSPITALIZED CHILDREN; VIRUSES	Background Pneumonia is common in children and mostly caused by many pathogens. The aim of this study was to investigate whether the incidence of pediatric mycoplasma pneumoniae (MP) pneumonia and respiratory syncytial virus (RSV) pneumonia was associated with meteorological factors in Hangzhou, China. Methods A total of 36500 pneumonia patients were recruited to participate in the study. Nasopharyngeal swabs were collected for the detection of MP and RSV using real-time polymerase chain reaction (RT-PCR) and direct immunofluorescence (DIF) assays, respectively. We used a distributed lag non-linear model (DLNM) to evaluate the correlations between the MP/RSV incidence and meteorological factors. Results The detection rates of MP and RSV were 18.4% and 10.4%, respectively. There was a positive correlation between temperature and the MP infection rate, but RSV infection rate was negatively associated with temperature. Moreover, the impact of temperature on infection with RSV presented evident lag and cumulative effects. There was also an evident lag effect of temperature on the infection rate of MP; however, there was no evident cumulative effect. Conclusions In this study, the results showed meteorological factors play an important role in the incidence of these two pathogens. All these results can provide the laboratory basis for the early diagnosis and treatment of pneumonia in children.	[Tian, Dan-dan; Jiang, Rong; Chen, Xue-jun; Ye, Qing] Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Ye, Q (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China.	qingye@zju.edu.cn			National Natural Science Foundation of China [81501760]; Zhejiang Provincial Healthy Science Foundation of China [2015KYB191]; Zhejiang Provincial Natural Science Foundation of China [LQ16H050002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Healthy Science Foundation of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This project was funded by grants from the National Natural Science Foundation of China (Grant No. 81501760), Zhejiang Provincial Healthy Science Foundation of China (Grant No. 2015KYB191), and Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ16H050002). Qing Ye received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cui BL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0863-6; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Gasparrini A, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-55; Ji Wei, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P205; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kochanek KD, 2009, NATL VITAL STAT REP, V59, P1; Lin YK, 2013, ENVIRON RES, V120, P109, DOI 10.1016/j.envres.2012.09.002; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P839, DOI 10.3109/00365548.2010.498020; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Xu YC, 2011, WORLD J PEDIATR, V7, P240, DOI 10.1007/s12519-011-0318-0; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X; Zhang HY, 2009, JPN J INFECT DIS, V62, P458; Zou LR, 2012, APMIS, V120, P683, DOI 10.1111/j.1600-0463.2012.02890.x	18	24	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e173409	10.1371/journal.pone.0173409	http://dx.doi.org/10.1371/journal.pone.0173409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282391	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800039
J	Clair, MP; Rambaud, J; Flahault, A; Guedj, R; Guilbert, J; Guellec, I; Durandy, A; Demoulin, M; Jean, S; Mitanchez, D; Chalard, F; Sileo, C; Carbajal, R; Renolleau, S; Leger, PL				Clair, Marie-Philippine; Rambaud, Jerome; Flahault, Adrien; Guedj, Romain; Guilbert, Julia; Guellec, Isabelle; Durandy, Amelie; Demoulin, Maryne; Jean, Sandrine; Mitanchez, Delphine; Chalard, Francois; Sileo, Chiara; Carbajal, Ricardo; Renolleau, Sylvain; Leger, Pierre-Louis			Prognostic value of cerebral tissue oxygen saturation during neonatal extracorporeal membrane oxygenation	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; RESPIRATORY-FAILURE; CARBON-DIOXIDE; CHILDREN; INJURY; BRAIN; CANNULATION; ECMO	Objectives Extracorporeal membrane oxygenation support is indicated in severe and refractory respiratory or circulatory failures. Neurological complications are typically represented by acute ischemic or hemorrhagic lesions, which induce higher morbidity and mortality. The primary goal of this study was to assess the prognostic value of cerebral tissue oxygen saturation (StcO(2)) on mortality in neonates and young infants treated with ECMO. A secondary objective was to evaluate the association between StcO(2) and the occurrence of cerebral lesions. Study design This was a prospective study in infants < 3 months of age admitted to a pediatric intensive care unit and requiring ECMO support. Measurements The assessment of cerebral perfusion was made by continuous StcO(2) monitoring using near-infrared spectroscopy (NIRS) sensors placed on the two temporo-parietal regions. Neurological lesions were identified by MRI or transfontanellar echography. Results Thirty-four infants < 3 months of age were included in the study over a period of 18 months. The ECMO duration was 10 +/- 7 days. The survival rate was 50% (17/34 patients), and the proportion of brain injuries was 20% (7/34 patients). The mean StcO(2) during ECMO in the non-survivors was reduced in both hemispheres (p = 0.0008 right, p = 0.03 left) compared to the survivors. StcO(2) was also reduced in deceased or brain-injured patients compared to the survivors without brain injury (p = 0.002). Conclusion StcO(2) appears to be a strong prognostic factor of survival and of the presence of cerebral lesions in young infants during ECMO.	[Clair, Marie-Philippine; Rambaud, Jerome; Guilbert, Julia; Guellec, Isabelle; Durandy, Amelie; Demoulin, Maryne; Jean, Sandrine; Carbajal, Ricardo; Leger, Pierre-Louis] Trousseau Hosp, AP HP, Dept Neonatal, Paris, France; [Clair, Marie-Philippine; Rambaud, Jerome; Guilbert, Julia; Guellec, Isabelle; Durandy, Amelie; Demoulin, Maryne; Jean, Sandrine; Carbajal, Ricardo; Leger, Pierre-Louis] Trousseau Hosp, AP HP, Pediat Intens Care Unit, Paris, France; [Flahault, Adrien] CIRB, INSERM, Lab Cent Neuropeptides Regulat Body Fluid Homeost, U1050, Paris, France; [Flahault, Adrien] CNRS, UMR 7241, Paris, France; [Guedj, Romain; Carbajal, Ricardo] Trousseau Hosp, AP HP, Dept Emergency Med, Paris, France; [Mitanchez, Delphine] Trousseau Hosp, AP HP, Dept Neonatol, Paris, France; [Chalard, Francois; Sileo, Chiara] Trousseau Hosp, AP HP, Dept Pediat Radiol, Paris, France; [Carbajal, Ricardo] UPMC Pierre & Marie Curie Univ, Paris VI, France; [Renolleau, Sylvain] Hop Necker Enfants Malad, AP HP, Dept Pediat Intens Care Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Leger, PL (corresponding author), Trousseau Hosp, AP HP, Dept Neonatal, Paris, France.; Leger, PL (corresponding author), Trousseau Hosp, AP HP, Pediat Intens Care Unit, Paris, France.	pierre-louis.leger@aphp.fr	ISABELLE, GUELLEC/EXE-5877-2022; Flahault, Adrien/Q-4576-2017; Guedj, Romain/AAE-1419-2021; Chalard, François/GNH-5041-2022	Flahault, Adrien/0000-0003-4632-6332; Guedj, Romain/0000-0002-9497-4396; Rambaud, Jerome/0000-0001-5906-9107; Sileo, Chiara/0000-0001-6406-1951				Amigoni A, 2005, PEDIATR NEUROL, V32, P173, DOI 10.1016/j.pediatrneurol.2004.10.002; Ariturk C, 2014, HEART SURG FORUM, V17, pE169, DOI 10.1532/HSF98.2014319; Austin EH, 1997, J THORAC CARDIOV SUR, V114, P707, DOI 10.1016/S0022-5223(97)70074-6; AUSTIN EH, 1997, J THORAC CARDIOVASC, V114, P715, DOI DOI 10.1016/S0022-5223(97)70074-6; Brambrink A, 2010, ANESTHESIOLOGY, V112, P274, DOI 10.1097/ALN.0b013e3181ca8273; BRAZY JE, 1986, J PEDIATR-US, V108, P983, DOI 10.1016/S0022-3476(86)80944-1; CAMPBELL LR, 1988, J PEDIATR-US, V113, P110, DOI 10.1016/S0022-3476(88)80543-2; Chakravarti S, 2008, SEMIN CARDIOTHORAC V, V12, P70, DOI 10.1177/1089253208316444; Fenik JC, 2009, J PERINATOL, V29, P376, DOI 10.1038/jp.2008.231; Hayashida M, 2004, BRIT J ANAESTH, V92, P662, DOI 10.1093/bja/aeh120; Hirsch JC, 2009, J THORAC CARDIOV SUR, V137, P154, DOI 10.1016/j.jtcvs.2008.08.005; Leger PL, 2013, ARTIF ORGANS, V37, P57, DOI 10.1111/aor.12024; Liem K D, 1995, Acta Anaesthesiol Scand Suppl, V107, P157; Maldonado Y, 2014, CURR OPIN ANESTHESIO, V27, P81, DOI 10.1097/ACO.0000000000000035; Mehta Amit, 2013, World J Crit Care Med, V2, P40, DOI 10.5492/wjccm.v2.i4.40; Nasr DM, 2015, J CLIN NEUROL, V11, P383, DOI 10.3988/jcn.2015.11.4.383; Phelps HM, 2009, ANN THORAC SURG, V87, P1490, DOI 10.1016/j.athoracsur.2009.01.071; Quarti A, 2013, PERFUSION-UK, V28, P152, DOI 10.1177/0267659112464382; Raets MMA, 2013, PEDIATR CRIT CARE ME, V14, P884, DOI 10.1097/PCC.0b013e3182a555ac; Rollins MD, 2012, J PEDIATR SURG, V47, P68, DOI 10.1016/j.jpedsurg.2011.10.017; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; SHORT BL, 1993, PEDIATR RES, V33, P289, DOI 10.1203/00006450-199303000-00018; Short BL, 2005, SEMIN PERINATOL, V29, P45, DOI 10.1053/j.semperi.2005.02.007; Skarsgard ED, 2004, J PEDIATR SURG, V39, P672, DOI 10.1016/j.jpedsurg.2004.01.033; Soll RF, 1996, LANCET, V348, P70; Sood ED, 2013, J THORAC CARDIOV SUR, V145, P438, DOI 10.1016/j.jtcvs.2012.10.033; Wong JK, 2012, ARTIF ORGANS, V36, P659, DOI 10.1111/j.1525-1594.2012.01496.x; Zulueta JL, 2013, J CARDIAC SURG, V28, P446, DOI 10.1111/jocs.12122	28	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172991	10.1371/journal.pone.0172991	http://dx.doi.org/10.1371/journal.pone.0172991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE2BH	28278259	Green Published, gold, Green Submitted			2022-12-26	WOS:000431020000001
J	Mattie, J; Borisoff, J; Miller, WC; Noureddin, B				Mattie, Johanne; Borisoff, Jaimie; Miller, William C.; Noureddin, Borna			Characterizing the community use of an ultralight wheelchair with "on the fly" adjustable seating functions: A pilot study	PLOS ONE			English	Article							TILT-IN-SPACE; MANUAL WHEELCHAIR; RESNA POSITION; MOBILITY; PARTICIPATION; VALIDATION; BEHAVIORS; RECLINE	An ultralight manual wheelchair that allows users to independently adjust rear seat height and backrest angle during normal everyday usage was recently commercialized. Prior research has been performed on wheelchair tilt, recline, and seat elevation use in the community, however no such research has been done on this new class of manual ultralight wheelchair with "on the fly" adjustments. The objective of this pilot study was to investigate and characterize the use of the two adjustable seating functions available on the Elevation T ultralight dynamic wheelchair during its use in the community. Eight participants had data loggers installed onto their own wheelchair for seven days to measure rear seat height, backrest angle position, occupied sitting time, and distance traveled. Analysis of rear seat height and backrest adjustment data revealed considerable variability in the frequency of use and positions used by participants. There was a wide spread of mean daily rear seat heights among participants, from 34.1 cm to 46.7 cm. Two sub-groups of users were further identified: those who sat habitually at a single typical rear seat height, and those who varied their rear seat height more continuously. Findings also showed that participants used the rear seat height adjustment feature significantly more often than the backrest adjustment feature. This obvious contrast in feature use may indicate that new users of this class of wheelchair may benefit from specific training. While the small sample size and exploratory nature of this study limit the generalizability of our results, our findings offer a first look at how active wheelchairs users are using a new class of ultralight wheelchair with "on the fly" seating adjustments in their communities. Further studies are recommended to better understand the impact of dynamic seating and positioning on activity, participation and quality of life.	[Mattie, Johanne; Noureddin, Borna] British Columbia Inst Technol, MAKE, Burnaby, BC, Canada; [Borisoff, Jaimie; Miller, William C.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Fac Med, Vancouver, BC, Canada; [Borisoff, Jaimie; Miller, William C.] Int Collaborat Repair Discoveries, Vancouver, BC, Canada; [Borisoff, Jaimie] British Columbia Inst Technol, Canada Res Chair Rehabil Engn Design, Burnaby, BC, Canada; [Borisoff, Jaimie] Univ British Columbia, Biomed Engn Program, Vancouver, BC, Canada; [Miller, William C.] GF Strong Rehabil Res Lab, Vancouver, BC, Canada	British Columbia Institute of Technology; University of British Columbia; British Columbia Institute of Technology; University of British Columbia	Borisoff, J (corresponding author), Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Fac Med, Vancouver, BC, Canada.	Jaimie_Borisoff@bcit.ca	Miller, William/S-7407-2019		Canada Research Chair in Rehabilitation Engineering Design; National Science and Engineering Research Council of Canada -NSERC [RGPIN 418586-2013]; BCIT Discovery Parks Fund	Canada Research Chair in Rehabilitation Engineering Design; National Science and Engineering Research Council of Canada -NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BCIT Discovery Parks Fund	This project has been supported by the Canada Research Chair in Rehabilitation Engineering Design (JB) (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx); National Science and Engineering Research Council of Canada -NSERC grant # RGPIN 418586-2013 (JB) (http://www.nserc-crsng.gc.ca/index _eng.asp) and the BCIT Discovery Parks Fund (JB), (http://www. bcit.ca/appliecresearch/funding/institute.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arva J, 2009, ASSIST TECHNOL, V21, P69, DOI 10.1080/10400430902945587; Best KL, 2005, ARCH PHYS MED REHAB, V86, P2316, DOI 10.1016/j.apmr.2005.07.300; Borisoff JF, 2011, P RESNA 2011 ANN C 2; Carlson Dawn, 2002, TOP SPINAL CORD INJ, V7, P28, DOI DOI 10.1310/4VAG-D0BF-QLU5-Y1LT; Chaves ES, 2004, ARCH PHYS MED REHAB, V85, P1854, DOI 10.1016/j.apmr.2004.03.033; Collin C, 1988, Int Disabil Stud, V10, P61; Cooper RA, 2011, ASSIST TECHNOL, V23, P177, DOI 10.1080/10400435.2011.588991; Dicianno BE, 2009, ASSIST TECHNOL, V21, P13, DOI 10.1080/10400430902945769; Ding D, 2005, P 27 ANN INT C IEEE; Ding D, 2008, J REHABIL RES DEV, V45, P973, DOI 10.1682/JRRD.2007.11.0178; Fitzgerald SG, 2005, J REHABIL RES DEV, V42, P853, DOI 10.1682/JRRD.2004.10.0130; Frank AO, 2012, DISABIL REHABIL, V34, P770, DOI 10.3109/09638288.2011.619620; Hong EK, 2011, ASSIST TECHNOL, V23, P24, DOI 10.1080/10400435.2010.541405; Janssen-Potten YJM, 2000, ARCH PHYS MED REHAB, V81, P401, DOI 10.1053/mr.2000.3859; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kroemer KHE, 1994, HARD FACTS SOFT MACH, P181; Lueder R, 2005, ERGONOMICS OF SITTIN; MacPhee AH, 2004, ARCH PHYS MED REHAB, V85, P41, DOI 10.1016/S0003-9993(03)00364-2; Marshall S, 2010, AM J PREV MED, V39, P389, DOI 10.1016/j.amepre.2010.07.001; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Mills T, 2002, DISABIL REHABIL, V24, P38, DOI 10.1080/09638280110066334; Mills TL, 2007, ASSIST TECHNOL, V19, P61, DOI 10.1080/10400435.2007.10131866; Oyster ML, 2011, ARCH PHYS MED REHAB, V92, P484, DOI 10.1016/j.apmr.2010.09.025; Paralyzed Veterans of America Consortium for Spinal Cord Medicine, 2005, J Spinal Cord Med, V28, P434; PDG Mobility, 2012, PDG MOB WHEELCH FUNC; Sakakibara BM, 2013, ARCH PHYS MED REHAB, V94, P1031, DOI 10.1016/j.apmr.2013.01.016; Smith EM, 2014, DISABIL REHABIL ASSI, V11, P1; Sonenblum SE, 2008, ARCH PHYS MED REHAB, V89, P486, DOI 10.1016/j.apmr.2007.09.029; Sonenblum SE, 2011, DISABIL REHABIL-ASSI, V6, P526, DOI 10.3109/17483107.2011.580900; Sprigle S, 2013, DISABIL REHABIL-ASSI, V8, P225, DOI 10.3109/17483107.2012.713436; Tolerico ML, 2007, J REHABIL RES DEV, V44, P561, DOI 10.1682/JRRD.2006.02.0017; Wee J, 2009, DISABIL REHABIL, V31, P1633, DOI 10.1080/09638280902736346; Yang YS, 2009, SPINAL CORD, V47, P67, DOI 10.1038/sc.2008.72	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173662	10.1371/journal.pone.0173662	http://dx.doi.org/10.1371/journal.pone.0173662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278254	Green Submitted, gold, Green Published			2022-12-26	WOS:000396087900025
J	Nickerson, KM; Wang, YJ; Bastacky, S; Shlomchik, MJ				Nickerson, Kevin M.; Wang, Yujuan; Bastacky, Sheldon; Shlomchik, Mark J.			Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice	PLOS ONE			English	Article							ANTI-RNA AUTOANTIBODY; AUTOREACTIVE B-CELLS; INDUCED MURINE LUPUS; GERMINAL-CENTERS; DENDRITIC CELLS; MOUSE MODEL; T-CELLS; SYSTEMIC AUTOIMMUNITY; SOMATIC HYPERMUTATION; INTRINSIC TLR7	Genetic deficiency in TLR9 accelerates pathogenesis in the spontaneous polygenic MRL. Fas(lpr) murine model of systemic lupus erythematosus, despite the absence of anti-nucleosome autoantibodies. However, it could be argued that this result was dependent on Fas-deficiency rather than lupus-promoting genes in the MRL genetic background. Here we report the effects of TLR9 deficiency on autoimmune disease independent of the lpr mutation in Fas by characterizing Tlr9(-/-) and Tlr9(+/+) mice on the Fas-intact MRL/+ genetic background. By 30 weeks of age, Tlr9-deficient MRL/+ had more severe renal disease, increased T cell activation, and higher titers of anti-Sm and anti-RNA autoantibodies than Tlr9-intact animals, as had been the case in the MRL. Fas(lpr) model. In addition, Tlr9-deficient MRL/+ mice had increased numbers of germinal center phenotype B cells and an increase in splenic neutrophils and conventional dendritic cell populations. Thus, the disease accelerating effects of Tlr9 deficiency are separable from those mediated by the Fas mutation in the lupus-prone MRL genetic background. Nonetheless, disease acceleration in Tlr9-deficient MRL/+ mice was phenotypically distinct from that in Fas-deficient counterparts, which has important implications.	[Nickerson, Kevin M.; Wang, Yujuan; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Bastacky, Sheldon] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nickerson, KM (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA.	kevin.nickerson@pitt.edu	Shlomchik, Mark J./AAN-6189-2020; Nickerson, Kevin M/B-1351-2009	Shlomchik, Mark J./0000-0002-2152-0959; Nickerson, Kevin M/0000-0002-0114-2671	National Institutes of Health [7R01A1084958, 1R37A1118841]; Kidney Imaging Core of the Pittsburgh Center for Kidney Research (NIH) [P30DK079307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI118841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kidney Imaging Core of the Pittsburgh Center for Kidney Research (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work supported by National Institutes of Health (www://nih.gov) grants 7R01A1084958 and 1R37A1118841 (MJS) and in part by the Kidney Imaging Core of the Pittsburgh Center for Kidney Research (NIH grant P30DK079307) (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Bossaller L, 2016, J IMMUNOL, V197, P1044, DOI 10.4049/jimmunol.1501943; Brint E, 2013, CELL MOL LIFE SCI, V70, P4085, DOI 10.1007/s00018-013-1327-z; Buechler MB, 2013, J IMMUNOL, V190, P886, DOI 10.4049/jimmunol.1202739; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Chan OTM, 1999, J IMMUNOL, V163, P3592; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Desnues B, 2014, P NATL ACAD SCI USA, V111, P1497, DOI 10.1073/pnas.1314121111; EISENBERG RA, 1978, J EXP MED, V147, P582, DOI 10.1084/jem.147.2.582; Freeley SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074112; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Han JH, 2014, EUR J IMMUNOL, V44, P215, DOI 10.1002/eji.201343714; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; IZUI S, 1984, J IMMUNOL, V133, P227; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Joosten LAB, 2016, NAT REV RHEUMATOL, V12, P344, DOI 10.1038/nrrheum.2016.61; Khan WN, 2013, IMMUNOL RES, V57, P335, DOI 10.1007/s12026-013-8466-z; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Lartigue A, 2006, J IMMUNOL, V177, P1349, DOI 10.4049/jimmunol.177.2.1349; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Martina MN, 2015, IMMUNOL CELL BIOL, V93, P305, DOI 10.1038/icb.2014.99; Nickerson KM, 2013, J IMMUNOL, V190, P3889, DOI 10.4049/jimmunol.1203525; Nickerson KM, 2013, J IMMUNOL, V190, P1447, DOI 10.4049/jimmunol.1202115; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Nickerson KM, 2016, ENCY IMMUNOBIOLOGY, V5, P227; Nundel K, 2015, J IMMUNOL, V194, P2504, DOI 10.4049/jimmunol.1402425; Ols ML, 2016, IMMUNITY, V45, P1052, DOI 10.1016/j.immuni.2016.10.005; Peng SL, 1998, CLIN EXP IMMUNOL, V111, P107; Pillai S, 2011, CURR OPIN IMMUNOL, V23, P721, DOI 10.1016/j.coi.2011.10.007; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Relle M, 2015, AUTOIMMUN REV, V14, P1005, DOI 10.1016/j.autrev.2015.07.003; Sang A, 2014, MOL IMMUNOL, V62, P329, DOI 10.1016/j.molimm.2013.11.013; Sang A, 2014, J IMMUNOL, V193, P1609, DOI 10.4049/jimmunol.1303000; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P339, DOI 10.1016/j.jaut.2009.11.001; Shah S, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0462-4; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Soni C, 2014, J IMMUNOL, V193, P4400, DOI 10.4049/jimmunol.1401720; Stoehr AD, 2011, J IMMUNOL, V187, P2953, DOI 10.4049/jimmunol.1003340; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Sweet RA, 2011, P NATL ACAD SCI USA, V108, P7932, DOI 10.1073/pnas.1018571108; Sweet RA, 2010, AUTOIMMUNITY, V43, P607, DOI 10.3109/08916930903567500; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Walsh ER, 2012, P NATL ACAD SCI USA, V109, P16276, DOI 10.1073/pnas.1209372109; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; WOFSY D, 1984, J EXP MED, V159, P629, DOI 10.1084/jem.159.2.629; Yu P, 2006, INT IMMUNOL, V18, P1211, DOI 10.1093/intimm/dxl067	57	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173471	10.1371/journal.pone.0173471	http://dx.doi.org/10.1371/journal.pone.0173471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278279	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900098
J	Lee, Y; Fluckey, JD; Chakraborty, S; Muthuchamy, M				Lee, Yang; Fluckey, James D.; Chakraborty, Sanjukta; Muthuchamy, Mariappan			Hyperglycemia- and hyperinsulinemia-induced insulin resistance causes alterations in cellular bioenergetics and activation of inflammatory signaling in lymphatic muscle	FASEB JOURNAL			English	Article						metabolism; lymphatic contractility; insulin signaling; glycolysis; signal transduction	VASCULAR SMOOTH-MUSCLE; GLUCOSE-TRANSPORTER GLUT4; PERINUCLEAR STORAGE COMPARTMENT; OXIDATIVE STRESS; SKELETAL-MUSCLE; PROTEIN-KINASE; ADIPOSE-TISSUE; METABOLIC SYNDROME; MICE LACKING; RAT MODEL	Insulin resistance is a well-known risk factor for obesity, metabolic syndrome (MetSyn) and associated cardiovascular diseases, but its mechanisms are undefined in the lymphatics. Mesenteric lymphatic vessels from MetSyn or LPS-injected rats exhibited impaired intrinsic contractile activity and associated inflammatory changes. Hence, we hypothesized that insulin resistance in lymphatic muscle cells (LMCs) affects cell bioenergetics and signaling pathways that consequently alter contractility. LMCs were treated with different concentrations of insulin or glucose or both at various time points to determine insulin resistance. Onset of insulin resistance significantly impaired glucose uptake, mitochondrial function, oxygen consumption rates, glycolysis, lactic acid, and ATP production in LMCs. Hyperglycemia and hyperinsulinemia also impaired the PI3K/Akt while enhancing the ERK/p38MAPK/JNK pathways in LMCs. Increased NF-kappa B nuclear translocation and macrophage chemoattractant protein-1 and VCAM-1 levels in insulin-resistant LMCs indicated activation of inflammatory mechanisms. In addition, increased phosphorylation of myosin light chain-20, a key regulator of lymphatic muscle contraction, was observed in insulin-resistant LMCs. Therefore, our data elucidate the mechanisms of insulin resistance in LMCs and provide the first evidence that hyperglycemia and hyperinsulinemia promote insulin resistance and impair lymphatic contractile status by reducing glucose uptake, altering cellular metabolic pathways, and activating inflammatory signaling cascades.-Lee, Y., Fluckey, J.D., Chakraborty, S., Muthuchamy, M. Hyperglycemia- and hyperinsulinemia-induced insulin resistance causes alterations in cellular bioenergetics and activation of inflammatory signaling in lymphatic muscle.	[Lee, Yang; Chakraborty, Sanjukta; Muthuchamy, Mariappan] Texas A&M Univ, Dept Med Physiol, College Stn, TX USA; [Fluckey, James D.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Chakraborty, S; Muthuchamy, M (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Med Physiol, College Stn, TX 77843 USA.	schakraborty@medicine.tamhsc.edu; marim@tamu.edu	Chakraborty, Sanjukta/AFO-9240-2022	Chakraborty, Sanjukta/0000-0002-4869-3198; Lee, Yang/0000-0002-8004-338X	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [RO1 DK99221]; Department of Medical Physiology, Lymphatic Graduate Student Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099221] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Medical Physiology, Lymphatic Graduate Student Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Texas A&M Health Science Center Integrated Microscopy and Imaging Laboratory, Texas A&M Image Analysis Laboratory, and Texas A&M Qualitative Biology Facility Core for their technical support. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant RO1 DK99221 (to M.M.) and Department of Medical Physiology, Lymphatic Graduate Student Fellowship (to Y.L.). The authors declare no conflicts of interest.	Arngrim N, 2013, INT J OBESITY, V37, P748, DOI 10.1038/ijo.2012.98; Aroor AR, 2014, DIABETES, V63, P2216, DOI 10.2337/db14-0424; Avogaro A, 2008, FREE RADICAL BIO MED, V44, P1209, DOI 10.1016/j.freeradbiomed.2007.12.021; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Chakraborty S, 2015, AM J PHYSIOL-HEART C, V309, pH2042, DOI 10.1152/ajpheart.00467.2015; Chakraborty S, 2015, AM J PHYSIOL-CELL PH, V309, pC680, DOI 10.1152/ajpcell.00122.2015; Chakraborty S, 2015, SEMIN CELL DEV BIOL, V38, P55, DOI 10.1016/j.semcdb.2015.01.005; Chakraborty S, 2011, MICROCIRCULATION, V18, P24, DOI 10.1111/j.1549-8719.2010.00064.x; Chakraborty S, 2010, ANN NY ACAD SCI, V1207, pE94, DOI 10.1111/j.1749-6632.2010.05752.x; Chen RC, 2015, DIABETES RES CLIN PR, V108, P235, DOI 10.1016/j.diabres.2015.02.012; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Davidoff AJ, 2004, MOL CELL BIOCHEM, V262, P155, DOI 10.1023/B:MCBI.0000038231.68078.4b; Davidoff AJ, 1997, AM J PHYSIOL-HEART C, V272, pH159, DOI 10.1152/ajpheart.1997.272.1.H159; de Figueiredo ASP, 2015, J BIOL CHEM, V290, P13427, DOI 10.1074/jbc.M114.626077; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Egawa K, 2001, J BIOL CHEM, V276, P10207, DOI 10.1074/jbc.M009489200; Fulton DJR, 2009, CIRC RES, V104, P1035, DOI 10.1161/CIRCRESAHA.109.198028; Gardner SE, 2015, ARTERIOSCL THROM VAS, V35, P1963, DOI 10.1161/ATVBAHA.115.305896; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; HENRY RR, 1990, DIABETES, V39, P149, DOI 10.2337/diabetes.39.2.149; Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; International Diabetes Federation Task Force on Epidemiology and Prevention, 2009, CIRCULATION; Izawa Y, 2005, EXP CELL RES, V308, P291, DOI 10.1016/j.yexcr.2005.04.028; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Lee JH, 2006, AM J PHYSIOL-CELL PH, V291, pC1355, DOI 10.1152/ajpcell.00125.2006; Lee JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1371, DOI 10.1152/ajpcell.00254.2011; Lee JH, 2009, AM J PHYSIOL-CELL PH, V296, pC327, DOI 10.1152/ajpcell.00254.2008; Li H, 2014, EXP BIOL MED, V239, P954, DOI 10.1177/1535370214527903; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liu YH, 2013, BIOCHEM BIOPH RES CO, V438, P78, DOI 10.1016/j.bbrc.2013.07.029; Lloyd PG, 1999, PHYSIOL RES, V48, P401; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Martinez-Arca S, 2000, J CELL SCI, V113, P1705; Martinez-Hervas S, 2014, CARDIOVASC RES, V103, P324, DOI 10.1093/cvr/cvu115; Merdzo I, 2016, AM J PHYSIOL-HEART C, V310, pH830, DOI 10.1152/ajpheart.00964.2015; Muthuchamy M, 2003, FASEB J, V17, P920, DOI 10.1096/fj.02-0626fje; Muthuchamy M, 2008, ANN NY ACAD SCI, V1131, P89, DOI 10.1196/annals.1413.008; Nadler ST, 2001, AM J PHYSIOL-ENDOC M, V281, pE1249, DOI 10.1152/ajpendo.2001.281.6.E1249; Nepiyushchikh ZV, 2011, J PHYSIOL-LONDON, V589, P5415, DOI 10.1113/jphysiol.2011.218446; Niu PG, 2013, PLANTA MED, V79, P452, DOI 10.1055/s-0032-1328325; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; Nurmi H, 2015, EMBO MOL MED, V7, P1418, DOI 10.15252/emmm.201505731; Palacios S, 2001, J BIOL CHEM, V276, P3371, DOI 10.1074/jbc.M006739200; Pandey G, 2015, J BIOL CHEM, V290, P5582, DOI 10.1074/jbc.M114.592741; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; PAUL RJ, 1983, AM J PHYSIOL, V244, pC399, DOI 10.1152/ajpcell.1983.244.5.C399; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Qi YJ, 2015, CIRC-HEART FAIL, V8, P198, DOI 10.1161/CIRCHEARTFAILURE.114.001457; Rasmussen JC, 2014, OBESITY, V22, P2186, DOI 10.1002/oby.20836; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Robichaux JL, 2010, ANAT REC, V293, P1629, DOI 10.1002/ar.21195; Saltiel AR, 1996, AM J PHYSIOL-ENDOC M, V270, pE375, DOI 10.1152/ajpendo.1996.270.3.E375; Sandu OA, 2000, DIABETES, V49, P2178, DOI 10.2337/diabetes.49.12.2178; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Savetsky IL, 2014, AM J PHYSIOL-HEART C, V307, pH165, DOI 10.1152/ajpheart.00244.2014; Schmitz-Peiffer C, 2003, IUBMB LIFE, V55, P367, DOI 10.1080/1521654031000138569; Sen S, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0224-9; SHIMOJO N, 1993, CLIN CHEM, V39, P2312; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Suhane S, 2013, BIOL OPEN, V2, P295, DOI 10.1242/bio.20133244; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Tang X, 2011, ACTA PHARMACOL SIN, V32, P1138, DOI 10.1038/aps.2011.75; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Tomas E, 2002, ANN NY ACAD SCI, V967, P43; Vaidyula VR, 2006, DIABETES, V55, P202, DOI 10.2337/diabetes.55.1.202; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; von der Weid Pierre-Yves, 2010, Pathophysiology, V17, P263, DOI 10.1016/j.pathophys.2009.10.005; Vuorio T, 2014, ARTERIOSCL THROM VAS, V34, P1162, DOI 10.1161/ATVBAHA.114.302528; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Wang W, 2009, AM J PHYSIOL-HEART C, V297, pH726, DOI 10.1152/ajpheart.00312.2009; Weitman ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070703; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Zawieja SD, 2016, MICROCIRCULATION, V23, P558, DOI 10.1111/micc.12307; Zawieja SD, 2016, AM J PHYSIOL-HEART C, V310, pH385, DOI 10.1152/ajpheart.00664.2015; Zawieja SD, 2012, AM J PHYSIOL-HEART C, V302, pH643, DOI 10.1152/ajpheart.00606.2011; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473	89	32	33	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2744	2759		10.1096/fj.201600887R	http://dx.doi.org/10.1096/fj.201600887R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28298335	Green Published			2022-12-26	WOS:000405931000004
J	Zhang, YY; Rogers, HM; Zhang, XJ; Noguchi, CT				Zhang, Yuanyuan; Rogers, Heather M.; Zhang, Xiaojie; Noguchi, Constance Tom			Sex difference in mouse metabolic response to erythropoietin	FASEB JOURNAL			English	Article						adipose tissue; estrogen; nonhematopoietic; weight loss	RECOMBINANT-HUMAN-ERYTHROPOIETIN; HYPOXIC VENTILATION; FEMALE MICE; OBESITY; RECEPTOR; ESTROGEN; ISCHEMIA/REPERFUSION; INFLAMMATION; EXPRESSION; INDUCTION	Erythropoietin (EPO) is the cytokine that regulates red blood cell production. Less understood is the nonerythroid action of EPO, including metabolic regulation of fat accumulation and glucose homeostasis. Although EPO treatment increased hematocrit and improved glucose tolerance in male and female mice, we observed a gender difference in EPO effects in weight control. EPO treatment reduced diet-induced weight gain from 9.6 +/- 1.5 to 4.2 +/- 1.4 g in male mice (P < 0.001), while the weight gain in female mice was similar (4.7 +/- 2.0 g with PBS treatment and 3.3 +/- 2.1 g with EPO treatment). EPO treatment also reduced weight gain in ovariectomized female mice, while the effect was abrogated with estradiol supplementation, suggesting that the sex-differential response to EPO was associated with estrogen. Furthermore, mice with targeted deletion of EPO receptor in white adipose tissue exhibited sex-differential phenotype in weight control and glucose sensitivity, and EPO receptor gene expression was reduced in wild-type female mice, suggesting that white adipose tissue plays an integral role in mediating the metabolic effects of EPO. Our data provide evidence for a sex-differential response to EPO in weight control in mice and underscore the potential for gender specific EPO action beyond erythropoiesis.	[Zhang, Yuanyuan; Rogers, Heather M.; Noguchi, Constance Tom] Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bldg 10,Room 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA; [Zhang, Xiaojie] Natl Inst Diabet & Digest & Kidney Dis, Lab Anim Sci Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Noguchi, CT (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bldg 10,Room 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.	connien@helix.nih.gov	zhang, yuanyuan/GYA-4428-2022		National Institute of Diabetes and Digestive and Kidney Diseases; U.S. National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025061] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and the U.S. National Institutes of Health.	Alnaeeli M, 2015, ADIPOCYTE, V4, P153, DOI 10.4161/21623945.2014.978654; Ballot O, 2015, J APPL PHYSIOL, V118, P1386, DOI 10.1152/japplphysiol.00143.2015; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Beleslin-Cokic BB, 2011, CYTOKINE, V54, P129, DOI 10.1016/j.cyto.2011.01.015; BOFILL C, 1994, METABOLISM, V43, P614, DOI 10.1016/0026-0495(94)90204-6; Caillaud C, 2015, J ENDOCRINOL, V225, P77, DOI 10.1530/JOE-15-0010; Chen LN, 2015, MOL MED REP, V12, P5391, DOI 10.3892/mmr.2015.4006; Chikuma M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1242, DOI 10.1152/ajpendo.2000.279.6.E1242; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Christensen B, 2012, J APPL PHYSIOL, V112, P1114, DOI 10.1152/japplphysiol.01391.2011; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Eshraghi-Jazi F, 2013, IRAN J KIDNEY DIS, V7, P383; Foskett A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/373781; Gassmann M, 2010, AM J PHYSIOL-REG I, V299, pR1511, DOI 10.1152/ajpregu.00205.2010; Gassmann M, 2009, ANN NY ACAD SCI, V1177, P151, DOI 10.1111/j.1749-6632.2009.05028.x; Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Katz O, 2010, J ENDOCRINOL, V205, P87, DOI 10.1677/JOE-09-0425; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Mak RHK, 1996, J PEDIATR-US, V129, P97, DOI 10.1016/S0022-3476(96)70195-6; Mak RHK, 1998, PEDIATR NEPHROL, V12, P660, DOI 10.1007/s004670050524; Meng R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053557; Mikolas E, 2012, HORM METAB RES, V44, P279, DOI 10.1055/s-0032-1301901; Mukundan H, 2002, AM J PHYSIOL-REG I, V283, pR496, DOI 10.1152/ajpregu.00573.2001; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Prokai A, 2011, SURGERY, V150, P39, DOI 10.1016/j.surg.2011.02.019; Reinhardt M, 2016, OBESITY, V24, P1530, DOI 10.1002/oby.21537; Rui T, 2005, CARDIOVASC RES, V65, P719, DOI 10.1016/j.cardiores.2004.11.019; Soliz J, 2009, AM J PHYSIOL-REG I, V296, pR1837, DOI 10.1152/ajpregu.90967.2008; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Teng RF, 2011, BASIC RES CARDIOL, V106, P343, DOI 10.1007/s00395-011-0158-z; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518; Wang RY, 1998, MECH AGEING DEV, V103, P81, DOI 10.1016/S0047-6374(98)00031-1; Wen TC, 2006, NEUROSCIENCE, V139, P803, DOI 10.1016/j.neuroscience.2006.02.057; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; Yasuda Y, 1998, J BIOL CHEM, V273, P25381, DOI 10.1074/jbc.273.39.25381; Zhang YY, 2014, INT J MOL SCI, V15, P10296, DOI 10.3390/ijms150610296	42	17	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2661	2673		10.1096/fj.201601223RRR	http://dx.doi.org/10.1096/fj.201601223RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28283542	Green Published			2022-12-26	WOS:000401553400036
J	Suber, T; Wei, JX; Jacko, AM; Nikolli, I; Zhao, YT; Zhao, J; Mallampalli, RK				Suber, Tomeka; Wei, Jianxin; Jacko, Anastasia M.; Nikolli, Ina; Zhao, Yutong; Zhao, Jing; Mallampalli, Rama K.			SCFFBXO17 E3 ligase modulates inflammation by regulating proteasomal degradation of glycogen synthase kinase-3 beta in lung epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; inflammation; lung; lung injury; ubiquitin	F-BOX PROTEINS; TUMOR-NECROSIS-FACTOR; CYTOKINE PRODUCTION; UBIQUITIN LIGASES; 3-BETA; CANCER; GSK3; PHOSPHORYLATION; INHIBITION; DIVERSITY	Glycogen synthase kinase-3 (GSK3) has diverse biological roles including effects on cellular differentiation, migration, and inflammation. GSK3 phosphorylates proteins to generate phosphodegrons necessary for recognition by Skp1/Cullin-1/F-box (SCF) E3 ubiquitin ligases leading to subsequent proteasomal degradation of these substrates. However, little is known regarding how GSK3 protein stability itself is regulated and how its stability may influence inflammation. Here we show that GSK3 is degraded by the ubiquitin-proteasome pathway in murine lung epithelial cells through lysine 183 as an acceptor site for K48 polyubiquitination. We have identified FBXO17 as an F-box protein subunit that recognizes and mediates GSK3 polyubiquitination. Both endogenous and ectopically expressed FBXO17 associate with GSK3, and its overexpression leads to decreased protein levels of GSK3. Silencing FBXO17 gene expression increased the half-life of GSK3 in cells. Furthermore, overexpression of FBXO17 inhibits agonist-induced release of keratinocyte-derived cytokine (KC) and interleukin-6 (IL-6) production by cells. Thus, the SCFFBXO17 E3 ubiquitin ligase complex negatively regulates inflammation by targeting GSK3 in lung epithelia.	[Suber, Tomeka; Wei, Jianxin; Jacko, Anastasia M.; Nikolli, Ina; Zhao, Yutong; Zhao, Jing; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, 930 Scaife Hall, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol Physiol & Bioengn, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, Dept Med, UPMC Montefiore, Pulm Allergy & Crit Care Med, NW 628, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu			United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs; Flight Attendant Medical Research Institute; National Institutes of Health R01 Grants [HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, P01HL114453, R01 HL131665, R01 GM115389]; American Heart Association GIA award; American Lung Association [BRG RG350146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL137248, P01HL114453, R01HL098174, T32HL007563, R01HL096376, R01HL112791, R01HL131665, R01HL081784, UH2HL123502, R01HL097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115389] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); United States Department of Veterans Affairs(US Department of Veterans Affairs); Flight Attendant Medical Research Institute; National Institutes of Health R01 Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association GIA award(American Heart Association); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, a Merit Review Award from the United States Department of Veterans Affairs, the Flight Attendant Medical Research Institute, and National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, 1UH2HL123502, P01HL114453 (to R. K. M.), R01 HL131665 (to Y. Z.), R01 GM115389 (to J. Z), an American Heart Association GIA award (to Y. Z), and American Lung Association Grant BRG RG350146 (to J. Z). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs.	Alper S, 2016, GENETICS, V204, P327, DOI 10.1534/genetics.115.185314; Balch WE, 2014, AM J RESP CRIT CARE, V189, P96, DOI 10.1164/rccm.201306-1164WS; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Bouchecareilh Marion, 2011, Proc Am Thorac Soc, V8, P189, DOI 10.1513/pats.201008-055MS; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chen BB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.271; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang CH, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-015-0246-z; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Ko R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7765; Liao XB, 2003, MOL CANCER THER, V2, P1215; Liu ZY, 2015, MOL MED, V21, P937, DOI 10.2119/molmed.2015.00198; Mallampalli RK, 2013, J IMMUNOL, V191, P5247, DOI 10.4049/jimmunol.1300456; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mialki RK, 2013, J BIOL CHEM, V288, P15437, DOI 10.1074/jbc.C112.446682; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Park DW, 2014, AM J PHYSIOL-LUNG C, V307, pL735, DOI 10.1152/ajplung.00165.2014; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Peng D, 2017, J IMMUNOL, V198, P808, DOI 10.4049/jimmunol.1601009; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Reichard EL, 2016, J BIOL CHEM, V291, P18547, DOI 10.1074/jbc.M116.720151; Ren F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.56; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Teixeira FR, 2016, BIOCHEM J, V473, P3563, DOI 10.1042/BCJ20160387; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Wang HZ, 2014, TRENDS MICROBIOL, V22, P208, DOI 10.1016/j.tim.2014.01.009; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Weathington NM, 2014, J CLIN INVEST, V124, P6, DOI 10.1172/JCI71602; Weathington NM, 2013, CELL SIGNAL, V25, P1792, DOI 10.1016/j.cellsig.2013.05.003; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhang H., 2014, MEDIATORS INFLAMM; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341	50	24	27	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7452	7461		10.1074/jbc.M116.771667	http://dx.doi.org/10.1074/jbc.M116.771667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28298444	Green Published, hybrid			2022-12-26	WOS:000400761300015
J	Wang, J; Sun, LF; Cui, WW; Zhao, WS; Ma, XF; Li, B; Liu, Y; Yang, Y; Hu, YM; Huang, LD; Cheng, XY; Li, LY; Lu, XY; Tian, Y; Yu, Y				Wang, Jin; Sun, Liang-Fei; Cui, Wen-Wen; Zhao, Wen-Shan; Ma, Xue-Fei; Li, Bin; Liu, Yan; Yang, Yang; Hu, You-Min; Huang, Li-Dong; Cheng, Xiao-Yang; Li, Lingyong; Lu, Xiang-Yang; Tian, Yun; Yu, Ye			Intersubunit physical couplings fostered by the left flipper domain facilitate channel opening of P2X4 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; gating; ion channel; protein domain; receptor structure-function; P2X receptors; molecular simulations; physical couplings; single channel recording	SENSING ION CHANNELS; SALT BRIDGE STABILIZES; ATP-BINDING; CONFORMATIONAL-CHANGES; TRANSMEMBRANE HELICES; OPTICAL CONTROL; OPEN STATE; ACTIVATION; MECHANISM; GATE	P2X receptors are ATP-gated trimeric channels with important roles in diverse pathophysiological functions. A detailed understanding of the mechanism underlying the gating process of these receptors is thus fundamentally important and may open new therapeutic avenues. The left flipper (LF) domain of the P2X receptors is a flexible loop structure, and its coordinated motions together with the dorsal fin (DF) domain are crucial for the channel gating of the P2X receptors. However, the mechanism underlying the crucial role of the LF domain in the channel gating remains obscure. Here, we propose that the ATP-induced allosteric changes of the LF domain enable it to foster intersubunit physical couplings among the DF and two lower body domains, which are pivotal for the channel gating of P2X4 receptors. Metadynamics analysis indicated that these newly established intersubunit couplings correlate well with the ATP-bound open state of the receptors. Moreover, weakening or strengthening these physical interactions with engineered intersubunit metal bridges remarkably decreased or increased the open probability of the receptors, respectively. Further disulfide cross-linking and covalent modification confirmed that the intersubunit physical couplings among the DF and two lower body domains fostered by the LF domain at the open state act as an integrated structural element that is stringently required for the channel gating of P2X4 receptors. Our observations provide new mechanistic insights into P2X receptor activation and will stimulate development of new allosteric modulators of P2X receptors.	[Wang, Jin; Sun, Liang-Fei; Cui, Wen-Wen; Zhao, Wen-Shan; Ma, Xue-Fei; Li, Bin; Liu, Yan; Yang, Yang; Hu, You-Min; Huang, Li-Dong; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China; [Wang, Jin; Sun, Liang-Fei; Cui, Wen-Wen; Zhao, Wen-Shan; Ma, Xue-Fei; Li, Bin; Liu, Yan; Yang, Yang; Hu, You-Min; Huang, Li-Dong; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Hongqiao Int Inst Med, Shanghai 200025, Peoples R China; [Ma, Xue-Fei; Li, Bin; Lu, Xiang-Yang; Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Li, Lingyong] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Hunan Agricultural University; University of Texas System; UTMD Anderson Cancer Center	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Hongqiao Int Inst Med, Shanghai 200025, Peoples R China.; Tian, Y; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.	tianyun79616@163.com; yuye@shsmu.edu.cn	Cheng, Xiaoyang/N-9970-2019; Cheng, Xiaoyang/M-1257-2017	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Wang, Jin/0000-0001-8337-0434; Zhao, Wenshan/0000-0002-8018-5978; Yu, Ye/0000-0002-4054-8543	National Natural Science Foundation of China [31570832, 31170787, 31400707]; National Program on Key Basic Research Project of China [2014CB910302]; National Excellent Young Scientist Foundation of China [31222018]; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine Grant [13XJ10042]; Opening Project of State Key Laboratory of Drug Research Grant [SIMM1601KF-02]; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine Grant [BXJ201405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project of China(National Basic Research Program of China); National Excellent Young Scientist Foundation of China; Science and Technology Fund of Shanghai Jiao Tong University School of Medicine Grant; Opening Project of State Key Laboratory of Drug Research Grant; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine Grant	This work was supported by National Natural Science Foundation of China Grants 31570832, 31170787, and 31400707, National Program on Key Basic Research Project of China Grant 2014CB910302, National Excellent Young Scientist Foundation of China Grant 31222018, Science and Technology Fund of Shanghai Jiao Tong University School of Medicine Grant 13XJ10042, the Opening Project of State Key Laboratory of Drug Research Grant SIMM1601KF-02, and Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine Grant BXJ201405. The authors declare that they have no conflicts of interest with the contents of this article.	Aboul-Enein HY, 2003, PREP BIOCHEM BIOTECH, V33, P173, DOI 10.1081/PB-120022986; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2013, CURR OPIN STRUC BIOL, V23, P277, DOI 10.1016/j.sbi.2013.04.005; Beamer E, 2016, NEUROPHARMACOLOGY, V104, P94, DOI 10.1016/j.neuropharm.2015.09.019; Browne LE, 2014, P NATL ACAD SCI USA, V111, P521, DOI 10.1073/pnas.1318582111; Burnstock G, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0422; Burnstock G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00204; Chataigneau T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00273; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Cremlyn R. J., 1996, INTRO ORGANOSULFUR C, P7; Du J, 2012, P NATL ACAD SCI USA, V109, P4140, DOI 10.1073/pnas.1119546109; Evans RJ, 1996, NEUROSCI LETT, V212, P212, DOI 10.1016/0304-3940(96)12804-4; Fryatt AG, 2014, MOL PHARMACOL, V86, P707, DOI 10.1124/mol.114.095307; Habermacher C, 2016, ELIFE, V5, DOI 10.7554/eLife.11050; Habermacher C, 2016, NEUROPHARMACOLOGY, V104, P18, DOI 10.1016/j.neuropharm.2015.07.032; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Heymann G, 2013, P NATL ACAD SCI USA, V110, pE4045, DOI 10.1073/pnas.1311071110; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Jie YL, 2014, NEUROSCI LETT, V582, P1, DOI 10.1016/j.neulet.2014.08.038; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Karasawa A, 2016, ELIFE, V5, DOI 10.7554/eLife.22153; Kasuya G, 2016, CELL REP, V14, P932, DOI 10.1016/j.celrep.2015.12.087; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kellenberger S, 2015, J MOL BIOL, V427, P54, DOI 10.1016/j.jmb.2014.06.004; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Kowalski M, 2014, BRIT J PHARMACOL, V171, P5093, DOI 10.1111/bph.12830; Kuan YH, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0240-4; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lemoine D, 2013, P NATL ACAD SCI USA, V110, P20813, DOI 10.1073/pnas.1318715110; Lewis CJ, 2000, BRIT J PHARMACOL, V131, P1659, DOI 10.1038/sj.bjp.0703744; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Limongelli V, 2010, P NATL ACAD SCI USA, V107, P5411, DOI 10.1073/pnas.0913377107; Lorinczi E, 2012, P NATL ACAD SCI USA, V109, P11396, DOI 10.1073/pnas.1118759109; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Minato Y, 2016, P NATL ACAD SCI USA, V113, P4741, DOI 10.1073/pnas.1600519113; Negulyaev YA, 2000, NEUROSCI LETT, V279, P165, DOI 10.1016/S0304-3940(99)00976-3; North RA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0427; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Pippel A, 2017, P NATL ACAD SCI USA, V114, pE2156, DOI 10.1073/pnas.1610414114; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Rokic MB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; SATAV JG, 1977, EUR J BIOCHEM, V73, P287, DOI 10.1111/j.1432-1033.1977.tb11318.x; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Wang J, 2016, ACTA PHARMACOL SIN, V37, P44, DOI 10.1038/aps.2015.127; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhao WS, 2016, J BIOL CHEM, V291, P7990, DOI 10.1074/jbc.M115.711127; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	63	15	15	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7619	7635		10.1074/jbc.M116.771121	http://dx.doi.org/10.1074/jbc.M116.771121			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302727	hybrid, Green Published			2022-12-26	WOS:000400761300029
J	Das, K; Eisel, D; Lenkl, C; Goyal, A; Diederichs, S; Dickes, E; Osen, W; Eichmueller, SB				Das, Krishna; Eisel, David; Lenkl, Clarissa; Goyal, Ashish; Diederichs, Sven; Dickes, Elke; Osen, Wolfram; Eichmueller, Stefan B.			Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CLASS-I; TRANSGENIC MICE; T-CELLS; ANTIGEN; IDENTIFICATION; SPECIFICITY; NUCLEASES; MELANOMA; CANCER	In this study, the CRISPR/Cas9 technology was used to establish murine tumor cell lines, devoid of MHC I or MHC II surface expression, respectively. The melanoma cell line B16F10 and the murine breast cancer cell line EO-771, the latter stably expressing the tumor antigen NY-BR-1 (EO-NY), were transfected with an expression plasmid encoding a beta(2)m-specific single guide (sg) RNA and Cas9. The resulting MHC I negative cells were sorted by flow cytometry to obtain single cell clones, and loss of susceptibility of peptide pulsed MHC I negative clones to peptide-specific CTL recognition was determined by IFN gamma ELISpot assay. The beta(2)m knockout (KO) clones did not give rise to tumors in syngeneic mice (C57BL/6N), unless NK cells were depleted, suggesting that outgrowth of the beta(2)m KO cell lines was controlled by NK cells. Using sgRNAs targeting the beta-chain encoding locus of the IA(b) molecule we also generated several B16F10 MHC II KO clones. Peptide loaded B16F10 MHC II KO cells were insusceptible to recognition by OT-II cells and tumor growth was unaltered compared to parental B16F10 cells. Thus, in our hands the CRISPR/Cas9 system has proven to be an efficient straight forward strategy for the generation of MHC knockout cell lines. Such cell lines could serve as parental cells for co-transfection of compatible HLA alleles together with human tumor antigens of interest, thereby facilitating the generation of HLA matched transplantable tumor models, e.g. in HLAtg mouse strains of the newer generation, lacking cell surface expression of endogenous H2 molecules. In addition, our tumor cell lines established might offer a useful tool to investigate tumor reactive T cell responses that function independently from MHC molecule surface expression by the tumor.	[Das, Krishna; Eisel, David; Lenkl, Clarissa; Dickes, Elke; Osen, Wolfram; Eichmueller, Stefan B.] German Canc Res Ctr, GMP & T Cell Therapy Unit, Heidelberg, Germany; [Goyal, Ashish; Diederichs, Sven] German Canc Res Ctr, Div RNA Biol & Canc, Heidelberg, Germany; [Diederichs, Sven] Univ Freiburg, Fac Med, Dept Thorac Surg, Med Ctr,Div Canc Res, Freiburg, Germany; [Diederichs, Sven] German Canc Consortium DKTK, Freiburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ)	Eichmueller, SB (corresponding author), German Canc Res Ctr, GMP & T Cell Therapy Unit, Heidelberg, Germany.	s.eichmueller@dkfz.de	Eichmüller, Stefan B/A-5053-2008; Diederichs, Sven/J-6237-2012	Eichmüller, Stefan B/0000-0002-3497-6904; Diederichs, Sven/0000-0001-7901-4752				Abrahimi P, 2015, CIRC RES, V117, P121, DOI 10.1161/CIRCRESAHA.117.306290; ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; Bernal M, 2012, IMMUNOTHERAPY, V61, P1359; BIX M, 1992, J EXP MED, V176, P829, DOI 10.1084/jem.176.3.829; Bohm W, 1998, J IMMUNOL, V161, P897; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Clay TM, 2001, CLIN CANCER RES, V7, P1127; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; EVAN GI, 1983, EUR J IMMUNOL, V13, P160, DOI 10.1002/eji.1830130213; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gardyan A, 2015, INT J CANCER, V136, P2588, DOI 10.1002/ijc.29322; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; Horii T, 2013, PEERJ, V1, DOI 10.7717/peerj.230; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jager D, 2007, APPL IMMUNOHISTO M M, V15, P77; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lei J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138458; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Osen W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014137; Pajot A, 2004, INT IMMUNOL, V16, P1275, DOI 10.1093/intimm/dxh129; Parkhurst MR, 1998, CANCER RES, V58, P4895; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pol J, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.974411; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sawada Y, 2014, ONCOL REP, V31, P1051, DOI 10.3892/or.2013.2941; SEGE K, 1981, BIOCHEMISTRY-US, V20, P4523, DOI 10.1021/bi00519a003; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Speidel K, 1997, EUR J IMMUNOL, V27, P2391, DOI 10.1002/eji.1830270938; TADA N, 1980, IMMUNOGENETICS, V11, P441, DOI 10.1007/BF01567813; Tveita A, 2016, ONCOTARGET; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921	43	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174077	10.1371/journal.pone.0174077	http://dx.doi.org/10.1371/journal.pone.0174077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301575	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300123
J	Duque, J; Gaga, S; Clark, D; Muller, M; Kuwane, B; Cohen, C; Walaza, S; Tempia, S; Ramatoboe, P; Furumele, T; Widdowson, MA; McMorrow, ML; Cohen, AL				Duque, Jazmin; Gaga, Sisanda; Clark, David; Muller, Madeleine; Kuwane, Bulenani; Cohen, Cheryl; Walaza, Sibongile; Tempia, Stefano; Ramatoboe, Puleng; Furumele, Tsakani; Widdowson, Marc-Alain; McMorrow, Meredith L.; Cohen, Adam L.			Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals	PLOS ONE			English	Article							UNITED-STATES	Background The South African Department of Health (DOH) publishes annual guidelines identifying priority groups, including immunosuppressed individuals and healthcare workers (HCW), for influenza vaccination and treatment. How these guidelines have impacted HCW and their patients, particularly those infected with HIV, remains unknown. Methods We aimed to describe the knowledge, attitudes and practices regarding influenza and the vaccine among South African HCW. Surveys were distributed by two local non-governmental organizations in public health clinics and hospitals in 21 districts/municipalities (5 of 9 provinces). Results There were 1164 respondents; median age 41 years; 978/1126 (87%) female; 801/1122 (71%) nurses. One-third (34%) of HCW reported getting influenza vaccine 2013/2014 and most (94%) recommended influenza vaccine to patients infected with HIV. Ability to get vaccine free of charge (aOR 1.69; 95% CI 1.21 +/- 2.37) and having received influenza government training (aOR 1.50; 95% CI 1.04 +/- 2.15) were significantly associated with self-reported vaccination in 2013/2014. Self-reported 2013/2014 vaccination (aOR 3.76; 95% CI 1.28 +/- 11.03) and availability of influenza vaccine during the healthcare visit (aOR 2.56; 95% CI 1.18-5.57) were significantly associated with recommending influenza vaccine to patients infected with HIV/AIDS. Conclusion Only one-third of participants were vaccinated in 2013-2014 but those who were vaccinated were more likely to recommend vaccination to their patients. Free and close access to influenza vaccine were associated with a higher likelihood of getting vaccinated in 2013/2014. HCW who reported getting the influenza vaccine themselves, had vaccine to offer during the patient consult and were familiar with DOH guidelines/trainings were more likely to recommend vaccine to HIV-infected patients.	[Duque, Jazmin; Tempia, Stefano; Widdowson, Marc-Alain; McMorrow, Meredith L.; Cohen, Adam L.] US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Duque, Jazmin] Battelle Atlanta, Atlanta, GA 30329 USA; [Gaga, Sisanda; Muller, Madeleine] Beyond Zero, Port Elizabeth, South Africa; [Clark, David; Kuwane, Bulenani] Aurum Inst, Johannesburg, South Africa; [Cohen, Cheryl; Walaza, Sibongile; Tempia, Stefano] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl; Walaza, Sibongile] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Tempia, Stefano; Ramatoboe, Puleng; McMorrow, Meredith L.; Cohen, Adam L.] US Ctr Dis Control & Prevent South Africa, Pretoria, South Africa; [Furumele, Tsakani] Natl Dept Hlth, Pretoria, South Africa; [McMorrow, Meredith L.; Cohen, Adam L.] US PHS, Rockville, MD USA	Centers for Disease Control & Prevention - USA; National Institute for Communicable Diseases (NICD); University of Witwatersrand; United States Public Health Service	Duque, J (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.; Duque, J (corresponding author), Battelle Atlanta, Atlanta, GA 30329 USA.	JDuque@cdc.gov	McMorrow, Meredith/M-1274-2019	Cohen, Cheryl/0000-0003-0376-2302; McMorrow, Meredith/0000-0001-6363-4033; Duque, Jazmin/0000-0003-3484-276X	NCIRD CDC HHS [U01 IP001048] Funding Source: Medline; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	NCIRD CDC HHS; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Black CL, 2014, MMWR-MORBID MORTAL W, V63, P805; Christini AB, 2007, INFECT CONT HOSP EP, V28, P171, DOI 10.1086/511796; Cohen C, 2015, PEDIATR INFECT DIS J, V34, P66, DOI 10.1097/INF.0000000000000478; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Green RJ, 2008, SAMJ S AFR MED J, V98, P224; McAnerney JM, 2015, EFFECTIVENESS KNOWLE; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Otieno NA, 2014, VACCINE, V32, P6699, DOI 10.1016/j.vaccine.2013.10.089; Palache A, 2011, VACCINE, V29, P9459, DOI 10.1016/j.vaccine.2011.10.030; Ramkrishna W, 2013, OPTIONS CONTROL INFL; Sanchez-Paya J, 2011, GAC SANIT, V25, P29, DOI 10.1016/j.gaceta.2010.09.018	12	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173983	10.1371/journal.pone.0173983	http://dx.doi.org/10.1371/journal.pone.0173983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301593	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300104
J	Geng, X; Zhao, HL; Zhang, SM; Li, J; Tian, F; Feng, N; Fan, R; Jia, M; Guo, HT; Cheng, L; Liu, JC; Chen, WS; Pei, JM				Geng, Xiao; Zhao, Honglin; Zhang, Shumiao; Li, Juan; Tian, Fei; Feng, Na; Fan, Rong; Jia, Min; Guo, Haitao; Cheng, Liang; Liu, Jincheng; Chen, Wensheng; Pei, Jianming			K-opioid receptor is involved in the cardioprotection induced by exercise training	PLOS ONE			English	Article							IMPROVES MYOCARDIAL TOLERANCE; ISCHEMIA-REPERFUSION INJURY; CORONARY-ARTERY OCCLUSION; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; RAT-HEART; IN-VIVO; AEROBIC EXERCISE; NITRIC-OXIDE; APOPTOSIS	The present study was designed to test the hypothesis that exercise training elicited a cardioprotective effect against ischemia and reperfusion (I/R) via the K-opioid receptor (K-OR) mediated signaling pathway. Rats were randomly divided into four groups: the control group, the moderate intensity exercise (ME) group, the high intensity exercise (HE) group, and the acute exercise (AE) group. For the exercise training protocols, the rats were subjected to one week of adaptive treadmill training, while from the second week, the ME and HE groups were subjected to eight weeks of exercise training, and the AE group was subjected to three days of adaptive treadmill training and one day of vigorous exercise. After these protocols, the three exercise training groups were divided into different treatment groups, and the rats were subjected to 30 min of ischemia and 120 min of reperfusion. Changes in infarct size and serum cTnT (cardiac troponin T) caused by I/R were reduced by exercise training. Moreover, cardiac dysfunction caused by I/R was also alleviated by exercise training. These effects of exercise training were reversed by nor-BNI (a selective K-OR antagonist), Compound C (a selective AMPK inhibitor), Akt inhibitor and L-NAME (a nonselective eNOS inhibitor). Expression of K-OR and phosphorylation of AMPK, Akt and eNOS were significantly increased in the ME, HE and AE groups. These findings demonstrated that the cardioprotective effect of exercise training is possibly mediated by the K-ORAMPK-Akt-eNOS signaling pathway.	[Geng, Xiao; Zhang, Shumiao; Li, Juan; Tian, Fei; Feng, Na; Fan, Rong; Jia, Min; Guo, Haitao; Pei, Jianming] Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian, Shaanxi Provinc, Peoples R China; [Geng, Xiao] Changan Univ, Dept Phys Educ, Xian, Shaanxi Provinc, Peoples R China; [Zhao, Honglin] Lanzhou Univ, Hosp 1, Dept Cardiovasc Surg, Lanzhou, Gansu, Peoples R China; [Cheng, Liang; Liu, Jincheng; Chen, Wensheng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Chang'an University; Lanzhou University; Air Force Military Medical University	Pei, JM (corresponding author), Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian, Shaanxi Provinc, Peoples R China.; Chen, WS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shaanxi Provinc, Peoples R China.	chenws@fmmu.edu.cn; jmpei8@fmmu.edu.cn			National Natural Science Foundation of China [81270402]; National Natural Science Foundation of Shaanxi Province [2016KTCL03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shaanxi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 81270402) and Shaanxi Province (No. 2016KTCL03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arida RM, 2015, J NEUROCHEM, V132, P206, DOI 10.1111/jnc.12976; Babai L, 2002, CLIN SCI, V102, P435, DOI 10.1042/CS20010296; BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Borges JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113541; Brown DA, 2005, J PHYSIOL-LONDON, V564, P619, DOI 10.1113/jphysiol.2004.081323; Cheng L, 2007, HEART VESSELS, V22, P335, DOI 10.1007/s00380-007-0983-z; Demirel HA, 2001, J APPL PHYSIOL, V91, P2205, DOI 10.1152/jappl.2001.91.5.2205; Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007; French JP, 2006, AM J PHYSIOL-HEART C, V290, pH128, DOI 10.1152/ajpheart.00739.2005; Galvao TFG, 2011, CLINICS, V66, P151, DOI 10.1590/S1807-59322011000100026; Grijalva J, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-34; Guo HT, 2011, J CARDIOVASC PHARM, V58, P207, DOI 10.1097/FJC.0b013e318220e37f; HUTTER MM, 1994, CIRCULATION, V89, P355, DOI 10.1161/01.CIR.89.1.355; Jensen TE, 2009, ACTA PHYSIOL, V196, P155, DOI 10.1111/j.1748-1716.2009.01979.x; Ji L L, 1995, Exerc Sport Sci Rev, V23, P135; Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069910; JI LL, 1994, ACTA PHYSIOL SCAND, V151, P279, DOI 10.1111/j.1748-1716.1994.tb09747.x; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Laughlin MH, 1998, MED SCI SPORT EXER, V30, P352, DOI 10.1097/00005768-199803000-00004; Lee Y, 2012, MED SCI SPORT EXER, V44, P397, DOI 10.1249/MSS.0b013e318231c037; Loomis A L, 1889, Trans Am Climatol Assoc Meet, V6, P253; Lu K, 2015, MOL MED REP, V12, P2374, DOI 10.3892/mmr.2015.3669; Marini M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-188; MCELROY CL, 1978, CIRCULATION, V57, P958, DOI 10.1161/01.CIR.57.5.958; Miller LE, 2015, EXP PHYSIOL, V100, P410, DOI 10.1113/expphysiol.2014.083436; Nakamura M, 2000, CARDIOVASC RES, V45, P661, DOI 10.1016/S0008-6363(99)00393-4; Paiva MA, 2010, CARDIOVASC DRUG THER, V24, P25, DOI 10.1007/s10557-010-6222-3; Powers SK, 2014, PHYSIOLOGY, V29, P27, DOI 10.1152/physiol.00030.2013; Powers SK, 1998, AM J PHYSIOL-REG I, V275, pR1468, DOI 10.1152/ajpregu.1998.275.5.R1468; PUGSLEY MK, 1992, EUR J PHARMACOL, V212, P15, DOI 10.1016/0014-2999(92)90066-D; Quindry JC, 2010, AM J PHYSIOL-HEART C, V299, pH175, DOI 10.1152/ajpheart.01211.2009; Rodrigues F, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-84; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Shi QX, 2013, AM J THER, V20, P493, DOI 10.1097/MJT.0b013e3182456676; Solskov L, 2012, MOL CELL BIOCHEM, V360, P353, DOI 10.1007/s11010-011-1075-z; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; TAI KK, 1992, LIFE SCI, V51, P909, DOI 10.1016/0024-3205(92)90398-9; Tong GA, 2011, LIFE SCI, V88, P31, DOI 10.1016/j.lfs.2010.10.018; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Wang QM, 2014, EUR J PHARMACOL, V737, P177, DOI 10.1016/j.ejphar.2014.05.006; Xiao XY, 2010, J NUTR BIOCHEM, V21, P621, DOI 10.1016/j.jnutbio.2009.03.011; Xiu J, 2013, AM J MED SCI, V345, P129, DOI 10.1097/MAJ.0b013e31824ceba7; Yang KC, 2012, J MOL CELL CARDIOL, V53, P532, DOI 10.1016/j.yjmcc.2012.07.004; Yang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096892; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8; Zhang QJ, 2007, CARDIOVASC RES, V75, P369, DOI 10.1016/j.cardiores.2007.04.015; Zhang QY, 2010, CRIT CARE MED, V38, P2365, DOI 10.1097/CCM.0b013e3181fa0437	49	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0170463	10.1371/journal.pone.0170463	http://dx.doi.org/10.1371/journal.pone.0170463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301473	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300005
J	Gu, LT; Sun, CH; Gong, YZ; Yu, M; Li, SJ				Gu, Lantao; Sun, Chenghao; Gong, Yangzhang; Yu, Mei; Li, Shijun			Novel copy number variation of the TGF beta 3 gene is associated with TGF beta 3 gene expression and duration of fertility traits in hens	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; UTERO-VAGINAL JUNCTION; T-CELL GROWTH; SPERM-STORAGE; ARTIFICIAL-INSEMINATION; ANAS-PLATYRHYNCHOS; BROILER BREEDERS; CAIRINA-MOSCHATA; POTENTIAL ROLE; MESSENGER-RNA	Improvements in the duration of fertility (DF) could increase the interval between successive artificial inseminations, thereby decreasing the cost associated with production of hatching eggs. The molecular mechanisms involved in DF in hens remains under-explored. In this study, expression levels of the transforming growth factor-/3 genes (TGF/3s: TGF/31, TGFI32, TGFI33) were investigated in utero-vaginal junctions (UVJs) of hens with long DF (Group L, n = 10) and short DF (Group S, n = 1 0). TGFI31 and 2 tended to exhibit higher expression levels in UVJs from Group L hens. The expression levels of TGFI33 mRNA and protein were significantly increased in UVJs of hens from Group L compared to hens in Group S. Consistently, six TGF/3s downstream genes (DAXX, MEKK1, T-BET, GATA-3, TAK1, and FOXP3) associated with the immune response were found to be significantly differentially expressed in UVJs of Group L than Group S hens. In addition, four SNPs were identified in intron 1 of TGFI33, and these SNPs were significantly associated with DF traits (P< 0.05). Furthermore, we identified multi-copy and copy number variants (CNVs) in chicken TGF/33 and later determined significant associations between TGF/33 CNVs and DF traits in hens. Specifically, TGF/33 copy number exhibited a significant positive correlation with its expression (P < 0.05). Collectively, our results suggest that chicken DF traits may be regulated by the expression of TGFI33 in UVJ. Meanwhile, the copy number variation in the TGF/33 gene identified in this study seems to be one marker for DF traits.	[Gu, Lantao; Gong, Yangzhang; Yu, Mei; Li, Shijun] HuaZhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China; [Sun, Chenghao] Huadu Yukou Poultry Ind Co Ltd, Beijing, Peoples R China	Huazhong Agricultural University	Li, SJ (corresponding author), HuaZhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China.	lishijun@mail.hzau.edu.cn			National Nature Scientific Foundation of China [31372301]; Fundamental Research Funds for the Central Universities of China [2662015PY145]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	The current research was financially supported by the National Nature Scientific Foundation of China (31372301) and the Fundamental Research Funds for the Central Universities of China (No. 2662015PY145). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Bakst MR, 2011, J ANIM SCI, V89, P1323, DOI 10.2527/jas.2010-3663; Bakst MR, 2010, POULTRY SCI, V89, P986, DOI 10.3382/ps.2009-00481; BAKST MR, 1993, REPROD FERT DEVELOP, V5, P595, DOI 10.1071/RD9930595; BAKST MR, 1987, SCANNING MICROSCOPY, V1, P1257; Birkhead TR, 2007, TRENDS ECOL EVOL, V22, P266, DOI 10.1016/j.tree.2007.02.004; BRILLARD JP, 1990, BRIT POULTRY SCI, V31, P635, DOI 10.1080/00071669008417294; Brun JM, 2012, ANIMAL, V6, P1731, DOI 10.1017/S1751731112001206; Burgtorf C, 2003, GENOME RES, V13, P2717, DOI 10.1101/gr.1442303; Burt David W., 1994, Progress in Growth Factor Research, V5, P99; Cheng YS, 2002, GENET SEL EVOL, V34, P597, DOI [10.1051/gse:2002025, 10.1186/1297-9686-34-5-597]; Cheng YS, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-32; Das SC, 2005, J REPROD DEVELOP, V51, P683, DOI 10.1262/jrd.17027; Das SC, 2008, AM J REPROD IMMUNOL, V60, P477, DOI 10.1111/j.1600-0897.2008.00651.x; Das SC, 2006, REPRODUCTION, V132, P781, DOI 10.1530/rep.1.01177; Goerzen PR, 1996, POULTRY SCI, V75, P962, DOI 10.3382/ps.0750962; Higaki Kuniaki, 1995, Japanese Poultry Science, V32, P387; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1991, J IMMUNOL, V146, P4016; Kehrl JH, 2014, J IMMUNOL, V192, P2939; KOSBA MA, 1983, BEITR TROP LANDWIRT, V21, P365; Lake P.E., 1975, Symposia Zool Soc Lond, VNo. 35, P225; Liu GQ, 2008, BRIT POULTRY SCI, V49, P770, DOI 10.1080/00071660802433131; NOCERA M, 1995, AM J REPROD IMMUNOL, V33, P282, DOI 10.1111/j.1600-0897.1995.tb00897.x; OTTINGER MA, 1989, BRIT POULTRY SCI, V30, P431, DOI 10.1080/00071668908417167; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; PINGEL M, 1985, MONATSHEFTEFUR VET M, V40, P129; Schmidt-Weber CB, 2004, CURR OPIN IMMUNOL, V16, P709, DOI 10.1016/j.coi.2004.09.008; Shi T, 2016, ANIM SCI J, V87, P336, DOI 10.1111/asj.12531; Silber S, 2010, FERTIL STERIL, V94, P2191, DOI 10.1016/j.fertnstert.2009.12.073; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; WISHART GJ, 1987, J REPROD FERTIL, V80, P493, DOI 10.1530/jrf.0.0800493; Zheng WM, 2001, REPRODUCTION, V122, P581, DOI 10.1530/reprod/122.4.581	33	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173696	10.1371/journal.pone.0173696	http://dx.doi.org/10.1371/journal.pone.0173696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301526	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300063
J	Iloh, AC; Schmidt, M; Muellner-Riehl, AN; Ogundipe, OT; Paule, J				Iloh, Andrew Chibuzor; Schmidt, Marco; Muellner-Riehl, Alexandra Nora; Ogundipe, Oluwatoyin Temitayo; Paule, Juraj			Pleistocene refugia and genetic diversity patterns in West Africa: Insights from the liana Chasmanthera dependens (Menispermaceae)	PLOS ONE			English	Article							RAIN-FOREST TREES; DAHOMEY GAP; ENVIRONMENTAL-CHANGE; MAXIMUM-LIKELIHOOD; TROPICAL AFRICA; HISTORY; CLIMATE; PHYLOGEOGRAPHY; EVOLUTION; FRAGMENTATION	Processes shaping the African Guineo-Congolian rain forest, especially in the West African part, are not well understood. Recent molecular studies, based mainly on forest tree species, confirmed the previously proposed division of the western African Guineo-Congolian rain forest into Upper Guinea (UG) and Lower Guinea (LG) separated by the Dahomey Gap (DG). Here we studied nine populations in the area of the DG and the borders of LG and UG of the widespread liana species, Chasmanthera dependens (Menispermaceae) by amplified fragment length polymorphism (AFLP), a chloroplast DNA sequence marker, and modelled the distribution based on current as well as paleoclimatic data (Holocene Climate Optimum, ca. 6 kyr BP and Last Glacial Maximum, ca. 22 kyr BP). Current population genetic structure and geographical pattern of cpDNA was related to present as well as historical modelled distributions. Results from this study show that past historical factors played an important role in shaping the distribution of C. dependens across West Africa. The Cameroon Volcanic Line seems to represent a barrier for gene flow in the present as well as in the past. Distribution modelling proposed refugia in the Dahomey Gap, supported also by higher genetic diversity. This is in contrast with the phylogeographic patterns observed in several rainforest tree species and could be explained by either diverging or more relaxed ecological requirements of this liana species.	[Iloh, Andrew Chibuzor; Schmidt, Marco; Muellner-Riehl, Alexandra Nora] Senckenberg Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, Frankfurt, Germany; [Schmidt, Marco; Paule, Juraj] Senckenberg Res Inst, Dept Bot & Mol Evolut, Senckenberganlage 25, Frankfurt, Germany; [Schmidt, Marco; Paule, Juraj] Nat Hist Museum Frankfurt, Senckenberganlage 25, Frankfurt, Germany; [Muellner-Riehl, Alexandra Nora] Univ Leipzig, Inst Biol, Dept Mol Evolut & Plant Systemat, Johannisallee 21-23, Leipzig, Germany; [Muellner-Riehl, Alexandra Nora] Univ Leipzig, Herbarium LZ, Johannisallee 21-23, Leipzig, Germany; [Muellner-Riehl, Alexandra Nora] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, Leipzig, Germany; [Ogundipe, Oluwatoyin Temitayo] Univ Lagos, Dept Bot, Mol Systemat Lab, Lagos, Nigeria; [Iloh, Andrew Chibuzor] Sheda Sci & Technol Complex, Ctr Adv Res Biotechnol, Biodivers & Climate Res Lab, Abuja, Nigeria	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); Leipzig University; Leipzig University; University of Lagos	Iloh, AC (corresponding author), Senckenberg Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, Frankfurt, Germany.; Iloh, AC (corresponding author), Sheda Sci & Technol Complex, Ctr Adv Res Biotechnol, Biodivers & Climate Res Lab, Abuja, Nigeria.	chibaziloh@gmail.com	Muellner-Riehl, Alexandra N/C-6261-2013; Paule, Juraj/A-2998-2017; Schmidt, Marco/C-3821-2009	Muellner-Riehl, Alexandra N/0000-0002-2710-469X; Paule, Juraj/0000-0001-5375-7689; Schmidt, Marco/0000-0001-6087-6117; ILOH, Andrew Chibuzor/0000-0001-5052-3430	Alexander von Humboldt Foundation, Germany	Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	Funding was provided by the Alexander von Humboldt Foundation, Germany in the scope of International Climate Protection Fellowship granted to Andrew Chibuzor Iloh.	Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; BAWA KS, 1977, EVOLUTION, V31, P64, DOI 10.1111/j.1558-5646.1977.tb00982.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; BOOTH AH, 1958, EVOLUTION, V12, P48, DOI 10.2307/2405903; Budde KB, 2013, HEREDITY, V111, P66, DOI 10.1038/hdy.2013.21; Burkill HM, 1997, USEFUL PLANTS W TROP, V4; Charlesworth B, 2009, NATURE REV GENETICS, V10, P1; Chave J, 2001, J TROP ECOL, V17, P79, DOI 10.1017/S0266467401001055; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Convention on Biological Diversity (CBD), 2007, EM ISS BIOD CONS CHA; Dainou K, 2010, MOL ECOL, V19, P4462, DOI 10.1111/j.1365-294X.2010.04831.x; Dauby G, 2014, MOL ECOL, V23, P2299, DOI 10.1111/mec.12724; Demenou BB, 2016, J BIOGEOGR, V43, P1020, DOI 10.1111/jbi.12688; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duminil J, 2010, MOL ECOL, V19, P5469, DOI 10.1111/j.1365-294X.2010.04917.x; Duminil J, 2015, J BIOGEOGR, V42, P1443, DOI 10.1111/jbi.12510; Duminil J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-195; Dupont LM, 2001, GEOLOGY, V29, P195, DOI 10.1130/0091-7613(2001)029<0195:MPECIT>2.0.CO;2; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gerwing JJ, 2000, J TROP ECOL, V16, P327, DOI 10.1017/S0266467400001437; Gerwing JJ, 2004, FOREST ECOL MANAG, V190, P57, DOI 10.1016/j.foreco.2003.10.006; Global Biodiversity Information Facility (GBIF, 2016, CHASM DEP DAT BAS; Gnoumou A, 2015, CHECK LIST, V11, P1, DOI DOI 10.15560/11.1.1557; HAMILTON AC, 1991, CLIMATIC CHANGE, V19, P65, DOI 10.1007/BF00142215; Hamilton MB, 2002, GENETICS, V162, P1897; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hardy OJ, 2013, CR GEOSCI, V345, P284, DOI 10.1016/j.crte.2013.05.001; Heuertz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084307; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Iwu M. M., 2014, HDB AFRICAN MED PLAN; Klopper RR, 2007, TAXON, V56, P201, DOI 10.2307/25065751; Ley AC, 2016, BIOTROPICA, V48, P618, DOI 10.1111/btp.12341; Ley AC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00403; Lowe A. J., 2010, Tropical Plant Biology, V3, P50, DOI 10.1007/s12042-010-9045-2; Maley J, 1996, P ROYAL SOC EDINBURG, V104B, P31, DOI 10.1017/S0269727000006114; Mannah A, 2009, HEILTRADITIONEN BIOD; Martin PH, 2004, BIOTROPICA, V36, P297; Matallana G, 2005, AM J BOT, V92, P1513, DOI 10.3732/ajb.92.9.1513; Miller CS, 2014, QUATERNARY SCI REV, V84, P7, DOI 10.1016/j.quascirev.2013.10.027; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Mosango DM, 2008, PROTA PLANT RESOURCE, P23; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nason JD, 1996, J BIOGEOGR, V23, P501, DOI 10.1111/j.1365-2699.1996.tb00012.x; NEI M, 1983, GENETICS, V105, P207; Nei M., 1987, MOL EVOLUTIONARY GEN; Brandes AFN, 2011, TREES-STRUCT FUNCT, V25, P133, DOI 10.1007/s00468-010-0529-3; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Plana V, 2004, PHILOS T ROY SOC B, V359, P1585, DOI 10.1098/rstb.2004.1535; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Salzmann U, 2005, HOLOCENE, V15, P190, DOI 10.1191/0959683605hl799rp; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Troupin G, 1962, MONOGRAPHIE MENISPER; Vollmert P, 2004, ERDE, V134, P375; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wefferling KM, 2013, AM J BOT, V100, P883, DOI 10.3732/ajb.1200556; WHITE F, 1979, Bulletin du Jardin Botanique National de Belgique, V49, P11, DOI 10.2307/3667815; Yao XH, 2007, NEW PHYTOL, V176, P472, DOI 10.1111/j.1469-8137.2007.02175.x; Zeng XQ, 2012, J PLANT ECOL-UK, V5, P270, DOI 10.1093/jpe/rtr029	69	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0170511	10.1371/journal.pone.0170511	http://dx.doi.org/10.1371/journal.pone.0170511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301470	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300007
J	Mandraffino, G; Aragona, CO; Cairo, V; Scuruchi, M; Lo Gullo, A; D'Ascola, A; Alibrandi, A; Loddo, S; Quartuccio, S; Morace, C; Mormina, E; Basile, G; Saitta, A; Imbalzano, E				Mandraffino, Giuseppe; Aragona, Caterina Oriana; Cairo, Valentina; Scuruchi, Michele; Lo Gullo, Alberto; D'Ascola, Angela; Alibrandi, Angela; Loddo, Saverio; Quartuccio, Sebastiano; Morace, Carmela; Mormina, Enricomaria; Basile, Giorgio; Saitta, Antonino; Imbalzano, Egidio			Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects	PLOS ONE			English	Article							ANGIOTENSIN-II; CARDIOVASCULAR RISK; OXIDATIVE STRESS; NADPH OXIDASE; ENDOTHELIAL-CELLS; TYPE-1 RECEPTOR; CD34(+) CELLS; MICRORNAS; EXPRESSION; ATHEROSCLEROSIS	CD34+ circulating progenitor cells (CD34+ CPCs) are a population of multipotent cells which can delay the development of atherosclerosis and cardiovascular disease (CVD) in conditions of increased CV risk. MicroRNAs (miRs) 221 and 222 modulate different genes regulating angiogenesis and inflammation; moreover, miR221/22 have beenshown to participate in differentiation and proliferation of CD34+ CPCs, inhibiting cell migration and homing. miR221/222 in CD34+ CPCs from hypertensive subjects are also increased and associated with CD34+ cell number and reactive oxygen species (ROS). We evaluated CD34+ CPC number, intracellular miR221/222 and ROS levels, arterial stiffness (AS) and echocardiography indices at baseline (T0). Then, after a six-month treatment with olmesartan, 20 mg/day (T1), in 57 hypertensive patients with left ventricular hypertrophy (LVH) and with no additional risk factor for CVD, and in 29 healthy controls (baseline), fibrinogen, C-reactive protein (CRP), glucose and lipid profiles were also evaluated. At T1, blood pressure values, CRP and fibrinogen levels, ROS and miR221/222 were significantly decreased (all p < 0.001), as were AS indices and LV mass index (p< 0.001), while cell number was increased (p< 0.001). Olmesartan is effective in reducing miR and ROS levels in CD34+ CPCs from hypertensive subjects, as well as in increasing CD34+ CPC number, providing multilevel CV protection, in addition to its expected pharmacological effects.	[Mandraffino, Giuseppe; Aragona, Caterina Oriana; Cairo, Valentina; Lo Gullo, Alberto; Quartuccio, Sebastiano; Morace, Carmela; Basile, Giorgio; Saitta, Antonino; Imbalzano, Egidio] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Scuruchi, Michele; D'Ascola, Angela; Loddo, Saverio] Univ Messina, Dept Biochem Physiol & Nutr Sci, Messina, Italy; [Alibrandi, Angela] Univ Messina, Dept Stat, Messina, Italy; [Mormina, Enricomaria] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy	University of Messina; University of Messina; University of Messina; University of Messina	Mandraffino, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	gmandraffino@unime.it	Imbalzano, Egidio/A-2063-2015; Scuruchi, Michele/K-2533-2018; Mandraffino, Giuseppe/K-4346-2018; Gullo, Alberto Lo/AAC-2766-2019; Mormina, Enricomaria/K-4664-2016	Imbalzano, Egidio/0000-0003-2656-5467; Mandraffino, Giuseppe/0000-0003-0272-2237; Mormina, Enricomaria/0000-0003-2716-5772; SCURUCHI, Michele/0000-0002-5282-1690; Lo Gullo, Alberto/0000-0003-4383-0314; CAIRO, VALENTINA/0000-0001-6921-3037; d'ascola, angela/0000-0001-7530-1316; BASILE, Giorgio/0000-0002-0040-8618	Clinical and Experimental Medicine Department, University of Messina	Clinical and Experimental Medicine Department, University of Messina	This study has been carried out with a support of funds allocated by our Department (Clinical and Experimental Medicine Department, University of Messina) for Clinical Research. These funding are annually assigned by the University of Messina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batkai S, 2012, CURR HYPERTENS REP, V14, P79, DOI 10.1007/s11906-011-0235-6; Bo S, 2012, NUTR METAB CARDIOVAS, V22, P668, DOI 10.1016/j.numecd.2010.11.004; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Calo LA, 2014, J HYPERTENS, V32, P193, DOI 10.1097/HJH.0b013e32836522c3; Chao H, 2010, MICROVASC RES, V79, P169, DOI 10.1016/j.mvr.2010.02.003; Chappell MC, 2016, AM J PHYSIOL-HEART C, V310, pH137, DOI 10.1152/ajpheart.00618.2015; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; de Boer HC, 2011, ARTERIOSCL THROM VAS, V31, P408, DOI 10.1161/ATVBAHA.110.216879; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Endtmann C, 2011, HYPERTENSION, V58, P394, DOI 10.1161/HYPERTENSIONAHA.110.169193; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fliser D, 2004, CIRCULATION, V110, P1103, DOI 10.1161/01.CIR.0000140265.21608.8E; Gong X, 2015, MED SCI MONITOR, V21, P1189, DOI 10.12659/MSM.892996; Gutierrez-Fernandez M, 2015, J NEUROSCI RES, V93, P806, DOI 10.1002/jnr.23532; Heggermont WA, 2012, HYPERTENSION, V60, P1088, DOI 10.1161/HYPERTENSIONAHA.111.187104; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Imanishi T, 2005, J HYPERTENS, V23, P1831, DOI 10.1097/01.hjh.0000183524.73746.1b; Imanishi T, 2005, J HYPERTENS, V23, P97, DOI 10.1097/00004872-200501000-00018; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Leung A, 2013, CIRC RES, V113, P266, DOI 10.1161/CIRCRESAHA.112.300849; Lo Gullo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134602; Mandraffino G, 2014, J HUM HYPERTENS, V28, P543, DOI 10.1038/jhh.2014.7; Mandraffino G, 2014, J HUM HYPERTENS; Mandraffino G, 2012, EXP GERONTOL, V47, P394, DOI 10.1016/j.exger.2012.03.007; Mandraffino G, 2010, CLIN BIOCHEM, V43, P1436, DOI 10.1016/j.clinbiochem.2010.09.023; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Minami Y, 2009, EUR J CLIN INVEST, V39, P359, DOI 10.1111/j.1365-2362.2009.02110.x; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Morris BJ, 2015, HYPERTENSION, V65, P956, DOI 10.1161/HYPERTENSIONAHA.114.04366; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; Norata GD, 2013, ATHEROSCLEROSIS, V227, P209, DOI 10.1016/j.atherosclerosis.2012.11.019; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pesarin F., 2010, PERMUTATION TESTS CO; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pirro M, 2007, J HYPERTENS, V25, P2093, DOI 10.1097/HJH.0b013e32828e506d; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009; Rigato M, 2015, J CLIN ENDOCR METAB, V100, P2666, DOI 10.1210/jc.2015-1687; Roks AJM, 2011, CURR OPIN PHARMACOL, V11, P162, DOI 10.1016/j.coph.2011.01.002; Shi LJ, 2015, DRUG DISCOV TODAY, V20, P1188, DOI 10.1016/j.drudis.2015.05.007; Shilo S, 2008, ARTERIOSCL THROM VAS, V28, P471, DOI 10.1161/ATVBAHA.107.160655; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Singh K. D., 2016, J CELL SIGNAL, V1; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Tsuda M, 2005, HYPERTENSION, V45, P545, DOI 10.1161/01.HYP.0000157409.88971.fc; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031; Yatabe J, 2009, AM J PHYSIOL-RENAL, V296, pF1052, DOI 10.1152/ajprenal.00580.2007; Yoder MC, 2013, J MOL MED, V91, P285, DOI 10.1007/s00109-013-1002-8; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	65	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173030	10.1371/journal.pone.0173030	http://dx.doi.org/10.1371/journal.pone.0173030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301500	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300023
J	Miller, AL; Elam, WA; Johnson, BH; Khan, SH; Kumar, R; Thompson, EB				Miller, Aaron L.; Elam, W. Austin; Johnson, Betty H.; Khan, Shagufta H.; Kumar, Raj; Thompson, E. Brad			Restored mutant receptor: Corticoid binding in chaperone complexes by trimethylamine N-oxide	PLOS ONE			English	Article							HUMAN GLUCOCORTICOID-RECEPTOR; RESISTANT; PROTEINS; CELLS; EXPRESSION; OSMOLYTES; DOMAIN; GENE	Without a glucocorticoid (GC) ligand, the transcription factor glucocorticoid receptor (GR) is largely cytoplasmic, with its GC-binding domain held in high affinity conformation by a cluster of chaperones. Binding a GC causes serial dis- and re-associations with chaperones, translocation of the GR to the nucleus, where it binds to DNA sites and associates with coregulatory proteins and basic transcription complexes. Herein, we describe the effects of a potent protective osmolyte, trimethylamine N-oxide (TMAO), on a conditions-dependent "activation-labile" mutant GR (GR(act/l)), which under GR-activating conditions cannot bind GCs in cells or in cell cytosols. In both cells and cytosols, TMAO restores binding to GR(act/l) by stabilizing it in complex with chaperones. Cells bathed in much lower concentrations of TMAO than those required in vitro show restoration of GC binding, presumably due to intracellular molecular crowding effects.	[Miller, Aaron L.; Elam, W. Austin; Johnson, Betty H.; Thompson, E. Brad] Univ Texas Med Branch, Sealy Ctr Struct Biol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Khan, Shagufta H.; Kumar, Raj] Geisinger Commonwealth Sch Med, Dept Basic Sci, Scranton, PA USA; [Miller, Aaron L.] Univ Texas Med Branch, Dept Pediat Vaccinol, Galveston, TX 77555 USA; [Elam, W. Austin] C4 Therapeutics, Dept Biophys & Biochem, Cambridge, MA USA; [Thompson, E. Brad] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Houston System; University of Houston	Thompson, EB (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Thompson, EB (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA.	bthompso@utmb.edu			National Institute of Health [5RO1 CA]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in whole or part by National Institute of Health Grant 5RO1 CA (to EBT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTAKLY T, 1990, CANCER RES, V50, P1337; ASHRAF J, 1993, MOL ENDOCRINOL, V7, P631, DOI 10.1210/me.7.5.631; Auton M, 2011, BIOPHYS CHEM, V159, P90, DOI 10.1016/j.bpc.2011.05.012; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; Breydo L, 2015, ARCH BIOCHEM BIOPHYS, V570, P66, DOI 10.1016/j.abb.2015.02.021; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Chebotareva NA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1478, DOI 10.1134/S0006297907130056; Chen DWC, 2013, ONCOGENE, V32, P3039, DOI 10.1038/onc.2012.321; Fan YQ, 2012, INT J BIOL MACROMOL, V51, P845, DOI 10.1016/j.ijbiomac.2012.07.026; HARMON JM, 1981, MOL CELL BIOL, V1, P512, DOI 10.1128/MCB.1.6.512; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Li J, 2012, J BIOL CHEM, V287, P26777, DOI 10.1074/jbc.M112.355651; Medh RD, 2003, GENOMICS, V81, P543, DOI 10.1016/S0888-7543(03)00045-4; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Mittal S, 2015, BBA-GEN SUBJECTS, V1850, P1822, DOI 10.1016/j.bbagen.2015.05.002; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Simons SS, 2014, MOL ENDOCRINOL, V28, P173, DOI 10.1210/me.2013-1334; Stepanenko OV, 2016, J BIOMOL STRUCT DYN, V34, P2155, DOI 10.1080/07391102.2015.1109554; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; ten Wolde PR, 2014, INT REV CEL MOL BIO, V307, P419, DOI 10.1016/B978-0-12-800046-5.00012-6; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Vandevyver S, 2012, TRAFFIC, V13, P364, DOI 10.1111/j.1600-0854.2011.01288.x; Zhang Z, 2003, AM J PHYSIOL-RENAL, V285, pF688, DOI 10.1152/ajprenal.00028.2003	27	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174183	10.1371/journal.pone.0174183	http://dx.doi.org/10.1371/journal.pone.0174183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301576	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300131
J	Crittenden, AN; Sorrentino, J; Moonie, SA; Peterson, M; Mabulla, A; Ungar, PS				Crittenden, Alyssa N.; Sorrentino, John; Moonie, Sheniz A.; Peterson, Mika; Mabulla, Audax; Ungar, Peter S.			Oral health in transition: The Hadza foragers of Tanzania	PLOS ONE			English	Article							DENTAL-CARIES PREVALENCE; SEX-DIFFERENCES; HUNTER-GATHERERS; ANTIMICROBIAL ACTIVITY; XAVANTE INDIANS; LENGUA INDIANS; AGRICULTURE; WEAR; MICROBIOME; OCCLUSAL	Conventional wisdom holds that a decline in oral health accompanies the transition from hunting and gathering to agriculture, given increased consumption of carbohydrates. This widely touted example of the mismatch between our biology and modern lifestyle has been intuited largely from the bioarchaeological record of the Neolithic Revolution in the New World. Recent studies of other populations have, however, challenged the universality of this assertion. Here, we present the first comprehensive study of oral health among a living population in transition from the bush to village life, the Hadza hunter-gatherers of Tanzania, to test the hypothesis that the shift from foraging to farming, or agricultural intensification, inevitably leads to increased periodontal disease, caries, and orthodontic disorders. Our results showed that women living in villages consuming a mostly agricultural diet exhibited more caries and periodontal disease than those living in the bush consuming a mostly wild-food diet. Furthermore, men living in the bush consuming mostly a wild-food diet had more than those living in the village consuming a mostly agricultural diet. These findings are explained by the high incidence of maize consumption in village settings, along with previously recognized variation in rate of caries between men and women. The unexpected discovery of high caries incidences for men in the bush is likely explained by heavy reliance on honey, and perhaps differential access to tobacco and marijuana. These data support the notions that mechanisms of cariogenesis are multifactorial and that the relationships between oral health and the shift from a predominantly wild-food diet to one dominated by cultigens are nuanced.	[Crittenden, Alyssa N.] Univ Nevada, Dept Anthropol, Metab Anthropometry & Nutr Lab, Las Vegas, NV 89154 USA; [Sorrentino, John] DMD Family & Cosmet Dent, New York, NY USA; [Moonie, Sheniz A.] Univ Nevada, Epidemiol & Biostat, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Peterson, Mika] Dorobo Fund, Arusha, Tanzania; [Mabulla, Audax] Univ Dar Es Salaam, Dept Archaeol, Dar Es Salaam, Tanzania; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Dar es Salaam; University of Arkansas System; University of Arkansas Fayetteville	Ungar, PS (corresponding author), Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA.	pungar@uark.edu	Moonie, Sheniz/R-6215-2016; Mabulla, Audax ZP/ABE-2455-2020	Moonie, Sheniz/0000-0002-3192-9205; Ungar, Peter/0000-0002-5936-471X	National Science Foundation [1539843, 1539841]; University of Nevada, Las Vegas; D.M.D. Family and Cosmetic Dentistry	National Science Foundation(National Science Foundation (NSF)); University of Nevada, Las Vegas; D.M.D. Family and Cosmetic Dentistry	This work was supported by the National Science Foundation (grant # 1539843 to ANC and # 1539841 to PSU) and the University of Nevada, Las Vegas (Individual Investigator Award to ANC). D.M.D. Family and Cosmetic Dentistry provided support in the form of salary for author JS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ahmadi-Motamayel Fatemeh, 2013, J Dent (Tehran), V10, P10; Al-Bayati FA, 2008, TURK J BIOL, V32, P57; Alves P, 2009, CAD SAUDE PUBLICA, V25, P37, DOI 10.1590/S0102-311X2009000100004; Anderson Max, 2002, Pediatr Dent, V24, P377; [Anonymous], 2012, MOSBYS MED DICT; Arantes R, 2003, SAUDE BUCAL POVOS IN, P49; Arantes R, 2009, ANN HUM BIOL, V36, P162, DOI 10.1080/03014460802672844; Armelagos GJ, 1984, PALEOPATHOLOGY ORIGI, P235; Axelsson P, 1998, J CLIN PERIODONTOL, V25, P297, DOI 10.1111/j.1600-051X.1998.tb02444.x; Barnes S, 1998, P SOC EXP BIOL MED, V217, P386; Berbesque JC, 2012, HUM NATURE-INT BIOS, V23, P270, DOI 10.1007/s12110-012-9145-9; Berbesque JC, 2011, AM J HUM BIOL, V23, P339, DOI 10.1002/ajhb.21139; Berbesque JC, 2016, EVOL HUM BEHAV, DOI DOI 10.1016/J.EVOLHUMBEHAY.2016.01.003; Berbesque JC, 2009, EVOL PSYCHOL-US, V7, P601, DOI 10.1177/147470490900700409; Blurton Jones N, 2016, DEMOGRAPHY EVOLUTION; BORGOGNINITARLI SM, 1985, J HUM EVOL, V14, P241; Bowen WH, 2005, PEDIATRICS, V116, P921, DOI 10.1542/peds.2004-2462; Cho CM, 2005, AUST DENT J, V50, P70, DOI 10.1111/j.1834-7819.2005.tb00343.x; Collins HB, 1932, AM J PHYS ANTHROPOL, V16, P451, DOI 10.1002/ajpa.1330160415; CORRUCCINI RS, 1990, AM J PHYS ANTHROPOL, V82, P257, DOI 10.1002/ajpa.1330820304; Corruccini RS, 1999, ANTHR INFORM ORTHODO; Crittenden A. N., 2016, WILD HARVEST PLANTS, P319; Crittenden AN, 2013, EVOL HUM BEHAV, V34, P299, DOI 10.1016/j.evolhumbehav.2013.04.004; Crittenden AN, 2014, CUNA HUMANIDAD, P209; Darling M R, 1992, Int Dent J, V42, P19; de Souza BS, 2015, ARCH ORAL BIOL, V60, P1177, DOI 10.1016/j.archoralbio.2015.04.007; Demirtas H, 2016, COMMUN STAT-SIMUL C, V45, P2744, DOI 10.1080/03610918.2014.920883; Deter CA, 2009, AM J PHYS ANTHROPOL, V138, P247, DOI 10.1002/ajpa.20922; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Ditmyer M, 2013, J ADOLESCENT HEALTH, V52, P641, DOI 10.1016/j.jadohealth.2012.11.002; Domett KM, 2001, BRITISH ARCHAEOLOGIC, V946; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Eshed V, 2006, AM J PHYS ANTHROPOL, V130, P145, DOI 10.1002/ajpa.20362; Ettinger R L, 1999, Dent Clin North Am, V43, P679; Ezoddini-Ardakani F., 2010, Health, V2, P499, DOI 10.4236/health.2010.25074; Fields M., 2009, J DENT ORAL HYG, V1, P42; Fosbrooke H. A., 1956, S AFRICAN ARCHEOLOGI, V11, P3; Fyfe DM., 1993, INT J OSTEOARCHAEOL, V3, P29; Gadegaard E, EPIDEMIOLOGIC DATA C; Gordon AJ, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0419-7; Hara Anderson T, 2010, Dent Clin North Am, V54, P455, DOI 10.1016/j.cden.2010.03.008; HILDEBOLT CF, 1988, AM J PHYS ANTHROPOL, V75, P1, DOI 10.1002/ajpa.1330750102; Hillson S, 2001, INT J OSTEOARCHAEOL, V11, P249; Hillson S, 2008, DENT PATHOLOGY BIOL, P299; Humphrey LT, 2014, P NATL ACAD SCI USA, V111, P954, DOI 10.1073/pnas.1318176111; Jin JS, 2010, INT J SYST EVOL MICR, V60, P1721, DOI 10.1099/ijs.0.016774-0; Johnson GK, 2004, J PERIODONTOL, V75, P196, DOI 10.1902/jop.2004.75.2.196; Khan MN, 2000, PHARM BIOL, V38, P235, DOI 10.1076/1388-0209(200007)3831-SFT235; KIESER JA, 1984, COMMUNITY DENT ORAL, V12, P406, DOI 10.1111/j.1600-0528.1984.tb01481.x; KIESER JA, 1985, AM J PHYS ANTHROPOL, V66, P21, DOI 10.1002/ajpa.1330660103; Kornbrot D., POINT BISERIAL CORRE; Laine MA, 2002, ACTA ODONTOL SCAND, V60, P257, DOI 10.1080/00016350260248210; Lampe JW, 2009, AM J CLIN NUTR, V89, pS1664, DOI 10.3945/ajcn.2009.26736T; Larmas M, 2010, CARIES RES, V44, P81, DOI 10.1159/000279327; Larsen C. S., 1991, ADV DENT ANTHR, P179; Larsen C.S, 2015, BIOARCHAEOLOGY INTER, DOI DOI 10.1016/j.bone.2012.05.023; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; LARSEN CS, 1981, CURR ANTHROPOL, V22, P422, DOI 10.1086/202697; LEMBARITI BS, 1988, COMMUNITY DENT ORAL, V16, P240, DOI 10.1111/j.1600-0528.1988.tb01763.x; LEVERETT DH, 1982, SCIENCE, V217, P26, DOI 10.1126/science.7089534; LUBELL D, 1994, J ARCHAEOL SCI, V21, P201, DOI 10.1006/jasc.1994.1022; Lukacs JR, 2008, CURR ANTHROPOL, V49, P901, DOI 10.1086/592111; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; Lukacs JR, 1996, CURR ANTHROPOL, V37, P147, DOI 10.1086/204481; Lukacs JR, 2008, TECHNIQUE APPL DENT; Maat GJR, 2000, INT J OSTEOARCHAEOL, V10, P142, DOI 10.1002/(SICI)1099-1212(200003/04)10:2<142::AID-OA519>3.0.CO;2-L; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Marlowe FW, 2014, J HUM EVOL, V71, P119, DOI 10.1016/j.jhevol.2014.03.006; Marlowe FW, 2004, ENCY MED ANTHROPOLOG, P689; Martin-Frances L, 2014, CR PALEVOL, V13, P189, DOI 10.1016/j.crpv.2013.10.007; MAYHALL JT, 1970, ARCTIC ANTHROPOL, V7, P117; Mazengo MC, 1996, COMMUNITY DENT ORAL, V24, P169, DOI 10.1111/j.1600-0528.1996.tb00836.x; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; Meiklejohn C., 1992, INT J ANTHR, V7, P17, DOI DOI 10.1007/BF02445038; MILNER GR, 1984, COLLEGIUM ANTROPOL, V8, P77; Moynihan P., 2000, BNF Nutrition Bulletin, V25, P281, DOI 10.1046/j.1467-3010.2000.00033.x; Nassar HM, 2012, APPL ENVIRON MICROB, V78, P536, DOI 10.1128/AEM.05538-11; NEEL JV, 1964, AM J HUM GENET, V16, P52; Prodan A, 2015, EUR J ORAL SCI, V123, P149, DOI 10.1111/eos.12182; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Schoeninger MJ, 2001, J FOOD COMPOS ANAL, V14, P15, DOI 10.1006/jfca.2000.0961; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Shaffer JR, 2015, CARIES RES, V49, P133, DOI 10.1159/000369103; SHANNON IL, 1979, J DENT CHILD, V46, P29; Shearer DM, 2011, J DENT RES, V90, P672, DOI 10.1177/0022034510393349; Steckel RH, 2002, BACKBONE HIST LONG T; Struzycka I, 2014, POL J MICROBIOL, V63, P127; TURNER CG, 1979, AM J PHYS ANTHROPOL, V51, P619, DOI 10.1002/ajpa.1330510413; Turroni S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00865; Vellappally Sajith, 2007, Acta Medica (Hradec Kralove), V50, P161; WALKER PL, 1990, AM ANTHROPOL, V92, P383, DOI 10.1525/aa.1990.92.2.02a00080; Walker PL, 1998, U OREGON ANTHR PAPER, V54, P355; Watson JT, 2008, INT J OSTEOARCHAEOL, V18, P202, DOI 10.1002/oa.917; Watson JT, 2010, AM J HUM BIOL, V22, P92, DOI 10.1002/ajhb.20958; WOLINSKY LE, 1984, CARIES RES, V18, P216, DOI 10.1159/000260768; Woodburn J., 1970, HUNTERS GATHERERS MA; Yatsuka H., 2015, African Study Monographs, V36, P27	99	25	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172197	10.1371/journal.pone.0172197	http://dx.doi.org/10.1371/journal.pone.0172197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296885	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700005
J	Ge, QM; Huang, CM; Zhu, XY; Bian, F; Pan, SM				Ge, Qin-Min; Huang, Chun-Mei; Zhu, Xiang-Yang; Bian, Fan; Pan, Shu-Ming			Differentially expressed miRNAs in sepsisinduced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SEPSIS; PATHOPHYSIOLOGY; MICRORNAS; BIOGENESIS; METABOLISM; BIOMARKERS; MODEL	Objective To identify specific miRNAs involved in sepsis-induced AKI and to explore their targeting pathways. Methods The expression profiles of miRNAs in serum from patients with sepsis-induced AKI (n = 6), sepsis-non AKI (n = 6), and healthy volunteers (n = 3) were investigated by microarray assay and validated by quantitative PCR (qPCR). The targets of the differentially expressed miRNAs were predicted by Target Scan, mirbase and Miranda. Then the significant functions and involvement in signaling pathways of gene ontology (GO) and KEGG pathways were analyzed. Furthermore, eight miRNAs were randomly selected out of the differentially expressed miRNAs for further testing by qPCR. Results qPCR analysis confirmed that the expressions levels of hsa-miR-23a-3p, hsa-miR-4456, hsa-miR-142-5p, hsa-miR-22-3p and hsa-miR-191-5p were significantly lower in patients with sepsis compared with the healthy volunteers, while hsa-miR-4270, hsa-miR-4321, hsa-miR-3165 were higher in the sepsis patients. Statistically, miR-4321; miR-4270 were significantly upregulated in the sepsis-induced AKI compared with sepsis-non AKI, while only miR-4321 significantly overexpressed in the sepsis groups compared with control groups. GO analysis showed that biological processes regulated by the predicted target genes included diverse terms. They were related to kidney development, regulation of nitrogen compound metabolic process, regulation of cellular metabolic process, cellular response to oxidative stress, mitochondrial outer membrane permeabilization, etc. Pathway analysis showed that several significant pathways of the predicted target genes related to oxidative stress. miR-4321 was involved in regulating AKT1, mTOR and NOX5 expression while miR-4270 was involved in regulating PPARGC1A, AKT3, NOX5, PIK3C3, WNT1 expression. Function and pathway analysis highlighted the possible involvement of miRNA-deregulated mRNAs in oxidative stress and mitochondrial dysfunction. Conclusion This study might help to improve understanding of the relationship between serum miRNAs and sepsis-induced AKI, and laid an important foundation for further identification of the potential mechanisms of sepsis-induced AKI and oxidative stress and mitochondrial dysfunction.	[Ge, Qin-Min; Huang, Chun-Mei; Pan, Shu-Ming] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Emergency, Shanghai, Peoples R China; [Zhu, Xiang-Yang] Mayo Clin, Coll Med, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN USA; [Bian, Fan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Nephrol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Mayo Clinic; Shanghai Jiao Tong University	Pan, SM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Emergency, Shanghai, Peoples R China.	drpanshuming@163.com			National Natural Science Foundation of China [81000354]; Shanghai Nature Science Foundation [14ZR1427000]; National clinical key specialty construction project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation; National clinical key specialty construction project	This study was supported by National Natural Science Foundation of China (No.81000354), Shanghai Nature Science Foundation (14ZR1427000) and 2013-2014 National clinical key specialty construction project.	Aguado-Fraile E, 2013, NEFROLOGIA, V33, P826, DOI 10.3265/Nefrologia.pre2013.Aug.12198; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Bagshaw SM, 2007, INTENS CARE MED, V33, P1285, DOI 10.1007/s00134-007-0656-5; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Basile David P., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P3; Bellinger MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093297; Benes J, 2011, CRIT CARE, V15, DOI 10.1186/cc10517; Chaudhuri AD, 2013, FASEB J, V27, P3720, DOI 10.1096/fj.13-232678; Chawla LS, 2007, CLIN J AM SOC NEPHRO, V2, P22, DOI 10.2215/CJN.02510706; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cho E, 2014, NEPHROLOGY, V19, P318, DOI 10.1111/nep.12230; Christian P, 2014, AM J PHYSIOL-ENDOC M, V307, pE729, DOI 10.1152/ajpendo.00194.2014; Essandoh K, 2014, BBA-MOL BASIS DIS, V1842, P2155, DOI 10.1016/j.bbadis.2014.07.021; Fourcade S, 2015, FREE RADICAL BIO MED, V88, P18, DOI 10.1016/j.freeradbiomed.2015.05.041; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Holly MK, 2006, KIDNEY INT, V70, P496, DOI 10.1038/sj.ki.5001575; Keir I, 2015, J VET EMERG CRIT CAR, V25, P200, DOI 10.1111/vec.12297; Lan YF, 2012, J AM SOC NEPHROL, V23, P2012, DOI 10.1681/ASN.2012050438; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Parikh SM, 2015, SEMIN NEPHROL, V35, P108, DOI 10.1016/j.semnephrol.2015.01.011; Pinto CF, 2012, REV ESC ENFERM USP, V46, P86, DOI 10.1590/S0080-62342012000700013; Quoilin C, 2014, BBA-BIOENERGETICS, V1837, P1790, DOI 10.1016/j.bbabio.2014.07.005; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rossaint J, 2011, KIDNEY INT, V80, P493, DOI 10.1038/ki.2011.125; Saikumar J, 2012, TOXICOL SCI, V129, P256, DOI 10.1093/toxsci/kfs210; Sun L., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1111/MPP.12078; Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011606, 10.1371/journal.pone.0009518]; Tran M, 2014, NEPHRON CLIN PRACT, V127, P42, DOI 10.1159/000363715; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031	34	76	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173292	10.1371/journal.pone.0173292	http://dx.doi.org/10.1371/journal.pone.0173292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296904	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700032
J	Yang, YL; Zhang, L; Wang, XF; Lu, Q; He, L; Wang, J; Wang, B; Li, L; Yuan, L; Liu, JF; Ge, SP; Xie, MX				Yang, Yali; Zhang, Li; Wang, Xinfang; Lu, Qing; He, Lin; Wang, Jing; Wang, Bin; Li, Ling; Yuan, Li; Liu, Jinfeng; Ge, Shuping; Xie, Mingxing			Echocardiographic diagnosis of rare pathological patterns of sinus of Valsalva aneurysm	PLOS ONE			English	Article							LEFT CORONARY-SINUS; CONGENITAL ANEURYSM; LEFT-VENTRICLE; EXPERIENCE; RUPTURE	Objective To evaluate the value and improve the diagnostic accuracy of echocardiography in the diagnosis of a sinus of Valsalva aneurysm (SVA) with rare pathological patterns. Methods Echocardiographic features and surgical findings from 270 Chinese patients with SVA treated in the last 18 years (1995-2013) at the Union Hospital were compared retrospectively; 22 of 270 cases had rare patterns. Results The patients with SVA, a rare origin, a rare extending position, or a rare course accounted for 3.4%, 7.4%, and 0.4% of the 270 cases, respectively. The three most common aneurysmal complications of the patients with rare patterns were severe aortic regurgitation (16), obstruction of the ventricular outflow tract or valvular orifice (3), and conduction disturbance (3). The origin, course, extending position and rupture status of the SVAs determined by echocardiography were entirely consistent with surgical findings in 81.8% of the 22 cases. With the exception of one failed diagnosis of an aneurysmal wall dissection and one misdiagnosis of a descending aortic dissection, the echocardiographic results of SVA complications and associated cardiovascular lesions were also confirmed. Conclusion We could accurately diagnose SVAs with rare pathological patterns by echocardiographic identification of distinguishing features. However, for several conditions, we could not accurately identify the origin or course of the aneurysm or define its relationship to adjacent structures using conventional echocardiography alone. Therefore, we recommend combining conventional echocardiography with different imaging techniques, such as transesophageal echocardiography, three-dimensional echocardiography, computed tomography angiography, and aortic angiography.	[Yang, Yali; Zhang, Li; Wang, Xinfang; Lu, Qing; He, Lin; Wang, Jing; Wang, Bin; Li, Ling; Yuan, Li; Liu, Jinfeng; Ge, Shuping; Xie, Mingxing] Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Yang, Yali; Zhang, Li; Wang, Xinfang; Lu, Qing; He, Lin; Wang, Jing; Wang, Bin; Li, Ling; Yuan, Li; Liu, Jinfeng; Ge, Shuping; Xie, Mingxing] Hubei Prov Key Lab Mol Imaging, Wuhan, Hubei, Peoples R China; [Ge, Shuping] St Christophers Hosp Children, Ctr Heart, Philadelphia, PA 19133 USA; [Ge, Shuping] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Huazhong University of Science & Technology; Drexel University	Ge, SP; Xie, MX (corresponding author), Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China.; Ge, SP; Xie, MX (corresponding author), Hubei Prov Key Lab Mol Imaging, Wuhan, Hubei, Peoples R China.; Ge, SP (corresponding author), St Christophers Hosp Children, Ctr Heart, Philadelphia, PA 19133 USA.; Ge, SP (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	shuping.ge@drexelmed.edu; xiemx64@126.com	Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022; Zhang, L/ABG-4378-2020; Zhang, L/A-8465-2019; yang, yang/HGT-7999-2022	Zhang, L/0000-0003-1620-1512; Zhang, L/0000-0003-1620-1512; Xie, Mingxing/0000-0003-4984-1567; Yang, Yali/0000-0002-6778-3869	National Natural Science Foundation of China [81000615, 81530056, 81671705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This manuscript is supported by the National Natural Science Foundation of China (Grant No. 81000615 received by YLY, No. 81530056 received by MXX and No. 81671705 received by LZ). The URL of National Natural Science Foundation of China is: https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We confirm that there are no known conflicts of interest associated with this publication and these financial supports have no influence on our outcome.	Abe T, 2012, CIRCULATION, V125, pE389, DOI 10.1161/CIRCULATIONAHA.111.058701; Cheng TO, 2014, INT J CARDIOL, V173, P33, DOI 10.1016/j.ijcard.2014.02.003; Choudhary SK, 2012, IND J THORAC CARDIOV, V16, P93; CHU SH, 1990, J THORAC CARDIOV SUR, V99, P288; Desurkar VN, 2006, J CARDIOTHOR VASC AN, V20, P276, DOI 10.1053/j.jvca.2005.11.019; El Hattaoui Mustapha, 2008, Can J Cardiol, V24, pe28; Gaitan-Roman D, 2010, REV ESP CARDIOL, V63, P745, DOI 10.1016/S0300-8932(10)70171-8; GLOCK Y, 1990, J CARDIOVASC SURG, V31, P235; Morais H, 2009, CARDIOVASC J AFR, V20, P192; RIES M, 1994, Z KARDIOL, V83, P519; SAKAKIBARA S, 1962, AM HEART J, V63, P405, DOI 10.1016/0002-8703(62)90287-9; Tian JW, 2001, CHINESE J ULTRASONOG, V10, P573; Tsukui H, 2000, HEART VESSELS, V15, P289, DOI 10.1007/s003800070007; XU QB, 1995, AM HEART J, V130, P1265, DOI 10.1016/0002-8703(95)90153-1; Yang YL, 2011, INT J CARDIOL, V151, pE35, DOI 10.1016/j.ijcard.2010.05.049; Yildirim SV, 2006, INT J CARDIOVAS IMAG, V22, P399, DOI 10.1007/s10554-005-9071-6; 夏家红, 2006, [中华胸心血管外科杂志, Chinese Journal of Thoracic and Cardiovascular Surgery], V22, P111	17	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173122	10.1371/journal.pone.0173122	http://dx.doi.org/10.1371/journal.pone.0173122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291779	Green Published, gold, Green Submitted			2022-12-26	WOS:000396094700014
J	Courtney, CR; Mayr, L; Nanfack, AJ; Banin, AN; Tuen, M; Pan, RM; Jiang, XQ; Kong, XP; Kirkpatrick, AR; Bruno, D; Martens, CA; Sykora, L; Porcella, SF; Redd, AD; Quinn, TC; Nyambi, PN; Durr, R				Courtney, Colleen R.; Mayr, Luzia; Nanfack, Aubin J.; Banin, Andrew N.; Tuen, Michael; Pan, Ruimin; Jiang, Xunqing; Kong, Xiang-Peng; Kirkpatrick, Allison R.; Bruno, Daniel; Martens, Craig A.; Sykora, Lydia; Porcella, Stephen F.; Redd, Andrew D.; Quinn, Thomas C.; Nyambi, Phillipe N.; Duerr, Ralf			Contrasting antibody responses to intrasubtype superinfection with CRF02_AG	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 SUPERINFECTION; NEUTRALIZING ANTIBODIES; DUAL INFECTIONS; IMMUNE PRESSURE; IDENTIFICATION; FREQUENCY; INDIVIDUALS; PREVALENCE; RESISTANCE	HIV superinfection describes the sequential infection of an individual with two or more unrelated HIV strains. Intersubtype superinfection has been shown to cause a broader and more potent heterologous neutralizing antibody response when compared to singly infected controls, yet the effects of intrasubtype superinfection remain controversial. Longitudinal samples were analyzed phylogenetically for pol and env regions using Next-Generation Sequencing and envelope cloning. The impact of CRF02_AG intrasubtype superinfection was assessed for heterologous neutralization and antibody binding responses. We compared two cases of CRF02_AG intrasubtype superinfection that revealed complete replacement of the initial virus by superinfecting CRF02_AG variants with signs of recombination. NYU6564, who became superinfected at an early time point, exhibited greater changes in antibody binding profiles and generated a more potent neutralizing antibody response post-superinfection compared to NYU6501. In contrast, superinfection occurred at a later time point in NYU6501 with strains harboring significantly longer V1V2 regions with no observable changes in neutralization patterns. Here we show that CRF02_AG intrasubtype superinfection can induce a cross-subtype neutralizing antibody response, and our data suggest timing and/or superinfecting viral envelope characteristics as contributing factors. These results highlight differential outcomes in intrasubtype superinfection and provide the first insight into cases with CRF02_AG, the fourth most prevalent HIV-1 strain worldwide.	[Courtney, Colleen R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Mayr, Luzia; Nanfack, Aubin J.; Banin, Andrew N.; Tuen, Michael; Nyambi, Phillipe N.; Duerr, Ralf] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Banin, Andrew N.] Univ Yaounde, Fac Med & Biomed Sci, Yaounde, Cameroon; [Pan, Ruimin; Jiang, Xunqing; Kong, Xiang-Peng] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Kirkpatrick, Allison R.; Quinn, Thomas C.] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Bruno, Daniel; Martens, Craig A.; Sykora, Lydia; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Branch, Rocky Mt Labs,Div Intramural Res,NIH, Hamilton, MT USA; [Redd, Andrew D.; Quinn, Thomas C.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Nyambi, Phillipe N.] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Mayr, Luzia] Univ Strasbourg, Strasbourg, France; [Mayr, Luzia] Dept Virol, 4 Rue Blaise Pascal, Strasbourg, France	New York University; New York University; University of Yaounde I; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Durr, R (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	ralf.duerr@nyumc.org		Duerr, Ralf/0000-0001-9569-9237; Holloway, Courtney Jean/0000-0003-3661-1957; Kong, Xiang-Peng/0000-0001-5773-2681	National Institutes of Health [R01 AI083142, D43 TW009604, AI100151]; Division of Intramural Research, NIAID, NIH; FOGARTY INTERNATIONAL CENTER [D43TW009604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151, P30AI094189, R01AI083142, ZIAAI000361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (R01 AI083142, D43 TW009604; PNN) to PNN, RD, CRC, LM, AJN and ANB; (AI100151; XK) to XK, XJ, RP; and in part by the Division of Intramural Research, NIAID, NIH (TCQ) to TCQ, ADR, ARK, DB, CAM, LS, SFP.	Agyingi L, 2014, J MED VIROL, V86, P385, DOI 10.1002/jmv.23846; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Chaillon A, 2013, J VIROL, V87, P12737, DOI 10.1128/JVI.02260-13; Cortez V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004973; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Courtney CR, 2016, AIDS RES HUM RETROV, V32, P381, DOI 10.1089/aid.2015.0286; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Gordon K, 2016, AIDS RES HUM RETROV, V32, P303, DOI [10.1089/aid.2014.0100, 10.1089/AID.2014.0100]; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Kraft CS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-22; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lehman DA, 2012, JAIDS-J ACQ IMM DEF, V60, P225, DOI 10.1097/QAI.0b013e3182515730; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Mayr LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038989; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Pacold ME, 2012, AIDS, V26, P157, DOI 10.1097/QAD.0b013e32834dcd26; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Pernas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134054; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Powell RLR, 2008, AIDS RES HUM RETROV, V24, P100, DOI 10.1089/aid.2007.0162; Powell RLR, 2010, J VIROL, V84, P9415, DOI 10.1128/JVI.02732-09; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Rambaut A., 2012, FIGTREE MOL EVOLUTIO; Redd AD, 2014, AIDS, V28, P2147, DOI 10.1097/QAD.0000000000000365; Redd AD, 2013, LANCET INFECT DIS, V13, P622, DOI 10.1016/S1473-3099(13)70066-5; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Redd AD, 2011, J CLIN MICROBIOL, V49, P2859, DOI 10.1128/JCM.00804-11; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Ronen K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003593; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Sheward DJ, 2015, J INFECT DIS, V212, P904, DOI 10.1093/infdis/jiv136; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith DM, 2004, JAMA-J AM MED ASSOC, V292, P1177, DOI 10.1001/jama.292.10.1177; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wagner GA, 2014, J INFECT DIS, V209, P1032, DOI 10.1093/infdis/jit633; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Zolla-Pazner S, 2016, J VIROL, V90, P636, DOI 10.1128/JVI.01645-15; Zolla-Pazner S, 2014, EBIOMEDICINE, V1, P37, DOI 10.1016/j.ebiom.2014.10.022	53	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173705	10.1371/journal.pone.0173705	http://dx.doi.org/10.1371/journal.pone.0173705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288209	Green Submitted, gold, Green Published			2022-12-26	WOS:000396092400030
J	Maeo, S; Yamamoto, M; Kanehisa, H; Nosaka, K				Maeo, Sumiaki; Yamamoto, Masayoshi; Kanehisa, Hiroaki; Nosaka, Kazunori			Prevention of downhill walking-induced muscle damage by non-damaging downhill walking	PLOS ONE			English	Article							ECCENTRIC EXERCISE; CONTRACTIONS; BOUT; FREQUENCY; STRENGTH; SORENESS	Purpose Mountain trekking involves level, uphill, and downhill walking (DW). Prolonged DW induces damage to leg muscles, reducing force generating ability and muscle coordination. These increase risks for more serious injuries and accidents in mountain trekking, thus a strategy to minimize muscle damage is warranted. It has been shown that low-intensity eccentric contractions confer protective effect on muscle damage induced by high-intensity eccentric contractions. This study tested the hypothesis that 5-min non-damaging DW would attenuate muscle damage induced by 40-min DW, but 5-min level walking (LW) would not. Methods Untrained young men were allocated (n = 12/group) to either a control or one of the two preconditioning groups (PRE-DW or PRE-LW). The PRE-DW and PRE-LW groups performed 5-min DW (-28%) and 5-min LW, respectively, at 5 km/h with a load of 10% body mass, 1 week before 40-min DW (-28%, 5 km/h, 10% load). The control group performed 40-min DW only. Maximal knee extension strength, plasma creatine kinase (CK) activity, and muscle soreness (0-100 mm visual analogue scale) were measured before and 24 h after 5-min DW and 5-min LW, and before and 24, 48, and 72 h after 40-min DW. Results No significant changes in any variables were evident after 5-min DW and 5-min LW. After 40 min DW, the control and PRE-LW groups showed significant (P<0.05) changes in the variables without significant differences between groups (control vs. PRE-LW; peak strength reduction:-19.2 6.9% vs.-18.7 11.0%, peak CK: 635.5 306.0 vs. 639.6 405.4 U/L, peak soreness: 81.4 14.8 vs. 72.0 29.2 mm). These changes were significantly (P<0.05) attenuated (47-64%) for the PRE-DW group (-9.9 9.6%, 339.3 148.4 U/L, 27.8 16.8 mm). Conclusions The results supported the hypothesis and suggest that performing small volume of downhill walking is crucial in preparation for trekking.	[Maeo, Sumiaki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Maeo, Sumiaki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Yamamoto, Masayoshi; Kanehisa, Hiroaki] Natl Inst Fitness & Sports Kanoya, Sports & Life Sci, Kanoya, Kagoshima, Japan; [Nosaka, Kazunori] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia	Waseda University; Japan Society for the Promotion of Science; National Institute Fitness & Sports Kanoya; Edith Cowan University	Maeo, S (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.; Maeo, S (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan.	smaeo1985@gmail.com	Nosaka, Kazunori/H-4412-2011	Nosaka, Kazunori/0000-0001-7373-4994; Maeo, Sumiaki/0000-0003-0919-4799	Promotion of Science Research Fellow [15J03228]	Promotion of Science Research Fellow	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Research Fellow (15J03228) to SM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi S, 2008, CLIN PHYSIOL FUNCT I, V28, P55, DOI 10.1111/j.1475-097X.2007.00777.x; Burt D, 2015, EUR J APPL PHYSIOL, V115, P1523, DOI 10.1007/s00421-015-3131-y; Byrne C, 2004, SPORTS MED, V34, P49, DOI 10.2165/00007256-200434010-00005; Byrne C, 2001, SCAND J MED SCI SPOR, V11, P134, DOI 10.1046/j.1524-4725.2001. 110302.x; Chen HL, 2012, EUR J APPL PHYSIOL, V112, P555, DOI 10.1007/s00421-011-1999-8; Chen TC, 2013, EUR J APPL PHYSIOL, V113, P1005, DOI 10.1007/s00421-012-2517-3; ESTON RG, 1995, BRIT J SPORT MED, V29, P89, DOI 10.1136/bjsm.29.2.89; Eston RG, 2002, J PHYSIOL-LONDON, V539, p75P; Farr T, 2002, J SCI MED SPORT, V5, P297, DOI 10.1016/S1440-2440(02)80018-4; Heggie TW, 2009, J TRAVEL MED, V16, P23, DOI 10.1111/j.1708-8305.2008.00269.x; Howatson G, 2011, MED SCI SPORT EXER, V43, P140, DOI 10.1249/MSS.0b013e3181e4b649; Isner-Horobeti ME, 2013, SPORTS MED, V43, P483, DOI 10.1007/s40279-013-0052-y; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Lima LCR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00300; Maeo S, 2015, INT J SPORTS MED, V36, P150, DOI 10.1055/s-0034-1385885; Maeo S, 2016, J SPORT SCI, V34, P2018, DOI 10.1080/02640414.2016.1149607; Maeo S, 2015, APPL PHYSIOL NUTR ME, V40, P274, DOI 10.1139/apnm-2014-0390; McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, pC621, DOI 10.1152/ajpcell.2001.280.3.C621; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; Morgan DL, 2006, J PHYSIOL-LONDON, V574, P627, DOI 10.1113/jphysiol.2006.574201; Penailillo L, 2015, MED SCI SPORT EXER, V47, P708, DOI 10.1249/MSS.0000000000000473; Raastad T, 2010, MED SCI SPORT EXER, V42, P86, DOI 10.1249/MSS.0b013e3181ac7afa; Soares S, 2015, J STRENGTH COND RES, V29, P2594, DOI 10.1519/JSC.0000000000000899; Takagi R, 2016, PFLUG ARCH EUR J PHY, V468, P1565, DOI 10.1007/s00424-016-1860-3; Warren GL, 2000, MED SCI SPORT EXER, V32, P820, DOI 10.1097/00005768-200004000-00015; Yamamoto M, 2003, JPN J PHYS FIT SPORT, V52, P543, DOI 10.7600/jspfsm1949.52.543	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173909	10.1371/journal.pone.0173909	http://dx.doi.org/10.1371/journal.pone.0173909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288187	Green Published, gold, Green Submitted			2022-12-26	WOS:000396092400041
J	Murray, GM; O'Neill, RG; Lee, AM; McElroy, MC; More, SJ; Monagle, A; Earley, B; Cassidy, JP				Murray, Gerard M.; O'Neill, Ronan G.; Lee, Alison M.; McElroy, Maire C.; More, Simon J.; Monagle, Aisling; Earley, Bernadette; Cassidy, Joseph P.			The bovine paranasal sinuses: Bacterial flora, epithelial expression of nitric oxide and potential role in the in-herd persistence of respiratory disease pathogens	PLOS ONE			English	Article							PARA-INFLUENZA-3 VIRUS; PARAINFLUENZA-3 VIRUS; SYNCYTIAL VIRUSES; MAXILLARY SINUS; DAIRY-CATTLE; ANTIBODIES; PNEUMONIA; CALVES; INFECTION; OUTBREAKS	The bovine paranasal sinuses are a group of complex cavernous air-filled spaces, lined by respiratory epithelium, the exact function of which is unclear. While lesions affecting these sinuses are occasionally reported in cattle, their microbial flora has not been defined. Furthermore, given that the various bacterial and viral pathogens causing bovine respiratory disease (BRD) persist within herds, we speculated that the paranasal sinuses may serve as a refuge for such infectious agents. The paranasal sinuses of clinically normal cattle (n = 99) and of cattle submitted for post-mortem examination (PME : n = 34) were examined by microbial culture, PCR and serology to include bacterial and viral pathogens typically associated with BRD: Mycoplasma bovis, Histophilus somni, Mannheimia haemolytica and Pasteurella multocida, bovine respiratory syncytial virus (BRSV) and bovine parainfluenza-3 virus (BPIV-3). Overall, the paranasal sinuses were either predominantly sterile or did not contain detectable microbes (83.5%: 94.9% of clinically normal and 50.0% of cattle submitted for PME). Bacteria, including BRD causing pathogens, were identified in relatively small numbers of cattle (<10%). While serology indicated widespread exposure of both clinically normal and cattle submitted for PME to BPIV-3 and BRSV (seroprevalences of 91.6% and 84.7%, respectively), PCR identified BPIV-3 in only one animal. To further explore these findings we investigated the potential role of the antimicrobial molecule nitric oxide (NO) within paranasal sinus epithelium using immunohistochemistry. Expression of the enzyme responsible for NO synthesis, inducible nitric oxide synthase (iNOS), was detected to varying degrees in 76.5% of a sub-sample of animals suggesting production of this compound plays a similar protective role in the bovine sinus as it does in humans.	[Murray, Gerard M.] Dept Agr Food & Marine, Sligo Reg Vet Lab, Doonally, Sligo, Ireland; [O'Neill, Ronan G.; McElroy, Maire C.] Dept Agr Food & Marine, Cent Vet Res Lab, Celbridge, Kildare, Ireland; [Lee, Alison M.; Monagle, Aisling; Cassidy, Joseph P.] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland; [More, Simon J.] Univ Coll Dublin, UCD Sch Vet Med, Ctr Vet Epidemiol & Risk Anal, Dublin, Ireland; [Earley, Bernadette] TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland	University College Dublin; University College Dublin; Teagasc	Murray, GM (corresponding author), Dept Agr Food & Marine, Sligo Reg Vet Lab, Doonally, Sligo, Ireland.	gerard.murray@agriculture.gov.ie		Cassidy, Joseph/0000-0002-9229-1831; More, Simon/0000-0002-4270-0385; Lee, Alison/0000-0002-2224-5549; Earley, Bernadette/0000-0002-9772-2813				Abou Hamad W, 2009, AM J RHINOL ALLERGY, V23, P261, DOI 10.2500/ajra.2009.23.3317; Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Albu S, 2013, AM J OTOLARYNG, V34, P327, DOI 10.1016/j.amjoto.2013.01.001; ALLAN EM, 1978, RES VET SCI, V24, P339, DOI 10.1016/S0034-5288(18)33045-5; Anand VK, 2004, ANN OTO RHINOL LARYN, V113, P3, DOI 10.1177/00034894041130S502; Andersson JA, 2002, ACTA OTO-LARYNGOL, V122, P861, DOI 10.1080/003655402/000028053; Bidokhti MRM, 2012, ARCH VIROL, V157, P601, DOI 10.1007/s00705-011-1209-3; BROOK I, 1981, LARYNGOSCOPE, V91, P372; BRYSON DG, 1990, J COMP PATHOL, V103, P433, DOI 10.1016/S0021-9975(08)80031-X; Budras K.D., 2011, BOVINE ANATOMY ILLUS, V1st; CASTRUCCI G, 1983, COMP IMMUNOL MICROB, V6, P193, DOI 10.1016/0147-9571(83)90010-3; Caswell JL, 2014, VET PATHOL, V51, P393, DOI 10.1177/0300985813502821; Crilly J. P., 2013, Livestock, V18, P230, DOI 10.12968/live.2013.18.6.230; Crocker CB, 1998, J AM VET MED ASSOC, V213, P1472; DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162; Dyce KM., 2002, TXB VET ANATOMY, V3rd ed.; ELVANDER M, 1995, J VET DIAGN INVEST, V7, P177, DOI 10.1177/104063879500700202; Farke AA, 2010, ZOOL J LINN SOC-LOND, V159, P988, DOI 10.1111/j.1096-3642.2009.00586.x; FRANK GH, 1973, J AM VET MED ASSOC, V163, P858; FRANK GH, 1971, AM J VET RES, V32, P1707; Graham DA, 1997, J VET DIAGN INVEST, V9, P24, DOI 10.1177/104063879700900105; Griffin D, 2010, VET CLIN N AM-FOOD A, V26, P381, DOI 10.1016/j.cvfa.2010.04.004; GUSTAFSSON LE, 1991, BIOCHEM BIOPH RES CO, V181, P852, DOI 10.1016/0006-291X(91)91268-H; Guterbock WM, 2014, ANIM HEALTH RES REV, V15, P130, DOI 10.1017/S1466252314000140; Hauser LJ, 2015, INT FORUM ALLERGY RH, V5, P3, DOI 10.1002/alr.21428; Jiang RS, 1999, J LARYNGOL OTOL, V113, P825, DOI 10.1017/S0022215100145311; Kim JW, 2001, LARYNGOSCOPE, V111, P246, DOI 10.1097/00005537-200102000-00011; Klima CL, 2014, CAN J VET RES, V78, P38; Larsen LE, 2000, J CLIN MICROBIOL, V38, P4222, DOI 10.1128/JCM.38.11.4222-4227.2000; Lewandowski K, 1998, J APPL PHYSIOL, V85, P405, DOI 10.1152/jappl.1998.85.2.405; Lima SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29050; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P113, DOI 10.3109/00016489709118001; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P728, DOI 10.3109/00016489709113468; Liu DY, 2004, J MICROBIOL METH, V58, P263, DOI 10.1016/j.mimet.2004.04.008; Lundberg JON, 1996, EUR RESPIR J, V9, P1344, DOI 10.1183/09031936.96.09071344; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; LUNDBERG JON, 1994, ACTA PHYSIOL SCAND, V152, P431, DOI 10.1111/j.1748-1716.1994.tb09826.x; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mugera GM, 2000, VET PATHOLOGY TROPIC; Mundell LDM, 1996, J AM VET MED ASSOC, V209, P127; Murray GM, 2017, J VET DIAGN INVEST, V29, P20, DOI 10.1177/1040638716674757; Naraghi M, 2007, AM J OTOLARYNG, V28, P334, DOI 10.1016/j.amjoto.2006.10.014; O'Neill R, 2014, VET REC, V175, DOI 10.1136/vr.102574; Regev-Shoshani G, 2013, RES VET SCI, V95, P606, DOI 10.1016/j.rvsc.2013.06.016; Regev-Shoshani G, 2013, J APPL MICROBIOL, V114, P536, DOI 10.1111/jam.12047; Regev-Shoshani G, 2015, PREV VET ME IN PRESS; Rodriguez F, 1996, J COMP PATHOL, V115, P151, DOI 10.1016/S0021-9975(96)80037-5; Schedin U, 1997, ACTA ANAESTH SCAND, V41, P1133; Serrano C, 2004, ARCH BRONCONEUMOL, V40, P222; SOBIN J, 1992, SCAND J INFECT DIS, V24, P633, DOI 10.3109/00365549209054650; SU WY, 1983, LARYNGOSCOPE, V93, P931; WARD JL, 1992, J AM VET MED ASSOC, V201, P326	52	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173845	10.1371/journal.pone.0173845	http://dx.doi.org/10.1371/journal.pone.0173845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282443	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800084
J	Reyes-Aldasoro, CC				Reyes-Aldasoro, Constantino Carlos			The proportion of cancer-related entries in PubMed has increased considerably; is cancer truly "The Emperor of All Maladies"?	PLOS ONE			English	Article							BREAST-CANCER; NEGLECTED DISEASES; MATHEMATICAL-MODEL; NORDIC COUNTRIES; INCIDENCE RATES; UNITED-STATES; DECREASE; GENE; CELL; AWARENESS	In this work, the public database of biomedical literature PubMed was mined using queries with combinations of keywords and year restrictions. It was found that the proportion of Cancer-related entries per year in PubMed has risen from around 6% in 1950 to more than 16% in 2016. This increase is not shared by other conditions such as AIDS, Malaria, Tuberculosis, Diabetes, Cardiovascular, Stroke and Infection some of which have, on the contrary, decreased as a proportion of the total entries per year. Organ-related queries were performed to analyse the variation of some specific cancers. A series of queries related to incidence, funding, and relationship with DNA, Computing and Mathematics, were performed to test correlation between the keywords, with the hope of elucidating the cause behind the rise of Cancer in PubMed. Interestingly, the proportion of Cancer-related entries that contain "DNA", "Computational" or "Mathematical" have increased, which suggests that the impact of these scientific advances on Cancer has been stronger than in other conditions. It is important to highlight that the results obtained with the data mining approach here presented are limited to the presence or absence of the keywords on a single, yet extensive, database. Therefore, results should be observed with caution. All the data used for this work is publicly available through PubMed and the UK's Office for National Statistics. All queries and figures were generated with the software platform Matlab and the files are available as supplementary material.	[Reyes-Aldasoro, Constantino Carlos] Univ London, Sch Math Comp Sci & Engn City, London, England	University of London	Reyes-Aldasoro, CC (corresponding author), Univ London, Sch Math Comp Sci & Engn City, London, England.	reyes@city.ac.uk	Reyes-Aldasoro, Constantino/S-5093-2019	Reyes-Aldasoro, Constantino/0000-0002-9466-2018				Abbasi K, 2005, J ROY SOC MED, V98, P389, DOI 10.1258/jrsm.98.9.389; Akachi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021309; Anders ME, 2010, RESP CARE, V55, P578; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Annertz K, 2012, ACTA OTO-LARYNGOL, V132, P552, DOI 10.3109/00016489.2011.649146; Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Barbolosi D, 2016, NAT REV CLIN ONCOL, V13, P242, DOI 10.1038/nrclinonc.2015.204; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P269; Chaplain MAJ, 1996, INVAS METAST, V16, P222; Choices NHS, 2016, PREDICTIVE GENETIC T; Crocetti E, 2010, J MED SCREEN, V17, P50, DOI 10.1258/jms.2009.009123; Crowell HL, 2016, J THEOR BIOL, V401, P43, DOI 10.1016/j.jtbi.2016.04.002; CZERNILOFSKY AP, 1980, NATURE, V287, P198, DOI 10.1038/287198a0; Dehlendorff C, 2014, JAMA NEUROL, V71, P978, DOI 10.1001/jamaneurol.2014.1017; Dikshit RP, 2012, CANCER EPIDEMIOL, V36, pE215, DOI 10.1016/j.canep.2012.03.009; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Evans CJ, 2009, J THEOR BIOL, V257, P598, DOI 10.1016/j.jtbi.2008.11.031; Figueredo GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095150; Fitchett JR, 2014, INT HEALTH, V6, P74, DOI 10.1093/inthealth/iht036; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Frick M, FLATLINED US GOVERNM; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Giles GG, 2009, MED J AUSTRALIA, V190, P164, DOI 10.5694/j.1326-5377.2009.tb02329.x; Gompel A, 2010, ANN NY ACAD SCI, V1205, P268, DOI 10.1111/j.1749-6632.2010.05664.x; Gonzalez-Gomez FJ, 2016, REV CLIN ESP, V216, P345, DOI 10.1016/j.rce.2016.05.008; Grimmett C, 2014, PERSPECT PUBLIC HEAL, V134, P268, DOI 10.1177/1757913914534840; Groh CM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1173; Guo Y, 2016, J STROKE CEREBROVASC, V25, P2995, DOI 10.1016/j.jstrokecerebrovasdis.2016.08.018; Gupta A, 2015, EUR J CANCER, V51, P2058, DOI 10.1016/j.ejca.2015.07.008; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haley MJ, 2016, J CEREBR BLOOD F MET, V36, P2007, DOI 10.1177/0271678X16670411; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hayden EC, 2009, NATURE, V460, P940, DOI 10.1038/460940a; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hou NQ, 2013, BREAST CANCER RES TR, V138, P633, DOI 10.1007/s10549-013-2434-0; Hull D., TWENTY MILLION PAPER; Jacobsen R, 2006, INT J ANDROL, V29, P199, DOI 10.1111/j.1365-2605.2005.00605.x; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; Kershaw SK, 2013, IET SYST BIOL, V7, P57, DOI 10.1049/iet-syb.2012.0019; Kyle RG, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-286; LEBEAU MM, 1985, NATURE, V316, P826, DOI 10.1038/316826a0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lyrdal D, 2013, SCAND J UROL, V47, P302, DOI 10.3109/00365599.2012.732608; MacLean AL, 2014, P NATL ACAD SCI USA, V111, P3883, DOI 10.1073/pnas.1317072111; MARSH K, 1992, PARASITOLOGY, V104, pS53, DOI 10.1017/S0031182000075247; McAuley PA, 2011, J SPORT SCI, V29, P773, DOI 10.1080/02640414.2011.553965; Mitchell AB, 2015, STROKE, V46, P1690, DOI 10.1161/STROKEAHA.115.008940; Molarius A, 2016, EUR J PUBLIC HEALTH, V26, P622, DOI 10.1093/eurpub/ckw042; Morel CM, 2003, EMBO REP, V4, pS35, DOI 10.1038/sj.embor.embor851; Mukherjee S., 2011, THE EMPEROR OF ALL M; Murphy CC, 2016, CLIN GASTROENTEROL H; Pandeya N, 2016, CLIN ENDOCRINOL, V84, P257, DOI 10.1111/cen.12724; Perez-Gomez B, 2010, ANN ONCOL, V21, piii61, DOI 10.1093/annonc/mdq093; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Plank MJ, 2004, J THEOR BIOL, V229, P435, DOI 10.1016/j.jtbi.2004.04.012; Polednak AP, 2015, J CANCER EPIDEMIOL, V2015, DOI 10.1155/2015/710106; Powathil GG, 2015, SEMIN CANCER BIOL, V30, P13, DOI 10.1016/j.semcancer.2014.02.003; Ramos JM, 2008, INT J TUBERC LUNG D, V12, P1461; Rebbeck TR, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0768-3; RICHMAN DD, 1988, AIDS, V2, pS137, DOI 10.1097/00002030-198800001-00021; RIESENBERG DE, 1985, JAMA-J AM MED ASSOC, V254, P2521, DOI 10.1001/jama.254.18.2521; RUZICKA T, 1987, LANCET, V2, P1469; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Schiermeier Q, 2016, NATURE, V532, P18, DOI [10.1038/nature.2016.19672, 10.1038/nature.2016.20893]; Scott JG, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004712; Sogaard M, 2012, AM J INFECT CONTROL, V40, P237, DOI 10.1016/j.ajic.2011.03.011; Starke JR, 2014, PEDIATRICS, V133, pE725, DOI 10.1542/peds.2013-4139; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Theodosiou T, 2011, J BIOMED INFORM, V44, P919, DOI 10.1016/j.jbi.2011.05.009; van Weert H, 2016, EUR J GEN PRACT, V22, P69, DOI 10.1080/13814788.2016.1180361; Vanteru BC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S10; Wang Y, 2016, EUR J CLIN NUTR; WEISS SR, 1981, VIROLOGY, V110, P476; World Health Organization, 2003, Midwifery, V19, P72; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	82	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173671	10.1371/journal.pone.0173671	http://dx.doi.org/10.1371/journal.pone.0173671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282418	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000396091800067
J	Sharma, S; Ryndak, MB; Aggarwal, AN; Yadav, R; Sethi, S; Masih, S; Laal, S; Verma, I				Sharma, Sumedha; Ryndak, Michelle B.; Aggarwal, Ashutosh N.; Yadav, Rakesh; Sethi, Sunil; Masih, Shet; Laal, Suman; Verma, Indu			Transcriptome analysis of mycobacteria in sputum samples of pulmonary tuberculosis patients	PLOS ONE			English	Article							2-COMPONENT SYSTEM; VIRULENCE FACTORS; EXPRESSION; GENES; LUNG; ATTENUATION; MICROARRAYS; ADAPTATION; INFECTION; TRANSPORT	Pulmonary tuberculosis, the disease caused by Mycobacterium tuberculosis, still retains a top rank among the deadliest communicable diseases. Sputum expectorated during the disease continues to be a primary diagnostic specimen and also serves as a reservoir of bacteria. The expression pattern of mycobacteria in sputum will lead to an insight into bacterial adaptation at the most highly transmissible stage of infection and can also help in identifying newer diagnostic as well as drug targets. Thus, in the present study, a whole genome microarray of Mycobacterium tuberculosis was used to elucidate the transcriptional profile of mycobacteria in the sputum samples of smear positive pulmonary tuberculosis patients. Overall, the mycobacteria in sputum appeared to be in a low energy and low replicative state as compared to in vitro grown log phase M. tb with downregulation of genes involved in ATP synthesis, aerobic respiration and translational machinery. Simultaneously, downregulation was also seen in the genes involved in secretion machinery of mycobacteria along with the downregulation of genes involved in the synthesis of phthiocerol dimycocerosate and phenol glycolipids. In contrast, the majority of the genes which showed an upregulation in sputum mycobacteria were of unknown function. Further identification of these genes may provide new insights into the mycobacterial behavior during this phase of infection and may help in deciphering candidates for development of better diagnostic and drug candidates.	[Sharma, Sumedha; Verma, Indu] Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India; [Ryndak, Michelle B.; Laal, Suman] NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Aggarwal, Ashutosh N.] Post Grad Inst Med Educ & Res, Dept Pulm Med, Chandigarh, India; [Yadav, Rakesh; Sethi, Sunil] Post Grad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh, India; [Masih, Shet] MDRL Pvt Ltd, Chandigarh, India; [Laal, Suman] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; New York University; NYU Langone Medical Center; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Verma, I (corresponding author), Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India.	induvemabio@gmail.com	Verma, Indu/AAF-3514-2020		NIH/FIC AIDS International Training and Research Program (AITRP) grant [TW001409]; Council of Scientific and Industrial Research [09/141(0180)2011-EMR-I]; FOGARTY INTERNATIONAL CENTER [D43TW009588] Funding Source: NIH RePORTER	NIH/FIC AIDS International Training and Research Program (AITRP) grant; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The current study is funded by NIH/FIC AIDS International Training and Research Program (AITRP) grant TW001409 awarded to Dr. Suman Laal and Council of Scientific and Industrial Research 09/141(0180)2011-EMR-I which provided salary for author SS. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company MDRL Pvt. Ltd. was not a funder in the current study. Dr Shet Masih, Founder and Director of the MDRL was involved in planning and execution of some part of the study and also provided materials required for some experiments in this study.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Barrios-Payan J, 2012, J INFECT DIS, V206, P1194, DOI 10.1093/infdis/jis381; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Daum LT, 2014, INT J TUBERC LUNG D, V18, P847, DOI 10.5588/ijtld.13.0021; Daum LT, 2011, EPIDEMIOL INFECT, V139, P1764, DOI 10.1017/S0950268810002384; Dudoit S, 2000, 578 U CAL DEP STAT; Fan WC, 2014, LUNG CANCER, V85, P472, DOI 10.1016/j.lungcan.2014.07.001; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; Honeyborne I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0609-3; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Mannhalter C, 2000, CLIN CHEM LAB MED, V38, P171, DOI 10.1515/CCLM.2000.026; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Okkels LM, 2004, J BACTERIOL, V186, P2487, DOI 10.1128/JB.186.8.2487-2491.2004; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pang XH, 2013, J BACTERIOL, V195, P66, DOI 10.1128/JB.01067-12; Parish T, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0010-2013; Quadri LEN, 2014, CRIT REV BIOCHEM MOL, V49, P179, DOI 10.3109/10409238.2014.896859; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Ryndak M, 2008, TRENDS MICROBIOL; Ryndak MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123745; Ryndak MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094939; Schlingemann J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni029; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Simeone R, 2015, TUBERCULOSIS, P1; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Sirakova TD, 2003, INFECT IMMUN, V71, P3794, DOI 10.1128/IAI.71.7.3794-3801.2003; Sirakova TD, 2003, J BACTERIOL, V185, P2999, DOI 10.1128/JB.185.10.2999-3008.2003; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Walter ND, 2015, J INFECT DIS, V212, P990, DOI 10.1093/infdis/jiv149; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198	53	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173508	10.1371/journal.pone.0173508	http://dx.doi.org/10.1371/journal.pone.0173508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282458	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800046
J	Marshall, L; Vivien, C; Girardot, F; Pericard, L; Demeneix, BA; Coen, L; Chai, N				Marshall, Lindsey; Vivien, Celine; Girardot, Fabrice; Pericard, Louise; Demeneix, Barbara A.; Coen, Laurent; Chai, Norin			Persistent fibrosis, hypertrophy and sarcomere disorganisation after endoscopy-guided heart resection in adult Xenopus	PLOS ONE			English	Article							NEONATAL MOUSE HEART; CARDIAC-TROPONIN-T; ANIMAL-MODELS; REGENERATION; ZEBRAFISH; INJURY; MECHANISMS; AMPHIBIANS; DISEASE; ALPHA-ACTININ-3	Models of cardiac repair are needed to understand mechanisms underlying failure to regenerate in human cardiac tissue. Such studies are currently dominated by the use of zebrafish and mice. Remarkably, it is between these two evolutionary separated species that the adult cardiac regenerative capacity is thought to be lost, but causes of this difference remain largely unknown. Amphibians, evolutionary positioned between these two models, are of particular interest to help fill this lack of knowledge. We thus developed an endoscopy-based resection method to explore the consequences of cardiac injury in adult Xenopus laevis. This method allowed in situ live heart observation, standardised tissue amputation size and reproducibility. During the first week following amputation, gene expression of cell proliferation markers remained unchanged, whereas those relating to sarcomere organisation decreased and markers of inflammation, fibrosis and hypertrophy increased. One-month post-amputation, fibrosis and hypertrophy were evident at the injury site, persisting through 11 months. Moreover, cardiomyocyte sarcomere organisation deteriorated early following amputation, and was not completely recovered as far as 11 months later. We conclude that the adult Xenopus heart is unable to regenerate, displaying cellular and molecular marks of scarring. Our work suggests that, contrary to urodeles and teleosts, with the exception of medaka, adult anurans share a cardiac injury outcome similar to adult mammals. This observation is at odds with current hypotheses that link loss of cardiac regenerative capacity with acquisition of homeothermy.	[Marshall, Lindsey; Vivien, Celine; Girardot, Fabrice; Pericard, Louise; Demeneix, Barbara A.; Coen, Laurent] Sorbonne Univ, Museum Natl Hist Nat, Evolut Regulat Endocriniennes, Dept Regulat,Dev & Diversite Mol,UNR CNRS 7221, Paris, France; [Chai, Norin] Museum Natl Hist Nat, Menagerie Jardin Plantes, Paris, France; [Vivien, Celine] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Vivien, Celine] Univ Queensland, Ctr Cardiac & Vasc Biol, Brisbane, Qld, Australia	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); University of Queensland; University of Queensland	Coen, L (corresponding author), Sorbonne Univ, Museum Natl Hist Nat, Evolut Regulat Endocriniennes, Dept Regulat,Dev & Diversite Mol,UNR CNRS 7221, Paris, France.; Chai, N (corresponding author), Museum Natl Hist Nat, Menagerie Jardin Plantes, Paris, France.	coen@mnhn.fr; chai@mnhn.fr	Girardot, Fabrice/B-7587-2012; Vivien, Celine/AAJ-8066-2020	Girardot, Fabrice/0000-0002-0916-877X; 	EU Grant Crescendo; French PNR-PE Program; Watchfrog S.A. under CIFRE Convention [216/2011]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [607142]	EU Grant Crescendo; French PNR-PE Program; Watchfrog S.A. under CIFRE Convention; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant	The research leading to these results has received funding from EU Grant Crescendo and the French PNR-PE Program, by Watchfrog S.A. under CIFRE Convention 216/2011 Ph.D. fellowship (to C. V.) and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7-2013 under REA grant agreement no607142, DevCom Ph.D fellowship (to L. M.).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersen DC, 2016, J MOL CELL CARDIOL, V90, P47, DOI 10.1016/j.yjmcc.2015.11.031; Andersen DC, 2014, STEM CELL REP, V2, P406, DOI 10.1016/j.stemcr.2014.02.008; Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; Becker JR, 2011, DIS MODEL MECH, V4, P400, DOI 10.1242/dmm.006148; BECKER RO, 1974, NATURE, V248, P145, DOI 10.1038/248145a0; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Boppart SA, 1997, P NATL ACAD SCI USA, V94, P4256, DOI 10.1073/pnas.94.9.4256; Borchardt T, 2007, THROMB HAEMOSTASIS, V98, P311, DOI 10.1160/TH07-02-0153; Bryant DM, 2015, J MOL CELL CARDIOL, V79, P315, DOI 10.1016/j.yjmcc.2014.12.011; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Burggren WW, 2007, ILAR J, V48, P260, DOI 10.1093/ilar.48.3.260; Cano-Martínez Agustina, 2010, Arch. Cardiol. Méx., V80, P79; Chai Norin, 2016, Vet Clin North Am Exot Anim Pract, V19, P77, DOI 10.1016/j.cvex.2015.08.004; Chai Norin, 2015, Veterinary Clinics of North America Exotic Animal Practice, V18, P479, DOI 10.1016/j.cvex.2015.04.006; Chen J, 2013, ZEBRAFISH, V10, P389, DOI 10.1089/zeb.2013.0875; Coen L, 2007, P NATL ACAD SCI USA, V104, P8502, DOI 10.1073/pnas.0608877104; Dickover MS, 2013, METHODS MOL BIOL, V1037, P463, DOI 10.1007/978-1-62703-505-7_27; Gamba Laurent, 2014, Curr Treat Options Cardiovasc Med, V16, P288, DOI 10.1007/s11936-013-0288-8; Gardner S, 2012, AM J PHYSIOL-CELL PH, V303, pC1292, DOI 10.1152/ajpcell.00259.2012; Gilchrist J, 1919, DISSECTION PLATANA F; Goss RJ., 1969, PRINCIPLES REGENERAT; Hein SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122665; Heinz-Taheny Kathleen M., 2009, Veterinary Clinics of North America Exotic Animal Practice, V12, P39, DOI 10.1016/j.cvex.2008.08.005; Hempel A, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3020021; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Holterhoff CK, 2009, DEV DYNAM, V238, P2936, DOI 10.1002/dvdy.22123; Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039; Ito K, 2014, DEV DYNAM, V243, P1106, DOI [10.1002/DVDY.24154, 10.1002/dvdy.24154]; Jaworska-Wilczynska M, 2016, FOLIA HISTOCHEM CYTO, V54, P121, DOI 10.5603/FHC.a2016.0014; Jazwinska A, 2016, J PATHOL, V238, P233, DOI 10.1002/path.4644; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Karmon A, 2016, ELIFE, V5, DOI 10.7554/eLife.14424; Klocke R, 2007, CARDIOVASC RES, V74, P29, DOI 10.1016/j.cardiores.2006.11.026; Konfino T, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001320; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Liu LS, 2016, ZOOL RES, V37, P237, DOI 10.13918/j.issn.2095-8137.2016.4.237; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Nakamura R, 2016, DEV GROWTH DIFFER, V58, P367, DOI 10.1111/dgd.12281; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Polizzotti BD, 2016, NAT PROTOC, V11, P542, DOI 10.1038/nprot.2016.031; Porrello ER, 2014, STEM CELL RES, V13, P556, DOI 10.1016/j.scr.2014.06.003; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Rasband W.S., 1997, IMAGE J; REICHMAN OJ, 1984, AM NAT, V123, P752, DOI 10.1086/284237; Rumyantsev P., 1961, ARKH ANAT GISTOL EMB, V376, P65; RUMYANTSEV PP, 1973, Z ZELLFORSCH MIK ANA, V139, P431, DOI 10.1007/BF00306596; RUMYANTSEV PP, 1977, INT REV CYTOL, V51, P187; Sallin P, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160012; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Seto JT, 2011, HUM MOL GENET, V20, P2914, DOI 10.1093/hmg/ddr196; Simon HG, 2015, METHODS MOL BIOL, V1290, P227, DOI 10.1007/978-1-4939-2495-0_18; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; Teramoto N, 2011, J NUCL MED, V52, P761, DOI 10.2967/jnumed.110.084848; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; Vargas-Gonzalez A., 2005, ARCH CARDIOL MEX S3, V75; Vivien CJ, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.12; Warkman AS, 2007, SEMIN CELL DEV BIOL, V18, P46, DOI 10.1016/j.semcdb.2006.11.010; Witman N, 2011, DEV BIOL, V354, P67, DOI 10.1016/j.ydbio.2011.03.021; World Health Organization, 2014, TOP 10 CAUS DEATH; Xiang MSW, 2016, INT REV CEL MOL BIO, V326, P67, DOI 10.1016/bs.ircmb.2016.04.002; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhou HY, 2015, P NATL ACAD SCI USA, V112, P11864, DOI 10.1073/pnas.1516237112; Zielonko J., 1874, ARCH PATHOL ANAT PHY, V62, P29	71	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173418	10.1371/journal.pone.0173418	http://dx.doi.org/10.1371/journal.pone.0173418			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278282	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900090
J	Vientos-Plotts, AI; Ericsson, AC; Rindt, H; Grobman, ME; Graham, A; Bishop, K; Cohn, LA; Reinero, CR				Vientos-Plotts, Aida I.; Ericsson, Aaron C.; Rindt, Hansjorg; Grobman, Megan E.; Graham, Amber; Bishop, Kaitlin; Cohn, Leah A.; Reinero, Carol R.			Dynamic changes of the respiratory microbiota and its relationship to fecal and blood microbiota in healthy young cats	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY MICROBIOME; LUNG; BACTERIAL; ASTHMA; COMMUNITIES; FIBROSIS; DIVERSITY; COMMENSAL; DNA	Advances in the field of metagenomics using culture-independent methods of microbial identification have allowed characterization of rich and diverse communities of bacteria in the lungs of healthy humans, mice, dogs, sheep and pigs. These data challenge the long held belief that the lungs are sterile and microbial colonization is synonymous with pathology. Studies in humans and animals demonstrate differences in the composition of airway microbiota in health versus disease suggesting respiratory dysbiosis occurs. Using 16S rRNA amplicon sequencing of DNA extracted from rectal and oropharyngeal (OP) swabs, bronchoalveolar lavage fluid (BALF), and blood, our objective was to characterize the fecal, OP, blood, and lower airway microbiota over time in healthy cats. This work in healthy cats, a species in which a respiratory microbiota has not yet been characterized, sets the stage for future studies in feline asthma in which cats serve as a comparative and translational model for humans. Fecal, OP and BALF samples were collected from six healthy research cats at day 0, week 2, and week 10; blood was collected at week 10. DNA was extracted, amplified via PCR, and sequenced using the Illumina MiSeq platform. Representative operational taxonomic units (OTUs) were identified and microbial richness and diversity were assessed. Principal component analysis (PCA) was used to visualize relatedness of samples and PERMANOVA was used to test for significant differences in microbial community composition. Fecal and OP swabs provided abundant DNA yielding a mean +/- SEM of 65,653 6,145 and 20,6323 +/- 4,360 sequences per sample, respectively while BALF and blood samples had lower coverage (1,489 +/- 430 and 269 +/- 18 sequences per sample, respectively). Oropharyngeal and fecal swabs were significantly richer than BALF (mean number OTUs 93, 88 and 36, respectively; p < 0.001) with no significant difference (p = 0.180) in richness between time points. PCA revealed site-specific microbial communities in the feces, and upper and lower airways. In comparison, blood had an apparent compositional similarity with BALF with regard to a few dominant taxa, but shared more OTUs with feces. Samples clustered more by time than by individual, with OP swabs having subjectively greater variation than other samples. In summary, healthy cats have a rich and distinct lower airway microbiome with dynamic bacterial populations. The microbiome is likely to be altered by factors such as age, environmental influences, and disease states. Further data are necessary to determine how the distinct feline microbiomes from the upper and lower airways, feces and blood are established and evolve. These data are relevant for comparisons between healthy cats and cats with respiratory disease.	[Vientos-Plotts, Aida I.; Ericsson, Aaron C.; Rindt, Hansjorg; Grobman, Megan E.; Graham, Amber; Bishop, Kaitlin; Cohn, Leah A.; Reinero, Carol R.] Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA; [Vientos-Plotts, Aida I.; Grobman, Megan E.; Cohn, Leah A.; Reinero, Carol R.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Vientos-Plotts, Aida I.; Rindt, Hansjorg; Grobman, Megan E.; Cohn, Leah A.; Reinero, Carol R.] Univ Missouri, Comparat Internal Med Lab, Columbia, MO 65211 USA; [Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA; [Ericsson, Aaron C.] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC; Reinero, CR (corresponding author), Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA.; Reinero, CR (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.; Reinero, CR (corresponding author), Univ Missouri, Comparat Internal Med Lab, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.	ericssona@missouri.edu; reineroc@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021; Graham, Amber/GVS-1651-2022	Ericsson, Aaron C./0000-0002-3053-7269; Vientos-Plotts, Aida/0000-0002-8146-0580	NIH HHS [K01 OD019924] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019924] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054461; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Charlson ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042786; Dickson R. R, 2016, GUT; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Dye JA, 1996, J VET INTERN MED, V10, P385, DOI 10.1111/j.1939-1676.1996.tb02086.x; Einarsson GG, 2016, THORAX, V71, P795, DOI 10.1136/thoraxjnl-2015-207235; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154646; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hogan DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149998; Huang YJ, 2017, TRANSL RES, V179, P71, DOI 10.1016/j.trsl.2016.06.007; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Kennedy PJ, 2014, WORLD J GASTROENTERO, V20, P14105, DOI 10.3748/wjg.v20.i39.14105; Lelouvier B, 2016, HEPATOLOGY, V64, P2015, DOI 10.1002/hep.28829; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Martin R, 2014, VIRULENCE, V5, P413, DOI 10.4161/viru.27864; Martin R, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-71; MCCARTHY GM, 1991, AM J VET RES, V52, P254; Mentula S, 2005, APPL ENVIRON MICROB, V71, P4169, DOI 10.1128/AEM.71.8.4169-4175.2005; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; PADRID PA, 1991, AM J VET RES, V52, P1300; Paisse S, 2016, TRANSFUSION, V56, P1138, DOI 10.1111/trf.13477; Park H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109710; Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Reinero CR, 2009, ENVIRON RES, V109, P634, DOI 10.1016/j.envres.2009.02.001; Reinero CRN, 2004, INT ARCH ALLERGY IMM, V135, P117, DOI 10.1159/000080654; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Ritchie LE, 2010, VET MICROBIOL, V144, P140, DOI 10.1016/j.vetmic.2009.12.045; Smits HH, 2016, J ALLERGY CLIN IMMUN, V137, P690, DOI 10.1016/j.jaci.2016.01.004; Wang H, 2013, WORLD J GASTROENTERO, V19, P6794, DOI 10.3748/wjg.v19.i40.6794; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Warner BB, 2015, NEONATOLOGY, V107, P337, DOI 10.1159/000381124; Williams K, 2016, J PATHOL, V238, P220, DOI 10.1002/path.4658; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Yun YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113466	51	35	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173818	10.1371/journal.pone.0173818	http://dx.doi.org/10.1371/journal.pone.0173818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278278	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900037
J	Singaravelu, P; Lee, WL; Wee, S; Ghoshdastider, U; Ding, K; Gunaratne, J; Grimes, JM; Swaminathan, K; Robinson, RC				Singaravelu, Pavithra; Lee, Wei Lin; Wee, Sheena; Ghoshdastider, Umesh; Ding, Ke; Gunaratne, Jayantha; Grimes, Jonathan M.; Swaminathan, Kunchithapadam; Robinson, Robert C.			Yersinia effector protein (YopO)-mediated phosphorylation of host gelsolin causes calcium-independent activation leading to disruption of actin dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; KINASE; YOPO; EVOLUTIONARY; MODULATION; MECHANISMS; NUCLEATION; FRAGMENT; COMPLEX; BINDING	Pathogenic Yersinia bacteria cause a range of human diseases. To modulate and evade host immune systems, these yersiniae inject effector proteins into host macrophages. One such protein, the serine/threonine kinase YopO (YpkA in Yersinia pestis), uses monomeric actin as bait to recruit and phosphorylate host actin polymerization-regulating proteins, including the actin-severing protein gelsolin, to disrupt actin filaments and thus impair phagocytosis. However, the YopO phosphorylation sites on gelsolin and the consequences of YopO-mediated phosphorylation on actin remodeling have yet to be established. Here we determined the effects of YopO-mediated phosphorylation on gelsolin and identified its phosphorylation sites by mass spectrometry. YopO phosphorylated gelsolin in the linker region between gelsolin homology domains G3 and G4, which, in the absence of calcium, are compacted but adopt an open conformation in the presence of calcium, enabling actin binding and severing. Using phosphomimetic and phospho-deletion gelsolin mutants, we found that YopO-mediated phosphorylation partially mimics calcium-dependent activation of gelsolin, potentially contributing to a reduction in filamentous actin and altered actin dynamics in phagocytic cells. In summary, this work represents the first report of the functional outcome of serine/threonine phosphorylation in gelsolin regulation and provides critical insight into how YopO disrupts normal gelsolin function to alter host actin dynamics and thus cripple phagocytosis.	[Singaravelu, Pavithra; Lee, Wei Lin; Wee, Sheena; Ghoshdastider, Umesh; Ding, Ke; Gunaratne, Jayantha; Grimes, Jonathan M.; Robinson, Robert C.] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Grimes, Jonathan M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England; [Grimes, Jonathan M.] Diamond Light Source Ltd, Diamond House,Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England; [Singaravelu, Pavithra; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Oxford; Wellcome Centre for Human Genetics; Diamond Light Source; National University of Singapore	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.; Lee, WL (corresponding author), Singapore MIT Alliance Res & Technol, Singapore, Singapore.	dbsks@nus.edu.sg; weilin@smart.mit.edu	Ghoshdastider, Umesh/O-5327-2015; robinson, robert/G-9702-2011	Lee, Wei Lin/0000-0003-1048-7556; Grimes, Jonathan Mark/0000-0001-9698-0389; Ghoshdastider, Umesh/0000-0003-4471-9394; Wee, Sheena/0000-0003-2536-3433; Singaravelu, Pavithra/0000-0002-4799-807X; robinson, robert/0000-0001-6367-6903	Nanyang Technological University; Wellcome Trust [090532/Z/09/Z]	Nanyang Technological University(Nanyang Technological University); Wellcome Trust(Wellcome TrustEuropean Commission)	We acknowledge the Joint Centre for Structural Biology, Singapore, which is supported by Nanyang Technological University and the Biomedical Research Council of A*STAR, for providing research facilities. Wellcome Trust Centre for Human Genetics is supported by the Wellcome Trust Core award (090532/Z/09/Z).	Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Boekhorst J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r144; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Corte V, 1999, PROTEIN SCI, V8, P234; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Heroven AK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00146; HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x; Huang BH, 2016, ONCOTARGET, V7, P25391, DOI 10.18632/oncotarget.8603; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; LAMB JA, 1993, J BIOL CHEM, V268, P8999; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Lee WL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39998; Lee WL, 2015, NAT STRUCT MOL BIOL, V22, P248, DOI 10.1038/nsmb.2964; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Martin P, 2010, J BIOL CHEM, V285, P18918, DOI 10.1074/jbc.M109.056028; MAURY CPJ, 1991, J CLIN INVEST, V87, P1195, DOI 10.1172/JCI115118; Nag S, 2013, CYTOSKELETON, V70, P360, DOI 10.1002/cm.21117; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Ohki T, 2009, BIOCHEM BIOPH RES CO, V383, P146, DOI 10.1016/j.bbrc.2009.03.144; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Serrander L, 2000, J IMMUNOL, V165, P2451, DOI 10.4049/jimmunol.165.5.2451; Takiguchi K, 2000, CELL STRUCT FUNCT, V25, P57, DOI 10.1247/csf.25.57; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112	40	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8092	8100		10.1074/jbc.M116.757971	http://dx.doi.org/10.1074/jbc.M116.757971			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28280241	hybrid, Green Published			2022-12-26	WOS:000401154100033
J	Jacobsen, SE; Ammendrup-Johnsen, I; Jansen, AM; Gether, U; Madsen, KL; Brauner-Osborne, H				Jacobsen, Stine Engesgaard; Ammendrup-Johnsen, Ina; Jansen, Anna Mai; Gether, Ulrik; Madsen, Kenneth Lindegaard; Brauner-Osborne, Hans			The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; METABOTROPIC GLUTAMATE-RECEPTOR; CALCIUM-SENSING RECEPTOR; AMINO-ACID RECEPTOR; ALLOSTERIC ANTAGONISTS; LYSOSOMAL DEGRADATION; PEPTIDE-1 RECEPTOR; GABA(B) RECEPTORS; PLASMA-MEMBRANE; BETA-ARRESTINS	The class C G protein-coupled receptor GPRC6A is a putative nutrient-sensing receptor and represents a possible new drug target in metabolic disorders. However, the specific physiological role of this receptor has yet to be identified, and the mechanisms regulating its activity and cell surface availability also remain enigmatic. In the present study, we investigated the trafficking properties of GPRC6A by use of both a classical antibody feeding internalization assay in which cells were visualized using confocal microscopy and a novel internalization assay that is based on real-time measurements of fluorescence resonance energy transfer. Both assays revealed that GPRC6A predominantly undergoes constitutive internalization, whereas the agonist-induced effects were imperceptible. Moreover, postendocytic sorting was investigated by assessing the co-localization of internalized GPRC6A with selected Rab protein markers. Internalized GPRC6A was mainly co-localized with the early endosome marker Rab5 and the long loop recycling endosome marker Rab11 and to a much lesser extent with the late endosome marker Rab7. This suggests that upon agonist-independent internalization, GPRC6A is recycled via the Rab11-positive slow recycling pathway, which may be responsible for ensuring a persistent pool of GPRC6A receptors at the cell surface despite chronic agonist exposure. Distinct trafficking pathways have been reported for several of the class C receptors, and our results thus substantiate that non-canonical trafficking mechanisms are a common feature for the nutrient-sensing class C family that ensure functional receptors in the cell membrane despite prolonged agonist exposure.	[Jacobsen, Stine Engesgaard; Brauner-Osborne, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Ammendrup-Johnsen, Ina; Jansen, Anna Mai; Gether, Ulrik; Madsen, Kenneth Lindegaard] Univ Copenhagen, Fac Hlth & Med Sci, Lundbeck Fdn Ctr Biomembranes Nanomed, Mol Neuropharmacol Lab,Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark	University of Copenhagen; Lundbeckfonden; University of Copenhagen	Brauner-Osborne, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark.	hbo@sund.ku.dk	Madsen, Kenneth/C-7778-2012; Brauner-Osborne, Hans/D-7260-2011	Madsen, Kenneth/0000-0001-9274-6691; Gether, Ulrik/0000-0002-0020-3807; Brauner-Osborne, Hans/0000-0001-9495-7388	Lundbeck Foundation; Danish Council for Independent Research\Medical Sciences; Lundbeck Foundation [R126-2012-12484] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research\Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Lundbeck Foundation and the Danish Council for Independent Research vertical bar Medical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Clemmensen C, 2013, PHYSIOL BEHAV, V118, P144, DOI 10.1016/j.physbeh.2013.05.015; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Gloriam DE, 2011, CHEM BIOL, V18, P1489, DOI 10.1016/j.chembiol.2011.09.012; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Grant MP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002208; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Johansson H, 2015, J MED CHEM, V58, P8938, DOI 10.1021/acs.jmedchem.5b01254; Jorgensen S, 2017, J BIOL CHEM, V292, P1524, DOI 10.1074/jbc.M116.756577; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kuang DH, 2003, J BIOL CHEM, V278, P42551, DOI 10.1074/jbc.M307120200; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Norskov-Lauritsen L, 2015, FEBS LETT, V589, P588, DOI 10.1016/j.febslet.2015.01.019; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2005, MOL ENDOCRINOL, V19, P1078, DOI 10.1210/me.2004-0450; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; Roed SN, 2015, J BIOL CHEM, V290, P1233, DOI 10.1074/jbc.M114.592436; Roed SN, 2014, MOL CELL ENDOCRINOL, V382, P938, DOI 10.1016/j.mce.2013.11.010; Rueda P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146846; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8; THOMSEN C, 1994, J NEUROCHEM, V63, P2038; Tilakaratne N, 2005, CLIN EXP PHARMACOL P, V32, P979, DOI 10.1111/j.1440-1681.2005.04295.x; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Wellendorph P, 2007, GENE, V396, P257, DOI 10.1016/j.gene.2007.03.008; Xiong XF, 2016, NAT CHEM, V8, P1035, DOI [10.1038/NCHEM.2577, 10.1038/nchem.2577]; Yao Y, 2003, J NEUROCHEM, V86, P947, DOI 10.1046/j.1471-4159.2003.01906.x; Zhang C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600241; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200; Zhuang XL, 2012, J BIOL CHEM, V287, P4165, DOI 10.1074/jbc.M111.271528	56	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6910	6926		10.1074/jbc.M116.762385	http://dx.doi.org/10.1074/jbc.M116.762385			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28280242	hybrid, Green Published			2022-12-26	WOS:000400478300005
J	Bevacqua, RJ; Fernandez-Martin, R; Canel, NG; Gibbons, A; Texeira, D; Lange, F; Landschoot, GV; Savy, V; Briski, O; Hiriart, MI; Grueso, E; Ivics, Z; Taboga, O; Kues, WA; Ferraris, S; Salamone, DF				Bevacqua, R. J.; Fernandez-Martin, R.; Canel, N. G.; Gibbons, A.; Texeira, D.; Lange, F.; Vans Landschoot, G.; Savy, V.; Briski, O.; Hiriart, M. I.; Grueso, E.; Ivics, Z.; Taboga, O.; Kues, W. A.; Ferraris, S.; Salamone, D. F.			Assessing Tn5 and Sleeping Beauty for transpositional transgenesis by cytoplasmic injection into bovine and ovine zygotes	PLOS ONE			English	Article							HUMAN POLYCLONAL ANTIBODIES; FETAL FIBROBLASTS; NUCLEAR TRANSFER; GENE-TRANSFER; HUMAN-CELLS; FACTOR IX; IN-VITRO; EMBRYOS; TRANSPOSASE; EXPRESSION	Transgenic domestic animals represent an alternative to bioreactors for large-scale production of biopharmaceuticals and could also provide more accurate biomedical models than rodents. However, their generation remains inefficient. Recently, DNA transposons allowed improved transgenesis efficiencies in mice and pigs. In this work, Tn5 and Sleeping Beauty (SB) transposon systems were evaluated for transgenesis by simple cytoplasmic injection in livestock zygotes. In the case of Tn5, the transposome complex of transposon nucleic acid and Tn5 protein was injected. In the case of SB, the supercoiled plasmids encoding a transposon and the SB transposase were co-injected. In vitro produced bovine zygotes were used to establish the cytoplasmic injection conditions. The in vitro cultured blastocysts were evaluated for reporter gene expression and genotyped. Subsequently, both transposon systems were injected in seasonally available ovine zygotes, employing transposons carrying the recombinant human factor IX driven by the beta-lactoglobulin promoter. The Tn5 approach did not result in transgenic lambs. In contrast, the Sleeping Beauty injection resulted in 2 lambs (29%) carrying the transgene. Both animals exhibited cellular mosaicism of the transgene. The extraembryonic tissues (placenta or umbilical cord) of three additional animals were also transgenic. These results show that transpositional transgenesis by cytoplasmic injection of SB transposon components can be applied for the production of transgenic lambs of pharmaceutical interest.	[Bevacqua, R. J.; Fernandez-Martin, R.; Canel, N. G.; Vans Landschoot, G.; Savy, V.; Briski, O.; Hiriart, M. I.; Salamone, D. F.] Univ Buenos Aires, Anim Biotechnol Lab, Fac Agron, INPA,CONICET, Buenos Aires, DF, Argentina; [Gibbons, A.] INTA, Expt Stn Bariloche, San Carlos De Bariloche, Rio Negro, Argentina; [Texeira, D.] Univ Estadual Ceara, Lab Fisiol & Controle Reprod, FAVET, Fortaleza, Ceara, Brazil; [Lange, F.; Vans Landschoot, G.; Ferraris, S.] Maimonides Univ, Cloning & Transgenesis Lab, Buenos Aires, DF, Argentina; [Grueso, E.; Ivics, Z.] Paul Ehrlich Inst, Langen, Germany; [Taboga, O.] INTA Castelar, CICVyA Biotechnol Inst, Buenos Aires, DF, Argentina; [Kues, W. A.] Friedrich Loeffler Inst, Neustadt, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidade Estadual do Ceara; Paul Ehrlich Institute; Instituto Nacional de Tecnologia Agropecuaria (INTA); Friedrich Loeffler Institute	Salamone, DF (corresponding author), Univ Buenos Aires, Anim Biotechnol Lab, Fac Agron, INPA,CONICET, Buenos Aires, DF, Argentina.	salamone@agro.uba.ar	Briski, Olinda/AAM-3972-2020; Bevacqua, Romina/AAU-9227-2021; Salamone, Daniel F/G-1096-2019; Hierro, Esther Grueso/C-8107-2019	Briski, Olinda/0000-0002-6574-4479; Salamone, Daniel F/0000-0003-0858-0313; Bevacqua, Romina J/0000-0002-3903-6508; Grueso, Esther/0000-0002-5365-5129; , Oscar/0000-0001-9575-3045; Kues, Wilfried/0000-0002-0850-8103; canel, natalia/0000-0002-6154-2132; Fernandez-Martin, Rafael/0000-0002-4838-407X	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2013-2375]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Grant: Agencia Nacional de Promocion Cientifica y Tecnologica PICT-2013-2375 received by Daniel Salamone (DS); http://www.agencia.mincyt.gob.ar/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevacqua RJ, 2013, THERIOGENOLOGY, V80, P104, DOI 10.1016/j.theriogenology.2013.03.017; Bevacqua RJ, 2012, THERIOGENOLOGY, V78, P57, DOI 10.1016/j.theriogenology.2012.01.020; Bevacqua RJ, 2010, THERIOGENOLOGY, V74, P922, DOI 10.1016/j.theriogenology.2010.04.017; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Carlson DF, 2011, TRANSGENIC RES, V20, P29, DOI 10.1007/s11248-010-9386-5; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Cueto MI, 2011, REPROD DOMEST ANIM, V46, P770, DOI 10.1111/j.1439-0531.2010.01738.x; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Dyck MK, 2003, TRENDS BIOTECHNOL, V21, P394, DOI 10.1016/S0167-7799(03)00190-2; Garrels W, 2011, PLOS ONE, V6; Garrels W, 2014, REPROD FERT DEVELOP, V27, P266; Gomez MC, 1998, THERIOGENOLOGY, V49, P1143, DOI 10.1016/S0093-691X(98)00062-4; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Goryshin IY, 1998, P NATL ACAD SCI USA, V95, P10716, DOI 10.1073/pnas.95.18.10716; Goryshin IY, 2003, GENOME RES, V13, P644, DOI 10.1101/gr.611403; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97, DOI 10.1038/72017; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Habermann FA, 2007, THERIOGENOLOGY, V68, pS116, DOI 10.1016/j.theriogenology.2007.05.055; Hackett CS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S12; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Henikoff S, 1998, CELL, V93, P329, DOI 10.1016/S0092-8674(00)81161-7; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Iqbal K, 2009, BIOTECHNIQUES, V47, P959, DOI 10.2144/000113270; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jacobsen JC, 2010, HUM MOL GENET, V19, P1873, DOI 10.1093/hmg/ddq063; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Kuroiwa Y, 2002, GENE THER, V9, P708, DOI 10.1038/sj.gt.3301754; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; Mates L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S1; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; MAXWELL WMC, 1984, J AGR SCI-CAMBRIDGE, V102, P233, DOI 10.1017/S002185960004168X; Meissner A, 2006, DEV DYNAM, V235, P2460, DOI 10.1002/dvdy.20915; Memili E, 1999, BIOL REPROD, V61, P1198, DOI 10.1095/biolreprod61.5.1198; Naumann TA, 2002, J BACTERIOL, V184, P233, DOI 10.1128/JB.184.1.233-240.2002; Naumann TA, 2002, J BIOL CHEM, V277, P17623, DOI 10.1074/jbc.M200742200; Nowak-Imialek M, 2013, REPROD FERT DEVELOP, V25, P103, DOI 10.1071/RD12265; Nowak-Imialek M, 2011, STEM CELLS DEV, V20, P1564, DOI 10.1089/scd.2010.0399; Pereyra-Bonnet F, 2008, REPROD FERT DEVELOP, V20, P741, DOI 10.1071/RD07172; Pereyra-Bonnet F, 2009, REPROD FERT DEVELOP, V21, P250, DOI 10.1071/RDv21n1Ab307; Pereyra-Bonnet F, 2011, TRANSGENIC RES, V20, P1379, DOI 10.1007/s11248-011-9503-0; Robl JM, 2007, CLONING STEM CELLS, V9, P12, DOI 10.1089/clo.2006.0083; Rossant J, 2011, P NATL ACAD SCI USA, V108, P7659, DOI 10.1073/pnas.1104844108; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Santos C, 2006, J BIOTECHNOL, V124, P469; SAS Institute Inc. SAS/STAT, 1989, US GUID VERS 6, V1, P943; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Suganuma R, 2005, BIOL REPROD, V73, P1157, DOI 10.1095/biolreprod.105.044669; TERVIT HR, 1972, J REPROD FERTIL, V30, P493, DOI 10.1530/jrf.0.0300493; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yekta AA, 2013, TRANSGENIC RES, V22, P131, DOI 10.1007/s11248-012-9634-y	59	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174025	10.1371/journal.pone.0174025	http://dx.doi.org/10.1371/journal.pone.0174025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301581	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300114
J	Kozuki, N; Oseni, L; Mtimuni, A; Sethi, R; Rashidi, T; Kachale, F; Rawlins, B; Gupta, S				Kozuki, Naoko; Oseni, Lolade; Mtimuni, Angella; Sethi, Reena; Rashidi, Tambudzai; Kachale, Fannie; Rawlins, Barbara; Gupta, Shivam			Health facility service availability and readiness for intrapartum and immediate postpartum care in Malawi: A cross-sectional survey	PLOS ONE			English	Article							PROGRAM	This analysis seeks to identify strengths and gaps in the existing facility capacity for intrapar-tum and immediate postpartum fetal and neonatal care, using data collected as a part of Malawi's Helping Babies Breath program evaluation. From August to September 2012, the Maternal and Child Health Integrated Program (MCHIP) conducted a cross-sectional survey in 84 Malawian health facilities to capture current health facility service availability and readi-ness and health worker capacity and practice pertaining to labor, delivery, and immediate postpartum care. The survey collected data on availability of equipment, supplies, and medi-cations, and health worker knowledge and performance scores on intrapartum care simula-tion and actual management of real clients at a subset of facilities. We ran linear regression models to identify predictors of high simulation performance of routine delivery care and management of asphyxiated newborns across all facilities surveyed. Key supplies for infec-tion prevention and thermal care of the newborn were found to be missing in many of the surveyed facilities. At the health center level, 75% had no clinician trained in basic emer-gency obstetric care or newborn care and 39% had no midwife trained in the same. We observed that there were no proportional increases in available transport and staff at a facility as catchment population increased. In simulations of management of newborns with breathing problems, health workers were able to complete a median of 10 out of 16 tasks for a full-term birth case scenario and 20 out of 30 tasks for a preterm birth case scenario. Health workers who had more years of experience appeared to perform worse. Our study provides a benchmark and highlights gaps for future evaluations and studies as Malawi con-tinues to make strides in improving facility-based care. Further progress in reducing the bur-den of neonatal and fetal death in Malawi will be partly predicated on guaranteeing properly equipped and staffed facilities in addition to ensuring the presence of skilled health workers.	[Kozuki, Naoko; Gupta, Shivam] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Oseni, Lolade; Rashidi, Tambudzai] Jhpiego, Lilongwe, Malawi; [Mtimuni, Angella] USAID, Lilongwe, Malawi; [Sethi, Reena; Rawlins, Barbara] Jhpiego, Washington, DC USA; [Kachale, Fannie] Malawi Minist Hlth, Lilongwe, Malawi	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jhpiego; United States Agency for International Development (USAID); Jhpiego	Gupta, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	sgupta23@jhu.edu		Kozuki, Naoko/0000-0003-2850-3956	USAID through the Maternal and Child Health Integrated Program; SSDI-Services bilateral program in Malawi	USAID through the Maternal and Child Health Integrated Program(United States Agency for International Development (USAID)); SSDI-Services bilateral program in Malawi	We acknowledge support from USAID through the Maternal and Child Health Integrated Program and the SSDI-Services bilateral program in Malawi.	American Academy of Pediatrics, HELP BAB BREATH; American Academy of Pediatrics, HELP BAB BREATH FAC, V2 nd; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2015, COUNTDOWN 2015 COUNT; [Anonymous], 2007, MAN COMPL PREGN CHIL; [Anonymous], 2010, MAL DEM HLTH SURV 20; Berg A BL, 2012, EVALUATION KANGAROO; Blencowe H, 2016, LANCET GLOBAL HLTH; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Brenner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123968; Callaghan-Koru JA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1052; Demographic and Health Survey, SPA OV; Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005; Goggin K, 2016, AIDS BEHAV, V20, P2141, DOI 10.1007/s10461-016-1404-z; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lee ACC, 2013, PEDIATR RES, V74, P50, DOI 10.1038/pr.2013.206; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Malawi Ministry of Health, EV NEWB ACT PLAN ACT; McPherson RA, 2013, PROCESS DOCUMENTATIO; Sethi R, 2015, MEASUREMENT QUALITY; Thorsen VC, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-9; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; USAID, 2015, USAID MAL HLTH COMM; van Lettow M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-426; Wendo D, 2015, SUPPORT SERVICE DELI; Zimba E, 2012, HEALTH POLICY PLANN, V27, P88, DOI 10.1093/heapol/czs043	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172492	10.1371/journal.pone.0172492	http://dx.doi.org/10.1371/journal.pone.0172492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301484	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300015
J	Ranjha, R; Meena, NK; Singh, A; Ahuja, V; Paul, J				Ranjha, Raju; Meena, Naresh Kumar; Singh, Abhiraman; Ahuja, Vineet; Paul, Jaishree			Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENETIC-VARIANTS; CANCER-RISK; FUNCTIONAL POLYMORPHISMS; COLORECTAL-CANCER; PRE-MICRORNAS; SUSCEPTIBILITY; RS3746444	Background and aim MicroRNAs are small non-coding RNAs that play an important role in regulating the gene expression of their target genes. SNP miR-196a-2 rs11614913 and miR-499 rs3746444 are reported to have association with the risk and prognosis of multiple-types of inflammatory diseases including IBD. This study was conducted to show if any association of SNP miR-196a- 2rs11614913 and miR-499 rs3746444 exists with ulcerative colitis (UC) patients of north Indian population and how these polymorphisms modulate the expression profile of the respective miRNAs. Methods A total of 638 participants including 197 UC patients and 441 controls were included in this study. Polymorphisms were genotyped by PCR-RFLP and the miRNA expression was measured using qRT-PCR. Genotypes and allele frequencies were calculated using SPSS 16 software. Results MiR-196a-2 rs11614913 (C> T) and miR-499 rs3746444 (T> C) were found to be associated with UC. TT genotype of miR-196a-2 rs11614913 (p = 0.03) was negatively associated with UC whereas the heterozygous TC genotype of miR-499 rs3746444 (p = 0.003) was showing positive association with UC. Patients having a combination of both SNPs, developed disease at older age and they suffered from severe disease extent. Genotype that showed association with the disease also showed correlation with the changes in miRNA expression. Conclusion In this study we found miR-196a-2 rs11614913 and miR-499 rs3746444 were associated with UC in north Indian population. We found the genotype that showed association with UC also altered the expression of respective miRNA in the patient harboring the genotype. There was correlation between associated genotype and altered miRNA expression.	[Ranjha, Raju; Meena, Naresh Kumar; Singh, Abhiraman; Paul, Jaishree] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India; [Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Ranjha, Raju] Natl Inst Malaria Res, New Delhi, India	Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Paul, J (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India.	jpaul33@hotmail.com	Ahuja, Vineet/N-1705-2019	Ahuja, Vineet/0000-0002-5474-9709; Meena, Naresh Kumar/0000-0001-5450-5184	Department of Biotechnology, New Delhi [BT/PR8348/MED/30/1023/2013]; Department of Science and Technology in the form of DST PURSE [6(54)/SLS/JP/DST PURSE/2016-17]; CSIR, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Department of Science and Technology in the form of DST PURSE; CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	JP acknowledges the financial support received from the Department of Biotechnology, New Delhi through a research grant (No.BT/PR8348/MED/30/1023/2013) and partial support from Department of Science and Technology in the form of DST PURSE Grant II-File No. 6(54)/SLS/JP/DST PURSE/2016-17 to the university. RR received JRF/SRF fellowship from CSIR, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030049; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0126-1; Dai ZJ, 2015, CURR PHARM DESIGN, V21, P1455, DOI 10.2174/1381612821666141208143533; Du M, 2014, CARCINOGENESIS; Garud Sagar, 2009, Therap Adv Gastroenterol, V2, P99, DOI 10.1177/1756283X09102329; Gazouli M, 2013, DIGEST DIS SCI, V58, P2324, DOI 10.1007/s10620-013-2640-y; Guo J, 2012, PLOS ONE, P7; Hu XJ, 2014, TUMOR BIOL, V35, P2151, DOI 10.1007/s13277-013-1285-y; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li LJ, 2011, CLIN BIOCHEM, V44, P813, DOI 10.1016/j.clinbiochem.2011.04.021; Matricon J, 2010, SELF NONSELF, V1, P299, DOI DOI 10.4161/SELF.1.4.13560; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Okubo M, 2011, J CLIN IMMUNOL, V31, P69, DOI 10.1007/s10875-010-9461-y; Ranjha R, 2013, INFLAMM RES, V62, P343, DOI 10.1007/s00011-013-0600-9; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Wang F, 2013, MOL BIOL REP, V40, P109, DOI 10.1007/s11033-012-2039-4; Wang G, 2014, TUMOR BIOL, V35, P2693, DOI 10.1007/s13277-013-1355-1; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Xu Y, 2013, PLOS ONE, V8; Yang B, 2012, HUM IMMUNOL, V73, P101, DOI 10.1016/j.humimm.2011.10.005; Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhang YG, 2013, ASIAN PAC J CANCER P, V14, P2337, DOI 10.7314/APJCP.2013.14.4.2337; Zou MN, 2012, MOL BIOL REP, V39, P3385, DOI 10.1007/s11033-011-1109-3	33	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173447	10.1371/journal.pone.0173447	http://dx.doi.org/10.1371/journal.pone.0173447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301487	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300040
J	Howle, LE; Weber, PW; Hada, EA; Vann, RD; Denoble, PJ				Howle, Laurens E.; Weber, Paul W.; Hada, Ethan A.; Vann, Richard D.; Denoble, Petar J.			The probability and severity of decompression sickness	PLOS ONE			English	Article							ILLNESS; MODELS; RISK	Decompression sickness (DCS), which is caused by inert gas bubbles in tissues, is an injury of concern for scuba divers, compressed air workers, astronauts, and aviators. Case reports for 3322 air and N-2-O-2 dives, resulting in 190 DCS events, were retrospectively analyzed and the outcomes were scored as (1) serious neurological, (2) cardiopulmonary, (3) mild neurological, (4) pain, (5) lymphatic or skin, and (6) constitutional or nonspecific manifestations. Following standard U.S. Navy medical definitions, the data were grouped into mild-Type I (manifestations 4-6)-and serious-Type II (manifestations 1-3). Additionally, we considered an alternative grouping of mild-Type A (manifestations 3-6)-and serious-Type B (manifestations 1 and 2). The current U.S. Navy guidance allows for a 2% probability of mild DCS and a 0.1% probability of serious DCS. We developed a hierarchical trinomial (3-state) probabilistic DCS model that simultaneously predicts the probability of mild and serious DCS given a dive exposure. Both the Type I/II and Type A/B discriminations of mild and serious DCS resulted in a highly significant (p << 0.01) improvement in trinomial model fit over the binomial (2-state) model. With the Type I/II definition, we found that the predicted probability of 'mild' DCS resulted in a longer allowable bottom time for the same 2% limit. However, for the 0.1% serious DCS limit, we found a vastly decreased allowable bottom dive time for all dive depths. If the Type A/B scoring was assigned to outcome severity, the no decompression limits (NDL) for air dives were still controlled by the acceptable serious DCS risk limit rather than the acceptable mild DCS risk limit. However, in this case, longer NDL limits were allowed than with the Type I/II scoring. The trinomial model mild and serious probabilities agree reasonably well with the current air NDL only with the Type A/B scoring and when 0.2% risk of serious DCS is allowed.	[Howle, Laurens E.; Weber, Paul W.] Duke Univ, Dept Mech Engn & Mat Sci, Hudson Hall,Res Dr, Durham, NC 27706 USA; [Howle, Laurens E.; Hada, Ethan A.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Howle, Laurens E.; Weber, Paul W.] BelleQuant Engn PLLC, Mebane, NC 27302 USA; [Vann, Richard D.; Denoble, Petar J.] Divers Alert Network, 6 West Colony Pl, Durham, NC USA	Duke University; Duke University	Howle, LE (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Hudson Hall,Res Dr, Durham, NC 27706 USA.; Howle, LE (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA.; Howle, LE (corresponding author), BelleQuant Engn PLLC, Mebane, NC 27302 USA.	laurens.howle@duke.edu	Denoble, Petar/AAU-5109-2021; Howle, Laurens/AAJ-2238-2021	Denoble, Petar/0000-0002-6770-8674; Howle, Laurens/0000-0002-1495-2788	Naval Sea Systems Command [NAVSEA-00C, N61331-06-C-0014, N00024-13-C-4104]; National Defense Science & Engineering Graduate Fellowship	Naval Sea Systems Command; National Defense Science & Engineering Graduate Fellowship	This work was supported by Naval Sea Systems Command (NAVSEA-00C - http://www.navsea.navy.mil/) under contracts #N61331-06-C-0014 and #N00024-13-C-4104. BelleQuant Engineering, PLLC provided computational resources. Neither the funding agency nor the commercial entity played any role in designing this study, data collection and analysis, decision to publish, interpreting the results, or writing the manuscript. BelleQuant Engineering, PLLC did not provide salary support to any author. The funding agency provided salary support to LH and RV. PW received salary support for a National Defense Science & Engineering Graduate Fellowship. The specific roles of the authors are articulated in the 'author contributions section.	[Anonymous], 1969, RANDOM HOUSE DICT EN; [Anonymous], 2008, US NAVY DIVING MANUA; BERGHAGE T E, 1974, Undersea Biomedical Research, V1, P189; Blatteau JE, 2005, SCI SPORT, V20, P119, DOI 10.1016/j.scispo.2005.04.001; Boycott AE, 1908, J HYG-CAMBRIDGE, V8, P342, DOI 10.1017/S0022172400003399; Cantais E, 2003, CRIT CARE MED, V31, P84, DOI 10.1097/00003246-200301000-00013; Francis TJR, 1991, DESCRIBING DECOMPRES; Howle LE, 2013, COMPUT BIOL MED, V43, P1739, DOI 10.1016/j.compbiomed.2013.07.026; Howle LE, 2009, COMPUT BIOL MED, V39, P1117, DOI 10.1016/j.compbiomed.2009.09.006; Howle LE, 2009, J APPL PHYSIOL, V107, P1539, DOI 10.1152/japplphysiol.00185.2009; Lang MA, 1992, P REP DIV WORKSH AM; Lowrance WW, 1976, J ELECTROCHEMICAL SO, DOI DOI 10.1149/1.2132690; McKimmon RC., 2000, CAUSE EFFECT CONTROL; MOON RE, 1995, SCI AM, V273, P70, DOI 10.1038/scientificamerican0895-70; Operational Risk Management (ORM), 3500 ORM; Ozyigit T, 2010, AVIAT SPACE ENVIR MD, V81, P3, DOI 10.3357/ASEM.2495.2010; Parker E.C., 1992, 9273 NMRI; Parker EC, 1998, J APPL PHYSIOL, V84, P1096, DOI 10.1152/jappl.1998.84.3.1096; Shields TG, 1986, 9322147 OTO R GORD I; Stein J, 1969, RANDOM HOUSE DICT EN; Temple DJ, 1999, 9902 NMRC DEP NAV, VII; Temple DJ, 1999, 9902 NMRC DEP NAV, VI; Thalmann ED, 1997, UNDERSEA HYPERBAR M, V24, P255; Van Liew HD, 2005, UNDERSEA HYPERBAR M, V32, P187; Vann RD, 2005, REPORT DECOMPRESSION; Vann RD, 2009, AVIAT SPACE ENVIR MD, V80, P466, DOI 10.3357/ASEM.2471.2009; Weathersby P. K., 2002, 51 WORKSH UND HYP ME; WEATHERSBY PK, 1992, J APPL PHYSIOL, V72, P1541, DOI 10.1152/jappl.1992.72.4.1541; WEATHERSBY PK, 1984, J APPL PHYSIOL, V57, P815, DOI 10.1152/jappl.1984.57.3.815; Weathersby PK, 1992, 9285 NMRI	30	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172665	10.1371/journal.pone.0172665	http://dx.doi.org/10.1371/journal.pone.0172665			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296928	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700012
J	Ng, CG; Mohamed, S; Kaur, K; Sulaiman, AH; Zainal, NZ; Taib, NA				Ng, Chong Guan; Mohamed, Salina; Kaur, Kiran; Sulaiman, Ahmad Hatim; Zainal, Nor Zuraida; Taib, Nur Aishah		MyBCC Study Grp	Perceived distress and its association with depression and anxiety in breast cancer patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; 1ST YEAR; WOMEN; DIAGNOSIS; SURGERY; STRESS; PREVALENCE; MORTALITY; SYMPTOMS	Background Breast cancer patients often experience a high level of distress. Psychological distress is a broad construct encompass both depression and anxiety. Previous studies in examining which of these psychological symptoms (either anxiety or depression) were more significantly associated with the distress level in breast cancer patients is lacking. This study aims to compare the level of depression and anxiety between patients with different level of distress. The correlation between the changes in distress level with depression or anxiety over 12 months was also examined. Methods This study is from the MyBCC cohort study. Two hundred and twenty one female breast cancer patients were included into the study. They were assessed at the time of diagnosis, 6 months and 12 month using Hospital Anxiety and Depression Scale (HADS) and distress thermometer. The information on age, ethnicity, treatment types and staging of cancer were collected. Results 50.2%, 51.6% and 40.3% of patients had perceived high level of distress at baseline, 6 months and 1 year after diagnosis. Those with high perceived level of distress had significant higher anxiety scores even after adjusted for the underlying depressive scores (Adjusted OR at baseline = 1.28, 95% CI = 1.13-1.44; adjusted OR at 6 months = 1.27, 95% CI = 1.11-1.45; adjusted OR at 12 months = 1.51, 95% CI = 1.29-1.76). There were no significant differences in the depressive scores between the subjects with either low or high distress level. There was reduction in perceived level of distress, anxiety and depression scores at 12 months after the diagnosis. The decrease of distress was positively correlated with the reduction of anxiety scores but not the changes of depressive scores (r' = 0.25). Conclusion Anxiety is a more significant psychological state that contributed to the feeling of distress in breast cancer as compared with depression. Levels of anxiety at diagnosis in this study would justify screening for anxiety, early identification and therapy for maintaining the psychological well-being of breast cancer patients. Further studies will be needed to measure the effectiveness of therapeutic interventions.	[Ng, Chong Guan; Sulaiman, Ahmad Hatim; Zainal, Nor Zuraida] Univ Malaya, Med Ctr, Dept Psychol Med, Kuala Lumpur, Malaysia; [Mohamed, Salina] Univ Teknol MARA, Fac Med, Dept Psychiat, Kuala Lumpur, Malaysia; [Kaur, Kiran; Taib, Nur Aishah] Univ Malaya, Med Ctr, Dept Surg, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Universiti Malaya	Ng, CG (corresponding author), Univ Malaya, Med Ctr, Dept Psychol Med, Kuala Lumpur, Malaysia.	chong_guan@um.edu.my	ZAINAL, NOR ZURAIDA/B-9329-2010; SULAIMAN, AHMAD HATIM/B-8156-2010; Taib, Nur Aishah Mohd/B-2370-2010; Ng, Chong Guan/G-6170-2010; Kiran, Kaur/B-8793-2010	SULAIMAN, AHMAD HATIM/0000-0002-8364-4594; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Kiran, Kaur/0000-0003-3021-2576	HIR grant from the Ministry of Higher Education of Malaysia [UM.C/HIR/MOHE/06]; UM [UM-QUB3C-2011]; University Malaya [RP046A- 15HTM]; Queen's University Belfast [UM-QUB3C-2011]	HIR grant from the Ministry of Higher Education of Malaysia; UM; University Malaya(Universiti Malaya); Queen's University Belfast	This study was supported by the HIR grant (HIR Grant UM.C/HIR/MOHE/06) from the Ministry of Higher Education of Malaysia and joint grant from UM and Queen's University Belfast (UM-QUB3C-2011). This study was also supported in part by the University Malaya Research Grant (RP046A- 15HTM) from the University Malaya, for the Promotion of Health Science. The grantors were not involved in the study design, subject enrolment, study analysis or interpretation or decision to submit this manuscript.	[Anonymous], 2003, J NATL COMPR CANC NE, V1, P344, DOI [DOI 10.6004/JNCCN.2003.0031, 10.6004/jnccn.2003.0031]; Badger TA, 2004, RES NURS HEALTH, V27, P19, DOI 10.1002/nur.20002; Bailey RK, 2005, INT J GYNECOL CANCER, V15, P203, DOI 10.1111/j.1525-1438.2005.15204.x; Barlow DH, 2000, AM PSYCHOL, V55, P1247, DOI 10.1037/0003-066X.55.11.1247; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; BURGESS C, 1988, J PSYCHOSOM RES, V32, P263, DOI 10.1016/0022-3999(88)90067-0; CARLSON LE, 2010, SCREENING DEPRESSION, P265; Carlson Linda E, 2003, Health Qual Life Outcomes, V1, P8, DOI 10.1186/1477-7525-1-8; Colleoni M, 2000, LANCET, V356, P1326, DOI 10.1016/S0140-6736(00)02821-X; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Donovan KA, 2014, PSYCHO-ONCOLOGY, V23, P241, DOI 10.1002/pon.3430; Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724; Golden-Kreutz DM, 2004, PSYCHO-ONCOLOGY, V13, P211, DOI 10.1002/pon.736; Hall A, 1999, EUR J CANCER, V35, P79, DOI 10.1016/S0959-8049(98)00308-6; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Islam T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008643; Iwamitsu Y, 2005, PSYCHOSOMATICS, V46, P19, DOI 10.1176/appi.psy.46.1.19; Jacobsen PB, 2007, J CLIN ONCOL, V25, P4526, DOI 10.1200/JCO.2007.13.1367; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kirsh Kenneth L, 2004, Palliat Support Care, V2, P33; Liao MN, 2008, CANCER NURS, V31, P274, DOI 10.1097/01.NCC.0000305744.64452.fe; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; MAGUIRE GP, 1978, BMJ-BRIT MED J, V1, P963, DOI 10.1136/bmj.1.6118.963; Manne SL, 2006, PSYCHO-ONCOL, V15, P234, DOI 10.1002/pon.941; Massie Mary Jane, 2004, J Natl Cancer Inst Monogr, P57; McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002; Millar K, 2005, J PSYCHOSOM RES, V58, P335, DOI 10.1016/j.jpsychores.2004.10.005; Mols F, 2013, J CANCER SURVIV, V7, P484, DOI 10.1007/s11764-013-0286-6; Montgomery GH, 2003, J BEHAV MED, V26, P153, DOI 10.1023/A:1023034706298; National Comprehensive Cancer Network, 2013, J NATL COMPR CANC NE, V1, P344; Pandey M, 2007, PSYCHO-ONCOL, V16, P582, DOI 10.1002/pon.1123; Pasquini Massimo, 2007, Clin Pract Epidemiol Ment Health, V3, P2, DOI 10.1186/1745-0179-3-2; Pirl William F, 2004, J Natl Cancer Inst Monogr, P32; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Saboonchi F, 2014, EUR J ONCOL NURS, V18, P598, DOI 10.1016/j.ejon.2014.06.007; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Shapiro SL, 2001, J CLIN PSYCHOL, V57, P501, DOI 10.1002/jclp.1026; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405; von Heymann-Horan AB, 2013, ACTA ONCOL, V52, P382, DOI 10.3109/0284186X.2012.746468; Voogt E, 2005, PSYCHO-ONCOLOGY, V14, P262, DOI 10.1002/pon.842; Voorwinden J S, 2015, J CLIN ONCOL, V31, P2724; Walker LG, 1999, EUR J CANCER, V35, P1783, DOI 10.1016/S0959-8049(99)00169-0; Yen JY, 2006, PSYCHIAT CLIN NEUROS, V60, P147, DOI 10.1111/j.1440-1819.2006.01479.x; Yusoff N, 2011, ASIAN PAC J CANCER P, V12, P915; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	66	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172975	10.1371/journal.pone.0172975	http://dx.doi.org/10.1371/journal.pone.0172975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296921	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700019
J	Tripathi, P; Behera, MD; Roy, PS				Tripathi, Poonam; Behera, Mukund Dev; Roy, Partha Sarathi			Optimized grid representation of plant species richness in India-Utility of an existing national database in integrated ecological analysis	PLOS ONE			English	Article							BIODIVERSITY INVENTORIES; MONSOON RAINFALL; WINTER MONSOON; BIAS; COMPLETENESS; PERFORMANCE; ESTIMATORS; DIVERSITY	Data on the distribution of plant species at spatial (grid) scales are required as input for integrative analysis along with related climate, environment, topography and soil data. Although the world's scientific community is increasingly generating data on plant species at various spatial grids and statistically interpolating and extrapolating the available information, data on plant diversity from the Asian continent are scant. Such data are unavailable for India, the mainland of which has part of three of the world's 36 biodiversity hotspots. Although sufficient field sampling is always impossible and impractical, it is essential to utilize fully any available database by adjudging the sampling sufficiency at a given scale. In this work, we used an exhaustive database of the plant species of the Indian mainland that was sufficient in terms of sampling vegetation types. We transformed the data, obtained the distribution at the 1 and 2 spatial grid levels and evaluated the sampling sufficiency at acceptable threshold limits (60% to 80%). The greatest species richness values recorded in the 0.04 ha quadrant, 1 degrees grid and 2 degrees grid were 59, 623 and 1244, respectively. Clench model was significantly (p value < 0.001) fitted using the plant species data at both the grid levels with a very high coefficient of determination (>0.95). At an acceptable threshold limit of 70%, almost all the grids at the 2 level and more than 80% of the grids at the 1 level were found to be sufficiently sampled. Sampling sufficiency was observed to be highly scale-dependent as a greater number of 2 grids attained asymptotic behaviour following the species area curve. Grid-level sampling insufficiency was attributed to lower numbers of sampling quadrats in forests with poor approachability, which coincided with the world biodiversity hotspots', suggesting that additional sampling was required. We prescribe the use of the 1 degrees and 2 degrees spatial grids with sufficient sampling for any ecological analysis in conjunction with other data and thereby offer grid-level plant species richness data for the Indian mainland for the first time.	[Tripathi, Poonam; Behera, Mukund Dev] Indian Inst Technol Kharagpur, Ctr Oceans Rivers Atmosphere & Land Sci CORAL, Kharagpur, W Bengal, India; [Roy, Partha Sarathi] Univ Hyderabad, Ctr Earth & Space Sci, Hyderabad, Andhra Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Hyderabad	Tripathi, P (corresponding author), Indian Inst Technol Kharagpur, Ctr Oceans Rivers Atmosphere & Land Sci CORAL, Kharagpur, W Bengal, India.	tripathy.poonam@gmail.com	Roy, Parth Sarathi/O-8586-2019	Roy, Parth Sarathi/0000-0002-6803-6785; Behera, Mukunda/0000-0002-9976-6270; tripathi, poonam/0000-0003-1534-4650				Gomez-Anaya JA, 2014, REV MEX BIODIVERS, V85, P218, DOI 10.7550/rmb.36978; CHAO A, 1984, SCAND J STAT, V11, P265; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Diaz-Frances E, 2005, CONSERV BIOL, V19, P569, DOI 10.1111/j.1523-1739.2005.00453.x; Dimri AP, 2014, CLIM DYNAM, V42, P1793, DOI 10.1007/s00382-013-1797-6; Dimri AP, 2013, INT J CLIMATOL, V33, P2185, DOI 10.1002/joc.3584; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 2000, PATTERN PROCESS MACR; Gotelli Nicholas J., 2011, P39; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hortal J, 2005, BIODIVERS CONSERV, V14, P2913, DOI 10.1007/s10531-004-0224-z; Sanchez-Reyes UJ, 2014, ZOOKEYS, P103, DOI 10.3897/zookeys.417.7551; Jimenez-Valverde A, 2006, BIODIVERS CONSERV, V15, P177, DOI 10.1007/s10531-004-5016-y; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; KODRICBROWN A, 1993, ECOL APPL, V3, P736, DOI 10.2307/1942104; Kripalani RH, 2003, THEOR APPL CLIMATOL, V74, P1, DOI 10.1007/s00704-002-0699-z; Kumar P, 2007, CLIM DYNAM, V28, P649, DOI [10.1007/s00382-006-0210-0, 10.1007/S00382-006-0210-0]; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lobo JM, 2008, BIODIVERS CONSERV, V17, P873, DOI 10.1007/s10531-008-9333-4; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pardo I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052786; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rodgers W.A., 1988, PLANNING WILDLIFE PR; Roy PS, 2015, INT J APPL EARTH OBS, V39, P142, DOI 10.1016/j.jag.2015.03.003; Roy P.S, 2012, BIODIVERSITY CHARACT; Sanchez-Fernandez D, 2008, DIVERS DISTRIB, V14, P754, DOI 10.1111/j.1472-4642.2008.00474.x; Simova I, 2013, J ECOL, V101, P161, DOI 10.1111/1365-2745.12011; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; SOBERON J, 1993, CONSERV BIOL, V7, P480, DOI 10.1046/j.1523-1739.1993.07030480.x; Ulrich W, 2010, OIKOS, V119, P1149, DOI 10.1111/j.1600-0706.2009.18236.x; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wei SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095890; Williams PH, 2002, J BIOSCIENCES, V27, P327, DOI 10.1007/BF02704963; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	38	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173774	10.1371/journal.pone.0173774	http://dx.doi.org/10.1371/journal.pone.0173774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296954	gold, Green Submitted, Green Published			2022-12-26	WOS:000396311700061
J	Royall, DR; Al-Rubaye, S; Bishnoi, R; Palmer, RF				Royall, Donald R.; Al-Rubaye, Safa; Bishnoi, Ram; Palmer, Raymond F.			Few serum proteins mediate APOE's association with dementia	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DEFAULT MODE NETWORK; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; COGNITIVE DECLINE; MISSING DATA; BRAIN; BIOMARKERS; GENOTYPE; RISK	The latent variable "delta"(for "dementia ") appears to be uniquely responsible for the dementing aspects of cognitive impairment. Age, depression, gender and the apolipoprotein E (APOE) e4 allele are independently associated with delta. In this analysis, we explore serum proteins as potential mediators of APOE's specific association with delta in a large, ethnically diverse longitudinal cohort, the Texas Alzheimer's Research and Care Consortium (TARCC). APOE was associated only with C-Reactive Protein (CRP), Adiponectin (APN) and Amphiregulin (AREG), although the latter two's associations did not survive Bonferroni correction for multiple comparisons. All three proteins were associated with delta and had weak potential mediation effects on APOE's association with that construct. Our findings suggest that APOE's association with cognitive performance is specific to delta and partially mediated by serum inflammatory proteins. The majority of APOE's significant unadjusted effect on delta is unexplained. It may instead arise from direct central nervous system effects, possibly on native intelligence. If so, then APOE may exert a life-long influence over delta and therefore all-cause dementia risk.	[Royall, Donald R.; Al-Rubaye, Safa] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Royall, Donald R.; Palmer, Raymond F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA; [Royall, Donald R.] Res Educ & Clin Care Ctr, S Texas Vet Hlth Syst Audie L Murphy Div, San Antonio, TX USA; [Royall, Donald R.] South Texas Vet Hlth Syst Audie L Murphy Div Geri, San Antonio, TX USA; [Bishnoi, Ram] Med Coll Georgia, Dept Psychiat, Augusta, GA 30912 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University System of Georgia; Augusta University	Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Res Educ & Clin Care Ctr, S Texas Vet Hlth Syst Audie L Murphy Div, San Antonio, TX USA.; Royall, DR (corresponding author), South Texas Vet Hlth Syst Audie L Murphy Div Geri, San Antonio, TX USA.	royall@uthscsa.edu	Bishnoi, Ram/P-4019-2014	Bishnoi, Ram/0000-0002-5202-5117	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders	This study was made possible by the Texas Alzheimer's Research Consortium (TARCC) funded by the state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders. The TARCC funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle JL, 2006, ANAL MOMENT STRUCTUR; Austin MA, 2004, ANN HUM GENET, V68, P179, DOI 10.1046/j.1529-8817.2004.00078.x; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Benton AL., 1983, MULTILINGUAL APHASIA; Bishnoi RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117282; Bishnoi RJ, 2015, J ALZHEIMERS DIS, V43, P37, DOI 10.3233/JAD-140042; Bollen K. A., 1993, TESTING STRUCTURAL E; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Calderon-Garciduenas L, 2015, J ALZHEIMERS DIS, V45, P757, DOI 10.3233/JAD-142685; Carlson JOE, 2015, J NEUROPATH EXP NEUR, V74, P1061, DOI 10.1097/NEN.0000000000000251; Chetelat G, 2013, REV NEUROL-FRANCE, V169, P729, DOI 10.1016/j.neurol.2013.07.025; Chu AY, 2012, CIRC-CARDIOVASC GENE, V5, P58, DOI 10.1161/CIRCGENETICS.111.961847; Czarees A, 1994, NIDA RES MONOGR, V139, P137; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; Falk A, 2002, J NEUROSCI RES, V69, P757, DOI 10.1002/jnr.10410; Gavett BE, 2016, J ALZHEIMERS DIS, V49, P531, DOI 10.3233/JAD-150252; Gavett BE, 2015, NEUROPSYCHOLOGY, V29, P344, DOI 10.1037/neu0000128; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Grice JW, 2001, PSYCHOL METHODS, V6, P430, DOI 10.1037//1082-989X.6.4.430; Haan MN, 2008, NEUROBIOL AGING, V29, P1774, DOI 10.1016/j.neurobiolaging.2007.04.020; Hubacek JA, 2010, HUM IMMUNOL, V71, P304, DOI 10.1016/j.humimm.2010.01.008; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Kleiman T, 2006, DEMENT GERIATR COGN, V22, P73, DOI 10.1159/000093316; Koch W, 2002, CLIN CHEM LAB MED, V40, P1123, DOI 10.1515/CCLM.2002.197; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lima TAS, 2014, AGE AGEING, V43, P289, DOI 10.1093/ageing/aft193; Lyall DM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.89; Metti AL, 2014, NEUROBIOL AGING, V35, P2785, DOI 10.1016/j.neurobiolaging.2014.05.030; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Morgan AR, 2016, J ALZHEIMER IN PRESS; Novak U, 2001, J CLIN NEUROSCI, V8, P106, DOI 10.1054/jocn.2000.0799; Palmer RF, 2016, J ALZHEIMERS DIS, V49, P521, DOI 10.3233/JAD-150254; Palmer RF, 2010, J AM GERIATR SOC, V58, pS343, DOI 10.1111/j.1532-5415.2010.03053.x; Royall Donald R, 2016, Alzheimers Dement (Amst), V3, P35, DOI 10.1016/j.dadm.2016.02.003; Royall DR, 2015, J ALZHEIMERS DIS, V43, P275, DOI 10.3233/JAD-140264; Royall DR, 2012, J ALZHEIMERS DIS, V32, P467, DOI 10.3233/JAD-2012-120424; Royall DR, J PREVENTION ALZHEIM; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sharma M, 2016, J AM GERIATR SOC, V64, P1171, DOI 10.1111/jgs.14140; Shi J, 2014, J ALZHEIMERS DIS, V38, P1, DOI 10.3233/JAD-130623; Song HQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133179; Spearman C, 1951, HUMAN ABILITY; SPSS Inc, 2009, PASW STAT WIND VERS; Su YY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001734; Tucker-Drob EM, 2014, PSYCHOL AGING, V29, P236, DOI 10.1037/a0036187; US Food and Drug Administration, 2012, FDA DRUG SAF COMM IM; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wheaton B, 1977, SOCIOLOGY METHODOLOG; Wolters FJ, 2016, NEUROSCI LETT, V617, P139, DOI 10.1016/j.neulet.2016.02.018; Yeo RA, 2011, CURR ALZHEIMER RES, V8, P345; ZWEIG MH, 1993, CLIN CHEM, V39, P561	55	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0172268	10.1371/journal.pone.0172268	http://dx.doi.org/10.1371/journal.pone.0172268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291794	Green Published, gold, Green Submitted			2022-12-26	WOS:000396094700004
J	Maier, IL; Behme, D; Schnieder, M; Tsogkas, I; Schregel, K; Bahr, M; Knauth, M; Liman, J; Psychogios, MN				Maier, Ilko L.; Behme, Daniel; Schnieder, Marlena; Tsogkas, Ioannis; Schregel, Katharina; Baehr, Mathias; Knauth, Michael; Liman, Jan; Psychogios, Marios-Nikos			Early computed tomography-based scores to predict decompressive hemicraniectomy after endovascular therapy in acute ischemic stroke	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; CT PERFUSION; ALBERTA STROKE; INFARCTION; THROMBECTOMY; METAANALYSIS; MANAGEMENT; OCCLUSION; TRIALS; MAPS	Background Identification of patients requiring decompressive hemicraniectomy (DH) after endovascular therapy (EVT) is crucial as clinical signs are not reliable and early DH has been shown to improve clinical outcome. The aim of our study was to identify imaging-based scores to predict the risk for space occupying ischemic stroke and DH. Methods Prospectively derived data from patients with acute large artery occlusion within the anterior circulation and EVT was analyzed in this monocentric study. Predictive value of non-contrast cranial computed tomography (ncCT) and cerebral blood volume (CBV) Alberta Stroke Program Early CT score (ASPECTS) were investigated for DH using logistic regression models and Receiver Operating Characteristic Curve analysis. Results From 218 patients with EVT, DH was performed in 20 patients (9.2%). Baseline- (7 vs. 9; p = 0.009) and follow-up ncCT ASPECTS (1 vs. 7, p< 0.001) as well as baseline CBV ASPECTS (5 vs. 7, p< 0.001) were significantly lower in patients with DH. ncCT (baseline: OR 0.71, p = 0.018; follow-up: OR 0.32, p = < 0.001) and CBV ASPECTS (OR 0.63, p = 0.008) predicted DH. Cut-off ncCT-ASPECTS on baseline was 7-, ncCT- ASPECTS on follow-up was 4- and CBV ASPECTS on baseline was 5 points. Conclusions ASPECTS could be useful to early identify patients requiring DH after EVT for acute large vessel occlusion.	[Maier, Ilko L.; Schnieder, Marlena; Baehr, Mathias; Liman, Jan] Univ Med Ctr Goettingen, Dept Neurol, Gottingen, Germany; [Behme, Daniel; Tsogkas, Ioannis; Schregel, Katharina; Knauth, Michael; Psychogios, Marios-Nikos] Univ Med Ctr Goettingen, Dept Neuroradiol, Gottingen, Germany	University of Gottingen; University of Gottingen	Maier, IL (corresponding author), Univ Med Ctr Goettingen, Dept Neurol, Gottingen, Germany.	ilko.maier@med.uni-goettingen.de	Behme, Daniel/H-4551-2019; Mingmei, Zhao/N-7178-2014	Mingmei, Zhao/0000-0002-0047-5220	German Research Foundation; Gottingen University	German Research Foundation(German Research Foundation (DFG)); Gottingen University	The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Fahmi F, 2012, AM J NEURORADIOL, V33, P2074, DOI 10.3174/ajnr.A3110; Geuskens RREG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141571; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Grotta J, 1997, STROKE, V28, P2338, DOI 10.1161/01.STR.28.12.2338; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; Krieger DW, 1999, STROKE, V30, P287, DOI 10.1161/01.STR.30.2.287; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Leyhe J. R., 2016, J NEUROINTERV SURG; MacCallum C, 2014, CEREBROVASC DIS, V38, P39, DOI 10.1159/000363619; Mori K, 2004, SURG NEUROL, V62, P420, DOI 10.1016/j.surneu.2003.12.017; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schregel K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169192; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Sporns PB, 2015, CLIN NEURORADIOL; Treadwell SD, 2010, POSTGRAD MED J, V86, P235, DOI 10.1136/pgmj.2009.094292; Tsogkas I, 2016, EUR RADIOL, V26, P4213, DOI 10.1007/s00330-016-4257-y; Vagal A, 2016, STROKE, V47, P535, DOI 10.1161/STROKEAHA.115.011461; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; Wijdicks EFM, 2004, CRIT CARE MED, V32, P2332, DOI 10.1097/01.CCM.0000145949.34618.E1; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	31	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173737	10.1371/journal.pone.0173737	http://dx.doi.org/10.1371/journal.pone.0173737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282456	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800075
J	Haglund, S; Vikingsson, S; Almer, S; Soderman, J				Haglund, Sofie; Vikingsson, Svante; Almer, Sven; Soderman, Jan			Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LOW-DOSE AZATHIOPRINE; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEPATOMA HEPARG CELLS; IN-VITRO; 6-THIOGUANINE NUCLEOTIDE; MITOCHONDRIAL INJURY; XANTHINE-OXIDASE; T-LYMPHOCYTES; BLOOD	Combination treatment with low-dose thiopurine and allopurinol (AP) has successfully been used in patients with inflammatory bowel disease with a so called skewed thiopurine metabolite profile. In red blood cells in vivo, it reduces the concentration of methylated metabolites and increases the concentration of the phosphorylated ones, which is associated with improved therapeutic efficacy. This study aimed to investigate the largely unknown mechanism of AP on thiopurine metabolism in cells with an active thiopurine metabolic pathway using HepG2 and HEK293 cells. Cells were treated with 6-mercaptopurine (6MP) and AP or its metabolite oxypurinol. The expression of genes known to be associated with thiopurine metabolism, and the concentration of thiopurine metabolites were analyzed. Gene expression levels were only affected by AP in the presence of 6MP. The addition of AP to 6MP affected the expression of in total 19 genes in the two cell lines. In both cell lines the expression of the transporter SLC29A2 was reduced by the combined treatment. Six regulated genes in HepG2 cells and 8 regulated genes in HEK293 cells were connected to networks with 18 and 35 genes, respectively, present at known susceptibility loci for inflammatory bowel disease, when analyzed using a protein-protein interaction database. The genes identified as regulated as well as the disease associated interacting genes represent new candidates for further investigation in the context of combination therapy with thiopurines and AP. However, no differences in absolute metabolite concentrations were observed between 6MP+AP or 6MP +oxypurinol vs. 6MP alone in either of the two cell lines. In conclusion; the effect of AP on=gene expression levels requires the presence of 6MP, at least in vitro. Previously described AP-effects on metabolite concentrations observed in red blood cells in vivo could not be reproduced in our cell lines in vitro. AP's effects in relation to thiopurine metabolism are complex. The network-identified susceptibility genes represented biological processes mainly associated with purine nucleotide biosynthetic processes, lymphocyte proliferation, NF-KB activation, JAK-STAT signaling, and apoptotic signaling at oxidative stress.	[Haglund, Sofie; Soderman, Jan] Reg Jonkoping Cty, Lab Med, Jonkoping, Sweden; [Haglund, Sofie; Almer, Sven] Karolinska Inst, Dept Med, Stockholm, Sweden; [Vikingsson, Svante] Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden; [Almer, Sven] Karolinska Univ Hosp, Ctr Digest Dis, Stockholm, Sweden; [Soderman, Jan] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Karolinska Institutet; Linkoping University; Karolinska Institutet; Karolinska University Hospital; Linkoping University	Haglund, S (corresponding author), Reg Jonkoping Cty, Lab Med, Jonkoping, Sweden.	sofie.haglund@rjl.se		Almer, Sven/0000-0001-9334-1821; Soderman, Jan/0000-0001-7505-7210	Futurum - the academy for health and care; Region Jonkoping County; Magtarm-fonden; Bengt-Ihre fonden; Karolinska Institutets forskningsfonder, Sweden	Futurum - the academy for health and care; Region Jonkoping County; Magtarm-fonden; Bengt-Ihre fonden; Karolinska Institutets forskningsfonder, Sweden	This study was performed with financial support from Futurum - the academy for health and care, Region Jonkoping County, Magtarm-fonden, Bengt-Ihre fonden, and Karolinska Institutets forskningsfonder, Sweden.	Aldinucci A, 2010, J NEUROIMMUNOL, V218, P28, DOI 10.1016/j.jneuroim.2009.11.001; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersson TB, 2012, EXPERT OPIN DRUG MET, V8, P909, DOI 10.1517/17425255.2012.685159; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Ansari A, 2008, ALIMENT PHARM THER, V28, P734, DOI 10.1111/j.1365-2036.2008.03782.x; Ansari A, 2010, ALIMENT PHARM THER, V31, P640, DOI 10.1111/j.1365-2036.2009.04221.x; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Appell ML, 2013, J CROHNS COLITIS, V7, P510, DOI 10.1016/j.crohns.2012.10.016; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergan S, 1997, THER DRUG MONIT, V19, P502, DOI 10.1097/00007691-199710000-00003; BOKKERINK JPM, 1993, BIOCHEM PHARMACOL, V45, P1455, DOI 10.1016/0006-2952(93)90045-X; Broekman MMTJ, 2015, CELL BIOL TOXICOL, V31, P161, DOI 10.1007/s10565-015-9301-1; Broekman MM, 2017, PHARMACOGENOMICS J; Burnstock G, 2014, PURINERG SIGNAL, V10, P51, DOI 10.1007/s11302-013-9398-8; Coulthard SA, 2002, MOL PHARMACOL, V62, P102, DOI 10.1124/mol.62.1.102; Day RO, 2007, CLIN PHARMACOKINET, V46, P623, DOI 10.2165/00003088-200746080-00001; De MIRANDA P, 1973, J Pharmacol Exp Ther, V187, P588; Duley JA, 2005, ALIMENT PHARM THERAP, V22, P1161, DOI 10.1111/j.1365-2036.2005.02703.x; Egmond Rv, 2011, GUT, V60, pA187; Eklund BI, 2006, MOL PHARMACOL, V70, P747, DOI 10.1124/mol.106.025288; ELION GB, 1972, P ROY SOC MED, V65, P257, DOI 10.1177/003591577206500315; ELION GB, 1967, FED PROC, V26, P898; Fotoohi AK, 2006, BIOCHEM BIOPH RES CO, V343, P208, DOI 10.1016/j.bbrc.2006.02.134; Glander P, 2001, CLIN BIOCHEM, V34, P543, DOI 10.1016/S0009-9120(01)00267-3; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Guo L, 2011, DRUG METAB DISPOS, V39, P528, DOI 10.1124/dmd.110.035873; Haglund S, 2008, BRIT J CLIN PHARMACO, V65, P69, DOI 10.1111/j.1365-2125.2007.02985.x; Haglund S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056989; Haglund S, 2011, THER DRUG MONIT, V33, P200, DOI 10.1097/FTD.0b013e31820b42bb; Hart SN, 2010, DRUG METAB DISPOS, V38, P988, DOI 10.1124/dmd.109.031831; Hatano R, 2013, IMMUNOLOGY, V138, P165, DOI 10.1111/imm.12028; Hindorf U, 2006, GUT, V55, P1423, DOI 10.1136/gut.2005.074930; Hogarth LA, 2008, BIOCH PHARM; Jharap B, 2010, INFLAMM BOWEL DIS, V16, P1541, DOI 10.1002/ibd.21221; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lancaster DL, 2002, CANCER CHEMOTH PHARM, V50, P33, DOI 10.1007/s00280-002-0442-6; Lee AU, 2001, J HEPATOL, V35, P756, DOI 10.1016/S0168-8278(01)00196-9; LENNARD L, 1992, J CHROMATOGR-BIOMED, V583, P83, DOI 10.1016/0378-4347(92)80347-S; LENNARD L, 1993, BRIT J CLIN PHARMACO, V36, P277, DOI 10.1111/j.1365-2125.1993.tb00365.x; LENNARD L, 1983, J PHARM PHARMACOL, V35, P15, DOI 10.1111/j.2042-7158.1983.tb04255.x; Leung Y, 2009, J CROHNS COLITIS, V3, P162, DOI 10.1016/j.crohns.2009.02.003; LILIEMARK J, 1990, CANCER RES, V50, P108; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Nelson D J, 1977, Adv Exp Med Biol, V76A, P121; PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87; PARKS RE, 1975, ANN NY ACAD SCI, V255, P412, DOI 10.1111/j.1749-6632.1975.tb29249.x; PATERSON ARP, 1975, ANTINEOPLASTIC IMM 2, P384; Pelin M, 2016, CURR DRUG METAB, V17, P542, DOI 10.2174/1389200217666160303104153; Petit E, 2008, TOXICOL IN VITRO, V22, P632, DOI 10.1016/j.tiv.2007.12.004; Rowland K, 1999, XENOBIOTICA, V29, P615, DOI 10.1080/004982599238434; Saleh EM, 2013, ONCOL LETT, V5, P321, DOI 10.3892/ol.2012.965; Sparrow MP, 2007, CLIN GASTROENTEROL H, V5, P209, DOI 10.1016/j.cgh.2006.11.020; STET EH, 1993, BIOCHIM BIOPHYS ACTA, V1180, P277, DOI 10.1016/0925-4439(93)90050-B; Tapner MJ, 2004, J HEPATOL, V40, P454, DOI 10.1016/j.jhep.2003.11.024; Thomas CW, 2005, J PHARMACOL EXP THER, V312, P537, DOI 10.1124/jpet.104.074815; TIDD DM, 1974, CANCER RES, V34, P738; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Timmer A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub2; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; van Asseldonk DP, 2011, DIGEST LIVER DIS, V43, P270, DOI 10.1016/j.dld.2010.09.001; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wei FY, 2011, ENDOCR J, V58, P819, DOI 10.1507/endocrj.EJ11-0099; WEINSHILBOUM RM, 1978, CLIN CHIM ACTA, V85, P323, DOI 10.1016/0009-8981(78)90311-X; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Wong DR, 2007, THER DRUG MONIT, V29, P845, DOI 10.1097/FTD.0b013e31815bf4dc	66	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173825	10.1371/journal.pone.0173825	http://dx.doi.org/10.1371/journal.pone.0173825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278299	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900038
J	Harrison, C; Henderson, J; Miller, G; Britt, H				Harrison, Christopher; Henderson, Joan; Miller, Graeme; Britt, Helena			The prevalence of diagnosed chronic conditions and multimorbidity in Australia: A method for estimating population prevalence from general practice patient encounter data	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORD; PRIMARY-CARE	Objectives To estimate the prevalence of common chronic conditions and multimorbidity among patients at GP encounters and among people in the Australian population. To assess the extent to which use of each individual patient's GP attendance over the previous year, instead of the average for their age-sex group, affects the precision of national population prevalence estimates of diagnosed chronic conditions. Design, setting and participants A sub-study (between November 2012 and March 2016) of the Bettering the Evaluation and Care of Health program, a continuous national study of GP activity. Each of 1,449 GPs provided data for about 30 consecutive patients (total 43,501) indicating for each, number of GP attendances in previous year and all diagnosed chronic conditions, using their knowledge of the patient, patient self-report, and patient's health record. Results Hypertension (26.5%) was the most prevalent diagnosed chronic condition among patients surveyed, followed by osteoarthritis (22.7%), hyperlipidaemia (16.6%), depression (16.3%), anxiety (11.9%), gastroesophageal reflux disease (GORD) (11.3%), chronic back pain (9.7%) and Type 2 diabetes (9.6%). After adjustment, we estimated population prevalence of hypertension as 12.4%, 9.5% osteoarthritis, 8.2% hyperlipidaemia, 8.0% depression, 5.8% anxiety and 5.2% asthma. Estimates were significantly lower than those derived using the previous method. About half (51.6%) the patients at GP encounters had two or more diagnosed chronic conditions and over one third (37.4%) had three or more. Population estimates were: 25.7% had two or more diagnosed chronic conditions and 15.8% had three or more. Conclusions Of the three approaches we have tested to date, this study provides the most accurate method for estimation of population prevalence of chronic conditions using the GP as an expert interviewer, by adjusting for each patient's reported attendance.	[Harrison, Christopher] Univ Sydney, Sydney Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Harrison, Christopher; Henderson, Joan; Miller, Graeme; Britt, Helena] Univ Sydney, Sydney Sch Publ Hlth, Family Med Res Ctr, Sydney, NSW, Australia	University of Sydney; University of Sydney	Harrison, C (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, NSW, Australia.; Harrison, C (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Family Med Res Ctr, Sydney, NSW, Australia.	christopher.harrison@sydney.edu.au		Henderson, Joan/0000-0002-8456-7455; Harrison, Christopher/0000-0002-8769-6877				[Anonymous], 2015, NAT HLTH SURV; Aus Tender, 2016, PROV RISK STRAT INCL; Austin PC, 2002, J VASC SURG, V36, P194, DOI 10.1067/mva.2002.125015; Australian Bureau of Statistics, 2013, POP PROJ AUSTR 2012; Australian Bureau of Statistics, 2014, AUSTR HIST POP STAT; Australian Government Department of Health, 2016, HEALTH MED REF PRIM; Brett T, 2013, ANN FAM MED, V11, P535, DOI 10.1370/afm.1570; BRITT H, 1992, FAM PRACT, V9, P191, DOI 10.1093/fampra/9.2.191; Britt H, 2016, GEN PRACTICE SERIES; Britt H., 2016, GEN PRACTICE ACTIVIT; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Classification Committee of the World Organization of Family Doctors, 1998, ICPC 2 INTERNATIONAL; Harrison C, 2014, PHCRIS ANN M; Harrison C, 2016, AUST NZ J PUBL HEAL, V40, P239, DOI 10.1111/1753-6405.12509; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Harrison C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067494; Harrison C, 2011, AUST FAM PHYSICIAN, V40, P12; Hersh WR, 2013, MED CARE, V51, pS30, DOI 10.1097/MLR.0b013e31829b1dbd; Knox SA, 2008, MED J AUSTRALIA, V189, P66, DOI 10.5694/j.1326-5377.2008.tb01918.x; Liaw Siaw-Teng, 2013, Aust Fam Physician, V42, P820; LINET MS, 1989, J CLIN EPIDEMIOL, V42, P1207, DOI 10.1016/0895-4356(89)90119-4; Mackenbach JP, 1996, AM J PUBLIC HEALTH, V86, P706, DOI 10.2105/AJPH.86.5.706; Merkin SS, 2007, J CLIN EPIDEMIOL, V60, P634, DOI 10.1016/j.jclinepi.2006.09.003; Mohangoo AD, 2006, EUR J PUBLIC HEALTH, V16, P101, DOI 10.1093/eurpub/cki043; National Center for Health Statistics. National Health Interview Survey, 2016, NAT HLTH INT SURV; NHS Information Centre for Health and Social Care, 2015, HLTH SURV ENGL 2014; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Statistics Canada, 2016, CAN COMM HLTH SURV; Tse J, 2011, STUD HEALTH TECHNOL, V168, P158, DOI 10.3233/978-1-60750-791-8-158; Willis E., 2016, UNDERSTANDING AUSTR; Win KT, 2007, J MED SYST, V31, P91, DOI 10.1007/s10916-006-9030-3	31	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172935	10.1371/journal.pone.0172935	http://dx.doi.org/10.1371/journal.pone.0172935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278241	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900133
J	Levin, I; Zaretsky, M; Aharoni, A				Levin, Itay; Zaretsky, Marianna; Aharoni, Amir			Directed evolution of a soluble human DR3 receptor for the inhibition of TL1A induced cytokine secretion	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; YEAST SURFACE DISPLAY; ENZYME EVOLUTION; T-CELL; INFLAMMATION; PROTEINS; DISEASE; SUPERFAMILY; EXPRESSION; GENERATION	TNF-like 1A (TL1A) is a cytokine belonging to the TNF superfamily that promotes inflammation in autoimmune diseases. Inhibiting the interaction of TL1A with the endogenous death-domain receptor 3 (DR3) offers a therapeutic approach for treating TL1A-induced autoimmune diseases. Here, we generated improved DR3 variants showing increased TL1A binding affinity and stability using a directed evolution approach. Given the high cysteine content and post-translational modification of DR3, we employed yeast surface display and expression in mammalian cell lines for screening, expression and characterization of improved DR3 variants. A cell-based assay performed with the human TF-1 cell line and CD4(+) T cells showed that two improved DR3 mutants efficiently inhibited TL1A-induced cell death and secretion of IFN-gamma, respectively. These DR3 mutants can be used as drug candidates for the treatment of inflammatory bowel diseases and for other autoimmune diseases, including rheumatic arthritis and asthma.	[Levin, Itay; Zaretsky, Marianna; Aharoni, Amir] Ben Gurion Univ Negev, NIBN, Beer Sheva, Israel; [Zaretsky, Marianna; Aharoni, Amir] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Aharoni, A (corresponding author), Ben Gurion Univ Negev, NIBN, Beer Sheva, Israel.; Aharoni, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	aaharoni@bgu.ac.il		Aharoni, Amir/0000-0003-2701-6996	National Institute for Biotechnology in the Negev (NIBN); Israeli Science Foundation (ISF)	National Institute for Biotechnology in the Negev (NIBN); Israeli Science Foundation (ISF)(Israel Science Foundation)	This work was supported by a grant from the National Institute for Biotechnology in the Negev (NIBN) and the Israeli Science Foundation (ISF) to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chen Varol, Nahum Shpigel and Irit Sagi for stimulating discussions on the role of TL1A in IBD. We thank the National Institute for Biotechnology in the Negev (NIBN) and the Israeli Science Foundation (ISF) for grant support.	Aharoni A, 2005, CHEM BIOL, V12, P1281, DOI 10.1016/j.chembiol.2005.09.012; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Amar D, 2012, J MOL BIOL, V416, P21, DOI 10.1016/j.jmb.2011.12.013; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chew LJ, 2002, FASEB J, V16, P742, DOI 10.1096/fj.01-0757fje; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gershoni JM, 2008, CURR OPIN BIOTECH, V19, P644, DOI 10.1016/j.copbio.2008.10.001; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Kariolis MS, 2013, CURR OPIN BIOTECH, V24, P1072, DOI 10.1016/j.copbio.2013.03.017; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Tao HY, 2002, CURR OPIN CHEM BIOL, V6, P858, DOI 10.1016/S1367-5931(02)00396-4; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Umetsu M, 2010, FEBS J, V277, P2006, DOI 10.1111/j.1742-4658.2010.07627.x; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Young HA, 2006, P NATL ACAD SCI USA, V103, P8303, DOI 10.1073/pnas.0602655103; Yu KY, 1999, J BIOL CHEM, V274, P13733, DOI 10.1074/jbc.274.20.13733; Zaretsky M, 2013, CHEM BIOL, V20, P202, DOI 10.1016/j.chembiol.2012.11.012; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004	36	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173460	10.1371/journal.pone.0173460	http://dx.doi.org/10.1371/journal.pone.0173460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278297	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900096
J	Parkkonen, O; Nieminen, MT; Vesterinen, P; Tervahartiala, T; Perola, M; Salomaa, V; Jousilahti, P; Sorsa, T; Pussinen, PJ; Sinisalo, J				Parkkonen, Olavi; Nieminen, Mikko T.; Vesterinen, Paula; Tervahartiala, Taina; Perola, Markus; Salomaa, Veikko; Jousilahti, Pekka; Sorsa, Timo; Pussinen, Pirkko J.; Sinisalo, Juha			Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIM P-1 may help to differentiate it from acute coronary syndrome	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; TAKO-TSUBO CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; NEUTROPHIL COLLAGENASE; STRESS CARDIOMYOPATHY; TISSUE INHIBITORS; ST-ELEVATION; RISK; ATHEROSCLEROSIS; FINLAND	Background Matrix metalloproteinase 8 (MMP-8) is the most potent type-I collagen protease. Such collagen mainly constitutes the transient fibrosis in takotsubo cardiomyopathy (TTC) endomyocardial biopsies. High MMP-8 and tissue-inhibitor of matrix metalloproteinase-1 (TIMP-1) levels are implicated in acute coronary syndrome (ACS). We compared MMP-8 and TIM P-1 levels in consecutive TTC and ACS patients, and their association to TTC severity. Methods and results In 45 acute serum samples of TTC, 2072 ACS and 1000 controls, TI MP-1 differed between ACS 146.7ng/mL (115.0-186.3) (median (interquartile range)), TTC 115.7 (94.3-137.7) and controls 80.9 (73.2-90.4), (p<0.0001). MMP-8 levels were similar between ACS and TTC. In receiver-operating characteristics analysis, TIM P-1 differentiated TTC from ACS with an area under the curve (AUC) of 0.679 (p<0.0001) surpassing troponin T (TnT) at 0.522 (p = 0.66). Compared to other differing factors (age, sex, smoking), TIMP-1 improved diagnostic specificity and sensitivity from AUC of 0.821 to 0.844 (p = 0.007). The MMP8/TIMP-1 molar ratio differentiated normal ejection fraction (EF) at 0.27 (0.13-0.51) from decreased EF<50 at 0.08 (0.05-0.20), (p = 0.04) in TTC, but not in ACS. Conclusions Even with other differing factors considered, TIMP-1 differentiated TTC from ACS better than TnT. In TTC, the low MMP-8/TIM P-1 molar ratio may reflect decreased proteolysis and increased transient fibrosis, perhaps in part explaining the left-ventricle impairment.	[Parkkonen, Olavi; Vesterinen, Paula; Sinisalo, Juha] Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland; [Parkkonen, Olavi; Vesterinen, Paula; Sinisalo, Juha] Univ Helsinki, Helsinki, Finland; [Nieminen, Mikko T.; Tervahartiala, Taina; Sorsa, Timo; Pussinen, Pirkko J.] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Nieminen, Mikko T.; Tervahartiala, Taina; Sorsa, Timo; Pussinen, Pirkko J.] Helsinki Univ Hosp, Helsinki, Finland; [Perola, Markus; Salomaa, Veikko; Jousilahti, Pekka] Natl Inst Hlth & Welf, Helsinki, Finland; [Sorsa, Timo] Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Karolinska Institutet	Parkkonen, O (corresponding author), Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland.; Parkkonen, O (corresponding author), Univ Helsinki, Helsinki, Finland.	olavi.parkkonen@hus.fi; juha.sinisalo@hus.fi		Sinisalo, Juha/0000-0002-0169-5137; Nieminen, Mikko/0000-0001-6427-3196; Pussinen, Pirkko/0000-0003-3563-1876	Finnish Foundation for Cardiovascular Research; Academy of Finland [1266053]; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Aarno Koskelo Foundation; Helsinki University Central Hospital [TYH7215, TKK2012005, TYH2012209, TYH2014312, TYH2014244, TYH2016251]	Finnish Foundation for Cardiovascular Research; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Aarno Koskelo Foundation; Helsinki University Central Hospital	This study was funded by grants from the Finnish Foundation for Cardiovascular Research (to OP, VS and JS) (http.//www.sydantutkimussaabo. Wen/foundation); the Academy of Finland (#1266053 to PJP) (http://www.aka.fi/en/); the Sigrid Juselius Foundation (to PJP) (http://www. sigridjuselius.fi/foundafien); the Yrjo Jahnsson Foundation (to PJP) (http://www.yjs/en/); the Aarno Koskelo Foundation (to JS) (rittp://www. aarnekoskelonsaatio.fi/); and Helsinki University Central Hospital special government funds (to JS EVO #TYH7215, #TKK2012005, #TYH2012209, #TYH2014312, TS EVO #TYH2014244, #TYH2016251).	Akashi YJ, 2015, NAT REV CARDIOL, V12, P387, DOI 10.1038/nrcardio.2015.39; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Coker ML, 2001, AM J PHYSIOL-HEART C, V281, pH543, DOI 10.1152/ajpheart.2001.281.2.H543; Djuric T, 2010, J CLIN LAB ANAL, V24, P246, DOI 10.1002/jcla.20393; Essa EM, 2012, J CARD FAIL, V18, P487, DOI 10.1016/j.cardfail.2012.04.002; Fertin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071280; Galiuto L, 2010, EUR HEART J, V31, P1319, DOI 10.1093/eurheartj/ehq039; Guzel S, 2013, KOREAN J INTERN MED, V28, P165, DOI 10.3904/kjim.2013.28.2.165; HASTY KA, 1987, J BIOL CHEM, V262, P10048; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Parkkonen O, 2014, J ELECTROCARDIOL, V47, P692, DOI 10.1016/j.jelectrocard.2014.06.006; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Peltonen M, 2008, KANSALLINEN FINRISK1; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Pussinen PJ, 2013, INT J CARDIOL, V167, P362, DOI 10.1016/j.ijcard.2011.12.095; Pussinen PJ, 2011, DIABETES CARE, V34, P392, DOI 10.2337/dc10-1676; Sharkey SW, 2008, AM J CARDIOL, V101, P1723, DOI 10.1016/j.amjcard.2008.02.062; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Szardien S, 2013, INT J CARDIOL, V168, P1685, DOI 10.1016/j.ijcard.2013.03.075; Tanindi A, 2011, OPEN CARDIOVASC MED, V5, P110, DOI 10.2174/1874192401105010110; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; Vaara S, 2012, INT J EPIDEMIOL, V41, P1265, DOI 10.1093/ije/dyr090; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Yang EV, 2002, J NEUROIMMUNOL, V133, P144, DOI 10.1016/S0165-5728(02)00270-9; Yoshiji H, 1998, INT J CANCER, V75, P81, DOI 10.1002/(SICI)1097-0215(19980105)75:1<81::AID-IJC13>3.3.CO;2-J	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173371	10.1371/journal.pone.0173371	http://dx.doi.org/10.1371/journal.pone.0173371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278213	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900079
J	Zhang, Z; Joyce, BT; Kresovich, JK; Zheng, YA; Zhong, J; Patel, R; Zhang, W; Liu, L; Dou, C; McCracken, JP; Diaz, A; Motta, V; Sanchez-Guerra, M; Bian, S; Bertazzi, PA; Schwartz, J; Baccarelli, AA; Wang, S; Hou, LF				Zhang, Zhou; Joyce, Brian Thomas; Kresovich, Jacob K.; Zheng, Yinan; Zhong, Jia; Patel, Ruchi; Zhang, Wei; Liu, Lei; Dou, Chang; McCracken, John P.; Diaz, Anaite; Motta, Valeria; Sanchez-Guerra, Marco; Bian, Shurui; Bertazzi, Pier Alberto; Schwartz, Joel; Baccarelli, Andrea A.; Wang, Sheng; Hou, Lifang			Blood pressure and expression of microRNAs in whole blood	PLOS ONE			English	Article							PARTICULATE MATTER EXPOSURE; GENE-EXPRESSION; AIR-POLLUTION; HYPERTENSION; INDIVIDUALS; METHYLATION; EPIGENETICS; PROGNOSIS; PROFILES; DISEASE	Background Blood pressure (BP) is a complex, multifactorial clinical outcome driven by genetic susceptibility, behavioral choices, and environmental factors. Many molecular mechanisms have been proposed for the pathophysiology of high BP even as its prevalence continues to grow worldwide, increasing morbidity and marking it as a major public health concern. To address this, we evaluated miRNA profiling in blood leukocytes as potential biomarkers of BP and BP-related risk factors. Methods The Beijing Truck Driver Air Pollution Study included 60 truck drivers and 60 office workers examined in 2008. On two days separated by 1-2 weeks, we examined three BP measures: systolic, diastolic, and mean arterial pressure measured at both pre-and post-work exams for blood NanoString nCounter miRNA profiles. We used covariate-adjusted linear mixed-effect models to examine associations between BP and increased miRNA expression in both pooled and risk factor-stratified analyses. Results Overall 43 miRNAs were associated with pre-work BP (FDR<0.05). In stratified analyses different but overlapping groups of miRNAs were associated with pre-work BP in truck drivers, high-BMI participants, and usual alcohol drinkers (FDR<0.05). Only four miRNAs were associated with post-work BP (FDR<0.05), in ever smokers. Conclusion Our results suggest that many miRNAs were significantly associated with BP in subgroups exposed to known hypertension risk factors. These findings shed light on the underlying molecular mechanisms of BP, and may assist with the development of a miRNA panel for early detection of hypertension.	[Zhang, Zhou; Bian, Shurui] Northwestern Univ, Feinberg Sch Med, Driskill Grad Program Life Sci, Chicago, IL 60611 USA; [Zhang, Zhou; Joyce, Brian Thomas; Kresovich, Jacob K.; Zheng, Yinan; Patel, Ruchi; Zhang, Wei; Liu, Lei; Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Joyce, Brian Thomas; Kresovich, Jacob K.] Univ Illinois, Sch Publ Hlth, Div Epidemiol Biostat, Chicago, IL USA; [Zheng, Yinan] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Zhong, Jia; Sanchez-Guerra, Marco; Schwartz, Joel; Hou, Lifang] Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Zhang, Wei; McCracken, John P.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Dou, Chang] China Inst Ind Relat, Dept Safety Engn, Beijing, Peoples R China; [Diaz, Anaite] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Motta, Valeria; Bertazzi, Pier Alberto] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Motta, Valeria; Bertazzi, Pier Alberto] IRCCS Fdn Ca Granda, Osped Maggiore Policlin, Milan, Italy; [Sanchez-Guerra, Marco] CDMX, Natl Inst Perinatol, Dept Dev Neurobiol, Mexico City, DF, Mexico; [Baccarelli, Andrea A.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Wang, Sheng] Peking Univ, Hlth Sci Ctr, Dept Occupat & Environm Hlth, Beijing, Peoples R China	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Universidad del Valle de Guatemala; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Columbia University; Peking University	Hou, LF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.	shengw@bjmu.edu.cn; l-hou@northwestern.edu	diaz-artiga, anaite/GOJ-7894-2022; Joyce, Brian/AAF-2478-2020; Stefanadis, Christodoulos/ABH-2232-2020; Sanchez-Guerra, Marco/V-7693-2019; Liu, Lei/B-4968-2009	diaz-artiga, anaite/0000-0002-2508-8710; Joyce, Brian/0000-0002-5271-6161; Stefanadis, Christodoulos/0000-0001-5974-6454; Sanchez-Guerra, Marco/0000-0002-8354-1157; Liu, Lei/0000-0003-1844-338X; Kresovich, Jacob/0000-0002-9577-226X; Zhang, Zhou/0000-0002-9639-052X; Zheng, Yinan/0000-0002-2006-7320	National Institute of Environmental Health Sciences [R21ES020984]; American Heart Association [12GRNT12070254]; Robert H. Lurie Comprehensive Cancer Center - Rosenberg Family Cancer Research Fund; Fundacion Mexico en Harvard, A.C.; Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020010, P30ES009089] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); Robert H. Lurie Comprehensive Cancer Center - Rosenberg Family Cancer Research Fund; Fundacion Mexico en Harvard, A.C.; Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (grant numbers, R21ES020984), American Heart Association (grant number 12GRNT12070254), and the Robert H. Lurie Comprehensive Cancer Center - Rosenberg Family Cancer Research Fund. MSG was financially supported by the Fundacion Mexico en Harvard, A.C. and Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, RISK FACT HIGH BLOOD; Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; Asayama K, 2015, HYPERTENSION, V65, P1170, DOI 10.1161/HYPERTENSIONAHA.115.04808; Baccarelli A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-108; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertero T, 2015, J BIOL CHEM, V290, P2069, DOI 10.1074/jbc.M114.617845; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Calderon-Garciduenas L, 2008, INHAL TOXICOL, V20, P499, DOI 10.1080/08958370701864797 ; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Cui K, 2014, INTEGR BIOL-UK, V6, P1141, DOI 10.1039/c4ib00156g; das Neves VJ, 2014, WORLD J CARDIOL, V6, P713, DOI 10.4330/wjc.v6.i8.713; Dubowsky SD, 2006, ENVIRON HEALTH PERSP, V114, P992, DOI 10.1289/ehp.8469; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friese RS, 2013, HUM MOL GENET, V22, P3624, DOI 10.1093/hmg/ddt213; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holgate Stephen T, 2003, Res Rep Health Eff Inst, P1; Hou L, 2015, ENV HLTH PERSPECT; Hou LF, 2016, ENVIRON HEALTH PERSP, V124, P344, DOI 10.1289/ehp.1408519; Hou LF, 2014, ENVIRON MOL MUTAGEN, V55, P256, DOI 10.1002/em.21829; Hou LF, 2013, PART FIBRE TOXICOL, V10, DOI [10.1186/1743-8977-10-17, 10.1186/1743-8977-10-47]; Jiang JY, 2015, J HYPERTENS, V33, P2223, DOI 10.1097/HJH.0000000000000710; Kario K, 2015, HYPERTENSION, V65, P1163, DOI 10.1161/HYPERTENSIONAHA.115.04800; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Liu C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0052-5; Ma L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140339; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; MILLARCRAIG MW, 1978, LANCET, V1, P795; Millis RM, 2011, CURR HYPERTENS REP, V13, P21, DOI 10.1007/s11906-010-0173-8; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; National Climatic Data Center (U.S.), NNDC CLIM DAT ONL; Nwankwo T, 2013, NCHS DATA BRIEF, V133, P1; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Raftopoulos L, 2015, LIFE SCI, V129, P22, DOI 10.1016/j.lfs.2014.08.003; Sanchez-Guerra M, 2015, EPIGENETICS-US, V10, P633, DOI 10.1080/15592294.2015.1050174; Tabassum R, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0209-4; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wallace E, 2015, AM J RESP CRIT CARE, V191, P1432, DOI 10.1164/rccm.201412-2148OC; Wang W, 2014, BIOMED ENVIRON SCI, V27, P552, DOI 10.3967/bes2014.085; Wang ZX, 2005, ENVIRON HEALTH PERSP, V113, P233, DOI 10.1289/txg.7273; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; Weinhold B, 2006, ENVIRON HEALTH PERSP, V114, pA160, DOI 10.1289/ehp.114-a160; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong MCS, 2015, EUR HEART J, V36, P2598, DOI 10.1093/eurheartj/ehv329; Xu JH, 2012, J MOL MED, V90, P865, DOI 10.1007/s00109-011-0840-5; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zheng YA, 2017, ENVIRON RES, V153, P112, DOI 10.1016/j.envres.2016.11.015; Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR	51	8	8	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173550	10.1371/journal.pone.0173550	http://dx.doi.org/10.1371/journal.pone.0173550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278198	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900011
J	Vineis, P; Chatziioannou, A; Cunliffe, VT; Flanagan, JM; Hanson, M; Kirsch-Volders, M; Kyrtopoulos, S				Vineis, Paolo; Chatziioannou, Aristotelis; Cunliffe, Vincent T.; Flanagan, James M.; Hanson, Mark; Kirsch-Volders, Micheline; Kyrtopoulos, Soterios			Epigenetic memory in response to environmental stressors	FASEB JOURNAL			English	Article						environmental exposures; DNA methylation; genes	DIFFERENTIAL DNA METHYLATION; MATERNAL SMOKING; TOBACCO-SMOKING; MICRONUTRIENT SUPPLEMENTATION; PRENATAL EXPOSURE; BUCCAL MUCOSA; EPIGENOME; NUTRITION; GENOME; CANCER	Exposure to environmental stressors, toxicants, and nutrient deficiencies can affect DNA in several ways. Some exposures cause damage and alter the structure of DNA, but there is increasing evidence that the same or other environmental exposures, including those that occur during fetal development in utero, can cause epigenetic effects that modulate DNA function and gene expression. Some epigenetic changes to DNA that affect gene transcription are at least partially reversible (i.e., they can be enzymatically reversed after cessation of exposure to environmental agents), but some epigenetic modifications seem to persist, even for decades. To explain the effects of early life experiences (such as famine and exposures to other stressors) on the long-term persistence of specific patterns of epigenetic modifications, such as DNA methylation, we propose an analogy with immune memory. We propose that an epigenetic memory can be established and maintained in self-renewing stem cell compartments. We suggest that the observations on early life effects on adult diseases and the persistence of methylation changes in smokers support our hypothesis, for which a mechanistic basis, however, needs to be further clarified. We outline a new model based on methylation changes. Although these changes seem to be mainly adaptive, they are also implicated in the pathogenesis and onset of diseases, depending on individual genotypic background and types of subsequent exposures. Elucidating the relationships between the adaptive and maladaptive consequences of the epigenetic modifications that result from complex environmental exposures is a major challenge for current and future research in epigenetics.	[Vineis, Paolo] Imperial Coll London, MRC, Publ Hlth England Ctr Environm & Hlth, London W2 1PG, England; [Flanagan, James M.] Imperial Coll London, Dept Surg & Canc, Epigenet Unit, London, England; [Chatziioannou, Aristotelis; Kyrtopoulos, Soterios] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece; [Cunliffe, Vincent T.] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England; [Hanson, Mark] Univ Southampton, Univ Hosp Southampton, Inst Dev Sci, Southampton, Hants, England; [Kirsch-Volders, Micheline] Vrije Univ Brussels, Lab Cell Genet, Brussels, Belgium	Imperial College London; Public Health England; Imperial College London; National Hellenic Research Foundation; University of Sheffield; University of Southampton; Vrije Universiteit Brussel	Vineis, P (corresponding author), Imperial Coll London, MRC, PHE Ctr Environm & Hlth, Norfolk Pl, London W21PG, England.	p.vineis@imperial.ac.uk	Kyrtopoulos, Soterios/AAI-6426-2020; Hanson, Mark/AAE-8236-2019	Hanson, Mark/0000-0002-6907-613X; Cunliffe, Vincent/0000-0001-7483-7610; Kyrtopoulos, Soterios/0000-0002-6821-6532; Flanagan, James/0000-0003-4955-1383	Enhanced Exposure Assessment and Omic Profiling for High Priority Environmental Exposures in Europe (EXPOSOMICS) - EC FP7 [308610]; European Union's Horizon 2020 Research and Innovation Programme [633666]; Cancer Research UK (CRUK) Centres; Experimental Cancer Medicine Centre (ECMC); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC); ESRC [ES/N000528/1] Funding Source: UKRI; British Heart Foundation [RG/15/17/31749] Funding Source: researchfish; Economic and Social Research Council [ES/N000528/1] Funding Source: researchfish	Enhanced Exposure Assessment and Omic Profiling for High Priority Environmental Exposures in Europe (EXPOSOMICS) - EC FP7; European Union's Horizon 2020 Research and Innovation Programme; Cancer Research UK (CRUK) Centres; Experimental Cancer Medicine Centre (ECMC); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Enhanced Exposure Assessment and Omic Profiling for High Priority Environmental Exposures in Europe (EXPOSOMICS) funded by EC FP7 Grant 308610, and by the European Union's Horizon 2020 Research and Innovation Programme (Grant 633666 to P.V.). The authors acknowledge support from Cancer Research UK (CRUK) Centres, the Experimental Cancer Medicine Centre (ECMC), and the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust, Imperial College London, and at University of Southampton. The authors declare no conflicts of interest.	Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Ambatipudi S, 2016, EPIGENOMICS-UK, V8, P599, DOI 10.2217/epi-2016-0001; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Anderson OS, 2012, ENVIRON MOL MUTAGEN, V53, P334, DOI 10.1002/em.21692; Basham KJ, 2014, BIOORG MED CHEM LETT, V24, P2473, DOI 10.1016/j.bmcl.2014.04.013; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bouwland-Both MI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0115-z; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Burdge GC, 2008, BRIT J NUTR, V99, P540, DOI 10.1017/S0007114507815819; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Cohn M, 2007, NAT REV IMMUNOL, V7, P823, DOI 10.1038/nri2177; Cooper WN, 2012, FASEB J, V26, P1782, DOI 10.1096/fj.11-192708; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Du Q, 2015, EPIGENOMICS-UK, V7, P1051, DOI 10.2217/epi.15.39; Dudley JT, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.66; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Fournier A, 2012, BRIEF FUNCT GENOMICS, V11, P251, DOI 10.1093/bfgp/elr040; Gabriel HE, 2006, AM J CLIN NUTR, V83, P835, DOI 10.1093/ajcn/83.4.835; Georgiadis P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20544; Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hoile SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021668; Holbrook JD, 2016, EPIGENOMICS-UK, V8, P741, DOI 10.2217/epi-2016-0023; Huang T, 2011, OMICS, V15, P665, DOI 10.1089/omi.2011.0034; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Joubert BR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10577; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Khulan B, 2012, HUM MOL GENET, V21, P2086, DOI 10.1093/hmg/dds026; Kim JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-30; Koutsandreas T., 2015, IEEE 15 INT C BIOINF, P1; Kuhnen P, 2016, CELL METAB, V24, P502, DOI 10.1016/j.cmet.2016.08.001; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Kupers LK, 2015, INT J EPIDEMIOL, V44, P1224, DOI 10.1093/ije/dyv048; Ladd-Acosta C, 2016, ENVIRON RES, V144, P139, DOI 10.1016/j.envres.2015.11.014; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Li GD, 2013, TRENDS IMMUNOL, V34, P460, DOI 10.1016/j.it.2013.03.006; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Ma J, 2015, TOXICOL APPL PHARM, V289, P193, DOI 10.1016/j.taap.2015.09.024; Ma YY, 2016, AM J CLIN NUTR, V103, P567, DOI 10.3945/ajcn.115.112987; Marco A, 2016, DIABETES, V65, P2258, DOI 10.2337/db15-1608; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Novakovic B, 2014, EPIGENETICS-US, V9, P377, DOI 10.4161/epi.27248; Panni T, 2016, ENVIRON HEALTH PERSP, V124, P983, DOI 10.1289/ehp.1509966; Papoutsis AJ, 2015, MOL CARCINOGEN, V54, P261, DOI 10.1002/mc.22095; Philibert RA, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-19; Reese SE, 2017, ENVIRON HEALTH PERSP, V125, P760, DOI 10.1289/EHP333; Richmond RC, 2015, HUM MOL GENET, V24, P2201, DOI 10.1093/hmg/ddu739; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sawarkar R, 2013, TRENDS CELL BIOL, V23, P193, DOI 10.1016/j.tcb.2012.11.007; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; Teschendorff AE, 2015, JAMA ONCOL, V1, P476, DOI 10.1001/jamaoncol.2015.1053; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wan ES, 2015, AM J RESP CELL MOL, V53, P246, DOI 10.1165/rcmb.2014-0103OC; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	69	42	44	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2241	2251		10.1096/fj.201601059RR	http://dx.doi.org/10.1096/fj.201601059RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28280003	Green Accepted			2022-12-26	WOS:000401553400003
J	van Haaften-Visser, DY; Harakalova, M; Mocholi, E; van Montfrans, JM; Elkadri, A; Rieter, E; Fiedler, K; van Hasselt, PM; Triffaux, EMM; van Haelst, MM; Nijman, IJ; Kloosterman, WP; Nieuwenhuis, EES; Muise, AM; Cuppen, E; Houwen, RHJ; Coffer, PJ				van Haaften-Visser, Desiree Y.; Harakalova, Magdalena; Mocholi, Enric; van Montfrans, Joris M.; Elkadri, Abdul; Rieter, Ester; Fiedler, Karoline; van Hasselt, Peter M.; Triffaux, Emily M. M.; van Haelst, Mieke M.; Nijman, Isaac J.; Kloosterman, Wigard P.; Nieuwenhuis, Edward E. S.; Muise, Aleixo M.; Cuppen, Edwin; Houwen, Roderick H. J.; Coffer, Paul J.			Ankyrin repeat and zinc-finger domain-containing 1 mutations are associated with infantile-onset inflammatory bowel disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL DYSFUNCTION; ULCERATIVE-COLITIS; CROHNS-DISEASE; MODIFIER GENES; PATHOGENESIS; PROTEIN; STABILIZATION; RECEPTOR; CELLS	Infantile-onset inflammatory bowel disease (IO IBD) is an invalidating illness with an onset before 2 years of age and has a complex pathophysiology in which genetic factors are important. Homozygosity mapping and whole-exome sequencing in an IO IBD patient and subsequent sequencing of the candidate gene in 12 additional IO IBD patients revealed two patients with two mutated ankyrin repeat and zinc-finger domain-containing 1 (ANKZF1) alleles (homozygous ANKZF1 R585Q mutation and compound heterozygous ANKZF1 E152K and V32_Q87del mutations, respectively) and two patients with one mutated ANKZF1 allele. Although the function of ANKZF1 in mammals had not been previously evaluated, we show that ANKZF1 has an indispensable role in the mitochondrial response to cellular stress. ANKZF1 is located diffusely in the cytoplasm and translocates to the mitochondria upon cellular stress. ANKZF1 depletion reduces mitochondrial integrity and mitochondrial respiration under conditions of cellular stress. The ANKZF1 mutations identified in IO IBD patients with two mutated ANKZF1 alleles result in dysfunctional ANKZF1, as shown by an increased level of apoptosis in patients' lymphocytes, a decrease in mitochondrial respiration in patient fibroblasts with a homozygous ANKZF1 R585Q mutation, and an inability of ANKZF1 R585Q and E152K to rescue the phenotype of yeast deficient in Vms1, the yeast homologue of ANKZF1. These data indicate that loss-of-function mutations in ANKZF1 result in deregulation of mitochondrial integrity, and this may play a pathogenic role in the development of IO IBD.	[van Haaften-Visser, Desiree Y.; van Montfrans, Joris M.; van Hasselt, Peter M.; Nieuwenhuis, Edward E. S.; Houwen, Roderick H. J.; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, NL-3584 CT Utrecht, Netherlands; [van Haaften-Visser, Desiree Y.; Mocholi, Enric; Rieter, Ester; Triffaux, Emily M. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Regenerat Med Ctr, Uppsalalaan 6, NL-3584 CT Utrecht, Netherlands; [van Haaften-Visser, Desiree Y.; Mocholi, Enric; Rieter, Ester; Triffaux, Emily M. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Ctr Mol Med, NL-3584 CT Utrecht, Netherlands; [Harakalova, Magdalena; van Haelst, Mieke M.; Nijman, Isaac J.; Kloosterman, Wigard P.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, NL-3584 CT Utrecht, Netherlands; [Elkadri, Abdul; Fiedler, Karoline; Muise, Aleixo M.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Elkadri, Abdul; Fiedler, Karoline; Muise, Aleixo M.] Hosp Sick Children, SickKids Inflammatory Bowel Dis Ctr, Toronto, ON M5G 1X8, Canada; [Elkadri, Abdul; Fiedler, Karoline; Muise, Aleixo M.] Hosp Sick Children, Res Inst, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Cuppen, Edwin] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Regenerat Med Ctr, Uppsalalaan 6, NL-3584 CT Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Coffer, Paul/AAF-7970-2020; Mocholi, Enric/ABH-5275-2020; Elkadri, Abdul/CAJ-1902-2022	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Mocholi Gimeno, Enric/0000-0002-6614-3173	Dutch Rheumatology Foundation (ReumaFonds) [2016-1-003]; Marie Curie Initial Training Network grant: European Translational tRaining for Autoimmunity and Immune manipulation Network (EU-TRAIN) [R2409]	Dutch Rheumatology Foundation (ReumaFonds); Marie Curie Initial Training Network grant: European Translational tRaining for Autoimmunity and Immune manipulation Network (EU-TRAIN)	Supported by Dutch Rheumatology Foundation (ReumaFonds) Grant 2016-1-003.r Supported by a Marie Curie Initial Training Network grant: European Translational tRaining for Autoimmunity and Immune manipulation Network (EU-TRAIN) Grant R2409.	Adolph TE, 2012, DIGEST DIS, V30, P341, DOI 10.1159/000338121; Avitzur Y, 2014, GASTROENTEROLOGY, V146, P1028, DOI 10.1053/j.gastro.2014.01.015; Beltran B, 2010, INFLAMM BOWEL DIS, V16, P76, DOI 10.1002/ibd.21027; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, CURR OPIN GASTROEN, V26, P318, DOI 10.1097/MOG.0b013e32833a9ff1; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nazli A, 2004, AM J PATHOL, V164, P947, DOI 10.1016/S0002-9440(10)63182-3; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Paul T, 2006, J CLIN GASTROENTEROL, V40, P583, DOI 10.1097/00004836-200608000-00004; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Restivo NL, 2004, J PEDIATR GASTR NUTR, V38, P534, DOI 10.1097/00005176-200405000-00014; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santhanam S, 2012, INFLAMM BOWEL DIS, V18, P2158, DOI 10.1002/ibd.22926; Sifroni KG, 2010, MOL CELL BIOCHEM, V342, P111, DOI 10.1007/s11010-010-0474-x; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yano M, 1997, J BIOL CHEM, V272, P8459, DOI 10.1074/jbc.272.13.8459; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	35	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7904	7920		10.1074/jbc.M116.772038	http://dx.doi.org/10.1074/jbc.M116.772038			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302725	Green Published, hybrid			2022-12-26	WOS:000401154100018
J	Malonis, RJ; Fu, WX; Jelcic, MJ; Thompson, M; Canter, BS; Tsikitis, M; Esteva, FJ; Sanchez, I				Malonis, Ryan J.; Fu, Wenxiang; Jelcic, Mark J.; Thompson, Marae; Canter, Brian S.; Tsikitis, Mary; Esteva, Francisco J.; Sanchez, Irma			RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; E3 ubiquitin ligase; endosome; transforming growth factor beta (TGF-B); ubiquitylation (ubiquitination)	FINGER PROTEIN 11; TGF-BETA RECEPTOR; UBIQUITIN LIGASE; BREAST-CANCER; I RECEPTOR; DOMAIN; DEGRADATION; METASTASIS; INTERACTS; PATHWAYS	The activity of the E3 ligase, SMURF2, is antagonized by an intramolecular, autoinhibitory interaction between its C2 and Hect domains. Relief of SMURF2 autoinhibition is induced by TGF and is mediated by the inhibitory SMAD, SMAD7. In a proteomic screen for endomembrane interactants of the RING-domain E3 ligase, RNF11, we identified SMURF2, among a cohort of Hect E3 ligases previously implicated in TGF signaling. Reconstitution of the SMURF2<bold>RNF</bold>11 complex in vitro unexpectedly revealed robust SMURF2 E3 ligase activity, with biochemical properties previously restricted to the SMURF2<bold>SMAD</bold>7 complex. Using in vitro binding assays, we find that RNF11 can directly compete with SMAD7 for SMURF2 and that binding is mutually exclusive and dependent on a proline-rich domain. Moreover, we found that co-expression of RNF11 and SMURF2 dramatically reduced SMURF2 ubiquitylation in the cell. This effect is strictly dependent on complex formation and sorting determinants that regulate the association of RNF11 with membranes. RNF11 is overexpressed in certain tumors, and, importantly, we found that depletion of this protein down-regulated gene expression of several TGF-responsive genes, dampened cell proliferation, and dramatically reduced cell migration in response to TGF. Our data suggest for the first time that the choice of binding partners for SMURF2 can sustain or repress TGF signaling, and RNF11 may promote TGF-induced cell migration.	[Malonis, Ryan J.; Fu, Wenxiang; Jelcic, Mark J.; Thompson, Marae; Canter, Brian S.; Tsikitis, Mary; Esteva, Francisco J.; Sanchez, Irma] NYU Langone, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Malonis, Ryan J.] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Fu, Wenxiang] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Jelcic, Mark J.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Canter, Brian S.] Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Tsikitis, Mary] Acad Athens, Div Cell Biol, Athens 11527, Greece	NYU Langone Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Basel; Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Academy of Athens	Sanchez, I (corresponding author), NYU Langone, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.	Irma.Sanchez@nyumc.org		Esteva, Francisco J./0000-0003-2437-3920; Canter, Brian/0000-0002-4496-3293	Center to Reduce Cancer Health Disparities (CRCHD) of NCI, National Institutes of Health [R21CA153179, R21CA15317902-S1, R21CA15317902-S2]; Department of Pathology at the NYU School of Medicine; NATIONAL CANCER INSTITUTE [R21CA153179] Funding Source: NIH RePORTER	Center to Reduce Cancer Health Disparities (CRCHD) of NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology at the NYU School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Center to Reduce Cancer Health Disparities (CRCHD) of NCI, National Institutes of Health, Grants R21CA153179, R21CA15317902-S1, and R21CA15317902-S2 (to I. S.) and bridging funds from the Department of Pathology at the NYU School of Medicine. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Anderson L. B., 2007, THESIS; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Duffy MJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0428-4; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fu WX, 2016, CELL REP, V17, P1505, DOI 10.1016/j.celrep.2016.10.018; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kitching R, 2003, BBA-MOL BASIS DIS, V1639, P104, DOI 10.1016/j.bbadis.2003.07.001; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kostaras E, 2013, ONCOGENE, V32, P5220, DOI 10.1038/onc.2012.554; Krstic J, 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/521754; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lallemand F, 2005, J BIOL CHEM, V280, P27645, DOI 10.1074/jbc.M500188200; Mazzoccoli G, 2012, J CANCER RES CLIN, V138, P501, DOI 10.1007/s00432-011-1126-6; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Santonico E, 2015, ONCOGENE, V34, P3377, DOI 10.1038/onc.2014.256; Santonico E, 2010, ONCOGENE, V29, P5604, DOI 10.1038/onc.2010.294; Seki N, 1999, BBA-GENE STRUCT EXPR, V1489, P421, DOI 10.1016/S0167-4781(99)00190-6; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Subramaniam V, 2003, BRIT J CANCER, V89, P1538, DOI 10.1038/sj.bjc.6601301; Wang L, 2015, AM J TRANSL RES, V7, P1629; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050	31	20	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7435	7451		10.1074/jbc.M117.783662	http://dx.doi.org/10.1074/jbc.M117.783662			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28292929	Green Published, hybrid			2022-12-26	WOS:000400761300014
J	Chao, JY; Zhang, YM; Kong, M; Zhuang, W; Wang, LM; Shao, KQ; Gao, G				Chao, Jian-Ying; Zhang, Yi-Min; Kong, Ming; Zhuang, Wei; Wang, Long-Mian; Shao, Ke-Qiang; Gao, Guang			Long-term moderate wind induced sediment resuspension meeting phosphorus demand of phytoplankton in the large shallow eutrophic Lake Taihu	PLOS ONE			English	Article								The objective of this study was to investigate the impact of sediment resuspension and phosphorus (P) release on phytoplankton growth under different kinds of wind-wave disturbance conditions in the large and shallow eutrophic Lake Taihu in China. Short-term strong wind (STSW) conditions, long-term moderate wind (LTMW) conditions, and static/calm conditions were investigated. To address this objective, we (1) monitored changes in surface water P composition during field-based sediment resuspension caused by STSW conditions in Lake Taihu, and also conducted (2) a series of laboratory-based sediment resuspension experiments to simulate LTMW and calm conditions. The results showed that under both strong and moderate wind-wave conditions, suspended solids (SS) and total phosphorus (TP) in the water column increased significantly, but total dissolved phosphorus (TDP) and soluble reactive phosphorus (SRP) remained low throughout the experiments, indicating that the P released from sediments mainly existed in particulate forms. In STSW conditions, alkaline phosphatase activity (APA) and enzymatically hydrolysable phosphorus (EHP) increased rapidly, with the peak value occurring following the peak value of wind speed for 1-2 days, and then rapidly decreased after the wind stopped. Under LTMW conditions, APA and EHP increased steadily, and by the end of the laboratory experiments, APA increased by 11 times and EHP increased by 5 times. Chlorophyll a (Chl-a) in LTMW conditions increased significantly, but remained low under STSW conditions, demonstrating that the former type of sediment P release promoted phytoplankton growth more effectively, and the latter type did not. Despite the fact that STSW conditions resulted in the release of more TP, TP settled to the bottom rapidly with SS after the wind stopped, and did not promote algal growth. Under LTMW conditions, suspended particulate P was hydrolyzed to SRP by phosphatase and promoted algae growth. Algal growth in turn secreted more phosphatase and accelerated particulate P regeneration, which may be the main mechanism of sediment bioavailable P release that promotes phytoplankton growth in shallow lakes.	[Chao, Jian-Ying; Shao, Ke-Qiang; Gao, Guang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Chao, Jian-Ying; Zhang, Yi-Min; Kong, Ming; Zhuang, Wei; Wang, Long-Mian] Nanjing Inst Environm Sci, Minist Environm Protect, Nanjing, Jiangsu, Peoples R China; [Chao, Jian-Ying] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, G (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	guanggao@niglas.ac.cn	Wang, Longmian/AAR-3970-2021		Chinese National Science Foundation [41301556]; Water Pollution Control and Management of Major Projects committee of China [2014ZX07101-011, JC.2012ZX07101-007]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Water Pollution Control and Management of Major Projects committee of China	This work was supported by 1) Chinese National Science Foundation, URL: http://www.nsfc.gov.cn/, grant numbers: 41301556, JC; 2) The Water Pollution Control and Management of Major Projects committee of China, URL:http://nwpcp.mep.gov.cn/, grant number: 2014ZX07101-011, JC; and 3) The Water Pollution Control and Management of Major Projects committee of China, URL: http://nwpcp.mep.gov.cn/, grant number: JC.2012ZX07101-007, YZ.	ANDERSEN JM, 1976, WATER RES, V10, P329, DOI 10.1016/0043-1354(76)90175-5; Aubriot L, 2012, AQUAT MICROB ECOL, V67, P251, DOI 10.3354/ame01596; Bai X, 2009, ENVIRON POLLUT, V8-9, P2507; BOON PI, 1989, ARCH HYDROBIOL, V115, P339; Burkhardt BG, 2014, MAR CHEM, V163, P1, DOI 10.1016/j.marchem.2014.03.007; CHROST RJ, 1986, LIMNOL OCEANOGR, V31, P662, DOI 10.4319/lo.1986.31.3.0662; Couceiro F, 2013, BIOGEOCHEMISTRY, V113, P37, DOI 10.1007/s10533-012-9710-7; EBINA J, 1983, WATER RES, V17, P1721, DOI 10.1016/0043-1354(83)90192-6; EVANS RD, 1994, HYDROBIOLOGIA, V284, P5, DOI 10.1007/BF00005727; Gao L, 2012, PROCEDIA ENV SCI, P2077; Graneli W, 1999, HYDROBIOLOGIA, V404, P19, DOI 10.1023/A:1003705520085; Huang JY, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0317-2; Hudson JJ, 1999, NATURE, V400, P659, DOI 10.1038/23240; JENSEN HS, 1992, HYDROBIOLOGIA, V235, P731, DOI 10.1007/BF00026261; Jiang X, 2008, WATER RES, V42, P2251, DOI 10.1016/j.watres.2007.12.003; Kang YH, 2013, HYDROBIOLOGIA, V710, P117, DOI 10.1007/s10750-012-1221-y; Li DP, 2011, CHEM ENG J, V168, P1049, DOI 10.1016/j.cej.2011.01.082; Linge KL, 2004, APPL GEOCHEM, V19, P1377, DOI 10.1016/j.apgeochem.2003.12.009; Matisoff G, 2014, J GREAT LAKES RES, V40, P532, DOI 10.1016/j.jglr.2014.02.001; Morgan B, 2012, SCI TOTAL ENVIRON, V432, P47, DOI 10.1016/j.scitotenv.2012.05.065; MORTIMER CH, 1971, LIMNOL OCEANOGR, V16, P387, DOI 10.4319/lo.1971.16.2.0387; Papista E, 2002, HYDROBIOLOGIA, V485, P191, DOI 10.1023/A:1021329602685; Puttonen I, 2014, ESTUARINE COASTAL SH, P9; Qian J, 2011, J HYDRODYN, V23, P826, DOI 10.1016/S1001-6058(10)60182-5; Qin B, 2006, SCI CHINA, V1, P38; Qin B, 2008, CHINA DYNAMICS ENV C; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Rice E.W., 2012, STANDARD METHODS EXA; Sannigrahi P, 2006, GEOCHIM COSMOCHIM AC, V70, P5868, DOI 10.1016/j.gca.2006.08.037; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Shinohara R, 2012, ENVIRON SCI TECHNOL, V46, P10572, DOI 10.1021/es301887z; Shinohara R, 2012, MAR FRESHWATER RES, V63, P119, DOI 10.1071/MF11182; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Stahlberg C, 2006, ESTUARINE COASTAL SH, V1-2, P317; Stuart G, 1984, DEEP-SEA RES PT 1, V5, P509; Sun XJ, 2006, SCI CHINA SER D, V49, P92, DOI 10.1007/s11430-006-8109-5; Tammeorg O, 2013, AQUAT SCI, V75, P559, DOI 10.1007/s00027-013-0300-0; Wang J, 2015, ENVIRON SCI POLLUT R, P10471; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wu D, 2014, ECOL ENG, V69, P55, DOI 10.1016/j.ecoleng.2014.03.059; Wu QLL, 2007, HYDROBIOLOGIA, V581, P241, DOI 10.1007/s10750-006-0500-x; Xie P, 2006, SCI CHINA SER D, V49, P14, DOI 10.1007/s11430-006-8102-z; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; You BS, 2007, J ENVIRON SCI, V9, P1055; Zhang R, 2008, ENVIRON POLLUT, V2, P366; Zhang T, 2007, ENVIRON POLLUT, P288; Zheng SS, 2015, INT J SEDIMENT RES, V30, P48, DOI 10.1016/S1001-6279(15)60005-1; Zhu GW, 2007, HYDROBIOLOGIA, V581, P53, DOI 10.1007/s10750-006-0519-z; Zhu GW, 2005, CHINESE SCI BULL, V50, P577, DOI 10.1360/04wd0083; Zhu YR, 2013, ENVIRON SCI TECHNOL, V47, P7679, DOI 10.1021/es305277g	50	18	20	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173477	10.1371/journal.pone.0173477	http://dx.doi.org/10.1371/journal.pone.0173477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301502	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300044
J	Vasina, DV; Moiseenko, KV; Fedorova, TV; Tyazhelova, TV				Vasina, Daria V.; Moiseenko, Konstantin V.; Fedorova, Tatiana V.; Tyazhelova, Tatiana V.			Lignin-degrading peroxidases in white-rot fungus Trametes hirsuta 072. Absolute expression quantification of full multigene family	PLOS ONE			English	Article							DROPLET DIGITAL PCR; DNA COPY NUMBER; MANGANESE PEROXIDASE; PLEUROTUS-OSTREATUS; GENE-EXPRESSION; PHANEROCHAETE-CHRYSOSPORIUM; DIFFERENTIAL REGULATION; SULFONPHTHALEIN DYES; MOLECULAR-STRUCTURE; CORIOLUS-HIRSUTUS	Ligninolytic heme peroxidases comprise an extensive family of enzymes, which production is characteristic for white-rot Basidiomycota. The majority of fungal heme peroxidases are encoded by multigene families that differentially express closely related proteins. Currently, there were very few attempts to characterize the complete multigene family of heme peroxidases in a single fungus. Here we are focusing on identification and characterization of peroxidase genes, which are transcribed and secreted by basidiomycete Trametes hirsuta 072, an efficient lignin degrader. The T. hirsuta genome contains 18 ligninolytic peroxidase genes encoding 9 putative lignin peroxidases (LiP), 7 putative short manganese peroxidases (MnP) and 2 putative versatile peroxidases (VP). Using ddPCR method we have quantified the absolute expression of the 18 peroxidase genes under different culture conditions and on different growth stages of basidiomycete. It was shown that only two genes (one MnP and one VP) were prevalently expressed as well as secreted into cultural broth under all conditions investigated. However their transcriptome and protein profiles differed in time depending on the effector used. The expression of other peroxidase genes revealed a significant variability, so one can propose the specific roles of these enzymes in fungal development and lifestyle.	[Vasina, Daria V.; Moiseenko, Konstantin V.; Fedorova, Tatiana V.; Tyazhelova, Tatiana V.] Russian Acad Sci, Biotechnol Res Ctr, AN Bach Inst Biochem, 33,bld. 2 Leninsky Ave, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Moiseenko, KV (corresponding author), Russian Acad Sci, Biotechnol Res Ctr, AN Bach Inst Biochem, 33,bld. 2 Leninsky Ave, Moscow, Russia.	mr.moiseenko@gmail.com	Moiseenko, Konstantin V/F-9802-2015; Vasina, Daria V/R-4644-2016	Vasina, Daria V/0000-0003-1965-0700	Russian Science Foundation [14-14-00620]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation, project no. 14-14-00620. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro M, 2014, J PROTEOMICS, V102, P28, DOI 10.1016/j.jprot.2014.03.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAO WL, 1994, FEBS LETT, V354, P297, DOI 10.1016/0014-5793(94)01146-X; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; Brzonova I, 2014, BIORESOURCE TECHNOL, V173, P352, DOI 10.1016/j.biortech.2014.09.057; Castanera R, 2015, APPL ENVIRON MICROB, V81, P4120, DOI 10.1128/AEM.00402-15; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Christian VV, 2003, FOLIA MICROBIOL, V48, P771, DOI 10.1007/BF02931512; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dreo T, 2014, ANAL BIOANAL CHEM, V406, P6513, DOI 10.1007/s00216-014-8084-1; Fedorova TV, 2013, APPL BIOCHEM MICRO+, V49, P570, DOI 10.1134/S0003683813060082; Fernandez-Fueyo E, 2014, FUNGAL GENET BIOL, V72, P150, DOI 10.1016/j.fgb.2014.02.003; Fernandez-Fueyo E, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-114; Fernandez-Fueyo E, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-2; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giardina P, 2000, ARCH BIOCHEM BIOPHYS, V376, P171, DOI 10.1006/abbi.1999.1691; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hilden L, 2000, FEBS LETT, V477, P79, DOI 10.1016/S0014-5793(00)01757-9; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Hollox EJ, 2014, HUM GENET, V133, P1217, DOI 10.1007/s00439-014-1457-x; Janusz G, 2013, ENZYME MICROB TECH, V52, P1, DOI 10.1016/j.enzmictec.2012.10.003; Kapich AN, 1999, FEBS LETT, V461, P115, DOI 10.1016/S0014-5793(99)01432-5; Kim TG, 2014, APPL MICROBIOL BIOT, V98, P6105, DOI 10.1007/s00253-014-5794-4; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Koroleva OV, 2002, J BIOSCI BIOENG, V93, P449, DOI 10.1263/jbb.93.449; Koroljova-Skorobogat'ko OV, 1998, BIOTECHNOL APPL BIOC, V28, P47; Korripally P, 2015, APPL ENVIRON MICROB, V81, P7802, DOI 10.1128/AEM.02064-15; Kues U, 2015, CURR OPIN BIOTECH, V33, P268, DOI 10.1016/j.copbio.2015.03.006; Kulikova NA, 2011, APPL BIOCHEM MICRO+, V47, P565, DOI 10.1134/S000368381106007X; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Manubens A, 2003, CURR GENET, V43, P433, DOI 10.1007/s00294-003-0410-7; Miki Y, 2006, J FAC AGR KYUSHU U, V51, P99; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Passardi F, 2007, PHYTOCHEMISTRY, V68, P1605, DOI 10.1016/j.phytochem.2007.04.005; Pavlov AR, 2015, GENOME ANNOUNC, V3; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Raffaello T, 2014, ENVIRON MICROBIOL, V16, P1654, DOI 10.1111/1462-2920.12321; Ruiz-Duenas FJ, 2013, MYCOLOGIA, V105, P1428, DOI 10.3852/13-059; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Sedlak RH, 2014, J CLIN MICROBIOL, V52, P2844, DOI 10.1128/JCM.00803-14; Shrivastava R, 2005, ENZYME MICROB TECH, V36, P333, DOI 10.1016/j.enzmictec.2004.09.004; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Steffen KT, 2002, APPL ENVIRON MICROB, V68, P3442, DOI 10.1128/AEM.68.7.3442-3448.2002; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vasina DV, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0729-0; Vasina DV, 2015, BIOCHIMIE, V116, P154, DOI 10.1016/j.biochi.2015.07.015; Vincent ME, 2010, CHEM SOC REV, V39, P974, DOI 10.1039/b917851a; Yakovlev IA, 2013, FUNGAL GENET BIOL, V56, P17, DOI 10.1016/j.fgb.2013.04.011; Yang RC, 2014, INT J PARASITOL, V44, P1105, DOI 10.1016/j.ijpara.2014.08.004; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhu H, 2009, APPL BIOCHEM BIOTECH, V152, P366, DOI 10.1007/s12010-008-8236-x; Zmienko A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118226	60	18	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173813	10.1371/journal.pone.0173813	http://dx.doi.org/10.1371/journal.pone.0173813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301519	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300076
J	Bu, DP; Bionaz, M; Wang, MZ; Nan, XM; Ma, L; Wang, JQ				Bu, Dengpan; Bionaz, Massimo; Wang, Mengzhi; Nan, Xuemei; Ma, Lu; Wang, Jiaqi			Transcriptome difference and potential crosstalk between liver and mammary tissue in mid-lactation primiparous dairy cows	PLOS ONE			English	Article							GROWTH-FACTOR; GENE-EXPRESSION; MICRORNA EXPRESSION; MILK-PRODUCTION; GLAND; LACTATION; RUMINANT; METABOLISM; INSULIN; CATTLE	Liver and mammary gland are among the most important organs during lactation in dairy cows. With the purpose of understanding both the different and the complementary roles and the crosstalk of those two organs during lactation, a transcriptome analysis was performed on liver and mammary tissues of 10 primiparous dairy cows in mid-lactation. The analysis was performed using a 4x44K Bovine Agilent microarray chip. The transcriptome difference between the two tissues was analyzed using SAS JMP Genomics using ANOVA with a false discovery rate correction (FDR). The analysis uncovered >9,000 genes differentially expressed (DEG) between the two tissues with a FDR<0.001. The functional analysis of the DEG uncovered a larger metabolic (especially related to lipid) and inflammatory response capacity in liver compared with mammary tissue while the mammary tissue had a larger protein synthesis and secretion, proliferation/differentiation, signaling, and innate immune system capacity compared with the liver. A plethora of endogenous compounds, cytokines, and transcription factors were estimated to control the DEG between the two tissues. Compared with mammary tissue, the liver transcriptome appeared to be under control of a large array of ligand-dependent nuclear receptors and, among endogenous chemical, fatty acids and bacteria-derived compounds. Compared with liver, the transcriptome of the mammary tissue was potentially under control of a large number of growth factors and miRNA. The in silico crosstalk analysis between the two tissues revealed an overall large communication with a reciprocal control of lipid metabolism, innate immune system adaptation, and proliferation/differentiation. In summary the transcriptome analysis confirmed prior known differences between liver and mammary tissue, especially considering the indication of a larger metabolic activity in liver compared with the mammary tissue and the larger protein synthesis, communication, and proliferative capacity in mammary tissue compared with the liver. Relatively novel is the indication by the data that the transcriptome of the liver is highly regulated by dietary and bacteria-related compounds while the mammary transcriptome is more under control of hormones, growth factors, and miRNA. A large crosstalk between the two tissues with a reciprocal control of metabolism and innate immune-adaptation was indicated by the network analysis that allowed uncovering previously unknown crosstalk between liver and mammary tissue for several signaling molecules.	[Bu, Dengpan; Nan, Xuemei; Ma, Lu; Wang, Jiaqi] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China; [Bu, Dengpan] World Agroforestry Ctr, CAAS ICRAF Joint Lab Agroforestry & Sustainable A, Beijing, Peoples R China; [Bu, Dengpan] Synerget Innovat Ctr Food Safety & Nutr, Harbin, Peoples R China; [Bionaz, Massimo] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Wang, Mengzhi] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Chinese Academy of Agricultural Sciences; Oregon State University; Yangzhou University	Wang, JQ (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China.; Bionaz, M (corresponding author), Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA.	massimo.bionaz@oregonstate.edu; wang-jia-qi@263.net	Bionaz, Massimo/I-4222-2018	Bionaz, Massimo/0000-0002-0674-1892	"Natural Science Foundation of China [31372341]; Ministry of Science and Technology of China [2012BAD12B02-5]; Agriculture Science and Technology Innovation Program [ASTIP-IAS07]; USDA NEFA Multistate Project [NE-1048]	"Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Agriculture Science and Technology Innovation Program; USDA NEFA Multistate Project	This research was supported by the "Natural Science Foundation of China (31372341), the Ministry of Science and Technology of China (2012BAD12B02-5), the Agriculture Science and Technology Innovation Program (ASTIP-IAS07), and the USDA NEFA Multistate Project (NE-1048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers RM, 2006, J DAIRY SCI, V89, P1222, DOI 10.3168/jds.S0022-0302(06)72191-9; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Basham KJ, 2015, TOXICOL SCI, V143, P36, DOI 10.1093/toxsci/kfu203; Bauman DE, 2006, J DAIRY SCI, V89, P1235, DOI 10.3168/jds.S0022-0302(06)72192-0; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGMAN EN, 1974, FED PROC, V33, P1849; BERNAERT D, 1977, J CELL BIOL, V74, P878, DOI 10.1083/jcb.74.3.878; Bian YJ, 2015, J CELL PHYSIOL, V230, P2152, DOI 10.1002/jcp.24944; Bionaz M, 2015, J ANIM SCI; Bionaz M, 2013, PPAR RES, V2013, DOI DOI 10.1155/2013/684159; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2012, MILK PROTEIN, P285, DOI 10.5772/46054; Bionaz M, 2012, GENE REGUL SYST BIO, V6, P109, DOI 10.4137/GRSB.S9852; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032455; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; Bloise E, 2010, J DAIRY SCI, V93, P4592, DOI 10.3168/jds.jds.2009-2981; Burgos SA, 2010, DOMEST ANIM ENDOCRIN, V38, P211, DOI 10.1016/j.domaniend.2009.10.005; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Edgerton DS, 2009, DIABETES, V58, P2766, DOI 10.2337/db09-0328; Gotze A, 2010, J DAIRY SCI, V93, P38, DOI 10.3168/jds.2008-1781; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Han RW, 2014, ARCH ANIM NUTR, V68, P63, DOI 10.1080/1745039X.2013.869986; Hou ZH, 2014, LIVER INT, V34, P58, DOI 10.1111/liv.12244; Hu M, 2014, CELL CYCLE, V13, P2349, DOI 10.4161/cc.29298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUGHES JP, 1962, AM J VET RES, V23, P1111; INGLE DL, 1972, J NUTR, V102, P617, DOI 10.1093/jn/102.5.617; INGLE DL, 1972, J NUTR, V102, P609, DOI 10.1093/jn/102.5.609; Ito S, 2003, ADV DRUG DELIVER REV, V55, P653, DOI 10.1016/S0169-409X(03)00031-0; Jabed A, 2012, P NATL ACAD SCI USA, V109, P16811, DOI 10.1073/pnas.1210057109; Jiang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-443; Jiang SM, 2015, J HEPATOL, V62, P371, DOI 10.1016/j.jhep.2014.09.026; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Ju YF, 2012, ENDOCRINOLOGY, V153, P5522, DOI 10.1210/en.2012-1334; Kim KH, 2014, CANCER GENET-NY, V207, P365, DOI 10.1016/j.cancergen.2014.04.004; Kuhn C, 1999, ANIM GENET, V30, P333, DOI 10.1046/j.1365-2052.1999.00487.x; Lametsch R, 2000, J BIOL CHEM, V275, P19469, DOI 10.1074/jbc.M002550200; Le Provost F, 2003, GENE, V313, P83, DOI 10.1016/S0378-1119(03)00632-2; Lecchi C, 2015, VET J, V203, P296, DOI 10.1016/j.tvjl.2015.01.009; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Loor JJ, 2013, ANNU REV ANIM BIOSCI, V1, P365, DOI 10.1146/annurev-animal-031412-103728; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Minuti A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12388; Moyes KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157480; MUNDAY MR, 1987, BIOCHEM J, V242, P905, DOI 10.1042/bj2420905; Mysickova A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S2; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Piantoni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-331; Rawson P, 2012, J PROTEOMICS, V75, P4429, DOI 10.1016/j.jprot.2012.04.019; REYNOLDS CK, 1992, J NUTR, V122, P850, DOI 10.1093/jn/122.suppl_3.850; Rodriguez-Ortigosa CM, 2014, GASTROENTEROLOGY, V147, P1084, DOI 10.1053/j.gastro.2014.07.030; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Samdani P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12340; Schingoethe DJ, 1988, RUMINANT ANIMAL DIGE, P421; Sciascia Q, 2013, J DAIRY SCI, V96, P2327, DOI 10.3168/jds.2012-6267; Serra Rosa, 2003, Breast Dis, V18, P61; Sood AK, 2009, CANCER EPIDEM BIOMAR, V18, P1899, DOI 10.1158/1055-9965.EPI-09-0055; Sulman FG, 1970, HYPOTHALAMIC CONTROL, Vxii, P235; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Sureshbabu A, 2011, INT J DEV BIOL, V55, P781, DOI 10.1387/ijdb.113364as; Tanioka N, 2014, BIOMED REP, V2, P359, DOI 10.3892/br.2014.235; Trevisi E, 2011, ACUTE PHASE PROTEINS AS EARLY NON-SPECIFIC BIOMARKERS OF HUMAN AND VETERINARY DISEASES, P355; Tucker HA, 2000, J DAIRY SCI, V83, P874, DOI 10.3168/jds.S0022-0302(00)74951-4; Veitia Reiner A, 2000, GENOME BIOL, V2; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Wang W, 2008, J CELL PHYSIOL, V214, P38, DOI 10.1002/jcp.21159; Wang YF, 2010, BIOTECHNOL LETT, V32, P1789, DOI 10.1007/s10529-010-0359-9	71	13	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173082	10.1371/journal.pone.0173082	http://dx.doi.org/10.1371/journal.pone.0173082			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291785	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700010
J	Aas, A; Isakson, P; Bindesboll, C; Alemu, EA; Klungland, A; Simonsen, A				Aas, Aleksander; Isakson, Pauline; Bindesboll, Christian; Alemu, Endalkachew A.; Klungland, Arne; Simonsen, Anne			Nucleocytoplasmic Shuttling of FTO Does Not Affect Starvation-Induced Autophagy	PLOS ONE			English	Article							FAT MASS; OBESITY; GENE; RNA; EXPRESSION; CHILDHOOD; SUBSTRATE; VARIANTS	Polymorphic variants of the FTO (fat mass and obesity) gene associate with body mass index in humans, but the underlying molecular mechanisms have not been firmly determined. FTO is linked to energy homeostasis via amino acid sensing and is thought to activate the mammalian target of rapamycin complex 1, a negative regulator of autophagy. FTO localises both to the nucleus and the cytoplasm, and in this study we identify a functional nuclear localisation signal (NLS) in the N-terminus of FTO, as well as nuclear localization information in its very C-terminus. Inhibition of FTO nuclear transport has no effect on autophagy and in contrast to a previously proposed role of FTO in autophagy, we find no difference in starvation-induced autophagy in control cells compared to a panel of cell types depleted of FTO. Future studies that further characterise the cellular functions of FTO will be important to understand why variants in FTO are associated with body weight.	[Aas, Aleksander; Isakson, Pauline; Bindesboll, Christian; Simonsen, Anne] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Alemu, Endalkachew A.; Klungland, Arne] Natl Hosp Norway, Oslo Univ Hosp, Dept Mol Microbiol, A3-3021,Sognsvannsveien 20, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Simonsen, A (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway.	anne.simonsen@medisin.uio.no	Klungland, Arne/X-1233-2019	Klungland, Arne/0000-0001-7274-3661	Medical Faculty, University of Oslo; Research Council of Norway; Norwegian Cancer Society; European Union Seventh Framework Programme (FP7-PEOPLE-COFUND) [609020]	Medical Faculty, University of Oslo; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); European Union Seventh Framework Programme (FP7-PEOPLE-COFUND)	This research was supported by the MD PhD program of the Medical Faculty, University of Oslo(AA), the Research Council of Norway (AS, CB), the Norwegian Cancer Society(AS, PI) and the European Union Seventh Framework Programme (EA,AK) (FP7-PEOPLE-2013-COFUND) under grant agreement no 609020 - Scientia Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the MD PhD program of the Medical Faculty, University of Oslo (AA), the Research Council of Norway (AS,CB), the Norwegian Cancer Society (AS,PI) and the European Union Seventh Framework Programme (EA,AK)(FP7-PEOPLE-2013COFUND) under grant agreement no 609020-Scientia Fellows. The authors declare no competing financial interests.	Berulava T, 2013, EUR J HUM GENET, V21, P317, DOI 10.1038/ejhg.2012.168; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cheung MK, 2012, INT J OBESITY, P1; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Hernandez-Caballero ME, 2015, MOL BIOL REP, V42, P699, DOI 10.1007/s11033-014-3817-y; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2014, BIOSCIENCE REP, V34, P621, DOI 10.1042/BSR20140111; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Tews D, 2013, ENDOCRINOLOGY, V154, P3141, DOI 10.1210/en.2012-1873; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wu Q, 2010, BIOCHEM BIOPH RES CO, V401, P390, DOI 10.1016/j.bbrc.2010.09.064; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0168182	10.1371/journal.pone.0168182	http://dx.doi.org/10.1371/journal.pone.0168182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288181	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400001
J	Hernandez-Mir, G; McGeachy, MJ				Hernandez-Mir, Gerard; McGeachy, Mandy J.			CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis	PLOS ONE			English	Article							REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; CYTOKINE GM-CSF; TGF-BETA; CUTTING EDGE; T(H)17 CELLS; IN-VIVO; NEUROINFLAMMATION; ADENOSINE; CD39	CD73 works together with CD39 to convert extracellular ATP to immunoregulatory adenosine, thus inhibiting inflammation. TGF beta-mediated CD73 expression on 'regulatory' Th17 cells limits their ability to eradicate tumors, similar to the immunosuppressive mechanism described for CD73 on Tregs. However, CD73 is also expressed on Th17 cells thought to be inflammatory in Crohn's disease. CD73 has previously been reported to contribute to inflammation in the central nervous system (CNS). In experimental autoimmune encephalomyelitis (EAE), we found that inflammatory cytokine-producing Th17 cells showed increased CD73 expression as disease progressed. We therefore hypothesized that CD73 could be important for limiting the expansion or pathogenic function of Th17 cells in autoimmune inflammation of the CNS. Surprisingly, EAE development was not enhanced or inhibited by CD73 deficiency; there was correspondingly no difference in induction of Th17-associated cytokines IL-17, IFN gamma or GM-CSF or recruitment of either inflammatory or regulatory cells to the central nervous system. We confirmed that CD73 was similarly not required for differentiation of Th17 cells in vitro. These data show that while CD73 expression is regulated during EAE, this enzyme is not absolutely required to either promote or limit Th17 cell expansion or EAE severity.	[Hernandez-Mir, Gerard; McGeachy, Mandy J.] Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McGeachy, MJ (corresponding author), Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA.	mandymcgeachy@pitt.edu	Hernández Mir, Gerard/AAH-1971-2022; Hernández Mir, Gerard/AEP-4408-2022	Hernández Mir, Gerard/0000-0002-8934-4875; Hernández Mir, Gerard/0000-0002-8934-4875	NIH [AI110822]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI110822, R01AI110822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH AI110822 (to MJM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study provided by NIH AI110822 (to MJM). Thanks to Sarah Gaffen and Partha Biswas for helpful comments and suggestions.	Alam MS, 2009, J INFECT DIS, V199, P494, DOI 10.1086/596205; Antonioli L, 2016, TRENDS CANCER, V2, P95, DOI 10.1016/j.trecan.2016.01.003; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chatterjee S, 2014, CANCER RES, V74, P6048, DOI 10.1158/0008-5472.CAN-14-1450; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Doherty GA, 2012, EUR J IMMUNOL, V42, P3062, DOI 10.1002/eji.201242623; Duhen R, 2013, J IMMUNOL, V190, P4478, DOI 10.4049/jimmunol.1203172; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fernandez D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157889; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Haines CJ, 2013, CELL REP, V3, P1378, DOI 10.1016/j.celrep.2013.03.035; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huizinga R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-266; Ingwersen J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0512-z; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Martin BN, 2016, NAT IMMUNOL, V17, P583, DOI 10.1038/ni.3389; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2012, J IMMUNOL, V189, P3285, DOI 10.4049/jimmunol.1201834; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Mills JH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-193; Mills JH, 2012, J IMMUNOL, V188, P5713, DOI 10.4049/jimmunol.1200545; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Takenaka MC, 2016, TRENDS IMMUNOL, V37, P427, DOI 10.1016/j.it.2016.04.009; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5432; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173655	10.1371/journal.pone.0173655	http://dx.doi.org/10.1371/journal.pone.0173655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288184	Green Submitted, gold, Green Published			2022-12-26	WOS:000396092400024
J	Korhonen, M; Parkkonen, J; Hedman, M; Muuronen, A; Onatsu, J; Mustonen, P; Vanninen, R; Taina, M				Korhonen, Miika; Parkkonen, Johannes; Hedman, Marja; Muuronen, Antti; Onatsu, Juha; Mustonen, Pirjo; Vanninen, Ritva; Taina, Mikko			Morphological features of the left atrial appendage in consecutive coronary computed tomography angiography patients with and without atrial fibrillation	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; THROMBOEMBOLIC RISK; THROMBUS FORMATION; VOLUME OVERLOAD; STROKE; ANATOMY; AGE; REGURGITATION; PRESSURE; DISEASE	The majority of intracardiac thrombi form in the left atrial appendage (LAA). Enlargement of this structure, together with certain morphological features, may indicate a predisposition to the formation of thrombi and subsequent cardioembolic stroke. Thus far, studies on LAA morphology have largely focused on those patients with atrial fibrillation (AF). Taking a different approach, we investigated the variation in LAA morphology in a consecutive patient population with and without AF. We evaluated 808 consecutive patients (529 females; mean age 52.5 +/- 9.9 years) who underwent coronary artery computed tomography angiography (CCTA), the majority of whom (749) had no history of AF. We assessed the length, lobe number, and morphological classification of their LAAs. Demographic data and medical histories were collated from medical records and then correlated with LAA morphology. The proportions of each of the four morphological classes of LAA for the overall vs. non-AF population were: WindSock, 62.3/61.5%; Cactus, 18.6/18.8%; ChickenWing, 10.0/10.0%; and CauliFlower, 9.2/9.6%. Age (p<0.001; r = 0.156) and female gender (p<0.001) were both found to be associated with an increased body surface area (BSA)-related LAA length. Male patients were more likely to manifest multi-lobed (p = 0.003) LAAs, and overweight patients with a greater number of multi-lobed LAA morphological classes (p = 0.010). No associations with morphological LAA features could be found for patients with diabetes, hypertension, or dyslipidemia. Nor did the size of the left atrium exhibit any correlation with BSA-related LAA length. In the overall and non-AF populations, aging and female gender were associated with longer BSA-indexed LAAs.	[Korhonen, Miika; Parkkonen, Johannes; Muuronen, Antti; Vanninen, Ritva; Taina, Mikko] Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland; [Korhonen, Miika; Parkkonen, Johannes; Muuronen, Antti; Vanninen, Ritva; Taina, Mikko] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, Kuopio, Finland; [Onatsu, Juha] Kuopio Univ Hosp, Neuro Ctr, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital	Korhonen, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland.; Korhonen, M (corresponding author), Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland.	miika.korhonen@kuh.fi		Korhonen, Miika/0000-0001-5280-1772	Kuopio University Hospital [5063519]; Finnish Cultural Foundation [65151616, 65161521]; Instrumentarium Science Foundation; Finnish Medical Foundation; Aarne Koskelo Foundation; Mauri and Sirkka Wiljasalo Fund	Kuopio University Hospital; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Instrumentarium Science Foundation; Finnish Medical Foundation; Aarne Koskelo Foundation; Mauri and Sirkka Wiljasalo Fund	This study was supported by the Kuopio University Hospital (5063519; www.kuh.fi), the Finnish Cultural Foundation (65151616 and 65161521; https://skr.fi/en), the Instrumentarium Science Foundation (no grant number available, granted on Jan 15th 2016; http://www.instrufoundation.fi/en.php), the Finnish Medical Foundation (no grant number available, applicant number and grant years: 3887/2015 and 3887/2016; http://www.laaketieteensaatio.fi/fin/in_english/), the Aarne Koskelo Foundation (no grant number available, granted on Dec 8th 2015; http://www.aamekoskelonsaatio.fi/) and the Mauri and Sirkka Wiljasalo Fund (no grant number available, granted on Apr 7th 2016; http://hae.uef.fi/en/web/guest/news-and-events/foundation-contacts-kuo). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this manuscript.	Aurigemma GP, 2009, CIRC-CARDIOVASC IMAG, V2, P282, DOI 10.1161/CIRCIMAGING.108.826602; Beigel R, 2014, JACC-CARDIOVASC IMAG, V7, P1251, DOI 10.1016/j.jcmg.2014.08.009; Boucebci S, 2016, EUR RADIOL, V26, P1512, DOI 10.1007/s00330-015-3962-2; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Cohoon KP, 2015, J THROMB THROMBOLYS, V141, P1; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Di Biase L, 2010, CIRCULATION, V122, P109, DOI 10.1161/CIRCULATIONAHA.109.928903; Faustino A, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-28; Fukushima K, 2016, EUR HEART J-CARD IMG, V17, P59, DOI 10.1093/ehjci/jev117; GEHL LG, 1982, AM J CARDIOL, V49, P33, DOI 10.1016/0002-9149(82)90274-0; Gotzmann M, 2012, AM HEART J, V163, P903, DOI 10.1016/j.ahj.2012.03.017; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Ilercil A, 2001, CLIN CARDIOL, V24, P39, DOI 10.1002/clc.4960240107; Imada M, 2007, INT J CARDIOL, V119, P384, DOI 10.1016/j.ijcard.2006.07.162; Iozzo P, 2011, DIABETES CARE, V34, pS371, DOI 10.2337/dc11-s250; KENNEDY JW, 1970, CIRCULATION, V41, P817, DOI 10.1161/01.CIR.41.5.817; Khurram IM, 2013, HEART RHYTHM, V10, P1843, DOI 10.1016/j.hrthm.2013.09.065; Kimura T, 2013, HEART RHYTHM, V10, P921, DOI 10.1016/j.hrthm.2013.01.036; Korhonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118822; Li CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126818; Ma XJ, 2009, CLIN CARDIOL, V32, P264, DOI 10.1002/clc.20449; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Movahed Mohammad Reza, 2008, Exp Clin Cardiol, V13, P89; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nedios S, 2014, HEART RHYTHM, V11, P2239, DOI 10.1016/j.hrthm.2014.08.016; Pan NH, 2008, CHEST, V133, P190, DOI 10.1378/chest.07-1769; Patel DA, 2009, OCHSNER J, V9, P191; Ploumen MAM, 2010, NETH HEART J, V18, P243, DOI 10.1007/BF03091770; Popescu BA, 2004, AM J CARDIOL, V93, P1156, DOI 10.1016/j.amjcard.2004.01.046; Romero J, 2014, NAT REV CARDIOL, V11, P470, DOI 10.1038/nrcardio.2014.77; Sabarudin A, 2013, WORLD J CARDIOL, V5, P459, DOI 10.4330/wjc.v5.i12.459; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Shirani J, 2000, CARDIOVASC PATHOL, V9, P95, DOI 10.1016/S1054-8807(00)00030-2; Tabata T, 1996, J Am Soc Echocardiogr, V9, P857, DOI 10.1016/S0894-7317(96)90478-2; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Telman G, 2008, ACTA NEUROL SCAND, V117, P311, DOI 10.1111/j.1600-0404.2007.00953.x; Tsao Hsuan-Ming, 2016, Medicine (Baltimore), V95, pe3260, DOI 10.1097/MD.0000000000003260; Veinot JP, 1997, CIRCULATION, V96, P3112, DOI 10.1161/01.CIR.96.9.3112; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; Weigner MJ, 1999, HEART, V82, P555, DOI 10.1136/hrt.82.5.555; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamamoto M, 2014, CIRC-CARDIOVASC IMAG, V7, P337, DOI 10.1161/CIRCIMAGING.113.001317	44	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173703	10.1371/journal.pone.0173703	http://dx.doi.org/10.1371/journal.pone.0173703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288200	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400029
J	Wieczorek, K; Lachowska-Cierlik, D; Kajtoch, L; Kanturski, M				Wieczorek, Karina; Lachowska-Cierlik, Dorota; Kajtoch, Lukasz; Kanturski, Mariusz			The relationships within the Chaitophorinae and Drepanosiphinae (Hemiptera, Aphididae) inferred from molecular-based phylogeny and comprehensive morphological data	PLOS ONE			English	Article							NUCLEAR GENE EF-1-ALPHA; SYCAMORE APHID; BAYESIAN-INFERENCE; MITOCHONDRIAL; HOMOPTERA; SYSTEMATICS; EVOLUTION; TRIBE; INSECTA; HOST	The Chaitophorinae is a bionomically diverse Holarctic subfamily of Aphididae. The current classification includes two tribes: the Chaitophorini associated with deciduous trees and shrubs, and Siphini that feed on monocotyledonous plants. We present the first phylogenetic hypothesis for the subfamily, based on molecular and morphological datasets. Molecular analyses were based on the mitochondrial gene cytochrome oxidase subunit I (COI) and the nuclear gene elongation factor-1 alpha (EF-1 alpha). Phylogenetic inferences were obtained individually on each of genes and joined alignments using Bayesian inference (BI) and Maximum likelihood (ML). In phylogenetic trees reconstructed on the basis of nuclear and mitochondrial genes as well as a morphological dataset, the monophyly of Siphini and the genus Chaitophorus was supported. Periphyllus forms independent lineages from Chaitophorus and Siphini. Within this genus two clades comprising European and Asiatic species, respectively, were indicated. Concerning relationships within the subfamily, EF-1 alpha and joined COI and EF-1 alpha genes analysis strongly supports the hypothesis that Chaitophorini do not form a monophyletic clade. Periphyllus is a sister group to a clade containing Chaitophorus and Siphini. The Asiatic unit of Periphyllus also includes Trichaitophorus koyaensis. The analysis of morphological dataset under equally weighted parsimony also supports the view that Chaitophorini is an artificial taxon, as Lambersaphis pruinosae and Pseudopterocomma hughi, both traditionally included in the Chaitophorini, formed independent lineages. COI analyses support consistent groups within the subfamily, but relationships between groups are poorly resolved. These analyses were extended to include the species of closely related and phylogenetically unstudied subfamily Drepanosiphinae, which produced congruent results. Genera Drepanosiphum and Depanaphis are monophyletic and sister. The position of Yamatocallis tokyoensis differs in the molecular and morphological analyses, i.e. it is either an independent lineage (EF-1 alpha, COI, joined COI and EF-1 alpha genes) or is nested inside this unit (morphology). Our data also support separation of Chaitophorinae from Drepanosiphinae.	[Wieczorek, Karina; Kanturski, Mariusz] Univ Silesia, Fac Biol & Environm Protect, Dept Zool, Katowice, Poland; [Lachowska-Cierlik, Dorota] Jagiellonian Univ, Inst Zool, Dept Entomol, Krakow, Poland; [Kajtoch, Lukasz] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland	University of Silesia in Katowice; Jagiellonian University; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences	Wieczorek, K (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Zool, Katowice, Poland.	karina.wieczorek@us.edu.pl	Kajtoch, Łukasz/B-4236-2012	Kajtoch, Łukasz/0000-0001-7345-9400; Wieczorek, Karina/0000-0002-8331-5731; Kanturski, Mariusz/0000-0002-1674-1028	National Science Centre, Poland [2011/01/B/NZ8/00157]	National Science Centre, Poland(National Science Centre, Poland)	This research was supported by the National Science Centre, Poland, grant no. 2011/01/B/NZ8/00157.	Basu AN, 1966, ENTOMOLOGISCHE BERIC, V26, P27; Blackman R. L., 2016, APHIDS WORLDS PLANTS; Blackman R.L., 2021, APHIDS WORLDS PLANTS; Blackman R.L., 2006, APHIDS WORLDS HERBAC, V1; Borner C., 1944, FAUNA DEUTSCHLAND BE; Borner C, 1957, HDB PFLANZENKRANKHEI, VV; Borner C., 1952, SCHRIFTEN THURINGISC, V3, P1; CHAKRABARTI S, 1986, ZOOL J LINN SOC-LOND, V88, P329, DOI 10.1111/j.1096-3642.1986.tb02250.x; Chen J, 2014, CLADISTICS, V30, P26, DOI 10.1111/cla.12024; Chen R, 2015, CLADISTICS; Chen R, 2013, SYST ENTOMOL, V38, P615, DOI 10.1111/syen.12018; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Coeur d'Acier A, 2008, ZOOL SCR, V37, P175, DOI 10.1111/j.1463-6409.2007.00317.x; Damgaard J, 2000, INSECT SYST EVOL, V31, P71, DOI 10.1163/187631200X00327; Dixon A.F.G., 1990, P11; DIXON AFG, 1966, J ANIM ECOL, V35, P105, DOI 10.2307/2692; DIXON AFG, 1969, J ANIM ECOL, V38, P585, DOI 10.2307/3037; DIXON AFG, 1972, J ANIM ECOL, V41, P689, DOI 10.2307/3203; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Durak R, 2014, J APPL GENET, V55, P89, DOI 10.1007/s13353-013-0184-7; Essig EO, 1952, APHID GENUS PERIPHYL; Favret C., 2011, REGISTERS FAMILY GRO; Favret C., 2016, APHID SPECIES FILE V; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Friedrich F, 2014, ENTOMOL SCI, V17, P1, DOI 10.1111/ens.12053; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P5315, DOI 10.1128/AEM.67.11.5315-5320.2001; GHOSH AK, 1980, FAUNA INDIA ADJACE 1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heie O. E., 1967, Spolia Zoologica Musei Hauniensis, V26, P1; Heie OE, 1987, APHIDS THEIR BIOL NA, P392; HEIE OE, 1995, ENTOMOL MEDD, V63, P17; Heie OE, 1982, FAUNA ENTOMOLOGICA S; Heie Ole E., 2009, Redia, V92, P69; Higuchi H., 1972, Insecta Matsum, V35, P19; Hille Ris Lambers D, 1960, TIJDSCHR ENTOMOL, V103, P1; Holman J, 2009, HOST PLANT CATALOG A; Huang XL, 2012, ZOOL J LINN SOC-LOND, V165, P73, DOI 10.1111/j.1096-3642.2011.00795.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jousselin E, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-56; Kanturski M, 2016, ZOOTAXA IN PRESS; Kanturski MZ, 2015, MICRON, V76, P23, DOI 10.1016/j.micron.2015.05.004; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2008, MOL CELLS, V25, P510; Li XY, 2014, TURK J ZOOL, V38, P285, DOI 10.3906/zoo-1303-15; Lozier JD, 2008, ZOOTAXA, P1; MacGILLIVRAY M. E., 1963, CANADIAN ENTOMOL, V95, P941; MACKAUER M, 1965, CAN ENTOMOL, V97, P1016, DOI 10.4039/Ent971016-10; Martinez-Torres D, 2001, MOL PHYLOGENET EVOL, V20, P437, DOI 10.1006/mpev.2001.0983; Mier-Durante MP, 1998, FAUNA IBERICA, P11; MORDVILKO AK, 1948, OPREDELITEL NASEKOMY, P187; NARZIKULOV M. N., 1961, DOKL AKAD NAUK TADZHIKSK SSR, V4, P49; Normark BB, 2000, MOL PHYLOGENET EVOL, V14, P131, DOI 10.1006/mpev.1999.0699; Novakova E, 2014, MOL PHYLOGENET EVOL, V68, P12; Nylander J., 2004, MRMODELTEST V2, V2; Ortiz-Rivas B, 2004, MOL PHYLOGENET EVOL, V30, P24, DOI 10.1016/S1055-7903(03)00155-6; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Ortiz-Rivas B, 2009, SYST ENTOMOL, V34, P293, DOI 10.1111/j.1365-3113.2008.00464.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Papasotiropoulos V, 2014, J BIOL RES IN PRESS, V20; Perez-Brocal Vicente, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/250154; PINTERA A, 1987, DEUT ENTOMOL Z, V34, P219, DOI 10.1002/mmnd.19870340402; PONSEN M B, 1983, Mededelingen Landbouwhogeschool Wageningen, V83, P1; Quednau F.W., 2010, MEMOIRS AM ENTOMOLOG, V83; QUEDNAU FW, 1976, CAN ENTOMOL, V108, P461, DOI 10.4039/Ent108461-5; RAMBAUT A., 2009, TRACER VERSION 1 5 M; Remaudiere G., 1997, CATALOGUE WORLDS APH; Richards WR, 1972, CHAITOPHORINAE CANAD, V87; Shaposhnikov G.C., 1985, P19; Shaposhnikov G.Kh, 1964, OPREDELITELNASEKOMYK, V1, P489; Shingleton AW, 2003, MOL PHYLOGENET EVOL, V26, P26, DOI 10.1016/S1055-7903(02)00328-7; SIMPSON Kathryn Mary, 2013, THESIS, P292; SMITH CF, 1968, ANN ENTOMOL SOC AM, V61, P185, DOI 10.1093/aesa/61.1.185; SORIN M, 1979, Kontyu, V47, P117; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STARY P, 1970, ACTA ENTOMOL BOHEMOS, V67, P351; Stern DL, 1997, SYST ENTOMOL, V22, P81, DOI 10.1046/j.1365-3113.1997.d01-20.x; Sucimoto Shun'ichiro, 2013, Insecta Matsumurana, V69, P27; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szelegiewicz H., 1985, Klucze do Oznaczania Owadow Polski, V17, P1; SZELEGIEWICZ HENRYK, 1961, ANN ZOOL [POLAND], V19, P229; Takahashi R., 1923, GOVT RES I FORMOSA R, V4, P1; Takahashi R., 1927, DEP AGR GOVT RES I F, V22, P1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDERGOOT P, 1915, BEITRAGE KENNTNIS HO; von Dohlen Carol D., 2009, Redia, V92, P39; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; von Dohlen CD, 2002, MOL PHYLOGENET EVOL, V23, P257, DOI 10.1016/S1055-7903(02)00025-8; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wieczorek K, 2004, INSECT SYST EVOL, V35, P317, DOI 10.1163/187631204788920158; Wieczorek K, 2010, MONOGRAPH SIPHINI MO; Wieczorek K, 2016, ZOOL ANZ, V263, P92, DOI 10.1016/j.jcz.2016.04.005; Wieczorek K, 2016, ZOOTAXA, V4092, P583, DOI 10.11646/zootaxa.4092.4.8; Wieczorek K, 2015, ZOOL ANZ, V257, P39, DOI 10.1016/j.jcz.2015.04.002; Wieczorek K, 2014, AGR FOREST ENTOMOL, V16, P434, DOI 10.1111/afe.12073; Wieczorek K, 2013, ZOOTAXA, V3731, P324, DOI 10.11646/zootaxa.3731.3.2; Wieczorek K, 2011, ZOOMORPHOLOGY, V130, P289, DOI 10.1007/s00435-011-0134-z; Wieczorek K, 2011, SYST ENTOMOL, V36, P164, DOI 10.1111/j.1365-3113.2010.00550.x; Wojciechowski W., 1992, STUDIES SYSTEMATIC S; Yang ZX, 2010, ENTOMOL SCI, V13, P351, DOI 10.1111/j.1479-8298.2010.00391.x; Zhang HC, 2008, B ENTOMOL RES, V98, P499, DOI 10.1017/S0007485308005828; Zhang HC, 2007, B ENTOMOL RES, V97, P379, DOI 10.1017/S0007485307005020; Zhang RL, 2011, CURR ZOOL, V57, P806, DOI 10.1093/czoolo/57.6.806	107	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173608	10.1371/journal.pone.0173608	http://dx.doi.org/10.1371/journal.pone.0173608			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288166	Green Published, gold			2022-12-26	WOS:000396092400021
J	Park, YG; Mun, BG; Kang, SM; Hussain, A; Shahzad, R; Seo, CW; Kim, AY; Lee, SU; Oh, KY; Lee, DY; Lee, IJ; Yun, BW				Park, Yeon-Gyeong; Mun, Bong-Gyu; Kang, Sang-Mo; Hussain, Adil; Shahzad, Raheem; Seo, Chang-Woo; Kim, Ah-Yeong; Lee, Sang-Uk; Oh, Kyeong Yeol; Lee, Dong Yeol; Lee, In-Jung; Yun, Byung-Wook			Bacillus aryabhattai SRB02 tolerates oxidative and nitrosative stress and promotes the growth of soybean by modulating the production of phytohormones	PLOS ONE			English	Article							PHYTOCHROME-MEDIATED ATTACHMENT; INDUCED SYSTEMIC RESISTANCE; ABSCISIC-ACID ANTAGONISM; PLANT-GROWTH; HEAT-STRESS; CYTOKININ PRODUCTION; PSEUDOMONAS-AERUGINOSA; INDOLEACETIC-ACID; DROUGHT STRESS; SALICYLIC-ACID	Plant growth promoting rhizobacteria (PGPR) are diverse, naturally occurring bacteria that establish a close association with plant roots and promote the growth and immunity of plants. Established mechanisms involved in PGPR-mediated plant growth promotion include regulation of phytohormones, improved nutrient availability, and antagonistic effects on plant pathogens. In this study, we isolated a bacterium from the rhizospheric soil of a soybean field in Chungcheong buk-do, South Korea. Using 16S rRNA sequencing, the bacterium was identified as Bacillus aryabhattai strain SRB02. Here we show that this strain significantly promotes the growth of soybean. Gas chromatography-mass spectrometry analysis showed that SRB02 produced significant amounts of abscisic acid, indole acetic acid, cytokinin and different gibberellic acids in culture. SRB02-treated soybean plants showed significantly better heat stress tolerance than did untreated plants. These plants also produced consistent levels of ABA under heat stress and exhibited ABA-mediated stomatal closure. High levels of IAA, JA, GA12, GA4, and GA7, were recorded in SRB02-treated plants. These plants produced longer roots and shoots than those of control plants. B. aryabhattai SRB02 was found to be highly tolerant to oxidative stress induced by H2O2 and MV potentiated by high catalase (CAT) and superoxide dismutase (SOD) activities. SRB02 also tolerated high nitrosative stress induced by the nitric oxide donors GSNO and CysNO. Because of these attributes, B. aryabhattai SRB02 may prove to be a valuable resource for incorporation in biofertilizers and other soil amendments that seek to improve crop productivity.	[Park, Yeon-Gyeong; Mun, Bong-Gyu; Kang, Sang-Mo; Hussain, Adil; Shahzad, Raheem; Seo, Chang-Woo; Kim, Ah-Yeong; Lee, Sang-Uk; Lee, In-Jung; Yun, Byung-Wook] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Hussain, Adil] Abdul Wali Khan Univ, Dept Agr, Mardan, Khyber Pakhtunk, Pakistan; [Oh, Kyeong Yeol; Lee, Dong Yeol] Gyeongnam Oriental Med Herb Inst, Sancheong, South Korea	Kyungpook National University; Abdul Wali Khan University	Lee, IJ; Yun, BW (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	ijlee@knu.ac.kr; bwyun@knu.ac.kr	Hussain, Adil/K-6016-2018; Mun, BongGyu/GYD-6010-2022; Lee, In-Jung/GLS-0432-2022; Shahzad, Raheem/AAG-8370-2019	Hussain, Adil/0000-0002-7803-429X; Mun, BongGyu/0000-0002-6670-1315; Lee, In-Jung/0000-0001-7154-4820; Shahzad, Raheem/0000-0002-6594-8287	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2A10058022]; Next Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ01110201]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Next Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2A10058022) to In-Jung Lee and by a grant from the Next Generation BioGreen 21 Program (SSAC, Grant No. PJ01110201), Rural Development Administration, Republic of Korea to Byung-Wook Yun.	Abd El-Daim IA, 2014, PLANT SOIL, V379, P337, DOI 10.1007/s11104-014-2063-3; Ahemad Munees, 2014, Journal of King Saud University Science, V26, P1, DOI 10.1016/j.jksus.2013.05.001; Ali SZ, 2011, J PLANT INTERACT, V6, P239, DOI 10.1080/17429145.2010.545147; Astacio MG, 2011, HORTSCIENCE, V46, P1640, DOI 10.21273/HORTSCI.46.12.1640; ATZORN R, 1988, PLANTA, V175, P532, DOI 10.1007/BF00393076; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; Bertrand H, 2001, BIOL FERT SOILS, V33, P152, DOI 10.1007/s003740000305; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bohme L, 2006, EUR J SOIL BIOL, V42, P1, DOI 10.1016/j.ejsobi.2005.08.001; Bottini R, 2004, APPL MICROBIOL BIOT, V65, P497, DOI 10.1007/s00253-004-1696-1; BOTTINI R, 1989, PLANT PHYSIOL, V90, P45, DOI 10.1104/pp.90.1.45; Chang WS, 2009, ENVIRON MICROBIOL, V11, P1482, DOI 10.1111/j.1462-2920.2009.01876.x; Chanway CP, 1997, FOREST SCI, V43, P99; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Cohen AC, 2008, PLANT GROWTH REGUL, V54, P97, DOI 10.1007/s10725-007-9232-9; Cohen AC, 2015, PHYSIOL PLANTARUM, V153, P79, DOI 10.1111/ppl.12221; Cohen AC, 2009, BOTANY, V87, P455, DOI 10.1139/B09-023; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Creus CM, 2005, PLANTA, V221, P297, DOI 10.1007/s00425-005-1523-7; CROZIER A, 1988, APPL ENVIRON MICROB, V54, P2833, DOI 10.1128/AEM.54.11.2833-2837.1988; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; de Salamone IEG, 2001, CAN J MICROBIOL, V47, P404, DOI 10.1139/cjm-47-5-404; Ding W, 2010, BIOL PLANTARUM, V54, P607, DOI 10.1007/s10535-010-0110-3; Djanaguiraman M, 2013, J AGRON CROP SCI, V199, P171, DOI 10.1111/jac.12005; Dobbelaere S, 1999, PLANT SOIL, V212, P155, DOI 10.1023/A:1004658000815; Dodd IC, 2010, ANN APPL BIOL, V157, P361, DOI 10.1111/j.1744-7348.2010.00439.x; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Etesami H, 2014, J PLANT GROWTH REGUL, V33, P654, DOI 10.1007/s00344-014-9415-3; Fan SK, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00721; Fones H, 2012, FEMS MICROBIOL LETT, V327, P1, DOI 10.1111/j.1574-6968.2011.02449.x; Frey AD, 2003, FEMS MICROBIOL REV, V27, P525, DOI 10.1016/S0168-6445(03)00056-1; Garcia JAL, 2004, ENVIRON EXP BOT, V52, P239, DOI 10.1016/j.envexpbot.2004.02.003; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Govind Gupta, 2015, Journal of Microbial and Biochemical Technology, V7, P96; Grosskinsky DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23310; Grosskinsky DK, 2014, PHYTOPATHOLOGY, V104, P1283, DOI 10.1094/PHYTO-03-14-0076-R; Gu RL, 2010, J PLANT GROWTH REGUL, V29, P428, DOI 10.1007/s00344-010-9155-y; Gutierrez-Manero FJ, 2001, PHYSIOL PLANTARUM, V111, P206, DOI 10.1034/j.1399-3054.2001.1110211.x; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Huang XD, 2004, ENVIRON POLLUT, V130, P453, DOI 10.1016/j.envpol.2003.12.018; Hussain A, 2009, AFR J MICROBIOL RES, V3, P704; Idris EE, 2004, Z PFLANZENK PFLANZEN, V111, P583; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Islam F, 2014, ECOTOX ENVIRON SAFE, V104, P285, DOI 10.1016/j.ecoenv.2014.03.008; JANZEN RA, 1992, SOIL BIOL BIOCHEM, V24, P1061, DOI 10.1016/0038-0717(92)90036-W; Jiang CJ, 2013, MOL PLANT MICROBE IN, V26, P287, DOI 10.1094/MPMI-06-12-0152-R; Kalita M, 2015, INDIAN J EXP BIOL, V53, P56; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Kang SM, 2012, J MICROBIOL, V50, P902, DOI 10.1007/s12275-012-2273-4; Karlidag H, 2013, HORTSCIENCE, V48, P563, DOI 10.21273/HORTSCI.48.5.563; Khan N, 2016, INT J PHYTOREMEDIAT; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; Kokalis-Burelle N, 2006, APPL SOIL ECOL, V31, P91, DOI 10.1016/j.apsoil.2005.03.007; Kuiper I, 2004, MOL PLANT MICROBE IN, V17, P6, DOI 10.1094/MPMI.2004.17.1.6; Kumar A, 2011, BACTERIA IN AGROBIOLOGY: CROP ECOSYSTEMS, P37, DOI 10.1007/978-3-642-18357-7_2; KUMAR SP, 2012, INDIAN J DENT ED, V5, P5; Lee IJ, 1998, PLANT PHYSIOL, V116, P1003, DOI 10.1104/pp.116.3.1003; Lee S, 2012, J MICROBIOL, V50, P45, DOI 10.1007/s12275-012-1415-z; Li PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1009; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lim JH, 2013, PLANT PATHOLOGY J, V29, P201, DOI 10.5423/PPJ.SI.02.2013.0021; Liu FC, 2013, APPL MICROBIOL BIOT, V97, P4617, DOI 10.1007/s00253-012-4255-1; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Loper J, 1982, PHYTOPATHOLOGY; Lu YD, 2014, PLANT J, V80, P52, DOI 10.1111/tpj.12615; Lucy M, 2004, ANTON LEEUW INT J G, V86, P1, DOI 10.1023/B:ANTO.0000024903.10757.6e; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Majeed A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00198; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Meena H, 2015, BIOSCI BIOTECHNO RES, V8, P171; Miransari M., 2015, ABIOTIC BIOTIC STRES; Naseem M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003026; Ng JLP, QUANTIFYING AUXIN ME; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Ortiz-Castro R, 2008, PLANT SIGNAL BEHAV, V3, P263, DOI 10.4161/psb.3.4.5204; Pailan S, 2015, INT BIODETER BIODEGR, V103, P191, DOI 10.1016/j.ibiod.2015.05.006; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Park JM, 2015, INDIAN J MICROBIOL, V55, P207, DOI 10.1007/s12088-015-0515-y; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; Porcel R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-36; Press CM, 1997, MOL PLANT MICROBE IN, V10, P761, DOI 10.1094/MPMI.1997.10.6.761; Press CM, 2001, PHYTOPATHOLOGY, V91, P593, DOI 10.1094/PHYTO.2001.91.6.593; Qi QG, 1998, PLANT PHYSIOL, V117, P979, DOI 10.1104/pp.117.3.979; Rahman A, 2010, BIOSCI BIOTECH BIOCH, V74, P2202, DOI 10.1271/bbb.100360; Ramasarma T, 2015, MOL CELL BIOCHEM, V400, P277, DOI 10.1007/s11010-014-2284-z; Ramesh A, 2014, APPL SOIL ECOL, V73, P87, DOI 10.1016/j.apsoil.2013.08.009; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Ryu CM, 2005, PLANT SOIL, V268, P285, DOI 10.1007/s11104-004-0301-9; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; Selim S, 2015, FASEB J, V29; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Seskar M, 1998, PLANT PHYSIOL, V116, P387, DOI 10.1104/pp.116.1.387; Sharp RE, 2000, J EXP BOT, V51, P1575, DOI 10.1093/jexbot/51.350.1575; Shen XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-271; 이현주, 2008, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V37, P1095; Shivaji S, 2009, INT J SYST EVOL MICR, V59, P2977, DOI 10.1099/ijs.0.002527-0; Siewers V, 2006, APPL ENVIRON MICROB, V72, P4619, DOI 10.1128/AEM.02919-05; Singh Y, 2014, J CHEM TECHNOL BIOT, V89, P117, DOI 10.1002/jctb.4121; Singh Y, 2013, INDIAN J EXP BIOL, V51, P322; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Swamy PM, 1999, CURR SCI INDIA, V76, P1220; Szkop M, 2012, FOLIA MICROBIOL, V57, P1, DOI 10.1007/s12223-011-0089-y; Talanova VV, 2003, RUSS J PLANT PHYSL+, V50, P90, DOI 10.1023/A:1021996703940; TANADA T, 1973, PLANT PHYSIOL, V51, P154, DOI 10.1104/pp.51.1.154; TANADA T, 1973, PLANT PHYSIOL, V51, P150, DOI 10.1104/pp.51.1.150; Tanada T., 1972, ANTAGONISM INDOLEACE; Terrile MC, 2012, PLANT J, V70, P492, DOI 10.1111/j.1365-313X.2011.04885.x; Timmusk S, 1999, SOIL BIOL BIOCHEM, V31, P1847, DOI 10.1016/S0038-0717(99)00113-3; Vacheron J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00356; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Vandeputte O, 2005, APPL ENVIRON MICROB, V71, P1169, DOI 10.1128/AEM.71.3.1169-1177.2005; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Vurukonda SSKP, 2016, MICROBIOL RES, V184, P13, DOI 10.1016/j.micres.2015.12.003; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Weaver GM, 2014, HORTSCIENCE, V49, P779, DOI 10.21273/HORTSCI.49.6.779; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Wu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep34978; Yan Y, 2016, GENES GENOM, V38, P293, DOI 10.1007/s13258-015-0366-2; Yan YS, 2011, PLANT J, V65, P820, DOI 10.1111/j.1365-313X.2010.04467.x; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Yuan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13438; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026	132	120	136	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173203	10.1371/journal.pone.0173203	http://dx.doi.org/10.1371/journal.pone.0173203			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282395	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800020
J	Zhou, N; Swamy, KBS; Leu, JY; McDonald, MJ; Galafassi, S; Compagno, C; Piskur, J				Zhou, Nerve; Swamy, Krishna B. S.; Leu, Jun-Yi; McDonald, Michael J.; Galafassi, Silvia; Compagno, Concetta; Piskur, Jure			Coevolution with bacteria drives the evolution of aerobic fermentation in Lachancea kluyveri	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-WALL; METABOLISM; MITOCHONDRIA; DUPLICATION; YEASTS; DOA1; GENE	The Crabtree positive yeasts, such as Saccharomyces cerevisiae, prefer fermentation to respiration, even under fully aerobic conditions. The selective pressures that drove the evolution of this trait remain controversial because of the low ATP yield of fermentation compared to respiration. Here we propagate experimental populations of the weak-Crabtree yeast Lachancea kluyveri, in competitive co-culture with bacteria. We find that L. kluyveri adapts by producing quantities of ethanol lethal to bacteria and evolves several of the defining characteristics of Crabtree positive yeasts. We use precise quantitative analysis to show that the rate advantage of fermentation over aerobic respiration is insufficient to provide an overall growth advantage. Thus, the rapid consumption of glucose and the utilization of ethanol are essential for the success of the aerobic fermentation strategy. These results corroborate that selection derived from competition with bacteria could have provided the impetus for the evolution of the Crabtree positive trait.	[Zhou, Nerve; Piskur, Jure] Lund Univ, Dept Biol, Lund, Sweden; [Swamy, Krishna B. S.; Leu, Jun-Yi] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [McDonald, Michael J.] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia; [Galafassi, Silvia; Compagno, Concetta] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy	Lund University; Academia Sinica - Taiwan; Monash University; University of Milan	Swamy, KBS (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Nerve.Zhou@biol.lu.se; swamykrishnabs@gate.sinica.edu.tw	Galafassi, Silvia/ABI-7576-2020; SWAMY, KRISHNA/AAE-2637-2019; Leu, Jun-Yi/A-7364-2009	Galafassi, Silvia/0000-0001-5392-0271; SWAMY, KRISHNA/0000-0002-3868-6699; Leu, Jun-Yi/0000-0001-5445-2799; Zhou, Nerve/0000-0002-8822-1347	Cornucopia Project [264717]; Fysiografen Foundation; Lindstrom Foundation; Academia Sinica distinguished postdoctoral fellowship; Marie Curie Foundation; Academia Sinica of Taiwan [100-CDA-L04]; Taiwan Ministry of Science and Technology [NSC103-2321-B-001-001]	Cornucopia Project; Fysiografen Foundation; Lindstrom Foundation; Academia Sinica distinguished postdoctoral fellowship(Academia Sinica - Taiwan); Marie Curie Foundation(European Commission); Academia Sinica of Taiwan(Academia Sinica - Taiwan); Taiwan Ministry of Science and Technology	NZ was funded by the Marie Curie, Cornucopia Project (264717), Fysiografen and Lindstrom Foundations. KBSS was funded by an Academia Sinica distinguished postdoctoral fellowship. JYL was supported by Academia Sinica of Taiwan (100-CDA-L04) and the Taiwan Ministry of Science and Technology (NSC103-2321-B-001-001).	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Cherry JM., 2015, COLD SPRING HARB PRO, V2015; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Dashko S, 2014, FEMS YEAST RES, V14, P826, DOI 10.1111/1567-1364.12161; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Hagman A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116942; Hagman A, 2014, FEBS J, V281, P4805, DOI 10.1111/febs.13019; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Ishchenko AA, 2005, MOL CELL BIOL, V25, P6380, DOI 10.1128/MCB.25.15.6380-6390.2005; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moller K, 2002, BIOTECHNOL BIOENG, V77, P186, DOI 10.1002/bit.10122; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mrsa V, 1999, YEAST, V15, P813, DOI 10.1002/(SICI)1097-0061(199907)15:10A<813::AID-YEA421>3.0.CO;2-Y; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Okada N, 2014, FEMS YEAST RES, V14, P425, DOI 10.1111/1567-1364.12136; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Pardo M, 1999, YEAST, V15, P459, DOI 10.1002/(SICI)1097-0061(199904)15:6<459::AID-YEA387>3.0.CO;2-L; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pfeiffer Thomas, 2014, Front Mol Biosci, V1, P17, DOI 10.3389/fmolb.2014.00017; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; SEEBOTH PG, 1990, J BACTERIOL, V172, P678, DOI 10.1128/jb.172.2.678-685.1990; Shulman RG, 2015, P NATL ACAD SCI USA, V112, P10902, DOI 10.1073/pnas.1510730112; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; van Hoek P, 2000, ENZYME MICROB TECH, V26, P724, DOI 10.1016/S0141-0229(00)00164-2; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Vongsamphanh R, 2001, MOL CELL BIOL, V21, P1647, DOI 10.1128/MCB.21.5.1647-1655.2001; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wu X, 2016, J CELL BIOL, V213, P49, DOI 10.1083/jcb.201510098	37	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173318	10.1371/journal.pone.0173318	http://dx.doi.org/10.1371/journal.pone.0173318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282411	Green Published, gold			2022-12-26	WOS:000396091800029
J	Le, M; Fernandez-Palomo, C; McNeill, FE; Seymour, CB; Rainbow, AJ; Mothersill, CE				Le, Michelle; Fernandez-Palomo, Cristian; McNeill, Fiona E.; Seymour, Colin B.; Rainbow, Andrew J.; Mothersill, Carmel E.			Exosomes are released by bystander cells exposed to radiation-induced biophoton signals: Reconciling the mechanisms mediating the bystander effect	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGES; HUMAN KERATINOCYTE CELLS; CHRONIC-FATIGUE-SYNDROME; IONIZING-RADIATION; PHOTON-EMISSION; ALPHA-PARTICLES; INTERCELLULAR COMMUNICATION; INDUCTION; BIOLOGY; IMMUNE	Objective The objective of our study was to explore a possible molecular mechanism by which ultraviolet (UV) biophotons could elicit bystander responses in reporter cells and resolve the problem of seemingly mutually exclusive mechanisms of a physical UV signal & a soluble factormediated bystander signal. Methods The human colon carcinoma cell line, HCT116 p53+/+, was directly irradiated with 0.5 Gy tritium beta particles to induce ultraviolet biophoton emission. Bystander cells were not directly irradiated but were exposed to the emitted UV biophotons. Medium was subsequently harvested from UV-exposed bystander cells. The exosomes extracted from this medium were incubated with reporter cell populations. These reporter cells were then assayed for clonogenic survival and mitochondrial membrane potential with and without prior treatment of the exosomes with RNase. Results Clonogenic cell survival was significantly reduced in reporter cells incubated with exosomes extracted from cells exposed to secondarily-emitted UV. These exosomes also induced significant mitochondrial membrane depolarization in receiving reporter cells. Conversely, exosomes extracted from non-UV-exposed cells did not produce bystander effects in reporter cells. The treatment of exosomes with RNase prior to their incubation with reporter cells effectively abolished bystander effects in reporter cells and this suggests a role for RNA in mediating the bystander response elicited by UV biophotons and their produced exosomes. Conclusion This study supports a role for exosomes released from UV biophoton-exposed bystander cells in eliciting bystander responses and also indicates a reconciliation between the UVmediated bystander effect and the bystander effect which has been suggested in the literature to be mediated by soluble factors.	[Le, Michelle; McNeill, Fiona E.] McMaster Univ, Radiat Sci Grad Program, Hamilton, ON, Canada; [Fernandez-Palomo, Cristian] Univ Bern, Inst Anat, Bern, Switzerland; [McNeill, Fiona E.] McMaster Univ, Dept Phys & Astron, Hamilton, ON, Canada; [Seymour, Colin B.; Rainbow, Andrew J.; Mothersill, Carmel E.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University; University of Bern; McMaster University; McMaster University	Le, M (corresponding author), McMaster Univ, Radiat Sci Grad Program, Hamilton, ON, Canada.	lem8@mcmaster.ca	Fernandez-Palomo, Cristian/J-8943-2019	Fernandez-Palomo, Cristian/0000-0002-5095-262X	National Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Foundation; Natural Sciences and Engineering Research Council of Canada [RGPIN293153-12, RGPIN203611-12]; Canada Research Chairs Programme [950-221284]; CANDU Owners Group [CRDPJ484381-15]	National Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Programme(Canada Research Chairs); CANDU Owners Group	The authors would like to thank the following funding agencies for providing financial support for this research endeavour: The National Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Foundation (url: http://www.ncf-net.org/; recipient: CEM), the Natural Sciences and Engineering Research Council of Canada (url: http://www.nserc-crsng.gc.ca/index_eng.asp; recipient: CEM; grant number RGPIN293153-12; recipient: FEM; grant number RGPIN203611-12), Canada Research Chairs Programme (url: http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx; recipient: CEM; grant number 950-221284), CANDU Owners Group (url: http://www.candu.org/; recipient: CBS; grant number CRDPJ484381-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SB, 2012, NUCL INSTRUM METH B, V288, P81, DOI 10.1016/j.nimb.2012.05.043; Ahmad SB, 2014, NUCL INSTRUM METH B, V319, P48, DOI 10.1016/j.nimb.2013.10.012; Ahmad SB, 2013, DOSE-RESPONSE, V11, P498, DOI 10.2203/dose-response.12-048.Ahmad; Al-Mayah A, 2015, MUTAT RES-FUND MOL M, V772, P38, DOI 10.1016/j.mrfmmm.2014.12.007; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Albanese J, 2003, EXP HEMATOL, V31, P455, DOI 10.1016/S0301-472X(03)00050-X; [Anonymous], 2016, ANTI TSG101 ANTIBODY; [Anonymous], 2016, ANTI CD63 ANTIBODY; Arscott WT, 2013, TRANSL ONCOL, V6, P638, DOI 10.1593/tlo.13640; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; BAJPAI RP, 1991, J BIOLUM CHEMILUM, V6, P227, DOI 10.1002/bio.1170060403; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Gow MD, 2010, RADIAT RES, V173, P769, DOI 10.1667/RR1895.1; GURWITSCH AA, 1988, EXPERIENTIA, V44, P545, DOI 10.1007/BF01953301; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Iyer R, 2000, CANCER RES, V60, P1290; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; Jelonek K, 2015, ACTA BIOCHIM POL, V62, P265, DOI 10.18388/abp.2015_970; KAZNACHEEV VP, 1980, B EXP BIOL MED+, V89, P345; Le M, 2015, PHYS MED BIOL, V60, P6371, DOI 10.1088/0031-9155/60/16/6371; Le M., 2016, RADIAT RES MANUSCRIP; Le M, 2015, RADIAT RES, V183, P279, DOI 10.1667/RR13827.1; Lehnert BE, 1997, CANCER RES, V57, P2164; Lo Cicero A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8506; Lotvall J, 2014, COMMUNICATION; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Lyng FM, 2002, RADIAT RES, V157, P365, DOI 10.1667/0033-7587(2002)157[0365:IOAICE]2.0.CO;2; Mayburov SN, 2012, QUANT COM COM, V11, P1; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Myhill S, 2009, INT J CLIN EXP MED, V2, P1; NAGASAWA H, 1992, CANCER RES, V52, P6394; Pall ML, 2008, MED HYPOTHESES, V71, P537, DOI 10.1016/j.mehy.2008.05.023; POPP FA, 1984, CELL BIOPHYS, V6, P33, DOI 10.1007/BF02788579; Prise KM, 1998, STUDIES OF BYSTANDER, V74; Sharetsky A. N., 2012, Radiatsionnaya Biologiya Radioekologiya, V52, P229; Surinov BP, 2007, NATO SCI PEACE SECUR, P127, DOI 10.1007/978-1-4020-6335-0_9; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; VANWIJK R, 1993, J PHOTOCH PHOTOBIO B, V18, P75, DOI 10.1016/1011-1344(93)80042-8; VANWIJK R, 2001, J SCI EXPLOR, V0015, P00183; Whiteside JR, 2011, PHOTOCHEM PHOTOBIOL, V87, P435, DOI 10.1111/j.1751-1097.2010.00881.x; Whiteside JR, 2009, RADIAT RES, V171, P204, DOI 10.1667/RR1508.1; Wu L, 2016, TUMOUR BIOL; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089534; Xu S, 2015, RNA BIOL, V12, P1355, DOI 10.1080/15476286.2015.1100795; Zhang HG, 2016, ONCOTARGET, V5	46	60	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173685	10.1371/journal.pone.0173685	http://dx.doi.org/10.1371/journal.pone.0173685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278290	Green Published, gold			2022-12-26	WOS:000396087900028
J	Sellam, A; Lode, N; Ayachi, A; Jourdain, G; Dauger, S; Jones, P				Sellam, Aurelie; Lode, Noella; Ayachi, Azzedine; Jourdain, Gilles; Dauger, Stephane; Jones, Peter			Passive hypothermia (>= 35-< 36 degrees C) during transport of newborns with hypoxic-ischaemic encephalopathy	PLOS ONE			English	Article							WHOLE-BODY HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; MODERATE HYPOTHERMIA; ASPHYXIA; INFANTS; TERM	Background Hypothermia initiated in the first six hours of life in term infants with hypoxic ischemic encephalopathy reduces the risk of death and severe neurological sequelae. Our study's principal objective was to evaluate transport predictors potentially influencing arrival in NICU (Neonatal Intensive Care Unit) at a temperature >= 35-<36 degrees C. Methodology/Principal findings A multi-centric, prospective cohort study was conducted during 18 months by the three Neonatal Transport Teams and 13 NICUs. Newborns were selected for inclusion according to biological and clinical criteria before transport using passive hypothermia using a target temperature of >= 35-<36 degrees C. Data on 120 of 126 inclusions were available for analysis. Thirty-three percent of the children arrived in NICU with the target temperature of >= 35-<36 degrees C. The mean temperature for the whole group of infants on arrival in NICU was 35.4 degrees C (34.3-36.5). The median age of all infants on arrival in NICU was 3h03min [2h25min-3h56min]. Three infants arrived in NICU with a temperature of <33 degrees C and eleven with a temperature >= 37 degrees C. Adrenaline during resuscitation was associated with a lower mean temperature on arrival in NICU. Conclusions/Significance Our strategy using >= 35-<36 degrees C passive hypothermia combined with short transport times had little effect on temperature after the arrival of Neonatal Transport Team although did reduce numbers of infants arriving in NICU in deep hypothermia. For those infants where hypothermia was discontinued in NICU our strategy facilitated re-warming. Re-adjustment to a lower target temperature to >= 34.5-<35.5 degrees C may reduce the proportion of infants with high/normothermic temperatures.	[Sellam, Aurelie; Lode, Noella; Jones, Peter] Hop Robert Debre, AP HP, SMUR Pediat, Paris, France; [Ayachi, Azzedine] Hop Andre Gregoire, AP HP, SMUR Pediat, Montreuil, France; [Jourdain, Gilles] Hop Clamart, SMUR Pediat, Clamart, France; [Dauger, Stephane; Jones, Peter] Hop Robert Debre, Reanimat Pediat PICU, Paris, France; [Jones, Peter] UCL, Inst Child Hlth, Portex Unit, Crit Care Grp,Portex Unit, London, England; [Jones, Peter] London Sch Hyg & Trop Med, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Jones, P (corresponding author), Hop Robert Debre, AP HP, SMUR Pediat, Paris, France.; Jones, P (corresponding author), Hop Robert Debre, Reanimat Pediat PICU, Paris, France.; Jones, P (corresponding author), UCL, Inst Child Hlth, Portex Unit, Crit Care Grp,Portex Unit, London, England.; Jones, P (corresponding author), London Sch Hyg & Trop Med, London, England.	sejjprj@ucl.ac.uk	Dauger, Stéphane/AAX-9669-2021					Akula VP, 2012, AM J PERINAT, V29, P319, DOI 10.1055/s-0031-1295661; Azzopardi D, NEW ENGL J MED, V371, P140, DOI [10.1056/NEJMeal315788, DOI 10.1056/NEJMEAL315788]; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; BURNARD ED, 1958, BRIT MED J, V2, P1197, DOI 10.1136/bmj.2.5106.1197; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Fairchild K, 2010, J PERINATOL, V30, P324, DOI 10.1038/jp.2009.168; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1999, PEDIATR RES, V46, P274, DOI 10.1203/00006450-199909000-00005; Hallberg B, 2009, ACTA PAEDIATR, V98, P942, DOI 10.1111/j.1651-2227.2009.01303.x; Hobson Andrea, 2011, Air Med J, V30, P197, DOI 10.1016/j.amj.2011.03.010; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Johnston ED, 2010, ARCH DIS CHILD-FETAL, V97, pF365; Kendall GS, 2010, ARCH DIS CHILD-FETAL, V95, pF408, DOI 10.1136/adc.2010.187211; Khurshid F, 2011, PAED CHILD HEALT-CAN, V16, P153, DOI 10.1093/pch/16.3.153; Laptook AR, 2013, ANN NEUROL, V73, P520, DOI 10.1002/ana.23843; Laptook AR, 2010, PEDIATRICS, V126, pE965, DOI 10.1542/peds.2010-2075; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Merchant N, 2015, DEV MED CHILD NEUROL, V57, P8, DOI 10.1111/dmcn.12726; MYERS RE, 1975, BIOL NEONATE, V26, P21; O'Reilly D, 2013, J PERINATOL, V33, P435, DOI 10.1038/jp.2012.138; Oncel MY, 2013, PEDIATR HEMAT ONCOL, V30, P246, DOI 10.3109/08880018.2013.771240; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Savarese I, 2015, J MATERN-FETAL NEO M, V14, P1; Schierholz Elizabeth, 2014, Adv Neonatal Care, V14 Suppl 5, pS24, DOI 10.1097/ANC.0000000000000121; Shah NA, 2015, AM J PERINAT, V32, P755, DOI 10.1055/s-0034-1395483; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHANKARAN S, 1991, EARLY HUM DEV, V25, P135, DOI 10.1016/0378-3782(91)90191-5; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Thoresen M, 2013, NEONATOLOGY, V104, P228, DOI 10.1159/000353948; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Weiss M D, 2014, J Neonatal Perinatal Med, V7, P173, DOI 10.3233/NPM-14814018	32	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0170100	10.1371/journal.pone.0170100	http://dx.doi.org/10.1371/journal.pone.0170100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278217	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900105
J	Witting, M; Ruttkies, C; Neumann, S; Schmitt-Kopplin, P				Witting, Michael; Ruttkies, Christoph; Neumann, Steffen; Schmitt-Kopplin, Philippe			LipidFrag: Improving reliability of in silico fragmentation of lipids and application to the Caenorhabditis elegans lipidome	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; DATA-DEPENDENT ACQUISITION; SHOTGUN LIPIDOMICS; ELECTROSPRAY-IONIZATION; IDENTIFICATION; DATABASE; METABOLOMICS	Lipid identification is a major bottleneck in high-throughput lipidomics studies. However, tools for the analysis of lipid tandem MS spectra are rather limited. While the comparison against spectra in reference libraries is one of the preferred methods, these libraries are far from being complete. In order to improve identification rates, the in silico fragmentation tool MetFrag was combined with Lipid Maps and lipid-class specific classifiers which calculate probabilities for lipid class assignments. The resulting LipidFrag workflow was trained and evaluated on different commercially available lipid standard materials, measured with data dependent UPLC-Q-ToF-MS/MS acquisition. The automatic analysis was compared against manual MS/MS spectra interpretation. With the lipid class specific models, identification of the true positives was improved especially for cases where candidate lipids from different lipid classes had similar MetFrag scores by removing up to 56% of false positive results. This LipidFrag approach was then applied to MS/MS spectra of lipid extracts of the nematode Caenorhabditis elegans. Fragments explained by LipidFrag match known fragmentation pathways, e.g., neutral losses of lipid headgroups and fatty acid side chain fragments. Based on prediction models trained on standard lipid materials, high probabilities for correct annotations were achieved, which makes LipidFrag a good choice for automated lipid data analysis and reliability testing of lipid identifications.	[Witting, Michael; Schmitt-Kopplin, Philippe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Analyt BioGeoChem, Ingolstaedter Landstr, Neuherberg, Germany; [Witting, Michael; Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany; [Ruttkies, Christoph; Neumann, Steffen] IPB Halle, Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, Halle, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Leibniz Institut fur Pflanzenbiochemie	Witting, M (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Analyt BioGeoChem, Ingolstaedter Landstr, Neuherberg, Germany.; Witting, M (corresponding author), Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany.	michael.witting@helmholtz-muenchen.de	Neumann, Steffen/K-5554-2012; Schmitt-Kopplin, Philippe/H-6271-2011; Witting, Michael/AAI-1338-2019	Neumann, Steffen/0000-0002-7899-7192; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Witting, Michael/0000-0002-1462-4426	DFG [NE/1396/5-1]	DFG(German Research Foundation (DFG))	Christoph Ruttkies acknowledges funding from DFG grant NE/1396/5-1.r Christoph Ruttkies acknowledges funding from DFG grant NE/1396/5-1. C. elegans samples were kindly provided by Steve Garvis, ENS Lyon. We thank Emma Schymanski (Eawag, Dubendorf, Switzerland) for fruitful and intensive discussions and comments on the manuscript.	Ahmed Z, 2015, BIOINFORMATICS, V31, P1150, DOI 10.1093/bioinformatics/btu796; Aimo L, 2015, BIOINFORMATICS, V31, P2860, DOI 10.1093/bioinformatics/btv285; Almeida R, 2015, J AM SOC MASS SPECTR, V26, P133, DOI 10.1007/s13361-014-1013-x; Bird SS, 2012, ANAL CHEM, V84, P5509, DOI 10.1021/ac300953j; CAFFREY M, 1992, CHEM PHYS LIPIDS, V61, P1, DOI 10.1016/0009-3084(92)90002-7; Castro-Perez JM, 2010, J PROTEOME RES, V9, P2377, DOI 10.1021/pr901094j; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Foster JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061951; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P797, DOI 10.1016/S1044-0305(00)00151-3; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Ishida M, 2004, RAPID COMMUN MASS SP, V18, P2486, DOI 10.1002/rcm.1650; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Kerber A, 1998, MATCH-COMMUN MATH CO, P205; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kochen MA, 2016, ANAL CHEM, V88, P5733, DOI 10.1021/acs.analchem.6b00021; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Luo P, 2015, ANAL CHEM, V87, P5050, DOI 10.1021/acs.analchem.5b00615; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Papan C, 2014, ANAL CHEM, V86, P2703, DOI 10.1021/ac404083u; Pham HT, 2014, ANALYST, V139, P204, DOI 10.1039/c3an01712e; Schwudke D, 2007, METHOD ENZYMOL, V433, P175, DOI 10.1016/S0076-6879(07)33010-3; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Watanabe K, 2000, TRENDS GLYCOSCI GLYC, V12, P175, DOI 10.4052/tigg.12.175; Witting M, 2016, ARCH BIOCHEM BIOPHYS, V589, P27, DOI 10.1016/j.abb.2015.06.003; Witting M, 2014, COMP ANAL C, V63, P421, DOI 10.1016/B978-0-444-62651-6.00018-0; Witting M, 2014, J CHROMATOGR A, V1359, P91, DOI 10.1016/j.chroma.2014.07.021; Wolf S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-148; Yan ZX, 2015, ANAL CHEM, V87, P2861, DOI 10.1021/ac504325x; Yang K, 2011, METABOLITES, V1, P21, DOI 10.3390/metabo1010021; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u	39	17	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172311	10.1371/journal.pone.0172311	http://dx.doi.org/10.1371/journal.pone.0172311			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278196	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900117
J	Morais, MAB; Giuseppe, PO; Souza, TACB; Castro, H; Honorato, RV; Oliveira, PSL; Netto, LES; Tomas, AM; Murakami, MT				Morais, Mariana A. B.; Giuseppe, Priscila O.; Souza, Tatiana A. C. B.; Castro, Helena; Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Netto, Luis E. S.; Tomas, Ana M.; Murakami, Mario T.			Calcium and magnesium ions modulate the oligomeric state and function of mitochondrial 2-Cys peroxiredoxins in Leishmania parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPAREDOXIN PEROXIDASE; ANTIOXIDANT PROTEIN; DECAMER; AHPC; CA2+; CRYSTALLIZATION; INTERCONVERSION; COORDINATION; STIMULATION; RESOLUTION	Leishmania parasites have evolved a number of strategies to cope with the harsh environmental changes during mammalian infection. One of these mechanisms involves the functional gain that allows mitochondrial 2-Cys peroxiredoxins to act as molecular chaperones when forming decamers. This function is critical for parasite infectivity in mammals, and its activation has been considered to be controlled exclusively by the enzyme redox state under physiological conditions. Herein, we have revealed that magnesium and calcium ions play a major role in modulating the ability of these enzymes to act as molecular chaperones, surpassing the redox effect. These ions are directly involved in mitochondrial metabolism and participate in a novel mechanism to stabilize the decameric form of 2-Cys peroxiredoxins in Leishmania mitochondria. Moreover, we have demonstrated that a constitutively dimeric Prx1m mutant impairs the survival of Leishmania under heat stress, supporting the central role of the chaperone function of Prx1m for Leishmania parasites during the transition from insect to mammalian hosts.	[Morais, Mariana A. B.; Giuseppe, Priscila O.; Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Murakami, Mario T.] Natl Ctr Res Energy & Mat, Biosci Natl Lab, Rua Giuseppe Maximo Scolfaro 10000, BR-13083100 Campinas, SP, Brazil; [Souza, Tatiana A. C. B.] Fiocruz MS, Carlos Chagas Inst, Prote & Prot Engn Lab, Rua Prof Algacyr Munhoz Mader 2135, BR-81310020 Curitiba, PR, Brazil; [Castro, Helena; Tomas, Ana M.] Univ Porto, I3S Inst Invest & Innovat Hlth, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Castro, Helena; Tomas, Ana M.] Univ Porto, Inst Mol & Cell Biol IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Netto, Luis E. S.] Univ State Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, Rua Matao 14, BR-05508090 Sao Paulo, SP, Brazil; [Tomas, Ana M.] Univ Porto, Abel Salazar Biomed Sci Inst, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal	Fundacao Oswaldo Cruz; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade Estadual Paulista; Universidade do Porto	Murakami, MT (corresponding author), Natl Ctr Res Energy & Mat, Biosci Natl Lab, Giuseppe Maximo Scolfaro 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Oliveira de Giuseppe, Priscila/GLR-1319-2022; Castro, Helena/J-4794-2013; Oliveira, Paulo S/K-5588-2013; Honorato, Rodrigo Vargas/AAY-9375-2020; Netto, Luis/A-3783-2008; Murakami, Mario T/F-5640-2016; Tomas, Ana/J-9919-2013	Oliveira de Giuseppe, Priscila/0000-0003-2094-7325; Castro, Helena/0000-0002-6021-9210; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Netto, Luis/0000-0002-4250-9177; Murakami, Mario T/0000-0002-0405-8010; Morais, Mariana Abrahao Bueno de/0000-0003-1012-1394; Tomas, Ana/0000-0002-0781-9567	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/51730-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Norte Portugal Regional Operational Programme (NORTE) under the Quadro de Referencia Estrategico Nacional through the European Regional Development Fund (ERDF); Portuguese Foundation for Science and Technology; NORTE under the PORTUGAL Partnership Agreement through ERDF); FAPESP [2011/10248-4, 2012/24134-3, 2015/05851-4]; Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) through the "Investigador FCT" programme;  ["NORTE-07-0124-FEDER-000002"];  ["NORTE-01-0145-FEDER-000012"]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Norte Portugal Regional Operational Programme (NORTE) under the Quadro de Referencia Estrategico Nacional through the European Regional Development Fund (ERDF); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NORTE under the PORTUGAL Partnership Agreement through ERDF); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) through the "Investigador FCT" programme; ; 	This work was supported by Grant 2010/51730-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (to M. T. M.). This work was also supported by grants from Project "NORTE-07-0124-FEDER-000002" (co-funded by the Norte Portugal Regional Operational Programme (NORTE 2020) under the Quadro de Referencia Estrategico Nacional through the European Regional Development Fund (ERDF) and by the the Portuguese Foundation for Science and Technology) and from Project "NORTE-01-0145-FEDER-000012" (supported by NORTE 2020 under the PORTUGAL 2020 Partnership Agreement through ERDF) (to A. M. T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by FAPESP Fellowships 2011/10248-4, 2012/24134-3, and 2015/05851-4.; Supported by the Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) through the "Investigador FCT" programme.	Andreini C, 2012, BIOINFORMATICS, V28, P1658, DOI 10.1093/bioinformatics/bts246; Angelucci F, 2016, MOL BIOCHEM PARASIT, V206, P2, DOI 10.1016/j.molbiopara.2016.03.005; Barranco-Medina S, 2008, BIOCHEMISTRY-US, V47, P7196, DOI 10.1021/bi8002956; BENAIM G, 1990, MOL BIOCHEM PARASIT, V39, P61, DOI 10.1016/0166-6851(90)90008-A; Bernier-Villamor L, 2004, J EXP BOT, V55, P2191, DOI 10.1093/jxb/erh238; Beverley S M, 1993, Methods Mol Biol, V21, P333; de Morais MAB, 2013, ACTA CRYSTALLOGR F, V69, P408, DOI 10.1107/S1744309113003989; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Castro H, 2004, MOL BIOCHEM PARASIT, V136, P137, DOI 10.1016/j.molbiopara.2004.02.015; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Castro H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002325; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; de Oliveira MA, 2007, ACTA CRYSTALLOGR F, V63, P665, DOI 10.1107/S1744309107031557; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kitano K, 1999, J BIOCHEM, V126, P313, DOI 10.1093/oxfordjournals.jbchem.a022451; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Kristensen P, 1999, BIOCHEM BIOPH RES CO, V262, P127, DOI 10.1006/bbrc.1999.1107; LETILLY V, 1993, BIOCHEMISTRY-US, V32, P7753, DOI 10.1021/bi00081a021; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Morais MAB, 2015, J BIOL CHEM, V290, P8582, DOI 10.1074/jbc.M114.619205; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Pearson R. D., 1989, Parasitic infections in the compromised host., P31; Pineyro MD, 2005, J STRUCT BIOL, V150, P11, DOI 10.1016/j.jsb.2004.12.005; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Prasad A, 2001, MOL CELL BIOCHEM, V224, P39, DOI 10.1023/A:1011965109446; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; RUTTER GA, 1990, BIOCHEM J, V271, P627, DOI 10.1042/bj2710627; Sarkar AR, 2016, CHEM SCI, V7, P766, DOI 10.1039/c5sc03708e; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Sousa AF, 2014, FREE RADICAL BIO MED, V73, P229, DOI 10.1016/j.freeradbiomed.2014.05.007; Suzuki N, 2005, J MOL BIOL, V353, P80, DOI 10.1016/j.jmb.2005.08.018; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Teixeira F, 2015, P NATL ACAD SCI USA, V112, pE616, DOI 10.1073/pnas.1419682112; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhao Q, 2015, CHEM SCI, V6, P4124, DOI 10.1039/c5sc00633c	52	6	6	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7023	7039		10.1074/jbc.M116.762039	http://dx.doi.org/10.1074/jbc.M116.762039			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28292930	Green Published, hybrid			2022-12-26	WOS:000400478300014
J	Lukacisin, M; Landon, M; Jajoo, R				Lukacisin, Martin; Landon, Matthieu; Jajoo, Rishi			Sequence-specific thermodynamic properties of nucleic acids influence both transcriptional pausing and backtracking in yeast	PLOS ONE			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE RESOLUTION; GENOME INSTABILITY; ELONGATION COMPLEX; PREDICT STABILITY; STRUCTURAL BASIS; DNA HYBRID; IN-VIVO; DYNAMICS; DUPLEXES	RNA Polymerase II pauses and backtracks during transcription, with many consequences for gene expression and cellular physiology. Here, we show that the energy required to melt double-stranded nucleic acids in the transcription bubble predicts pausing in Saccharomyces cerevisiae far more accurately than nucleosome roadblocks do. In addition, the same energy difference also determines when the RNA polymerase backtracks instead of continuing to move forward. This data-driven model corroborates-in a genome wide and quantitative manner-previous evidence that sequence-dependent thermodynamic features of nucleic acids influence both transcriptional pausing and backtracking.	[Lukacisin, Martin; Landon, Matthieu; Jajoo, Rishi] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Lukacisin, Martin] IST Austria, Klosterneuburg, Austria; [Landon, Matthieu] Harvard Med Sch, Dept Genet, Boston, MA USA; [Landon, Matthieu] Mines Paristech, Ecole Mines Paris, Paris, France	Harvard University; Harvard Medical School; Institute of Science & Technology - Austria; Harvard University; Harvard Medical School; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Jajoo, R (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	rjajoo@uci.edu		Lukacisin, Martin/0000-0001-6549-4177	National Institutes of Health [GM08017]; Lynch Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lynch Foundation	RJ has received support from National Institutes of Health Training Grant GM08017 and is a fellow of the Jane Coffin Childs Memorial Fund. MLa is a Lynch Fellow, supported by The Lynch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bai L, 2006, ANNU REV BIOPH BIOM, V35, P343, DOI 10.1146/annurev.biophys.35.010406.150153; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Depken M, 2013, CELL REP, V5, P521, DOI 10.1016/j.celrep.2013.09.007; Depken M, 2009, BIOPHYS J, V96, P2189, DOI 10.1016/j.bpj.2008.12.3918; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hein PP, 2014, NAT STRUCT MOL BIOL, V21, P794, DOI 10.1038/nsmb.2867; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; HYMAN LE, 1993, MOL CELL BIOL, V13, P5159, DOI 10.1128/MCB.13.9.5159; Imashimizu M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0666-5; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; OMAOILEIDIGH D, 2011, BIOPHYS J, V100, P1157; Proctor JR, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt174; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Sydow JF, 2009, CURR OPIN STRUC BIOL, V19, P732, DOI 10.1016/j.sbi.2009.10.009; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Watkins NE, 2011, NUCLEIC ACIDS RES, V39, P1894, DOI 10.1093/nar/gkq905; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Zamft B, 2012, P NATL ACAD SCI USA, V109, P8948, DOI 10.1073/pnas.1205063109; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174066	10.1371/journal.pone.0174066	http://dx.doi.org/10.1371/journal.pone.0174066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301878	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300121
J	Boulanger, M; Giraudet, G; Faubert, J				Boulanger, Mathieu; Giraudet, Guillaume; Faubert, Jocelyn			Interaction between the oculomotor and postural systems during a dual-task: Compensatory reductions in head sway following visually-induced postural perturbations promote the production of accurate double-step saccades in standing human adults	PLOS ONE			English	Article							NECK MUSCLE RESPONSES; TRANSCRANIAL MAGNETIC STIMULATION; MONKEY SUPERIOR COLLICULUS; EYE-MOVEMENTS; GAZE SHIFTS; VESTIBULOOCULAR REFLEX; UNRESTRAINED MONKEY; FEEDBACK-CONTROL; BODY SWAY; COORDINATION	Humans routinely scan their environment for useful information using saccadic eye movements and/or coordinated movements of the eyes and other body segments such the head and the torso. Most previous eye movement studies were conducted with seated subject and showed that single saccades and sequences of saccades (e.g. double-step saccades) made to briefly flashed stimuli were equally accurate and precise. As one can easily appreciate, most gaze shifts performed daily by a given person are not produced from a seated position, but rather from a standing position either as subjects perform an action from an upright stance or as they walk from one place to another. In the experiments presented here, we developed a new dual-task paradigm in order to study the interaction between the gaze control system and the postural system. Healthy adults (n = 12) were required to both maintain balance and produce accurate single-step and double-step eye saccades from a standing position. Visually-induced changes in head sway were evoked using wide-field background stimuli that either moved in the mediolateral direction or in the anteroposterior direction. We found that, as in the seated condition, single-and double-step saccades were very precise and accurate when made from a standing position, but that a tighter control of head sway was necessary in the more complex double-step saccades condition for equivalent results to be obtained. Our perturbation results support the "common goal" hypothesis that state that if necessary, as was the case during the more complex oculomotor task, context-dependent modulations of the postural system can be triggered to reduced instability and therefore support the accomplishment of a suprapostural goal.	[Boulanger, Mathieu; Giraudet, Guillaume; Faubert, Jocelyn] Univ Montreal, Ecole Optometrie, Montreal, PQ, Canada; [Boulanger, Mathieu] McGill Univ, Jewish Rehabil Hosp, Laval, PQ, Canada	Universite de Montreal; McGill University	Boulanger, M (corresponding author), Univ Montreal, Ecole Optometrie, Montreal, PQ, Canada.; Boulanger, M (corresponding author), McGill Univ, Jewish Rehabil Hosp, Laval, PQ, Canada.	mathieu.boulanger@mail.mcgill.ca	Faubert, Jocelyn/E-2207-2011		Natural Sciences and Engineering Research Council of Canada (NSERC) [IRCPJ 305729-13]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC). NSERC-ESSILOR Industrial Chair IRCPJ 305729-13; www.nserc-crsng.gc.ca/index_eng.asp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasopoulos D, 2011, MOVEMENT DISORD, V26, P2201, DOI 10.1002/mds.23798; Anastasopoulos D, 2009, EXP BRAIN RES, V193, P323, DOI 10.1007/s00221-008-1627-y; ANDREDESHAYS C, 1988, EXP BRAIN RES, V69, P399; ANDREDESHAYS C, 1991, EXP BRAIN RES, V84, P359; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Bernstein NA., 1967, COORDINATION REGULAT; BIZZI E, 1971, SCIENCE, V173, P452, DOI 10.1126/science.173.3995.452; Bonnet CT, 2014, J MOTOR BEHAV, V46, P397, DOI 10.1080/00222895.2014.924472; Bonnet CT, 2012, HUM MOVEMENT SCI, V31, P1541, DOI 10.1016/j.humov.2012.05.001; Boulanger M, 2012, J NEUROPHYSIOL, V108, P39, DOI 10.1152/jn.01092.2011; Buonocore A, 2015, EXP BRAIN RES, V233, P1893, DOI 10.1007/s00221-015-4261-5; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Chapman BB, 2012, J NEUROPHYSIOL, V107, P1694, DOI 10.1152/jn.00487.2011; Choi WY, 2006, NEURON, V50, P491, DOI 10.1016/j.neuron.2006.03.032; Choi WY, 2009, J NEUROSCI, V29, P7166, DOI 10.1523/JNEUROSCI.5038-08.2009; Corneil BD, 2002, J NEUROPHYSIOL, V88, P2000, DOI 10.1152/jn.2002.88.4.2000; Corneil BD, 2002, J NEUROPHYSIOL, V88, P1980, DOI 10.1152/jn.2002.88.4.1980; Corneil BD, 2014, NEURON, V82, P1230, DOI 10.1016/j.neuron.2014.05.040; Cullen KE, 2004, J NEUROPHYSIOL, V92, P3408, DOI 10.1152/jn.01156.2003; DASSONVILLE P, 1992, EXP BRAIN RES, V89, P300; Elsley JK, 2007, J NEUROPHYSIOL, V98, P1333, DOI 10.1152/jn.00386.2007; Faubert J, 2004, PROC SPIE, V5291, P491, DOI 10.1117/12.527017; Gandhi NJ, 2005, J NEUROPHYSIOL, V93, P1718, DOI 10.1152/jn.00854.2004; GELLMAN RS, 1991, EXP BRAIN RES, V87, P433; Giveans MR, 2011, ECOL PSYCHOL, V23, P247, DOI 10.1080/10407413.2011.617215; Goonetilleke SC, 2015, J NEUROPHYSIOL, V114, P902, DOI 10.1152/jn.00230.2015; Goonetilleke SC, 2011, EUR J NEUROSCI, V33, P2155, DOI 10.1111/j.1460-9568.2011.07711.x; Goossens HHLM, 2010, J NEUROPHYSIOL, V103, P1685, DOI 10.1152/jn.00788.2009; Goossens HHLM, 1997, J NEUROPHYSIOL, V78, P533, DOI 10.1152/jn.1997.78.1.533; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3411, DOI 10.1152/jn.2000.83.6.3411; Goossens HHLM, 1997, EXP BRAIN RES, V114, P542, DOI 10.1007/PL00005663; Greffou S, 2008, J VISION, V8, DOI 10.1167/8.11.15; Gu C, 2014, J NEUROSCI, V34, P14803, DOI 10.1523/JNEUROSCI.2907-14.2014; GUITTON D, 1987, J NEUROPHYSIOL, V58, P427, DOI 10.1152/jn.1987.58.3.427; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; Hanssens JM, 2013, EXP BRAIN RES, V229, P75, DOI 10.1007/s00221-013-3592-3; Hunter MC, 2001, GAIT POSTURE, V13, P41, DOI 10.1016/S0966-6362(00)00089-8; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Jahn K, 2006, EXP BRAIN RES, V174, P152, DOI 10.1007/s00221-006-0431-9; Kikukawa M., 1985, VESTIBULAR VISUAL CO, P355; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Laurens J, 2010, GAIT POSTURE, V31, P37, DOI 10.1016/j.gaitpost.2009.08.241; LAURUTIS VP, 1986, J PHYSIOL-LONDON, V373, P209, DOI 10.1113/jphysiol.1986.sp016043; Legrand A, 2013, EXP BRAIN RES, V227, P397, DOI 10.1007/s00221-013-3519-z; Lehnen N, 2009, EXP BRAIN RES, V194, P495, DOI 10.1007/s00221-009-1708-6; Marino AC, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00003; MAYS LE, 1980, SCIENCE, V208, P1163, DOI 10.1126/science.6769161; McCluskey MK, 2007, J NEUROPHYSIOL, V97, P2976, DOI 10.1152/jn.00822.2006; Medendorp WP, 2006, J NEUROPHYSIOL, V95, P1645, DOI 10.1152/jn.00905.2005; Monzani D, 2005, Acta Otorhinolaryngol Ital, V25, P224; Oblak B., 1985, VESTIBULAR VISUAL CO, P122; Oommen BS, 2005, BRAIN RES, V1065, P68, DOI 10.1016/j.brainres.2005.10.029; PELISSON D, 1989, EXP BRAIN RES, V78, P654; PELISSON D, 1995, EXP BRAIN RES, V106, P196; PELISSON D, 1988, J NEUROPHYSIOL, V59, P997, DOI 10.1152/jn.1988.59.3.997; Piponnier JC, 2009, J VISION, V9, DOI 10.1167/9.1.13; Quaia C, 2010, J VISION, V10, DOI 10.1167/10.14.28; Ray S, 2004, VISION RES, V44, P2707, DOI 10.1016/j.visres.2004.05.029; Rey F, 2008, AURIS NASUS LARYNX, V35, P185, DOI 10.1016/j.anl.2007.07.001; Rodrigues ST, 2015, NEUROSCI LETT, V584, P292, DOI 10.1016/j.neulet.2014.10.045; Roll J. P., 1987, EYE MOVEMENTS PHYSL, P57; ROLL JP, 1988, INT CONGR SER, V812, P155; Rougier P, 2006, NEUROPHYSIOL CLIN, V36, P235, DOI 10.1016/j.neucli.2006.09.003; Rougier P, 2007, MOTOR CONTROL, V11, P213, DOI 10.1123/mcj.11.3.213; Saglam M, 2011, J NEUROSCI, V31, P16185, DOI 10.1523/JNEUROSCI.3721-11.2011; Scharli AM, 2013, EXP BRAIN RES, V227, P523, DOI 10.1007/s00221-013-3528-y; Scharli AM, 2012, GAIT POSTURE, V36, P78, DOI 10.1016/j.gaitpost.2012.01.008; SCHLAGREY M, 1989, EXP BRAIN RES, V76, P537, DOI 10.1007/BF00248910; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; Stahl JS, 2001, EXP BRAIN RES, V136, P200, DOI 10.1007/s002210000593; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Stoffregen TA, 2006, ECOL PSYCHOL, V18, P191, DOI 10.1207/s15326969eco1803_3; Sylvestre PA, 2006, J NEUROSCI, V26, P4922, DOI 10.1523/JNEUROSCI.4099-05.2006; Tabak S, 1996, J NEUROPHYSIOL, V76, P3249, DOI 10.1152/jn.1996.76.5.3249; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TOMLINSON RD, 1986, J NEUROPHYSIOL, V56, P1542, DOI 10.1152/jn.1986.56.6.1542; TOMLINSON RD, 1990, J NEUROPHYSIOL, V64, P1873, DOI 10.1152/jn.1990.64.6.1873; UCHIDA T, 1980, NEUROSCI LETT, V18, P219, DOI 10.1016/0304-3940(80)90329-8; UCHIDA T, 1979, NEUROSCI LETT, V13, P253, DOI 10.1016/0304-3940(79)91503-9; van der Kooij H, 2011, GAIT POSTURE, V34, P19, DOI 10.1016/j.gaitpost.2011.02.025; VIDAL PP, 1982, EXP BRAIN RES, V46, P448; Vliegen J, 2005, J NEUROPHYSIOL, V94, P4300, DOI 10.1152/jn.00027.2005; WHITE KD, 1980, SCIENCE, V208, P621, DOI 10.1126/science.7367888; Wolsley CJ, 1996, EXP BRAIN RES, V111, P283; Wolsley CJ, 1996, BRAIN RES BULL, V40, P437, DOI 10.1016/0361-9230(96)00139-6; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	93	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173678	10.1371/journal.pone.0173678	http://dx.doi.org/10.1371/journal.pone.0173678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296958	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700049
J	Hradec, M; Linhart, P; Bartos, L; Bolechova, P				Hradec, Michal; Linhart, Pavel; Bartos, Ludek; Bolechova, Petra			The traits of the great calls in the juvenile and adolescent gibbon males Nomascus gabriellae	PLOS ONE			English	Article							HYLOBATES-GABRIELLAE	Knowledge about vocal ontogeny and vocal plasticity during ontogeny in primate species is central to understanding the evolution of human speech. Vocalizations in gibbons (Hominoidea) are very interesting and contain complex species-and sex-specific patterns. However, ontogeny of gibbon songs is little studied. Here, we document regular production and ontogenetic changes of female-specific "great call" in 4 immature (2 juvenile-c.a. 3 years old; and 2 adolescent-c.a. 5 years old) males of southern yellow-cheeked gibbon (N. gabriellae) over nine months. None of the males produced fully developed adult-like "great call" and little ontogenetic changes to "great calls" occurred. "Great calls" of sons were shorter, started higher and ended lower than those of their mothers. Regular production of twitter part of great call likely appears around 4th year as it was observed in adolescent but not in juvenile males.	[Hradec, Michal; Bartos, Ludek; Bolechova, Petra] Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Prague, Czech Republic; [Linhart, Pavel; Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Bolechova, Petra] Zoo Liberec, Liberec, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Hradec, M (corresponding author), Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Prague, Czech Republic.	hradecm@af.czu.cz	Hradec, Michal/Y-7786-2018; Linhart, Pavel/AAZ-7474-2021; Bolechova, Petra/Z-1214-2018	Hradec, Michal/0000-0002-0961-9921; Linhart, Pavel/0000-0002-6097-5892; Bolechova, Petra/0000-0001-9007-1213	Ministry of Agriculture of Czech Republic [MZeRO 0714]; Czech University of Life Sciences Prague [SV15-70-21370]	Ministry of Agriculture of Czech Republic(Ministry of Agriculture, Czech Republic); Czech University of Life Sciences Prague	This work was supported by the Ministry of Agriculture of Czech Republic (MZeRO 0714) and the Czech University of Life Sciences Prague (SV15-70-21370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett TQ, 2003, INT J PRIMATOL, V24, P239, DOI 10.1023/A:1023088814263; Burns BL, 2016, AM J PRIMATOL, V78, P610, DOI 10.1002/ajp.22523; Burns BL, 2011, PRIMATES, V52, P271, DOI 10.1007/s10329-011-0247-5; COWLISHAW G, 1992, BEHAVIOUR, V121, P131, DOI 10.1163/156853992X00471; Deppute B., 1982, COMMUNICATION; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; Geissmann T, 2002, BIOL REV, V77, P57, DOI 10.1017/S1464793101005826; GEISSMANN T, 1995, PRIMATES, V36, P447, DOI 10.1007/BF02382867; Haimoff E, 1984, LESSER APES EVOLUTIO; Hradec M, 2016, PRIMATES, V57, P445, DOI 10.1007/s10329-016-0569-4; Koda H, 2014, PRIMATES, V55, P13, DOI 10.1007/s10329-013-0390-2; Koda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071432; Konrad R, 2006, INT J PRIMATOL, V27, P713, DOI 10.1007/s10764-006-9042-3; Leighton DR., 1987, PRIMATES SOC, P135; MARSHALL JT, 1976, SCIENCE, V193, P235, DOI 10.1126/science.193.4249.235; Merker B, 1999, FOLIA PRIMATOL, V70, P97, DOI 10.1159/000021680; MITANI JC, 1987, BEHAV ECOL SOCIOBIOL, V20, P265, DOI 10.1007/BF00292179; Reichard U. H., 2003, MONOGAMY MATING STRA; Schilling D, 1984, LESSER APES EVOLUTIO; Tao J., 2002, MIXED MODEL ANAL USI	20	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173959	10.1371/journal.pone.0173959	http://dx.doi.org/10.1371/journal.pone.0173959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296969	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700082
J	Morrison, PK; Harris, PA; Maltin, CA; Grove-White, D; Argo, CM				Morrison, Philippa K.; Harris, Patricia A.; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline McG.			EQUIFAT: A novel scoring system for the semi-quantitative evaluation of regional adipose tissues in Equidae	PLOS ONE			English	Article							BODY-FAT; INSULIN-RESISTANCE; METABOLIC SYNDROME; EPICARDIAL FAT; RISK-FACTORS; HORSES; OBESITY; PONIES; COMPARTMENTS; ASSOCIATION	Anatomically distinct adipose tissues represent variable risks to metabolic health in man and some other mammals. Quantitative-imaging of internal adipose depots is problematic in large animals and associations between regional adiposity and health are poorly understood. This study aimed to develop and test a semi-quantitative system (EQUIFAT) which could be applied to regional adipose tissues. Anatomically-defined, photographic images of adipose depots (omental, mesenteric, epicardial, rump) were collected from 38 animals immediately post-mortem. Images were ranked and depot-specific descriptors were developed (1 = no fat visible; 5 = excessive fat present). Nuchal-crest and ventro-abdominalretroperitoneal adipose depot depths (cm) were transformed to categorical 5 point scores. The repeatability and reliability of EQUIFAT was independently tested by 24 observers. When half scores were permitted, inter-observer agreement was substantial (average kappa(w): mesenteric, 0.79; omental, 0.79; rump 0.61) or moderate (average. w; epicardial, 0.60). Intra-observer repeatability was tested by 8 observers on 2 occasions. Kappa analysis indicated perfect (omental and mesenteric) and substantial agreement (epicardial and rump) between attempts. A further 207 animals were evaluated ante-mortem (age, height, breed-type, gender, body condition score [BCS]) and again immediately post-mortem (EQUIFAT scores, carcass weight). Multivariable, random effect linear regression models were fitted (breed as random effect; BCS as outcome variable). Only height, carcass weight, omental and retroperitoneal EQUIFAT scores remained as explanatory variables in the final model. The EQUIFAT scores developed here demonstrate clear functional differences between regional adipose depots and future studies could be directed towards describing associations between adiposity and disease risk in surgical and post-mortem situations.	[Morrison, Philippa K.; Argo, Caroline McG.] Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford, England; [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Freeby Lane, Melton Mowbray, Leics, England; [Maltin, Charlotte A.; Grove-White, Dai] Univ Liverpool, Fac Hlth & Life Sci, Dept Obes & Endocrinol, Leahurst Campus,Chester High Rd, Wirral, Merseyside, England; [Maltin, Charlotte A.] Biomics Ltd, Inverurie, Aberdeen, Scotland	University of Surrey; Mars; WALTHAM Petcare Science Institute; University of Liverpool	Argo, CM (corresponding author), Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford, England.	c.argo@surrey.ac.uk		Morrison, Philippa/0000-0003-4187-0371; Argo, Caroline/0000-0002-8279-6350	WALTHAM	WALTHAM	This research was funded by a PhD scholarship from WALTHAM. The funders (with the exception of Patricia A. Harris, co-author and collaborator) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The lead author was funded by a PhD studentship provided by WALTHAM. The authors wish to thank all those who participated in using the EQUIFAT scoring system to enable the repeatability and reliability to be assessed. In addition, the authors wish to acknowledge the statistical advice regarding kappa analysis from Dr Joeeph Angell. Finally, the authors wish to acknowledge the kind support for research activities offered by the UK equine slaughter industry.	Argo CM, 2012, VET J; Argo CM, 2014, FARM ANIMAL IMAGING, P12; Bailey SR, 2008, AM J VET RES, V69, P122, DOI 10.2460/ajvr.69.1.122; Bruynsteen L, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-240; Burns TA, 2010, J VET INTERN MED, V24, P932, DOI 10.1111/j.1939-1676.2010.0551.x; Burrows AM, 2013, J EQUINE VET SCI, V33, P361; CARROLL CL, 1988, EQUINE VET J, V20, P41, DOI 10.1111/j.2042-3306.1988.tb01451.x; Catalano KJ, 2010, DIABETES, V59, P1416, DOI 10.2337/db08-0675; Chapados N, 2008, BRIT J NUTR, V100, P518, DOI 10.1017/S0007114508921735; Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761; Cohen CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066477; Dugdale AHA, 2011, EQUINE VET J, V43, P552, DOI 10.1111/j.2042-3306.2010.00330.x; Dugdale AHA, 2012, VET J, V194, P173, DOI 10.1016/j.tvjl.2012.03.024; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Geor RJ, 2008, J EQUINE VET SCI, V28, P753, DOI 10.1016/j.jevs.2008.10.016; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Gjerlaug-Enger E, 2012, ANIMAL, V6, P9, DOI 10.1017/S1751731111001455; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Holbrook TC, 2012, VET IMMUNOL IMMUNOP, V145, P283, DOI 10.1016/j.vetimm.2011.11.013; Hung CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112355; Kearns CF, 2002, VET J, V163, P260, DOI 10.1053/tvjl.2001.0656; Kohnke JR., 1992, FEEDING NUTR MAKING, P163; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lottati M, 2009, OBESITY, V17, P674, DOI 10.1038/oby.2008.642; Mair TS, 2005, EQUINE VET J, V37, P296, DOI 10.2746/0425164054529409; Martin-Gimenez T, 2016, J EQUINE VET SCI, V39, P69, DOI 10.1016/j.jevs.2016.01.010; Mottet R., 2009, J EQUINE VET SCI, V29, P417, DOI [DOI 10.1016/j.jevs.2009.04.116, 10.1016/j.jevs.2009.04.116, DOI 10.1016/J.JEVS.2009.04.116]; Newkirk K. M., 2014, Open Journal of Veterinary Medicine, V4, P190, DOI 10.4236/ojvm.2014.49022; Okada K, 2014, J CARDIOVASC MED, V15, P384, DOI 10.2459/JCM.0b013e32836094da; Robin CA, 2015, EQUINE VET J, V47, P196, DOI 10.1111/evj.12275; Ross R, 1992, QUANTIFICATION ADIPO, P787; Sacks HS, 2009, J CLIN ENDOCR METAB, V94, P3611, DOI 10.1210/jc.2009-0571; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Speakman JR, 2003, AGING CELL, V2, P265, DOI 10.1046/j.1474-9728.2003.00061.x; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Vick MM, 2007, J ANIM SCI, V85, P1144, DOI 10.2527/jas.2006-673; Wang CP, 2009, CLIN ENDOCRINOL, V70, P876, DOI 10.1111/j.1365-2265.2008.03411.x; WESTERVELT RG, 1976, J ANIM SCI, V43, P781, DOI 10.2527/jas1976.434781x; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Wylie CE, 2013, RES VET SCI, V95, P410, DOI 10.1016/j.rvsc.2013.05.004	44	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173753	10.1371/journal.pone.0173753	http://dx.doi.org/10.1371/journal.pone.0173753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296956	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700056
J	Trojan, K; Unterrainer, C; Weimer, R; Bulut, N; Morath, C; Aly, M; Zhu, L; Opelz, G; Daniel, V				Trojan, Karina; Unterrainer, Christian; Weimer, Rolf; Bulut, Nuray; Morath, Christian; Aly, Mostafa; Zhu, Li; Opelz, Gerhard; Daniel, Volker			Helios expression and Foxp3 TSDR methylation of IFNy plus and IFNy- Treg from kidney transplant recipients with good long-term graft function	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VITRO; IMMUNOSUPPRESSIVE DRUGS; ORGAN-TRANSPLANTATION; INTERFERON-GAMMA; DNA METHYLATION; SURVIVAL; VIVO	Background There is circumstantial evidence that IFNy+ Treg might have clinical relevance in transplantation. IFNy+ Treg express IFNy receptors and are induced by IFNy. In the present study we investigated in kidney transplant recipients with good long-term stable graft function the absolute cell counts of IFNy+ Treg subsets and whether their expression of Foxp3 is stable or transient. Method Helios expression determined by eight-color-fluorescence flow cytometry and methylation status of the Foxp3 Treg specific demethylation region (TSDR) served as indicators for stability of Foxp3 expression. Methylation status was investigated in enriched IFNy+ and IFNy-Treg preparations originating from peripheral blood using high resolution melt analysis. A total of 136 transplant recipients and 52 healthy controls were studied. Results Proportions of IFNy+ Treg were similar in patients and healthy controls (0.05% and 0.04% of all CD4+ lymphocytes; p = n.s.). Patients also had similar absolute counts of IFNy producing Helios+ and Helios-Treg (p = n.s.). Most of the IFNy+ and IFNy-Treg in transplant recipients had a methylated Foxp3 TSDR, however, there was a sizeable proportion of IFNy+ and IFNy-Treg with demethylated Foxp3 TSDR. Male and female patients showed more frequently methylated IFNy+ and IFNy-Treg than male and female controls (all p<0.05). Conclusions Kidney transplant recipients with good long-term stable graft function have similar levels of IFNy+ Treg as healthy controls. IFNy+ and IFNy-Treg subsets in patients consist of cells with stable and cells with transient Foxp3 expression; however, patients showed more frequently methylated IFNy+ and IFNy- Treg than controls. The data show increased levels of Treg subsets with stable as well as transient Foxp3 expression in patients with stable allograft acceptance compared to healthy controls.	[Trojan, Karina; Unterrainer, Christian; Aly, Mostafa; Zhu, Li; Opelz, Gerhard; Daniel, Volker] Univ Heidelberg Hosp, Transplantat Immunol Inst Immunol, Heidelberg, Germany; [Weimer, Rolf; Bulut, Nuray] Univ Giessen, Dept Internal Med, Giessen, Germany; [Morath, Christian] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Aly, Mostafa] Assiut Univ, Dept Internal Med, Nephrol Unit, Assiut, Egypt; [Zhu, Li] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Wuhan, Peoples R China	Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; Ruprecht Karls University Heidelberg; Egyptian Knowledge Bank (EKB); Assiut University; Huazhong University of Science & Technology	Daniel, V (corresponding author), Univ Heidelberg Hosp, Transplantat Immunol Inst Immunol, Heidelberg, Germany.	Volker.Daniel@med.uni-heidelberg.de	Morath, Christian/ABC-5091-2021	Daniel, Volker/0000-0001-8345-1031				Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Daniel V, 2008, TRANSPL INT, V21, P646, DOI 10.1111/j.1432-2277.2008.00662.x; Daniel V, 2016, HUM IMMUNOL, V77, P146, DOI 10.1016/j.humimm.2015.11.006; Daniel V, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0111-2; Daniel V, 2014, INT REV IMMUNOL, V33, P195, DOI 10.3109/08830185.2013.845181; Daniel V, 2013, HUM IMMUNOL, V74, P151, DOI 10.1016/j.humimm.2012.09.010; Daniel V, 2012, TRANSPL IMMUNOL, V27, P114, DOI 10.1016/j.trim.2012.08.003; Daniel V, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-47; Daniel V, 2011, HUM IMMUNOL, V72, P699, DOI 10.1016/j.humimm.2011.05.020; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Greenland JR, 2016, TRANSPLANTATION; Grzanka J, 2013, INT IMMUNOPHARMACOL, V16, P343, DOI 10.1016/j.intimp.2013.02.004; Hall BM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00208; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Kim J, 2012, AM J RESP CRIT CARE, V185, P330, DOI 10.1164/rccm.201106-1026OC; Marcen R, 2009, DRUGS, V69, P2227, DOI 10.2165/11319260-000000000-00000; Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937; Nakagawa H, 2016, P NATL ACAD SCI USA, V113, P6248, DOI 10.1073/pnas.1604765113; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Schmitt EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00152; Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704; Sela U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146412; Tahvildari M, 2016, TRANSPLANTATION, V100, P525, DOI 10.1097/TP.0000000000001044; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; van der Net JB, 2016, TRANSPL INT, V29, P3, DOI 10.1111/tri.12608; Wang LQ, 2013, MOL CELL BIOL, V33, P4106, DOI 10.1128/MCB.00144-13; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173773	10.1371/journal.pone.0173773	http://dx.doi.org/10.1371/journal.pone.0173773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296931	Green Submitted, gold, Green Published			2022-12-26	WOS:000396311700060
J	Jia, PF; Li, F; Gu, WT; Zhang, WF; Cai, Y				Jia, Pifeng; Li, Feng; Gu, Weiting; Zhang, Weifeng; Cai, Yu			Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation	PLOS ONE			English	Article							MALIGNANT GLIOMA; CANCER STATISTICS; PROTEIN; INHIBITION; EXPRESSION; THERAPY	This current study tested expression and potential biological functions of Gab3 in human glioma. Gab3 mRNA and protein expression was significantly elevated in human glioma tissues and glioma cells. Its level was however low in normal brain tissues and primary human astrocytes. In both established (U251MG cell line) and primary human glioma cells, Gab3 knockdown by shRNA/siRNA significantly inhibited Akt activation and cell proliferation. Reversely, forced Gab3 overexpression in U251MG cells promoted Akt activation and cell proliferation. In vivo, the growth of U251MG tumors in nude mice was inhibited following expressing Gab3 shRNA. Akt activation in cancer tissues was also suppressed by Gab3 shRNA. Together, we conclude that Gab3 overexpression in human glioma mediates Akt activation and cancer cell proliferation.	[Jia, Pifeng; Li, Feng; Gu, Weiting; Zhang, Weifeng; Cai, Yu] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp North, Dept Neurosurg, Shanghai, Peoples R China	Shanghai Jiao Tong University	Cai, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp North, Dept Neurosurg, Shanghai, Peoples R China.	aihaozuqiu22@163.com			RuiJin Hospital Scientific Funds [RJ20140121]	RuiJin Hospital Scientific Funds	This study was supported by RuiJin Hospital Scientific Funds (RJ20140121 to Yu Cai). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgin C, 2002, MOL CELL BIOL, V22, P3744, DOI 10.1128/MCB.22.11.3744-3756.2002; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Chautard E, 2014, J NEURO-ONCOL, V117, P205, DOI 10.1007/s11060-014-1382-9; Chen MB, 2016, ONCOTARGET, V7, P17047, DOI 10.18632/oncotarget.7742; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; He XY, 2013, BIOCHEM BIOPH RES CO, V435, P397, DOI 10.1016/j.bbrc.2013.04.099; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Jiang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161017; Khasraw M, 2009, NAT REV NEUROL, V5, P646, DOI 10.1038/nrneurol.2009.194; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Li X, 2016, PI3K AKT MTOR SIGNAL; Li ZW, 2016, OVEREXPRESSION OF GA; Lu PH, 2016, AQUEOUS OLDENLANDIA; Pan SJ, 2015, INT J MOL SCI, V16, P5363, DOI 10.3390/ijms16035363; Pan SJ, 2015, BIOCHEM BIOPH RES CO, V458, P476, DOI 10.1016/j.bbrc.2015.01.128; Pollack IF, 2010, NAT REV NEUROL, V6, P533, DOI 10.1038/nrneurol.2010.144; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Seiffert M, 2003, MOL CELL BIOL, V23, P2415, DOI 10.1128/MCB.23.7.2415-2424.2003; Shioyama W, 2011, CIRC RES, V108, P664, DOI 10.1161/CIRCRESAHA.110.232223; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Xu FL, 2015, TUMOR BIOL, V36, P9553, DOI 10.1007/s13277-015-3724-4; Yart A, 2003, CURR CANCER DRUG TAR, V3, P177, DOI 10.2174/1568009033481976; Zhu J, 2016, BIOCHEM BIOPH RES CO, V476, P522, DOI 10.1016/j.bbrc.2016.05.156	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173473	10.1371/journal.pone.0173473	http://dx.doi.org/10.1371/journal.pone.0173473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291820	gold, Green Published, Green Submitted			2022-12-26	WOS:000396094700027
J	Azad, AKM; Lawen, A; Keith, JM				Azad, A. K. M.; Lawen, Alfons; Keith, Jonathan M.			Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CELL LUNG-CANCER; MOLECULAR-MECHANISMS; LAPATINIB RESISTANCE; EGFR; NETWORK; PATHWAY; APOPTOSIS; HER2	Small molecule inhibitors, such as lapatinib, are effective against breast cancer in clinical trials, but tumor cells ultimately acquire resistance to the drug. Maintaining sensitization to drug action is essential for durable growth inhibition. Recently, adaptive reprogramming of signaling circuitry has been identified as a major cause of acquired resistance. We developed a computational framework using a Bayesian statistical approach to model signal rewiring in acquired resistance. We used the p1-model to infer potential aberrant gene-pairs with differential posterior probabilities of appearing in resistant-vs-parental networks. Results were obtained using matched gene expression profiles under resistant and parental conditions. Using two lapatinib-treated ErbB2-positive breast cancer cell-lines: SKBR3 and BT474, our method identified similar dysregulated signaling pathways including EGFRrelated pathways as well as other receptor-related pathways, many of which were reported previously as compensatory pathways of EGFR-inhibition via signaling cross-talk. A manual literature survey provided strong evidence that aberrant signaling activities in dysregulated pathways are closely related to acquired resistance in EGFR tyrosine kinase inhibitors. Our approach predicted literature-supported dysregulated pathways complementary to both node-centric (SPIA, DAVID, and GATHER) and edge-centric (ESEA and PAGI) methods. Moreover, by proposing a novel pattern of aberrant signaling called V-structures, we observed that genes were dysregulated in resistant-vs-sensitive conditions when they were involved in the switch of dependencies from targeted to bypass signaling events. A literature survey of some important V-structures suggested they play a role in breast cancer metastasis and/or acquired resistance to EGFR-TKIs, where the mRNA changes of TGFBR2, LEF1 and TP53 in resistant-vs-sensitive conditions were related to the dependency switch from targeted to bypass signaling links. Our results suggest many signaling pathway structures are compromised in acquired resistance, and V-structures of aberrant signaling within/among those pathways may provide further insights into the bypass mechanism of targeted inhibition.	[Azad, A. K. M.; Keith, Jonathan M.] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Lawen, Alfons] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University	Azad, AKM (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic, Australia.	aaza7@student.monash.edu	; Lawen, Alfons/A-6598-2008	Keith, Jonathan/0000-0002-9675-3976; Lawen, Alfons/0000-0001-6553-9945	Monash International Postgraduate Research Scholarship at the Monash University, Australia; Monash Graduate Scholarship at the Monash University, Australia	Monash International Postgraduate Research Scholarship at the Monash University, Australia; Monash Graduate Scholarship at the Monash University, Australia	This research was supported by Monash International Postgraduate Research Scholarship and Monash Graduate Scholarship at the Monash University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S., 2008, CONNECTIONS, p[28, 17], DOI DOI 10.1007/978-0-8176-4749-0; Akhavan D, 2013, CANCER DISCOV, V3, P534, DOI 10.1158/2159-8290.CD-12-0502; Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Azad AKM, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-014-0135-x; Azuaje F, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0098-6; Azuma K, 2014, ONCOTARGET, V5, P5908, DOI 10.18632/oncotarget.1866; Azuma K, 2011, BIOCHEM BIOPH RES CO, V407, P219, DOI 10.1016/j.bbrc.2011.03.002; Baker AT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00360; Ballas MS, 2011, ONCOTARGETS THER, V4, P43, DOI 10.2147/OTT.S18155; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Bean J, 2008, CLIN CANCER RES, V14, P7519, DOI 10.1158/1078-0432.CCR-08-0151; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2102er11; Bianco R, 2008, CLIN CANCER RES, V14, P5069, DOI 10.1158/1078-0432.CCR-07-4905; Boeckx C, 2013, ONCOLOGIST, V18, P850, DOI 10.1634/theoncologist.2013-0013; Bouchalova K, 2010, BIOMED PAP, V154, P281, DOI 10.5507/bp.2010.043; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Bulashevska S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-46; Canfield K, 2015, CELL CYCLE, V14, P648, DOI 10.4161/15384101.2014.994966; Carpenter RL, 2013, J CARCINOGENESIS MUT, P1; Carson C, 2012, PIGM CELL MELANOMA R, V25, P514, DOI 10.1111/j.1755-148X.2012.01010.x; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheung HW, 2011, CANC DISCOVERY; Chikazawa N, 2010, ANTICANCER RES, V30, P2041; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Du Ge, 2015, Zhonghua Yi Xue Za Zhi, V95, P2264; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Ennen M, 2013, CANCER RES, V73, P5040, DOI 10.1158/0008-5472.CAN-12-3655; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Guney E, 2012, UNDERSTANDING CANC P, P167; Han CH, 2014, MOL CANCER RES, V12, P784, DOI 10.1158/1541-7786.MCR-13-0638; Han JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13044; Han JW, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0937; He YH., 2012, THESIS; Hegde PS, 2007, MOL CANCER THER, V6, P1629, DOI 10.1158/1535-7163.MCT-05-0399; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Hu JF, 2014, BIOINFORMATICS, V30, P141, DOI 10.1093/bioinformatics/btt627; Huang C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2936; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; Huang LH, 2015, ACTA PHARM SIN B, V5, P390, DOI 10.1016/j.apsb.2015.07.001; Huang S, 2011, CANCER RES, V71, P7071, DOI 10.1158/0008-5472.CAN-11-0128; Jung S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku099; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Karakashev SV, 2015, ONCOTARGET, V6, P1967, DOI 10.18632/oncotarget.2806; Kattan Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002002; Kechagioglou P, 2014, ANTICANCER RES, V34, P1387; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Khalil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033421; Kim HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016694; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; Komurov K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.25; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067811; Landi L, 2013, EXPERT REV ANTICANC, V13, P1219, DOI 10.1586/14737140.2013.846830; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Liu NN, 2014, TUMOR BIOL, V35, P641, DOI 10.1007/s13277-013-1088-1; Locasale JW, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.30; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; Loh YN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-174; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Luo M, 2014, AM J CANCER RES, V4, P608; Lynch MA, 2001, GENE EXPRESSION, V9, P157, DOI 10.3727/000000001783992560; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Mao H, 2012, CANCER INVEST, V30, P48, DOI 10.3109/07357907.2011.630050; McCleary-Wheeler AL, 2012, MOL CARCINOGEN, V51, P25, DOI 10.1002/mc.20827; Ng CP, 2002, ADV CANCER RES, V85, P145, DOI 10.1016/S0065-230X(02)85005-9; Nieto-Sampedro M, 2011, CLIN MED INSIGHTS-ON, V5, P265, DOI 10.4137/CMO.S7685; Peled N, 2013, CELL ONCOL, V36, P277, DOI 10.1007/s13402-013-0133-9; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Roberts CG, 2011, ONCOGENE, V30, P3186, DOI 10.1038/onc.2011.36; Sarkar S, 2009, BREAST CANCER-BASIC, V3, P47; Sasaki T, 2003, CANCER RES, V63, P801; Saul ZM, 2007, BIOINFORMATICS, V23, P2604, DOI 10.1093/bioinformatics/btm370; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Serizawa M, 2013, J THORAC ONCOL, V8, P259, DOI 10.1097/JTO.0b013e318279e942; Serra V, 2013, J CLIN INVEST, V123, P2551, DOI 10.1172/JCI66343; Sharifnia T, 2014, P NATL ACAD SCI USA, V111, P18661, DOI 10.1073/pnas.1412228112; Shi I, 2011, CANCER INFORM, V10, P273, DOI 10.4137/CIN.S8283; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun NK, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-27; Takano Y, 1999, J PATHOL, V189, P194; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tian Y, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0087-1; Toyooka S, 2007, CLIN CANCER RES, V13, P3431, DOI 10.1158/1078-0432.CCR-07-0070; Wang E., 2014, DATABASE CANC SYSTEM; Wang E., 2017, COSMIC CANC GENE CEN; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Xia WL, 2010, MOL CANCER THER, V9, P292, DOI 10.1158/1535-7163.MCT-09-1041; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao YL, 2015, INT J CANCER, V137, P2767, DOI 10.1002/ijc.29293	112	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173331	10.1371/journal.pone.0173331	http://dx.doi.org/10.1371/journal.pone.0173331			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288164	Green Published, gold, Green Submitted			2022-12-26	WOS:000396092400013
J	Bardach, AE; Caporale, JE; Rubinstein, AL; Danaei, G				Esteban Bardach, Ariel; Enzo Caporale, Joaquin; Luis Rubinstein, Adolfo; Danaei, Goodarz			Impact of level and patterns of alcohol drinking on coronary heart disease and stroke burden in Argentina	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; LATIN-AMERICA; MORTALITY; CONSUMPTION; MORBIDITY; ANGINA; INJURY; HEALTH	Background Deaths from cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke are expected to increase in Latin America. Moderate and regular alcohol consumption confers cardiovascular protection, while binge drinking increases risk. We estimated the effects of alcohol use on the number of annual CHD and stroke deaths and disability-adjusted life years (DALYs) in Argentina. Methods Alcohol use data were obtained from a nationally representative survey (EnPreCosp 2011), and etiological effect sizes from meta-analyses of epidemiological studies. Cause-specific mortality rates were from the vital registration system. Results There were 291,475 deaths in 2010 including 24,893 deaths from CHD and 15,717 from stroke. 62.7% of men and 38.7% of women reported drinking alcohol in the past year. All heavy drinkers (i.e. women who drank >20g/day and men who drank >40g/day of alcohol) met the definition of binge drinking and therefore did not benefit from cardioprotective effects. Alcohol drinking prevented 1,424 CHD deaths per year but caused 935 deaths from stroke (121 ischemic and 814 hemorrhagic), leading to 448 CVD deaths prevented (58.3% in men). Alcohol use was estimated to save 85,772 DALYs from CHD, but was responsible for 52,171 lost from stroke. Conclusions In Argentina, the cardioprotective effect of regular and moderate alcohol drinking is slightly larger than the harmful impact of binge drinking on CVD. However, considering global deleterious effects of alcohol in public health, policies to reduce binge drinking should be enforced, especially for young people. Studies are still needed to elucidate effects on cardiovascular health.	[Esteban Bardach, Ariel; Enzo Caporale, Joaquin; Luis Rubinstein, Adolfo] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Esteban Bardach, Ariel; Enzo Caporale, Joaquin; Luis Rubinstein, Adolfo] Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina; [Danaei, Goodarz] Harvard Sch Publ Hlth, Dept Epidemiol, Dept Global Hlth & Populat, Boston, MA USA; [Esteban Bardach, Ariel] Inst Clin Effectiveness & Hlth Policy IECS, Dr Emilio Ravignani 2024 C1014CPV, Buenos Aires, DF, Argentina; [Danaei, Goodarz] Harvard Sch Publ Hlth, 677 Huntington Ave,Bldg 1, Boston, MA USA	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Bardach, AE (corresponding author), Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina.; Bardach, AE (corresponding author), Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina.; Bardach, AE (corresponding author), Inst Clin Effectiveness & Hlth Policy IECS, Dr Emilio Ravignani 2024 C1014CPV, Buenos Aires, DF, Argentina.	abardach@iecs.org.ar	Bardach, Ariel/H-9566-2019; Danaei, Goodarz/B-6085-2008	Bardach, Ariel/0000-0003-4437-0073; 	Promoting Capacity Building in Chronic Diseases Research in South America; FOGARTY INTERNATIONAL CENTER [4D43TW009126-02]	Promoting Capacity Building in Chronic Diseases Research in South America; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by funding from Promoting Capacity Building in Chronic Diseases Research in South America. FOGARTY INTERNATIONAL CENTER. Grant # 4D43TW009126-02.	Aleman A, 2014, NEUROLOGOIA ARGENTIN, V7, P3; Americas Udl, 2008, PROYECC EST CARG ENF; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Argentinean Ministry of Health D Directorate of Statistics and Health Information (DEIS), 2011, ARG 2010 VIT STAT; Bagnardi V, 2008, J EPIDEMIOL COMMUNIT, V63, P615; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Bazzino O, 1999, AM HEART J, V137, P322, DOI 10.1053/hj.1999.v137.93029; Borras X, 2012, REV ESP CARDIOL, V65, P734, DOI 10.1016/j.rec.2012.03.010; Borruel M., 2010, ESTUDIO CARGO ENFERM; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Connor J, 2005, NEW ZEAL MED J, V118; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Cremonte M, 2016, INT J PSYCHOL; Eidelman Rachel S, 2002, Semin Vasc Med, V2, P253, DOI 10.1055/s-2002-35393; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Ferlay J, 2013, CANCER; Fernando L, 2014, PROG CARDIOVASC DIS, V57, P262, DOI 10.1016/j.pcad.2014.07.007; Forouzanfar MH, 2012, GLOB HEART, V7, P331, DOI 10.1016/j.gheart.2012.10.003; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Gutjahr E, 2001, EUR ADDICT RES, V7, P117, DOI 10.1159/000050729; Insitute of Health Metrics, 2015, GBD HEAETM; Institute for Health Metrics and Evaluation (IHME), 2013, GBD HEATM; Instituto Nacional de Estadisticas y Censos (INDEC), 2011, ENC NAC PREV CONS SU; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maredza M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0311-7; Martin J, 2010, ALCOHOL ALCOHOLISM, V45, P379, DOI 10.1093/alcalc/agq032; Mazzaglia G, 2001, ADDICTION, V96, P1743, DOI 10.1046/j.1360-0443.2001.961217434.x; Ministerio de Salud de Argentina, 2012, BAS EGR HOSP 2012 M; Ministerio de Salud de Argentina, 2011, BAS DAT MORT 2010 M; Ministerio de Salud de Argentina, 2011, EST VIT INF BAS AN 5, V5; Ministerio de Salud de Argentina. Direccion de Estadistica e Informacion en Salud (DEIS), 2010, BAS DAT MORT 2010 MI; Ministerio de Salud de Argentina. Direccion de Estadistica e Informacion en Salud (DEIS), 2014, BAS EGR HOSP 2012 MI; Ministry of Health Argentina, 2013, TERC ENC NAC FACT RI; Ministry of Health-Directorate of Statistics and Health Information (DEIS), 2012, HOSP DISCH DAT ARG; Monteiro MG, 2013, ADICCIONES, V25, P99; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J, 2011, DRUG ALCOHOL REV, V30, P335, DOI 10.1111/j.1465-3362.2011.00338.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ridolfo B, 2001, QUANTIFICATION DRUG; Robaina K, 2017, ADDICTION, V112, P122, DOI 10.1111/add.13625; Roerecke M, 2011, AM J EPIDEMIOL, V173, P245, DOI 10.1093/aje/kwq364; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Rubinstein A, 2010, REV PANAM SALUD PUBL, V27, P237, DOI 10.1590/S1020-49892010000400001; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Saposnik G, 2003, STROKE, V34, P2103, DOI 10.1161/01.STR.0000088063.74250.DB; Saposnik G, 2000, STROKE, V31, P2385, DOI 10.1161/01.STR.31.10.2385; Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112; Single E, 1999, AM J PUBLIC HEALTH, V89, P385, DOI 10.2105/AJPH.89.3.385; Velasqeuz Valdivia A, 2008, CARGA ENFERMEDAD LES; Wong MD, 2006, PUBLIC HEALTH REP, V121, P746, DOI 10.1177/003335490612100615; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	56	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173704	10.1371/journal.pone.0173704	http://dx.doi.org/10.1371/journal.pone.0173704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282416	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800071
J	Sominsky, L; Ziko, I; Spencer, SJ				Sominsky, Luba; Ziko, Ilvana; Spencer, Sarah J.			Neonatal overfeeding disrupts pituitary ghrelin signalling in female rats long-term; Implications for the stress response	PLOS ONE			English	Article							GENDER-DIFFERENCES; MATERNAL-CARE; SEX-DIFFERENCES; MESSENGER-RNA; ADRENAL AXIS; PSYCHOLOGICAL STRESS; CIRCULATING GHRELIN; HORMONAL-REGULATION; IMMUNE CHALLENGE; DESACYL GHRELIN	The hypothalamic-pituitary-adrenal (HPA) axis responses to psychological stress are exacerbated in adult female but not male rats made obese due to overfeeding in early life. Ghrelin, traditionally known for its role in energy homeostasis, has been recently recognised for its role in coordinating the HPA responses to stress, particularly by acting directly at the anterior pituitary where the growth hormone secretagogue receptor (GHSR), the receptor for acyl ghrelin, is abundantly expressed. We therefore hypothesised that neonatal overfeeding in female rats would compromise pituitary responsiveness to ghrelin, contributing to a hyperactive central stress responsiveness. Unlike in males where hypothalamic ghrelin signalling is compromised by neonatal overfeeding, there was no effect of early life diet on circulating ghrelin or hypothalamic ghrelin signalling in females, indicating hypothalamic feeding and metabolic ghrelin circuitry remains intact. However, neonatal overfeeding did lead to long-term alterations in the pituitary ghrelin system. The neonatally overfed females had increased neonatal and reduced adult expression of GHSR and ghrelin-O-acyl transferase (GOAT) in the pituitary as well as reduced pituitary responsiveness to exogenous acyl ghrelin-induced adrenocorticotropic hormone (ACTH) release in vitro. These data suggest that neonatal overfeeding dysregulates pituitary ghrelin signalling long-term in females, potentially accounting for the hyper-responsive HPA axis in these animals. These findings have implications for how females may respond to stress throughout life, suggesting the way ghrelin modifies the stress response at the level of the pituitary may be less efficient in the neonatally overfed.	[Sominsky, Luba; Ziko, Ilvana; Spencer, Sarah J.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Sominsky, L (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia.	Luba.Sominsky@rmit.edu.au	Spencer, Sarah J/D-5777-2018	Sominsky, Luba/0000-0002-0674-8824; Spencer, Sarah/0000-0001-8832-4824	Discovery Project Grant from the Australian Research Council (ARC) [DP130100508]; ARC Future Fellowship [FT110100084]; RMIT University VC Senior Research Fellowship	Discovery Project Grant from the Australian Research Council (ARC)(Australian Research Council); ARC Future Fellowship(Australian Research Council); RMIT University VC Senior Research Fellowship	This work was supported by a Discovery Project Grant from the Australian Research Council (ARC) www.arc.gov.au to SJS (DP130100508), an ARC Future Fellowship (FT110100084) and an RMIT University VC Senior Research Fellowship to SJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Discovery Project Grant from the Australian Research Council (ARC) to SJS (DP130100508), an ARC Future Fellowship (FT110100084) and an RMIT University VC Senior Research Fellowship to SJS.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Andrews ZB, 2011, PEPTIDES, V32, P2248, DOI 10.1016/j.peptides.2011.05.014; Arvat E, 2001, J CLIN ENDOCR METAB, V86, P1169, DOI 10.1210/jc.86.3.1169; AUTELITANO DJ, 1989, ANNU REV PHYSIOL, V51, P715, DOI 10.1146/annurev.physiol.51.1.715; Barkan AL, 2003, J CLIN ENDOCR METAB, V88, P2180, DOI 10.1210/jc.2002-021169; Barry D, 2008, ANN EPIDEMIOL, V18, P458, DOI 10.1016/j.annepidem.2007.12.009; Becker JB, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0087-5; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Bouret SG, 2013, FRONT NEUROENDOCRIN, V34, P18, DOI 10.1016/j.yfrne.2013.01.001; Cabral A, 2014, J NEUROENDOCRINOL, V26, P542, DOI 10.1111/jne.12168; Cabral A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031462; Cai G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21097; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Clarke MA, 2012, J NEUROENDOCRINOL, V24, P511, DOI 10.1111/j.1365-2826.2011.02269.x; Cohen EP, 2011, TRANSL RES, V157, P38, DOI 10.1016/j.trsl.2010.09.007; Collden G, 2015, MOL METAB, V4, P15, DOI 10.1016/j.molmet.2014.10.003; Currie PJ, 2005, AM J PHYSIOL-REG I, V289, pR353, DOI 10.1152/ajpregu.00756.2004; Daee A, 2002, SOUTH MED J, V95, P1032, DOI 10.1097/00007611-200209000-00021; De Luca SN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0578-7; DEKLOET ER, 1987, PSYCHONEUROENDOCRINO, V12, P83, DOI 10.1016/0306-4530(87)90040-0; Del Cerro MCR, 2010, BEHAV BRAIN RES, V208, P593, DOI 10.1016/j.bbr.2010.01.003; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; DENENBERG VH, 1963, J REPROD FERTIL, V5, P133, DOI 10.1530/jrf.0.0050133; Dimitsantos E, 2007, PHYSIOL BEHAV, V92, P708, DOI 10.1016/j.physbeh.2007.05.066; Espelund U, 2005, J CLIN ENDOCR METAB, V90, P741, DOI 10.1210/jc.2004-0604; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Fowler-Brown AG, 2009, OBESITY; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Gayle DA, 2006, LIFE SCI, V79, P1531, DOI 10.1016/j.lfs.2006.04.015; Hagobian TA, 2010, EXERC SPORT SCI REV, V38, P25, DOI 10.1097/JES.0b013e3181c5cd98; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Hosoda H, 2004, CLIN CHEM, V50, P1077, DOI 10.1373/clinchem.2003.025841; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Irving LM, 2002, PREV MED, V34, P299, DOI 10.1006/pmed.2001.0997; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Jaaskelainen A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-321; Jaremka LM, 2014, PSYCHONEUROENDOCRINO, V48, P178, DOI 10.1016/j.psyneuen.2014.06.018; Johnstone LE, 2005, STRESS, V8, P59, DOI 10.1080/10253890500095283; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lopez M, 2007, INT J OBESITY, V31, P371, DOI 10.1038/sj.ijo.0803425; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Makovey J, 2007, CLIN ENDOCRINOL, V66, P530, DOI 10.1111/j.1365-2265.2007.02768.x; Marcus SM, 2005, J AFFECT DISORDERS, V87, P141, DOI 10.1016/j.jad.2004.09.008; Meyer RM, 2013, MOL PSYCHIAT; Monteleone P, 2012, NEUROPSYCHOBIOLOGY, V66, P230, DOI 10.1159/000341877; Moriyama C, 2013, EPILEPSY BEHAV, V29, P19, DOI 10.1016/j.yebeh.2013.06.017; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ochi M, 2008, LIFE SCI, V82, P862, DOI 10.1016/j.lfs.2008.01.020; Ostergard T, 2003, DIABETOLOGIA, V46, P134, DOI 10.1007/s00125-002-0985-4; Patterson ZR, 2010, EUR J NEUROSCI, V32, P632, DOI 10.1111/j.1460-9568.2010.07310.x; Pryce CR, 2001, DEV PSYCHOBIOL, V38, P239, DOI 10.1002/dev.1018; Raspopow K, 2014, APPETITE, V74, P35, DOI 10.1016/j.appet.2013.11.018; Raspopow K, 2010, HORM BEHAV, V58, P677, DOI 10.1016/j.yhbeh.2010.06.003; Reichenbach A, 2012, ENDOCRINOLOGY, V153, P5452, DOI 10.1210/en.2012-1622; Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Schmid DA, 2005, NEUROPSYCHOPHARMACOL, V30, P1187, DOI 10.1038/sj.npp.1300670; Schmidt I, 2001, INT J OBESITY, V25, P1168, DOI 10.1038/sj.ijo.0801669; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith JT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097758; Soares VM, 2012, REGUL PEPTIDES, V174, P6, DOI 10.1016/j.regpep.2011.11.002; Sominsky L, 2017, NEUROPHARMACOLOGY, V113, P21, DOI 10.1016/j.neuropharm.2016.09.023; Sominsky L, 2016, MOL CELL ENDOCRINOL, V431, P24, DOI 10.1016/j.mce.2016.05.001; Soriano-Guillen L, 2016, CLIN CHEM LAB MED, V54, P1371, DOI 10.1515/cclm-2015-0555; Spencer SJ, 2015, BIOL PSYCHIAT, V78, P19, DOI 10.1016/j.biopsych.2014.10.021; Spencer SJ, 2012, BIOL PSYCHIAT, V72, P457, DOI 10.1016/j.biopsych.2012.03.010; Spencer SJ, 2009, PSYCHONEUROENDOCRINO, V34, P1133, DOI 10.1016/j.psyneuen.2009.02.013; Stark R, 2016, ENDOCRINOLOGY, V157, P3946, DOI 10.1210/en.2016-1306; Steculorum SM, 2015, J CLIN INVEST; Steculorum SM GMaBS, 2010, 7 INT C NEUR; Steculorum SM, 2011, PEPTIDES, V32, P2362, DOI 10.1016/j.peptides.2011.06.021; Stefanidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052130; Stengel A, 2011, PEPTIDES, V32, P2208, DOI 10.1016/j.peptides.2011.07.002; Suckow MA, 2006, AM COLL LAB, pXI, DOI 10.1016/B978-012074903-4/50001-7; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Ter Horst GJ, 2009, PHYSIOL BEHAV, V97, P239, DOI 10.1016/j.physbeh.2009.02.036; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Young EA, 1996, MOL PSYCHIATR, V1, P313; Zelena D, 2011, STRESS, V14, P420, DOI 10.3109/10253890.2011.552991; Zigman JM, 2016, TRENDS ENDOCRIN MET, V27, P54, DOI 10.1016/j.tem.2015.09.010; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Ziko I, 2014, BRAIN BEHAV IMMUN, V41, P32, DOI 10.1016/j.bbi.2014.06.014	89	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173498	10.1371/journal.pone.0173498	http://dx.doi.org/10.1371/journal.pone.0173498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282447	Green Submitted, gold, Green Published			2022-12-26	WOS:000396091800045
J	Wood, LE; De Grave, S; Daniels, SR				Wood, Louisa E.; De Grave, Sammy; Daniels, Savel R.			Phylogeographic patterning among two codistributed shrimp species (Crustacea: Decapoda: Palaemonidae) reveals high levels of connectivity across biogeographic regions along the South African coast	PLOS ONE			English	Article							GENETIC-STRUCTURE; LARVAL DEVELOPMENT; CARIDEA PALAEMONIDAE; POPULATION-GENETICS; PACIFICUS STIMPSON; FISH EVIDENCE; LIFE-HISTORY; SPECIATION; GROWTH; PLEISTOCENE	We compare the genetic structuring and demographic history of two sympatric caridean shrimp species with distinct life history traits, one amphidromous species Palaemon capensis and one marine/estuarine species Palaemon peringueyi, in the historical biogeographical context of South Africa. A total of 103 specimens of P. capensis collected from 12 localities and 217 specimens of P. peringueyi collected from 24 localities were sequenced for the mitochondrial cytochrome oxidase one (CO1) locus. Results from analyses of molecular variance (AMOVA), pairwise phi(ST) comparisons and haplotype networks demonstrate weak to moderate genetic differentiation in P. capensis and P. peringueyi respectively. P. peringueyi exhibits partial isolation between populations associated with distinct biogeographic regions, likely driven by the region's oceanography. However, there is minimal evidence for the occurrence of discrete regional evolutionary lineages. This demonstrated lack of genetic differentiation is consistent with a marine, highly dispersive planktonic phase in both the amphidromous P. capensis and the marine/estuarine P. peringueyi. Bayesian skyline plots, mismatch expansions and time since expansion indicate that both species maintained stable populations during the Last Glacial Maximum (LGM), unlike other southern African aquatic species.	[Wood, Louisa E.; Daniels, Savel R.] Univ Stellenbosch, Dept Bot & Zool, Private Bag X1, Matieland, South Africa; [De Grave, Sammy] Univ Oxford, Museum Nat Hist, Parks Rd, Oxford, England	Stellenbosch University; University of Oxford	Wood, LE (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Private Bag X1, Matieland, South Africa.	LEWood@sun.ac.za		Daniels, Savel/0000-0003-2956-3256; Wood, Louisa/0000-0002-8649-5010	National Research Foundation [98122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding provided by the National Research Foundation to SD (98122) http://www.nrf.ac.za/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Baeza JA, 2013, MAR ECOL-EVOL PERSP, V34, P381, DOI 10.1111/maec.12038; Ashelby CW, 2012, ZOOL SCR, V41, P293, DOI 10.1111/j.1463-6409.2012.00535.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bauer RT, 2013, LAT AM J AQUAT RES, V41, P633, DOI 10.3856/vol41-issue4-fulltext-2; Bauer Raymond T., 2011, V15, P145; Brown L, 2012, STORY LIFE ENV AFRIC; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Chaves-Campos J, 2011, CONSERV GENET, V12, P557, DOI 10.1007/s10592-010-0163-z; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COETZEE DJ, 1989, S AFR J WILDL RES, V19, P107; COETZEE DJ, 1988, S AFR J ZOOL, V23, P59; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crandall ED, 2010, HEREDITY, V104, P563, DOI 10.1038/hdy.2009.138; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dawson MN, 2005, J BIOGEOGR, V32, P515, DOI 10.1111/j.1365-2699.2004.01193.x; de Carvalho FL, 2013, LAT AM J AQUAT RES, V41, P707, DOI 10.3856/vol41-issue4-fulltext-7; de Villiers Casper, 1999, P167, DOI 10.1017/CBO9780511525490.008; Dennenmoser S, 2010, J CRUSTACEAN BIOL, V30, P762, DOI 10.1651/09-3273.1; Dobkin S, 1963, CRUSTACEANA, V6, P41; Drost E, 2016, MAR BIODIVERS, V46, P465, DOI 10.1007/s12526-015-0389-6; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EMMERSON WD, 1986, T ROY SOC S AFR, V46, P79, DOI 10.1080/00359198609520108; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 2006, BIOL J LINN SOC, V88, P673, DOI 10.1111/j.1095-8312.2006.00651.x; Grant WS, 2015, J HERED, V106, P333, DOI 10.1093/jhered/esv020; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; GUERAO G, 1994, J CRUSTACEAN BIOL, V14, P280, DOI 10.2307/1548908; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Henriques R, 2016, J BIOGEOGR, V43, P1820, DOI 10.1111/jbi.12829; Henriques R, 2015, MAR BIOL RES, V11, P423, DOI 10.1080/17451000.2014.952309; Henriques R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087907; Hoareau TB, 2007, MAR ECOL PROG SER, V333, P303, DOI 10.3354/meps333303; Hughes JM, 2014, MOL ECOL, V23, P1000, DOI 10.1111/mec.12661; HUTSON WH, 1980, SCIENCE, V207, P64, DOI 10.1126/science.207.4426.64; Keating JP, 2014, FISH RES, V157, P1, DOI 10.1016/j.fishres.2014.03.009; Keith P, 2003, J FISH BIOL, V63, P831, DOI 10.1046/j.1095-8649.2003.00197.x; Kikkert DA, 2009, J N AM BENTHOL SOC, V28, P233, DOI 10.1899/08-019.1; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Le Roux JJ, 2011, DIVERS DISTRIB, V17, P861, DOI 10.1111/j.1472-4642.2011.00784.x; MACPHERSON E, 1990, J NAT HIST, V24, P627, DOI 10.1080/00222939000770421; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Mmonwa KL, 2015, AFR J MAR SCI, V37, P11, DOI 10.2989/1814232X.2015.1009165; Muller CM, 2012, MAR ECOL PROG SER, V468, P203, DOI 10.3354/meps09956; Myers MJ, 2000, FRESHWATER BIOL, V44, P535, DOI 10.1046/j.1365-2427.2000.00599.x; Page TJ, 2007, LIMNOL OCEANOGR, V52, P1055, DOI 10.4319/lo.2007.52.3.1055; Page TJ, 2013, BIOTROPICA, V45, P236, DOI 10.1111/j.1744-7429.2012.00900.x; Papadopoulos I, 2014, AFR J AQUAT SCI, V39, P347, DOI 10.2989/16085914.2014.938600; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; PEREIRA GA, 1995, J CRUSTACEAN BIOL, V15, P117; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pyron M, 2003, CARIBB J SCI, V39, P338; Qhaji Y, 2015, AFR J MAR SCI, V37, P345, DOI 10.2989/1814232X.2015.1077474; Rambaut A., 2007, TRACER V1 5; Reynolds TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102115; Rodriguez-Almaraz GA, 2010, REV MEX BIODIVERS, V81, pS73; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Romero O, 2003, J QUATERNARY SCI, V18, P733, DOI 10.1002/jqs.789; Rossi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054698; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; TAJIMA F, 1989, GENETICS, V123, P585; Teske PR, 2007, AFR J MAR SCI, V29, P253, DOI 10.2989/AJMS.2007.29.2.9.192; Teske PR, 2007, MAR BIOL, V152, P697, DOI 10.1007/s00227-007-0724-y; Teske PR, 2006, MAR ECOL PROG SER, V314, P283, DOI 10.3354/meps314283; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thuesen PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026685; von der Heyden S, 2009, AFR J MAR SCI, V31, P263, DOI 10.2989/AJMS.2009.31.2.14.886; von der Heyden S, 2008, MOL ECOL, V17, P4812, DOI 10.1111/j.1365-294X.2008.03959.x; von der Heyden S, 2007, MOL PHYLOGENET EVOL, V42, P517, DOI 10.1016/j.ympev.2006.08.004; VONDERHEYDEN S, 2013, FRONT BIOGEOG, V5, P1; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Whitfield AK, 2000, 577300 WRC; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135	80	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e3356	10.1371/journal.pone.0173356	http://dx.doi.org/10.1371/journal.pone.0173356			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282399	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800032
J	Yin, XX; Hadjiloucas, S; Chen, JH; Zhang, Y; Wu, JL; Su, MY				Yin, X. -X.; Hadjiloucas, S.; Chen, J. -H.; Zhang, Y.; Wu, J. -L.; Su, M. -Y.			Tensor based multichannel reconstruction for breast tumours identification from DCE-MRIs	PLOS ONE			English	Article							SOFT-TISSUE TUMORS; LESIONS; CANCER; DECOMPOSITIONS; CLASSIFICATION; ENHANCEMENT; FEATURES; BONE	A new methodology based on tensor algebra that uses a higher order singular value decomposition to perform three-dimensional voxel reconstruction from a series of temporal images obtained using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is proposed. Principal component analysis (PCA) is used to robustly extract the spatial and temporal image features and simultaneously de-noise the datasets. Tumour segmentation on enhanced scaled (ES) images performed using a fuzzy C-means (FCM) cluster algorithm is compared with that achieved using the proposed tensorial framework. The proposed algorithm explores the correlations between spatial and temporal features in the tumours. The multi-channel reconstruction enables improved breast tumour identification through enhanced de-noising and improved intensity consistency. The reconstructed tumours have clear and continuous boundaries; furthermore the reconstruction shows better voxel clustering in tumour regions of interest. A more homogenous intensity distribution is also observed, enabling improved image contrast between tumours and background, especially in places where fatty tissue is imaged. The fidelity of reconstruction is further evaluated on the basis of five new qualitative metrics. Results confirm the superiority of the tensorial approach. The proposed reconstruction metrics should also find future applications in the assessment of other reconstruction algorithms.	[Yin, X. -X.; Zhang, Y.] Victoria Univ, Sch Sci & Engn, Ctr Appl Informat, Melbourne, Vic, Australia; [Hadjiloucas, S.] Univ Reading, Sch Syst Engn, Reading RG6 6AY, Berks, England; [Hadjiloucas, S.] Univ Reading, Dept Bioengn, Reading RG6 6AY, Berks, England; [Chen, J. -H.; Su, M. -Y.] Univ Calif Irvine, Dept Radiol Sci, Tu & Yuen Ctr Funct Oncoimaging, Irvine, CA 92717 USA; [Chen, J. -H.] EDa Hosp, Dept Radiol, Kaohsiung, Taiwan; [Chen, J. -H.; Zhang, Y.] I Shou Univ, Kaohsiung, Taiwan; [Zhang, Y.] Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China; [Wu, J. -L.] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian, Liaoning, Peoples R China	Victoria University; University of Reading; University of Reading; University of California System; University of California Irvine; E-Da Hospital; I Shou University; Fudan University; Dalian University	Yin, XX; Zhang, Y (corresponding author), Victoria Univ, Sch Sci & Engn, Ctr Appl Informat, Melbourne, Vic, Australia.; Zhang, Y (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China.; Wu, JL (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian, Liaoning, Peoples R China.	xiaoxia.yin@vu.edu.au; yanchun.zhang@vu.edu.au; cjr.wujianlin@vip.163.com		Su, Min-Ying/0000-0002-3069-0271; Hadjiloucas, Sillas/0000-0003-2380-6114	Australian Research Council [140100841]; National Natural Science Foundation of China [63132013, 81371526]; Nanjing Nandian Technology PTY LTD, China; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Nandian Technology PTY LTD, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Australian Research Council Discovery Project 140100841, National Natural Science Foundation of China 63132013, National Natural Science Foundation of China 81371526, and Nanjing Nandian Technology PTY LTD, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Australian Research Council Discovery Project 140100841, National Natural Science Foundation of China (No. 63132013 and No. 81371526) and Nanjing Nandian Technology PTY LTD, China	Agner SC, 2011, J DIGIT IMAGING, V24, P446, DOI 10.1007/s10278-010-9298-1; Andreea GI, 2011, J CURR HLTH SCI, V37, P55; Phan AH, 2010, IEICE NONLINEAR THEO, V1, P37, DOI 10.1587/nolta.1.37; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Bediou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088432; Bennani-Baiti B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160346; Bradley P. S., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P9; Brawley OW, 2012, ANN INTERN MED, V156, P662, DOI 10.7326/0003-4819-156-9-201205010-00012; Cichocki A, 2009, NONNEGATIVE MATRIX A; Dorrius MD, 2011, EUR RADIOL, V21, P1600, DOI 10.1007/s00330-011-2091-9; Evans KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064366; Eyal E, 2009, NMR BIOMED, V22, P40, DOI 10.1002/nbm.1221; Gibbs P, 2003, MAGN RESON MED, V50, P92, DOI 10.1002/mrm.10496; Gubern-Merida A, 2015, MED IMAGE ANAL, V20, P265, DOI 10.1016/j.media.2014.12.001; Gubern-Merida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085952; Hauth EAM, 2008, EUR J RADIOL, V66, P300, DOI 10.1016/j.ejrad.2007.05.026; Hawighorst H, 1999, JMRI-J MAGN RESON IM, V10, P286, DOI 10.1002/(SICI)1522-2586(199909)10:3<286::AID-JMRI9>3.3.CO;2-E; Hendrick RE., 2008, FUNDAMENTALS AND TEC; Karathanasis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005843; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kroonenberg PM., 1983, THREE MODE PRINCIPAL; Lee SH, 2010, MED PHYS, V37, P3940, DOI 10.1118/1.3446799; Levman J, 2008, IEEE T MED IMAGING, V27, P688, DOI 10.1109/TMI.2008.916959; Morris EA, 2014, J CLIN ONCOL, V32, P2281, DOI 10.1200/JCO.2014.56.1514; Newell D, 2010, EUR RADIOL, V20, P771, DOI 10.1007/s00330-009-1616-y; Pages EB, 2012, RADIOLOGY, V264, P40, DOI 10.1148/radiol.12111917; Pan J, 2013, J DIGIT IMAGING, V26, P971, DOI 10.1007/s10278-013-9602-y; Rakoczy M, 2013, J DIGIT IMAGING, V26, P198, DOI 10.1007/s10278-012-9506-2; Stoutjesdijk MJ, 2007, J MAGN RESON IMAGING, V26, P606, DOI 10.1002/jmri.21026; Sun J., 2006, ACM SIGKDD INT C KNO, P374, DOI DOI 10.1145/1150402.1150445; Szabo BK, 2004, ACAD RADIOL, V11, P1344, DOI 10.1016/j.acra.2004.09.006; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Twellmann T, 2008, ENG APPL ARTIF INTEL, V21, P129, DOI 10.1016/j.engappai.2007.04.005; van Rijswijk CSP, 2004, RADIOLOGY, V233, P493, DOI 10.1148/radiol.2332031110; Verstraete KL, 2000, EUR J RADIOL, V34, P229, DOI 10.1016/S0720-048X(00)00202-3; Wang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062876, 10.1371/journal.pone.0080980]; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Yamaguchi K, 2013, AM J ROENTGENOL, V201, P1155, DOI 10.2214/AJR.12.9707; Yin X, 2012, TERAHERTZ IMAGING FO; Zheng YJ, 2009, MED PHYS, V36, P3192, DOI 10.1118/1.3151811	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172111	10.1371/journal.pone.0172111	http://dx.doi.org/10.1371/journal.pone.0172111			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282379	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800007
J	Cuvelier, ML; Guo, J; Ortiz, AC; van Baren, MJ; Tariq, MA; Partensky, F; Worden, AZ				Cuvelier, Marie L.; Guo, Jian; Ortiz, Alejandra C.; van Baren, Marijke J.; Tariq, Muhammad Akram; Partensky, Frederic; Worden, Alexandra Z.			Responses of the picoprasinophyte Micromonas commoda to light and ultraviolet stress	PLOS ONE			English	Article							ALGA CHLAMYDOMONAS-REINHARDTII; XANTHOPHYLL-DEFICIENT MUTANT; CHLOROPHYLL-A/B PROTEINS; GENE-EXPRESSION; UV-B; PHOTOSYNTHETIC EUKARYOTES; PHOTOOXIDATIVE STRESS; OSTREOCOCCUS-TAURI; NITRITE REDUCTASE; PHOTOSYSTEM-II	Micromonas is a unicellular marine green alga that thrives from tropical to polar ecosystems. We investigated the growth and cellular characteristics of acclimated mid-exponential phase Micromonas commoda RCC299 over multiple light levels and over the diel cycle (14: 10 hour light: dark). We also exposed the light: dark acclimated M. commoda to experimental shifts from moderate to high light (HL), and to HL plus ultraviolet radiation (HL+UV), 4.5 hours into the light period. Cellular responses of this prasinophyte were quantified by flow cytometry and changes in gene expression by qPCR and RNA-seq. While proxies for chlorophyll a content and cell size exhibited similar diel variations in HL and controls, with progressive increases during day and decreases at night, both parameters sharply decreased after the HL+UV shift. Two distinct transcriptional responses were observed among chloroplast genes in the light shift experiments: i) expression of transcription and translation-related genes decreased over the time course, and this transition occurred earlier in treatments than controls; ii) expression of several photosystem I and II genes increased in HL relative to controls, as did the growth rate within the same diel period. However, expression of these genes decreased in HL+UV, likely as a photoprotective mechanism. RNA-seq also revealed two genes in the chloroplast genome, ycf2-like and ycf1-like, that had not previously been reported. The latter encodes the second largest chloroplast protein in Micromonas and has weak homology to plant Ycf1, an essential component of the plant protein translocon. Analysis of several nuclear genes showed that the expression of LHCSR2, which is involved in non-photochemical quenching, and five light-harvesting-like genes, increased 30 to >50-fold in HL+UV, but was largely unchanged in HL and controls. Under HL alone, a gene encoding a novel nitrite reductase fusion protein (NIRFU) increased, possibly reflecting enhanced N-assimilation under the 625 mu mol photons m(-2) s(-1) supplied in the HL treatment. NIRFU's domain structure suggests it may have more efficient electron transfer than plant NIR proteins. Our analyses indicate that Micromonas can readily respond to abrupt environmental changes, such that strong photoinhibition was provoked by combined exposure to HL and UV, but a ca. 6-fold increase in light was stimulatory.	[Cuvelier, Marie L.; Guo, Jian; Ortiz, Alejandra C.; van Baren, Marijke J.; Worden, Alexandra Z.] MBARI, Moss Landing, CA USA; [Tariq, Muhammad Akram] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Partensky, Frederic] UPMC Univ Paris 06, Sorbonne Univ, CNRS, UMR,Stn Biol,CS, Roscoff, France; [Worden, Alexandra Z.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Worden, Alexandra Z.] Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON, Canada; [Cuvelier, Marie L.] Nova Southeastern Univ, Dept Biol Sci, Ft Lauderdale, FL 33314 USA; [Guo, Jian] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Ortiz, Alejandra C.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Tariq, Muhammad Akram] Univ Management & Technol, Sch Hlth Sci, Lahore, Pakistan	Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Cruz; Canadian Institute for Advanced Research (CIFAR); Nova Southeastern University; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; University of Management & Technology (UMT)	Worden, AZ (corresponding author), MBARI, Moss Landing, CA USA.; Worden, AZ (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.; Worden, AZ (corresponding author), Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON, Canada.	azworden@mbari.org	Worden, Alexandra Z./AAD-6567-2019; Tariq, Muhammad/ABC-2204-2020; Partensky, Frédéric/B-9194-2018; Partensky, Frédéric/AAH-1170-2021	Tariq, Muhammad/0000-0002-8239-9339; Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Worden, Alexandra/0000-0002-9888-9324	Gordon and Betty Moore Foundation [NSF-IOS0843119, DOE-DE-SC0004765, GBMF3788]; National Science Foundation [NSF-IOS0843119]; US Department of Energy [DOE-DE SC0004765]; Hanse-Wissenschaftskolleg; Directorate For Geosciences [1246761] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Hanse-Wissenschaftskolleg; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding comes from grants from the Gordon and Betty Moore Foundation (GBMF3788), https://www.moore.org/; the National Science Foundation (NSF-IOS0843119), https://www.nsf.gov/; and the US Department of Energy (DOE-DE SC0004765). A.Z.W. thanks the Hanse-Wissenschaftskolleg for a Marine and Climate Fellowship that facilitated writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank C. Bachy, C. Berthiaume, E. Demir-Hilton, A. Engman, J. Lake, S. McDonald, M. P. Simmons, R. M. Welsh and H. M. Wilcox for help with experiments, qPCR design, and/or discussion of analysis approaches. We are grateful to V. Shankey and Beckman-Coulter Corporation for loaning us the Epics XL instrument, Pierre Setif for discussing NIRFU and the reviewers of the manuscript for constructive comments. This research was supported by a Gordon and Betty Moore Foundation Investigator Award (GBMF3788), NSF-IOS0843119 and DOE-DE-SC0004765 grants to A.Z.W.	Adamska I, 2001, J BIOL CHEM, V276, P8582, DOI 10.1074/jbc.M010447200; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Andersson U, 2003, PLANT PHYSIOL, V132, P811, DOI 10.1104/pp.102.019281; Anning T, 2000, LIMNOL OCEANOGR, V45, P1807, DOI 10.4319/lo.2000.45.8.1807; [Anonymous], 2012, USDA TECHNICAL B, V8160; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Calderon RH, 2013, J BIOL CHEM, V288, P26688, DOI 10.1074/jbc.M113.487629; Castenholz RW, 2002, ECOLOGY CYANOBACTERI, P591; Chaturvedi R, 2000, J BIOSCIENCE, V25, P65; Choquet Y, 1998, P NATL ACAD SCI USA, V95, P4380, DOI 10.1073/pnas.95.8.4380; Cohen I, 2005, PLANT PHYSIOL, V137, P738, DOI 10.1104/pp.104.056341; Davis MC, 2013, PLANT CELL ENVIRON, V36, P1391, DOI 10.1111/pce.12071; Demir-Hilton E, 2011, ISME J, V5, P1095, DOI 10.1038/ismej.2010.209; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; DuRand MD, 2002, J PHYCOL, V38, P1132, DOI 10.1046/j.1529-8817.2002.02008.x; Durnford DG, 2003, PHYSIOL PLANTARUM, V118, P193, DOI 10.1034/j.1399-3054.2003.00078.x; Einsle O, 2011, METHOD ENZYMOL, V496, P399, DOI 10.1016/B978-0-12-386489-5.00016-6; Farinas B, 2006, PLANT MOL BIOL, V60, P277, DOI 10.1007/s11103-005-4066-1; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Foulon E, 2008, ENVIRON MICROBIOL, V10, P2433, DOI 10.1111/j.1462-2920.2008.01673.x; Geider RJ, 1998, LIMNOL OCEANOGR, V43, P679, DOI 10.4319/lo.1998.43.4.0679; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Heddad M, 2002, COMP FUNCT GENOM, V3, P504, DOI 10.1002/cfg.221; Heddad M, 2006, PLANT PHYSIOL, V142, P75, DOI 10.1104/pp.106.081489; Hirasawa M, 2009, MOL PLANT, V2, P407, DOI 10.1093/mp/ssn098; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; Hutin C, 2003, P NATL ACAD SCI USA, V100, P4921, DOI 10.1073/pnas.0736939100; Inoue-Kashino N, 2011, J PHOTOCH PHOTOBIO B, V104, P220, DOI 10.1016/j.jphotobiol.2011.01.024; IRIARTE A, 1993, J EXP MAR BIOL ECOL, V168, P239, DOI 10.1016/0022-0981(93)90263-N; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Jacquet S, 2001, J PHYCOL, V37, P357, DOI 10.1046/j.1529-8817.2001.037003357.x; Jansson S, 2000, PLANT MOL BIOL, V42, P345, DOI 10.1023/A:1006365213954; Kataria S, 2014, J PHOTOCH PHOTOBIO B, V137, P55, DOI 10.1016/j.jphotobiol.2014.02.004; KELLER MD, 1987, J PHYCOL, V23, P633; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kirk J. T. O., 1994, ARCH HYDROBIOL BEIH, V43, P1; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kucho K, 2005, PLANT MOL BIOL, V57, P889, DOI 10.1007/s11103-005-3248-1; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledford HK, 2004, MOL GENET GENOMICS, V272, P470, DOI 10.1007/s00438-004-1078-5; Lee J, 2002, PHOTOSYNTH RES, V72, P295, DOI 10.1023/A:1019881306640; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maclntyre H.L., 2002, J PHYCOL, V38, P17, DOI DOI 10.1046/J.1529; Marin B, 2010, PROTIST, V161, P304, DOI 10.1016/j.protis.2009.10.002; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; McDonald SM, 2010, MOL BIOL EVOL, V27, P2268, DOI 10.1093/molbev/msq113; Mckim SM, 2006, PLANT PHYSIOL BIOCH, V44, P857, DOI 10.1016/j.plaphy.2006.10.018; MEYER G, 1984, EUR J BIOCHEM, V138, P201, DOI 10.1111/j.1432-1033.1984.tb07900.x; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Montane MH, 2000, GENE, V258, P1, DOI 10.1016/S0378-1119(00)00413-3; Moreau H, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r74; Moulager M, 2007, PLANT PHYSIOL, V144, P1360, DOI 10.1104/pp.107.096149; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Neilson JAD, 2010, GENOME, V53, P68, DOI [10.1139/G09-081, 10.1139/g09-081]; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Noren H, 2003, PLANT CELL ENVIRON, V26, P245, DOI 10.1046/j.1365-3040.2003.00954.x; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Pinnola A, 2015, PLANT CELL, V27, P3213, DOI 10.1105/tpc.15.00443; POST AF, 1984, MAR BIOL, V83, P231, DOI 10.1007/BF00397454; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez F, 2005, ENVIRON MICROBIOL, V7, P853, DOI 10.1111/j.1462-2920.2005.00758.x; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Setif P, 2009, BIOCHEMISTRY-US, V48, P2828, DOI 10.1021/bi802096f; Shapira M, 1997, PLANT MOL BIOL, V33, P1001, DOI 10.1023/A:1005814800641; Simmons MP, 2016, APPL ENVIRON MICROB, V82, P1693, DOI 10.1128/AEM.02730-15; Simmons MP, 2015, MOL BIOL EVOL, V32, P2219, DOI 10.1093/molbev/msv122; Six C, 2005, MOL BIOL EVOL, V22, P2217, DOI 10.1093/molbev/msi220; Six C, 2008, LIMNOL OCEANOGR, V53, P255, DOI 10.4319/lo.2008.53.1.0255; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Smith DR, 2013, BRIEF FUNCT GENOMICS, V12, P454, DOI 10.1093/bfgp/els066; Swingley WD, 2010, BBA-BIOENERGETICS, V1797, P1458, DOI 10.1016/j.bbabio.2010.04.017; TERADA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P2183, DOI 10.1271/bbb.59.2183; Teramoto H, 2006, PLANT CELL PHYSIOL, V47, P419, DOI 10.1093/pcp/pcj009; Teramoto H, 2004, PLANT CELL PHYSIOL, V45, P1221, DOI 10.1093/pcp/pch157; Teramoto H, 2002, PLANT PHYSIOL, V130, P325, DOI 10.1104/pp.004622; Tilbrook K, 2016, PLANT CELL, V28, P966, DOI 10.1105/tpc.15.00287; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Treusch AH, 2012, ISME J, V6, P481, DOI 10.1038/ismej.2011.117; van Baren MJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2585-6; Waltman PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155839; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wostrikoff K, 2004, EMBO J, V23, P2696, DOI 10.1038/sj.emboj.7600266; Yoshioka-Nishimura M, 2016, PLANT CELL PHYSL; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	102	10	10	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172135	10.1371/journal.pone.0172135	http://dx.doi.org/10.1371/journal.pone.0172135			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278262	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000396087900116
J	Liu, JX; Wu, ZB; Wu, J; Dong, J; Zhao, Y; Wen, DX				Liu, Jiaxi; Wu, Zhibo; Wu, Jin; Dong, Jian; Zhao, Yao; Wen, Dongxin			A Weibull distribution accrual failure detector for cloud computing	PLOS ONE			English	Article							SERVICE	Failure detectors are used to build high availability distributed systems as the fundamental component. To meet the requirement of a complicated large-scale distributed system, accrual failure detectors that can adapt to multiple applications have been studied extensively. However, several implementations of accrual failure detectors do not adapt well to the cloud service environment. To solve this problem, a new accrual failure detector based on Weibull Distribution, called the Weibull Distribution Failure Detector, has been proposed specifically for cloud computing. It can adapt to the dynamic and unexpected network conditions in cloud computing. The performance of the Weibull Distribution Failure Detector is evaluated and compared based on public classical experiment data and cloud computing experiment data. The results show that the Weibull Distribution Failure Detector has better performance in terms of speed and accuracy in unstable scenarios, especially in cloud computing.	[Liu, Jiaxi; Wu, Zhibo; Wu, Jin; Dong, Jian; Zhao, Yao; Wen, Dongxin] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Institute of Technology	Dong, J (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China.	hitljx@gmail.com			National Natural Science Foundation of China [61100029, 61370087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (No. 61100029 and 61370087); the website is http.// www.nsfc.gov.cn/. Jian Dong is responsible for organizing and implementing the project 61100029, while Dongxin Wen is responsible for organizing and implementing the project 61370087.; This work was supported by the National Natural Science Foundation of China (No. 61100029 and 61370087).	Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Chandra TD, 1996, J ACM, V43, P225, DOI 10.1145/226643.226647; Chen W, 2002, IEEE T COMPUT, V51, P561, DOI 10.1109/TC.2002.1004595; Defago X, 2005, I C DEPEND SYS NETWO, P206, DOI 10.1109/DSN.2005.37; Felber P., 1999, Proceedings of the International Symposium on Distributed Objects and Applications, P132, DOI 10.1109/DOA.1999.794001; Fetzer C, 2001, 2001 PACIFIC RIM INTERNATIONAL SYMPOSIUM ON DEPENDABLE COMPUTING, PROCEEDINGS, P146, DOI 10.1109/PRDC.2001.992691; Ganga K., 2013, Proceedings of the 2013 International Conference on Pattern Recognition, Informatics and Mobile Engineering (PRIME), P387, DOI 10.1109/ICPRIME.2013.6496507; Guo CX, 2008, ACM SIGCOMM COMP COM, V38, P75, DOI 10.1145/1402946.1402968; Hayashibara N, 2004, SYM REL DIST SYST, P66, DOI 10.1109/RELDIS.2004.1353004; Horita Y, 2005, 2005 6TH INTERNATIONAL WORKSHOP ON GRID COMPUTING (GRID), P202; Lavinia Andrei, 2010, Proceedings of the Fourth International Conference on Complex, Intelligent and Software Intensive Systems (CISIS 2010), P482, DOI 10.1109/CISIS.2010.29; Lin RH, 2014, CHINA COMMUN, V11, P1, DOI 10.1109/CC.2014.6827564; Shojafar M, 2020, IEEE T CLOUD COMPUT, V8, P1162, DOI 10.1109/TCC.2016.2617367; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Takeuchi K, 2008, IEEE J SEL AREA COMM, V26, P486, DOI 10.1109/JSAC.2008.080407; Tomsic AZ, 2015, INT PARALL DISTRIB P, P885, DOI 10.1109/IPDPS.2015.74; Wang F, 2014, P 2014 INT C C COMP, P14; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Xiong N., 2007, JAIST; Xiong NX, 2012, INT PARALL DISTRIB P, P668, DOI 10.1109/IPDPS.2012.126	20	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173666	10.1371/journal.pone.0173666	http://dx.doi.org/10.1371/journal.pone.0173666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278229	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900026
J	Ogino, H; Ishino, S; Kohda, D; Ishino, Y				Ogino, Hiromi; Ishino, Sonoko; Kohda, Daisuke; Ishino, Yoshizumi			The RecJ2 protein in the thermophilic archaeon Thermoplasma acidophilum is a 3 '-5 ' exonuclease that associates with a DNA replication complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GINS COMPLEX; MCM HELICASE; PYROCOCCUS-FURIOSUS; ESCHERICHIA-COLI; CDC45; REPAIR; ACTIVATION; RECOMBINATION; SUGGESTS; FORK	RecJ/cell division cycle 45 (Cdc45) proteins are widely conserved in the three domains of life, i. e. in bacteria, Eukarya, and Archaea. Bacterial RecJ is a 5'-3' exonuclease and functions in DNA repair pathways by using its 5'-3' exonuclease activity. Eukaryotic Cdc45 has no identified enzymatic activity but participates in theCMGcomplex, so named because it is composed of Cdc45, minichromosome maintenance protein complex (MCM) proteins 2-7, and GINS complex proteins (Sld5, Psf113). Eukaryotic Cdc45 and bacterial/archaeal RecJ share similar amino acid sequences and are considered functional counterparts. In Archaea, a RecJ homolog in Thermococcus kodakarensis was shown to associate with GINS and accelerate its nuclease activity and was, therefore, designated GAN (GINS-associated nuclease); however, to date, no archaeal RecJ.MCM.GINS complex has been isolated. The thermophilic archaeon Thermoplasma acidophilum has two RecJ-like proteins, designated TaRecJ1 and TaRecJ2. TaRecJ1 exhibited DNA-specific 5'-3' exonuclease activity, whereas TaRecJ2 had 3'-5' exonuclease activity and preferred RNA over DNA. TaRecJ2, but not TaRecJ1, formed a stable complex with TaGINS in a 2: 1 molar ratio. Furthermore, the TaRecJ2.TaGINS complex stimulated activity of TaMCM (T. acidophilum MCM) helicase in vitro, and the TaRecJ2.TaMCM.TaGINS complex was also observed in vivo. However, TaRecJ2 did not interact with TaMCM directly and was not required for the helicase activation in vitro. These findings suggest that the function of archaeal RecJ in DNA replication evolved divergently from Cdc45 despite conservation of the CMG-like complex formation between Archaea and Eukarya.	[Ogino, Hiromi; Ishino, Sonoko; Ishino, Yoshizumi] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan; [Kohda, Daisuke; Ishino, Yoshizumi] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Ogino, Hiromi] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu, Gifu 5011193, Japan; [Ishino, Yoshizumi] Univ Illinois, Inst Univ Biol, Urbana, IL 61801 USA; [Ishino, Yoshizumi] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA	Kyushu University; Kyushu University; Gifu University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ishino, Y (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.; Ishino, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.; Ishino, Y (corresponding author), Univ Illinois, Inst Univ Biol, Urbana, IL 61801 USA.; Ishino, Y (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	ishino@agr.kyushu-u.ac.jp	Kohda, Daisuke/I-4990-2019	Kohda, Daisuke/0000-0001-8234-3776; Ishino, Yoshizumi/0000-0001-9419-0826; Ishino, Sonoko/0000-0002-1833-1735	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26242075]; Institute for Fermentation, Osaka (IFO); JSPS (Japan Society for the Promotion of Science) bilateral program	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Fermentation, Osaka (IFO)(Institute for Fermentation (IFO)); JSPS (Japan Society for the Promotion of Science) bilateral program	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant 26242075 (to Y. I.) and in part by the Institute for Fermentation, Osaka (IFO). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a JSPS (Japan Society for the Promotion of Science) bilateral program. Member of affiliated faculty at the Institute for Universal Biology and Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois. To whom correspondence should be addressed. Tel.: 81-92-642-4218; Fax: 81-92-642-3051; E-mail: ishino@agr.kyushu-u.ac.jp.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Ciaramella M, 2005, TRENDS MICROBIOL, V13, P49, DOI 10.1016/j.tim.2004.12.001; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; Fujikane R, 2006, GENES CELLS, V11, P99, DOI 10.1111/j.1365-2443.2006.00925.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giroux Xavier, 2015, Methods Mol Biol, V1300, P187, DOI 10.1007/978-1-4939-2596-4_13; Goswami K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09057; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishino S, 2011, GENES CELLS, V16, P1176, DOI 10.1111/j.1365-2443.2011.01562.x; Ishino Y, 2012, SCI CHINA LIFE SCI, V55, P386, DOI 10.1007/s11427-012-4324-9; Krastanova I, 2012, J BIOL CHEM, V287, P4121, DOI 10.1074/jbc.M111.285395; Lang SW, 2015, J BACTERIOL, V197, P3409, DOI 10.1128/JB.00496-15; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Makarova KS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-7; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Morimatsu K, 2014, P NATL ACAD SCI USA, V111, pE5133, DOI 10.1073/pnas.1420009111; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Ogino H, 2015, BIOSCI BIOTECH BIOCH, V79, P432, DOI 10.1080/09168451.2014.982503; Ogino H, 2014, EXTREMOPHILES, V18, P915, DOI 10.1007/s00792-014-0673-6; Ogino H, 2011, EXTREMOPHILES, V15, P529, DOI 10.1007/s00792-011-0383-2; Oyama T, 2016, NUCLEIC ACIDS RES, V44, P9505, DOI 10.1093/nar/gkw789; Perez-Arnaiz P, 2016, NUCLEIC ACIDS RES, V44, P315, DOI 10.1093/nar/gkv1260; Persky NS, 2008, CRIT REV BIOCHEM MOL, V43, P347, DOI [10.1080/10409230802485358, 10.1080/10409230802485358 ]; Rajman LA, 2000, J BACTERIOL, V182, P607, DOI 10.1128/JB.182.3.607-612.2000; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; SEARCY DG, 1976, BIOCHIM BIOPHYS ACTA, V451, P278, DOI 10.1016/0304-4165(76)90278-6; Simon AC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11638; Sutera VA, 1999, J BACTERIOL, V181, P6098, DOI 10.1128/JB.181.19.6098-6102.1999; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Xia YS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01247; Xu Y, 2016, P NATL ACAD SCI USA, V113, P13390, DOI 10.1073/pnas.1613825113; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; YASUDA M, 1995, APPL ENVIRON MICROB, V61, P3482, DOI 10.1128/AEM.61.9.3482-3485.1995; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; Yuan H, 2013, NUCLEIC ACIDS RES, V41, P5817, DOI 10.1093/nar/gkt275; Yuan ZN, 2016, NAT STRUCT MOL BIOL, V23, P217, DOI 10.1038/nsmb.3170	42	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7921	7931		10.1074/jbc.M116.767921	http://dx.doi.org/10.1074/jbc.M116.767921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302716	hybrid, Green Published			2022-12-26	WOS:000401154100019
J	Kacprzak, S; Njimona, I; Renz, A; Feng, J; Reijerse, E; Lubitz, W; Krauss, N; Scheerer, P; Nagano, S; Lamparter, T; Weber, S				Kacprzak, Sylwia; Njimona, Ibrahim; Renz, Anja; Feng, Juan; Reijerse, Edward; Lubitz, Wolfgang; Krauss, Norbert; Scheerer, Patrick; Nagano, Soshichiro; Lamparter, Tilman; Weber, Stefan			Intersubunit distances in full-length, dimeric, bacterial phytochrome Agp1, as measured by pulsed electron-electron double resonance (PELDOR) between different spin label positions, remain unchanged upon photoconversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; dimerization; electron paramagnetic resonance (EPR); histidine kinase; photoreceptor; spectroscopy; PELDOR; SDSL; biliprotein; phytochrome	INDUCED CONFORMATIONAL-CHANGES; HISTIDINE-KINASE; CRYSTAL-STRUCTURE; SENSORY MODULE; CHROMOPHORE; CYANOBACTERIAL; REVEALS; BIOMACROMOLECULES; REARRANGEMENTS; PROTEIN	Bacterial phytochromes are dimeric light-regulated histidine kinases that convert red light into signaling events. Light absorption by the N-terminal photosensory core module (PCM) causes the proteins to switch between two spectrally distinct forms, Pr and Pfr, thus resulting in a conformational change that modulates the C-terminal histidine kinase region. To provide further insights into structural details of photoactivation, we investigated the full-length Agp1 bacteriophytochrome from the soil bacterium Agrobacterium fabrum using a combined spectroscopic and modeling approach. We generated seven mutants suitable for spin labeling to enable application of pulsed EPR techniques. The distances between attached spin labels were measured using pulsed electron-electron double resonance spectroscopy to probe the arrangement of the subunits within the dimer. We found very good agreement of experimental and calculated distances for the histidine-kinase region when both subunits are in a parallel orientation. However, experimental distance distributions surprisingly showed only limited agreement with either parallel- or antiparallel-arranged dimer structures when spin labels were placed into the PCM region. This observation indicates that the arrangements of the PCM subunits in the full-length protein dimer in solution differ significantly from that in the PCM crystals. The pulsed electron-electron double resonance data presented here revealed either no or only minor changes of distance distributions upon Pr-to-Pfr photoconversion.	[Kacprzak, Sylwia; Renz, Anja; Weber, Stefan] Albert Ludwigs Univ Freiburg, Inst Phys Chem, Albertstr 21, D-79104 Freiburg, Germany; [Njimona, Ibrahim; Feng, Juan; Krauss, Norbert; Lamparter, Tilman] Karlsruhe Inst Technol, Bot Inst 1, D-76131 Karlsruhe, Germany; [Reijerse, Edward; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Scheerer, Patrick] Charite Univ Med Berlin, Grp Prot Xray Crystallog & Signal Transduct, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Nagano, Soshichiro] Justus Liebig Univ Giessen, Inst Pflanzenphysiol, D-35390 Giessen, Germany; [Njimona, Ibrahim] Bamenda Univ Sci & Technol, POB 277, Nkwen, Bamenda, Cameroon; [Renz, Anja] Friedrich Schiller Univ Jena, Jena Univ Hosp, Single Mol Microscopy Grp, Nonnenplan 2-4, D-07743 Jena, Germany; [Feng, Juan] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Justus Liebig University Giessen; Friedrich Schiller University of Jena; University of Electronic Science & Technology of China	Kacprzak, S (corresponding author), Albert Ludwigs Univ Freiburg, Inst Phys Chem, Albertstr 21, D-79104 Freiburg, Germany.	Sylwia.Kacprzak@physchem.uni-freiburg.de	Weber, Stefan/G-6164-2010; Lamparter, Tilman/E-4421-2013	Scheerer, Patrick/0000-0001-5028-2075; Lamparter, Tilman/0000-0003-4327-9737; Krauss, Norbert/0000-0002-7128-4632	Deutsche Forschungsgemeinschaft [WE 2376/3-1, LA 799/11-1, SFB740-B6, SFB1078-B6, INST 39/928-1FUGG]; Max Planck Gesellschaft; Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" Research Field Grant [D3/E3-1]; Struktur- und Innovationsfond fur die Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" Research Field Grant(German Research Foundation (DFG)); Struktur- und Innovationsfond fur die Forschung	This work was supported by Deutsche Forschungsgemeinschaft Grants WE 2376/3-1 and LA 799/11-1 and by the Max Planck Gesellschaft. This work was also supported in part by Deutsche Forschungsgemeinschaft Grants SFB740-B6 and SFB1078-B6 (to P. S.), by Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" Research Field Grant D3/E3-1 (to P. S.), by Struktur- und Innovationsfond fur die Forschung (to S. W. and S. K.), and by Deutsche Forschungsgemeinschaft Grant INST 39/928-1FUGG(to S. W. and S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bjorling A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600920; Borbat PP, 2014, STRUCT BOND, V152, P1, DOI 10.1007/430_2012_82; Borucki B, 2009, J BIOL CHEM, V284, P26005, DOI 10.1074/jbc.M109.049056; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Heyes DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052418; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Nagano S, 2016, J BIOL CHEM, V291, P20674, DOI 10.1074/jbc.M116.739136; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Noack S, 2007, METHOD ENZYMOL, V423, P203, DOI 10.1016/S0076-6879(07)23009-5; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rottwinkel G, 2010, J BACTERIOL, V192, P5124, DOI 10.1128/JB.00672-10; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; Schiemann O, 2007, Q REV BIOPHYS, V40, P1, DOI 10.1017/S003358350700460X; Song PS, 1999, J BIOCHEM MOL BIOL, V32, P215; Strauss HM, 2005, FEBS LETT, V579, P3970, DOI 10.1016/j.febslet.2005.06.025; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yamada S, 2006, J MOL BIOL, V362, P123, DOI 10.1016/j.jmb.2006.07.012; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106	34	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7598	7606		10.1074/jbc.M116.761882	http://dx.doi.org/10.1074/jbc.M116.761882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28289094	Green Published, hybrid			2022-12-26	WOS:000400761300027
J	de Cassia-Pires, R; de Melo, MDAD; Barbosa, RD; Roque, ALR				de Cassia-Pires, Renata; Alheiros Dias de Melo, Myllena de Fatima; Barbosa, Raquel da Hora; Rodrigues Roque, Andrea Luiz			Multiplex PCR as a tool for the diagnosis of Leishmania spp. kDNA and the gapdh housekeeping gene of mammal hosts	PLOS ONE			English	Article							REAL-TIME PCR; INFECTION; WILD	Background The PCR assays usually employed for Leishmania diagnosis does not simultaneously detect a constitutive gene that would certify the viability of the DNA sample. We present a multiplex PCR approach for the simultaneous diagnosis of the Leishmania sp. kDNA fragment and a catalytic domain segment of a conserved region of the mammalian gapdh gene. Methodology The proposed multiplex protocol was designed through in silico PCR. The annealing temperature, concentration of primer pairs, number of cycles, distinct polymerase enzymes and premix kit were defined to achieve an optimal reaction. The DNA detection sensitivity was tested with different concentrations of known L. tropica DNA, and the reproducibility of the assay was confirmed using samples from 106 wild mammals that were previously subject to Leishmania sp. kDNA analysis through singleplex reactions. Principal findings The following optimal conditions were established: 95 degrees C for 1 min followed by 30 cycles of 95 degrees C for 30 s, 61 degrees C for 30 s, and 72 degrees C for 30 s and a final extension at 72 degrees C for 1 min. The multiplex PCR system was capable of detecting 0.1 ng of L. tropica diluted in 100 ng of mammalian DNA. Of 51 kDNA samples that were previously found to be positive, 45 (88.2%) were positive for both targets, two were positive only for kDNA and four were negative for both. Of 55 kDNA samples that were previously identified as negative, 38 (69.1%) were positive for gapdh whereas the other 17 were negative for both targets. Conclusions/Significance The proposed multiplex PCR system allows the simultaneous detection of the gapdh gene and Leishmania sp. kDNA in tissue samples derived from distinct wild mammal species. The amplification of the gapdh mammalian gene in the same reaction ensures the quality and viability of the DNA in the sample, eliminating the possibility of false-negative results that would impair an accurate description of the infection rates in a given population.	[de Cassia-Pires, Renata; Rodrigues Roque, Andrea Luiz] Fiocruz MS, Inst Oswaldo Cruz, Lab Trypanosomatid Biol, Rio De Janeiro, RJ, Brazil; [Alheiros Dias de Melo, Myllena de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Biol & Endem Dis, Rio De Janeiro, RJ, Brazil; [Barbosa, Raquel da Hora] Univ Fed Fluminense, Inst Biomed, Ctr Med Sci, Niteroi, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Roque, ALR (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Trypanosomatid Biol, Rio De Janeiro, RJ, Brazil.	roque@ioc.fiocruz.br	Roque, André Luiz Rodrigues/W-7528-2019	Roque, Andre/0000-0002-8740-052X	FAPERJ [E-26/102.172/2013]; PAPES-FIOCRUZ [401764/2015-0]; CNPq [446468/2014-2]	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PAPES-FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FAPERJ (E-26/102.172/2013), PAPES-FIOCRUZ (401764/2015-0) and CNPq (446468/2014-2) supported this study through research grants provided to ALRR, while RCP had scholarship supported by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan AA, 2010, EXP PARASITOL, V126, P552, DOI 10.1016/j.exppara.2010.06.003; Brazil R.P., 2015, ENTOMOLOGY ORNITHOLO, V04, P4, DOI [10.4172/2161, DOI 10.1089/VBZ.2007.0180.V, DOI 10.4172/2161-0983.1000144]; Brito MEF, 2009, TROP MED INT HEALTH, V14, P1278, DOI 10.1111/j.1365-3156.2009.02361.x; Cassia-Pires R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003389; Castilho TM, 2003, J CLIN MICROBIOL, V41, P540, DOI 10.1128/JCM.41.2.540-546.2003; de Assis J, 2010, REV BRAS PARASITOL V, V19, P17, DOI 10.1590/S1984-29612010000100005; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; Floeter-Winter Lucile M., 1993, Ciencia e Cultura (Sao Paulo), V45, P210; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Goncalves SC, 2012, J VENOM ANIM TOXINS, V18, P188, DOI 10.1590/S1678-91992012000200009; Goncalves-de-Albuquerque SD, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-16; Jorquera A, 2005, MEM I OSWALDO CRUZ, V100, P43, DOI 10.1590/S0074-02762005000100008; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Paiva-Cavalcanti M, 2010, J VENOM ANIM TOXINS, V16, P537, DOI 10.1590/S1678-91992010000400004; Roque ALR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000589; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Shi CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071034; SIMPSON L, 1973, J PROTOZOOL, V20, P2, DOI 10.1111/j.1550-7408.1973.tb05993.x; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410	23	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173922	10.1371/journal.pone.0173922	http://dx.doi.org/10.1371/journal.pone.0173922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301553	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300096
J	Winther, TL; Torp, SH				Winther, Theo L.; Torp, Sverre H.			DNA topoisomerase IIa and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TISSUE MICROARRAY TECHNIQUE; INTRACRANIAL MENINGIOMAS; CELL-PROLIFERATION; PROGNOSTIC-SIGNIFICANCE; MALIGNANT MENINGIOMAS; LABELING INDEX; GENETIC MODEL; CANCER; MARKER	Background The 2016 WHO histopathological grade or conventional biomarker MIB-1 is insufficient for predicting meningioma recurrence after initial treatment and alternative strategies are required. In this study, we investigated whether DNA topoisomerase IIa and/or mitosin expression can predict tumor recurrence with greater accuracy than conventional methods. Methods The expression of MIB-1, topoisomerase IIa, and mitosin were determined as proliferation indices in tissue microarrays using immunohistochemistry. The accuracy of prognostication was assessed with receiver operating characteristic (ROC) analyses and standard survival analyses. Results Expression of topoisomerase IIa and mitosin was significantly higher in recurrent meningioma than in non-recurrent meningioma (P <= 0.031), but no difference in MIB-1 expression was observed (P = 0.854). ROC analysis found topoisomerase IIa and mitosin expression to be the most reliable predictors of recurrence compared to WHO histopathological grade and MIB-1 expression. This result was supported by the multivariate survival analysis, in which mitosin expression was a significant predictor of recurrence-free survival (P < 0.001) and no association was found with histopathological grade or MIB-1 expression (P >= 0.158). Conclusions The results suggest that topoisomerase IIa and mitosin improve prognostication of patients resected for meningioma. Tumors with higher topoisomerase IIa and/or mitosin expression have a higher risk of recurrence after initial treatment, and these patients may benefit from adjuvant treatment and closer radiological follow-up.	[Winther, Theo L.; Torp, Sverre H.] Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Torp, Sverre H.] St Olavs Hosp, Dept Pathol & Med Genet, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Winther, TL (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway.	theolw@stud.ntnu.no	Torp, Sverre Helge/AAN-4229-2020	Torp, Sverre Helge/0000-0001-8345-6852	Norwegian University of Science and Technology	Norwegian University of Science and Technology	This study was funded by the Norwegian University of Science and Technology (website: http://www.ntnu.no/), and 50 000 kr was received by TLW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abry E, 2010, PATHOL RES PRACT, V206, P810, DOI 10.1016/j.prp.2010.09.002; Aghi MK, 2009, NEUROSURGERY, V64, P56, DOI 10.1227/01.NEU.0000330399.55586.63; Alahmadi H, 2011, SEMIN DIAGN PATHOL, V28, P314, DOI 10.1053/j.semdp.2011.01.002; Alama A, 2007, J CLIN NEUROSCI, V14, P355, DOI 10.1016/j.jocn.2006.04.001; Backer-Grondahl T, 2014, APMIS, V122, P856, DOI 10.1111/apm.12248; Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231; Bruna J, 2007, NEUROPATHOLOGY, V27, P114, DOI 10.1111/j.1440-1789.2007.00750.x; Clark GM, 1997, CANCER RES, V57, P5505; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Engellau J, 2001, APPL IMMUNOHISTO M M, V9, P358, DOI 10.1097/00022744-200112000-00012; Fernebro E, 2002, ARCH PATHOL LAB MED, V126, P702; Fontaine B, 1991, ANN NY ACAD SCI, V615, P338; Ho DMT, 2002, CANCER, V94, P1538, DOI 10.1002/cncr.10351; Hong Y, 2012, NEUROSCI LETT, V518, P138, DOI 10.1016/j.neulet.2012.04.071; Hoos A, 2001, AM J PATHOL, V158, P1245, DOI 10.1016/S0002-9440(10)64075-8; Hwang WL, 2016, NEURO-ONCOLOGY, V18, P863, DOI 10.1093/neuonc/nov285; Joachim T, 2001, INT J CANCER, V94, P218, DOI 10.1002/ijc.1467; Kasuya H, 2006, NEUROSURG REV, V29, P293, DOI 10.1007/s10143-006-0039-3; Kaur G, 2014, NEURO-ONCOLOGY, V16, P628, DOI 10.1093/neuonc/nou025; Konstantinidou AE, 2003, HISTOL HISTOPATHOL, V18, P67, DOI 10.14670/HH-18.67; Konstantinidou AE, 2001, HISTOPATHOLOGY, V39, P402, DOI 10.1046/j.1365-2559.2001.01229.x; Korkolopoulou P, 2001, APPL IMMUNOHISTO M M, V9, P207, DOI 10.1097/00022744-200109000-00003; Korshunov A, 2002, ARCH PATHOL LAB MED, V126, P1079; Kunishio K, 2000, Brain Tumor Pathol, V17, P105, DOI 10.1007/BF02484281; Leone PE, 1999, ONCOGENE, V18, P2231, DOI 10.1038/sj.onc.1202531; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu BH, 2016, THORAC CANCER, V7, P486, DOI 10.1111/1759-7714.12359; Ma L, 2006, J BIOMED SCI, V13, P205, DOI 10.1007/s11373-005-9057-3; Matsuno A, 1996, ACTA NEUROPATHOL, V91, P504, DOI 10.1007/s004010050458; MUNAKATA S, 1993, J HISTOCHEM CYTOCHEM, V41, P1241, DOI 10.1177/41.8.8331288; Nakasu S, 2001, AM J SURG PATHOL, V25, P472, DOI 10.1097/00000478-200104000-00006; Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008; Perry A, 1998, CANCER-AM CANCER SOC, V82, P2262, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.3.CO;2-O; Perry A, 2016, WHO CLASSIFICATION T, P231; Raspollini MR, 2016, HUM PATHOL; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Roessler K, 2002, NEUROL RES, V24, P241, DOI 10.1179/016164102101199855; Rubin MA, 2002, AM J SURG PATHOL, V26, P312, DOI 10.1097/00000478-200203000-00004; Sahin S, 2016, INT J SURG PATHOL; SIMON M, 1995, CANCER RES, V55, P4696; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Terzi A, 2008, PATHOL RES PRACT, V204, P305, DOI 10.1016/j.prp.2008.01.013; Torp SH, 2001, CLIN NEUROPATHOL, V20, P190; van Alkemade H, 2012, NEURO-ONCOLOGY, V14, P658, DOI 10.1093/neuonc/nos013; Vankalakunti M, 2007, NEUROPATHOLOGY, V27, P407, DOI 10.1111/j.1440-1789.2007.00801.x; Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0; Varughese RK, 2016, J CLIN PATHOL, V69, P26, DOI 10.1136/jclinpath-2015-202983; Weber RG, 1997, P NATL ACAD SCI USA, V94, P14719, DOI 10.1073/pnas.94.26.14719; Wester K, 2000, APPL IMMUNOHISTO M M, V8, P61, DOI 10.1097/00022744-200003000-00010	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172316	10.1371/journal.pone.0172316	http://dx.doi.org/10.1371/journal.pone.0172316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301542	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300014
J	Yang, Y; Qiu, S; Qian, L; Tian, Y; Chen, YN; Bi, L; Chen, WP				Yang, Ye; Qiu, Shuang; Qian, Lei; Tian, Yuan; Chen, Yingna; Bi, Lei; Chen, Weiping			OCF can repress tumor metastasis by inhibiting epithelial-mesenchymal transition involved in PTEN/PI3K/AKT pathway in lung cancer cells	PLOS ONE			English	Article							SALVIANOLIC ACIDS; SIGNALING PATHWAY; PTEN; EXPRESSION; RADIATION; PI3K/AKT; ROLES; EMT	A component formula with definite compositions provides a new approach to treat various diseases. Salvia miltiorrhiza and Panax ginseng are widely used in China because of their antitumor properties. In the previous study, the optimizing component formula (OCF), prepared with salvianolic acids, ginsenosides, and ginseng polysaccharides (5, 10, and 5 mg.L-1, respectively) extracted from S. miltiorrhiza and P. ginseng on the basis of IC50 in lung cancer A549 cells and damage minimization on human bronchial epithelial cells in vitro. Currently, we also have demonstrated the inhibitory effect of OCF on A549 cell migration and invasion in vitro. According to Lewis lung cancer cells (LLC) allograft in C57BL/6 mice and A549 xenograft in nude mice experiment, we found that the anti-tumor and anti-metastasis effects of OCF treatment were related to the inhibition of epithelial-mesenchymal transition (EMT). Further studies showed that the inhibitory effect of OCF on EMT was associated with the PTEN/ PI3K/ AKT pathway. Therefore, all studies revealed that OCF could prevent cancer progression and tumor metastasis by inhibiting EMT involved PTEN/PI3K/ AKT signaling pathway in lung cancer cells.	[Yang, Ye; Qiu, Shuang; Qian, Lei; Tian, Yuan; Chen, Yingna; Bi, Lei; Chen, Weiping] Nanjing Univ Chinese Med, Dept Preclin Med, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Bi, L; Chen, WP (corresponding author), Nanjing Univ Chinese Med, Dept Preclin Med, Nanjing, Jiangsu, Peoples R China.	bella_nj@163.com; wp2002123@163.com	Lang, Ming/HIK-0758-2022; yang, yang/GWB-9426-2022; Chen, Wei/GZK-7348-2022	Bi, Lei/0000-0002-2951-0966	National Natural Sciences Foundation of China [81273638, 81503486]; Key Project of Science and Technology from Administration of Traditional Chinese Medicine in Jiangsu Province [ZD201502]; scientific innovation research of college graduate in Jiangsu province [KYLX15_0997, KYLX16_1153]; Priority Academic Program Development of Jiangsu Higher Education Institutions (integration of traditional Chinese and western medicine)	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology from Administration of Traditional Chinese Medicine in Jiangsu Province; scientific innovation research of college graduate in Jiangsu province; Priority Academic Program Development of Jiangsu Higher Education Institutions (integration of traditional Chinese and western medicine)	This work was supported by: grants from National Natural Sciences Foundation of China (No. 81273638 and 81503486); the Key Project of Science and Technology from Administration of Traditional Chinese Medicine in Jiangsu Province (ZD201502); scientific innovation research of college graduate in Jiangsu province (No. KYLX15_0997 and KYLX16_1153); and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (integration of traditional Chinese and western medicine).	Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang L, 2014, CANCER METAST REV, V33, P469, DOI 10.1007/s10555-014-9493-5; Cho YJ, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0283-1; Du GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072044; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Hellevik T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-59; Ho JHC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-30; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karamitopoulou E, 2011, HUM PATHOL, V42, P1888, DOI 10.1016/j.humpath.2010.06.020; Kharbanda A, 2014, ONCOTARGET, V5, P8893, DOI 10.18632/oncotarget.2360; Kim RH, 2006, BRIT J CANCER, V94, P620, DOI 10.1038/sj.bjc.6602994; Kim YJ, 2014, J GINSENG RES, V38, P66, DOI 10.1016/j.jgr.2013.11.001; Langdon SP, 2012, CURR DRUG TARGETS, V13, P1535; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li CL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1411-x; Li SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078902; Ma XH, 2015, MOLECULES, V20, P16235, DOI 10.3390/molecules200916235; Martinelli E, 2013, INT J CANCER, V133, P2089, DOI 10.1002/ijc.28236; Pan Fuqiang, 2015, Drug Des Devel Ther, V9, P4779, DOI 10.2147/DDDT.S84628; Perez-Ramirez C, 2015, PHARMACOGENOMICS, V16, P1843, DOI 10.2217/pgs.15.122; Rammah M, 2012, TOXICOL LETT, V211, P220, DOI 10.1016/j.toxlet.2012.04.003; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089123; Shimamura T, 2004, CANCER RES, V64, P6989, DOI 10.1158/0008-5472.CAN-04-1166; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tu KS, 2016, INT J ONCOL, V48, P965, DOI 10.3892/ijo.2015.3309; Wu WY, 2012, ACTA PHARMACOL SIN, V33, P1119, DOI 10.1038/aps.2012.126; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Xu XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096780, 10.1371/journal.pone.0109950]; [颜晓静 Yan Xiaojing], 2014, [中国中药杂志, China Journal of Chinese Materia Medica], V39, P4436; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678; Yoshioka H, 2012, TOXICOL LETT, V211, P257, DOI 10.1016/j.toxlet.2012.04.005; Yuan X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0087-z; Zhang LG, 2014, J ETHNOPHARMACOL, V155, P1424, DOI 10.1016/j.jep.2014.07.011; Zhou GJ, 2014, MOLECULES, V19, P7207, DOI 10.3390/molecules19067207	39	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174021	10.1371/journal.pone.0174021	http://dx.doi.org/10.1371/journal.pone.0174021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301605	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300112
J	Cheon, YH; Kim, HO; Suh, YS; Kim, MG; Yoo, WH; Kim, RB; Yang, HS; Lee, SI; Park, KS				Cheon, Yun-Hong; Kim, Hyun-Ok; Suh, Young Sun; Kim, Min Gyo; Yoo, Wan-Hee; Kim, Rock Bum; Yang, Hyun-Su; Lee, Sang-Il; Park, Ki-Soo			Relationship between decreased lower extremity muscle mass and knee pain severity in both the general population and patients with knee osteoarthritis: Findings from the KNHANES V 1-2	PLOS ONE			English	Article							QUALITY-OF-LIFE; NATIONAL-HEALTH; CARTILAGE LOSS; PREVALENCE; OBESITY; MEN; COMMUNITY; STRENGTH; RISK; ASSOCIATION	Objective To identify the prevalence of and risk factors for knee pain and radiographic knee osteoarthritis (RKOA) and to investigate the relationship between decreased lower extremity muscle mass (DLEM) and knee pain severity. Methods Using data from the Korea National Health and Nutrition Examination Survey, 3,278 participants who were >= 50 years old and who underwent dual x-ray absorptiometry, plain knee radiographs and completed a knee pain questionnaire were enrolled. Lower extremity muscle mass (LEM) was defined as the sum of the fat-free soft tissue mass of the legs, and lower extremity muscle mass index (LMI) was calculated as LEM/body weight (%). DLEM was defined as an LMI more than two standard deviations below the mean of a gender-matched young reference group. Categorical variables were presented as numbers (weighted %). Results The prevalence of knee pain and RKOA were 22% (n = 721) and 34.7% (n = 1,234), respectively. Multivariate logistic regression analysis showed being female (OR 2.15, 95% CI 1.67-2.79), older (OR 1.03, 95% CI 1.01-1.04), less educated (OR 1.72, 95% CI 1.09-2.71), stiffness (OR 16.15, 95% CI 12.04-21.66), bed rest (OR 2.49, 95% CI 1.81-3.43), RKOA (OR 2.20, 95% CI 1.78-2.74) and DLEM (OR 1.54, 95% CI 1.09-2.17) were associated with knee pain. Participants with simultaneous RKOA and DLEM complained of more severe pain (pain score 7.18 +/- 2.48) than those with knee pain without RKOA or DLEM (5.02 +/- 2.44), those with only RKOA (6.29 +/- 2.50), or those with only DLEM (6.78 +/- 2.18) (P<0.001). These results remained after multivariate analyses of variance (MANOVAs). Conclusion The prevalence of knee pain and RKOA were 22% and 34.7%, respectively, in the general Korean population. DLEM was an independent risk factor for knee pain and it was associated with increased pain severity, regardless of RKOA.	[Cheon, Yun-Hong; Kim, Hyun-Ok; Suh, Young Sun; Kim, Min Gyo; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Internal Med & Inst Hlth Sci, Jinju, South Korea; [Yoo, Wan-Hee] Chonbuk Natl Univ, Sch Med, Dept Rheumatol, Internal Med, Chonju, South Korea; [Kim, Rock Bum; Yang, Hyun-Su; Park, Ki-Soo] Gyeongsang Natl Univ, Sch Med, Dept Prevent Med, Jinju, South Korea	Gyeongsang National University; Jeonbuk National University; Gyeongsang National University	Lee, SI (corresponding author), Gyeongsang Natl Univ, Sch Med, Internal Med & Inst Hlth Sci, Jinju, South Korea.; Park, KS (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Prevent Med, Jinju, South Korea.	goldgu@gnu.ac.kr; kisoo1030@gmail.com		Kim, Mingyo/0000-0003-3744-8522	National Research Foundation of Korea (NRF) - the Korean government (MSIP) [NRF-2014R1A2A1A11051360, NRF-2015R1A5A2008833]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C2497]	National Research Foundation of Korea (NRF) - the Korean government (MSIP); Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by grants NRF-2014R1A2A1A11051360 and NRF-2015R1A5A2008833 from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP), and (HI15C2497) from Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea.	Amin S, 2007, ANN RHEUM DIS, V66, P18, DOI 10.1136/ard.2006.056697; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Boling M, 2010, SCAND J MED SCI SPOR, V20, P725, DOI 10.1111/j.1600-0838.2009.00996.x; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dawson J, 2004, RHEUMATOLOGY, V43, P497, DOI 10.1093/rheumatology/keh086; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; FELSON DT, 1989, ARTHRITIS RHEUM, V32, P166, DOI 10.1002/anr.1780320209; Frilander H, 2016, EUR J PAIN, V20, P1278, DOI 10.1002/ejp.852; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Ho-Pham LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094563; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Jhun HJ, 2013, J KOREAN MED SCI, V28, P1807, DOI 10.3346/jkms.2013.28.12.1807; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kiadaliri AA, 2016, SCAND J RHEUMATOL, V6, P1; Kim IJ, 2011, J KOREAN MED SCI, V26, P1140, DOI 10.3346/jkms.2011.26.9.1140; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; Lee JC, 2016, AIP CONF PROC, V1774, DOI 10.1063/1.4965062; Lee S, 2012, ARTHRITIS RHEUM-US, V64, P3947, DOI 10.1002/art.37696; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Mendieta EDM, 2006, OSTEOARTHR CARTILAGE, V14, P540, DOI 10.1016/j.joca.2005.12.012; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Muraki S, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0737-5; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Reid KF, 2015, ARTHRITIS RHEUMATOL, V67, P3166, DOI 10.1002/art.39336; Riddle DL, 2015, OSTEOARTHR CARTILAGE, V23, P391, DOI 10.1016/j.joca.2014.12.013; Roos EM, 2011, NAT REV RHEUMATOL, V7, P57, DOI 10.1038/nrrheum.2010.195; Ruhdorfer A, 2014, ARTHRIT CARE RES, V66, P1344, DOI 10.1002/acr.22317; Sattler M, 2012, OSTEOARTHR CARTILAGE, V20, P532, DOI 10.1016/j.joca.2012.02.635; Schaible HG, 2002, ANN NY ACAD SCI, V966, P343, DOI 10.1111/j.1749-6632.2002.tb04234.x; Schiphof D, 2013, ARTHRIT CARE RES, V65, P695, DOI 10.1002/acr.21886; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; Soni A, 2012, ARTHRITIS RHEUM-US, V64, P1145, DOI 10.1002/art.33434; Suh DH, 2016, OSTEOARTHR CARTILAGE, V24, P605, DOI 10.1016/j.joca.2015.10.011; Turkiewicz A, 2015, RHEUMATOLOGY, V54, P827, DOI 10.1093/rheumatology/keu409; Wang YY, 2012, ARTHRITIS RHEUM-US, V64, P3917, DOI 10.1002/art.34681; World Health Organization, 2008, WHO TECH REP SER 200, P1; Zhai GJ, 2006, ARTHRIT RHEUM-ARTHR, V55, P264, DOI 10.1002/art.21835	41	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173036	10.1371/journal.pone.0173036	http://dx.doi.org/10.1371/journal.pone.0173036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296926	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700022
J	Radhakrishnan, S; Literman, R; Neuwald, J; Severin, A; Valenzuela, N				Radhakrishnan, Srihari; Literman, Robert; Neuwald, Jennifer; Severin, Andrew; Valenzuela, Nicole			Transcriptomic responses to environmental temperature by turtles with temperature-dependent and genotypic sex determination assessed by RNAseq inform the genetic architecture of embryonic gonadal development	PLOS ONE			English	Article							EARED SLIDER TURTLE; NF-KAPPA-B; APALONE-MUTICA TURTLES; CHRYSEMYS-PICTA; DIFFERENTIAL EXPRESSION; TRACHEMYS-SCRIPTA; MESSENGER-RNA; STEROIDOGENIC FACTOR-1; MOLECULAR-MECHANISMS; TESTIS DETERMINATION	Vertebrate sexual fate is decided primarily by the individual's genotype (GSD), by the environmental temperature during development (TSD), or both. Turtles exhibit TSD and GSD, making them ideal to study the evolution of sex determination. Here we analyze temperature-specific gonadal transcriptomes (RNA-sequencing validated by qPCR) of painted turtles (Chrysemys picta TSD) before and during the thermosensitive period, and at equivalent stages in soft-shell turtles (Apalone spinifera-GSD), to test whether TSD's and GSD's transcriptional circuitry is identical but deployed differently between mechanisms. Our data show that most elements of the mammalian urogenital network are active during turtle gonadogenesis, but their transcription is generally more thermoresponsive in TSD than GSD, and concordant with their sex-specific function in mammals [e.g., upregulation of Amh, Ar, Esr1, Fog2, Gata4, Igf1r, Insr, and Lhx9 at male-producing temperature, and of beta-catenin, Foxl2, Aromatase (Cyp19a1), Fst, Nf-kb, Crabp2 at female-producing temperature in Chrysemys]. Notably, antagonistic elements in gonadogenesis (e.g., beta-catenin and Insr) were thermosensitive only in TSD early-embryos. Cirbp showed warm-temperature upregulation in both turtles disputing its purported key TSD role. Genes that may convert thermal inputs into sex-specific development (e.g., signaling and hormonal pathways, RNA-binding and heat-shock) were differentially regulated. Jak-Stat, Nf-kappa B, retinoic-acid, Wnt, and Mapk-signaling (not Akt and Ras-signaling) potentially mediate TSD thermosensitivity. Numerous species-specific ncRNAs (including Xist) were differentially-expressed, mostly upregulated at colder temperatures, as were unannotated loci that constitute novel TSD candidates. Cirbp showed warm-temperature upregulation in both turtles. Consistent transcription between turtles and alligator revealed putatively-critical reptilian TSD elements for male (Sf1, Amh, Amhr2) and female (Crabp2 and Hspb1) gonadogenesis. In conclusion, while preliminary, our data helps illuminate the regulation and evolution of vertebrate sex determination, and contribute genomic resources to guide further research into this fundamental biological process.	[Radhakrishnan, Srihari] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA USA; [Radhakrishnan, Srihari; Literman, Robert; Neuwald, Jennifer; Severin, Andrew; Valenzuela, Nicole] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Literman, Robert] Iowa State Univ, Ecol & Evolutionary Biol Program, Ames, IA USA; [Severin, Andrew] Iowa State Univ, Genome Informat Facil, Ames, IA USA; [Neuwald, Jennifer] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Colorado State University	Valenzuela, N (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	nvalenzu@iastate.edu	Neuwald, Jennifer/AAH-3468-2021	Neuwald, Jennifer/0000-0002-8850-5534; Valenzuela, Nicole/0000-0003-1148-631X; Literman, Robert/0000-0002-1784-0407	Sigma Xi [G20120315162029]; US National Science Foundation [IOS-0743284, MCB-1244355]	Sigma Xi; US National Science Foundation(National Science Foundation (NSF))	This work was supported by Sigma Xi grant G20120315162029 to S.R. and US National Science Foundation grants IOS-0743284 and MCB-1244355 to NV.	Al Seesi S, 2014, BMC GENOMICS, V15; Anders S., 2014, HTSEQ PYTHON FRAMEWO; Anders S, 2012, ANAL RNA SEQ DATA DE, P1; Ashman TL, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.15; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Bachvarova RF, 2009, EVOL DEV, V11, P525, DOI 10.1111/j.1525-142X.2009.00360.x; Badenhorst D, 2015, GENOME BIOL EVOL, V7, P2038, DOI 10.1093/gbe/evv119; Badenhorst D, 2013, CHROMOSOME RES, V21, P137, DOI 10.1007/s10577-013-9343-2; Barske LA, 2010, DEV BIOL, V341, P305, DOI 10.1016/j.ydbio.2010.02.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron JM, 1998, DEV GROWTH DIFFER, V40, P243; Bernard P, 2012, ENDOCRINOLOGY, V153, P901, DOI 10.1210/en.2011-1347; Bieser KL, 2014, SEX DEV, V8, P364, DOI 10.1159/000369116; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bott RC, 2008, REPROD DOMEST ANIM, V43, P310, DOI 10.1111/j.1439-0531.2008.01179.x; BULL JJ, 1981, J EXP ZOOL, V218, P435, DOI 10.1002/jez.1402180315; BULL JJ, 1979, SCIENCE, V206, P1186, DOI 10.1126/science.505003; Bull JJ, 1983, EVOLUTION SEX DETERM, P173; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carmi I, 1998, NATURE, V396, P168, DOI 10.1038/24164; Castro LFC, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-43; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; Chassot AA, 2012, WNT4 RSPO1 TOGETHER; Chavez B, 2009, GEN COMP ENDOCR, V162, P203, DOI 10.1016/j.ygcen.2009.02.010; Chocu S, 2012, SYST BIOL REPROD MED, V58, P179, DOI 10.3109/19396368.2012.691943; Costanzo JP, 2001, J COMP PHYSIOL B, V171, P335, DOI 10.1007/s003600100181; Crews D, 2001, J EXP ZOOL, V290, P597, DOI 10.1002/jez.1110; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Czerwinski M, 2016, DEV BIOL; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; Devonshire AS, 2013, METHODS, V59, P89, DOI 10.1016/j.ymeth.2012.07.021; Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; GEORGE FW, 1978, J CLIN ENDOCR METAB, V47, P550, DOI 10.1210/jcem-47-3-550; Girondot Marc, 2004, P148; Gomez-Saldarriaga C, 2016, CHELONIAN CONSERV BI, V15, P43, DOI 10.2744/CCB-1170.1; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graves JAM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-205; Grayson KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094214; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Hou SX, 2002, JAK STAT PATHWAY MOD, P765; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hughes IA, 1999, ACTA PAEDIATR, V88, P23, DOI 10.1111/j.1651-2227.1999.tb14347.x; James S, 2012, PALGRAVE STUD EUR UN, P8; Janes DE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0809; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kaplinsky NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066357; Kawagoshi T, 2009, CYTOGENET GENOME RES, V125, P125, DOI 10.1159/000227837; Keenan SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131669; Kettlewell JR, 2000, GENESIS, V26, P174, DOI 10.1002/(SICI)1526-968X(200003)26:3<174::AID-GENE2>3.0.CO;2-J; Kohno S, 2010, SEX DEV, V4, P73, DOI 10.1159/000260374; Korus M, 2002, ONCOGENE, V21, P4601, DOI 10.1038/sj.onc.1205678; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Literman R, 2014, METHODS ECOL EVOL, V5, P872, DOI 10.1111/2041-210X.12228; Liu C, 2016, DEVELOPMENT, V143, P3700, DOI 10.1242/dev.135756; Liu CF, 2010, CURR TOP DEV BIOL, V90, P263, DOI 10.1016/S0070-2153(10)90007-0; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Maldonado LCT, 2002, GEN COMP ENDOCR, V129, P20, DOI 10.1016/S0016-6480(02)00511-7; Matsumoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063599; Matsumoto Y, 2013, J MOL ENDOCRINOL, V50, P389, DOI 10.1530/JME-12-0260; Meeks JJ, 2003, NAT GENET, V34, P32, DOI 10.1038/ng1141; Merchant-Larios H, 2010, SEX DEV, V4, P50, DOI 10.1159/000276768; Minkina A, 2014, DEV CELL, V29, P511, DOI 10.1016/j.devcel.2014.04.017; Miqueloto CA, 2007, J ANAT, V211, P16, DOI 10.1111/j.1469-7580.2007.00741.x; Mitchell NJ, 2010, SEX DEV, V4, P129, DOI 10.1159/000282494; Mittwoch U, 2004, J THEOR BIOL, V228, P359, DOI 10.1016/j.jtbi.2004.02.001; Mittwoch U, 2013, EMBO REP, V14, P588, DOI 10.1038/embor.2013.84; Mizoguchi BA, 2016, SEX DEV; Morian CL, 2001, J HERPETOL, V35, P668, DOI 10.2307/1565908; Morjan CL, 2003, BEHAV ECOL SOCIOBIOL, V53, P254, DOI 10.1007/s00265-002-0570-3; Morrish BC, 2002, REPRODUCTION, V124, P447, DOI 10.1530/rep.0.1240447; Mu XY, 2013, J CELL PHYSIOL, V228, P627, DOI 10.1002/jcp.24172; Munger SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003630; Nanda I, 2002, CYTOGENET GENOME RES, V99, P178, DOI 10.1159/000071591; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Nef Serge, 2009, Journal of Biology (London), V8, P74, DOI 10.1186/jbiol173; Neuwald JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018117; Oreal E, 2002, DEV DYNAM, V225, P221, DOI 10.1002/dvdy.10153; Organ CL, 2008, INTEGR COMP BIOL, V48, P512, DOI 10.1093/icb/icn041; Palmieri F, 2013, MITOCHONDRIAL TRANSP, P465; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; Pieau C, 2004, J ENDOCRINOL, V181, P367, DOI 10.1677/joe.0.1810367; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Pokorna MJ, 2016, BIOL REV; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Ramkissoon Y, 1996, CURR OPIN GENET DEV, V6, P316, DOI 10.1016/S0959-437X(96)80008-6; Ramsey M, 2007, DIFFERENTIATION, V75, P978, DOI 10.1111/j.1432-0436.2007.00182.x; Ramsey M, 2007, J EXP ZOOL PART A, V307A, P463, DOI 10.1002/jez.399; Ramsey M, 2009, SEMIN CELL DEV BIOL, V20, P283, DOI 10.1016/j.semcdb.2008.10.004; Rhen T, 2007, SEX DEV, V1, P255, DOI 10.1159/000104775; Rhen T, 2010, SEX DEV, V4, P16, DOI 10.1159/000282495; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roos-Mattjus P, 2004, ANN MED, V36, P285, DOI 10.1080/07853890310016324; Sabath N, 2016, ECOLOGY EVOLUTION; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Schroeder AL, 2016, GENETICS, V115; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; Shoemaker C, 2007, DEV DYNAM, V236, P1055, DOI 10.1002/dvdy.21096; Shoemaker-Daly CM, 2010, DEV DYNAM, V239, P1061, DOI 10.1002/dvdy.22266; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Spotila LD, 1998, J EXP ZOOL, V281, P417, DOI 10.1002/(SICI)1097-010X(19980801)281:5<417::AID-JEZ7>3.0.CO;2-R; Sundaram M, 1996, DEVELOPMENT, V122, P2823; Szymanski M, 2003, NUCLEIC ACIDS RES, V31, P429, DOI 10.1093/nar/gkg124; Valenzuela N, 2001, EVOL ECOL RES, V3, P779; Valenzuela N, 2003, AM NAT, V161, P676, DOI 10.1086/368292; Valenzuela N, 2010, SEX DEV, V4, P39, DOI 10.1159/000277935; Valenzuela N, 2001, ECOLOGY, V82, P3010, DOI 10.2307/2679831; Valenzuela N, 2009, COLD SPRING HARB PRO, V4, P1, DOI DOI 10.1101/PDB.EMO124:1-9; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Valenzuela N, 2008, INTEGR COMP BIOL, V48, P476, DOI 10.1093/icb/icn031; Valenzuela N, 2008, EVOLUTION, V62, P234, DOI 10.1111/j.1558-5646.2007.00279.x; Valenzuela N, 2007, DEV GENES EVOL, V217, P55, DOI 10.1007/s00427-006-0106-3; Valenzuela N, 2006, EVOL DEV, V8, P424, DOI 10.1111/j.1525-142X.2006.00116.x; Valenzuela N, 2014, CYTOGENET GENOME RES, V144, P39, DOI 10.1159/000366076; Valenzuela N, 2013, DEV DYNAM, V242, P307, DOI 10.1002/dvdy.23897; Valenzuela N, 2011, EVOLUTION, V65, P1808, DOI 10.1111/j.1558-5646.2011.01258.x; VOGT RC, 1982, COPEIA, P699, DOI 10.2307/1444672; Wainwright EN, 2010, CURR TOP DEV BIOL, V90, P231, DOI 10.1016/S0070-2153(10)90006-9; Wang C, 2015, ZOOL SCI, V32, P151, DOI 10.2108/zs140246; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Weiner SA, 2013, NATURWISSENSCHAFTEN, V100, P795, DOI 10.1007/s00114-013-1064-z; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yamamoto Y., 2014, PLOS ONE, V9; Yatsu R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2396-9; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	149	40	42	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172044	10.1371/journal.pone.0172044	http://dx.doi.org/10.1371/journal.pone.0172044			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296881	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700004
J	Schmied, V; Black, E; Naidoo, N; Dahlen, HG; Liamputtong, P				Schmied, Virginia; Black, Emma; Naidoo, Norell; Dahlen, Hannah G.; Liamputtong, Pranee			Migrant women's experiences, meanings and ways of dealing with postnatal depression: A meta-ethnographic study	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; HELP-SEEKING; HEALTH-SERVICES; IMMIGRANT WOMEN; MENTAL-HEALTH; QUALITATIVE RESEARCH; LIVED EXPERIENCES; RISK-FACTORS; REFUGEE; BARRIERS	Aim To conduct a meta-ethnographic study of the experiences, meanings and ways of 'dealing with' symptoms or a diagnosis of postnatal depression amongst migrant women living in high income countries. Background Prevalence of postnatal depression is highest amongst women who are migrants. Yet many women do not seek help for their symptoms and health services do not always respond appropriately to migrant women's needs. Studies have reported migrant women's experiences of postnatal depression and it is timely to synthesise findings from these studies to understand how services can be improved. Design A meta-ethnographic synthesis of 12 studies reported in 15 papers Data sources Five databases were searched for papers published between January 1999 and February 2016 Review methods The quality of included studies was assessed using the Critical Appraisal Skills Program tool. The synthesis process was guided by the seven steps of meta-ethnography outlined by Noblit and Hare. Findings Four key metaphors were identified: "I am alone, worried and angry-this is not me!"; 'Making sense of my feelings' 'Dealing with my feelings' and 'What I need to change the way I feel!'. Primarily women related their feelings to their position as a migrant and as women, often living in poor socio-economic circumstances and they were exhausted keeping up with expected commitments. Many women were resourceful, drawing on their personal strengths and family / community resources. All the studies reported that women experienced difficulties in accessing appropriate services. Conclusion The meta-ethnographic study demonstrates the impact of migration on perinatal mental health, particularly for women lacking family support, who have no employment, a precarious migration status and/or relationship conflict. Migrant women are resourceful and this requires support through appropriate services. Further research is needed to evaluate effective support strategies for migrant women in the perinatal period.	[Schmied, Virginia; Naidoo, Norell; Dahlen, Hannah G.] Univ Western Sydney, Sch Nursing & Midwifery, Sydney, NSW, Australia; [Black, Emma] St John God Hlth Care, Perinatal & Womens Mental Hlth Unit, Burwood, NSW, Australia; [Black, Emma] Univ New South Wales, Sch Psychiat, Burwood, NSW, Australia; [Dahlen, Hannah G.] Ingham Inst Hlth & Med Res, Liverpool, NSW, Australia; [Liamputtong, Pranee] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia	Western Sydney University; St John of God Health Care; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Western Sydney University	Schmied, V (corresponding author), Univ Western Sydney, Sch Nursing & Midwifery, Sydney, NSW, Australia.	v.schmied@westernsydney.edu.au	Dahlen, Hannah/V-1034-2019	Dahlen, Hannah/0000-0002-4450-3078; Schmied, Virginia/0000-0002-4066-1781; Black, Emma/0000-0002-3936-2434				Abrams LS, 2011, QUAL HEALTH RES, V21, P373, DOI 10.1177/1049732310385123; Ahmed A, 2008, ARCH WOMEN MENT HLTH, V11, P295, DOI 10.1007/s00737-008-0025-6; Almeida L, 2013, MATERN CHILD HLTH J, V17, P1346, DOI 10.1007/s10995-012-1149-x; Bandyopadhyay M, 2010, AUST NZ J PUBL HEAL, V34, P412, DOI 10.1111/j.1753-6405.2010.00575.x; Beck CT, 1998, ARCH PSYCHIAT NURS, V12, P12, DOI 10.1016/S0883-9417(98)80004-6; Beck CT, 2002, QUAL HEALTH RES, V12, P453, DOI 10.1177/104973202129120016; Benza S, 2014, MIDWIFERY, V30, P575, DOI 10.1016/j.midw.2014.03.005; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Burns E, 2010, MATERN CHILD NUTR, V6, P201, DOI 10.1111/j.1740-8709.2009.00209.x; Burr J, 2004, SOCIOL HEALTH ILL, V26, P433, DOI 10.1111/j.0141-9889.2004.00398.x; Callister LC, 2011, JOGNN-J OBST GYN NEO, V40, P440, DOI 10.1111/j.1552-6909.2011.01254.x; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; Chisholm D, 2004, BRIT J PSYCHIAT, V184, pS45, DOI 10.1192/bjp.184.46.s45; Collins CH, 2011, ARCH WOMEN MENT HLTH, V14, P3, DOI 10.1007/s00737-010-0198-7; Critical Appraisal Skills Programme (CASP), 2013, QUAL RES CHECKL VERS; Dahlen HG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0681-2; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; Elmir R, 2016, MIDWIFERY, V32, P66, DOI 10.1016/j.midw.2015.09.008; Evagorou O, 2015, PSYCHIAT QUART; Falah-Hassani K, 2015, J PSYCHIATR RES, V70, P67, DOI 10.1016/j.jpsychires.2015.08.010; Fellmeth G, 2016, BJOG; Foulkes M, 2011, JOGNN-J OBST GYN NEO, V40, P450, DOI 10.1111/j.1552-6909.2011.01264.x; France EF, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-119; Fung K, 2010, CURR OPIN PSYCHIATR, V23, P342, DOI 10.1097/YCO.0b013e32833ad721; Gardner PL, 2014, MIDWIFERY, V30, P756, DOI 10.1016/j.midw.2013.08.001; Goodman JH, 2009, BIRTH-ISS PERINAT C, V36, P60, DOI 10.1111/j.1523-536X.2008.00296.x; Henderson S, 2011, AUST J PRIM HEALTH, V17, P195, DOI 10.1071/PY10065; Kim JJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.004; Kim JJ, 2010, J OBSTET GYNECOLOGY, V202; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Knudson-Martin C, 2009, J MARITAL FAM THER, V35, P145, DOI 10.1111/j.1752-0606.2009.00112.x; Letourneau N, 2011, INT J MENT HEALTH NU, V20, P345, DOI 10.1111/j.1447-0349.2010.00736.x; Liamputtong P., 2006, QUAL SOCIOL, V29, P25, DOI [DOI 10.1007/S11133-005-9006-5, 10.1007/s11133-005-9006-5]; Mamisachvili L, 2013, J TRANSCULT NURS, V24, P162, DOI 10.1177/1043659612472197; Matthey S, 2009, EVID-BASED MENT HEAL, V12, P82, DOI 10.1136/ebmh.12.3.82; McCarthy R., 2013, BRIT J MIDWIFERY, V21, P404, DOI [10.12968/bjom.2013.21.6.404, DOI 10.12968/BJOM.2013.21.6.404, DOI 10.12968/bjom.2013.21.6.404]; McGarry J, 2009, J MIDWIFERY WOM HEAL, V54, P50, DOI 10.1016/j.jmwh.2008.07.003; McLeish J., 2005, BRIT J MIDWIFERY, V13, P782, DOI [DOI 10.12968/BJ0M.2005.13.12.20125, 10.12968/BJOM.2005.13.12.20125, DOI 10.12968/BJOM.2005.13.12.20125]; Mollard EK, 2014, ISSUES MENT HEALTH N, V35, P656, DOI 10.3109/01612840.2014.893044; Morrow M, 2008, HEALTH CARE WOMEN IN, V29, P593, DOI 10.1080/07399330802089156; Nahas V, 1999, J Transcult Nurs, V10, P37, DOI 10.1177/104365969901000113; Nahas VL, 1999, J NURSE-MIDWIFERY, V44, P65, DOI 10.1016/S0091-2182(98)00083-4; Nilaweera I, 2014, J AFFECT DISORDERS, V166, P213, DOI 10.1016/j.jad.2014.05.021; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Norhayati MN, 2015, J AFFECT DISORDERS, V175, P34, DOI 10.1016/j.jad.2014.12.041; O'Mahony J, 2010, J PSYCHIATR MENT HLT, V17, P917, DOI 10.1111/j.1365-2850.2010.01625.x; O'Mahony JM, 2013, J PSYCHIATR MENT HLT, V20, P714, DOI 10.1111/jpm.12005; O'Mahony JM, 2013, J IMMIGR MINOR HEALT, V15, P300, DOI 10.1007/s10903-012-9663-x; O'Mahony Joyce Maureen, 2012, Issues Ment Health Nurs, V33, P735, DOI 10.3109/01612840.2012.701707; O'Mahony JM, 2012, ADV NURS SCI, V35, pE42, DOI 10.1097/ANS.0b013e3182626137; Ornelas IJ, 2009, J FAM ISSUES, V30, P1556, DOI 10.1177/0192513X09336651; Parvin A, 2004, FAM PRACT, V21, P254, DOI 10.1093/fampra/cmh307; Priddis H, 2013, J ADV NURS, V69, P748, DOI 10.1111/jan.12005; Raman S, 2014, MIDWIFERY, V30, P130, DOI 10.1016/j.midw.2013.03.003; Raymond JE, 2009, MIDWIFERY, V25, P39, DOI 10.1016/j.midw.2007.01.005; Reay R, 2008, 2 YEAR OUTCOMES MOTH; Rodrigues M, 2003, SOC SCI MED, V57, P1797, DOI 10.1016/S0277-9536(03)00062-5; Rollans M, 2013, MIDWIFERY, V29, P935, DOI 10.1016/j.midw.2012.11.013; Sandelowski M., 2007, HDB SYNTHESIZING QUA; Schmied V, 2013, WOMEN BIRTH, V26, P167, DOI 10.1016/j.wombi.2013.02.006; Shafiei T, 2015, MIDWIFERY, V31, P671, DOI 10.1016/j.midw.2015.03.011; Smith MV, 2009, GEN HOSP PSYCHIAT, V31, P155, DOI 10.1016/j.genhosppsych.2008.10.002; Stapleton H, 2013, WOMEN BIRTH, V26, P260, DOI 10.1016/j.wombi.2013.07.004; Templeton L, 2003, ETHNIC HEALTH, V8, P207, DOI 10.1080/1355785032000136425; Tobin C, 2015, J IMMIGR MINOR HEALT, V17, P1019, DOI 10.1007/s10903-014-0041-8; Vogel DL, 2003, J COUNS PSYCHOL, V50, P351, DOI 10.1037/0022-0167.50.3.351; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Westall C, 2011, MOTHERHOOD AND POSTNATAL DEPRESSION: NARRATIVES OF WOMEN AND THEIR PARTNERS, P1, DOI 10.1007/978-94-007-1694-0; Woolhouse H, 2015, BJOG-INT J OBSTET GY, V122, P312, DOI 10.1111/1471-0528.12837; Youssef J, 2006, MENT HEALTH RELIG CU, V9, P43, DOI 10.1080/13674670512331335686	70	39	39	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172385	10.1371/journal.pone.0172385	http://dx.doi.org/10.1371/journal.pone.0172385			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296887	gold, Green Published			2022-12-26	WOS:000396311700007
J	Ades, F; Senterre, C; Zardavas, D; de Azambuja, E; Popescu, R; Piccart, M				Ades, Felipe; Senterre, Christelle; Zardavas, Dimitrios; de Azambuja, Evandro; Popescu, Razvan; Piccart, Martine			Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; ADJUVANT CHEMOTHERAPY; MORTALITY; SURVIVAL; TRENDS; PLUS; DOCETAXEL; HEALTH	Background The development of trastuzumab is considered to be one of the greatest improvements in breast cancer treatment in recent years. This study aims to evaluate changes in the uptake of trastuzumab over the last 12 years and to determine whether its use is proportional to patient needs in the European Union and the USA. Methods Using national registry data, the number of new cases of HER2-positive breast cancer patients per year was estimated. The number of likely trastuzumab treatments per year was estimated using trastuzumab procurement data for each country. Results Western Europe and the USA show increasing procurement level of trastuzumab over the years studied, reaching proportional of use of trastuzumab few years after its marketing authorization in the early 2000's. After the approval in the adjuvant setting, in the year 2006, it was observed underuse of trastuzumab given the increase of the number of patients in need of treatment. Proportional use was shortly met after a couple of years. Few countries in Eastern Europe acquired the needed quantity of trastuzumab, with procurement levels starting to increase only after approval in the adjuvant setting in 2006. Conclusion Significant differences in trastuzumab procurement are observed between Western Europe, the USA and Eastern Europe, with the latter geographic region acquiring insufficient amounts of the drug required to treat all patients in need.	[Ades, Felipe; de Azambuja, Evandro; Piccart, Martine] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med Oncol, Brussels, Belgium; [Ades, Felipe] Hosp Israelita Albert Einstein, Ctr Oncol & Hematol, Sao Paulo, Brazil; [Senterre, Christelle] Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Epidemiol Biostat & Clin Res, Brussels, Belgium; [Zardavas, Dimitrios] Breast Int Grp Headquarters BIG Aisbl, Brussels, Belgium; [Popescu, Razvan] Hirslanden Clin Aarau, Dept Med Oncol, Aarau, Switzerland	Institut Jules Bordet; Universite Libre de Bruxelles; Hospital Israelita Albert Einstein; Universite Libre de Bruxelles; Breast International Group	Ades, F (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Dept Med Oncol, Brussels, Belgium.	felipeades@gmail.com	Popescu, Razvan/AAP-9418-2021	de Azambuja, Evandro/0000-0001-9501-4509; Ades, Felipe/0000-0002-6074-6133	IMS Health; ESMO Head Office, ESMO Executive Board and ESMO National Representatives	IMS Health; ESMO Head Office, ESMO Executive Board and ESMO National Representatives	ESMO financed the acquisition of the trastuzumab procurement data from IMS Health.; We would like to express our sincere gratitude to the ESMO Head Office, ESMO Executive Board and ESMO National Representatives for their scientific input, and their logistical and financial support for the acquisition of the IMS database. We extend our gratitude to Carolyn Straehle for the valuable language editing support.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ades F, 2013, ANN ONCOL, V24, P2897, DOI 10.1093/annonc/mdt352; Ades F, 2014, EUR J CANCER, V50, P3089, DOI 10.1016/j.ejca.2014.09.011; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; [Anonymous], 2008, CYPRUS CANSER REGIST; [Anonymous], 2008, NATIONAL HEALTH STAT; Arnold M, 2013, EUR J CANCER OXF ENG; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Bartsch R, 2007, J CLIN ONCOL, V25, P3853, DOI 10.1200/JCO.2007.11.9776; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bosetti C, 2013, ANN ONCOL, V24, P2657, DOI 10.1093/annonc/mdt301; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Edwards BK, 2013, CANCER; Finucane MM, LANCET, V12, P557; Gelmon Karen A, 2004, Clin Breast Cancer, V5, P52, DOI 10.3816/CBC.2004.n.010; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Leopold C, 2013, HEALTH POLICY, V113, P313, DOI 10.1016/j.healthpol.2013.09.018; Lichtenberg Frank R, 2005, Int J Health Care Finance Econ, V5, P47, DOI 10.1007/s10754-005-6601-7; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Mackenbach JP, 2013, LANCET, V381, P1125, DOI 10.1016/S0140-6736(12)62082-0; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1; Munro AJ, 2014, BRIT MED BULL, V110, P5, DOI 10.1093/bmb/ldu009; Neyt MJ, 2005, INT J TECHNOL ASSESS, V21, P132, DOI 10.1017/S0266462305050178; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Spielmann M, 2009, J CLIN ONCOL, V27, P6129, DOI 10.1200/JCO.2009.23.0946; Staff DI, US CENSUS BUREAU HEA; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; VANDIJCK JAAM, 1994, J NATL CANCER I, V86, P934, DOI 10.1093/jnci/86.12.934; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; von Minckwitz G, 2011, EUR J CANCER, V47, P2273, DOI 10.1016/j.ejca.2011.06.021; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618; Vostakolaei FA, 2011, EUR J PUBLIC HEALTH, V21, P573, DOI 10.1093/eurpub/ckq120; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0172351	10.1371/journal.pone.0172351	http://dx.doi.org/10.1371/journal.pone.0172351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291814	Green Submitted, Green Published, gold			2022-12-26	WOS:000396094700005
J	Galdeano, DM; Breton, MC; Lopes, JRS; Falk, BW; Machado, MA				Galdeano, Diogo Manzano; Breton, Michele Claire; Spotti Lopes, Joao Roberto; Falk, Bryce W.; Machado, Marcos Antonio			Oral delivery of double-stranded RNAs induces mortality in nymphs and adults of the Asian citrus psyllid, Diaphorina citri	PLOS ONE			English	Article							CANDIDATUS-LIBERIBACTER-ASIATICUS; SPODOPTERA-EXIGUA; CHITIN SYNTHASES; GREENING DISEASE; CATHEPSIN-D; INTERFERENCE; DSRNA; VECTOR; INJECTION; SUCKING	The Asian citrus psyllid (ACP), Diaphorina citri Kuwayama, is one of the most important citrus pests. ACP is the vector of the phloem-limited bacteria Candidatus Liberibacter americanus and Candidatus Liberibacter asiaticus, the causal agents of the devastating citrus disease huanglongbing (HLB). The management of HLB is based on the use of healthy young plants, eradication of infected plants and chemical control of the vector. RNA interference (RNAi) has proven to be a promising tool to control pests and explore gene functions. Recently, studies have reported that target mRNA knockdown in many insects can be induced through feeding with double-stranded RNA (dsRNA). In the current study, we targeted the cathepsin D, chitin synthase and inhibitor of apoptosis genes of adult and nymph ACP by feeding artificial diets mixed with dsRNAs and Murraya paniculata leaves placed in dsRNAs solutions, respectively. Adult ACP mortality was positively correlated with the amount of dsRNA used. Both nymphs and adult ACP fed dsRNAs exhibited significantly increased mortality over time compared with that of the controls. Moreover, qRT-PCR analysis confirmed the dsRNA-mediated RNAi effects on target mRNAs. These results showed that RNAi can be a powerful tool for gene function studies in ACP and perhaps for HLB control.	[Galdeano, Diogo Manzano; Breton, Michele Claire; Machado, Marcos Antonio] Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, Lab Biotecnol, Cordeiropolis, SP, Brazil; [Galdeano, Diogo Manzano] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Spotti Lopes, Joao Roberto] Univ Sao Paulo, Escola Super Agr Luiz De Queiroz, Piracicaba, SP, Brazil; [Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; University of California System; University of California Davis	Machado, MA (corresponding author), Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, Lab Biotecnol, Cordeiropolis, SP, Brazil.	marcos@centrodecitricultura.br	Lopes, Joao/F-3439-2012; Galdeano, Diogo M/C-3662-2019; Machado, Marcos Antonio/G-3582-2012	Lopes, Joao/0000-0002-9998-5473; Galdeano, Diogo M/0000-0002-7411-5009; Yan, Zhiyong/0000-0001-8253-0694; Machado, Marcos Antonio/0000-0001-9780-3990	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/02138-0, 2014/03925-8, 2008/57909-2]; CNPq [573848/08-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/02138-0, 2014/03925-8 and 2008/57909-2), and CNPq (573848/08-4).; We thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2008/57909-2, 2013/02138-0, 2014/03925-8) and CNPq (573848/08-4) for supporting this work. We also thank Dra. Yen-Wen Kuo, Alyssa Oslan and Tera L. Pitman for helpful discussions, advice and assistance.	Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Baum JA, 2014, ADV INSECT PHYSL; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; El-Shesheny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065392; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Gui ZZ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-49; Hajeri S, 2014, J BIOTECHNOL, V176, P42, DOI 10.1016/j.jbiotec.2014.02.010; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hoddle MS, 2014, J ECON ENTOMOL, V107, P125, DOI 10.1603/EC13318; HOUSEMAN JG, 1983, COMP BIOCHEM PHYS B, V75, P509, DOI 10.1016/0305-0491(83)90367-X; Hoy MA, 2010, FLA ENTOMOL, V93, P24, DOI 10.1653/024.093.0103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Jarosch A, 2012, APIDOLOGIE, V43, P128, DOI 10.1007/s13592-011-0092-y; Jin SX, 2015, PLANT BIOTECHNOL J, V13, P435, DOI 10.1111/pbi.12355; Khan AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073657; Killiny N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110536; Li HC, 2015, PLANT CELL ENVIRON, V38, P2277, DOI 10.1111/pce.12546; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li JJ, 2015, PEST MANAG SCI, V71, P1175, DOI 10.1002/ps.3903; Li X, 2011, PLOS ONE, V6; Luan JB, 2013, INSECT BIOCHEM MOLEC, V43, P740, DOI 10.1016/j.ibmb.2013.05.012; Luo Y, 2013, INSECT MOL BIOL, V22, P574, DOI 10.1111/imb.12046; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Michaud JP, 2004, BIOCONTROL, V49, P417, DOI 10.1023/B:BICO.0000034605.53030.db; Nunes Francis M.F., 2013, Insects, V4, P90, DOI 10.3390/insects4010090; Otti MJZ, 2007, NEOTROP ENTOMOL, V44, P197; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Pridgeon JW, 2008, J MED ENTOMOL, V45, P414, DOI 10.1603/0022-2585(2008)45[414:TAADRK]2.0.CO;2; Rao KV., 2015, FRONT PHYSL, V6; Russell CW, 2015, ENTOMOL EXP APPL, V154, P171, DOI 10.1111/eea.12268; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Walker WB, 2011, ENTOMOL EXP APPL, V138, P83, DOI 10.1111/j.1570-7458.2010.01078.x; Wuriyanghan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066050; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Wynant N., 2014, INT REV CELL MOL BIO, V1st; Wynant N, 2014, INSECT BIOCHEM MOLEC, V46, P1, DOI 10.1016/j.ibmb.2013.12.008; YAMAMOTO PT, 2009, BIOASSAY, V4, P9; Yang J, 2014, J INTEGR AGR, V13, P115, DOI 10.1016/S2095-3119(13)60511-0; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x	57	43	45	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0171847	10.1371/journal.pone.0171847	http://dx.doi.org/10.1371/journal.pone.0171847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282380	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800004
J	Leung, PWL; Chan, JKY; Chen, LH; Lee, CC; Hung, SF; Ho, TP; Tang, CP; Moyzis, RK; Swanson, JM				Leung, Patrick Wing-leung; Chan, Janice Ka Yan; Chen, Lu Hua; Lee, Chi Chiu; Hung, Se Fong; Ho, Ting Pong; Tang, Chun Pan; Moyzis, Robert K.; Swanson, James M.			Family-based association study of DRD4 gene in methylphenidate-responded Attention Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; GENOME-WIDE ASSOCIATION; DOPAMINE-D4 RECEPTOR LOCUS; ALLELE FREQUENCIES; MOLECULAR-GENETICS; CHINESE CHILDREN; 2-REPEAT ALLELE; MATTER VOLUME; ADHD; PREVALENCE	The 48-basepair (48-bp) variable number tandem repeat (VNTR) polymorphism in exon 3 of the dopamine receptor D4 gene (DRD4) is implicated in the etiology of attention-deficit/ hyperactivity disorder (ADHD). In particular, ADHD in European-ancestry population is associated with an increased prevalence of the 7-repeat (7R) allele of the exon 3 VNTR. However, it is intriguing to note that the 7R allele has been found to be of very low prevalence in the Chinese general population. In a previous case-control study, our research team had found that the 7R allele was similarly absent in Chinese ADHD children in Hong Kong. Instead, there was an increased prevalence of the 2R allele in Chinese ADHD children. Interestingly, in Asian samples, the 2R allele had been found to be an evolutionary derivative of the 7R allele with equivalent biochemical functionality. So, the finding of an association between ADHD and 2R allele in Chinese population does not exactly contradict the original 7R allele finding in European-ancestry population. However, given the potential pitfall of population stratification in the previous case-control design, this current study tested the 2R allele and ADHD association using a methodologically more rigorous family-based approach on 33 Chinese ADHD probands who had favorable clinical responses to stimulant medication (methylphenidate). Haplotype Relative Risk (HRR) analysis and Transmission Disequilibrium Test (TDT) both showed a significant preferential transmission of the 2R allele from the biological parents to ADHD probands (p(one-tailed) = 0.038, OR = 2.04; p(one-tailed) = 0.048, OR = 2.29, respectively). A second hypothesis speculates that it is the deviation, including 7R and 2R alleles, from the conserved ancestral 4R allele which confers risk to ADHD. Thus, a preferential transmission of non-4R alleles, against the 4R allele, from biological parents to their ADHD probands is predicted. Both HRR analysis and TDT confirmed such prediction (p(one-tailed) = 0.029, OR = 2.07; p(one-tailed) = 0.032, OR = 2.43, respectively). This study re-confirmed the original finding of a previous study that in Chinese population, the 2R allele of the DRD4 exon 3 VNTR was related to ADHD. This endorses the general thesis that DRD4 exon 3 VNTR polymorphism is related to ADHD, despite that the exact length or number of repeats of the associated alleles varies across ethnicity. This in turn supports the dopamine dysregulation theory of ADHD.	[Leung, Patrick Wing-leung; Chen, Lu Hua] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Chan, Janice Ka Yan] Hosp Author, Duchess Kent Childrens Hosp Sandy Bay, Hong Kong, Hong Kong, Peoples R China; [Chen, Lu Hua; Ho, Ting Pong] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Lee, Chi Chiu; Tang, Chun Pan] Kwai Chung Hosp, Hong Kong, Hong Kong, Peoples R China; [Hung, Se Fong] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Moyzis, Robert K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Moyzis, Robert K.; Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA	Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; University of California System; University of California Irvine; University of California System; University of California Irvine	Leung, PWL (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	pleung@cuhk.edu.hk			General Research Fund (GRF); Research Grants Council (RGC) in Hong Kong [RGC 449511]	General Research Fund (GRF); Research Grants Council (RGC) in Hong Kong	This study is funded by a General Research Fund (GRF) grant to the first/corresponding author, Patrick WL Leung, from the Research Grants Council (RGC) (RGC 449511) in Hong Kong (http://www.ugc.edu .hk/eng/rgc/index.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by a General Research Fund (GRF) grant to the first/corresponding author, Patrick WL Leung, from the Research Grants Council (RGC) (RGC 449511) in Hong Kong.	Akutagava-Martins GC, 2016, EXPERT REV NEUROTHER, V16, P145, DOI 10.1586/14737175.2016.1130626; Anderson JC, 1996, LANCET, V348, P73, DOI 10.1016/S0140-6736(05)64598-9; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Brookes KJ, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-31; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Cheuk DKL, 2006, AM J MED GENET B, V141B, P907, DOI 10.1002/ajmg.b.30397; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Grady DL, 2003, MOL PSYCHIATR, V8, P536, DOI 10.1038/sj.mp.4001350; Hinney A, 2011, AM J MED GENET B, V156B, P888, DOI 10.1002/ajmg.b.31246; Kaiser R, 2002, CLIN BIOCHEM, V35, P49, DOI 10.1016/S0009-9120(02)00273-4; Kidd KK, 2014, HUM GENET, V133, P431, DOI 10.1007/s00439-013-1386-0; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Leung PWL, 2008, EUR CHILD ADOLES PSY, V17, P452, DOI 10.1007/s00787-008-0687-7; Leung PW, 1996, BRIT J PSYCHIAT, V168, P486, DOI 10.1192/bjp.168.4.486; Leung PWL, 2005, AM J MED GENET B, V133B, P54, DOI 10.1002/ajmg.b.30129; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Li YL, 2013, PSYCHIAT RES, V205, P143, DOI 10.1016/j.psychres.2012.08.016; Li Z, 2014, PSYCHIAT RES, V219, P10, DOI 10.1016/j.psychres.2014.05.005; Lidow MS, 1998, SYNAPSE, V28, P10, DOI 10.1002/(SICI)1098-2396(199801)28:1<10::AID-SYN2>3.0.CO;2-F; McAlonan GM, 2007, PSYCHIAT RES-NEUROIM, V154, P171, DOI 10.1016/j.pscychresns.2006.09.006; McAlonan GM, 2009, BRIT J PSYCHIAT, V194, P123, DOI 10.1192/bjp.bp.108.051359; Mick E, 2010, J AM ACAD CHILD PSY, V49, P898, DOI 10.1016/j.jaac.2010.02.014; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Noain D, 2006, EUR J NEUROSCI, V24, P2429, DOI 10.1111/j.1460-9568.2006.05148.x; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Qian Q, 2004, AM J MED GENET B, V128B, P84, DOI 10.1002/ajmg.b.30079; Qian QJ, 2007, AM J MED GENET B, V144B, P200, DOI 10.1002/ajmg.b.30422; Reist C, 2007, AM J MED GENET B, V144B, P453, DOI 10.1002/ajmg.b.30473; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551; Tahir E, 2000, MOL PSYCHIATR, V5, P396, DOI 10.1038/sj.mp.4000744; Turic D, 2010, PHARMACOGEN PERS MED, V3, P61, DOI 10.2147/PGPM.S6800; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	44	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173748	10.1371/journal.pone.0173748	http://dx.doi.org/10.1371/journal.pone.0173748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282463	Green Published, gold			2022-12-26	WOS:000396091800078
J	Okuda-Tanino, A; Sugawara, D; Tashiro, T; Iwashita, M; Obara, Y; Moriya, T; Tsushima, C; Saigusa, D; Tomioka, Y; Ishii, K; Nakahata, N				Okuda-Tanino, Asa; Sugawara, Daiki; Tashiro, Takumi; Iwashita, Masaya; Obara, Yutaro; Moriya, Takahiro; Tsushima, Chisato; Saigusa, Daisuke; Tomioka, Yoshihisa; Ishii, Kuniaki; Nakahata, Norimichi			Licochalcones extracted from Glycyrrhiza inflata inhibit platelet aggregation accompanied by inhibition of COX-1 activity	PLOS ONE			English	Article							THROMBOXANE A(2) RECEPTOR; ENDOPEROXIDE-H SYNTHASE-1; ANTIINFLAMMATORY ACTIVITY; CYCLOOXYGENASE; ACTIVATION; ANTAGONIST; LICORICE; CELLS	Licochalcones extracted from Glycyrrhiza inflata are known to have a variety of biological properties such as anti-inflammatory, anti-bacterial, and anti-tumor activities, but their action on platelet aggregation has not yet been reported. Therefore, in this study we investigated the effects of licochalcones on platelet aggregation. Collagen and U46619, a thromboxane A(2) receptor agonist, caused rabbit platelet aggregation, which was reversed by pretreatment with licochalcones A, C and D in concentration-dependent manners. Among these compounds, licochalcone A caused the most potent inhibitory effect on collagen-induced platelet aggregation. However, the licochalcones showed marginal inhibitory effects on thrombin or ADP-induced platelet aggregation. In addition to rabbit platelets, licochalcone A attenuated collagen-induced aggregation in human platelets. Because licochalcone A also inhibited arachidonic acid-induced platelet aggregation and production of thromboxane A2 induced by collagen in intact platelets, we further examined the direct interaction of licochalcone A with cyclooxygenase (COX)-1. As expected, licochalcone A caused an inhibitory effect on both COX-1 and COX-2 in vitro. Regarding the effect of licochalcone A on COX-1 enzyme reaction kinetics, although licochalcone A showed a stronger inhibition of prostaglandin E-2 synthesis induced by lower concentrations of arachidonic acid, Vmax values in the presence or absence of licochalcone A were comparable, suggesting that it competes with arachidonic acid at the same binding site on COX-1. These results suggest that licochalcones inhibit collagen-induced platelet aggregation accompanied by inhibition of COX-1 activity.	[Okuda-Tanino, Asa; Iwashita, Masaya; Obara, Yutaro; Moriya, Takahiro; Tsushima, Chisato; Nakahata, Norimichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Sendai, Miyagi, Japan; [Sugawara, Daiki; Tashiro, Takumi; Saigusa, Daisuke; Tomioka, Yoshihisa] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Oncol Pharm Practice & Sci, Sendai, Miyagi, Japan; [Obara, Yutaro; Ishii, Kuniaki] Yamagata Univ, Dept Pharmacol, Sch Med, Yamagata, Japan	Tohoku University; Tohoku University; Yamagata University	Obara, Y (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Sendai, Miyagi, Japan.; Obara, Y (corresponding author), Yamagata Univ, Dept Pharmacol, Sch Med, Yamagata, Japan.	obaray@med.id.yamagata-u.ac.jp		Saigusa, Daisuke/0000-0001-9484-9870	Minophagen Pharmaceutical Co. Ltd (Shinjuku, Japan); Grants-in-Aid for Scientific Research [26670118] Funding Source: KAKEN	Minophagen Pharmaceutical Co. Ltd (Shinjuku, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Minophagen Pharmaceutical Co. Ltd (Shinjuku, Japan). There was no additional external funding received for this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020062; Cao HM, 2011, J PHARMACEUT BIOMED, V54, P230, DOI 10.1016/j.jpba.2010.08.001; Choi J, 2011, MOL INTERV, V11, P111, DOI 10.1124/mi.11.2.9; Cui YM, 2008, Z NATURFORSCH C, V63, P361; De la Cruz JP, 2002, BRIT J PHARMACOL, V137, P1082, DOI 10.1038/sj.bjp.0704963; Fontana P, 2011, J THROMB HAEMOST, V9, P2109, DOI 10.1111/j.1538-7836.2011.04446.x; Friis-Moller A, 2002, PLANTA MED, V68, P416, DOI 10.1055/s-2002-32087; Funakoshi-Tago M, 2010, INT IMMUNOPHARMACOL, V10, P562, DOI 10.1016/j.intimp.2010.02.003; Funakoshi-Tago M, 2009, MOL PHARMACOL, V76, P745, DOI 10.1124/mol.109.057448; Grewal S, 2003, J CELL SCI, V116, P2303, DOI 10.1242/jcs.00446; Iwashita M, 2007, EUR J PHARMACOL, V570, P38, DOI 10.1016/j.ejphar.2007.05.073; Kim JK, 2010, J MOL MED, V88, P829, DOI 10.1007/s00109-010-0625-2; Kim YH, 2010, BIOCHEM PHARMACOL, V80, P1152, DOI 10.1016/j.bcp.2010.07.006; Mauricio I, 1997, BIOCHEM BIOPH RES CO, V235, P259, DOI 10.1006/bbrc.1997.6735; McNicol A, 1997, J PHARMACOL EXP THER, V281, P861; Mori K, 2010, PHYTOMEDICINE, V17, P1082, DOI 10.1016/j.phymed.2010.05.004; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; Nagatomo T, 2004, PHARMACOL THERAPEUT, V104, P59, DOI 10.1016/j.pharmthera.2004.08.005; NAITO J, 1983, EUR J PHARMACOL, V91, P41, DOI 10.1016/0014-2999(83)90359-X; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Nakatani K, 2002, BIOCHEM PHARMACOL, V63, P73, DOI 10.1016/S0006-2952(01)00810-3; Nieswandt B, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2009.03370.x; Park HG, 2012, J NUTR BIOCHEM, V23, P759, DOI 10.1016/j.jnutbio.2011.03.021; Rivera J, 2009, HAEMATOL-HEMATOL J, V94, P700, DOI 10.3324/haematol.2008.003178; Song NR, 2015, INT J MOL SCI, V16, P4453, DOI 10.3390/ijms16034453; Surin WR, 2008, THROMB RES, V122, P786, DOI 10.1016/j.thromres.2007.10.005; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Ting HJ, 2010, ACTA PHARMACOL SIN, V31, P150, DOI 10.1038/aps.2009.195; Xu YB, 2010, J GENET GENOMICS, V37, P117, DOI 10.1016/S1673-8527(09)60030-8; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200	31	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173628	10.1371/journal.pone.0173628	http://dx.doi.org/10.1371/journal.pone.0173628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282426	Green Submitted, gold, Green Published			2022-12-26	WOS:000396091800058
J	Walsh, NM; Wuthrich, M; Wang, HF; Klein, B; Hull, CM				Walsh, Naomi M.; Wuthrich, Marcel; Wang, Huafeng; Klein, Bruce; Hull, Christina M.			Characterization of C-type lectins reveals an unexpectedly limited interaction between Cryptococcus neoformans spores and Dectin-1	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; MEDIATED PHAGOCYTOSIS; HOST-DEFENSE; SCAVENGER RECEPTORS; RECOGNITION; MACROPHAGES; ACTIVATION; DIFFERENTIATION; MECHANISMS; REDUNDANCY	Phagocytosis by innate immune cells is an important process for protection against multiple pathologies and is particularly important for resistance to infection. However, phagocytosis has also been implicated in the progression of some diseases, including the dissemination of the human fungal pathogen, Cryptococcus neoformans. Previously, we identified Dectin-1 as a likely phagocytic receptor for C. neoformans spores through the use of soluble components in receptor-ligand blocking experiments. In this study, we used gain-of-function and loss-of-function assays with intact cells to evaluate the in vivo role of Dectin-1 and other C-type lectins in interactions with C. neoformans spores and discovered stark differences in outcome when compared with previous assays. First, we found that non-phagocytic cells expressing Dectin-1 were unable to bind spores and that highly sensitive reporter cells expressing Dectin-1 were not stimulated by spores. Second, we determined that some phagocytes from Dectin-1(-/-) mice interacted with spores differently than wild type (WT) cells, but the effects varied among assays and were modest overall. Third, while we detected small but statistically significant reductions in phagocytosis by primary alveolar macrophages from Dectin-1(-/-) mice compared to WT, we found no differences in survival between WT and Dectin-1(-/-) mice challenged with spores. Further analyses to assess the roles of other C-type lectins and their adapters revealed very weak stimulation of Dectin-2 reporter cells by spores and modest differences in binding and phagocytosis by Dectin-2(-/-) bone marrow-derived phagocytes. There were no discernable defects in binding or phagocytosis by phagocytes lacking Mannose Receptor, Mincle, Card-9, or FcR gamma. Taken together, these results lead to the conclusion that Dectin-1 and other C-type lectins do not individually play a major roles in phagocytosis and innate defense by phagocytes against C. neoformans spores and highlight challenges in using soluble receptor/ligand blocking experiments to recapitulate biologically relevant interactions.	[Walsh, Naomi M.; Hull, Christina M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Wuthrich, Marcel; Wang, Huafeng; Klein, Bruce; Hull, Christina M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Klein, Bruce] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hull, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	cmhull@wisc.edu			NIH [R01AI089370, R01AI035681, R01AI040996, R01AI93553]; NIH National Research Service Award [T32 GM07215]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01AI089370 (to CMH), R01AI035681 (to BK), R01AI040996 (to BK), and R01AI93553 (to MW). NW was supported by NIH National Research Service Award T32 GM07215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, MBIO, V2, DOI 10.1128/mBio.00158-11; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Botts MR, 2010, CURR OPIN MICROBIOL, V13, P437, DOI 10.1016/j.mib.2010.05.003; Botts MR, 2009, EUKARYOT CELL, V8, P595, DOI 10.1128/EC.00352-08; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brubaker SW, 2015, ANN REV IMMUN    MAR; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Court N, 2010, J IMMUNOL, V184, P7057, DOI 10.4049/jimmunol.1000164; Dagenais TRT, 2010, INFECT IMMUN, V78, P823, DOI 10.1128/IAI.00980-09; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Dykstra T, 2011, INNATE IMMUN-LONDON, V17, P388, DOI 10.1177/1753425910374889; Filler SG, 2013, TRENDS MICROBIOL, V21, P389, DOI 10.1016/j.tim.2013.05.006; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fuentes AL, 2011, INT IMMUNOPHARMACOL, V11, P1939, DOI 10.1016/j.intimp.2011.08.005; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Jozefowski S, 2012, INFLAMM RES, V61, P113, DOI 10.1007/s00011-011-0395-5; Lee Ji Eun, 2012, Environmental Engineering Research, V17, P17; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Nagelkerke SQ, 2014, BLOOD, V124, P3709, DOI 10.1182/blood-2014-05-576835; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Nakamura Y, 2015, INFECT IMMUN, V83, P671, DOI 10.1128/IAI.02835-14; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Sabiiti W, 2014, J CLIN INVEST, V124, P2000, DOI 10.1172/JCI72950; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sathish JG, 2013, NAT REV DRUG DISCOV, V12, P306, DOI 10.1038/nrd3974; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Sherman F., 1987, LAB COURSE MANUAL ME; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Wang HF, 2014, J IMMUNOL, V192, P1107, DOI 10.4049/jimmunol.1302314; Wuthrich M, 2015, EUR J IMMUNOL, V45, P2542, DOI 10.1002/eji.201545591; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zhang X, 2009, THE EXPRESSION OF EX	45	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173866	10.1371/journal.pone.0173866	http://dx.doi.org/10.1371/journal.pone.0173866			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282442	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800085
J	Li, Y; Liu, SX; Wang, HH; Mai, HR; Yuan, XL; Li, CG; Chen, XW; Wen, FQ				Li, Yue; Liu, Sixi; Wang, Huihui; Mai, Huirong; Yuan, Xiuli; Li, Changgang; Chen, Xiaowen; Wen, Feiqiu			Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia	PLOS ONE			English	Article							GLUTAMYL HYDROLASE; DNA METHYLATION; METHOTREXATE; POLYMORPHISMS; ACCUMULATION; CHILDREN; SYNTHETASE	Background gamma-Glutamyl hydrolase (GGH) regulates intracellular folates and antifolates such as methotrexate (MTX) for proper nucleotide biosynthesis and antifolate-induced cytotoxicity, respectively. In addition to genetic polymorphism and karyotypic abnormalities, methylation of CpG island 1 (CpG1) in the promoter region is found to modulate GGH activity by reducing GGH mRNA expression in acute lymphoblastic leukemia (ALL) cells. We aim to investigate methylation status of two CpG islands (CpG1 and CpG2) in the GGH promoter region in pediatric patients with ALL and acute myelogenous leukemia (AML). Methods 70B-ALL, 29 AML, 10 ITP (idiopathic thrombocytopenic purpura) and 40 healthy children are recruited in the present study. MS-HRM (methylation-sensitive high-resolution melting) and bisulfite sequencing PCR (BSP) are used to detect methylation change and its level in CpG1 and CpG2 in the GGH promoter region. GGH mRNA expression is quantified by realtime PCR. Correlation between CpG island methylation and GGH mRNA expression is assessed by statistical software. Results Methylations of CpG1 are detected in leukemia cells samples obtained from 30.9% (21/68) of patients with ALL and 20.7% (6/29) of patients with AML. These methylations are not detected in the controls. Methylations of CpG2 are detected in leukemia cell samples obtained from 44.1% (30/68) of the ALL patients and 37.9% (11/29) of the AML patients. These percentages are significantly higher than that observed in the control cell samples: 6.0% (3/50) (Fisher's exact test, P = 0.000). The abundance of CpG1 methylation in all leukemia cell samples is classified as Grade I (methylation level is less than 10%) and the abundance of CpG2 methylation in leukemia cell samples is classified in separate grades. Our results indicate that methylation of CpG1 or hypermethylation (the methylation level is greater than 10%) of CpG2 could significantly reduce GGH mRNA expression in leukemia cells from the ALL and AML patients (ALL-CpG1: t = 4.632, P = 0.000; ALL-CpG2: t = 3.250, P = 0.006; AML-CpG1: t = -2.254, P = 0.037; AML-CpG2: t = 1.328, P = 0.202). Conclusion Either methylation of CpG1 or hypermethylation of CpG2 in GGH promoter region can significantly reduce GGH mRNA expression in pediatric patients with acute leukemia, which can improve the response to treatment.	[Li, Yue; Liu, Sixi; Wang, Huihui; Mai, Huirong; Yuan, Xiuli; Li, Changgang; Wen, Feiqiu] Shenzhen Childrens Hosp, Div Hematol & Oncol, Shenzhen, Guangdong, Peoples R China; [Chen, Xiaowen] Shenzhen Childrens Hosp, Shenzhen Inst Pediat, Shenzhen, Guangdong, Peoples R China		Wen, FQ (corresponding author), Shenzhen Childrens Hosp, Div Hematol & Oncol, Shenzhen, Guangdong, Peoples R China.; Chen, XW (corresponding author), Shenzhen Childrens Hosp, Shenzhen Inst Pediat, Shenzhen, Guangdong, Peoples R China.	13510333196@139.com; fwen62@126.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022; Mai, Huirong/AAH-3768-2021	Chen, Xiaowen/0000-0002-3118-3837	Science and Technology Projects from Science Technology and Innovation Committee of Shenzhen Municipality [JCYJ20130401114111456, JCYJ20140416141331552]; Natural Science Foundation of Guangdong Province [2015A030313759]	Science and Technology Projects from Science Technology and Innovation Committee of Shenzhen Municipality; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by Science and Technology Projects (grant number JCYJ20130401114111456) from the Science Technology and Innovation Committee of Shenzhen Municipality, http://www.szsti.gov.cn/ services/plan/, XC; Science and Technology Projects (grant number JCYJ20140416141331552) from the Science Technology and Innovation Committee of Shenzhen Municipality, http://www.szst.gov.cn/ services/plan/, SL; and grant 2015A030313759 from the Natural Science Foundation of Guangdong Province, http://pro.gdstc.gov.cn/ egrantweb/, FW. ALL the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALINSKA M, 1981, CANCER RES, V41, P2751; BERTINO JR, 1993, J CLIN ONCOL, V11, P5, DOI 10.1200/JCO.1993.11.1.5; Bishop KS, 2015, NUTRIENTS, V7, P922, DOI 10.3390/nu7020922; Campa D, 2012, INT J CANCER, V131, P803, DOI 10.1002/ijc.26436; Chave KJ, 2003, GENE, V319, P167, DOI 10.1016/S0378-1119(03)00807-2; Cheng Q, 2005, NAT GENET, V37, P878, DOI 10.1038/ng1612; Cheng Q, 2004, PHARMACOGENETICS, V14, P557, DOI 10.1097/01.fpc.0000114761.78957.7e; Cheng Q, 2006, AM J HUM GENET, V79, P264, DOI 10.1086/505645; Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Galivan J, 2000, PHARMACOL THERAPEUT, V85, P207, DOI 10.1016/S0163-7258(99)00063-7; Hatano Y, 2015, CARCINOGENESIS, V36, P719, DOI 10.1093/carcin/bgv060; Lautner-Csorba O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069843; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; Moran RG, 1999, SEMIN ONCOL, V26, P24; Niedzielska E, 2013, ADV CLIN EXP MED, V22, P579; O'Donnell Anne H, 2014, J Cancer Ther, V5, P1311; Reddy KB, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0185-1; Rots MG, 1999, BLOOD, V93, P1677, DOI 10.1182/blood.V93.5.1677.405a16_1677_1683; Subspecialty Group of Hematology Diseases The Society of Pediatrics Chinese Medical Association, 2006, Zhonghua Er Ke Za Zhi, V44, P392; Tu JJ, 2015, INT J BIOCHEM CELL B, V67, P115, DOI 10.1016/j.biocel.2015.05.002; Veeck J, 2010, J MAMMARY GLAND BIOL, V15, P5, DOI 10.1007/s10911-010-9165-1; Wang SM, 2014, CANCER CHEMOTH PHARM, V74, P283, DOI 10.1007/s00280-014-2507-8; Zgheib NK, 2014, PHARMACOGENET GENOM, V24, P387, DOI 10.1097/FPC.0000000000000069	25	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173472	10.1371/journal.pone.0173472	http://dx.doi.org/10.1371/journal.pone.0173472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278270	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900099
J	Tanisawa, K; Taniguchi, H; Sun, XM; Ito, T; Kawakami, R; Sakamoto, S; Higuchi, M				Tanisawa, Kumpei; Taniguchi, Hirokazu; Sun, Xiaomin; Ito, Tomoko; Kawakami, Ryoko; Sakamoto, Shizuo; Higuchi, Mitsuru			Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia	PLOS ONE			English	Article							5'-AMP-ACTIVATED PROTEIN-KINASE; CARDIORESPIRATORY FITNESS; SUBUNIT EXPRESSION; SELENOPROTEIN-P; ADIPOSE-TISSUE; JAPANESE MEN; EXERCISE; LIVER; RISK; DETERMINANTS	Background Leukocyte cell-derived chemotaxin 2 (LECT2) is a hepatokine linking obesity to skeletal muscle insulin resistance. Although previous studies reported that obesity was associated with high levels of circulating LECT2 in human, the associations of detailed body fat distribution with LECT2 levels have not been examined. Furthermore, although animal study suggested that exercise decreased circulating LECT2 levels, it remains unknown whether physical fitness is associated with LECT2 levels in human. We therefore examined the relationship of plasma LECT2 levels with various adiposity indices and cardiorespiratory fitness (CRF) in middle-aged and elderly Japanese men. Furthermore, we examined the relationship of LECT2 levels with the presence of metabolic syndrome, hypertension, insulin resistance and dyslipidemia to determine the clinical significance of measuring circulating LECT2. Materials and methods This was a cross-sectional study of 143 Japanese men (age: 30-79 years). Participants' plasma LECT2 levels were measured by an enzyme-linked immunosorbent assay. To assess their abdominal fat distributions, visceral fat area (VFA) and subcutaneous fat area (SFA) were measured using magnetic resonance imaging. CRF was assessed by measuring peak oxygen uptake (VO2peak). Results All adiposity indices measured in this study were positively correlated with plasma LECT2 levels, while VO2peak was negatively correlated with LECT2 levels after adjustment for age. The correlations, except for VFA were no longer significant with further adjustment for VFA. Stepwise multiple linear regression analysis revealed that VFA was the strongest predictor of plasma LECT2 levels. Plasma LECT2 levels differed based on the presence of metabolic syndrome and dyslipidemia, but not hypertension and insulin resistance. Logistic regression analyses revealed that plasma LECT2 levels were significantly associated with dyslipidemia independently of VFA; VFA was not significantly associated with dyslipidemia after adjustment for LECT2. Conclusion VFA was the strongest predictor of plasma LECT2 that is a potential biomarker linking visceral obesity to dyslipidemia.	[Tanisawa, Kumpei] Natl Inst Biomed Innovat Hlth & Nutr, Dept Hlth Promot & Exercise, Tokyo, Japan; [Tanisawa, Kumpei] Japan Soc Promot Sci, Tokyo, Japan; [Tanisawa, Kumpei; Kawakami, Ryoko; Sakamoto, Shizuo; Higuchi, Mitsuru] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Tanisawa, Kumpei; Sakamoto, Shizuo; Higuchi, Mitsuru] Waseda Univ, Inst Adv Act Aging Res, Tokorozawa, Saitama, Japan; [Taniguchi, Hirokazu] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Sun, Xiaomin] Xi An Jiao Tong Univ, Sch Publ Hlth, Xian, Shaanxi, Peoples R China; [Ito, Tomoko] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Japan	Japan Society for the Promotion of Science; Waseda University; Waseda University; Ryukoku University; Xi'an Jiaotong University; Waseda University	Higuchi, M (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.; Higuchi, M (corresponding author), Waseda Univ, Inst Adv Act Aging Res, Tokorozawa, Saitama, Japan.	mhiguchi@waseda.jp	Kawakami, Ryoko/K-8149-2019	Kawakami, Ryoko/0000-0001-8211-1553; Tanisawa, Kumpei/0000-0002-9334-7104	Ministry of Education, Culture, Sports, Science, and Technology [14J03810, S1511017]; Grants-in-Aid for Scientific Research [16K13056] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by the Ministry of Education, Culture, Sports, Science, and Technology [http.//www.mext.go.jp/a_menu/shinkou/hoiyo/main5_a5.html]Award #14J03810 to Kumpei Tanisawa; and by the Ministry of Education, Culture, Sports, Science, and Technology [http://www.mext.go.jp/a_menu/shinkou/holyo/main5_a5.html] Award #S1511017 to Mitsuru Higuchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Clausen JO, 1996, J CLIN INVEST, V98, P1195, DOI 10.1172/JCI118903; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Harrell FE, 2001, REGRESSION MODELING; Iroz A, 2015, DIABETOLOGIA, V58, P1699, DOI 10.1007/s00125-015-3634-4; Kasa-Vubu JZ, 2005, J CLIN ENDOCR METAB, V90, P849, DOI 10.1210/jc.2004-0455; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Matsuzawa Y, 2005, J ATHEROSCLER THROMB, V12, P301, DOI 10.5551/jat.12.301; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Okumura A, 2013, BIOSCI TRENDS, V7, P276, DOI 10.5582/bst.2013.v7.6.276; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sawada SS, 2003, DIABETES CARE, V26, P2918, DOI 10.2337/diacare.26.10.2918; Sui X, 2008, DIABETES CARE, V31, P550, DOI 10.2337/dc07-1870; Takekoshi K, 2006, METABOLISM, V55, P1122, DOI 10.1016/j.metabol.2006.04.007; Taniguchi H, 2014, J CLIN ENDOCR METAB, V99, pE1877, DOI 10.1210/jc.2014-1877; Tanisawa K, 2015, J ATHEROSCLER THROMB, V22, P379, DOI 10.5551/jat.25098; Tanisawa K, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0416-4; Tanisawa K, 2014, PHYSIOL GENOMICS, V46, P207, DOI 10.1152/physiolgenomics.00182.2013; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wong SL, 2004, MED SCI SPORT EXER, V36, P286, DOI 10.1249/01.MSS.0000113665.40775.35; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yi XJ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/946432	32	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173310	10.1371/journal.pone.0173310	http://dx.doi.org/10.1371/journal.pone.0173310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278265	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900071
J	Brito-Moreira, J; Lourenco, MV; Oliveira, MM; Ribeiro, FC; Ledo, JH; Diniz, LP; Vital, JFS; Magdesian, MH; Melo, HM; Barros-Aragao, F; de Souza, JM; Alves-Leon, SV; Gomes, FCA; Clarke, JR; Figueiredo, CP; De Felice, FG; Ferreira, ST				Brito-Moreira, Jordano; Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ledo, Jose Henrique; Diniz, Luan P.; Vital, Juliana F. S.; Magdesian, Margaret H.; Melo, Helen M.; Barros-Aragao, Fernanda; de Souza, Jorge M.; Alves-Leon, Soniza V.; Gomes, Flavia C. A.; Clarke, Julia R.; Figueiredo, Claudia P.; De Felice, Fernanda G.; Ferreira, Sergio T.			Interaction of amyloid- (A) oligomers with neurexin 2 and neuroligin 1 mediates synapse damage and memory loss in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid (A); brain; neuron; synapse; amyloid oligomers; memory; neurexin; neuroligin	A-BETA OLIGOMERS; DEPRESSIVE-LIKE BEHAVIOR; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; BRAIN; RECOGNITION; INHIBITION; ADHESION; DYSFUNCTION	Brain accumulation of the amyloid- protein (A) and synapse loss are neuropathological hallmarks of Alzheimer disease (AD). A oligomers (AOs) are synaptotoxins that build up in the brains of patients and are thought to contribute to memory impairment in AD. Thus, identification of novel synaptic components that are targeted by AOs may contribute to the elucidation of disease-relevant mechanisms. Trans-synaptic interactions between neurexins (Nrxs) and neuroligins (NLs) are essential for synapse structure, stability, and function, and reduced NL levels have been associated recently with AD. Here we investigated whether the interaction of AOs with Nrxs or NLs mediates synapse damage and cognitive impairment in AD models. We found that AOs interact with different isoforms of Nrx and NL, including Nrx2 and NL1. Anti-Nrx2 and anti-NL1 antibodies reduced AO binding to hippocampal neurons and prevented AO-induced neuronal oxidative stress and synapse loss. Anti-Nrx2 and anti-NL1 antibodies further blocked memory impairment induced by AOs in mice. The results indicate that Nrx2 and NL1 are targets of AOs and that prevention of this interaction reduces the deleterious impact of AOs on synapses and cognition. Identification of Nrx2 and NL1 as synaptic components that interact with AOs may pave the way for development of novel approaches aimed at halting synapse failure and cognitive loss in AD.	[Brito-Moreira, Jordano; Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ledo, Jose Henrique; Vital, Juliana F. S.; Magdesian, Margaret H.; Melo, Helen M.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil; [Lourenco, Mychael V.; Oliveira, Mauricio M.; Ribeiro, Felipe C.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil; [Diniz, Luan P.; Barros-Aragao, Fernanda; Gomes, Flavia C. A.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21947902 Rio De Janeiro, RJ, Brazil; [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurosurg, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil; [de Souza, Jorge M.; Alves-Leon, Soniza V.] Univ Fed Rio de Janeiro, Div Neurol, Epilepsy Program, Clementino Fraga Filho Univ Hosp, BR-21947902 Rio De Janeiro, RJ, Brazil; [Clarke, Julia R.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21947902 Rio De Janeiro, RJ, Brazil; [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Queens University - Canada	Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21947902 Rio De Janeiro, RJ, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21947902 Rio De Janeiro, RJ, Brazil.	ferreira@bioqmed.ufrj.br	Lourenco, Mychael/G-2614-2014; Gomes, Flavia/AAX-6354-2021; Leon, Soniza V Alves/J-7786-2012; Ferreira, Sergio/AAZ-1576-2020; Figueiredo, Claudia P/F-8424-2012; Ribeiro, Felipe Campos/W-9758-2019; Clarke, Julia/AAF-9434-2019; De Felice, Fernanda G/M-1074-2017; Gomes, Flavia/C-5383-2013	Lourenco, Mychael/0000-0002-1078-0296; Ferreira, Sergio/0000-0001-7160-9866; Ribeiro, Felipe Campos/0000-0003-3028-3307; Gomes de Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; Gomes, Flavia/0000-0003-2966-0638; Figueiredo, Claudia/0000-0001-9467-9891	National Institute for Translational Neuroscience (INNT/Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Human Frontiers Science Program; CNPq; FAPERJ; CAPES (Brazil)	National Institute for Translational Neuroscience (INNT/Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Human Frontiers Science Program(Human Frontier Science Program); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from National Institute for Translational Neuroscience (INNT/Brazil) (to S. T. F.), the Brazilian funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to S. T. F. and F. G. F.), and the Human Frontiers Science Program (to F. G. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by predoctoral fellowships from CNPq, FAPERJ, or CAPES (Brazil).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bemben MA, 2015, TRENDS NEUROSCI, V38, P496, DOI 10.1016/j.tins.2015.06.004; Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Dachtler J, 2015, BEHAV NEUROSCI, V129, P765, DOI 10.1037/bne0000108; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Dinamarca MC, 2015, BIOCHEM BIOPH RES CO, V466, P66, DOI 10.1016/j.bbrc.2015.08.107; Dinamarca MC, 2011, BIOCHEMISTRY-US, V50, P8127, DOI 10.1021/bi201246t; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jiang M, 2017, MOL PSYCHIATR, V22, P375, DOI 10.1038/mp.2016.80; Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168; Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016; Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Liu A, 2016, J CELL BIOL, V212, P449, DOI 10.1083/jcb.201509023; Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nery AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067194; Nunomura A, 1999, J NEUROSCI, V19, P1959; Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304; SanMartin CD, 2012, NEURODEGENER DIS, V10, P34, DOI 10.1159/000334901; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shen HT, 2015, STROKE, V46, P2607, DOI 10.1161/STROKEAHA.115.009729; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tristan-Clavijo E, 2015, NEUROBIOL AGING, V36, P3171, DOI 10.1016/j.neurobiolaging.2015.09.004; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010	64	58	60	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7327	7337		10.1074/jbc.M116.761189	http://dx.doi.org/10.1074/jbc.M116.761189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28283575	hybrid, Green Published			2022-12-26	WOS:000400761300005
J	Arif, S; Thomson, PC; Hernandez-Jover, M; McGill, DM; Warriach, HM; Heller, J				Arif, Shumaila; Thomson, Peter C.; Hernandez-Jover, Marta; McGill, David M.; Warriach, Hassan Mahmood; Heller, Jane			Knowledge, attitudes and practices (KAP) relating to brucellosis in smallholder dairy farmers in two provinces in Pakistan	PLOS ONE			English	Article							RISK-FACTORS; SEROPREVALENCE; CATTLE; LIVESTOCK; HERDS	The present study aimed to assess the extent of knowledge and understanding of brucellosis in smallholder dairy farmers and identify practices at the farm and household level that might pose a risk for humans contracting brucellosis. Between February and June 2015 a cross-sectional study was conducted among smallholder farms (n = 420) in five districts of Punjab and two districts of Sindh province. Farmers were interviewed using a questionnaire to obtain information on farmers' knowledge about brucellosis and the potential risks for contracting the disease that are present for dairy farmers and their families. Logistic regression and ordinal logistic models were used to investigate potential predictors for risky behaviours. The results show almost all farmers (97%) were not aware of the modes of transmission of brucellosis. Relating to risk, the majority (66%) of the farmers' families were reported to consume raw milk and its products, live in shared housing with animals (49%) and not cover hand cuts during contact with animals (74%). All farmers performed at least one risky practice on a regular basis for brucellosis transmission from animal to human. A multivariable analysis highlighted that the respondents with no formal education and those who had not heard of the disease displayed greater risky behaviour. Poor understanding of the disease, presence of multiple risky practices on farm and at the household, and incorrect perception supports the need for an educational awareness program in order to ensure uptake of improved practices.	[Arif, Shumaila; Hernandez-Jover, Marta; Heller, Jane] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Arif, Shumaila; Thomson, Peter C.; Hernandez-Jover, Marta; Heller, Jane] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Thomson, Peter C.] Univ Sydney, Sch Life & Environm Sci, Camden, Australia; [Thomson, Peter C.; Warriach, Hassan Mahmood] Univ Vet & Anim Sci, ASLP Dairy Project, Lahore, Pakistan; [McGill, David M.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia	Charles Sturt University; Charles Sturt University; University of Sydney; University of Veterinary & Animal Science - Pakistan; University of Melbourne	Arif, S (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.; Arif, S (corresponding author), Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.	sarif@csu.edu.au	Hernandez-Jover, Marta/F-8688-2016; Heller, Jane/H-9596-2016; Thomson, Peter/V-7290-2019	Heller, Jane/0000-0003-3993-0160; Thomson, Peter/0000-0003-4428-444X; Arif, Shumaila/0000-0002-1103-333X; Hernandez-Jover, Marta/0000-0001-8803-9062; McGill, David/0000-0002-9621-9626	ACIAR (Australian Centre for International Agriculture Research); ACIAR	ACIAR (Australian Centre for International Agriculture Research)(Australian Ctr Intl Agr Res); ACIAR	This study was part of a PhD project by SA, funded by a scholarship from ACIAR (Australian Centre for International Agriculture Research). Field work for this study was supported by the ASLP Dairy Project in Pakistan which is also funded through ACIAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakkar M, 2011, PAKIATAN VET J, V32, P147; Afzal M, 2009, PAK VET J, V30, P187; Akinci E, 2006, INT J INFECT DIS, V10, P171, DOI 10.1016/j.ijid.2005.02.006; Al-Shamahy HA, 2000, EPIDEMIOL INFECT, V125, P309, DOI 10.1017/S0950268899004458; Ali S, 2013, FOODBORNE PATHOG DIS, V10, P500, DOI 10.1089/fpd.2012.1360; ASLP dairy project, AUSTR PAK AGR SECT L; Bercovich Z, 1998, VET QUART, V20, P81, DOI 10.1080/01652176.1998.9694845; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Coelho A.C., 2015, DOMESTIC WILD ANIMAL; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Dasari S, 2013, ASIAN PAC J TROP MED, V6, P823, DOI 10.1016/S1995-7645(13)60145-5; Diez JG, 2013, J INFECT PUBLIC HEAL, V6, P363, DOI 10.1016/j.jiph.2013.04.008; Doganay Mehmet, 2003, International Journal of Infectious Diseases, V7, P173, DOI 10.1016/S1201-9712(03)90049-X; England T, 2004, PREV VET MED, V63, P63, DOI 10.1016/j.prevetmed.2004.01.009; Ficht TA, 2003, VET MICROBIOL, V92, P213, DOI 10.1016/S0378-1135(02)00367-X; Gul S. T., 2007, Pakistan Veterinary Journal, V27, P145; Holt HR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-341; Kang'ethe E K, 2007, East Afr Med J, V84, pS96; Kansiime C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-242; Kozukeev Turatbek B, 2006, MMWR Suppl, V55, P31; Lindahl E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117318; Mai HM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-144; McDermott J, 2013, REV SCI TECH OIE, V32, P249; Mukhtar F, 2010, J PAK MED ASSOC, V60, P1031; Musallam II, 2015, AM J TROPICAL MED HY; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Park MY, 2005, J KOREAN MED SCI, V20, P941, DOI 10.3346/jkms.2005.20.6.941; R Core Team, 2013, R LANG ENV STAT COMP; Sammartino L.E., 2005, CAPACITY BUILDING SU; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Sofian M, 2008, INT J INFECT DIS, V12, P157, DOI 10.1016/j.ijid.2007.04.019; World Animal Health Information Database, 2016, LIST COUNTR DIS SIT; Yagupsky P, 2005, EMERG INFECT DIS, V11, P1180, DOI 10.3201/eid1108.041197; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283; Zia U., 2011, DAIRY DEV PAKISTAN	35	38	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173365	10.1371/journal.pone.0173365	http://dx.doi.org/10.1371/journal.pone.0173365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301498	Green Published, gold			2022-12-26	WOS:000396318300034
J	Robinson, JL; Fordyce, JA				Robinson, Jason L.; Fordyce, James A.			Species-free species distribution models describe macroecological properties of protected area networks	PLOS ONE			English	Article							CLIMATE-CHANGE; BIODIVERSITY; CONSERVATION; GEOGRAPHY; RICHNESS; IMPACTS; MANAGEMENT; RESPONSES; FUTURE	Among the greatest challenges facing the conservation of plants and animal species in protected areas are threats from a rapidly changing climate. An altered climate creates both challenges and opportunities for improving the management of protected areas in networks. Increasingly, quantitative tools like species distribution modeling are used to assess the performance of protected areas and predict potential responses to changing climates for groups of species, within a predictive framework. At larger geographic domains and scales, protected area network units have spatial geoclimatic properties that can be described in the gap analysis typically used to measure or aggregate the geographic distributions of species (stacked species distribution models, or S-SDM). We extend the use of species distribution modeling techniques in order to model the climate envelope (or "footprint") of individual protected areas within a network of protected areas distributed across the 48 conterminous United States and managed by the US National Park System. In our approach we treat each protected area as the geographic range of a hypothetical endemic species, then use MaxEnt and 5 uncorrelated BioClim variables to model the geographic distribution of the climatic envelope associated with each protected area unit (modeling the geographic area of park units as the range of a species). We describe the individual and aggregated climate envelopes predicted by a large network of 163 protected areas and briefly illustrate how macroecological measures of geodiversity can be derived from our analysis of the landscape ecological context of protected areas. To estimate trajectories of change in the temporal distribution of climatic features within a protected area network, we projected the climate envelopes of protected areas in current conditions onto a dataset of predicted future climatic conditions. Our results suggest that the climate envelopes of some parks may be locally unique or have narrow geographic distributions, and are thus prone to future shifts away from the climatic conditions in these parks in current climates. In other cases, some parks are broadly similar to large geographic regions surrounding the park or have climatic envelopes that may persist into near-term climate change. Larger parks predict larger climatic envelopes, in current conditions, but on average the predicted area of climate envelopes are smaller in our single future conditions scenario. Individual units in a protected area network may vary in the potential for climate adaptation, and adaptive management strategies for the network should account for the landscape contexts of the geodiversity or climate diversity within individual units. Conservation strategies, including maintaining connectivity, assessing the feasibility of assisted migration and other landscape restoration or enhancements can be optimized using analysis methods to assess the spatial properties of protected area networks in biogeographic and macroecological contexts.	[Robinson, Jason L.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Fordyce, James A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Tennessee System; University of Tennessee Knoxville	Robinson, JL (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA.	jrob@illinois.edu		Fordyce, James/0000-0002-2731-0418	University of Tennessee; Illinois Natural History Survey Postdoctoral Fellowship; Illinois Natural History Survey IDOT Further Studies Group	University of Tennessee; Illinois Natural History Survey Postdoctoral Fellowship; Illinois Natural History Survey IDOT Further Studies Group	This study was supported by University of Tennessee graduate student teaching assistantship; Illinois Natural History Survey Postdoctoral Fellowship; Illinois Natural History Survey IDOT Further Studies Group. The funders have had no role in the study design, data collection and analysis or decisions to prepare or publish this manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Anderson MG, CONSERVATION BIOLGOY, V29, P680; Anderson MG, 2010, CONSERVING STAGE CLI; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Bailey RG, 1995, ECOREGIONS ECOSYSTEM, V2; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Beyer H.L., 2015, GEOSPATIAL MODELLING; Bjorholm Stine, 2008, BMC Ecology, V8, P11, DOI 10.1186/1472-6785-8-11; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brown DG, 2016, PROF GEOGR, V58, P369; Cabeza M, 2013, ANIM CONSERV, V16, P381, DOI 10.1111/acv.12070; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Connor EF, 2013, ECOLOGY, V94, P2403, DOI 10.1890/12-1471.1; CONNOR EF, 1978, ECOL MONOGR, V48, P219, DOI 10.2307/2937300; Distler T, 2015, J BIOGEOGR, V42, P976, DOI 10.1111/jbi.12479; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2011, ARCGIS DESKT REL 10; Faith DP, 1996, BIODIVERS CONSERV, V5, P399, DOI 10.1007/BF00056387; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Gill JL, 2015, CONSERV BIOL, V29, P640, DOI 10.1111/cobi.12504; Gillingham PK, 2015, BIOL J LINN SOC, V115, P707, DOI 10.1111/bij.12506; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Godsoe W, 2010, OIKOS, V119, P53, DOI 10.1111/j.1600-0706.2009.17630.x; Gross JE, 2016, CLIMATE CHANGE WILDL; Guay K, 2016, CLIMATE CHANGE WILDL; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Hallfors MH, 2016, ECOL APPL, V26, P1154, DOI 10.1890/15-0926; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hansen AJ, 2016, CLIMATE CHANGE WILDL, P480; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hjort J, 2015, CONSERV BIOL, V29, P630, DOI 10.1111/cobi.12510; Hortal J, 2008, J BIOGEOGR, V35, P1335, DOI 10.1111/j.1365-2699.2008.01955.x; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Koch R, 2017, J NAT CONSERV, V35, P24, DOI 10.1016/j.jnc.2016.11.004; Lise W, 2002, CLIMATIC CHANGE, V55, P429, DOI 10.1023/A:1020728021446; Morelli TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159909; Nadeau CP, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00069.1; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Parker Charles R., 1998, Insecta Mundi, V12, P227; Parker CR, 2007, SOUTHEAST NAT, V6, P159, DOI 10.1656/1528-7092(2007)6[159:EPMATO]2.0.CO;2; Parker CR, 2000, AQUAT INSECT, V22, P271, DOI 10.1076/0165-0424(200010)22:4;1-Y;FT271; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pineda E, 2009, J ANIM ECOL, V78, P182, DOI 10.1111/j.1365-2656.2008.01471.x; Pottier J, 2013, GLOBAL ECOL BIOGEOGR, V22, P52, DOI 10.1111/j.1466-8238.2012.00790.x; Pouteau R, 2015, DIVERS DISTRIB, V21, P1329, DOI 10.1111/ddi.12374; Ramirez J, 2008, HIGH RESOLUTION DOWN; Robinson JL, 2016, J INSECT CONSERV, V20, P565, DOI 10.1007/s10841-016-9889-3; Schneider RR, 2015, RESERVE DESIGN CLIMA; Scott D, 2004, CLIMATE RES, V27, P105, DOI 10.3354/cr027105; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Simberloff D.S., 1979, Statistical Ecology Series, V12, P123; Stagl J, 2015, REG ENVIRON CHANGE, V15, P1409, DOI 10.1007/s10113-014-0704-y; Thomas CD, 2015, BIOL J LINN SOC, V115, P718, DOI 10.1111/bij.12510; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Virah-Sawmy M, 2016, LANDSCAPE ECOL, V31, P637, DOI 10.1007/s10980-015-0269-2; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Warren DL, 2012, TRENDS ECOL EVOL, V27, P497, DOI 10.1016/j.tree.2012.03.010; Wiens JA, 2010, CONSERV BIOL, V24, P51, DOI 10.1111/j.1523-1739.2009.01409.x	70	3	3	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173443	10.1371/journal.pone.0173443	http://dx.doi.org/10.1371/journal.pone.0173443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301488	gold, Green Submitted, Green Published			2022-12-26	WOS:000396318300038
J	Waite, RD; Qureshi, MR; Whiley, RA				Waite, Richard D.; Qureshi, Muhammad R.; Whiley, Robert A.			Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus	PLOS ONE			English	Article							LUNG-INFECTIONS; MICROBIAL COMPLEXITY; RESPIRATORY-TRACT; DISEASE; SPUTUM; BIOFILMS; CONVERSION; ADAPTATION; DIVERSITY; MECHANISM	Cystic fibrosis (CF) airways harbour complex and dynamic polymicrobial communities that include many oral bacteria. Despite increased knowledge of CF airway microbiomes the interaction between established CF pathogens and other resident microbes and resulting impact on disease progression is poorly understood. Previous studies have demonstrated that oral commensal streptococci of the Anginosus group (AGS) can establish chronic pulmonary infections and become numerically dominant in CF sputa indicating that they play an important role in CF microbiome dynamics. In this study a strain of Pseudomonas aeruginosa (DWW2) of the mucoid alginate overproducing phenotype associated with chronic CF airway infection and a strain of the oral commensal AGS species Streptococcus anginosus (3a) from CF sputum were investigated for their ability to co -exist and their responses to biofilm co -culture. Bacteria in biofilms were quantified, pyocyanin expression by DWW2 was measured and the effect of AGS strain 3a on reversion of DWW2 to a non-mucoidal phenotype investigated. The virulence of DWW2, 3a and colony variant phenotypes of DWW2 in mono- and co -culture were compared in a Galleria mellonella infection model. Co -culture biofilms were formed in normoxic, hypercapnic (10% CO2) and anoxic atmospheres with the streptococcus increasing in number in co -culture, indicating that these bacteria would be able to co -exist and thrive within the heterogeneous microenvironments of the CF airway. The streptococcus caused increased pyocyanin expression by DWW2 and colony variants by stimulating reversion of the mucoid phenotype to the high pyocyanin expressing non-mucoid phenotype. The latter was highly virulent in the infection model with greater virulence when in co-culture with the streptococcus. The results of this study demonstrate that the oral commensal S. anginosus benefits from interaction with P. aeruginosa of the CF associated mucoid phenotype and modulates the behaviour of the pseudomonad in ways that may be clinically relevant.	[Waite, Richard D.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunobiol, London, England; [Qureshi, Muhammad R.; Whiley, Robert A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Whiley, RA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England.	r.a.whiley@qmul.ac.uk						Barnard E, 2016, J PHYSL; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Boucher JC, 1996, J BACTERIOL, V178, P511, DOI 10.1128/jb.178.2.511-523.1996; Bradley S, 1999, CHEST, V116, P647, DOI 10.1378/chest.116.3.647; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Briaconi I, 2011, PLOS PATHOG, V7; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Conrad D, 2013, AM J RESP CELL MOL, V48, P150, DOI 10.1165/rcmb.2012-0059PS; DOGGETT RG, 1964, J BACTERIOL, V87, P427, DOI 10.1128/JB.87.2.427-431.1964; DOGGETT RG, 1969, APPL MICROBIOL, V18, P936, DOI 10.1128/AEM.18.5.936-937.1969; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fothergill JL, 2010, J MED MICROBIOL, V59, P472, DOI 10.1099/jmm.0.015875-0; Parazzi PLF, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0056-5; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Goulet O, 2015, NUTR REV, V73, P32, DOI 10.1093/nutrit/nuv039; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; HOIBY N, 1974, ACTA PATH MICRO IM B, VB 82, P551; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Kaidonis J, 2016, ANN ANAT, V203, P85, DOI 10.1016/j.aanat.2015.02.002; KOCH C, 1993, LANCET, V341, P1065, DOI 10.1016/0140-6736(93)92422-P; Kolak M, 2003, INT J MED MICROBIOL, V293, P309, DOI 10.1078/1438-4221-00265; Line L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00554; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Maeda Y, 2011, J CYST FIBROS, V10, P133, DOI 10.1016/j.jcf.2010.11.003; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Mayer-Hamblett N, 2014, AM J RESP CRIT CARE, V190, P289, DOI 10.1164/rccm.201404-0681OC; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Paun A, 2015, CURR OPIN IMMUNOL, V37, P34, DOI 10.1016/j.coi.2015.09.004; Pedersen S S, 1992, APMIS Suppl, V28, P1; PEDERSEN SS, 1990, INFECT IMMUN, V58, P3363, DOI 10.1128/IAI.58.10.3363-3368.1990; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Potera C, 1996, SCIENCE, V273, P1795, DOI 10.1126/science.273.5283.1795; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers GB, 2010, EXPERT REV MOL DIAGN, V10, P187, DOI 10.1586/ERM.09.81; Ryall B, PLOS ONE, V9; Salli KM, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.26149; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Smith DL, 1998, J INFECTION, V37, P41, DOI 10.1016/S0163-4453(98)90475-3; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stacy A, 2016, NAT REV MICROBIOL, V14, P93, DOI 10.1038/nrmicro.2015.8; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; THOMASSEN MJ, 1979, J INFECT DIS, V140, P873, DOI 10.1093/infdis/140.6.873; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Waite RD, 2012, J BACTERIOL, V194, P4521, DOI 10.1128/JB.06678-11; Waite RD, 2012, J CLIN MICROBIOL, V50, P1430, DOI 10.1128/JCM.06184-11; Waite RD, 2009, J BACTERIOL, V191, P1349, DOI 10.1128/JB.01458-08; Whiley RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115513; Whiley RA, 2014, J INFECT DIS, V209, P769, DOI 10.1093/infdis/jit568; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yang L, 2011, ENVIRON MICROBIOL, V13, P1682, DOI 10.1111/j.1462-2920.2011.02459.x	66	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173741	10.1371/journal.pone.0173741	http://dx.doi.org/10.1371/journal.pone.0173741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301571	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300069
J	Weldehaweria, NB; Abreha, EH; Weldu, MG; Misgina, KH				Weldehaweria, Negassie Berhe; Abreha, Elsa Hagos; Weldu, Meresa Gebremedhin; Misgina, Kebede Haile			Psychosocial correlates of nutritional status among people living with HIV on antiretroviral therapy: A matched case-control study in Central zone of Tigray, Northern Ethiopia	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; QUALITY-OF-LIFE; SOUTH-WEST ETHIOPIA; DEPRESSIVE SYMPTOMS; CIGARETTE-SMOKING; FOOD INSECURITY; HIV/AIDS; MORTALITY; ADHERENCE; INFECTION	Background Malnutrition hastens progression to Acquired Human Immunodeficiency Syndromes (AIDS) related illnesses; undermines adherence and response to antiretroviral therapy (ART) in resource-poor settings. However, nutritional status of people living with HIV (PLHIV) can be affected by various psychosocial factors which have not been well explored in Ethiopia. Therefore, the objective of this study was to determine psychosocial correlates of nutritional status among people living with HIV (PLHIV) on ART in Central zone of Tigray, Northern Ethiopia. Methods A matched case-control study design was conducted to assess psychosocial correlates of nutritional status among PLHIV on ART. Data were collected by an interviewer-administered technique using structured pre-tested questionnaire, record review using a checklist and anthropometric measurements. Cases were selected by simple random sampling and controls purposively to match the selected cases. Conditional logistic regression was used to compute relevant associations by STATA version 12. Results The psychosocial factors independently associated with malnutrition were ever consuming alcohol after starting ART [AOR = 4.7, 95% CI: 1.8.12.3], ever smoking cigarette after starting ART [AOR = 7.6, 95% CI: 2.3.25.5], depression [AOR = 2.8, 95% CI: 1.3, 6.1], not adhering to ART [AOR = 6.8,95% CI: 2.0.23.0] and being in the second lowest wealth quintile [AOR = 4.3,95% CI: 1.1.17.7]. Conclusion Ever consuming alcohol and ever smoking cigarette after starting ART, depression, not adhering to ART and being in the second lowest wealth quintile were significantly associated with malnutrition. Therefore; policies, strategies, and programs targeting people living with HIV should consider psychosocial factors that can impact nutritional status of people living with HIV enrolled on ART.	[Weldehaweria, Negassie Berhe; Weldu, Meresa Gebremedhin; Misgina, Kebede Haile] Aksum Univ, Dept Publ Hlth, Coll Hlth Sci, Aksum, Tigray, Ethiopia; [Abreha, Elsa Hagos] Samara Univ, Dept Biomed Sci, Coll Hlth Sci, Semara, Afar, Ethiopia	Samara University	Weldehaweria, NB (corresponding author), Aksum Univ, Dept Publ Hlth, Coll Hlth Sci, Aksum, Tigray, Ethiopia.	negelsa5960@gmail.com	Weldu, Meresa Gebremedhin/ABA-5452-2020		Aksum University	Aksum University	Funding body: Aksum University. Grant Amount: 20 000 ETB	Agudelo M, 2014, CURR HIV RES, V12, P234, DOI 10.2174/1570162X12666140721115045; Amedee AM, 2014, CURR HIV RES, V12, P243, DOI 10.2174/1570162X12666140721115717; Amico KR, 2009, MONITORING PATIENT A; [Anonymous], 2014, COUNTRY PROGR REPORT; [Anonymous], ETHIOPIAN J HLTH BIO; Azar MM, 2010, DRUG ALCOHOL DEPEN, V112, P178, DOI 10.1016/j.drugalcdep.2010.06.014; Bagby GJ, 2015, ALCOHOL RES-CURR REV, V37, P287; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; Berhe N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-233; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; Chan KCW, 2006, HIV MED, V7, P186, DOI 10.1111/j.1468-1293.2006.00352.x; Charles B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-463; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Crothers K, 2009, AIDS EDUC PREV, V21, P40, DOI 10.1521/aeap.2009.21.3_supp.40; Custodio JM, 2014, J CLIN PHARMACOL, V54, P378, DOI 10.1002/jcph.210; Daniel M., 2013, SCI J PUBL HLTH, V1, P24, DOI DOI 10.11648/J.SJPH.20130101.14; Demeke B, 2014, INT J PHARM SCI RES, V5, P572; EFDR MOH, 2008, NATL GUIDELINES HIVA, P1; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ethiopian Ministry of Agriculture and rural development FAO, 2005, NUTR CAR SUPP PLHIV; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; Food and Nutrition Technical Assistance (FANTA) Project and World Food Programme (WFP), 2007, FOOD ASS PROGR CONT; Fufa H, 2009, FOOD NUTR BULL, V30, P227, DOI 10.1177/156482650903000303; Gedle D., 2015, BMC NUTR, V1, P5, DOI [10.1186/2055-0928-1-5, DOI 10.1186/2055-0928-1-5]; Godfrey X, 2004, HLTH EATING BETTER L; Hadgu TH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-943; Hailemariam S, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-13; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Idindili B, 2012, TANZANIA J HLTH RES, V14; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Jaquet A, 2010, ADDICTION, V105, P1416, DOI 10.1111/j.1360-0443.2010.02978.x; Kalichman SC, 2015, INFECT DIS THER; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leserman J, 1999, PSYCHOSOM MED, V61, P397, DOI 10.1097/00006842-199905000-00021; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Mekuria A, 2015, ETHIOPIA OPEN ACCESS, V2, P1; Miguez-Burbano MJ, 2005, INT J INFECT DIS, V9, P208, DOI 10.1016/j.ijid.2004.07.010; Ministry of Health ICF International, ETH DEM HLTH SURV 20; Molina PE, 2014, CURR HIV RES, V12, P265, DOI 10.2174/1570162X12666140721121849; Musumari PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085327; Oka F, 2013, J INFECT CHEMOTHER, V19, P542, DOI 10.1007/s10156-012-0489-1; Palermo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062353; Petrosillo N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-16; Reis RK, 2011, REV LAT-AM ENFERM, V19, P874, DOI 10.1590/S0104-11692011000400004; Riley ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035207; Shuter J, 2012, AM J HEALTH BEHAV, V36, P75, DOI 10.5993/AJHB.36.1.8; Sieleunou I, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02183.x; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; Soboka M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0446-5; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Soysa NS, 2005, ORAL DIS, V11, P268, DOI 10.1111/j.1601-0825.2005.01115.x; Thapa R, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0056-9; Tirivayi Nyasha, 2012, J AIDS Clin Res, V3, P171; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; Tshingani K. S. C, 2013, HIV AIDS REV, V13; UNAIDS UN, 2014, GAP REP; Valiathan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097698; van Lettow M, 2003, NUTR REV, V61, P81, DOI 10.1301/nr.2003.marr.81-90; Vogenthaler NS, 2011, AIDS BEHAV, V15, P1520, DOI 10.1007/s10461-010-9668-1; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Weiser SD, 2009, AIDS BEHAV, V13, P841, DOI 10.1007/s10461-009-9597-z; WFP WHO UNAIDS, 2008, HIV FOOD SEC NUTR PO; WHO U, 2013, GLOB UPD HIV TREATM; Yaya I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1308; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	69	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174082	10.1371/journal.pone.0174082	http://dx.doi.org/10.1371/journal.pone.0174082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301592	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300124
J	Chen, MW; Wu, JH; Sun, M				Chen, Mao Wei; Wu, Jiang Hao; Sun, Mao			Generation of the pitch moment during the controlled flight after takeoff of fruitflies	PLOS ONE			English	Article							INSECT FLIGHT; HOVERING FLIGHT; KINEMATICS MEASUREMENT; STEERING MUSCLES; WING KINEMATICS; DYNAMIC FLIGHT; AERODYNAMICS; DROSOPHILA; BODY; STABILITY	In the present paper, the controlled flight of fruitflies after voluntary takeoff is studied. Wing and body kinematics of the insects after takeoff are measured using high-speed video techniques, and the aerodynamic force and moment are calculated by the computational fluid dynamics method based on the measured data. How the control moments are generated is analyzed by correlating the computed moments with the wing kinematics. A fruit-fly has a large pitch-up angular velocity owing to the takeoff jump and the fly controls its body attitude by producing pitching moments. It is found that the pitching moment is produced by changes in both the aerodynamic force and the moment arm. The change in the aerodynamic force is mainly due to the change in angle of attack. The change in the moment arm is mainly due to the change in the mean stroke angle and deviation angle, and the deviation angle plays a more important role than the mean stroke angle in changing the moment arm ( note that change in deviation angle implies variation in the position of the aerodynamic stroke plane with respect to the anatomical stroke plane). This is unlike the case of fruitflies correcting pitch perturbations in steady free flight, where they produce pitching moment mainly by changes in mean stroke angle.	[Chen, Mao Wei; Wu, Jiang Hao] Beihang Univ, Sch Transportat Sci & Engn, Beijing, Peoples R China; [Sun, Mao] Beihang Univ, Inst Fluid Mech, Beijing, Peoples R China	Beihang University; Beihang University	Chen, MW (corresponding author), Beihang Univ, Sch Transportat Sci & Engn, Beijing, Peoples R China.	aspenchen@buaa.edu.cn			National Natural Science Foundation of China [11232002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Natural Science Foundation of China (11232002) http://www.nsfc.gov.cn/ (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono H, 2008, J EXP BIOL, V211, P239, DOI 10.1242/jeb.008649; Beatus T, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022712; Beatus T, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0075; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Card G, 2008, J EXP BIOL, V211, P341, DOI 10.1242/jeb.012682; Chen MW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0808; Chen MW, 2014, ACTA MECH SINICA-PRC, V30, P495, DOI 10.1007/s10409-014-0059-0; Cheng B, 2011, J EXP BIOL, V214, P4092, DOI 10.1242/jeb.062760; Cheng B, 2011, IEEE T ROBOT, V27, P849, DOI 10.1109/TRO.2011.2156170; Combes SA, 2009, P NATL ACAD SCI USA, V106, P9105, DOI 10.1073/pnas.0902186106; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; Etkin B., 1996, DYNAMICS FLIGHT STAB, V3rd; Faruque I, 2010, J THEOR BIOL, V264, P538, DOI 10.1016/j.jtbi.2010.02.018; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Greeter JSM, 2016, BIOL OPEN, V5, P72, DOI 10.1242/bio.012922; Hilgenstock A., 1988, NUM GRID GENERATION; Lehmann FO, 1996, J COMP PHYSIOL A, V179, P311, DOI 10.1007/BF00194985; Liang B, 2011, CHINESE J AERONAUT, V24, P396, DOI 10.1016/S1000-9361(11)60047-2; Liu YP, 2008, J EXP BIOL, V211, P2014, DOI 10.1242/jeb.016931; Meng XG, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4914042; Meng XG, 2011, J BIONIC ENG, V8, P140, DOI 10.1016/S1672-6529(11)60015-2; Mou XL, 2011, J EXP BIOL, V214, P2832, DOI 10.1242/jeb.054874; Muijres FT, 2015, J EXP BIOL, V218, P864, DOI 10.1242/jeb.114280; Ortega-Jimenez VM, 2013, J EXP BIOL, V216, P4567, DOI 10.1242/jeb.089672; Ravi S, 2013, J EXP BIOL, V216, P4299, DOI 10.1242/jeb.090845; Ribak G, 2016, J EXP BIOL, V219, P1639, DOI 10.1242/jeb.127886; Ristroph L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0237; Ristroph L, 2010, P NATL ACAD SCI USA, V107, P4820, DOI 10.1073/pnas.1000615107; Rogers S. E., 1994, 940523 AIAA; ROGERS SE, 1991, AIAA J, V29, P603, DOI 10.2514/3.10627; Sun M, 2005, J EXP BIOL, V208, P447, DOI 10.1242/jeb.01407; Sun M, 2006, AIAA J, V44, P1532, DOI 10.2514/1.17356; Sun M, 2014, REV MOD PHYS, V86, P615, DOI 10.1103/RevModPhys.86.615; Tu MS, 1996, J COMP PHYSIOL A, V178, P813, DOI 10.1007/BF00225830; Vance JT, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/1/016004; Whitehead SC, 2015, J EXP BIOL, V218, P3508, DOI 10.1242/jeb.122622; Xu N, 2013, J THEOR BIOL, V319, P102, DOI 10.1016/j.jtbi.2012.11.033; Yu X, 2009, ACTA MECH SINICA-PRC, V25, P421, DOI 10.1007/s10409-009-0266-2; Zhang YL, 2010, ACTA MECH SINICA-PRC, V26, P371, DOI 10.1007/s10409-010-0339-2; Zhang YL, 2010, ACTA MECH SINICA-PRC, V26, P175, DOI 10.1007/s10409-009-0303-1	43	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173481	10.1371/journal.pone.0173481	http://dx.doi.org/10.1371/journal.pone.0173481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296907	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700039
J	Thamri, A; Letourneau, M; Djoboulian, A; Chatenet, D; Deziel, E; Castonguay, A; Perreault, J				Thamri, Amal; Letourneau, Myriam; Djoboulian, Alex; Chatenet, David; Deziel, Eric; Castonguay, Annie; Perreault, Jonathan			Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILM; IN-VITRO; RESISTANCE; IDENTIFICATION; LL-37; DATABASE; LIBRARY; AGENTS; STATE	Cationic antimicrobial peptides (CAMPs) occur naturally in numerous organisms and are considered as a class of antibiotics with promising potential against multi-resistant bacteria. Herein, we report a strategy that can lead to the discovery of novel small CAMPs with greatly enhanced antimicrobial activity and retained antibiofilm potential. We geared our efforts towards i) the N-terminal cysteine functionalization of a previously reported small synthetic cationic peptide (peptide 1037, KRFRIRVRV-NH2), its dimerization through a disulfide bond, and a preliminary antimicrobial activity assessment of the newly prepared dimer against Pseudomonas aeruginosa and Burkholderia cenocepacia, pathogens responsible for the formation of biofilms in lungs of individuals with cystic fibrosis. This dimer is of high interest as it does not only show greatly enhanced bacterial growth inhibition properties compared to its pep1037 precursor (up to 60 times), but importantly, also displays antibiofilm potential at sub-MICs. Our results suggest that the reported dimer holds promise for its use in future adjunctive therapy, in combination with clinically -relevant antibiotics.	[Thamri, Amal; Letourneau, Myriam; Djoboulian, Alex; Chatenet, David; Deziel, Eric; Castonguay, Annie; Perreault, Jonathan] Univ Quebec, INRS, Inst Armand Frappier, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Castonguay, A; Perreault, J (corresponding author), Univ Quebec, INRS, Inst Armand Frappier, Laval, PQ, Canada.	annie.castonguay@iaf.inrs.ca; jonathan.perreault@iaf.inrs.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115; Castonguay, Annie/0000-0001-5705-6353; Perreault, Jonathan/0000-0003-4726-6319	Fonds de recherche du Quebec - Sante [29164, 31227]; Natural Sciences and Engineering Research Council of Canada; Armand-Frappier Foundation of INRS University; Tunisia-INRS	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Armand-Frappier Foundation of INRS University; Tunisia-INRS	JP and AC both received a Junior 1 Research Scholar Award from Fonds de recherche du Quebec - Sante (29164 & 31227; http://www.frqs.gouv.qc.ca). JP, AC, ED and DC are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). AT is supported by an Excellence Scholarship from The Armand-Frappier Foundation of INRS University (http://www.fondation-afrappier-inrs.ca) and a Tunisia-INRS agreement. ED holds the Canada Research Chair in Sociomicrobiology (http://www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; Begolo D, 2014, ANTIMICROB AGENTS CH, V58, P6260, DOI 10.1128/AAC.03338-14; Chandrasekhar S, 2016, PHARM RES-DORDR, V33, P1370, DOI 10.1007/s11095-016-1879-3; Crusca E, 2011, BIOPOLYMERS, V96, P41, DOI 10.1002/bip.21454; Datta A, 2016, J COLLOID INTERF SCI, V461, P335, DOI 10.1016/j.jcis.2015.09.036; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de la Fuente-Nunez C, 2014, ANTIBIOTICS-BASEL, V3, P509, DOI 10.3390/antibiotics3040509; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Dean SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00128; Di Luca M, 2015, BIOFOULING, V31, P193, DOI 10.1080/08927014.2015.1021340; Durham-Colleran MW, 2010, MICROB ECOL, V59, P457, DOI 10.1007/s00248-009-9586-9; Franklin R. I Cockerill, 2012, CONTRACT NO 2; Godballe T, 2011, CHEM BIOL DRUG DES, V77, P107, DOI 10.1111/j.1747-0285.2010.01067.x; GORDON CA, 1988, J ANTIMICROB CHEMOTH, V22, P667, DOI 10.1093/jac/22.5.667; Guiot E, 2002, PHOTOCHEM PHOTOBIOL, V75, P570, DOI 10.1562/0031-8655(2002)075<0570:HODIMB>2.0.CO;2; Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; JORDAN GM, 1994, J PHARM PHARMACOL, V46, P182, DOI 10.1111/j.2042-7158.1994.tb03774.x; Leclercq R, 2008, M S-MED SCI, V24, P32; Liu SP, 2010, INT J PEPT RES THER, V16, P199, DOI 10.1007/s10989-010-9230-z; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Matthew A. M Wikler, 2012, CONTRACT NO 2; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Morrison GM, 2002, MAMM GENOME, V13, P445, DOI 10.1007/s00335-002-3014-5; Mosca DA, 2000, ANTIMICROB AGENTS CH, V44, P1803, DOI 10.1128/AAC.44.7.1803-1808.2000; Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Paulsen VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053326; Reffuveille F, 2014, ANTIMICROB AGENTS CH, V58, P5363, DOI 10.1128/AAC.03163-14; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Shigeta M, 1997, CHEMOTHERAPY, V43, P340, DOI 10.1159/000239587; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Tomlin KL, 2001, CAN J MICROBIOL, V47, P949, DOI 10.1139/cjm-47-10-949; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wu SL, 2000, INT J PHARM, V200, P1, DOI 10.1016/S0378-5173(99)00469-X; Yomogida S, 1996, ARCH BIOCHEM BIOPHYS, V328, P219, DOI 10.1006/abbi.1996.0166; YOSHIOKA S, 1993, PHARMACEUT RES, V10, P687, DOI 10.1023/A:1018951530927	39	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173783	10.1371/journal.pone.0173783	http://dx.doi.org/10.1371/journal.pone.0173783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296935	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700063
J	Doyle, MF; Tracy, RP; Parikh, MA; Hoffman, EA; Shimbo, D; Austin, JHM; Smith, BM; Hueper, K; Vogel-Claussen, J; Lima, J; Gomes, A; Watson, K; Kawut, S; Barr, RG				Doyle, Margaret F.; Tracy, Russell P.; Parikh, Megha A.; Hoffman, Eric A.; Shimbo, Daichi; Austin, John H. M.; Smith, Benjamin M.; Hueper, Katja; Vogel-Claussen, Jens; Lima, Joao; Gomes, Antoinette; Watson, Karol; Kawut, Steven; Barr, R. Graham			Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CONGESTIVE-HEART-FAILURE; BONE-MARROW; CARDIOVASCULAR-DISEASE; STATIN THERAPY; LUNG-FUNCTION; UP-REGULATION; COPD; ATHEROSCLEROSIS; APOPTOSIS	Endothelial injury is implicated in the pathogenesis of COPD and emphysema; however the role of endothelial progenitor cells (EPCs), a marker of endothelial cell repair, and circulating endothelial cells (CECs), a marker of endothelial cell injury, in COPD and its subphenotypes is unresolved. We hypothesized that endothelial progenitor cell populations would be decreased in COPD and emphysema and that circulating endothelial cells would be increased. Associations with other subphenotypes were examined. The Multi-Ethnic Study of Atherosclerosis COPD Study recruited smokers with COPD and controls age 50(_)79 years without clinical cardiovascular disease. Endothelial progenitor cell populations (CD34+KDR+ and CD34+KDR+CD133+cells) and circulating endothelial cells (CD45dimCD31+CD146+CD133-) were measured by flow cytometry. COPD was defined by standard spirometric criteria. Emphysema was assessed qualitatively and quantitatively on CT. Full pulmonary function testing and expiratory CTs were measured in a subset. Among 257 participants, both endothelial progenitor cell populations, and particularly CD34+KDR+ endothelial progenitor cells, were reduced in COPD. The CD34+KDR+CD133+ endothelial progenitor cells were associated inversely with emphysema extent. Both endothelial progenitor cell populations were associated inversely with extent of panlobular emphysema and positively with diffusing capacity. Circulating endothelial cells were not significantly altered in COPD but were inversely associated with pulmonary microvascular blood flow on MRI. There was no consistent association of endothelial progenitor cells or circulating endothelial cells with measures of gas trapping. These data provide evidence that endothelial repair is impaired in COPD and suggest that this pathological process is specific to emphysema.	[Doyle, Margaret F.; Tracy, Russell P.] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA; [Parikh, Megha A.; Shimbo, Daichi; Smith, Benjamin M.; Barr, R. Graham] Columbia Univ, Dept Med, New York, NY 10027 USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Austin, John H. M.] Columbia Univ, Dept Radiol, Coll Phys & Surg, New York, NY USA; [Hueper, Katja; Vogel-Claussen, Jens] Hannover Med Sch, Dept Radiol, Hannover, Germany; [Lima, Joao] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA; [Gomes, Antoinette] Univ Calif Los Angeles, Sch Med, Dept Radiol, Los Angeles, CA 90024 USA; [Watson, Karol] Univ Calif Los Angeles, Sch Med, Div Cardiol, Los Angeles, CA 90024 USA; [Kawut, Steven] Univ Penn, Sch Med, Penn Cardiovasc Inst, Pulm Allergy & Crit Care Div,Ctr Clinical Epidemi, Philadelphia, PA 19104 USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA	University of Vermont; Columbia University; University of Iowa; Columbia University; Hannover Medical School; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania; Columbia University	Barr, RG (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	rgb9@mail.cumc.columbia.edu	Watson, Karol/ABD-7425-2021; Vogel-Claussen, Jens/Q-3374-2019	Vogel-Claussen, Jens/0000-0001-5595-6948; Hoffman, Eric/0000-0001-8456-9437; Doyle, Margaret/0000-0001-6769-5386	National Institutes of Health / National Heart Lung and Blood Institute [R01-HL083091, HL077612, N01 HC 95159-95169]; Harold S. Geneen Charitable Trust Award Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112986, K24HL103844, R01HL093081, R01HL077612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health / National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Harold S. Geneen Charitable Trust Award Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health / National Heart Lung and Blood Institute R01-HL083091, HL077612, N01 HC 95159-95169 and the Harold S. Geneen Charitable Trust Award Program (MFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2014, AM J RESP CRIT CARE, V189, P909, DOI 10.1164/rccm.201308-1458OC; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barbera Joan Albert, 2011, Proc Am Thorac Soc, V8, P528, DOI 10.1513/pats.201101-010MW; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; Barr RG, 2014, PEDIATR RADIOL, V44, P559, DOI 10.1007/s00247-014-3100-3; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bonsignore Maria R, 2006, Proc Am Thorac Soc, V3, P537, DOI 10.1513/pats.200603-090MS; Boos CJ, 2008, J THROMB HAEMOST, V6, P1841, DOI 10.1111/j.1538-7836.2008.03148.x; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; Brittan M, 2013, AM J PHYSIOL-LUNG C, V305, pL964, DOI 10.1152/ajplung.00183.2013; Burkart K.M., 2010, B37 CHRONIC OBSTRUCT, pA2878; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; Eickhoff P, 2008, AM J RESP CRIT CARE, V178, P1211, DOI 10.1164/rccm.200709-1412OC; Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440; Fadini GP, 2006, AM J RESP CELL MOL, V35, P403, DOI 10.1165/rcmb.F319; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hirsch JA, 2015, J NEUROINTERV SURG, V7, P309, DOI 10.1136/neurintsurg-2014-011156; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Huertas A, 2011, EUR RESPIR J, V37, P426, DOI 10.1183/09031936.00034810; Huertas A, 2010, RESP PHYSIOL NEUROBI, V170, P23, DOI 10.1016/j.resp.2009.10.003; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Ito K, 2001, J BIOL CHEM, V276, P38108; Janssen WJ, 2014, COPD, V11, P277, DOI 10.3109/15412555.2013.841668; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kawasaki T, 2015, AM J RESP CELL MOL B; KIM WD, 1991, AM REV RESPIR DIS, V144, P1385, DOI 10.1164/ajrccm/144.6.1385; Kissel CK, 2007, J AM COLL CARDIOL, V49, P2341, DOI 10.1016/j.jacc.2007.01.095; Liu XR, 2013, EXPERT OPIN THER TAR, V17, P485, DOI 10.1517/14728222.2013.773975; Liu XR, 2012, MOL CELL BIOCHEM, V363, P53, DOI 10.1007/s11010-011-1157-y; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Lockett AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093979; Lockett AD, 2012, MOL MED, V18, P445, DOI 10.2119/molmed.2011.00207; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Makin AJ, 2004, EUR HEART J, V25, P371, DOI 10.1016/j.ehj.2003.04.001; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nonaka-Sarukawa M, 2007, INT J CARDIOL, V119, P344, DOI 10.1016/j.ijcard.2006.07.191; Olson NC, 2013, J CARDIOVASC TRANSL, V6, P772, DOI 10.1007/s12265-013-9496-6; Olson NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071498; Palange P, 2006, EUR RESPIR J, V27, P529, DOI 10.1183/09031936.06.00120604; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; Putcha N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114438; Rodriguez J, 2010, ANN INTERN MED, V152, P201, DOI 10.7326/0003-4819-152-4-201002160-00004; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; SAETTA M, 1994, EUR RESPIR J, V7, P664, DOI 10.1183/09031936.94.07040664; Sala E, 2010, LUNG, V188, P331, DOI 10.1007/s00408-009-9225-8; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Sieren JP, 2011, CT IMAGING PROTOCOL; Smith BM, 2014, CHEST, V145, P1305, DOI 10.1378/chest.13-1884; Smith BM, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2013.09.020; Stroncek JD, 2009, TISSUE ENG PT A, V15, P3473, DOI [10.1089/ten.tea.2008.0673, 10.1089/ten.TEA.2008.0673]; Takahashi T, 2012, THORAX, V67, P1067, DOI 10.1136/thoraxjnl-2011-201395; Takahashi T, 2011, RESPIROLOGY, V16, P680, DOI 10.1111/j.1440-1843.2011.01959.x; Thomashow MA, 2013, AM J RESP CRIT CARE, V188, P60, DOI 10.1164/rccm.201209-1697OC; Thyagarajan B, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0134-x; Tracy RP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000117; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang HY, 2007, HYPERTENS RES, V30, P133, DOI 10.1291/hypres.30.133; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Yang Y, 2013, CHINESE MED J-PEKING, V126, P3222, DOI 10.3760/cma.j.issn.0366-6999.20122633; Zhu JH, 2008, RESP MED, V102, P1073, DOI 10.1016/j.rmed.2007.12.030	78	17	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173446	10.1371/journal.pone.0173446	http://dx.doi.org/10.1371/journal.pone.0173446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291826	Green Published, gold, Green Submitted			2022-12-26	WOS:000396094700026
J	Nannyonga, B; Sumpter, DJT				Nannyonga, Betty; Sumpter, David J. T.			Modelling optimal allocation of resources in the context of an incurable disease	PLOS ONE			English	Article							TIME	Nodding syndrome has affected and led to the deaths of children between the ages of 5 and 15 in Northern Uganda since 2009. There is no reliable explanation of the disease, and currently the only treatment is through a nutritional programme of vitamins, combined with medication to prevent symptoms. In the absence of a proper medical treatment, we develop a dynamic compartmental model to plan the management of the syndrome and to curb its effects. We use incidence data from 2012 and 2013 from Pader, Lamwo and Kitgum regions of Uganda to parameterize the model. The model is then used to look at how to best plan the nutritional programme in terms of first getting children on to the programme through outreach, and then making sure they remain on the programme, through follow-up. For the current outbreak of nodding disease, we estimate that about half of available resources should be put into outreach. We show how to optimize the balance between outreach and follow-up in this particular example, and provide a general methodology for allocating resources in similar situations. Given the uncertainty of parameter estimates in such situations, we perform a robustness analysis to identify the best investment strategy. Our analysis offers a way of using available data to determine the best investment strategy of controlling nodding syndrome.	[Nannyonga, Betty] Makerere Univ, Coll Nat Sci, Sch Phys Sci, Dept Math, Kampala, Uganda; [Sumpter, David J. T.] Uppsala Univ, Math Inst, Ctr Interdisciplinary Math, Dept Math, Uppsala, Sweden	Makerere University; Uppsala University	Nannyonga, B (corresponding author), Makerere Univ, Coll Nat Sci, Sch Phys Sci, Dept Math, Kampala, Uganda.	bnk@cns.mak.a.ug			Faculty for the Future, Mathematics Institution, Uppsala University, Sweden; Center for Interdisciplinary Mathematics, Mathematics Institution, Uppsala University, Sweden	Faculty for the Future, Mathematics Institution, Uppsala University, Sweden; Center for Interdisciplinary Mathematics, Mathematics Institution, Uppsala University, Sweden	BN acknowledges funding from the Faculty for the Future and the Center for Interdisciplinary Mathematics, Mathematics Institution, Uppsala University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BN acknowledges funding from the Faculty for the Future and the Center for Interdisciplinary Mathematics, Mathematics Institution, Uppsala University, Sweden. BN thanks the Ministry of Health Uganda for the data. The authors extend gratitude to the constructive comments from the reviewers.	Abraham C., 2011, NEW SCI; [Anonymous], 2012, BBC NEWS; [Anonymous], 2005, MONITOR; Butagira T., 2014, NODDING DIS CRYSTALS; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; Castillo-Chavez C, 2002, HIST SEXUALITY, P229; Chester P, 1984, CLIN PARASITOLOGY; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Deng Y, 2013, MATH BIOSCI, V246, P213, DOI 10.1016/j.mbs.2013.09.007; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; Fleming W.H., 2012, DETERMINISTIC STOCHA; Foltz JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066419; Garcia LS, 1997, DIAGNOSTIC MED PARAS, V3rd ed; Harding A., 2003, BBC NEWS; Kamien M. I., 1991, DYNAMIC OPTIMIZATION; Kar TK, 2012, BIOSYSTEMS, V109, P220, DOI 10.1016/j.biosystems.2012.02.003; Kobayashi M, 2007, PREV VET MED, V79, P274, DOI 10.1016/j.prevetmed.2007.01.001; Lacy M., 2014, LANCET NEUROL, V12, P714; Makumbi C., 2014, PARENTS NEGLECT NODD; Nannyonga B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041135; Ocungi J., 2014, SCH BARS NODDING CHI; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Rodrigues Helena Sofia Ferreira, 2012, THESIS; ROLAND MO, 1986, BRIT MED J, V292, P874, DOI 10.1136/bmj.292.6524.874; Ross E., 2004, CBS NEWS; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Wadman M., 2011, NATURE	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0172401	10.1371/journal.pone.0172401	http://dx.doi.org/10.1371/journal.pone.0172401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288182	Green Published, gold, Green Submitted			2022-12-26	WOS:000396092400006
J	Radaszkiewicz, KA; Sykorova, D; Bino, L; Kudova, J; Bebarova, M; Prochazkova, J; Kotasova, H; Kubala, L; Pachernik, J				Radaszkiewicz, Katarzyna Anna; Sykorova, Dominika; Bino, Lucia; Kudova, Jana; Bebarova, Marketa; Prochazkova, Jirina; Kotasova, Hana; Kubala, Lukas; Pachernik, Jiri			The acceleration of cardiomyogenesis in embryonic stem cells in vitro by serum depletion does not increase the number of developed cardiomyocytes	PLOS ONE			English	Article							NEURAL DIFFERENTIATION; RETINOIC ACID; CARCINOMA-CELLS; EXPRESSION; DEPRIVATION; GENERATION; MESODERM; 3-KINASE; STRAIN	The differentiation of pluripotent embryonic stem (ES) cells into various lineages in vitro represents an important tool for studying the mechanisms underlying mammalian embryogenesis. It is a key technique in studies evaluating the molecular mechanisms of cardiomyogenesis and heart development and also in embryotoxicology. Herein, modest modifications of the basic protocol for ES cell differentiation into cardiomyocytes were evaluated in order to increase the yield and differentiation status of developed cardiomyocytes. Primarily, the data show that ES cell cultivation in the form of non-adherent embryoid bodies (EBs) for 5 days compared to 8 days significantly improved cardiomyogenic differentiation. This is illustrated by the appearance of beating foci in the adherent EBs layer at earlier phases of differentiation from day 10 up to day 16 and by the significantly higher expression of genes characteristic of cardiomyogenic differentiation (sarcomeric alpha actinin, myosin heavy chain alpha and beta, myosin light chain 2 and 7, and transcriptional factor Nkx2.5) in EBs cultivated under non- adherent conditions for 5 days. The ratio of cardiomyocytes per other cells was also potentiated in EBs cultivated in non- adherent conditions for only 5 days followed by cultivation in adherent serumfree culture conditions. Nevertheless, the alteration in the percentage of beating foci among these two tested cultivation conditions vanished at later phases and also did not affect the total number of cardiomyocytes determined as myosin heavy chain positive cells at the end of the differentiation process on day 20. Thus, although these modifications of the conditions of ES cells differentiation may intensify cardiomyocyte differentiation, the final count of cardiomyocytes might not change. Thus, serum depletion was identified as a key factor that intensified cardiomyogenesis. Further, the treatment of EBs with N-acetylcysteine, a reactive oxygen species scavenger, did not affect the observed increase in cardiomyogenesis under serum depleted conditions. Interestingly, a mild induction of the ventricular-like phenotype of cardiomyocytes was observed in 5-day-old EBs compared to 8-day-old EBs. Overall, these findings bring crucial information on the mechanisms of ES cells differentiation into cardiomyocytes and on the establishment of efficient protocols for the cardiomyogenic differentiation of ES cells. Further, the importance of determining the absolute number of formed cardiomyocyte-like cells per seeded pluripotent cells in contrast to the simple quantification of the ratios of cells is highlighted.	[Radaszkiewicz, Katarzyna Anna; Sykorova, Dominika; Bino, Lucia; Kudova, Jana; Pachernik, Jiri] Masaryk Univ, Dept Expt Biol, Fac Sci, Brno, Czech Republic; [Sykorova, Dominika; Bino, Lucia; Kudova, Jana; Kubala, Lukas] Acad Sci Czech Republ, Inst Biophys, Dept Free Radical Pathophysiol, Brno, Czech Republic; [Bino, Lucia; Prochazkova, Jirina; Kotasova, Hana; Kubala, Lukas] St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic; [Bebarova, Marketa] Masaryk Univ, Dept Physiol, Fac Med, Brno, Czech Republic; [Prochazkova, Jirina; Kotasova, Hana] Masaryk Univ, Dept Histol & Embryol, Fac Med, Brno, Czech Republic	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno	Pachernik, J (corresponding author), Masaryk Univ, Dept Expt Biol, Fac Sci, Brno, Czech Republic.	jipa@sci.muni.cz	Kubala, Lukas/H-6329-2014; Kotasova, Hana/F-6222-2012; Prochazkova, Jirina/D-4403-2015	Kubala, Lukas/0000-0002-7729-7338; Prochazkova, Jirina/0000-0003-2738-8546; Pereckova, Jana/0000-0002-7565-993X	Czech Grant Agency [GA13-29358S]; MEYS of the Czech Republick [LQ1605 NPU II]	Czech Grant Agency(Grant Agency of the Czech Republic); MEYS of the Czech Republick	This work was supported by the Czech Grant Agency (GA13-29358S) and by MEYS of the Czech Republick (LQ1605 NPU II).	Ao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041627; Bebarova M, 2016, N-S ARCH PHARMACOL, V389, P1049, DOI 10.1007/s00210-016-1265-z; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; David R, 2012, PHYSIOLOGY, V27, P119, DOI 10.1152/physiol.00044.2011; England J, 2013, CELL MOL LIFE SCI, V70, P1221, DOI 10.1007/s00018-012-1131-1; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Garbern JC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014019; Gissel Cornelia, 2006, V330, P191; Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Konopka R, 2010, FOLIA BIOL-PRAGUE, V56, P66; Konopka R, 2008, NEUROENDOCRINOL LETT, V29, P770; Kotasova H, 2012, J CELL BIOCHEM, V113, P563, DOI 10.1002/jcb.23380; Kudova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158358; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Liao SY, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt381; Mahmoud AI, 2012, TRENDS CARDIOVAS MED, V22, P128, DOI 10.1016/j.tcm.2012.07.008; Mansour H, 2004, CIRC RES, V94, P642, DOI 10.1161/01.RES.0000121101.32286.C8; Moretti A., 2013, COLD SPRING HARB PER, V3; Pachernik J, 2005, PHYSIOL RES, V54, P115, DOI 10.33549/physiolres.930526; Pachernik J, 2002, REPROD NUTR DEV, V42, P317, DOI 10.1051/rnd:2002028; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Prochazkova J, 2013, TOXICOL SCI, V134, P258, DOI 10.1093/toxsci/kft110; Radaszkiewicz KA, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4941776; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Sauer H, 2004, EXP CELL RES, V294, P313, DOI 10.1016/j.yexcr.2003.10.032; Sauer H, 2000, FEBS LETT, V476, P218, DOI 10.1016/S0014-5793(00)01747-6; Sauer Heinrich, 2008, V477, P397, DOI 10.1007/978-1-60327-517-0_30; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Stummann TC, 2008, ASSAY DRUG DEV TECHN, V6, P375, DOI 10.1089/adt.2008.129; Taha MF, 2007, INT J CARDIOL, V120, P92, DOI 10.1016/j.ijcard.2006.08.118; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Vesela I, 2010, FOLIA BIOL-PRAGUE, V56, P165; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Yamasaki S, 2013, INT J DEV BIOL, V57, P715, DOI 10.1387/ijdb.130173to; Zeineddine D, 2005, METH MOLEC MED, V112, P175	42	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173140	10.1371/journal.pone.0173140	http://dx.doi.org/10.1371/journal.pone.0173140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288171	Green Published, gold, Green Submitted			2022-12-26	WOS:000396092400008
J	Kassas-Guediri, A; Coudrat, J; Pacreau, E; Launay, P; Monteiro, RC; Blank, U; Charles, N; Benhamou, M				Kassas-Guediri, Asma; Coudrat, Julie; Pacreau, Emeline; Launay, Pierre; Monteiro, Renato C.; Blank, Ulrich; Charles, Nicolas; Benhamou, Marc			Phospholipid scramblase 1 amplifies anaphylactic reactions in vivo	PLOS ONE			English	Article							MAST-CELL ACTIVATION; UV-INDUCED APOPTOSIS; IGE RECEPTOR; MACROPHAGE PHAGOCYTOSIS; VIRUS-REPLICATION; PROTEIN; INTERFERON; INHIBITION; EXPRESSION; PHOSPHORYLATION	Mast cells are critical actors of hypersensitivity type I (allergic) reactions by the release of vasoactive and proinflammatory mediators following their activation by aggregation of the high-affinity receptor for immunoglobulin E (Fc epsilon RI). We have previously identified Phospholipid Scramblase 1 (PLSCR1) as a new molecular intermediate of FceRI signaling that amplifies degranulation of the rat mast cell line RBL-2H3. Here we characterized primary mast cells from Plscr1(-/-) mice. The absence of PLSCR1 expression did not impact mast cell differentiation as evidenced by unaltered Fc epsilon RI expression, general morphology, amount of histamine stored and expression of Fc epsilon RI signal effector molecules. No detectable mast cell deficiency was observed in Plscr1(-/-) adult mice. In dose-response and time-course experiments, primary cultures of mast cells (bone marrow-derived mast cells and peritoneal cell-derived mast cells) generated from Plscr1(-/-) mice exhibited a reduced release of beta-hexosaminidase upon Fc epsilon RI engagement as compared to their wild-type counterparts. In vivo, Plscr1(-/-) mice were protected in a model of passive systemic anaphylaxis when compared to wild-type mice, which was consistent with an observed decrease in the amounts of histamine released in the serum of Plscr1(-/-) mice during the reaction. Therefore, PLSCR1 aggravates anaphylactic reactions by increasing Fc epsilon RI-dependent mast cell degranulation. PLSCR1 could be a new therapeutic target in allergy.	[Kassas-Guediri, Asma; Coudrat, Julie; Pacreau, Emeline; Launay, Pierre; Monteiro, Renato C.; Blank, Ulrich; Charles, Nicolas; Benhamou, Marc] INSERM U1149, Fac Med Xavier Bichat, Paris, France; [Kassas-Guediri, Asma; Coudrat, Julie; Pacreau, Emeline; Launay, Pierre; Monteiro, Renato C.; Blank, Ulrich; Charles, Nicolas; Benhamou, Marc] Univ Paris Diderot, Lab Excellence INFLAMEX, Sorbonne Paris Cite, DHU FIRE, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Benhamou, M (corresponding author), INSERM U1149, Fac Med Xavier Bichat, Paris, France.; Benhamou, M (corresponding author), Univ Paris Diderot, Lab Excellence INFLAMEX, Sorbonne Paris Cite, DHU FIRE, Paris, France.	marc.benhamou@inserm.fr	Launay, Pierre/AAH-7076-2019; CHARLES, Nicolas/P-5430-2014; CHARLES, Nicolas/S-2214-2019; Monteiro, Renato C/U-8633-2017	CHARLES, Nicolas/0000-0002-5416-5834; CHARLES, Nicolas/0000-0002-5416-5834; Monteiro, Renato C/0000-0001-5202-5646; Benhamou, Marc/0000-0001-7763-3795; Blank, Ulrich/0000-0002-2661-2983	Investissements d'Avenir programme, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX [ANR-11-IDEX-0005-02]	Investissements d'Avenir programme, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX(French National Research Agency (ANR))	AKG was supported by Investissements d'Avenir programme ANR-11-IDEX-0005-02, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX (http://inflamex.fr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Moazami O, 2008, J BIOL CHEM, V283, P25514, DOI 10.1074/jbc.M705320200; Bailey K, 2005, BBA-MOL CELL BIOL L, V1733, P199, DOI 10.1016/j.bbalip.2004.12.013; BENHAMOU M, 1986, J IMMUNOL, V136, P1385; Chen CW, 2011, J LEUKOCYTE BIOL, V90, P221, DOI 10.1189/jlb.0111006; Cui W, 2012, HEPATOB PANCREAT DIS, V11, P393, DOI 10.1016/S1499-3872(12)60197-0; Dahdah A, 2014, J CLIN INVEST, V124, P4577, DOI 10.1172/JCI75212; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Galli SJ, 2016, ALLERGOL INT, V65, P3, DOI 10.1016/j.alit.2015.09.002; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Herate C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145617; Huang Y, 2006, ONCOGENE, V25, P6618, DOI 10.1038/sj.onc.1209677; Kalesnikoff J, 2010, CHEM IMMUNOL ALLERGY, V95, P45, DOI 10.1159/000315937; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kassas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109800; Kasukabe T, 1997, BLOOD, V89, P2975, DOI 10.1182/blood.V89.8.2975; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubo S, 2003, J IMMUNOL, V170, P775, DOI 10.4049/jimmunol.170.2.775; Kusano S, 2013, BIOCHEM BIOPH RES CO, V433, P438, DOI 10.1016/j.bbrc.2013.02.098; Kusano S, 2012, VIROLOGY, V432, P343, DOI 10.1016/j.virol.2012.06.019; Launay P, 1998, J LEUKOCYTE BIOL, V63, P636, DOI 10.1002/jlb.63.5.636; Li Yabin, 2006, POW EL MOT CONTR C 2, V1, P1, DOI DOI 10.1016/JJHAZMAT2006.02.011; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Mukai K, 2016, SEMIN IMMUNOPATHOL, V38, P581, DOI 10.1007/s00281-016-0565-1; Nakamaki T, 2002, EXP HEMATOL, V30, P421, DOI 10.1016/S0301-472X(02)00779-8; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Silverman RH, 2002, CANCER RES, V62, P397; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; STRACKE ML, 1987, MOL IMMUNOL, V24, P347, DOI 10.1016/0161-5890(87)90176-3; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; Yang J, 2012, ANTIVIR RES, V94, P9, DOI 10.1016/j.antiviral.2012.01.010; Yu A, 2004, BIOCHEM J, V381, P609, DOI 10.1042/BJ20031857; Yuan YZ, 2015, J PROTEOME RES, V14, P154, DOI 10.1021/pr500943x; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	44	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173815	10.1371/journal.pone.0173815	http://dx.doi.org/10.1371/journal.pone.0173815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282470	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800081
J	Orban, JC; Novain, M; Cattet, F; Plattier, R; Nefzaoui, M; Hyvernat, H; Raguin, O; Kaidomar, M; Kerever, S; Ichai, C				Orban, Jean-Christophe; Novain, Michael; Cattet, Florian; Plattier, Remi; Nefzaoui, Mohamed; Hyvernat, Herve; Raguin, Olivier; Kaidomar, Michel; Kerever, Sebastien; Ichai, Carole			Association of serum lactate with outcome after out-of-hospital cardiac arrest treated with therapeutic hypothermia	PLOS ONE			English	Article							EUROPEAN-RESUSCITATION-COUNCIL; INTENSIVE-CARE MEDICINE; SURVIVORS; PREDICTION; GUIDELINES; CLEARANCE; INJURY; SHOCK; MORTALITY; SOCIETY	Aims Lactate reflects hypoxic insult in many conditions and is considered as a prognosis factor. But, after cardiac arrest, its interest is still debated. Our study aimed to assess the prognosis value of lactate in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Methods This retrospective observational study included out-of-hospital cardiac arrest patients treated with therapeutic hypothermia in four ICUs. Lactate levels were compared at different times during the first 24 hours according to outcome at ICU discharge and to the type of death (multiorgan or neurologic failure). Results Two hundred and seventy-two patients were included, 89 good outcome and 183 poor outcome. In the latter group, 171 patients died, from multiorgan failure in 30% and neurologic failure in 70%. Lactate levels were higher in the poor compared to the good outcome patients at admission (5.4 (3.3-9.4) vs. 2.2 (1.5-3.6) mmol/L; p<0.01), 12 hours (2.5 (1.6-4.7) vs. 1.4 (1.0-2.2) mmol/L; p<0.01) and 24 hours (1.8 (1.1-2.8) vs. 1.3 (0.9-2.1) mmol/L; p<0.01). Patients succumbing from multiorgan failure exhibited higher lactate levels compared to those dying from neurologic failure at admission (7.9 (3.9-12.0) vs. 5.2 (3.3-8.8) mmol/L; p<0.01), H12 (4.9 (2.1-8.9) vs. 2.2 (1.4-3.4) mmol/L; p<0.01) and H24 (3.3 (1.8-5.5) vs. 1.4 (1.1-2.5) mmol/L; p<0.01). Initial lactate levels showed an increasing proportion of poor outcome from the first to fourth quartile. Conclusions After out-of-hospital cardiac arrest treated with therapeutic hypothermia, lactate levels during the first 24 hours seem linked with ICU outcome. Patients dying from multiorgan failure exhibit higher initial lactate concentrations than patients succumbing from neurological failure.	[Orban, Jean-Christophe; Novain, Michael; Cattet, Florian; Plattier, Remi; Nefzaoui, Mohamed; Ichai, Carole] Nice Univ Hosp, Pasteur Hosp 2, Med Surg ICU, 30 Voie Romaine, Nice, France; [Hyvernat, Herve] Nice Univ Hosp, Med ICU, Archet Hosp, 151 Route St Antoine, Nice, France; [Raguin, Olivier] Antibes Gen Hosp, Intens Care Unit, 107 Ave Nice, Antibes, France; [Kaidomar, Michel] Frejus St Raphael Gen Hosp, Intens Care Unit, 240 Ave St Lambert, Frejus, France; [Kerever, Sebastien] Lariboisiere Univ Hosp, Dept Anesthesiol, 2 Rue Ambroise Pare, Paris, France; [Kerever, Sebastien] Lariboisiere Univ Hosp, Dept Crit Care, 2 Rue Ambroise Pare, Paris, France	CHU Nice; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Orban, JC (corresponding author), Nice Univ Hosp, Pasteur Hosp 2, Med Surg ICU, 30 Voie Romaine, Nice, France.	orban.jc@chu-nice.fr	Kerever, Sébastien/S-1620-2019	Kerever, Sébastien/0000-0003-0764-4370; Orban, Jean-Christophe/0000-0002-8004-4809				Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; BAKKER J, 1991, CHEST, V99, P956, DOI 10.1378/chest.99.4.956; Bougouin W, 2014, INTENS CARE MED, V40, P846, DOI 10.1007/s00134-014-3252-5; CARDEN DL, 1985, AM J EMERG MED, V3, P120, DOI 10.1016/0735-6757(85)90033-6; Chamorro C, 2010, ANESTH ANALG, V110, P1328, DOI 10.1213/ANE.0b013e3181d8cacf; Cocchi MN, 2011, MINERVA ANESTESIOL, V77, P1063; Contenti J, 2015, AM J EMERG MED, V33, P167, DOI 10.1016/j.ajem.2014.11.003; Dankiewicz J, 2014, CRIT CARE MED, V42, P2537, DOI 10.1097/CCM.0000000000000543; de Vreede-Swagemakers JJM, 1998, HEART, V79, P356, DOI 10.1136/hrt.79.4.356; Donnino MW, 2007, RESUSCITATION, V75, P229, DOI 10.1016/j.resuscitation.2007.03.021; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Gasparetto N, 2014, RESUSCITATION, V85, P376, DOI 10.1016/j.resuscitation.2013.11.014; Grimaldi D, 2013, RESUSCITATION, V84, P60, DOI 10.1016/j.resuscitation.2012.06.010; Han F, 2008, CRIT CARE MED, V36, pS447, DOI 10.1097/CCM.0b013e31818a8a51; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; Kliegel A, 2004, MEDICINE, V83, P274, DOI 10.1097/01.md.0000141098.46118.4c; Korth U, 2003, RESUSCITATION, V58, P209, DOI 10.1016/S0300-9572(03)00119-9; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Lee TR, 2013, CRIT CARE, V17, DOI 10.1186/cc13090; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Levraut J, 1998, AM J RESP CRIT CARE, V157, P1021, DOI 10.1164/ajrccm.157.4.9705037; Mullner M, 1997, INTENS CARE MED, V23, P1138, DOI 10.1007/s001340050470; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Oddo M, 2014, CRIT CARE MED, V42, P1340, DOI 10.1097/CCM.0000000000000211; Orban JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045284; Revelly JP, 2005, CRIT CARE MED, V33, P2235, DOI 10.1097/01.CCM.0000181525.99295.8F; Sandroni C, 2014, INTENS CARE MED, V40, P1816, DOI 10.1007/s00134-014-3470-x; Shinozaki K, 2011, RESUSCITATION, V82, P404, DOI 10.1016/j.resuscitation.2010.10.026; Starodub R, 2013, RESUSCITATION, V84, P1078, DOI 10.1016/j.resuscitation.2013.02.001; Wolfrum S, 2007, RESUSCITATION, V72, P207, DOI 10.1016/j.resuscitation.2006.06.033; Zellner T, 2013, RESUSCITATION, V84, P1382, DOI 10.1016/j.resuscitation.2013.03.021	35	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173239	10.1371/journal.pone.0173239	http://dx.doi.org/10.1371/journal.pone.0173239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282398	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800024
J	Wlodarczyk, A; Sonakowska, L; Kaminska, K; Marchewka, A; Wilczek, G; Wilczek, P; Student, S; Rost-Roszkowska, M				Wlodarczyk, Agnieszka; Sonakowska, Lidia; Kaminska, Karolina; Marchewka, Angelika; Wilczek, Grazyna; Wilczek, Piotr; Student, Sebastian; Rost-Roszkowska, Magdalena			The effect of starvation and re-feeding on mitochondrial potential in the midgut of Neocaridina davidi (Crustacea, Malacostraca)	PLOS ONE			English	Article							CELL-DEATH; AUTOPHAGY; APOPTOSIS; EPITHELIUM; PHALANGIIDAE; STRESS; PARKIN; GLAND	The midgut in the freshwater shrimp Neocaridina davidi (previously named N. heteropoda) (Crustacea, Malacostraca) is composed of a tube-shaped intestine and a large hepatopancreas that is formed by numerous blind-ended tubules. The precise structure and ultrastructure of these regions were presented in our previous papers, while here we focused on the ultrastructural changes that occurred in the midgut epithelial cells (D-cells in the intestine, Band F-cells in the hepatopancreas) after long-term starvation and re-feeding. We used transmission electron microscopy, light and confocal microscopes and flow cytometry to describe all of the changes that occurred due to the stressor with special emphasis on mitochondrial alterations. A quantitative assessment of cells with depolarized mitochondria helped us to establish whether there is a relationship between starvation, re-feeding and the inactivation/activation of mitochondria. The results of our studies showed that in the freshwater shrimp N. davidi that were analyzed, long-term starvation activates the degeneration of epithelial cells at the ultrastructural level and causes an increase of cells with depolarized (non-active) mitochondria. The process of re-feeding leads to the gradual regeneration of the cytoplasm of the midgut epithelial cells; however, these changes were observed at the ultrastructural level. Additionally, re-feeding causes the regeneration of mitochondrial ultrastructure. Therefore, we can state that the increase in the number of cells with polarized mitochondria occurs slowly and does not depend on ultrastructural alterations.	[Wlodarczyk, Agnieszka; Sonakowska, Lidia; Kaminska, Karolina; Marchewka, Angelika; Rost-Roszkowska, Magdalena] Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland; [Wilczek, Grazyna] Univ Silesia, Dept Anim Physiol & Ecotoxicol, Katowice, Poland; [Wilczek, Piotr] Heart Prosthesis Inst, Bioengn Lab, Zabrze, Poland; [Student, Sebastian] Silesian Tech Univ, Inst Automat Control, Fac Automat Control Elect & Comp Sci, Gliwice, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Silesian University of Technology	Rost-Roszkowska, M (corresponding author), Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland.	magdalena.rost-roszkowska@us.edu.pl	Student, Sebastian/H-7895-2013; Rost-Roszkowska, Magdalena/AAM-7005-2020	Student, Sebastian/0000-0003-1812-5496; Wilczek, Piotr/0000-0002-4968-6512; Wlodarczyk, Agnieszka/0000-0002-2374-4892; Wilczek, Grazyna/0000-0002-3276-0333; Rost-Roszkowska, Magdalena/0000-0001-7124-8423	GCONiI - Upper - Silesian Center for Scientific Computation [POIG.02.03.01-24-099/13]	GCONiI - Upper - Silesian Center for Scientific Computation	This work was supported by POIG.02.03.01-24-099/13 grant: GCONiI - Upper - Silesian Center for Scientific Computation (SS).; We would like to express our gratitude to Professor Jerzy Klag (University of Silesia, Poland) for his substantive advice and Drs. Danuta Urbanska-Jasik, Alina Chachulska-Zymelka and Lukasz Chajec (University of Silesia, Poland) for their technical assistance. This work was performed using the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GCONiI-Upper-Silesian Center for Scientific Computation".	AFZELIUS BA, 1966, EXP CELL RES, V42, P10, DOI 10.1016/0014-4827(66)90314-4; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; DEPAZ O, 1986, MAMMALIA, V50, P243, DOI 10.1515/mamm.1986.50.2.243; Pantaleao JAF, 2015, J CRUSTACEAN BIOL, V35, P676, DOI 10.1163/1937240X-00002357; Faron J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117187; Fernandez-Checa JC, 2003, BIOCHEM BIOPH RES CO, V304, P471, DOI 10.1016/S0006-291X(03)00619-3; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; KALASHNIKOVA MM, 1979, B EXP BIOL MED+, V88, P771, DOI 10.1007/BF00804791; Karpeta-Kaczmarek J, 2016, ARTHROPOD STRUCT DEV, V45, P253, DOI 10.1016/j.asd.2016.02.002; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Lignot J.-H., 2012, COMP PHYSL FASTING S, P7; Lipovsek S, 2016, PROTOPLASMA, V253, P457, DOI 10.1007/s00709-015-0824-3; Lipovsek S, 2015, ARTHROPOD STRUCT DEV, V44, P131, DOI 10.1016/j.asd.2014.12.002; Lipovsek S, 2014, ARTHROPOD STRUCT DEV, V43, P493, DOI 10.1016/j.asd.2014.06.001; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Moyes CD, 1998, J EXP BIOL, V201, P299; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; RATCLIFFE NA, 1969, Z ZELLFORSCH MIK ANA, V99, P459, DOI 10.1007/BF00337615; Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4; Rost-Roszkowska MM, 2015, MICRON, V68, P130, DOI 10.1016/j.micron.2014.10.003; Rost-Roszkowska MM, 2012, ARTHROPOD STRUCT DEV, V41, P271, DOI 10.1016/j.asd.2012.01.001; Saleh RA, 2003, FERTIL STERIL, V79, P1597, DOI 10.1016/S0015-0282(03)00337-6; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sanchez-Paz A, 2007, J EXP MAR BIOL ECOL, V340, P184, DOI 10.1016/j.jembe.2006.09.006; Sonakowska L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147582; Sonakowska L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126900; SOUTY C, 1981, REPROD NUTR DEV, V21, P95, DOI 10.1051/rnd:19810108; Wilczek G, 2005, COMP BIOCHEM PHYS C, V141, P194, DOI 10.1016/j.cca.2005.06.007; Wilczek G, 2014, ECOTOX ENVIRON SAFE, V101, P157, DOI 10.1016/j.ecoenv.2013.09.034; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	35	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173563	10.1371/journal.pone.0173563	http://dx.doi.org/10.1371/journal.pone.0173563			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282457	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800050
J	Chen, D; Wan, SR; Xiang, J; Bao, FS				Chen, Duo; Wan, Suiren; Xiang, Jing; Bao, Forrest Sheng			A high-performance seizure detection algorithm based on Discrete Wavelet Transform (DWT) and EEG	PLOS ONE			English	Article							SIGNAL CLASSIFICATION; EPILEPSY DIAGNOSIS	In the past decade, Discrete Wavelet Transform (DWT), a powerful time-frequency tool, has been widely used in computer-aided signal analysis of epileptic electroencephalography (EEG), such as the detection of seizures. One of the important hurdles in the applications of DWT is the settings of DWT, which are chosen empirically or arbitrarily in previous works. The objective of this study aimed to develop a framework for automatically searching the optimal DWT settings to improve accuracy and to reduce computational cost of seizure detection. To address this, we developed a method to decompose EEG data into 7 commonly used wavelet families, to the maximum theoretical level of each mother wavelet. Wavelets and decomposition levels providing the highest accuracy in each wavelet family were then searched in an exhaustive selection of frequency bands, which showed optimal accuracy and low computational cost. The selection of frequency bands and features removed approximately 40% of redundancies. The developed algorithm achieved promising performance on two well-tested EEG datasets (accuracy > 90% for both datasets). The experimental results of the developed method have demonstrated that the settings of DWT affect its performance on seizure detection substantially. Compared with existing seizure detection methods based on wavelet, the new approach is more accurate and transferable among datasets.	[Chen, Duo; Wan, Suiren] Southeast Univ, Sch Biol Sci & Med Engn, Lab Med Elect, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Xiang, Jing] Cincinnati Childrens Hosp, Div Neurol, Cincinnati, OH USA; [Bao, Forrest Sheng] Univ Akron, Dept Elect & Comp Engn, Akron, OH 44325 USA	Southeast University - China; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Akron	Wan, SR (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Lab Med Elect, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.; Bao, FS (corresponding author), Univ Akron, Dept Elect & Comp Engn, Akron, OH 44325 USA.	srwan@seu.edu.cn; forrest.bao@gmail.com						Acharya UR, 2012, EXPERT SYST APPL, V39, P9072, DOI 10.1016/j.eswa.2012.02.040; Adeli H, 2003, J NEUROSCI METH, V123, P69, DOI 10.1016/S0165-0270(02)00340-0; Andrzejak RG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061907; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chapelle O, 2007, NEURAL COMPUT, V19, P1155, DOI 10.1162/neco.2007.19.5.1155; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104, DOI 10.1137/1.9781611970104, DOI 10.1063/1.4823127]; Faust O, 2015, SEIZURE-EUR J EPILEP, V26, P56, DOI 10.1016/j.seizure.2015.01.012; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fotiadis DI, 2016, HANDBOOK OF RESEARCH, DOI [10.4018/978-1-4666-8828-5, DOI 10.4018/978-1-4666-8828-5]; Gotman J, 2010, EPILEPSIA, V51, P63, DOI 10.1111/j.1528-1167.2009.02449.x; Guo L, 2010, J NEUROSCI METH, V193, P156, DOI 10.1016/j.jneumeth.2010.08.030; Guo L, 2010, J NEUROSCI METH, V191, P101, DOI 10.1016/j.jneumeth.2010.05.020; Jenssen S, 2010, AM J ALZHEIMERS DIS, V25, P18, DOI 10.1177/1533317508319433; Khan YU, 2003, CLIN NEUROPHYSIOL, V114, P898, DOI 10.1016/S1388-2457(03)00035-X; Knowlton RC, 2009, ANN NEUROL, V65, P716, DOI 10.1002/ana.21660; Koessler L, 2010, NEUROIMAGE, V51, P642, DOI 10.1016/j.neuroimage.2010.02.067; Lee SA, 2000, EPILEPSIA, V41, P297, DOI 10.1111/j.1528-1157.2000.tb00159.x; Lima CAM, 2011, ARTIF INTELL MED, V53, P83, DOI 10.1016/j.artmed.2011.07.003; Lima CAM, 2009, EXPERT SYST APPL, V36, P10054, DOI 10.1016/j.eswa.2009.01.022; Liu YX, 2012, IEEE T NEUR SYS REH, V20, P749, DOI 10.1109/TNSRE.2012.2206054; Magosso E, 2009, APPL MATH COMPUT, V207, P42, DOI 10.1016/j.amc.2007.10.069; MALLAT S, 1992, IEEE T PATTERN ANAL, V14, P710, DOI 10.1109/34.142909; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Nunes TM, 2014, NEUROCOMPUTING, V136, P103, DOI 10.1016/j.neucom.2014.01.020; Rankine L, 2007, MED BIOL ENG COMPUT, V45, P251, DOI 10.1007/s11517-006-0143-0; Shoeb A., 2010, 27 INT C MACH LEARN; Shoeb AH, 2009, APPLICATION OF MACHI; Tao JX, 2013, EPILEPSIA, V54, P858, DOI 10.1111/epi.12094; Ubeyli ED, 2009, DIGIT SIGNAL PROCESS, V19, P297, DOI 10.1016/j.dsp.2008.07.004; Ubeyli ED, 2008, COMPUT BIOL MED, V38, P14, DOI 10.1016/j.compbiomed.2007.06.002; Wei D., 1998, COIFLET TYPE WAVELET; who, EPILEPSY; Yi-Leh Wu, 2000, Proceedings of the Ninth International Conference on Information and Knowledge Management. CIKM 2000, P488; Zandi AS, 2010, IEEE T BIO-MED ENG, V57, P1639, DOI 10.1109/TBME.2010.2046417	36	58	60	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173138	10.1371/journal.pone.0173138	http://dx.doi.org/10.1371/journal.pone.0173138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278203	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900048
J	George, J; Ammar, ED; Hall, DG; Lapointe, SL				George, Justin; Ammar, El-Desouky; Hall, David G.; Lapointe, Stephen L.			Sclerenchymatous ring as a barrier to phloem feeding by Asian citrus psyllid: Evidence from electrical penetration graph and visualization of stylet pathways	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; DIAPHORINA-CITRI; BEHAVIOR; LIGNIFICATION; TRANSMISSION; ACQUISITION; DISEASE	Asian citrus psyllid (Diaphorina citri) feeding behaviors play a significant role in the transmission of the phloem-limited Candidatus Liberibacter asiaticus (CLas) bacterium that causes the economically devastating citrus greening disease. Sustained phloem ingestion by D. citri on CLas infected plants is required for pathogen acquisition and transmission. Recent studies have shown a fibrous ring of thick-walled sclerenchyma around the phloem in mature, fully expanded citrus leaves that is more prominent on the abaxial compared with the adaxial side. The composition and thickness of this fibrous ring may have an important role in selection of feeding sites by D. citri based on leaf age and leaf surface, which in turn can affect pathogen acquisition and transmission. We measured feeding behavior using electrical penetration graph (EPG) recordings of individual D. citri adults placed on abaxial or adaxial surfaces of young or mature Valencia orange leaves to study the role of the sclerenchymatous ring in modifying D. citri feeding behavior. Feeding sites on the same leaf tissues were then sectioned and examined by epifluorescence microscopy. The duration of phloem ingestion (E2 waveform) by psyllids was significantly reduced on mature compared with young leaves, and on abaxial compared with adaxial leaf surfaces. The longest duration of phloem ingestion was observed from psyllids placed on the adaxial side of young leaves that had the least developed sclerenchyma. Bouts of phloem salivation (E1 waveform), however, were significantly longer on mature leaves compared with young leaves. D. citri adults made consecutive phloem feeding attempts (bouts) on the abaxial side of mature leaves and those bouts resulted in unsuccessful or shorter periods of phloem ingestion. Adults also made more frequent and longer bouts of xylem ingestion on mature leaves compared with adult psyllids placed on young leaves. Epifluorescence microscopy showed that the fibrous ring in young leaves was thinner and autofluoresced in red whereas the ring in mature leaves was thicker and autofluoresced in blue, indicating changes in structure and composition (e.g., lignification) of sclerenchyma correlated with leaf age. Our results support the hypothesis that the presence of a thick, well-developed fibrous ring around phloem tissues of mature leaves acts as a barrier to frequent or prolonged phloem ingestion by D. citri from citrus leaves. This may have an important role in limiting or preventing CLas acquisition and/or transmission by D. citri, and could be used for identification and development of resistant citrus cultivars.	[George, Justin; Ammar, El-Desouky; Hall, David G.; Lapointe, Stephen L.] USDA ARS, Subtrop Insects & Hort Res Unit, US Hort Res Lab, Ft Pierce, FL 34945 USA; [Ammar, El-Desouky] Univ Florida, IFAS, Lake Alfred, FL USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Lapointe, SL (corresponding author), USDA ARS, Subtrop Insects & Hort Res Unit, US Hort Res Lab, Ft Pierce, FL 34945 USA.	Stephen.Lapointe@ars.usda.gov			USDA-ARS Project "IPM Methods for Insect Pests of Orchard Crops"; Citrus Research and Development Foundation [853]; ARS Project "IPM Methods for Insect Pests of Orchard Crops"	USDA-ARS Project "IPM Methods for Insect Pests of Orchard Crops"; Citrus Research and Development Foundation; ARS Project "IPM Methods for Insect Pests of Orchard Crops"	Funding was provided by USDA-ARS Project "IPM Methods for Insect Pests of Orchard Crops". Significant external funding was provided by the Citrus Research and Development Foundation, grant #853. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank Larry Markle and Arielly Dias (USDA-ARS, Ft. Pierce, FL) for technical assistance and Anna Sara Hill (USDA-ARS, Ft. Pierce, FL) for insect rearing. Funding for this work was provided by ARS Project "IPM Methods for Insect Pests of Orchard Crops". Significant external funding was provided by the Citrus Research and Development Foundation, grant #853. There was no additional external funding received for this study. USDA is an equal opportunity provider and employer. Mention of a trademark or proprietary product does not constitute a guarantee or warranty of the product by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may also be suitable.	AKIN DE, 1992, J SCI FOOD AGR, V59, P437, DOI 10.1002/jsfa.2740590403; Ammar ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159594; Ammar ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110919; Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059914; BLUM A, 1968, CROP SCI, V8, P388, DOI 10.2135/cropsci1968.0011183X000800030037x; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Duarte MR, 2005, FITOTERAPIA, V76, P41, DOI 10.1016/j.fitote.2004.10.003; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2016, J EC ENTOMOL; Hewer A, 2011, J EXP BIOL, V214, P3868, DOI 10.1242/jeb.060913; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Luo XZ, 2015, FLA ENTOMOL, V98, P186, DOI 10.1653/024.098.0132; Moore R., 1998, BOTANY, V3; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Rangasamy M, 2009, J ECON ENTOMOL, V102, P432, DOI 10.1603/029.102.0156; Richter S, 2011, PLANTA, V233, P763, DOI 10.1007/s00425-010-1338-z; Setamou M, 2016, J EC ENTOMOL; Setamou M, 2017, PLOS ONE, V11; Setamou M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131917; Skelley LH, 2004, BIOL CONTROL, V29, P14, DOI 10.1016/S1049-9644(03)00129-4; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Tomaseto AF, 2016, J APPL ENTOMOL, V140, P91, DOI 10.1111/jen.12249; Wang Y, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00220, 10.3389/fpls.2013.00314]; Xu C.F., 1988, P 10 C INT ORG CITRU, P243; Yasuda K, 2005, JPN J APPL ENTOMOL Z, V49, P146, DOI 10.1303/jjaez.2005.146	31	33	34	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173520	10.1371/journal.pone.0173520	http://dx.doi.org/10.1371/journal.pone.0173520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278248	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900004
J	Krucken, J; Blumke, J; Maaz, D; Demeler, J; Ramunke, S; Antolova, D; Schaper, R; von Samson-Himmelstjerna, G				Kruecken, Juergen; Bluemke, Julia; Maaz, Denny; Demeler, Janina; Ramuenke, Sabrina; Antolova, Daniela; Schaper, Roland; von Samson-Himmelstjerna, Georg			Small rodents as paratenic or intermediate hosts of carnivore parasites in Berlin, Germany	PLOS ONE			English	Article							ECHINOCOCCUS-MULTILOCULARIS-INFECTIONS; CENTRAL-NERVOUS-SYSTEM; TOXOPLASMA-GONDII; NEOSPORA-CANINUM; TOXOCARA-CANIS; TAENIA-MARTIS; ENVIRONMENTAL CONTAMINATION; NEGLECTED INFECTIONS; TOXASCARIS-LEONINA; BEHAVIORAL-CHANGES	Rodents are important intermediate and paratenic hosts for carnivore parasites, including the important zoonotic agents Toxoplasma, Echinococcus and Toxocara. Monitoring of such parasites in rodents can be used to detect increasing risks for human and veterinary public health. Rodents were trapped at four sites in Berlin, two near the city center, two at the periphery. PCRs were conducted to detect Coccidia (target ITS-1) and specifically Toxoplasma gondii (repetitive element) in brain and ascarids (ITS-2) in muscle or brain tissue. During necropsies, metacestodes were collected and identified using ITS-2 and 12S rRNA PCRs. An ELISA to detect antibodies against Toxocara canis ES antigens was performed. Within the 257 examined rodents, the most frequently observed parasite was Frenkelia glareoli predominantly found in Myodes glareolus. T. gondii was only detected in 12 rodents and Microtus spp. (although strongly underrepresented) had a significantly increased chance of being positive. Neither Echinococcus nor typical Taenia parasites of dogs and cats were found but Mesocestoides litteratus and Taenia martis metacestodes were identified which can cause severe peritoneal or ocular cysticercosis in dogs, primates and humans. Using PCR, the ascarids T. canis (n = 8), Toxocara cati (4) and Parascaris sp. (1) were detected predominantly in muscles. Seroprevalence of T. canis was 14.2% and ELISA was thus more sensitive than PCR to detect infection with this parasite. Non-parametric multidimensional scaling and cluster analysis revealed that parasite communities could be grouped into an urban and a peri-urban cluster with high frequency of ascarid-positive rodents in urban and high frequency of F. glareoli in peri-urban sites. Prevalence rates of parasites in rodents with potential impact for human or veterinary public health are considerable and the monitoring of transmission cycles of carnivore parasites in intermediate rodent hosts is recommended to estimate the health risks arising from wild and domesticated carnivores.	[Kruecken, Juergen; Bluemke, Julia; Maaz, Denny; Demeler, Janina; Ramuenke, Sabrina; von Samson-Himmelstjerna, Georg] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Antolova, Daniela] Slovak Acad Sci, Inst Parasitol, Kosice, Slovakia; [Schaper, Roland] Bayer Anim Hlth GmbH, Leverkusen, Germany	Free University of Berlin; Slovak Academy of Sciences; Bayer AG	von Samson-Himmelstjerna, G (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	gvsamson@fu-berlin.de	Schaper, Roland/ABC-5752-2020; Krücken, Jürgen/AAE-3133-2021; Antolová, Daniela/AAF-6411-2020; McKay-Demeler, Janina/AAO-4336-2020; Krücken, Jürgen/B-6794-2009; Krücken, Jürgen/CAF-6903-2022	Krücken, Jürgen/0000-0002-2842-8100; Antolová, Daniela/0000-0002-9358-2163; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Maaz, Denny/0000-0002-5005-4416; Ramunke, Sabrina/0000-0003-0195-4175	Bayer Animal Health, Leverkusen, Germany	Bayer Animal Health, Leverkusen, Germany(Bayer AG)	The funder Bayer Animal Health, Leverkusen, Germany provided financial support to the Freie Universitat Berlin to pay a stipend for one author [JB] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. RS is employed by Bayer Animal Health and participated in the conceptualization of the study and supported the study by facilitating the financial support through Bayer Animal Health. He did not have any influence on the conduct of the study, the data collection and analysis and the decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Afonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032489; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antolova D, 2004, VET PARASITOL, V126, P317, DOI 10.1016/j.vetpar.2004.08.005; Antolova D, 2013, J HELMINTHOL, V87, P52, DOI 10.1017/S0022149X11000848; Beste C, 2014, NEUROBIOL AGING, V35, P1037, DOI 10.1016/j.neurobiolaging.2013.11.012; Bordes F, 2015, INTEGR ZOOL, V10, P424, DOI 10.1111/1749-4877.12149; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Brunet J, 2015, J CLIN MICROBIOL, V53, P2756, DOI 10.1128/JCM.01033-15; Brunet J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-422; Charrad M, 2014, J STAT SOFTW, V61, P1; Chieffi PP, 2010, REV INST MED TROP SP, V52, P243, DOI 10.1590/S0036-46652010000500004; CUELLAR C, 1995, INT J PARASITOL, V25, P731, DOI 10.1016/0020-7519(94)00187-S; De Liberato C, 2014, PARASITOL INT, V63, P695, DOI 10.1016/j.parint.2014.05.008; Denzin N, 2014, TRANSBOUND EMERG DIS, V61, P239, DOI 10.1111/tbed.12026; Duscher GG, 2015, INT J PARASITOL-PAR, V4, P88, DOI 10.1016/j.ijppaw.2014.12.001; Eberwein P, 2013, EMERG INFECT DIS, V19, P1152, DOI 10.3201/eid1907.121114; Fichet-Calvet E, 2004, PARASITE, V11, P301, DOI 10.1051/parasite/2004113301; Finsterer J, 2013, J HELMINTHOL, V87, P257, DOI 10.1017/S0022149X12000600; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Fuehrer HP, 2010, PARASITOL RES, V107, P469, DOI 10.1007/s00436-010-1905-z; Fuhrer HP, 2010, PARASITOL RES, V106, P1001, DOI 10.1007/s00436-010-1753-x; GASSER RB, 1995, ACTA TROP, V59, P31, DOI 10.1016/0001-706X(94)00085-F; HAVASIOVA K, 1993, J HELMINTHOL, V67, P291, DOI 10.1017/S0022149X00013298; Herrmann DC, 2012, VET PARASITOL, V185, P78, DOI 10.1016/j.vetpar.2011.10.030; Ho MSY, 1996, J CLIN MICROBIOL, V34, P1203, DOI 10.1128/JCM.34.5.1203-1208.1996; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Hotez PJ, 2011, INT J INFECT DIS, V15, pE611, DOI 10.1016/j.ijid.2011.05.006; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256; Hrckova G, 2011, PARASITOLOGY, V138, P638, DOI 10.1017/S0031182011000047; Hughes JM, 2006, PARASITOLOGY, V132, P29, DOI 10.1017/S0031182005008784; Hurkova-Hofmannova L, 2014, J PARASITOL, V100, P139, DOI 10.1645/13-255.1; Ishiwata K, 2004, PARASITOL RES, V92, P50, DOI 10.1007/s00436-003-1010-7; Jin Y, 2015, J KOREAN MED SCI, V30, P549, DOI 10.3346/jkms.2015.30.5.549; Kazacos Kevin R, 2013, Handb Clin Neurol, V114, P251, DOI 10.1016/B978-0-444-53490-3.00020-0; Kunz Thomas H., 1996, P279; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Macpherson CNL, 2013, INT J PARASITOL, V43, P999, DOI 10.1016/j.ijpara.2013.07.004; Maenz M, 2014, PROG RETIN EYE RES, V39, P77, DOI 10.1016/j.preteyeres.2013.12.005; Meerburg BG, 2012, VET PARASITOL, V184, P317, DOI 10.1016/j.vetpar.2011.09.001; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Morgan ER, 2013, VET PARASITOL, V193, P390, DOI 10.1016/j.vetpar.2012.12.034; MORRIS P, 1972, Mammal Review, V2, P69, DOI 10.1111/j.1365-2907.1972.tb00160.x; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Niethammer J., 1982, HDB SAUGETIERE EUROP; Nijsse R, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1009-9; Palmer BS, 2007, SEIZURE-EUR J EPILEP, V16, P657, DOI 10.1016/j.seizure.2007.05.010; Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7; Reperant LA, 2009, PARASITOLOGY, V136, P329, DOI 10.1017/S0031182008005428; Rodriguez-Caballero A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0875-5; RYZHIKOV KM, 1978, KEY HELMINTH PARASIT; Salek M, 2015, MAMMAL REV, V45, P1, DOI 10.1111/mam.12027; Scheid R, 2008, CLIN NEUROL NEUROSUR, V110, P1054, DOI 10.1016/j.clineuro.2008.06.014; Schmidt S, 2001, UNTERSUCHUNGEN ZUM V; Schnieder T, 2011, VET PARASITOL, V175, P193, DOI 10.1016/j.vetpar.2010.10.027; Staubach C, 2001, AM J TROP MED HYG, V65, P943, DOI 10.4269/ajtmh.2001.65.943; Staubach C, 2011, VET PARASITOL, V179, P77, DOI 10.1016/j.vetpar.2011.01.065; Stieger C, 2002, PARASITOLOGY, V124, P631, DOI 10.1017/S0031182002001749; Strube C, 2013, VET PARASITOL, V193, P375, DOI 10.1016/j.vetpar.2012.12.033; Sutor A, 2014, ACTA THERIOL, V59, P49, DOI 10.1007/s13364-013-0138-9; Svobodova M, 2004, ACTA PROTOZOOL, V43, P251; Thomasson D, 2011, PARASITOLOGY, V138, P1117, DOI 10.1017/S0031182011000904; von Nickisch-Rosenegk M, 1999, J MOL EVOL, V48, P586, DOI 10.1007/PL00006501; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Walsh MG, 2012, INT J PARASITOL, V42, P1159, DOI 10.1016/j.ijpara.2012.10.002; Zahabiun F, 2015, AM J TROP MED HYG, V93, P319, DOI 10.4269/ajtmh.15-0190; Zalesny G, 2012, PARASITOL RES, V110, P1055, DOI 10.1007/s00436-011-2598-7; Zibaei M, 2016, J CLIN LAB ANAL, V30, P248, DOI 10.1002/jcla.21844	69	21	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172829	10.1371/journal.pone.0172829	http://dx.doi.org/10.1371/journal.pone.0172829			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278269	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900129
J	Jacobs, BL; McNally, RM; Kim, KJ; Blanco, R; Privett, RE; You, JS; Hornberger, TA				Jacobs, Brittany L.; McNally, Rachel M.; Kim, Kook-Joo; Blanco, Rocky; Privett, Rachel E.; You, Jae-Sung; Hornberger, Troy A.			Identification of mechanically regulated phosphorylation sites on tuberin (TSC2) that control mechanistic target of rapamycin (mTOR) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE HYPERTROPHY; MAMMALIAN TARGET; PHOSPHOINOSITIDE 3-KINASE; ECCENTRIC CONTRACTIONS; PHOSPHATIDIC-ACID; TSC1-TSC2 COMPLEX; SCLEROSIS COMPLEX; 14-3-3 PROTEINS; GENE-PRODUCT; OLDER-ADULTS	Mechanistic target of rapamycin (mTOR) signaling is necessary to generate a mechanically induced increase in skeletal muscle mass, but the mechanism(s) through which mechanical stimuli regulate mTOR signaling remain poorly defined. Recent studies have suggested that Ras homologue enriched in brain (Rheb), a direct activator of mTOR, and its inhibitor, the GTPase-activating protein tuberin (TSC2), may play a role in this pathway. To address this possibility, we generated inducible and skeletal muscle-specific knock-out mice for Rheb (iRhebKO) and TSC2 (iTSC2KO) and mechanically stimulated muscles from these mice with eccentric contractions (EC). As expected, the knock-out of TSC2 led to an elevation in the basal level of mTOR signaling. Moreover, we found that the magnitude of the EC-induced activation of mTOR signaling was significantly blunted in muscles from both inducible and skeletal muscle-specific knock-out mice for Rheb and iTSC2KO mice. Using mass spectrometry, we identified six sites on TSC2 whose phosphorylation was significantly altered by the EC treatment. Employing a transient transfection-based approach to rescue TSC2 function in muscles of the iTSC2KO mice, we demonstrated that these phosphorylation sites are required for the role that TSC2 plays in the EC-induced activation of mTOR signaling. Importantly, however, these phosphorylation sites were not required for an insulin-induced activation of mTOR signaling. As such, our results not only establish a critical role for Rheb and TSC2 in the mechanical activation of mTOR signaling, but they also expose the existence of a previously unknown branch of signaling events that can regulate the TSC2/mTOR pathway.	[Jacobs, Brittany L.; McNally, Rachel M.; Kim, Kook-Joo; Blanco, Rocky; Privett, Rachel E.; You, Jae-Sung; Hornberger, Troy A.] Univ Wisconsin Madison, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA; [Jacobs, Brittany L.; McNally, Rachel M.; Kim, Kook-Joo; Blanco, Rocky; Privett, Rachel E.; You, Jae-Sung; Hornberger, Troy A.] Univ Wisconsin Madison, Sch Vet Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hornberger, TA (corresponding author), Univ Wisconsin Madison, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA.	troy.hornberger@wisc.edu	You, Jae-Sung/ABF-6763-2020	You, Jae-Sung/0000-0001-7791-8563	NIAMS; National Institutes of Health [AR057347]; Department of Defense [W81XWH-14-1-0105]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health Grant AR057347 and Department of Defense Grant W81XWH-14-1-0105 (to T. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apro W, 2015, FASEB J, V29, P4358, DOI 10.1096/fj.15-273474; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Frey JW, 2014, CELL SIGNAL, V26, P313, DOI 10.1016/j.cellsig.2013.11.009; GOLDBERG AL, 1975, MED SCI SPORT EXER, V7, P185; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Hall MN, 2013, BIOCHEM SOC T, V41, P887, DOI 10.1042/BST20130092; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Hornberger TA, 2011, INT J BIOCHEM CELL B, V43, P1267, DOI 10.1016/j.biocel.2011.05.007; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hurley BF, 2011, SPORTS MED, V41, P289, DOI 10.2165/11585920-000000000-00000; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jacobs BL, 2014, J MUSCLE RES CELL M, V35, P11, DOI 10.1007/s10974-013-9367-4; Jacobs BL, 2013, J PHYSIOL-LONDON, V591, P4611, DOI 10.1113/jphysiol.2013.256339; Langlais P, 2010, J AM SOC MASS SPECTR, V21, P1490, DOI 10.1016/j.jasms.2010.05.009; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Miyazaki M, 2010, FEBS J, V277, P2180, DOI 10.1111/j.1742-4658.2010.07635.x; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Pahor M, 1998, J Nutr Health Aging, V2, P97; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Seguin R, 2003, AM J PREV MED, V25, P141, DOI 10.1016/S0749-3797(03)00177-6; Srikanthan P, 2014, AM J MED, V127, P547, DOI 10.1016/j.amjmed.2014.02.007; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; You JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047258; You JS, 2014, J BIOL CHEM, V289, P1551, DOI 10.1074/jbc.M113.531392; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhang YJ, 2015, EBIOMEDICINE, V2, P1944, DOI 10.1016/j.ebiom.2015.11.031; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	61	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6987	6997		10.1074/jbc.M117.777805	http://dx.doi.org/10.1074/jbc.M117.777805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28289099	hybrid, Green Published			2022-12-26	WOS:000400478300011
J	Chiu, HW; Chen, CH; Chen, YJ; Hsu, YH				Chiu, Hui-Wen; Chen, Cheng-Hsien; Chen, Yi-Jie; Hsu, Yung-Ho			Far-infrared suppresses skin photoaging in ultraviolet B-exposed fibroblasts and hairless mice	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; AUTOPHAGY; MTOR; CANCER; KERATINOCYTES; INHIBITION; ACTIVATION; RADIATION; APOPTOSIS; CELLS	Ultraviolet (UV) induces skin photoaging, which is characterized by thickening, wrinkling, pigmentation, and dryness. Collagen, which is one of the main building blocks of human skin, is regulated by collagen synthesis and collagen breakdown. Autophagy was found to block the epidermal hyperproliferative response to UVB and may play a crucial role in preventing skin photoaging. In the present study, we investigated whether far-infrared (FIR) therapy can inhibit skin photoaging via UVB irradiation in NIH 3T3 mouse embryonic fibroblasts and SKH-1 hairless mice. We found that FIR treatment significantly increased procollagen type I through the induction of the TGF-beta/Smad axis. Furthermore, UVB significantly enhanced the expression of matrix metalloproteinase-1 (MMP-1) and MMP-9. FIR inhibited UVB-induced MMP-1 and MMP-9. Treatment with FIR reversed UVB-decreased type I collagen. In addition, FIR induced autophagy by inhibiting the Akt/mTOR signaling pathway. In UVB-induced skin photoaging in a hairless mouse model, FIR treatment resulted in decreased skin thickness in UVB irradiated mice and inhibited the degradation of collagen fibers. Moreover, FIR can increase procollagen type I via the inhibition of MMP-9 and induction of TGF-beta in skin tissues. Therefore, our study provides evidence for the beneficial effects of FIR exposure in a model of skin photoaging.	[Chiu, Hui-Wen; Chen, Cheng-Hsien; Chen, Yi-Jie; Hsu, Yung-Ho] Taipei Med Univ, Shuang Ho Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan; [Chiu, Hui-Wen] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chen, Cheng-Hsien] Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Chen, Cheng-Hsien; Hsu, Yung-Ho] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Hsu, YH (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan.; Hsu, YH (corresponding author), Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan.	yhhsu@tmu.edu.tw			Taipei Medical University-Shuang Ho Hospital [105TMU-SHH-12]; Ministry of Science and Technology, Taiwan [MOST 105-2320-B-038-021-MY3]	Taipei Medical University-Shuang Ho Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Taipei Medical University-Shuang Ho Hospital (105TMU-SHH-12) and the Ministry of Science and Technology, Taiwan (MOST 105-2320-B-038-021-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridgeman BB, 2016, CELL SIGNAL, V28, P460, DOI 10.1016/j.cellsig.2016.02.008; Capon A, 2003, AM J CLIN DERMATOL, V4, P1, DOI 10.2165/00128071-200304010-00001; Carr TD, 2012, CANCER PREV RES, V5, P1394, DOI 10.1158/1940-6207.CAPR-12-0272-T; Chang JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30436; Chen CH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40442; Chen YC, 2012, J PHOTOCH PHOTOBIO B, V106, P61, DOI 10.1016/j.jphotobiol.2011.10.006; Chiu HW, 2016, J MOL MED, V94, P809, DOI 10.1007/s00109-016-1389-0; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Cimino F, 2007, BIOFACTORS, V30, P129, DOI 10.1002/biof.5520300206; Einspahr JG, 2012, CANCER PREV RES, V5, P403, DOI 10.1158/1940-6207.CAPR-11-0427; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; FLEISCHMAJER R, 1988, J HISTOCHEM CYTOCHEM, V36, P1425, DOI 10.1177/36.11.3049791; Hendershot LM, 2000, CURR BIOL, V10, pR912, DOI 10.1016/S0960-9822(00)00850-2; Hsu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030674; INOUE S, 1989, INT J BIOMETEOROL, V33, P145, DOI 10.1007/BF01084598; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Kim MA, 2009, ONCOGENE, V28, P1241, DOI 10.1038/onc.2008.487; Leung TK, 2011, J MED BIOL ENG, V31, P345, DOI 10.5405/jmbe.777; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003; Park WH, 2013, ONCOL LETT, V5, P1633, DOI 10.3892/ol.2013.1216; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Thomes PG, 2016, INT J BIOCHEM CELL B, V81, P137, DOI 10.1016/j.biocel.2016.11.007; Toyokawa H, 2003, EXP BIOL MED, V228, P724, DOI 10.1177/153537020322800612; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wang HW, 2016, PLOS ONE, V11; Wang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18987; Wang M, 2012, AGING CELL, V11, P668, DOI 10.1111/j.1474-9726.2012.00833.x; WEISS JS, 1988, JAMA-J AM MED ASSOC, V259, P527, DOI 10.1001/jama.259.4.527; Yang YH, 2013, APOPTOSIS, V18, P1363, DOI 10.1007/s10495-013-0867-x; Yu SY, 2006, PHOTODERMATOL PHOTO, V22, P78, DOI 10.1111/j.1600-0781.2006.00208.x; Zhang JA, 2016, MIR 23A DEPRESSED AU	40	20	21	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174042	10.1371/journal.pone.0174042	http://dx.doi.org/10.1371/journal.pone.0174042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301572	Green Submitted, gold, Green Published			2022-12-26	WOS:000396318300117
J	Franceschi, S; Lessi, F; Panebianco, F; Tantillo, E; La Ferla, M; Menicagli, M; Aretini, P; Apollo, A; Naccarato, AG; Marchetti, I; Mazzanti, CM				Franceschi, Sara; Lessi, Francesca; Panebianco, Federica; Tantillo, Elena; La Ferla, Marco; Menicagli, Michele; Aretini, Paolo; Apollo, Alessandro; Naccarato, Antonio Giuseppe; Marchetti, Ivo; Mazzanti, Chiara Maria			Loss of c-KIT expression in thyroid cancer cells	PLOS ONE			English	Article							CARCINOMA; MUTATIONS; RECEPTOR; TUMORS; RECURRENCE; NEOPLASMS; DIAGNOSIS; CYTOLOGY; PATHWAY; NODULES	Papillary thyroid carcinoma is the most frequent histologic type of thyroid tumor. Few studies investigated the role of c-KIT expression in thyroid tumors, suggesting a role for this receptor and its ligand in differentiation and growth control of thyroid epithelium and a receptor loss following malignant transformation. We investigated and correlated c-KIT expression levels and two known markers of thyrocytes differentiation, PAX8 and TTF-1, in malignant and benign cytological thyroid samples. Moreover, we performed functional studies on human papillary thyroid carcinoma cell line to associated c-KIT expression to thyrocytes differentiation and tumor proliferation. c-KIT and PAX8 expression resulted higher in benign samples compared to the malignant ones, and the expression levels of these two genes were significantly correlated to each other. We also observed that c-KIT overexpression led to an increase of PAX8 expression level together with a decrease of proliferation. Furthermore, c-KIT overexpressing cells showed a regression of typical morphological features of malignancy. Taken together these results suggest that c-KIT could be involved in the differentiation of thyroid cells and in tumor progression.	[Franceschi, Sara; Lessi, Francesca; Tantillo, Elena; La Ferla, Marco; Menicagli, Michele; Aretini, Paolo; Mazzanti, Chiara Maria] FPS Pisa Sci Fdn, Pisa, Italy; [Panebianco, Federica; Apollo, Alessandro; Naccarato, Antonio Giuseppe; Marchetti, Ivo] Univ Hosp Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Panebianco, Federica] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Apollo, Alessandro] Ist Toscano Tumori, Core Res Lab, Florence, Italy	University of Pisa; Azienda Ospedaliero Universitaria Pisana; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Franceschi, S (corresponding author), FPS Pisa Sci Fdn, Pisa, Italy.	s.franceschi@fpscience.it	Mazzanti, Chiara/AAX-6539-2021; Lessi, Francesca/AAE-6812-2022; Aretini, Paolo/AAF-1205-2020	Lessi, Francesca/0000-0002-3346-4296; Aretini, Paolo/0000-0003-1075-4319; Franceschi, Sara/0000-0002-4246-4407; Panebianco, Federica/0000-0003-2301-7916				Broecker-Preuss M, 2008, HORM METAB RES, V40, P685, DOI 10.1055/s-2008-1080895; Chen EC, 2015, GASTROENTEROLOGY, V149, P705, DOI 10.1053/j.gastro.2015.05.042; Chitikova Z, 2015, ONCOTARGET, V6, P10978, DOI 10.18632/oncotarget.3452; Czarniecka A, 2016, GLAND SURG, V5, P495, DOI 10.21037/gs.2016.09.09; Dahl C, 2015, J INVEST DERMATOL, V135, P516, DOI 10.1038/jid.2014.372; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Doddi S, 2015, G CHIR, V36, P122, DOI 10.11138/gchir/2015.36.3.122; Fabbri M, 2009, CARCINOGENESIS, V30, P912, DOI 10.1093/carcin/bgp063; Fernandez LP, 2015, NAT REV ENDOCRINOL, V11, P29, DOI 10.1038/nrendo.2014.186; Guerra A, 2014, THYROID, V24, P254, DOI 10.1089/thy.2013.0235; Hajmanoochehri F, 2015, J CYTOL, V32, P238, DOI 10.4103/0970-9371.171234; Kwon H, 2016, ENDOCRINOL METAB, V31, P586, DOI 10.3803/EnM.2016.31.4.586; Lau ST, 2015, ONCOGENE, V34, P1019, DOI 10.1038/onc.2014.24; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Matsumura Y, 2015, J CANCER RES CLIN, V141, P2159, DOI 10.1007/s00432-015-1989-z; Mazzanti C, 2004, CANCER RES, V64, P2898, DOI 10.1158/0008-5472.CAN-03-3811; Miettinen M, 2000, MODERN PATHOL, V13, P536, DOI 10.1038/modpathol.3880093; Murakawa T, 2005, PATHOL INT, V55, P757, DOI 10.1111/j.1440-1827.2005.01902.x; NATALI PG, 1995, CANCER RES, V55, P1787; Nonaka D, 2008, MODERN PATHOL, V21, P192, DOI 10.1038/modpathol.3801002; Panebianco F, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1917-2; Pusztaszeri MP, 2014, CANCER CYTOPATHOL, V122, P596, DOI 10.1002/cncy.21437; Rago T, 2014, J CLIN ENDOCR METAB, V99, P3700, DOI 10.1210/jc.2013-4401; Rizzo FM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2111-x; Sanlorenzo M, 2016, J PROTEOMICS, V144, P140, DOI 10.1016/j.jprot.2016.05.019; Sehitoglu I, 2016, AN BRAS DERMATOL, V91, P430, DOI 10.1590/abd1806-4841.20164331; TANAKA T, 1995, ENDOCR J, V42, P723, DOI 10.1507/endocrj.42.723; Tomei S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-7; Tramm T, 2016, VIRCHOWS ARCH, V469, P285, DOI 10.1007/s00428-016-1966-1; Yamashita AS, 2013, TRANSL ONCOL, V6, P197, DOI 10.1593/tlo.12442; Yu GP, 2016, ONCOL REP, V36, P1626, DOI 10.3892/or.2016.4963; Zou MJ, 2014, THYROID, V24, P1256, DOI 10.1089/thy.2013.0610	32	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173913	10.1371/journal.pone.0173913	http://dx.doi.org/10.1371/journal.pone.0173913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301608	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300093
J	Stothers, L; Macnab, AJ; Bajunirwe, F; Mutabazi, S; Berkowitz, J				Stothers, Lynn; Macnab, Andrew J.; Bajunirwe, Francis; Mutabazi, Sharif; Berkowitz, Jonathan			Associations between the severity of obstructive lower urinary tract symptoms and care-seeking behavior in rural Africa: A cross-sectional survey from Uganda	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; QUALITY-OF-LIFE; INDEX; MEN	Study type A cross sectional survey. Background Global estimates indicate that by 2018 2.3 billion individuals worldwide will suffer from lower urinary tract symptoms (LUTS), with 1.1 billion having LUTS related to bladder outlet obstruction (BOO). Left untreated BOO in men causes irreversible changes to the urinary tract leading to urinary retention, the need for catheterization, renal failure and even death. Estimates suggest that Africa will be one of the continents with the greatest increase in (LUTS) by 2018 however direct measures in Africa are lacking. The objectives were to: (1) measure of prevalence of LUTS/BOO in a community-based sample of men in Africa, (2) compare community-based LUTS/BOO frequency to those seeking care for LUTS in a local clinic (3) quantify bother, interference with daily living, worry and quality of life related to LUTS/BOO between community and clinic settings and (4) examine relationships between socioeconomic and demographics related to LUTS/BOO. Methods and findings 473 men from a rural Ugandan community (238 residents living with their symptoms and 177 presenting at a clinic for care) completed the International Prostate Symptom Scale (IPSS) and a 53-item validated LUTS symptom, bother and quality of life index. Severity of symptoms was categorized based on reference ranges for mild, moderate and severe levels of the IPSS, comparing those in the community versus those seeking care for symptoms. IPSS indicated that 55.9% of men in the community versus 17.5% of those at the clinic had mild symptoms, 31.5% in the community versus 52.5% of those at the clinic had moderate symptoms and 12.6% of those in the community versus 29.9% of those at the clinic had severe symptoms (p< 0.001). Men seeking care for LUTS/BOO had a lower quality of life (p< 0.05), were more bothered by their urinary symptoms (p< 0.05), had more interference with daily activity and worry (p< 0.05) but this did not have an impact on their general sense of wellbeing. Conclusions The burden of disease of LUTS/BOO in this rural African cohort is high and significantly higher among those seeking care due to the bother of their symptoms. One in 4 men will spend money for transport to clinic due to LUTS/BOO despite low economic resources. Educational tools for patients structured to the level of literacy are justified.	[Stothers, Lynn; Macnab, Andrew J.] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada; [Stothers, Lynn] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Stothers, Lynn] Univ British Columbia, ICORD, Vancouver, BC, Canada; [Macnab, Andrew J.] Wallenberg Res Ctr, Stellenbosch Inst Adv Study, Stellenbosch, South Africa; [Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Mutabazi, Sharif] Cure Med Ctr Ishaka, Hlth & Dev Agcy HEADA, Ishaka, Uganda; [Berkowitz, Jonathan] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Berkowitz, Jonathan] Univ British Columbia, Sauder Sch Business, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Stellenbosch University; Mbarara University of Science & Technology; University of British Columbia; University of British Columbia	Stothers, L (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada.; Stothers, L (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Stothers, L (corresponding author), Univ British Columbia, ICORD, Vancouver, BC, Canada.	lynns@mail.ubc.ca			Grand Challenges Canada Stars in Global Health program [0382-01]	Grand Challenges Canada Stars in Global Health program	This study was made possible through a competitive grant from Grand Challenges Canada Stars in Global Health program: award number 0382-01.	[Anonymous], 2010, AM UROLOGIC ASS GUID; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BOSCH JLHR, 1995, BRIT J UROL, V75, P622, DOI 10.1111/j.1464-410X.1995.tb07421.x; Boyle P, 1996, J UROLOGY, V155, P176, DOI 10.1016/S0022-5347(01)66587-X; Diener E, 2012, AM PSYCHOL, V67, P590, DOI 10.1037/a0029541; EPSTEIN RS, 1992, J CLIN EPIDEMIOL, V45, P1431, DOI 10.1016/0895-4356(92)90205-2; Fowke JH, 2011, J GEN INTERN MED, V26, P1305, DOI 10.1007/s11606-011-1776-8; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Latz I, 2013, WORLD J UROL, V31, P673, DOI 10.1007/s00345-012-0937-7; MacDonald D, 2003, DRUGS, V63, P1947, DOI 10.2165/00003495-200363180-00004; Pinto JDO, 2015, J CLIN NURS, V24, P511, DOI 10.1111/jocn.12636; SAGNIER PP, 1994, J UROLOGY, V151, P1266, DOI 10.1016/S0022-5347(17)35229-1; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141	13	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173631	10.1371/journal.pone.0173631	http://dx.doi.org/10.1371/journal.pone.0173631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301527	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300056
J	Ito, K; Nakajima, A; Fukushima, Y; Suzuki, K; Sakamoto, K; Hamazaki, Y; Ogasawara, K; Minato, N; Hattori, M				Ito, Koyu; Nakajima, Akira; Fukushima, Yuji; Suzuki, Keiichiro; Sakamoto, Keiko; Hamazaki, Yoko; Ogasawara, Kouetsu; Minato, Nagahiro; Hattori, Masakazu			The potential role of Osteopontin in the maintenance of commensal bacteria homeostasis in the intestine	PLOS ONE			English	Article							MEMORY T-CELLS; INNATE IMMUNE-RESPONSE; INTRAEPITHELIAL LYMPHOCYTES; PEYERS-PATCHES; GUT MICROBIOTA; IGA SYNTHESIS; CRUCIAL ROLE; EXPRESSION; PROGRESSION; INFECTION	Osteopontin (Opn), a multifunctional extracellular matrix protein, is implicated in the pathogenesis of various inflammatory disorders. Under physiologic conditions, its expression is restricted to certain tissues including bone and kidney tubule. However, cellular activation during disease development induces Opn expression in various immune cells. In this study, using Opn-EGFP knock-in (KI) mice we found that CD8 alpha(+) T cells in the intestinal tissues, including Peyer's patch, lamina propria and epithelium, express Opn under steady state conditions. Therefore, we examined the role of Opn-expressing CD8 alpha(+) T cells in intestinal homeostasis. Interestingly, Opn knockout (KO) mice had altered fecal microflora concordant with a reduction of TCR gamma delta(+) intraepithelial lymphocytes (IELs). Consistent with this result, both treatment with anti-Opn blocking antibody and deficiency of Opn resulted in decreased survival of TCR gamma delta(+) and TCR alpha beta(+) IELs. This data suggests that a possibility that Opn may function as a survival factor for IELs in the intestinal tissue. Collectively, these data suggest the possibility that Opn might regulate the homeostasis of intestinal microflora through maintenance of TCR gamma delta(+) IELs, possibly by support of IEL survival.	[Ito, Koyu; Nakajima, Akira; Fukushima, Yuji; Suzuki, Keiichiro; Hattori, Masakazu] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan; [Ito, Koyu; Ogasawara, Kouetsu] Tohoku Univ, Dept Immunobiol, Inst Dev Ageing & Canc, Aoba Ku, Sendai, Miyagi, Japan; [Sakamoto, Keiko; Hamazaki, Yoko; Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan	Kyoto University; Tohoku University; Kyoto University	Ito, K; Hattori, M (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.; Ito, K (corresponding author), Tohoku Univ, Dept Immunobiol, Inst Dev Ageing & Canc, Aoba Ku, Sendai, Miyagi, Japan.	koyu.ito.c6@tohoku.ac.jp; hattori@ak.med.kyoto-u.ac.jp	Ito, Koyu/CAH-5669-2022; Hamazaki, Y*/Q-3076-2019	Hamazaki, Y*/0000-0001-5866-7340	Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Japan Societies for the Promotion of Sciences [15K19075]; Grants-in-Aid for Scientific Research [24111008] Funding Source: KAKEN	Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Japan Societies for the Promotion of Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported from grants from Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program and from Japan Societies for the Promotion of Sciences, Grant-in-Aid for Young Scientists (B) (Grant Number: 15K19075 to K. I. https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K19075/). Publication of this article was approved by an intellectual property committee composed of representatives from Kyoto University and Astellas Pharma Inc. The funders had no role in study design, data collection and analysis, decision to publish.	Beura LK, 2014, CELL, V157, P1488, DOI 10.1016/j.cell.2014.05.026; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chagan-Yasutan H, 2014, THROMB RES, V134, P449, DOI 10.1016/j.thromres.2014.05.003; CHEN JK, 1993, MATRIX, V13, P113, DOI 10.1016/S0934-8832(11)80070-3; Chen Q, 2014, STEM CELLS, V32, P327, DOI 10.1002/stem.1567; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Daft JG, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0080-y; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gerard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; Hamamoto S, 2011, J BONE MINER RES, V26, P2967, DOI 10.1002/jbmr.495; Heilmann K, 2009, J CELL MOL MED, V13, P1162, DOI 10.1111/j.1582-4934.2008.00428.x; Holm E, 2014, BIOCHEM J, V464, P355, DOI 10.1042/BJ20140702; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kourepini E, 2014, P NATL ACAD SCI USA, V111, pE856, DOI 10.1073/pnas.1316447111; LAGOO AS, 1994, EUR J IMMUNOL, V24, P3087, DOI 10.1002/eji.1830241226; Lai YK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03009; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; Leavenworth JW, 2015, P NATL ACAD SCI USA, V112, P494, DOI 10.1073/pnas.1423011112; Liaw L, 1997, ARTERIOSCL THROM VAS, V17, P188, DOI 10.1161/01.ATV.17.1.188; Liaw L, 1998, J CLIN INVEST, V101, P1468; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Lycke NY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00329; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Oz HS, 2012, DIGEST DIS SCI, V57, P1554, DOI 10.1007/s10620-011-2009-z; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Shitara S, 2013, J IMMUNOL, V190, P6173, DOI 10.4049/jimmunol.1202573; Suzuki K, 2014, INT IMMUNOL, V26, P489, DOI 10.1093/intimm/dxu059; Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319; Thelemann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086844; van der Windt GJW, 2011, J INFECT DIS, V203, P1850, DOI 10.1093/infdis/jir185; Zhong J, 2006, INFLAMM BOWEL DIS, V12, P790, DOI 10.1097/00054725-200608000-00015	42	10	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173629	10.1371/journal.pone.0173629	http://dx.doi.org/10.1371/journal.pone.0173629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296922	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700047
J	Noel, SJ; Attwood, GT; Rakonjac, J; Moon, CD; Waghorn, GC; Janssen, PH				Noel, Samantha J.; Attwood, Graeme T.; Rakonjac, Jasna; Moon, Christina D.; Waghorn, Garry C.; Janssen, Peter H.			Seasonal changes in the digesta-adherent rumen bacterial communities of dairy cattle grazing pasture	PLOS ONE			English	Article							RUMINAL CELLULOLYTIC BACTERIA; DIVERSITY; DIET; POPULATION; MICROBIOME; DILUTION; ECOLOGY; COWS	The complex microbiota that resides within the rumen is responsible for the break-down of plant fibre. The bacteria that attach to ingested plant matter within the rumen are thought to be responsible for initial fibre degradation. Most studies examining the ecology of this important microbiome only offer a 'snapshot' in time. We monitored the diversity of rumen bacteria in four New Zealand dairy cows, grazing a rye-grass and clover pasture over five consecutive seasons, using high throughput pyrosequencing of bacterial 16S rRNA genes. We chose to focus on the digesta-adherent bacterial community to learn more about the stability of this community over time. 16S rRNA gene sequencing showed a high level of bacterial diversity, totalling 1539 operational taxonomic units (OTUs, grouped at 96% sequence similarity) across all samples, and ranging from 653 to 926 OTUs per individual sample. The nutritive composition of the pasture changed with the seasons as did the production phase of the animals. Sequence analysis showed that, overall, the bacterial communities were broadly similar between the individual animals. The adherent bacterial community was strongly dominated by members of Firmicutes (82.1%), followed by Bacteroidetes (11.8%). This community differed between the seasons, returning to close to that observed in the same season one year later. These seasonal differences were only small, but were statistically significant (p < 0.001), and were probably due to the seasonal differences in the diet. These results demonstrate a general invariability of the ruminal bacterial community structure in these grazing dairy cattle.	[Noel, Samantha J.; Attwood, Graeme T.; Moon, Christina D.; Janssen, Peter H.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand; [Noel, Samantha J.; Rakonjac, Jasna] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Noel, Samantha J.] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Waghorn, Garry C.] DairyNZ, Hamilton, New Zealand	AgResearch - New Zealand; Massey University; Aarhus University; DairyNZ	Noel, SJ (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand.; Noel, SJ (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.; Noel, SJ (corresponding author), Aarhus Univ, Dept Anim Sci, Tjele, Denmark.	Samantha.noel@anis.au.dk	Rakonjac, Jasna V/E-6836-2011; Noel, Samantha/AAM-4090-2021	Rakonjac, Jasna V/0000-0002-6756-4682; Noel, Samantha Joan/0000-0003-4529-9598; Moon, Christina/0000-0001-9692-9559	New Zealand Ministry of Business, Innovation and Employment [C10X0803]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was supported by the New Zealand Ministry of Business, Innovation and Employment New Economy Research Fund (contract C10X0803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2005, ANAEROBE, V11, P207, DOI 10.1016/j.anaerobe.2005.02.001; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Corson D. C., 1999, Proceedings of the New Zealand Grassland Association, V61, P127; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Gado HM, 2009, ANIM FEED SCI TECH, V154, P36, DOI 10.1016/j.anifeedsci.2009.07.006; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jami E, 2012, ANAEROBE, V18, P338, DOI 10.1016/j.anaerobe.2012.04.003; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Jewell KA, 2015, APPL ENVIRON MICROB, V81, P4697, DOI 10.1128/AEM.00720-15; Kenters N, 2011, J MICROBIOL METH, V84, P52, DOI 10.1016/j.mimet.2010.10.011; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Kocherginskaya SA, 2001, ANAEROBE, V7, P119, DOI 10.1006/anae.2001.0378; Koike S, 2003, J DAIRY SCI, V86, P1429, DOI 10.3168/jds.S0022-0302(03)73726-6; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machado CF, 2005, NEW ZEAL J AGR RES, V48, P265, DOI 10.1080/00288233.2005.9513655; McEwan NR, 2005, LETT APPL MICROBIOL, V41, P97, DOI 10.1111/j.1472-765X.2005.01707.x; Oksanen J., 2007, COMMUN ECOL PACK, P631; Pinheiro J, R PACKAGE VERSION; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramsak A, 2000, FEMS MICROBIOL ECOL, V33, P69, DOI 10.1111/j.1574-6941.2000.tb00728.x; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tajima K, 2000, ANAEROBE, V6, P273, DOI 10.1006/anae.2000.0353; Tajima K, 2007, ANAEROBE, V13, P57, DOI 10.1016/j.anaerobe.2006.12.001; Uyeno Y, 2009, ANAEROBE; Waghorn GC, 2007, OCCASIONAL PUBLICATI, V14, P35; Wanapat M, 2009, ANIM FEED SCI TECH, V151, P205, DOI 10.1016/j.anifeedsci.2009.01.017; WEIMER PJ, 1993, ARCH MICROBIOL, V160, P288, DOI 10.1007/BF00292079; Weimer PJ, 1999, J DAIRY SCI, V82, P122, DOI 10.3168/jds.S0022-0302(99)75216-1; Welkie DG, 2010, ANAEROBE, V16, P94, DOI 10.1016/j.anaerobe.2009.07.002; Wu S., 2012, METAGENOMICS, V1, P1	47	26	28	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173819	10.1371/journal.pone.0173819	http://dx.doi.org/10.1371/journal.pone.0173819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296930	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700069
J	Pages-Monteiro, L; Marti, R; Commun, C; Alliot, N; Bardel, C; Meugnier, H; Perouse-de-Montclos, M; Reix, P; Durieu, I; Durupt, S; Vandenesch, F; Freney, J; Cournoyer, B; Doleans-Jordheim, A				Pages-Monteiro, Laurence; Marti, Romain; Commun, Carine; Alliot, Nolwenn; Bardel, Claire; Meugnier, Helene; Perouse-de-Montclos, Michele; Reix, Philippe; Durieu, Isabelle; Durupt, Stephane; Vandenesch, Francois; Freney, Jean; Cournoyer, Benoit; Doleans-Jordheim, Anne			Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; STAPHYLOCOCCUS-AUREUS; MICROBIAL DIVERSITY; AIRWAY MICROBIOTA; STENOTROPHOMONAS-MALTOPHILIA; YOUNG-CHILDREN; LUNG-FUNCTION; COMMUNITIES; INFECTIONS; RESISTANCE	Cystic fibrosis (CF) lungs harbor a complex community of interacting microbes, including pathogens like Pseudomonas aeruginosa. Meta-taxogenomic analysis based on V5-V6 rrs PCR products of 52 P. aeruginosa-positive (Pp) and 52 P. aeruginosa-negative (Pn) pooled DNA extracts from CF sputa suggested positive associations between P. aeruginosa and Stenotrophomonas and Prevotella, but negative ones with Haemophilus, Neisseria and Burkholderia. Internal Transcribed Spacer analyses (RISA) from individual DNA extracts identified three significant genetic structures within the CF cohorts, and indicated an impact of P. aeruginosa. RISA clusters Ip and IIIp contained CF sputa with a P. aeruginosa prevalence above 93%, and of 24.2% in cluster IIp. Clusters Ip and IIIp showed lower RISA genetic diversity and richness than IIp. Highly similar cluster IIp RISA profiles were obtained from two patients harboring isolates of a same P. aeruginosa clone, suggesting convergent evolution in the structure of their microbiota. CF patients of cluster IIp had received significantly less antibiotics than patients of clusters Ip and IIIp but harbored the most resistant P. aeruginosa strains. Patients of cluster IIIp were older than those of Ip. The effects of P. aeruginosa on the RISA structures could not be fully dissociated from the above two confounding factors but several trends in these datasets support the conclusion of a strong incidence of P. aeruginosa on the genetic structure of CF lung microbiota.	[Pages-Monteiro, Laurence; Marti, Romain; Commun, Carine; Alliot, Nolwenn; Freney, Jean; Cournoyer, Benoit; Doleans-Jordheim, Anne] Univ Lyon 1, UMR CNRS Ecol Microbienne 5557, Equipe Rech Bacteries Pathogenes Opportunistes &, Villeurbanne, France; [Pages-Monteiro, Laurence; Marti, Romain; Commun, Carine; Alliot, Nolwenn; Freney, Jean; Cournoyer, Benoit; Doleans-Jordheim, Anne] VetAgro Sup, Villeurbanne, France; [Pages-Monteiro, Laurence; Vandenesch, Francois; Freney, Jean; Doleans-Jordheim, Anne] Hosp Civils Lyon HCL, Ctr Biol & Pathol Est, Lab Bacteriol, Bron, France; [Bardel, Claire] Univ Lyon 1, Equipe Rech, UMR CNRS 5558, INRA,INRIA,Lab Biometrie & Biol Evolut, Lyon, France; [Bardel, Claire] ISPB, Lyon, France; [Meugnier, Helene] Univ Lyon, Ecole Normale Super Lyon, INSERM, CIRI,Int Ctr Infectiol Res,CNRS UMR5308,U1111, Lyon, France; [Perouse-de-Montclos, Michele] Hosp Civils Lyon, Lab Bacteriol, St Genis Laval, France; [Perouse-de-Montclos, Michele; Durieu, Isabelle; Durupt, Stephane] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Ressources & Competences CRCM Adulte, Pierre Benite, France; [Reix, Philippe] Hosp Civils Lyon, Ctr Ressources & Competences CRCM Enfant, Hop Femme Mere Enfant, Lyon, France; [Vandenesch, Francois] INSERM, U851, Equipe Rech Pathogenie Staphylocoques, Bron, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); INRAE; Inria; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Doleans-Jordheim, A (corresponding author), Univ Lyon 1, UMR CNRS Ecol Microbienne 5557, Equipe Rech Bacteries Pathogenes Opportunistes &, Villeurbanne, France.; Doleans-Jordheim, A (corresponding author), VetAgro Sup, Villeurbanne, France.; Doleans-Jordheim, A (corresponding author), Hosp Civils Lyon HCL, Ctr Biol & Pathol Est, Lab Bacteriol, Bron, France.	anne.doleans-jordheim@univ-lyon1.fr	Marti, Romain/F-5645-2014; Vandenesch, Francois/C-7209-2014	Marti, Romain/0000-0002-2887-2201; Vandenesch, Francois/0000-0001-9412-7106	ONG Vaincre la Mucoviscidose; Association Gregory Lemarchal; ONG soroptimist european club; french GDR (Group de recherche) Pseudomonas; CNRS; Universite Lyon 1; VetAgro Sup	ONG Vaincre la Mucoviscidose; Association Gregory Lemarchal; ONG soroptimist european club; french GDR (Group de recherche) Pseudomonas; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Lyon 1; VetAgro Sup	The author received funding from ONG Vaincre la Mucoviscidose and the Association Gregory Lemarchal, from ONG soroptimist european club, french GDR (Group de recherche) Pseudomonas, CNRS, Universite Lyon 1, and VetAgro Sup. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge LP Jordheim for assistance with the preparation of the manuscript. We acknowledge the ONG VLM (Vaincre la mucoviscidose) and the association Gregory Lemarchal. Thanks are expressed to GDR Pseudomonas, and funding from CNRS, Universite Lyon 1 and VetAgro Sup. We acknowledge all members of the ONG Soroptimist International Europe club for financial contribution.	Adabi M, 2015, INFECT CHEMOTHER, V47, P98, DOI 10.3947/ic.2015.47.2.98; Ahlgren HG, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0062-7; [Anonymous], 2015, R LANG ENV STAT COMP; Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614; Ballmann M, 1998, THORAX, V53, P732, DOI 10.1136/thx.53.9.732; Barnabie PM, 2015, J BACTERIOL, V197, P2250, DOI 10.1128/JB.00303-15; Beaume M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00321; Birtel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125356; Bonnet R, 2014, A A, P325; Brady C, 2014, J CYST FIBROS, V13, P43, DOI 10.1016/j.jcf.2013.08.002; Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Colinon C, 2010, ENVIRON MICROBIOL, V12, P716, DOI 10.1111/j.1462-2920.2009.02115.x; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cuthbertson L, 2015, ISME J; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Davenport CF, 2013, ENVIRON MICROBIOL, V15, P1, DOI 10.1111/j.1462-2920.2012.02843.x; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Flight WG, 2015, J CLIN MICROBIOL, V53, P2022, DOI 10.1128/JCM.00432-15; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gibson RL, 2003, AM J RESP CRIT CARE, V167, P841, DOI 10.1164/rccm.200208-855OC; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Goeminne PC, 2015, J CYST FIBROS; Goss CH, 2004, THORAX, V59, P955, DOI 10.1136/thx.2003.017707; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hewson I, 2006, MICROB ECOL, V51, P147, DOI 10.1007/s00248-005-0144-9; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Ishii S, 2009, J MICROBIOL METH, V78, P344, DOI 10.1016/j.mimet.2009.07.005; Jarry TM, 2006, INFECT IMMUN, V74, P2568, DOI 10.1128/IAI.74.5.2568-2577.2006; Keravec M, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1207-0; Kiley JP, 2011, CHEST, V140, P497, DOI 10.1378/chest.11-0774; Klepac-Ceraj V, 2012, GEOBIOLOGY, V10, P223, DOI 10.1111/j.1472-4669.2012.00317.x; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lavenir R, 2007, J MICROBIOL METH, V70, P20, DOI 10.1016/j.mimet.2007.03.008; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Moree WJ, 2012, P NATL ACAD SCI USA, V109, P13811, DOI 10.1073/pnas.1206855109; Nazaret S, 2009, J MICROBIOL METH, V76, P58, DOI 10.1016/j.mimet.2008.09.019; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Pompilio- A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00951; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; Psoter KJ, 2015, EPIDEMIOL INFECT, P1; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Raidt L, 2015, PEDIATR INFECT DIS J, V34, P700, DOI 10.1097/INF.0000000000000714; Ramsey KA, 2014, AM J RESP CRIT CARE, V190, P1111, DOI 10.1164/rccm.201407-1277OC; Renwick J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109798; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Rogers GB, 2013, TRENDS MICROBIOL, V21, P271, DOI 10.1016/j.tim.2013.03.004; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sherrard LJ, 2014, LANCET, V384, P703, DOI 10.1016/S0140-6736(14)61137-5; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; TODER DS, 1994, INFECT IMMUN, V62, P1320, DOI 10.1128/IAI.62.4.1320-1327.1994; Twomey KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082432; Tyrrell J, 2015, MICROBIOLOGY; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; VandenBranden SL, 2012, PEDIATR PULM, V47, P135, DOI 10.1002/ppul.21526; Whiley RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115513; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; WOOD RE, 1987, J PEDIATR-US, V111, P841, DOI 10.1016/S0022-3476(87)80198-1; Yang L, 2011, ENVIRON MICROBIOL, V13, P1682, DOI 10.1111/j.1462-2920.2011.02459.x; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	72	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173022	10.1371/journal.pone.0173022	http://dx.doi.org/10.1371/journal.pone.0173022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282386	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800015
J	Wang, LF; Shen, DX; Wu, H; Ma, YN				Wang, Lifeng; Shen, Dingxia; Wu, Hua; Ma, Yanning			Resistance of hypervirulent Klebsiella pneumoniae to both intracellular and extracellular killing of neutrophils	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; LIVER-ABSCESS; TRAPS; CAPSULE; DISEASE; CHINA	Hypervirulent Klebsiella pneumoniae (HvKP) is hypermucoviscous organism, carrying genes of rmpA and aerobactin, causing serious community-acquired infection and metastatically spread in young healthy hosts. Neutrophils play an important role during innate immune response against bacterial infection by phagocytosis and neutrophil extracellular traps (NETs). Whether neutrophils can effectively defend against HvKP remains unclear. In this study, we observed that the HvKP was significantly more resistant to neutrophil-mediated phagocytosis and intracellular killing than classic Klebsiella pneumoniae (cKP) isolates. Although both HvKP and cKP induced NETs under scanning electron microscopy and confocal microscopy, more cKP than HvKP were trapped in NETs, and the killing by intracellular and extracellular mechanisms of neutrophils was detected only on cKP. Together, our results demonstrated that HvKP resisted to both intracellular and extracellular killing of neutrophils.	[Wang, Lifeng; Shen, Dingxia; Wu, Hua; Ma, Yanning] Chinese Gen Hosp Peoples Liberat Army, Dept Microbiol, Beijing, Peoples R China		Shen, DX (corresponding author), Chinese Gen Hosp Peoples Liberat Army, Dept Microbiol, Beijing, Peoples R China.	shendx301@sina.com			National Natural Science Foundation of China [81472012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 81472012). DXS acquired the funder, who participated in study design, decision to publish, and preparation of the manuscript.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Bachiega TF, 2016, IMMUNOBIOLOGY, V221, P228, DOI 10.1016/j.imbio.2015.09.003; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Casutt-Meyer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015159; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fung CP, 2011, LAB INVEST, V91, P1029, DOI 10.1038/labinvest.2011.52; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Grinberg N, 2008, INFECT IMMUN, V76, P2802, DOI 10.1128/IAI.00051-08; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Lee HC, 2006, J INTERN MED, V259, P606, DOI 10.1111/j.1365-2796.2006.01641.x; Lin JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015005; Lin YT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-13; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Sun YF, 2016, J MOL MICROB BIOTECH, V26, P245, DOI 10.1159/000444367; TOMAS JM, 1986, INFECT IMMUN, V54, P85; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Yan Q, 2016, EUR J CLIN MICROBIOL, V35, P387, DOI 10.1007/s10096-015-2551-2	20	22	33	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173638	10.1371/journal.pone.0173638	http://dx.doi.org/10.1371/journal.pone.0173638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282434	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800059
J	Yao, Q; Liu, KB				Yao, Qiang; Liu, Kam-biu			Dynamics of marsh-mangrove ecotone since the mid-Holocene: A palynological study of mangrove encroachment and sea level rise in the Shark River Estuary, Florida	PLOS ONE			English	Article							EVERGLADES-NATIONAL-PARK; CLIMATE-CHANGE; COASTAL EVERGLADES; CARIBBEAN COAST; WATER FLOW; HOLOCENE; VEGETATION; RECORD; USA; HISTORY	Sea level rise and the associated inland shift of the marsh-mangrove ecotone in south Florida have raised many scientific and management concerns in recent years. Holocene paleoecological records can provide an important baseline to shed light on the long-term dynamics of vegetation changes across this ecotone in the past, which is needed to predict the future. In this study, we present palynological, X-ray fluorescence, and loss-on ignition data from four sedimentary cores recovered from a 20-km marine-to-freshwater transect along the Shark River Estuary, southwest Everglades, to document the patterns and processes of coastal vegetation changes in response to sea level rise since the mid-Holocene. Our record indicates that freshwater marsh progressively replaced marl prairies at the Shark River Estuary between 5700 and 4400 cal yr BP. As marine transgression continued, marine influence reached the threshold necessary for mangroves to establish at the current mouth of the Shark River Slough at 3800 cal yr BP. During the next 3000 years, although sea level rise in the Western North Atlantic slowed down to 0.4 mm/yr, a spatial and temporal gradient was evident as the marshmangrove ecotone shifted inland by 20 km from 3800 to 800 cal yr BP, accompanied by a gradual landward replacement of freshwater marsh by mangrove forest. If sea level continues to rise at 2.33 mm/yr in the 21(st) century in south Florida, it is possible that marine influence will reach the threshold for mangroves to establish in the central Everglades, and we could expect a much more aggressive mangrove encroachment toward the northern and interior parts of south Florida in the next few centuries.	[Yao, Qiang; Liu, Kam-biu] Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Yao, Q (corresponding author), Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	qyao4@lsu.edu	Liu, Kam-Biu/B-4966-2012; Lu, houyuan/AAD-3100-2019	Liu, Kam-Biu/0000-0002-0038-2198; Lu, houyuan/0000-0001-5721-6679; Yao, Qiang/0000-0003-4833-7510	National Science Foundation (NSF DDRI Grant) [BCS-1303114]; Inter-American Institute for Global Change Research (IAI) [SGP-CRA-2050]; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	National Science Foundation (NSF DDRI Grant)(National Science Foundation (NSF)); Inter-American Institute for Global Change Research (IAI); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by National Science Foundation (NSF DDRI Grant No. BCS-1303114). KBL QY and the Inter-American Institute for Global Change Research (IAI #SGP-CRA-2050). KBL.	Armentano T.V., 1995, J COASTAL RES, P111; Bernhardt CE, 2009, ECOL APPL, V19, P1723, DOI 10.1890/08-0779.1; Blaauw M., 2013, BACON MANUAL V233 BE; Castaneda-Moya E, 2013, FOREST ECOL MANAG, V307, P226, DOI 10.1016/j.foreco.2013.07.011; Castaneda-Moya E, 2010, ESTUAR COAST, V33, P45, DOI 10.1007/s12237-009-9242-0; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Donders TH, 2005, P NATL ACAD SCI USA, V102, P10904, DOI 10.1073/pnas.0505015102; Gabriel JJ, 2009, J PALEOLIMNOL, V42, P199, DOI 10.1007/s10933-008-9271-x; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Giri CP, 2014, P NATL ACAD SCI USA, V111, pE1447, DOI 10.1073/pnas.1400687111; Gleason Patrick J., 1994, P149; GRIMM EC, 1993, SCIENCE, V261, P198, DOI 10.1126/science.261.5118.198; Hendy IL, 2016, QUATERNARY SCI REV, V145, P152, DOI 10.1016/j.quascirev.2016.05.039; Islebe G, 2002, PLANT ECOL, V160, P187, DOI 10.1023/A:1015865932012; Joo-Chang JC, 2015, HOLOCENE, V25, P651, DOI 10.1177/0959683614566217; Krauss KW, 2011, J COAST CONSERV, V15, P629, DOI 10.1007/s11852-011-0153-4; Langevin C, 2005, J HYDROL, V314, P212, DOI 10.1016/j.jhydrol.2005.04.015; Light Stephen S., 1994, P47; Liu KB, 2011, J COASTAL RES, P1866; LIU KB, 1990, ECOL MONOGR, V60, P179, DOI 10.2307/1943044; Lodge TE, 2010, EVERGLADES HDB UNDER; MCANDREWS J H, 1966, Memoirs of the Torrey Botanical Club, V22, P1; McAndrews JH, 1973, LIFE SCI MISCELLANEO, V64; McCloskey TA, 2012, QUATERNARY RES, V78, P454, DOI 10.1016/j.yqres.2012.07.003; McLean A. R., 2002, COMPREHENSIVE EVERGL; MILLER R, 1945, AM MINERAL, V30, P65; Monacci NM, 2009, PALAEOGEOGR PALAEOCL, V280, P37, DOI 10.1016/j.palaeo.2009.05.013; Osland MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099604; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parkinson RW, 2015, CLIMATIC CHANGE, V128, P85, DOI 10.1007/s10584-014-1301-2; PARKINSON RW, 1989, J SEDIMENT PETROL, V59, P960; Peros MC, 2007, QUATERNARY RES, V67, P69, DOI 10.1016/j.yqres.2006.08.004; Platt William J., 1999, P23; Robbin D. M., 1984, ENV S FLORIDA PRESEN, V2, P437; Ross MS, 2000, J VEG SCI, V11, P101, DOI 10.2307/3236781; Saha AK, 2012, ESTUAR COAST, V35, P459, DOI 10.1007/s12237-011-9454-y; Schmitz M, 2002, PLANT ECOL, V160, P137, DOI 10.1023/A:1015848300802; SCHOLL DW, 1967, GEOL SOC AM BULL, V78, P437, DOI 10.1130/0016-7606(1967)78[437:RSOSFA]2.0.CO;2; SCHOLL DW, 1969, SCIENCE, V163, P562, DOI 10.1126/science.163.3867.562; Simard M, 2006, PHOTOGRAMM ENG REM S, V72, P299, DOI 10.14358/PERS.72.3.299; Slocum MG, 2003, RESTOR ECOL, V11, P91, DOI 10.1046/j.1526-100X.2003.00115.x; Smith TJ, 2013, FIRE ECOL, V9, P66, DOI 10.4996/fireecology.0901066; Solomon S., 2014, CONTRIBUTION WORKING; Stuiver M., 2010, CALIB RADIOCARBON CA; van Soelen EE, 2012, HOLOCENE, V22, P929, DOI 10.1177/0959683611434226; van Soelen EE, 2010, ESTUAR COAST SHELF S, V86, P216, DOI 10.1016/j.ecss.2009.11.010; Wanless Harold R., 1994, P199; WATTS WA, 1980, SCIENCE, V210, P325, DOI 10.1126/science.210.4467.325; WATTS WA, 1994, PALAEOGEOGR PALAEOCL, V109, P163, DOI 10.1016/0031-0182(94)90174-0; Webb T., 1986, PLANT ECOL, V67, P75, DOI DOI 10.1007/BF00037359; Willard DA, 2001, REV PALAEOBOT PALYNO, V113, P213, DOI 10.1016/S0034-6667(00)00042-7; Willard Debra A., 2004, Palynology, V28, P175, DOI 10.2113/28.1.175; Willard DA, 2011, CLIMATIC CHANGE, V107, P59, DOI 10.1007/s10584-011-0078-9; WOODROFFE CD, 1985, NATURE, V317, P711, DOI 10.1038/317711a0; Wooller MJ, 2007, HOLOCENE, V17, P1129, DOI 10.1177/0959683607082553; Yao Q, 2015, QUATERNARY RES, V83, P449, DOI 10.1016/j.yqres.2015.03.005	57	36	36	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173670	10.1371/journal.pone.0173670	http://dx.doi.org/10.1371/journal.pone.0173670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282415	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800066
J	Vermeersch, E; Denorme, F; Maes, W; De Meyer, SF; Vanhoorelbeke, K; Edwards, J; Shevach, EM; Unutmaz, D; Fujii, H; Deckmyn, H; Tersteeg, C				Vermeersch, Elien; Denorme, Frederik; Maes, Wim; De Meyer, Simon F.; Vanhoorelbeke, Karen; Edwards, Justin; Shevach, Ethan M.; Unutmaz, Derya; Fujii, Hodaka; Deckmyn, Hans; Tersteeg, Claudia			The role of platelet and endothelial GARP in thrombosis and hemostasis	PLOS ONE			English	Article							LATENT TGF-BETA; MESSENGER-RNA EXPRESSION; REGULATORY T-CELL; IN-VIVO; GENE-EXPRESSION; TRANSGENIC MICE; MODEL; SURFACE; ACTIVATION; TGF-BETA-1	Background Glycoprotein-A Repetitions Predominant protein (GARP or LRRC32) is present on among others human platelets and endothelial cells. Evidence for its involvement in thrombus formation was suggested by full knockout of GARP in zebrafish. Objectives To evaluate the role of GARP in platelet physiology and in thrombus formation using platelet and endothelial conditional GARP knock out mice. Methods Platelet and endothelial specific GARP knockout mice were generated using the Cre-loxP recombination system. The function of platelets without GARP was measured by flow cytometry, spreading analysis and aggregometry using PAR4-activating peptide and collagen related peptide. Additionally, clot retraction and collagen-induced platelet adhesion and aggregation under flow were analyzed. Finally, in vivo tail bleeding time, occlusion time of the mesenteric and carotid artery after FeCI3-induced thrombosis were determined in platelet and endothelial specific GARP knock out mice. Results Platelet specific GARP knockout mice had normal surface GPIb, GPVI and integrin al lb glycoprotein expression. Although GARP expression was increased upon platelet activation, platelets without GARP displayed normal agonist induced activation, spreading on fibrinogen and aggregation responses. Furthermore, absence of GARP on platelets did not influence clot retraction and had no impact on thrombus formation on collagen-coated surfaces under flow. In line with this, neither the tail bleeding time nor the occlusion time in the carotidand mesenteric artery after FeCI3-induced thrombus formation in platelet or endothelial specific GARP knock out mice were affected. Conclusions Evidence is provided that platelet and endothelial GARP are not important in hemostasis and thrombosis in mice.	[Vermeersch, Elien; Denorme, Frederik; Maes, Wim; De Meyer, Simon F.; Vanhoorelbeke, Karen; Deckmyn, Hans; Tersteeg, Claudia] Katholieke Univ Leuven, IRF Life Sci, Lab Thrombosis Res, Campus Kulak Kortrijk, Kortrijk, Belgium; [Edwards, Justin; Shevach, Ethan M.] NIAID, Immunol Lab, Bldg 10, Bethesda, MD 20892 USA; [Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT USA; [Fujii, Hodaka] Osaka Univ, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Microbial Dis Res Inst, Osaka, Japan	KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Jackson Laboratory; Osaka University	Deckmyn, H (corresponding author), Katholieke Univ Leuven, IRF Life Sci, Lab Thrombosis Res, Campus Kulak Kortrijk, Kortrijk, Belgium.	Hans.Deckmyn@kuleuven.be	Fujii, Hodaka/A-2420-2008; Deckmyn, Hans/N-8932-2019; Deckmyn, Hans/L-9434-2015; Fujii, Hodaka/N-9792-2019; Tersteeg, Claudia/V-3758-2018	Fujii, Hodaka/0000-0003-1296-4256; Deckmyn, Hans/0000-0003-3952-5501; Deckmyn, Hans/0000-0003-3952-5501; Fujii, Hodaka/0000-0003-1296-4256; Tersteeg, Claudia/0000-0002-6380-6349; Vanhoorelbeke, Karen/0000-0003-2288-8277; Denorme, Frederik/0000-0003-1442-3568; Maes, Wim/0000-0002-4629-6674; Edwards, Justin/0000-0001-8936-2136; De Meyer, Simon/0000-0002-1807-5882; Vermeersch, Elien/0000-0002-1425-9561	Research Foundation Flanders (FWO), Belgium [G.0628.13]; FWO, Belgium [12N0715N]; Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065303, ZIAAI000224] Funding Source: NIH RePORTER	Research Foundation Flanders (FWO), Belgium(FWO); FWO, Belgium(FWO); Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HD received funding from the Research Foundation Flanders (FWO, http://www.fwo.be), Belgium (FWO grant G.0628.13). CT is a Postdoctoral Fellow also supported by the FWO, Belgium (12N0715N). JE and EMS are supported by funds from the Division of Intramural Research, NIAID (http://www.niaid.niti.gov/about/dir). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; De Meyer SF, 2008, ARTERIOSCL THROM VAS, V28, P1621, DOI 10.1161/ATVBAHA.108.168369; De Meyer Simon F, 2011, Exp Transl Stroke Med, V3, P9, DOI 10.1186/2040-7378-3-9; Denorme F, 2016, THROMB HAEMOSTASIS, V116, P597, DOI 10.1160/TH16-01-0036; Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199; Fridrich S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153290; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; Hofmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115306; Kehrmann A, 2013, CANCER GENET-NY, V206, P279, DOI 10.1016/j.cancergen.2013.06.002; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kooijman S, 2015, J THROMB HAEMOST, V13, P126, DOI 10.1111/jth.12765; Korporaal SJA, 2011, ARTERIOSCL THROM VAS, V31, P34, DOI 10.1161/ATVBAHA.110.210252; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lang MR, 2010, J THROMB HAEMOST, V8, P1159, DOI 10.1111/j.1538-7836.2010.03815.x; Lev PR, 2007, PLATELETS, V18, P35, DOI 10.1080/09537100600800743; Li Y, 2015, J IMMUNOL, V195, P2648, DOI 10.4049/jimmunol.1500139; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; O'Connor MN, 2009, BLOOD, V113, P4754, DOI 10.1182/blood-2008-06-162693; OLLENDORFF V, 1992, MAMM GENOME, V2, P195, DOI 10.1007/BF00302877; Roubin R, 1996, INT J DEV BIOL, V40, P545; Salles-Crawley II, 2014, BLOOD, V123, P2873, DOI 10.1182/blood-2013-10-534024; Soslau G, 1997, CYTOKINE, V9, P405, DOI 10.1006/cyto.1996.0182; Stalker TJ, 2009, J THROMB HAEMOST, V7, P1886, DOI 10.1111/j.1538-7836.2009.03606.x; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tersteeg C, 2014, CIRC RES, V114, P780, DOI 10.1161/CIRCRESAHA.114.302361; Thijs T, 2012, BLOOD, V119, P1634, DOI 10.1182/blood-2011-10-381715; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Verhenne S, 2015, BLOOD, V126, P1715, DOI 10.1182/blood-2015-03-632901; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Weyand AC, 2014, CURR OPIN HEMATOL, V21, P418, DOI 10.1097/MOH.0000000000000075; Wu QY, 1998, J CLIN INVEST, V101, P321, DOI 10.1172/JCI1617	35	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173329	10.1371/journal.pone.0173329	http://dx.doi.org/10.1371/journal.pone.0173329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278197	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900073
J	Tripathi, A; Mandon, EC; Gilmore, R; Rapoport, TA				Tripathi, Arati; Mandon, Elisabet C.; Gilmore, Reid; Rapoport, Tom A.			Two alternative binding mechanisms connect the protein translocation Sec71-Sec72 complex with heat shock proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPRO-ALPHA-FACTOR; ENDOPLASMIC-RETICULUM; SEC PROTEINS; HSP70; YEAST; RECOGNITION; CHAPERONES; TRANSPORT; DOMAINS; SYSTEM	The biosynthesis of many eukaryotic proteins requires accurate targeting to and translocation across the endoplasmic reticulum membrane. Post-translational protein translocation in yeast requires both the Sec61 translocation channel, and a complex of four additional proteins: Sec63, Sec62, Sec71, and Sec72. The structure and function of these proteins are largely unknown. This pathway also requires the cytosolic Hsp70 protein Ssa1, but whether Ssa1 associates with the translocation machinery to target protein substrates to the membrane is unclear. Here, we use a combined structural and biochemical approach to explore the role of Sec71-Sec72 subcomplex in post-translational protein translocation. To this end, we report a crystal structure of the Sec71-Sec72 complex, which revealed that Sec72 contains a tetratricopeptide repeat (TPR) domain that is anchored to the endoplasmic reticulum membrane by Sec71. We also determined the crystal structure of this TPR domain with a C-terminal peptide derived from Ssa1, which suggests how Sec72 interacts with full-length Ssa1. Surprisingly, Ssb1, a cytoplasmic Hsp70 that binds ribosome-associated nascent polypeptide chains, also binds to the TPR domain of Sec72, even though it lacks the TPR-binding C-terminal residues of Ssa1. We demonstrate that Ssb1 binds through its ATPase domain to the TPR domain, an interaction that leads to inhibition of nucleotide exchange. Taken together, our results suggest that translocation substrates can be recruited to the Sec71-Sec72 complex either post-translationally through Ssa1 or co-translationally through Ssb1.	[Tripathi, Arati; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Tripathi, Arati; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Mandon, Elisabet C.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Tripathi, A; Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.; Tripathi, A; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	arati_tripathi@hms.harvard.edu; tom_rapoport@hms.harvard.edu			National Institutes of Health [RO1 GM35687, RO1 GM 052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035687, R01GM052586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 GM35687 (to R. G.) and RO1 GM 052586 (to T. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Becker J, 1996, MOL CELL BIOL, V16, P4378; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HANSEN W, 1988, J CELL BIOL, V106, P1075, DOI 10.1083/jcb.106.4.1075; Harada Y, 2011, J BIOL CHEM, V286, P2956, DOI 10.1074/jbc.M110.159517; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li JZ, 2006, BIOCHEM J, V398, P353, DOI 10.1042/BJ20060618; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Panigrahi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083461; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; ROTHBLATT JA, 1986, EMBO J, V5, P1031; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; WATERS MG, 1986, J CELL BIOL, V102, P1543, DOI 10.1083/jcb.102.5.1543; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	50	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8007	8018		10.1074/jbc.M116.761122	http://dx.doi.org/10.1074/jbc.M116.761122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28286332	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000401154100026
J	Koole, C; Reynolds, CA; Mobarec, JC; Hick, C; Sexton, PM; Sakmar, TP				Koole, Cassandra; Reynolds, Christopher A.; Mobarec, Juan C.; Hick, Caroline; Sexton, Patrick M.; Sakmar, Thomas P.			Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CORTICOTROPIN-RELEASING-FACTOR; PHOTOREACTIVE AMINO-ACID; CLASS-B GPCRS; EXTRACELLULAR DOMAIN; MAMMALIAN-CELLS; CROSS-LINKERS; TRP-CAGE; MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE	The glucagon-like peptide-1 receptor (GLP-1R) is a key therapeutic target in the management of type II diabetes mellitus, with actions including regulation of insulin biosynthesis and secretion, promotion of satiety, and preservation of beta-cell mass. Like most class B G protein-coupled receptors (GPCRs), there is limited knowledge linking biological activity of the GLP-1R with the molecular structure of an intact, full-length, and functional receptor.ligand complex. In this study, we have utilized genetic code expansion to site-specifically incorporate the photoactive amino acid p-azido-L-phenylalanine (azF) into N-terminal residues of a full-length functional human GLP-1R in mammalian cells. UV-mediated photolysis of azF was then carried out to induce targeted photocross-linking to determine the proximity of the azido group in the mutant receptor with the peptide exendin-4. Cross-linking data were compared directly with the crystal structure of the isolated N-terminal extracellular domain of the GLP-1R in complex with exendin(9-39), revealing both similarities as well as distinct differences in the mode of interaction. Generation of a molecular model to accommodate the photo-cross-linking constraints highlights the potential influence of environmental conditions on the conformation of the receptor center dot peptide complex, including folding dynamics of the peptide and formation of dimeric and higher order oligomeric receptor multimers. These data demonstrate that crystal structures of isolated receptor regions may not give a complete reflection of peptide/receptor interactions and should be combined with additional experimental constraints to reveal peptide/receptor interactions occurring in the dynamic, native, and full-length receptor state.	[Koole, Cassandra; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave,Box 187, New York, NY 10065 USA; [Koole, Cassandra; Hick, Caroline; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Reynolds, Christopher A.; Mobarec, Juan C.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England	Rockefeller University; Monash University; University of Essex	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave,Box 187, New York, NY 10065 USA.	sakmar@mail.rockefeller.edu	Sexton, Patrick M/B-1319-2008; Sakmar, Thomas P/D-1833-2015; Reynolds, Christopher/G-1036-2010	Sexton, Patrick M/0000-0001-8902-2473; Sakmar, Thomas P/0000-0002-2836-8953; Mobarec, Juan Carlos/0000-0001-9482-4294; Reynolds, Christopher/0000-0001-9267-5141	Rockefeller University; National Health and Medical Research Council of Australia [1061044, 1055134]; Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/M006883/1]; BBSRC [BB/M007529/1, BB/M006883/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M007529/1, BB/M006883/1] Funding Source: researchfish	Rockefeller University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by institutional funds from The Rockefeller University, National Health and Medical Research Council of Australia Grants 1061044 and 1055134 (to P. M. S.) and Biotechnology and Biological Sciences Research Council of the United Kingdom Project Grant BB/M006883/1 (to C. A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P11803, DOI 10.1073/pnas.1309584110; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen QA, 2010, AM J PHYSIOL-ENDOC M, V299, pE62, DOI 10.1152/ajpendo.00067.2010; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Coin I, 2011, ANGEW CHEM INT EDIT, V50, P8077, DOI 10.1002/anie.201102646; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Culik RM, 2011, ANGEW CHEM INT EDIT, V50, P10884, DOI 10.1002/anie.201104085; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Dong M, 2014, BRIT J PHARMACOL, V171, P1085, DOI 10.1111/bph.12293; ENG J, 1992, J BIOL CHEM, V267, P7402; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Harikumar KG, 2012, P NATL ACAD SCI USA, V109, P18607, DOI 10.1073/pnas.1205227109; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hino N, 2011, J MOL BIOL, V406, P343, DOI 10.1016/j.jmb.2010.12.022; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Koole C, 2013, BIOCHEM SOC T, V41, P172, DOI 10.1042/BST20120236; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koole C, 2011, MOL PHARMACOL, V80, P486, DOI 10.1124/mol.111.072884; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Linhananta A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1874812; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Meuzelaar H, 2013, J PHYS CHEM B, V117, P11490, DOI 10.1021/jp404714c; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Rannversson H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11261; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Valentin-Hansen L, 2014, J BIOL CHEM, V289, P18045, DOI 10.1074/jbc.M113.527085; VanEyll B, 1996, PEPTIDES, V17, P565, DOI 10.1016/0196-9781(96)00019-8; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Wang WJ, 2014, ACS CHEM BIOL, V9, P2165, DOI 10.1021/cb500351s; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; Wootten D, 2016, BIOCHEM PHARMACOL, V118, P68, DOI 10.1016/j.bcp.2016.08.015; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Yin YT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.42	61	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7131	7144		10.1074/jbc.M117.779496	http://dx.doi.org/10.1074/jbc.M117.779496			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28283573	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000400478300023
J	Heng, JF; Guo, XW; Wu, WH; Wang, Y; Li, GL; Chen, M; Peng, LM; Wang, SM; Dai, LZ; Tang, LL; Wang, J				Heng, Jianfu; Guo, Xinwu; Wu, Wenhan; Wang, Yue; Li, Guoli; Chen, Ming; Peng, Limin; Wang, Shouman; Dai, Lizhong; Tang, Lili; Wang, Jun			Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients	PLOS ONE			English	Article							ABERRANT METHYLATION; PATHWAY; ASSOCIATION; AKT1(E17K); REGIONS	Background As downstream mediators of PI3K/PTEN/AKT/mTORC1 pathway, the AKT isoforms play critical roles in tumorgenesis. Although the pleiotropic effects of AKT1 in breast cancer have been reported, the genetic and epigenetic characteristics of AKT1 promoter region in breast cancer remains to be identified. In this study we aimed to investigate the promoter mutation spectrum, methylation and gene expression pattern of AKT1 and their relationship with breast cancer. Methods By using PCR target sequence enrichment and next-generation sequencing technology, we sequenced AKT1 promoter region in pairs of breast tumor and normal tissues from 95 unselected Chinese breast cancer patients. The methylation of the promoter region and the expression profile of AKT1 in the same cohort were detected with bisulfite next-generation sequencing and qPCR, respectively. Results We identified 28 somatic mutations in 23 of the 95 (24.2%) breast cancer samples. And 19 of the 28 mutations were located in transcription factor (TF) binding sites. In the 23 patients with somatic mutations, no significant change of methylation or expression was found comparing with other patients. AKT1 promoter region was significantly hypo-methylated in tumor compared with matched normal tissue (P = 0.0014) in the 95 patients. The expression of AKT1 was significantly suppressed in tumor tissue (P = 0.0375). In clinicopathological factor analysis, AKT1 showed significant hypo-methylation (P = 0.0249) and suppressed expression (P = 0.0375) in HER2 negative subtype. And a trend of decrease in expression level (P = 0.0624) of AKT1 in the ER negative subtype was observed, which is significantly decreased in basal-like breast tumor ( P = 0.0328). Conclusions Hypo-methylation and suppressed expression of AKT1 was observed to be associated with breast cancer in our cohort. The methylation and expression of AKT1 were both significantly associated with HER2 status. The promoter mutation of AKT1 did not show significant association with its methylation and expression status. These results suggested that the promoter mutation, methylation and gene expression of AKT1 may play distinct roles in tumorgenesis of breast cancer and the integrated analysis of methylation and expression of AKT1 might serve as potential biomarkers for diagnosis and classification of breast cancer.	[Heng, Jianfu; Wu, Wenhan; Wang, Yue; Li, Guoli; Wang, Jun] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Heng, Jianfu; Wu, Wenhan; Wang, Yue; Li, Guoli; Wang, Jun] Cent S Univ, Sch Life Sci, Changsha, Hunan, Peoples R China; [Guo, Xinwu; Chen, Ming; Peng, Limin; Dai, Lizhong] Sanway Gene Technol Inc, Changsha, Hunan, Peoples R China; [Wang, Shouman; Tang, Lili] Cent S Univ, Dept Breast Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Dai, Lizhong; Wang, Jun] Res Ctr Technol Nucle Acid Based Diagnost, Changsha, Hunan, Peoples R China; [Dai, Lizhong; Wang, Jun] Res Ctr Technol Nucle Acid Based Diagnost & Thera, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Wang, J (corresponding author), Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.; Wang, J (corresponding author), Cent S Univ, Sch Life Sci, Changsha, Hunan, Peoples R China.; Tang, LL (corresponding author), Cent S Univ, Dept Breast Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China.; Wang, J (corresponding author), Res Ctr Technol Nucle Acid Based Diagnost, Changsha, Hunan, Peoples R China.; Wang, J (corresponding author), Res Ctr Technol Nucle Acid Based Diagnost & Thera, Changsha, Hunan, Peoples R China.	tlli77@medmail.com.cn; junwang@csu.edu.cn			Natural Science Foundation of China [81272296, 81372228]; Major Special Projects of the Science and Technology Bureau of Changsha, China [K1204017-31, K1306011-31]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Special Projects of the Science and Technology Bureau of Changsha, China	This work was supported in part by grants from the Natural Science Foundation of China (No. 81272296 and 81372228), and the Major Special Projects of the Science and Technology Bureau of Changsha, China (No. K1204017-31 and K1306011-31).	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Colebatch AJ, 2016, ONCOTARGET; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flatley E, 2013, HUM PATHOL, V44, P1320, DOI 10.1016/j.humpath.2012.10.018; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gray J, 2012, NATURE, V486, P328, DOI 10.1038/486328a; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kostroma II, 2016, TERAPEVT ARKH, V88, P31, DOI 10.17116/terarkh201688731-36; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2016, BREAST CANC RES TREA; Li ZB, 2016, BREAST CANCER RES TR, V160, P371, DOI 10.1007/s10549-016-4004-8; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lin FDL, 2014, REV BRAS GINECOL OBS, V36, P340, DOI 10.1509/SO100-720320140005034; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Nishizawa D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/316829; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Rahat B, 2016, EPIGENOMICS-UK, V8, P767, DOI 10.2217/epi.16.7; Rudolph M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2626-1; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tokunaga E, 2006, INT J CANCER, V118, P284, DOI 10.1002/ijc.21358; Troxell ML, 2012, J CLIN EXPT PATHOL S, VS1; Wang MY, 2016, SCI REPORTS, V6; Yang W, 2011, CELL SIGNAL, V23, P19, DOI 10.1016/j.cellsig.2010.07.016; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561	39	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174022	10.1371/journal.pone.0174022	http://dx.doi.org/10.1371/journal.pone.0174022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301567	gold, Green Submitted, Green Published			2022-12-26	WOS:000396318300113
J	Morais, DB; Puga, LCHP; De Paula, TAR; Freitas, MBD; Da Matta, SLP				Morais, Danielle Barbosa; Porcaro Puga, Luciano Carlos Heringer; Rego de Paula, Tarcizio Antonio; Duca Freitas, Mariella Bontempo; Pinto da Matta, Sergio Luis			The spermatogenic process of the common vampire bat Desmodus rotundus under a histomorphometric view	PLOS ONE			English	Article							SEMINIFEROUS EPITHELIUM CYCLE; MOLOSSUS-MOLOSSUS CHIROPTERA; DAILY SPERM PRODUCTION; INTERTUBULAR COMPARTMENT; TUBULAR COMPARTMENT; TESTIS; ORGANIZATION; DURATION; LENGTH; QUANTIFICATION	Among all bat species, Desmodus rotundus stands out as one of the most intriguing due to its exclusively haematophagous feeding habits. However, little is known about their spermatogenic cycle. This study aimed at describing the spermatogenic process of common vampire bats through testicular histomorphometric characterization of adult specimens, spermatogenic production indexes, description of stages of the seminiferous epithelium cycle and estimative of the spermatogenic process duration. Morphometrical and immunohistochemical analyzes for bromodeoxiuridine were conducted under light microscopy and ultrastructural analyzes were performed under transmission electron microscopy. Vampire bats showed higher investment in gonadal tissue (gonadosomatic index of 0.54%) and in seminiferous tubules (tubulesomatic index of 0.49%) when compared to larger mammals. They also showed a high tubular length per gram of testis (34.70 m). Approximately half of the intertubular compartment was found to be comprised by Leydig cells (51.20%), and an average of 23.77x10(6) of these cells was found per gram of testis. The germline cells showed 16.93% of mitotic index and 2.51% of meiotic index. The overall yield of spermatogenesis was 60% and the testicular spermatic reserve was 71.44x10(7) spermatozoa per gram of testis. With a total spermatogenesis duration estimated at 37.02 days, vampire bats showed a daily sperm production of 86.80x10(6) gametes per gram of testis. These findings demonstrate a high sperm production, which is commonly observed in species with promiscuous mating system.	[Morais, Danielle Barbosa] Univ Fed Rio Grande do Norte, Dept Morphol, BR-59072970 Natal, RN, Brazil; [Porcaro Puga, Luciano Carlos Heringer; Rego de Paula, Tarcizio Antonio] Univ Fed Vicosa, Dept Veterinary, BR-36570 Vicosa, MG, Brazil; [Duca Freitas, Mariella Bontempo] Univ Fed Vicosa, Dept Anim Biol, BR-36570 Vicosa, MG, Brazil; [Pinto da Matta, Sergio Luis] Univ Fed Vicosa, Dept Gen Biol, BR-36570 Vicosa, MG, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Morais, DB (corresponding author), Univ Fed Rio Grande do Norte, Dept Morphol, BR-59072970 Natal, RN, Brazil.	daniellebmorais@gmail.com	Freitas, Mariella B/H-9512-2015	Freitas, Mariella/0000-0001-5132-242X; Morais, Danielle/0000-0003-3277-1857	CAPES Foundation, Ministry of Education - Brazil	CAPES Foundation, Ministry of Education - Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge CAPES Foundation, Ministry of Education - Brazil, for the scholarship provided to DBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Acha P. N., 1988, Natural history of vampire bats., P207; Alencar A. O, 1994, PESQUI VET BRASIL, V14, P95; AMANN RP, 1962, J DAIRY SCI, V45, P774, DOI 10.3168/jds.S0022-0302(62)89487-9; Balarini MK, 2012, THERIOGENOLOGY, V77, P873, DOI 10.1016/j.theriogenology.2011.09.011; Barros JBG, 2005, THESIS; Beguelini MR, 2012, MICROSC RES TECHNIQ, V75, P856, DOI 10.1002/jemt.22005; Beguelini MR, 2011, MICRON, V42, P586, DOI 10.1016/j.micron.2011.02.004; Beguelini MR, 2009, J MORPHOL, V270, P943, DOI 10.1002/jmor.10731; BERNDTSON WE, 1977, J ANIM SCI, V44, P818, DOI 10.2527/jas1977.445818x; Bitencourt VL, 2007, MICRON, V38, P584, DOI 10.1016/j.micron.2006.10.004; Bittencourt V. L., 2004, Revista Brasileira de Reproducao Animal, V28, P108; Bittencourt VL, 2007, CERES, V54, P329; Caldeira Bianca Cabral, 2010, Rev. Ceres, V57, P569; Costa KLC, 2011, ANIM REPROD SCI, V127, P202, DOI 10.1016/j.anireprosci.2011.07.016; Costa DS, 2007, ANIM REPROD SCI, V98, P322, DOI 10.1016/j.anireprosci.2006.03.014; Costa DS, 2006, ANIM REPROD SCI, V91, P173, DOI 10.1016/j.anireprosci.2005.03.013; Costa GMJ, 2008, THERIOGENOLOGY, V70, P1136, DOI 10.1016/j.theriogenology.2008.06.035; Costa GMJ, 2010, J ANDROL, V31, P221, DOI 10.2164/jandrol.109.008524; Crichton E. G., 2000, LIFE HIST REPROD STR, P364; de Barros JBG, 2007, ANIM REPROD SCI, V102, P350, DOI 10.1016/j.anireprosci.2007.04.002; Duarte A, 2012, PLOS ONE, V7; Farias TO, 2015, ANAT HISTOL EMBRYOL, V44, P361, DOI 10.1111/ahe.12148; Azevedo MHF, 2008, MICRON, V39, P1166, DOI 10.1016/j.micron.2008.05.005; de Azevedo MHF, 2010, ANIM REPROD SCI, V118, P83, DOI 10.1016/j.anireprosci.2009.05.018; Franca LR, 1998, BIOL REPROD, V59, P1371, DOI 10.1095/biolreprod59.6.1371; Franca LR, 2003, BIOL REPROD, V68, P1554, DOI 10.1095/biolreprod.102.010652; Franca LR, 1998, MALE REPROD MULTIDIS, V197, P219; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; Guiao-Leite F. L., 2003, Revista Brasileira de Reproducao Animal, V27, P21; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; KUNZ TH, 1982, J MAMMAL, V63, P23, DOI 10.2307/1380667; Leal MC, 2006, BIOL REPROD, V74, P616, DOI 10.1095/biolreprod.105.048074; Leite FLG, 2006, ANIM REPROD SCI, V91, P307, DOI 10.1016/j.anireprosci.2005.04.003; Mayen F, 2003, J VET MED B, V50, P469, DOI 10.1046/j.1439-0450.2003.00713.x; Melo FCSA, 2010, BIOL RES, V43, P445, DOI [/S0716-97602010000400009, 10.4067/S0716-97602010000400009]; Miranda DC, 2012, THESIS; Morais AC., 2016, IOSR J PHARM BIOL SC, V11, P61; Morais DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101759; Morais DB, 2014, ANIM REPROD SCI, V147, P180, DOI 10.1016/j.anireprosci.2014.03.008; Morais DB, 2013, ANIM REPROD SCI, V140, P268, DOI 10.1016/j.anireprosci.2013.06.003; Morais DB, 2013, J ANAT, V222, P372, DOI 10.1111/joa.12016; Morais DB, 2013, MICROSC RES TECHNIQ, V76, P94, DOI 10.1002/jemt.22141; Morais DB, 2012, ASIAN PAC J REPROD, V1, P303, DOI DOI 10.1016/S2305-0500(13)60097-4; Neves ES, 2002, BIOL REPROD, V67, P247, DOI 10.1095/biolreprod67.1.247; ORSI A M, 1990, Revista Brasileira de Biologia, V50, P221; Orsi Antonio Marcos, 1993, Revista Brasileira de Biologia, V53, P583; Paula T. A. R. C., 2002, J BIOSCIENCES, V18, P121; Paula TAR, 1999, TISSUE CELL, V31, P327, DOI 10.1054/tice.1999.0039; QUEIROZ GF, 1992, REPROD FERT DEVELOP, V4, P213, DOI 10.1071/RD9920213; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sarti P, 2011, ARQ BRAS MED VET ZOO, V63, P1060, DOI 10.1590/S0102-09352011000500003; Taddei VA, DESMODUS ROTUNDUS ES; Morais ACT, 2014, ANIM REPROD SCI, V149, P249, DOI 10.1016/j.anireprosci.2014.06.027; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P111; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284; Zhengwei Y, 1997, J Androl, V18, P681	59	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173856	10.1371/journal.pone.0173856	http://dx.doi.org/10.1371/journal.pone.0173856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301534	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300081
J	Rauzan, M; Chuah, CTH; Ko, TK; Ong, T				Rauzan, Muhammad; Chuah, Charles T. H.; Ko, Tun Kiat; Ong, Tiong			The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CHAPERONE FUNCTION; CANCER; ACETYLATION; IMATINIB; CML; COMBINATION; THERAPY; DOMAIN; CELLS	Chronic myeloid leukemia (CML) treatment has been improved by tyrosine kinase inhibitors (TKIs) such as imatinib mesylate (IM) but various factors can cause TKI resistance in patients with CML. One factor which contributes to TKI resistance is a germline intronic deletion polymorphism in the BCL2-like 11 (BIM) gene which impairs the expression of pro-apoptotic splice isoforms of BIM. SB939 (pracinostat) is a hydroxamic acid based HDAC inhibitor with favorable pharmacokinetic, physicochemical and pharmaceutical properties, and we investigated if this drug could overcome BIM deletion polymorphism-induced TKI resistance. We found that SB939 corrects BIM pre-mRNA splicing in CML cells with the BIM deletion polymorphism, and induces apoptotic cell death in CML cell lines and primary cells with the BIM deletion polymorphism. More importantly, SB939 both decreases the viability of CML cell lines and primary CML progenitors with the BIM deletion and restores TKI-sensitivity. Our results demonstrate that SB939 overcomes BIM deletion polymorphism-induced TKI resistance, and suggest that SB939 may be useful in treating CML patients with BIM deletion-associated TKI resistance.	[Rauzan, Muhammad; Chuah, Charles T. H.; Ko, Tun Kiat; Ong, Tiong] Duke NUS Med Sch, Canc & Stem Cell Biol Signature Res Programme, Singapore, Singapore; [Chuah, Charles T. H.; Ong, Tiong] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Ong, Tiong] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Ong, Tiong] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Duke University	Ko, TK; Ong, T (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Biol Signature Res Programme, Singapore, Singapore.; Ong, T (corresponding author), Singapore Gen Hosp, Dept Haematol, Singapore, Singapore.; Ong, T (corresponding author), Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore.; Ong, T (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	tunkiat.ko@duke-nus.edu.sg; sintiong.ong@duke-nus.edu.sg		Ong, S. Tiong/0000-0001-9460-3483	Singapore Ministry of Health's National Medical Research Council [NMRC/CIRG/1330/2012, NMRC/CSA/0051/2013]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	STO was supported by the Singapore Ministry of Health's National Medical Research Council under its Clinician Scientists Individual Research Grant (NMRC/CIRG/1330/2012), and the Clinician Scientist Award (NMRC/CSA/0051/2013) (URL: http://www.nmrc.gov.sg/content/nmrc_internet/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Lee SM, 2007, J PHARMACOL EXP THER, V322, P1084, DOI 10.1124/jpet.107.124461; Lim S, 2013, P NATL ACAD SCI USA, V110, pE2298, DOI 10.1073/pnas.1301838110; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Novotny-Diermayr V, 2010, MOL CANCER THER, V9, P642, DOI 10.1158/1535-7163.MCT-09-0689; Okabe S, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-32; PENDERGAST AM, 1993, MOL CELL BIOL, V13, P1728, DOI 10.1128/MCB.13.3.1728; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shuai K, 1996, ONCOGENE, V13, P247	17	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174107	10.1371/journal.pone.0174107	http://dx.doi.org/10.1371/journal.pone.0174107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301600	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300127
J	Tashiro, T; Okuyama, H; Endo, H; Kawada, K; Ashida, Y; Ohue, M; Sakai, Y; Inoue, M				Tashiro, Takahiro; Okuyama, Hiroaki; Endo, Hiroko; Kawada, Kenji; Ashida, Yasuko; Ohue, Masayuki; Sakai, Yoshiharu; Inoue, Masahiro			In vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer	PLOS ONE			English	Article							EGFR MONOCLONAL-ANTIBODY; GROWTH-FACTOR RECEPTOR; RAS MUTATIONS; ACQUIRED-RESISTANCE; PATHWAY ACTIVATION; TUMOR XENOGRAFTS; DRUG DEVELOPMENT; CHEMOTHERAPY; SPHEROIDS; THERAPIES	In clinic, cetuximab, an anti-EGFR antibody, improves treatment outcomes in colorectal cancer (CRC). KRAS-mutant CRC is generally resistant to cetuximab, although difference of the sensitivity among KRAS-mutants has not been studied in detail. We previously developed the cancer tissue-originated spheroid (CTOS) method, a primary culture method for cancer cells. We applied CTOS method to investigate whether ex vivo cetuximab sensitivity assays reflect the difference in sensitivity in the xenografts. Firstly, in vivo cetuximab treatment was performed with xenografts derived from 10 CTOS lines (3 KRAS-wildtype and 7 KRAS mutants). All two CTOS lines which exhibited tumor regression were KRAS-wildtype, meanwhile all KRAS-mutant CTOS lines grew more than the initial size: were resistant to cetuximab according to the clinical evaluation criteria, although the sensitivity was quite diverse. We divided KRAS-mutants into two groups; partially responsive group in which cetuximab had a substantial growth inhibitory effect, and resistant group which exhibited no effect. The ex vivo signaling assay with EGF stimulation revealed that the partially responsive group, but not the resistant group, exhibited suppressed ERK phosphorylation ex vivo. Furthermore, two lines from the partially responsive group, but none of the lines in the resistant group, exhibited a combinatory effect of cetuximab and trametinib, a MEK inhibitor, ex vivo and in vivo. Taken together, the results indicate that ex vivo signaling assay reflects the difference in sensitivity in vivo and stratifies KRAS mutant CTOS lines by sensitivity. Therefore, coupling the in vivo and ex vivo assays with CTOS can be a useful platform for understanding the mechanism of diversity in drug sensitivity.	[Tashiro, Takahiro; Okuyama, Hiroaki; Endo, Hiroko; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Osaka, Japan; [Tashiro, Takahiro; Kawada, Kenji; Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Kyoto, Japan; [Ashida, Yasuko] Charles River Labs Japan, Yokohama, Kanagawa, Japan; [Ohue, Masayuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Osaka, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Kyoto University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Inoue, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Osaka, Japan.	inoue-ma2@mc.pref.osaka.jp			Japan Agency for Medical Research and Development [15cm0106155h0002, 16cm0106203h0001]; Takeda Science Foundation; Charles River Laboratory Japans; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [26111005] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Charles River Laboratory Japans; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from P-DIRECT (15cm0106155h0002), and P-CREATE (16cm0106203h0001), Japan Agency for Medical Research and Development (MI, HO, and HE) and the Takeda Science Foundation (MI). Charles River Laboratory Japans provided support in the form of salaries for YA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank A. Mizukoshi, N. Kanto, and T. Yasuda for technical assistance and M. Izutsu for secretarial assistance. The SCADS Inhibitor Kit was kindly provided by the Screening Committee of Anticancer Drugs supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Support Programs for Cancer Research, from The Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bertotti A, 2015, NATURE, V526, P263, DOI 10.1038/nature14969; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kiyohara Y, 2016, CANCER SCI, V107, P452, DOI 10.1111/cas.12898; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Krumbach R, 2011, EUR J CANCER, V47, P1231, DOI 10.1016/j.ejca.2010.12.019; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Nakajima A, 2015, INT J CANCER, V136, P2949, DOI 10.1002/ijc.29349; Napolitano S, 2015, CLIN CANCER RES, V21, P2975, DOI 10.1158/1078-0432.CCR-15-0020; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Nunes M, 2015, CANCER RES, V75, P1560, DOI 10.1158/0008-5472.CAN-14-1590; Okuyama H, 2013, J UROLOGY, V190, P302, DOI 10.1016/j.juro.2012.12.106; Peeters M, 2013, CLIN CANCER RES, V19, P1902, DOI 10.1158/1078-0432.CCR-12-1913; Sorich MJ, 2015, ANN ONCOL, V26, P13, DOI 10.1093/annonc/mdu378; Tabernero J, 2015, LANCET ONCOL, V16, P499, DOI 10.1016/S1470-2045(15)70127-0; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Troiani T, 2014, CLIN CANCER RES, V20, P3775, DOI 10.1158/1078-0432.CCR-13-2181; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yamaki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01160; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yoon J, 2011, CANCER RES, V71, P445, DOI 10.1158/0008-5472.CAN-10-3058; Yoshii Y, 2015, BIOMATERIALS, V51, P278, DOI 10.1016/j.biomaterials.2015.02.008; Zanella ER, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010445	39	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174151	10.1371/journal.pone.0174151	http://dx.doi.org/10.1371/journal.pone.0174151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301591	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300130
J	Sato, K; Kanazawa, S; Yamaguchi, MK				Sato, Kazuki; Kanazawa, So; Yamaguchi, Masami K.			Infants' perception of lightness changes related to cast shadows	PLOS ONE			English	Article							WALLACHS RATIO RULE; 4-MONTH-OLD INFANTS; DEPTH; CONSTANCY; SHAPE; DISCRIMINATION; CONTRAST; FIGURES	When humans perceive the lightness of an object's surface in shadows there is an implicit assumption that cast shadows dim the surface. In two experiments, we investigated whether 5- to 8-month-old infants make this assumption about shadows. According to this shadow assumption, the apparent change in lightness produced by shadows on an object's surface are attributed to blocked light sources. If infants can use the shadow assumption to perceive the object's lightness in shadows, they will also be able to detect unnatural lightness changes in shadows. We compared the infants' looking times to the unnatural and the natural lightness changes in the shadow when an object (duck) goes through the cast shadow. In Experiment 1, we examined whether infants could detect the unnatural lightness changes of the object's surface in shadows. We created computer-graphic movies of unnatural and natural lightness changes to the duck's surface. Our results showed that 7- to 8-month-olds but not 5- to 6-month-olds significantly preferred the movie with the unnatural changes in lightness, indicating that only the older infants could detect these changes. In Experiment 2, we confirmed that the infants' preference was based on the detection of unnatural lightness changes according to the shadow assumption. The natural and the unnatural lightness changes of Experiment 1 were presented without cast shadows. Under these conditions, neither younger nor older infants showed a significant preference. Taken together, the experiments showed that 7- to 8-month-old infants could detect the unnaturalness of a surface's lightness changes produced by shadows. In conclusion, our findings suggest that 7- to 8-month-old infants can perceive an object's lightness in shadows by using an assumption that cast shadows dim the surface of an object.	[Sato, Kazuki; Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Hachioji, Tokyo, Japan; [Sato, Kazuki] Japan Soc Promot Sci, Tokyo, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan	Chuo University; Japan Society for the Promotion of Science; Japan Womens University	Sato, K (corresponding author), Chuo Univ, Dept Psychol, Hachioji, Tokyo, Japan.; Sato, K (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	a12.rrx5@g.chuo-u.ac.jp			MEXT, Japan [25135729, 16H01677]; Japan Society for the Promotion of Science [26.6887]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant in-Aid for Scientific Research on Innovative Areas "Shitsukan" (25135729, and 16H01677) from MEXT, Japan to MKY, and Japan and a Grant-in-Aid for JSPS Fellows (26.6887) from Japan Society for the Promotion of Science to KS.	Adelson E. H, 1995, CHECKER SHADOW ILLUS; Chien SHL, 2006, VISION RES, V46, P2139, DOI 10.1016/j.visres.2005.11.027; Chien SHL, 2005, VISION RES, V45, P2854, DOI 10.1016/j.visres.2004.07.035; Chien SHL, 2003, PSYCHOL SCI, V14, P291, DOI 10.1111/1467-9280.14411; Csibra G, 2001, DEVELOPMENTAL SCI, V4, pF7, DOI 10.1111/1467-7687.00179; Elder JH, 2004, PERCEPTION, V33, P1319, DOI 10.1068/p5323; GILCHRIST A, 2006, SEEING BLACK WHITE, P180; GILCHRIST AL, 1988, PERCEPT PSYCHOPHYS, V43, P415, DOI 10.3758/BF03207877; GRANRUD CE, 1985, PERCEPT PSYCHOPHYS, V37, P415, DOI 10.3758/BF03202872; HERSHBERGER W, 1970, J COMP PHYSIOL PSYCH, V73, P407, DOI 10.1037/h0030223; HESS EH, 1950, J COMP PHYSIOL PSYCH, V43, P112, DOI 10.1037/h0059235; Hillis JM, 2007, CURR BIOL, V17, P1714, DOI 10.1016/j.cub.2007.09.012; Imura T, 2006, VISION RES, V46, P652, DOI 10.1016/j.visres.2005.07.028; Kersten D, 1997, PERCEPTION, V26, P171, DOI 10.1068/p260171; Kingdom FAA, 2011, VISION RES, V51, P652, DOI 10.1016/j.visres.2010.09.012; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; Logvinenko AD, 1999, PERCEPTION, V28, P803, DOI 10.1068/p2801; RAMACHANDRAN VS, 1988, SCI AM, V259, P76, DOI 10.1038/scientificamerican0888-76; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Sato K, 2016, ATTEN PERCEPT PSYCHO, V78, P1453, DOI 10.3758/s13414-016-1114-7; Sato K, 2015, I-PERCEPTION, V6, P91, DOI 10.1068/i0681; Shuwairi SM, 2007, PSYCHOL SCI, V18, P303, DOI 10.1111/j.1467-9280.2007.01893.x; Shuwairi SM, 2009, J EXP CHILD PSYCHOL, V104, P115, DOI 10.1016/j.jecp.2008.10.001; Van de Walle GA, 1998, COGNITIVE DEV, V13, P387, DOI 10.1016/S0885-2014(98)90001-6; WALLACH H, 1948, J EXP PSYCHOL, V38, P310, DOI 10.1037/h0053804; WHITE M, 1982, PERCEPTION, V11, P103, DOI 10.1068/p110103; WHITE M, 1981, PERCEPTION, V10, P215, DOI 10.1068/p100215; Yonas A, 2006, PERCEPT PSYCHOPHYS, V68, P154, DOI 10.3758/BF03193665	28	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173591	10.1371/journal.pone.0173591	http://dx.doi.org/10.1371/journal.pone.0173591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296912	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700044
J	Peters, DL; Stothard, P; Dennis, JJ				Peters, Danielle L.; Stothard, Paul; Dennis, Jonathan J.			The isolation and characterization of Stenotrophomonas maltophilia T4-like bacteriophage DLP6	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; PHAGE THERAPY; SEQUENCE; INFECTION; GENOME; ALGORITHMS; DEFINITION; PREDICTION; DIVERSITY	Increasing isolation of the extremely antibiotic resistant bacterium Stenotrophomonas maltophilia has caused alarm worldwide due to the limited treatment options available. A potential treatment option for fighting this bacterium is 'phage therapy', the clinical application of bacteriophages to selectively kill bacteria. Bacteriophage DLP6 (vB_SmoM-DLP6) was isolated from a soil sample using clinical isolate S. maltophilia strain D1571 as host. Host range analysis of phage DLP6 against 27 clinical S. maltophilia isolates shows successful infection and lysis in 13 of the 27 isolates tested. Transmission electron microscopy of DLP6 indicates that it is a member of the Myoviridae family. Complete genome sequencing and analysis of DLP6 reveals its richly recombined evolutionary history, featuring a core of both T4-like and cyanophage genes, which suggests that it is a member of the T4-superfamily. Unlike other T4-superfamily phages however, DLP6 features a transposase and ends with 229 bp direct terminal repeats. The isolation of this bacteriophage is an exciting discovery due to the divergent nature of DLP6 in relation to the T4-superfamily of phages.	[Peters, Danielle L.; Dennis, Jonathan J.] Univ Alberta, Dept Biol Sci, Centennial Ctr Interdisciplinary Sci 6 065, Edmonton, AB, Canada; [Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Dennis, JJ (corresponding author), Univ Alberta, Dept Biol Sci, Centennial Ctr Interdisciplinary Sci 6 065, Edmonton, AB, Canada.	jon.dennis@ualberta.ca		Dennis, Jonathan/0000-0002-3925-9533; Peters, Danielle/0000-0003-0176-9463	Natural Sciences and Engineering Research Council of Canada (NSERC) [238414]; NSERC PGS-D graduate scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-D graduate scholarship	This study was supported by Operating grant #238414 to JJD from the Natural Sciences and Engineering Research Council of Canada (NSERC) and The authors also acknowledge funding supportfor DLP by a NSERC PGS-D graduate scholarship. http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon Stephen T, 2011, Bacteriophage, V1, P66; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beeton ML, 2015, INT J ANTIMICROB AG, V46, P196, DOI 10.1016/j.ijantimicag.2015.04.005; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Brewer TE, 2014, VIROLOGY, V450, P84, DOI 10.1016/j.virol.2013.11.027; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dreher TW, 2011, ENVIRON MICROBIOL, V13, P1858, DOI 10.1111/j.1462-2920.2011.02502.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2051; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Golshahi L, 2011, J APPL MICROBIOL, V110, P106, DOI 10.1111/j.1365-2672.2010.04863.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagens S, 2004, ANTIMICROB AGENTS CH, V48, P3817, DOI 10.1128/AAC.48.10.3817-3822.2004; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Holguin AV, 2015, VIRUSES-BASEL, V7, P4602, DOI 10.3390/v7082835; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koch Thomas, 1995, Gene Expression, V4, P253; Kumari S, 2011, J MED MICROBIOL, V60, P205, DOI 10.1099/jmm.0.018580-0; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lavigne Rob, 2009, V502, P113, DOI 10.1007/978-1-60327-565-1_8; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Lynch KH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-574; Lynch KH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-223; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Olaitan AO, 2016, INT J ANTIMICROB AG, V47, P1, DOI 10.1016/j.ijantimicag.2015.11.009; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Peters DL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1848-y; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Pincus NB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124280; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Promega Corporation, 2006, DNA IS LAMBD LYS US; Rhoads D D, 2009, J Wound Care, V18, P237; Rose T, 2014, INT J BURNS TRAUMA, V4, P66; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Seed KD, 2009, ANTIMICROB AGENTS CH, V53, P2205, DOI 10.1128/AAC.01166-08; Semler DD, 2014, ANTIMICROB AGENTS CH, V58, P4005, DOI 10.1128/AAC.02388-13; Shueh CS, 2013, J MICROBIOL METH, V94, P141, DOI 10.1016/j.mimet.2013.06.001; Sullivan MB, 2008, ENVIRON MICROBIOL, V10, P2810, DOI 10.1111/j.1462-2920.2008.01702.x; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Tiemann B, 2004, J BACTERIOL, V186, P7262, DOI 10.1128/JB.186.21.7262-7272.2004; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Waseh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013904; Waters V, 2013, J CYST FIBROS, V12, P482, DOI 10.1016/j.jcf.2012.12.006; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Zhong Y, 2002, APPL ENVIRON MICROB, V68, P1576, DOI 10.1128/AEM.68.4.1576-1584.2002	57	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173341	10.1371/journal.pone.0173341	http://dx.doi.org/10.1371/journal.pone.0173341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291834	Green Submitted, Green Published, gold			2022-12-26	WOS:000396094700021
J	Lewis, A; Felice, C; Kumagai, T; Lai, C; Singh, K; Jeffery, RR; Feakins, R; Giannoulatou, E; Armuzzi, A; Jawad, N; Lindsay, JO; Silver, A				Lewis, Amy; Felice, Carla; Kumagai, Tomoko; Lai, Cecilia; Singh, Kriti; Jeffery, Rosemary R.; Feakins, Roger; Giannoulatou, Eleni; Armuzzi, Alessandro; Jawad, Noor; Lindsay, James O.; Silver, Andrew			The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients	PLOS ONE			English	Article							LOW-GRADE DYSPLASIA; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; CROHNS-DISEASE; RISK; SURVEILLANCE; MICRORNAS; MLL3; METAANALYSIS; PROGRESSION	Background Colorectal cancer (CRC) is a life-threatening complication of ulcerative colitis (UC), and patients are routinely screened for the development of precancerous lesions (dysplasia). However, rates of CRC development in patients with confirmed low-grade dysplasia vary widely between studies, suggesting a large degree of heterogeneity between these lesions that is not detectable macroscopically. A better understanding of the underlying molecular changes that occur in dysplasia will help to identify lesions at higher risk of malignancy. MicroRNAs (miRNAs) post-transcriptionally regulate protein expression and cell-signalling networks. Aberrant miRNA expression is a feature of sporadic CRC but much less is known about the changes that occur in dysplasia and in UC. Methods Comprehensive microRNA profiling was performed on RNA extracted from UC dysplastic lesions (n = 7) and UC controls (n = 10). The expression of miRNAs in UC post inflammatory polyps (n = 7) was also assessed. Candidate miRNAs were further validated by qPCR, and miRNA in situ hybridization. Serum levels of miRNAs were also assessed with a view to identification of non-invasive biomarkers of dysplasia. Results UC dysplasia was associated with a shift in miRNA expression profiles that was not seen in inflammatory polyps. In particular, levels of miR-200b-3p were increased in dysplasia, and this miRNA was localised to epithelial cells in dysplastic lesions and in UC cancers. No changes in miRNA levels were detected in the serum. Conclusion UC-Dysplasia is linked to altered miRNA expression in the mucosa and elevated miR-200b-3p levels.	[Lewis, Amy; Felice, Carla; Kumagai, Tomoko; Lai, Cecilia; Singh, Kriti; Jeffery, Rosemary R.; Silver, Andrew] Barts & London Queen Marys Sch Med & Dent, Ctr Genom & Child Hlth, Blizard Inst, London E1 2AT, England; [Felice, Carla; Armuzzi, Alessandro] Catholic Univ Fdn, Gemelli Hosp, IBD Unit, Complesso Integrato Columbus, Rome, Italy; [Feakins, Roger] Royal London Hosp, Dept Histopathol, London E1 1BB, England; [Giannoulatou, Eleni] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Giannoulatou, Eleni] Univ New South Wales, Sydney, NSW, Australia; [Jawad, Noor] Barts & London Queen Marys Sch Med & Dent, Barts Canc Inst, London EC1M 6BQ, England; [Lindsay, James O.] Barts & London Queen Marys Sch Med & Dent, Ctr Immunobiol, Blizard Inst, London E1 2AT, England	University of London; Queen Mary University London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Barts Health NHS Trust; Royal London Hospital; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of London; Queen Mary University London; University of London; Queen Mary University London	Silver, A (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Genom & Child Hlth, Blizard Inst, London E1 2AT, England.; Lindsay, JO (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Immunobiol, Blizard Inst, London E1 2AT, England.	james.lindsay@bartshealth.nhs.uk; a.silver@qmul.ac.uk	Armuzzi, Alessandro/AIC-5188-2022; Feakins, Roger/J-6782-2019; Felice, Carla/M-1914-2018; Feakins, Roger/AAO-5570-2020	Felice, Carla/0000-0001-6646-6231; Giannoulatou, Eleni/0000-0002-7084-6736	Broad Medical Research Program of the Broad Foundation [IBD-0289R]; Barts and The London Charity [MGD0016]	Broad Medical Research Program of the Broad Foundation; Barts and The London Charity	This work was supported by the Broad Medical Research Program of the Broad Foundation [http://www.ccfa.org/science-and.professionals/broad/] (grant no IBD-0289R to Professor Silver and Dr James Lindsay) and Barts and The London Charity [https://bartscharity.org.uk] (grant no MGD0016 to Noor Jawad). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data and preparation, review, or approval of the manuscript.	Befrits R, 2002, DIS COLON RECTUM, V45, P615, DOI 10.1007/s10350-004-6255-4; BERNSTEIN CN, 1994, LANCET, V343, P71; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Charatcharoenwitthaya Phunchai, 2006, Curr Gastroenterol Rep, V8, P75, DOI 10.1007/s11894-006-0067-8; Chen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.22; Choi CHR, 2015, AM J GASTROENTEROL, V110, P1461, DOI 10.1038/ajg.2015.248; Choo KB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0095-x; CONNELL WR, 1994, GASTROENTEROLOGY, V107, P934, DOI 10.1016/0016-5085(94)90216-X; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Guo CC, 2013, ONCOTARGET, V4, P2144, DOI 10.18632/oncotarget.1555; Hedback N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095193; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Je EM, 2013, NEOPLASMA, V60, P188, DOI 10.4149/neo_2013_025; Jess T, 2006, INFLAMM BOWEL DIS, V12, P669, DOI 10.1097/00054725-200608000-00001; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lewis A, 2015, INFLAMM BOWEL DIS, V21, P1141, DOI 10.1097/MIB.0000000000000298; Li B, 2014, GENET MOL RES, V13, P7513, DOI 10.4238/2014.September.12.18; Li WD, 2013, BLOOD, V121, P1478, DOI 10.1182/blood-2012-12-470559; Ludwig K, 2013, VIRCHOWS ARCH, V462, P57, DOI 10.1007/s00428-012-1345-5; Lutgens M, 2015, CLIN GASTROENTEROL H, V13, P148, DOI 10.1016/j.cgh.2014.06.032; Olaru AV, 2013, INFLAMM BOWEL DIS, V19, P471, DOI 10.1097/MIB.0b013e31827e78eb; Ording AG, 2013, INFLAMM BOWEL DIS, V19, P800, DOI 10.1097/MIB.0b013e3182802af7; Pekow J, 2013, INFLAMM BOWEL DIS, V19, P461, DOI 10.1097/MIB.0b013e3182802bac; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Rutter MD, 2004, GUT, V53, P1813, DOI 10.1136/gut.2003.038505; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Scarpati GDV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/840921; Schetter AJ, 2012, CANCER J, V18, P244, DOI 10.1097/PPO.0b013e318258b78f; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Thomas T, 2007, ALIMENT PHARM THER, V25, P657, DOI 10.1111/j.1365-2036.2007.03241.x; Ullman T, 2003, GASTROENTEROLOGY, V125, P1311, DOI 10.1016/j.gastro.2003.08.023; Ullman TA, 2002, AM J GASTROENTEROL, V97, P922; Van Assche G, 2013, J CROHNS COLITIS, V7, P1, DOI 10.1016/j.crohns.2012.09.005; Velayos FS, 2006, GASTROENTEROLOGY, V130, P1941, DOI 10.1053/j.gastro.2006.03.028; Walton Sarah-Jane, 2016, Oncoscience, V3, P173, DOI 10.18632/oncoscience.312; Watanabe Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023320; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yang YZ, 2013, BIOCHEM BIOPH RES CO, V434, P746, DOI 10.1016/j.bbrc.2013.03.122; Zidar N, 2016, J CELL MOL MED, V20, P1813, DOI 10.1111/jcmm.12869	40	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173664	10.1371/journal.pone.0173664	http://dx.doi.org/10.1371/journal.pone.0173664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288169	gold, Green Published			2022-12-26	WOS:000396092400027
J	de Carcer, DA; Hernaez, B; Rastrojo, A; Alcami, A				Aguirre de Carcer, Daniel; Hernaez, Bruno; Rastrojo, Alberto; Alcami, Antonio			Infection with diverse immune-modulating poxviruses elicits different compositional shifts in the mouse gut microbiome	PLOS ONE			English	Article							ECTROMELIA; RECEPTOR; VIRUS	It is often not possible to demonstrate causality within the context of gut microbiota dysbiosislinked diseases. Thus, we need a better understanding of the mechanisms whereby an altered host immunophysiology shapes its resident microbiota. In this regard, immune-modulating poxvirus strains and mutants could differentially alter gut mucosal immunity in the context of a natural immune response, providing a controlled natural in vivo setting to deepen our understanding of the immune determinants of microbiome composition. This study represents a proof-of-concept that the use of an existing collection of different immune-modulating poxviruses may represent an innovative tool in gut microbiome research. To this end, 16S rRNA amplicon sequencing and RNAseq transcriptome profiling were employed as proxies for microbiota composition and gut immunophysiological status in the analysis of caecal samples from control mice and mice infected with various poxvirus types. Our results show that different poxvirus species and mutants elicit different shifts in the mice mucosa-associated microbiota and, in some instances, significant concomitant shifts in gut transcriptome profiles, thus providing an initial validation to the proposed model.	[Aguirre de Carcer, Daniel; Hernaez, Bruno; Rastrojo, Alberto; Alcami, Antonio] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Aguirre de Carcer, Daniel] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	de Carcer, DA; Alcami, A (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.; de Carcer, DA (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	daniel.aguirre@uam.es; aalcami@cbm.csic.es	Hernaez, Bruno/N-4547-2014; de Carcer, Daniel Aguirre/C-7000-2011; Rastrojo, Alberto/N-4607-2014; Alcami, Antonio/F-8512-2015	Hernaez, Bruno/0000-0002-4351-0102; de Carcer, Daniel Aguirre/0000-0003-1104-9566; Rastrojo, Alberto/0000-0003-4381-7267; Alcami, Antonio/0000-0002-3333-6016	Spanish Ministry of Economy and Competitiveness Explora Ciencia [BFU2013-50537-EXP, SAF2012-38957]; Marie Curie IIF grant [PIIF-GA-2012-328287]; program JAE-Doc of CSIC	Spanish Ministry of Economy and Competitiveness Explora Ciencia; Marie Curie IIF grant; program JAE-Doc of CSIC	This work was funded by the Spanish Ministry of Economy and Competitiveness Explora Ciencia grant BFU2013-50537-EXP awarded to DAC and SAF2012-38957 awarded to AA. DAC was partially supported by the Marie Curie IIF grant PIIF-GA-2012-328287. BH was supported by the program JAE-Doc of CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alejo A, 2011, ADV EXP MED BIOL, V691, P203, DOI 10.1007/978-1-4419-6612-4_21; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P6310, DOI 10.1128/AEM.05146-11; Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572; Dray S, 2015, MOL ECOL RESOUR, V15, P242, DOI 10.1111/1755-0998.12300; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2009, CYTOKINE, V48, P144, DOI 10.1016/j.cyto.2009.07.007; Heumuller-Klug S, 2015, WORLD J GASTROENTERO, V21, P3499, DOI 10.3748/wjg.v21.i12.3499; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Mavian C, 2014, VIROLOGY, V462, P218, DOI 10.1016/j.virol.2014.06.010; Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173697	10.1371/journal.pone.0173697	http://dx.doi.org/10.1371/journal.pone.0173697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282449	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800069
J	Chandran, P; Rao, HL; Mandal, AK; Choudhari, NS; Garudadri, CS; Senthil, S				Chandran, Premanand; Rao, Harsha L.; Mandal, Anil K.; Choudhari, Nikhil S.; Garudadri, Chandra S.; Senthil, Sirisha			Glaucoma associated with iridocorneal endothelial syndrome in 203 Indian subjects	PLOS ONE			English	Article							ESSENTIAL IRIS ATROPHY; CHANDLERS SYNDROME; CLINICAL VARIATIONS; COGAN-REESE; SPECTRUM; DISEASE	Purpose To report the demographic profile, clinical features, and prevalence of glaucoma and its management in patients with Iridocorneal endothelial (ICE) syndrome. Methods Retrospective review of 203 consecutive subjects with ICE syndrome at a tertiary eye care centre between January 1988 and June 2013. Results ICE syndrome was present in 223 eyes of 203 subjects, 124 (61%) were female and 79 (39%) were male. The median age at presentation was 43 years (1st (Q1) and 3rd (Q3) quartile; 34, 51 years). ICE syndrome was unilateral in 183 (90%) subjects, and bilateral in 20 (10%) subjects. The most common clinical variant was progressive iris atrophy (PIA, 115; 52% eyes), followed by Chandler syndrome (CS, 87; 39% eyes) and Cogan-Reese syndrome (CRS, 21; 9% eyes). Glaucoma was found in 156 eyes (70%) at presentation and the median (Q1, Q3) intraocular pressure in eyes with glaucoma was 24 (16, 38) mm Hg. Seven eyes developed glaucoma during the follow-up period, increasing the percentage of eyes with glaucoma to 73%. Intraocular pressure was managed medically in 81 eyes (50%) and the other 82 eyes (50%) required surgical intervention. Corneal edema was present in 124 eyes (56%) of which, 32 eyes (14%) required keratoplasty. Conclusions In our study on ICE syndrome in Indian population, the presentation was predominantly uniocular and more common in middle aged women. Progressive iris atrophy was the most common clinical variant. ICE syndrome was associated with glaucoma in over 70% of the eyes and half of the eyes had corneal edema.	[Chandran, Premanand; Rao, Harsha L.; Mandal, Anil K.; Choudhari, Nikhil S.; Garudadri, Chandra S.; Senthil, Sirisha] L V Prasad Eye Inst, VST Glaucoma Ctr, Hyderabad, Telangana, India; [Rao, Harsha L.] Narayana Nethralaya, Bangalore, Karnataka, India	L. V. Prasad Eye Institute	Senthil, S (corresponding author), L V Prasad Eye Inst, VST Glaucoma Ctr, Hyderabad, Telangana, India.	sirishasenthil@lvpei.org	Mandal, Anil/AAY-4809-2020; Choudhari, Nikhil/AAD-7157-2019; Chandran, Premanand/X-8935-2019	Chandran, Premanand/0000-0002-2252-1507; Rao, Harsha/0000-0001-5866-9856				ALVARADO JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1601, DOI 10.1001/archopht.1994.01090240107034; CAMPBELL DG, 1978, AM J OPHTHALMOL, V86, P317, DOI 10.1016/0002-9394(78)90232-5; Chandran P, 2016, J GLAUCOMA, V25, pE652, DOI 10.1097/IJG.0000000000000268; HEMADY RK, 1994, CORNEA, V13, P368, DOI 10.1097/00003226-199407000-00015; HETHERINGTON J, 1978, OPHTHALMOLOGY, V85, P240; HIRST LW, 1980, AUST J OPHTHALMOL, V8, P139, DOI 10.1111/j.1442-9071.1980.tb01672.x; Hodapp E, 1993, CLIN DECISIONS GLAUC, P52; Huna R, 1996, J GLAUCOMA, V5, P60; KIDD M, 1988, ARCH OPHTHALMOL-CHIC, V106, P199; LAGANOWSKI HC, 1992, ARCH OPHTHALMOL-CHIC, V110, P346, DOI 10.1001/archopht.1992.01080150044025; RICHARDSON TM, 1979, ARCH OPHTHALMOL-CHIC, V97, P2112, DOI 10.1001/archopht.1979.01020020430003; RODRIGUES MM, 1978, ARCH OPHTHALMOL-CHIC, V96, P643, DOI 10.1001/archopht.1978.03910050339009; SHIELDS MB, 1978, AM J OPHTHALMOL, V85, P749; SHIELDS MB, 1979, SURV OPHTHALMOL, V24, P3, DOI 10.1016/0039-6257(79)90143-7; Teekhasaenee C, 2000, ARCH OPHTHALMOL-CHIC, V118, P187; WILSON MC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1465, DOI 10.1001/archopht.1989.01070020539035; YANOFF M, 1979, SURV OPHTHALMOL, V24, P1, DOI 10.1016/0039-6257(79)90142-5	17	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0171884	10.1371/journal.pone.0171884	http://dx.doi.org/10.1371/journal.pone.0171884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282413	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800005
J	Desbordes, P; Ruan, S; Modzelewski, R; Pineau, P; Vauclin, S; Gouel, P; Michel, P; Di Fiore, F; Vera, P; Gardin, I				Desbordes, Paul; Ruan, Su; Modzelewski, Romain; Pineau, Pascal; Vauclin, Sebastien; Gouel, Pierrick; Michel, Pierre; Di Fiore, Frederic; Vera, Pierre; Gardin, Isabelle			Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier	PLOS ONE			English	Article							METABOLIC TUMOR VOLUME; CT TEXTURE ANALYSIS; F-18-FDG PET; NEOADJUVANT CHEMORADIOTHERAPY; PATHOLOGICAL RESPONSE; PROGNOSTIC VALUE; HETEROGENEITY; RADIOMICS; PARAMETERS; CHEMOTHERAPY	Purpose In oncology, texture features extracted from positron emission tomography with 18-fluoro-deoxyglucose images (FDG-PET) are of increasing interest for predictive and prognostic studies, leading to several tens of features per tumor. To select the best features, the use of a random forest (RF) classifier was investigated. Methods Sixty-five patients with an esophageal cancer treated with a combined chemo-radiation therapy were retrospectively included. All patients underwent a pretreatment whole-body FDG-PET. The patients were followed for 3 years after the end of the treatment. The response assessment was performed 1 month after the end of the therapy. Patients were classified as complete responders and non-complete responders. Sixty-one features were extracted from medical records and PET images. First, Spearman's analysis was performed to eliminate correlated features. Then, the best predictive and prognostic subsets of features were selected using a RF algorithm. These results were compared to those obtained by a Mann-Whitney U test (predictive study) and a univariate Kaplan-Meier analysis (prognostic study). Results Among the 61 initial features, 28 were not correlated. From these 28 features, the best subset of complementary features found using the RF classifier to predict response was composed of 2 features: metabolic tumor volume (MTV) and homogeneity from the co-occurrence matrix. The corresponding predictive value (AUC = 0.836 +/- 0.105, Se = 82 +/- 9%, Sp = 91 +/- 12%) was higher than the best predictive results found using the Mann-Whitney test: busyness from the gray level difference matrix (P < 0.0001, AUC = 0.810, Se = 66%, Sp = 88%). The best prognostic subset found using RF was composed of 3 features: MTV and 2 clinical features (WHO status and nutritional risk index) (AUC = 0.822 +/- 0.059, Se = 79 +/- 9%, Sp = 95 +/- 6%), while no feature was significantly prognostic according to the Kaplan-Meier analysis. Conclusions The RF classifier can improve predictive and prognostic values compared to the Mann-Whitney U test and the univariate Kaplan-Meier survival analysis when applied to several tens of features in a limited patient database.	[Desbordes, Paul; Ruan, Su; Modzelewski, Romain; Vera, Pierre; Gardin, Isabelle] Univ Rouen, LITIS Quantif, EA4108, Rouen, France; [Desbordes, Paul; Pineau, Pascal; Vauclin, Sebastien] Dosisoft, Cachan, France; [Modzelewski, Romain; Gouel, Pierrick; Vera, Pierre; Gardin, Isabelle] Ctr Henri Becquerel, Dept Nucl Med, Rouen, France; [Michel, Pierre] Normandie Univ, UNIROUEN, Inserm 1245, Rouen Univ Hosp,Dept Hepatogastroenterol, Rouen, France; [Di Fiore, Frederic] Ctr Henri Becquerel, Dept Oncol, Rouen, France	Universite de Rouen Normandie; UNICANCER; Centre Henri Becquerel; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Henri Becquerel	Desbordes, P (corresponding author), Univ Rouen, LITIS Quantif, EA4108, Rouen, France.; Desbordes, P (corresponding author), Dosisoft, Cachan, France.	desbordespaul@gmail.com	Desbordes, Paul/W-6780-2019	Desbordes, Paul/0000-0002-1521-7590; Ruan, Su/0000-0001-8785-6917; Gardin, Isabelle/0000-0002-6342-6127	ANRT (French National Association for Research and Technology) under the contract ANRT [2013/1153]; Dosisoft	ANRT (French National Association for Research and Technology) under the contract ANRT(French National Research Agency (ANR)); Dosisoft	This work was partly funded by ANRT (French National Association for Research and Technology) under the contract ANRT no2013/1153. This work was also funded by Dosisoft. Dosisoft provided support in the form of salaries for authors PD, SV and PP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Altman DG, 1998, BREAST CANCER RES TR, V52, P289, DOI 10.1023/A:1006193704132; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Blom RLGM, 2013, EUR J NUCL MED MOL I, V40, P1500, DOI 10.1007/s00259-013-2468-x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Bundschuh RA, 2014, J NUCL MED, V55, P891, DOI 10.2967/jnumed.113.127340; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Czernin J, 2007, J NUCL MED, V48, p78S; Demsar J, 2006, J MACH LEARN RES, V7, P1; Desseroit MC, 2016, EUR J NUCL MED MOL I, V43, P1477, DOI 10.1007/s00259-016-3325-5; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Gao X, 2015, EUR J RADIOL, V84, P312, DOI 10.1016/j.ejrad.2014.11.006; Giganti F, 2017, EUR RADIOL, V27, P1831, DOI 10.1007/s00330-016-4540-y; Giganti F, 2016, RADIOL MED, V121, P173, DOI 10.1007/s11547-015-0585-2; Giorgetti A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003151; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hatt M, 2013, J NUCL MED, V54, P341, DOI 10.2967/jnumed.112.108837; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1595, DOI 10.1007/s00259-011-1834-9; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1191, DOI 10.1007/s00259-011-1755-7; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hofheinz F, 2015, EUR J NUCL MED MOL I, V42, P429, DOI 10.1007/s00259-014-2953-x; Hyun SH, 2010, ANN SURG ONCOL, V17, P115, DOI 10.1245/s10434-009-0719-7; Lartizien C, 2014, IEEE J BIOMED HEALTH, V18, P946, DOI 10.1109/JBHI.2013.2283658; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Lemarignier C, 2014, EUR J NUCL MED MOL I, V41, P2008, DOI 10.1007/s00259-014-2839-y; Mi HM, 2015, ARTIF INTELL MED, V64, P195, DOI 10.1016/j.artmed.2015.07.002; Orlhac F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145063; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Palie O, 2013, EUR J NUCL MED MOL I, V40, P1345, DOI 10.1007/s00259-013-2450-7; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087; Paul D, 2017, COMPUT MED IMAG GRAP, V60, P42, DOI 10.1016/j.compmedimag.2016.12.002; Raman SP, 2014, ACAD RADIOL, V21, P1587, DOI 10.1016/j.acra.2014.07.023; Tan S, 2013, MED PHYS, V40, DOI 10.1118/1.4820445; Tan S, 2013, INT J RADIAT ONCOL, V85, P1375, DOI 10.1016/j.ijrobp.2012.10.017; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Van de Wiele C, 2013, EUR J NUCL MED MOL I, V40, P290, DOI 10.1007/s00259-012-2280-z; van Rossum PSN, 2016, J NUCL MED, V57, P691, DOI 10.2967/jnumed.115.163766; Vauclin S, 2009, PHYS MED BIOL, V54, P6901, DOI 10.1088/0031-9155/54/22/010; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Yu CH, 2003, RESAMPLING METHODS C, V8; Zhang H, 2014, INT J RADIAT ONCOL, V88, P195, DOI 10.1016/j.ijrobp.2013.09.037	52	30	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173208	10.1371/journal.pone.0173208	http://dx.doi.org/10.1371/journal.pone.0173208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282392	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800021
J	Knitlova, M; Horacek, I				Knitlova, Marketa; Horacek, Ivan			Late Pleistocene-Holocene paleobiogeography of the genus Apodemus in Central Europe	PLOS ONE			English	Article							WESTERN PALEARCTIC REGION; CYTOCHROME-B; MORPHOMETRIC CHARACTERS; DISCRIMINANT-ANALYSIS; MOLECULAR PHYLOGENY; GENETIC-VARIATION; MICE APODEMUS; RODENTIA; SYLVATICUS; MAMMALIA	Wood mice of the genus Apodemus are an essential component of small mammal communities throughout Europe. Molecular data suggest the postglacial colonization of current ranges from south European glacial refugia, different in particular species. Yet, details on the course of colonization and Holocene history of particular species are not available, partly because of a lack of reliable criteria for species identification in the fossil record. Using a sample of extant species, we analyzed variation patterns and between-species overlaps for a large set of metric and non-metric dental variables and established the criteria enabling the reliable species identification of fragmentary fossil material. The corresponding biometrical analyses were undertaken with fossil material of the genus (2528 items, 747 MNI) from 22 continuous sedimentary series in the Czech Republic and Slovakia, from LGM to Recent. In Central Europe, the genus is invariantly absent in LGM assemblages but regularly appears during the Late Vistulian. All the earliest records belong to A. flavicollis, the species clearly predominating in the fossil record until the Late Holocene. A. uralensis accompanied it in all regions until the late Boreal when disappeared from the fossil record (except for Pannonia). A few items identified as A. sylvaticus had already appeared in the early Holocene assemblages, first in the western part of the region, yet the regular appearance of the species is mostly in the post-Neolithic age. A. agrarius appeared sparsely from the Boreal with a maximum frequency during the post-Neolithic period. The results conform well to the picture suggested by molecular phylogeography but demonstrate considerable differences among particular species in dynamic of the range colonization. Further details concerning Holocene paleobiogeography of individual species in the medium latitude Europe are discussed.	[Knitlova, Marketa; Horacek, Ivan] Charles Univ Prague, Dept Zool, Vinicna 7, Prague 2, Czech Republic	Charles University Prague	Horacek, I (corresponding author), Charles Univ Prague, Dept Zool, Vinicna 7, Prague 2, Czech Republic.	horacek@natur.cuni.cz	Horacek, Ivan/V-9741-2017; Knitlova, Marketa/Q-1044-2017	Horacek, Ivan/0000-0002-8356-5554; Knitlova, Marketa/0000-0001-6271-9991	Grantova Agentura, Univerzita Karlova [355511]; SW Programme, Charles University [260313/2016]; Grantova Agentura Ceske Republiky [13-08169S];  [GAUK 355511];  [SVV 260313/2016];  [GACR 13-08169S]	Grantova Agentura, Univerzita Karlova; SW Programme, Charles University; Grantova Agentura Ceske Republiky(Grant Agency of the Czech Republic); ; ; 	Support was provided by Grantova Agentura, Univerzita Karlova, 355511 to MSc Marketa Knitlova; SW Programme, Charles University, 260313/2016 to MSc Marketa Knitlova; Grantova Agentura Ceske Republiky, 13-08169S to Dr. Ivan Horacek.; The work was supported by grants GAUK 355511, SVV 260313/2016 (to MK) and GACR 13-08169S.	Aguilar JP, 2008, CR PALEVOL, V7, P217, DOI 10.1016/j.crpv.2008.02.004; Amori G, 2008, IUCN RED LIST THREAT; Ancillotto L., 2016, MAMM REV; Atopkin DM, 2007, RUSS J GENET+, V43, P665, DOI 10.1134/S1022795407060105; Barciova L, 2009, ACTA ZOOL ACAD SCI H, V55, P31; Bellinvia E, 2004, J ZOOL SYST EVOL RES, V42, P289, DOI 10.1111/j.1439-0469.2004.00270.x; Bellinvia E, 1999, FOLIA ZOOL, V48, P241; BENECKE N, 1999, ARCHAOLOGIE EURASIEN, V6, P43; BOHME WOLFGANG, 1966, ZOOL ANZ, V177, P319; David A.I., 2005, PROBLEMS PALEONTOLOG, P21; DAVID AI, 1999, ARCHAOLOGIE EURASIEN, V6, P59; David AI, 1978, LATE CENOZOIC FAUNA, P75; Davis BAS, 2003, QUATERNARY SCI REV, V22, P1701, DOI 10.1016/S0277-3791(03)00173-2; Englisch H, 1996, BONNER ZOOLOGISCHE B, V46, P249; Fahlke J.M., 2009, THESIS; Filippucci Maria Grazia, 1996, Senckenbergiana Biologica, V75, P1; Filippucci MG, 2002, BIOL J LINN SOC, V75, P395, DOI 10.1111/j.1095-8312.2002.tb02080.x; Freudenthal Mathijs, 1999, P401; Frynta D, 2001, ISRAEL J ZOOL, V47, P243; Gromov IM, 1961, TR KOMISS IZUCH CHET, V17; Haarsma A, 2016, POPUL ECOL; Heinrich W.-D., 1983, Wissenschaftliche Zeitschrift der Humboldt-Universitaet zu Berlin Mathematisch-Naturwissenschaftliche Reihe, V32, P729; Heinrich WD, 1983, WISS Z HUMBOLDT U BE, V32, P45; Herman JS, 2016, BIOL J LINN SOC LOND; Hor?ek I., 2015, FORGOTTEN TIMES SPAC, P363; Horacek I, 2005, ACTA CHIROPTEROL, V7, P189, DOI 10.3161/1733-5329(2005)7[189:HOTPPG]2.0.CO;2; HORACEK I, 1988, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V98, P1; Horacek I, 2002, PREHISTORICKE JESKYN, P313; Horacek I, 2007, SANDSTONE LANDSCAPES, P265; Horacek I., 2006, PLEISTOCENE ENV ARCH, P157; Horacek I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062498; Horakova J., 2014, QUATERN INT, V357, P207; JANOSSY D, 1976, Annales Historico-Naturales Musei Nationalis Hungarici, V68, P5; Janossy D., 1986, PLEISTOCENE VERTEBRA; Jojic V, 2012, J EVOLUTION BIOL, V25, P2489, DOI 10.1111/j.1420-9101.2012.02612.x; KANEKO Y., 2008, IUCN RED LIST THREAT, DOI http://dx.doi.org/10.2305/IUCN.UK.2008.RLTS.T1888A8654207.en; Koh HS, 2014, ACTA ZOOL ACAD SCI H, V60, P73; KORDOS L, 1977, FOLDR KOZL, V25, P144; Kowalski K., 2001, FOLIA QUATERNARIA, V72, P1; Krokhmal AI, 2010, LOCALITIES PLEISTOCE; Krystufek B, 2008, IUCN RED LIST THREAT; Krystufek B, 2009, MAMMALS TURKEY CYPRU; Krystufek Boris, 2007, Zoology in the Middle East, V42, P25; Libois RM, 2001, CAN J ZOOL, V79, P1503, DOI 10.1139/cjz-79-8-1503; Liu XM, 2004, MOL PHYLOGENET EVOL, V33, P1, DOI 10.1016/j.ympev.2004.05.011; Lozek V., 1982, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V92, P1; Lozek V., 1964, Rozpravy ustred Ust geol, V31, P1; Martin Suarez Elvira, 1998, Geobios (Lyon), V31, P87, DOI 10.1016/S0016-6995(98)80099-5; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Michaux JR, 2004, MOL PHYLOGENET EVOL, V32, P788, DOI 10.1016/j.ympev.2004.02.018; Michaux JR, 2003, MOL ECOL, V12, P685, DOI 10.1046/j.1365-294X.2003.01752.x; Michaux JR, 2002, MOL PHYLOGENET EVOL, V23, P123, DOI 10.1016/S1055-7903(02)00007-6; Moncel MH, 2015, J ANTHROPOL ARCHAEOL, V40, P302, DOI 10.1016/j.jaa.2015.09.005; MONTGOMERY WI, 1980, J ZOOL, V192, P351; Musser G.G., 1996, BONNER ZOOL BEITR, V46, P143; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nadachowski A, 2009, LATE PLEISTOCENE ENVIRONMENT OF THE CZESTOCHOWA UPLAND (POLAND) RECONSTRUCTED ON THE BASIS OF FAUNISTIC EVIDENCE FROM ARCHAEOLOGICAL CAVE SITES, P1; NIETHAMMER J, 1978, HDB SAUGETIERE EUROP, V1, P325; Pazonyi P, 2004, PALAEOGEOGR PALAEOCL, V212, P295, DOI 10.1016/j.palaeo.2004.06.008; POPOV VV, 1994, TEMNATA CAVE EXCAVAT, P11; Reutter BA, 1999, ACTA THERIOL, V44, P299, DOI 10.4098/AT.arch.99-28; Royer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145600; Schlitter D., 2008, IUCN RED LIST THREAT; Serizawa K, 2000, BIOCHEM GENET, V38, P27, DOI 10.1023/A:1001828203201; Socha P, 2014, QUATERN INT, V326, P64, DOI 10.1016/j.quaint.2013.12.027; Spitzenberger F., 2001, SAUGETIERFAUNA OSTER; Spitzenberger F., 2014, LYNX, V45, P69; Stanko M., 2014, APODEMUS AGRARIUS PA; STEINER HM, 1968, Z WISS ZOOL ABT A, V177, P1; STORCH G, 1989, Z SAUGETIERKD, V54, P337; Storch G, 1978, TUBINGER MONOGRAPHIE, V5, P131; Storch G., 1978, TUBINGER MONOGRAPHIE, V5, P133; Storch G, 1987, FELSTALLE FORSCHUNGE, V23, P275; STORCH G, 1992, COURIER FORSCHUNGSIN, V153, P135; Storch G., 1973, PALAOLITHICUM BRILLE, P106; Storch G., 1974, Z SAUGETIERKD, V39, P84; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; Suzuki H, 2008, BIOCHEM GENET, V46, P329, DOI 10.1007/s10528-008-9149-7; Tatarinov K. A., 1970, THESIS; Toskan B, 2006, MAMMALIA, V70, P98, DOI 10.1515/MAMM.2006.002; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1; van Kolfschoten T., 1985, Mededelingen Rijks Geologische Dienst, V39, P45; van Kolfschoten T, 1991, MEDED RIJKS GEOL DIE, V46, P37; Van Kolfschoten Th., 2014, SESSELFELSGROTTE 6 N, P27; Vogel P., 1995, SAUGETIERE SCHWEIZ V, P178; Vohralik Vladimir, 2002, Acta Societatis Zoologicae Bohemicae, V66, P67; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zimov SA, 2012, QUATERNARY SCI REV, V57, P26, DOI 10.1016/j.quascirev.2012.10.005	89	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173668	10.1371/journal.pone.0173668	http://dx.doi.org/10.1371/journal.pone.0173668			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282422	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800065
J	Heissig, P; Schrimpf, W; Hadwiger, P; Wagner, E; Lamb, DC				Heissig, Philipp; Schrimpf, Waldemar; Hadwiger, Philipp; Wagner, Ernst; Lamb, Don C.			Monitoring integrity and localization of modified single-stranded RNA oligonucleotides using ultrasensitive fluorescence methods	PLOS ONE			English	Article							PULSED INTERLEAVED EXCITATION; ANTISENSE OLIGONUCLEOTIDES; CHEMICAL-MODIFICATION; SIRNA DELIVERY; THERAPEUTICS; INTERFERENCE; ANTAGOMIRS; MICRORNA; DESIGN; QUANTIFICATION	Short single-stranded oligonucleotides represent a class of promising therapeutics with diverse application areas. Antisense oligonucleotides, for example, can interfere with various processes involved in mRNA processing through complementary base pairing. Also RNA interference can be regulated by antagomirs, single-stranded siRNA and single-stranded microRNA mimics. The increased susceptibility to nucleolytic degradation of unpaired RNAs can be counteracted by chemical modification of the sugar phosphate backbone. In order to understand the dynamics of such single-stranded RNAs, we investigated their fate after exposure to cellular environment by several fluorescence spectroscopy techniques. First, we elucidated the degradation of four differently modified, dual-dye labeled short RNA oligonucleotides in HeLa cell extracts by fluorescence correlation spectroscopy, fluorescence cross-correlation spectroscopy and Forster resonance energy transfer. We observed that the integrity of the oligonucleotide sequence correlates with the extent of chemical modifications. Furthermore, the data showed that nucleolytic degradation can only be distinguished from unspecific effects like aggregation, association with cellular proteins, or intramolecular dynamics when considering multiple measurement and analysis approaches. We also investigated the localization and integrity of the four modified oligonucleotides in cultured HeLa cells using fluorescence lifetime imaging microscopy. No intracellular accumulation could be observed for unmodified oligonucleotides, while completely stabilized oligonucleotides showed strong accumulation within HeLa cells with no changes in fluorescence lifetime over 24 h. The integrity and accumulation of partly modified oligonucleotides was in accordance with their extent of modification. In highly fluorescent cells, the oligonucleotides were transported to the nucleus. The lifetime of the RNA in the cells could be explained by a balance between release of the oligonucleotides from endosomes, degradation by RNases and subsequent depletion from the cells.	[Heissig, Philipp; Wagner, Ernst] Univ Munich LMU, Dept Pharm, Pharmaceut Biotechnol, Munich, Germany; [Heissig, Philipp; Schrimpf, Waldemar; Wagner, Ernst; Lamb, Don C.] Univ Munich LMU, Ctr NanoSci CeNS, Munich, Germany; [Schrimpf, Waldemar; Lamb, Don C.] Univ Munich LMU, Dept Chem, Phys Chem, Munich, Germany; [Hadwiger, Philipp] Axolabs GmbH, Kulmbach, Germany	University of Munich; University of Munich; University of Munich	Wagner, E (corresponding author), Univ Munich LMU, Dept Pharm, Pharmaceut Biotechnol, Munich, Germany.; Wagner, E; Lamb, DC (corresponding author), Univ Munich LMU, Ctr NanoSci CeNS, Munich, Germany.; Lamb, DC (corresponding author), Univ Munich LMU, Dept Chem, Phys Chem, Munich, Germany.	ernst.wagner@cup.uni-muenchen.de; don.lamb@cup.uni-muenchen.de	Wagner, Ernst/A-7435-2012; Lamb, Don C/G-9501-2014; Wagner, Ernst/ABB-5976-2020	Wagner, Ernst/0000-0001-8413-0934; Lamb, Don C/0000-0002-0232-1903; Wagner, Ernst/0000-0001-8413-0934				Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Chan JHP, 2006, CLIN EXP PHARMACOL P, V33, P533, DOI 10.1111/j.1440-1681.2006.04403.x; Chen AK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp837; Chorn G, 2012, RNA, V18, P1796, DOI 10.1261/rna.031278.111; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; CIAFRE SA, 1995, NUCLEIC ACIDS RES, V23, P4134; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; Cortez MA, 2014, MOL THER, V22, P1494, DOI 10.1038/mt.2014.79; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dohmen C, 2012, ACS NANO, V6, P5198, DOI 10.1021/nn300960m; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Frohlich T, 2012, J CONTROL RELEASE, V160, P532, DOI 10.1016/j.jconrel.2012.03.018; Hendrix J, 2013, BIOPHYS J, V105, P848, DOI 10.1016/j.bpj.2013.05.059; Hirsch M, 2015, NUCLEIC ACIDS RES, V43, P4650, DOI 10.1093/nar/gkv307; Juliano RL, 2016, NUCLEIC ACIDS RES, V44, P6518, DOI 10.1093/nar/gkw236; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kopp F, 2014, ONCOTARGET, V5, P185, DOI 10.18632/oncotarget.1427; Kopp F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050469; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lorenz P, 1998, MOL BIOL CELL, V9, P1007, DOI 10.1091/mbc.9.5.1007; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; Lundin KE, 2015, HUM GENE THER, V26, P475, DOI 10.1089/hum.2015.070; Mattes J, 2007, AM J RESP CELL MOL, V36, P8, DOI 10.1165/rcmb.2006-0227TR; Muller K, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/46/464001; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Reinhard S, 2016, MACROMOL BIOSCI; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Schaffert D, 2011, ANGEW CHEM INT EDIT, V50, P8986, DOI 10.1002/anie.201102165; Smart N, 2005, BIOL PROCED ONLINE, V7, P1, DOI 10.1251/bpo99; Thomson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055214; Troiber C, 2013, BIOMATERIALS, V34, P1624, DOI 10.1016/j.biomaterials.2012.11.021; Velu Chinavenmeni S, 2012, Methods Mol Biol, V928, P185, DOI 10.1007/978-1-62703-008-3_15; Wagner E, 2012, ACCOUNTS CHEM RES, V45, P1005, DOI 10.1021/ar2002232; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	43	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173401	10.1371/journal.pone.0173401	http://dx.doi.org/10.1371/journal.pone.0173401			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278199	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900086
J	Gupta, R; Yang, Q; Dogra, SK; Wajapeyee, N				Gupta, R.; Yang, Q.; Dogra, S. K.; Wajapeyee, N.			Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression	ONCOGENE			English	Article							APOPTOSIS INDUCTION; WT1 EXPRESSION; METABOLISM; PATHWAY; SHMT1; SUPPRESSORS; CARCINOMA; CELLS; PROLIFERATION; POLYMORPHISMS	High-grade serous (HGS) ovarian cancer accounts for 90% of all ovarian cancer-related deaths. However, factors that drive HGS ovarian cancer tumor growth have not been fully elucidated. In particular, comprehensive analysis of the metabolic requirements of ovarian cancer tumor growth has not been performed. By analyzing The Cancer Genome Atlas mRNA expression data for HGS ovarian cancer patient samples, we observed that six enzymes of the folic acid metabolic pathway were overexpressed in HGS ovarian cancer samples compared with normal ovary samples. Systematic knockdown of all six genes using short hairpin RNAs (shRNAs) and follow-up functional studies demonstrated that serine hydroxymethyl transferase 1 (SHMT1) was necessary for ovarian cancer tumor growth and cell migration in culture and tumor formation in mice. SHMT1 promoter analysis identified transcription factor Wilms tumor 1 (WT1) binding sites, and WT1 knockdown resulted in reduced SHMT1 transcription in ovarian cancer cells. Unbiased large-scale metabolomic analysis and transcriptome-wide mRNA expression profiling identified reduced levels of several metabolites of the amino sugar and nucleotide sugar metabolic pathways, including sialic acid N-acetylneuraminic acid (Neu5Ac), and downregulation of pro-oncogenic cytokines interleukin-6 and 8 (IL-6 and IL-8) as unexpected outcomes of SHMT1 loss. Overexpression of either IL-6 or IL-8 partially rescued SHMT1 loss-induced tumor growth inhibition and migration. Supplementation of culture medium with Neu5Ac stimulated expression of IL-6 and IL-8 and rescued the tumor growth and migratory phenotypes of ovarian cancer cells expressing SHMT1 shRNAs. In agreement with the ovarian tumor-promoting role of Neu5Ac, treatment with Neu5Ac-targeting glycomimetic P-3Fax-Neu5Ac blocked ovarian cancer growth and migration. Collectively, these results demonstrate that SHMT1 controls the expression of pro-oncogenic inflammatory cytokines by regulating sialic acid Neu5Ac to promote ovarian cancer tumor growth and migration. Thus, targeting of SHMT1 and Neu5Ac represents a precision therapy opportunity for effective HGS ovarian cancer treatment.	[Gupta, R.; Yang, Q.; Wajapeyee, N.] Yale Univ, Sch Med, Dept Pathol, LH-214A,310 Cedar St, New Haven, CT 06510 USA; [Dogra, S. K.] ASTAR, Singapore Inst Clin Sci, Brenner Ctr Mol Med, Singapore, Singapore	Yale University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Wajapeyee, N (corresponding author), Yale Univ, Sch Med, Dept Pathol, LH-214A,310 Cedar St, New Haven, CT 06510 USA.	Narendra.Wajapeyee@yale.edu	Dogra, Shaillay Kumar/K-7073-2015		National Institutes of Health [R21CA197758-01, R21CA191364-01, R01CA196566-01A1, R01CA200919-01, R41 (1R41CA195908-01A1)]; American Cancer Society [128347-RSG-15-212-01-TBG]; NATIONAL CANCER INSTITUTE [R21CA195077, R21CA197758, R41CA195908, R01CA200919, R21CA191364, R01CA196566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the following grants from the National Institutes of Health: R21CA197758-01 (to NW), R21CA191364-01 (to NW), R01CA196566-01A1 (to NW), R01CA200919-01 (to NW) and R41 (1R41CA195908-01A1) (to NW). NW is also supported by a research scholar grant from the American Cancer Society (128347-RSG-15-212-01-TBG).	Alvero AB, 2014, ONCOTARGET, V5, P8703, DOI 10.18632/oncotarget.2367; Bahari G, 2016, CELL MOL BIOL, V62, P45; Bull C, 2015, ACS NANO, V9, P733, DOI 10.1021/nn5061964; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30404; Forloni M, 2016, CELL REP, V16, P457, DOI 10.1016/j.celrep.2016.05.087; Gao B, 2016, J GENE MED, V49, P1325; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Huang WH, 2016, INT J ONCOL, V48, P1125, DOI 10.3892/ijo.2016.3318; Kohnz RA, 2016, ACS CHEM BIOL, V11, P2131, DOI 10.1021/acschembio.6b00433; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Lin L, 2014, CANCER DISCOV, V4, P1168, DOI 10.1158/2159-8290.CD-13-0747; Liu ZY, 2014, ANTICANCER RES, V34, P2331; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miranda F, 2016, CANCER CELL, V30, P273, DOI 10.1016/j.ccell.2016.06.020; Pabalan N, 2013, INT J COLORECTAL DIS, V28, P925, DOI 10.1007/s00384-013-1639-3; Paone A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.482; Pearce OMT, 2016, GLYCOBIOLOGY, V26, P111, DOI 10.1093/glycob/cwv097; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Succi M, 2014, MOL BIOL REP, V41, P581, DOI 10.1007/s11033-013-2895-6; Tania M, 2010, CURR ONCOL, V17, P6; Vachharajani VT, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8167273; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wang YW, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0065-z; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Williams SJ, 2009, GYNECOL ONCOL, V112, P637, DOI 10.1016/j.ygyno.2008.11.015; Wu SJ, 2016, TUMOR BIOL, V37, P5193, DOI 10.1007/s13277-015-4369-z; Yamamoto S, 2007, VIRCHOWS ARCH, V451, P27, DOI 10.1007/s00428-007-0433-4; Yang LF, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.20134892; Zhang SY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2218-0	42	21	21	3	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 13	2017	36	28					4014	4024		10.1038/onc.2017.37	http://dx.doi.org/10.1038/onc.2017.37			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FA3YD	28288142	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000405379900007
J	Vaidyanathan, K; Niranjan, T; Selvan, N; Teo, CF; May, M; Patel, S; Weatherly, B; Skinner, C; Opitz, J; Carey, J; Viskochil, D; Gecz, J; Shaw, M; Peng, YH; Alexov, E; Wang, T; Schwartz, C; Wells, L				Vaidyanathan, Krithika; Niranjan, Tejasvi; Selvan, Nithya; Teo, Chin Fen; May, Melanie; Patel, Sneha; Weatherly, Brent; Skinner, Cindy; Opitz, John; Carey, John; Viskochil, David; Gecz, Jozef; Shaw, Marie; Peng, Yunhui; Alexov, Emil; Wang, Tao; Schwartz, Charles; Wells, Lance			Identification and characterization of a missense mutation in the O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase gene that segregates with X-linked intellectual disability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-RETARDATION; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; NUCLEOCYTOPLASMIC PROTEINS; CHROMOSOME INACTIVATION; SUBSTRATE-SPECIFICITY; INSULIN-RESISTANCE; FRAGILE-X; GLYCOSYLATION; NUCLEAR	O-GlcNAc is a regulatory post-translational modification of nucleocytoplasmic proteins that has been implicated in multiple biological processes, including transcription. In humans, single genes encode enzymes for its attachment (O-GlcNAc transferase (OGT)) and removal (O-GlcNAcase (OGA)). An X-chromosome exome screen identified a missense mutation, which encodes an amino acid in the tetratricopeptide repeat, in OGT (759G>T (p.L254F)) that segregates with X-linked intellectual disability (XLID) in an affected family. A decrease in steady-state OGT protein levels was observed in isolated lymphoblastoid cell lines from affected individuals, consistent with molecular modeling experiments. Recombinant expression of L254F-OGT demonstrated that the enzyme is active as both a glycosyltransferase and an HCF-1 protease. Despite the reduction in OGT levels seen in the L254F-OGT individual cells, we observed that steady-state global O-GlcNAc levels remained grossly unaltered. Surprisingly, lymphoblastoids from affected individuals displayed a marked decrease in steady-state OGA protein and mRNA levels. We observed an enrichment of the OGT-containing transcriptional repressor complex mSin3A-HDAC1 at the proximal promoter region of OGA and correspondingly decreased OGA promoter activity in affected cells. Global transcriptome analysis of L254F-OGT lymphoblastoids compared with controls revealed a small subset of genes that are differentially expressed. Thus, we have begun to unravel the molecular consequences of the 759G>T (p.L254F) mutation in OGT that uncovered a compensation mechanism, albeit imperfect, given the phenotype of affected individuals, to maintain steady-state O-GlcNAc levels. Thus, a single amino acid substitution in the regulatory domain (the tetratricopeptide repeat domain) of OGT, which catalyzes the O-GlcNAc post-translational modification of nuclear and cytosolic proteins, appears causal for XLID.	[Vaidyanathan, Krithika; Selvan, Nithya; Teo, Chin Fen; Patel, Sneha; Weatherly, Brent; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 220 Riverbend Rd, Athens, GA 30602 USA; [Niranjan, Tejasvi; Wang, Tao] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [May, Melanie; Skinner, Cindy; Schwartz, Charles] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Opitz, John; Carey, John; Viskochil, David] Univ Utah, Sch Med, Pediat Med Genet Pediat Pathol Human Genet Obstet, Salt Lake City, UT 84132 USA; [Gecz, Jozef; Shaw, Marie] Univ Adelaide, Dept Paediat, Adelaide, SA 5006, Australia; [Gecz, Jozef; Shaw, Marie] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5006, Australia; [Peng, Yunhui; Alexov, Emil] Clemson Univ, Dept Computat Biophys & Bioinformat, Clemson, SC 29634 USA	University System of Georgia; University of Georgia; Johns Hopkins University; Greenwood Genetic Center; Utah System of Higher Education; University of Utah; University of Adelaide; Robinson Research Institute; University of Adelaide; Clemson University	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 220 Riverbend Rd, Athens, GA 30602 USA.; Schwartz, C (corresponding author), Greenwood Genet Ctr, Greenwood, SC 29646 USA.	ceschwartz@ggc.org; lwells@ccrc.uga.edu	Peng, Yunhui/AAA-3393-2021; Niranjan, Tejasvi/ABD-2892-2020; Vaidyanathan, Krithika/AAN-4574-2020; Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861; Wells, Lance/0000-0003-4956-5363	W.M. Keck Foundation; NIGMS, National Institutes of Health (NIH) [P41GM103490]; NINDS, NIH [RO1NS073854]; South Carolina Department of Disabilities and Special Needs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073854] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); South Carolina Department of Disabilities and Special Needs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a grant from the W.M. Keck Foundation (to L. W.); NIGMS, National Institutes of Health (NIH) Grant P41GM103490 (to L. W.); NINDS, NIH, Grant RO1NS073854 (to C. E. S. and T. W.); and a grant from the South Carolina Department of Disabilities and Special Needs (to C. E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; [Anonymous], 2010, R LANG ENV STAT COMP; ANTECOL MH, 1986, CANCER RES, V46, P1867; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekanayake D, 2011, EUKARYOT CELL, V10, P1465, DOI 10.1128/EC.05185-11; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HALTIWANGER RS, 1992, BIOCHEM SOC T, V20, P264, DOI 10.1042/bst0200264; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HART GW, 1989, CIBA F SYMP, V145, P102; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Huq A., 2015, AM SOC HUM GEN ANN M, p2297T; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Janetzko J, 2016, NAT CHEM BIOL, V12, P899, DOI [10.1038/NCHEMBIO.2173, 10.1038/nchembio.2173]; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lisik MZ, 2008, MED SCI MONITOR, V14, pRA221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; Otte Christine, 2013, Praxis (Bern 1994), V102, P1467, DOI 10.1024/1661-8157/a001488; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Raymond FL, 2006, J MED GENET, V43, P193, DOI 10.1136/jmg.2005.033043; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Salvador-Carulla L, 2008, PSYCHOPATHOLOGY, V41, P10, DOI 10.1159/000109950; Selvan N, 2015, J BIOL CHEM, V290, P11969, DOI 10.1074/jbc.M114.628750; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaidyanathan K, 2014, CRIT REV BIOCHEM MOL, V49, P140, DOI 10.3109/10409238.2014.884535; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	73	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8948	8963		10.1074/jbc.M116.771030	http://dx.doi.org/10.1074/jbc.M116.771030			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28302723	hybrid, Green Published			2022-12-26	WOS:000402153900046
J	Kang, H; Bang, I; Jin, KS; Lee, B; Lee, J; Shao, XQ; Heier, JA; Kwiatkowski, AV; Nelson, WJ; Hardin, J; Weis, WI; Choi, HJ				Kang, Hyunook; Bang, Injin; Jin, Kyeong Sik; Lee, Boyun; Lee, Junho; Shao, Xiangqiang; Heier, Jonathon A.; Kwiatkowski, Adam V.; Nelson, W. James; Hardin, Jeff; Weis, William I.; Choi, Hee-Jung			Structural and functional characterization of Caenorhabditis elegans alpha-catenin reveals constitutive binding to beta-catenin and F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; ADHERENS JUNCTIONS; IN-VITRO; CADHERIN; COMPLEX; VINCULIN; SWITCH; TENSION; SYSTEM; DOMAIN	Intercellular epithelial junctions formed by classical cadherins, beta-catenin, and the actin-binding protein alpha-catenin link the actin cytoskeletons of adjacent cells into a structural continuum. These assemblies transmit forces through the tissue and respond to intracellular and extracellular signals. However, the mechanisms of junctional assembly and regulation are poorly understood. Studies of cadherin-catenin assembly in a number of metazoans have revealed both similarities and unexpected differences in the biochemical properties of the cadherin center dot catenin complex that likely reflect the developmental and environmental requirements of different tissues and organisms. Here, we report the structural and biochemical characterization of HMP-1, the Caenorhabditis elegans alpha-catenin homolog, and compare it with mammalian alpha-catenin. HMP-1 shares overall similarity in structure and actin-binding properties, but displayed differences in conformational flexibility and allosteric regulation from mammalian alpha-catenin. HMP-1 bound filamentous actin with an affinity in the single micromolar range, even when complexed with the beta-catenin homolog HMP-2 or when present in a complex of HMP-2 and the cadherin homolog HMR-1, indicating that HMP-1 binding to F-actin is not allosterically regulated by the HMP-2.HMR-1 complex. The middle (i.e. M) domain of HMP-1 appeared to be less conformationally flexible than mammalian alpha-catenin, which may underlie the dampened effect of HMP-2 binding on HMP-1 actin-binding activity compared with that of the mammalian homolog. In conclusion, our data indicate that HMP-1 constitutively binds beta-catenin and F-actin, and although the overall structure and function of HMP-1 and related alpha-catenins are similar, the vertebrate proteins appear to be under more complex conformational regulation.	[Kang, Hyunook; Bang, Injin; Lee, Junho; Choi, Hee-Jung] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Jin, Kyeong Sik] Pohang Accelerator Lab, Pohang 37673, Gyeongbuk, South Korea; [Lee, Boyun; Lee, Junho] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 08826, South Korea; [Lee, Junho] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 08826, South Korea; [Shao, Xiangqiang; Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Shao, Xiangqiang; Hardin, Jeff] Univ Wisconsin, Program Genet, Madison, WI 53706 USA; [Heier, Jonathon A.; Kwiatkowski, Adam V.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Sch Med, Stanford, CA 94305 USA; [Nelson, W. James; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University (SNU); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Stanford University; Stanford University	Choi, HJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.	choihj@snu.ac.kr	; Weis, William/G-1437-2011	Choi, Hee-Jung/0000-0002-1167-1526; Bang, Injin/0000-0003-0247-6056; Kang, Hyunook/0000-0002-7017-4597; Weis, William/0000-0002-5583-6150; Shao, Xiangqiang/0000-0002-8789-2333	TJ Park Science Fellowship; Basic Research Laboratory Grant from the National Research Foundation of Korea [NRF-2014R1A4A10052590]; National Institutes of Health [GM094663, GM114462, GM058038, HL127711]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058038, P41GM103393, P50GM107615, U01GM094663, R35GM118064, R01GM114462] Funding Source: NIH RePORTER	TJ Park Science Fellowship; Basic Research Laboratory Grant from the National Research Foundation of Korea(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a TJ Park Science Fellowship (to H. J. C.), Basic Research Laboratory Grant NRF-2014R1A4A10052590 from the National Research Foundation of Korea (to H. J. C. and J. L.), and National Institutes of Health Grants GM094663 (to W. J. N. and W. I. W.), GM114462 (to W. I. W.), GM058038 (to J. H.), and HL127711 (to A. V. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Callaci S, 2015, BIOCHEM J, V472, P339, DOI 10.1042/BJ20150410; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi HJ, 2015, DEV CELL, V33, P82, DOI 10.1016/j.devcel.2015.02.005; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Kang H, 2016, ACTA CRYSTALLOGR F, V72, P234, DOI 10.1107/S2053230X16001862; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Ladoux B, 2015, INTEGR BIOL-UK, V7, P1109, DOI 10.1039/c5ib00070j; Li J, 2015, J BIOL CHEM, V290, P18890, DOI 10.1074/jbc.M115.647941; Maki K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24878; Miller PW, 2013, CURR TOP MEMBR, V72, P267, DOI 10.1016/B978-0-12-417027-8.00008-8; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shibahara T, 2015, FEBS LETT, V589, P1754, DOI 10.1016/j.febslet.2015.05.053; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wickline ED, 2016, J BIOL CHEM, V291, P15687, DOI 10.1074/jbc.M116.735423; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	34	12	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7077	7086		10.1074/jbc.M116.769778	http://dx.doi.org/10.1074/jbc.M116.769778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28298447	hybrid, Green Published			2022-12-26	WOS:000400478300018
J	Chen, IC; Lin, MY; Liu, YC; Cheng, HC; Wu, JR; Hsu, JH; Dai, ZK				Chen, I-Chen; Lin, Ming-Yen; Liu, Yi-Ching; Cheng, Hsiao-Chi; Wu, Jiunn-Ren; Hsu, Jong-Hau; Dai, Zen-Kong			The role of transthoracic ultrasonography in predicting the outcome of community-acquired pneumonia in hospitalized children	PLOS ONE			English	Article							LUNG ULTRASOUND; DIAGNOSIS; SEVERITY	Transthoracic ultrasound (TUS) has recently become a valuable tool in the diagnosis of community-acquired pneumonia (CAP). This study assessed the association between TUS findings and clinical outcome in children with CAP. The medical records of pediatric patients hospitalized with CAP who underwent transthoracic ultrasonography within 48 hours of admission were retrospectively reviewed. Associations between the TUS findings and patient outcome were analyzed, including intensive care unit (ICU) admission, length of hospital stay, and tube thoracotomy. The study enrolled 142 patients (median age, 60 months): 28 (19.7%) required ICU admission, 14 (9.89%) underwent tube thoracotomy, and 26 (18.3%) had a hospital stay > 9 days. Multifocal involvement seen by TUS were independently associated with ICU admission, a prolonged hospital stay, and tube thoracotomy (p = 0.0027, p = 0.02, and p = 0.0262, respectively). A pleural effusion and fluid bronchogram were independent predictors of a longer hospital stay (p = 0.003 and p = 0.006, respectively). In addition, a fluid bronchogram was an independent predictor of tube thoracotomy (p = 0.0262). Conclusion TUS findings of fluid bronchogram, multifocal involvement, and pleural effusion were associated with adverse outcomes, including longer hospital stay, ICU admission, and tube thoracotomy in hospitalized CAP children. Therefore, TUS is a novel tool for prognostic stratifications of CAP in hospitalized children.	[Chen, I-Chen; Liu, Yi-Ching; Cheng, Hsiao-Chi; Wu, Jiunn-Ren; Hsu, Jong-Hau; Dai, Zen-Kong] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Lin, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Ming-Yen] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Wu, Jiunn-Ren; Hsu, Jong-Hau; Dai, Zen-Kong] Kaohsiung Med Univ, Sch Med, Dept Pediat, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Hsu, JH; Dai, ZK (corresponding author), Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.; Hsu, JH; Dai, ZK (corresponding author), Kaohsiung Med Univ, Sch Med, Dept Pediat, Coll Med, Kaohsiung, Taiwan.	jhh936@yahoo.com.tw; zenkong@kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Chen, I-Chen/0000-0002-9770-8544	Kaohsiung Medical University Hospital, Taiwan [KMUH103-3M30]; Ministry of Science and Technology, R.O.C. [MOST105-2314-B-037-011-, MOST 103-2314-B-037-023-MY3]	Kaohsiung Medical University Hospital, Taiwan; Ministry of Science and Technology, R.O.C.	This research was supported by the grant from the Kaohsiung Medical University Hospital, Taiwan (KMUH103-3M30) and Ministry of Science and Technology, R.O.C. (MOST105-2314-B-037-011- and MOST 103-2314-B-037-023-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Kishk I, 2014, MINERVA PEDIAT; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chen IC, 2015, PEDIAT NEONATOLOGY; Copetti R, 2008, RADIOL MED, V113, P190, DOI 10.1007/s11547-008-0247-8; de Hoyos A, 2002, SURG CLIN N AM, V82, P643, DOI 10.1016/S0039-6109(02)00022-1; Ferrero F, 2010, PEDIATR PULM, V45, P1009, DOI 10.1002/ppul.21287; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Ho MC, 2015, PEDIATR NEONATOL, V56, P40, DOI 10.1016/j.pedneo.2014.03.007; Key NK, 2009, PEDIATR PULM, V44, P249, DOI 10.1002/ppul.20988; Lai SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130082; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin Chao-Jen, 2006, Journal of Microbiology Immunology and Infection, V39, P489; Mathis G, 2011, CHEST SONOGRAPHY; Patria MF, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-56; Reali F, 2014, RESPIRATION, V88, P112, DOI 10.1159/000362692; Reissig A, 2012, EUR J INTERN MED, V23, P391, DOI 10.1016/j.ejim.2012.01.003; Shah VP, 2013, JAMA PEDIATR, V167, P119, DOI 10.1001/2013.jamapediatrics.107; Sperandeo M, 2014, RADIOL MED, V119, P729, DOI 10.1007/s11547-014-0385-0; Trovato GM, 2013, AM J RESP CRIT CARE, V187, P780, DOI 10.1164/ajrccm.187.7.780; Urbankowska E, 2015, RESP MED, V109, P1207, DOI 10.1016/j.rmed.2015.06.011; Varshney T, 2016, EMERG MED J, V33, P603, DOI 10.1136/emermed-2015-205302; Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4; Wallihan R, 2014, J INFECTION, V69, pS87, DOI 10.1016/j.jinf.2014.07.021; WIENERKRONISH JP, 1985, AM REV RESPIR DIS, V132, P1253	25	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173343	10.1371/journal.pone.0173343	http://dx.doi.org/10.1371/journal.pone.0173343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301494	gold, Green Submitted, Green Published			2022-12-26	WOS:000396318300033
J	Chin, EH; Schmidt, KL; Martel, KM; Wong, CK; Hamden, JE; Gibson, WT; Soma, KK; Christians, JK				Chin, Eunice H.; Schmidt, Kim L.; Martel, Kaitlyn M.; Wong, Chi Kin; Hamden, Jordan E.; Gibson, William T.; Soma, Kiran K.; Christians, Julian K.			A maternal high-fat, high-sucrose diet has sexspecific effects on fetal glucocorticoids with little consequence for offspring metabolism and voluntary locomotor activity in mice	PLOS ONE			English	Article							PLACENTAL NUTRIENT TRANSPORT; PHYSICAL-ACTIVITY; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; OBESOGENIC DIET; INDUCED OBESITY; ANIMAL-MODELS; BIRTH-WEIGHT	Maternal overnutrition and obesity during pregnancy can have long-term effects on offspring physiology and behaviour. These developmental programming effects may be mediated by fetal exposure to glucocorticoids, which is regulated in part by placental 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) type 1 and 2. We tested whether a maternal high-fat, high-sucrose diet would alter expression of placental 11 beta-HSD1 and 2, thereby increasing fetal exposure to maternal glucocorticoids, with downstream effects on offspring physiology and behaviour. C57BL/6J mice were fed a high-fat, high-sucrose (HFHS) diet or a nutrient-matched low-fat, no-sucrose control diet prior to and during pregnancy and lactation. At day 17 of gestation, HFHS dams had similar to 20% lower circulating corticosterone levels than controls. Furthermore, there was a significant interaction between maternal diet and fetal sex for circulating corticosterone levels in the fetuses, whereby HFHS males tended to have higher corticosterone than control males, with no effect in female fetuses. However, placental 11 beta-HSD1 or 11 beta-HSD2 expression did not differ between diets or show an interaction between diet and sex. To assess potential long-term consequences of this sex-specific effect on fetal corticosterone, we studied locomotor activity and metabolic traits in adult offspring. Despite a sex-specific effect of maternal diet on fetal glucocorticoids, there was little evidence of sex-specific effects on offspring physiology or behaviour, although HFHS offspring of both sexes had higher circulating corticosterone at 9 weeks of age. Our results suggest the existence of as yet unknown mechanisms that mitigate the effects of altered glucocorticoid exposure early in development, making offspring resilient to the potentially negative effects of a HFHS maternal diet.	[Chin, Eunice H.; Schmidt, Kim L.; Martel, Kaitlyn M.; Christians, Julian K.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Schmidt, Kim L.; Soma, Kiran K.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Wong, Chi Kin; Gibson, William T.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Wong, Chi Kin; Gibson, William T.] BC Childrens Hosp, Vancouver, BC, Canada; [Hamden, Jordan E.; Soma, Kiran K.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia	Christians, JK (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.	julian_christians@sfu.ca	Christians, J.K./AAL-2547-2020; Soma, Kiran K/B-9772-2012; Gibson, William/AFL-3634-2022	Christians, J.K./0000-0003-1797-0591; Soma, Kiran K/0000-0003-2169-8092; Gibson, William/0000-0002-6552-402X; Wong, Chi Kin/0000-0003-4828-8413; Schmidt, Kim/0000-0003-2311-9285; Hamden, Jordan/0000-0002-8152-6113	Natural Sciences and Engineering Research Council of Canada [402576-11, 2014-04884, 326791-2011]; postdoctoral fellowships	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); postdoctoral fellowships	This project was funded by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grants to WTG (402576-11), KKS (2014-04884), and JKC (326791-2011) and postdoctoral fellowships to EHC and KLS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bellisario V, 2015, PSYCHONEUROENDOCRINO, V60, P138, DOI 10.1016/j.psyneuen.2015.06.012; Bowe JE, 2014, J ENDOCRINOL, V222, pG13, DOI 10.1530/JOE-14-0182; Bronson SL, 2016, NEUROPSYCHOPHARMACOL, V41, P207, DOI 10.1038/npp.2015.231; Chin EH, 2015, J DEV ORIG HLTH DIS, V6, P438, DOI 10.1017/S2040174415001348; Christians JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056260; Connor KL, 2009, REPROD SCI, V16, P1201, DOI 10.1177/1933719109345162; Cottrell EC, 2014, ACTA PHYSIOL, V210, P288, DOI 10.1111/apha.12187; Cottrell EC, 2012, FASEB J, V26, P1866, DOI 10.1096/fj.12-203489; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; Diaz P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121798; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Gaccioli F, 2013, J DEV ORIG HLTH DIS, V4, P101, DOI 10.1017/S2040174412000529; Garbrecht MR, 2013, ISRN ENDOCRINOL, V2013; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; Hale MW, 2015, NEUROSCI BIOBEHAV R, V58, P46, DOI 10.1016/j.neubiorev.2014.12.009; Ingvorsen C, 2014, INT J OBESITY, V38, P1282, DOI 10.1038/ijo.2014.69; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kim DW, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117259; King V, 2013, PLACENTA, V34, P1087, DOI 10.1016/j.placenta.2013.09.006; King V, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-73; King V, 2013, ENDOCRINOLOGY, V154, P2514, DOI 10.1210/en.2013-1013; Lager S, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.242; LangleyEvans SC, 1996, PLACENTA, V17, P169, DOI 10.1016/S0143-4004(96)80010-5; Li G, 2013, DIABETES, V62, P2773, DOI 10.2337/db12-1306; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Mark PJ, 2009, BIOL REPROD, V80, P1209, DOI 10.1095/biolreprod.108.073650; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; Mendes-da-Silva C, 2014, ARQ NEURO-PSIQUIAT, V72, P136, DOI 10.1590/0004-282X20130220; Mina TH, 2015, PSYCHONEUROENDOCRINO, V59, P112, DOI 10.1016/j.psyneuen.2015.05.004; Ngai YF, 2010, ENDOCRINOLOGY, V151, P5226, DOI 10.1210/en.2010-0496; O'Connor DM, 2007, ENDOCRINOLOGY, V148, P3750, DOI 10.1210/en.2007-0310; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Rosario FJ, 2015, OBESITY, V23, P1663, DOI 10.1002/oby.21165; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sasson IE, 2015, DIABETOLOGIA, V58, P615, DOI 10.1007/s00125-014-3466-7; Sferruzzi-Perri AN, 2013, FASEB J, V27, P3928, DOI 10.1096/fj.13-234823; Sferruzzi-Perri AN, 2013, CURR OPIN CLIN NUTR, V16, P298, DOI 10.1097/MCO.0b013e32835e3643; Stirrat LI, 2016, J STEROID BIOCHEM, V160, P214, DOI 10.1016/j.jsbmb.2015.07.003; Stirrat LI, 2016, PSYCHONEUROENDOCRINO, V63, P135, DOI 10.1016/j.psyneuen.2015.09.019; Stocker C, 2004, INT J OBESITY, V28, P129, DOI 10.1038/sj.ijo.0802476; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Taves MD, 2015, ENDOCRINOLOGY, V156, P511, DOI 10.1210/en.2013-1606; Tessier DR, 2013, PLACENTA, V34, P205, DOI 10.1016/j.placenta.2012.11.035; Togher KL, 2014, EPIGENETICS-US, V9, P816, DOI 10.4161/epi.28703; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006; Zhu SY, 2016, P NUTR SOC, V75, P73, DOI 10.1017/S0029665115004127	51	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174030	10.1371/journal.pone.0174030	http://dx.doi.org/10.1371/journal.pone.0174030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301585	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300115
J	Gamez, J; Salvado, M; Martinez-de La Ossa, A; Deu, M; Romero, L; Roman, A; Sacanell, J; Laborda, C; Rochera, I; Nadal, M; Carmona, F; Santamarina, E; Raguer, N; Canela, M; Sole, J				Gamez, Josep; Salvado, Maria; Martinez-de La Ossa, Alejandro; Deu, Maria; Romero, Laura; Roman, Antonio; Sacanell, Judith; Laborda, Cesar; Rochera, Isabel; Nadal, Miriam; Carmona, Francesc; Santamarina, Estevo; Raguer, Nuria; Canela, Merce; Sole, Joan			Influence of early neurological complications on clinical outcome following lung transplant	PLOS ONE			English	Article							CRITICAL ILLNESS POLYNEUROPATHY; NERVOUS-SYSTEM COMPLICATIONS; ISHLT INTERNATIONAL REGISTRY; LONG-TERM SURVIVAL; HEART-LUNG; ADULT LUNG; MECHANICAL VENTILATION; PEDIATRIC LUNG; SOCIETY; GASTROPARESIS	Background Neurological complications after lung transplantation are common. The full spectrum of neurological complications and their impact on clinical outcomes has not been extensively studied. Methods We investigated the neurological incidence of complications, categorized according to whether they affected the central, peripheral or autonomic nervous systems, in a series of 109 patients undergoing lung transplantation at our center between January 1 2013 and December 31 2014. Results Fifty-one patients (46.8%) presented at least one neurological complication. Critical illness polyneuropathy-myopathy (31 cases) and phrenic nerve injury (26 cases) were the two most prevalent complications. These two neuromuscular complications lengthened hospital stays by a median period of 35.5 and 32.5 days respectively. However, neurological complications did not affect patients' survival. Conclusions The real incidence of neurological complications among lung transplant recipients is probably underestimated. They usually appear in the first two months after surgery. Despite not affecting mortality, they do affect the mean length of hospital stay, and especially the time spent in the Intensive Care Unit. We found no risk factor for neurological complications except for long operating times, ischemic time and need for transfusion. It is necessary to develop programs for the prevention and early recognition of these complications, and the prevention of their precipitant and risk factors.	[Gamez, Josep; Salvado, Maria; Santamarina, Estevo] Autonomous Univ Barcelona, Dept Neurol, Vall dHebron Res Inst, Vall dHebron Univ Hosp, Barcelona, Spain; [Martinez-de La Ossa, Alejandro] Autonomous Univ Barcelona, Dept Neurophysiol, Vall dHebron Univ Hosp, Barcelona, Spain; [Deu, Maria; Romero, Laura; Canela, Merce; Sole, Joan] Vall dHebron Univ Hosp, Dept Thorac Surg, Lung Transplant Unit, Barcelona, Spain; [Roman, Antonio] Vall dHebron Univ Hosp, Dept Pulmonol, Lung Transplant Unit, Barcelona, Spain; [Sacanell, Judith; Laborda, Cesar] Vall dHebron Univ Hosp, Crit Care Dept, Lung Transplant Unit, Barcelona, Spain; [Rochera, Isabel; Nadal, Miriam] Vall dHebron Univ Hosp, Dept Anesthesiol, Barcelona, Spain; [Carmona, Francesc] Univ Barcelona, Dept Stat, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; University of Barcelona	Gamez, J (corresponding author), Autonomous Univ Barcelona, Dept Neurol, Vall dHebron Res Inst, Vall dHebron Univ Hosp, Barcelona, Spain.	josepgamez.bcn@gmail.com	de Nadal, Miriam/J-8127-2017	de Nadal, Miriam/0000-0002-4559-2463; Romero Vielva, Laura/0000-0002-5839-4693; Raguer, Nuria/0000-0002-9471-9096; Gamez, Josep/0000-0003-3127-7486; Deu Martin, Maria/0000-0002-8441-9196; Laborda, Cesar/0000-0002-5642-5847	Spanish Fondo de Investigaciones Sanitarias [FIS PI13-01272-FEDER]	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	JG is the recipient of a grant from the Spanish Fondo de Investigaciones Sanitarias (FIS PI13-01272-FEDER).	Alejaldre A, 2010, CURR CARDIOL REV, V6, P214, DOI 10.2174/157340310791658811; Amodio P, 2007, DIGEST LIVER DIS, V39, P740, DOI 10.1016/j.dld.2007.05.004; Benden C, 2014, J HEART LUNG TRANSPL, V33, P1025, DOI 10.1016/j.healun.2014.08.005; BERKOWITZ N, 1995, CHEST, V108, P1602, DOI 10.1378/chest.108.6.1602; BOLTON CF, 1984, J NEUROL NEUROSUR PS, V47, P1223, DOI 10.1136/jnnp.47.11.1223; BOLTON CF, 1987, MUSCLE NERVE, V10, P129, DOI 10.1002/mus.880100205; Bolton CF, 2010, CAN J NEUROL SCI, V37, P431, DOI 10.1017/S031716710001043X; Canbaz Suat, 2004, BMC Surg, V4, P2, DOI 10.1186/1471-2482-4-2; Chan EG, 2016, J THORAC CARDIOV SUR, V151, P1171, DOI 10.1016/j.jtcvs.2015.11.058; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Dorffner R, 1997, J HEART LUNG TRANSPL, V16, P566; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Ferdinande P, 2004, J HEART LUNG TRANSPL, V23, P105, DOI 10.1016/S1053-2498(03)00068-8; Fu KA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00275; Goldstein AB, 2000, PEDIATR PULM, V30, P203, DOI 10.1002/1099-0496(200009)30:3<203::AID-PPUL4>3.3.CO;2-X; Goldstein LS, 1998, J HEART LUNG TRANSPL, V17, P185; Gutmann L, 1999, ARCH NEUROL-CHICAGO, V56, P527, DOI 10.1001/archneur.56.5.527; HALL WA, 1989, ARCH NEUROL-CHICAGO, V46, P173, DOI 10.1001/archneur.1989.00520380077017; Hermans G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006832.pub3; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Isnard J, 2007, J RADIOL, V88, P339, DOI 10.1016/S0221-0363(07)89830-1; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Kinaschuk K, 2016, J THORAC CARDIOV SUR, V151, P1181, DOI 10.1016/j.jtcvs.2015.12.045; Latronico N, 2008, MINERVA ANESTESIOL, V74, P319; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Marco S, 2009, TRANSPL INT, V22, P269, DOI 10.1111/j.1432-2277.2008.00780.x; MARKAND ON, 1984, NEUROLOGY, V34, P604, DOI 10.1212/WNL.34.5.604; Mateen FJ, 2010, AM J TRANSPLANT, V10, P908, DOI 10.1111/j.1600-6143.2009.02998.x; Maziak DE, 1996, ANN THORAC SURG, V61, P170, DOI 10.1016/0003-4975(95)00823-3; Mazzoni M, 1996, CHEST, V109, P1455, DOI 10.1378/chest.109.6.1455; Nwakanma LU, 2007, J THORAC CARDIOV SUR, V133, P541, DOI 10.1016/j.jtcvs.2006.09.062; PATCHELL RA, 1994, ANN NEUROL, V36, P688, DOI 10.1002/ana.410360503; Paul S, 2009, J HEART LUNG TRANSPL, V28, P475, DOI 10.1016/j.healun.2009.02.011; Perez-Miralles F, 2005, TRANSPL P, V37, P4067, DOI 10.1016/j.transproceed.2005.09.162; Pietrantoni C, 2003, CHEST, V123, P504, DOI 10.1378/chest.123.2.504; Ponticelli C, 2005, J NEPHROL, V18, P521; Scannell JG, 1963, J THORAC CARDIOVASC, V45, P64; SHERIDAN PH, 1995, J HEART LUNG TRANSPL, V14, P684; Stehlik J, 2014, J HEART LUNG TRANSPL, V33, P975, DOI 10.1016/j.healun.2014.08.001; Stehlik J, 2013, J HEART LUNG TRANSPL, V32, P941, DOI 10.1016/j.healun.2013.08.009; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Wong M, 1999, NEUROLOGY, V53, P1542, DOI 10.1212/WNL.53.7.1542; Yiannopoulos A, 2004, J HEART LUNG TRANSPL, V23, P371, DOI 10.1016/S1053-2498(03)00188-8; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007; Zivkovic Sasa A, 2014, Handb Clin Neurol, V121, P1305, DOI 10.1016/B978-0-7020-4088-7.00089-4; Zivkovic SA, 2009, J NEUROL SCI, V280, P90, DOI 10.1016/j.jns.2009.02.308	46	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174092	10.1371/journal.pone.0174092	http://dx.doi.org/10.1371/journal.pone.0174092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301586	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300125
J	Khodayari, N; Wang, RL; Marek, G; Krotova, K; Kirst, M; Liu, C; Rouhani, F; Brantly, M				Khodayari, Nazli; Wang, Rejean Liqun; Marek, George; Krotova, Karina; Kirst, Mariana; Liu, Chen; Rouhani, Farshid; Brantly, Mark			SVIP regulates Z variant alpha-1 antitrypsin retro-translocation by inhibiting ubiquitin ligase gp78	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; ER-ASSOCIATED DEGRADATION; MOTILITY FACTOR-RECEPTOR; ENDOPLASMIC-RETICULUM; INTRACELLULAR DEGRADATION; QUALITY-CONTROL; LIVER-DISEASE; CELL-DEATH; ALPHA(1)-ANTITRYPSIN; DEFICIENCY	Alpha-1 antitrypsin deficiency (AATD) is an inherited disorder characterized by early-onset emphysema and liver disease. The most common disease-causing mutation is a single amino acid substitution (Glu/Lys) at amino acid 342 of the mature protein, resulting in disruption of the 290 - 342 salt bridge (an electrophoretic abnormality defining the mutation [Z allele, or ZAAT]), protein misfolding, polymerization, and accumulation in the endoplasmic reticulum of hepatocytes and monocytes. The Z allele causes a toxic gain of function, and the E3 ubiquitin ligase gp78 promotes degradation and increased solubility of endogenous ZAAT. We hypothesized that the accumulation of ZAAT is influenced by modulation of gp78 E3 ligase and SVIP (small VCP-interacting protein) interaction with p97/VCP in ZAAT-expressing hepatocytes. We showed that the SVIP inhibitory effect on ERAD due to overexpression causes the accumulation of ZAAT in a human Z hepatocyte-like cell line (AT01). Overexpression of gp78, as well as SVIP suppression, induces gp78-VCP/p97 interaction in AT01 cells. This interaction leads to retro-translocation of ZAAT and reduction of the SVIP inhibitory role in ERAD. In this context, overexpression of gp78 or SVIP suppression may eliminate the toxic gain of function associated with polymerization of ZAAT, thus providing a potential new therapeutic approach to the treatment of AATD.	[Khodayari, Nazli; Wang, Rejean Liqun; Marek, George; Krotova, Karina; Kirst, Mariana; Rouhani, Farshid; Brantly, Mark] Univ Florida, Dept Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32611 USA; [Liu, Chen] Rutgers State Univ, Dept Pathol & Lab Med, New Brunswick, NJ USA	State University System of Florida; University of Florida; Rutgers State University New Brunswick	Brantly, M (corresponding author), Univ Florida, Dept Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32611 USA.	mbrantly@ufl.edu	Brantly, Mark/AAH-2922-2020	Krotova, Karina/0000-0002-2248-1277	Alpha-1 Foundation; Fundacion Leopoldo Fernandez	Alpha-1 Foundation; Fundacion Leopoldo Fernandez	This work was supported by research grants from the Alpha-1 Foundation (www.alpha1.org) to MB and the Fundacion Leopoldo Fernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussouan LS, 2009, RESP MED, V103, P335, DOI 10.1016/j.rmed.2008.10.006; Alonzi DS, 2008, BIOCHEM J, V409, P571, DOI 10.1042/BJ20070748; Ballar P, 2008, BIOCHEM SOC T, V36, P818, DOI 10.1042/BST0360818; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; BRANTLY M, 1988, SCIENCE, V242, P1700, DOI 10.1126/science.2904702; BRANTLY ML, 1988, AM REV RESPIR DIS, V138, P327, DOI 10.1164/ajrccm/138.2.327; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; de Bernard M, 1998, TOXICOL LETT, V99, P109, DOI 10.1016/S0378-4274(98)00140-4; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P42; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P2136, DOI 10.1111/j.1572-0241.2008.01955.x; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Guo F, 2013, J CELL SCI, V126, P1429, DOI 10.1242/jcs.118182; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; He XY, 2011, DEV GROWTH DIFFER, V53, P312, DOI 10.1111/j.1440-169X.2010.01236.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hughes VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102617; Jezierski G, 2001, ACTA BIOCHIM POL, V48, P65; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; LEI KJ, 1992, MOL ENDOCRINOL, V6, P703, DOI 10.1210/me.6.5.703; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lindblad D, 2007, HEPATOLOGY, V46, P1228, DOI 10.1002/hep.21822; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Novoradovskaya N, 1998, J CLIN INVEST, V101, P2693, DOI 10.1172/JCI549; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; SIFERS RN, 1989, J BIOL CHEM, V264, P2997; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stoller JK, 2004, THORAX, V59, P92, DOI 10.1136/thorax.2003.017517; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Wang HP, 2011, MOL CELL BIOCHEM, V346, P137, DOI 10.1007/s11010-010-0600-9; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wu JW, 2013, BIOCHEM BIOPH RES CO, V440, P173, DOI 10.1016/j.bbrc.2013.09.056; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhong YW, 2015, BIOCHEM BIOPH RES CO, V458, P424, DOI 10.1016/j.bbrc.2015.01.133	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172983	10.1371/journal.pone.0172983	http://dx.doi.org/10.1371/journal.pone.0172983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301499	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300022
J	Lutton, EJ; Lammers, WJEP; James, S; van den Berg, HA; Blanks, AM				Lutton, E. Josiah; Lammers, Wim J. E. P.; James, Sean; van den Berg, Hugo A.; Blanks, Andrew M.			A computational method for three-dimensional reconstruction of the microarchitecture of myometrial smooth muscle from histological sections	PLOS ONE			English	Article							OPEN-SOURCE SOFTWARE; HUMAN UTERUS; QUANTIFICATION; SEGMENTATION; IMAGES; MRI	Background The fibrous structure of the myometrium has previously been characterised at high resolutions in small tissue samples (< 100 mm(3)) and at low resolutions (similar to 500 mu m per voxel edge) in whole-organ reconstructions. However, no high-resolution visualisation of the myometrium at the organ level has previously been attained. Methods and results We have developed a technique to reconstruct the whole myometrium from serial histological slides, at a resolution of approximately 50 mu m per voxel edge. Reconstructions of samples taken from human and rat uteri are presented here, along with histological verification of the reconstructions and detailed investigation of the fibrous structure of these uteri, using a range of tools specifically developed for this analysis. These reconstruction techniques enable the high-resolution rendering of global structure previously observed at lower resolution. Moreover, structures observed previously in small portions of the myometrium can be observed in the context of the whole organ. The reconstructions are in direct correspondence with the original histological slides, which allows the inspection of the anatomical context of any features identified in the three-dimensional reconstructions. Conclusions and significance The methods presented here have been used to generate a faithful representation of myometrial smooth muscle at a resolution of similar to 50 mu m per voxel edge. Characterisation of the smooth muscle structure of the myometrium by means of this technique revealed a detailed view of previously identified global structures in addition to a global view of the microarchitecture. A suite of visualisation tools allows researchers to interrogate the histological microarchitecture. These methods will be applicable to other smooth muscle tissues to analyse fibrous microarchitecture.	[Lutton, E. Josiah; Blanks, Andrew M.] Warwick Med Sch, Div Biomed Sci, Cell & Dev Biol, Coventry, W Midlands, England; [Lammers, Wim J. E. P.] Univ Auckland, Bioengn Inst, Auckland, New Zealand; [Lammers, Wim J. E. P.] UAE Univ, Dept Physiol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [James, Sean] NHS Trust, UHCW, Dept Pathol, Coventry, W Midlands, England; [van den Berg, Hugo A.] Univ Warwick, Coventry, W Midlands, England	University of Warwick; University of Auckland; United Arab Emirates University; University of Warwick; University of Warwick	Blanks, AM (corresponding author), Warwick Med Sch, Div Biomed Sci, Cell & Dev Biol, Coventry, W Midlands, England.	andrew.blanks@warwick.ac.uk	Lutton, Josiah/ABH-5383-2020	Lutton, Josiah/0000-0002-0554-3456; van den Berg, Hugo/0000-0002-8230-6227; Blanks, Andrew/0000-0003-1073-6081	Medical Research Council (United Kingdom) [G0900208-2]; Medical Research Council [981408] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EJL, AMB, and HAB were supported by a grant from the Medical Research Council (United Kingdom), grant number G0900208-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	3DHISTECH, PANN VIEW; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Blanks AM, 2007, BEST PRACT RES CL OB, V21, P807, DOI 10.1016/j.bpobgyn.2007.03.003; Can A, 2008, I S BIOMED IMAGING, P288, DOI 10.1109/ISBI.2008.4540989; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen CJ, 1986, CHINESE J PHYSL, V30, P35; CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L; Damon BM, 2008, MAGN RESON MED, V60, P934, DOI 10.1002/mrm.21707; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gartner L.P., 2009, COLOR ATLAS HISTOLOG; Gerneke DA, 2007, MICROSC RES TECHNIQ, V70, P886, DOI 10.1002/jemt.20491; Gibbons J. D., 2011, NONPARAMETRIC STAT I; Gilbert SH, 2012, AM J PHYSIOL-HEART C, V302, pH287, DOI 10.1152/ajpheart.00824.2011; Goerttler K, 1931, JB MORPH MICROSK ANA, V65, P45; Gomez G., 2000, P BRIT MACH VIS C, P1; Goode Adam, 2013, J Pathol Inform, V4, P27, DOI 10.4103/2153-3539.119005; Howard C, 1998, UNBIASED STEREOLOGY; HUIJSMANS DP, 1986, ANAT RECORD, V216, P449, DOI 10.1002/ar.1092160402; Kaganami Hassana Grema, 2009, Proceedings of the 2009 Fifth International Conference on Intelligent Information Hiding and Multimedia Signal Processing. IIH-MSP 2009, P1217, DOI 10.1109/IIH-MSP.2009.13; MARK JST, 1956, ANAT REC, V125, P473, DOI 10.1002/ar.1091250306; Martinez K, 2005, IEEE INT C IMAGE PRO, V2, P574, DOI DOI 10.1109/1CIP.2005.1530120; Roberts N, 2012, AM J PATHOL, V180, P1835, DOI 10.1016/j.ajpath.2012.01.033; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Sheldon RE, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0458; Toennies K. D., 2012, GUIDE MED IMAGE ANAL; Tomita, 1976, PROGR BIOPHYSICS MOL, V30, P185; Verbeek FJ, 2002, PROC SPIE, V4621, P65, DOI 10.1117/12.467833; Weiss N, 2015, BILDVERARBEITUNG FUR DIE MEDIZIN 2015: ALGORITHMEN - SYSTEME - ANWENDUNGEN, P245, DOI 10.1007/978-3-662-46224-9_43; Weiss S, 2006, ANAT REC PART A, V288A, P84, DOI 10.1002/ar.a.20274; Young RC, 1999, OBSTET GYNECOL, V93, P94, DOI 10.1016/S0029-7844(98)00345-7; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	34	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173404	10.1371/journal.pone.0173404	http://dx.doi.org/10.1371/journal.pone.0173404			72	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301486	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300035
J	Matsuda, J; Maeda, Y; Nagasawa, J; Setoguchi, H				Matsuda, Junshi; Maeda, Yoshiyuki; Nagasawa, Junichi; Setoguchi, Hiroaki			Tight species cohesion among sympatric insular wild gingers (Asarum spp. Aristolochiaceae) on continental islands: Highly differentiated floral characteristics versus undifferentiated genotypes	PLOS ONE			English	Article							RECENT POPULATION BOTTLENECKS; ALLELE FREQUENCY DATA; REPRODUCTIVE ISOLATION; GENE FLOW; PHYLOGENETIC-RELATIONSHIPS; ECOLOGICAL SPECIATION; ADAPTIVE RADIATION; AREA RELATIONSHIP; HOMOZYGOSITY TEST; SPATIAL SCALE	The Amami Island group of the Ryukyu Archipelago, Japan, harbors extensive species diversity of Asarum in a small landmass. The fine-scale population genetic structure and diversity of nine insular endemic Asarum species were examined using nuclear DNA microsatellite loci and ITS sequences. High population genetic diversity (H-S = 0.45 - 0.79) was estimated based on the microsatellites, implying outcrossing of Asarum species within populations accompanied by inbreeding. Bayesian clustering analyses revealed that species were divided into three robust genetic clusters and that the species within each cluster had a homogeneous genetic structure, indicating incomplete lineage sorting. This conclusion was supported by an ITS phylogeny. The degree of genetic differentiation among species was very low both within and between clusters (F-ST = 0.096 - 0.193, and 0.096 - 0.266, respectively). Although species can be crossed artificially to produce fertile hybrids, our results indicate that there is very little evidence of hybridization or introgression occurring among species in the wild, even within stands composed of multiple sympatric species. The highly differentiated floral morphology of the studied species is likely to impose reproductive isolation between them and maintain their integrity in the wild. A lack of genetic differentiation between sympatric species suggests that speciation within this group occurred rapidly and recently.	[Matsuda, Junshi; Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto, Japan; [Maeda, Yoshiyuki] Kagoshima Univ, Fac Sci, Kagoshima, Japan; [Nagasawa, Junichi] Kyoto Bot Garden, Shimokamo Hangi Cho, Kyoto, Kyoto, Japan; [Maeda, Yoshiyuki] Hookaen Nursery, Tean,Setouchi Cho, Kagoshima, Japan	Kyoto University; Kagoshima University	Setoguchi, H (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto, Japan.	setoguchi.hiroai.2c@kyoto-u.ac.jp	Setoguchi, Hiroaki/AAM-5312-2021		Ministry of Education, Culture, Sports, Science, and Technology, Japan [21370036]; Environment Research and Technology Development Fund (ERTDF) from the Ministry of Environment, Japan [4-1403]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Environment Research and Technology Development Fund (ERTDF) from the Ministry of Environment, Japan	This work was supported by a Grant-in-Aid for Scientific Research (#21370036) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan to H.S. and by the Environment Research and Technology Development Fund (ERTDF) (#4-1403) from the Ministry of Environment, Japan to H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2010, BIOCHEM SYST ECOL, V38, P548, DOI 10.1016/j.bse.2010.06.002; Cornuet JM, 1996, GENETICS, V144, P2001; Cowie RH, 2008, PHILOS T R SOC B, V363, P3363, DOI 10.1098/rstb.2008.0061; Coyne J.A., 2004, SPECIATION; Coyne JA, 2000, EVOLUTION, V54, P2166; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gillespie RG, 2005, J ARACHNOL, V33, P313, DOI 10.1636/05-15.1; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; Grant P. R., 2008, WHY SPECIES MULTIPLY; Hatusima S, 1988, J PHYTOGEOGR TAXON, V36, P1; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Hiura I., 1978, HIST TRACED BUTTERFL; Huang SQ, 2013, NEW PHYTOL, V199, P858, DOI 10.1111/nph.12327; HUANG SM, 2003, FLORA CHINA, V5, P246; Itou Y., 2000, SCI REP RES I EVOL B, V9, P121; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kay KM, 2008, EVOLUTION, V62, P2628, DOI 10.1111/j.1558-5646.2008.00463.x; Kelly LM, 1998, AM J BOT, V85, P1454, DOI 10.2307/2446402; Kimura M., 1996, QUAT PALEOGEOGR RYUK, V105, P259, DOI 10.5026/jgeography.105.3_259; Kimura M., 2000, TROPICS, V10, P5, DOI [10.3759/tropics.10.5, DOI 10.3759/TROPICS.10.5]; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Kizaki K., 1980, NATURAL HIST RYUKYUS; Kizaki K., 1977, MARINE SCI MONTHLY, V9, P542; Lexer C, 2005, J EVOLUTION BIOL, V18, P893, DOI 10.1111/j.1420-9101.2005.00901.x; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2010, SPECIATION AREA RELA; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; LU KL, 1982, SYST BOT, V7, P150, DOI 10.2307/2418323; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MAC ARTHUR ROBERT H., 1967; MacArthur R. H., 1969, Biological Journal of the Linnean Society, V1, P19, DOI 10.1111/j.1095-8312.1969.tb01809.x; MARUYAMA T, 1985, GENETICS, V111, P675; Matsuda J, 2012, CONSERV GENET RESOUR, V4, p597 ; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mitsui Y, 2011, EVOLUTION, V65, P335, DOI 10.1111/j.1558-5646.2010.01129.x; Mitsui Y, 2010, AM J BOT, V97, P101, DOI 10.3732/ajb.0800220; Moyle LC, 2004, EVOLUTION, V58, P1195, DOI 10.1111/j.0014-3820.2004.tb01700.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schiestl FP, 2009, ANNU REV ENTOMOL, V54, P425, DOI 10.1146/annurev.ento.54.110807.090603; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Scopece G, 2013, EVOLUTION, V67, P2083, DOI 10.1111/evo.12091; SETOGUCHI H, 1995, J PLANT RES, V108, P87, DOI 10.1007/BF02344310; Setoguchi H, 2000, AM J BOT, V87, P793, DOI 10.2307/2656887; SUGAWARA T, 1988, Plant Species Biology, V3, P7, DOI 10.1111/j.1442-1984.1988.tb00166.x; Sugawara T., 2006, FLORA JAPAN A, VIIa, P368; Takano A, 2013, PLANT SYST EVOL, V299, P865, DOI 10.1007/s00606-013-0768-z; Tanaka H., 1987, PLANT SPEC BIOL, V2, P133; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ujiie H., 1990, GEOLOGICAL HIST RYUK, P251; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Vogel S., 1978, LINN SOC S SERIES, V6; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1986, GENETICS, V112, P899; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1943, GENETICS, V28, P114	80	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173489	10.1371/journal.pone.0173489	http://dx.doi.org/10.1371/journal.pone.0173489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301540	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300045
J	Monk, CT; Arlinghaus, R				Monk, Christopher Thomas; Arlinghaus, Robert			Encountering a bait is necessary but insufficient to explain individual variability in vulnerability to angling in two freshwater benthivorous fish in the wild	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; COMMON CARP; BEHAVIORAL SYNDROMES; LIFE-HISTORY; PERSONALITY-TRAITS; ENERGETIC STATUS; ESOX-LUCIUS; CATCH RATES; FISHERIES; SELECTION	Fish personality traits, such as swimming activity, or personality related emergent behavioural properties, such as the degree of space use shown by an individual fish, should affect encounter rates between individual fish and fishing gear. Increased encounters should in turn drive vulnerability to capture by passively operated gears. However, empirical evidence documenting a relationship between activity-based behaviours and vulnerability to capture by passive fishing gear in the wild is limited. Using whole-lake acoustic telemetry, we first documented significant repeatabilities over several months in a suite of encounter rate-associated behaviours (swimming distance, activity space size, time on baited feeding sites, switching frequency among baited feeding sites, distance to the lake bottom) in two recreationally important benthivorous cyprinid species, the common carp (Cyprinus carpio) and tench (Tinca tinca). We then experimentally targeted both species using stationary angling on baited feeding sites. Individual fish regularly visited the angling sites, documenting that the fishes encountered the angling baits. When attempting to explain individual variation in vulnerability as a function of repeatable behavioural traits, we found no evidence of a significant relationship among various encounter-based behaviours and vulnerability to angling for both species. There was also no evidence for size selection or for energetically less conditioned fish to be more vulnerable. The data cumulatively suggest that fine-scale behaviours after encountering a bait (e.g., frequency of bait intake) may be ultimately decisive for determining vulnerability to angling in benthivorous fish. Based on our work, fishing-induced selection on encounter-based behaviours in recreational angling for benthivorous fish in the wild appears unlikely.	[Monk, Christopher Thomas; Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Arlinghaus, Robert] Humboldt Univ, Div Integrat Fisheries Management, Dept Crop & Anim Sci, Fac Life Sci, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Monk, CT (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany.	monk@igb-berlin.de	Arlinghaus, Robert/E-3340-2010; Arlinghaus, Robert/J-6171-2019; Monk, Christopher/HGB-4122-2022	Arlinghaus, Robert/0000-0003-2861-527X; Monk, Christopher/0000-0002-1647-4740	B-Types grant (Gottfried-Wilhelm-Leibniz-Community) [SAW-2013-IGB-2]; Leibniz Association	B-Types grant (Gottfried-Wilhelm-Leibniz-Community); Leibniz Association	This work was funded by the B-Types grant (Gottfried-Wilhelm-Leibniz-Community, grant no. SAW-2013-IGB-2) to R.A. We thank Shimano and SPRO for their generous donation of carp fishing tackle. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek Z, 2003, J APPL ICHTHYOL, V19, P165, DOI 10.1046/j.1439-0426.2003.00467.x; Adamek Z, 1995, POL ARCH HYDROBIOL, V42, P9; Alos J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38093; Alos J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135348; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Arlinghaus R, 2005, FISHERIES MANAG ECOL, V12, P91, DOI 10.1111/j.1365-2400.2004.00425.x; Arlinghaus R, 2003, FISH RES, V61, P19, DOI 10.1016/S0165-7836(02)00243-6; Arlinghaus R, 2015, FISHERIES MANAG ECOL, V22, P45, DOI 10.1111/fme.12075; Arlinghaus R, 2016, TRENDS ECOL EVOL, V31, P92, DOI 10.1016/j.tree.2015.11.008; Askey PJ, 2006, N AM J FISH MANAGE, V26, P1020, DOI 10.1577/M06-035.1; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Bajer PG, 2010, ENVIRON BIOL FISH, V88, P295, DOI 10.1007/s10641-010-9643-8; Baktoft H, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cov055; Baktoft H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126534; Beck CM, 2015, FISCHEREILICHE STERB; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Berndt K, 2012, ICES J MAR SCI J CON; BEUKEMA J J, 1970, Netherlands Journal of Zoology, V20, P81; Binder TR, 2012, T AM FISH SOC, V141, P1252, DOI 10.1080/00028487.2012.688919; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Biro PA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2283; BURKETT D P, 1986, North American Journal of Fisheries Management, V6, P109, DOI 10.1577/1548-8659(1986)6<109:HVAMRO>2.0.CO;2; Burnham K P, 2003, MODEL SELECT MULTIMO; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cox SP, 2002, N AM J FISH MANAGE, V22, P21, DOI 10.1577/1548-8675(2002)022&lt;0021:MEIRFA&gt;2.0.CO;2; Crane DP, 2015, FISHERIES, V40, P258, DOI 10.1080/03632415.2015.1038382; Daniel AJ, 2009, MAR FRESHWATER RES, V60, P328, DOI 10.1071/MF08139; Diaz Pauli B, 2015, J FISH BIOL, V86, P1030, DOI 10.1111/jfb.12620; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dochtermann NA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2201; Dohm MR, 2002, FUNCT ECOL, V16, P273; Eckmann R., 1995, Ecology of Freshwater Fish, V4, P62, DOI 10.1111/j.1600-0633.1995.tb00118.x; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; Evangelista C, 2015, ECOL EVOL, V5, P2193, DOI 10.1002/ece3.1471; Fleig R, 2001, FISCHER TEICHWIRT, V52, P129; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Harkonen L, 2016, ACTA ETHOL, V19, P21, DOI 10.1007/s10211-015-0219-7; Harkonen L, 2014, CAN J FISH AQUAT SCI, V71, P1900, DOI 10.1139/cjfas-2014-0221; Harrison PM, 2015, BEHAV ECOL, V26, P483, DOI 10.1093/beheco/aru216; Hart Paul J.B., 1997, P104; Heino M, 2015, ANNU REV ECOL EVOL S, V46, P461, DOI 10.1146/annurev-ecolsys-112414-054339; Hougaard P, 1999, BIOMETRICS, V55, P13, DOI 10.1111/j.0006-341X.1999.00013.x; Huntingford F, 2005, BEHAVIOUR, V142, P1207, DOI 10.1163/156853905774539382; Huntingford FA, 2013, J FISH BIOL, V83, P1453, DOI [10.1111/jf, 10.1111/jfb.12246]; Huntingford FA, 2010, J FISH BIOL, V76, P1576, DOI 10.1111/j.1095-8649.2010.02582.x; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kasumyan A.O, 2000, J ICHTHYOL, V40, P661; Kekalainen J, 2014, INDIVIDUALLY ASSESSE, P1603; Killen SS, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow007; Klefoth T, 2008, HYDROBIOLOGIA, V601, P99, DOI 10.1007/s10750-007-9257-0; Klefoth T, 2013, FISHERIES MANAG ECOL, V20, P174, DOI 10.1111/j.1365-2400.2012.00865.x; Klefoth T, 2013, FISH RES, V146, P18, DOI 10.1016/j.fishres.2013.03.010; Klefoth T, 2012, BEHAV ECOL SOCIOBIOL, V66, P547, DOI 10.1007/s00265-011-1303-2; Kobler A, 2009, OECOLOGIA, V161, P837, DOI 10.1007/s00442-009-1415-9; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Kuparinen A, 2010, FISH RES, V105, P111, DOI 10.1016/j.fishres.2010.03.011; Laskowski KL, 2016, J FISH BIOL, V88, P1544, DOI 10.1111/jfb.12933; Laugen AT, 2014, FISH FISH, V15, P65, DOI 10.1111/faf.12007; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lokkeborg S, 2014, REV FISH BIOL FISHER, V24, P985, DOI 10.1007/s11160-014-9360-z; Matsumura S, 2011, EVOL ECOL, V25, P711, DOI 10.1007/s10682-010-9444-8; Mesquita FO, 2015, BEHAV PROCESS, V115, P25, DOI 10.1016/j.beproc.2015.02.017; MILLER RB, 1957, J FISH RES BOARD CAN, V14, P797, DOI 10.1139/f57-034; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Muller W, 1961, DTSCH FISCH, V8, P256; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nakayama S, 2017, J ANIM ECOL, V86, P192, DOI 10.1111/1365-2656.12603; Nakayama S, 2016, BEHAV ECOL, V27, P1676, DOI 10.1093/beheco/arw090; Nannini MA, 2011, J FISH BIOL, V79, P1017, DOI 10.1111/j.1095-8649.2011.03079.x; Niesar M, 2004, FISHERIES MANAG ECOL, V11, P225, DOI 10.1111/j.1365-2400.2004.00400.x; Olsen EM, 2012, ECOL EVOL, V2, P1549, DOI 10.1002/ece3.244; Perrow MR, 1996, J FISH BIOL, V48, P859; Pfeifer M, 1998, AUFZUCHT WELS SCHLEI; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Pieterek T, 2014, DETERMINANTEN ANGLER; Pine WE, 2009, FISHERIES, V34, P165, DOI 10.1577/1548-8446-34.4.165; PITCHER TJ, 1995, SCI MAR, V59, P295; Pollux BJA, 2017, OECOLOGIA, V183, P81, DOI 10.1007/s00442-016-3749-4; RAAT A J P, 1985, Aquaculture and Fisheries Management, V16, P171, DOI 10.1111/j.1365-2109.1985.tb00305.x; Rapp T, 2008, FISH RES, V94, P79, DOI 10.1016/j.fishres.2008.06.019; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Redpath TD, 2009, EVOL APPL, V2, P312, DOI 10.1111/j.1752-4571.2009.00078.x; RUDSTAM LG, 1984, CAN J FISH AQUAT SCI, V41, P1252, DOI 10.1139/f84-151; Saura M, 2010, FRESHWATER BIOL, V55, P923, DOI 10.1111/j.1365-2427.2009.02346.x; Schreckenbach K, 2001, J APPL ICHTHYOL, V17, P142, DOI 10.1046/j.1439-0426.2001.00295.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Sutter DAH, 2012, P NATL ACAD SCI USA, V109, P20960, DOI 10.1073/pnas.1212536109; Taylor MK, 2014, J FISH BIOL, V84, P1240, DOI 10.1111/jfb.12334; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; Videler J.J., 1991, Reviews in Fish Biology and Fisheries, V1, P23, DOI 10.1007/BF00042660; Ward TD, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow005; Wilson ADM, 2011, CAN J FISH AQUAT SCI, V68, P749, DOI 10.1139/F2011-019; Wilson B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124214; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; Wisniewolski W., 2009, ARCH POL FISH, V17, P211; WOLOS A, 1992, Aquaculture and Fisheries Management, V23, P499, DOI 10.1111/j.1365-2109.1992.tb00793.x; Zuur AF, 2007, STAT BIOL HEALTH, P1; 2003, J FISH BIOL, V62, P735, DOI DOI 10.1046/J.0022-1112.2003.00043.X	104	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173989	10.1371/journal.pone.0173989	http://dx.doi.org/10.1371/journal.pone.0173989			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301558	Green Published, gold			2022-12-26	WOS:000396318300106
J	Muema, JM; Nyanjom, SG; Mutunga, JM; Njeru, SN; Bargul, JL				Muema, Jackson M.; Nyanjom, Steven G.; Mutunga, James M.; Njeru, Sospeter N.; Bargul, Joel L.			Green tea proanthocyanidins cause impairment of hormone-regulated larval development and reproductive fitness via repression of juvenile hormone acid methyltransferase, insulin-like peptide and cytochrome P450 genes in Anopheles gambiae sensu stricto	PLOS ONE			English	Article							VECTORIAL CAPACITY; MOSQUITOS; TRAITS	Successful optimization of plant-derived compounds into control of nuisance insects would benefit from scientifically validated targets. However, the close association between the genotypic responses and physiological toxicity effects mediated by these compounds remains underexplored. In this study, we evaluated the sublethal dose effects of proanthocyanidins (PAs) sourced from green tea (Camellia sinensis) on life history traits of Anopheles gambiae (sensu stricto) mosquitoes with an aim to unravel the probable molecular targets. Based on the induced phenotypic effects, genes selected for study targeted juvenile hormone (JH) biosynthesis, signal transduction, oxidative stress response and xenobiotic detoxification in addition to vitellogenesis in females. Our findings suggest that chronic exposure of larval stages (L3/L4) to sublethal dose of 5 ppm dramatically extended larval developmental period for up to 12 days, slowed down pupation rates, induced abnormal larval-pupal intermediates and caused 100% inhibition of adult emergence. Further, females exhibited significant interference of fecundity and egg hatchability relative to controls (p < 0.001). Using reverse transcription quantitative polymerase chain reaction (RT-qPCR), our findings show that PA-treated larvae exhibited significant repression of AgamJHAMT (p < 0.001), AgamILP1 (p < 0.001) and AgamCYP6M2 (p < 0.001) with upregulation of Hsp70 (p < 0.001). Females exposed as larvae demonstrated down-regulation of AgamVg (p = 0.03), AgamILP1 (p = 0.009), AgamCYP6M2 (p = 0.05) and AgamJHAMT (p = 0.02). Our findings support that C. sinensis proanthocyanidins affect important vectorial capacity components such as mosquito survival rates and reproductive fitness thus could be potentially used for controlling populations of malaria vectors.	[Muema, Jackson M.; Nyanjom, Steven G.; Bargul, Joel L.] Jomo Kenyatta Univ Agr & Technol, Dept Biochem, Nairobi, Kenya; [Mutunga, James M.] Int Ctr Insect Physiol & Ecol, Malaria Res Programme, Nairobi, Kenya; [Njeru, Sospeter N.] Kisii Univ, Fac Hlth Sci, Dept Med, Kisii, Kenya; [Bargul, Joel L.] Int Ctr Insect Physiol & Ecol, Mol Biol & Bioinformat Unit, Nairobi, Kenya; [Njeru, Sospeter N.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	Jomo Kenyatta University of Agriculture & Technology; International Centre of Insect Physiology & Ecology (ICIPE); International Centre of Insect Physiology & Ecology (ICIPE); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Muema, JM (corresponding author), Jomo Kenyatta Univ Agr & Technol, Dept Biochem, Nairobi, Kenya.	Jackson_mbithi@yahoo.com	Muema, Jackson Mbithi/AAS-3089-2020; Bargul, Joel L./ABB-5310-2021	Muema, Jackson Mbithi/0000-0002-5713-5067; Nyanjom, Steven/0000-0002-6290-991X; Mutunga, James/0000-0002-7321-3176; Bargul, Joel/0000-0001-8573-6807; Njeru, Sospeter/0000-0003-1154-0777	Biochemistry Department of Jomo Kenyatta University of Agriculture and Technology (JKUAT)	Biochemistry Department of Jomo Kenyatta University of Agriculture and Technology (JKUAT)	This work was partially supported by Biochemistry Department of Jomo Kenyatta University of Agriculture and Technology (JKUAT).	Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; Aly HAA, 2015, WHO TECH REP SER, V994, P1; Araujo MD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-261; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Killeen GF, 2002, MALARIA J, V1, P1; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Moller-Jacobs LL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0593-4; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Patz JA, 2008, INFECT DIS, V9, P103; Poopathi S, 2006, BIOTECHNOLOGY MOL BI, V1, P51; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Shapiro LLM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0298; Vantaux A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36778; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; Weetman D, 2015, TRENDS PARASITOL, V31, P39, DOI 10.1016/j.pt.2015.01.001	15	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173564	10.1371/journal.pone.0173564	http://dx.doi.org/10.1371/journal.pone.0173564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301607	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300051
J	Panigrahi, SK; Manterola, M; Wolgemuth, DJ				Panigrahi, Sunil K.; Manterola, Marcia; Wolgemuth, Debra J.			Meiotic failure in cyclin A1-deficient mouse spermatocytes triggers apoptosis through intrinsic and extrinsic signaling pathways and 14-3-3 proteins	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO4; PROGRAMMED CELL-DEATH; GERM-LINE; DNA-BINDING; KINASE 2; PHOSPHORYLATION; SURVIVAL; MEIOSIS; SUPPRESSION; ACTIVATION	Cyclin A1 (Ccna1), a member of the mammalian A type cyclins, is most abundantly expressed in spermatocytes and is essential for spermatogenesis in the mouse. Ccna1-deficient spermatocytes arrest at late meiotic prophase and undergo apoptosis. To further delineate the mechanisms and key factors involved in this process, we have examined changes in expression of genes involved in both intrinsic and extrinsic signaling pathways that trigger apoptosis in the mutant spermatocytes. Our results show that both pathways are involved, and that the factors involved in the intrinsic pathway were expressed earlier than those involved in the extrinsic pathway. We have also begun to identify in vivo Ccna1-interacting proteins, using an unbiased biochemical approach, and identified 14-3-3, a key regulator of apoptosis, as a Ccna1-interacting protein. Expression levels of 14-3-3 proteins remain unchanged between wild type and mutant testes but there were differences in the subcellular distribution. In wild type control, 14-3-3 is detected in both cytosolic and nuclear fractions whereas it is restricted to the cytoplasm in mutant testes. This differential distribution of 14-3-3 may contribute to the induction of apoptosis in Ccna1-deficient spermatocytes. These results provide insight into the apoptotic mechanisms and pathways that are triggered when progression through the meiotic cell cycle is defective in male gametogenesis.	[Panigrahi, Sunil K.; Manterola, Marcia; Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Dept Genet, New York, NY 10027 USA; [Panigrahi, Sunil K.; Manterola, Marcia; Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Dept Dev, New York, NY 10027 USA; [Manterola, Marcia] Univ Chile, Program Human Genet, ICBM, Fac Med, Santiago, Chile; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Obstet & Gynecol, New York, NY 10027 USA; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10027 USA; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Universidad de Chile; Columbia University; Columbia University; Columbia University	Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Dept Genet, New York, NY 10027 USA.; Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Dept Dev, New York, NY 10027 USA.; Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Obstet & Gynecol, New York, NY 10027 USA.; Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10027 USA.; Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.	djw3@cumc.columbia.edu	Manterola, Marcia/H-9420-2016	Manterola, Marcia/0000-0002-5802-1301	National Institute of Health (US) [R01 HD034915]; Lalor Foundation; NIH [R01 HD034915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034915] Funding Source: NIH RePORTER	National Institute of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lalor Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grants from the National Institute of Health (US), R01 HD034915 (DJW) and the Lalor Foundation (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Mary Ann Handel for kindly providing the anti-Hlt antibody. This work was supported in part by grants from the NIH, R01 HD034915 (DJW) and the Lalor Foundation (MM).	Aitken RJ, 2011, REPRODUCTION, V141, P139, DOI 10.1530/REP-10-0232; Berkovits BD, 2012, NUCLEIC ACIDS RES, V40, P7162, DOI 10.1093/nar/gks342; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Chu JH, 2014, BIOMED PHARMACOTHER, V68, P1089, DOI 10.1016/j.biopha.2014.10.001; Correia S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2014.25; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Pol A, 1998, ANTICANCER RES, V18, P3457; Dubois T, 1997, J BIOL CHEM, V272, P28882, DOI 10.1074/jbc.272.46.28882; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Giussani P, 2014, INT J MOL SCI, V15, P4356, DOI 10.3390/ijms15034356; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Liu D, 2000, DEV BIOL, V224, P388, DOI 10.1006/dbio.2000.9776; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Pacheco S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005017; Panigrahi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047862; Perego L, 1997, MOL REPROD DEV, V47, P370, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;370::AID-MRD3&gt;3.0.CO;2-H; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Salazar G, 2005, DEV DYNAM, V234, P114, DOI 10.1002/dvdy.20533; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Silhan J, 2009, J BIOL CHEM, V284, P19349, DOI 10.1074/jbc.M109.002725; Subramanian VV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016675; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tiwari M, 2015, APOPTOSIS, V20, P1019, DOI 10.1007/s10495-015-1136-y; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; WOLGEMUTH DJ, 1985, GAMETE RES, V12, P1, DOI 10.1002/mrd.1120120102; Yamaguchi Y, 2015, CURR TOP DEV BIOL, V114, P159, DOI 10.1016/bs.ctdb.2015.07.016; Yuasa K, 2015, BIOCHEM BIOPH RES CO, V464, P70, DOI 10.1016/j.bbrc.2015.05.105	35	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173926	10.1371/journal.pone.0173926	http://dx.doi.org/10.1371/journal.pone.0173926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301569	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300097
J	Rahnama, S; Deuis, JR; Cardoso, FC; Ramanujam, V; Lewis, RJ; Rash, LD; King, GF; Vetter, I; Mobli, M				Rahnama, Sassan; Deuis, Jennifer R.; Cardoso, Fernanda C.; Ramanujam, Venkatraman; Lewis, Richard J.; Rash, Lachlan D.; King, Glenn F.; Vetter, Irina; Mobli, Mehdi			The structure, dynamics and selectivity profile of a Na(V)1.7 potency-optimised huwentoxin-IV variant	PLOS ONE			English	Article							COMMON MOLECULAR DETERMINANTS; SODIUM-CHANNEL ANTAGONIST; RAT FORMALIN TEST; PROTEIN BACKBONE; TORSION ANGLES; MORPHINE; TOXIN; VENOM; PAIN; INHIBITION	Venom-derived peptides have attracted much attention as potential lead molecules for pharmaceutical development. A well-known example is Huwentoxin-IV (HwTx-IV), a peptide toxin isolated from the venom of the Chinese bird-eating spider Haplopelma schmitdi. HwTx-IV was identified as a potent blocker of a human voltage-gated sodium channel (hNa(V)1.7), which is a genetically validated analgesic target. The peptide was promising as it showed high potency at Na(V)1.7 (IC50 similar to 26 nM) and selectivity over the cardiac Na-V subtype (Na(V)1.5). Mutagenesis studies aimed at optimising the potency of the peptide resulted in the development of a triple-mutant of HwTx-IV (E1G, E4G, Y33W, m(3)-HwTx-IV) with significantly increased potency against hNa(V)1.7 (IC50 = 0.4 +/- 0.1 nM) without increased potency against hNa(V)1.5. The activity of m3-HwTx-IV against other Na-V subtypes was, however, not investigated. Similarly, the structure of the mutant peptide was not characterised, limiting the interpretation of the observed increase in potency. In this study we produced isotope-labelled recombinant m3-HwTx-IV in E. coli, which enabled us to characterise the atomic-resolution structure and dynamics of the peptide by NMR spectroscopy. The results show that the structure of the peptide is not perturbed by the mutations, whilst the relaxation studies reveal that residues in the active site of the peptide undergo conformational exchange. Additionally, the NaV subtype selectivity of the recombinant peptide was characterised, revealing potent inhibition of neuronal Na-V subtypes 1.1, 1.2, 1.3, 1.6 and 1.7. In parallel to the in vitro studies, we investigated Na(V)1.7 target engagement of the peptide in vivo using a rodent pain model, where m3-HwTx-IV dose-dependently suppressed spontaneous pain induced by the Na(V)1.7 activator OD1. Thus, our results provide further insight into the structure and dynamics of this class of peptides that may prove useful in guiding the development of inhibitors with improved selectivity for analgesic NaV subtypes.	[Rahnama, Sassan; Ramanujam, Venkatraman; Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia; [Rahnama, Sassan; Deuis, Jennifer R.; Cardoso, Fernanda C.; Lewis, Richard J.; Rash, Lachlan D.; King, Glenn F.; Vetter, Irina] Univ Queensland, Inst Mol BioSci, St Lucia, Qld, Australia; [Rash, Lachlan D.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Mobli, M (corresponding author), Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia.	m.mobli@uq.edu.au	Mobli, Mehdi/O-7244-2014; Deuis, Jennifer/R-2440-2017; Vetter, Irina/A-6035-2010; Cardoso, Fernanda C/J-7147-2013; Rash, Lachlan D/A-3858-2010; Lewis, Richard J./E-8674-2013	Mobli, Mehdi/0000-0003-2420-4262; Deuis, Jennifer/0000-0002-5107-8938; Vetter, Irina/0000-0002-3594-9588; Cardoso, Fernanda C/0000-0002-0068-9974; Rash, Lachlan D/0000-0003-3616-0279; King, Glenn/0000-0002-2308-2200; Lewis, Richard J./0000-0003-3470-923X	Australian National Health & Medical Research Council [APP1034958, APP1080405, APP569927]; Australian Research Council	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The authors would like to acknowledge financial support from the Australian National Health & Medical Research Council (Project Grant APP1034958 [GFK and MM], APP1080405 [MM], Program Grant APP569927 [RJL and GFK], Principal Research Fellowship to GFK and RJL) and the Australian Research Council (Future Fellowship to MM and IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Bagal SK, 2014, BIOORG MED CHEM LETT, V24, P3690, DOI 10.1016/j.bmcl.2014.06.038; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Deuis JR, 2016, TOXINS, V8, DOI 10.3390/toxins8030078; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Klint JK, 2015, MOL PHARMACOL, V88, P1002, DOI 10.1124/mol.115.100784; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865; Lau CHY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34333; Liu Y, 2014, PROTEIN PEPTIDE LETT, V21, P153; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; McGivern JG, 2007, EXPERT OPIN THER TAR, V11, P265, DOI 10.1517/14728222.11.3.265; Minassian NA, 2013, J BIOL CHEM, V113; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Minett MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9967; Mobli M, 2007, NAT METHODS, V4, P467, DOI 10.1038/nmeth0607-467; Mobli M, 2015, J MAGN RESON, V256, P60, DOI 10.1016/j.jmr.2015.04.003; Mobli M, 2010, TOXICON, V56, P849, DOI 10.1016/j.toxicon.2010.06.018; Mobli M, 2010, J MAGN RESON, V204, P160, DOI 10.1016/j.jmr.2010.02.012; Munro G, 2009, EUR J PHARMACOL, V605, P95, DOI 10.1016/j.ejphar.2009.01.004; Murray JK, 2016, J MED CHEM, V59, P2704, DOI 10.1021/acs.jmedchem.5b01947; Patel RR, 2016, BRAIN, V139, P2164, DOI 10.1093/brain/aww129; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Rode F, 2007, EUR J PHARMACOL, V564, P103, DOI 10.1016/j.ejphar.2007.02.009; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Sermadiras I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083202; Sevostianova N, 2005, EUR J PHARMACOL, V525, P83, DOI 10.1016/j.ejphar.2005.10.010; Sevostianova N, 2003, EUR J PHARMACOL, V462, P109, DOI 10.1016/S0014-2999(03)01345-1; Shcherbatko A, 2016, J BIOL CHEM, V291, P13974, DOI 10.1074/jbc.M116.725978; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13	43	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173551	10.1371/journal.pone.0173551	http://dx.doi.org/10.1371/journal.pone.0173551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301520	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300049
J	Batova, A; Altomare, D; Creek, KE; Naviaux, RK; Wang, L; Li, KF; Green, E; Williams, R; Naviaux, JC; Diccianni, M; Yu, AL				Batova, Ayse; Altomare, Diego; Creek, Kim E.; Naviaux, Robert K.; Wang, Lin; Li, Kefeng; Green, Erica; Williams, Richard; Naviaux, Jane C.; Diccianni, Mitchell; Yu, Alice L.			Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; CALCIUM-CHANNELS; OPEN-LABEL; PKC-THETA; CERAMIDE; APOPTOSIS; PROTEIN; CANCER	Renal cell carcinoma (RCC) is among the top ten most common forms of cancer and is the most common malignancy of the kidney. Clear cell renal carcinoma (cc-RCC), the most common type of RCC, is one of the most refractory cancers with an incidence that is on the rise. Screening of plant extracts in search of new anti-cancer agents resulted in the discovery of englerin A, a guaiane sesquiterpene with potent cytotoxicity against renal cancer cells and a small subset of other cancer cells. Though a few cellular targets have been identified for englerin A, it is still not clear what mechanisms account for the cytotoxicity of englerin A in RCC, which occurs at concentrations well below those used to engage the targets previously identified. Unlike any prior study, the current study used a systems biology approach to explore the mechanism(s) of action of englerin A. Metabolomics analyses indicated that englerin A profoundly altered lipid metabolism by 24 h in cc-RCC cell lines and generated significant levels of ceramides that were highly toxic to these cells. Microarray analyses determined that englerin A induced ER stress signaling and an acute inflammatory response, which was confirmed by quantitative PCR and Western Blot analyses. Additionally, fluorescence confocal microscopy revealed that englerin A at 25 nM disrupted the morphology of the ER confirming the deleterious effect of englerin A on the ER. Collectively, our findings suggest that cc-RCC is highly sensitive to disruptions in lipid metabolism and ER stress and that these vulnerabilities can be targeted for the treatment of cc-RCC and possibly other lipid storing cancers. Furthermore, our results suggest that ceramides may be a mediator of some of the actions of englerin A. Lastly, the acute inflammatory response induced by englerin A may mediate anti-tumor immunity.	[Batova, Ayse; Naviaux, Robert K.; Williams, Richard; Diccianni, Mitchell; Yu, Alice L.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Altomare, Diego; Creek, Kim E.; Green, Erica] Univ South Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC USA; [Naviaux, Robert K.; Wang, Lin; Li, Kefeng; Naviaux, Jane C.] Univ Calif San Diego, Dept Pathol, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Yu, Alice L.] Chang Gung Mem Hosp, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan	University of California System; University of California San Diego; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California San Diego; University of California System; University of California San Diego; Chang Gung Memorial Hospital	Batova, A (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.	abatova@ucsd.edu	, MitchDiccianni/AAF-8486-2019; Li, Kefeng/U-9431-2018	, MitchDiccianni/0000-0002-5017-9585; Li, Kefeng/0000-0002-7233-4347; yu, alice/0000-0003-2444-0505; Green, Erica/0000-0003-2832-5301	Bridgeman Memorial Fund; GoFundME	Bridgeman Memorial Fund; GoFundME	This work is supported by Bridgeman Memorial Fund (AY), GoFundME (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2000, PHARMACOL TOXICOL, V86, P114, DOI 10.1034/j.1600-0773.2000.d01-21.x; Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Amato RJ, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi002; Apostolova N, 2013, J HEPATOL, V59, P780, DOI 10.1016/j.jhep.2013.06.005; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Beech DJ, 2009, CELL CALCIUM, V45, P583, DOI 10.1016/j.ceca.2009.02.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron S, 2004, MOL CANCER THER, V3, P1659; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Caropreso V, 2016, J BIOL CHEM, V291, P10058, DOI 10.1074/jbc.M115.701375; Carson C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127498; Chang KT, 2015, BBA-BIOMEMBRANES, V1848, P2374, DOI 10.1016/j.bbamem.2015.07.013; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063726; Chik CL, 1999, ENDOCRINOLOGY, V140, P5682, DOI 10.1210/en.140.12.5682; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Choueiri TK, 2016, LANCET ONCOL, V17, P917, DOI 10.1016/S1470-2045(16)30107-3; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; GARBE LR, 1981, HUM PATHOL, V12, P891, DOI 10.1016/S0046-8177(81)80193-1; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Gong T, 2012, BIOCHEM BIOPH RES CO, V427, P461, DOI 10.1016/j.bbrc.2012.08.068; Griciuc A, 2014, J NEUROSCI, V34, P2797, DOI 10.1523/JNEUROSCI.2982-13.2014; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Guo Deliang, 2013, CNS Oncol, V2, P289; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Lane BR, 2007, UROLOGY, V69, P3, DOI 10.1016/j.urology.2006.09.028; Levine T.B., 2006, METABOLIC SYNDROME C; Li Y, 2014, MED HYPOTHESES, V83, P56, DOI 10.1016/j.mehy.2014.04.009; Lipina C, 2011, DIABETOLOGIA, V54, P1596, DOI 10.1007/s00125-011-2127-3; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Martson A., 2013, GENOM DISCOV, V1, P3, DOI [10.7243/2052-7993-1-3, DOI 10.7243/2052-7993-1-3]; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nguyen MM, 2006, J UROLOGY, V176, P2397, DOI 10.1016/j.juro.2006.07.144; Nicolaou KC, 2010, J AM CHEM SOC, V132, P8219, DOI 10.1021/ja102927n; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Park SH, 2014, J BIOL CHEM, V289, P27118, DOI 10.1074/jbc.M114.568717; Parra V, 2013, BBA-MOL BASIS DIS, V1832, P1334, DOI 10.1016/j.bbadis.2013.04.009; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Ratnayake R, 2009, ORG LETT, V11, P57, DOI 10.1021/ol802339w; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Rodrigues T, 2016, ANGEW CHEM INT ED EN; Roy PK, 2008, WORLD J GASTROENTERO, V14, P200, DOI 10.3748/wjg.14.200; Salem ML, 2016, J ADV RES, V7, P243, DOI 10.1016/j.jare.2015.06.001; SEGLEN PO, 1980, BIOCHIM BIOPHYS ACTA, V630, P103, DOI 10.1016/0304-4165(80)90141-5; Singer EA, 2011, CURR OPIN ONCOL, V23, P283, DOI 10.1097/CCO.0b013e32834479c0; Sourbier C, 2013, CANCER CELL, V23, P228, DOI 10.1016/j.ccr.2012.12.007; Straczkowski Marek, 2008, Rev Diabet Stud, V5, P13, DOI 10.1900/RDS.2008.5.13; Sulzmaier FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048032; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Testerink N, 2009, J LIPID RES, V50, P2182, DOI 10.1194/jlr.M800660-JLR200; Tornquist K, 2004, BIOCHEM J, V380, P661, DOI 10.1042/BJ20031637; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; White NMA, 2014, ONCOTARGET, V5, P506, DOI 10.18632/oncotarget.1529; Wikstrom JD, 2013, MOL ENDOCRINOL, V27, P1706, DOI 10.1210/me.2013-1109; Williams RT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-57; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu J, 2012, CHEM-ASIAN J, V7, P1052, DOI 10.1002/asia.201101021; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zhang JY, 2008, CELL MOL LIFE SCI, V65, P1435, DOI 10.1007/s00018-008-8047-9; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109	75	20	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172632	10.1371/journal.pone.0172632	http://dx.doi.org/10.1371/journal.pone.0172632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296891	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700011
J	Griffiths, K; Michelutti, N; Sugar, M; Douglas, MSV; Smol, JP				Griffiths, Katherine; Michelutti, Neal; Sugar, Madeline; Douglas, Marianne S. V.; Smol, John P.			Ice-cover is the principal driver of ecological change in High Arctic lakes and ponds	PLOS ONE			English	Article							PERIPHYTIC DIATOM ASSEMBLAGES; RECENT CLIMATIC-CHANGE; ELLESMERE-ISLAND; CAPE-HERSCHEL; CORNWALLIS ISLAND; BATHURST ISLAND; COMMUNITIES; POPULATIONS; RESPONSES; DYNAMICS	Recent climate change has been especially pronounced in the High Arctic, however, the responses of aquatic biota, such as diatoms, can be modified by site-specific environmental characteristics. To assess if climate-mediated ice cover changes affect the diatom response to climate, we used paleolimnological techniques to examine shifts in diatom assemblages from ten High Arctic lakes and ponds from Ellesmere Island and nearby Pim Island (Nunavut, Canada). The sites were divided a priori into four groups ("warm", "cool", "cold", and "oasis") based on local elevation and microclimatic differences that result in differing lengths of the ice-free season, as well as about three decades of personal observations. We characterized the species changes as a shift from Condition 1 (i.e. a generally low diversity, predominantly epipelic and epilithic diatom assemblage) to Condition 2 (i.e. a typically more diverse and ecologically complex assemblage with an increasing proportion of epiphytic species). This shift from Condition 1 to Condition 2 was a consistent pattern recorded across the sites that experienced a change in ice cover with warming. The "warm" sites are amongst the first to lose their ice covers in summer and recorded the earliest and highest magnitude changes. The "cool" sites also exhibited a shift from Condition 1 to Condition 2, but, as predicted, the timing of the response lagged the "warm" sites. Meanwhile some of the "cold" sites, which until recently still retained an ice raft in summer, only exhibited this shift in the upper-most sediments. The warmer "oasis" ponds likely supported aquatic vegetation throughout their records. Consequently, the diatoms of the "oasis" sites were characterized as high-diversity, Condition 2 assemblages throughout the record. Our results support the hypothesis that the length of the ice-free season is the principal driver of diatom assemblage responses to climate in the High Arctic, largely driven by the establishment of new aquatic habitats, resulting in increased diversity and the emergence of novel growth forms and epiphytic species.	[Griffiths, Katherine; Michelutti, Neal; Sugar, Madeline; Douglas, Marianne S. V.; Smol, John P.] Queens Univ, Dept Biol, PEARL, Kingston, ON, Canada; [Griffiths, Katherine] McGill Univ, Dept Biol, Montreal, PQ, Canada	Queens University - Canada; McGill University	Griffiths, K (corresponding author), Queens Univ, Dept Biol, PEARL, Kingston, ON, Canada.; Griffiths, K (corresponding author), McGill Univ, Dept Biol, Montreal, PQ, Canada.	katie.t.griffiths@gmail.com		Smol, John/0000-0002-2499-6696	National Sciences and Engineering Research Council (NSERC) [2360-2009]; Northern Scientific Training Program (NSTP) [306-059]; Polar Continental Shelf Program (PCSP) [624-11, 651-11]	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Northern Scientific Training Program (NSTP); Polar Continental Shelf Program (PCSP)(Natural Resources Canada)	This work was supported by National Sciences and Engineering Research Council (NSERC): 2360-2009, http://www.nserc-crsng.gc.ca/index_eng.asp; Northern Scientific Training Program (NSTP): 306-059, http://www.polarcom.gc.ca/eng/content/northern-scientific-training-program; and Polar Continental Shelf Program (PCSP): 624-11, 651-11, http://www.nrcan.gc.ca/the-north/polar-continental-shelf-program/polar-shelf/10003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN HL, 1971, ECOL MONOGR, V41, P97, DOI 10.2307/1942387; Anderson NJ, 2000, EUR J PHYCOL, V35, P307, DOI 10.1017/S0967026200002857; Antoniades D, 2005, J PALEOLIMNOL, V33, P349, DOI 10.1007/s10933-004-6611-3; Antoniades D, 2005, J PHYCOL, V41, P30, DOI 10.1111/j.1529-8817.2005.04049.x; Antoniades D., 2008, ICONOGRAPHIA DIATOMO, V17, P1; Antoniades D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030947; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Bao R, 1999, PALAEOGEOGR PALAEOCL, V153, P309, DOI 10.1016/S0031-0182(99)00066-8; Bennett JR, 2016, CAN J FISH AQUAT SCI, P1; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; BERGSMA BM, 1984, ARCTIC, V37, P49; Blake Jr W, 1978, 781C GEOL SURV CAN P, V78, P119; BLAKE W, 1992, CAN J EARTH SCI, V29, P1958, DOI 10.1139/e92-153; Cremer H, 2004, CAN J BOT, V82, P1744, DOI [10.1139/b04-127, 10.1139/B04-127]; DOUBLEDAY NC, 1995, SCI TOTAL ENVIRON, V160-61, P661, DOI 10.1016/0048-9697(95)04400-U; Douglas M. S. V., 2010, The diatoms: applications for the environmental and earth sciences, P249; DOUGLAS MSV, 1994, SCIENCE, V266, P416, DOI 10.1126/science.266.5184.416; DOUGLAS MSV, 1995, J PHYCOL, V31, P60, DOI 10.1111/j.0022-3646.1995.00060.x; DOUGLAS MSV, 1993, NOVA HEDWIGIA, V57, P511; DOUGLAS MSV, 1994, ARCH HYDROBIOL, V131, P401; Elster Josef, 1999, Polar Record, V35, P231; Environment Canada, 2016, EUR A NUN 1981 2010; Frisch T, 1984, GEOLOGY PRINCE WALES; Geogratis, GEOGR; Glew J.R., 1989, J PALEOLIMNOL, V2, P241, DOI [DOI 10.1007/BF00195474, 10.1007/BF00195474]; Glew J.R., 1988, J PALEOLIMNOL, V1, P235, DOI DOI 10.1007/BF00177769; Glew JR, 2016, J PALEOLIMNOL, V56, P67, DOI 10.1007/s10933-015-9873-z; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; HARRISON J.C., 2015, TECTONIC ASSEMBLAGE; Harrison JC, 2006, BEDROCK GEOLOGY NARE; HENRY G, 1986, ARCTIC, V39, P78; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jia GSJ, 2009, J ENVIRON MONITOR, V11, P2231, DOI 10.1039/b911677j; Ju JC, 2016, REMOTE SENS ENVIRON, V176, P1, DOI 10.1016/j.rse.2016.01.001; Juggins S., 2007, C2 VERSION 15 USER G; Keatley BE, 2008, ARCT ANTARCT ALP RES, V40, P364, DOI 10.1657/1523-0430(06-068)[KEATLEY]2.0.CO;2; Keatley B, 2009, HYDROBIOLOGIA, V621, P191, DOI 10.1007/s10750-008-9670-z; Kingston John C., 2003, P595, DOI 10.1016/B978-012741550-5/50017-9; Kociolek J. P., 2003, P637, DOI 10.1016/B978-012741550-5/50018-0; Krammer K, 1991, BACILLARIOPHYCEAE 4; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krammer K., 1991, SUSSWASSERFLORA MITT, V23, P1; Krammer K., 1988, SUSSWASSER FLORA MIT; La Farge C, 2013, P NATL ACAD SCI USA, V110, P9839, DOI 10.1073/pnas.1304199110; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Levesque E, 1996, ARCTIC ALPINE RES, V28, P156, DOI 10.2307/1551755; Lim DSS, 2001, HYDROBIOLOGIA, V450, P215, DOI 10.1023/A:1017553112643; Lim DSS, 2001, J PHYCOL, V37, P379, DOI 10.1046/j.1529-8817.2001.037003379.x; Lotter AF, 2000, AQUAT SCI, V62, P125, DOI 10.1007/s000270050002; MacDonald LA, 2012, HYDROBIOLOGIA, V683, P231, DOI 10.1007/s10750-011-0960-5; Michel TJ, 2006, HYDROBIOLOGIA, V568, P235, DOI 10.1007/s10750-006-0109-0; Michelutti N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023693; Michelutti N, 2002, INT VER THEOR ANGEW, V28, P1533; Michelutti N, 2003, GLOBAL PLANET CHANGE, V38, P257, DOI 10.1016/S0921-8181(02)00260-6; Michelutti N, 2003, J PHYCOL, V39, P465, DOI 10.1046/j.1529-8817.2003.02153.x; Michelutti N, 2007, AQUAT SCI, V69, P523, DOI 10.1007/s00027-007-0928-8; Michelutti N, 2006, QUATERNARY RES, V65, P421, DOI 10.1016/j.yqres.2006.02.001; Michelutti N, 2016, J PALEOLIMNOL, V56, P253, DOI 10.1007/s10933-016-9921-3; Michelutti N, 2013, J PHYCOL, V49, P41, DOI 10.1111/jpy.12024; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; MONCREIFF CA, 1992, MAR ECOL PROG SER, V87, P161, DOI 10.3354/meps087161; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Perren BB, 2003, ARCT ANTARCT ALP RES, V35, P271, DOI 10.1657/1523-0430(2003)035[0271:RLRTRH]2.0.CO;2; Pienitz R., 2004, LONG TERM ENV CHANGE, P117, DOI DOI 10.1007/978-1-4020-2126-8_5; Pinseel E, 2016, POLAR BIOL, P1; Quinlan R, 2005, GLOBAL CHANGE BIOL, V11, P1381, DOI 10.1111/j.1365-2486.2005.00981.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Riis T, 2014, FRESHWATER BIOL, V59, P1622, DOI 10.1111/fwb.12368; Rouillard A, 2012, PALAEOGEOGR PALAEOCL, V321, P1, DOI 10.1016/j.palaeo.2012.01.011; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Ryves DB, 2002, FRESHWATER BIOL, V47, P995, DOI 10.1046/j.1365-2427.2002.00832.x; Sand-Jensen K, 1999, CAN J FISH AQUAT SCI, V56, P388, DOI 10.1139/cjfas-56-3-388; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; SCHLEDERMANN P, 1978, ARCTIC, V31, P459; Schmidt Roland, 2004, Journal of Limnology, V63, P171; Smol J.P., 2008, POLLUTION LAKES RIVE, V2nd ed.; Smol J.P., 1988, VERH INT VEREIN LIMN, V23, P837, DOI [DOI 10.1080/03680770.1987.11899722, 10.1080/03680770.1987.11899722]; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104; SMOL JP, 1983, CAN J BOT, V61, P2195, DOI 10.1139/b83-238; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Smol JP, 2010, DIATOMS APPL ENV EAR, P3, DOI DOI 10.1017/CB09780511763175.002; Thomas EK, 2011, QUATERNARY RES, V75, P491, DOI 10.1016/j.yqres.2011.03.003; Veillette J, 2010, ANN GLACIOL, V51, P56, DOI 10.3189/172756411795931921; Wilson SE, 1996, CAN J FISH AQUAT SCI, V53, P1580, DOI 10.1139/f96-094; Wolfe AP, 2004, LONG TERM ENV CHANGE, P19, DOI DOI 10.1007/978-1-4020-2126-8_2; Zgrundo A, 2016, POLAR BIOL, P1	90	46	47	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172989	10.1371/journal.pone.0172989	http://dx.doi.org/10.1371/journal.pone.0172989			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296897	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700020
J	Ji, RJ; Zhou, LM; Liu, JL; Wang, Y; Yang, L; Zheng, QS; Zhang, C; Zhang, B; Ge, HM; Yang, YH; Zhao, FG; Luan, S; Lan, WZ				Ji, Ruijie; Zhou, Liming; Liu, Jinglong; Wang, Yuan; Yang, Lei; Zheng, Qinsong; Zhang, Chi; Zhang, Bin; Ge, Haiman; Yang, Yonghua; Zhao, Fugeng; Luan, Sheng; Lan, Wenzhi			Calcium-dependent protein kinase CPK31 interacts with arsenic transporter AtNIP1; 1 and regulates arsenite uptake in Arabidopsis thaliana	PLOS ONE			English	Article							ANION CHANNEL SLAH3; POLLEN-TUBE GROWTH; PLANTS; PATHWAY; ACCUMULATION; PHOSPHORYLATION; TRANSLOCATION; AQUAPORINS; METABOLISM; EXPRESSION	Although arsenite [As(III)] is non-essential and toxic for plants, it is effectively absorbed through various transporters into the roots. Here we identified a calcium-dependent protein kinase (CPK31) response for As(III) tolerance in Arabidopsis. We identified CPK31 as an interacting protein of a nodulin 26-like intrinsic protein (NIP1; 1), an aquaporin involved in As (III) uptake. Similarly to the nip1; 1 mutants, the loss-of-function mutants of CPK31 improved the tolerance against As(III) but not As(V), and accumulated less As(III) in roots than that of the wild-type plants. The promoter-beta-glucuronidase and quantitative Real-Time PCR analysis revealed that CPK31 displayed overlapping expression profiles with NIP1; 1 in the roots, suggesting that they might function together in roots. Indeed, the cpk31 nip1; 1 double mutants exhibited stronger As(III) tolerance than cpk31 mutants, but similar to nip1; 1 mutants, supporting the idea that CPK31 might serve as an upstream regulator of NIP1; 1. Furthermore, transient CPK31 overexpression induced by dexamethasone caused the decrease in As(III) tolerance of transgenic Arabidopsis lines. These findings reveal that CPK31 is a key factor in As(III) response in plants.	[Ji, Ruijie; Zheng, Qinsong] Nanjing Agr Univ, Coll Resources & Environm Sci, Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China; [Zhou, Liming] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Liu, Jinglong; Wang, Yuan; Yang, Lei; Zhang, Chi; Zhang, Bin; Ge, Haiman; Yang, Yonghua; Zhao, Fugeng; Lan, Wenzhi] Nanjing Univ, Nanjing Forestry Univ, Joint Inst Plant Mol Biol, State Key Lab Pharmaceut Biotechnol,Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Luan, Sheng] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Nanjing Agricultural University; Fujian Agriculture & Forestry University; Nanjing Forestry University; Nanjing University; University of California System; University of California Berkeley	Zheng, QS (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China.; Lan, WZ (corresponding author), Nanjing Univ, Nanjing Forestry Univ, Joint Inst Plant Mol Biol, State Key Lab Pharmaceut Biotechnol,Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	qszheng@njau.edu.cn; lanw@nju.edu.cn		yang, lei/0000-0003-2009-7316	National Natural Science Foundation of China [31271626]; Ministry of Education of the People's Republic of China, Doctoral Fund of Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China, Doctoral Fund of Ministry of Education of China	This work was supported by the National Natural Science Foundation of China Grant, 31271626 and by the Ministry of Education of the People's Republic of China, Doctoral Fund of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2009, CELL MOL LIFE SCI, V66, P2329, DOI 10.1007/s00018-009-0021-7; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Catarecha P, 2007, PLANT CELL, V19, P1123, DOI 10.1105/tpc.106.041871; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; Demir F, 2013, P NATL ACAD SCI USA, V110, P8296, DOI 10.1073/pnas.1211667110; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Ghosh P, 2008, MUTAT RES-REV MUTAT, V659, P293, DOI 10.1016/j.mrrev.2008.06.003; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Gutermuth T, 2013, PLANT CELL, V25, P4525, DOI 10.1105/tpc.113.118463; Huang TL, 2012, PLANT MOL BIOL, V80, P587, DOI 10.1007/s11103-012-9969-z; Isayenkov SV, 2008, FEBS LETT, V582, P1625, DOI 10.1016/j.febslet.2008.04.022; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kamiya T, 2009, J BIOL CHEM, V284, P2114, DOI 10.1074/jbc.M806881200; Kamiya T, 2009, PLANT CELL PHYSIOL, V50, P1977, DOI 10.1093/pcp/pcp130; Kopittke PM, 2012, PLANT PHYSIOL, V159, P1149, DOI 10.1104/pp.112.197277; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Li NN, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv143; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Maurel C, 2015, PHYSIOL REV, V95, P1321, DOI 10.1152/physrev.00008.2015; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Ronzier E, 2014, PLANT PHYSIOL, V166, P314, DOI 10.1104/pp.114.240226; Tripathi RD, 2007, TRENDS BIOTECHNOL, V25, P158, DOI 10.1016/j.tibtech.2007.02.003; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; WEAVER CD, 1992, BIOCHEMISTRY-US, V31, P8954, DOI 10.1021/bi00152a035; Wu ZC, 2011, PLANT PHYSIOL, V157, P498, DOI 10.1104/pp.111.178921; Xu WZ, 2015, MOL PLANT, V8, P722, DOI 10.1016/j.molp.2015.01.005; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152; Zhou LM, 2014, MOL PLANT, V7, P369, DOI 10.1093/mp/sst125	34	38	38	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173681	10.1371/journal.pone.0173681	http://dx.doi.org/10.1371/journal.pone.0173681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296918	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700051
J	Brown, JM; Mosley, M; Montes-Berrueta, D; Hou, YQ; Yang, F; Scarbrough, C; Witman, GB; Wirschell, M				Brown, Jason M.; Mosley, Matthew; Montes-Berrueta, Daniela; Hou, Yuqing; Yang, Fan; Scarbrough, Chasity; Witman, George B.; Wirschell, Maureen			Characterization of a new oda3 allele, oda3-6, defective in assembly of the outer dynein arm-docking complex in Chlamydomonas reinhardtii	PLOS ONE			English	Article							CILIARY DYSFUNCTION; GENETIC-ANALYSIS; SUBUNIT; PROTEIN; CILIOPATHIES; MECHANISMS; RESISTANCE; MEMBRANE; FLAGELLA; MUTANTS	We have used an insertional mutagenesis approach to generate new C. reinhardtii motility mutants. Of 56 mutants isolated, one is a new allele at the ODA3 locus, called oda3-6. Similar to the previously characterized oda3 alleles, oda3-6 has a slow-jerky swimming phenotype and reduced swimming speed. The oda3-6 mutant fails to assemble the outer dynein arm motor and outer dynein arm-docking complex (ODA-DC) in the ciliary axoneme due to an insertion in the 5' end of the DCC1 gene, which encodes the DC1 subunit of the ODADC. Transformation of oda3-6 with the wild-type DCC1 gene rescues the mutant swimming phenotype and restores assembly of the ODA-DC and the outer dynein arm in the cilium. This is the first oda3 mutant to be characterized at the molecular level and is likely to be very useful for further analysis of DC1 function.	[Brown, Jason M.; Montes-Berrueta, Daniela] Salem State Univ, Dept Biol, Salem, MA USA; [Mosley, Matthew; Yang, Fan; Scarbrough, Chasity; Wirschell, Maureen] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Hou, Yuqing; Witman, George B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA	Massachusetts System of Public Higher Education; Salem State University; University of Mississippi; University of Mississippi Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Wirschell, M (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	mwirschell@umc.edu		Wirschell, Maureen/0000-0002-2998-2023; Mosley, Matthew/0000-0002-2181-923X; Hou, Yuqing/0000-0002-7038-675X; Witman, George/0000-0002-9497-9218	University of Mississippi Medical Center, Department of Biochemistry; National Institutes of Health [R37 GM030626]; Robert W. Booth Endowment at the University of Massachusetts Medical School; University of Mississippi Medical Center SURE (Summer Undergraduate Research Experience) Program; SSU College of Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030626, R35GM122574] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021580] Funding Source: NIH RePORTER	University of Mississippi Medical Center, Department of Biochemistry; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert W. Booth Endowment at the University of Massachusetts Medical School; University of Mississippi Medical Center SURE (Summer Undergraduate Research Experience) Program; SSU College of Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by research funds from the University of Mississippi Medical Center, Department of Biochemistry to MW, and by National Institutes of Health grant R37 GM030626 to GBW and by the Robert W. Booth Endowment at the University of Massachusetts Medical School (to GBW). Additionally, MM was supported, in part, by the University of Mississippi Medical Center SURE (Summer Undergraduate Research Experience) Program. JMB and DM were supported by an SSU Internal Mini-grant and research start-up funds from the SSU College of Arts and Sciences, both to JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata J, 2014, J CELL SCI, V127, P4714, DOI 10.1242/jcs.155275; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Brown JM, 2014, BIOSCIENCE, V64, P1126, DOI 10.1093/biosci/biu174; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Casey DM, 2003, MOL BIOL CELL, V14, P3650, DOI 10.1091/mbc.E03-01-0057; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; DUTCHER SK, 1995, METHOD CELL BIOL, V47, P531, DOI 10.1016/S0091-679X(08)60857-2; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; HOOPS HJ, 1995, METHOD CELL BIOL, V47, P193, DOI 10.1016/S0091-679X(08)60809-2; Horani A, 2014, PEDIATR RES, V75, P158, DOI 10.1038/pr.2013.200; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; King SM, 2009, CHLAMYDOMONAS SOURCE, V3, P131; Knowles MR, 2016, CLIN CHEST MED, V37, P449, DOI 10.1016/j.ccm.2016.04.008; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Lobo J, 2015, SEMIN RESP CRIT CARE, V36, P169, DOI 10.1055/s-0035-1546748; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Matsuo T, 2008, GENE DEV, V22, P918, DOI 10.1101/gad.1650408; Oda T, 2016, J CELL SCI, V129, P1547, DOI 10.1242/jcs.184598; Pan JM, 2008, SCI CHINA SER C, V51, P479, DOI 10.1007/s11427-008-0071-3; Pazour G.J., 2009, CHLAMYDOMONAS SOURCE, P445; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; SAGER R, 1953, ANN NY ACAD SCI, V56, P831, DOI 10.1111/j.1749-6632.1953.tb30261.x; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; TAKADA S, 1992, J BIOCHEM, V111, P758, DOI 10.1093/oxfordjournals.jbchem.a123832; Wakabayashi K, 2001, CELL MOTIL CYTOSKEL, V48, P277, DOI 10.1002/cm.1015; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Wirschell M, 2008, CELL MOTIL CYTOSKEL, V65, P238, DOI 10.1002/cm.20257; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Yang F, 2015, AM J PHYSIOL-LUNG C, V308, pL569, DOI 10.1152/ajplung.00257.2014; Zhang R, 2014, PLANT CELL, V26, P1398, DOI 10.1105/tpc.114.124099	37	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173842	10.1371/journal.pone.0173842	http://dx.doi.org/10.1371/journal.pone.0173842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291812	Green Submitted, gold, Green Published			2022-12-26	WOS:000396094700045
J	Mahmoudzadeh, M; Dehaene-Lambertz, G; Wallois, F				Mahmoudzadeh, Mahdi; Dehaene-Lambertz, Ghislaine; Wallois, Fabrice			Electrophysiological and hemodynamic mismatch responses in rats listening to human speech syllables	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; NEAR-INFRARED SPECTROSCOPY; HUMAN AUDITORY-CORTEX; INITIAL DIP; LANGUAGE DISCRIMINATION; ANESTHETIZED RATS; NEGATIVITY MMN; BLOOD-FLOW; SCALP EEG; BRAIN	Speech is a complex auditory stimulus which is processed according to several time-scales. Whereas consonant discrimination is required to resolve rapid acoustic events, voice perception relies on slower cues. Humans, right from preterm ages, are particularly efficient to encode temporal cues. To compare the capacities of preterms to those observed in other mammals, we tested anesthetized adult rats by using exactly the same paradigm as that used in preterm neonates. We simultaneously recorded neural (using ECoG) and hemodynamic responses (using fNIRS) to series of human speech syllables and investigated the brain response to a change of consonant (ba vs. ga) and to a change of voice (male vs. female). Both methods revealed concordant results, although ECoG measures were more sensitive than fNIRS. Responses to syllables were bilateral, but with marked right-hemispheric lateralization. Responses to voice changes were observed with both methods, while only ECoG was sensitive to consonant changes. These results suggest that rats more effectively processed the speech envelope than fine temporal cues in contrast with human preterm neonates, in whom the opposite effects were observed. Cross-species comparisons constitute a very valuable tool to define the singularities of the human brain and species-specific bias that may help human infants to learn their native language.	[Mahmoudzadeh, Mahdi; Wallois, Fabrice] Univ Picardie Jules Verne, CHU SUD Amiens, GRAMFC, INSERM U1105, Amiens, France; [Dehaene-Lambertz, Ghislaine] Univ Paris Saclay, Univ Paris Sud, NeuroSpin Ctr, Cognit Neuroimaging Unit,CEA DSV I2BM,INSERM,CNRS, Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Mahmoudzadeh, M (corresponding author), Univ Picardie Jules Verne, CHU SUD Amiens, GRAMFC, INSERM U1105, Amiens, France.	mahdi.mahmoudzadeh@u-picardie.fr	Mahmoudzadeh/AAG-8578-2021; Dehaene, Ghislaine/O-3633-2017	Mahmoudzadeh/0000-0003-3145-2133; Dehaene, Ghislaine/0000-0003-2221-9081	Picardie regional council	Picardie regional council(Region Hauts-de-France)	This work was supported by the Picardie regional council. The authors would especially like to thank Marc Fournier for his help on hemodynamic projection on the rat brain.	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Ahmed M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00283; Aslin RN, 2012, COGN NEUROPSYCHOL, V29, P7, DOI 10.1080/02643294.2012.654773; Astikainen P, 2006, NEUROREPORT, V17, P1561, DOI 10.1097/01.wnr.0000233097.13032.7d; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Boyd SG, 1996, NEUROPEDIATRICS, V27, P211, DOI 10.1055/s-2007-973791; Bristow D, 2009, J COGNITIVE NEUROSCI, V21, P905, DOI 10.1162/jocn.2009.21076; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; CAPLAN D, 1995, NEUROLOGY, V45, P293, DOI 10.1212/WNL.45.2.293; Caspers H., 1984, SELF REGULATION BRAI, P26; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Dehaene-Lambertz G, 2001, NEUROREPORT, V12, P3155, DOI 10.1097/00001756-200110080-00034; Dehaene-Lambertz G, 2010, BRAIN LANG, V114, P53, DOI 10.1016/j.bandl.2009.09.003; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; DEHAENELAMBERTZ G, 1994, NATURE, V370, P292, DOI 10.1038/370292a0; Ehlis AC, 2009, NEUROSCIENCE, V159, P1032, DOI 10.1016/j.neuroscience.2009.01.015; Eriksson J, 2005, BIOSYSTEMS, V79, P207, DOI 10.1016/j.biosystems.2004.09.017; Ernst MD, 2004, PERMUTATION METHODS, P676; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; FITCH RH, 1993, ANN NY ACAD SCI, V682, P346, DOI 10.1111/j.1749-6632.1993.tb22989.x; Franceschini MA, 2008, NEUROIMAGE, V41, P189, DOI 10.1016/j.neuroimage.2008.02.061; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hays W.L., 1994, STATISTICS-ABINGDON, V5th ed.; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Howell TJ, 2012, BEHAV PROCESS, V89, P8, DOI 10.1016/j.beproc.2011.09.009; Imada A, 2013, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00127; JAVITT DC, 1992, ELECTROEN CLIN NEURO, V83, P87, DOI 10.1016/0013-4694(92)90137-7; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Jung F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063203; King C, 1999, NEUROSCI LETT, V267, P89, DOI 10.1016/S0304-3940(99)00336-5; Koenig T, 2010, BRAIN TOPOGR, V23, P233, DOI 10.1007/s10548-010-0142-1; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Leroy F, 2015, P NATL ACAD SCI USA, V112, P1208, DOI 10.1073/pnas.1412389112; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Mahmoudzadeh M., 2016, CEREB CORTEX; Mahmoudzadeh M. WF, FUNCTIONAL IN PRESS; Mahmoudzadeh M, 2013, P NATL ACAD SCI USA, V110, P4846, DOI 10.1073/pnas.1212220110; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; McGee T, 1996, J ACOUST SOC AM, V99, P3606, DOI 10.1121/1.414958; McGee TJ, 2001, PSYCHOPHYSIOLOGY, V38, P653, DOI 10.1017/S0048577201990973; MICELI G, 1978, BRAIN LANG, V2, P434; Miller JW, 2007, NEUROIMAGE, V35, P583, DOI 10.1016/j.neuroimage.2006.12.018; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Papp N, 1977, Biomed Sci Instrum, V13, P135; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; RANSOM BR, 1992, J CLIN NEUROPHYSIOL, V9, P224, DOI 10.1097/00004691-199204010-00005; ROBLEDO P, 1995, PSYCHOPHARMACOLOGY, V118, P410, DOI 10.1007/BF02245941; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Ruusuvirta T, 2010, NEUROSCIENCE, V170, P232, DOI 10.1016/j.neuroscience.2010.06.062; Ruusuvirta T, 2007, EUR J NEUROSCI, V26, P701, DOI 10.1111/j.1460-9568.2007.05687.x; Ruusuvirta T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054624; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Rybalko N, 2010, BEHAV BRAIN RES, V209, P123, DOI 10.1016/j.bbr.2010.01.028; Salkind N., 2007, ENCY MEASUREMENT STA; Schall U, 2015, NEUROREPORT, V26, P239, DOI 10.1097/WNR.0000000000000323; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Sherman GF, TRENDS NEUROSCIENCES, V5, P429; Shinba T, 1997, EVOKED POTENTIAL, V104, P447, DOI 10.1016/S0168-5597(97)00047-6; Siero JCW, 2015, MAGN RESON MED, V73, P2283, DOI 10.1002/mrm.25349; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Skrandies W, 2007, BRAIN TOPOGR, V20, P15, DOI 10.1007/s10548-007-0026-1; Speckman EJ, 1993, ELECTROENCEPHALOGRAP; Strauss M, 2015, P NATL ACAD SCI USA, V112, pE1353, DOI 10.1073/pnas.1501026112; Telkemeyer S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00062; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Toro JM, 2005, PERCEPT PSYCHOPHYS, V67, P867, DOI 10.3758/BF03193539; Toro JM, 2005, J EXP PSYCHOL-ANIM B, V31, P95, DOI 10.1037/0097-7403.31.1.95; Toro JM, 2003, ANIM COGN, V6, P131, DOI 10.1007/s10071-003-0172-0; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Umbricht D, 2005, CLIN NEUROPHYSIOL, V116, P353, DOI 10.1016/j.clinph.2004.08.015; Vanzetta I, 2001, NEUROIMAGE, V13, P959, DOI 10.1006/nimg.2001.0843; Voipio J, 2003, J NEUROPHYSIOL, V89, P2208, DOI 10.1152/jn.00915.2002; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Wallois F, 2009, NEUROPHYSIOL CLIN, V39, P217, DOI 10.1016/j.neucli.2009.08.001; Yacoub E, 2001, NMR BIOMED, V14, P408, DOI 10.1002/nbm.715; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	90	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173801	10.1371/journal.pone.0173801	http://dx.doi.org/10.1371/journal.pone.0173801			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291832	Green Submitted, Green Published, gold			2022-12-26	WOS:000396094700041
J	Kodo, K; Sugimoto, S; Nakajima, H; Mori, J; Itoh, I; Fukuhara, S; Shigehara, K; Nishikawa, T; Kosaka, K; Hosoi, H				Kodo, Kazuki; Sugimoto, Satoru; Nakajima, Hisakazu; Mori, Jun; Itoh, Ikuyo; Fukuhara, Shota; Shigehara, Keiichi; Nishikawa, Taichiro; Kosaka, Kitaro; Hosoi, Hajime			Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice	PLOS ONE			English	Article							INCREASES ENERGY-EXPENDITURE; HEPATIC INSULIN-RESISTANCE; FAT OXIDATION; PPAR-GAMMA; METABOLIC-ACTIVITY; SENSITIVITY; DIFFERENTIATION; ADIPOGENESIS; INFLAMMATION; ADIPOCYTES	Erythropoietin (EPO), clinically used as a hematopoietic drug, has received much attention due to its nonhematopoietic effects. EPO reportedly has beneficial effects on obesity and diabetes mellitus. We investigated whether interscapular brown adipose tissue (iBAT: main part of classical BAT) could play a role in EPO's anti-obesity and anti-diabetic effects in diet-induced obese mice. Four-week-old male C57BL/6J mice were fed a high-fat diet (HFD-Con), and half were additionally given an intraperitoneal injection of recombinant human EPO (200 IU/kg) (HFD-EPO) thrice a week for four weeks. At 8 weeks, EPO-injected mice showed significantly reduced body weight with reduced epididymal and subcutaneous white fat mass and unchanged caloric intake and locomotor activity. HOMA-IR (insulin resistance index) and glucose levels during intraperitoneal glucose tolerance test (IPGTT) were significantly lower in HFD-EPO mice than in HFD-Con mice. EPO-injected mice also showed increased oxygen consumption, indicative of metabolic rate, and skin temperature around iBAT tissue masses. EPO significantly upregulated the PRD1-BF1-RIZ1 homologous domain containing 16 (PRDM16), a transcriptional factor with a crucial role in brown adipocyte differentiation. EPO significantly increased phosphorylated signal transducer and activator of transcription 3 (STAT3), which is downstream of erythropoietin receptor (EpoR) and known to stabilize PRDM16. EPO's suppression of myocyte enhancer factor 2c (Mef2c) and microRNA-133a (miR-133a) via beta 3-adrenergic receptor caused PRDM16 upregulation. EPO-mediated enhancement of EpoR/STAT3 and beta-adrenergic receptor/Mef2c/miR-133 pathways dramatically increases total uncoupling protein 1 (UCP1), an essential enzyme for BAT thermogenesis. Furthermore, EPO activated BAT's endocrine functions. EPO facilitated fibroblast growth factor 21 (FGF21) production and excretion in iBAT, associated with reduction of liver gluconeogenesis-related genes. Thus, EPO's improvement of obesity and glucose homeostasis can be attributed to increased iBAT thermogenic capacity and activation of BAT's endocrine functions.	[Kodo, Kazuki; Sugimoto, Satoru; Nakajima, Hisakazu; Mori, Jun; Itoh, Ikuyo; Fukuhara, Shota; Shigehara, Keiichi; Kosaka, Kitaro; Hosoi, Hajime] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Sugimoto, Satoru] Ayabe Municipal Hosp, Dept Pediat, Ayabe City, Japan; [Nishikawa, Taichiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Sugimoto, S; Nakajima, H (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan.; Sugimoto, S (corresponding author), Ayabe Municipal Hosp, Dept Pediat, Ayabe City, Japan.	satoru-s@koto.kpu-m.ac.jp; hisakazu@koto.kpu-m.ac.jp	Nakajima, Hisakazu/AAH-7764-2021	Nakajima, Hisakazu/0000-0002-3678-9918	JSPS KAKENHI Grant [24650427]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this work was supported by JSPS KAKENHI Grant Number 24650427 (H. N. received) (https://kaken.nii.ac.jp/ja/search/?kw=24650427).	Alnaeeli M, 2014, DIABETES, V63, P2415, DOI 10.2337/db13-0883; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2014, MOL MED, V20, P658, DOI 10.2119/molmed.2014.00215; Caillaud C, 2015, J ENDOCRINOL, V225, P77, DOI 10.1530/JOE-15-0010; Caillaud C, 2015, J PHYSIOL BIOCHEM, V71, P9, DOI 10.1007/s13105-014-0374-8; Camporez JPG, 2015, J ENDOCRINOL, V226, P207, DOI 10.1530/JOE-15-0136; Cazzola M, 1998, Curr Opin Hematol, V5, P103; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Christensen B, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0327-z; Christensen B, 2012, J APPL PHYSIOL, V112, P1114, DOI 10.1152/japplphysiol.01391.2011; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Derecka M, 2012, CELL METAB, V16, P814, DOI 10.1016/j.cmet.2012.11.005; Ge ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17878; Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523; Gorbenko O, 2006, HYBRIDOMA, V25, P86, DOI 10.1089/hyb.2006.25.86; Guadalupe-Grau A, 2015, J SPORT SCI, V33, P570, DOI 10.1080/02640414.2014.951872; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Katz O, 2010, J ENDOCRINOL, V205, P87, DOI 10.1677/JOE-09-0425; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kornfeld JW, 2012, NAT CELL BIOL, V14, P1248, DOI 10.1038/ncb2642; Kotanko P, 2008, BLOOD PURIFICAT, V26, P82, DOI 10.1159/000110571; Lee YH, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.163; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003626; Liu YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15134; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Saito M, 2014, ENDOCR J, V61, P409, DOI 10.1507/endocrj.EJ13-0527; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Scully MS, 2011, EXP DIABETES RES, DOI 10.1155/2011/910159; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sell H, 2004, INT J BIOCH CELL BIO, V36; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Sugimoto S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-14; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Townsend K L, 2015, Int J Obes Suppl, V5, pS15, DOI 10.1038/ijosup.2015.5; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Villarroya J, 2013, AM J PHYSIOL-ENDOC M, V305, pE567, DOI 10.1152/ajpendo.00250.2013; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang L, 2014, INT J BIOCHEM CELL B, V54, P1, DOI 10.1016/j.biocel.2014.06.008; Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518; Woo M, 2014, DIABETES, V63, P2229, DOI 10.2337/db14-0566; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamazaki H, 2002, AM J PHYSIOL-ENDOC M, V283, pE536, DOI 10.1152/ajpendo.00094.2001; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004	50	24	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173661	10.1371/journal.pone.0173661	http://dx.doi.org/10.1371/journal.pone.0173661			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288167	Green Published, gold, Green Submitted			2022-12-26	WOS:000396092400025
J	Muhle, M; Lehmann, M; Hoffmann, K; Stern, D; Kroniger, T; Luttmann, W; Denner, J				Muehle, Michael; Lehmann, Melissa; Hoffmann, Kerstin; Stern, Daniel; Kroniger, Tobias; Luttmann, Werner; Denner, Joachim			Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; IN-VIVO; RECEPTOR ANTAGONIST; IL-10 PRODUCTION; CELL-LINE; TYPE-1; PEPTIDE; MONOCYTES; INFECTION	The transmembrane envelope (TM) protein gp41 of the human immunodeficiency virus-1 (HIV-1) plays an important role during virus infection inducing the fusion of the viral and cellular membranes. In addition, there are indications that the TM protein plays a role in the immunopathogenesis leading to the acquired immunodeficiency syndrome (AIDS). Inactivated virus particles and recombinant gp41 have been reported to inhibit lymphocyte proliferation, as well as to alter cytokine release and gene expression. The same was shown for a peptide corresponding to a highly conserved domain of all retroviral TM proteins, the immunosuppressive domain. Due to its propensity to aggregate and to be expressed at low levels, studies comprising authentic gp41 produced in eukaryotic cells are extremely rare. Here we describe the production of a secreted, soluble recombinant gp41 in 293 cells. The antigen was purified to homogeneity and characterised thoroughly by various biochemical and immunological methods. It was shown that the protein was glycosylated and assembled into trimers. Binding studies by ELISA and surface plasmon resonance using conformation-specific monoclonal antibodies implied a six-helix bundle conformation. The low binding of broadly neutralising antibodies (bnAb) directed against the membrane proximal external region (MPER) suggested that this gp41 is probably not suited as vaccine to induce such bnAb. Purified gp41 bound to monocytes and to a lesser extent to lymphocytes and triggered the production of specific cytokines when added to normal peripheral blood mononuclear cells. In addition, gp41 expressed on target cells inhibited the antigen-specific response of murine CD8(+) T cells by drastically impairing their IFN gamma production. To our knowledge, this is the first comprehensive analysis of a gp41 produced in eukaryotic cells including its immunosuppressive properties. Our data provide another line of evidence that gp41 might be directly involved in HIV-1 immunopathogenesis through modulation of the cytokine release and active inhibition of immune responses.	[Muehle, Michael; Stern, Daniel; Kroniger, Tobias; Denner, Joachim] Robert Koch Inst, Berlin, Germany; [Lehmann, Melissa; Luttmann, Werner] ImmunoTools GmbH, Friesoythe, Germany; [Hoffmann, Kerstin] Berlin Ctr Regenerat Therapies, Div Regenerat Immunol & Aging, Berlin, Germany	Robert Koch Institute	Denner, J (corresponding author), Robert Koch Inst, Berlin, Germany.	DennerJ@rki.de	Stern, Daniel/AAF-6280-2020; Dabrowski, Piotr Wojtek/L-1423-2015	Stern, Daniel/0000-0001-9057-4283; Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Muhle, Kerstin/0000-0002-4179-819X; Kroniger, Tobias/0000-0002-6611-1956	Federal Ministry for Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi) under the grant ZIM [AIF KF 2928202AJ2]; Friede Springer Foundation, Berlin, Germany	Federal Ministry for Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi) under the grant ZIM; Friede Springer Foundation, Berlin, Germany	The study has been supported by the Federal Ministry for Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi) under the grant ZIM (AIF KF 2928202AJ2) (http://www.zim-bmwi.de/) and by the Friede Springer Foundation, Berlin, Germany (http://www.friedespringerstitung.de/). The funder provided support in the form of salaries for authors MM and ML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Barcova M, 1998, J INFECT DIS, V177, P905, DOI 10.1086/515230; Blaise S, 2001, J GEN VIROL, V82, P1597, DOI 10.1099/0022-1317-82-7-1597; CHEN YH, 1993, IMMUNOL LETT, V37, P41, DOI 10.1016/0165-2478(93)90130-T; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Denner J, 1996, J ACQ IMMUN DEF SYND, V12, P442, DOI 10.1097/00042560-199608150-00002; DENNER J, 1994, AIDS, V8, P1063, DOI 10.1097/00002030-199408000-00005; DENNER J, 1993, J CANCER RES CLIN S1, V119, P28; Denner J, 2014, AIDS, V28, P1081, DOI 10.1097/QAD.0000000000000195; Denner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055199; Denner J, 2011, HUM VACCINES, V7, P4, DOI 10.4161/hv.7.0.14555; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Feldmann J, 2010, VIRUSES-BASEL, V2, P1666, DOI 10.3390/v2081666; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Fumakia M., 2015, REV MED VIROL; Garg H, 2006, J LEUKOCYTE BIOL, V79, P351, DOI 10.1189/jlb.0805430; GORNY MK, 1989, P NATL ACAD SCI USA, V86, P1624, DOI 10.1073/pnas.86.5.1624; Gustchina E, 2008, J VIROL, V82, P10032, DOI 10.1128/JVI.01050-08; HENDERSON LA, 1993, J BIOL CHEM, V268, P15291; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Irikura VM, 1999, INFECT IMMUN, V67, P1901; Ivanusic D, 2014, BIOTECHNIQUES, V57, P188, DOI 10.2144/000114215; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koutsonikolis A, 1997, IMMUNOL LETT, V55, P109, DOI 10.1016/S0165-2478(97)02695-3; Li CW, 2009, J VIROL, V83, P6817, DOI 10.1128/JVI.00278-09; Mangeney M, 1998, P NATL ACAD SCI USA, V95, P14920, DOI 10.1073/pnas.95.25.14920; Mangeney M, 2001, J GEN VIROL, V82, P2515, DOI 10.1099/0022-1317-82-10-2515; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Morozov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070399; Morozov VA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-67; Muhle M, 2016, IMMUNOL RES, V64, P721, DOI 10.1007/s12026-015-8776-4; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; PINTER A, 1989, J VIROL, V63, P2674, DOI 10.1128/JVI.63.6.2674-2679.1989; Roth Z, 2012, MOL REPROD DEV, V79, P478, DOI 10.1002/mrd.22055; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Speth C, 2000, AIDS, V14, P629, DOI 10.1097/00002030-200004140-00001; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tacke SJ, 2000, VIROLOGY, V268, P87, DOI 10.1006/viro.1999.0149; TAKESHITA S, 1995, CELL IMMUNOL, V165, P234, DOI 10.1006/cimm.1995.1210; Wang Q, 2015, J NANOMATER, V2015, DOI 10.1155/2015/408634; Weiss RA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-57; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991	49	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173454	10.1371/journal.pone.0173454	http://dx.doi.org/10.1371/journal.pone.0173454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282446	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800042
J	Blundon, EG; Rumak, SP; Ward, LM				Blundon, Elizabeth G.; Rumak, Samuel P.; Ward, Lawrence M.			Sequential search asymmetry: Behavioral and psychophysiological evidence from a dual oddball task	PLOS ONE			English	Article							OPEN-SOURCE TOOLBOX; MISMATCH NEGATIVITY; ELECTROPHYSIOLOGICAL EVIDENCE; SELECTIVE ATTENTION; P300 LATENCY; STIMULUS; AMPLITUDE; P3A; IDENTIFICATION; ORGANIZATION	We conducted five experiments in order to explore the generalizability of a new type of search asymmetry, which we have termed sequential search asymmetry, across sensory modalities, and to better understand its origin. In all five experiments rare oddballs occurred randomly within longer sequences of more frequent standards. Oddballs and standards all consisted of rapidly-presented runs of five pure tones (Experiments 1 and 5) or five colored annuli (Experiments 2 through 4) somewhat analogous to simultaneously-presented feature-present and feature-absent stimuli in typical visual search tasks. In easy tasks fea-turepresent reaction times and P300 latencies were shorter than feature-absent ones, similar to findings in search tasks with simultaneously-presented stimuli. Moreover the P3a subcom-ponent of the P300 ERP was strongly apparent only in the feature-present condition. In more difficult tasks requiring focused attention, however, RT and P300 latency differences disappeared but the P300 amplitude difference was significant. Importantly in all five experi-ments d for feature-present targets was larger than that for feature-absent targets. These results imply that sequential search asymmetry arises from discriminability differences between feature-present and feature-absent targets. Response time and P300 latency differences can be attributed to the use of different attention strategies in search for featurepresent and feature-absent targets, indexed by the presence of a dominant P3a subcompo-nent in the feature-present target-evoked P300s that is lacking in the P300s to the feature-absent targets.	[Blundon, Elizabeth G.; Rumak, Samuel P.; Ward, Lawrence M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Ward, LM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.; Ward, LM (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada.	lward@psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015	Natural Sciences and Engineering Research Council (NSERC) of Canada [A9958]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by grant A9958 from the Natural Sciences and Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to LMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Bishop DVM, 2005, COGNITIVE BRAIN RES, V24, P177, DOI 10.1016/j.cogbrainres.2004.12.007; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Cusack R, 2003, J EXP PSYCHOL HUMAN, V29, P713, DOI 10.1037/0096-1523.29.3.713; Czigler I, 2014, COGN AFFECT BEHAV NE, V14, P278, DOI 10.3758/s13415-013-0193-3; Dell'Acqua R, 2015, J COGNITIVE NEUROSCI, V27, P720, DOI 10.1162/jocn_a_00752; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; LUCK SJ, 1990, PERCEPT PSYCHOPHYS, V48, P603, DOI 10.3758/BF03211606; Macmillan NA, 2005, DETECTION THEORY USE; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; MOCKS J, 1988, PSYCHOPHYSIOLOGY, V25, P217; NEISSER U, 1963, AM J PSYCHOL, V76, P376, DOI 10.2307/1419778; Overvliet KE, 2008, ACTA PSYCHOL, V127, P51, DOI 10.1016/j.actpsy.2007.01.001; Pickles J. O, 1988, INTRO PHYSL HEARING; Plaisier MA, 2008, ACTA PSYCHOL, V128, P368, DOI 10.1016/j.actpsy.2008.03.011; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; SATHIAN K, 1991, PERCEPT PSYCHOPHYS, V50, P237, DOI 10.3758/BF03206747; Sussman E, 1998, BRAIN RES, V789, P130, DOI 10.1016/S0006-8993(97)01443-1; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Sussman ES, 2005, NEUROREPORT, V16, P1519, DOI 10.1097/01.wnr.0000177002.35193.4c; Timm J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00189; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Walhovd KB, 2008, PSYCHOPHYSIOLOGY, V45, P545, DOI 10.1111/j.1469-8986.2008.00661.x; WHANG KC, 1991, PERCEPT PSYCHOPHYS, V50, P157, DOI 10.3758/BF03212216; WOODY CD, 1967, MED BIOL ENG, V5, P539, DOI 10.1007/BF02474247; Wright R.D, 2008, ORIENTING ATTENTION	40	4	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173237	10.1371/journal.pone.0173237	http://dx.doi.org/10.1371/journal.pone.0173237			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278202	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900056
J	Borschmann, KN; Rewell, SS; Iuliano, S; Ghasem-Zadeh, A; Davey, RA; Ho, HD; Skeers, PN; Bernhardt, J; Howells, DW				Borschmann, Karen N.; Rewell, Sarah S.; Iuliano, Sandra; Ghasem-Zadeh, Ali; Davey, Rachel A.; Ho, Heidi; Skeers, Peta N.; Bernhardt, Julie; Howells, David W.			Reduced bone formation markers, and altered trabecular and cortical bone mineral densities of non-paretic femurs observed in rats with ischemic stroke: A randomized controlled pilot study	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; MICRO-COMPUTED TOMOGRAPHY; PHYSICAL-ACTIVITY; OCCLUSION; MODEL; GUIDELINES; INJURY; MASS	Background Immobility and neural damage likely contribute to accelerated bone loss after stroke, and subsequent heightened fracture risk in humans. Objective To investigate the skeletal effect of middle cerebral artery occlusion (MCAo) stroke in rats and examine its utility as a model of human post-stroke bone loss. Methods Twenty 15-week old spontaneously hypertensive male rats were randomized to MCAo or sham surgery controls. Primary outcome: group differences in trabecular bone volume fraction (BV/TV) measured by Micro-CT (10.5 micron istropic voxel size) at the ultra-distal femur of stroke affected left legs at day 28. Neurological impairments (stroke behavior and foot faults) and physical activity (cage monitoring) were assessed at baseline, and days 1 and 27. Serum bone turnover markers (formation: N-terminal propeptide of type 1 procollagen, PINP; resorption: C-terminal telopeptide of type 1 collagen, CTX) were assessed at baseline, and days 7 and 27. Results No effect of stroke was observed on BV/TV or physical activity, but PINP decreased by -24.5% (IQR-34.1,-10.5, p= 0.046) at day 27. In controls, cortical bone volume (5.2%, IQR 3.2, 6.9) and total volume (6.4%, IQR 1.2, 7.6) were higher in right legs compared to left legs, but these side-to-side differences were not evident in stroke animals. Conclusion MCAo may negatively affect bone formation. Further investigation of limb use and physical activity patterns after MCAo is required to determine the utility of this current model as a representation of human post-stroke bone loss.	[Borschmann, Karen N.; Bernhardt, Julie] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia; [Borschmann, Karen N.; Rewell, Sarah S.; Ho, Heidi; Skeers, Peta N.; Bernhardt, Julie; Howells, David W.] Florey Inst Neurosci & Mental Hlth, Stroke Div, Heidelberg, Vic, Australia; [Borschmann, Karen N.; Bernhardt, Julie] NHMRC Ctr Res Excellence Stroke Rehabil & Recover, Melbourne, Vic, Australia; [Iuliano, Sandra; Ghasem-Zadeh, Ali] Univ Melbourne, Austin Hlth, Dept Endocrinol, Heidelberg, Vic, Australia; [Iuliano, Sandra; Ghasem-Zadeh, Ali; Davey, Rachel A.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Howells, David W.] Univ Tasmania, Sch Med, Fac Hlth, Hobart, Tas, Australia	La Trobe University; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Tasmania	Borschmann, KN (corresponding author), La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia.; Borschmann, KN (corresponding author), Florey Inst Neurosci & Mental Hlth, Stroke Div, Heidelberg, Vic, Australia.; Borschmann, KN (corresponding author), NHMRC Ctr Res Excellence Stroke Rehabil & Recover, Melbourne, Vic, Australia.	karen.borschmann@florey.edu.au	; Bernhardt, Julie/F-9538-2015; Borschmann, Karen/I-3692-2016	DAVEY, RACHEL A/0000-0001-5121-0209; Bernhardt, Julie/0000-0002-2787-8484; Howells, David/0000-0002-2512-7724; Borschmann, Karen/0000-0001-5364-2718				Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360; Bernhardt J, 2016, INT J STROKE; Bolton DAE, 2006, BEHAV BRAIN RES, V168, P272, DOI 10.1016/j.bbr.2005.11.017; BORLONGAN CV, 1995, PHYSIOL BEHAV, V58, P909, DOI 10.1016/0031-9384(95)00103-P; Borschmann K, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/103697; Borschmann K, 2012, INT J STROKE, V7, P330, DOI 10.1111/j.1747-4949.2011.00645.x; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chiang C, 2009, J BONE MINER RES, V24, P621, DOI 10.1359/JBMR.081217; Dion N, 2011, OSTEOPOROSIS RESEARCH: ANIMAL MODELS, P37, DOI 10.1007/978-0-85729-293-3_4; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; English C, 2014, PHYS THER, V94, P185, DOI 10.2522/ptj.20130175; Erben R, 2003, HDB HISTOLOGY METHOD; Erben RG, 2000, J BONE MINER RES, V15, P1085, DOI 10.1359/jbmr.2000.15.6.1085; Fisher A, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/641943; FOX KM, 1995, ANAT RECORD, V241, P284, DOI 10.1002/ar.1092410215; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; HUGHES PCR, 1970, J ANAT, V106, P371; Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708; Jorgensen L, 2001, CALCIFIED TISSUE INT, V68, P11, DOI 10.1007/BF02684997; Jorgensen L, 2001, BONE, V28, P655, DOI 10.1016/S8756-3282(01)00434-3; Jorgensen L, 2000, OSTEOPOROSIS INT, V11, P381, DOI 10.1007/s001980070103; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338; Metz GA, 2009, J VIS EXP; Miklyaeva EI, 1997, BEHAV BRAIN RES, V88, P143, DOI 10.1016/S0166-4328(97)00043-0; Pang MYC, 2007, OSTEOPOROSIS INT, V18, P1243, DOI 10.1007/s00198-007-0372-6; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Quinn LP, 2005, BRAIN RES, V1031, P118, DOI 10.1016/j.brainres.2004.10.036; Rewell SSJ, 2010, J CEREBR BLOOD F MET, V30, P729, DOI 10.1038/jcbfm.2009.273; Roach HI, 2003, J HISTOCHEM CYTOCHEM, V51, P373, DOI 10.1177/002215540305100312; Snow LM, 2012, AM J PHYS MED REHAB, V91, P965, DOI 10.1097/PHM.0b013e31825f18e1; Stryjek R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066055; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Vignaux G, 2015, J BONE MINER RES, V30, P1103, DOI 10.1002/jbmr.2426; Vignaux G, 2013, J BONE MINER RES, V28, P2136, DOI 10.1002/jbmr.1940; Windle V, 2005, BRAIN RES, V1044, P25, DOI 10.1016/j.brainres.2005.02.060; Wong IPL, 2008, SEMIN CELL DEV BIOL, V19, P452, DOI 10.1016/j.semcdb.2008.08.001; Zebaze R, 2013, BONE, V54, P8, DOI 10.1016/j.bone.2013.01.007	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172889	10.1371/journal.pone.0172889	http://dx.doi.org/10.1371/journal.pone.0172889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278253	gold, Green Published, Green Accepted			2022-12-26	WOS:000396087900131
J	Masuda, Y; Nakayama, Y; Tanaka, A; Naito, K; Konishi, M				Masuda, Yuki; Nakayama, Yoshiaki; Tanaka, Akihiro; Naito, Kenta; Konishi, Morichika			Antitumor activity of orally administered maitake alpha-glucan by stimulating antitumor immune response in murine tumor	PLOS ONE			English	Article							ENZYMATICALLY SYNTHESIZED GLYCOGEN; NUCLEAR-MAGNETIC-RESONANCE; GRIFOLA-FRONDOSA MAITAKE; MACROPHAGE ACTIVATION; FRUIT BODY; CANCER; CELLS; POLYSACCHARIDE; COMBINATION; SYSTEM	Maitake alpha-glucan, YM-2A, isolated from Grifola frondosa, has been characterized as a highly alpha-1,6-branched alpha-1,4 glucan. YM-2A has been shown to possess an anti-virus effect in mice; however, it does not directly inhibit growth of the virus in vitro, indicating that the anti-virus effect of YM-2A might be associated with modulation of the host immune system. In this study, we found that oral administration of YM-2A could inhibit tumor growth and improve survival rate in two distinct mouse models of colon-26 carcinoma and B16 melanoma. Orally administered YM-2A enhanced antitumor immune response by increasing INF-gamma-expressing CD4(+) and CD8(+) cells in the spleen and INF-gamma-expressing CD8(+) cells in tumor-draining lymph nodes. In vitro study showed that YM-2A directly activated splenic CD11b(+) myeloid cells, peritoneal macrophages and bone marrow-derived dendritic cells, but did not affect splenic CD11b -lymphocytes or colon-26 tumor cells. YM-2A is more slowly digested by pancreatic alpha-amylase than are amylopectin and rabbit liver glycogen, and orally administered YM-2A enhanced the expression of MHC class II and CD86 on dendritic cells and the expression of MHC class II on macrophages in Peyer's patches. Furthermore, in vitro stimulation of YM-2A increased the expression of pro-inflammatory cytokines in Peyer's patch CD11c(+) cells. These results suggest that orally administered YM-2A can activate dendritic cells and macrophages in Peyer's patches, inducing systemic antitumor T-cell response. Thus, YM-2A might be a candidate for an oral therapeutic agent in cancer immunotherapy.	[Masuda, Yuki; Nakayama, Yoshiaki; Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo, Japan; [Tanaka, Akihiro; Naito, Kenta] Yukiguni Maitake Co Ltd, Dept Res & Dev, Niigata, Japan	Kobe Pharmaceutical University	Masuda, Y (corresponding author), Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo, Japan.	organic@kobepharma-u.ac.jp			Yukiguni Maitake Co., Ltd.	Yukiguni Maitake Co., Ltd.	Yukiguni Maitake Co., Ltd. provided research materials and a research grant for consumables, but did not have any input into the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; BOCK K, 1984, ADV CARBOHYD CHEM BI, V42, P193, DOI 10.1016/S0065-2318(08)60125-0; Furuyashiki T, 2011, FOOD FUNCT, V2, P183, DOI 10.1039/c0fo00171f; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Hayashi K, 2013, J BREW SOC JAPAN, V108, P401; Kakutani R, 2007, CARBOHYD RES, V342, P2371, DOI 10.1016/j.carres.2007.07.024; Kakutani R, 2012, INT IMMUNOPHARMACOL, V12, P80, DOI 10.1016/j.intimp.2011.10.017; Kakutani R, 2012, GLYCOBIOLOGY, V22, P146, DOI 10.1093/glycob/cwr122; KUBO K, 1994, BIOL PHARM BULL, V17, P1106, DOI 10.1248/bpb.17.1106; Kubo K, 1997, BIOL PHARM BULL, V20, P781, DOI 10.1248/bpb.20.781; Kushner BH, 2014, CLIN CANCER RES, V20, P1375, DOI 10.1158/1078-0432.CCR-13-1012; Lo TCT, 2011, J AGR FOOD CHEM, V59, P11997, DOI 10.1021/jf202457r; Masuda Y, 2015, J LEUKOCYTE BIOL, V98, P1015, DOI 10.1189/jlb.1A0814-415RR; Masuda Y, 2013, INT J CANCER, V133, P108, DOI 10.1002/ijc.27999; Masuda Y, 2010, CANCER IMMUNOL IMMUN, V59, P1531, DOI 10.1007/s00262-010-0880-7; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; NANBA H, 1987, CHEM PHARM BULL, V35, P1162; NISHIJIMA M, 1985, P NATL ACAD SCI USA, V82, P282, DOI 10.1073/pnas.82.2.282; Ryoyama K, 2004, BIOSCI BIOTECH BIOCH, V68, P2332, DOI 10.1271/bbb.68.2332; SAITO H, 1977, BIOCHEMISTRY-US, V16, P908, DOI 10.1021/bi00624a015; Sun L, 2012, GLYCOCONJUGATE J, V29, P357, DOI 10.1007/s10719-012-9403-4; Takaya Y, 1998, J MAR BIOTECHNOL, V6, P208; Tsoni SV, 2008, ANN NY ACAD SCI, V1143, P45, DOI 10.1196/annals.1443.019; Tsung K, 1997, J IMMUNOL, V158, P3359; Wesa KM, 2015, CANCER IMMUNOL IMMUN, V64, P237, DOI 10.1007/s00262-014-1628-6; Wojtowicz ME, 2016, SEMIN ONCOL, V43, P161, DOI 10.1053/j.seminoncol.2015.11.001; Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871; Yasuda M, 2013, FOOD FUNCT, V4, P1387, DOI 10.1039/c3fo60035a; Yoon YD, 2004, INT IMMUNOPHARMACOL, V4, P1477, DOI 10.1016/j.intimp.2004.06.012; Zhang YJ, 2002, J AGR FOOD CHEM, V50, P7581, DOI 10.1021/jf0257648	33	21	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173621	10.1371/journal.pone.0173621	http://dx.doi.org/10.1371/journal.pone.0173621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278221	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900018
J	Nagao, R; Yamaguchi, M; Nakamura, S; Ueoka-Nakanishi, H; Noguchi, T				Nagao, Ryo; Yamaguchi, Motoki; Nakamura, Shin; Ueoka-Nakanishi, Hanayo; Noguchi, Takumi			Genetically introduced hydrogen bond interactions reveal an asymmetric charge distribution on the radical cation of the special-pair chlorophyll P680	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chlorophyll; cyanobacteria; hydrogen bond; photosynthesis; photosystem II; site-directed mutagenesis; FTIR; quantum chemical calculation; special pair; thermoluminescence	TRANSFORM INFRARED DIFFERENCE; PRIMARY ELECTRON-DONOR; II CORE COMPLEXES; TYROSINE Y-Z; PHOTOSYSTEM-II; REACTION CENTERS; FTIR DIFFERENCE; PLASTOQUINONE Q(A); MN4CAO5 CLUSTER; WATER OXIDATION	The special-pair chlorophyll (Chl) P680 in photosystem II has an extremely high redox potential (E-m) to enable water oxidation in photosynthesis. Significant positive-charge localization on one of the Chl constituents, P-D1 or P-D2, in P680(+) has been proposed to contribute to this high E-m. To identify the Chl molecule on which the charge is mainly localized, we genetically introduced a hydrogen bond to the 13(1)-keto C=O group of P-D1 and P-D2 by changing the nearby D1-Val-157 and D2-Val-156 residues to His, respectively. Successful hydrogen bond formation at P-D1 and P-D2 in the obtained D1-V157H and D2-V156H mutants, respectively, was monitored by detecting 13(1)-keto C=O vibrations in Fourier transfer infrared (FTIR) difference spectra upon oxidation of P680 and the symmetrically located redox-active tyrosines Y-Z and Y-D, and they were simulated by quantum-chemical calculations. Analysis of the P680(+)/P680 FTIR difference spectra of D1-V157H and D2-V156H showed that upon P680(+) formation, the 13(1)-keto C=O frequency upshifts by a much larger extent in P-D1 (23 cm(-1)) than in P-D2 (<9 cm(-1)). In addition, thermoluminescence measurements revealed that the D1-V157H mutation increased the E-m of P680 to a larger extent than did the D2-V156H mutation. These results, together with the previous results for the mutants of the His ligands of P-D1 and P-D2, lead to a definite conclusion that a charge is mainly localized to P-D1 in P680(+).	[Nagao, Ryo; Yamaguchi, Motoki; Nakamura, Shin; Ueoka-Nakanishi, Hanayo; Noguchi, Takumi] Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Nagoya University	Nagao, R; Noguchi, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	nagao@bio.phys.nagoya-u.ac.jp; tnoguchi@bio.phys.nagoya-u.ac.jp	NAGAO, Ryo/D-4117-2012; Noguchi, Takumi/I-7105-2014	NAGAO, Ryo/0000-0001-8212-3001; zhong xi, hua dai/0000-0001-8619-9513	Japan Society for the Promotion of Science [15J10320, 26840091, 24000018, 24107003]; Grants-in-Aid for Scientific Research [17K07442] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Japan Society for the Promotion of Science Fellows 15J10320 (to S. N.) and Scientific Research from Japan Society for the Promotion of Science 26840091 (to R. N.) and 24000018 and 24107003 (to T. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Azai C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19878; BALLSCHMITER K, 1969, J AM CHEM SOC, V91, P2661, DOI 10.1021/ja01038a044; Berthomieu C, 1998, BIOCHEMISTRY-US, V37, P10547, DOI 10.1021/bi980788m; BUSER CA, 1990, BIOCHEMISTRY-US, V29, P8977, DOI 10.1021/bi00490a014; Case DA, 2012, AMBER 12; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; Chu HA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00146; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Debus RJ, 2015, BBA-BIOENERGETICS, V1847, P19, DOI 10.1016/j.bbabio.2014.07.007; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEGROOTH BG, 1981, BIOCHIM BIOPHYS ACTA, V635, P445, DOI 10.1016/0005-2728(81)90104-3; Diner BA, 2005, ADV PHOTO RESPIRAT, V22, P207; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Diner BA, 2001, BIOCHEMISTRY-US, V40, P9265, DOI 10.1021/bi010121r; Faller P, 2001, P NATL ACAD SCI USA, V98, P14368, DOI 10.1073/pnas.251382598; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frisch G. W., 2013, GAUSSIAN 09; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; Grabolle M, 2005, BBA-BIOENERGETICS, V1708, P209, DOI 10.1016/j.bbabio.2005.03.007; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hasegawa K, 2005, BIOCHEMISTRY-US, V44, P8865, DOI 10.1021/bi050273c; HEALD RL, 1990, J PHYS CHEM-US, V94, P3968, DOI 10.1021/j100373a019; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; Hienerwadel R, 1996, BIOCHEMISTRY-US, V35, P15447, DOI 10.1021/bi961952d; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P4118, DOI 10.1021/bi047922p; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Ito H, 2011, P NATL ACAD SCI USA, V108, P18014, DOI 10.1073/pnas.1107590108; Ivancich A, 1998, BIOCHEMISTRY-US, V37, P11812, DOI 10.1021/bi9806908; Kato Y, 2016, BIOMED SPECTROSC IMA, V5, P269, DOI 10.3233/BSI-160146; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; Kitajima Y, 2006, BIOCHEMISTRY-US, V45, P1938, DOI 10.1021/bi052346y; KLIMOV VV, 1979, DOKL AKAD NAUK SSSR+, V249, P227; KRAWCZYK S, 1989, BIOCHIM BIOPHYS ACTA, V976, P140, DOI 10.1016/S0005-2728(89)80223-3; LIN X, 1994, P NATL ACAD SCI USA, V91, P10265, DOI 10.1073/pnas.91.22.10265; Lutz M., 1991, CHLOROPHYLLS, P855; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 2011, RSC ENERGY ENVIRON S, P163; METZ JG, 1989, BIOCHEMISTRY-US, V28, P6960, DOI 10.1021/bi00443a028; NABEDRYK E, 1990, BIOCHEMISTRY-US, V29, P3242, DOI 10.1021/bi00465a015; NABEDRYK E, 1993, BIOCHEMISTRY-US, V32, P13879, DOI 10.1021/bi00213a017; Nakamura S, 2016, P NATL ACAD SCI USA, V113, P12727, DOI 10.1073/pnas.1607897113; Nakamura S, 2016, BIOCHEMISTRY-US, V55, P597, DOI 10.1021/acs.biochem.5b01120; Nakamura S, 2015, BIOCHEMISTRY-US, V54, P5045, DOI 10.1021/acs.biochem.5b00568; Nakamura S, 2014, BIOCHEMISTRY-US, V53, P3131, DOI 10.1021/bi500237y; Narzi D, 2016, J AM CHEM SOC, V138, P257, DOI 10.1021/jacs.5b10523; Noguchi T, 1998, BIOCHEMISTRY-US, V37, P13614, DOI 10.1021/bi9812975; Noguchi T, 2005, ADV PHOTO RESPIRAT, V22, P367; Noguchi T, 2002, SPECTROSC-INT J, V16, P89, DOI 10.1155/2002/960232; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P2322, DOI 10.1021/bi011954k; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Noguchi T, 2015, BBA-BIOENERGETICS, V1847, P35, DOI 10.1016/j.bbabio.2014.06.009; Okubo T, 2007, BIOCHEMISTRY-US, V46, P4390, DOI 10.1021/bi700157n; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Rappaport F, 2005, BIOPHYS J, V88, P1948, DOI 10.1529/biophysj.104.050237; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Rappaport F, 2009, J AM CHEM SOC, V131, P4425, DOI 10.1021/ja808604h; Raszewski G, 2005, BIOPHYS J, V88, P986, DOI 10.1529/biophysj.104.050294; Raszewski G, 2008, BIOPHYS J, V95, P105, DOI 10.1529/biophysj.107.123935; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Renger T, 2011, J PHOTOCH PHOTOBIO B, V104, P126, DOI 10.1016/j.jphotobiol.2011.03.016; RIGBY SEJ, 1994, BIOCHEMISTRY-US, V33, P10043, DOI 10.1021/bi00199a031; Rutherford AW, 2003, PHILOS T R SOC B, V358, P245, DOI 10.1098/rstb.2002.1186; Saito K, 2013, P NATL ACAD SCI USA, V110, P7690, DOI 10.1073/pnas.1300817110; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Saito K, 2011, J AM CHEM SOC, V133, P14379, DOI 10.1021/ja203947k; Sakurai I, 2007, PLANT PHYSIOL, V144, P1336, DOI 10.1104/pp.107.098731; SETIF P, 1980, ARCH BIOCHEM BIOPHYS, V204, P477, DOI 10.1016/0003-9861(80)90059-4; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Styring S, 2012, BBA-BIOENERGETICS, V1817, P76, DOI 10.1016/j.bbabio.2011.03.016; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2016, BBA-BIOENERGETICS, V1857, P1943, DOI 10.1016/j.bbabio.2016.09.012; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Takahashi R, 2008, BIOCHEMISTRY-US, V47, P6289, DOI 10.1021/bi8007998; Takahashi R, 2007, J PHYS CHEM B, V111, P13833, DOI 10.1021/jp0760556; Takahashi R, 2007, BIOCHEMISTRY-US, V46, P14245, DOI 10.1021/bi701752d; TANG XS, 1993, BIOCHEMISTRY-US, V32, P13742, DOI 10.1021/bi00212a045; Tomo T, 2007, P NATL ACAD SCI USA, V104, P7283, DOI 10.1073/pnas.0701847104; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANMIEGHEM FJE, 1989, BIOCHIM BIOPHYS ACTA, V977, P207, DOI 10.1016/S0005-2728(89)80073-8; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; Vreven T, 2006, J CHEM THEORY COMPUT, V2, P815, DOI 10.1021/ct050289g; Zhang HM, 1997, BIOCHEMISTRY-US, V36, P11762, DOI 10.1021/bi970815t	87	15	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7474	7486		10.1074/jbc.M117.781062	http://dx.doi.org/10.1074/jbc.M117.781062			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302724	Green Published, hybrid			2022-12-26	WOS:000400761300017
J	Chehboun, S; Labrecque-Carbonneau, J; Pasquin, S; Meliani, Y; Meddah, B; Ferlin, W; Sharma, M; Tormo, A; Masson, JF; Gauchat, JF				Chehboun, Salma; Labrecque-Carbonneau, Jeremie; Pasquin, Sarah; Meliani, Yasmine; Meddah, Bouchra; Ferlin, Walter; Sharma, Mukut; Tormo, Aurelie; Masson, Jean-Francois; Gauchat, Jean-Francois			Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESIGNER CYTOKINE; SOLUBLE IL-6; FACTOR CNTF; IN-VIVO; RECEPTOR; EXPRESSION; SUBUNIT; INDUCTION; PROTEIN; CELLS	Epstein-Barr virus-induced gene 3 (EBI3) is a subunit of the composite cytokines IL-27 and IL-35. Both have beneficial functions or effects in models of infectious and autoimmune diseases. This suggests that administration of EBI3 could be therapeutically useful by binding free p28 and p35 to generate IL-27 and IL-35. IL-27-and IL-35-independent functions of EBI3 could compromise its therapeutic uses. We therefore assessed the effects of EBI3 on cytokine receptor-expressing cells. We observed that EBI3 activates STAT3 and induces the proliferation of the IL-6-dependent B9 mouse plasmacytoma cell line. Analyses using blocking mAbs and Ba/F3 transfectants expressing gp130 indicate that EBI3 activity was linked to its capacity to mediate IL-6 trans-signaling, albeit less efficiently than soluble IL-6R alpha. In line with this interpretation, co-immunoprecipitation and SPR experiments indicated that EBI3 binds IL-6. An important pro-inflammatory function of IL-6 trans-signaling is to activate blood vessel endothelial cells. Weobserved that EBI3 in combination with IL-6 could induce the expression of chemokines by human venal endothelial cells. Our results indicate that EBI3 can promote pro-inflammatory IL-6 functions by mediating trans-signaling. These unexpected observations suggest that use of EBI3 as a therapeutic biologic for autoimmune diseases will likely require co-administration of soluble gp130 to prevent the side effects associated with IL-6 trans-signaling. Together with previous studies that demonstrated activation of IL-6R by p28 (IL-30), new findings further suggest a complex interrelation between IL-27 and IL-6.	[Chehboun, Salma; Pasquin, Sarah; Meliani, Yasmine; Tormo, Aurelie; Gauchat, Jean-Francois] Univ Montreal, Dept Pharmacol, Pavillon Roger Gaudry S455-N424, Montreal, PQ H3T 1J4, Canada; [Labrecque-Carbonneau, Jeremie; Masson, Jean-Francois] Univ Montreal, Dept Chim, Montreal, PQ H3T 1J4, Canada; [Meddah, Bouchra] Univ Mohammed 5, Fac Med & Pharm, Lab Pharmacol & Toxicol, Rabat, Morocco; [Ferlin, Walter] NovImmune, CH-1228 Plan Les Ouates, Switzerland; [Sharma, Mukut] Kansas City Vet Affairs Med Ctr, Res Serv, Kansas City, MO 64128 USA; [Sharma, Mukut] Midwest Biomed Res Fdn, Kansas City, MO 64128 USA	Universite de Montreal; Universite de Montreal; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Gauchat, JF (corresponding author), Univ Montreal, Dept Pharmacol, Pavillon Roger Gaudry S455-N424, Montreal, PQ H3T 1J4, Canada.	jf.gauchat@umontreal.ca	Masson, Jean-Francois/C-4893-2008; Labrecque-Carbonneau, Jeremie/AAR-7732-2020	chehboun, Salma/0000-0002-9509-6185	Canadian Institutes of Health Research Grant [MOP-57832]; Natural Science and Engineering Research Council of Canada Grant [412305-2011]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Grant MOP-57832 (to J.-F. G.) and Natural Science and Engineering Research Council of Canada Grant 412305-2011 (to J.-F. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107; Brahmachari S, 2008, Minerva Med, V99, P105; Chiesa C, 2015, CYTOKINE, V76, P1, DOI 10.1016/j.cyto.2015.03.015; Chung YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003628; Cognet I, 2004, EUR CYTOKINE NETW, V15, P255; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; DIAMANT M, 1994, J IMMUNOL METHODS, V173, P229, DOI 10.1016/0022-1759(94)90301-8; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2013, J BIOL CHEM, V288, P4346, DOI 10.1074/jbc.M112.432955; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Hill M, 2011, AM J TRANSPLANT, V11, P2036, DOI 10.1111/j.1600-6143.2011.03651.x; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; Jana M, 2009, GLIA, V57, P1553, DOI 10.1002/glia.20869; Jones LL, 2012, MOL IMMUNOL, V51, P234, DOI 10.1016/j.molimm.2012.03.025; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Lacroix M, 2015, J BIOL CHEM, V290, P26943, DOI 10.1074/jbc.M115.682138; Larousserie F, 2005, AM J PATHOL, V166, P1217, DOI 10.1016/S0002-9440(10)62340-1; Lee SY, 2011, J IMMUNOL, V186, P3226, DOI 10.4049/jimmunol.1003587; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Liu JQ, 2012, J IMMUNOL, V188, P3099, DOI 10.4049/jimmunol.1100106; Liu ZZ, 2013, AM J TRANSL RES, V5, P470; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Maaser C, 2004, IMMUNOLOGY, V112, P437, DOI 10.1111/j.1365-2567.2004.01895.x; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Peters M, 1998, J IMMUNOL, V161, P3575; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Ratel M, 2013, ANAL CHEM, V85, P5770, DOI 10.1021/ac400386z; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Rousseau F, 2010, P NATL ACAD SCI USA, V107, P19420, DOI 10.1073/pnas.1005793107; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thibault V, 1997, FEBS LETT, V408, P182, DOI 10.1016/S0014-5793(97)00417-1; Tormo AJ, 2013, J IMMUNOL, V191, P1657, DOI 10.4049/jimmunol.1201595; Tormo AJ, 2013, J IMMUNOL, V190, P2931, DOI 10.4049/jimmunol.1201460; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Zhao SS, 2015, BIOSENS BIOELECTRON, V64, P664, DOI 10.1016/j.bios.2014.09.082	52	29	31	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6644	6656		10.1074/jbc.M116.762021	http://dx.doi.org/10.1074/jbc.M116.762021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28280243	hybrid, Green Published			2022-12-26	WOS:000399813400017
J	Klebaner, D; Hamilton-Dutoit, S; Ahern, T; Crawford, A; Jakobsen, T; Cronin-Fenton, DP; Damkier, P; Janssen, E; Kjaersgaard, A; Ording, AG; Soiland, H; Sorensen, HT; Lash, TL; Hellberg, Y				Klebaner, Daniella; Hamilton-Dutoit, Stephen; Ahern, Thomas; Crawford, Anatasha; Jakobsen, Thomas; Cronin-Fenton, Deirdre P.; Damkier, Per; Janssen, Emiel; Kjaersgaard, Anders; Ording, Anne Gulbech; Soiland, Havard; Sorensen, Henrik Toft; Lash, Timothy L.; Hellberg, Ylva			Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients	PLOS ONE			English	Article							BINDING CYST PROTEIN; ESTROGEN-RECEPTOR; ADJUVANT TAMOXIFEN; ENDOCRINE THERAPY; MECHANISMS; RESISTANCE; REGISTRATION; SURVIVAL; MARKERS; TRENDS	Background Apolipoprotein D (ApoD) has been proposed as a predictor of breast cancer recurrence among estrogen receptor-positive (ER+), tamoxifen-treated patients. Methods We conducted a population-based case-control study nested in a population of 11,251 women aged 35-69 years at diagnosis with Stage I-III breast cancer between 1985 and 2001 on Denmark's Jutland Peninsula and registered with the Danish Breast Cancer Coop-erative Group. We identified 541 recurrent or contralateral breast cancers cases among women with ER+ disease treated with tamoxifen for at least 1 year and 300 cases in women with ER-disease never treated with tamoxifen. We matched one control subject per case and assessed ApoD expression in the tumor cell nucleus and cytoplasm using tissue micro-array immunohistochemistry. We computed the odds ratio (OR) associating ApoD expression with recurrence and adjusted for potential confounding using logistic regression. Results Cytoplasmic ApoD expression was seen in 68% of ER+ tumors, in 66% of ER-tumors, and in 66% of controls across both groups. In women with ER+ tumors, the associations of cyto-plasmic ApoD expression with recurrence (OR = 1.0; 95% CI = 0.7 to 1.4) and increasing cytoplasmic expression with recurrence (OR = 1.0; 95% CI = 0.996 to 1.003) were null, as were those for women with ER-tumors. Associations for nuclear ApoD expression and combined nuclear and cytoplasmic expression were similarly near-null. Conclusion ApoD expression is likely not a predictor of recurrence in tamoxifen-treated patients.	[Klebaner, Daniella; Crawford, Anatasha; Lash, Timothy L.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hamilton-Dutoit, Stephen; Jakobsen, Thomas; Hellberg, Ylva] Aarhus Univ Hosp, Inst Pathol, Aarhus, Denmark; [Ahern, Thomas] Univ Vermont, Coll Med, Dept Surg, Burlington, VT USA; [Ahern, Thomas] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Cronin-Fenton, Deirdre P.; Kjaersgaard, Anders; Ording, Anne Gulbech; Sorensen, Henrik Toft; Lash, Timothy L.] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark; [Damkier, Per] Odense Univ Hosp, Dept Clin Chem & Pharmacol, Odense, Denmark; [Janssen, Emiel] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Soiland, Havard] Stavanger Univ Hosp, Dept Breast & Endocrine Surg, Stavanger, Norway; [Soiland, Havard] Univ Bergen, Dept Clin Sci, Bergen, Norway	Emory University; Rollins School Public Health; Aarhus University; University of Vermont; University of Vermont; Aarhus University; University of Southern Denmark; Odense University Hospital; Stavanger University Hospital; Stavanger University Hospital; University of Bergen	Lash, TL (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.; Lash, TL (corresponding author), Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark.	Tlash@emory.edu	Sorensen, Henrik Toft/Z-6181-2019; Janssen, Emiel A.M./AAM-2357-2020; Damkier, Per/P-8217-2019; Jakobsen, Thomas Stax/GVU-5079-2022	Sorensen, Henrik Toft/0000-0003-4299-7040; Damkier, Per/0000-0003-0591-7187; Hamilton-Dutoit, Stephen/0000-0003-2158-3885; Jakobsen, Thomas Stax/0000-0002-5393-3918; Ahern, Thomas/0000-0003-0440-8727	Danish Medical Research Council [DOK 1158859]; U.S. National Cancer Institute at the U.S. National Institutes of Health [R01 CM 18708, R01 CM 66825]; Danish Cancer Society [DP06117]; Karen Elise Jensen Foundation; Program for Clinical Research Infrastructure established by the Lundbeck; Novo Nordisk Foundations; Susan G. Komen for the Cure [CCR13264024]; Mary Kay Foundation [003-14]; Lundbeck Foundation [R1672013-15861]; Lundbeck Foundation [R155-2014-2647, R167-2013-15861] Funding Source: researchfish; Novo Nordisk Fonden [NNF14SA0015794] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. National Cancer Institute at the U.S. National Institutes of Health; Danish Cancer Society(Danish Cancer Society); Karen Elise Jensen Foundation; Program for Clinical Research Infrastructure established by the Lundbeck; Novo Nordisk Foundations(Novo Nordisk Foundation); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Mary Kay Foundation; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Danish Medical Research Council [DOK 1158859 (T. L. Lash)], U.S. National Cancer Institute at the U.S. National Institutes of Health [R01 CM 18708 and R01 CM 66825 (T. L. Lash)]; Danish Cancer Society [DP06117 (S. Hamilton-Dutoit)]; Karen Elise Jensen Foundation (H. T. Sorensen); Henrik Toft Sorensen is supported by the Program for Clinical Research Infrastructure established by the Lundbeck and the Novo Nordisk Foundations; Susan G. Komen for the Cure [CCR13264024 (T. Ahern)]; The Mary Kay Foundation [003-14 (T. Ahern)]; and the Lundbeck Foundation [R1672013-15861 (D.P. Cronin-Fenton)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Beelen K, 2012, NAT REV CLIN ONCOL, V9, P529, DOI 10.1038/nrclinonc.2012.121; Burstein HJ, 2012, J CLIN ONCOL, V30, P684, DOI 10.1200/JCO.2011.40.1455; Carreno G, 2007, BREAST CANCER RES TR, V102, P61, DOI 10.1007/s10549-006-9310-0; Chlebowski RT, 2013, CLIN BREAST CANCER, V13, P159, DOI 10.1016/j.clbc.2012.11.002; Christiansen P, 2008, ACTA ONCOL, V47, P691, DOI 10.1080/02841860802056594; Cronin-Fenton DP, 2012, ACTA ONCOL, V51, P254, DOI 10.3109/0284186X.2011.633556; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; DIEZITZA I, 1994, AM J PATHOL, V144, P310; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Harding C, 2000, BRIT J CANCER, V82, P354, DOI 10.1054/bjoc.1999.0926; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Jensena AR, 2003, EUR J CANCER, V39, P1783, DOI 10.1016/S0959-8049(03)00377-0; Kelly E, 2015, J CLIN PHARM THER, V40, P76, DOI 10.1111/jcpt.12227; Lamelas M L, 2000, Int J Surg Investig, V2, P285; Lash TL, 2011, JNCI-J NATL CANCER I, V103, P489, DOI 10.1093/jnci/djr010; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Milani A, 2014, WORLD J CLIN ONCOL, V5, P990, DOI 10.5306/wjco.v5.i5.990; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; National Comprehensive Cancer Network, STAG 1 2 BREAST CANC; National Comprehensive Cancer Network, 2014, STAG 3 BREAST CANC V; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rastelli F, 2008, TUMORI J, V94, P370; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; SIMARD J, 1990, ENDOCRINOLOGY, V126, P3223, DOI 10.1210/endo-126-6-3223; Soiland H, 2007, CELL ONCOL, V29, P195; Soiland H, 2009, ACTA ONCOL, V48, P514, DOI 10.1080/02841860802620613; Soiland H, 2009, BREAST CANCER RES TR, V113, P519, DOI 10.1007/s10549-008-9955-y; SOREIDE JA, 1991, ANTICANCER RES, V11, P601; SOREIDE JA, 1994, ANTICANCER RES, V14, P2105; Surveillance Epidemiology and End Results (SEER), 2009, SEER STAT FACT SHEET; Tao Z, 2014, BREAST CANC EPIDEMIO; Union for International Cancer Control, 1997, TNM CLASSIFICATION M; Viedma-Rodriguez R, 2014, ONCOL REP, V32, P3, DOI 10.3892/or.2014.3190; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	40	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171253	10.1371/journal.pone.0171453	http://dx.doi.org/10.1371/journal.pone.0171453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301514	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300012
J	Opiol, H; de Zavalia, N; Delorme, T; Solis, P; Rutherford, S; Shalev, U; Amir, S				Opiol, Hanna; de Zavalia, Nuria; Delorme, Tara; Solis, Pavel; Rutherford, Spencer; Shalev, Uri; Amir, Shimon			Exploring the role of locomotor sensitization in the circadian food entrainment pathway	PLOS ONE			English	Article							RATS MOTOR RESPONSE; BEHAVIORAL SENSITIZATION; COCAINE SENSITIZATION; ANTICIPATORY ACTIVITY; CROSS-SENSITIZATION; LIMBIC FOREBRAIN; SELF-STIMULATION; PERIOD2 PROTEIN; DORSAL STRIATUM; DRUG REWARD	Food entrainment is the internal mechanism whereby the phase and period of circadian clock genes comes under the control of daily scheduled food availability. Food entrainment allows the body to efficiently realign the internal timing of behavioral and physiological functions such that they anticipate food intake. Food entrainment can occur with or without caloric restriction, as seen with daily schedules of restricted feeding (RF) or restricted treat (RT) that restrict food or treat intake to a single feeding time. However, the extent of clock gene control is more pronounced with caloric restriction, highlighting the role of energy balance in regulating clock genes. Recent studies have implicated dopamine (DA) to be involved in food entrainment and caloric restriction is known to affect dopaminergic pathways to enhance locomotor activity. Since food entrainment results in the development of a distinct behavioral component, called food anticipatory activity (FAA), we examined the role of locomotor sensitization (LS) in food entrainment by 1) observing whether amphetamine (AMPH) sensitization results in enhanced locomotor output of FAA and 2) measuring LS of circadian and non-circadian feeding paradigms to an acute injection of AMPH (AMPH cross-sensitization). Unexpectedly, AMPH sensitization did not show enhancement of FAA. On the contrary, LS did develop with sufficient exposure to RF. LS was present after 2 weeks of RF, but not after 1, 3 or 7 days into RF. When food was returned and rats regain their original body weight at 10-15 days post-RF, LS remained present. LS did not develop to RT, nor to feedings of a non-circadian schedule, e.g. variable restricted feeding (VRF) or variable RT (VRT). Further, when RF was timed to the dark period, LS was observed only when tested at night; RF timed to the light period resulted in LS that was present during day and night. Taken together our results show that LS develops with food entrainment to RF, an effect that is dependent on the chronicity and circadian phase of RF but independent of body weight. Given that LS involves reorganization of DA-regulated motor circuitry, our work provides indirect support for the role of DA in the food entrainment pathway of RF. The findings also suggest differences in neuronal pathways involved in LS from AMPH sensitization and LS from RF.	[Opiol, Hanna; de Zavalia, Nuria; Delorme, Tara; Solis, Pavel; Rutherford, Spencer; Shalev, Uri; Amir, Shimon] Concordia Univ, Ctr Studies Behav Neurobiol, Dept Psychol, Montreal, PQ, Canada	Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Ctr Studies Behav Neurobiol, Dept Psychol, Montreal, PQ, Canada.	shimon.amir@concordia.ca	Rutherford, Spencer/GPS-9422-2022; Amir, Shimon/AAE-4635-2022; Shalev, Uri/I-1803-2019	Shalev, Uri/0000-0002-7860-6016	Canadian Institutes of Health Research [MOP142458]; Natural Sciences and Engineering Council of Canada [37358-2013]; Fonds de Recherche Sante Quebec [5833]; Natural Sciences and Engineering Research Council of Canada; Les Fonds de la recherche en sante Quebec; Canadian Institutes for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Sante Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Les Fonds de la recherche en sante Quebec; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work received support from: Canadian Institutes of Health Research (MOP142458) http://www.cihr-irsc.gc.ca/; Natural Sciences and Engineering Council of Canada (37358-2013) http://www.nserc-crsng.gc.ca/; and Fonds de Recherche Sante Quebec (5833) http://www.frqs.gouv.qc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, Les Fonds de la recherche en sante Quebec, and the Canadian Institutes for Health Research.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; ABRAHAMSEN GC, 1995, BRAIN RES, V695, P186, DOI 10.1016/0006-8993(95)00764-H; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Arvanitogiannis A, 2000, NEUROSCIENCE, V101, P1, DOI 10.1016/S0306-4522(00)00401-2; Avena NA, 2003, PHARMACOL BIOCHEM BE, V74, P635, DOI 10.1016/S0091-3057(02)01050-X; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Beyer CE, 2002, CEREB CORTEX, V12, P526, DOI 10.1093/cercor/12.5.526; Blum ID, 2014, ELIFE, V3, DOI 10.7554/eLife.05105; Browman KE, 1998, PSYCHOPHARMACOLOGY, V137, P90, DOI 10.1007/s002130050597; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Carr KD, 2003, NEUROSCIENCE, V119, P1157, DOI 10.1016/S0306-4522(03)00227-6; CARR KD, 1993, BRAIN RES, V607, P141, DOI 10.1016/0006-8993(93)91499-I; Carr KD, 2007, PHYSIOL BEHAV, V91, P459, DOI 10.1016/j.physbeh.2006.09.021; Chaix A, 2016, TRENDS ENDOCRIN MET, V27, P350, DOI 10.1016/j.tem.2016.03.014; de Vaca SC, 2004, PSYCHOPHARMACOLOGY, V175, P106, DOI 10.1007/s00213-003-1768-4; de Vaca SC, 1998, J NEUROSCI, V18, P7502; Escobar C, 2007, EUR J NEUROSCI, V26, P2804, DOI 10.1111/j.1460-9568.2007.05893.x; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fletcher PJ, 2005, PSYCHOPHARMACOLOGY, V183, P190, DOI 10.1007/s00213-005-0157-6; Flores DEFL, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00143; Frederick A, 2015, DISTRIBUTED NETWORKS, P52; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Gallardo CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03781; Gaytan O, 1998, PHARMACOL BIOCHEM BE, V59, P459, DOI 10.1016/S0091-3057(97)00438-3; Gaytan O, 1998, EUR J PHARMACOL, V345, P119, DOI 10.1016/S0014-2999(97)01558-6; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Iijima M, 2002, EUR J NEUROSCI, V16, P921, DOI 10.1046/j.1460-9568.2002.02140.x; Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044; KALIVAS PW, 1993, BEHAV PHARMACOL, V4, P315; Kosobud AEK, 1998, NEUROSCI LETT, V250, P99, DOI 10.1016/S0304-3940(98)00439-X; Landry GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040895; Liu Y, 2007, NEUROSCIENCE, V146, P265, DOI 10.1016/j.neuroscience.2007.01.009; Liu Y, 2005, NEUROSCIENCE, V130, P383, DOI 10.1016/j.neuroscience.2004.09.012; Liu YY, 2012, J BIOL RHYTHM, V27, P398, DOI 10.1177/0748730412455913; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; Opiol H, 2015, BEHAV BRAIN RES, V284, P42, DOI 10.1016/j.bbr.2015.02.003; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Patton DF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00185; PAULSON PE, 1995, SYNAPSE, V19, P56, DOI 10.1002/syn.890190108; Paulson PE, 1996, NEUROPSYCHOPHARMACOL, V14, P325, DOI 10.1016/0893-133X(95)00141-Y; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Singer BF, 2012, BEHAV BRAIN RES, V226, P340, DOI 10.1016/j.bbr.2011.09.003; Smit AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082381; Song SS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00336; STEWART J, 1993, BEHAV PHARMACOL, V4, P289; Vanderschuren LJMJ, 2010, CURR TOP BEHAV NEURO, V3, P179, DOI 10.1007/7854_2009_21; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Verwey M, 2008, NEUROSCI LETT, V440, P54, DOI 10.1016/j.neulet.2008.05.043; Verwey M, 2012, J MOL NEUROSCI, V46, P258, DOI 10.1007/s12031-011-9529-z; VEZINA P, 1989, BRAIN RES, V499, P108, DOI 10.1016/0006-8993(89)91140-2; Vezina P, 1996, J NEUROSCI, V16, P2411	61	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174113	10.1371/journal.pone.0174113	http://dx.doi.org/10.1371/journal.pone.0174113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301599	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000396318300128
J	Salzberg, AC; Harris-Becker, A; Popova, EY; Keasey, N; Loughran, TP; Claxton, DF; Grigoryev, SA				Salzberg, Anna C.; Harris-Becker, Abigail; Popova, Evgenya Y.; Keasey, Nikki; Loughran, Thomas P.; Claxton, David F.; Grigoryev, Sergei A.			Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; METHYLTRANSFERASE G9A; CHROMATIN-STRUCTURE; HETEROCHROMATIN; DNA; CANCER; METHYLATION; ERG; ORGANIZATION; DYNAMICS	A facultative heterochromatin mark, histone H3 lysine 9 dimethylation (H3K9me2), which is mediated by histone methyltransferases G9a/GLP (EHMT2/1), undergoes dramatic rearrangements during myeloid cell differentiation as observed by chromatin imaging. To determine whether these structural transitions also involve genomic repositioning of H3K9me2, we used ChIP-sequencing to map genome-wide topography of H3K9me2 in normal human granulocytes, normal CD34+ hematopoietic progenitors, primary myeloblasts from acute myeloid leukemia (AML) patients, and a model leukemia cell line K562. We observe that H3K9me2 naturally repositions from the previously designated "repressed" chromatin state in hematopoietic progenitors to predominant association with heterochromatin regions in granulocytes. In contrast, AML cells accumulate H3K9me2 on previously undefined large (> 100 Kb) genomic blocks that are enriched with AML -specific single nucleotide variants, sites of chromosomal translocations, and genes downregulated in AML. Specifically, the AML -specific H3K9me2 blocks are enriched with genes regulated by the proto-oncogene ERG that promotes stem cell characteristics. The AML -enriched H3K9me2 blocks (in contrast to the heterochromatin-associated H3K9me2 blocks enriched in granulocytes) are reduced by pharmacological inhibition of the histone methyltransferase G9a/GLP in K562 cells concomitantly with transcriptional activation of ERG and ETS1 oncogenes. Our data suggest that G9a/GLP mediate formation of transient H3K9me2 blocks that are preserved in AML myeloblasts and may lead to an increased rate of AML -specific mutagenesis and chromosomal translocations.	[Salzberg, Anna C.] Div Biostat & Bioinformat, Hershey, PA USA; [Salzberg, Anna C.] Penn State Inst Personalized Med, Hershey, PA USA; [Harris-Becker, Abigail; Grigoryev, Sergei A.] Penn State Coll Med, Dept Biochem & Mol Biol, H171, Hershey, PA USA; [Popova, Evgenya Y.] Penn State Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Keasey, Nikki; Claxton, David F.] Milton S Hershey Med Ctr, Penn State Canc Inst, 500 Univ Dr, Hershey, PA USA; [Loughran, Thomas P.] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Virginia	Grigoryev, SA (corresponding author), Penn State Coll Med, Dept Biochem & Mol Biol, H171, Hershey, PA USA.; Claxton, DF (corresponding author), Milton S Hershey Med Ctr, Penn State Canc Inst, 500 Univ Dr, Hershey, PA USA.	dclaxton@hmc.psu.edu; sag17@psu.edu			Pennsylvania Department of Health [4100050904]; Penn State Hershey Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE [P01CA171983] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002014, UL1TR000127] Funding Source: NIH RePORTER	Pennsylvania Department of Health; Penn State Hershey Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support was provided by Pennsylvania Department of Health using Tobacco Settlement Funds Grant 4100050904. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions (Recipients: SAG, DFC, TPL). Support was also provided by Penn State Hershey Clinical and Translational Science Institute grant (Recipients: SAG, DFC).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Capala ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111568; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen M, 2015, GENE DEV, V29, P2123, DOI 10.1101/gad.267278.115; Chen XJ, 2012, GENE DEV, V26, P2499, DOI 10.1101/gad.200329.112; Coligan SE, 1991, CURRENT PROTOCOLS IM; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cullen SM, 2014, CURR TOP DEV BIOL, V107, P39, DOI 10.1016/B978-0-12-416022-4.00002-0; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; Goodarzi AA, 2012, INT J MOL SCI, V13, P11844, DOI 10.3390/ijms130911844; Grigoryev SA, 2006, CHROMOSOME RES, V14, P53, DOI 10.1007/s10577-005-1021-6; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hu DQ, 2016, GENE DEV, V30, P2021, DOI 10.1101/gad.284109.116; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Knudsen KJ, 2015, GENE DEV, V29, P1915, DOI 10.1101/gad.268409.115; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Kornberg RD, 2007, NAT STRUCT MOL BIOL, V14, P986, DOI 10.1038/nsmb1107-986; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Lukasova E, 2013, BBA-MOL CELL RES, V1833, P767, DOI 10.1016/j.bbamcr.2012.12.012; Maher K, 2014, J BIOL CHEM, V289, P31736, DOI 10.1074/jbc.M114.609396; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mieczkowski J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11485; Mochmann LH, 2014, ONCOTARGET, V5, P351, DOI 10.18632/oncotarget.1449; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Nekrasov M, 2012, NAT STRUCT MOL BIOL, V19, P1076, DOI 10.1038/nsmb.2424; Ng AP, 2011, BLOOD, V118, P2454, DOI 10.1182/blood-2011-03-344739; Nichols MH, 2015, CELL, V162, P702, DOI 10.1016/j.cell.2015.07.053; Pappano WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131716; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Popova EY, 2013, J BIOL CHEM, V288, P17895, DOI 10.1074/jbc.M113.452144; Popova EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046867; Popova EY, 2006, EXP HEMATOL, V34, P453, DOI 10.1016/j.exphem.2006.01.003; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shema E, 2016, SCIENCE, V352, P717, DOI 10.1126/science.aad7701; Socitey LaL, 2014, LEUK LYMPH MYEL FACT; Son HJ, 2012, MOL CELL BIOL, V32, P3681, DOI 10.1128/MCB.00673-12; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Tursky ML, 2015, LEUKEMIA, V29, P819, DOI 10.1038/leu.2014.299; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; Wang SW, 2010, MOL BIOL CELL, V21, P821, DOI 10.1091/mbc.E09-06-0456; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011	77	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173723	10.1371/journal.pone.0173723	http://dx.doi.org/10.1371/journal.pone.0173723			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301528	Green Submitted, gold, Green Published			2022-12-26	WOS:000396318300067
J	Lin, E; Kuo, PH; Liu, YL; Yang, AC; Kao, CF; Tsai, SJ				Lin, Eugene; Kuo, Po-Hsiu; Liu, Yu-Li; Yang, Albert C.; Kao, Chung-Feng; Tsai, Shih-Jen			Effects of circadian clock genes and health-related behavior on metabolic syndrome in a Taiwanese population: Evidence from association and interaction analysis	PLOS ONE			English	Article							OBESITY; PHENOTYPES; VARIANT; POLYMORPHISM; PREVALENCE; DISORDER; ALPHA; MASS	Increased risk of developing metabolic syndrome (MetS) has been associated with the circadian clock genes. In this study, we assessed whether 29 circadian clock-related genes (including ADCYAP1, ARNTL, ARNTL2, BHLHE40, CLOCK, CRY1, CRY2, CSNK1D, CSNK1E, GSK3B, HCRTR2, KLF10, NFIL3, NPAS2, NR1D1, NR1D2, PER1, PER2, PER3, REV1, RORA, RORB, RORC, SENP3, SERPINE1, TIMELESS, TIPIN, VIP, and VIPR2) are associated with MetS and its individual components independently and/or through complex interactions in a Taiwanese population. We also analyzed the interactions between environmental factors and these genes in influencing MetS and its individual components. A total of 3,000 Taiwanese subjects from the Taiwan Biobank were assessed in this study. Metabolic traits such as waist circumference, triglyceride, high-density lipoprotein cholesterol, systolic and diastolic blood pressure, and fasting glucose were measured. Our data showed a nominal association of MetS with several single nucleotide polymorphisms (SNPs) in five key circadian clock genes including ARNTL, GSK3B, PER3, RORA, and RORB; but none of these SNPs persisted significantly after performing Bonferroni correction. Moreover, we identified the effect of GSK3B rs2199503 on high fasting glucose (P = 0.0002). Additionally, we found interactions among the ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, and RORB rs972902 SNPs influenced MetS (P < 0.001 similar to P = 0.002). Finally, we investigated the influence of interactions between ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, and RORB rs972902 with environmental factors such as alcohol consumption, smoking status, and physical activity on MetS and its individual components (P < 0.001 similar to P = 0.002). Our study indicates that circadian clock genes such as ARNTL, GSK3B, PER3, RORA, and RORB genes may contribute to the risk of MetS independently as well as through gene-gene and gene-environment interactions.	[Lin, Eugene] China Med Univ, Inst Biomed Sci, Taichung, Taiwan; [Lin, Eugene] Vita Genom Inc, Taipei, Taiwan; [Lin, Eugene] TickleFish Syst Corp, Seattle, WA USA; [Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei, Taiwan; [Liu, Yu-Li] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan Township, Miaoli County, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Natl Yang Ming Univ, Div Psychiat, Taipei, Taiwan; [Kao, Chung-Feng] Natl Chung Hsing Univ, Dept Agron, Coll Agr & Nat Resources, Taichung, Taiwan	China Medical University Taiwan; Vita Genomics Incorporated; National Taiwan University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University	Lin, E (corresponding author), China Med Univ, Inst Biomed Sci, Taichung, Taiwan.; Lin, E (corresponding author), Vita Genom Inc, Taipei, Taiwan.; Lin, E (corresponding author), TickleFish Syst Corp, Seattle, WA USA.; Tsai, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.; Tsai, SJ (corresponding author), Natl Yang Ming Univ, Div Psychiat, Taipei, Taiwan.	eugene.lin@vitagenomics.com; tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Kuo, Po-Hsiu/0000-0003-0365-3587	Ministry of Economic Affairs in Taiwan [S099000280249-154]; Taipei Veterans General Hospital, Taiwan [VGHUST103-G1-4-1, V105C-008, V105E17-002-MY2-1]; National Health Research Institutes, Taiwan [NP-105-SP-04]; Ministry of Science and Technology, Taiwan [MST 102-2314-B-002-117-MY3]; Vita Genomics, Inc.	Ministry of Economic Affairs in Taiwan(Ministry of Economic Affairs, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Vita Genomics, Inc.	This work was supported by the Ministry of Economic Affairs in Taiwan (http://www.moea.gov.tw/; SBIR Grant S099000280249-154; EL), by Taipei Veterans General Hospital, Taiwan (www.vghtpe.gov.tw/; Grants VGHUST103-G1-4-1, V105C-008, and V105E17-002-MY2-1; SJT), by National Health Research Institutes, Taiwan (www.nhri.org.tw/; Grant NP-105-SP-04; YLL), and by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/; Grant MST 102-2314-B-002-117-MY3; PHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation, Vita Genomics, Inc., provided support in the form of salary for author EL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; CHEN C, 2016, HUM MOL GENET; Chen H, 2016, P NATL ACAD SCI USA, V113, P5754, DOI 10.1073/pnas.1601355113; Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Fan CT, 2008, PHARMACOGENOMICS, V9, P235, DOI 10.2217/14622416.9.2.235; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Gonzalez R, 2015, J AFFECT DISORDERS, V186, P367, DOI 10.1016/j.jad.2015.07.014; Hsiao TJ, 2017, DIABETES METAB, V43, P83, DOI 10.1016/j.diabet.2016.05.003; Hsiao TJ, 2016, BIOCHEM GENET, V54, P830, DOI 10.1007/s10528-016-9760-y; Hsiao TJ, 2016, J GENET, V95, P595, DOI 10.1007/s12041-016-0671-9; Hsiao TJ, 2016, MOL CELL ENDOCRINOL, V433, P20, DOI 10.1016/j.mce.2016.05.020; Hsiao TJ, 2015, ENDOCRINE, V48, P786, DOI 10.1007/s12020-014-0407-7; Hsiao TJ, 2014, J INVEST MED, V62, P310, DOI 10.2310/JIM.0000000000000030; Hsiao TJ, 2014, GENE, V533, P32, DOI 10.1016/j.gene.2013.10.016; Hsiao TJ, 2013, GENES NUTR, V8, P137, DOI 10.1007/s12263-012-0304-8; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Jim HS, 2015, J GENET GENOME RES, V2; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kovanen L, 2015, HYPERTENS RES, V38, P186, DOI 10.1038/hr.2014.157; Lane HY, 2012, MOL DIAGN THER, V16, P15, DOI 10.2165/11597270-000000000-00000; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lin E, 2017, PLOS ONE IN PRESS; Lin E, 2017, ONCOTARGET IN PRESS; Lin E, 2017, DEMENT GERIATR COGN, V43, P119, DOI 10.1159/000455833; Liou YJ, 2012, PHARMACOGENOMICS J, V12, P54, DOI 10.1038/tpj.2010.74; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2014, DIABETES METAB, V40, P338, DOI 10.1016/j.diabet.2013.12.005; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Ribas-Latre A, 2016, MOL METAB, V5, P133, DOI 10.1016/j.molmet.2015.12.006; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shakes LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-451; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang H, 2003, MOL GENET METAB, V79, P176, DOI 10.1016/S1096-7192(03)00096-9; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104	46	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173861	10.1371/journal.pone.0173861	http://dx.doi.org/10.1371/journal.pone.0173861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296937	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700072
J	Lood, R; Molina, H; Fischetti, VA				Lood, Rolf; Molina, Henrik; Fischetti, Vincent A.			Determining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Forster resonance energy transfer (FRET) assays	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PYOGENES; ACTIVITY PROTECTS; PROTEASE; LYSIN; HYDROLASE; LYSOSTAPHIN; BACTEREMIA; INFECTION; SUBSTRATE	The necessity of identifying novel methods to combat infections caused by antibiotic resistant bacteria is increasing each year. Recent advancements in the development of peptidoglycan hydrolases (e.g. lysins) from bacterial viruses (bacteriophages) have revealed the efficiency of this class of enzymes in treating serious bacterial infections. Though promising results have been obtained regarding the lethal action of lysin on bacterial pathogens both in vitro and in vivo, an often-overlooked factor in these studies is precisely identifying their peptidoglycan cleavage site. This knowledge would be useful for following the activity of the enzyme during development, without the need for whole-organism lytic assays. However, more importantly, it would enable the selection of lysins with different cleavage activities that would act synergistically for enhanced efficacy. Here, we have developed two new methods to accurately identify the cleavage site of lysins using liquid chromatography mass spectrometry (LC-MS) on peptidoglycan-like fluorophore-quencher modified synthetic peptides, as well as determining the enzymatic action and kinetics of the enzymes on modified peptides in a Forster resonance energy transfer (FRET) assay. These methods should facilitate progress within the lysin field, accelerating the development of therapeutic lysins to combat antibiotic resistant bacterial infections.	[Lood, Rolf; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA; [Lood, Rolf] Lund Univ, Div Infect Med, Dept Clin Sci Lund, Lund, Sweden; [Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Lund University; Rockefeller University	Fischetti, VA (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.	vaf@rockefeller.edu			Contrafect Inc; The Tegger Foundation	Contrafect Inc; The Tegger Foundation	This work was supported in part by Contrafect Inc to VAF (http://www.contrafect.com/), and by The Tegger Foundation to RL (http://teggerstatelsen.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Cummings RT, 2002, P NATL ACAD SCI USA, V99, P6603, DOI 10.1073/pnas.062171599; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Gargis SR, 2009, APPL ENVIRON MICROB, V75, P72, DOI 10.1128/AEM.01647-08; Gilmer DB, 2013, ANTIMICROB AGENTS CH, V57, P2743, DOI 10.1128/AAC.02526-12; Hu HY, 2014, BIOTECHNOL J, V9, P266, DOI 10.1002/biot.201300201; Jin S, 2011, BIOTECHNOL PROGR, V27, P1107, DOI 10.1002/btpr.628; Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y; Linden SB, 2015, APPL MICROBIOL BIOT, V99, P741, DOI 10.1007/s00253-014-5930-1; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Lood R, 2015, ANTIMICROB AGENTS CH, V59, P1983, DOI 10.1128/AAC.04641-14; Lood R, 2014, ANTIMICROB AGENTS CH, V58, P3073, DOI 10.1128/AAC.00115-14; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Lutzner N, 2009, BIOCHEM BIOPH RES CO, V380, P554, DOI 10.1016/j.bbrc.2009.01.140; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MAEDA H, 1980, J BIOCHEM-TOKYO, V88, P1185, DOI 10.1093/oxfordjournals.jbchem.a133073; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Warfield R, 2006, ORG BIOMOL CHEM, V4, P3626, DOI 10.1039/b607999g; Xu NX, 1997, ANAL BIOCHEM, V248, P7, DOI 10.1006/abio.1997.2073; Zauner T, 2011, ANAL CHEM, V83, P7356, DOI 10.1021/ac201274f	25	13	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173919	10.1371/journal.pone.0173919	http://dx.doi.org/10.1371/journal.pone.0173919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296948	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700078
J	Jacques, A; Laurent, M; Ribiere-Chabert, M; Saussac, M; Bougeard, S; Budge, GE; Hendrikx, P; Chauzat, MP; de Graaf, D; Meroc, E; Nguyen, BK; Roelandt, S; Roels, S; Van der Stede, Y; Tonnersen, T; Kryger, P; Jaarma, K; Kuus, M; Raie, A; Heinikainen, S; Pelkonen, S; Vahanikkila, N; Andrieux, C; Ballis, A; Barrieu, G; Bendali, F; Brugoux, C; Franco, S; Fuentes, AM; Joel, A; Layec, Y; Lopez, J; Lozach, A; Malherbe, DL; Mariau, V; Meziani, F; Monod, D; Mutel, S; Oesterle, E; Orlowski, M; Petit, M; Pillu, P; Poret, F; Viry, A; Berg, S; Buchler, R; de Craigher, D; Genersch, E; Kaatz, HH; Meixner, MD; von der Ohe, W; Otten, C; Rosenkranz, P; Schaefer, MO; Schroeder, A; Agianiotaki, E; Arfara, S; Boutsini, S; Giannoulopoulou, M; Hondrou, V; Karipidou, S; Katsaros, D; Katzagiannakis, A; Kiriakopoulos, A; Oureilidis, K; Panteli, A; Pantoleon, F; Papagianni, Z; Papalexiou, E; Perdikaris, S; Prapas, A; Siana, P; Skandalakis, I; Stougiou, D; Tomazinakis, I; Tsali, E; Tseliou, E; Tsiplakidis, A; Tsompanellis, E; Vamvakas, G; Varvarouta, V; Vourvidis, D; Dan, A; Daroczi, G; Lang, M; Papp, M; Paulus, PD; Pupp, E; Szalo, M; Toth, A; Zseli, S; Bressan, G; Cerrone, A; Formato, G; Granato, A; Lavazza, A; Macellari, P; Marcello, P; Ghittino, C; Maroni, PA; Possidente, R; Mutinelli, F; Nassuato, C; Pintore, A; Ricchiuti, L; Ruocco, L; Salvaggio, A; Troiano, P; Voltini, B; Avsejenko, J; Ciekure, E; Deksne, G; Eglite, I; Granta, R; Olsevski, E; Rodze, I; Stinka, M; Sirutkaityte, R; Siriukaitis, S; Bober, A; Jazdzewski, K; Pohorecka, K; Skubida, M; Zdanska, D; Amador, MRR; Freitas, S; Quintans, S; Santos, PT; Brezinova, N; Brtkova, A; Cuvalova, Z; Filipova, M; Jurovcikova, J; Kantikova, M; Kubicova, Z; Papiernikova, E; Sulejova, L; Toporcak, J; Ares, CCM; Ariza, J; Berna, SN; Cabeza, NA; Casasempere, CJ; Cid, GC; Corzan, RJM; De Abajo, DMA; Diaz, RR; Esteban, RA; Fernandez, SP; Garcia, PA; Gonzalez, BC; Minguez, GO; Onate, ML; Oteiza, OP; Perez, CI; Plaza, PM; Puy, PDJR; Riol, GR; Romero, GLJ; Soldevilla, YJF; Barrasus, MSI; Soriano, GM; Vigo, LV; Villarta, RJL; Fabricius-Kristiansen, L; Forsgren, E; Brown, M; Budge, G; Grant, R; Marris, G; Powell, M; Wattam, A; Whiting, I; Cauquil, L; Riviere, MP; Garin, E				Jacques, Antoine; Laurent, Marion; Ribiere-Chabert, Magali; Saussac, Mathilde; Bougeard, Stephanie; Budge, Giles E.; Hendrikx, Pascal; Chauzat, Marie-Pierre; de Graaf, Dirk; Meroc, Estelle; Nguyen, Bach Kim; Roelandt, Stefan; Roels, Stefan; Van der Stede, Yves; Tonnersen, Tina; Kryger, Per; Jaarma, Kart; Kuus, Merle; Raie, Arvi; Heinikainen, Sirpa; Pelkonen, Sinikka; Vahanikkila, Nella; Andrieux, Christophe; Ballis, Alexis; Barrieu, Guy; Bendali, Fatah; Brugoux, Corinne; Franco, Stephanie; Fuentes, Anne-Marie; Joel, Alain; Layec, Yves; Lopez, Jacqueline; Lozach, Andre; Malherbe, Duluc Laure; Mariau, Viviane; Meziani, Faycal; Monod, Denis; Mutel, Sebastien; Oesterle, Eric; Orlowski, Muriel; Petit, Manuel; Pillu, Patricia; Poret, Florence; Viry, Alain; Berg, Stefan; Buechler, Ralph; de Craigher, Doris; Genersch, Elke; Kaatz, Hans-Hinrich; Meixner, Marina D.; von der Ohe, Werner; Otten, Christoph; Rosenkranz, Peter; Schaefer, Marc O.; Schroeder, Annette; Agianiotaki, Eirini; Arfara, Stamatia; Boutsini, Sofia; Giannoulopoulou, Marianthi; Hondrou, Varvara; Karipidou, Sonia; Katsaros, Dimitrios; Katzagiannakis, Aristomenis; Kiriakopoulos, Antonios; Oureilidis, Konstantinos; Panteli, Aspasia; Pantoleon, Fotis; Papagianni, Zoi; Papalexiou, Eleni; Perdikaris, Socrates; Prapas, Athanasios; Siana, Panagiota; Skandalakis, Ioannis; Stougiou, Despoina; Tomazinakis, Ioannis; Tsali, Eleftheria; Tseliou, Evgenia; Tsiplakidis, Achillefs; Tsompanellis, Efstratios; Vamvakas, Giorgos; Varvarouta, Vasiliki; Vourvidis, Dimitris; Dan, Adam; Daroczi, Gyongyi; Lang, Maria; Papp, Melitta; Paulus, Petra-Deakne; Pupp, Eszter; Szalo, Marta; Toth, Adam; Zseli, Szilvia; Bressan, Gianluigi; Cerrone, Anna; Formato, Giovanni; Granato, Anna; Lavazza, Antonio; Macellari, Piero; Marcello, Paola; Ghittino, Claudio; Maroni, Ponti Andrea; Possidente, Rosaria; Mutinelli, Franco; Nassuato, Claudia; Pintore, Antonio; Ricchiuti, Luciano; Ruocco, Luigi; Salvaggio, Antonio; Troiano, Pasquale; Voltini, Barbara; Avsejenko, Jelena; Ciekure, Elina; Deksne, Gunita; Eglite, Ineta; Granta, Rita; Olsevski, Edvins; Rodze, Ieva; Stinka, Madara; Sirutkaityte, Rasa; Siriukaitis, Sigitas; Bober, Andrzej; Jazdzewski, Krzysztof; Pohorecka, Krystyna; Skubida, Marta; Zdanska, Dagmara; Amador, Maria Rita Ramos; Freitas, Susana; Quintans, Sofia; Santos, Patricia Tavares; Brezinova, Nicole; Brtkova, Andrea; Cuvalova, Zuzana; Filipova, Miriam; Jurovcikova, Julia; Kantikova, Miriam; Kubicova, Zuzana; Papiernikova, Erika; Sulejova, Lucia; Toporcak, Juraj; Ares, Cenador Carmen Maria; Ariza, Javier; Berna, Serna Nieves; Cabeza, Nunez Amparo; Casasempere, Cascales Jorge; Cid, Gonzalez Carlos; Corzan, Ripoll Jose Manuel; De Abajo, Domingo Miguel Angel; Diaz, Rey Roberto; Esteban, Royo Angel; Fernandez, Somalo Pilar; Garcia, Pascualvaca Alejandra; Gonzalez, Brena Carlos; Minguez, Gonzalez Olga; Onate, Maria Luisa; Oteiza, Orradre Pedro; Perez, Cobo Iratxe; Plaza, Perez Margarita; Puy, Pitarque D. Juan Ramon; Riol, Guinea Ruben; Romero, Gonzalez Luis Jose; Soldevilla, Yanguas Jose Fernando; Soler i Barrasus, Merce; Soriano, Gonzalez Mario; Vigo, Lopez Virginia; Villarta, Rivas Jose Luis; Fabricius-Kristiansen, Lotta; Forsgren, Eva; Brown, Mike; Budge, Giles; Grant, Ruth; Marris, Gay; Powell, Michelle; Wattam, Andy; Whiting, Ilex; Cauquil, Laura; Riviere, Marie-Pierre; Garin, Emmanuel		EPILOBEE Consortium	A pan-European epidemiological study reveals honey bee colony survival depends on beekeeper education and disease control	PLOS ONE			English	Article							POLLINATORS; LOSSES	Reports of honey bee population decline has spurred many national efforts to understand the extent of the problem and to identify causative or associated factors. However, our collective understanding of the factors has been hampered by a lack of joined up trans-national effort. Moreover, the impacts of beekeeper knowledge and beekeeping management practices have often been overlooked, despite honey bees being a managed pollinator. Here, we established a standardised active monitoring network for 5 798 apiaries over two consecutive years to quantify honey bee colony mortality across 17 European countries. Our data demonstrate that overwinter losses ranged between 2% and 32%, and that high summer losses were likely to follow high winter losses. Multivariate Poisson regression models revealed that hobbyist beekeepers with small apiaries and little experience in beekeeping had double the winter mortality rate when compared to professional beekeepers. Furthermore, honey bees kept by professional beekeepers never showed signs of disease, unlike apiaries from hobbyist beekeepers that had symptoms of bacterial infection and heavy Varroa infestation. Our data highlight beekeeper background and apicultural practices as major drivers of honey bee colony losses. The benefits of conducting trans-national monitoring schemes and improving beekeeper training are discussed.	[Jacques, Antoine; Saussac, Mathilde; Hendrikx, Pascal; Chauzat, Marie-Pierre] ANSES, Sci Affairs Dept Labs, Unit Coordinat & Support Surveillance, Maisons Alfort, France; [Jacques, Antoine; Laurent, Marion; Ribiere-Chabert, Magali; Chauzat, Marie-Pierre] ANSES, Unit Honey Bee Pathol, European Union & Natl Reference Lab Honey Bee Hlt, Sophia Antipolis, France; [Bougeard, Stephanie] ANSES, Unit Epidemiol & Welf Pork, Ploufragan, France; [Budge, Giles E.] Fera, York, N Yorkshire, England; [Budge, Giles E.] Newcastle Univ, Inst Agri Food Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England; [de Graaf, Dirk] Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium; [Meroc, Estelle; Roelandt, Stefan] Natl Ref Lab Honeybee Dis CODA CERVA VAR, Brussels, Belgium; [Nguyen, Bach Kim] Ulg, Fac Gembloux Agro Bio Tech, Gembloux, Belgium; [Roels, Stefan; Van der Stede, Yves] CODA CERVA VAR, Brussels, Belgium; [Tonnersen, Tina; Kryger, Per] Univ Aarhus, Natl Reference Lab Honeybee Dis, DK-8000 Aarhus C, Denmark; [Jaarma, Kart; Raie, Arvi] Estonian Vet & Food Board, Tallinn, Estonia; [Kuus, Merle] Estonian Vet & Food Lab, Tallinn, Estonia; [Heinikainen, Sirpa; Pelkonen, Sinikka] Finnish Food Safety Author EVIRA, Vet Bacteriol Res Unit, Kuopio, Finland; [Andrieux, Christophe; Pillu, Patricia] DDPP Cantal, Aurillac, France; [Ballis, Alexis] Chambre Agr Haut Rhin, Sainte Croix Plaine, France; [Barrieu, Guy] DDPP Bouches Rhone, Marseille, France; [Bendali, Fatah; Meziani, Faycal] Direct Gen Alimentat, Paris, France; [Brugoux, Corinne; Poret, Florence] Groupement Defense Sanitaire Cantal, Aurillac, France; Anses, Natl Reference Lab Honeybee Dis, Sophia Antipolis, France; [Fuentes, Anne-Marie] Groupement Defense Sanitaire Drome, Bourg Les Valence, France; [Joel, Alain; Petit, Manuel] DDPP Finistere, Quimper, France; [Malherbe, Duluc Laure; Oesterle, Eric] Groupement Defense Sanitaire Indre & Loire, Tours, France; [Layec, Yves; Lozach, Andre] Groupement Defense Sanitaire Apicole Finistere, Quimper, France; [Lopez, Jacqueline; Mariau, Viviane] DDPP Indre & Loire, Tours, France; [Monod, Denis] Groupement Defense Sanitaire Apicole Bouches Rhon, Marseille, France; [Mutel, Sebastien] DDCSPP Haut-Rhin, Colmar, France; [Orlowski, Muriel] DDPP Drome, Valence, France; [Viry, Alain] Lab Anal Jura, Poligny, France; [Berg, Stefan] Bavarian State Inst Viticulture & Horticulture, Bee Res Ctr, Veitshochheim, Germany; [Buechler, Ralph; Meixner, Marina D.] LLH Bieneninst Kirchhain, Kirchhain, Germany; [de Craigher, Doris; Rosenkranz, Peter; Schroeder, Annette] Univ Hohenheim, Apicultural State Inst, Stuttgart, Germany; [Genersch, Elke] Inst Bee Res, Hohen Neuendorf, Germany; [Kaatz, Hans-Hinrich] Univ Halle Wittenberg, Dept Zool, Halle, Germany; [von der Ohe, Werner] LAVES Inst Bienenkunde, Celle, Germany; [Otten, Christoph] Dienstleistungszentrum Landlicher Raum, Fachzentrum Bienen Imkerei Mayen, Mainz, Germany; [Agianiotaki, Eirini; Arfara, Stamatia; Boutsini, Sofia; Panteli, Aspasia; Papagianni, Zoi; Papalexiou, Eleni; Perdikaris, Socrates; Prapas, Athanasios; Stougiou, Despoina] Ctr Vet Inst Athens, Athens, Greece; [Giannoulopoulou, Marianthi; Katzagiannakis, Aristomenis; Varvarouta, Vasiliki] Regional Vet Lab Heraclio, Iraklion, Greece; [Hondrou, Varvara; Kiriakopoulos, Antonios; Tsompanellis, Efstratios] Reg Vet Lab Mytilini, Mitilini, Greece; [Karipidou, Sonia; Vamvakas, Giorgos] Reg Vet Lab Kozani, Kozani, Greece; [Katsaros, Dimitrios] Reg Vet Lab Chalkis, Chalkis, Greece; [Oureilidis, Konstantinos; Tsiplakidis, Achillefs] Reg Vet Lab Kavala, Kavala, Greece; [Pantoleon, Fotis; Siana, Panagiota] Reg Vet Lab Tripoli, Tripoli, Greece; [Perdikaris, Socrates; Vourvidis, Dimitris] Minist Rural Dev & Food, Thessaloniki, Greece; [Skandalakis, Ioannis; Tomazinakis, Ioannis] Reg Vet Lab Chania, Khania, Greece; [Tsali, Eleftheria] Reg Vet Lab Larisa, Larisa, Greece; [Tseliou, Evgenia] Reg Vet Lab Kerkyra, Kerkyra, Greece; [Dan, Adam; Daroczi, Gyongyi; Lang, Maria; Papp, Melitta; Paulus, Petra-Deakne; Pupp, Eszter] Vet Diagnost Directorate NRL Bee Hlth, Natl Food Chain Safety Off, Budapest, Hungary; [Szalo, Marta] Minist of Agr, Food Chain Control Dept, Budapest, Hungary; [Toth, Adam; Zseli, Szilvia] NRL Bee Hlth, Budapest, Hungary; [Bressan, Gianluigi] Ulss22, Bussolengo, Italy; [Cerrone, Anna] IZS Mezzogiorno, Naples, Italy; [Formato, Giovanni] IZS Reg Lazio & Toscana, Rome, Italy; [Granato, Anna; Mutinelli, Franco] IZS Venezie, Legnaro, Italy; [Lavazza, Antonio] IZS Lombardia & Emilia Romagna, Brescia, Italy; [Macellari, Piero] Asl Umbria, Perugia, Italy; [Marcello, Paola] ASL Sassari, Sassari, Italy; [Ghittino, Claudio] IZS Umbria & Marche, Perugia, Italy; [Maroni, Ponti Andrea; Ruocco, Luigi] Ministero Salute, Rome, Italy; [Possidente, Rosaria] IZS Piemonte Liguria & Valle Aosta, Imperia, Italy; [Nassuato, Claudia] Reg Lombardia, Milan, Italy; [Pintore, Antonio] IZS Sardegna, Cagliari, Italy; [Ricchiuti, Luciano] IZS Abruzzo & Molise, Teramo, Italy; [Salvaggio, Antonio] IZS Sicilia, Palermo, Italy; [Troiano, Pasquale] IZS Puglia & Basilicata, Foggia, Italy; [Voltini, Barbara] Reg Toscana, Pisa, Italy; [Avsejenko, Jelena; Ciekure, Elina; Deksne, Gunita] BIOR, Inst Food Safety Anim Hlth & Environm, Riga, Latvia; [Eglite, Ineta] Latvian Beekeepers Assoc, Jelgava, Latvia; [Granta, Rita; Rodze, Ieva] BIOR, Riga, Latvia; [Olsevski, Edvins; Stinka, Madara] Food & Vet Serv Republ Latvia, Riga, Latvia; [Sirutkaityte, Rasa; Siriukaitis, Sigitas] State Food & Vet Serv, Anim Hlth & Welfare Dept, Vilnius, Lithuania; [Bober, Andrzej; Pohorecka, Krystyna; Skubida, Marta; Zdanska, Dagmara] Natl Vet Res Inst, Pulawy, Poland; [Jazdzewski, Krzysztof] Gen Vet Inspectorate, Warsaw, Poland; [Amador, Maria Rita Ramos; Freitas, Susana; Quintans, Sofia; Santos, Patricia Tavares] Direcao Geral Alimentacao & Vet, Lisbon, Portugal; [Brezinova, Nicole; Brtkova, Andrea; Cuvalova, Zuzana; Filipova, Miriam; Jurovcikova, Julia; Kantikova, Miriam; Kubicova, Zuzana; Sulejova, Lucia] State Vet & Food Inst, Dolny Kubin, Slovakia; [Papiernikova, Erika] State Vet & Food Adm Slovak Republ, Bratislava, Slovakia; [Toporcak, Juraj] Univ Vet Med & Pharm Kosice, Kosice, Slovakia; [Ares, Cenador Carmen Maria] Consejeria Agroganaderia & Recursos Autoctonos Pr, Gijon, Spain; [Ariza, Javier; Villarta, Rivas Jose Luis] Consejeria Agr Junta Comunidades Castill La Manch, Guadalajara, Spain; [Berna, Serna Nieves; Casasempere, Cascales Jorge] Consejeria Presidencia Agr Pesca Alimentac & Agua, Valencia, Spain; [Cabeza, Nunez Amparo; Garcia, Pascualvaca Alejandra] Consejeria Agr & Pesca Junta Andalucia, Seville, Spain; [Cid, Gonzalez Carlos; Diaz, Rey Roberto] Subdirec Xeral Ganderia Conselleria Medio Rural, Vilanova De Arousa, Spain; [Corzan, Ripoll Jose Manuel; Esteban, Royo Angel; Onate, Maria Luisa] Consejeria Agr & Ganaderia & Medio Ambiente Diput, Zaragoza, Spain; [De Abajo, Domingo Miguel Angel; Minguez, Gonzalez Olga; Riol, Guinea Ruben] Consejeria Agr & Ganaderia Junta Castilla & Leon, Valladolid, Spain; [Fernandez, Somalo Pilar; Perez, Cobo Iratxe; Romero, Gonzalez Luis Jose] M Agr Alim & Medio Ambiente, SG Sanidad Higiene Anim & Trazabilidad, Madrid, Spain; [Gonzalez, Brena Carlos] Consejeria Agr Desarrollo Rural, Medio Ambiente & Energia J Extremadura, Merida, Spain; [Oteiza, Orradre Pedro] Diputac Foral Navarra, Dpto Desarrollo Rural Ind Empleo & Medio Ambiente, Madrid, Spain; [Plaza, Perez Margarita] Consejeria Agr & Agua Reg Murcia, Murcia, Spain; [Puy, Pitarque D. Juan Ramon] Pesca & Alimentac Gobierno Vasco, Dept Agr, Madrid, Spain; [Soldevilla, Yanguas Jose Fernando] Consejeria Agr Ganaderia & Medio Ambiente, Comunidad Autonoma Rioja, La Rioja, Spain; [Soler i Barrasus, Merce] Generalitat Catalunya, Dept Agr Ramaderia Pesca Alimentacio & Medi Nat, Barcelona, Spain; [Soriano, Gonzalez Mario] Generalitat Valenciana, Consejeria Presidencia Agr Pesca Alim & Agua, Valencia, Spain; [Vigo, Lopez Virginia] Consejeria Agr Ganaderia Pesca & Aguas Gobierno, Las Palmas Gran Canaria, Spain; [Forsgren, Eva] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Brown, Mike; Budge, Giles; Grant, Ruth; Marris, Gay; Powell, Michelle; Wattam, Andy; Whiting, Ilex] Food & Environm Res Agcy, NBU, York, N Yorkshire, England; [Cauquil, Laura; Riviere, Marie-Pierre] Unit Honey Bee Pathol, Sophia Antipolis, France; [Garin, Emmanuel] Unit Coordinat & Support Surveillance, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Food & Environment Research Agency; Newcastle University - UK; Ghent University; University of Liege; Aarhus University; Finnish Food Authority; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); University Hohenheim; Martin Luther University Halle Wittenberg; IZS del Mezzogiorno; IZS Lazio e Toscana; IZS delle Venezie; IZS Lombardia e Emilia; IZS Umbria e Marche; IZS Piemonte Liguria e Valle D'aosta; IZS Della Sardegna; IZS Sicilia; IZS Puglia e Basilicata; Institute of Food Safety, Animal Health & Environment "BIOR"; Institute of Food Safety, Animal Health & Environment "BIOR"; National Veterinary Institute - National Research Institute; University of Veterinary Medicine Kosice; Swedish University of Agricultural Sciences; Food & Environment Research Agency; Ecole Nationale Veterinaire d'Alfort (ENVA)	Chauzat, MP (corresponding author), ANSES, Sci Affairs Dept Labs, Unit Coordinat & Support Surveillance, Maisons Alfort, France.; Chauzat, MP (corresponding author), ANSES, Unit Honey Bee Pathol, European Union & Natl Reference Lab Honey Bee Hlt, Sophia Antipolis, France.	marie-pierre.chauzat@anses.fr	Skubida, Marta/Y-3172-2018; Formato, Giovanni/ABA-6990-2021; de Graaf, Dirk C./HGD-4017-2022; Büchler, Ralph/AAI-3540-2020; MUTINELLI, FRANCO/K-7525-2018; Kryger, Per/H-4600-2019; Meixner, Marina/ABD-6400-2021; Dán, Ádám/G-6018-2012; Bober, Andrzej/AAW-1046-2020	Skubida, Marta/0000-0002-9959-443X; Formato, Giovanni/0000-0002-1202-5745; MUTINELLI, FRANCO/0000-0003-2903-9390; Kryger, Per/0000-0001-5306-3230; Meixner, Marina/0000-0002-7785-4894; Dán, Ádám/0000-0001-7849-7721; Chauzat, Marie-Pierre/0000-0001-8842-741X	EFSA; Fera; Welsh Government; EURL for honey bee health; European Commission; EU Reference Laboratory	EFSA; Fera; Welsh Government; EURL for honey bee health; European Commission(European CommissionEuropean Commission Joint Research Centre); EU Reference Laboratory	The financers of EPILOBEE were the European Commission, the Member States and the EU Reference Laboratory. The statistical analysis was co-funded by EFSA together with the EURL for honey bee health. GB acknowledges support from Fera and the Welsh Government (and MB, RG, GM, MP AW and IW in the Epilobee consortium) but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific role of these authors rare articulated in author contribution section.	Aizen MA, 2009, CURR BIOL, V4; Budge GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133228; Burkle LA, 2013, SCIENCE, P1; Chauzat MP, 2016, APIDOLOGIE, V47, P348, DOI 10.1007/s13592-016-0440-z; EU (European Union), 2010, OFF J EUR UNION, VL073, P1; EURL, 2013, AM GUID EUR PROJ HON; EURL, 2011, GUID EUR PROJ HON CO; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Garibaldi LA, 2013, SCIENCE, P1; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garratt MPD, 2014, BIOL CONSERV, V169, P128, DOI 10.1016/j.biocon.2013.11.001; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Henry M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2110; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Husson F, 2015, EXPLORATORY DATA ANA; Jacques A, 2016, EFSA SUPP PUBL; Josse J, 2012, J CLASSIF, V29, P91, DOI 10.1007/s00357-012-9097-0; Lee K, 2015, CURR OPIN INSECT SCI, V10, P37, DOI 10.1016/j.cois.2015.04.009; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Marghitas L. A., 2008, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V41, P309; Meixner M, 2015, CURRENT OPINION INSE, V10, P8; Meixner MD, 2014, J APICULT RES, V53, P215, DOI 10.3896/IBRA.1.53.2.04; Mill AC, 2014, ENVIRON MICROBIOL, V16, P3753, DOI 10.1111/1462-2920.12292; Moritz RFA, 2016, AGR ECOSYST ENVIRON, V216, P44, DOI 10.1016/j.agee.2015.09.027; Muli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094459; Pirk CWW, 2014, J APICULT RES, V53, P35, DOI 10.3896/IBRA.1.53.1.03; Porrini C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155411; Simone-Finstrom M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32023; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; van der Zee R, 2014, J APICULT RES, V53, P19, DOI 10.3896/IBRA.1.53.1.02; Van Oldenborgh GJ, 2015, MILD WEATHER EUROPE, P707; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011	34	99	104	8	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172591	10.1371/journal.pone.0172591	http://dx.doi.org/10.1371/journal.pone.0172591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278255	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900124
J	Lulic, T; El-Sayes, J; Fassett, HJ; Nelson, AJ				Lulic, Tea; El-Sayes, Jenin; Fassett, Hunter J.; Nelson, Aimee J.			Physical activity levels determine exercise-induced changes in brain excitability	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; HUMAN MOTOR CORTEX; AEROBIC EXERCISE; NEUROTROPHIC FACTOR; INTRACORTICAL INHIBITION; SINGLE BOUT; MAGNETIC STIMULATION; INDUCED INCREASE; NO INFLUENCE; FITNESS	Emerging evidence suggests that regular physical activity can impact cortical function and facilitate plasticity. In the present study, we examined how physical activity levels influence corticospinal excitability and intracortical circuitry in motor cortex following a single session of moderate intensity aerobic exercise. We aimed to determine whether exercise-induced short-term plasticity differed between high versus low physically active individuals. Participants included twenty-eight young, healthy adults divided into two equal groups based on physical activity level determined by the International Physical Activity Questionnaire: lowto-moderate (LOW) and high (HIGH) physical activity. Transcranial magnetic stimulation was used to assess motor cortex excitability via motor evoked potential (MEP) recruitment curves for the first dorsal interosseous (FDI) muscle at rest (MEPREST) and during tonic contraction (MEPACTIVE), short-interval intracortical inhibition (SICI) and facilitation (SICF), and intracortical facilitation (ICF). All dependent measures were obtained in the resting FDI muscle, with the exception of AMT and MEPACTIVE recruitment curves that were obtained during tonic FDI contraction. Dependent measures were acquired before and following moderate intensity aerobic exercise (20 mins, similar to 60% of the age-predicted maximal heart rate) performed on a recumbent cycle ergometer. Results indicate that MEPREST recruitment curve amplitudes and area under the recruitment curve (AURC) were increased following exercise in the HIGH group only (p = 0.002 and p = 0.044, respectively). SICI and ICF were reduced following exercise irrespective of physical activity level (p = 0.007 and p = 0.04, respectively). MEPACTIVE recruitment curves and SICF were unaltered by exercise. These findings indicate that the propensity for exercise-induced plasticity is different in high versus low physically active individuals. Additionally, these data highlight that a single session of aerobic exercise can transiently reduce inhibition in the motor cortex regardless of physical activity level, potentially priming the system for plasticity induction.	[Lulic, Tea; El-Sayes, Jenin; Fassett, Hunter J.; Nelson, Aimee J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University	Nelson, AJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	nelsonaj@mcmaster.ca		Lulic, Tea/0000-0002-7501-3493	Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN-2015-06309]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC RGPIN-2015-06309).; The authors thank the Natural Sciences and Engineering Research Council for funding to AJN.	Bailey AZ, 2016, TRANSLATIONAL NEUROS, V6; Bergen JL, 2002, NEUROREHABILITATION, V17, P161; Bestmann S, 2015, EXP BRAIN RES, V233, P679, DOI 10.1007/s00221-014-4183-7; Bos I, 2011, NEUROSCI LETT, V500, P129, DOI 10.1016/j.neulet.2011.06.019; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chang WH, 2016, CLIN NEUROPHYSIOL, V127, P2892, DOI 10.1016/j.clinph.2016.04.001; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; Cho HC, 2012, NEUROSCI LETT, V519, P78, DOI 10.1016/j.neulet.2012.05.025; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crizzle AM, 2006, CLIN J SPORT MED, V16, P422, DOI 10.1097/01.jsm.0000244612.55550.7d; Currie J, 2009, NEUROSCI LETT, V451, P152, DOI 10.1016/j.neulet.2008.12.043; Cuypers K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086380; D Kuipers S, 2006, CURR OPIN DRUG DISC, V9, P580; Dai W, 2016, NEUROSCIENCE, V336, P114, DOI 10.1016/j.neuroscience.2016.08.053; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Ding YH, 2006, CURR NEUROVASC RES, V3, P15, DOI 10.2174/156720206775541787; Doeltgen SH, 2011, EXP BRAIN RES, V215, P199, DOI 10.1007/s00221-011-2886-6; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; Frederiksen KS, 2015, INT J GERIATR PSYCH, V30, P744, DOI 10.1002/gps.4220; Goekint M, 2008, MED SCI SPORT EXER, V40, P1990, DOI 10.1249/MSS.0b013e31817eee85; Goekint M, 2012, J APPL PHYSIOL, V112, P535, DOI 10.1152/japplphysiol.00306.2011; Goekint M, 2011, NEUROSCI LETT, V494, P150, DOI 10.1016/j.neulet.2011.03.001; Goldsworthy MR, 2016, NEUROSCIENCE, V320, P205, DOI 10.1016/j.neuroscience.2016.02.012; Gomez-Merino D, 2001, NEUROSCI LETT, V301, P143, DOI 10.1016/S0304-3940(01)01626-3; Gordon BA, 2008, PSYCHOPHYSIOLOGY, V45, P825, DOI 10.1111/j.1469-8986.2008.00676.x; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; HATTORI S, 1994, BRAIN RES BULL, V35, P41, DOI 10.1016/0361-9230(94)90214-3; Herting MM, 2013, J COGNITIVE NEUROSCI, V25, P595, DOI 10.1162/jocn_a_00344; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jovanovic JN, 2004, BRAIN DERIVED NEUROT; Killgore WDS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03457; Kitaoka R, 2010, J NUTR SCI VITAMINOL, V56, P185, DOI 10.3177/jnsv.56.185; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Korchounov A, 2007, J NEURAL TRANSM, V114, P223, DOI 10.1007/s00702-006-0523-5; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Leon-Sarmiento FE, 2013, ARCH MED RES, V44, P221, DOI 10.1016/j.arcmed.2013.03.003; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Maddock RJ, 2016, J NEUROSCI, V36, P2449, DOI 10.1523/JNEUROSCI.3455-15.2016; Maddock RJ, 2011, NEUROIMAGE, V57, P1324, DOI 10.1016/j.neuroimage.2011.05.048; Mang CS, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6797928; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; McAllister SM, 2009, CLIN NEUROPHYSIOL, V120, P820, DOI 10.1016/j.clinph.2009.02.003; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; Meeusen R, 1997, INT J SPORTS MED, V18, P571, DOI 10.1055/s-2007-972683; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; Mooney R.A., 2016, EXP BRAIN RES; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Ni Z, 2013, NEUROLOGY, V80, P1746, DOI 10.1212/WNL.0b013e3182919029; Nofuji Y, 2012, J SPORT SCI MED, V11, P83; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortu E, 2013, CLIN NEUROPHYSIOL, V124, P1381, DOI 10.1016/j.clinph.2013.02.005; Petriz BA, 2017, J CELL PHYSIOL, V232, P257, DOI 10.1002/jcp.25477; Ploughman M, 2007, EUR J NEUROSCI, V25, P3453, DOI 10.1111/j.1460-9568.2007.05591.x; Prakash RS, 2010, BRAIN RES, V1341, P41, DOI 10.1016/j.brainres.2009.06.063; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Schmidt S, 2009, CLIN NEUROPHYSIOL, V120, P987, DOI 10.1016/j.clinph.2009.02.164; Schmolesky MT, 2013, J SPORT SCI MED, V12, P502; Schwenkreis P, 1999, NEUROSCI LETT, V270, P137, DOI 10.1016/S0304-3940(99)00492-9; Singh AM, 2014, EXP BRAIN RES, V232, P3675, DOI 10.1007/s00221-014-4049-z; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Smith AE, 2014, EXP BRAIN RES, V232, P1875, DOI 10.1007/s00221-014-3879-z; Snow NP, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150039, 10.1371/journal.pone.0146712]; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Sutoo D, 2003, NEUROBIOL DIS, V13, P1, DOI 10.1016/S0969-9961(03)00030-5; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tang SW, 2008, NEUROSCI LETT, V431, P62, DOI 10.1016/j.neulet.2007.11.019; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tergau F, 2000, MED SCI SPORT EXER, V32, P1942, DOI 10.1097/00005768-200011000-00019; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Thirugnanasambandam N, 2015, J NEUROPHYSIOL, V114, P1102, DOI 10.1152/jn.00791.2014; van de Ruit M, 2015, BRAIN STIMUL, V8, P231, DOI 10.1016/j.brs.2014.10.020; Vega SR, 2012, INT J SPORTS MED, V33, P8, DOI 10.1055/s-0031-1285929; Vega SR, 2006, BRAIN RES, V1121, P59, DOI 10.1016/j.brainres.2006.08.105; Vega SR, 2011, PSYCHONEUROENDOCRINO, V36, P220, DOI 10.1016/j.psyneuen.2010.07.012; Veniero D, 2013, J NEUROSCI, V33, P13773, DOI 10.1523/JNEUROSCI.1777-13.2013; Wang GJ, 2000, J NUCL MED, V41, P1352; Warburton DER, 2011, APPL PHYSIOL NUTR ME, V36, pS266, DOI [10.1139/H11-062, 10.1139/h11-062]; Wilmore JH, 2001, MED SCI SPORT EXER, V33, P99; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 1998, ELECTROMYOGR MOTOR C, V109, P321, DOI 10.1016/S0924-980X(98)00023-X; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028; Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004	94	55	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173672	10.1371/journal.pone.0173672	http://dx.doi.org/10.1371/journal.pone.0173672			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278300	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900027
J	Noah, JA; Dravida, S; Zhang, X; Yahil, S; Hirsch, J				Noah, J. Adam; Dravida, Swethasri; Zhang, Xian; Yahil, Shaul; Hirsch, Joy			Neural correlates of conflict between gestures and words: A domain-specific role for a temporal-parietal complex	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; DIFFUSE OPTICAL TOMOGRAPHY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; COGNITIVE CONTROL MECHANISMS; HUMAN BRAIN; PREFRONTAL CORTEX; FUNCTIONAL BRAIN; RESPONSE-INHIBITION; FNIRS DATA; FMRI	The interpretation of social cues is a fundamental function of human social behavior, and resolution of inconsistencies between spoken and gestural cues plays an important role in successful interactions. To gain insight into these underlying neural processes, we compared neural responses in a traditional color/word conflict task and to a gesture/word conflict task to test hypotheses of domain-general and domain-specific conflict resolution. In the gesture task, recorded spoken words ("yes" and "no") were presented simultaneously with video recordings of actors performing one of the following affirmative or negative gestures: thumbs up, thumbs down, head nodding (up and down), or head shaking (side-to-side), thereby generating congruent and incongruent communication stimuli between gesture and words. Participants identified the communicative intent of the gestures as either positive or negative. In the color task, participants were presented the words "red" and "green" in either red or green font and were asked to identify the color of the letters. We observed a classic "Stroop" behavioral interference effect, with participants showing increased response time for incongruent trials relative to congruent ones for both the gesture and color tasks. Hemodynamic signals acquired using functional near-infrared spectroscopy (fNIRS) were increased in the right dorsolateral prefrontal cortex (DLPFC) for incongruent trials relative to congruent trials for both tasks consistent with a common, domain-general mechanism for detecting conflict. However, activity in the left DLPFC and frontal eye fields and the right temporal-parietal junction (TPJ), superior temporal gyrus (STG), supramarginal gyrus (SMG), and primary and auditory association cortices was greater for the gesture task than the color task. Thus, in addition to domain-general conflict processing mechanisms, as suggested by common engagement of right DLPFC, socially specialized neural modules localized to the left DLPFC and right TPJ including adjacent homologous receptive language areas were engaged when processing conflicting communications. These findings contribute to an emerging view of specialization within the TPJ and adjacent areas for interpretation of social cues and indicate a role for the region in processing social conflict.	[Noah, J. Adam; Dravida, Swethasri; Zhang, Xian; Hirsch, Joy] Yale Sch Med, Dept Psychiat, Brain Funct Lab, New Haven, CT 06510 USA; [Dravida, Swethasri] Yale Sch Med, Med Scientist Training Program, New Haven, CT USA; [Yahil, Shaul] Washington Univ, Dept Neurosci, St Louis, MO USA; [Hirsch, Joy] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Hirsch, Joy] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [Hirsch, Joy] Yale Sch Med, Dept Comparat Med, New Haven, CT 06510 USA; [Hirsch, Joy] UCL, Dept Med Phys & Bioengn, London, England	Yale University; Yale University; Washington University (WUSTL); Yale University; Yale University; Yale University; University of London; University College London	Hirsch, J (corresponding author), Yale Sch Med, Dept Psychiat, Brain Funct Lab, New Haven, CT 06510 USA.; Hirsch, J (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.; Hirsch, J (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Hirsch, J (corresponding author), Yale Sch Med, Dept Comparat Med, New Haven, CT 06510 USA.; Hirsch, J (corresponding author), UCL, Dept Med Phys & Bioengn, London, England.	joyhirsch@yahoo.com		Hirsch, Joy/0000-0002-1418-6489; Noah, J. Adam/0000-0001-9773-2790	NIH Medical Scientist Training Program Training Grant [T32GM007205]; National Institute of Mental Health of the National Institutes of Health [R01MH107513]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107513, R01MH111629] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by NIH Medical Scientist Training Program Training Grant T32GM007205. The work also received partial supported by the National Institute of Mental Health of the National Institutes of Health under award number R01MH107513 (PI JH).	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Boehme S, 2015, SOC COGN AFFECT NEUR, V10, P856, DOI 10.1093/scan/nsu128; Caldwell M, 2016, NEUROIMAGE; Carter RM, 2013, TRENDS COGN SCI, V17, P328, DOI 10.1016/j.tics.2013.05.007; Carter RM, 2012, SCIENCE, V337, P109, DOI 10.1126/science.1219681; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Chen K, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600115; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Eggebrecht AT, 2014, NAT PHOTONICS, V8, P448, DOI 10.1038/nphoton.2014.107; Eggebrecht AT, 2012, NEUROIMAGE, V61, P1120, DOI 10.1016/j.neuroimage.2012.01.124; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2006, NEURON, V52, P1121, DOI 10.1016/j.neuron.2006.12.003; Ferradal SL, 2014, NEUROIMAGE, V85, P117, DOI 10.1016/j.neuroimage.2013.03.069; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; HAZEKI O, 1988, J APPL PHYSIOL, V64, P796, DOI 10.1152/jappl.1988.64.2.796; Hellendoorn A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00850; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Iwanaga R, 2013, PSYCHIAT CLIN NEUROS, V67, P203, DOI 10.1111/pcn.12052; Keehn B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00444; Keller E, 2007, LECT NOTES COMPUT SC, V4775, P85; Kelly SD, 2010, PSYCHOL SCI, V21, P260, DOI 10.1177/0956797609357327; Kelly SD, 2010, J COGNITIVE NEUROSCI, V22, P683, DOI 10.1162/jocn.2009.21254; Kikuchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056087; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Kita Y, 2011, BRAIN DEV-JPN, V33, P494, DOI 10.1016/j.braindev.2010.11.007; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lotze M, 2006, NEUROPSYCHOLOGIA, V44, P1787, DOI 10.1016/j.neuropsychologia.2006.03.016; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; McNeill David., 1994, RES LANG SOC INTERAC, V27, P223, DOI [10.1207/s15327973rlsi2703_4, DOI 10.1207/S15327973RLSI2703_4]; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Noah JA, 2015, JOVE-J VIS EXP, DOI 10.3791/52116; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ono Y, 2014, NEUROIMAGE, V85, P461, DOI 10.1016/j.neuroimage.2013.05.071; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tachibana A, 2011, NEUROSCI LETT, V503, P125, DOI 10.1016/j.neulet.2011.08.023; Tachtsidis Ilias, 2016, Neurophotonics, V3, P030401, DOI 10.1117/1.NPh.3.3.030401; Tachtsidis I, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031405; Tak S, 2014, NEUROIMAGE, V85, P72, DOI 10.1016/j.neuroimage.2013.06.016; Wible CG, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/920485; Xiao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046569; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yasumura A, 2014, BRAIN DEV-JPN, V36, P97, DOI 10.1016/j.braindev.2013.01.005; Zaki J, 2010, J NEUROSCI, V30, P8481, DOI 10.1523/JNEUROSCI.0382-10.2010; Zhang X, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.015004	64	11	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173525	10.1371/journal.pone.0173525	http://dx.doi.org/10.1371/journal.pone.0173525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278240	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900005
J	Walls, GV; Stevenson, M; Lines, KE; Newey, PJ; Reed, AAC; Bowl, MR; Jeyabalan, J; Harding, B; Bradley, KJ; Manek, S; Chen, J; Wang, P; Williams, BO; Teh, BT; Thakker, RV				Walls, G. V.; Stevenson, M.; Lines, K. E.; Newey, P. J.; Reed, A. A. C.; Bowl, M. R.; Jeyabalan, J.; Harding, B.; Bradley, K. J.; Manek, S.; Chen, J.; Wang, P.; Williams, B. O.; Teh, B. T.; Thakker, R. V.			Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome	ONCOGENE			English	Article							SUPPRESSOR GENE; DOWN-REGULATION; BETA-CATENIN; HUMAN PAF1; HPT-JT; EXPRESSION; PARAFIBROMIN; MUTATIONS; CANCER; HRPT2	The hyperparathyroidism-jaw tumour (HPT-JT) syndrome is an autosomal dominant disorder characterized by occurrence of parathyroid tumours, often atypical adenomas and carcinomas, ossifying jaw fibromas, renal tumours and uterine benign and malignant neoplasms. HPT-JT is caused by mutations of the cell division cycle 73 (CDC73) gene, located on chromosome 1q31.2 and encodes a 531 amino acid protein, parafibromin. To facilitate in vivo studies of Cdc73 in tumourigenesis we generated conventional (Cdc73(+/-)) and conditional parathyroid-specific (Cdc73(+/L)/PTH-Cre and Cdc73(L/L)/PTH-Cre) mouse models. Mice were aged to 18-21 months and studied for survival, tumour development and proliferation, and serum biochemistry, and compared to age-matched wild-type (Cdc73(+/+) and Cdc73(+/+)/PTH-Cre) littermates. Survival of Cdc73(+/)-mice, when compared to Cdc73(+/+) mice was reduced (Cdc73+/-= 80%; Cdc73(+/+) = 90% at 18 months of age, P<0.05). Cdc73(+/-), Cdc73(+/L)/PTH-Cre and Cdc73(L/L)/PTH-Cre mice developed parathyroid tumours, which had nuclear pleomorphism, fibrous septation and increased galectin-3 expression, consistent with atypical parathyroid adenomas, from 9 months of age. Parathyroid tumours in Cdc73(+/-), Cdc73(+/L)/PTH-Cre and Cdc73(L/L)/PTH-Cre mice had significantly increased proliferation, with rates 4fourfold higher than that in parathyroid glands of wild-type littermates (P<0.0001). Cdc73(+/-), Cdc73(+/L)/PTH-Cre and Cdc73(L/L)/PTH-Cre mice had higher mean serum calcium concentrations than wild-type littermates, and Cdc73(+/)-mice also had increased mean serum parathyroid hormone (PTH) concentrations. Parathyroid tumour development, and elevations in serum calcium and PTH, were similar in males and females. Cdc7(3+)/-mice did not develop bone or renal tumours but female Cdc73(+/-)mice, at 18 months of age, had uterine neoplasms comprising squamous metaplasia, adenofibroma and adenomyoma. Uterine neoplasms, myometria and jaw bones of Cdc73(+/)-mice had increased proliferation rates that were 2-fold higher than in Cdc73(+/+) mice (P<0.05). Thus, our studies, which have established mouse models for parathyroid tumours and uterine neoplasms that develop in the HPT-JT syndrome, provide in vivo models for future studies of these tumours.	[Walls, G. V.; Stevenson, M.; Lines, K. E.; Newey, P. J.; Reed, A. A. C.; Bowl, M. R.; Jeyabalan, J.; Harding, B.; Bradley, K. J.; Thakker, R. V.] Univ Oxford, Radcliffe Dept Med, OCDEM, Acad Endocrine Unit,Churchill Hosp, Oxford OX3 7LJ, England; [Manek, S.] John Radcliffe Hosp, Dept Pathol, Headley Way, Oxford, England; [Chen, J.; Wang, P.; Teh, B. T.] Van Andel Res Inst, Lab Canc Genet, Grand Rapids, MI USA; [Williams, B. O.] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI USA	University of Oxford; University of Oxford; Van Andel Institute; Van Andel Institute	Thakker, RV (corresponding author), Univ Oxford, Radcliffe Dept Med, OCDEM, Acad Endocrine Unit,Churchill Hosp, Oxford OX3 7LJ, England.	rajesh.thakker@ndm.ox.ac.uk	Stevenson, Mark/GRF-5876-2022; Williams, Bart/A-3539-2013	Stevenson, Mark/0000-0001-8616-0205; Williams, Bart/0000-0002-5261-5301; Teh, Bin Tean/0000-0003-1514-1124; Bowl, Michael/0000-0001-7971-445X; Lines, Kate/0000-0002-0764-8681	Medical Research Council (MRC), UK [G9825289/2004, G1000467/2010]; Van Andel Foundation, Grand Rapids, USA; United Kingdom Medical Research Council (MRC) [G9825289, G1000467]; Medical Research Council [G9825289, G1000467] Funding Source: researchfish; National Institute for Health Research [CL-2010-13-004] Funding Source: researchfish; MRC [G9825289, G1000467] Funding Source: UKRI	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Van Andel Foundation, Grand Rapids, USA; United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MRC), UK (grant number G9825289/2004 and G1000467/2010), (GV Walls, M Stevenson, KE Lines, MR Bowl, J Jeyabalan, PJ Newey, AAC Reed, B Harding, KJ Bradley and RV Thakker), and the Van Andel Foundation, Grand Rapids, USA (P Wang, J Chen, BO Williams, BT Teh). GV Walls, PJ Newey and KJ Bradley received MRC Clinical Research Training Fellowships. This work was supported by grants from the United Kingdom Medical Research Council (MRC) (G9825289 and G1000467) to GVW, MS, KEL, PJN, AACR, MRB, JJ, BH, KJB, and RVT; and the Van Andel Foundation, Grand Rapids, USA to JC, PW, BOW and BTT.	Amrich CG, 2012, J BIOL CHEM, V287, P10863, DOI 10.1074/jbc.M111.325647; Arnett-Mansfield RL, 2001, CANCER RES, V61, P4576; Bergero N, 2005, HUM PATHOL, V36, P908, DOI 10.1016/j.humpath.2005.06.020; Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891; Bradley KJ, 2005, J INTERN MED, V257, P18, DOI 10.1111/j.1365-2796.2004.01421.x; Bricaire L, 2013, J CLIN ENDOCR METAB, V98, pE403, DOI 10.1210/jc.2012-2789; Bush BM, 2013, CELL BIOCHEM FUNCT, V31, P228, DOI 10.1002/cbf.2876; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cetani F, 2016, J ENDOCRINOL INVEST, V39, P595, DOI 10.1007/s40618-016-0447-3; Chan JKC, 2013, DIAGNOSTIC HISTOPATH, V2, P1273; Commandeur AE, 2015, HUM REPROD UPDATE, V21, P593, DOI 10.1093/humupd/dmv030; CRYNS VL, 1994, NEW ENGL J MED, V330, P757, DOI 10.1056/NEJM199403173301105; CRYNS VL, 1994, J CLIN ENDOCR METAB, V78, P1320, DOI 10.1210/jc.78.6.1320; DeLellis RA, 2004, PATHOLOGY GENETICS T, V8; DeLellis RA, 2011, MODERN PATHOL, V24, pS78, DOI 10.1038/modpathol.2010.132; Duan K, 2015, J CLIN PATHOL, V68, P771, DOI 10.1136/jclinpath-2015-203186; Ensembl, ENSMUSG00000026361; Evans P, 2007, AM FAM PHYSICIAN, V75, P1503; Farber LJ, 2010, MOL CARCINOGEN, V49, P215, DOI 10.1002/mc.20591; FUJIMOTO J, 1995, TUMOR BIOL, V16, P254, DOI 10.1159/000217942; Fukuda K, 1998, GYNECOL ONCOL, V69, P220, DOI 10.1006/gyno.1998.5023; Gill AJ, 2006, AM J SURG PATHOL, V30, P1140; Gill AJ, 2014, ENDOCR PATHOL, V25, P30, DOI 10.1007/s12022-013-9294-3; Givi B, 2010, CLIN ONCOL-UK, V22, P498, DOI 10.1016/j.clon.2010.04.007; Grigorieva IV, 2010, J CLIN INVEST, V120, P2144, DOI 10.1172/JCI42021; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; Haven CJ, 2000, J CLIN ENDOCR METAB, V85, P1449, DOI 10.1210/jc.85.4.1449; Hayes MP, 2010, GYNECOL ONCOL, V116, P286, DOI 10.1016/j.ygyno.2009.11.012; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Howitt BE, 2015, J PATHOL, V235, P37, DOI 10.1002/path.4442; Imanishi Y, 2001, J CLIN INVEST, V107, P1093, DOI 10.1172/JCI10523; Jenkins PJ, 1997, CLIN ENDOCRINOL, V47, P747, DOI 10.1046/j.1365-2265.1997.3421147.x; Juhlin CC, 2011, VIRCHOWS ARCH, V459, P47, DOI 10.1007/s00428-010-1032-3; Juhlin CC, 2009, INT J ONCOL, V34, P481, DOI 10.3892/ijo_00000173; Juodele L, 2011, MEDICINA-LITHUANIA, V47, P635, DOI 10.3390/medicina47110092; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kruijff S, 2014, ANN SURG ONCOL, V21, P426, DOI 10.1245/s10434-013-3288-8; Kumar NS, 1998, CANCER RES, V58, P1860; Kumari N, 2016, ENDOCR PATHOL, V27, P87, DOI 10.1007/s12022-016-9426-7; Libutti SK, 2003, CANCER RES, V63, P8022; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Loffler KA, 2007, ONCOGENE, V26, P4009, DOI 10.1038/sj.onc.1210163; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mosimann C, 2009, MECH DEVELOP, V126, P394, DOI 10.1016/j.mod.2009.02.002; Myant K, 2011, EXP CELL RES, V317, P2725, DOI 10.1016/j.yexcr.2011.08.001; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Newey PJ, 2010, HUM MUTAT, V31, P295, DOI 10.1002/humu.21188; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Piret SE, 2011, J ENDOCRINOL, V211, P211, DOI 10.1530/JOE-11-0193; Rather MI, 2014, J BIOL CHEM, V289, P968, DOI 10.1074/jbc.M113.483255; REUBER MD, 1981, J GERONTOL, V36, P663, DOI 10.1093/geronj/36.6.663; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Saggiorato E, 2006, AM J CLIN PATHOL, V126, P59, DOI 10.1309/9NXP7FRF87MU2PCK; Sato M, 2000, ENDOCRINE, V12, P223, DOI 10.1385/ENDO:12:3:223; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Svedlund J, 2014, ENDOCR-RELAT CANCER, V21, P231, DOI 10.1530/ERC-13-0497; SZABO J, 1995, AM J HUM GENET, V56, P944; Teh BT, 1996, J CLIN ENDOCR METAB, V81, P4204, DOI 10.1210/jc.81.12.4204; Tesfaye A, 2007, CANCER RES, V67, P3998, DOI 10.1158/0008-5472.CAN-05-1684; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Varghese BV, 2013, P NATL ACAD SCI USA, V110, P2187, DOI 10.1073/pnas.1215759110; Vasef MA, 1999, MODERN PATHOL, V12, P412; Walls GV, 2012, ENDOCRINOLOGY, V153, P5167, DOI 10.1210/en.2012-1675; Wang PF, 2008, MOL CELL BIOL, V28, P2930, DOI 10.1128/MCB.00654-07; Witteveen JE, 2011, MODERN PATHOL, V24, P688, DOI 10.1038/modpathol.2010.236; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Xu Y, 2004, CANCER RES, V64, P3371, DOI 10.1158/0008-5472.CAN-04-0044; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Yu W, 2015, J CLIN ENDOCR METAB, V100, pE360, DOI 10.1210/jc.2014-3238; Zhang C, 2006, BIOCHEM BIOPH RES CO, V350, P17, DOI 10.1016/j.bbrc.2006.08.169	75	18	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 13	2017	36	28					4025	4036		10.1038/onc.2017.43	http://dx.doi.org/10.1038/onc.2017.43			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FA3YD	28288139	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000405379900008
J	Haneklaus, M; O'Neil, JD; Clark, AR; Masters, SL; O'Neill, LAJ				Haneklaus, Moritz; O'Neil, John D.; Clark, Andrew R.; Masters, Seth L.; O'Neill, Luke A. J.			The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA; TNF-ALPHA; ALTERNATIVE POLYADENYLATION; KAPPA-B; ACTIVATION; STABILITY; KINASE; INTERLEUKIN-1-BETA; EXPRESSION	The NLRP3 inflammasome is a central regulator of inflammation in many common diseases, including atherosclerosis and type 2 diabetes, driving the production of pro-inflammatory mediators such as IL-1 beta and IL-18. Due to its function as an inflammatory gatekeeper, expression and activation of NLRP3 need to be tightly regulated. In this study, we highlight novel post-transcriptional mechanisms that can modulate NLRP3 expression. We have identified the RNA-binding protein Tristetraprolin (TTP) as a negative regulator of NLRP3 in human macrophages. TTP targets AU-rich elements in the NLRP3 3'-untranslated region (UTR) and represses NLRP3 expression. Knocking down TTP in primary macrophages leads to an increased induction of NLRP3 by LPS, which is also accompanied by increased Caspase-1 and IL-1 beta cleavage upon NLRP3, but not AIM2 or NLRC4 inflammasome activation. Furthermore, we found that human NLRP3 can be alternatively polyadenylated, producing a short 3'-UTR isoform that excludes regulatory elements, including the TTP- and miRNA-223-binding sites. Because TTP also represses IL-1 beta expression, it is a dual inhibitor of the IL-1 beta system, regulating expression of the cytokine and the upstream controller NLRP3.	[Haneklaus, Moritz; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [O'Neil, John D.; Clark, Andrew R.] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England; [Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic 3052, Australia	Trinity College Dublin; University of Birmingham; Walter & Eliza Hall Institute	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie	Haneklaus, Moritz/AAE-4728-2020; Masters, Seth L/N-2886-2013; Clark, Andrew/AAN-4043-2021	Masters, Seth L/0000-0003-4763-576X; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; European Research Council; Medical Research Council [G0800207] Funding Source: researchfish; Versus Arthritis [19614] Funding Source: researchfish; MRC [G0800207] Funding Source: UKRI	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Science Foundation Ireland and the European Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Broderick L, 2015, ANNU REV PATHOL-MECH, V10, P395, DOI 10.1146/annurev-pathol-012414-040431; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chang JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8218; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clark AR, 2016, BIOCHEM SOC T, V44, P1321, DOI 10.1042/BST20160166; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elkon R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r59; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Filardy AA, 2016, MUCOSAL IMMUNOL, V9, P850, DOI 10.1038/mi.2015.109; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Gaba A, 2012, J IMMUNOL, V189, P2089, DOI 10.4049/jimmunol.1201126; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Greenhill CJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0419-y; Gurung P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14488; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Joe Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088776; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kang JG, 2011, J IMMUNOL, V187, P2696, DOI 10.4049/jimmunol.1101149; Kaplan IM, 2011, J IMMUNOL, V186, P2826, DOI 10.4049/jimmunol.1002806; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lacey D, 2015, P NATL ACAD SCI USA, V112, P9698, DOI 10.1073/pnas.1508399112; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molle C, 2013, J EXP MED, V210, P1675, DOI 10.1084/jem.20120707; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Patial S, 2016, P NATL ACAD SCI USA, V113, P1865, DOI 10.1073/pnas.1519906113; Qi MY, 2012, MOL CELL BIOL, V32, P913, DOI 10.1128/MCB.05340-11; Ross EA, 2017, ANN RHEUM DIS, V76, P612, DOI 10.1136/annrheumdis-2016-209424; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Sedlyarov V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156628; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Tao XZ, 2015, MOL CELL BIOL, V35, P3921, DOI 10.1128/MCB.00845-15; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tiedje C, 2016, NUCLEIC ACIDS RES, V44, P7418, DOI 10.1093/nar/gkw474; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Yang J, 2017, CELL MOL IMMUNOL, V14, P65, DOI 10.1038/cmi.2016.29; Yao Y, 2015, J IMMUNOL, V195, P488, DOI 10.4049/jimmunol.1403225; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhang J, 2014, MUCOSAL IMMUNOL, V7, P1139, DOI 10.1038/mi.2014.1	82	38	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6869	6881		10.1074/jbc.M116.772947	http://dx.doi.org/10.1074/jbc.M116.772947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28302726	hybrid, Green Published			2022-12-26	WOS:000400478300002
J	Castaldi, PJ; Cho, MH; Liang, LM; Silverman, EK; Hersh, CP; Rice, K; Aschard, H				Castaldi, Peter J.; Cho, Michael H.; Liang, Liming; Silverman, Edwin K.; Hersh, Craig P.; Rice, Kenneth; Aschard, Hugues			Screening for interaction effects in gene expression data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DIFFERENTIAL EXPRESSION; NORMALIZATION; EPISTASIS; TESTS; POWER; TRANSFORMATION; TRANSCRIPTION; EXPLANATION; QUANTILE	Expression quantitative trait (eQTL) studies are a powerful tool for identifying genetic variants that affect levels of messenger RNA. Since gene expression is controlled by a complex network of gene-regulating factors, one way to identify these factors is to search for interaction effects between genetic variants and mRNA levels of transcription factors (TFs) and their respective target genes. However, identification of interaction effects in gene expression data pose a variety of methodological challenges, and it has become clear that such analyses should be conducted and interpreted with caution. Investigating the validity and interpretability of several interaction tests when screening for eQTL SNPs whose effect on the target gene expression is modified by the expression level of a transcription factor, we characterized two important methodological issues. First, we stress the scale-dependency of interaction effects and highlight that commonly applied transformation of gene expression data can induce or remove interactions, making interpretation of results more challenging. We then demonstrate that, in the setting of moderate to strong interaction effects on the order of what may be reasonably expected for eQTL studies, standard interaction screening can be biased due to heteroscedasticity induced by true interactions. Using simulation and real data analysis, we outline a set of reasonable minimum conditions and sample size requirements for reliable detection of variant-by-environment and variant-by-TF interactions using the heteroscedasticity consistent covariance-based approach.	[Castaldi, Peter J.; Cho, Michael H.; Silverman, Edwin K.; Hersh, Craig P.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Castaldi, Peter J.; Cho, Michael H.; Silverman, Edwin K.; Hersh, Craig P.] Harvard Med Sch, Channing Div Network Med, Boston, MA USA; [Castaldi, Peter J.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Cho, Michael H.; Silverman, Edwin K.; Hersh, Craig P.] Brigham & Womens Hosp, Pulm & Crit Care Div, 75 Francis St, Boston, MA 02115 USA; [Cho, Michael H.; Silverman, Edwin K.; Hersh, Craig P.] Harvard Med Sch, Pulm & Crit Care Div, Boston, MA USA; [Liang, Liming; Aschard, Hugues] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Aschard, Hugues] Inst Pasteur, Ctr Bioinformat, Biostat & Biol Integrat C3BI, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Castaldi, PJ (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Castaldi, PJ (corresponding author), Harvard Med Sch, Channing Div Network Med, Boston, MA USA.; Castaldi, PJ (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.; Aschard, H (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.; Aschard, H (corresponding author), Inst Pasteur, Ctr Bioinformat, Biostat & Biol Integrat C3BI, Paris, France.	repjc@channing.harvard.edu; haschard@hsph.harvard.edu		Aschard, Hugues/0000-0002-7554-6783	National Institutes of Health [R21HG007687, R01HL124233, R01HL126596, P01HL105339, R01HL089856, R01HL094635, R01NR013377, R01HL125583, R01HL113264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124233, R01HL125583, R01HL126596] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG007687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by funding from the National Institutes of Health R21HG007687 (HA), R01HL124233 and R01HL126596 (PJC), P01HL105339 and R01HL089856 (EKS), R01HL094635, R01NR013377, R01HL125583 (CPH), and R01HL113264 (EKS and MHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli LM, 2014, JAMA PSYCHIAT, V71, P1392, DOI 10.1001/jamapsychiatry.2014.1339; Andersson P.K., 2010, REGRESSION LINEAR PR, DOI [DOI 10.1007/978-1-4419-7170-8, 10.1007/978-1-4419-7170-8]; Aschard H, 2016, GENET EPIDEMIOL, V40, P678, DOI 10.1002/gepi.21989; Aschard H, 2013, GENET EPIDEMIOL, V37, P323, DOI 10.1002/gepi.21716; Aschard H, 2012, HUM GENET, V131, P1591, DOI 10.1007/s00439-012-1192-0; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Becker J, 2012, EUR J HUM GENET, V20, P97, DOI 10.1038/ejhg.2011.156; BLAIR RC, 1987, COMMUN STAT SIMULAT, V16, P1133, DOI 10.1080/03610918708812642; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; Brown AA, 2014, ELIFE, V3, DOI 10.7554/eLife.01381; Carey VJ, 2007, BIOINFORMATICS, V23, P522, DOI 10.1093/bioinformatics/btl628; Castaldi PJ, 2015, HUM MOL GENET, V24, P1200, DOI 10.1093/hmg/ddu525; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cornelis MC, 2012, AM J EPIDEMIOL, V175, P191, DOI 10.1093/aje/kwr368; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fusi N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002330; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geller SC, 2003, BIOINFORMATICS, V19, P1817, DOI 10.1093/bioinformatics/btg245; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hemani G, 2014, NATURE, V514, pE5, DOI 10.1038/nature13692; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leek JT, 2010, NATURE REV GENETICS, V11; MacKinnon J.G., 2013, RECENT ADV FUTURE DI, P437, DOI DOI 10.1007/978-1-4614-1653-1_17; MACKINNON JG, 1985, J ECONOMETRICS, V29, P305, DOI 10.1016/0304-4076(85)90158-7; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Qin Shaopu, 2013, Frontiers in Genetics, V3, P160, DOI 10.3389/fgene.2012.00160; Qiu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024395; Qiu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-124; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rantalainen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127882; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sokal RR, 1994, BIOMETRY PRINCIPLES; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tchetgen EJT, 2011, EPIDEMIOLOGY, V22, P257, DOI 10.1097/EDE.0b013e31820877c5; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Voorman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019416; Wan ES, 2011, AM J RESP CELL MOL, V45, P304, DOI 10.1165/rcmb.2010-0294OC; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Zhang JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008064	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173847	10.1371/journal.pone.0173847	http://dx.doi.org/10.1371/journal.pone.0173847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301596	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300079
J	Joo, JH; Kim, YS; Cho, BC; Jeong, CY; Park, W; Kim, HJ; Yoon, WS; Yoon, MS; Kim, JY; Choi, JH; Choi, Y; Kim, JY				Joo, Ji Hyeon; Kim, Young Seok; Cho, Byung Chul; Jeong, Chi Young; Park, Won; Kim, Hak Jae; Yoon, Won Sup; Yoon, Mee Sun; Kim, Ji-Yoon; Choi, Jin Hwa; Choi, Youngmin; Kim, Joo-Young			Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06)	PLOS ONE			English	Article							MODULATED PELVIC RADIOTHERAPY; CONSENSUS GUIDELINES; SMALL-BOWEL; CANCER; VOLUME; MORTALITY	Purpose To determine inter-observer variability in target volume definition of cervical cancer in radical and adjuvant radiotherapy (RT) settings. Methods Eight physicians contoured CTVs of 2 patients underwent definitive and postoperative RT. Each volume was analyzed using the individual/median volume ratio and generalized conformity index (CIgen). And center of mass (COM) of each contour was calculated. Expert agreement was quantified using an expectation maximization algorithm for Simultaneous Truth and Performance Level Estimation (STAPLE). Results For definitive RT, the individual/median volume ratio ranged from 0.51 to 1.41, and CIgen was 0.531. Mean 3-dimensional distances of average to each COM were 7.8 mm. For postoperative RT setting, corresponding values were 0.65 - 1.38, 0.563, and 5.3 mm. Kappa value of expert agreement was 0.65 and 0.67, respectively. STAPLE estimates of the sensitivity, specificity, and kappa measures of inter-physician agreement were 0.73, 0.98, and 0.65 for the definitive and 0.75, 0.98, and 0.67 for the adjuvant radiotherapy setting. The largest difference was observed in the superior-inferior direction, particularly in the upper vagina and the common iliac area. Conclusion As there was still some variability in target delineation, more detailed guidelines for target volume delineation and continuing education would help to reduce this uncertainty.	[Joo, Ji Hyeon; Kim, Young Seok; Cho, Byung Chul; Jeong, Chi Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Park, Won] Sungkyunkwan Univ Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Hak Jae] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Yoon, Won Sup] Korea Univ Ansan Hosp, Dept Radiat Oncol, Ansan, Gyeonggi Do, South Korea; [Yoon, Mee Sun] Chonnam Natl Univ Hwasun Hosp, Chonnam Natl Univ Med Sch, Dept Radiat Oncol, Hwasun, Jeollanam Do, South Korea; [Kim, Ji-Yoon] Catholic Univ Korea, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Choi, Jin Hwa] Chung Ang Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Choi, Youngmin] Dong A Univ Hosp, Dept Radiat Oncol, Busan, South Korea; [Kim, Joo-Young] Natl Canc Ctr, Res Inst & Hosp, Ctr Uterine Canc, Goyang, Gyeonggi Do, South Korea	University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Chonnam National University; Chonnam National University Hospital; Catholic University of Korea; Chung Ang University; Chung Ang University Hospital; Dong A University; National Cancer Center - Korea (NCC)	Kim, YS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	ysk@amc.seoul.kr		Kim, Young Seok/0000-0003-4739-4476				Allozi R, 2010, RADIOTHER ONCOL, V97, P572, DOI 10.1016/j.radonc.2010.06.009; BenedettiPanici P, 1996, GYNECOL ONCOL, V62, P19, DOI 10.1006/gyno.1996.0184; Chao KSC, 2002, INT J RADIAT ONCOL, V54, P1147, DOI 10.1016/S0360-3016(02)03040-7; Dinniwell R, 2009, INT J RADIAT ONCOL, V74, P844, DOI 10.1016/j.ijrobp.2008.09.026; Eminowicz G, 2015, RADIOTHER ONCOL, V117, P542, DOI 10.1016/j.radonc.2015.10.007; Gwynne S, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120398; Jung KW, 2015, CANCER RES TREAT, V47, P142, DOI 10.4143/crt.2015.066; Kouwenhoven E, 2009, PHYS MED BIOL, V54, P2863, DOI 10.1088/0031-9155/54/9/018; Lee JY, 2014, J GYNECOL ONCOL, V25, P174, DOI 10.3802/jgo.2014.25.3.174; Lim K, 2011, INT J RADIAT ONCOL, V79, P348, DOI 10.1016/j.ijrobp.2009.10.075; Mitchell DM, 2009, INT J RADIAT ONCOL, V75, P990, DOI 10.1016/j.ijrobp.2008.12.042; Ohara K, 2004, INT J RADIAT ONCOL, V60, P258, DOI 10.1016/j.ijrobp.2004.02.023; Oike T, 2010, J RADIAT RES, V51, P715, DOI 10.1269/jrr.10046; Portelance L, 2001, INT J RADIAT ONCOL, V51, P261, DOI 10.1016/S0360-3016(01)01664-9; Sakuragi N, 1999, CANCER, V85, P1547, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2; Small W, 2008, INT J RADIAT ONCOL, V71, P428, DOI 10.1016/j.ijrobp.2007.09.042; Taylor A, 2005, INT J RADIAT ONCOL, V63, P1604, DOI 10.1016/j.ijrobp.2005.05.062; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Weiss E, 2003, RADIOTHER ONCOL, V67, P87, DOI 10.1016/S0167-8140(02)00373-0	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173476	10.1371/journal.pone.0173476	http://dx.doi.org/10.1371/journal.pone.0173476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301492	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300043
J	Krawczyk, M; Zimmermann, S; Hess, G; Holz, R; Dauer, M; Raedle, J; Lammert, F; Grunhage, F				Krawczyk, Marcin; Zimmermann, Simone; Hess, Georg; Holz, Robert; Dauer, Marc; Raedle, Jochen; Lammert, Frank; Gruenhage, Frank			Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; GROWTH; DIAGNOSIS; CIRRHOSIS	Latest data suggest that placental growth factor (PLGF), growth differentiation factor-15 (GDF-15) and hepatic growth factor (HGF) are involved in hepatic fibrogenesis. Diagnostic performance of these markers for non-invasive liver fibrosis prediction was evaluated based on liver histology and stiffness. In total 834 patients were recruited. Receiver-operating-characteristics were used to define cut-offs for markers correlating to fibrosis stages. Oddsratios were calculated for the presence/absence of fibrosis/cirrhosis and confirmed in the sub-group of patients phenotyped by elastography only. Logistic and uni-and multivariate regression analyses were used to test for association of markers with liver fibrosis stages and for independent prediction of liver histology and stiffness. Marker concentrations correlated significantly (P< 0.001) with histology and stiffness. Cut-offs for liver fibrosis (>= F2) were PLGF = 20.20 pg/ml, GDF15 = 1582.76 pg/ml and HGF = 2598.00 pg/ml. Logistic regression confirmed an increase of ORs from 3.6 over 33.0 to 108.4 with incremental (1 - 3) markers positive for increased liver stiffness (>= 12.8kPa; all P< 0.05). Subgroup analysis revealed associations with advanced fibrosis for HCV (three markers positive: OR = 59.9, CI 23.4 - 153.4, P< 0.001) and non-HCV patients (three markers positive: OR = 144, CI 59 - 3383, P< 0.001). Overall, serum markers identified additional 50% of patients at risk for advanced fibrosis presenting with low elastography results. In conclusion, this novel combination of markers reflects the presence of significant liver fibrosis detected by elastography and histology and may also identify patients at risk presenting with low elastography values.	[Krawczyk, Marcin; Zimmermann, Simone; Holz, Robert; Dauer, Marc; Raedle, Jochen; Lammert, Frank; Gruenhage, Frank] Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany; [Krawczyk, Marcin] Med Univ Warsaw, Transplant & Liver Surg, Dept Gen, Lab Metabol Liver Dis, Warsaw, Poland; [Hess, Georg] Roche Diagnost, Grenzach Wyhlen, Germany; [Raedle, Jochen] Westfalz Klinikum, Dept Med 3, Kaiserslautern, Germany; [Gruenhage, Frank] RKN Hosp, Dept Gastroenterol & Oncol, Grevenbroich, Germany	Saarland University; Medical University of Warsaw	Grunhage, F (corresponding author), RKN Hosp, Dept Gastroenterol & Oncol, Grevenbroich, Germany.	frank.gruenhage@kkh-ne.de	Krawczyk, Marcin/AAG-4356-2020	Krawczyk, Marcin/0000-0002-0113-0777				Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; [Anonymous], 1999, J Hepatol, V30, P956; [Anonymous], 2015, PLOS ONE; Asrani SK, 2015, CLIN GASTROENTEROL H; Boursier J, 2012, HEPATOLOGY, V55, P58, DOI 10.1002/hep.24654; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Friedrich-Rust M, 2016, NAT REV GASTRO HEPAT, V13, P402, DOI 10.1038/nrgastro.2016.86; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Matsuda Y, 1997, HEPATOLOGY, V26, P81; Obara N, 2008, J GASTROENTEROL, V43, P720, DOI 10.1007/s00535-008-2225-2; Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019; Pavlov CS, 2016, ALIMENT PHARM THER, V43, P575, DOI 10.1111/apt.13524; Poynard T, 2011, J HEPATOL, V54, P586, DOI 10.1016/j.jhep.2010.09.012; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sharma S, 2014, WORLD J GASTROENTERO, V20, P16820, DOI 10.3748/wjg.v20.i45.16820; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Van Steenkiste C, 2011, HEPATOLOGY, V53, P1629, DOI 10.1002/hep.24238; VANZANTEN RAA, 1988, CLIN CHIM ACTA, V177, P141, DOI 10.1016/0009-8981(88)90135-0; Walsh KM, 1999, DIGEST DIS SCI, V44, P624, DOI 10.1023/A:1026630129025; Wolska-Krawczyk M, 2013, ABDOM IMAGING, V38, P461, DOI 10.1007/s00261-012-9939-6; Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x	30	15	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173506	10.1371/journal.pone.0173506	http://dx.doi.org/10.1371/journal.pone.0173506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301573	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300047
J	Middelweerd, A; te Velde, SJ; Abbott, G; Timperio, A; Brug, J; Ball, K				Middelweerd, Anouk; te Velde, Saskia J.; Abbott, Gavin; Timperio, Anna; Brug, Johannes; Ball, Kylie			Do intrapersonal factors mediate the association of social support with physical activity in young women living in socioeconomically disadvantaged neighbourhoods? A longitudinal mediation analysis	PLOS ONE			English	Article							STRUCTURAL EQUATION ANALYSIS; SELF-EFFICACY; COGNITIVE THEORY; HEALTH-PROMOTION; AUSTRALIAN WOMEN; DETERMINANTS; ADULTS; EXERCISE; BEHAVIOR; STUDENTS	Background Levels of physical activity (PA) decrease when transitioning from adolescence into young adulthood. Evidence suggests that social support and intrapersonal factors (self-efficacy, outcome expectations, PA enjoyment) are associated with PA. The aim of the present study was to explore whether cross-sectional and longitudinal associations of social support from family and friends with leisure-time PA (LTPA) among young women living in disadvantaged areas were mediated by intrapersonal factors (PA enjoyment, outcome expectations, self-efficacy). Methods Survey data were collected from 18 - 30 year-old women living in disadvantaged suburbs of Victoria, Australia as part of the READI study in 2007 - 2008 (T0, N = 1197), with follow-up data collected in 2010 - 2011 (T1, N = 357) and 2012 - 2013 (T2, N = 271). A series of single-mediator models were tested using baseline (T0) and longitudinal data from all three time points with residual change scores for changes between measurements. Results Cross-sectional analyses showed that social support was associated with LTPA both directly and indirectly, mediated by intrapersonal factors. Each intrapersonal factor explained between 5.9 - 37.5% of the associations. None of the intrapersonal factors were significant mediators in the longitudinal analyses. Conclusions Results from the cross-sectional analyses suggest that the associations of social support from family and from friends with LTPA are mediated by intrapersonal factors (PA enjoyment, outcome expectations and self-efficacy). However, longitudinal analyses did not confirm these findings.	[Middelweerd, Anouk; te Velde, Saskia J.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Middelweerd, Anouk; te Velde, Saskia J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Abbott, Gavin; Timperio, Anna; Ball, Kylie] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Brug, Johannes] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Deakin University; University of Amsterdam	Ball, K (corresponding author), Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.	kylie.ball@deakin.edu.au	Brug, Johannes/A-8242-2018; Ball, Kylie/B-5866-2015; Timperio, Anna F/A-3086-2013	Brug, Johannes/0000-0002-1904-7349; Ball, Kylie/0000-0003-2893-8415; Timperio, Anna F/0000-0002-8773-5012; Middelweerd, Anouk/0000-0002-1274-968X; Abbott, Gavin/0000-0003-4014-0705; te Velde, Saskia/0000-0002-4674-8052	Australian National Health and Medical Research Council [374241]; Philips and Technology Foundation STW; Nationaal Initiatief Hersenen en Cognitie NIHC [12014]; Albert Renold Travel fellowship from the European foundation for the Study of Diabetes; Marie Curie Actions [FP7-PEOPLE-2009-IRSES-247630]; NHMRC Principal Research Fellowship [1042442]; National Heart Foundation of Australia Future Leader Fellowship [100046]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Philips and Technology Foundation STW; Nationaal Initiatief Hersenen en Cognitie NIHC; Albert Renold Travel fellowship from the European foundation for the Study of Diabetes; Marie Curie Actions(European Commission); NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia)	The READI study was funded by the Australian National Health and Medical Research Council, ID 374241. AM is supported by the Philips and Technology Foundation STW and Nationaal Initiatief Hersenen en Cognitie NIHC under the Partnership program Healthy Lifestyle Solutions (grant no. 12014) and Albert Renold Travel fellowship from the European foundation for the Study of Diabetes. Analyses for the current paper were part of the MeMo International Exchange program funded under Marie Curie Actions (FP7-PEOPLE-2009-IRSES-247630). KB is supported by an NHMRC Principal Research Fellowship, ID 1042442. AT is supported by a National Heart Foundation of Australia Future Leader Fellowship, Award ID 100046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2008, HEALTH PROMOT INT, V23, P160, DOI 10.1093/heapro/dan012; Anderson ES, 2006, HEALTH PSYCHOL, V25, P510, DOI 10.1037/0278-6133.25.4.510; Australian Bureau of Statistics. Canberra Australia: ABS, 2011, AUSTR HLTH SURV PHYS; Ayotte BJ, 2010, J HEALTH PSYCHOL, V15, P173, DOI 10.1177/1359105309342283; Bakhtari Aghdam Fatemeh, 2013, Glob J Health Sci, V5, P189, DOI 10.5539/gjhs.v5n4p189; Ball K, 2012, INT J OBESITY, V36, P855, DOI 10.1038/ijo.2011.183; Ball K, 2013, INT J EPIDEMIOL, V42, P1629, DOI 10.1093/ije/dys165; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Bell S, 2005, INT J BEHAV MED, V12, P227, DOI 10.1207/s15327558ijbm1204_3; Buchan DS, 2012, J OBES, V2012, DOI 10.1155/2012/546459; Cerin E, 2009, PUBLIC HEALTH NUTR, V12, P1182, DOI 10.1017/S1368980008003649; Chen Y, 2006, PREV MED, V42, P261, DOI 10.1016/j.ypmed.2006.01.006; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dai SL, 2014, AM J PREV MED, V47, P123, DOI 10.1016/j.amepre.2014.04.003; Deliens T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1553-4; Duin DK, 2015, EVAL PROGRAM PLANN, V51, P45, DOI 10.1016/j.evalprogplan.2014.12.006; Gabriele JM, 2005, ANN BEHAV MED, V29, P210, DOI 10.1207/s15324796abm2903_7; Giles-Corti B, 2002, SOC SCI MED, V54, P1793, DOI 10.1016/S0277-9536(01)00150-2; Jeffery RW, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-52; Kavanagh AM, 2005, J EPIDEMIOL COMMUN H, V59, P934, DOI 10.1136/jech.2005.035931; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kilpatrick M, 2005, J AM COLL HEALTH, V54, P87, DOI 10.3200/JACH.54.2.87-94; Kwan MY, 2012, AM J PREV MED, V42, P14, DOI 10.1016/j.amepre.2011.08.026; Lockhart G, 2011, PSYCHOSOM MED, V73, P29, DOI 10.1097/PSY.0b013e318200a54b; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MACKINNON DAVID P., 2008, INTRO STAT MEDIATION, P1; MARCUS BH, 1992, RES Q EXERCISE SPORT, V63, P60, DOI 10.1080/02701367.1992.10607557; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; McNeill LH, 2006, ANN BEHAV MED, V31, P36, DOI 10.1207/s15324796abm3101_7; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Motl RW, 2006, ANN BEHAV MED, V32, P154, DOI 10.1207/s15324796abm3202_13; Rovniak LS, 2002, ANN BEHAV MED, V24, P149, DOI 10.1207/S15324796ABM2402_12; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Schoenborn CA, 2011, AM J PREV MED, V40, P514, DOI 10.1016/j.amepre.2010.12.029; Selig JP, 2009, RES HUM DEV, V6, P144, DOI 10.1080/15427600902911247; Spring B, 2014, CIRCULATION, V130, P10, DOI 10.1161/CIRCULATIONAHA.113.005445; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; Williams L, 2012, PUBLIC HEALTH NUTR, V15, P1396, DOI 10.1017/S1368980011003430; Winters ER, 2003, J ADOLESCENT HEALTH, V32, P436, DOI 10.1016/S1054-139X(03)00046-6; World Health Organisation, 2009, GLOB HLTH RISKS MORT, P1	46	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173231	10.1371/journal.pone.0173231	http://dx.doi.org/10.1371/journal.pone.0173231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301538	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300029
J	Arthaut, LD; Jourdan, N; Mteyrek, A; Procopio, M; El-Esawi, M; d'Harlingue, A; Bouchet, PE; Witczak, J; Ritz, T; Klarsfeld, A; Birman, S; Usselman, RJ; Hoecker, U; Martino, CF; Ahmad, M				Arthaut, Louis-David; Jourdan, Nathalie; Mteyrek, Ali; Procopio, Maria; El-Esawi, Mohamed; d'Harlingue, Alain; Bouchet, Pierre-Etienne; Witczak, Jacques; Ritz, Thorsten; Klarsfeld, Andre; Birman, Serge; Usselman, Robert J.; Hoecker, Ute; Martino, Carlos F.; Ahmad, Margaret			Blue-light induced accumulation of reactive oxygen species is a consequence of the Drosophila cryptochrome photocycle	PLOS ONE			English	Article							ARABIDOPSIS CRYPTOCHROME; DNA PHOTOLYASE; MECHANISM; PHOTORECEPTORS; RHYTHMS	Cryptochromes are evolutionarily conserved blue-light absorbing flavoproteins which participate in many important cellular processes including in entrainment of the circadian clock in plants, Drosophila and humans. Drosophila melanogaster cryptochrome (DmCry) absorbs light through a flavin (FAD) cofactor that undergoes photoreduction to the anionic radical (FAD(center dot-)) redox state both in vitro and in vivo. However, recent efforts to link this photoconversion to the initiation of a biological response have remained controversial. Here, we show by kinetic modeling of the DmCry photocycle that the fluence dependence, quantum yield, and half-life of flavin redox state interconversion are consistent with the anionic radical (FAD(center dot-)) as the signaling state in vivo. We show by fluorescence detection techniques that illumination of purified DmCry results in enzymatic conversion of molecular oxygen (O-2) to reactive oxygen species (ROS). We extend these observations in living cells to demonstrate transient formation of superoxide (O-2(center dot-)), and accumulation of hydrogen peroxide (H2O2) in the nucleus of insect cell cultures upon DmCry illumination. These results define the kinetic parameters of the Drosophila cryptochrome photocycle and support light-driven electron transfer to the flavin in DmCry signaling. They furthermore raise the intriguing possibility that light-dependent formation of ROS as a byproduct of the cryptochrome photocycle may contribute to its signaling role.	[Arthaut, Louis-David; Jourdan, Nathalie; Procopio, Maria; El-Esawi, Mohamed; d'Harlingue, Alain; Bouchet, Pierre-Etienne; Witczak, Jacques; Ahmad, Margaret] Univ Paris VI, IBPS, UMR CNRS B2A 8256, Paris, France; [Arthaut, Louis-David; Martino, Carlos F.] Florida Inst Technol, Dept Biomed Engn, Melbourne, FL 32901 USA; [Mteyrek, Ali; Klarsfeld, Andre; Birman, Serge] PSL Res Univ, UMR CNRS ESPCI Paris 8249, Brain Plast Unit, GCRN Team, Paris, France; [Procopio, Maria; Ritz, Thorsten] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA USA; [El-Esawi, Mohamed] Tanta Univ, Dept Bot, Fac Sci, Tanta, Egypt; [Usselman, Robert J.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Hoecker, Ute] Univ Cologne, Bioctr, Inst Bot, Cologne, Germany; [Hoecker, Ute] Univ Cologne, Bioctr, Cluster Excellence Plant Sci CEPLAS, Cologne, Germany; [Ahmad, Margaret] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA	UDICE-French Research Universities; Sorbonne Universite; Florida Institute of Technology; UDICE-French Research Universities; PSL Research University Paris; University of California System; University of California Irvine; Egyptian Knowledge Bank (EKB); Tanta University; Montana State University System; Montana State University Bozeman; University of Cologne; University of Cologne; Xavier University	Ahmad, M (corresponding author), Univ Paris VI, IBPS, UMR CNRS B2A 8256, Paris, France.; Ahmad, M (corresponding author), Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA.	margaret.ahmad@upmc.fr	Ritz, Thorsten/B-5260-2008; Martino, Carlos F/C-6597-2016; El-Esawi, Mohamed A./F-1953-2017; Procopio, Maria/AAN-1442-2020	Martino, Carlos F/0000-0002-0560-2604; El-Esawi, Mohamed A./0000-0002-8871-5689; Procopio, Maria/0000-0002-2521-3067; Hoecker, Ute/0000-0002-5636-9777; Ahmad, Margaret/0000-0003-4524-5813; Klarsfeld, Andre/0000-0001-9293-4887; Ritz, Thorsten/0000-0002-2713-539X	Air Force Office of Sponsored Research [FA9550-14-0-0409]	Air Force Office of Sponsored Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by Air Force Office of Sponsored Research, FA9550-14-0-0409 (to MA, TR, CFM).	Ahmad M, 2016, CURR OPIN PLANT BIOL, V33, P108, DOI 10.1016/j.pbi.2016.06.013; Alex A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137236; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Consentino L, 2015, NEW PHYTOL, V206, P1450, DOI 10.1111/nph.13341; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; El-Esawi M, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1063758; Engelhard C, 2014, PLANT CELL, V26, P4519, DOI 10.1105/tpc.114.129809; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; GALSTON AW, 1974, PLANT PHYSIOL, V54, P427, DOI 10.1104/pp.54.4.427; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hoecker U, 1999, SCIENCE, V284, P496, DOI 10.1126/science.284.5413.496; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; Jourdan N, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1042647; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Fanjul-Moles ML, 2013, FRONT BIOSCI-LANDMRK, V18, P665, DOI 10.2741/4129; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Nixdorf M, 2010, PLANTA, V231, P825, DOI 10.1007/s00425-009-1088-y; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Ozturk N, 2014, J BIOL CHEM, V289, P4634, DOI 10.1074/jbc.M113.542498; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Paulus B, 2015, FEBS J, V282, P3175, DOI 10.1111/febs.13299; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Procopio M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00888; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; van Wilderen LJGW, 2015, FEBS OPEN BIO, V5, P885, DOI 10.1016/j.fob.2015.10.007; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Vieira J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031867; Vinayak P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003615; Yoshii Taishi, 2016, Commun Integr Biol, V9, pe1102805, DOI 10.1080/19420889.2015.1102805; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	38	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0171836	10.1371/journal.pone.0171836	http://dx.doi.org/10.1371/journal.pone.0171836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296892	gold, Green Submitted, Green Published			2022-12-26	WOS:000396311700003
J	Kim, Y; Lee, JM; Kim, J; Dhurandhar, E; Soliman, G; Wehbi, NK; Canedy, J				Kim, Youngdeok; Lee, Jung-Min; Kim, Jungyoon; Dhurandhar, Emily; Soliman, Ghada; Wehbi, Nizar K.; Canedy, James			Longitudinal associations between body mass index, physical activity, and healthy dietary behaviors in adults: A parallel latent growth curve modeling approach	PLOS ONE			English	Article							WEIGHT-GAIN; ENERGY-BALANCE; UNITED-STATES; OBESITY; WOMEN; RISK; PATTERNS; TRENDS; PREVALENCE; OVERWEIGHT	Background Physical activity (PA) and healthy dietary behaviors (HDB) are two well-documented lifestyle factors influencing body mass index (BMI). This study examined 7-year longitudinal associations between changes in PA, HDB, and BMI among adults using a parallel latent growth curve modeling (LGCM). Methods We used prospective cohort data collected by a private company (SimplyWell LLC, Omaha, NE, USA) implementing a workplace health screening program. Data from a total of 2,579 adults who provided valid BMI, PA, and HDB information for at least 5 out of 7 follow-up years from the time they entered the program were analyzed. PA and HDB were subjectively measured during an annual online health survey. Height and weight measured during an annual onsite health screening were used to calculate BMI (kg.m(2)). The parallel LGCMs stratified by gender and baseline weight status (normal: BMI< 25, overweight BMI 25-29.9, and obese: BMI> 30) were fitted to examine the longitudinal associations of changes in PA and HDB with change in BMI over years. Results On average, BMI gradually increased over years, at rates ranging from 0.06 to 0.20 kg.m(2).year, with larger increases observed among those of normal baseline weight status across genders. The increases in PA and HDB were independently associated with a smaller increase in BMI for obese males (b = -1.70 and -1.98, respectively), and overweight females (b = -1.85 and -2.46, respectively) and obese females (b = -2.78 and -3.08, respectively). However, no significant associations of baseline PA and HDB with changes in BMI were observed. Conclusions Our study suggests that gradual increases in PA and HDB are independently associated with smaller increases in BMI in overweight and obese adults, but not in normal weight individuals. Further study is warranted to address factors that check increases in BMI in normal weight adults.	[Kim, Youngdeok; Dhurandhar, Emily] Texas Tech Univ, Dept Kinesiol & Sport Management, Lubbock, TX 79409 USA; [Lee, Jung-Min] Univ Nebraska, Sch Hlth Phys Educ & Recreat, Omaha, NE 68182 USA; [Kim, Jungyoon; Wehbi, Nizar K.] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA; [Soliman, Ghada] CUNY, Dept Environm Occupat & Geospatial Hlth Sci, New York, NY 10021 USA; [Canedy, James] Nebraska Med, Omaha, NE USA	Texas Tech University System; Texas Tech University; University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center; City University of New York (CUNY) System	Kim, Y (corresponding author), Texas Tech Univ, Dept Kinesiol & Sport Management, Lubbock, TX 79409 USA.	youngdeok.kim@ttu.edu	Soliman, Ghada A/U-6472-2017; Lee, Jung-Min/L-8227-2016	Soliman, Ghada A/0000-0002-8629-6062; Lee, Jung-Min/0000-0002-8033-0725; Wehbi, Nizar/0000-0001-5350-2643				Arabshahi S, 2012, BRIT J NUTR, V107, P1376, DOI 10.1017/S0007114511004351; Baskin ML, 2005, OBES REV, V6, P5, DOI 10.1111/j.1467-789X.2005.00165.x; Buijsse B, 2009, AM J CLIN NUTR, V90, P202, DOI 10.3945/ajcn.2008.27394; Catenacci VA, 2014, J PHYS ACT HEALTH, V11, P1540, DOI 10.1123/jpah.2012-0250; Cordain L, 1998, INT J SPORTS MED, V19, P328, DOI 10.1055/s-2007-971926; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Gordon-Larsen P, 2009, AM J CLIN NUTR, V89, P19, DOI 10.3945/ajcn.2008.26147; Hamer M, 2013, OBESITY, V21, pE755, DOI 10.1002/oby.20446; Hankinson AL, 2010, JAMA-J AM MED ASSOC, V304, P2603, DOI 10.1001/jama.2010.1843; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Katan MB, 2009, NEW ENGL J MED, V360, P923, DOI 10.1056/NEJMe0810291; Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920; Luke A, 2013, INT J EPIDEMIOL, V42, P1831, DOI 10.1093/ije/dyt159; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Thomas JG, 2014, AM J PREV MED, V46, P17, DOI 10.1016/j.amepre.2013.08.019; Togo P, 2004, INT J OBESITY, V28, P583, DOI 10.1038/sj.ijo.0802598; Vioque J, 2008, OBESITY, V16, P664, DOI 10.1038/oby.2007.121; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	33	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173986	10.1371/journal.pone.0173986	http://dx.doi.org/10.1371/journal.pone.0173986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296945	gold, Green Published			2022-12-26	WOS:000396311700085
J	Perez-Vidal, C; Gracia, L; Carmona, C; Alorda, B; Salinas, A				Perez-Vidal, Carlos; Gracia, Luis; Carmona, Cristian; Alorda, Bartomeu; Salinas, Antonio			Wireless transmission of biosignals for hyperbaric chamber applications	PLOS ONE			English	Article							SENSOR PLATFORM	This paper presents a wireless system to send biosignals outside a hyperbaric chamber avoiding wires going through the chamber walls. Hyperbaric chambers are becoming more and more common due to new indications of hyperbaric oxygen treatments. Metallic walls physically isolate patients inside the chamber, where getting a patient's vital signs turns into a painstaking task. The paper proposes using a ZigBee-based network to wirelessly transmit the patient's biosignals to the outside of the chamber. In particular, a wearable battery supported device has been designed, implemented and tested. Although the implementation has been conducted to transmit the electrocardiography signal, the device can be easily adapted to consider other biosignals.	[Perez-Vidal, Carlos] Miguel Hernandez Univ, Dept Syst Engn & Automat, Elche, Spain; [Gracia, Luis] Univ Politecn Valencia, Inst IDF, Valencia, Spain; [Carmona, Cristian; Alorda, Bartomeu] Univ Illes Balears, Dept Phys, Palma De Mallorca, Spain; [Salinas, Antonio] Perpetuo Socorro Hosp, MEDIBAROX Hyperbar Unit, Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat Politecnica de Valencia; Universitat de les Illes Balears	Perez-Vidal, C (corresponding author), Miguel Hernandez Univ, Dept Syst Engn & Automat, Elche, Spain.	carlos.perez@umh.es	Carmona, Cristian/S-5180-2018; Alorda, Bartomeu/X-8716-2018	Carmona, Cristian/0000-0001-7872-535X; Alorda, Bartomeu/0000-0002-5617-6254	Miguel Hernandez University	Miguel Hernandez University	This research has been carried out with funding and promotion of "Catedra de Medicina Hiperbarica" of the Miguel Hernandez University. http://nbio.umh.es/es/2010/12/01/catedra-de-medicina-hiperbarica-medibarox/.	Barea-Navarro R., BIOMEDICAL INSTRUMEN; Brubakk AO, 2004, UNDERSEA HYPERBAR M, V31, P73; Burns A, 2010, IEEE SENS J, V10, P1527, DOI 10.1109/JSEN.2010.2045498; Chen C., 2013, J MOD INT THINGS, V2, P24; Chung WY, 2008, IEEE ENG MED BIO, P1529, DOI 10.1109/IEMBS.2008.4649460; Fadlullah ZM, 2011, IEEE COMMUN MAG, V49, P60, DOI 10.1109/MCOM.2011.5741147; Gesell L.B., 2008, HYPERBARIC OXYGEN TH, V12th ed.; Gil Y, 2012, SENSORS-BASEL, V12, P10381, DOI 10.3390/s120810381; Hu S, 2012, SENSORS-BASEL, V12, P12844, DOI 10.3390/s120912844; Lee JS, 2007, IEEE IND ELEC, P46; Lin BS, 2006, IEEE T INF TECHNOL B, V10, P647, DOI 10.1109/TITB.2006.874194; Lin CT, 2010, IEEE T INF TECHNOL B, V14, P726, DOI 10.1109/TITB.2010.2047401; Lindell K., HYPERBARIC OXIGEN TH; Branco BHM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150517; Mahmood A, 2015, RENEW SUST ENERG REV, V41, P248, DOI 10.1016/j.rser.2014.08.036; Marks Robert J., 1991, SPRINGER TEXTS ELECT, pxiii; Olteanu AC, 2013, I C CONTR SYS COMP S, P189, DOI 10.1109/CSCS.2013.63; Parikh P.P., 2010, IEEE PES GEN M, P1, DOI DOI 10.1109/PES.2010.5589988; Semmlow J. L., 2011, BIOSIGNAL MED IMAGE; Shang YL, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012813; Sidhu B, 2007, PROC WRLD ACAD SCI E, V19, P308; Sureda A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163371; Tortora G.J., 2009, PRINCIPLES ANATOMY P, P729; Xu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148324	24	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172768	10.1371/journal.pone.0172768	http://dx.doi.org/10.1371/journal.pone.0172768			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296900	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700013
J	Wang, BF; Qi, ZQ; Chen, SZ; Liu, ZD; Ma, GC				Wang, Baofeng; Qi, Zhiquan; Chen, Sizhong; Liu, Zhaodu; Ma, Guocheng			Multi-vehicle detection with identity awareness using cascade Adaboost and Adaptive Kalman filter for driver assistant system	PLOS ONE			English	Article							MONOCULAR VEHICLE DETECTION	Vision-based vehicle detection is an important issue for advanced driver assistance systems. In this paper, we presented an improved multi-vehicle detection and tracking method using cascade Adaboost and Adaptive Kalman filter (AKF) with target identity awareness. A cascade Adaboost classifier using Haar-like features was built for vehicle detection, followed by a more comprehensive verification process which could refine the vehicle hypothesis in terms of both location and dimension. In vehicle tracking, each vehicle was tracked with independent identity by an Adaptive Kalman filter in collaboration with a data association approach. The AKF adaptively adjusted the measurement and process noise covariance through on-line stochastic modelling to compensate the dynamics changes. The data association correctly assigned different detections with tracks using global nearest neighbour (GNN) algorithm while considering the local validation. During tracking, a temporal context based track management was proposed to decide whether to initiate, maintain or terminate the tracks of different objects, thus suppressing the sparse false alarms and compensating the temporary detection failures. Finally, the proposed method was tested on various challenging real roads, and the experimental results showed that the vehicle detection performance was greatly improved with higher accuracy and robustness.	[Wang, Baofeng; Qi, Zhiquan; Chen, Sizhong; Liu, Zhaodu; Ma, Guocheng] Beijing Inst Technol, Sch Mech Engn, Lab Vehicle Engn, Beijing 100081, Peoples R China	Beijing Institute of Technology	Qi, ZQ (corresponding author), Beijing Inst Technol, Sch Mech Engn, Lab Vehicle Engn, Beijing 100081, Peoples R China.	qizhiquan@bit.edu.cn			National Natural Science Foundation of China [51005019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is sponsored by the National Natural Science Foundation of China under Grant No. 51005019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shalom Y., 1987, TRACKING DATA ASS; DEHGHAN A, 2015, PROC CVPR IEEE, P4091, DOI DOI 10.1109/CVPR.2015; Felzenszwalb PF, 2010, IEEE T PATTERN ANAL, V32, P1627, DOI 10.1109/TPAMI.2009.167; Graves Alex, 2013, AC SPEECH SIGN PROC; Hawe S., 2008, THESIS; Hu C., 2009, J SENSORS, V2009, P1; Hu XS, 2016, IEEE T TRANSP ELECTR, V2, P140, DOI 10.1109/TTE.2015.2512237; Hu XS, 2013, SIMUL MODEL PRACT TH, V34, P1, DOI 10.1016/j.simpat.2013.01.001; Karasalo M, 2011, AUTOMATICA, V47, P1785, DOI 10.1016/j.automatica.2011.04.004; Kim G, 2012, OPT REV, V19, P388, DOI 10.1007/s10043-012-0063-1; Konstantinova P., 2003, P 4 INT C C COMP SYS, P290; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Matthews ND, 1996, CONTROL ENG PRACT, V4, P473, DOI 10.1016/0967-0661(96)00028-7; Musicki D, 2004, IEEE T AERO ELEC SYS, V40, P1093, DOI 10.1109/TAES.2004.1337482; REID DB, 1979, IEEE T AUTOMAT CONTR, V24, P843, DOI 10.1109/TAC.1979.1102177; Schubert R, 2012, 2012 IEEE INTELLIGENT VEHICLES SYMPOSIUM (IV), P962, DOI 10.1109/IVS.2012.6232272; Sivaraman S, 2013, IEEE INT VEH SYM, P310, DOI 10.1109/IVS.2013.6629487; Sivaraman S, 2013, IEEE T INTELL TRANSP, V14, P906, DOI 10.1109/TITS.2013.2246835; Sivaraman S, 2009, IEEE INT VEH SYM, P399, DOI 10.1109/IVS.2009.5164311; Stanciulescu B, 2009, ARXIV09101293; Teoh SS, 2012, MACH VISION APPL, V23, P831, DOI 10.1007/s00138-011-0355-7; Tuohy S, 2010, P IRISH SIGN SYST C; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; von Seelen W., 1998, VEHICLE DETECTION TR	24	2	2	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173424	10.1371/journal.pone.0173424	http://dx.doi.org/10.1371/journal.pone.0173424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296902	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700037
J	Ward, EJ; Adkison, M; Couture, J; Dressel, SC; Litzow, MA; Moffitt, S; Neher, TH; Trochta, J; Brenner, R				Ward, Eric J.; Adkison, Milo; Couture, Jessica; Dressel, Sherri C.; Litzow, Michael A.; Moffitt, Steve; Neher, Tammy Hoem; Trochta, John; Brenner, Rich			Evaluating signals of oil spill impacts, climate, and species interactions in Pacific herring and Pacific salmon populations in Prince William Sound and Copper River, Alaska	PLOS ONE			English	Article							EXXON-VALDEZ OIL; HEMORRHAGIC SEPTICEMIA VIRUS; FRESH-WATER DISCHARGE; PINK SALMON; CLUPEA-PALLASI; ONCORHYNCHUS-GORBUSCHA; SOCKEYE-SALMON; TROPHIC DYNAMICS; KODIAK ISLAND; BOTTOM-UP	The Exxon Valdez oil spill occurred in March 1989 in Prince William Sound, Alaska, and was one of the worst environmental disasters on record in the United States. Despite long-term data collection over the nearly three decades since the spill, tremendous uncertainty remains as to how significantly the spill affected fishery resources. Pacific herring (Clupea pallasii) and some wild Pacific salmon populations (Oncorhynchus spp.) in Prince William Sound declined in the early 1990s, and have not returned to the population sizes observed in the 1980s. Discerning if, or how much of, this decline resulted from the oil spill has been difficult because a number of other physical and ecological drivers are confounded temporally with the spill; some of these drivers include environmental variability or changing climate regimes, increased production of hatchery salmon in the region, and increases in populations of potential predators. Using data pre-and post-spill, we applied time-series methods to evaluate support for whether and how herring and salmon productivity has been affected by each of five drivers: (1) density dependence, (2) the EVOS event, (3) changing environmental conditions, (4) interspecific competition on juvenile fish, and (5) predation and competition from adult fish or, in the case of herring, humpback whales. Our results showed support for intraspecific density-dependent effects in herring, sockeye, and Chinook salmon, with little overall support for an oil spill effect. Of the salmon species, the largest driver was the negative impact of adult pink salmon returns on sockeye salmon productivity. Herring productivity was most strongly affected by changing environmental conditions; specifically, freshwater discharge into the Gulf of Alaska was linked to a series of recruitment failures-before, during, and after EVOS. These results highlight the need to better understand long terms impacts of pink salmon on food webs, as well as the interactions between nearshore species and freshwater inputs, particularly as they relate to climate change and increasing water temperatures.	[Ward, Eric J.] NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Adkison, Milo] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK USA; [Couture, Jessica] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Dressel, Sherri C.; Brenner, Rich] Alaska Dept Fish & Game, Div Commercial Fisheries, Juneau, AK USA; [Litzow, Michael A.] Farallon Inst Adv Ecosyst Res, Petaluma, CA USA; [Moffitt, Steve] Alaska Dept Fish & Game, Div Commercial Fisheries, Cordova, AK USA; [Neher, Tammy Hoem] NOAA, Kasitsna Bay Lab, Natl Ocean Serv, Homer, AK USA; [Trochta, John] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; National Center for Ecological Analysis & Synthesis; Alaska Department of Fish & Game; Alaska Department of Fish & Game; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of Washington; University of Washington Seattle	Ward, EJ (corresponding author), NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	eric.ward@noaa.gov	Couture, Jessica/AAU-3840-2021		NCEAS working group (National Center for Ecological Analysis and Synthesis); Exxon Valdez Oil Spill Trustee Council (EVOSTC)	NCEAS working group (National Center for Ecological Analysis and Synthesis); Exxon Valdez Oil Spill Trustee Council (EVOSTC)(Exxon Mobil Corporation)	This project was funded as an NCEAS working group (National Center for Ecological Analysis and Synthesis, https://www.nceas.ucsb.edu/) by Kristin Marshall, "Applying portfolio effects to the Gulf of Alaska ecosystem". Funding for the working group was provided by the Exxon Valdez Oil Spill Trustee Council (EVOSTC).	Abdul-Aziz OI, 2011, CAN J FISH AQUAT SCI, V68, P1660, DOI [10.1139/F2011-079, 10.1139/f2011-079]; ADF&G Chinook Salmon Research Team, 2013, CHIN SALM STOCK ASS, P56; Agler BA, 1999, WATERBIRDS, V22, P98, DOI 10.2307/1521998; Anderson D, 2004, MODEL SELECTION MULT, V2nd; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Auburn Mary E., 2000, North Pacific Anadromous Fish Commission Bulletin, V2, P89; Batten S, 2015, ENV DRIVERS REGIONAL; Beamish RJ, 1997, ICES J MAR SCI, V54, P1200, DOI 10.1006/jmsc.1997.0305; Beamish RJ, 2012, INT WORKSH EXPL HIGH; Beamish RJ, 2010, 1284 N PAC AN FISH C, P26; Bechtol WR, 2001, PRINCE WILLIAM SOUND; Bishop MA, 2015, FISH OCEANOGR, V24, P1, DOI 10.1111/fog.12073; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Brannon EL, 2012, REV FISH SCI, V20, P20, DOI 10.1080/10641262.2011.643697; Bugaev VF, 2001, FISH OCEANOGR, V10, P26, DOI 10.1046/j.1365-2419.2001.00150.x; Carls MG, 2002, CAN J FISH AQUAT SCI, V59, P153, DOI 10.1139/F01-200; Cooney RT, 2001, FISH OCEANOGR, V10, P1, DOI 10.1046/j.1054-6006.2001.00039.x; Cross AD, 2009, MAR COAST FISH, V1, P57, DOI 10.1577/C08-005.1; Davis N., 2003, FEEDING ECOLOGY PACI; Deriso RB, 2008, ECOL APPL, V18, P1270, DOI 10.1890/07-0708.1; Donaldson W, 1995, 2A95XX AL DEP FISH G; Doyle MJ, 2009, PROG OCEANOGR, V80, P163, DOI 10.1016/j.pocean.2009.03.002; Elston RA, 2009, DIS AQUAT ORGAN, V83, P223, DOI 10.3354/dao02005; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; Exxon Valdez Oil Spill Trustee Council, EVOS SHOR SURF OIL; Fair LE, 2011, ESCAPEMENT GOAL REV; Francis Robert C., 1994, Fisheries Oceanography, V3, P279, DOI 10.1111/j.1365-2419.1994.tb00105.x; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; Funk F, 1993, FORECAST PACIFIC HER; Funk FC, 1990, ADF G FISH RES B, V90-01; GALT JA, 1991, ENVIRON SCI TECHNOL, V25, P202, DOI 10.1021/es00014a001; Galvan I, 2014, FUNCT ECOL, V28, P1387, DOI 10.1111/1365-2435.12283; Geiger HJ, 1995, RUN RECONSTRUCTION L; Geiger HJ, 1992, 5J9212 AL DEP FISH G; Habicht C, 2000, BROODSTOCK ACQUISITI; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hershberger PK, 2016, J FISH DIS, V39, P395, DOI 10.1111/jfd.12370; Hilborn R, 2000, T AM FISH SOC, V129, P333, DOI 10.1577/1548-8659(2000)129<0333:AROTHP>2.0.CO;2; HILBORN R, 1992; Holmes EE, 2012, R J, V4, P11; Hulson PJF, 2008, ICES J MAR SCI, V65, P25, DOI 10.1093/icesjms/fsm162; Incardona JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep13499; Johnson SP, 2009, ECOL RES, V24, P855, DOI 10.1007/s11284-008-0559-0; Kaeriyama M, 2004, FISH OCEANOGR, V13, P197, DOI 10.1111/j.1365-2419.2004.00286.x; Kaeriyama M, 2000, FEEDING ECOLOGY SOCK, P55; Kemp IM, 2013, POTENTIAL COMPETITIO, P139; Kingston PF, 2002, SPILL SCI TECHNOL B, V7, P53, DOI 10.1016/S1353-2561(02)00051-8; Kuletz KJ, 1996, P INT S ROL FOR FISH, P703; Litzow MA, 2014, GLOBAL CHANGE BIOL, V20, P38, DOI 10.1111/gcb.12373; Mackas DL, 2007, PROG OCEANOGR, V75, P223, DOI 10.1016/j.pocean.2007.08.010; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinson Ellen C., 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P177; Martinson EC, 2008, MAR ECOL PROG SER, V370, P1, DOI 10.3354/meps07665; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; McGurk MD, 1996, CAN J FISH AQUAT SCI, V53, P2343, DOI 10.1139/cjfas-53-10-2343; Merrick RL, 1997, CAN J FISH AQUAT SCI, V54, P1342, DOI 10.1139/cjfas-54-6-1342; MEYERS TR, 1994, DIS AQUAT ORGAN, V19, P27, DOI 10.3354/dao019027; Moffitt SD, 2014, ESCAPEMENT GOAL REV; Moore JW, 2010, CONSERV LETT, V3, P340, DOI 10.1111/j.1755-263X.2010.00119.x; Mueter FJ, 2005, T AM FISH SOC, V134, P105, DOI 10.1577/T-04-033.1; Mundy PR., 2005, GULF ALASKA BIOL OCE, P220; Neff JM, 1995, EXXON VALDEZ OIL SPI; NIEBAUER HJ, 1994, J GEOPHYS RES-OCEANS, V99, P14113, DOI 10.1029/94JC00712; Norcross BL, 2001, FISH OCEANOGR, V10, P42, DOI 10.1046/j.1054-6006.2001.00040.x; Payne MR, 2009, ICES J MAR SCI, V66, P272, DOI 10.1093/icesjms/fsn211; Pearson WH, 2012, REV FISH BIOL FISHER, V22, P95, DOI 10.1007/s11160-011-9225-7; Pearson WH, 1999, CAN J FISH AQUAT SCI, V56, P711, DOI 10.1139/cjfas-56-4-711; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Peterson CH, 2001, MAR ECOL PROG SER, V210, P255, DOI 10.3354/meps210255; Piatt JF, 1996, AM FISH S S, V18, P712; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; R Core Development Team, 2015, R LANG ENV STAT COMP; Rice S, 2007, PRINCE WILLIAM SOUND; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROYER TC, 1982, J GEOPHYS RES-OCEANS, V87, P2017, DOI 10.1029/JC087iC03p02017; Royer TC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026767; Ruggerone GT, 2015, CAN J FISH AQUAT SCI, V72, P818, DOI 10.1139/cjfas-2014-0134; Ruggerone GT, 2004, REV FISH BIOL FISHER, V14, P371, DOI 10.1007/s11160-004-6927-0; Ruggerone GT, 2003, FISH OCEANOGR, V12, P209, DOI 10.1046/j.1365-2419.2003.00239.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schweigert JF, 2010, ICES J MAR SCI, V67, P1903, DOI 10.1093/icesjms/fsq134; Short JW, 1997, ENVIRON SCI TECHNOL, V31, P2375, DOI 10.1021/es960985d; Short JW, 2004, ENVIRON SCI TECHNOL, V38, P19, DOI 10.1021/es0348694; Siple MC, 2016, OECOLOGIA, V180, P111, DOI 10.1007/s00442-015-3439-7; SPIES RB, 2007, LONGT EC CHANG NO, P1; Springer AM, 2014, P NATL ACAD SCI USA, V111, pE1880, DOI 10.1073/pnas.1319089111; Stopha M, 2013, KOERNIG SALMON HATCH; Sturdevant MS, 2013, DOES PREDATION RETUR, P153; Sturdevant MV, 2001, FISH B-NOAA, V99, P482; Sturdevant MV, 1999, FORAGE FISH DIET OVE; Teerlink SF, 2015, ENVIRON ECOL STAT, V22, P345, DOI 10.1007/s10651-014-0301-8; Thorne RE, 2008, ICES J MAR SCI, V65, P44, DOI 10.1093/icesjms/fsm176; Wang Y, 2013, MODEL STUDY COPPER R; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wessel M, 2014, 1442 AL DEP FISH GAM; Wiese A, 2015, PRINCE WILLIAM SOUND; Wikner J, 2012, GLOBAL CHANGE BIOL, V18, P2509, DOI 10.1111/j.1365-2486.2012.02718.x; Willette TM, 2001, FISH OCEANOGR, V10, P14, DOI 10.1046/j.1054-6006.2001.00043.x; Willette TM, 1996, RESTORATION COGHILL; Williams EH, 2000, FISH OCEANOGR, V9, P285, DOI 10.1046/j.1365-2419.2000.00145.x; WOLFE DA, 1994, ENVIRON SCI TECHNOL, V28, pA560, DOI 10.1021/es00062a712; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Zebdi Abdelkrim, 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P277	104	23	23	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172898	10.1371/journal.pone.0172898	http://dx.doi.org/10.1371/journal.pone.0172898			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296895	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700017
J	Harnod, T; Wang, YC; Lin, CL; Tseng, CH				Harnod, Tomor; Wang, Yu-Chiao; Lin, Cheng-Li; Tseng, Chun-Hung			High risk of developing subsequent epilepsy in patients with sleep-disordered breathing	PLOS ONE			English	Article							MORTALITY; PREVALENCE; ROCHESTER; INSOMNIA; ADULTS	Purpose Sleep-disordered breathing (SDB) is often associated with other medical disorders. Whether SDB interacts with other factors for developing subsequent epilepsy remains unclear. Methods This population-based cohort study was conducted using the National Health Insurance Research Database of Taiwan. Patients aged >20 years and diagnosed with SDB between 2000 and 2010 comprised the SDB cohort (n = 138,507), and their data were compared with those of the comparison cohort (n = 138,507). The adjusted hazard ratio (aHR) for epilepsy was calculated using a multivariate Cox proportional hazards model. Results The SDB cohort had an increased risk of epilepsy (aHR = 1.50, 95% confidence interval [CI] = 1.36(_)1.66). The sex-stratified analysis revealed a significant adjusted hazard ratio (aHR) for epilepsy with a 1.51-fold higher risk for female patients, and also a significantly 1.49-fold higher risk for male patients in the SDB cohort. Although epilepsy incidence increased with age in both cohorts, different age groups in the SDB cohort all had a significantly higher risk of developing epilepsy than comparison cohort. Conclusion This population-based cohort study indicates that patients with SDB are at a high risk of developing subsequent epilepsy, in both sexes and all age groups.	[Harnod, Tomor] Hualien Tzu Chi Gen Hosp, Dept Neurosurg, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan; [Harnod, Tomor] Tzu Chi Univ, Coll Med, Hualien, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tseng, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Tseng, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Tseng, CH (corresponding author), China Med Univ Hosp, Dept Neurol, Taichung, Taiwan.	Tseng.nm@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding has been received for this study.	Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; Aurlien D, 2012, SEIZURE-EUR J EPILEP, V21, P573, DOI 10.1016/j.seizure.2012.05.015; Benbadis SR, 2000, SEIZURE-EUR J EPILEP, V9, P280, DOI 10.1053/seiz.2000.0409; Chang YH, 2012, SEIZURE-EUR J EPILEP, V21, P254, DOI 10.1016/j.seizure.2012.01.006; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chihorek AM, 2007, NEUROLOGY, V69, P1823, DOI 10.1212/01.wnl.0000279334.78298.d5; Harden CL, 1999, EPILEPSIA, V40, P1402, DOI 10.1111/j.1528-1157.1999.tb02012.x; Harnod T, 2015, QJM-INT J MED, V108, P449, DOI 10.1093/qjmed/hcu215; Harnod T, 2015, MEDICINE, V94, DOI [10.1097/MD.0000000000001506, 10.1097/MD.0000000000001571]; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Henderson VW, 2006, NEUROLOGIST, V12, P149, DOI 10.1097/01.nrl.0000215750.52786.b1; Jain SV, 2015, SEMIN PEDIATR NEUROL, V22, P86, DOI 10.1016/j.spen.2015.03.005; Khachatryan SG, 2015, SLEEP MED, V16, P1017, DOI 10.1016/j.sleep.2015.03.019; Lucey BP, 2015, SLEEP, V38, P777, DOI 10.5665/sleep.4674; Morrell MJ, 2002, AM FAM PHYSICIAN, V66, P1489; Neligan A, 2011, BRAIN, V134, P388, DOI 10.1093/brain/awq378; Nevalainen O, 2013, EUR J EPIDEMIOL, V28, P981, DOI 10.1007/s10654-013-9848-1; Ohayon MM, 2009, SLEEP MED CLIN, V4, P87, DOI 10.1016/j.jsmc.2008.12.002; Schmitt B, 2015, NEUROPEDIATRICS, V46, P171, DOI 10.1055/s-0035-1551574; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173491	10.1371/journal.pone.0173491	http://dx.doi.org/10.1371/journal.pone.0173491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291799	gold, Green Submitted, Green Published			2022-12-26	WOS:000396094700029
J	Peng, CK; Huang, KL; Lan, CC; Hsu, YJ; Wu, GC; Peng, CH; Wu, CP; Chan, KS				Peng, Chung-Kan; Huang, Kun-Lun; Lan, Chou-Chin; Hsu, Yu-Juei; Wu, Geng-Chin; Peng, Chia-Hui; Wu, Chin-Pyng; Chan, Khee-Siang			Experimental chronic kidney disease attenuates ischemia-reperfusion injury in an ex vivo rat lung model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; HEAT-SHOCK PROTEINS; RENAL-FAILURE; ACUTE ENDOTOXEMIA; XANTHINE-OXIDASE; TRANSPLANTATION; INHIBITION; EXPRESSION	Lung ischemia reperfusion injury (LIRI) is one of important complications following lung transplant and cardiopulmonary bypass. Although patients on hemodialysis are still excluded as lung transplant donors because of the possible effects of renal failure on the lungs, increased organ demand has led us to evaluate the influence of chronic kidney disease (CKD) on LIRI. A CKD model was induced by feeding Sprague-Dawley rats an adenine- rich (0.75%) diet for 2, 4 and 6 weeks, and an isolated rat lung in situ model was used to evaluate ischemia reperfusion (IR)-induced acute lung injury. The clinicopathological parameters of LIRI, including pulmonary edema, lipid peroxidation, histopathological changes, immunohistochemistry changes, chemokine CXCL1, inducible nitric oxide synthase (iNOS), proinflammatory and anti-inflammatory cytokines, heat shock protein expression, and nuclear factor-kappa B (NF-kappa B) activation were determined. Our results indicated that adenine-fed rats developed CKD as characterized by increased blood urea nitrogen and creatinine levels and the deposition of crystals in the renal tubules and interstitium. IR induced a significant increase in the pulmonary arterial pressure, lung edema, lung injury scores, the expression of CXCL1 mRNA, iNOS level, and protein concentration of the bronchial alveolar lavage fluid (BALF). The tumor necrosis factor-a levels in the BALF and perfusate; the interleukin-10 level in the perfusate; and the malondialdehyde levels in the lung tissue and perfusate were also significantly increased by LIRI. Counterintuitively, adenine-induced CKD significantly attenuated the severity of lung injury induced by IR. CKD rats exhibited increased heat shock protein 70 expression and decreased activation of NF-kappa B signaling. In conclusion, adenine-induced CKD attenuated LIRI by inhibiting the NF-kappa B pathway.	[Peng, Chung-Kan] Triserv Gen Hosp, Div Pulm & Crit Care, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan; [Huang, Kun-Lun] Natl Def Med Ctr, Inst Undersea & Hyperbar Med, Taipei, Taiwan; [Lan, Chou-Chin] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Pulm Med, Taipei, Taiwan; [Lan, Chou-Chin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hsu, Yu-Juei] Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, Taipei, Taiwan; [Wu, Geng-Chin] Taoyuan Armed Forces Gen Hosp, Div Pulm Med, Dept Internal Med, Lungtan, Taiwan; [Peng, Chia-Hui] Taoyuan Armed Forces Gen Hosp, Div Clin Nutr, Lungtan, Taiwan; [Wu, Chin-Pyng] Li Shin Hosp, Dept Crit Care Med, Taoyuan, Taiwan; [Chan, Khee-Siang] Chi Mei Med Ctr, Dept Crit Care Med, Tainan, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tzu Chi University; National Defense Medical Center; Tri-Service General Hospital; Chi Mei Hospital	Wu, CP (corresponding author), Li Shin Hosp, Dept Crit Care Med, Taoyuan, Taiwan.; Chan, KS (corresponding author), Chi Mei Med Ctr, Dept Crit Care Med, Tainan, Taiwan.	chinpyng@mail.ndmctsgh.edu.tw; kheesiangchan@gmail.com	Wu, Chin-Pyng/W-8447-2019; Peng, Chung-Kang/N-1308-2019	Peng, Chung-Kang/0000-0003-3666-9833	cooperative research projects of Chi-Mei Medical Center and National Defense Medical Center [CMNDMC10011, CMNDMC10109]; Li-Shin Hospital [1S52010-07]; Tri-Service General Hospital [TSGH-C100-79]; Ministry of National Defense [MAB101-65]	cooperative research projects of Chi-Mei Medical Center and National Defense Medical Center; Li-Shin Hospital; Tri-Service General Hospital; Ministry of National Defense	This work was supported by grants from the cooperative research projects of Chi-Mei Medical Center and National Defense Medical Center (CMNDMC10011 and CMNDMC10109), the Li-Shin Hospital (1S52010-07), the Tri-Service General Hospital (TSGH-C100-79), and the Ministry of National Defense (MAB101-65).	ADKINS WK, 1990, J APPL PHYSIOL, V69, P2012, DOI 10.1152/jappl.1990.69.6.2012; Arkovitz MS, 1996, J PEDIATR SURG, V31, P1009, DOI 10.1016/S0022-3468(96)90075-5; BarbotinLarrieu F, 1996, J APPL PHYSIOL, V80, P782, DOI 10.1152/jappl.1996.80.3.782; Basu RK, 2013, PEDIATR NEPHROL, V28, P2239, DOI 10.1007/s00467-012-2386-3; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR; Bosutti A, 2007, CYTOKINE, V40, P71, DOI 10.1016/j.cyto.2007.09.002; BUSH A, 1991, THORAX, V46, P424, DOI 10.1136/thx.46.6.424; Chu SJ, 2002, CRIT CARE MED, V30, P1605, DOI 10.1097/00003246-200207000-00034; COOPER JD, 1992, AM REV RESPIR DIS, V146, P803, DOI 10.1164/ajrccm/146.3.803; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Eppinger MJ, 1996, J THORAC CARDIOV SUR, V112, P1301, DOI 10.1016/S0022-5223(96)70144-7; Granton J, 2006, CURR OPIN CRIT CARE, V12, P19, DOI 10.1097/01.ccx.0000198995.44943.63; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; Haverich A, 1985, J Heart Transplant, V4, P234; Heinzelmann M, 1999, AM J KIDNEY DIS, V34, P384, DOI 10.1016/S0272-6386(99)70375-6; Hopkinson DN, 1998, J HEART LUNG TRANSPL, V17, P525; Ishiyama T, 2005, J THORAC CARDIOV SUR, V130, P194, DOI 10.1016/j.jtcvs.2005.02.040; King RC, 2000, ANN THORAC SURG, V69, P1681, DOI 10.1016/S0003-4975(00)01425-9; KIRSCHNER RE, 1994, J AM COLL SURGEONS, V179, P103; Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100; Li MH, 2009, BRIT J PHARMACOL, V157, P244, DOI 10.1111/j.1476-5381.2009.00139.x; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu SF, 1997, J IMMUNOL, V159, P3976; LYNCH MJ, 1988, J SURG RES, V44, P538, DOI 10.1016/0022-4804(88)90159-X; MYERS BD, 1975, CHEST, V68, P191, DOI 10.1378/chest.68.2.191; Ng CSH, 2006, SURG TODAY, V36, P205, DOI 10.1007/s00595-005-3124-2; Peng CK, 2011, PULM PHARMACOL THER, V24, P153, DOI 10.1016/j.pupt.2010.07.002; Ross SD, 2000, AM J PHYSIOL-LUNG C, V279, pL528, DOI 10.1152/ajplung.2000.279.3.L528; Ross SD, 1999, ANN THORAC SURG, V67, P1428, DOI 10.1016/S0003-4975(99)00248-9; Sawant KV, 2015, J INNATE IMMUN, V7, P647, DOI 10.1159/000430914; Shlomi D, 2006, ANN THORAC SURG, V81, P1131, DOI 10.1016/j.athoracsur.2005.01.062; Singleton KD, 2005, CRIT CARE MED, V33, P1206, DOI 10.1097/01.CCM.0000166357.10996.8A; SPINK J, 1995, J BIOL CHEM, V270, P29541, DOI 10.1074/jbc.270.49.29541; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Turcios NL, 2012, PAEDIATR RESPIR REV, V13, P44, DOI 10.1016/j.prrv.2011.04.006; Weiss YG, 2002, J CLIN INVEST, V110, P801, DOI 10.1172/JCI200215888; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; WIZEMANN TM, 1994, J LEUKOCYTE BIOL, V56, P759, DOI 10.1002/jlb.56.6.759; Wong HR, 1996, AM J PHYSIOL-LUNG C, V271, pL166, DOI 10.1152/ajplung.1996.271.1.L166; Wu SY, 2012, CRIT CARE MED, V40, P553, DOI 10.1097/CCM.0b013e318232d776; XIE QW, 1994, J BIOL CHEM, V269, P4705; YOKOZAWA T, 1984, J NUTR SCI VITAMINOL, V30, P245, DOI 10.3177/jnsv.30.245	44	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0171736	10.1371/journal.pone.0171736	http://dx.doi.org/10.1371/journal.pone.0171736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291795	gold, Green Published, Green Submitted			2022-12-26	WOS:000396094700003
J	Chen, LY; Ma, X; Li, HZ; Gu, LY; Li, XT; Gao, Y; Xie, YP; Zhang, X				Chen, Luyao; Ma, Xin; Li, Hongzhao; Gu, Liangyou; Li, Xintao; Gao, Yu; Xie, Yongpeng; Zhang, Xu			Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy	PLOS ONE			English	Article							PERINEPHRIC FAT INFILTRATION; TNM STAGING SYSTEM; PROGNOSTIC-SIGNIFICANCE; MULTICENTER EXPERIENCE; T3A; CLASSIFICATION; CANCER; IMPACT	Objective To evaluate the prognostic significance of tumor size in pathological T3aN0M0 renal cell carcinoma (RCC) treated by radical nephrectomy. Materials and methods Patients who underwent radical nephrectomy for sporadic RCC with pathological T3aN0M0 RCC at our institution between January 2006 and June 2015 were identified. The entire cohort was divided into two groups according to the cutoff of tumor size obtained from receiver operating characteristic (ROC) curve. Clinicopathological variables were retrospectively collected and compared. Kaplan-Meier analysis and multivariate Cox regression were conducted to evaluate the effect of tumor size on survival outcomes. Results 163 pT3aNOMO RCC patients were included with a median follow-up period of 31 months. The optimal cutoff for tumor size was 7 cm according to the ROC curve. 90 cases (55.2%) presented tumors which measured 7 cm or less, and 73 cases (44.8%) showed tumor size greater than 7 cm. Patients with larger tumors tended to exhibit higher rates of symptoms and higher Fuhrman grades; they also indicated more necrosis features, and were more likely to invade the collecting system and renal vein. Compared with patients who exhibited tumor size of <= 7 cm, those with tumor size>7 cm were associated with shorter estimated five-year cancer-specific survival (CSS, 46.6% versus 75.0%, P=0.003) and five-year recurrence-free survival (RFS, 35.6% versus 62.7%, P = 0.011). Multivariate Cox analysis revealed that tumor size was retained as an independent factor for CSS (HR = 2.506, 95% CI 1.169-5.373, P=0.018). Conclusions The tumor size significantly affected the survival outcomes of pT3aN0M0 RCC treated by radical nephrectomy, and a cutoff size of 7 cm can help enhance the prognostic discrimination. Thus, the tumor size may be considered in the future TNM classification of stage pT3a.	[Chen, Luyao; Ma, Xin; Li, Hongzhao; Gu, Liangyou; Li, Xintao; Gao, Yu; Xie, Yongpeng; Zhang, Xu] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Xie, Yongpeng] Nankai Univ, Sch Med, Tianjin, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University	Zhang, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing, Peoples R China.	xzhang@tjh.tjmu.edu.cn	zhang, xu/GYE-3558-2022					Brookman-May SD, 2015, EUR UROL, V67, P943, DOI 10.1016/j.eururo.2014.11.055; Chevinsky M, 2015, J UROLOGY, V194, P310, DOI 10.1016/j.juro.2015.02.013; Crispen PL, 2011, EUR UROL, V59, P18, DOI 10.1016/j.eururo.2010.08.042; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elmore JM, 2003, CANCER-AM CANCER SOC, V98, P2329, DOI 10.1002/cncr.11806; Ficarra V, 2007, LANCET ONCOL, V8, P554, DOI 10.1016/S1470-2045(07)70173-0; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gofrit ON, 2007, J UROLOGY, V177, P1682, DOI 10.1016/j.juro.2007.01.064; Gospodarowicz MK, 2004, CANCER, V100, P1, DOI 10.1002/cncr.11898; Klatte T, 2007, J UROLOGY, V178, P35, DOI 10.1016/j.juro.2007.03.046; Lam JS, 2007, EUR UROL, V52, P155, DOI 10.1016/j.eururo.2007.01.106; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Moch H, 2009, EUR UROL, V56, P636, DOI 10.1016/j.eururo.2009.06.036; Schiavina R, 2015, CLIN GENITOURIN CANC, V13, pE235, DOI 10.1016/j.clgc.2014.06.011; Siemer S, 2005, J UROLOGY, V173, P33, DOI 10.1097/01.ju.0000146719.43269.e8; Suer E, 2013, UROL J, V10, P774; Tsui KH, 2000, J UROLOGY, V163, P1090, DOI 10.1016/S0022-5347(05)67699-9; Yoo C, 2008, J UROLOGY, V180, P486, DOI 10.1016/j.juro.2008.04.034; Zhang ZL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149420	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173953	10.1371/journal.pone.0173953	http://dx.doi.org/10.1371/journal.pone.0173953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288191	Green Published, gold, Green Submitted			2022-12-26	WOS:000396092400045
J	Peverill, RE; Chou, B; Donelan, L				Peverill, Roger E.; Chou, Bon; Donelan, Lesley			Left ventricular long axis tissue Doppler systolic velocity is independently related to heart rate and body size	PLOS ONE			English	Article							INCREMENTAL PROGNOSTIC VALUE; ATRIOVENTRICULAR PLANE DISPLACEMENT; MITRAL ANNULAR VELOCITIES; INTACT UNANESTHETIZED MAN; FORCE-FREQUENCY RELATION; DIASTOLIC FUNCTION; DILATED CARDIOMYOPATHY; HEALTHY-SUBJECTS; CARDIOVASCULAR-DISEASE; REFERENCE VALUES	Background The physiological factors which affect left ventricular (LV) long-axis function are not fully defined. We investigated the relationships of resting heart rate and body size with the peak velocities and amplitudes of LV systolic and early diastolic long axis motion, and also with long-axis contraction duration. Methods Two groups of adults free of cardiac disease underwent pulsed-wave tissue Doppler imaging at the septal and lateral mitral annular borders. Group 1 (n = 77) were healthy subjects < 50 years of age and Group 2 (n = 65) were subjects between 40-80 years of age referred for stress echocardiography. Systolic excursion (SExc), duration (SDur) and peak velocity (s') and early diastolic excursion (EDExc) and peak velocity (e') were measured. Results SExc was not correlated with heart rate, height or body surface area (BSA) for either LV wall in either group, but SDur was inversely correlated with heart rate for both walls and both groups, and after adjustment for heart rate, males in both groups had a shorter septal SDur. Septal and lateral s' were independently and positively correlated with SExc, heart rate and height in both groups, independent of sex and age. There were no correlations of heart rate, height or BSA with either e' or EDExc for either wall in either group. Conclusion Heart rate and height independently modify the relationship between s' and SExc, but neither are related to EDExc or e'. These findings suggest that s' and SExc cannot be used interchangeably for the assessment of LV long-axis contraction.	[Peverill, Roger E.] Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Clayton, Vic, Australia; Monash Univ, Dept Med, Sch Clin Sci, Monash Med Ctr, Clayton, Vic, Australia; Monash Hlth, Clayton, Vic, Australia	Monash University; Monash University	Peverill, RE (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Clayton, Vic, Australia.	roger.peverill@monash.edu		Peverill, Roger/0000-0002-3319-5356				ALAM M, 1990, J INTERN MED, V228, P569, DOI 10.1111/j.1365-2796.1990.tb00281.x; Alam M, 2003, J AM SOC ECHOCARDIOG, V16, P240, DOI 10.1067/mje.2003.52; Alam M, 1999, J AM SOC ECHOCARDIOG, V12, P618, DOI 10.1053/je.1999.v12.a99246; Arce OX, 2002, J AM SOC ECHOCARDIOG, V15, P906, DOI 10.1067/mje.2002.121436; AROESTY JM, 1985, CIRCULATION, V71, P889, DOI 10.1161/01.CIR.71.5.889; BONAA KH, 1992, CIRCULATION, V86, P394; BOUDOULAS H, 1990, EUR HEART J, V11, P93, DOI 10.1093/eurheartj/11.suppl_I.93; BOUDOULAS H, 1981, CHEST, V80, P613, DOI 10.1378/chest.80.5.613; Bowditch HP., 1871, VERH K SACHS GES WIS, V23, P652; Bruch C, 2003, J AM SOC ECHOCARDIOG, V16, P1031, DOI 10.1016/S0894-7317(03)00634-5; Burns AT, 2007, ECHOCARDIOGR-J CARD, V24, P697, DOI 10.1111/j.1540-8175.2007.00466.x; Cacciapuoti F, 2009, AGING CLIN EXP RES, V21, P22; CAILLET D, 1982, CARDIOVASC RES, V16, P107, DOI 10.1093/cvr/16.2.107; Cain P, 2002, AM J CARDIOL, V89, P1347, DOI 10.1016/S0002-9149(02)02345-7; Carlsson M, 2007, AM J PHYSIOL-HEART C, V292, pH1452, DOI 10.1152/ajpheart.01148.2006; Chahal NS, 2010, EUR J ECHOCARDIOGR, V11, P51, DOI 10.1093/ejechocard/jep164; Cheng K, 2012, J HYPERTENS, V30, P2395, DOI 10.1097/HJH.0b013e328358bee2; Crendal E, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-95; Cui W, 2008, J AM SOC ECHOCARDIOG, V21, P361, DOI 10.1016/j.echo.2007.05.034; Custodis F, 2013, J CARDIOL, V62, P183, DOI 10.1016/j.jjcc.2013.02.018; Dalen H, 2010, CIRC-CARDIOVASC IMAG, V3, P614, DOI 10.1161/CIRCIMAGING.109.926022; DEMARIA AN, 1979, AM J CARDIOL, V43, P1, DOI 10.1016/0002-9149(79)90036-5; Dewey FE, 2008, CIRCULATION, V117, P2279, DOI 10.1161/CIRCULATIONAHA.107.736785; FELDMAN MD, 1988, J CLIN INVEST, V82, P1661, DOI 10.1172/JCI113778; FREEMAN GL, 1987, CIRC RES, V61, P455, DOI 10.1161/01.RES.61.3.455; Gibson DG, 2003, HEART, V89, P231, DOI 10.1136/heart.89.2.231; GLICK G, 1965, J CLIN INVEST, V44, P978, DOI 10.1172/JCI105215; Gulati VK, 1996, AM J CARDIOL, V77, P979, DOI 10.1016/S0002-9149(96)00033-1; Henein M, 2002, EUR HEART J, V23, P162, DOI 10.1053/euhj.2001.3032; Henein MY, 1999, HEART, V81, P111, DOI 10.1136/hrt.81.2.111; Henein MY, 1999, HEART, V81, P229, DOI 10.1136/hrt.81.3.229; HIGGINS CB, 1973, J CLIN INVEST, V52, P1187, DOI 10.1172/JCI107285; Innelli P, 2008, EUR J ECHOCARDIOGR, V9, P241, DOI 10.1016/j.euje.2007.03.04; Isaaz K, 1993, J Am Soc Echocardiogr, V6, P166; Janssen PML, 2007, J MOL CELL CARDIOL, V43, P523, DOI 10.1016/j.yjmcc.2007.08.012; Jasaityte R, 2014, ULTRASOUND MED BIOL, V40, P37, DOI 10.1016/j.ultrasmedbio.2013.09.005; Kraigher-Krainer E, 2014, J AM COLL CARDIOL, V63, P447, DOI 10.1016/j.jacc.2013.09.052; Kukulski T, 2000, J AM SOC ECHOCARDIOG, V13, P194, DOI 10.1067/mje.2000.103106; Lee KS, 2007, J AM SOC ECHOCARDIOG, V20, P773, DOI 10.1016/j.echo.2007.03.002; Matos J, 2012, J AM SOC ECHOCARDIOG, V25, P969, DOI 10.1016/j.echo.2012.06.011; Mogelvang R, 2009, CIRCULATION, V119, P2679, DOI 10.1161/CIRCULATIONAHA.108.793471; Mottram PM, 2011, J AM SOC ECHOCARDIOG, V24, P782, DOI 10.1016/j.echo.2011.04.004; MULIERI LA, 1992, CIRCULATION, V85, P1743, DOI 10.1161/01.CIR.85.5.1743; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Nagueh SF, 2004, CLIN SCI, V106, P147, DOI 10.1042/CS20030204; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nikitin NP, 2006, HEART, V92, P775, DOI 10.1136/hrt.2005.067140; Nikitin NP, 2005, AGE AGEING, V34, P343, DOI 10.1093/ageing/afi043; Nilsson B, 2000, CLIN PHYSIOL, V20, P272; Oki T, 1999, J AM SOC ECHOCARDIOG, V12, P308, DOI 10.1016/S0894-7317(99)70051-9; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; PAI RG, 1991, AM J CARDIOL, V67, P222, DOI 10.1016/0002-9149(91)90453-R; Pasquet A, 1999, AM HEART J, V138, P753, DOI 10.1016/S0002-8703(99)70192-4; Pela G, 2004, J AM SOC ECHOCARDIOG, V17, P205, DOI 10.1016/j.echo.2003.12.004; Peterson LR, 2004, J AM COLL CARDIOL, V43, P1399, DOI 10.1016/j.jacc.2003.10.062; Petrie MC, 2002, HEART, V87, P29, DOI 10.1136/heart.87.1.29; Peverill RE, 2004, J AM SOC ECHOCARDIOG, V17, P1146, DOI 10.1016/j.echo.2004.06.007; Ross J, 1998, BASIC RES CARDIOL, V93, P95; ROSS J, 1995, CIRCULATION, V92, P2327, DOI 10.1161/01.CIR.92.8.2327; ROSS J, 1965, CIRCULATION, V32, P549, DOI 10.1161/01.CIR.32.4.549; Rossman EI, 2004, J MOL CELL CARDIOL, V36, P33, DOI 10.1016/j.yjmcc.2003.09.001; Ruan QY, 2006, AM J CARDIOL, V97, P872, DOI 10.1016/j.amjcard.2005.10.024; Ruan QY, 2005, EXP PHYSIOL, V90, P527, DOI 10.1113/expphysiol.2005.030007; Simonson J S, 1989, J Am Soc Echocardiogr, V2, P25; Smulyan H, 1998, J AM COLL CARDIOL, V31, P1103, DOI 10.1016/S0735-1097(98)00056-4; SONNENBLICK EH, 1965, J CLIN INVEST, V44, P2051, DOI 10.1172/JCI105312; SONNENBLICK EH, 1965, J CLIN INVEST, V44, P966, DOI 10.1172/JCI105214; SONNENBLICK EH, 1966, CIRCULATION, V33, P945, DOI 10.1161/01.CIR.33.6.945; Svealv BG, 2006, EUR J ECHOCARDIOGR, V7, P298, DOI 10.1016/j.euje.2005.06.008; TAMIYA K, 1979, AM J PHYSIOL, V237, pH83, DOI 10.1152/ajpheart.1979.237.1.H83; Thorstensen A, 2011, EUR J ECHOCARDIOGR, V12, P924, DOI 10.1093/ejechocard/jer178; Tighe DA, 2003, AM J CARDIOL, V91, P254, DOI 10.1016/S0002-9149(02)03122-3; VATNER SF, 1974, CIRCULATION, V50, P728, DOI 10.1161/01.CIR.50.4.728; Vinereanu D, 2005, EUR J HEART FAIL, V7, P820, DOI 10.1016/j.ejheart.2005.02.003; Vinereanu D, 2002, ECHOCARDIOGR-J CARD, V19, P177, DOI 10.1046/j.1540-8175.2002.00177.x; Wang M, 2005, J AM COLL CARDIOL, V45, P272, DOI 10.1016/j.jacc.2004.09.059; Wang M, 2005, J HYPERTENS, V23, P183, DOI 10.1097/00004872-200501000-00029; Wang M, 2003, J AM COLL CARDIOL, V41, P820, DOI 10.1016/S0735-1097(02)02921-2; WEISSLER AM, 1961, AM HEART J, V62, P367, DOI 10.1016/0002-8703(61)90403-3; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Yamakado T, 1998, AM HEART J, V135, P584, DOI 10.1016/S0002-8703(98)70271-6; Yip GW, 2002, CLIN SCI, V102, P515, DOI 10.1042/CS20010196; Yu CM, 2007, J AM COLL CARDIOL, V49, P1903, DOI 10.1016/j.jacc.2007.01.078; Yu CM, 2002, CIRCULATION, V105, P1195, DOI 10.1161/hc1002.105185; Yu CM, 2003, ECHOCARDIOGR-J CARD, V20, P19, DOI 10.1046/j.1540-8175.2003.00003.x	85	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173383	10.1371/journal.pone.0173383	http://dx.doi.org/10.1371/journal.pone.0173383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288162	gold, Green Submitted, Green Published			2022-12-26	WOS:000396092400014
J	Bell, SM; Wendt, DJ; Zhang, YH; Taylor, TW; Long, SN; Tsuruda, L; Zhao, B; Laipis, P; Fitzpatrick, PA				Bell, Sean M.; Wendt, Dan J.; Zhang, Yanhong; Taylor, Timothy W.; Long, Shinong; Tsuruda, Laurie; Zhao, Bin; Laipis, Phillip; Fitzpatrick, Paul A.			Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL; ENZYME-REACTORS; MANAGEMENT; CLEARANCE; FORMS	Phenylketonuria (PKU) is a genetic metabolic disease in which the decrease or loss of phenylalanine hydroxylase (PAH) activity results in elevated, neurotoxic levels of phenylalanine (Phe). Due to many obstacles, PAH enzyme replacement therapy is not currently an option. Treatment of PKU with an alternative enzyme, phenylalanine ammonia lyase (PAL), was first proposed in the 1970s. However, issues regarding immunogenicity, enzyme production and mode of delivery needed to be overcome. Through the evaluation of PAL enzymes from multiple species, three potential PAL enzymes from yeast and cyanobacteria were chosen for evaluation of their therapeutic potential. The addition of polyethylene glycol (PEG, MW=20,000), at a particular ratio to modify the protein surface, attenuated immunogenicity in an animal model of PKU. All three PEGylated PAL candidates showed efficacy in a mouse model of PKU (BTBR Pah(enu2)) upon subcutaneous injection. However, only PEGylated Anabaena variabilis (Av) PAL-treated mice demonstrated sustained low Phe levels with weekly injection and was the only PAL evaluated that maintained full enzymatic activity upon PEGylation. A PEGylated recombinant double mutant version of AvPAL (Cys503Ser/Cys565Ser), rAvPAL-PEG, was selected for drug development based on its positive pharmacodynamic profile and favorable expression titers. PEGylation was shown to be critical for rAvPAL-PEG efficacy as under PEGylated rAvPAL had a lower pharmacodynamic effect. rAvPAL and rAvPAL-PEG had poor stability at 4 degrees C. L-Phe and trans-cinnamate were identified as activity stabilizing excipients. rAvPAL-PEG is currently in Phase 3 clinical trials to assess efficacy in PKU patients.	[Bell, Sean M.; Wendt, Dan J.; Zhang, Yanhong; Taylor, Timothy W.; Long, Shinong; Tsuruda, Laurie; Zhao, Bin; Fitzpatrick, Paul A.] BioMarin Pharmaceut, Novato, CA USA; [Laipis, Phillip] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Zhao, Bin] BioZ Consulting, San Ramon, CA USA	BioMarin Pharmaceutical Inc.; State University System of Florida; University of Florida	Bell, SM (corresponding author), BioMarin Pharmaceut, Novato, CA USA.	sbell@bmrn.com			BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.	This study was funded by BioMarin Pharmaceutical Inc. the employer of all the authors except Phillip Laipis.	ABELL CW, 1972, CANCER RES, V32, P285; Alunni S, 2003, ARCH BIOCHEM BIOPHYS, V412, P170, DOI 10.1016/S0003-9861(03)00007-9; AMBRUS CM, 1983, J PHARMACOL EXP THER, V224, P598; AMBRUS CM, 1978, SCIENCE, V201, P837, DOI 10.1126/science.567372; [Anonymous], 2001, METABOLIC MOL BASES, DOI DOI 10.1036/OMMBID.97; Belanger-Quintana A, 2011, MOL GENET METAB, V104, pS19, DOI 10.1016/j.ymgme.2011.08.009; Blau N, 2013, EXPERT OPIN DRUG MET, V9, P1207, DOI 10.1517/17425255.2013.804064; Blau N, 2009, MOL GENET METAB, V96, P158, DOI 10.1016/j.ymgme.2009.01.002; BOURGET L, 1989, BIOMATER ARTIF CELL, V17, P161, DOI 10.3109/10731198909118278; Bowersox J, 2001, PEDIATRICS, V108, P972; Calabrese JC, 2004, BIOCHEMISTRY-US, V43, P11403, DOI 10.1021/bi049053+; Cui JD, 2014, CRIT REV BIOTECHNOL, V34, P258, DOI 10.3109/07388551.2013.791660; Fisch RO, 2000, EUR J PEDIATR, V159, pS142, DOI 10.1007/PL00014378; Gamez A, 2005, MOL THER, V11, P986, DOI 10.1016/j.ymthe.2005.02.013; Gamez A, 2004, MOL THER, V9, P124, DOI 10.1016/j.ymthe.2003.11.002; Gamez A, 2007, MOL GENET METAB, V91, P325, DOI 10.1016/j.ymgme.2007.04.015; HOSKINS JA, 1982, RES COMMUN CHEM PATH, V35, P275; HOSKINS JA, 1980, LANCET, V1, P392; Ikeda K, 2005, AMINO ACIDS, V29, P283, DOI 10.1007/s00726-005-0218-5; INOUE S, 1986, BIOCHEM BIOPH RES CO, V141, P165, DOI 10.1016/S0006-291X(86)80349-7; Jingzhong L, 1998, Chin J Biotechnol, V14, P227; Kim W, 2004, MOL THER, V10, P220, DOI 10.1016/j.ymthe.2004.05.001; Longo N, 2014, LANCET; Martynyuk AE, 2007, EPILEPSIA, V48, P1143, DOI 10.1111/j.1528-1167.2007.01115.x; Mima Y, 2015, MOL PHARMACEUT, V12, P2429, DOI 10.1021/acs.molpharmaceut.5b00144; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; Moffitt MC, 2007, BIOCHEMISTRY-US, V46, P1004, DOI 10.1021/bi061774g; Poppe L, 2005, ANGEW CHEM INT EDIT, V44, P3668, DOI 10.1002/anie.200461377; Rauk AP, 2014, J PHARM SCI-US, V103, P2278, DOI 10.1002/jps.24063; ROBERTS J, 1976, CANCER TREAT REP, V60, P261; Sarkissian CN, 2008, P NATL ACAD SCI USA, V105, P20894, DOI 10.1073/pnas.0808421105; Sarkissian CN, 1999, P NATL ACAD SCI USA, V96, P2339, DOI 10.1073/pnas.96.5.2339; SCHULZ W, 1989, FEBS LETT, V258, P335, DOI 10.1016/0014-5793(89)81687-4; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; SHEN RS, 1979, CANCER TREAT REP, V63, P1063; SHEN RS, 1977, CANCER RES, V37, P1051; Walter JH, 2002, LANCET, V360, P55, DOI 10.1016/S0140-6736(02)09334-0; Wang L, 2005, MOL GENET METAB, V86, P134, DOI 10.1016/j.ymgme.2005.05.012; Wang L, 2008, J MOL BIOL, V380, P623, DOI 10.1016/j.jmb.2008.05.025; WIEDER KJ, 1979, J BIOL CHEM, V254, P2579; Yang Q, 2015, WIRES NANOMED NANOBI, V7, P655, DOI 10.1002/wnan.1339; ZUCKER M, 1969, PLANT PHYSIOL, V44, P912, DOI 10.1104/pp.44.6.912; Zurfluh MR, 2008, HUM MUTAT, V29, P167, DOI 10.1002/humu.20637	43	42	45	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173269	10.1371/journal.pone.0173269	http://dx.doi.org/10.1371/journal.pone.0173269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282402	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800026
J	Peter, M; Glatz, A; Gudmann, P; Gombos, I; Torok, Z; Horvath, I; Vigh, L; Balogh, G				Peter, Maria; Glatz, Attila; Gudmann, Peter; Gombos, Imre; Toeroek, Zsolt; Horvath, Ibolya; Vigh, Laszlo; Balogh, Gaabor			Metabolic crosstalk between membrane and storage lipids facilitates heat stress management in Schizosaccharomyces pombe	PLOS ONE			English	Article							PROTEIN-KINASE-C; MESSENGER-RNA TRANSLATION; FISSION YEAST; TRIACYLGLYCEROL-METABOLISM; TEMPERATURE ADAPTATION; PHYSICAL STATE; DROPLETS; CELLS; SHOCK; CERAMIDE	Cell membranes actively participate in stress sensing and signalling. Here we present the first in-depth lipidomic analysis to characterize alterations in the fission yeast Schizosaccharomyces pombe in response to mild heat stress (HS). The lipidome was assessed by a simple one-step methanolic extraction. Genetic manipulations that altered triglyceride (TG) content in the absence or presence of HS gave rise to distinct lipidomic fingerprints for S. pombe. Cells unable to produce TG demonstrated long-lasting growth arrest and enhanced signalling lipid generation. Our results reveal that metabolic crosstalk between membrane and storage lipids facilitates homeostatic maintenance of the membrane physical/chemical state that resists negative effects on cell growth and viability in response to HS. We propose a novel stress adaptation mechanism in which heat-induced TG synthesis contributes to membrane rigidization by accommodating unsaturated fatty acids of structural lipids, enabling their replacement by newly synthesized saturated fatty acids.	[Peter, Maria; Glatz, Attila; Gudmann, Peter; Gombos, Imre; Toeroek, Zsolt; Horvath, Ibolya; Vigh, Laszlo; Balogh, Gaabor] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Balogh, G (corresponding author), Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary.	balogh.gabor@brc.mta.hu	Balogh, Gábor/AIC-8192-2022	Balogh, Gábor/0000-0002-4565-6850	Hungarian Basic Research Fund [OTKA ANN112372, OTKA NN111006]; Hungarian National Development Agency [TAMOP-4.2.4.N2-11/1-2012-0001]; Ministry for National Economy [GINOP-2.3.2-15-2016-00001, GINOP-2.3.2-15-2016-00006, GINOP-2.2.1-152016-00007]	Hungarian Basic Research Fund; Hungarian National Development Agency; Ministry for National Economy	This work was supported by the Hungarian Basic Research Fund (OTKA ANN112372 and OTKA NN111006), by the Hungarian National Development Agency (TAMOP-4.2.4.N2-11/1-2012-0001), and by the Ministry for National Economy (GINOP-2.3.2-15-2016-00001, GINOP-2.3.2-15-2016-00006 and GINOP-2.2.1-152016-00007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen A, 2017, CURR OPIN BIOTECH, V43, P96, DOI 10.1016/j.copbio.2016.10.003; Antal O, 2015, BBA-MOL CELL BIOL L, V1851, P1271, DOI 10.1016/j.bbalip.2015.06.003; Balogh G, 2005, FEBS J, V272, P6077, DOI 10.1111/j.1742-4658.2005.04999.x; Balogh G, 2013, FEBS LETT, V587, P1970, DOI 10.1016/j.febslet.2013.05.016; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Covino R, 2016, MOL CELL, V63, P49, DOI 10.1016/j.molcel.2016.05.015; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; De Smet CH, 2013, BBA-MOL CELL BIOL L, V1831, P1167, DOI 10.1016/j.bbalip.2013.03.002; Du ZY, 2016, SUBCELL BIOCHEM, V86, P179, DOI 10.1007/978-3-319-25979-6_8; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Elbein AD, 2003, GLYCOBIOLOGY, V13, P17; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Forsburg Susan L, 2003, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1317s64; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Glatz A, 2016, CELL STRESS CHAPERON, V21, P327, DOI 10.1007/s12192-015-0662-4; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guan XL, 2010, METHOD ENZYMOL, V470, P369, DOI 10.1016/S0076-6879(10)70015-X; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; He Y, 2014, MOL BIOL CELL, V25, P4083, DOI 10.1091/mbc.E14-03-0832; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; HORVATH I, 1986, CHEM PHYS LIPIDS, V39, P251, DOI 10.1016/0009-3084(86)90014-9; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Horvath I, 2012, PROG LIPID RES, V51, P208, DOI 10.1016/j.plipres.2012.02.002; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Kheirolomoom A, 2005, CRYOBIOLOGY, V51, P290, DOI 10.1016/j.cryobiol.2005.08.003; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Kucsera J, 2000, J MICROBIOL METH, V41, P19, DOI 10.1016/S0167-7012(00)00136-6; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Low CP, 2005, FEMS YEAST RES, V5, P1199, DOI 10.1016/j.femsyr.2005.07.004; Madeira JB, 2015, MOL CELL BIOL, V35, P737, DOI 10.1128/MCB.01314-14; Makarova M, 2016, CURR BIOL, V26, P237, DOI 10.1016/j.cub.2015.11.061; Markgraf DF, 2014, CELL REP, V6, P44, DOI 10.1016/j.celrep.2013.11.046; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; Niki H, 2014, YEAST, V31, P83, DOI 10.1002/yea.2996; Nkeze J, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0037-7; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; PAINTING K, 1990, WORLD J MICROB BIOT, V6, P346, DOI 10.1007/BF01201311; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Rabhi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148640; Radulovic M, 2013, CURR GENET, V59, P231, DOI 10.1007/s00294-013-0407-9; Renne Mike F, 2015, Lipid Insights, V8, P33, DOI 10.4137/LPI.S31780; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; SILVIUS JR, 1980, P NATL ACAD SCI-BIOL, V77, P1255, DOI 10.1073/pnas.77.3.1255; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SINERIZ F, 1973, J BACTERIOL, V115, P723; Soto T, 2007, MICROBIOL-SGM, V153, P1519, DOI 10.1099/mic.0.2006/004283-0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; SUUTARI M, 1990, J GEN MICROBIOL, V136, P1469, DOI 10.1099/00221287-136-8-1469; Tarasov K, 2014, MOL BIOSYST, V10, P1364, DOI 10.1039/c3mb70599d; Torok Z, 2014, BBA-BIOMEMBRANES, V1838, P1594, DOI 10.1016/j.bbamem.2013.12.015; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Wang JX, 2004, BRIT J PHARMACOL, V141, P586, DOI 10.1038/sj.bjp.0705646; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yang PL, 2016, MOL BIOL CELL, V27, P2368, DOI 10.1091/mbc.E16-02-0106; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200	94	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173739	10.1371/journal.pone.0173739	http://dx.doi.org/10.1371/journal.pone.0173739			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282432	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800076
J	Sidana, S; Narkhede, M; Elson, P; Hastings, D; Faiman, B; Valent, J; Samaras, C; Hamilton, K; Liu, HK; Smith, MR; Reu, FJ				Sidana, Surbhi; Narkhede, Mayur; Elson, Paul; Hastings, Debbie; Faiman, Beth; Valent, Jason; Samaras, Christy; Hamilton, Kimberly; Liu, Hien K.; Smith, Mitchell R.; Reu, Frederic J.			Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis	PLOS ONE			English	Article							ORAL PROTEASOME INHIBITOR; RANDOMIZED PHASE-III; PERIPHERAL NEUROPATHY; INTRAVENOUS BORTEZOMIB; DEXAMETHASONE; LENALIDOMIDE; COMBINATION; IXAZOMIB; SAFETY; CRITERIA	Introduction Randomized studies have shown that bortezomib (BTZ) can be given weekly via intravenous (IV) route or twice weekly via subcutaneous (SC) route with lower neuropathy risk and no loss of anti-myeloma efficacy compared to original standard IV twice weekly schedule. Weekly SC should therefore yield the best therapeutic index and is widely used but has not been compared to established administration schedules in the context of a clinical trial. Methods Comprehensive electronic medical record review was done for disease control and neuropathy symptoms of 344 consecutive patients who received their first BTZ-containing regimen for myeloma or AL amyloidosis before or after we changed to SC weekly in December 2010. Univariate and multivariable analyses were carried out that adjusted for age, underlying disease, concurrently used anticancer agents, underlying conditions predisposing to neuropathy, and number of prior regimens compared SC weekly to other schedules. Results Fifty-three patients received BTZ SC weekly, 17 SC twice weekly, 127 IV weekly and 147 IV twice weekly. Risk for neuropathy of any grade was higher with other schedules compared to SC weekly (44.3% vs. 26.9%, p = 0.001) while response rate was similar (72.1% vs. 76.6%, respectively, p = 0.15). Multivariable analyses upheld higher neuropathy risk (Odds ratio 2.45, 95% CI 1.26-4.76, p = 0.008) while the likelihood of not achieving a response (= partial response or better) was comparable (Odds ratio 1.25, 95% CI 0.58-2.71, p = 0.56) for other schedules compared to SC weekly, respectively. Lower neuropathy risk translated into longer treatment duration when BTZ was started SC weekly (p = 0.001). Conclusions Weekly SC BTZ has activity comparable to other schedules and causes low rates of neuropathy.	[Sidana, Surbhi; Narkhede, Mayur] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Hastings, Debbie] Cleveland Clin, Dept Canc Ctr Res, Cleveland, OH 44106 USA; [Faiman, Beth; Valent, Jason; Samaras, Christy; Hamilton, Kimberly; Liu, Hien K.; Smith, Mitchell R.; Reu, Frederic J.] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44106 USA; [Sidana, Surbhi] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA; [Narkhede, Mayur] Georgetown Univ, Dept Hematol & Med Oncol, Washington, DC USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Mayo Clinic; Georgetown University	Reu, FJ (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44106 USA.	reuf@ccf.org		Sidana, Surbhi/0000-0003-3288-7614; Reu, Frederic/0000-0003-1160-8030				Argyriou AA, 2014, ARCH TOXICOL, V88, P1669, DOI 10.1007/s00204-014-1316-5; Arnulf B, 2012, HAEMATOL-HEMATOL J, V97, P1925, DOI 10.3324/haematol.2012.067793; Barbee MS, 2013, ANN PHARMACOTHER, V47, P1136, DOI 10.1177/1060028013503122; Bringhen S, 2010, BLOOD, V116, P4745, DOI 10.1182/blood-2010-07-294983; Broyl A, 2012, SEMIN HEMATOL, V49, P249, DOI 10.1053/j.seminhematol.2012.04.001; Burnette BL, 2013, CANCER-AM CANCER SOC, V119, P4308, DOI 10.1002/cncr.28340; Dispenzieri A, 2005, BEST PRACT RES CL HA, V18, P673, DOI 10.1016/j.beha.2005.01.024; Harousseau JL, 2006, HAEMATOLOGICA, V91, P1498; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jagannath S, 2005, BRIT J HAEMATOL, V129, P776, DOI 10.1111/j.1365-2141.2005.05540.x; Jakubowiak AJ, 2012, BLOOD, V120, P1801, DOI 10.1182/blood-2012-04-422683; Kastritis E, 2010, J CLIN ONCOL, V28, P1031, DOI 10.1200/JCO.2009.23.8220; Kumar SK, 2014, LANCET ONCOL, V15, P1503, DOI 10.1016/S1470-2045(14)71125-8; Kumar SK, 2014, BLOOD, V124, P1047, DOI 10.1182/blood-2014-01-548941; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Landowski TH, 2005, CANCER RES, V65, P3828, DOI 10.1158/0008-5472.CAN-04-3684; Merlini G, 2011, J CLIN ONCOL, V29, P1924, DOI 10.1200/JCO.2010.32.2271; Minarik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123866; Moreau P, 2016, NEW ENGL J MED, V374, P1621, DOI 10.1056/NEJMoa1516282; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; National Comprehensive Cancer Network (NCCN), 2015, NCCN CLIN PRACT GUID; (NCCN) NCCN, 2016, NCCN CLIN PRACT GUID; Palladini G, 2012, J CLIN ONCOL, V30, P4541, DOI 10.1200/JCO.2011.37.7614; Poruchynsky MS, 2008, CELL CYCLE, V7, P940, DOI 10.4161/cc.7.7.5625; Reece DE, 2011, BLOOD, V118, P865, DOI 10.1182/blood-2011-02-334227; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; Richardson PG, 2009, J CLIN ONCOL, V27, P3518, DOI 10.1200/JCO.2008.18.3087; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Straka C V M, 2015, J CLIN ONCOL; Takamatsu Y, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.5382.5382; Wang Liang, 2015, Asian Pac J Cancer Prev, V16, P2093	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172996	10.1371/journal.pone.0172996	http://dx.doi.org/10.1371/journal.pone.0172996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278302	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900134
J	Sharma, AK; Birrane, G; Anklin, C; Rigby, AC; Alper, SL				Sharma, Alok K.; Birrane, Gabriel; Anklin, Clemens; Rigby, Alan C.; Alper, Seth L.			NMR insight into myosin-binding subunit coiled-coil structure reveals binding interface with protein kinase G-I alpha leucine zipper in vascular function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; SMOOTH-MUSCLE RELAXATION; BACKBONE DYNAMICS; PKGI-ALPHA; SPECTROSCOPY; DOMAINS; ELECTROSTATICS; ASSIGNMENT; ISOFORMS; PIPELINE	Nitrovasodilators relax vascular smooth-muscle cells in part by modulating the interaction of the C-terminal coiled-coil domain (CC) and/or the leucine zipper (LZ) domain of the myosin light-chain phosphatase component, myosin-binding subunit (MBS), with the N-terminal LZ domain of protein kinase G (PKG)-I alpha. Despite the importance of vasodilation in cardiovascular homeostasis and therapy, our structural understanding of the MBS CC interaction with LZ PKG-1 alpha has remained limited. Here, we report the 3D NMR solution structure of homodimeric CC MBS in which amino acids 932-967 form a coiled-coil of two monomeric alpha-helices in parallel orientation. We found that the structure is stabilized by non-covalent interactions, with dominant contributions from hydrophobic residues at a and d heptad positions. Using NMR chemical-shift perturbation (CSP) analysis, we identified a subset of hydrophobic and charged residues of CC MBS (localized within and adjacent to the C-terminal region) contributing to the dimer-dimer interaction interface between homodimeric CC MBS and homodimeric LZ PKG-I alpha. N-15 backbone relaxation NMR revealed the dynamic features of the CC MBS interface residues identified by NMR CSP. Paramagnetic relaxation enhancement-and CSP-NMR-guided HADDOCK modeling of the dimer-dimer interface of the heterotetrameric complex exhibits the involvement of non-covalent intermolecular interactions that are localized within and adjacent to the C-terminal regions of each homodimer. These results deepen our understanding of the binding restraints of this CC MBS.LZ PKG-I alpha low-affinity heterotetrameric complex and allow reevaluation of the role(s) of myosin light-chain phosphatase partner polypeptides in regulation of vascular smooth-muscle cell contractility.	[Sharma, Alok K.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Sharma, Alok K.; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Ctr Vasc Biol Res, Boston, MA 02215 USA; [Birrane, Gabriel] Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA; [Birrane, Gabriel; Alper, Seth L.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA; [Anklin, Clemens] Bruker Biospin Corp, Billerica, MA 01821 USA; [Rigby, Alan C.] Warp Drive Bio Inc, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Bruker Corporation; Bruker BioSpin GmbH	Sharma, AK (corresponding author), Beth Israel Deaconess Med Ctr, 99 Brookline Ave,RN386, Boston, MA 02215 USA.; Alper, SL (corresponding author), Beth Israel Deaconess Med Ctr, 99 Brookline Ave,RN380F, Boston, MA 02215 USA.	aksharma@bidmc.harvard.edu; salper@bidmc.harvard.edu	Anklin, Clemens/P-6469-2019	Anklin, Clemens/0000-0002-3421-8951; Birrane, Gabriel/0000-0002-1759-5499	Atorvastatin research award	Atorvastatin research award	This work was supported by an Atorvastatin research award (to A. C. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Bermel W, 2005, ANGEW CHEM INT EDIT, V44, P3089, DOI 10.1002/anie.200461794; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Butler T, 2013, AM J PHYSIOL-CELL PH, V304, pC485, DOI 10.1152/ajpcell.00161.2012; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo YR, 2015, J BIOL CHEM, V290, P7707, DOI 10.1074/jbc.M114.632786; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Hubbard S. J., 1993, NACCESS; IKEBE M, 1985, EXPERIENTIA, V41, P1006, DOI 10.1007/BF01952122; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mackay JP, 1996, BIOCHEMISTRY-US, V35, P4867, DOI 10.1021/bi952761y; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Rathinavelan T, 2011, J BIOL CHEM, V286, P4922, DOI 10.1074/jbc.M110.159434; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Sharma AK, 2008, J BIOL CHEM, V283, P32860, DOI 10.1074/jbc.M804916200; Sharma AK, 2014, PROTEIN PEPTIDE LETT, V21, P639, DOI 10.2174/0929866521666140328112426; Sharma AK, 2012, PROTEIN EXPRES PURIF, V81, P126, DOI 10.1016/j.pep.2011.09.013; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Takahashi N, 1997, GENOMICS, V44, P150, DOI 10.1006/geno.1997.4859; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2	57	3	3	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7052	7065		10.1074/jbc.M117.781260	http://dx.doi.org/10.1074/jbc.M117.781260			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28280239	hybrid, Green Published			2022-12-26	WOS:000400478300016
J	Glinton, K; Beck, J; Liang, Z; Qiu, CJ; Lee, SW; Ploplis, VA; Castellino, FJ				Glinton, Kristofor; Beck, Julia; Liang, Zhong; Qiu, Cunjia; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.			Variable region in streptococcal M-proteins provides stable binding with host fibrinogen for plasminogen-mediated bacterial invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; GENOME SEQUENCE; MOLECULAR-INTERACTIONS; CRYSTAL-STRUCTURE; PYOGENES; STRAIN; STREPTOKINASE; PATTERN; ACTIVATION; PHAGOCYTOSIS	Dimeric M-proteins (M-Prt) in group A Streptococcus pyogenes (GAS) are surface-expressed virulence factors implicated in processes that contribute to the pathogenicity of infection. Sequence analyses of various GAS M-Prts have shown that they contain a highly conserved sortase A-dependent cell wall-anchored C terminus, whereas the surface-exposed N terminus is highly variable, a feature used for identification and serotyping of various GAS strains. This variability also allows for strainspecific responses that suppress host defenses. Previous studies have indeed identified the N-terminal M-Prt B-domain as the site interacting with antiphagocytotic human-host fibrinogen (hFg). Herein, we show that hFg strongly interacts with M-Prts containing highly variable B-domains. We further demonstrate that specific GAS clinical isolates display high affinity for the D-domain of hFg, and this interaction allowed for subsequent surface binding of human-host plasminogen (hPg) to the E-domain of hFg. This GAS surface-bound hPg is then activated by GAS-secreted streptokinase, leading to the generation of an invasive proteolytic bacterial surface. Our results underscore the importance of the human fibrinolytic system in host-pathogen interactions in invasive GAS infections.	[Glinton, Kristofor; Beck, Julia; Liang, Zhong; Qiu, Cunjia; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Glinton, Kristofor; Beck, Julia; Qiu, Cunjia; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.; Castellino, FJ (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	fcastell@nd.edu		Glinton, Kristofor/0000-0001-9301-7132	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013423, R01HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL013423. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrahari G, 2016, J BIOL CHEM, V291, P9181, DOI 10.1074/jbc.M115.704221; Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; Bao YJ, 2016, J BACTERIOL, V198, P1712, DOI 10.1128/JB.01019-15; Bao YJ, 2014, J BACTERIOL, V196, P4089, DOI 10.1128/JB.02131-14; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; BERGE A, 1993, J BIOL CHEM, V268, P25417; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bhattacharya S, 2014, J BIOL CHEM, V289, P21684, DOI 10.1074/jbc.M114.570218; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chandrahas V, 2015, J BIOL CHEM, V290, P18833, DOI 10.1074/jbc.M115.655365; Cole Jason N., 2008, V425, P295, DOI 10.1007/978-1-60327-210-0_24; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Figuera-Losada M, 2010, BBA-PROTEINS PROTEOM, V1804, P1342, DOI 10.1016/j.bbapap.2010.01.019; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Flores AR, 2013, INFECT IMMUN, V81, P4128, DOI 10.1128/IAI.00405-13; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hess JL, 2006, PROTEOMICS, V6, P375, DOI 10.1002/pmic.200500189; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Johnson DR, 2006, J MED MICROBIOL, V55, P157, DOI 10.1099/jmm.0.46224-0; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Lannergard J, 2015, MICROBIOLOGYOPEN, V4, P774, DOI 10.1002/mbo3.278; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Lijnen HR, 2000, FIBRINOLYSIS PROTEOL, V14, P175, DOI 10.1054/fipr.2000.0065; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Pahlman LI, 2008, CELL MICROBIOL, V10, P404, DOI 10.1111/j.1462-5822.2007.01053.x; Pietrocola G, 2016, J BIOL CHEM, V291, P18148, DOI 10.1074/jbc.M116.731125; Port GC, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00725-15; Ringdahl U, 2000, METHODS, V21, P143, DOI 10.1006/meth.2000.0985; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; STRICKLAND DK, 1982, BIOCHEMISTRY-US, V21, P721, DOI 10.1021/bi00533a021; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Waldemarsson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007279; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 1999, FEBS LETT, V459, P85, DOI 10.1016/S0014-5793(99)01214-4; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Zhang Y, 2013, J MATER CHEM B, V1, P132, DOI 10.1039/c2tb00071g; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	57	11	13	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6775	6785		10.1074/jbc.M116.768937	http://dx.doi.org/10.1074/jbc.M116.768937			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28280245	hybrid, Green Published			2022-12-26	WOS:000399813400028
J	Eastburn, DJ; O'Geen, AT; Tate, KW; Roche, LM				Eastburn, Danny J.; O'Geen, Anthony T.; Tate, Kenneth W.; Roche, Leslie M.			Multiple ecosystem services in a working landscape	PLOS ONE			English	Article							RANGELANDS; MANAGEMENT; CALIFORNIA; MODELS	Policy makers and practitioners are in need of useful tools and models for assessing ecosystem service outcomes and the potential risks and opportunities of ecosystem management options. We utilize a state-and-transition model framework integrating dynamic soil and vegetation properties to examine multiple ecosystem services specifically agricultural production, biodiversity and habitat, and soil health across human created vegetation states in a managed oak woodland landscape in a Mediterranean climate. We found clear tradeoffs and synergies in management outcomes. Grassland states maximized agricultural productivity at a loss of soil health, biodiversity, and other ecosystem services. Synergies existed among multiple ecosystem services in savanna and woodland states with significantly larger nutrient pools, more diversity and native plant richness, and less invasive species. This integrative approach can be adapted to a diversity of working landscapes to provide useful information for science-based ecosystem service valuations, conservation decision making, and management effectiveness assessments.	[Eastburn, Danny J.; Tate, Kenneth W.; Roche, Leslie M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [O'Geen, Anthony T.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Roche, LM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	lmroche@ucdavis.edu		Roche, Leslie/0000-0003-2954-8056	Kearney Foundation of Soil Science	Kearney Foundation of Soil Science	The Kearney Foundation of Soil Science (kearney.ucdavis.edu) provided funding for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECOLOGICAL SITE DESC; [Anonymous], 2013, MEASUREMENTS TERREST; BARTOLOME JW, 2002, CALIFORNIA GUIDELINE; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Briske D.D., 2011, CONSERVATION BENEFIT, P22; Briske DD, 2005, RANGELAND ECOL MANAG, V58, P1, DOI 10.2111/1551-5028(2005)58&lt;1:SMTARH&gt;2.0.CO;2; Brown J, 2011, RANGELAND J, V33, P99, DOI 10.1071/RJ11006; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; CDFA, 2014, CAL AGR STAT REV 201, DOI 10.1016/j.jad; Claassen R., 2011, AMBER WAVES, P9; Costech Analytical Technologies Inc, TOT C N AN US DRY CO; DiTomaso J.M., 2007, WEEDS CALIFORNIA OTH, V3488; Havstad KM, 2007, ECOL ECON, V64, P261, DOI 10.1016/j.ecolecon.2007.08.005; Holechek JL, 1989, RANGE MANAGEMENT PRI; Huntsinger L, 2010, RANGELAND ECOL MANAG, V63, P324, DOI 10.2111/08-166.1; Inc. N, NEXTENGINE DESKTOP 3; Interagency. Utilization studies and residual measurements, 1996, BLMRSST960041730 USD; Keeley JE, 2005, J VEG SCI, V16, P249, DOI 10.1111/j.1654-1103.2005.tb02362.x; Keeley JE, 2003, J BIOGEOGR, V30, P1629, DOI 10.1046/j.1365-2699.2003.00950.x; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kumar P., 2010, EC ECOSYSTEMS BIODIV; Lopez-Hoffman L., 2011, RANGELANDS, V33, P4, DOI 10.2111/1551-501x-33.5.4; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maranon T., 2009, WEB ECOLOGY, V9, P30, DOI [10.5194/we-9-30-2009, DOI 10.5194/WE-9-30-2009]; McCreary DD, 2010, CALIF AGR, V64, P63, DOI 10.3733/ca.v064n02p63; Merenlender AM, 2004, CONSERV BIOL, V18, P65, DOI 10.1111/j.1523-1739.2004.00401.x; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Pinheiro J, 2000, MIXED EFIECTS MODELS; Rabe-Hesketh S, 2009, CH CRC HANDB MOD STA, P79; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Roche LM, 2015, RANGELAND ECOL MANAG, V68, P383, DOI 10.1016/j.rama.2015.07.006; Roche LM, 2012, BIODIVERS CONSERV, V21, P2555, DOI 10.1007/s10531-012-0317-z; Rossi AM, 2008, SOIL SCI SOC AM J, V72, P1591, DOI 10.2136/sssaj2008.0072N; Rudd MA, 2014, BIOSCIENCE, V64, P219, DOI 10.1093/biosci/bit035; Rumpff L, 2011, BIOL CONSERV, V144, P1224, DOI 10.1016/j.biocon.2010.10.026; Shaw MR, 2011, CLIMATIC CHANGE, V109, P465, DOI 10.1007/s10584-011-0313-4; Twidwell D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00124.1; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492	39	25	25	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0166595	10.1371/journal.pone.019595	http://dx.doi.org/10.1371/journal.pone.019595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301475				2022-12-26	WOS:000396318300001
J	Prathikanti, S; Rivera, R; Cochran, A; Tungol, JG; Fayazmanesh, N; Weinmann, E				Prathikanti, Sudha; Rivera, Renee; Cochran, Ashly; Tungol, Jose Gabriel; Fayazmanesh, Nima; Weinmann, Eva			Treating major depression with yoga: A prospective, randomized, controlled pilot trial	PLOS ONE			English	Article							STAR-ASTERISK-D; REDUCE PRENATAL DEPRESSION; MINI-MENTAL-STATE; COGNITIVE THERAPY; HATHA YOGA; UNITED-STATES; INVENTORY-II; ANTIDEPRESSANT MEDICATION; PSYCHOMETRIC PROPERTIES; SELF-EFFICACY	Background Conventional pharmacotherapies and psychotherapies for major depression are associated with limited adherence to care and relatively low remission rates. Yoga may offer an alternative treatment option, but rigorous studies are few. This randomized controlled trial with blinded outcome assessors examined an 8-week hatha yoga intervention as mono-therapy for mild-to-moderate major depression. Methods Investigators recruited 38 adults in San Francisco meeting criteria for major depression of mild-to-moderate severity, per structured psychiatric interview and scores of 14 +/- 28 on Beck Depression Inventory-II (BDI). At screening, individuals engaged in psychotherapy, antidepressant pharmacotherapy, herbal or nutraceutical mood therapies, or mind-body practices were excluded. Participants were 68% female, with mean age 43.4 years (SD = 14.8, range = 22 +/- 72), and mean BDI score 22.4 (SD = 4.5). Twenty participants were randomized to 90-minute hatha yoga practice groups twice weekly for 8 weeks. Eighteen participants were randomized to 90-minute attention control education groups twice weekly for 8 weeks. Certified yoga instructors delivered both interventions at a university clinic. Primary outcome was depression severity, measured by BDI scores every 2 weeks from baseline to 8 weeks. Secondary outcomes were self-efficacy and self-esteem, measured by scores on the General Self-Efficacy Scale (GSES) and Rosenberg Self-Esteem Scale (RSES) at baseline and at 8 weeks. Results In intent-to-treat analysis, yoga participants exhibited significantly greater 8-week decline in BDI scores than controls (p-value = 0.034). In sub-analyses of participants completing final 8-week measures, yoga participants were more likely to achieve remission, defined per final BDI score <= 9 (p-value = 0.018). Effect size of yoga in reducing BDI scores was large, per Cohen's d = -0.96 [95% CI, -1.81 to -0.12]. Intervention groups did not differ significantly in 8-week change scores for either the GSES or RSES. Conclusion In adults with mild-to-moderate major depression, an 8-week hatha yoga intervention resulted in statistically and clinically significant reductions in depression severity.	[Prathikanti, Sudha] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA USA; [Rivera, Renee] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA USA; [Cochran, Ashly] Cornell Univ, Dept Psychiat, Weill Cornell Med, New York, NY USA; [Tungol, Jose Gabriel] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Fayazmanesh, Nima] Vet Affairs Long Beach Healthcare Syst, Dept Psychiat, Long Beach, CA USA; [Weinmann, Eva] Svastha Yoga Therapy Program, Fuss Ueber Kopf Yoga Studio, Stuttgart, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cornell University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Prathikanti, S (corresponding author), Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA USA.	sudha.prathikanti@gmail.com			Mental Insight Foundation [435299-86871-01]; Pritzker Family Foundation [556501-41743]; Mt. Zion Health Fund [P0035738]	Mental Insight Foundation; Pritzker Family Foundation; Mt. Zion Health Fund	SP obtained 3 grants: 1) Mental Insight Foundation 435299-86871-01, 2) Pritzker Family Foundation 556501-41743, and 3) Mt. Zion Health Fund P0035738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aan het Rot M, 2012, CLIN PSYCHOL REV, V32, P510, DOI 10.1016/j.cpr.2012.05.007; Alan Gelenberg, 2010, PRACTICE GUIDELINE T; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amick HR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6019; Anderzen-Carlsson A, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23033; Angst J, 1999, J CLIN PSYCHIAT S, V60, P113; Arnow BA, 2007, J AFFECT DISORDERS, V97, P197, DOI 10.1016/j.jad.2006.06.017; Atkinson C, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI DOI 10.1001/JAMA.2013.13805; Balasubramaniam Meera, 2012, Front Psychiatry, V3, P117, DOI 10.3389/fpsyt.2012.00117; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; BECK AT, 1991, AM PSYCHOL, V46, P368, DOI 10.1037/0003-066X.46.4.368; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belisario JSM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000042.pub2; Bentley SM, 2014, MED CLIN N AM, V98, P981, DOI 10.1016/j.mcna.2014.06.013; Bertisch SM, 2009, J PSYCHOSOM RES, V66, P511, DOI 10.1016/j.jpsychores.2008.12.003; Birdee GS, 2008, J GEN INTERN MED, V23, P1653, DOI 10.1007/s11606-008-0735-5; Bonura KB, 2014, J PHYS ACT HEALTH, V11, P1334, DOI 10.1123/jpah.2012-0365; Bos FM, 2015, EUR NEUROPSYCHOPHARM, V25, P1853, DOI 10.1016/j.euroneuro.2015.08.008; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Broota A, 1990, J CLIN STUD; Brown RP, 2005, J ALTERN COMPLEM MED, V11, P189, DOI 10.1089/acm.2005.11.189; Bschor T, 2016, EXPERT REV NEUROTHER, V16, P367, DOI 10.1586/14737175.2016.1155985; Butler LD, 2008, J CLIN PSYCHOL, V64, P806, DOI 10.1002/jclp.20496; Buttner MM, 2015, COMPLEMENT THER CLIN, V21, P94, DOI 10.1016/j.ctcp.2015.03.003; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cabral Patricia, 2011, Prim Care Companion CNS Disord, V13, DOI 10.4088/PCC.10r01068; Canadian Agency for Drugs and Technologies in Health, 2015, YOG TREATM POSTTR ST; Casacalenda N, 2002, AM J PSYCHIAT, V159, P1354, DOI 10.1176/appi.ajp.159.8.1354; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Clarke Tainya C, 2015, Natl Health Stat Report, P1; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Cooper AA, 2015, CLIN PSYCHOL REV, V40, P57, DOI 10.1016/j.cpr.2015.05.001; Cramer H, 2016, AM J PREV MED, V50, P230, DOI 10.1016/j.amepre.2015.07.037; Cramer H, 2015, AM J EPIDEMIOL, V182, P281, DOI 10.1093/aje/kwv071; Cramer H, 2013, DEPRESS ANXIETY, V30, P1068, DOI 10.1002/da.22166; Cramer H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075515; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; da Silva TL, 2009, ASIAN J PSYCHIATR, V2, P6, DOI 10.1016/j.ajp.2008.12.002; Das M, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00062; Davis K, 2015, COMPLEMENT THER CLIN, V21, P166, DOI 10.1016/j.ctcp.2015.06.005; De Maat S, 2006, PSYCHOTHER RES, V16, P562, DOI 10.1080/10503300600756402; de Sousa RT, 2015, CURR NEUROPHARMACOL, V13, P616, DOI 10.2174/1570159X13666150630173522; Deshpande Sudheer, 2009, Int J Yoga, V2, P13, DOI 10.4103/0973-6131.43287; Dhar AK, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00033; Dimidjian S, 2011, ANNU REV CLIN PSYCHO, V7, P1, DOI 10.1146/annurev-clinpsy-032210-104535; Driessen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137864; Dunlop BW, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-106; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Edlund MJ, 2002, AM J PSYCHIAT, V159, P845, DOI 10.1176/appi.ajp.159.5.845; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Ekkekakis P, 2015, MENT HEALTH PHYS ACT, V8, P21, DOI 10.1016/j.mhpa.2014.12.001; Epel E, 2009, ANN NY ACAD SCI, V1172, P34, DOI 10.1111/j.1749-6632.2009.04414.x; Fernandes R, 2005, NAT I MENT HLTH SUMM; Ferreira-Vorkapic C., 2015, EVID-BASED COMPL ALT, V2015, P1; Field T, 2013, J BODYW MOV THER, V17, P397, DOI 10.1016/j.jbmt.2013.03.010; Field T, 2013, COMPLEMENT THER CLIN, V19, P6, DOI 10.1016/j.ctcp.2012.10.001; Field T, 2012, J BODYW MOV THER, V16, P204, DOI 10.1016/j.jbmt.2011.08.002; Fishbein D, 2014, J ALTERN COMPLEM MED, V20, pA21, DOI DOI 10.1089/ACM.2014.5052.ABSTRACT; Flint J, 2015, Psychol Med, V45, P439, DOI 10.1017/S0033291714001421; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Freedland KE, 2015, JAMA INTERN MED, V175, P1773, DOI 10.1001/jamainternmed.2015.5220; Gaynes BN, 2008, CLEV CLIN J MED, V75, P57, DOI 10.3949/ccjm.75.1.57; Gong H, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0393-1; Gonzalez HM, 2010, ARCH GEN PSYCHIAT, V67, P37, DOI 10.1001/archgenpsychiatry.2009.168; Hedden S, 2015, NSDUH SER H, V50; Hillhouse TM, 2015, EXP CLIN PSYCHOPHARM, V23, P1, DOI 10.1037/a0038550; Hofmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079809; Holden SC, 2015, BIRTH-ISS PERINAT C, V42, P261, DOI 10.1111/birt.12177; Huynh Nhu N, 2008, Prim Care Companion J Clin Psychiatry, V10, P91; Israel JA, 2010, PHARMACEUTICALS, V3, P2426, DOI 10.3390/ph3082426; Iyengar B. K. S, 1979, LIGHT YOGA YOGA DIPI; Jacobs TL, 2011, PSYCHONEUROENDOCRINO, V36, P664, DOI 10.1016/j.psyneuen.2010.09.010; Jain FA, 2015, PSYCHOSOMATICS, V56, P140, DOI 10.1016/j.psym.2014.10.007; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Janakiramaiah N, 2000, J AFFECT DISORDERS, V57, P255, DOI 10.1016/S0165-0327(99)00079-8; Javnbakht M, 2009, Complement Ther Clin Pract, V15, P102, DOI 10.1016/j.ctcp.2009.01.003; Khan A, 2002, J CLIN PSYCHOPHARM, V22, P40, DOI 10.1097/00004714-200202000-00007; Khin NA, 2011, J CLIN PSYCHIAT, V72, P464, DOI 10.4088/JCP.10m06191; Khumar S, 1993, INDIAN J CLIN PSYCH; Kingston T, 2007, PSYCHOL PSYCHOTHER-T, V80, P193, DOI 10.1348/147608306X116016; Kinser PA, 2014, ARCH PSYCHIAT NURS, V28, P377, DOI 10.1016/j.apnu.2014.08.014; Kinser PA, 2013, ARCH PSYCHIAT NURS, V27, P137, DOI 10.1016/j.apnu.2013.01.003; Kinser PA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/140467; Kinser PA, 2012, EXPLORE-NY, V8, P118, DOI 10.1016/j.explore.2011.12.005; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kovacic T, 2011, J ALTERN COMPLEM MED, V17, P1157, DOI 10.1089/acm.2010.0653; Krishnamurthy MN, 2007, J GERONTOL NURS, V33, P17, DOI 10.3928/00989134-20070201-05; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lavretsky H, 2013, INT J GERIATR PSYCH, V28, P57, DOI 10.1002/gps.3790; Lee SW, 2004, J GEN INTERN MED, V19, P760, DOI 10.1111/j.1525-1497.2004.30011.x; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lin P, 2005, ANN BEHAV MED, V30, P164, DOI 10.1207/s15324796abm3002_9; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; MacCoon DG, 2012, BEHAV RES THER, V50, P3, DOI 10.1016/j.brat.2011.10.011; Masand PS, 2003, CLIN THER, V25, P2289, DOI 10.1016/S0149-2918(03)80220-5; McGrath CL, 2014, BIOL PSYCHIAT, V76, P527, DOI 10.1016/j.biopsych.2013.12.005; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Mitchell J., 2012, PSYCHOLOGY, V3, P782, DOI DOI 10.4236/PSYCH.2012.329118; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mohr DC, 2006, ANN BEHAV MED, V32, P254, DOI 10.1207/s15324796abm3203_12; Moradveisi L, 2014, J BEHAV THER EXP PSY, V45, P170, DOI 10.1016/j.jbtep.2013.10.003; Moradveisi L, 2013, BRIT J PSYCHIAT, V202, P204, DOI 10.1192/bjp.bp.112.113696; Mota-Pereira J, 2011, J PSYCHIATR RES, V45, P1005, DOI 10.1016/j.jpsychires.2011.02.005; Nagarathna R, 2001, YOGA ANXIETY DEPRESS; Newham JJ, 2014, DEPRESS ANXIETY, V31, P631, DOI 10.1002/da.22268; Olfson M, 2009, PSYCHIAT SERV, V60; ORETZKY S, 2007, DISS ABSTR INT B, V67, P5458; Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Pascoe MC, 2015, J PSYCHIATR RES, V68, P270, DOI 10.1016/j.jpsychires.2015.07.013; Pence BW, 2012, CURR PSYCHIAT REP, V14, P328, DOI 10.1007/s11920-012-0274-y; Phillips ML, 2015, AM J PSYCHIAT, V172, P124, DOI 10.1176/appi.ajp.2014.14010076; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Purohit MP, 2013, J CLIN PSYCHIAT, V74, pE520, DOI 10.4088/JCP.12m08246; Quitkin FM, 2005, J CLIN PSYCHIAT, V66, P670, DOI 10.4088/JCP.v66n0601; Ramsey AT, 2016, J TECHNOL HUMAN SERV, V34, P209, DOI 10.1080/15228835.2016.1170649; Reeves GM, 2012, J AFFECT DISORDERS, V138, P123, DOI 10.1016/j.jad.2011.12.003; Rethorst CD, 2013, J PSYCHIATR PRACT, V19, P204, DOI 10.1097/01.pra.0000430504.16952.3e; Rethorst CD, 2009, SPORTS MED, V39, P491, DOI 10.2165/00007256-200939060-00004; Roberson AM, 2015, J CLIN PSYCHIAT; Rohini V., 2000, NIMHANS J, V18, P53; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Ross A, 2010, J ALTERN COMPLEM MED, V16, P3, DOI 10.1089/acm.2009.0044; Rush AJ, 2009, CNS DRUGS, V23, P627, DOI 10.2165/00023210-200923080-00001; Rutherford BR, 2010, CURR PSYCHIATRY REV, V6, P1, DOI 10.2174/157340010790596571; Saper RB, 2004, ALTERN THER HEALTH M, V10, P44; Sarubin N, 2014, J PSYCHIATR RES, V53, P76, DOI 10.1016/j.jpsychires.2014.02.022; Satchidananda Patanjali, 2012, YOGA SUTRAS PATANJAL; Satyapriya M, 2013, COMPLEMENT THER CLIN, V19, P230, DOI 10.1016/j.ctcp.2013.06.003; Schuver KJ, 2016, COMPLEMENT THER MED, V26, P85, DOI 10.1016/j.ctim.2016.03.003; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Scult Matthew, 2015, Adv Mind Body Med, V29, P26; Sethi Jaspal Kaur, 2013, J Educ Health Promot, V2, P55, DOI 10.4103/2277-9531.119043; Shahidi M, 2011, INT J GERIATR PSYCH, V26, P322, DOI 10.1002/gps.2545; Sharf J, 2010, PSYCHOTHERAPY, V47, P637, DOI 10.1037/a0021175; Sharma V K, 2005, Indian J Physiol Pharmacol, V49, P462; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simon G, 2010, PSYCHIAT SERV, V61; Sinclair SJ, 2010, EVAL HEALTH PROF, V33, P56, DOI 10.1177/0163278709356187; Sirey JA, 2001, AM J PSYCHIAT, V158, P479, DOI 10.1176/appi.ajp.158.3.479; Steer RA, 2001, PSYCHOL REP, V88, P1075, DOI 10.2466/PR0.88.3.1075-1076; Stewart JG, 2012, J AFFECT DISORDERS, V137, P87, DOI 10.1016/j.jad.2011.12.015; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; Streeter CC, 2012, MED HYPOTHESES, V78, P571, DOI 10.1016/j.mehy.2012.01.021; Stussman Barbara J, 2015, Natl Health Stat Report, P1; Svatmarama S, 1987, HATHAYOGAPRADIPIKA H; Swift JK, 2011, J CLIN PSYCHOL, V67, P155, DOI 10.1002/jclp.20759; Taspinar B, 2014, COMPLEMENT THER MED, V22, P433, DOI 10.1016/j.ctim.2014.03.007; Telles S, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-37; Thase ME, 2003, J CLIN PSYCHIAT, V64, P3; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; Torous J, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.3889; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Uebelacker LA, 2015, ARCH WOMENS MENT HLT; Uebelacker LA, 2010, J PSYCHIATR PRACT, V16, P22, DOI 10.1097/01.pra.0000367775.88388.96; Uher R, 2011, J CLIN PSYCHIAT, V72, P1478, DOI 10.4088/JCP.10m06419; Upchurch DM, 2010, J WOMENS HEALTH, V19, P23, DOI 10.1089/jwh.2008.1096; van Aalderen JR, 2012, PSYCHOL MED, V42, P989, DOI 10.1017/S0033291711002054; VEALE D, 1992, J ROY SOC MED, V85, P541; Vedamurthachar A, 2006, J AFFECT DISORDERS, V94, P249, DOI 10.1016/j.jad.2006.04.025; Waelde LC, 2004, J CLIN PSYCHOL, V60, P677, DOI 10.1002/jclp.10259; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Warden D, 2009, J PSYCHIATR PRACT, V15, P113, DOI 10.1097/01.pra.0000348364.88676.83; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; WIERZBICKI M, 1993, PROF PSYCHOL-RES PR, V24, P190, DOI 10.1037/0735-7028.24.2.190; Wiles N, 2014, HLTH TECHNOL ASSESS, V18; Wolsko PM, 2004, J GEN INTERN MED, V19, P43, DOI 10.1111/j.1525-1497.2004.21019.x; Woolery A, 2004, ALTERN THER HEALTH M, V10, P60; World Health Organization, 2005, HDB GOOD CLIN RES PR; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089	178	59	62	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173869	10.1371/journal.pone.0173869	http://dx.doi.org/10.1371/journal.pone.0173869			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301561	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300087
J	Foster, WJ; Danise, S; Price, GD; Twitchett, RJ				Foster, William J.; Danise, Silvia; Price, Gregory D.; Twitchett, Richard J.			Subsequent biotic crises delayed marine recovery following the late Permian mass extinction event in northern Italy	PLOS ONE			English	Article							U-PB AGES; SOUTHERN ALPS; TRIASSIC BOUNDARY; AMMONOID BIOCHRONOZONES; ORGANIC-CARBON; WESTERN TETHYS; LOW-OXYGEN; DOLOMITES; PERTURBATIONS; ASSEMBLAGES	The late Permian mass extinction event was the largest biotic crisis of the Phanerozoic and has the longest recovery interval of any extinction event. It has been hypothesised that subsequent carbon isotope perturbations during the Early Triassic are associated with biotic crises that impeded benthic recovery. We test this hypothesis by undertaking the highest-resolution study yet made of the rock and fossil records of the entire Werfen Formation, Italy. Here, we show that elevated extinction rates were recorded not only in the Dienerian, as previously recognised, but also around the Smithian/Spathian boundary. Functional richness increases across the Smithian/Spathian boundary associated with elevated origination rates in the lower Spathian. The taxonomic and functional composition of benthic faunas only recorded two significant changes: (1) reduced heterogeneity in the Dienerian, and (2) and a faunal turnover across the Smithian/Spathian boundary. The elevated extinctions and compositional shifts in the Dienerian and across the Smithian/Spathian boundary are associated with a negative and positive isotope excursion, respectively, which supports the hypothesis that subsequent biotic crises are associated with carbon isotope shifts. The Spathian fauna represents a more advanced ecological state, not recognised in the previous members of the Werfen Formation, with increased habitat differentiation, a shift in the dominant modes of life, appearance of stenohaline taxa and the occupation of the erect and infaunal tiers. In addition to subsequent biotic crises delaying the recovery, therefore, persistent environmental stress limited the ecological complexity of benthic recovery prior to the Spathian.	[Foster, William J.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Danise, Silvia; Price, Gregory D.] Univ Plymouth, Earth Sci, Plymouth, Devon, England; [Danise, Silvia] Univ Georgia, Dept Geol, Athens, GA 30602 USA; [Twitchett, Richard J.] Nat Hist Museum, Dept Earth Sci, London, England	University of Texas System; University of Texas Austin; University of Plymouth; University System of Georgia; University of Georgia; Natural History Museum London	Foster, WJ (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	w.j.foster@gmx.co.uk	Price, Gregory/AAC-1801-2020	Price, Gregory/0000-0002-2461-7465; Foster, William/0000-0002-9595-8195; Danise, Silvia/0000-0002-6098-609X	Natural Environment Research Council [NE/I005641]; Natural Environment Research Council [NE/I005641/2, 1244831] Funding Source: researchfish; NERC [NE/I005641/2] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support was provided by the Natural Environment Research Council, grant awarded to RJT NE/I005641.	Algeo TJ, 2010, GEOLOGY, V38, P1023, DOI 10.1130/G31203.1; [Anonymous], 1985, GEOLOGISCH PALAONTOL; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; BAUMILLER TK, 1995, LETHAIA, V28, P221, DOI 10.1111/j.1502-3931.1995.tb01425.x; Beatty TW, 2008, GEOLOGY, V36, P771, DOI 10.1130/G24952A.1; Berner RA, 2005, GEOCHIM COSMOCHIM AC, V69, P3211, DOI 10.1016/j.gca.2005.03.021; Blakey R, 2012, GLOBAL PALEOGEOGRAPH; Broglio Longs C., 1990, MEM SCI GEOL, V42, P41; Broglio Loriga C, 1986, MEMORIE SCI GEOLOGIC, V38, P245; Broglio Loriga C., 1986, RIV ITAL PALEONTOL S, V92, P89; Burgess SD, 2014, P NATL ACAD SCI USA, V111, P3316, DOI 10.1073/pnas.1317692111; Clapham ME, 2007, P NATL ACAD SCI USA, V104, P12971, DOI 10.1073/pnas.0705280104; Clarke K. R., 2002, CHANGE MARINE COMMUN; Clarkson MO, 2016, NATURE COMMUNICATION, P7; Farabegoli E, 2007, GLOBAL PLANET CHANGE, V55, P109, DOI 10.1016/j.gloplacha.2006.06.009; Foster WJ, 2015, PALAEOGEOGR PALAEOCL, V440, P374, DOI 10.1016/j.palaeo.2015.09.004; Foster WJ, 2014, NAT GEOSCI, V7, P233, DOI [10.1038/ngeo2079, 10.1038/NGEO2079]; Foster WJ, 2016, J SYSTEMATIC PALAEON; Galfetti T, 2007, EARTH PLANET SC LETT, V258, P593, DOI 10.1016/j.epsl.2007.04.023; Geyer Gerd, 2005, Palaeontologische Zeitschrift, V79, P429; Gianolla P., 1998, MESOZOIC CENOZOIC SE, V60, DOI DOI 10.2110/PEC.98.02.0719; GLAZEK J, 1968, B ACAD POL SCI GEO G, V16, P91; Grasby SE, 2016, GEOL MAG, V153, P285, DOI 10.1017/S0016756815000436; Greene SE, 2011, PALAEOGEOGR PALAEOCL, V308, P224, DOI 10.1016/j.palaeo.2010.08.019; Groves JR, 2007, J PALEONTOL, V81, P415, DOI 10.1666/05123.1; Hausmann IM, 2015, LETHAIA, V48, P235, DOI 10.1111/let.12102; Hofmann R, 2015, LETHAIA, V48, P474, DOI 10.1111/let.12121; Hofmann R, 2014, PALAEONTOLOGY, V57, P547, DOI 10.1111/pala.12076; Hofmann R, 2011, PALAEOGEOGR PALAEOCL, V310, P216, DOI 10.1016/j.palaeo.2011.07.014; Horacek M, 2007, PALAEOGEOGR PALAEOCL, V252, P347, DOI 10.1016/j.palaeo.2006.11.049; Horacek M, 2010, PALAEOGEOGR PALAEOCL, V290, P65, DOI 10.1016/j.palaeo.2010.02.016; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kaim A, 2011, PALAEOGEOGR PALAEOCL, V308, P190, DOI 10.1016/j.palaeo.2010.04.008; Kraus SH, 2009, FOSS REC, V12, P197, DOI 10.1002/mmng.200900007; Lehrmann DJ, 2006, GEOLOGY, V34, P1053, DOI 10.1130/G22827A.1; Loriga C Broglio, 1983, RIV ITAL PALEONTOL S, V88, P45; Lucas SG, 2010, GEOL SOC SPEC PUBL, V334, P1, DOI 10.1144/SP334.1; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Nakazawa K., 1977, J PALAEONTOL SOC IND, V20, P191; Nutzel A, 2005, FACIES, V51, P480, DOI 10.1007/s10347-005-0074-5; Nutzel A, 2005, ACTA PALAEONTOL POL, V50, P19; Oji T, 2015, ZOOL SCI, V32, P211, DOI 10.2108/zs140240; Ovtcharova M, 2006, EARTH PLANET SC LETT, V243, P463, DOI 10.1016/j.epsl.2006.01.042; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; PERRI M C, 1991, Bollettino della Societa Paleontologica Italiana, V30, P23; Perri MC, 2003, COUR FOR SEKENBG, V245, P281; Pietsch C, 2016, PALAEOGEOGR PALAEOCL, V451, P183, DOI 10.1016/j.palaeo.2016.02.056; Pietsch C, 2014, PALAEOGEOGR PALAEOCL, V399, P98, DOI 10.1016/j.palaeo.2014.02.011; POSENATO R, 1992, ECLOGAE GEOL HELV, V85, P893; POSENATO R., 1985, ATT 3 S EC PAL COM B, P141; Posenato R, 2008, PALAEOGEOGR PALAEOCL, V261, P145, DOI 10.1016/j.palaeo.2008.01.006; Posenato R, 2014, PALAEOGEOGR PALAEOCL, V399, P373, DOI 10.1016/j.palaeo.2014.01.028; Posenato R, 2009, PALAEOGEOGR PALAEOCL, V280, P150, DOI 10.1016/j.palaeo.2009.06.009; Posenato R, 2008, EARTH-SCI REV, V91, P93, DOI 10.1016/j.earscirev.2008.09.001; Scholger R, 2000, EARTH PLANET SC LETT, V176, P495, DOI 10.1016/S0012-821X(00)00026-1; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Siegert S, 2011, FOSS REC, V14, P207, DOI 10.1002/mmng.201100008; Stanley SM, 2016, P NATL ACAD SCI USA, V113, pE6325, DOI 10.1073/pnas.1613094113; Sun YD, 2015, PALAEOGEOGR PALAEOCL, V427, P62, DOI 10.1016/j.palaeo.2015.03.038; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Twitchett RJ, 2006, PALAEOGEOGR PALAEOCL, V232, P190, DOI 10.1016/j.palaeo.2005.05.019; Twitchett RJ, 2004, GEOLOGY, V32, P805, DOI 10.1130/G20585.1; Twitchett RJ, 1996, PALAEOGEOGR PALAEOCL, V124, P137, DOI 10.1016/0031-0182(96)00008-9; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; Velledits F, 2011, RIV ITAL PALEONTOL S, V117, P221, DOI 10.13130/2039-4942/5973; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Wheeley JR, 2005, LETHAIA, V38, P37, DOI 10.1080/0024116051003150; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155; Yin HF, 2001, EPISODES, V24, P102; Zanche V, 1981, GEOL PALAONT MITT IN, V10, P289; Zaton M, 2013, J PALEONTOL, V87, P159, DOI 10.1666/12-060R.1; Zhang L, 2015, BIOGEOSCIENCES, V12, P1597, DOI 10.5194/bg-12-1597-2015	74	45	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172321	10.1371/journal.pone.0172321	http://dx.doi.org/10.1371/journal.pone.0172321			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296886	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700006
J	Haga, PT; Pizzichelli, G; Mortensen, M; Kuchta, M; Pahlavian, SH; Sinibaldi, E; Martin, BA; Mardal, KA				Haga, Per Thomas; Pizzichelli, Giulia; Mortensen, Mikael; Kuchta, Miroslav; Pahlavian, Soroush Heidari; Sinibaldi, Edoardo; Martin, Bryn A.; Mardal, Kent-Andre			A numerical investigation of intrathecal isobaric drug dispersion within the cervical subarachnoid space	PLOS ONE			English	Article							ANATOMICAL FINE-STRUCTURE; CEREBROSPINAL-FLUID; SPINAL-ANESTHESIA; BACLOFEN; FLOW; DELIVERY; THERAPY; BRAIN; BOLUS; CNS	Intrathecal drug and gene vector delivery is a procedure to release a solute within the cerebrospinal fluid. This procedure is currently used in clinical practice and shows promise for treatment of several central nervous system pathologies. However, intrathecal delivery protocols and systems are not yet optimized. The aim of this study was to investigate the effects of injection parameters on solute distribution within the cervical subarachnoid space using a numerical platform. We developed a numerical model based on a patient-specific three dimensional geometry of the cervical subarachnoid space with idealized dorsal and ventral nerve roots and denticulate ligament anatomy. We considered the drug as massless particles within the flow field and with similar properties as the CSF, and we analyzed the effects of anatomy, catheter position, angle and injection flow rate on solute distribution within the cerebrospinal fluid by performing a series of numerical simulations. Results were compared quantitatively in terms of drug peak concentration, spread, accumulation rate and appearance instant over 15 seconds following the injection. Results indicated that solute distribution within the cervical spine was altered by all parameters investigated within the time range analyzed following the injection. The presence of spinal cord nerve roots and denticulate ligaments increased drug spread by 60% compared to simulations without these anatomical features. Catheter position and angle were both found to alter spread rate up to 86%, and catheter flow rate altered drug peak concentration up to 78%. The presented numerical platform fills a first gap towards the realization of a tool to parametrically assess and optimize intrathecal drug and gene vector delivery protocols and systems. Further investigation is needed to analyze drug spread over a longer clinically relevant time frame.	[Haga, Per Thomas; Mortensen, Mikael; Mardal, Kent-Andre] Simula Res Lab, Ctr Biomed Comp, Fornebu, Norway; [Pizzichelli, Giulia; Sinibaldi, Edoardo] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Pizzichelli, Giulia] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy; [Mortensen, Mikael; Kuchta, Miroslav; Mardal, Kent-Andre] Univ Oslo, Dept Math, Oslo, Norway; [Pahlavian, Soroush Heidari] Univ Akron, Dept Mech Engn, Conquer Chiari Res Ctr, Akron, OH 44325 USA; [Martin, Bryn A.] Univ Idaho, Dept Biol Engn, Moscow, ID 83843 USA	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna; University of Oslo; University System of Ohio; University of Akron; Idaho; University of Idaho	Martin, BA (corresponding author), Univ Idaho, Dept Biol Engn, Moscow, ID 83843 USA.	brynm@uidaho.edu	Sinibaldi, Edoardo/AAV-9599-2021; Martin, Bryn A./N-6640-2016; Mardal, Kent-Andre/G-8296-2018	Sinibaldi, Edoardo/0000-0002-9755-3431; Martin, Bryn A./0000-0003-1234-7880; Mardal, Kent-Andre/0000-0002-4946-1110; Mortensen, Mikael/0000-0002-3293-7573	National Institute of General Medical Sciences [P20GM103408, 4U54GM104944-04]; University of Idaho, Vandal Ideas Project; American Syringomyelia and Chiari Alliance Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Idaho, Vandal Ideas Project; American Syringomyelia and Chiari Alliance Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences, grants P20GM103408 and 4U54GM104944-04 to BM, the University of Idaho, Vandal Ideas Project to BM and by the American Syringomyelia and Chiari Alliance Project to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belichenko PV, 2005, MOL GENET METAB, V86, P141, DOI 10.1016/j.ymgme.2005.04.013; Berselli LC, 2014, SIAM J APPL MATH, V74, P40, DOI 10.1137/120903385; Bhatia G, 2013, F1000RES, V2, P1; Bottros MM, 2014, J PAIN RES, V7, P615, DOI 10.2147/JPR.S37591; Calias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030341; Cheng S, 2014, J BIOMECH, V47, P2826, DOI 10.1016/j.jbiomech.2014.04.027; CLARK SL, 1983, BRIT J PHARMACOL, V79, P807, DOI 10.1111/j.1476-5381.1983.tb10019.x; De Pinto M, 2015, PAIN PHYSICIAN, V18, pE651; Dickson P, 2007, MOL GENET METAB, V91, P61, DOI 10.1016/j.ymgme.2006.12.012; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Dziurzynski K, 2006, CHILD NERV SYST, V22, P270, DOI 10.1007/s00381-004-1129-6; Farhat HI, 2011, NEUROSURGERY, V68, P52, DOI 10.1227/NEU.0b013e318207b20a; Flack SH, 2010, ANESTHESIOLOGY, V112, P165, DOI 10.1097/ALN.0b013e3181c38da5; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Heetla HW, 2014, ARCH PHYS MED REHAB, V95, P2199, DOI 10.1016/j.apmr.2014.04.030; Hocking G, 2004, BRIT J ANAESTH, V93, P568, DOI 10.1093/bja/aeh204; Hsu Y, 2012, ANESTH ANALG, V115, P386, DOI 10.1213/ANE.0b013e3182536211; Ianniello S, 2010, J COMPUT PHYS, V229, P1353, DOI 10.1016/j.jcp.2009.10.034; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Jose DA, 2013, KOREAN J PAIN, V26, P336, DOI 10.3344/kjp.2013.26.4.336; Kuttler A, 2010, J PHARMACOKINET PHAR, V37, P629, DOI 10.1007/s10928-010-9184-y; Linninger AA, 2008, J BIOMECH, V41, P2176, DOI 10.1016/j.jbiomech.2008.04.025; McCall TD, 2006, NEUROSURGERY, V59, P634, DOI 10.1227/01.NEU.0000227570.40402.77; Meythaler JM, 2001, STROKE, V32, P2099, DOI 10.1161/hs0901.095682; Morrison C, 2015, NAT BIOTECHNOL, V33, P217, DOI 10.1038/nbt0315-217; Myers MR, 1998, ANAESTHESIA, V53, P151, DOI 10.1046/j.1365-2044.1998.00286.x; Myers MR, 1996, J BIOMECH, V29, P139, DOI 10.1016/0021-9290(95)00043-7; Narouze SN, 2014, PAIN PRACT, V14, P57, DOI 10.1111/papr.12024; Nelissen R. M., 2008, THESIS; Pahlavian SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091888; Papisov MI, 2013, MOL PHARMACEUT, V10, P1522, DOI 10.1021/mp300474m; Perruchoud C, 2010, SWISS MED WEEKL S184, V140; Perruchoud C, 2011, PAIN MED, V12, P571, DOI 10.1111/j.1526-4637.2011.01088.x; Pohl M, 2003, J NEUROL, V250, P1195, DOI 10.1007/s00415-003-0178-1; ROBINSON RA, 1994, ANESTHESIOLOGY, V81, P1053, DOI 10.1097/00000542-199410000-00030; Schuster DJ, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00066; Soderquist RG, 2010, EXPERT OPIN DRUG DEL, V7, P285, DOI 10.1517/17425240903540205; Stockman HW, 2007, J BIOMECH ENG-T ASME, V129, P666, DOI 10.1115/1.2768112; Stockman HW, 2006, J BIOMECH ENG-T ASME, V128, P106, DOI 10.1115/1.2132372; Stokic DS, 2005, ARCH PHYS MED REHAB, V86, P1801, DOI 10.1016/j.apmr.2005.03.027; Stoverud KH, 2016, COMPUT METHOD BIOMEC, V19, P686, DOI 10.1080/10255842.2015.1058927; Tangen K, 2016, ANN BIOMED ENG, V6, P1; Tangen KM, 2015, J BIOMECH, V48, P2144, DOI 10.1016/j.jbiomech.2015.02.018; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Van Damme P, 2014, EXPERT OPIN INV DRUG, V23, P955, DOI 10.1517/13543784.2014.912275; Xie HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122453; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284	49	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173680	10.1371/journal.pone.0173680	http://dx.doi.org/10.1371/journal.pone.0173680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296953	Green Submitted, gold, Green Published			2022-12-26	WOS:000396311700050
J	Kavokin, K				Kavokin, Kirill			Can a hybrid chemical-ferromagnetic model of the avian compass explain its outstanding sensitivity to magnetic noise?	PLOS ONE			English	Article							RADICAL-PAIR MECHANISM; PHOTORECEPTOR-BASED MAGNETORECEPTION; MIGRATORY BIRDS; FIELD; NANOPARTICLES; ANISOTROPY; SPIN	While many properties of the magnetic compass of migratory birds are satisfactory explained within the chemical model of magnetoreception, its extreme sensitivity to radio-frequency magnetic fields remains a mystery. Apparently, this difficulty could be overcome if the magnetoreceptor model were augmented with a magnetite nanoparticle, which would amplify the magnetic field at the position of the magneto-sensitive cryptochrome molecule. However, comparison of the radio-frequency power used in the experiment with intrinsic magnetization noise of such a particle, estimated from the theory of fluctuations, shows that the required sensitivity cannot be reached with realistic parameters of iron-oxide nanocrystals.	[Kavokin, Kirill] St Petersburg State Univ, Spin Opt Lab, St Petersburg, Russia; [Kavokin, Kirill] IM Sechenov Inst Evolutionary Physiol & Biochem R, St Petersburg, Russia	Saint Petersburg State University; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Kavokin, K (corresponding author), St Petersburg State Univ, Spin Opt Lab, St Petersburg, Russia.; Kavokin, K (corresponding author), IM Sechenov Inst Evolutionary Physiol & Biochem R, St Petersburg, Russia.	kkavokin@gmail.com	Kavokin, Kirill V/I-7736-2013	Kavokin, Kirill V/0000-0002-0047-5706	Russian Science Foundation [16-14-10159]	Russian Science Foundation(Russian Science Foundation (RSF))	Funded by Russian Science Foundation grant 16-14-10159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I am grateful to N.Chernetsov, J.Bojarinova and R.Cherbunin for helpful discussions, to M.Winklhofer for advice on the literature on magnetic particles, and to E.Chernetsova for assistance in preparing figures. This work was supported by grant 16-14-10159 from Russian Science Foundation.	Binhi V, 2008, INT J RADIAT BIOL, V84, P569, DOI 10.1080/09553000802195323; Butler RF, 1992, PALEOMAGNETISM MAGNE; Cai JM, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.040304; Cai JM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.100501; Cao CQ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006855; Cohen AE, 2009, J PHYS CHEM A, V113, P11084, DOI 10.1021/jp907113p; Dellis AT, 2012, BIOSYSTEMS, V107, P153, DOI 10.1016/j.biosystems.2011.11.007; Gauger EM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040503; Heider F, 1996, PHYS EARTH PLANET IN, V93, P239, DOI 10.1016/0031-9201(95)03071-9; Hiscock HG, 2016, P NATL ACAD SCI USA, V113, P4634, DOI 10.1073/pnas.1600341113; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Kattnig DR, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/6/063007; Kattnig DR, 2016, PHYS CHEM CHEM PHYS, V18, P12443, DOI 10.1039/c5cp06731f; Kattnig DR, 2016, NAT CHEM, V8, P384, DOI [10.1038/NCHEM.2447, 10.1038/nchem.2447]; Kavokin KV, 2009, BIOELECTROMAGNETICS, V30, P402, DOI 10.1002/bem.20485; Kavokin K, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0451; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; Landau LD, 1980, COURSE THEORETICAL P, V3; Landau LD, 1980, COURSE THEORETICAL P, V5; Lee H, 2011, NANO LETT, V11, P5367, DOI 10.1021/nl202950h; Moskowitz BM, 1997, J GEOPHYS RES-SOL EA, V102, P22671, DOI 10.1029/97JB01698; Mouritsen H., 2013, NEUROSCIENCES MOL BE, P427; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2010, J R SOC INTERFACE, V7, pS135, DOI 10.1098/rsif.2009.0456.focus; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Schwarze S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00055; Shcherbakov VP, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031921; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; TURRO NJ, 1983, P NATL ACAD SCI USA, V80, P609, DOI 10.1073/pnas.80.2.609; Winklhofer M, 1997, J GEOPHYS RES-SOL EA, V102, P22695, DOI 10.1029/97JB01730; Winklhofer M, 2014, GEOCHEM GEOPHY GEOSY, V15, P1558, DOI 10.1002/2013GC005121; Yoon S, 2011, J KOREAN PHYS SOC, V59, P3069, DOI 10.3938/jkps.59.3069	36	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173887	10.1371/journal.pone.0173887	http://dx.doi.org/10.1371/journal.pone.0173887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296939	gold, Green Submitted, Green Published			2022-12-26	WOS:000396311700074
J	Khoo, SYS; McNally, GP; Clemens, KJ				Khoo, Shaun Yon-Seng; McNally, Gavan P.; Clemens, Kelly J.			The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; NEURONS; COCAINE; ACTIVATION; REWARD; HYPOTHALAMUS; ALMOREXANT; MOTIVATION; PREFERENCE; GLUTAMATE	The orexin/hypocretin system is important for appetitive motivation towards multiple drugs of abuse, including nicotine. Both OX1 and OX2 receptors individually have been shown to influence nicotine self-administration and reinstatement. Due to the increasing clinical use of dual orexin receptor antagonists in the treatment of disorders such as insomnia, we examined whether a dual orexin receptor antagonist may also be effective in reducing nicotine seeking. We tested the effect of intracerebroventricular (i.c.v.) administration of the potent and selective dual orexin receptor antagonist TCS1102 on orexin-A-induced food self-administration, nicotine self-administration and reinstatement of nicotine-seeking in rats. Our results show that 30 mu g of TCS1102 i.c.v. abolishes orexin-A-induced increases in food self-administration but does not reduce nicotine self-administration. Neither i.c.v. 10 mu g nor 30 mu g of TCS1102 reduced compound reinstatement after short-term (15 days) self-administration nicotine, but 30 mu g transiently reduced cue/nicotine compound reinstatement after chronic self-administration (29 days). These results indicate that TCS1102 has no substantial effect on motivation for nicotine seeking following chronic self-administration and no effect after shorter periods of intake. Orexin receptor antagonists may therefore have little clinical utility against nicotine addiction.	[Khoo, Shaun Yon-Seng; McNally, Gavan P.; Clemens, Kelly J.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Clemens, KJ (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW, Australia.	k.clemens@unsw.edu.au		McNally, Gavan/0000-0001-9061-6463; Khoo, Shaun/0000-0002-0972-3788	National Health & Medical Research Council of Australia [1047899]; Australian Research Council [FT120100250]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health & Medical Research Council of Australia (project grant 1047899) and a Future Fellowship to GPM (FT120100250) from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2012, NEUROSCIENCE, V211, P107, DOI 10.1016/j.neuroscience.2011.08.014; Ambrose N, 2000, DEV AN VET, V31, P1159; Anderson RI, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00033; Asai H, 2009, CLIN NEUROL NEUROSUR, V111, P341, DOI 10.1016/j.clineuro.2008.11.007; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Bergman JM, 2008, BIOORG MED CHEM LETT, V18, P1425, DOI 10.1016/j.bmcl.2008.01.001; Bird K. D., 2004, ANAL VARIANCE VIA CO; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Cahill K, 2016, COCHRANE DB SYST REV, V5, DOI [DOI 10.1002/14651858.CD006103.PUB.7, 10.1002/14651858.CD006103.pub.7]; Chaudhri N, 2006, PSYCHOPHARMACOLOGY, V184, P353, DOI 10.1007/s00213-005-0178-1; Clemens KJ, 2015, ADDICTION BIOL; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Furutani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062391; Gao XB, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00142; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Henny P, 2010, NEUROSCIENCE, V169, P1150, DOI 10.1016/j.neuroscience.2010.06.003; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Hughes JR, 2016, NICOTINE TOB RES, V18, P1299, DOI 10.1093/ntr/ntv137; Huynh C, 2015, ADDICT BIOL, V22, P142; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; LeSage MG, 2010, PSYCHOPHARMACOLOGY, V209, P203, DOI 10.1007/s00213-010-1792-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lutgen V, 2014, ADDICT BIOL, V19, P529, DOI 10.1111/j.1369-1600.2012.00493.x; Macnamara CL, 2016, NEUROPHARMACOLOGY, V105, P463, DOI 10.1016/j.neuropharm.2016.02.023; Madsen HB, 2015, ADDICT BIOL, V20, P433, DOI 10.1111/adb.12134; Malherbe P, 2009, MOL PHARMACOL, V76, P618, DOI 10.1124/mol.109.055152; Moorman DE, 2017, BRAIN RES, V1654, P34, DOI 10.1016/j.brainres.2016.10.018; Mould R, 2014, BRIT J PHARMACOL, V171, P351, DOI 10.1111/bph.12245; Muschamp JW, 2014, P NATL ACAD SCI USA, V111, pE1648, DOI 10.1073/pnas.1315542111; Pasumarthi RK, 2010, J NEUROCHEM, V113, P1023, DOI 10.1111/j.1471-4159.2010.06666.x; Pasumarthi RK, 2008, BRAIN RES BULL, V77, P367, DOI 10.1016/j.brainresbull.2008.09.014; Pasumarthi RK, 2006, EUR J PHARMACOL, V535, P172, DOI 10.1016/j.ejphar.2006.02.021; Peyron C, 1998, J NEUROSCI, V18, P9996; Plaza-Zabala A, 2013, NEUROPSYCHOPHARMACOL, V38, P1724, DOI 10.1038/npp.2013.72; Plaza-Zabala A, 2012, BIOL PSYCHIAT, V71, P214, DOI 10.1016/j.biopsych.2011.06.025; Porter RA, 2001, BIOORG MED CHEM LETT, V11, P1907, DOI 10.1016/S0960-894X(01)00343-2; Rao Y, 2013, J PHYSIOL-LONDON, V591, P1951, DOI 10.1113/jphysiol.2012.246983; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schenck CH, 2003, SLEEP MED, V4, P251, DOI 10.1016/S1389-9457(02)00257-5; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044726; Steiner MA, 2013, INT J NEUROPSYCHOPH, V16, P417, DOI 10.1017/S1461145712000193; Uslaner JM, 2014, BEHAV BRAIN RES, V269, P61, DOI 10.1016/j.bbr.2014.04.012; Winrow CJ, 2010, NEUROPHARMACOLOGY, V58, P185, DOI 10.1016/j.neuropharm.2009.07.008; Yeoh JW, 2012, J PHYSIOL-LONDON, V590, P3677, DOI 10.1113/jphysiol.2012.230268	48	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173967	10.1371/journal.pone.0173967	http://dx.doi.org/10.1371/journal.pone.0173967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296947	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700083
J	Mikiewicz, D; Bierczynska-Krzysik, A; Sobolewska, A; Stadnik, D; Bogiel, M; Pawlowska, M; Wojtowicz-Krawiec, A; Baran, PA; Lukasiewicz, N; Romanik-Chruscielewska, A; Sokolowska, I; Stadnik, J; Borowicz, P; Plucienniczak, G; Plucienniczak, A				Mikiewicz, Diana; Bierczynska-Krzysik, Anna; Sobolewska, Agnieszka; Stadnik, Dorota; Bogiel, Monika; Pawlowska, Monika; Wojtowicz-Krawiec, Anna; Baran, Piotr A.; Lukasiewicz, Natalia; Romanik-Chruscielewska, Agnieszka; Sokolowska, Iwona; Stadnik, Jacek; Borowicz, Piotr; Plucienniczak, Grazyna; Plucienniczak, Andrzej			Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties - From an efficient E. coli expression system to a pharmaceutical formulation	PLOS ONE			English	Article							SELF-ASSOCIATION; NMR STRUCTURE; DEO OPERON; THERAPY; DEAMIDATION; GLARGINE; PROTEIN; ASPART; PROTRACTION; MECHANISM	The discovery of insulin led to a revolution in diabetes management. Since then, many improvements have been introduced to insulin preparations. The availability of molecular genetic techniques has enabled the creation of insulin analogs by changing the structure of the native protein in order to improve the therapeutic properties. A new expression vector pIBAINS for production of four recombinant human insulin (INS) analogs (GKR, GEKR, AKR, SR) was constructed and overexpressed in the new E. coli 20 strain as a fusion protein with modified human superoxide dismutase (SOD). The SOD gene was used as a signal peptide to enhance the expression of insulin. SOD:: INS was manufactured in the form of insoluble inclusion bodies. After cleavage of the fusion protein with trypsin, the released insulin analogs were refolded and purified by reverse-phase high performance liquid chromatography (RP-HPLC). Elongation of chain A, described here for the first time, considerably improved the stability of the selected analogs. Their identity was confirmed with mass spectrometric techniques. The biological activity of the insulin derivatives was tested on rats with experimental diabetes. The obtained results proved that the new analogs described in this paper have the potential to generate prolonged hypoglycemic activity and may allow for even less frequent subcutaneous administration than once-a-day. When applied, all the analogs demonstrate a rapid onset of action. Such a combination renders the proposed bio-synthetic insulin unique among already known related formulations.	[Mikiewicz, Diana; Bierczynska-Krzysik, Anna; Sobolewska, Agnieszka; Stadnik, Dorota; Bogiel, Monika; Pawlowska, Monika; Wojtowicz-Krawiec, Anna; Baran, Piotr A.; Lukasiewicz, Natalia; Romanik-Chruscielewska, Agnieszka; Sokolowska, Iwona; Stadnik, Jacek; Borowicz, Piotr; Plucienniczak, Grazyna; Plucienniczak, Andrzej] Inst Biotechnol & Antibiot, Staroscinska 5, PL-02516 Warsaw, Poland	Institute of Biotechnology & Antibiotics (IBA)	Mikiewicz, D (corresponding author), Inst Biotechnol & Antibiot, Staroscinska 5, PL-02516 Warsaw, Poland.	mikiewiczd@iba.waw.pl	Romanik, Agnieszka/B-3364-2019; Łukasiewicz, Natalia/B-2574-2019; Romanik-Chruścielewska, Agnieszka/AAW-6799-2020; Baran, Piotr A/Y-6777-2018; Sokolowska, Iwona/B-2751-2019; Bierczynska-Krzysik, Anna/B-8384-2019	Romanik, Agnieszka/0000-0002-8537-5041; Łukasiewicz, Natalia/0000-0003-0250-3165; Baran, Piotr A/0000-0002-4309-1278; Sokolowska, Iwona/0000-0003-1556-7731; Stadnik, Dorota/0000-0003-2864-672X; Mikiewicz, Diana/0000-0002-0954-291X; Stadnik, Jacek/0000-0003-4023-5421; Bierczynska-Krzysik, Anna/0000-0002-2794-3151	European Regional Development Fund [POIG.01.01.02-00-007/08]	European Regional Development Fund(European Commission)	This work was supported by The European Regional Development Fund, POIG.01.01.02-00-007/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality (AHRQ), 2009, AHRQ PUB; [Anonymous], 2011, APPL GUID PA 800 PLU; [Anonymous], 2010, MONOGRAPH; Berti L, 1998, HORM METAB RES, V30, P123, DOI 10.1055/s-2007-978849; Bliss M., 1982, DISCOVERY INSULIN; Bocian W, 2008, BIOPOLYMERS, V89, P820, DOI 10.1002/bip.21018; Borowicz P, 2009, European Patent Application, Patent No. [EP 2 321 344 A2, 321344]; Borowicz P, 2011, INT J BIOL MACROMOL, V49, P548, DOI 10.1016/j.ijbiomac.2011.06.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brange J., 1994, STABILITY INSULIN ST; CHANCE RE, 1981, DIABETES CARE, V4, P147, DOI 10.2337/diacare.4.2.147; Cheng YE, United States patent, Patent No. [US 4,480,038, 4480038]; CHENG YSE, 1981, GENE, V14, P121, DOI 10.1016/0378-1119(81)90154-2; DARRINGTON RT, 1994, PHARMACEUT RES, V11, P784, DOI 10.1023/A:1018909220255; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; Donner T, INSULIN PHARM THERAP; Fischer J, 2015, SUCCESSFUL DRUG DISC, V1, P37; Freeman JS, 2009, J AM OSTEOPATH ASSOC, V109, P26; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Gumprecht J, 2009, INT J CLIN PRACT, V63, P966, DOI 10.1111/j.1742-1241.2009.02064.x; HALLEWELL RA, 1985, NUCLEIC ACIDS RES, V13, P2017, DOI 10.1093/nar/13.6.2017; HAMMERJESPERSEN K, 1975, MOL GEN GENET, V137, P327, DOI 10.1007/BF00703258; Hartman I, 2008, CLIN MED RES, V6, P54, DOI 10.3121/cmr.2008.793; Hartman JR, Generation of human insulin. International publication number: Worldwide International Property Organization WO96/20724 A1, Patent No. 9620724; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Heller S, 2007, DIABETES RES CLIN PR, V78, P149, DOI 10.1016/j.diabres.2007.04.001; Hermansen K, 2004, DIABETOLOGIA, V47, P622, DOI 10.1007/s00125-004-1365-z; Hilgenfeld R, 2014, DRUGS, V74, P911, DOI 10.1007/s40265-014-0226-4; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Jonassen I, 2006, PHARM RES-DORDR, V23, P49, DOI 10.1007/s11095-005-9047-1; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; Joshi Shashank R, 2007, J Assoc Physicians India, V55 Suppl, P19; Kalra S, 2014, DIABETES THER, V5, P65, DOI 10.1007/s13300-014-0067-x; KEMMLER W, 1971, J BIOL CHEM, V246, P6786; Madhu S V, 2013, Indian J Endocrinol Metab, V17, P249, DOI 10.4103/2230-8210.109690; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; Miller JH., 1972, EXPERIMENTS IN MOLEC; NAKHODA A, 1979, EXPERIENTIA, V35, P1679, DOI 10.1007/BF01953269; NICOL DSHW, 1960, NATURE, V187, P483, DOI 10.1038/187483a0; Porcellati F, 2011, DIABETES TECHNOL S1, V13, P15; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Rivers J, 2008, J PROTEOME RES, V7, P921, DOI 10.1021/pr070425l; Roach P, 2008, CLIN PHARMACOKINET, V47, P595, DOI 10.2165/00003088-200847090-00003; Robinson N. E., 2004, MOL CLOCKS DEAMIDATI; Rosskamp RH, 1999, DIABETES CARE, V22, pB109; SANGER F, 1951, BIOCHEM J, V49, P481, DOI 10.1042/bj0490481; SANGER F, 1951, BIOCHEM J, V49, P463, DOI 10.1042/bj0490463; Sillero A, 2006, COMPUT BIOL MED, V36, P157, DOI 10.1016/j.compbiomed.2004.09.006; Stretton AOW, 2002, GENETICS, V162, P527; Swinnen SG, 2009, DIABETES CARE, V32, pS253, DOI 10.2337/dc09-S318; The Canadian Agency for Drugs and Technologies in Health (CADTH), 2008, 87 CADTH COMPUS, V2; Vajo Z, 2000, PHARMACOL REV, V52, P1; VALENTINHANSEN P, 1982, EMBO J, V1, P317, DOI 10.1002/j.1460-2075.1982.tb01167.x; Wang F, 2003, CLIN THER, V25, P1541, DOI 10.1016/S0149-2918(03)80156-X; Wang P, 2015, NAT REV ENDOCRINOL, V11, P201, DOI 10.1038/nrendo.2015.9; WebMD, DIAB TYP INS; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532	57	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172600	10.1371/journal.pone.0172600	http://dx.doi.org/10.1371/journal.pone.0172600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296883	Green Submitted, gold, Green Published			2022-12-26	WOS:000396311700010
J	Wang, WY; Ding, ZP; Solares, GJ; Choi, SM; Wang, B; Yoon, A; Farrar, RP; Ivy, JL				Wang, Wanyi; Ding, Zhenping; Solares, Geoffrey J.; Choi, Soon-Mi; Wang, Bo; Yoon, Aram; Farrar, Roger P.; Ivy, John L.			Co-ingestion of carbohydrate and whey protein increases fasted rates of muscle protein synthesis immediately after resistance exercise in rats	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; AMINO-ACID-TRANSPORT; ENDURANCE EXERCISE; MAMMALIAN TARGET; INSULIN ACTION; PHOSPHORYLATION; INITIATION; GLUCOSE; KINASE; MTOR	The objective of the study was to investigate whether co-ingestion of carbohydrate and protein as compared with protein alone augments muscle protein synthesis (MPS) during early exercise recovery. Two months old rats performed 10 repetitions of ladder climbing with 75% of body weight attached to their tails. Placebo (PLA), whey protein (WP), or whey protein plus carbohydrate (CP) was then given to rats by gavage. An additional group of sedentary rats (SED) was used as controls. Blood samples were collected immediately and at either 1 or 2 h after exercise. The flexor hallucis longus muscle was excised at 1 or 2 h post exercise for analysis of MPS and related signaling proteins. MPS was significantly increased by CP compared with PLA (p<0.05), and approached significance compared with WP at 1 h post exercise (p = 0.08). CP yielded a greater phosphorylation of mTOR compared with SED and PLA at 1 h post exercise and SED and WP at 2 h post exercise. CP also increased phosphorylation of p70S6K compared with SED at 1 and 2 h post exercise. 4E-BP1 phosphorylation was inhibited by PLA at 1 h but elevated by WP and CP at 2 h post exercise relative to SED. The phosphorylation of AMPK was elevated by exercise at 1 h post exercise, and this elevated level was sustained only in the WP group at 2 h. The phosphorylation of Akt, GSK3, and elF2Bc were unchanged by treatments. Plasma insulin was transiently increased by CP at 1 h post exercise. In conclusion, post-exercise CP supplementation increases MPS post exercise relative to PLA and possibly WP, which may have been mediated by greater activation of the mTOR signaling pathway.	[Wang, Wanyi; Ding, Zhenping; Solares, Geoffrey J.; Yoon, Aram; Ivy, John L.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Exercise Physiol & Metab Lab, Austin, TX 78712 USA; [Choi, Soon-Mi] Midwestern State Univ, Dept Athlet Training & Exercise Physiol, Wichita Falls, TX 76308 USA; [Wang, Bo] Beijing Sports Univ, Sports Sci Coll, Beijing, Peoples R China; [Farrar, Roger P.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Muscle Physiol Lab, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Beijing Sport University; University of Texas System; University of Texas Austin	Ivy, JL (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Exercise Physiol & Metab Lab, Austin, TX 78712 USA.	johnivy@utexas.edu		Wang, Wanyi/0000-0001-9482-9968				[Anonymous], AMINO ACIDS; Anthony TG, 2007, J NUTR, V137, P357, DOI 10.1093/jn/137.2.357; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; BIOLO G, 1995, J CLIN INVEST, V95, P811, DOI 10.1172/JCI117731; Biolo G, 1999, DIABETES, V48, P949, DOI 10.2337/diabetes.48.5.949; Bird SP, 2006, EUR J APPL PHYSIOL, V97, P225, DOI 10.1007/s00421-005-0127-z; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chow LS, 2006, AM J PHYSIOL-ENDOC M, V291, pE729, DOI 10.1152/ajpendo.00003.2006; Cuthbertson DJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE731, DOI 10.1152/ajpendo.00415.2005; Dreyer HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE392, DOI 10.1152/ajpendo.00582.2007; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Eng CM, 2008, J EXP BIOL, V211, P2336, DOI 10.1242/jeb.017640; Farrell PA, 2000, J APPL PHYSIOL, V88, P1036, DOI 10.1152/jappl.2000.88.3.1036; Ferguson-Stegall L, 2011, J STRENGTH COND RES, V25, P1210, DOI 10.1519/JSC.0b013e318212db21; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fluckey JD, 1996, AM J PHYSIOL-ENDOC M, V270, pE313, DOI 10.1152/ajpendo.1996.270.2.E313; Glover EI, 2008, AM J PHYSIOL-REG I, V295, pR604, DOI 10.1152/ajpregu.00097.2008; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hernandez JM, 2000, J APPL PHYSIOL, V88, P1142, DOI 10.1152/jappl.2000.88.3.1142; Hillier TA, 1998, AM J PHYSIOL-ENDOC M, V274, pE1067, DOI 10.1152/ajpendo.1998.274.6.E1067; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Ivy JL, 2008, AMINO ACIDS, V35, P89, DOI 10.1007/s00726-007-0620-2; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; JEFFREY IW, 1993, BIOCHIMIE, V75, P791, DOI 10.1016/0300-9084(93)90129-G; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Kimball SR, 1998, AM J PHYSIOL-CELL PH, V274, pC221, DOI 10.1152/ajpcell.1998.274.1.C221; Koopman R, 2007, AM J PHYSIOL-ENDOC M, V293, pE833, DOI 10.1152/ajpendo.00135.2007; Koopman R, 2006, AM J PHYSIOL-ENDOC M, V290, pE1245, DOI 10.1152/ajpendo.00530.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macnaughton LS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12893; Miller SL, 2003, MED SCI SPORT EXER, V35, P449, DOI 10.1249/01.MSS.0000053910.63105.45; Moore DR, 2009, AM J CLIN NUTR, V89, P161, DOI 10.3945/ajcn.2008.26401; Morrison PJ, 2008, J APPL PHYSIOL, V104, P1029, DOI 10.1152/japplphysiol.01173.2007; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; POZEFSKY T, 1969, J CLIN INVEST, V48, P2273, DOI 10.1172/JCI106193; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roy BD, 1997, J APPL PHYSIOL, V82, P1882, DOI 10.1152/jappl.1997.82.6.1882; Staples AW, 2011, MED SCI SPORT EXER, V43, P1154, DOI 10.1249/MSS.0b013e31820751cb; Tipton KD, 2004, MED SCI SPORT EXER, V36, P2073, DOI 10.1249/01.MSS.0000147582.99810.C5; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Wilkinson SB, 2007, AM J CLIN NUTR, V85, P1031, DOI 10.1093/ajcn/85.4.1031	47	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173809	10.1371/journal.pone.0173809	http://dx.doi.org/10.1371/journal.pone.0173809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296942	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700068
J	Bouvier, S; Paulmyer-Lacroix, O; Molinari, N; Bertaud, A; Paci, M; Leroyer, A; Robert, S; George, FD; Blot-Chabaud, M; Bardin, N				Bouvier, Sylvie; Paulmyer-Lacroix, Odile; Molinari, Nicolas; Bertaud, Alexandrine; Paci, Marine; Leroyer, Aurelie; Robert, Stephane; George, Francoise Dignat; Blot-Chabaud, Marcel; Bardin, Nathalie			Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization	PLOS ONE			English	Article							EXPRESSION; SINGLE; IDENTIFICATION; IMPLANTATION; MIGRATION; FAILURE; FORM	Although progress was made in in vitro fertilization (IVF) techniques, the majority of embryos transferred fail to implant. Morphology embryo scoring is the standard procedure for most of IVF centres for choosing the best embryo, but remains limited since even the embryos classified as "top quality" may not implant. As it has been shown that i) CD146 is involved in embryo implantation and ii) membrane form is shed to generate soluble CD146 (sCD146), we propose that sCD146 in embryo supernatants may constitute a new biomarker of embryo selection. Immunocytochemical staining showed expression of CD146 in early embryo stages and sCD146 was detected by ELISA and Western-blot in embryo supernatants from D2. We retrospectively studied 126 couples who underwent IVF attempt. The embryo culture medium from each transferred embryo (n = 222) was collected for measurement of sCD146 by ELISA. Significantly higher sCD146 concentrations were present in embryo supernatants that did not implant (n = 185) as compared to those that successfully implanted (n = 37) (1310 +/- 1152 pg.mL(-1) vs. 845 +/- 1173 pg.mL(-1), p = 0.024). Sensitivity analysis performed on single embryo transfers (n = 71) confirmed this association (p = 0.0054). The computed ROC curve established that the optimal sCD146 concentration for embryo implantation is under 1164 pg.mL(-1) (sensitivity: 76%, specificity: 48%, PPV: 25% and NPV: 92%). Over this sCD146 threshold, the implantation rate was significantly lower (9% with sCD146 levels > 1164 pg.ml(-1) vs. 22% with sCD146 levels <= 1164 pg.mL(-1), p = 0.01). Among the embryos preselected by morphologic scoring, sCD146 determination could allow a better selection of the embryo(s), thus improving the success of elective single embryo transfer. This study establishes the proof of concept for the use of sCD146 as a bio-marker for IVF by excluding the embryo with the highest sCD146 level. A multicentre prospective study will now be necessary to further establish its use in clinical practice.	[Bouvier, Sylvie; Bertaud, Alexandrine; Leroyer, Aurelie; Robert, Stephane; George, Francoise Dignat; Blot-Chabaud, Marcel; Bardin, Nathalie] Aix Marseille Univ, Inserm U1076, Marseille, France; [Paulmyer-Lacroix, Odile; Paci, Marine] Aix Marseille Univ, Assisted Reprod Ctr, Lab Reprod, CHU Concept,AP HM, Marseille, France; [Paulmyer-Lacroix, Odile; Paci, Marine] Aix Marseille Univ, Lab Histol Embryol Biol Reprod, Marseille, France; [Molinari, Nicolas] Univ Montpellier, CNRS UMR 9214, PhyMedExp, INSERM U1046, Montpellier, France; [Bardin, Nathalie] CHU Concept Marseille, AP HM, Pole Biol, Immunol Lab, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bardin, N (corresponding author), Aix Marseille Univ, Inserm U1076, Marseille, France.; Bardin, N (corresponding author), CHU Concept Marseille, AP HM, Pole Biol, Immunol Lab, Marseille, France.	nathalie.bardin@univ-amu.fr	Bardin, Nathalie/AAL-3663-2020; Bouvier, Sylvie/AAA-2757-2019; Leroyer, Aurelie S./M-4400-2016; molinari, nicolas/Y-9681-2019; Blot-Chabaud, Marcel/D-4064-2017; DIGNAT-GEORGE, Françoise/R-1129-2016	Bardin, Nathalie/0000-0003-3680-082X; Bouvier, Sylvie/0000-0001-8808-8841; Leroyer, Aurelie S./0000-0002-8079-7122; DIGNAT-GEORGE, Françoise/0000-0001-7006-4462	Agence de la Biomedecine	Agence de la Biomedecine	This work was supported by a grant from the Agence de la Biomedecine. The authors have no conflict of interest to declare.	Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Bardin N, 2003, THROMB HAEMOSTASIS, V90, P915, DOI 10.1160/TH02-11-0285; Bardin N, 1998, FEBS LETT, V421, P12, DOI 10.1016/S0014-5793(97)01455-5; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; Bolton VN, 2015, HUM FERTIL, V27, P1; Boneberg EM, 2009, MICROVASC RES, V78, P325, DOI 10.1016/j.mvr.2009.06.012; Botros L, 2008, MOL HUM REPROD, V14, P679, DOI 10.1093/molehr/gan066; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Dzafic E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/508216; Forman EJ, 2013, FERTIL STERIL, V100, P100, DOI 10.1016/j.fertnstert.2013.02.056; Glujovsky D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002118.pub4, 10.1002/14651858.CD002118.pub5]; Haikin Herzberger E, 2016, GYNECOL ENDOCRINOL, V26, P1; Harbottle SJ, 2015, HUM FERTIL, V11, P131; Kaspi E, 2013, ANGIOGENESIS, V16, P329, DOI 10.1007/s10456-012-9317-6; Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175; Liu Q, 2004, LAB INVEST, V84, P221, DOI 10.1038/labinvest.3700033; Liu Q, 2008, J CELL PHYSIOL, V215, P621, DOI 10.1002/jcp.21341; Martins WP, 2016, ULTRASOUND OBSTET GY; McLernon DJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6945; Montag M, 2013, REPROD BIOMED ONLINE, V27, P539, DOI 10.1016/j.rbmo.2013.05.013; Montsko G, 2015, FERTIL STERIL, V103, P687, DOI 10.1016/j.fertnstert.2014.11.031; Motato Y, 2015, FERTIL STERIL, V17; Pandian Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003416.pub4; Pasquier E, 2005, THROMB HAEMOSTASIS, V94, P1280, DOI 10.1160/TH05-04-0253; Rhenman A, 2015, HUM REPROD, V30, P28, DOI 10.1093/humrep/deu295; Rosenbluth EM, 2014, FERTIL STERIL, V101, P1493, DOI 10.1016/j.fertnstert.2014.01.058; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Shih IM, 1998, J CELL SCI, V111, P2655; Simopoulou M, 2014, IN VIVO, V28, P683; Wang H., 2008, J REPROD CONTRACEPT, V19, P7, DOI [10.1016/S1001-7844(08)60003-6, DOI 10.1016/S1001-7844(08)60003-6]; Yang YS, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0140-9	32	7	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173724	10.1371/journal.pone.0173724	http://dx.doi.org/10.1371/journal.pone.0173724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291830	Green Published, gold, Green Submitted			2022-12-26	WOS:000396094700036
J	Kudryavtsev, VA; Khokhlova, AV; Mosina, VA; Selivanova, EI; Kabakov, AE				Kudryavtsev, Vladimir A.; Khokhlova, Anna V.; Mosina, Vera A.; Selivanova, Elena I.; Kabakov, Alexander E.			Induction of Hsp70 in tumor cells treated with inhibitors of the Hsp90 activity: A predictive marker and promising target for radiosensitization	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; MULTITARGET APPROACH; STRESS-RESPONSE; BASE EXCISION; CANCER-CELLS; DNA-DAMAGE; IN-VITRO; RADIATION; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; REPAIR	We studied a role of the inducible heat shock protein 70 (Hsp70) in cellular response to radiosensitizing treatments with inhibitors of the heat shock protein 90 (Hsp90) chaperone activity. Cell lines derived from solid tumors of different origin were treated with the Hsp90 inhibitors (17AAG, geldanamycin, radicicol, NVP-AUY922) or/and gamma-photon radiation. For comparison, human cells of the non-cancerous origin were subjected to the same treatments. We found that the Hsp90 inhibitors yielded considerable radiosensitization only when they cause early and pronounced Hsp70 induction; moreover, a magnitude of radiosensitization was positively correlated with the level of Hsp70 induction. The quantification of Hsp70 levels in Hsp90 inhibitor-treated normal and cancer cells enabled to predict which of them will be susceptible to any Hsp90-inhibiting radiosensitizer as well as what concentrations of the inhibitors ensure the preferential cytotoxicity in the irradiated tumors without aggravating radiation damage to adjacent normal tissues. Importantly, the Hsp70 induction in the Hsp90 inhibitor-treated cancer cells appears to be their protective response that alleviates the tumor-sensitizing effects of the Hsp90 inactivation. Combination of the Hsp70-inducing inhibitors of Hsp90 with known inhibitors of the Hsp induction such as quercetin, triptolide, KNK437, NZ28 prevented up-regulation of Hsp70 in the cancer cells thereby increasing their post-radiation apoptotic/necrotic death and decreasing their post-radiation viability/clonogenicity. Similarly, co-treatment with the two inhibitors conferred the enhanced radiosensitization of proliferating rather than quiescent human vascular endothelial cells which may be used for suppressing the tumor-stimulated angiogenesis. Thus, the easily immunodetectable Hsp70 induction can be a useful marker for predicting effects of Hsp90-inhibiting radiosensitizers on tumors and normal tissues exposed to ionizing radiation. Moreover, targeting the Hsp70 induction in Hsp90 inhibitor-treated cancer cells and tumor vasculature cells may beneficially enhance the radiosensitizing effect.	[Kudryavtsev, Vladimir A.; Khokhlova, Anna V.; Mosina, Vera A.; Selivanova, Elena I.; Kabakov, Alexander E.] A Tsyb Med Radiol Res Ctr, Dept Radiat Biochem, Obninsk, Russia		Kabakov, AE (corresponding author), A Tsyb Med Radiol Res Ctr, Dept Radiat Biochem, Obninsk, Russia.	aekabakov@hotmail.com	Khokhlova, Anna/E-5181-2018; Kabakov, Alexander/S-9998-2017; Mosina, Vera/AAH-7502-2020; Selivanova, Elena I/T-1002-2017	Khokhlova, Anna/0000-0002-4391-6321; 				Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Bases R, 2006, CELL STRESS CHAPERON, V11, P240, DOI 10.1379/CSC-185R.1; Bisht KS, 2003, CANCER RES, V63, P8984; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Dote H, 2005, CANCER RES, V65, P6967, DOI 10.1158/0008-5472.CAN-05-1304; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Fujii Y, 2010, ONCOL REP, V23, P199, DOI 10.3892/or_00000623; Gabai VL, 2010, ONCOGENE, V29, P1952, DOI 10.1038/onc.2009.480; Goda K, 2009, CURR CANCER DRUG TAR, V9, P281, DOI 10.2174/156800909788166493; Guttmann DM, 2011, CANCER BIOL THER, V12, P1023, DOI 10.4161/cbt.12.12.18374; HOSOKAWA N, 1992, MOL CELL BIOL, V12, P3490, DOI 10.1128/MCB.12.8.3490; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Kabakov A.E., 2013, HEAT SHOCK PROTEINS, P25; Kabakov AE, 2006, RADIAT RES, V165, P410, DOI 10.1667/RR3514.1; Kabakov AE, 2008, INT J RADIAT ONCOL, V71, P858, DOI 10.1016/j.ijrobp.2008.02.034; Kabakov AE, 2011, METHODS MOL BIOL, V787, P231, DOI 10.1007/978-1-61779-295-3_17; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Koll TT, 2008, MOL CANCER THER, V7, P1985, DOI 10.1158/1535-7163.MCT-07-2104; Matsumoto Y, 2005, J RADIAT RES, V46, P215, DOI 10.1269/jrr.46.215; MICHELS AA, 1995, EUR J BIOCHEM, V234, P382, DOI 10.1111/j.1432-1033.1995.382_b.x; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Paul K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059505; Pennisi R, 2015, BIOMOLECULES, V5, P2589, DOI 10.3390/biom5042589; Russell JS, 2003, CLIN CANCER RES, V9, P3749; Schilling D, 2015, CANCER LETT, V360, P294, DOI 10.1016/j.canlet.2015.02.033; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Shintani S, 2006, INT J ONCOL, V29, P1111; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Taldone T, 2014, EXPERT OPIN THER PAT, V24, P501, DOI 10.1517/13543776.2014.887681; Tatokoro M, 2015, EXCLI J, V14, P48, DOI 10.17179/excli2015-586; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Voronezhskaya EE, 2004, DEVELOPMENT, V131, P3671, DOI 10.1242/dev.01237; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Yokota S, 2000, CANCER RES, V60, P2942; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692; Zaidi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035436; Zorzi Elisa, 2011, Cancers (Basel), V3, P3921, DOI 10.3390/cancers3043921	41	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173640	10.1371/journal.pone.0173640	http://dx.doi.org/10.1371/journal.pone.0173640			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291803	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700034
J	Besson, M; de Boer, IJM; Vandeputte, M; van Arendonk, JAM; Quillet, E; Komen, H; Aubin, J				Besson, M.; de Boer, I. J. M.; Vandeputte, M.; van Arendonk, J. A. M.; Quillet, E.; Komen, H.; Aubin, J.			Effect of production quotas on economic and environmental values of growth rate and feed efficiency in sea cage fish farming	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; NITROGEN OUTPUT LIMITATIONS; GREENHOUSE-GAS EMISSIONS; LIFE-CYCLE ASSESSMENT; SALMON SALMO-SALAR; WATER TEMPERATURE; PRODUCTION SYSTEMS; DAIRY-COWS; SELECTION; IMPACT	In sea cage fish farming, production quotas aim to constrain the impact of fish farming on the surrounding ecosystem. It is unknown how these quotas affect economic profitability and environmental impact of genetic improvement. We combined bioeconomic modelling with life cycle assessment (LCA) to calculate the economic (EV) and environmental (ENV) values of thermal growth coefficient (TGC) and feed conversion ratio (FCR) of sea bass reared in sea cages, given four types of quota commonly used in Europe: annual production (Qprod), annual feed distributed (Qannual_ feed), standing stock (Qstock), and daily feed distributed (Qdaily_ feed). ENV were calculated for LCA impact categories climate change, eutrophication and acidification. ENV were expressed per ton of fish produced per year (ENV(fish)) and per farm per year (ENV(farm)). Results show that irrespective of quota used, EV of FCR as well as ENV(fish) and ENV(farm) were always positive, meaning that improving FCR increased profit and decreased environmental impacts. However, the EV and the ENV(fish) of TGC were positive only when quota was Qstock or Qdaily_ feed. Moreover, the ENV(farm) of TGC was negative in Qstock and Qdaily_ feed quotas, meaning that improving TGC increased the environmental impact of the farm. We conclude that Qstock quota and Qdaily_ feed quota are economically favorable to a genetic improvement of TGC, a major trait for farmers. However, improving TGC increases the environmental impact of the farm. Improving FCR represents a good opportunity to balance out this increase but more information on its genetic background is needed to develop breeding programs improving FCR.	[Besson, M.; van Arendonk, J. A. M.; Komen, H.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Besson, M.; Vandeputte, M.; Quillet, E.] Univ Paris Saclay, AgroParisTech, INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [de Boer, I. J. M.] Wageningen Univ, Anim Prod Syst Grp, Wageningen, Netherlands; [Vandeputte, M.] IFREMER, Chemin Maguelone, Palavas Les Flots, France; [Aubin, J.] INRA, Agrocampus Ouest, Sol Agron Spatialisat UMR1069, Rennes, France	Wageningen University & Research; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research; Ifremer; INRAE; Institut Agro; Agrocampus Ouest	Besson, M (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands.; Besson, M (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Genet Anim & Biol Integrat, Jouy En Josas, France.	mathieu.besson@inra.fr	SAS, ASAE UMR/M-4978-2013; de Boer, Imke/P-7107-2014; Vandeputte, Marc/I-7218-2019; Aubin, Joël/ABC-7952-2020; Komen, Hans/D-8876-2012; van Arendonk, Johan/E-2536-2011; Aubin, Joel/B-8740-2016; Vandeputte, Marc/A-4734-2011	SAS, ASAE UMR/0000-0001-6346-7845; de Boer, Imke/0000-0002-0675-7528; Vandeputte, Marc/0000-0001-9929-4587; Aubin, Joël/0000-0003-4081-5426; van Arendonk, Johan/0000-0003-2592-3947; Vandeputte, Marc/0000-0001-9929-4587; Besson, Mathieu/0000-0001-7662-5451	IMARES [512052-EM-1-2010-FR-ERA MUNDUSEMJD]; European Commission [512052-EM-1-2010-FR-ERA MUNDUSEMJD]	IMARES; European Commission(European CommissionEuropean Commission Joint Research Centre)	M. Besson benefited from a joint grant from the European Commission and IMARES (512052-EM-1-2010-FR-ERA MUNDUSEMJD), within the framework of the Erasmus-Mundus joint doctorate "EGS-ABG".; M. Besson benefited from a joint grant from the European Commission and IMARES, within the framework of the Erasmus-Mundus joint doctorate "EGS-ABG". The authors thank Gloria Maris and Biomar for their collaboration.	Asche F., 2011, EC SALMON AQUACULTUR; Aubin J, 2009, J CLEAN PROD, V17, P354, DOI 10.1016/j.jclepro.2008.08.008; Aubin J., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138011; Bell MJ, 2011, J DAIRY SCI, V94, P3662, DOI 10.3168/jds.2010-4023; Bell MJ, 2010, ANIM PROD SCI, V50, P817, DOI 10.1071/AN10038; Besson M, 2016, AQUACULTURE, V462, P47, DOI 10.1016/j.aquaculture.2016.04.030; Besson M, 2016, J CLEAN PROD, V116, P100, DOI 10.1016/j.jclepro.2015.12.084; Besson M, 2014, J ANIM SCI, V92, P5394, DOI 10.2527/jas.2014-8266; Boissy J, 2011, AQUACULTURE, V321, P61, DOI 10.1016/j.aquaculture.2011.08.033; Cho C Y, 1990, World Rev Nutr Diet, V61, P132; COWEY CB, 1991, P 1 INT S NUTR STRAT; de Bruijn H., 2002, HDB LIFE CYCLE ASSES, V7; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Ervik A, 1997, AQUACULTURE, V158, P85, DOI 10.1016/S0044-8486(97)00186-5; FAO, 2014, NAT AQ LEG OV; FAO, 2014, VUE GEN SECT AQ NAT; FAO, 2014, CULT AQ SPEC INF PRO; FOLKE C, 1994, J ENVIRON MANAGE, V40, P173, DOI 10.1006/jema.1994.1013; GIBSON JP, 1989, ANIM PROD, V49, P171, DOI 10.1017/S0003356100032293; GROEN AF, 1989, LIVEST PROD SCI, V22, P17, DOI 10.1016/0301-6226(89)90122-X; Hansen PK, 2001, AQUACULTURE, V194, P75, DOI 10.1016/S0044-8486(00)00520-2; Hazel LN, 1943, GENETICS, V28, P476; Holmer Marianne, 2008, P47, DOI 10.1007/978-1-4020-6810-2_2; Janssen K., 2016, AQUACULTURE; Kause A, 2006, J ANIM SCI, V84, P807, DOI 10.2527/2006.844807x; Lanari D, 2002, ITAL J ANIM SCI, V1, P181, DOI 10.4081/ijas.2002.181; Lundebye A-K., 2013, SITE SELECTION CARRY, P171; Mallet JP, 1999, CAN J FISH AQUAT SCI, V56, P994, DOI 10.1139/cjfas-56-6-994; Mambrini M, 2004, J ANIM SCI, V82, P2865; Mente E, 2006, AQUACULT INT, V14, P499, DOI 10.1007/s10499-006-9051-4; Pelletier N, 2007, AQUACULTURE, V272, P399, DOI 10.1016/j.aquaculture.2007.06.024; Pelletier NL, 2007, INT J LIFE CYCLE ASS, V12, P414, DOI 10.1065/lca2006.09.275; Person-Le Ruyet J, 2004, AQUACULTURE, V237, P269, DOI 10.1016/j.aquaculture.2004.04.021; R Core Team, 2018, R LANG ENV STAT COMP; Read P, 2003, AQUACULTURE, V226, P139, DOI 10.1016/S0044-8486(03)00474-5; Rose G, 2015, ANIMAL, V9, P1268, DOI 10.1017/S1751731115000476; Sanchez MP, 2001, AQUAT LIVING RESOUR, V14, P41, DOI 10.1016/S0990-7440(00)01103-7; Stigebrandt A, 2004, AQUACULTURE, V234, P239, DOI 10.1016/j.aquaculture.2003.11.029; SUTHERLAND TM, 1965, BIOMETRICS, V21, P739, DOI 10.2307/2528555; Thodesen J, 2001, AQUACULTURE, V194, P273, DOI 10.1016/S0044-8486(00)00527-5; van Middelaar CE, 2014, J DAIRY SCI, V97, P5191, DOI 10.3168/jds.2013-7413; Vandeputte M, 2014, AQUACULTURE, V424, P239, DOI 10.1016/j.aquaculture.2014.01.005; Wall E, 2010, ANIMAL, V4, P366, DOI 10.1017/S175173110999070X; Ytrestoyl T, 2015, AQUACULTURE, V448, P365, DOI 10.1016/j.aquaculture.2015.06.023	44	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173131	10.1371/journal.pone.0173131	http://dx.doi.org/10.1371/journal.pone.0173131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288179	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400007
J	Daud, ANA; Bergman, JEH; Oktora, MP; Kerstjens-Frederikse, WS; Groen, H; Bos, JH; Hak, E; Wilffert, B				Daud, Aizati N. A.; Bergman, Jorieke E. H.; Oktora, Monika P.; Kerstjens-Frederikse, Wilhelmina S.; Groen, Henk; Bos, Jens H.; Hak, Eelko; Wilffert, Bob			Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies	PLOS ONE			English	Article							RESISTANCE PROTEIN BCRP/ABCG2; RNA EXPRESSION PROFILES; P-GLYCOPROTEIN; MESSENGER-RNA; MEMBRANE TRANSPORTERS; PREGNANCY; PHARMACOKINETICS; DISPOSITION; METABOLISM; EXPOSURE	Background A number of transporter proteins are expressed in the placenta, and they facilitate the placental transfer of drugs. The inhibition of P-glycoprotein (P-gp) was previously found to be associated with an increase in the risk of congenital anomalies caused by drug substrates of this transporter. We now explore the role of other placental transporter proteins. Methods A population-based case-referent study was performed using cases with congenital anomalies (N = 5,131) from EUROCAT Northern Netherlands, a registry of congenital anomalies. The referent population (N = 31,055) was selected from the pregnancy IADB. nl, a pharmacy prescription database. Results Ten placental transporters known to have comparable expression levels in the placenta to that of P-gp, were selected in this study. In total, 147 drugs were identified to be substrates, inhibitors or inducers, of these transporters. Fifty-eight of these drugs were used by at least one mother in our cases or referent population, and 28 were used in both. The highest user rate was observed for the substrates of multidrug resistance-associated protein 1, mainly folic acid (6% of cases, 8% of referents), and breast cancer resistance protein, mainly nitrofurantoin (2.3% of cases, 2.9% of referents). In contrast to P-gp, drug interactions involving substrates of these transporters did not have a significant effect on the risk of congenital anomalies. Conclusions Some of the drugs which are substrates or inhibitors of placental transporters were commonly used during pregnancy. No significant effect of transporter inhibition was found on fetal drug exposure, possibly due to a limited number of exposures.	[Daud, Aizati N. A.; Oktora, Monika P.; Bos, Jens H.; Hak, Eelko; Wilffert, Bob] Univ Groningen, Groningen Res Inst Pharm, PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands; [Daud, Aizati N. A.] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Bergman, Jorieke E. H.; Kerstjens-Frederikse, Wilhelmina S.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wilffert, Bob] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands	University of Groningen; Universiti Sains Malaysia; University of Groningen; University of Groningen; University of Groningen	Daud, ANA (corresponding author), Univ Groningen, Groningen Res Inst Pharm, PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands.; Daud, ANA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	aizati.daud@gmail.com	Daud, Aizati N.A./P-8506-2017; Kerstjens-Frederikse, Wilhelmina/GSE-0282-2022; Groen, Henk/B-2163-2013; Daud, Adil/T-3079-2019	Daud, Aizati N.A./0000-0003-4336-9468; Groen, Henk/0000-0002-6629-318X; Daud, Adil/0000-0002-6617-8421; Oktora, Monika/0000-0002-3116-787X; Kerstjens, Mieke/0000-0003-2528-2203	Ministry of Health, Welfare and Sports, the Netherlands; University of Groningen, The Netherlands; Ministry of Education in Malaysia; Universiti Sains Malaysia	Ministry of Health, Welfare and Sports, the Netherlands; University of Groningen, The Netherlands(Netherlands Government); Ministry of Education in Malaysia; Universiti Sains Malaysia(Universiti Sains Malaysia)	EUROCAT NNL is funded by the Ministry of Health, Welfare and Sports, the Netherlands. The IADB.nl database is funded by the University of Groningen, The Netherlands. Aizati Daud also thanks the Ministry of Education in Malaysia and Universiti Sains Malaysia for the scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EUROCAT GUID 1 3 REF; Ceccaldi PF, 2009, OBSTET GYNECOL INT, V2009, DOI 10.1155/2009/726593; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Daud ANA, 2015, DRUG SAFETY, V38, P651, DOI 10.1007/s40264-015-0299-3; Endres CJ, 2006, EUR J PHARM SCI, V27, P501, DOI 10.1016/j.ejps.2005.11.002; Ganapathy Vadivel, 2005, Toxicol Appl Pharmacol, V207, P381, DOI 10.1016/j.taap.2005.02.023; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hahnova-Cygalova L, 2011, DRUG METAB REV, V43, P53, DOI 10.3109/03602532.2010.512293; Ho RH, 2005, CLIN PHARMACOL THER, V78, P260, DOI 10.1016/j.clpt.2005.05.011; Holcberg G, 2003, EUR J OBSTET GYN R B, V109, P133, DOI 10.1016/S0301-2115(02)00513-4; Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc; Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008; Isoherranen N, 2013, DRUG METAB DISPOS, V41, P256, DOI 10.1124/dmd.112.050245; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Lee N, 2013, DRUG METAB DISPOS, V41, P2225, DOI 10.1124/dmd.113.054072; Mao QC, 2015, AAPS J, V17, P65, DOI 10.1208/s12248-014-9668-6; May K, 2008, DRUG METAB DISPOS, V36, P740, DOI 10.1124/dmd.107.019448; Molsa M, 2005, CLIN PHARMACOL THER, V78, P123, DOI 10.1016/j.clpt.2005.04.014; Muller F, 2011, PHARMACOGENOMICS, V12, P1017, DOI [10.2217/PGS.11.44, 10.2217/pgs.11.44]; Myllynen P, 2009, EXPERT OPIN DRUG MET, V5, P1483, DOI 10.1517/17425250903304049; Nanovskaya T, 2005, BIOCHEM PHARMACOL, V69, P1869, DOI 10.1016/j.bcp.2005.03.030; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Nishimura M, 2009, DRUG METAB PHARMACOK, V24, P91, DOI 10.2133/dmpk.24.91; Prouillac C, 2010, DRUG METAB DISPOS, V38, P1623, DOI 10.1124/dmd.110.033571; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Rubinchik-Stern M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00126; Schirm E, 2004, J CLIN EPIDEMIOL, V57, P737, DOI 10.1016/j.jclinepi.2002.12.001; St-Pierre MV, 2002, J CLIN ENDOCR METAB, V87, P1856, DOI 10.1210/jc.87.4.1856; Staud F, 2015, EXPERT OPIN DRUG MET, V11, P533, DOI 10.1517/17425255.2015.1005073; Staud F, 2012, J DRUG TARGET, V20, P736, DOI 10.3109/1061186X.2012.716847; Syme MR, 2004, CLIN PHARMACOKINET, V43, P487, DOI 10.2165/00003088-200443080-00001; Ugele B, 2008, J STEROID BIOCHEM, V111, P1, DOI 10.1016/j.jsbmb.2008.04.001; Unadkat JD, 2004, CURR DRUG METAB, V5, P125, DOI 10.2174/1389200043489171; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; van Roon EN, 2005, DRUG SAFETY, V28, P1131, DOI 10.2165/00002018-200528120-00007; Visser ST, 2013, EXPERT REV PHARM OUT, V13, P285, DOI [10.1586/ERP.13.20, 10.1586/erp.13.20]; Wang ZJ, 2008, PHARMACOGENET GENOM, V18, P637, DOI 10.1097/FPC.0b013e328302cd41; Xia BF, 2013, AAPS J, V15, P1012, DOI 10.1208/s12248-013-9505-3; Yeboah D, 2006, CAN J PHYSIOL PHARM, V84, P1251, DOI 10.1139/Y06-078	41	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173530	10.1371/journal.pone.0173530	http://dx.doi.org/10.1371/journal.pone.0173530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288183	gold, Green Published, Green Submitted			2022-12-26	WOS:000396092400018
J	Nam, KW; Kim, CK; Kim, TJ; An, SJ; Oh, K; Mo, H; Kang, MK; Han, MK; Demchuk, AM; Ko, SB; Yoon, BW				Nam, Ki-Woong; Kim, Chi Kyung; Kim, Tae Jung; An, Sang Joon; Oh, Kyungmi; Mo, Heejung; Kang, Min Kyoung; Han, Moon-Ku; Demchuk, Andrew M.; Ko, Sang-Bae; Yoon, Byung-Woo			Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke	PLOS ONE			English	Article							SURVIVAL	Background Stroke in cancer patients is not rare but is a devastating event with high mortality. However, the predictors of mortality in stroke patients with cancer have not been well addressed. D-dimer could be a useful predictor because it can reflect both thromboembolic events and advanced stages of cancer. Aim In this study, we evaluate the possibility of D-dimer as a predictor of 30-day mortality in stroke patients with active cancer. Methods We included 210 ischemic stroke patients with active cancer. The 30-day mortality data were collected by reviewing medical records. We also collected follow-up D-dimer levels in 106 (50%) participants to evaluate the effects of treatment response on D-dimer levels. Results Of the 210 participants, 30-day mortality occurred in 28 (13%) patients. Higher initial NIHSS scores, D-dimer levels, and CRP levels as well as frequent cryptogenic mechanism, systemic metastasis, multiple vascular territory lesion, hemorrhagic transformation, and larger infarct volume were related to 30-day mortality. In the multivariate analysis, D-dimer [adjusted OR (aOR) = 2.19; 95% CI, 1.46-3.28, P < 0.001] predicted 30-day mortality after adjusting for confounders. The initial NIHSS score (aOR = 1.07; 95% CI, 1.00-1.14, P = 0.043) and hemorrhagic transformation (aOR = 3.02; 95% CI, 1.10-8.29, P = 0.032) were also significant independent of D-dimer levels. In the analysis of D-dimer changes after treatment, the mortality group showed no significant decrease in D-dimer levels, despite treatment, while the survivor group showed the opposite response. Conclusions D-dimer levels may predict 30-day mortality in acute ischemic stroke patients with active cancer.	[Nam, Ki-Woong; Kim, Tae Jung; An, Sang Joon; Mo, Heejung; Kang, Min Kyoung; Ko, Sang-Bae; Yoon, Byung-Woo] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Kim, Chi Kyung; Oh, Kyungmi] Korea Univ, Dept Neurol, Guro Hosp, Seoul, South Korea; [Kim, Chi Kyung; Oh, Kyungmi] Korea Univ, Coll Med, Seoul, South Korea; [Kim, Chi Kyung; Demchuk, Andrew M.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci & Radiol, Calgary Stroke Program, Calgary, AB, Canada; [Han, Moon-Ku] Seoul Natl Univ, Dept Neurol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Calgary; Seoul National University (SNU)	Yoon, BW (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.	bwyoon@snu.ac.kr	Kim, Chi Kyung/AAR-9819-2020; Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Oh, Kyungmi/0000-0002-7304-0308; Ko, Sang-Bae/0000-0002-9429-9597; Nam, Ki-Woong/0000-0001-7514-6264	R&D support grant of Korea University Guro Hospital, Republic of Korea [01600161]; Ministry of Health and Welfare, Republic of Korea [HI16C1078]; Alberta Innovates [201300690] Funding Source: researchfish	R&D support grant of Korea University Guro Hospital, Republic of Korea; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Alberta Innovates	This work was funded by the R&D support grant (01600161) of Korea University Guro Hospital, Republic of Korea.; This work was supported by the R&D support grant (01600161) of Korea University Guro Hospital, Republic of Korea and by the Ministry of Health and Welfare (HI16C1078), Republic of Korea. The funding organization had no role in the design, conduct, or analyses conducted during this study or the preparation of this report.	Bang OY, 2011, J CLIN NEUROL, V7, P53, DOI 10.3988/jcn.2011.7.2.53; Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj.bjc.6600069; el-Shami K, 2007, ONCOLOGIST, V12, P518, DOI 10.1634/theoncologist.12-5-518; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; GRAUS F, 1985, MEDICINE, V64, P16, DOI 10.1097/00005792-198501000-00002; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Jeong HG, 2015, STROKE, V46, P687, DOI 10.1161/STROKEAHA.114.007466; Kim SG, 2010, STROKE, V41, P798, DOI 10.1161/STROKEAHA.109.571356; Lee AY, 2002, CANCER TREAT REV, V28, P137, DOI 10.1016/S0305-7372(02)00044-0; Lee MJ, 2016, STROKE, V5, P7; Oya M, 2001, JPN J CLIN ONCOL, V31, P388, DOI 10.1093/jjco/hye075; Saposnik G, 2008, STROKE, V39, P2318, DOI 10.1161/STROKEAHA.107.510362; Schwarzbach CJ, 2012, STROKE, V43, P3029, DOI 10.1161/STROKEAHA.112.658625; Schwarzbach CJ, 2015, CEREBROVASC DIS EXTR, V5, P139, DOI 10.1159/000439549; Seok JM, 2010, ANN NEUROL, V68, P213, DOI 10.1002/ana.22050; SILVER FL, 1984, STROKE, V15, P492, DOI 10.1161/01.STR.15.3.492; Szczudiik A, 2000, Med Sci Monit, V6, P75; Taccone Fabio Silvio, 2008, J Stroke Cerebrovasc Dis, V17, P169, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.007; Zi WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086465	19	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172793	10.1371/journal.pone.0172793	http://dx.doi.org/10.1371/journal.pone.0172793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282388	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800012
J	Parulekar, NN; Kolekar, P; Jenkins, A; Kleiven, S; Utkilen, H; Johansen, A; Sawant, S; Kulkarni-Kale, U; Kale, M; Saebo, M				Parulekar, Niranjan Nitin; Kolekar, Pandurang; Jenkins, Andrew; Kleiven, Synne; Utkilen, Hans; Johansen, Anette; Sawant, Sangeeta; Kulkarni-Kale, Urmila; Kale, Mohan; Saebo, Mona			Characterization of bacterial community associated with phytoplankton bloom in a eutrophic lake in South Norway using 16S rRNA gene amplicon sequence analysis	PLOS ONE			English	Article							SP-NOV.; HETEROTROPHIC BACTERIA; CYANOBACTERIAL BLOOMS; PROKARYOTIC DIVERSITY; METAGENOMIC ANALYSIS; ORGANIC-CARBON; ABUNDANT GROUP; GROWTH-RATES; WATER; BACTERIOPLANKTON	Interactions between different phytoplankton taxa and heterotrophic bacterial communities within aquatic environments can differentially support growth of various heterotrophic bacterial species. In this study, phytoplankton diversity was studied using traditional microscopic techniques and the bacterial communities associated with phytoplankton bloom were studied using High Throughput Sequencing ((HTS) analysis of 16S rRNA gene amplicons from the V1-V3 and V3-V4 hypervariable regions. Samples were collected from Lake Akersvannet, a eutrophic lake in South Norway, during the growth season from June to August 2013. Microscopic examination revealed that the phytoplankton community was mostly represented by Cyanobacteria and the dinoflagellate Ceratium hirundinella. The HTS results revealed that Proteobacteria ((Alpha, Beta, and Gamma), Bacteriodetes, Cyanobacteria, Actinobacteria and Verrucomicrobia dominated the bacterial community, with varying relative abundances throughout the sampling season. Species level identification of Cyanobacteria showed a mixed population of Aphanizomenon flos-aquae, Microcystis aeruginosa and Woronichinia naegeliana. A significant proportion of the microbial community was composed of unclassified taxa which might represent locally adapted freshwater bacterial groups. Comparison of cyanobacterial species composition from HTS and microscopy revealed quantitative discrepancies, indicating a need for cross validation of results. To our knowledge, this is the first study that uses HTS methods for studying the bacterial community associated with phytoplankton blooms in a Norwegian lake. The study demonstrates the value of considering results from multiple methods when studying bacterial communities.	[Parulekar, Niranjan Nitin; Jenkins, Andrew; Kleiven, Synne; Utkilen, Hans; Johansen, Anette; Saebo, Mona] Univ Coll Southeast Norway, Fac Technol Nat Sci & Maritime Sci, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway; [Kolekar, Pandurang; Sawant, Sangeeta; Kulkarni-Kale, Urmila] Savitribai Phule Pune Univ, Bioinformat Ctr, Pune, Maharashtra, India; [Kale, Mohan] Savitribai Phule Pune Univ, Dept Stat, Pune, Maharashtra, India	University College of Southeast Norway; Savitribai Phule Pune University; Savitribai Phule Pune University	Parulekar, NN (corresponding author), Univ Coll Southeast Norway, Fac Technol Nat Sci & Maritime Sci, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway.	niranjan.n.parulekar@usn.no	Kolekar, Pandurang/ABF-7389-2020; Kulkarni-Kale, Urmila/G-6946-2011	Kolekar, Pandurang/0000-0003-0044-0076; Jenkins, Andrew/0000-0003-2588-8483	SIU, Norway; UGC, India; Indo-Norwegian Cooperation Program	SIU, Norway; UGC, India(University Grants Commission, India); Indo-Norwegian Cooperation Program	We acknowledge funding from SIU, Norway and UGC, India under the Indo-Norwegian Cooperation Program (INCP-2014). None of the funds received from the Indo-Norwegian Cooperation Program were used specifically for this study.; The authors would like to thank Karin Brekke Li for technical assistance and guidance and Brett Neilan (University of New South Wales, Australia) for providing the DNA extraction protocol. We acknowledge funding from SIU, Norway and UGC, India under the Indo-Norwegian Cooperation Program (INCP-2014). None of the funds received from the Indo-Norwegian Cooperation Program were used specifically for this study.	Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Bagatini IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085950; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bertilsson S., 2003, AQUATIC ECOSYSTEMS I, P3, DOI DOI 10.1016/B978-012256371-3/50002-0; Blaha Ludek, 2009, Interdiscip Toxicol, V2, P36, DOI 10.2478/v10102-009-0006-2; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Brettar I, 2006, INT J SYST EVOL MICR, V56, P2177, DOI 10.1099/ijs.0.64172-0; Brettum P., 2004, 4818 SNO NORW I WAT, V4818, P33; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Cai M, 2002, J BACTERIOL, V184, P4672, DOI 10.1128/JB.184.17.4672-4680.2002; Cao Y, 1998, LIMNOL OCEANOGR, V43, P1403, DOI 10.4319/lo.1998.43.7.1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardman Z, 2014, APPL ENVIRON MICROB, V80, P3749, DOI 10.1128/AEM.00899-14; Chen C, 2011, PROCEDIA ENGINEER, V18, DOI 10.1016/j.proeng.2011.11.054; Chen WM, 2013, INT J SYST EVOL MICR, V63, P1457, DOI 10.1099/ijs.0.043836-0; Chorus EI, 1999, TOXIC CYANOBACTERIA, P1; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; COLE JJ, 1982, LIMNOL OCEANOGR, V27, P1080, DOI 10.4319/lo.1982.27.6.1080; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Dai GZ, 2012, GLOBAL CHANGE BIOL, V18, P1571, DOI 10.1111/j.1365-2486.2012.02638.x; Pinto PD, 2010, OIKOS, V119, P567, DOI 10.1111/j.1600-0706.2009.17924.x; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Dolman Andrew M, 2012, PLoS One, V7, pe38757, DOI 10.1371/journal.pone.0038757; Dziallas C, 2011, ENVIRON MICROBIOL, V13, P1632, DOI 10.1111/j.1462-2920.2011.02479.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eiler A, 2007, APPL ENVIRON MICROB, V73, P3511, DOI 10.1128/AEM.02534-06; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Falconer Ian R, 2005, Int J Environ Res Public Health, V2, P43, DOI 10.3390/ijerph2005010043; Feng XH, 1997, APPL ENVIRON MICROB, V63, P1332, DOI 10.1128/AEM.63.4.1332-1337.1997; Ferguson HW, 2004, J FISH DIS, V27, P249, DOI 10.1111/j.1365-2761.2004.00537.x; Fisher J, 2013, ACTA PROTOZOOL, V52, P203, DOI 10.4467/16890027AP.13.0018.1115; Fujii K, 2003, INT J SYST EVOL MICR, V53, P47, DOI 10.1099/ijs.0.02301-0; Fussel H-M, 2012, CLIM CHANG IMP VULN, P1725; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Harris TD, 2016, INLAND WATERS, V6, P199, DOI 10.5268/IW-6.2.938; Henriksen A, 1998, AMBIO, V27, P80; Imai H., 2009, INTERDISCIPLINARY ST, P269; Jiang LJ, 2007, HYDROBIOLOGIA, V581, P161, DOI 10.1007/s10750-006-0518-0; Jin L, 2014, INT J SYST EVOL MICR, V64, P762, DOI 10.1099/ijs.0.057240-0; Jin L, 2013, INT J SYST EVOL MICR, V63, P2559, DOI 10.1099/ijs.0.048884-0; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Karl David M., 1998, P29; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kielak A, 2010, FEMS MICROBIOL ECOL, V71, P23, DOI 10.1111/j.1574-6941.2009.00785.x; Kim MK, 2007, INT J SYST EVOL MICR, V57, P1527, DOI 10.1099/ijs.0.64579-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kolmonen E, 2004, AQUAT MICROB ECOL, V36, P201, DOI 10.3354/ame036201; Kormas KA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/463894; Louati I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140614; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Martinez-Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035314; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Miguens D, 2015, LIMNETICA, V34, P215; Miller TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074933; Miller TR, 2011, FEMS MICROBIOL ECOL, V78, P336, DOI 10.1111/j.1574-6941.2011.01162.x; Mou XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061890; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Olenina I., 2006, HELCON BALTIC SEA EN, P144; Oliver R. L., 2000, ECOLOGY CYANOBACTERI, P149, DOI [10.1007/0-306-46855-7_6, DOI 10.1007/0-306-46855-7_6]; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; PICK FR, 1987, NEW ZEAL J MAR FRESH, V21, P425, DOI 10.1080/00288330.1987.9516238; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; Pope PB, 2008, FEMS MICROBIOL ECOL, V64, P9, DOI 10.1111/j.1574-6941.2008.00448.x; Rapala J, 2005, INT J SYST EVOL MICR, V55, P1563, DOI 10.1099/ijs.0.63599-0; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Riemann L, 2001, MICROB ECOL, V42, P274, DOI 10.1007/s00248-001-0018-8; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Salcher MM, 2010, LIMNOL OCEANOGR, V55, P846, DOI 10.4319/lo.2009.55.2.0846; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Schartau AK, 2013, MILJOOVERVAKING VANN; Schirrmeister BE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-177; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shatwell T, 2008, GLOBAL CHANGE BIOL, V14, P2194, DOI 10.1111/j.1365-2486.2008.01630.x; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; Sime Ngando T., 1991, Archiv fuer Protistenkunde, V140, P109; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2011, APPL ENVIRON MICROB, V77, P7307, DOI 10.1128/AEM.05107-11; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; Sinha R, 2012, WATER RES, V46, P1408, DOI 10.1016/j.watres.2011.12.019; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Suchankova P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076431, 10.1371/journal.pone.0071284]; Tikkanen T, 1992, VAXTPLANKTONFLORA ST; Tillett D, 2000, J PHYCOL, V36, P251, DOI 10.1046/j.1529-8817.2000.99079.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tremblay Julien, 2015, Front Microbiol, V6, P771, DOI 10.3389/fmicb.2015.00771; Tsujimura Shigeo, 2001, Phycological Research, V49, P275, DOI 10.1111/j.1440-1835.2001.tb00257.x; Utkilen H., 1996, Phycologia, V35, P189, DOI 10.2216/i0031-8884-35-6S-189.1; Vareli K, 2009, J ENVIRON MONITOR, V11, P1506, DOI 10.1039/b903093j; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vinas M, 2005, CAN J MICROBIOL, V51, P897, DOI 10.1139/w05-090; Wang HJ, 2008, FRESHWATER BIOL, V53, P935, DOI 10.1111/j.1365-2427.2007.01950.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wehr J. D., 2003, FRESHWATER ALGAE N A; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27; Winsley T, 2012, APPL ENVIRON MICROB, V78, P5938, DOI 10.1128/AEM.01299-12; Wu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101837; Wu WJ, 2010, FRESEN ENVIRON BULL, V19, P846; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106510; Xie LQ, 2003, WATER RES, V37, P2073, DOI 10.1016/S0043-1354(02)00532-8; YABUUCHI E, 1990, MICROBIOL IMMUNOL, V34, P99, DOI 10.1111/j.1348-0421.1990.tb00996.x; Yamamoto Yoko, 1993, Japanese Journal of Phycology, V41, P215; Zarauz L, 2008, J PLANKTON RES, V30, P1297, DOI 10.1093/plankt/fbn084; Zheng W, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0110-9; Zhu L, 2014, APPL ENVIRON MICROB, V80, P1874, DOI 10.1128/AEM.02972-13; Zwart G, 2003, APPL ENVIRON MICROB, V69, P5875, DOI 10.1128/AEM.69.10.5875-5883.2003; Zwart G, 1998, SYST APPL MICROBIOL, V21, P546, DOI 10.1016/S0723-2020(98)80067-2; Zwisler W, 2003, AQUAT MICROB ECOL, V31, P211, DOI 10.3354/ame031211	123	50	55	7	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e173408	10.1371/journal.pone.0173408	http://dx.doi.org/10.1371/journal.pone.0173408			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282404	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800038
J	Raaijmakers, A; Jacobs, L; Rayyan, M; van Tienoven, TP; Ortibus, E; Levtchenko, E; Staessen, JA; Allegaert, K				Raaijmakers, Anke; Jacobs, Lotte; Rayyan, Maissa; van Tienoven, Theun Pieter; Ortibus, Els; Levtchenko, Elena; Staessen, Jan A.; Allegaert, Karel			Catch-up growth in the first two years of life in Extremely Low Birth Weight (ELBW) infants is associated with lower body fat in young adolescence	PLOS ONE			English	Article							CHILDREN BORN; PRETERM INFANTS; DEVELOPMENTAL-DISABILITY; BIOELECTRICAL-IMPEDANCE; POSTNATAL-GROWTH; PUBERTAL CHANGES; RESISTANT RULES; BLOOD-PRESSURE; AGE; PREMATURITY	Aim To investigate growth patterns and anthropometrics in former extremely low birth weight (ELBW, <1000 g) children and link these outcomes to neurocognition and body composition in childhood. Methods ELBW children were examined at birth (n = 140), at 9 and 24 months (n >= 96) and at approximately 11 years within the framework of the PREMATCH (PREMATurity as predictor children's of Cardiovascular and renal Health) case control (n = 93-87) study. Regional growth charts were used to convert anthropometrics into Z scores. Catch up growth in the first two years of life was qualified as present if Delta Z score >0.67 SDS. At 11 years, anthropometrics, neurocognitive performance, body composition, grip strength and puberty scores were assessed. Results ELBW neonates displayed extra uterine growth restriction with mean Z scores for height, weight and head circumference of 0.77, 0.93 and 0.46 at birth, 1.61, 1.67 and 0.72 at 9 months, 1.22, 1.61 and 0.84 at 24 months, and 0.42, 0.49 and 1.09 at 11 years. ELBW children performed consistently worse on neurocognitive testing with an average intelligence quotient equivalent at 11 years of 92.5 (SD 13.1). Catch up growth was not associated with neurocognitive performance. Compared to controls, ELBW cases had lower grip strength (13.6 vs. 15.9 kg) and percentage lean body weight (75.1 vs. 80.5%), but higher body fat (24.6 vs. 19.2%) and advanced puberty scores at 11 years (all P<0.025). Catch-up growth for weight and height in the first two years of life in cases was associated with a lower percentage body fat compared to cases without catch-up growth (16.8% catchup growth for weight vs. 25.7%, P<0.001; 20.9% catch-up for height vs. 25.8%, P= 0.049). Conclusions In young adolescence, former ELBW children still have difficulties to reach their target height. Compared to normal birth weight controls, ELBW adolescents show lower neurocognitive performance and grip strength and a higher percentage body fat, a potential risk factor for adverse health outcomes in adulthood. Our key finding is that catch-up growth in ELBW children in the first two years of life is associated with a lower percentage body fat and is therefore likely to be beneficial.	[Raaijmakers, Anke; Rayyan, Maissa; Ortibus, Els; Levtchenko, Elena] Univ Hosp Leuven, Dept Pediat & Neonatol, Leuven, Belgium; [Raaijmakers, Anke; Rayyan, Maissa; Levtchenko, Elena; Allegaert, Karel] Univ Leuven, KU Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Jacobs, Lotte] Univ Leuven, KU Leuven, Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Leuven, Belgium; [van Tienoven, Theun Pieter] Vrije Univ Brussel, Dept Sociol, Brussels, Belgium; [Staessen, Jan A.] Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands; [Allegaert, Karel] Erasmus MC, Sophia Childrens Hosp, Intens Care, Rotterdam, Netherlands; [Allegaert, Karel] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; Vrije Universiteit Brussel; Maastricht University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Raaijmakers, A (corresponding author), Univ Hosp Leuven, Dept Pediat & Neonatol, Leuven, Belgium.; Raaijmakers, A (corresponding author), Univ Leuven, KU Leuven, Dept Dev & Regenerat, Leuven, Belgium.	anke.raaijmakers@uzleuven.be	Staessen, Jan A/A-1065-2011; Ortibus, Els/GYJ-3215-2022; Levtchenko, Elena/AAO-7125-2020; allegaert, karel/C-3611-2016	Staessen, Jan A/0000-0002-3026-1637; allegaert, karel/0000-0001-9921-5105; Rayyan, Maissa/0000-0001-5718-6887; van Tienoven, Theun Pieter/0000-0003-1532-254X	"Agency for Innovation by Science and Technology in Flanders (IWT)" through the 'SAFE-PEDRUG' project [IWT/SBO 130033]; EURenOmics consortium [305608]; European Union [HEALTH-FP7-278249-EUMASCARA, HEALTH-F7-305507 HOMAGE]; European Research Council Advanced Researcher Grant [2011-294713-EXPLORE]; Fund for Scientific Research Flanders [G.0881.13, G.088013]	"Agency for Innovation by Science and Technology in Flanders (IWT)" through the 'SAFE-PEDRUG' project(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EURenOmics consortium; European Union(European Commission); European Research Council Advanced Researcher Grant(European Research Council (ERC)); Fund for Scientific Research Flanders(FWO)	This study was supported by the "Agency for Innovation by Science and Technology in Flanders (IWT)" through the 'SAFE-PEDRUG' project (IWT/SBO 130033). K.A. and E.L. are senior clinical investigators of the Fund for Scientific Research, Flanders (Fundamental Clinical lnvestigatorship, 1800214N and 1801110N) and E.L. is also supported by the EURenOmics consortium (grant agreement 305608). The European Union (HEALTH-FP7-278249-EUMASCARA, HEALTH-F7-305507 HOMAGE and the European Research Council Advanced Researcher Grant-2011-294713-EXPLORE) and the Fund for Scientific Research Flanders (G.0881.13 and G.088013) currently support the Studies Coordinating Centre in Leuven. J.A.S. is affiliated to R&D Group VitaK, part of Maastricht University, J. A.S. is not funded in any way by this affiliation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Breij LM, 2016, PEDIAT OBESITY; Clemm HH, 2015, ACTA PAEDIATR, V104, P1174, DOI 10.1111/apa.13080; Cole TJ, 2014, ARCH DIS CHILD-FETAL, V99, pF34, DOI 10.1136/archdischild-2012-303536; de Zegher F, 2016, PEDIAT OBESITY; de Zegher F, 2006, FERTIL STERIL, V86, pS4, DOI 10.1016/j.fertnstert.2006.03.013; DEVLIEGER H, 1993, CLIN NUTR, V12, P282, DOI 10.1016/0261-5614(93)90047-8; Embleton ND, 2016, ARCH DIS CHILDHOOD; Euser AM, 2008, HORM RES, V70, P319, DOI 10.1159/000161862; Euser AM, 2005, AM J CLIN NUTR, V81, P480; Feigin VL, 2016, LANCET NEUROLOGY; Fricke O, 2010, HORM RES PAEDIAT, V73, P390, DOI 10.1159/000308173; George I, 2011, PEDIATR NEPHROL, V26, P1843, DOI 10.1007/s00467-011-1883-0; Gianni ML, 2016, PEDIATR RES, V79, P710, DOI 10.1038/pr.2015.273; Guellec I, 2015, J PEDIATR-US, V167, P975, DOI 10.1016/j.jpeds.2015.08.025; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Ibanez L, 2006, MOL CELL ENDOCRINOL, V254, P22, DOI 10.1016/j.mce.2006.04.010; Ibanez L, 2011, FERTIL STERIL, V96, P220, DOI 10.1016/j.fertnstert.2011.03.107; Jarjour IT, 2015, PEDIATR NEUROL, V52, P143, DOI 10.1016/j.pediatrneurol.2014.10.027; Kerkhof GF, 2012, NAT REV ENDOCRINOL, V8, P689, DOI 10.1038/nrendo.2012.168; Lapillonne A, 2013, J PEDIATR-US, V162, pS7, DOI 10.1016/j.jpeds.2012.11.048; Lewandowski AJ, 2015, HYPERTENSION, V65, P607, DOI 10.1161/HYPERTENSIONAHA.114.04662; Ligi I, 2010, SEMIN PERINATOL, V34, P188, DOI 10.1053/j.semperi.2010.02.002; Lowe J, 2016, PAEDIAT RESP REV; Luo ZC, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e72; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Ong KK, 2015, ACTA PAEDIATR, V104, P974, DOI 10.1111/apa.13128; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Paul Alexandra, 2011, Int J Adolesc Med Health, V23, P175; Raaijmakers A, 2015, BLOOD PRESSURE, V24, P275, DOI 10.3109/08037051.2015.1053220; Ranke MB, 2015, DEV MED CHILD NEUROL, V57, P23, DOI 10.1111/dmcn.12582; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; SEGAL KR, 1991, AM J CLIN NUTR, V54, P26, DOI 10.1093/ajcn/54.1.26; Simeoni U, 2011, PEDIATR NEPHROL, V26, P493, DOI 10.1007/s00467-010-1648-1; Simon D, 2008, BEST PRACT RES CL EN, V22, P525, DOI 10.1016/j.beem.2008.03.003; Sniderman AD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003665; STEWART SP, 1993, BRIT J NUTR, V69, P645, DOI 10.1079/BJN19930066; Tanner J M, 1970, Arch Dis Child, V45, P819; Uthaya S, 2005, PEDIATR RES, V57, P211, DOI 10.1203/01.PDR.0000148284.58934.1C; VANDERMEULEN BF, 2002, BSID II NL DUTCH MAN; Vasquez-Garibay EM, 2014, NUTR HOSP, V30, P410, DOI 10.3305/nh.2014.30.2.7373; Wechsler D., 2008, WECHSLER NONVERBAL S; Wells GD, 2014, PEDIATR PULM, V49, P878, DOI 10.1002/ppul.22928; Welsh L, 2010, THORAX, V65, P165, DOI 10.1136/thx.2008.107474; Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Yamakawa T, 2016, EARLY HUM DEV, V92, P7, DOI 10.1016/j.earlhumdev.2015.10.019; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	54	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173349	10.1371/journal.pone.0173349	http://dx.doi.org/10.1371/journal.pone.0173349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278233	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900075
J	Bouillez, A; Rajabi, H; Jin, C; Samur, M; Tagde, A; Alam, M; Hiraki, M; Maeda, T; Hu, X; Adeegbe, D; Kharbanda, S; Wong, KK; Kufe, D				Bouillez, A.; Rajabi, H.; Jin, C.; Samur, M.; Tagde, A.; Alam, M.; Hiraki, M.; Maeda, T.; Hu, X.; Adeegbe, D.; Kharbanda, S.; Wong, K-K; Kufe, D.			MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer	ONCOGENE			English	Article							TOLL-LIKE RECEPTOR-9; ONCOPROTEIN; EXPRESSION; ACTIVATION; PATHWAY; ADENOCARCINOMA; INTERFERON; PROGNOSIS; BREAST; IFN	Immunotherapeutic approaches, particularly programmed death 1/programmed death ligand 1 (PD-1/PD-L1) blockade, have improved the treatment of non-small-cell lung cancer (NSCLC), supporting the premise that evasion of immune destruction is of importance for NSCLC progression. However, the signals responsible for upregulation of PD-L1 in NSCLC cells and whether they are integrated with the regulation of other immune-related genes are not known. Mucin 1 (MUC1) is aberrantly overexpressed in NSCLC, activates the nuclear factor-kappa B (NF-kappa B) p65. ZEB1 pathway and confers a poor prognosis. The present studies demonstrate that MUC1-C activates PD-L1 expression in NSCLC cells. We show that MUC1-C increases NF-kappa B p65 occupancy on the CD274/ PD-L1 promoter and thereby drives CD274 transcription. Moreover, we demonstrate that MUC1-C-induced activation of NF-kappa B -> ZEB1 signaling represses the TLR9 (toll-like receptor 9), IFNG, MCP-1 (monocyte chemoattractant protein-1) and GM-CSF genes, and that this signature is associated with decreases in overall survival. In concert with these results, targeting MUC1-C in NSCLC tumors suppresses PD-L1 and induces these effectors of innate and adaptive immunity. These findings support a previously unrecognized central role for MUC1-C in integrating PD-L1 activation with suppression of immune effectors and poor clinical outcome.	[Bouillez, A.; Rajabi, H.; Jin, C.; Samur, M.; Tagde, A.; Alam, M.; Hiraki, M.; Maeda, T.; Hu, X.; Adeegbe, D.; Kharbanda, S.; Wong, K-K; Kufe, D.] Harvard Med Sch, Dana Farber Canc Inst, Med Oncol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Dana Farber Canc Inst, Med Oncol, 450 Brookline Ave,Dana 830, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu		Samur, Mehmet/0000-0002-9978-5682; Adeegbe, Dennis/0000-0001-9233-3328	National Cancer Institute of the National Institutes of Health [CA97098, CA166480]; Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R21CA216553, P50CA100707, R01CA166480, R01CA097098] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers CA97098 and CA166480, and by the Lung Cancer Research Foundation.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Awaya H, 2004, AM J CLIN PATHOL, V121, P644, DOI 10.1039/U4WGE9EBFJN6CM8R; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bouillez A, 2016, CANCER RES, V76, P1538, DOI 10.1158/0008-5472.CAN-15-1804; Carrizosa DR, 2015, TRANSL LUNG CANCER R, V4, P553, DOI 10.3978/j.issn.2218-6751.2015.06.05; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chatterjee S, 2014, CANCER RES, V74, P5008, DOI 10.1158/0008-5472.CAN-13-2698; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Cherfils-Vicini J, 2010, J CLIN INVEST, V120, P1285, DOI 10.1172/JCI36551; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dajon M, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.991615; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Gnemmi V, 2014, CANCER LETT, V346, P225, DOI 10.1016/j.canlet.2013.12.029; Goodwin JM, 2014, MOL CELL, V55, P436, DOI 10.1016/j.molcel.2014.06.021; Gowrishankar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123410; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Hasegawa M, 2015, CLIN CANCER RES, V21, P2338, DOI 10.1158/1078-0432.CCR-14-3000; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jarrard JA, 1998, CANCER RES, V58, P5582; Kharbanda A, 2014, CLIN CANCER RES, V20, P5423, DOI 10.1158/1078-0432.CCR-13-3168; Kharbanda A, 2014, ONCOTARGET, V5, P8893, DOI 10.18632/oncotarget.2360; Khodarev NN, 2009, CANCER RES, V69, P2833, DOI 10.1158/0008-5472.CAN-08-4513; Koyama S, 2016, CANCER RES, V76, P999, DOI 10.1158/0008-5472.CAN-15-1439; KUFE D, 2009, CANCER BIOL THER, V8, P1201; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee J, 2009, BIOCHEM J, V421, P301, DOI 10.1042/BJ20090013; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Lou Y, 2016, CLIN CANCER RES, V31, P245; MacDermed DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-16; Mak MP, 2016, CLIN CANCER RES, V22, P609, DOI 10.1158/1078-0432.CCR-15-0876; Mayor M, 2016, EUR J CARDIO-THORAC, V49, P1324, DOI 10.1093/ejcts/ezv371; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Pivarcsi A, 2007, P NATL ACAD SCI USA, V104, P19055, DOI 10.1073/pnas.0705673104; Raina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135156; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Rajabi H, 2014, ONCOGENE, V33, P1680, DOI 10.1038/onc.2013.114; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Reck M, 2015, SEMIN ONCOL, V42, P402, DOI 10.1053/j.seminoncol.2015.02.013; Ronkainen H, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-84; Samur MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106397; Sandholm J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00330; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seliger B, 2008, ADV CANCER RES, V101, P249, DOI 10.1016/S0065-230X(08)00407-7; Situ DR, 2011, MED ONCOL, V28, pS596, DOI 10.1007/s12032-010-9752-4; Sunaga N, 2012, INT J CANCER, V130, P1733, DOI 10.1002/ijc.26164; Tagde A, 2016, BLOOD, V127, P2587, DOI 10.1182/blood-2015-07-659151; Takahashi H, 2015, ONCOGENE, V34, P5187, DOI 10.1038/onc.2014.442; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Welsh EA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-153; Xie Y, 2011, CLIN CANCER RES, V17, P5705, DOI 10.1158/1078-0432.CCR-11-0196; Xu F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002286	66	69	74	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 13	2017	36	28					4037	4046		10.1038/onc.2017.47	http://dx.doi.org/10.1038/onc.2017.47			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FA3YD	28288138	Green Accepted, Green Submitted			2022-12-26	WOS:000405379900009
J	Wen, J; Zeng, YW; Fang, ZQ; Gu, JJ; Ge, LX; Tang, F; Qu, ZP; Hu, J; Cui, YR; Zhang, KS; Wang, JB; Li, SG; Sun, Y; Jin, Y				Wen, Jing; Zeng, Yanwu; Fang, Zhuoqing; Gu, Junjie; Ge, Laixiang; Tang, Fan; Qu, Zepeng; Hu, Jing; Cui, Yaru; Zhang, Kushan; Wang, Junbang; Li, Siguang; Sun, Yi; Jin, Ying			Single-cell analysis reveals lineage segregation in early post-implantation mouse embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TRANSCRIPTION FACTOR; FATE DECISIONS; EXPRESSION ANALYSIS; PROGENITOR CELLS; BETA-CATENIN; PLURIPOTENCY; GASTRULATION; ENDODERM; AXIS	The mammalian post-implantation embryo has been extensively investigated at the tissue level. However, to unravel the molecular basis for the cell-fate plasticity and determination, it is essential to study the characteristics of individual cells. In particular, the individual definitive endoderm (DE) cells have not been characterized in vivo. Here, we report gene expression patterns in single cells freshly isolated from mouse embryos on days 5.5 and 6.5. Initial transcriptome data from 124 single cells yielded signature genes for the epiblast, visceral endoderm, and extra-embryonic ectoderm and revealed a unique distribution pattern of fibroblast growth factor (FGF) ligands and receptors. Further analysis indicated that early-stage epiblast cells do not segregate into lineages of the major germ layers. Instead, some cells began to diverge from epiblast cells, displaying molecular features of the premesendoderm by expressing higher levels of mesendoderm markers and lower levels of Sox3 transcripts. Analysis of single-cell high-throughput quantitative RT-PCR data from 441 cells identified a late stage of the day 6.5 embryo in which mesoderm and DE cells emerge, with many of them coexpressing Oct4 and Gata6. Analysis of single-cell RNA-sequence data from 112 cells of the late-stage day 6.5 embryos revealed differentially expressed signaling genes and networks of transcription factors that might underlie the segregation of the mesoderm and DE lineages. Moreover, we discovered a subpopulation of mesoderm cells that possess molecular features of the extraembryonic mesoderm. This study provides fundamental insight into the molecular basis for lineage segregation in post-implantation mouse embryos.	[Wen, Jing; Fang, Zhuoqing; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med,Shanghai Inst Biol Sci, Chinese Acad Sci,Key Lab Stem Cell Biol, CAS Ctr Excellence Mol Cell Sci,Inst Hlth Sci, Shanghai 200031, Peoples R China; [Zeng, Yanwu; Gu, Junjie; Ge, Laixiang; Tang, Fan; Qu, Zepeng; Hu, Jing; Jin, Ying] Shanghai Jiao Tong Univ, Dept Mol Dev Biol, Sch Med, Shanghai 200025, Peoples R China; [Cui, Yaru; Zhang, Kushan; Wang, Junbang; Li, Siguang; Sun, Yi] Tongji Univ, Sch Med, Tongji Hosp, Stem Cell Translat Res Ctr, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Jin, Y (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yjin@sibs.ac.cn	Qu, Zepeng/GYJ-3779-2022; Fang, Zhuoqing/AGF-7360-2022	Fang, Zhuoqing/0000-0002-7418-1313	Ministry of Science and Technology of China [2016YFA0100101, 2013CB966801, 2013CB967101]; Chinese Academy of Science [XDB19020103, XDA01010102]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grants 2016YFA0100101, 2013CB966801, and 2013CB967101 and Chinese Academy of Science Grants XDB19020103 and XDA01010102. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Barnes RM, 2011, CIRC RES, V108, P940, DOI 10.1161/CIRCRESAHA.110.233171; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Engert S, 2013, DEVELOPMENT, V140, P3128, DOI 10.1242/dev.088765; Fiorenzano A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12589; Frankenberg S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-8; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Goncalves L, 2011, INT J DEV BIOL, V55, P281, DOI 10.1387/ijdb.103273lg; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Jin JZ, 2013, DEV BIOL, V381, P170, DOI 10.1016/j.ydbio.2013.05.029; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Kopper O, 2010, STEM CELLS, V28, P75, DOI 10.1002/stem.260; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lawson KA, 1999, INT J DEV BIOL, V43, P773; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mitiku N, 2007, DEV CELL, V13, P897, DOI 10.1016/j.devcel.2007.10.004; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Moody S. A., 2014, PRINCIPLES DEV GENET, P245; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Nowotschin S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-15; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.03.023, 10.1016/j.cell.2016.08.009]; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Posfai E, 2014, CURR TOP DEV BIOL, V107, P1, DOI 10.1016/B978-0-12-416022-4.00001-9; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Robertson EJ, 2003, PHILOS T R SOC B, V358, P1351, DOI 10.1098/rstb.2003.1332; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tsakiridis A, 2015, DEVELOPMENT, V142, P809, DOI 10.1242/dev.122093; Viotti M, 2014, NAT CELL BIOL, V16, P1146, DOI 10.1038/ncb3070; Wallingford MC, 2013, DEV DYNAM, V242, P1110, DOI 10.1002/dvdy.23991; Weidgang CE, 2013, STEM CELL REP, V1, P248, DOI 10.1016/j.stemcr.2013.08.002; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196; Zhou CL, 2016, CELL RES, V26, P171, DOI 10.1038/cr.2016.15; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	70	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9840	9854		10.1074/jbc.M117.780585	http://dx.doi.org/10.1074/jbc.M117.780585			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28298438	hybrid, Green Published			2022-12-26	WOS:000403113000031
J	Horsthemke, M; Bachg, AC; Groll, K; Moyzio, S; Muther, B; Hemkemeyer, SA; Wedlich-Soldner, R; Sixt, M; Tacke, S; Bahler, M; Hanley, PJ				Horsthemke, Markus; Bachg, Anne C.; Groll, Katharina; Moyzio, Sven; Muether, Barbara; Hemkemeyer, Sandra A.; Wedlich-Soeldner, Roland; Sixt, Michael; Tacke, Sebastian; Baehler, Martin; Hanley, Peter J.			Multiple roles of filopodial dynamics in particle capture and phagocytosis and phenotypes of Cdc42 and Myo10 deletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-X; CELL-MIGRATION; F-ACTIN; MACROPHAGES; RECEPTOR; CYTOSKELETON; DECTIN-1; REORGANIZATION; ORGANIZATION; RECOGNITION	Macrophage filopodia, finger-like membrane protrusions, were first implicated in phagocytosis more than 100 years ago, but little is still known about the involvement of these actin-dependent structures in particle clearance. Using spinning disk confocal microscopy to image filopodial dynamics in mouse resident Lifeact-EGFP macrophages, we show that filopodia, or filopodia-like structures, support pathogen clearance by multiple means. Filopodia supported the phagocytic uptake of bacterial (Escherichia coli) particles by (i) capturing along the filopodial shaft and surfing toward the cell body, the most common mode of capture; (ii) capturing via the tip followed by retraction; (iii) combinations of surfing and retraction; or (iv) sweeping actions. In addition, filopodia supported the uptake of zymosan (Saccharomyces cerevisiae) particles by (i) providing fixation, (ii) capturing at the tip and filopodia-guided actin anterograde flow with phagocytic cup formation, and (iii) the rapid growth of new protrusions. To explore the role of filopodia-inducing Cdc42, we generated myeloid-restricted Cdc42 knock-out mice. Cdc42-deficient macrophages exhibited rapid phagocytic cup kinetics, but reduced particle clearance, which could be explained by the marked rounded-up morphology of these cells. Macrophages lacking Myo10, thought to act downstream of Cdc42, had normal morphology, motility, and phagocytic cup formation, but displayed markedly reduced filopodia formation. In conclusion, live-cell imaging revealed multiple mechanisms involving macrophage filopodia in particle capture and engulfment. Cdc42 is not critical for filopodia or phagocytic cup formation, but plays a key role in driving macrophage lamellipodial spreading.	[Horsthemke, Markus; Bachg, Anne C.; Groll, Katharina; Moyzio, Sven; Muether, Barbara; Hemkemeyer, Sandra A.; Baehler, Martin; Hanley, Peter J.] Westfal Wilhelms Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany; [Wedlich-Soeldner, Roland] Westfal Wilhelms Univ Munster, Inst Zelldynam & Bildgebung, D-48149 Munster, Germany; [Sixt, Michael] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Tacke, Sebastian] Westfal Wilhelms Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany	University of Munster; University of Munster; Institute of Science & Technology - Austria; University of Munster	Hanley, PJ (corresponding author), Westfal Wilhelms Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany.	hanley@uni-muenster.de	Hanley, Peter J/H-4915-2017	Tacke, Sebastian/0000-0002-4503-367X; Hemkemeyer, Sandra A./0000-0003-1854-9512; Sixt, Michael/0000-0002-6620-9179	Deutsche Forschungsgemeinschaft [HA 3271/4-1, EXC 1003]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HA 3271/4-1 (to P. J. H.) and EXC 1003 (Cluster of Excellence 1003), Cells in Motion (CiM). The authors declare that they have no conflicts of interest with the contents of this article.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Chavrier P, 2002, NAT CELL BIOL, V4, pE169, DOI 10.1038/ncb0702-e169; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Faust N, 2000, BLOOD, V96, P719; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Flannagan RS, 2010, J CELL BIOL, V191, P1205, DOI 10.1083/jcb.201007056; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kohler F, 2015, BIOPHYS J, V108, P2114, DOI 10.1016/j.bpj.2015.02.029; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lee CY, 2011, J CELL SCI, V124, P1106, DOI 10.1242/jcs.078592; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Metschnikoff E, 1902, IMMUNITAT BEI INFEKT; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884; Mohammadi S, 2013, J CELL BIOL, V200, P81, DOI 10.1083/jcb.201204090; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Plestant C, 2014, J CELL SCI, V127, P1660, DOI 10.1242/jcs.131284; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Roeder A, 2004, MED MYCOL, V42, P485, DOI 10.1080/13693780400011112; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Schulte C, 2016, EUR J CELL BIOL, V95, P1, DOI 10.1016/j.ejcb.2015.10.002; SPEERT DP, 1985, J LEUKOCYTE BIOL, V38, P655, DOI 10.1002/jlb.38.5.655; Spiller S, 2007, J BIOL CHEM, V282, P13190, DOI 10.1074/jbc.M610340200; SUNG SSJ, 1983, J CELL BIOL, V96, P160, DOI 10.1083/jcb.96.1.160; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Szczur K, 2009, BLOOD, V114, P4527, DOI 10.1182/blood-2008-12-195164; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; YOUNG VB, 1992, J CELL BIOL, V116, P197, DOI 10.1083/jcb.116.1.197	46	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7258	7273		10.1074/jbc.M116.766923	http://dx.doi.org/10.1074/jbc.M116.766923			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28289096	Green Published, hybrid			2022-12-26	WOS:000400478300035
J	Iwahori, S; Umana, AC; VanDeusen, HR; Kalejta, RF				Iwahori, Satoko; Umana, Angie C.; VanDeusen, Halena R.; Kalejta, Robert F.			Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; CELLULAR-DNA-SYNTHESIS; PRB-FAMILY PROTEINS; TUMOR-SUPPRESSOR; FUNCTIONAL INTERACTION; GROWTH SUPPRESSION; GENE-PRODUCT; MOLECULAR-MECHANISMS; VIRUS ONCOPROTEINS; POCKET PROTEINS	The human cytomegalovirus (HCMV)-encoded viral cyclindependent kinase (v-CDK) UL97 phosphorylates the retinoblastoma (Rb) tumor suppressor. Here, we identify the other Rb family members p107 and p130 as novel targets of UL97. UL97 phosphorylates p107 and p130 thereby inhibiting their ability to represstheE2F-responsiveE2F1promoter. AswithRb, thisphosphorylation, and the rescue of E2F-responsive transcription, is dependent on the L1 LXCXE motif in UL97 and its interacting clefts on p107 and p130. Interestingly, UL97 does not induce the disruption of all p107-E2F or p130-E2F complexes, as it does to Rb-E2F complexes. UL97 strongly interacts with p107 but not Rb or p130. Thus the inhibitory mechanisms of UL97 for Rb family protein-mediated repression of E2F-responsive transcription appear to differ for each of the Rb family proteins. The immediate early 1 (IE1) protein ofHCMValso rescues p107-and p130-mediated repression of E2F-responsive gene expression, but it does not induce their phosphorylation and does not disrupt p107-E2F or p130-E2F complexes. The unique regulation of Rb family proteins byHCMVUL97 and IE1 attests to the importance of modulating Rb family protein function in HCMV-infected cells.	[Kalejta, Robert F.] Univ Wisconsin, Inst Mol Virol, 1525 Linden Dr, Madison, WI 53706 USA; [Kalejta, Robert F.] Univ Wisconsin, McArdle Lab Canc Res, 1525 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kalejta, RF (corresponding author), Univ Wisconsin, Inst Mol Virol, 1525 Linden Dr, Madison, WI 53706 USA.; Kalejta, RF (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1525 Linden Dr, Madison, WI 53706 USA.	rfkalejta@wisc.edu	Iwahori, Satoko/L-1948-2019		National Institutes of Health [R01-AI080675, P01-CA022443, T32-GM08349, T32-CA009135]; Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research; University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program; NATIONAL CANCER INSTITUTE [P01CA022443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research; University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01-AI080675 (to R. F. K.) and P01-CA022443 (to Paul Lambert). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Japan Herpesvirus Infections Forum scholarship award in herpesvirus infection research.; Supported by University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program and by National Institutes of Health Training Grant T32-GM08349.; Supported by National Institutes of Health Training Grant T32-CA009135.	Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Ashizawa S, 2001, J BIOL CHEM, V276, P11362, DOI 10.1074/jbc.M007992200; Baker GL, 2005, CELL CYCLE, V4, P330; Bigley TM, 2013, J VIROL, V87, P7393, DOI 10.1128/JVI.02825-12; BIGNON YJ, 1990, CELL GROWTH DIFFER, V1, P647; Bresnahan WA, 1996, VIROLOGY, V224, P150, DOI 10.1006/viro.1996.0516; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Claudio PP, 2000, CANCER RES, V60, P372; Cobbs CS, 2002, CANCER RES, V62, P3347; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dong F, 1998, J BIOL CHEM, V273, P6190, DOI 10.1074/jbc.273.11.6190; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Fortunato EA, 1997, J VIROL, V71, P8176, DOI 10.1128/JVI.71.11.8176-8185.1997; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gill RB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-9; Guiley KZ, 2015, GENE DEV, V29, P961, DOI 10.1101/gad.257568.114; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; He ZW, 1997, J VIROL, V71, P405, DOI 10.1128/JVI.71.1.405-411.1997; Helin K, 1997, P NATL ACAD SCI USA, V94, P6933, DOI 10.1073/pnas.94.13.6933; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Herbein G, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00230; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Iwahori S, 2007, J VIROL, V81, P9653, DOI 10.1128/JVI.00568-07; Iwahori S, 2015, J BIOL CHEM, V290, P19666, DOI 10.1074/jbc.M115.660043; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Johnson RA, 1999, J GEN VIROL, V80, P1293, DOI 10.1099/0022-1317-80-5-1293; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kuny CV, 2016, J VIROL, V90, P8634, DOI 10.1128/JVI.00731-16; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Lacy S, 1997, ONCOGENE, V14, P2395, DOI 10.1038/sj.onc.1201085; Lee C, 2002, REV MED VIROL, V12, P81, DOI 10.1002/rmv.340; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Leng XH, 2002, MOL CELL BIOL, V22, P2242, DOI 10.1128/MCB.22.7.2242-2254.2002; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Liban TJ, 2016, J MOL BIOL, V428, P3960, DOI 10.1016/j.jmb.2016.08.017; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; MAYOL X, 1993, ONCOGENE, V8, P2561; Mcelroy AK, 2000, J VIROL, V74, P4192, DOI 10.1128/JVI.74.9.4192-4206.2000; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Oberstein A, 2015, PROTEOMICS, V15, P2006, DOI 10.1002/pmic.201400607; Paggi MG, 2001, CANCER RES, V61, P4651; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; Penkert RR, 2012, FUTURE VIROL, V7, P855, DOI 10.2217/FVL.12.86; Poma EE, 1996, J VIROL, V70, P7867, DOI 10.1128/JVI.70.11.7867-7877.1996; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Prichard MN, 2005, J VIROL, V79, P15494, DOI 10.1128/JVI.79.24.15494-15502.2005; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Saffert RT, 2007, J VIROL, V81, P9109, DOI 10.1128/JVI.00827-07; Salvant BS, 1998, J VIROL, V72, P3729, DOI 10.1128/JVI.72.5.3729-3741.1998; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Taher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056795; Ueno T, 2006, ONCOGENE, V25, P4155, DOI 10.1038/sj.onc.1209445; VAIRO G, 1995, GENE DEV, V9, P869, DOI 10.1101/gad.9.7.869; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; VanDeusen HR, 2015, J VIROL, V89, P11965, DOI 10.1128/JVI.01718-15; VanDeusen HR, 2015, J VIROL, V89, P5012, DOI 10.1128/JVI.00175-15; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHITE E, 1991, J VIROL, V65, P2968, DOI 10.1128/JVI.65.6.2968-2978.1991; Wiebusch L, 2001, EMBO J, V20, P1086, DOI 10.1093/emboj/20.5.1086; Wirt SE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-9; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	92	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6583	6599		10.1074/jbc.M116.773150	http://dx.doi.org/10.1074/jbc.M116.773150			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28289097	Green Published, hybrid			2022-12-26	WOS:000399813400013
J	Basu, A; Sridharan, S				Basu, Alakananda; Sridharan, Savitha			Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2	PLOS ONE			English	Article							BREAST-CANCER; CELL-DEATH; SIGNALING PATHWAYS; PI3K/AKT PATHWAY; DOWN-REGULATION; SURVIVAL; TRANSLATION; AKT; P53; ACTIVATION	The anti-apoptotic Bcl-2 family protein myeloid cell leukemia-1 (Mcl-1) plays an important role in breast cancer cell survival and chemoresistance. We have previously shown that knockdown of the 40S ribosomal protein S6 kinase-2 (S6K2), which acts downstream of the mechanistic target of rapamycin complex 1 (mTORC1), enhanced breast cancer cell death by apoptotic stimuli. The increase in cell death by S6K2 depletion was partly due to inactivation of Akt. In the present study, we investigated if S6K2 regulates Mcl-1, which acts downstream of Akt. Silencing of S6K2 but not S6K1 in T47D cells decreased Mcl-1 level, and potentiated apoptosis induced by TRAIL and doxorubicin. Knockdown of S6K2 also decreased the level of anti-apoptotic Bcl-xl. Depletion of the tumor suppressor protein PDCD4 (programmed cell death 4), which regulates translation of several anti-apoptotic proteins, reversed downregulation of Bcl-xl but not Mcl-1 and failed to reverse the effect of S6K2 knockdown on potentiation of doxorubicin-induced apoptosis. Downregulation of Mcl-1 by S6K2 knockdown was partly restored by the proteasome inhibitor MG132. Overexpression of catalytically-active Akt or knockdown of glycogen synthase kinase-3 (GSK3)-beta, a substrate for Akt, had little effect on Mcl-1 downregulation caused by S6K2 deficiency. Silencing of S6K2 increased the level of c-Jun N-terminal kinase (JNK) and knockdown of JNK1 increased basal Mcl-1 level and partly reversed the effect of S6K2 knockdown on Mcl1 downregulation. JNK1 knockdown also had a modest effect in attenuating the increase in doxorubicin-induced apoptosis caused by S6K2 deficiency. These results suggest that S6K2 regulates apoptosis via multiple mechanisms, and involves both Akt and JNK.	[Basu, Alakananda] Univ North Texas, Hlth Sci Ctr, Inst Mol Med, Ft Worth, TX USA; [Sridharan, Savitha] Univ Calif Berkeley, Berkeley, CA USA	University of North Texas System; University of North Texas Denton; University of California System; University of California Berkeley	Basu, A (corresponding author), Univ North Texas, Hlth Sci Ctr, Inst Mol Med, Ft Worth, TX USA.	Alakananda.basu@unthsc.edu		Basu, Alakananda/0000-0002-1656-0788	University of North Texas Health Science Center	University of North Texas Health Science Center	The study was partly supported by the Doctoral Bridge Funding (SS) from the University of North Texas Health Science Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Esposito F, 2010, CANCER RES, V70, P5379, DOI 10.1158/0008-5472.CAN-09-4199; HALDAR S, 1994, CANCER RES, V54, P2095; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Liwak U, 2013, ONCOTARGET, V4, P1365, DOI 10.18632/oncotarget.1154; Liwak U, 2012, MOL CELL BIOL, V32, P1818, DOI 10.1128/MCB.06317-11; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Merino D, 2016, ONCOGENE, V35, P1877, DOI 10.1038/onc.2015.287; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Mojsa B, 2014, CELLS-BASEL, V3, P418, DOI 10.3390/cells3020418; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pai C, 2016, J IMMUNOLOGY; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Pardo OE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00191; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Roy R, 2014, NUCLEIC ACIDS RES, V42, P12483, DOI 10.1093/nar/gku953; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Williams MM, 2015, ONCOTARGET, V6, P3519, DOI 10.18632/oncotarget.2792; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yamaguchi H, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00015; Yang SX, 2016, CANCER TREAT REV, V45, P87, DOI 10.1016/j.ctrv.2016.03.004; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	35	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173854	10.1371/journal.pone.0173854	http://dx.doi.org/10.1371/journal.pone.0173854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301598	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300080
J	Chen, SL; Feng, BA; Thomas, AA; Chakrabarti, S				Chen, Shali; Feng, Biao; Thomas, Anu Alice; Chakrabarti, Subrata			miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; FIBRONECTIN SYNTHESIS; EXPRESSION; MICRORNA-146A; PATHOGENESIS; CELLS; GENE; ACTIVATION; MECHANISMS	Hyperglycemic damage to the endothelial cells (ECs) leads to increased synthesis of inflammatory cytokines. We have previously shown miR-146a downregulation in ECs and in the tissues of diabetic mice. Here we investigated the role of miR-146a, in the production of specific inflammatory cytokines and extracellular matrix (ECM) proteins in retina and kidneys in diabetes. We generated an endothelial specific miR-146a overexpressing transgenic mice (TG). We investigated these mice and wild type (WT) controls with or without streptozotocin (STZ) induced diabetes. Retinal and renal cortical tissues from the mice were examined for mRNAs for specific inflammatory markers, (ECM) proteins and inflammation inducible transcription factor by real time RT-PCR. Corresponding proteins, where possible, were examined using immunofluorescence or ELISA. In parallel, we examined ECs following incubation with various levels of glucose with or without miR-146a mimic transfection. In the retina and kidneys of WT mice with diabetes, increased expression of inflammatory markers (IL-6, TNF alpha, IL1 beta) in association augmented expression of ECM proteins (collagen 1 alpha IV, fibronectin) and NF.B-P65 were observed, compared to WT non-diabetic controls. These changes were prevented in diabetic miR-146a TG mice along with retinal and renal functional and structural changes. In vitro studies showed similar changes in the ECs exposed to high glucose. Such changes were corrected in the cells following miR-146a mimic transfection. Further analyses of renal cortical tissues showed diabetes induced significant upregulation of two regulators of NF kappa B, namely Interleukin-1 associated Kinase 1 and tumour necrosis factor receptor associated factor. Such changes were prevented in diabetic TG animals. These data indicate that augmented production of inflammatory cytokines and ECM proteins in the retina and kidneys in diabetes are regulated through endothelium derived miR-146a. Identification of such novel mechanisms may potentially lead to the development of novel therapies.	[Chen, Shali; Feng, Biao; Thomas, Anu Alice; Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada	Western University (University of Western Ontario)	Chakrabarti, S (corresponding author), Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada.	subrata.chakrabarti@lhsc.uwo.ca		Chakrabarti, Subrata/0000-0002-0208-1401	Canadian Diabetes Association	Canadian Diabetes Association	This work was supported by the Canadian Diabetes Association (https://www.diabetes.ca/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Bao MH, 2015, INT J MOL SCI, V16, P14305, DOI 10.3390/ijms160714305; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beres NJ, 2016, INFLAMM BOWEL DIS, V22, P327, DOI 10.1097/MIB.0000000000000687; Bhatt K, 2016, J AM SOC NEPHROL, V27, P2277, DOI 10.1681/ASN.2015010111; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Cao YA, 2014, INVEST OPHTH VIS SCI, V55, P7321, DOI 10.1167/iovs.14-15167; Capitao M, 2016, J CELL BIOCHEM, V117, P2443, DOI 10.1002/jcb.25575; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218; Chen SL, 2012, INVEST OPHTH VIS SCI, V53, P8333, DOI 10.1167/iovs.12-9766; Chen SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE127, DOI 10.1152/ajpendo.00432.2009; Chen SL, 2003, AM J PHYSIOL-ENDOC M, V284, pE1089, DOI 10.1152/ajpendo.00540.2002; Chen SL, 2003, AM J PHYSIOL-CELL PH, V284, pC263, DOI 10.1152/ajpcell.00192.2002; Cukiernik M, 2004, DIABETES RES CLIN PR, V65, P197, DOI 10.1016/j.diabres.2004.02.002; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Emadi S S, 2014, Endocr Regul, V48, P103; Feng B, 2017, J MOL CELL IN PRESS; Feng BA, 2008, AM J PHYSIOL-ENDOC M, V294, pE1119, DOI 10.1152/ajpendo.00029.2008; Feng B, 2014, LIFE SCI, V98, P18, DOI 10.1016/j.lfs.2013.12.199; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Funari VA, PLOS ONE, V8, P1; Gao M, 2015, J IMMUNOL, V195, P672, DOI 10.4049/jimmunol.1403155; Giza DE, 2014, DISCOVERIES CRAIOVA, V2, P1; Golovchenko I, 2000, CIRC RES, V87, P746, DOI 10.1161/01.RES.87.9.746; Holohan KN, FRONT GENET, V3, P1; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Huang ZL, 2015, MOL MED REP, V12, P6997, DOI 10.3892/mmr.2015.4260; Kamali K, BRATISL LEK LISTY, V117; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kaur H, 2006, DIABETES, V55, P3104, DOI 10.2337/db06-0519; Khan ZA, 2004, INVEST OPHTH VIS SCI, V45, P287, DOI 10.1167/iovs.03-0540; Knott RM, 1996, BIOCHEM J, V318, P313, DOI 10.1042/bj3180313; Kolset SO, 2012, J HISTOCHEM CYTOCHEM, V60, P976, DOI 10.1369/0022155412465073; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Mariapan MM, 2012, EXP DIABETES RES, V2012, P1; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Mortuza R, 2014, DIABETOLOGIA, V57, P1037, DOI 10.1007/s00125-014-3197-9; Nahid MA, 2015, J INNATE IMMUN, V7, P428, DOI 10.1159/000371517; Patel S, 2009, PHARMACOL REP, V61, P595, DOI 10.1016/S1734-1140(09)70111-2; Popov D., INT J DIABETES MELLI, V2, P189; Ruiz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145372; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Stickel N, 2014, BLOOD, V124, P2586, DOI 10.1182/blood-2014-04-569046; Sun XX, 2015, CELL CYCLE, V14, P243, DOI 10.4161/15384101.2014.977112; Tufekci KU, 2014, METHODS MOL BIOL, V1107, P33, DOI 10.1007/978-1-62703-748-8_3; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang Q, 2014, INVEST OPHTH VIS SCI, V55, P3986, DOI 10.1167/iovs.13-13076; Wang XH, 2013, CARDIOVASC RES, V97, P432, DOI 10.1093/cvr/cvs356; Wertz IE, 2010, COLD SPRING HARBOR P, V2, P1; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wu YX, 2012, INVEST OPHTH VIS SCI, V53, P8405, DOI 10.1167/iovs.12-10553; Wu YX, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/465824; Ye EA, 2016, MEDIAT INFLAMM, V2016, P1; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; Yousefzadeh N, 2015, J PHYSIOL BIOCHEM, V71, P51, DOI 10.1007/s13105-014-0378-4; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	62	30	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173918	10.1371/journal.pone.0173918	http://dx.doi.org/10.1371/journal.pone.0173918			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301595	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300094
J	Desgarnier, MCD; Fournier, F; Droit, A; Rochette, PJ				Desgarnier, Marie-Catherine Drigeard; Fournier, Frederic; Droit, Arnaud; Rochette, Patrick J.			Influence of a pre-stimulation with chronic low-dose UVB on stress response mechanisms in human skin fibroblasts	PLOS ONE			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE RESPONSE; INDUCED PROTEIN EXPRESSION; ULTRAVIOLET-B RADIATION; HISTONE METHYLTRANSFERASE; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; MUTATIONS; INDUCTION	Exposure to solar ultraviolet type B (UVB), through the induction of cyclobutane pyrimidine dimer (CPD), is the major risk factor for cutaneous cancer. Cells respond to UV-induced CPD by triggering the DNA damage response (DDR) responsible for signaling DNA repair, programmed cell death and cell cycle arrest. Underlying mechanisms implicated in the DDR have been extensively studied using single acute UVB irradiation. However, little is known concerning the consequences of chronic low-dose of UVB (CLUV) on the DDR. Thus, we have investigated the effect of a CLUV pre-stimulation on the different stress response pathways. We found that CLUV pre-stimulation enhances CPD repair capacity and leads to a cell cycle delay but leave residual unrepaired CPD. We further analyzed the consequence of the CLUV regimen on general gene and protein expression. We found that CLUV treatment influences biological processes related to the response to stress at the transcriptomic and proteomic levels. This overview study represents the first demonstration that human cells respond to chronic UV irradiation by modulating their genotoxic stress response mechanisms.	[Desgarnier, Marie-Catherine Drigeard; Rochette, Patrick J.] Univ Laval, CHU Quebec, Ctr Rech, Axe Med Regeneratrice,Hop St Sacrement, Quebec City, PQ, Canada; [Desgarnier, Marie-Catherine Drigeard; Rochette, Patrick J.] Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada; [Fournier, Frederic; Droit, Arnaud] Univ Laval, CHU Quebec, Ctr Rech, Ctr Prote, Quebec City, PQ, Canada; [Droit, Arnaud] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Rochette, Patrick J.] Univ Laval, Dept Ophtalmol & ORL Chirurg Cervicofacial, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Rochette, PJ (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Axe Med Regeneratrice,Hop St Sacrement, Quebec City, PQ, Canada.; Rochette, PJ (corresponding author), Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada.; Rochette, PJ (corresponding author), Univ Laval, Dept Ophtalmol & ORL Chirurg Cervicofacial, Quebec City, PQ, Canada.	Patrick.rochette@orlo.ulaval.ca	Rochette, Patrick/HHN-2300-2022; Droit, Arnaud/AGZ-6283-2022	Droit, Arnaud/0000-0001-7922-790X; Rochette, Patrick/0000-0002-0678-8869; Fournier, Frederic/0000-0001-5785-5403	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05864]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to PJR. Grant #:RGPIN-2016-05864. URL: http://nserc.ca/.	Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P429, DOI 10.1001/jama.2016.8465; Black HS, 1997, J PHOTOCH PHOTOBIO B, V40, P29, DOI 10.1016/S1011-1344(97)00021-3; Boyle J, 2008, HUM MUTAT, V29, P1194, DOI 10.1002/humu.20768; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brash DE, 2001, J INVEST DERMATOL, V117, P1234, DOI 10.1046/j.0022-202x.2001.01554.x; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Conde F, 2009, GENETICS, V182, P437, DOI 10.1534/genetics.109.101899; Courdavault S, 2004, PHOTOCHEM PHOTOBIOL, V79, P145, DOI 10.1562/0031-8655(2004)079<0145:UCPDDN>2.0.CO;2; Cramers P, 2012, PHOTOCHEM PHOTOBIOL, V88, P147, DOI 10.1111/j.1751-1097.2011.01019.x; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; D'Errico M, 2003, CELL DEATH DIFFER, V10, P754, DOI 10.1038/sj.cdd.4401224; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gendron SP, 2015, AGING CELL, V14, P433, DOI 10.1111/acel.12324; Greussing R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-224; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Haruta N, 2012, NUCLEIC ACIDS RES, V40, P8406, DOI 10.1093/nar/gks580; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; HUTCHINSON F, 1994, MUTAT RES-FUND MOL M, V309, P11, DOI 10.1016/0027-5107(94)90037-X; Ichihashi M, 2014, EXP DERMATOL, V23, P43, DOI 10.1111/exd.12393; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Kadhim MA, 2004, MUTAT RES-FUND MOL M, V568, P21, DOI 10.1016/j.mrfmmm.2004.06.043; Kim W, 2014, CELL CYCLE, V13, P726, DOI 10.4161/cc.28104; Kulms D, 2002, SKIN PHARMACOL APPL, V15, P342, DOI 10.1159/000064539; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; Lamore SD, 2010, PHOTOCHEM PHOTOBIOL, V86, P1307, DOI 10.1111/j.1751-1097.2010.00818.x; LEBKOWSKI JS, 1985, P NATL ACAD SCI USA, V82, P8606, DOI 10.1073/pnas.82.24.8606; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Ljungman M, 1996, ONCOGENE, V13, P823; Lo HL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-135; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mallet JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162212; Mallet JD, 2011, PHOTOCHEM PHOTOBIOL, V87, P1363, DOI 10.1111/j.1751-1097.2011.00977.x; Mantymaa P, 2000, BRIT J HAEMATOL, V108, P574, DOI 10.1046/j.1365-2141.2000.01852.x; MCGREGOR WG, 1991, MOL CELL BIOL, V11, P1927, DOI 10.1128/MCB.11.4.1927; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Michaels CJ, 2015, J ANIM PHYSIOL AN N, V99, P391, DOI 10.1111/jpn.12203; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; MILLER JH, 1983, ANNU REV GENET, V17, P215, DOI 10.1146/annurev.ge.17.120183.001243; Mitchell DL, 1999, CANCER RES, V59, P2875; Mitchell DL, 2001, J INVEST DERMATOL, V117, P590, DOI 10.1046/j.0022-202x.2001.01442.x; Mitchell DL, 2001, J INVEST DERMATOL, V116, P209, DOI 10.1046/j.1523-1747.2001.01192.x; Mouret S, 2011, PHOTOCHEM PHOTOBIOL, V87, P109, DOI 10.1111/j.1751-1097.2010.00834.x; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Oksenych V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003611; Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268; Pastila R, 2013, ADV EXP MED BIOL, V990, P121, DOI 10.1007/978-94-007-5896-4_9; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Pope-Varsalona H, 2014, NUCLEIC ACIDS RES, V42, P13096, DOI 10.1093/nar/gku1030; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007; Rochette PJ, 2006, PHOTOCHEM PHOTOBIOL, V82, P1370, DOI 10.1562/2004-12-01-RA-390; Rochette PJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000926; Rochette PJ, 2002, ONCOGENE, V21, P5743, DOI 10.1038/sj.onc.1205641; Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Salucci S, 2013, INT J MOL SCI, V14, P532, DOI 10.3390/ijms14010532; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schuch AP, 2010, J PHOTOCH PHOTOBIO B, V99, P111, DOI 10.1016/j.jphotobiol.2010.03.004; Schwarz Thomas, 2005, Keio Journal of Medicine, V54, P165, DOI 10.2302/kjm.54.165; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheehan JM, 2002, J INVEST DERMATOL, V118, P825, DOI 10.1046/j.1523-1747.2002.01681.x; Singh RK, 2016, DERMATOLOGY THER, V6, P307, DOI 10.1007/s13555-016-0129-2; Slominski A.T., 2012, ADV ANAT EMBRYOL CEL, V212; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, pvii, Patent No. 22894052; Steerenberg PA, 2006, J PHOTOCH PHOTOBIO B, V84, P28, DOI 10.1016/j.jphotobiol.2006.01.009; Strozyk E, 2013, INT J MOL SCI, V14, P15260, DOI 10.3390/ijms140815260; Takahashi A, 2009, J RADIAT RES, V50, P385, DOI 10.1269/jrr.09048S; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Tornaletti S, 1996, BIOESSAYS, V18, P221, DOI 10.1002/bies.950180309; TORNALETTI S, 1993, ONCOGENE, V8, P2051; Vijayalaxmi Cao Y, 2014, MUTAT RES REV MUTAT; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Weinkauf B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039411; Wu CL, 2012, J PROTEOMICS, V75, P1991, DOI 10.1016/j.jprot.2011.12.038; Xu HX, 2010, PHOTODERMATOL PHOTO, V26, P198, DOI 10.1111/j.1600-0781.2010.00522.x; Xu X, 2015, MUTAT RES-REV MUTAT, V764, P43, DOI 10.1016/j.mrrev.2015.02.001; Yan Y, 2010, PHOTODERMATOL PHOTO, V26, P318, DOI 10.1111/j.1600-0781.2010.00556.x; Ye N, 1999, MUTAT RES-DNA REPAIR, V435, P43, DOI 10.1016/S0921-8777(99)00022-1; YOSHIKAWA T, 1990, J INVEST DERMATOL, V95, P530, DOI 10.1111/1523-1747.ep12504877; Zhao H, 2010, CYTOM PART A, V77A, P285, DOI 10.1002/cyto.a.20839	87	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173740	10.1371/journal.pone.0173740	http://dx.doi.org/10.1371/journal.pone.0173740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301513	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300068
J	Lu, YA; Tu, KH; Lee, CC; Wu, PW; Chang, CJ; Tian, YC; Yang, CW; Chu, PH				Lu, Yueh-An; Tu, Kun-Hua; Lee, Cheng-Chia; Wu, Patricia W.; Chang, Chee-Jen; Tian, Ya-Chung; Yang, Chih-Wei; Chu, Pao-Hsien			Prognostic impact of peritonitis in hemodialysis patients: A national-wide longitudinal study in Taiwan	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; LIVER-CIRRHOSIS; DIALYSIS; MORTALITY; SURVIVAL; OUTCOMES; PREVALENCE; PREDICTORS	Background Peritonitis has been independently associated with increased morbidity and mortality in peritoneal dialysis patients. However, there are few reports on peritonitis in hemodialysis patients. We aim at investigating both the risk profiles and prognostic impact of peritonitis in hemodialysis patients. Methods This nation-wide longitudinal study uses claims data obtained from the Taiwan National Health Insurance Research Database. A total of 80,733 incident hemodialysis patients of age >= 20 years without a history of peritonitis were identified between January 1, 1998 and December 31, 2009. Predictors of peritonitis events were estimated using Cox proportional hazard models. Time-dependent Cox proportional hazard models were used to estimate hazard ratio for mortality attributed to peritonitis exposure. Results Of 80,733 incident hemodialysis patients over a 13-year study period, peritonitis was diagnosed in 935 (1.16%), yielding an incidence rate of 2.91 per 1000 person-years. Female gender, liver cirrhosis and polycystic kidney disease were three of the most significant factors for peritonitis in both non -diabetic and diabetic hemodialysis patients. The cumulative survival rate of patients with peritonitis was 38.8% at 1 year and 10.1% at 5 years. A time dependent Cox multivariate analysis showed that peritonitis had significantly increased hazard ratio for all cause mortality. Additionally, the risk of mortality remained significantly higher for non-diabetic hemodialysis patients that experienced peritonitis. Conclusions The risk of peritonitis in hemodialysis patients is higher in female gender, liver cirrhosis and polycystic kidney disease. Although peritonitis is a rare condition, it is associated with significantly poorer outcome in hemodialysis patients.	[Lu, Yueh-An; Tu, Kun-Hua; Lee, Cheng-Chia; Tian, Ya-Chung; Yang, Chih-Wei] Linkou Chang Gung Mem Hosp, Dept Nephrol, Kidney Res Ctr, Taipei, Taiwan; [Lu, Yueh-An; Tu, Kun-Hua; Lee, Cheng-Chia; Tian, Ya-Chung; Yang, Chih-Wei] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Tu, Kun-Hua; Lee, Cheng-Chia; Yang, Chih-Wei] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Wu, Patricia W.] Chang Gung Mem Hosp, Dept Radiol, Linkou, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Res Serv Ctr Hlth Informat, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Chang, Chee-Jen; Chu, Pao-Hsien] Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taipei, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Healthcare Ctr, Chang Gung Mem Hosp, Taipei, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Heart Failure Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chu, PH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taipei, Taiwan.; Chu, PH (corresponding author), Chang Gung Univ, Coll Med, Healthcare Ctr, Chang Gung Mem Hosp, Taipei, Taiwan.; Chu, PH (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Heart Failure Ctr, Taipei, Taiwan.	taipei.chu@gmail.com	Tu, Kun-Hua/ABD-1751-2021; Chu, Pao-Hsien/P-5249-2019	Tu, Kun-Hua/0000-0002-7146-4481; Chu, Pao-Hsien/0000-0003-0361-6348; Wu, Patricia/0000-0002-7453-0368; Lu, Yueh-An/0000-0002-5486-2357; Lee, Cheng-Chia/0000-0002-6973-5908	Linkou Chang-Gung Memorial Hospital [CMRPG3F2691, CMRPG3B1352, CORPG3F581]; Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital [CLRPG3D0042]; Research Services Center For Health Information, Chang Gung University [CIRPD1D0031]	Linkou Chang-Gung Memorial Hospital; Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital; Research Services Center For Health Information, Chang Gung University	This work was supported by the Research Grant of Linkou Chang-Gung Memorial Hospital, grant number CMRPG3F2691, CMRPG3B1352 and CORPG3F581. The authors wish to acknowledge the Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital (Grant CLRPG3D0042) and Research Services Center For Health Information, Chang Gung University (Grant CIRPD1D0031) for statistical consultation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Dagher G, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0057-y; [Anonymous], 2016, 2015 ANN REPORT KIDN; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chiu YL, 2008, NEPHRON CLIN PRACT, V109, pC109, DOI 10.1159/000145453; Dalrymple LS, 2015, AM J KIDNEY DIS, V65, P754, DOI 10.1053/j.ajkd.2014.11.030; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; De Vecchi AF, 2002, AM J KIDNEY DIS, V40, P161, DOI 10.1053/ajkd.2002.33925; Doklestic S K, 2014, J Med Life, V7, P132; Eleftheriadis T, 2007, SEMIN DIALYSIS, V20, P440, DOI 10.1111/J.1525-139X.2007.00283.x; Fontan MP, 2005, PERITON DIALYSIS INT, V25, P274; Fried LF, 1996, J AM SOC NEPHROL, V7, P2176; Gunjaca I, 2010, ACTA CLIN CROAT, V49, P11; Hammami M, 2010, N AM J MED SCI, V2, P238; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Kim HW, 2011, CLIN EXP NEPHROL, V15, P258, DOI 10.1007/s10157-010-0379-8; Klaric D, 2013, INT UROL NEPHROL, V45, P519, DOI 10.1007/s11255-012-0257-2; Kotwal S, 2015, NEPHROLOGY; Kraja B, 2012, GASTROENTEROL RES PR, V2012; Lantinga MA, 2016, NEPHROLOGY DIALYSIS; Litjens NHR, 2008, J AM SOC NEPHROL, V19, P1483, DOI 10.1681/ASN.2007090971; de Bustillo EM, 2011, NEFROLOGIA, V31, P723, DOI 10.3265/Nefrologia.pre2011.Oct.10987; Nessim SJ, 2009, CLIN J AM SOC NEPHRO, V4, P1195, DOI 10.2215/CJN.00910209; Ono Yasuo, 2004, Journal of Infection and Chemotherapy, V10, P200; Ra G, 2015, J CLIN GASTROENTEROL, V49, P858, DOI 10.1097/MCG.0000000000000311; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Schirren CA, 1997, CLIN EXP IMMUNOL, V108, P144, DOI 10.1046/j.1365-2249.1997.d01-985.x; Selgas R, 2008, PERITON DIALYSIS INT, V28, P118; SKLAR AH, 1987, AM J KIDNEY DIS, V10, P81, DOI 10.1016/S0272-6386(87)80036-7; Suwabe T, 2015, EUR J CLIN MICROBIOL, V34, P1369, DOI 10.1007/s10096-015-2361-6; Taylor NJ, 2014, ALIMENT PHARM THER, V40, P705, DOI 10.1111/apt.12886; Thomas B, 2015, J AM SOC NEPHROL, V26, P2621, DOI 10.1681/ASN.2014101017; Tsung PC, 2013, CLIN MOL HEPATOL, V19, P131, DOI 10.3350/cmh.2013.19.2.131; van Esch S, 2014, PERITON DIALYSIS INT, V34, P162, DOI 10.3747/pdi.2013.00275; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wiest R, 2014, J HEPATOL, V60, P197, DOI 10.1016/j.jhep.2013.07.044; Zahir M, 2013, CASE REP UROL, V2013; Zimmerman D, 2012, NEPHROL DIAL TRANSPL, V27, P3816, DOI 10.1093/ndt/gfs416	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173710	10.1371/journal.pone.0173710	http://dx.doi.org/10.1371/journal.pone.0173710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301536	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300064
J	Thiebaut, C; Chamard-Jovenin, C; Chesnel, A; Morel, C; Djermoune, E; Boukhobza, T; Dumond, H				Thiebaut, Charlene; Chamard-Jovenin, Clemence; Chesnel, Amand; Morel, Chloe; Djermoune, El-Hadi; Boukhobza, Taha; Dumond, Helene			Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; TAMOXIFEN RESISTANCE; GLAND DEVELOPMENT; ER-ALPHA-36; EXPRESSION; VARIANT; PROLIFERATION; GPR30; RECEPTOR-ALPHA-36; 17-BETA-ESTRADIOL	Estrogen receptor alpha 36 (ER alpha 36) is a variant of the canonical estrogen receptor alpha (ER alpha 66), widely expressed in hormone sensitive cancer cells and whose high expression level correlates with a poor survival prognosis for breast cancer patients. While ER alpha 36 activity have been related to breast cancer progression or acquired resistance to treatment, expression level and location of ER alpha 36 are poorly documented in the normal mammary gland. Therefore, we explored the consequences of a ER alpha 36 overexpression in vitro in MCF-10A normal mammary epithelial cells and in vivo in a unique model of MMTV-ER alpha 36 transgenic mouse strain wherein ER alpha 36 mRNA was specifically expressed in the mammary gland. By a combination of bioinformatics and computational analyses of microarray data, we identified hierarchical gene networks, downstream of ER alpha 36 and modulated by the JAK2/STAT3 signaling pathway. Concomitantly, ER alpha 36 overexpression lowered proliferation rate but enhanced migration potential and resistance to staurosporin-induced apoptosis of the MCF-10A cell line. In vivo, ER alpha 36 expression led to duct epithelium thinning and disruption in adult but not in prepubescent mouse mammary gland. These phenotypes correlated with a loss of E-cadherin expression. Here, we show that an enhanced expression of ER alpha 36 is sufficient, by itself, to disrupt normal breast epithelial phenotype in vivo and in vitro through a dominant-positive effect on nongenomic estrogen signaling pathways. These results also suggest that, in the presence of adult endogenous steroid levels, ER alpha 36 overexpression in vivo contributes to alter mammary gland architecture which may support preneoplastic lesion and augment breast cancer risk.	[Thiebaut, Charlene; Chamard-Jovenin, Clemence; Chesnel, Amand; Morel, Chloe; Djermoune, El-Hadi; Boukhobza, Taha; Dumond, Helene] Univ Lorraine, CNRS, Ctr Rech Automat Nancy, UMR 7039, BP70239, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Dumond, H (corresponding author), Univ Lorraine, CNRS, Ctr Rech Automat Nancy, UMR 7039, BP70239, Vandoeuvre Les Nancy, France.	helene.dumond@univ-lorraine.fr		Boukhobza, Taha/0000-0003-1046-3554; Dumond, Helene/0000-0002-9697-3901; THIEBAUT, Charlene/0000-0002-4338-2753	Anses - Agence nationale de securite sanitaire de l'alimentation, de lenvironnement et du travail; Institut national de la sante et de la recherche medicale Plan Cancer/environnement [ENV201304]; La Ligue contre le cancer; Region Lorraine	Anses - Agence nationale de securite sanitaire de l'alimentation, de lenvironnement et du travail(French National Research Agency (ANR)); Institut national de la sante et de la recherche medicale Plan Cancer/environnement; La Ligue contre le cancer(Ligue nationale contre le cancer); Region Lorraine(Region Grand-Est)	The funders are all French: the Anses - Agence nationale de securite sanitaire de l'alimentation, de lenvironnement et du travail https://www.anses.fr/ (fund 2012/2/014; recipient HD), the Institut national de la sante et de la recherche medicale www.inserm.fr Plan Cancer/environnement (fund ENV201304; recipient HD), La Ligue contre le cancer www.ligue-cancer.net/ (fund 2016; recipient HD) and the Region Lorraine for a half PhD fellowship http://www.lorraine.eu (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajj H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061758; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Atwood CS, 2000, J ENDOCRINOL, V167, P39, DOI 10.1677/joe.0.1670039; Banerjee S, 2014, STEROIDS, V81, P64, DOI 10.1016/j.steroids.2013.11.002; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Brandt R, 2000, ONCOGENE, V19, P2129, DOI 10.1038/sj.onc.1203520; Chamard-Jovenin C, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0178-7; Chaudhri RA, 2014, STEROIDS, V81, P74, DOI 10.1016/j.steroids.2013.10.020; Chaudhri RA, 2012, J BIOL CHEM, V287, P7169, DOI 10.1074/jbc.M111.292946; Dimitrios Iliopoulos, 2009, CELL, V139, P693; Elbaradie KBY, 2013, BBA-MOL CELL RES, V1833, P1165, DOI 10.1016/j.bbamcr.2012.12.022; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Gao F, 2011, ENDOCRINOLOGY, V152, P1434, DOI 10.1210/en.2010-1368; Gibson DA, 2012, MOL CELL ENDOCRINOL, V348, P361, DOI 10.1016/j.mce.2011.09.026; Howroyd P, 2005, TOXICOL PATHOL, V33, P300, DOI 10.1080/01926230590896145; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Irsik DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070926; Javed A, 2013, SEMIN PLAST SURG, V27, P5, DOI 10.1055/s-0033-1343989; Kamran MZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421821; Kang LG, 2011, J STEROID BIOCHEM, V127, P262, DOI 10.1016/j.jsbmb.2011.08.011; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kwon O, 2014, METABOLISM, V63, P1455, DOI 10.1016/j.metabol.2014.07.015; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Mehta RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113175; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Panneerselvam M, 2015, MOL BIOSYST, V11, P2998, DOI 10.1039/c5mb00272a; Paulose T, 2015, REPROD TOXICOL, V54, P58, DOI 10.1016/j.reprotox.2014.09.012; Peng M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.210; Qian HY, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/7128702; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Soltysik K, 2015, EUR J CELL BIOL, V94, P611, DOI 10.1016/j.ejcb.2015.10.001; SOULE HD, 1990, CANCER RES, V50, P6075; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Tylcz JB, 2015, BIOMED SIGNAL PROCES, V20, P52, DOI 10.1016/j.bspc.2015.04.008; Vandenberg LN, 2007, ENDOCRINOLOGY, V148, P116, DOI 10.1210/en.2006-0561; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; [王健 Wang Jian], 2015, [第三军医大学学报, Journal of Third Military Medical University], V37, P340; Wang ZY, 2015, MOL CELL ENDOCRINOL, V418, P193, DOI 10.1016/j.mce.2015.04.017; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107369; Yu LF, 2014, STEROIDS, V84, P11, DOI 10.1016/j.steroids.2014.03.003; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhang XT, 2013, ENDOCRINOLOGY, V154, P1990, DOI 10.1210/en.2013-1116; Zhang XT, 2014, J STEROID BIOCHEM, V143, P434, DOI 10.1016/j.jsbmb.2014.06.009; Zhang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030174; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	55	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173931	10.1371/journal.pone.0173931	http://dx.doi.org/10.1371/journal.pone.0173931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301550	Green Submitted, gold, Green Published			2022-12-26	WOS:000396318300098
J	Bas, AA; Christiansen, F; Ozturk, AA; Ozturk, B; McIntosh, C				Bas, Aylin Akkaya; Christiansen, Fredrik; Ozturk, Ayaka Amaha; Ozturk, Bayram; McIntosh, Caley			The effects of marine traffic on the behaviour of Black Sea harbour porpoises (Phocoena phocoena relicta) within the Istanbul Strait, Turkey	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; TOUR BOATS; BAY; WHALES; DISTURBANCE; NOISE; RESPONSES; SOUND	Marine traffic is threatening cetaceans on a local and global scale. The Istanbul Strait is one of the busiest waterways, with up to 2,500 vessels present daily. This is the first study to assess the magnitude of short-and long-term behavioural changes of the endangered Black Sea harbour porpoises (Phocoena phocoena relicta) in the presence of marine vessels within the Istanbul Strait. Markov chains were used to investigate the effect of vessel presence on the transition probability between behavioural states (diving, surface-feeding and travelling), and to quantify the effect on the behavioural budget and bout length (duration of time spent in a given state) of porpoises. Further, the changes on swimming directions of porpoises in relation to vessel speed and distance was investigated using generalized linear models. In vessel presence, porpoises were less likely to remain in a given behavioural state and instead more likely to switch to another state. Because of this, the bout length of all three behavioural states decreased significantly in the presence of vessels. The vessel effect was sufficiently large to alter the behavioural budget, with surface-feeding decreasing significantly in the presence of vessels. However, when taking into account the proportion of time that porpoises were exposed to vessels (i.e. 50%), the measured effect size was not large enough to significantly alter the animals' cumulative (diurnal) behavioural budget. Additionally, vessel speed and distance had a significant effect on the probability of porpoises showing a response in their swimming directions. The southern and middle sections of the Istanbul Strait, which have the heaviest marine traffic pressure, had the lowest porpoise sightings throughout the year. Conversely, northern sections that were exposed to a lesser degree of marine traffic hold the highest porpoise sightings. The effect shown in this study in combination with increasing human impacts within the northern sections should be considered carefully and species-specific conservation actions, including establishment of protected areas, should be put in place to prevent the long-term consequences of marine traffic on the Black Sea harbour porpoise population.	[Bas, Aylin Akkaya; Ozturk, Ayaka Amaha; Ozturk, Bayram] Istanbul Univ, Fac Fisheries, Istanbul, Turkey; [Bas, Aylin Akkaya; Ozturk, Ayaka Amaha; Ozturk, Bayram] Turkish Marine Res Fdn, Istanbul, Turkey; [Bas, Aylin Akkaya; McIntosh, Caley] Marine Mammals Res Assoc, Antalya, Turkey; [Christiansen, Fredrik] Murdoch Univ, Sch Vet & Life Sci, Cetacean Res Unit, Murdoch, WA 6150, Australia	Istanbul University; Turkish Marine Research Foundation; Uludag University; Murdoch University	Bas, AA (corresponding author), Istanbul Univ, Fac Fisheries, Istanbul, Turkey.; Bas, AA (corresponding author), Turkish Marine Res Fdn, Istanbul, Turkey.; Bas, AA (corresponding author), Marine Mammals Res Assoc, Antalya, Turkey.	akkayaaylinn@gmail.com	Ozturk, Ayaka Amaha/ABI-4939-2020; Öztürk, Bayram/AAD-6228-2020; Christiansen, Fredrik/O-3655-2017; Amaha Ozturk, Ayaka/AAB-8197-2022; Ozturk, Ayaka Amaha/AAD-6380-2020	Öztürk, Bayram/0000-0001-7844-2448; Christiansen, Fredrik/0000-0001-9090-8458; AKKAYA BAS, AYLIN/0000-0002-0414-770X	Istanbul University [18476]	Istanbul University(Istanbul University)	Only part of the named research is funded by Istanbul University with a grant number of 18476 which was part of a PhD thesis named "Investigation on the interactions between cetaceans and marine traffic in the Istanbul Strait". However there was no additional external funding received for this study.	[Anonymous], 2013, ANN REPORT; [Anonymous], 2010, IMO ASS 61 SESS, P14; [Anonymous], 2014, R LANG ENV STAT COMP; Bain DE, 2006, AB133F05SE3965 NMFS; BAIN DE, 2002, MODEL LINKING ENERGE; Barr K, 1998, EFFECTS TOURISM DUSK; Bas AA, 2015, MAR MAMMAL SCI, V31, P979, DOI 10.1111/mms.12202; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder Lars, 2003, P229; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Birkun Jr A. A., 2008, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2008.RLTS.T17030A6737111.en, DOI 10.2305/IUCN.UK.2008.RLTS.T17030A6737111.EN]; Bryant P.J., 1984, P375; Christiansen F., 2014, WHALE WATCHING SUSTA, P177, DOI [10.1017/CBO9781139018166.016, DOI 10.1017/CBO9781139018166.016]; Christiansen F, 2015, CONSERV LETT, V8, P424, DOI 10.1111/conl.12166; Christiansen F, 2013, BEHAV ECOL, V24, P1415, DOI 10.1093/beheco/art086; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Currey RJC, 2009, BIOL CONSERV, V142, P1570, DOI 10.1016/j.biocon.2009.02.036; Dans SL, 2008, MAR ECOL PROG SER, V369, P287, DOI 10.3354/meps07629; Dede A, 2013, J MAR BIOL ASSOC UK, P1; Dede A, 2008, 22 ANN C EUR CET SOC, V22, P22; di Sciara G Notarbartolo, 2001, P WORKSH PROT AR CET, V38, P28; Dyndo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11083; European Commission, 2013, SWD2013524 EUR COMM; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Frantzis A, 2001, MAR MAMMAL SCI, V17, P937, DOI 10.1111/j.1748-7692.2001.tb01307.x; Gordon J., 1992, SCI RES SERIES, V52; Hastie GD, 2003, MAR MAMMAL SCI, V19, P74, DOI 10.1111/j.1748-7692.2003.tb01093.x; Hermannsen L, 2014, J ACOUST SOC AM, V136, P1640, DOI 10.1121/1.4893908; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Hoyt Erich, 2005, Biology and Environment, V105B, P141, DOI 10.3318/BIOE.2005.105.3.141; Istanbul Port Authority, 2011, DOM MAR TRAFF GUID; IWC, 2004, J CETACEAN RES MANAG, V6, P315; Kastelein RA, 2011, J ACOUST SOC AM, V129, P2307, DOI 10.1121/1.3559679; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Lemon M, 2006, BIOL CONSERV, V127, P363, DOI 10.1016/j.biocon.2005.08.016; Lusseau D., 2006, Tourism in Marine Environments, V3, P173, DOI 10.3727/154427306779435184; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2004, ECOL SOC, V9; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Martin J, 2015, METHODS ECOLOGY EVOL; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; Meissner AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116962; Neumann Dirk R., 2006, Aquatic Mammals, V32, P1, DOI 10.1578/AM.32.1.2006.1; Notarbartolo di Sciara, 2002, CETACEANS MEDITERRAN; Notarbartolo di Sciara G, 2002, CETACEANS MEDITERRAN, P98; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; Ozturk Bayram, 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V17, P205; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Polacheck T., 1990, REPORT INT WHALING C, V40, P463; Reeves R.R., 2006, STATUS DISTRIBUTION; RICHARDSON WJ, 1995, MAR MAMMAL SCI, V11, P1, DOI 10.1111/j.1748-7692.1995.tb00272.x; Simmonds Mark, 2004, OCEANS NOISE WDCS SC; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Van Parijs SM, 2001, J MAR BIOL ASSOC UK, V81, P533, DOI 10.1017/S0025315401004180; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010	61	12	13	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172970	10.1371/journal.pone.0172970	http://dx.doi.org/10.1371/journal.pone.0172970			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296899	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700018
J	Schroeder, DC; Guschlbauer, M; Maul, AC; Cremer, DA; Becker, I; Bethencourt, DD; Paal, P; Padosch, SA; Wetsch, WA; Annecke, T; Boettiger, BW; Sterner-Kock, A; Herff, H				Schroeder, Daniel C.; Guschlbauer, Maria; Maul, Alexandra C.; Cremer, Daniel A.; Becker, Ingrid; Bethencourt, David de la Puente; Paal, Peter; Padosch, Stephan A.; Wetsch, Wolfgang A.; Annecke, Thorsten; Boettiger, Bernd W.; Sterner-Kock, Anja; Herff, Holger			Oesophageal heat exchangers with a diameter of 11mm or 14.7mm are equally effective and safe for targeted temperature management	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; TRANSFER DEVICE; RESUSCITATION; ASSOCIATION; PREVENTION; GUIDELINES; INDUCTION	Background Targeted temperature management (TTM) is widely used in critical care settings for conditions including hepatic encephalopathy, hypoxic ischemic encephalopathy, meningitis, myocardial infarction, paediatric cardiac arrest, spinal cord injury, traumatic brain injury, ischemic stroke and sepsis. Furthermore, TTM is a key treatment for patients after out-of-hospital cardiac-arrest (OHCA). However, the optimal cooling method, which is quick, safe and cost-effective still remains controversial. Since the oesophagus is adjacent to heart and aorta, fast heat-convection to the central blood-stream could be achieved with a minimally invasive oesophageal heat exchanger (OHE). To date, the optimal diameter of an OHE is still unknown. While larger diameters may cause thermal-or pressure-related tissue damage after long-term exposure to the oesophageal wall, smaller diameter (e.g., gastric tubes, up to 11mm) may not provide effective cooling rates. Thus, the objective of the study was to compare OHE-diameters of 11mm (OHE11) and 14.7mm (OHE14.7) and their effects on tissue and cooling capability. Methods Pigs were randomized to OHE11 (N = 8) or OHE14.7 (N = 8). After cooling, pigs were maintained at 33 degrees C for 1 hour. After 10h rewarming, oesophagi were analyzed by means of histopathology. The oesophagus of four animals from a separate study that underwent exactly the identical preparation and cooling protocol described above but received a maintenance period of 24h were used as histopathological controls. Results Mean cooling rates were 2.8 +/- 0.4 degrees C degrees C/h (OHE11) and 3.0 +/- 0.3 degrees C degrees C/h (OHE14.7; p = 0.20). Occasional mild acute inflammatory transepithelial infiltrates were found in the cranial segment of the oesophagus in all groups including controls. Deviations from target temperature were 0.1 +/- 0.4 degrees C (OHE11) and 0 +/- 0.1 degrees C (OHE14.7; p = 0.91). Rewarming rates were 0.19 +/- 0.07 degrees C degrees C/h (OHE11) and 0.20 +/- 0.05 degrees C degrees C/h (OHE14.7; p = 0.75). Conclusions OHE with diameters of 11 mm and 14.7 mm achieve effective cooling rates for TTM and did not cause any relevant oesophageal tissue damage. Both OHE demonstrated acceptable deviations from target temperature and allowed for an intended rewarming rate (0.25 degrees C/h).	[Schroeder, Daniel C.; Cremer, Daniel A.; Bethencourt, David de la Puente; Padosch, Stephan A.; Wetsch, Wolfgang A.; Annecke, Thorsten; Boettiger, Bernd W.; Herff, Holger] Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Kerpener Str 62, Cologne, Germany; [Guschlbauer, Maria; Maul, Alexandra C.; Sterner-Kock, Anja] Univ Hosp Cologne, Dept Expt Med, Cologne, Germany; [Becker, Ingrid] Univ Hosp Cologne, Inst Med Stat Informat & Epidemiol, Kerpener Str 62, Cologne, Germany; [Paal, Peter] Queen Mary Univ London, Barts Heart Ctr, St Bartholomews Hosp, Barts Hlth NHS Trust, London, England; [Paal, Peter] Barmherzige Bruder Salzburg Hosp, Dept Anaesthesiol & Crit Care Med, Kajetanerpl 2, Salzburg, Austria	University of Cologne; University of Cologne; University of Cologne; Barts Health NHS Trust; University of London; Queen Mary University London; Konventhospital Der Barmherzigen Bruder	Schroeder, DC (corresponding author), Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Kerpener Str 62, Cologne, Germany.	Daniel.Schroeder@uk-koeln.de	Annecke, Thorsten/AAG-3909-2020	Annecke, Thorsten/0000-0002-2496-4432; Schroeder, Daniel/0000-0002-0104-5986; Paal, Peter/0000-0002-2939-4782; Guschlbauer, Maria/0000-0002-5401-4542; Becker, Ingrid/0000-0001-5829-3553	"The Central Innovation Program for Small and Medium-sized enterprises", German Federal Ministry for Economic affairs and Energy [KF2429611AK3]	"The Central Innovation Program for Small and Medium-sized enterprises", German Federal Ministry for Economic affairs and Energy	This work was supported by "The Central Innovation Program for Small and Medium-sized enterprises", German Federal Ministry for Economic affairs and Energy (KF2429611AK3) (HH). Equipment was provided by Hirtz & Co. KG, Cologne, Germany.	BUGGY D, 1994, BRIT J ANAESTH, V72, P393, DOI 10.1093/bja/72.4.393; Desai TK, 2005, GASTROINTEST ENDOSC, V61, P795, DOI 10.1016/S0016-5107(05)00313-5; Gotberg M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-7; Guluma KZ, 2006, ACAD EMERG MED, V13, P820, DOI 10.1197/j.aem.2006.03.559; He Xiaoming, 2003, Crit Rev Biomed Eng, V31, P355, DOI 10.1615/CritRevBiomedEng.v31.i56.10; HENRIQUES FC, 1947, AM J PATHOL, V23, P531; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; HUDACK STEPHEN, 1932, JOUR EXP MED, V55, P431, DOI 10.1084/jem.55.3.431; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; KOKATE JY, 1995, ARCH PHYS MED REHAB, V76, P666, DOI 10.1016/S0003-9993(95)80637-7; KULKARNI P, 1993, BRIT J ANAESTH, V70, P216, DOI 10.1093/bja/70.2.216; Kulstad E, 2013, RESUSCITATION, V84, P1619, DOI 10.1016/j.resuscitation.2013.06.019; Kulstad EB, 2012, WORLD J EMERG MED, V3, P118, DOI [10.5847/wjem.j.issn.1920-8642.2012.02.007, 10.5847/wjem.j.1920-8642.2012.02.007]; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Lequerica JL, 2009, INT J HYPERTHER, V25, P150, DOI 10.1080/02656730802537626; LI DJ, 1987, INT J HYPERTHER, V3, P143, DOI 10.3109/02656738709140382; Markota A, 2016, J EMERGENCY MED; Markota A, 2016, AM J EMERG MED, V34, P741, DOI 10.1016/j.ajem.2016.01.028; Markota A, 2015, RESUSCITATION, V89, pE1, DOI 10.1016/j.resuscitation.2015.01.032; McMaster PD, 1934, J EXP MED, V60, P479, DOI 10.1084/jem.60.4.479; Naiman M, 2016, EXPERT REV MED DEVIC, V13, P423, DOI 10.1080/17434440.2016.1174573; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Pehbock D, 2014, ANAESTHESIST; Piercy M, 2009, J CARDIOTHOR VASC AN, V23, P62, DOI 10.1053/j.jvca.2008.09.014; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Popugaev KA, 2014, J NEUROL SURG REP, V75, pE224, DOI 10.1055/s-0034-1387188; Ran ZG, 2015, J VIROL, V89, P4818, DOI 10.1128/JVI.00059-15; Rasmussen YH, 1998, ACTA ANAESTH SCAND, V42, P348; Saito T, 2013, J VASC SURG, V57, P173, DOI 10.1016/j.jvs.2012.05.101; Sause A, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-52; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Sessler DI, 2013, ANESTHESIOLOGY, V118, P181, DOI 10.1097/ALN.0b013e3182784df3; SESSLER DI, 1988, ANESTHESIOLOGY, V68, P836, DOI 10.1097/00000542-198806000-00002; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sleisenger M.H., 2002, GASTROINTESTINAL LIV, P551; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Tobey NA, 1999, AM J PHYSIOL-GASTR L, V276, pG1322, DOI 10.1152/ajpgi.1999.276.6.G1322	40	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173229	10.1371/journal.pone.0173229	http://dx.doi.org/10.1371/journal.pone.0173229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291783	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700016
J	Moo, EK; Peterson, DR; Leonard, TR; Kaya, M; Herzog, W				Moo, Eng Kuan; Peterson, Daniel R.; Leonard, Timothy R.; Kaya, Motoshi; Herzog, Walter			In vivo muscle force and muscle power during near-maximal frog jumps	PLOS ONE			English	Article							MEDIAL GASTROCNEMIUS; HINDLIMB MUSCLES; SARCOMERE-LENGTH; TENDON UNIT; PERFORMANCE; SOLEUS; STRAIN; OUTPUT; CAT; CONTRACTION	Frogs' outstanding jumping ability has been associated with a high power output from the leg extensor muscles. Two main theories have emerged to explain the high power output of the frog leg extensor muscles, either (i) the contractile conditions of all leg extensor muscles are optimized in terms of muscle length and speed of shortening, or (ii) maximal power is achieved through a dynamic catch mechanism that uncouples fibre shortening from the corresponding muscle-tendon unit shortening. As in vivo instantaneous power generation in frog hind limb muscles during jumping has never been measured directly, it is hard to distinguish between the two theories. In this study, we determined the instantaneous variable power output of the plantaris longus (PL) of Lithobates pipiens (also known as Rana pipiens), by directly measuring the in vivo force, length change, and speed of muscle and fibre shortening in near maximal jumps. Fifteen near maximal jumps (> 50cm in horizontal distance) were analyzed. High instantaneous peak power in PL (536 +/- 47 W/kg) was achieved by optimizing the contractile conditions in terms of the force-length but not the force-velocity relationship, and by a dynamic catch mechanism that decouples fascicle shortening from muscle-tendon unit shortening. We also found that the extra-muscular free tendon likely amplifies the peak power output of the PL by modulating fascicle shortening length and shortening velocity for optimum power output, but not by releasing stored energy through recoiling as the tendon only started recoiling after peak PL power had been achieved.	[Moo, Eng Kuan; Peterson, Daniel R.; Leonard, Timothy R.; Kaya, Motoshi; Herzog, Walter] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	University of Calgary	Herzog, W (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	wherzog@ucalgary.ca	Herzog, Walter/AAG-7188-2020	Herzog, Walter/0000-0002-5341-0033; Moo, Eng Kuan/0000-0001-6363-6063	Natural Sciences and Engineering Research Council (NSERC) of Canada; Alberta Innovates [201500764] Funding Source: researchfish	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	The work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; [Anonymous], 1977, SCALE EFFECTS ANIMAL; Astley HC, 2011, BIOL LETT; Astley HC, 2014, J EXP BIOL, V217, P4372, DOI 10.1242/jeb.110296; Azizi E, 2008, P NATL ACAD SCI USA, V105, P1745, DOI 10.1073/pnas.0709212105; Azizi E, 2010, P ROY SOC B-BIOL SCI, V277, P1523, DOI 10.1098/rspb.2009.2051; Azizi E, 2009, J PHYSIOL-LONDON, V587, P4309, DOI 10.1113/jphysiol.2009.173690; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Butterfield TA, 2005, J APPL PHYSIOL, V99, P1352, DOI 10.1152/japplphysiol.00481.2005; CALOW LJ, 1973, J ZOOL, V171, P293; Fontana HD, 2014, J ELECTROMYOGR KINES, V24, P934, DOI 10.1016/j.jelekin.2014.06.010; Galantis A, 2003, P ROY SOC B-BIOL SCI, V270, P1493, DOI 10.1098/rspb.2003.2403; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Grieve D. W., 1978, INT SERIES BIOMECH A, V4, P405; GRIFFITHS RI, 1989, J EXP BIOL, V147, P439; HERZOG W, 1993, J BIOMECH, V26, P945, DOI 10.1016/0021-9290(93)90056-K; HERZOG W, 1991, J BIOMECH, V24, P31, DOI 10.1016/0021-9290(91)90375-W; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HILL AV, 1949, PROC R SOC SER B-BIO, V136, P399, DOI 10.1098/rspb.1949.0033; HIRANO M, 1984, J EXP BIOL, V108, P429; Kargo WJ, 2002, J EXP BIOL, V205, P1683; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; Kaya M, 2002, J BIOMECH, V35, P893, DOI 10.1016/S0021-9290(02)00043-X; Kaya M, 2008, J R SOC INTERFACE, V5, P415, DOI 10.1098/rsif.2007.1158; LIEBER RL, 1991, AM J PHYSIOL, V261, pC86, DOI 10.1152/ajpcell.1991.261.1.C86; LUTZ GJ, 1994, SCIENCE, V263, P370, DOI 10.1126/science.8278808; LYNN R, 1994, J APPL PHYSIOL, V77, P1439, DOI 10.1152/jappl.1994.77.3.1439; Maganaris CN, 1998, J PHYSIOL-LONDON, V512, P603, DOI 10.1111/j.1469-7793.1998.603be.x; MAI MT, 1990, J BIOMECH, V23, P271, DOI 10.1016/0021-9290(90)90017-W; MARSH RL, 1994, J EXP BIOL, V188, P131; Mayfield DL, 2016, J EXP BIOL; Olson JM, 1998, J EXP BIOL, V201, P2763; Patek SN, 2004, NATURE, V428, P819, DOI 10.1038/428819a; Peplowski MM, 1997, J EXP BIOL, V200, P2861; Richards CT, 2007, J EXP BIOL, V210, P3147, DOI 10.1242/jeb.005207; Roberts TJ, 2003, J EXP BIOL, V206, P2567, DOI 10.1242/jeb.00452; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Sawicki GS, 2015, J EXP BIOL, V218, P3700, DOI 10.1242/jeb.126235; WALMSLEY B, 1978, J NEUROPHYSIOL, V41, P1203, DOI 10.1152/jn.1978.41.5.1203; ZUURBIER CJ, 1994, J BIOMECH, V27, P445, DOI 10.1016/0021-9290(94)90020-5	41	19	19	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e173415	10.1371/journal.pone.0173415	http://dx.doi.org/10.1371/journal.pone.0173415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282405	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800040
J	Chapman, R; Jongwe, TI; Douglass, N; Chege, G; Williamson, AL				Chapman, Ros; Jongwe, Tsungai Ivai; Douglass, Nicola; Chege, Gerald; Williamson, Anna-Lise			Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice	PLOS ONE			English	Article							T-CELL RESPONSES; RHESUS-MONKEYS; IMMUNE-RESPONSES; TYPE-1; PROTEINS; ANTIGENS; EFFICACY; PLASMID; REGIMEN; BREADTH	In an effort to make affordable vaccines suitable for the regions most affected by HIV-1, we have constructed stable vaccines that express an HIV-1 subtype C mosaic Gag immunogen (BCG-Gag(M), MVA-Gag(M) and DNA-Gag(M)). Mosaic immunogens have been designed to address the tremendous diversity of this virus. Here we have shown that Gag(M) buds from cells infected and transfected with MVA-Gag(M) and DNA-Gag(M) respectively and forms virus like particles. Previously we showed that a BCG-Gag(M) prime MVA-Gag(M) boost generated strong cellular immune responses in mice. In this study immune responses to the DNAGag(M) and MVA-Gag(M) vaccines were evaluated in homologous and heterologous prime boost vaccinations. The DNA homologous prime boost vaccination elicited predominantly CD8+ T cells while the homologous MVA vaccination induced predominantly CD4+ T cells. A heterologous DNA-Gag(M) prime MVA-Gag(M) boost induced strong, more balanced Gag CD8+ and CD4+ T cell responses and that were predominantly of an effector memory phenotype. The immunogenicity of the mosaic Gag (Gag(M)) was compared to a naturally occurring subtype C Gag (Gag(N)) using a DNA homologous vaccination regimen. DNA-Gag(N) expresses a natural Gag with a sequence that was closest to the consensus sequence of subtype C viruses sampled in South Africa. DNA-Gag(M) homologous vaccination induced cumulative HIV-1 Gag-specific IFN-y ELISPOT responses that were 6.5-fold higher than those induced by the DNA-Gag(N) vaccination. Similarly, DNA-Gag(M) vaccination generated 7-fold higher levels of cytokine-positive CD8+ T cells than DNA-Gag(N) indicating that this subtype C mosaic Gag elicits far more potent immune responses than a consensus type Gag. Cells transfected and infected with DNA-Gag(M) and MVA-Gag(M) respectively, expressed high levels of Gag(M) and produced budding virus-like particles. Our data indicates that a heterologous prime boost regimen using DNA and MVA vaccines expressing HIV-1 subtype C mosaic Gag is highly immunogenic in mice and warrants further investigation in non-human primates.	[Chapman, Ros; Jongwe, Tsungai Ivai; Douglass, Nicola; Chege, Gerald; Williamson, Anna-Lise] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Chapman, Ros; Jongwe, Tsungai Ivai; Douglass, Nicola; Chege, Gerald; Williamson, Anna-Lise] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Williamson, Anna-Lise] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Chapman, R (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Chapman, R (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa.	Ros.Chapman@uct.ac.za	Chapman, Rosamund/AAJ-6490-2020; Chege, Gerald/HIK-1573-2022	Chege, Gerald/0000-0003-3986-9638; Douglass, Nicola/0000-0002-8929-6279; Chapman, Rosamund/0000-0001-9162-2099; Williamson, Anna-Lise/0000-0002-5467-1200	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. Tsungai Jongwe received bursaries from the Schlumberger Foundation and the Poliomyelitis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Jawad S, 2016, MOL THER, V24, P375, DOI 10.1038/mt.2015.210; Asbach B, 2016, J VIROL, V90, P4133, DOI 10.1128/JVI.03135-15; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Chapman R, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071601, 10.1371/journal.pone.0076584]; Columb MO, 2006, CURR ANAESTH CRIT CA, V17, P233, DOI DOI 10.1016/J.CACC.2006.03.005; Datta SAK, 2016, J VIROL, V90, P1773, DOI 10.1128/JVI.02061-15; Ellenberger D, 2005, VIROLOGY, V340, P21, DOI 10.1016/j.virol.2005.06.014; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Gray GE, 2016, CLIN VACCINE IMMUNOL, V23, P496, DOI 10.1128/CVI.00717-15; Hanke T, 1998, VACCINE, V16, P426, DOI 10.1016/S0264-410X(97)00296-X; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Joachim A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118486; Jongwe TI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159141; Kardani K, 2016, VACCINE, V34, P413, DOI 10.1016/j.vaccine.2015.11.062; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Mascola JR, 2005, J VIROL, V79, P771, DOI 10.1128/JVI.79.2.771-779.2005; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Ndhlovu ZM, 2011, J IMMUNOL, V186, P6914, DOI 10.4049/jimmunol.1004231; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rueda P, 2004, J GEN VIROL, V85, P563, DOI 10.1099/vir.0.19525-0; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Santra S, 2010, J MED PRIMATOL, V39, P282; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tanzer FL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-51; Williamson AL, 2016, EXPERT REV VACCINES, V15, P585, DOI 10.1586/14760584.2016.1129904; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649	31	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173352	10.1371/journal.pone.0173352	http://dx.doi.org/10.1371/journal.pone.0173352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278263	gold, Green Submitted, Green Published			2022-12-26	WOS:000396087900076
J	Lee, SM; Baik, JM; Nguyen, D; Nguyen, V; Liu, SW; Hu, ZY; Abbott, GW				Lee, Soo Min; Baik, Jasmine; Nguyen, Dara; Nguyen, Victoria; Liu, Shiwei; Hu, Zhaoyang; Abbott, Geoffrey W.			Kcne2 deletion impairs insulin secretion and causes type 2 diabetes mellitus	FASEB JOURNAL			English	Article						KCNQ1; Kv1.5; K(v)2.1; potassium channel	GATED POTASSIUM CHANNELS; PANCREATIC BETA-CELL; K+ CHANNEL; ENDOPLASMIC-RETICULUM; CARDIAC-ARRHYTHMIA; I-KS; KCNQ1; SUBUNIT; KV2.1; RESISTANCE	Type 2 diabetes mellitus (T2DM) represents a rapidly increasing threat to global public health. T2DM arises largely from obesity, poor diet, and lack of exercise, but it also involves genetic predisposition. Here we report that the KCNE2 potassium channel transmembrane regulatory subunit is expressed in human and mouse pancreatic beta cells. Kcne2 deletion in mice impaired glucose tolerance as early as 5 wk of age in pups fed a Western diet, ultimately causing diabetes. In adult mice fed normal chow, skeletal muscle expression of insulin receptor beta and insulin receptor substrate 1 were down-regulated 2-fold by Kcne2 deletion, characteristic of T2DM. Kcne2 deletion also caused extensive pancreatic transcriptome changes consistent with facets of T2DM, including endoplasmic reticulum stress, inflammation, and hyperproliferation. Kcne2 deletion impaired beta-cell insulin secretion in vitro up to 8-fold and diminished beta-cell peak outward K+ current at positive membrane potentials, but also left-shifted its voltage dependence and slowed inactivation. Interestingly, we also observed an aging-dependent reduction in beta-cell outward currents in both Kcne2(+/+) and Kcne2(-/-) mice. Our results demonstrate that KCNE2 is required for normal beta-cell electrical activity and insulin secretion, and that Kcne2 deletion causes T2DM. KCNE2 may regulate multiple K+ channels in beta cells, including the T2DM-linked KCNQ1 potassium channel alpha subunit.	[Lee, Soo Min; Baik, Jasmine; Nguyen, Dara; Nguyen, Victoria; Liu, Shiwei; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Irvine, CA 92717 USA; [Lee, Soo Min; Baik, Jasmine; Nguyen, Dara; Nguyen, Victoria; Liu, Shiwei; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Irvine, CA 92717 USA; [Hu, Zhaoyang] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesiol & Crit Care Med, Chengdu, Peoples R China	University of California System; University of California Irvine; University of California System; University of California Irvine; Sichuan University	Abbott, GW (corresponding author), Univ Calif Irvine, Med Sch, 360 Med Surge 2, Irvine, CA 92697 USA.	abbottg@uci.edu			University of California; Irvine setup funds	University of California(University of California System); Irvine setup funds	This work was supported by University of California, Irvine setup funds (to G.W.A.). The authors gratefully acknowledge H. Ishii (University of California, Irvine) for helpful technical advice, and N. B. Doan (University of California, Los Angeles, Los Angeles, CA, USA) for performing human pancreas immunostaining.	Abbott GW, 2015, GENE, V569, P162, DOI 10.1016/j.gene.2015.06.061; Abbott GW, 2012, CHANNELS, V6, P1, DOI 10.4161/chan.19126; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Asahara S, 2015, P NATL ACAD SCI USA, V112, P8332, DOI 10.1073/pnas.1422104112; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Boini KM, 2009, AM J PHYSIOL-REG I, V296, pR1695, DOI 10.1152/ajpregu.90839.2008; CARO JF, 1987, J CLIN INVEST, V79, P1330, DOI 10.1172/JCI112958; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Gerich JE, 1999, DIABETES OBES METAB, V1, P257, DOI 10.1046/j.1463-1326.1999.00027.x; Gordon E, 2008, CARDIOVASC RES, V77, P98, DOI 10.1093/cvr/cvm030; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Hu ZY, 2016, CARDIOVASC RES, V110, P227, DOI 10.1093/cvr/cvw048; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Isbrandt D, 2002, J MOL MED-JMM, V80, P524, DOI 10.1007/s00109-002-0364-0; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kim SJ, 2013, BIOCHEM J, V451, P227, DOI 10.1042/BJ20121669; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Lee SM, 2015, J MOL CELL CARDIOL, V87, P148, DOI 10.1016/j.yjmcc.2015.08.013; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li XY, 2013, J PHARMACOL EXP THER, V344, P407, DOI 10.1124/jpet.112.199083; Li Y, 2013, P NATL ACAD SCI USA, V110, P18922, DOI 10.1073/pnas.1315649110; Liu L., 2014, INT J PHOTOENERGY, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0094160; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; Nichols CG, 2002, AM J PHYSIOL-ENDOC M, V283, pE403, DOI 10.1152/ajpendo.00168.2002; OLEFSKY JM, 1995, AM J CLIN NUTR, V61, p980S, DOI 10.1093/ajcn/61.4.980S; Panaghie G, 2006, CURR PHARM DESIGN, V12, P2285, DOI 10.2174/138161206777585175; Ramos RR, 2007, P NATL ACAD SCI USA, V104, P10470, DOI 10.1073/pnas.0701114104; Reutens AT, 2013, NEPHROL DIAL TRANSPL, V28, P1820, DOI 10.1093/ndt/gfs561; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Roura-Ferrer M, 2010, J CELL PHYSIOL, V225, P692, DOI 10.1002/jcp.22265; Su JP, 2001, PFLUG ARCH EUR J PHY, V442, P49, DOI 10.1007/s004240000508; Tarasov AI, 2006, DIABETES, V55, P3075, DOI 10.2337/db06-0637; Thierry M, 2015, EXP EYE RES, V135, P37, DOI 10.1016/j.exer.2015.04.012; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839	56	20	20	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2674	2685		10.1096/fj.201601347	http://dx.doi.org/10.1096/fj.201601347			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28280005				2022-12-26	WOS:000401553400037
J	Zhao, HX; Han, ZJ; Liu, XY; Gu, JJ; Tang, F; Wei, G; Jin, Y				Zhao, Haixin; Han, Zhijun; Liu, Xinyuan; Gu, Junjie; Tang, Fan; Wei, Gang; Jin, Ying			The chromatin remodeler Chd4 maintains embryonic stem cell identity by controlling pluripotency- and differentiation-associated genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; NURD; COMPONENT; COMPLEX; NANOG; MBD3; ACTIVATION; ENZYMES; OCT3/4; STATE	The unique properties of embryonic stem cells (ESCs), including unlimited self-renewal and pluripotent differentiation potential, are sustained by integrated genetic and epigenetic networks composed of transcriptional factors and epigenetic modulators. However, the molecular mechanisms underlying the function of these regulators are not fully elucidated. Chromodomain helicase DNA-binding protein 4 (Chd4), an ATPase subunit of the nucleosome remodeling and deacetylase (NuRD) complex, is highly expressed in ESCs. However, its function in ESC regulation remains elusive. Here we report that Chd4 is required for the maintenance of ESC self-renewal. RNAi-mediated silencing of Chd4 disrupted self-renewal and up-regulated lineage commitment-associated genes under self-renewal culture conditions. During ESC differentiation in embryoid body formation, we observed significantly stronger induction of differentiation-associated genes in Chd4-deficient cells. The phenotype was different from that caused by the deletion of Mbd3, another subunit of the NuRD complex. Transcriptomic analyses revealed that Chd4 secured ESC identity by controlling the expression of subsets of pluripotency- and differentiation-associated genes. Importantly, Chd4 repressed the transcription of T box protein 3 (Tbx3), a transcription factor with important functions in ESC fate determination. Tbx3 knockdown partially rescued aberrant activation of differentiation-associated genes, especially of endoderm-associated genes, induced by Chd4 depletion. Moreover, we identified an interaction of Chd4 with the histone variant H2A. Z. This variant stabilized Chd4 by inhibiting Chd4 protein degradation through the ubiquitin-proteasome pathway. Collectively, this study identifies the Chd4-Tbx3 axis in controlling ESC fate and a role of H2A. Z in maintaining the stability of Chd4 proteins.	[Zhao, Haixin; Liu, Xinyuan; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci,Inst Hlth Sci,Shanghai Inst Biol, Key Lab Stem Cell Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Zhao, Haixin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Han, Zhijun; Wei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Gu, Junjie; Tang, Fan; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Lab Mol Dev Biol, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Shanghai Jiao Tong University	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci,Inst Hlth Sci,Shanghai Inst Biol, Key Lab Stem Cell Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Lab Mol Dev Biol, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022; WEI, GANG/AGL-1853-2022	WEI, GANG/0000-0001-5839-1276; Liu, Xinyuan/0000-0002-9754-0593	Ministry of Science and Technology of China [2016YFA0100101, 2013CB966801, 2013CB967101]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010102, XDB19020100]; National Natural Science Foundation [91419309, 91019023]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2016YFA0100101, 2013CB966801, and 2013CB967101; Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA01010102 and XDB19020100; and National Natural Science Foundation Grants 91419309 and 91019023. The authors declare that they have no conflicts of interest with the contents of this article.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Fagnocchi L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11903; Gingold JA, 2014, MOL CELL, V56, P140, DOI 10.1016/j.molcel.2014.08.014; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Inoue T, 2004, DEV BIOL, V270, P146, DOI 10.1016/j.ydbio.2004.02.017; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jamaladdin S, 2014, P NATL ACAD SCI USA, V111, P9840, DOI 10.1073/pnas.1321330111; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Lee DF, 2012, NAT PROTOC, V7, P729, DOI 10.1038/nprot.2012.018; Li YZ, 2013, GENOMICS, V102, P456, DOI 10.1016/j.ygeno.2013.09.004; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Low JKK, 2016, J BIOL CHEM, V291, P15853, DOI 10.1074/jbc.M115.707018; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Luo ZJ, 2015, MOL CELL, V57, P685, DOI 10.1016/j.molcel.2015.01.007; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Morey L, 2015, MOL CELL BIOL, V35, P2716, DOI 10.1128/MCB.00266-15; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Waghray A, 2015, STEM CELL REP, V5, P97, DOI 10.1016/j.stemcr.2015.05.009; Wang HB, 2001, NUCLEIC ACIDS RES, V29, P2517, DOI 10.1093/nar/29.12.2517; Wang JX, 2015, STEM CELLS, V33, P2126, DOI 10.1002/stem.2011; Weidgang CE, 2013, STEM CELL REP, V1, P248, DOI 10.1016/j.stemcr.2013.08.002; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Yang J, 2016, CELL REP, V15, P1809, DOI 10.1016/j.celrep.2016.04.058; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zhang W, 2016, J MOL BIOL, V428, P2931, DOI 10.1016/j.jmb.2016.04.025; Zhao DY, 2014, BIOCHEM BIOPH RES CO, V444, P411, DOI 10.1016/j.bbrc.2014.01.093; Zhou Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.195; Zhu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007684; Zhu LL, 2014, EMBO REP, V15, P1286, DOI 10.15252/embr.201438643	49	21	24	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8507	8519		10.1074/jbc.M116.770248	http://dx.doi.org/10.1074/jbc.M116.770248			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28298436	hybrid, Green Published			2022-12-26	WOS:000401788600033
J	Karlowicz, A; Wegrzyn, K; Gross, M; Kaczynska, D; Ropelewska, M; Siemiatkowska, M; Bujnicki, JM; Konieczny, I				Karlowicz, Anna; Wegrzyn, Katarzyna; Gross, Marta; Kaczynska, Dagmara; Ropelewska, Malgorzata; Siemiatkowska, Malgorzata; Bujnicki, Janusz M.; Konieczny, Igor			Defining the crucial domain and amino acid residues in bacterial Lon protease for DNA binding and processing of DNA-interacting substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; DNA-binding protein; Escherichia coli (E; coli); protein-DNA interaction; proteolysis	FOLD-RECOGNITION MODELS; ESCHERICHIA-COLI; MITOCHONDRIAL LON; ALLOSTERIC REGULATION; LIMITED PROTEOLYSIS; STRUCTURAL BASIS; ATPASE ACTIVITY; PLASMID RK2; HOST-RANGE; REPLICATION	Lon protease previously has been shown to interact with DNA, but the role of this interaction for Lon proteolytic activity has not been characterized. In this study, we used truncated Escherichia coli Lon constructs, bioinformatics analysis, and site-directed mutagenesis to identify Lon domains and residues crucial for Lon binding with DNA and effects on Lon proteolytic activity. We found that deletion of Lon's ATPase domain abrogated interactions with DNA. Substitution of positively charged amino acids in this domain in full-length Lon with residues conferring a net negative charge disrupted binding of Lon to DNA. These changes also affected the degradation of nucleic acid-binding protein substrates of Lon, intracellular localization of Lon, and cell morphology. In vivo tests revealed that Lon-DNA interactions are essential for Lon activity in cell division control. In summary, we demonstrate that the ability of Lon to bind DNA is determined by its ATPase domain, that this binding is required for processing protein substrates in nucleoprotein complexes, and that Lon may help regulate DNA replication in response to growth conditions.	[Karlowicz, Anna; Wegrzyn, Katarzyna; Gross, Marta; Kaczynska, Dagmara; Ropelewska, Malgorzata; Konieczny, Igor] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, Abrahama 58, PL-80307 Gdansk, Poland; [Siemiatkowska, Malgorzata; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol Warsaw, Lab Bioinformat & Prot Engn, Ksiecia Trojdena 4, PL-02109 Warsaw, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Umultowska 89, PL-61614 Poznan, Poland	Fahrenheit Universities; University of Gdansk; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University	Konieczny, I (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, Abrahama 58, PL-80307 Gdansk, Poland.	igor.konieczny@biotech.ug.edu.pl		Partyka, Malgorzata/0000-0002-4690-9223; Karlowicz, Anna/0000-0002-6940-8210; Konieczny, Igor/0000-0002-1588-5601; Wegrzyn, Katarzyna/0000-0002-3743-8597; Ropelewska, Malgorzata/0000-0003-0342-8320; Gross, Marta/0000-0001-5523-5702	Polish National Science Centre [2012/04/A/NZ1/00048]; Foundation for Polish Science - European Union [MPD/2010/5]; International Institute of Molecular and Cell Biology in Warsaw	Polish National Science Centre; Foundation for Polish Science - European Union(Foundation for Polish Science); International Institute of Molecular and Cell Biology in Warsaw	This work was supported in part by Polish National Science Centre Grant 2012/04/A/NZ1/00048. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Project MPD/2010/5 operated within the Foundation for Polish Science International Ph.D. Projects (MPD) Programme co-financed by the European Union European Regional Development Fund, Operational Program Innovative Economy 2007-2013.; Supported by statutory funds of the International Institute of Molecular and Cell Biology in Warsaw.	Arias-Palomo E, 2015, CELL, V162, P860, DOI 10.1016/j.cell.2015.07.037; Bissonnette SA, 2010, MOL MICROBIOL, V75, P1539, DOI 10.1111/j.1365-2958.2010.07070.x; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Cecarini V, 2016, CELL MOL LIFE SCI, V73, P3433, DOI 10.1007/s00018-016-2238-6; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; CHARETTE MF, 1984, J BACTERIOL, V158, P195, DOI 10.1128/JB.158.1.195-201.1984; CHUNG CH, 1982, P NATL ACAD SCI-BIOL, V79, P795, DOI 10.1073/pnas.79.3.795; Diago-Navarro E, 2013, PLASMID, V70, P78, DOI 10.1016/j.plasmid.2013.01.010; Doran KS, 1998, J BIOL CHEM, V273, P8447, DOI 10.1074/jbc.273.14.8447; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Duman RE, 2010, J MOL BIOL, V401, P653, DOI 10.1016/j.jmb.2010.06.030; Duprey A, 2016, BBA-GENE REGUL MECH, V1859, P1470, DOI 10.1016/j.bbagrm.2016.08.001; Fu GK, 1997, J BIOL CHEM, V272, P534; Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; Gora KG, 2013, MOL MICROBIOL, V87, P1277, DOI 10.1111/mmi.12166; GOTTESMAN S, 1981, CELL, V24, P225, DOI 10.1016/0092-8674(81)90518-3; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur Eyal, 2013, Subcell Biochem, V66, P35, DOI 10.1007/978-94-007-5940-4_2; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; Kereiche S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33631; Kosinski J, 2005, PROTEINS, V61, P106, DOI 10.1002/prot.20726; Kosinski J, 2003, PROTEINS, V53, P369, DOI 10.1002/prot.10545; Kubik S, 2012, NUCLEIC ACIDS RES, V40, P1148, DOI 10.1093/nar/gkr813; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lau J, 2015, MOL CELL, V59, P104, DOI 10.1016/j.molcel.2015.05.014; Lee AYL, 2014, ACTA CRYSTALLOGR D, V70, P218, DOI 10.1107/S139900471302631X; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Li M, 2010, ACTA CRYSTALLOGR D, V66, P865, DOI 10.1107/S0907444910019554; Lin CC, 2016, STRUCTURE, V24, P667, DOI 10.1016/j.str.2016.03.001; Lin YC, 2009, BIOCHEM BIOPH RES CO, V388, P62, DOI 10.1016/j.bbrc.2009.07.118; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lu B, 2003, GENE, V306, P45, DOI 10.1016/S0378-1119(03)00403-7; Melnikov EE, 2008, ACTA BIOCHIM POL, V55, P281, DOI 10.18388/abp.2008_3075; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; Mukherjee S, 2015, P NATL ACAD SCI USA, V112, P250, DOI 10.1073/pnas.1417419112; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Nomura K, 2006, CELL MOL BIOL, V52, P22, DOI 10.1170/T723; Nomura K, 2004, J BIOL CHEM, V279, P34406, DOI 10.1074/jbc.M404725200; Park SC, 2006, MOL CELLS, V21, P129; Pierechod M, 2009, PROTEIN SCI, V18, P637, DOI 10.1002/pro.68; Pinti M, 2016, BBA-BIOENERGETICS, V1857, P1300, DOI 10.1016/j.bbabio.2016.03.025; Pinti M, 2015, CELL MOL LIFE SCI, V72, P4807, DOI 10.1007/s00018-015-2039-3; Quiros PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018; Rudyak SG, 2000, PROTEIN SCI, V9, P1810, DOI 10.1110/ps.9.9.1810; Rudyak SG, 2001, BIOCHEMISTRY-US, V40, P9317, DOI 10.1021/bi0102508; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; Shearstone JR, 1999, J BIOL CHEM, V274, P9937, DOI 10.1074/jbc.274.15.9937; Simmons LA, 2008, J BACTERIOL, V190, P6758, DOI 10.1128/JB.00590-08; Sonezaki S, 1995, APPL MICROBIOL BIOT, V44, P484; Stahlberg H, 1999, P NATL ACAD SCI USA, V96, P6787, DOI 10.1073/pnas.96.12.6787; Stein BJ, 2016, STRUCTURE, V24, P232, DOI 10.1016/j.str.2015.12.008; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; Su SC, 2016, STRUCTURE, V24, P676, DOI 10.1016/j.str.2016.03.003; TORRESCABASSA A, 1987, J BACTERIOL, V169, P4525, DOI 10.1128/jb.169.10.4525-4531.1987; Toukdarian AE, 1996, J BIOL CHEM, V271, P7072, DOI 10.1074/jbc.271.12.7072; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Vasilyeva OV, 2002, FEBS LETT, V526, P66, DOI 10.1016/S0014-5793(02)03117-4; Vieux EF, 2013, P NATL ACAD SCI USA, V110, pE2002, DOI 10.1073/pnas.1307066110; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Wawrzycka A, 2015, P NATL ACAD SCI USA, V112, pE4188, DOI 10.1073/pnas.1504926112; Wegrzyn K, 2014, NUCLEIC ACIDS RES, V42, P7807, DOI 10.1093/nar/gku453; Wegrzyn KE, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00039; WITKIN EM, 1947, GENETICS, V32, P221; Wohlever ML, 2014, MOL MICROBIOL, V91, P66, DOI 10.1111/mmi.12444; ZEHNBAUER BA, 1981, P NATL ACAD SCI-BIOL, V78, P2043, DOI 10.1073/pnas.78.4.2043; Zhang ET, 2015, P NATL ACAD SCI USA, V112, P14817, DOI 10.1073/pnas.1520104112; Zhong ZP, 2005, PLASMID, V54, P48, DOI 10.1016/j.plasmid.2004.11.001; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	73	14	14	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7507	7518		10.1074/jbc.M116.766709	http://dx.doi.org/10.1074/jbc.M116.766709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28292931	Green Published, hybrid			2022-12-26	WOS:000400761300019
J	Doci, CL; Mikelis, CM; Callejas-Valera, JL; Hansen, KK; Molinolo, AA; Inoue, A; Offermanns, S; Gutkind, JS				Doci, Colleen L.; Mikelis, Constantinos M.; Callejas-Valera, Juan Luis; Hansen, Karina K.; Molinolo, Alfredo A.; Inoue, Asuka; Offermanns, Stefan; Gutkind, J. Silvio			Epidermal loss of Gag confers a migratory and differentiation defect in keratinocytes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR-BETA; UVEAL MELANOMA; ANAPHYLACTIC SHOCK; MICE; SKIN; EXPRESSION; WOUNDS; TRANSACTIVATION; ACTIVATION	G-protein coupled receptors (GPCRs), which activate heterotrimeric G proteins, are an essential class of transmembrane receptors that are responsible for a myriad of signaling events in normal and pathologic conditions. Two members of the G protein family, Gaq and Ga-11, activate one of the main GPCR pathways and function as oncogenes by integrating mitogen-stimulated signaling cascades that are active under malignant conditions. Recently, it has been shown that targeted deletion of Ga-11 and Gaq from endothelial cells impairs the Rho -mediated formation of focal adherens junctions, suggesting that Gai vg signaling may also play a significant role in cytoskeletal-mediated cellular responses in epithelial cells. Indeed, combined deletion of Ga-11 and Gaq confers a significant migratory defect in keratinocytes that delays cutaneous wound healing in an in vivo setting. This delay can be attributed to a defect during the reepithelialization phase due to significantly attenuated migratory capacity of Gaq-null keratinocytes under combined Ga-11 deficiency. In fact, cells lacking Gaivg demonstrate a severely reduced ability to respond to mitogenic and migratory signals in the microenvironment, leading to inappropriate and premature terminal differentiation. These results suggest that Gaivg signaling pathways may be critical for integrating mitogenic signals and cytoskeletal function to achieve normal physiological responses. Emergence of a malignant phenotype may therefore arise from both under- and overexpression of Gai vg signaling, implicating its upstream regulation as a potential therapeutic target in a host of pathologic conditions.	[Doci, Colleen L.] Marian Univ Indianapolis, Coll Arts & Sci, Indianapolis, IN 46222 USA; [Mikelis, Constantinos M.] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; [Callejas-Valera, Juan Luis; Gutkind, J. Silvio] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Callejas-Valera, Juan Luis; Gutkind, J. Silvio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Hansen, Karina K.] NIDCD, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Molinolo, Alfredo A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of California System; University of California San Diego; Tohoku University; Japan Science & Technology Agency (JST); Max Planck Society	Doci, CL (corresponding author), Marian Univ Indianapolis, Coll Arts & Sci, Indianapolis, IN 46222 USA.	cdoci@marian.edu	Gutkind, J. Silvio/J-1201-2016; Doci, Colleen L/M-4389-2015; Mikelis, Constantinos/AGF-9423-2022; Offermanns, Stefan/L-3313-2017	Gutkind, J. Silvio/0000-0002-5150-4482; Offermanns, Stefan/0000-0001-8676-6805	Intramural Research Program of the National Institute of Dental and Craniofacial Research; Marian University Indianapolis; PRESTO, Japan Science and Technology Agency [13408007]; JST, PRESTO [13408007]	Intramural Research Program of the National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Marian University Indianapolis; PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JST, PRESTO(Japan Science & Technology Agency (JST))	This research was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, and in part by Marian University Indianapolis. AI received Grant #13408007 from PRESTO, Japan Science and Technology Agency. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; This research was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, and in part by Marian University Indianapolis. A.I. was funded by JST, PRESTO Grant #13408007.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; BETZ P, 1993, INT J LEGAL MED, V105, P229, DOI 10.1007/BF01642799; Chattopadhyay C, 2016, CANCER-AM CANCER SOC, V122, P2299, DOI 10.1002/cncr.29727; Cheng CF, 2008, J INVEST DERMATOL, V128, P1981, DOI 10.1038/jid.2008.34; Decatur CL, 2016, JAMA OPHTHALMOL, V134, P728, DOI 10.1001/jamaophthalmol.2016.0903; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; GLICK AB, 1993, P NATL ACAD SCI USA, V90, P6076, DOI 10.1073/pnas.90.13.6076; Griewank KG, 2016, EUR J CANCER, V57, P112, DOI 10.1016/j.ejca.2016.01.010; Griewank KV S, 2011, ATLAS GENET CYTOGENE, V15, P828; Hameedaldeen A, 2014, INT J MOL SCI, V15, P16257, DOI 10.3390/ijms150916257; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Hata A, 2016, COLD SPRING HARB PER; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Kim BC, 2003, J CELL PHYSIOL, V195, P331, DOI 10.1002/jcp.10301; Koivisto L, 2014, ADV WOUND CARE, V3, P762, DOI 10.1089/wound.2013.0436; Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150; Leiter Ulrike, 2014, Adv Exp Med Biol, V810, P120; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Sauer B, 2004, J INVEST DERMATOL, V123, P840, DOI 10.1111/j.0022-202X.2004.23458.x; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Seeger MA, 2015, ADV WOUND CARE, V4, P213, DOI 10.1089/wound.2014.0540; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Taboubi S, 2010, MOL BIOL CELL, V21, P946, DOI 10.1091/mbc.E09-06-0497; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173692	10.1371/journal.pone.0173692	http://dx.doi.org/10.1371/journal.pone.0173692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301547	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300062
J	Cowart, DA; Durand, L; Cambon-Bonavita, MA; Arnaud-Haond, S				Cowart, Dominique A.; Durand, Lucile; Cambon-Bonavita, Marie-Anne; Arnaud-Haond, Sophie			Investigation of bacterial communities within the digestive organs of the hydrothermal vent shrimp Rimicaris exoculata provide insights into holobiont geographic clustering	PLOS ONE			English	Article							SP NOV.; DIVERSITY; DEPOSITS; CHAMBER; CH4	Prokaryotic communities forming symbiotic relationships with the vent shrimp, Rimicaris exoculata, are well studied components of hydrothermal ecosystems at the Mid-Atlantic Ridge (MAR). Despite the tight link between host and symbiont, the observed lack of spatial genetic structure seen in R. exoculata contrasts with the geographic differentiation detected in specific bacterial ectosymbionts. The geographic clustering of bacterial lineages within a seemingly panmictic host suggests either the presence of finer scale restriction to gene flow not yet detected in the host, horizontal transmission (environmental selection) of its endosymbionts as a consequence of unique vent geochemistry, or vertically transmitted endosymbionts that exhibit genetic differentiation. To identify which hypothesis best fits, we tested whether bacterial assemblages exhibit differentiation across sites or host populations by performing a 16S rRNA metabarcoding survey on R. exoculata digestive prokaryote samples (n = 31) taken from three geochemically distinct vents across MAR: Rainbow, Trans-Atlantic Geotraverse (TAG) and Logatchev. Analysis of communities across two organs (digestive tract, stomach), three molt colors (white, red, black) and three life stages (eggs, juveniles, adults) also provided insights into symbiont transmission mode. Examining both whole communities and operational taxonomic units (OTUs) confirmed the presence of three main epibionts: Epsilonproteobacteria, Mollicutes and Deferribacteres. With these findings, we identified a clear pattern of geographic segregation by vent in OTUs assigned to Epsilonproteobacteria. Additionally, we detected evidence for differentiation among all communities associated to vents and life stages. Overall, results suggest a combination of environmental selection and vertical inheritance of some of the symbiotic lineages.	[Cowart, Dominique A.; Arnaud-Haond, Sophie] IFREMER, UMR MARBEC Marine Biodivers Exploitat & Conservat, BP 17, Sete, France; [Durand, Lucile; Cambon-Bonavita, Marie-Anne] IFREMER, Lab Microbiol Environm Extremes, Dept Ressources Phys & Ecosyst Fond Mer REM, UMR6197,ZI Pointe Diable,CS 10070, Plouzane, France; [Cambon-Bonavita, Marie-Anne] IFREMER, UBO, CNRS, UMR 6197, IUEM Rue Dumont dUrville, Plouzane, France; [Cambon-Bonavita, Marie-Anne] IFREMER, CNRS, UMR 6197, UBO, IUEM Rue Dumont dUrville, Plouzane, France; [Cowart, Dominique A.] Univ Illinois, Dept Anim Biol, Urbana, IL USA	Ifremer; Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Illinois System; University of Illinois Urbana-Champaign	Arnaud-Haond, S (corresponding author), IFREMER, UMR MARBEC Marine Biodivers Exploitat & Conservat, BP 17, Sete, France.	sophie.arnaud@ifremer.fr	Arnaud-Haond, Sophie/B-2479-2008	Arnaud-Haond, Sophie/0000-0001-5814-8452; Cowart, Dominique/0000-0002-2581-0355; Cambon-Bonavita, Marie-Anne/0000-0002-4076-0472	Hermione project (FP7, European Union); Ifremer	Hermione project (FP7, European Union); Ifremer	This work was supported the by Hermione project (FP7, European Union) to MACB and SAH; DAC and LD were supported by post-doctoral contracts at Ifremer.	Aires T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068429; Bandelt H-J, 1999, MOLECULAR BIOLOGY AN, P1; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; BOUGAULT H, 1993, J GEOPHYS RES-SOL EA, V98, P9643, DOI 10.1029/93JB00508; Buck KN, 2015, DEEP-SEA RES PT II, V116, P152, DOI 10.1016/j.dsr2.2014.11.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Charlou J, CHEM ECOLOGY; Charlou JL, 2010, GEOPHYS MONOGR SER, V188, P265, DOI 10.1029/2008GM000752; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Corbari L, 2008, AQUAT BIOL, V1, P225, DOI 10.3354/ab00024; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desbruyeres D, 2001, DEEP-SEA RES PT I, V48, P1325, DOI 10.1016/S0967-0637(00)00083-2; Douville E, 2002, CHEM GEOL, V184, P37, DOI 10.1016/S0009-2541(01)00351-5; Durand L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv101; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Flores G, 2011, ENV MICROBIOLOGY, V13; Fouquet Y, 2010, GEOPHYS MONOGR SER, V188, P321, DOI 10.1029/2008GM000746; Garrity G, 2001, BERGEYS MANUAL SYSTE, P465, DOI [10.1007/978-0-387-21609-6_26, DOI 10.1007/978-0-387-21609-6_26]; Gloter A, 2004, EARTH PLANET SC LETT, V222, P947, DOI 10.1016/j.epsl.2004.03.040; Guri M, 2012, ISME J, V6, P597, DOI 10.1038/ismej.2011.133; Harper D, 2013, PALAEONTOL ELECTRON, V4, P1; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Jan C, 2014, ENV MICROBIOLOGY, V16; Kaspari M, 2010, ECOLOGY, V91, P2221, DOI 10.1890/09-2089.1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P1637, DOI 10.1099/ijs.0.02673-0; Nieberding CM, 2007, TRENDS ECOL EVOL, V22, P156, DOI 10.1016/j.tree.2006.11.012; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Schmale O, 2012, GEOCHEM GEOPHY GEOSY, V13, P1; Schmidt C, 2008, J SHELLFISH RES, V27, P79, DOI 10.2983/0730-8000(2008)27[79:IODVIW]2.0.CO;2; Severi S, 2004, ESSDERC 2004: PROCEEDINGS OF THE 34TH EUROPEAN SOLID-STATE DEVICE RESEARCH CONFERENCE, P225; Slobodkina GB, 2009, INT J SYST EVOL MICR, V59, P1508, DOI 10.1099/ijs.0.006767-0; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; THOMPSON G, 1985, CHEM GEOL, V49, P243, DOI 10.1016/0009-2541(85)90159-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIVEY MK, 1995, J GEOPHYS RES-SOL EA, V100, P12527, DOI 10.1029/95JB00610; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	58	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172543	10.1371/journal.pone.0172543	http://dx.doi.org/10.1371/journal.pone.0172543			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296889	Green Submitted, gold, Green Published			2022-12-26	WOS:000396311700009
J	Esslinger, U; Garnier, S; Korniat, A; Proust, C; Kararigas, G; Muller-Nurasyid, M; Empana, JP; Morley, MP; Perret, C; Stark, K; Bick, AG; Prasad, SK; Kriebel, J; Li, J; Tiret, L; Strauch, K; O'Regan, DP; Marguiles, KB; Seidman, JG; Boutouyrie, P; Lacolley, P; Jouven, X; Hengstenberg, C; Komajda, M; Hakonarson, H; Isnard, R; Arbustini, E; Grallert, H; Cook, SA; Seidman, CE; Regitz-Zagrosek, V; Cappola, TP; Charron, P; Cambien, F; Villard, E				Esslinger, Ulrike; Garnier, Sophie; Korniat, Agathe; Proust, Carole; Kararigas, Georgios; Mueller-Nurasyid, Martina; Empana, Jean-Philippe; Morley, Michael P.; Perret, Claire; Stark, Klaus; Bick, Alexander G.; Prasad, Sanjay K.; Kriebel, Jennifer; Li, Jin; Tiret, Laurence; Strauch, Konstantin; O'Regan, Declan P.; Marguiles, Kenneth B.; Seidman, Jonathan G.; Boutouyrie, Pierre; Lacolley, Patrick; Jouven, Xavier; Hengstenberg, Christian; Komajda, Michel; Hakonarson, Hakon; Isnard, Richard; Arbustini, Eloisa; Grallert, Harald; Cook, Stuart A.; Seidman, Christine E.; Regitz-Zagrosek, Vera; Cappola, Thomas P.; Charron, Philippe; Cambien, Francois; Villard, Eric			Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy	PLOS ONE			English	Article							PROTEIN; MUTATIONS; HSPB7; FHOD3; DIFFERENTIATION; EXPRESSION; VARIANTS; PROMOTES; MYOPATHY; DOMAIN	Aims Dilated cardiomyopathy (DCM) is an important cause of heart failure with a strong familial component. We performed an exome-wide array-based association study (EWAS) to assess the contribution of missense variants to sporadic DCM. Methods and results 116,855 single nucleotide variants (SNVs) were analyzed in 2796 DCM patients and 6877 control subjects from 6 populations of European ancestry. We confirmed two previously identified associations with SNVs in BAG3 and ZBTB17 and discovered six novel DCM-associated loci (Q-value<0.01). The lead-SNVs at novel loci are common and located in TTN, SLC39A8, MLIP, FLNC, ALPK3 and FHOD3. In silico fine mapping identified HSPB7 as the most likely candidate at the ZBTB17 locus. Rare variant analysis (MAF<0.01) demonstrated significant association for TTN variants only (P = 0.0085). All candidate genes but one (SLC39A8) exhibit preferential expression in striated muscle tissues and mutations in TTN, BAG3, FLNC and FHOD3 are known to cause familial cardiomyopathy. We also investigated a panel of 48 known cardiomyopathy genes. Collectively, rare (n = 228, P = 0.0033) or common (n = 36, P = 0.019) variants with elevated in silico severity scores were associated with DCM, indicating that the spectrum of genes contributing to sporadic DCM extends beyond those identified here. Conclusion We identified eight loci independently associated with sporadic DCM. The functions of the best candidate genes at these loci suggest that proteostasis regulation might play a role in DCM pathophysiology.	[Esslinger, Ulrike; Garnier, Sophie; Korniat, Agathe; Proust, Carole; Perret, Claire; Tiret, Laurence; Komajda, Michel; Isnard, Richard; Charron, Philippe; Cambien, Francois; Villard, Eric] UPMC Univ Paris 06, Sorbonne Univ, INSERM UMR S1166, Team Genom & Pathophysiol Cardiovasc Dis, Paris, France; [Esslinger, Ulrike; Garnier, Sophie; Korniat, Agathe; Proust, Carole; Perret, Claire; Tiret, Laurence; Komajda, Michel; Isnard, Richard; Charron, Philippe; Cambien, Francois; Villard, Eric] ICAN Inst Cardiometab & Nutr, Paris, France; [Kararigas, Georgios; Regitz-Zagrosek, Vera] Charite, Inst Gender Med, Berlin, Germany; [Kararigas, Georgios; Regitz-Zagrosek, Vera] Charite, Ctr Cardiovasc Res, Berlin, Germany; [Kararigas, Georgios; Regitz-Zagrosek, Vera] DZHK, Berlin, Germany; [Mueller-Nurasyid, Martina] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Genet Epidemiol, Neuherberg, Germany; [Mueller-Nurasyid, Martina] Ludwig Maximilians Univ Munchen, Dept Med 1, Munich, Germany; [Mueller-Nurasyid, Martina] DZHK German Ctr Cardiovasc Res, Partnersite Munich Heart Alliance, Munich, Germany; [Mueller-Nurasyid, Martina] INSERM, UMR S970, Dept Epidemiol, Paris, France; [Empana, Jean-Philippe] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Morley, Michael P.; Marguiles, Kenneth B.; Cappola, Thomas P.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA USA; [Morley, Michael P.; Marguiles, Kenneth B.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA; [Stark, Klaus] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Bick, Alexander G.; Seidman, Jonathan G.] Harvard Med Sch, Dept Med & Genet, Boston, MA USA; [Prasad, Sanjay K.] Royal Brompton Hosp, London, England; [Kriebel, Jennifer] Helmholtz Zentrum Munchen German Res Ctr Environm, Res Unit Mol Epidemiol, Neuherberg, Germany; [Kriebel, Jennifer] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, Neuherberg, Germany; [Li, Jin] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA USA; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [O'Regan, Declan P.] Imperial Coll London, Fac Med, Med Res Council Clin Sci Ctr, London, England; [Seidman, Jonathan G.; Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Boutouyrie, Pierre] Georges Pompidou European Hosp, AP HP, Dept Pharmacol, Paris, France; [Lacolley, Patrick] Univ Lorraine, INSERM U1116, Nancy, France; [Jouven, Xavier] Georges Pompidou European Hosp, AP HP, Dept Cardiol, Paris, France; [Hengstenberg, Christian] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Komajda, Michel; Isnard, Richard; Charron, Philippe; Cambien, Francois; Villard, Eric] Hop La Pitie Salpetriere, AP HP, Dept Cardiol, Paris, France; [Komajda, Michel; Isnard, Richard] Pitie Salpetriere Hop, AP HP, Ctr Reference Malad Cardiaques Hereditaires, Paris, France; [Arbustini, Eloisa] IRCCS Fdn Policlin San Matteo, Pavia, Italy; [Cook, Stuart A.] Natl Heart Ctr Singapore, Singapore, Singapore; [Cook, Stuart A.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Cook, Stuart A.] Duke NUS, Singapore, Singapore; [Charron, Philippe] Univ Versailles St Quentin, Hop Ambroise Pare, AP HP, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Regensburg; Harvard University; Harvard Medical School; Royal Brompton Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Munich; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; German Heart Centre Munich; Technical University of Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; IRCCS Fondazione San Matteo; National Heart Centre Singapore; Imperial College London; National University of Singapore; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Cambien, F; Villard, E (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM UMR S1166, Team Genom & Pathophysiol Cardiovasc Dis, Paris, France.; Cambien, F; Villard, E (corresponding author), ICAN Inst Cardiometab & Nutr, Paris, France.; Cambien, F; Villard, E (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Cardiol, Paris, France.	francois.cambien@upmc.fr; eric.villard@upmc.fr	Cambien, Francois/AAP-9751-2020; Grallert, Harald/B-3424-2013; Kriebel, Jennifer/N-4782-2017; Stark, Klaus/L-7367-2013; villard, eric/AAH-2868-2021; Empana, Jean-Philippe/AAF-6923-2021; Hengstenberg, Christian/U-5485-2019; Villard, Eric/AAI-2464-2021; Lacolley, Patrick/G-3118-2013; boutouyrie, pierre/HGT-8201-2022; Müller-Nurasyid, Martina/I-8735-2018; Arbustini, Eloisa/K-8174-2016	Kriebel, Jennifer/0000-0003-4270-018X; Stark, Klaus/0000-0002-7832-1942; Empana, Jean-Philippe/0000-0002-1469-7772; Villard, Eric/0000-0001-9801-7297; boutouyrie, pierre/0000-0002-4375-3569; Müller-Nurasyid, Martina/0000-0003-3793-5910; Arbustini, Eloisa/0000-0003-2948-7994; Charron, Philippe/0000-0002-1782-1118; Garnier, Sophie/0000-0002-7492-1617; O'Regan, Declan/0000-0002-0691-0270; Isnard, Richard/0000-0002-3439-8104; Morley, Michael/0000-0002-0958-7376; Bick, Alexander/0000-0001-5824-9595; Regitz-Zagrosek, Vera/0000-0002-3566-3467; Kararigas, Georgios/0000-0002-8187-0176	Leducq Transatlantic Network; BestAgeing FP7 European Community project; Conny Maeva Charitable Foundation; British Heart Foundation, UK [PG/12/27/29489]; NMRC Singapore; Medical Research Council, UK; Tanoto Foundation; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust, Biomedical Research Unit in Cardiovascular Disease at Royal Brompton  Harefield NHS Foundation Trust and Imperial College London; National Research Agency (ANR); Research Foundation for Hypertension (FRHTA); Research Institute in Public Health (IRESP); Region Ile de France (DIM); ANR [ANR-09-GENO-010]; Helmholtz Zentrum Munchen German Research Center of Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; NIH [R01HL105993, R01HL088577]; Howard Hughes Medical Institute; National Institutes of Health; British Heart Foundation [PG/12/27/29489] Funding Source: researchfish; Rosetrees Trust [M232-CD1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Leducq Transatlantic Network(Leducq Foundation); BestAgeing FP7 European Community project; Conny Maeva Charitable Foundation; British Heart Foundation, UK(British Heart Foundation); NMRC Singapore(National Medical Research Council, Singapore); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tanoto Foundation; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust, Biomedical Research Unit in Cardiovascular Disease at Royal Brompton  Harefield NHS Foundation Trust and Imperial College London; National Research Agency (ANR)(French National Research Agency (ANR)); Research Foundation for Hypertension (FRHTA); Research Institute in Public Health (IRESP); Region Ile de France (DIM)(Region Ile-de-France); ANR(French National Research Agency (ANR)); Helmholtz Zentrum Munchen German Research Center of Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Rosetrees Trust(Rosetrees Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the Leducq Transatlantic Network: "Genomic, epigenomic and systems dissection of mechanisms underlyingdilated cardiomyopathy"; BestAgeing FP7 European Community project; and Conny Maeva Charitable Foundation. Other supports are from the British Heart Foundation, UK (PG/12/27/29489); NMRC Singapore; Medical Research Council, UK; Tanoto Foundation; and co-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust, Biomedical Research Unit in Cardiovascular Disease at Royal Brompton & Harefield NHS Foundation Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The PPS3 is organized under an agreement between INSERM and the IPC Center, and between INSERM and the Biological Research Center at the Europeen Georges Pompidou hospital, Paris, France. We thank the "Caisse Nationale d'Assurance Maladie des Travailleurs Salaries". The PPS3 Study is funded by the National Research Agency (ANR), the Research Foundation for Hypertension (FRHTA), the Research Institute in Public Health (IRESP) and the Region Ile de France (DIM). Genotyping in PPS3 substudy was supported by a grant from ANR (ANR-09-GENO-010). The KORA research platform was financed by the Helmholtz Zentrum Munchen German Research Center of Environmental Health, funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ. The MAGNet consortium is funded by NIH R01HL105993 and NIH R01HL088577. Support for this work was provided in part by the Howard Hughes Medical Institute and National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmady E, 2011, J BIOL CHEM, V286, P19702, DOI 10.1074/jbc.M110.165548; Almomani R, 2016, J AM COLL CARDIOL, V67, P515, DOI 10.1016/j.jacc.2015.10.093; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Cappola TP, 2011, P NATL ACAD SCI USA, V108, P2456, DOI 10.1073/pnas.1017494108; Cappola TP, 2010, CIRC-CARDIOVASC GENE, V3, P147, DOI 10.1161/CIRCGENETICS.109.898395; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Fujita M, 2012, DEV BIOL, V361, P79, DOI 10.1016/j.ydbio.2011.10.008; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hosoda T, 2001, J BIOL CHEM, V276, P35978, DOI 10.1074/jbc.M100485200; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang ZP, 2015, J CLIN INVEST, V125, P4122, DOI 10.1172/JCI82423; Huang ZP, 2012, CIRC RES, V110, P818, DOI 10.1161/CIRCRESAHA.111.259663; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Juo LY, 2016, J CELL SCI, V129, P1661, DOI 10.1242/jcs.179887; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kley RA, 2013, AUTOPHAGY, V9, P422, DOI 10.4161/auto.22921; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Li B, 2013, TOXICOL MECH METHOD, V23, P27, DOI 10.3109/15376516.2012.735277; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Schlossarek S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0235-3; Selcen Duygu, 2011, Neuromuscul Disord, V21, P161, DOI [10.1016/B978-0-08-045031-5.00011-6, 10.1016/j.nmd.2010.12.007]; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Ulbricht A, 2015, AUTOPHAGY, V11, P538, DOI 10.1080/15548627.2015.1017186; Valdes-Mas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6326; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; Van Sligtenhorst I, 2012, VET PATHOL, V49, P131, DOI 10.1177/0300985811402841; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yang Jian, 2013, Methods Mol Biol, V1019, P215, DOI 10.1007/978-1-62703-447-0_9	40	68	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172995	10.1371/journal.pone.0172995	http://dx.doi.org/10.1371/journal.pone.0172995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296976	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700021
J	Fujiwara, M; Ding, C; Kaunitz, L; Stout, JC; Thyagarajan, D; Tsuchiya, N				Fujiwara, Mana; Ding, Catherine; Kaunitz, Lisandro; Stout, Julie C.; Thyagarajan, Dominic; Tsuchiya, Naotsugu			Optokinetic nystagmus reflects perceptual directions in the onset binocular rivalry in Parkinson's disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; MOTOR-NEURON DISEASE; EYE-MOVEMENTS; OCULOMOTOR ABNORMALITIES; ATTENTION; CONSCIOUSNESS; COMPETITION; DOMINANCE; AWARENESS; HUMANS	Optokinetic nystagmus (OKN), the reflexive eye movements evoked by a moving field, has recently gained interest among researchers as a useful tool to assess conscious perception. When conscious perception and stimulus are dissociated, such as in binocular rivalry-when dissimilar images are simultaneously presented to each eye and perception alternates between the two images over time-OKN correlates with perception rather than with the physical direction of the moving field. While this relationship is well established in healthy subjects, it is yet unclear whether it also generalizes to clinical populations, for example, patients with Parkinson's disease. Parkinson's disease is a motor disorder, causing tremor, slow movements and rigidity. It may also be associated with oculomotor deficits, such as impaired saccades and smooth pursuit eye movements. Here, we employed short-duration, onset binocular rivalry (2 s trial of stimulus presentation followed by 1 s inter-trial interval) with moving grating stimuli to assess OKN in Parkinson's disease patients (N = 39) and controls (N = 29) of a similar age. Each trial was either non-rivalrous (same stimuli presented to both eyes) or rivalrous, as in binocular rivalry. We analyzed OKN to discriminate direction of stimulus and perception on a trial-by-trial basis. Although the speed of slow-phase OKN was slower in the patients, discriminability of conscious perception based on OKN was comparable between the groups. Treatment with anti-Parkinson drugs and deep brain stimulation improved motor ability of patients, but did not impact on OKN. Furthermore, OKN-based measures were robust and their latencies were shorter than manual button-based measures in both groups and stimulus conditions. To our knowledge, our study is the first to demonstrate that OKN can be used as a reliable indicator of conscious perception in binocular rivalry even in Parkinson's disease patients in whom impaired manual dexterity may render button-press reports less reliable.	[Fujiwara, Mana; Kaunitz, Lisandro; Stout, Julie C.; Tsuchiya, Naotsugu] Monash Univ, Sch Psychol Sci, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Fujiwara, Mana] Araya Brain Imaging, Tokyo, Japan; [Ding, Catherine; Thyagarajan, Dominic] Monash Hlth, Dept Neurosci, Southern Clin Sch, Melbourne, Vic, Australia; [Kaunitz, Lisandro] Univ Tokyo, RCAST, Tokyo, Japan; [Stout, Julie C.; Tsuchiya, Naotsugu] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia	Monash University; University of Tokyo; Monash University	Tsuchiya, N (corresponding author), Monash Univ, Sch Psychol Sci, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.; Thyagarajan, D (corresponding author), Monash Hlth, Dept Neurosci, Southern Clin Sch, Melbourne, Vic, Australia.; Tsuchiya, N (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia.	dominic.thyagarajan@monash.edu; naotsugu.tsuchiya@monash.edu	Thyagarajan, Dominic E S/H-6633-2014; Tsuchiya, Naotsugu/N-8153-2014	Thyagarajan, Dominic E S/0000-0002-7766-4003; Stout, Julie/0000-0001-9637-8590; Tsuchiya, Naotsugu/0000-0003-4216-8701	Australian Research Council [DP130100194, FT120100619]; Japanese Society for the Promotion of Science [JSPS P15048]; Precursory Research for Embryonic Science and Technology project from the JST [3630]; Monash Institute of Neurological Sciences; Australian Postgraduate Award from Monash University	Australian Research Council(Australian Research Council); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Precursory Research for Embryonic Science and Technology project from the JST; Monash Institute of Neurological Sciences; Australian Postgraduate Award from Monash University	LK and NT were supported by the Australian Research Council Discovery Project (DP130100194, http://www.arc.gov.au/discovery -projects). LK was supported by a fellowship from the Japanese Society for the Promotion of Science (JSPS P15048). NT was supported by Precursory Research for Embryonic Science and Technology project from the JST (3630, http://www.jst.go.jp/kisoken/presto/en/about/) and Australian Research Council Future Fellowship (FT120100619, http:// www.arc.gov.au/furure-fellowships). CD is supported by the Monash Institute of Neurological Sciences and an Australian Postgraduate Award from Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2008, TOP GERIATR REHABIL, V24, P166; Antoniades CA, 2015, EYE, V29, P200, DOI 10.1038/eye.2014.276; Arnulf I, 2009, PARKINSONISM RELAT D, V15, pS101, DOI 10.1016/S1353-8020(09)70792-8; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bor D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00063; Braak E., 1996, Neurobiology of Aging, V17, pS116, DOI 10.1016/S0197-4580(96)80469-6; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; COOPER JA, 1994, BRAIN, V117, P517, DOI 10.1093/brain/117.3.517; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Diaz-Santos M, 2015, NEUROPSYCHOLOGIA, V69, P183, DOI 10.1016/j.neuropsychologia.2015.01.044; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; ENOKSSON P, 1963, ACTA OPHTHALMOL, V41, P544; FOX R, 1975, VISION RES, V15, P849, DOI 10.1016/0042-6989(75)90265-5; Frasle S, 2014, J NEUROSCI, V34, P1738, DOI 10.1523/JNEUROSCI.4403-13.2014; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Garbutt S, 2004, J NEUROL NEUROSUR PS, V75, P1386, DOI 10.1136/jnnp.2003.027367; GIZZI M, 1992, NEUROLOGY, V42, P1037, DOI 10.1212/WNL.42.5.1037; HOWARD IP, 1984, VISION RES, V24, P969, DOI 10.1016/0042-6989(84)90072-5; Hugrass L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035963; Knapp CM., 2009, VERTICAL OPTOKINETIC; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Lau H, 2011, TRENDS COGN SCI, V15, P365, DOI 10.1016/j.tics.2011.05.009; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; Leopold D. A., 1995, ROLE ATTENTION BINOC; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LOGOTHETIS NK, 1990, VISION RES, V30, P1409, DOI 10.1016/0042-6989(90)90022-D; Logothetis NK., 1990, V4 RESPONSES GRATING; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MAGNUSSON M, 1985, AM J OTOLARYNG, V6, P419, DOI 10.1016/S0196-0709(85)80020-X; Maier A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00263; MARTIFABREGAS J, 1993, J NEUROL, V240, P475, DOI 10.1007/BF00874116; Naber M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020910; NAKAMURA T, 1991, ACTA OTO-LARYNGOL, P559; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PULLMAN SL, 1988, NEUROLOGY, V38, P249, DOI 10.1212/WNL.38.2.249; Rascol O, 1989, BRAIN; Rottach KG, 1996, ANN NEUROL, V39, P368, DOI 10.1002/ana.410390314; SHIBASAKI H, 1979, ARCH NEUROL-CHICAGO, V36, P360, DOI 10.1001/archneur.1979.00500420070009; Spering M, 2015, TRENDS NEUROSCI, V38, P247, DOI 10.1016/j.tins.2015.02.002; Spering M, 2011, PSYCHOL SCI, V22, P216, DOI 10.1177/0956797610394659; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2015, TRENDS COGN SCI, V19, P757, DOI 10.1016/j.tics.2015.10.002; VIDAILHET M, 1994, ANN NEUROL, V35, P420, DOI 10.1002/ana.410350408; Watanabe K, 1999, EXP BRAIN RES, V129, P156, DOI 10.1007/s002210050946; Wei M, 1998, BRAIN RES, V813, P406, DOI 10.1016/S0006-8993(98)01046-4; Wilimzig C, 2008, J VISION, V8, DOI 10.1167/8.5.7; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173707	10.1371/journal.pone.0173707	http://dx.doi.org/10.1371/journal.pone.0173707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CP	28288201	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400031
J	Shakiba, E; Edwards, JD; Jodari, F; Duke, SE; Baldo, AM; Korniliev, P; McCouch, SR; Eizenga, GC				Shakiba, Ehsan; Edwards, Jeremy D.; Jodari, Farman; Duke, Sara E.; Baldo, Angela M.; Korniliev, Pavel; McCouch, Susan R.; Eizenga, Georgia C.			Genetic architecture of cold tolerance in rice (Oryza sativa) determined through high resolution genome-wide analysis	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; LOW-TEMPERATURE GERMINABILITY; YIELD COMPONENTS; SEEDLING STAGE; CHILLING TOLERANCE; COMPLEX TRAITS; BOOTING STAGE; ASSOCIATION; QTLS; STRESS	Cold temperature is an important abiotic stress which negatively affects morphological development and seed production in rice (Oryza sativa L.). At the seedling stage, cold stress causes poor germination, seedling injury and poor stand establishment; and at the reproductive stage cold decreases seed yield. The Rice Diversity Panel 1 (RDP1) is a global collection of over 400 O. sativa accessions representing the five major subpopulations from the INDICA and JAPONICA varietal groups, with a genotypic dataset consisting of 700,000 SNP markers. The objectives of this study were to evaluate the RDP1 accessions for the complex, quantitatively inherited cold tolerance traits at the germination and reproductive stages, and to conduct genome-wide association (GWA) mapping to identify SNPs and candidate genes associated with cold stress at these stages. GWA mapping of the germination index (calculated as percent germination in cold divided by warm treatment) revealed 42 quantitative trait loci (QTLs) associated with cold tolerance at the seedling stage, including 18 in the panel as a whole, seven in temperate japonica, six in tropical japonica, 14 in JAPONICA, and nine in INDICA, with five shared across all subpopulations. Twenty-two of these QTLs co-localized with 32 previously reported cold tolerance QTLs. GWA mapping of cold tolerance at the reproductive stage detected 29 QTLs, including seven associated with percent sterility, ten with seed weight per panicle, 14 with seed weight per plant and one region overlapping for two traits. Fifteen co-localized with previously reported QTLs for cold tolerance or yield components. Candidate gene ontology searches revealed these QTLs were associated with significant enrichment for genes related to with lipid metabolism, response to stimuli, response to biotic stimuli (suggesting cross-talk between biotic and abiotic stresses), and oxygen binding. Overall the JAPONICA accessions were more tolerant to cold stress than INDICA accessions.	[Shakiba, Ehsan] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AK USA; [Edwards, Jeremy D.; Baldo, Angela M.; Eizenga, Georgia C.] Dale Bumpers Natl Rice Res Ctr, USDA ARS, Stuttgart, AR 72160 USA; [Jodari, Farman] RES, Biggs, CA USA; [Duke, Sara E.] USDA ARS, Plains Area, College Stn, TX USA; [Korniliev, Pavel] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [McCouch, Susan R.] Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Cornell University; Cornell University	Eizenga, GC (corresponding author), Dale Bumpers Natl Rice Res Ctr, USDA ARS, Stuttgart, AR 72160 USA.	georgia.eizenga@ars.usda.gov		Edwards, Jeremy/0000-0002-0237-0932	National Science Foundation-Plant Genome Project: "The Genetic Basis of Transgressive Variation in Rice" [1026555]; U.S. Department of Agriculture/Agricultural Research Service CRIS [6028-21220-005-00D]; California Cooperative Rice Research Foundation (CCRRF) [501(c)(5)]	National Science Foundation-Plant Genome Project: "The Genetic Basis of Transgressive Variation in Rice"; U.S. Department of Agriculture/Agricultural Research Service CRIS(United States Department of Agriculture (USDA)); California Cooperative Rice Research Foundation (CCRRF)	This research was supported by the National Science Foundation-Plant Genome Project: "The Genetic Basis of Transgressive Variation in Rice" (Award no. 1026555) to SRM and GCE in support of ES and PK; U.S. Department of Agriculture/Agricultural Research Service CRIS project 6028-21220-005-00D "Using Genetic Approaches to Reduce Crop Losses in Rice Due to Biotic and Abiotic Stress" in support of JDE, SED, AMB and GCE and the California Cooperative Rice Research Foundation (CCRRF), a private nonprofit research foundation [501(c)(5)], supporting breeding and genetics research and foundation seed production in support of FJ to collect the data at the reproductive stage. There was no additional external funding received for this study.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Andaya V, 2003, THEOR APPL GENET, V113, P467; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Badea C, 2009, PLANT OMICS, V2, P78; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browse J, 2001, CURR OPIN PLANT BIOL, V4, P241, DOI 10.1016/S1369-5266(00)00167-9; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Chen Y, 2013, PLANT MOL BIOL REP, V31, P87, DOI 10.1007/s11105-012-0481-z; Counce PA, 2000, CROP SCI, V40, P436, DOI 10.2135/cropsci2000.402436x; Cui D, 2013, EUPHYTICA, V193, P369, DOI 10.1007/s10681-013-0935-x; Cui KH, 2002, THEOR APPL GENET, V105, P745, DOI 10.1007/s00122-002-0908-2; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Cruz Renata Pereira da, 2010, Braz. J. Plant Physiol., V22, P199, DOI 10.1590/S1677-04202010000300007; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edwards JD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw107; Eizenga GC, 2014, J PLANT REGIST, V8, P109, DOI 10.3198/jpr2013.03.0013crmp; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Fujino K, 2015, BREEDING SCI, V65, P403, DOI 10.1270/jsbbs.65.403; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Greening P, 1992, CROP SCI, P660; Greening P, 1998, CROP SCI, V38, P660; He CiXin, 2000, Scientia Agricultura Sinica, V33, P24; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang J, 2013, J INTEGR PLANT BIOL, V55, P735, DOI 10.1111/jipb.12051; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jacobs BC, 1999, J AGRON CROP SCI, V182, P79, DOI 10.1046/j.1439-037x.1999.00259.x; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Kim SI, 2011, BIOCHEM J, V435, P373, DOI 10.1042/BJ20101610; Kissoudis C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00207; Koseki M, 2010, MOL GENET GENOMICS, V284, P45, DOI 10.1007/s00438-010-0548-1; Li ZK, 1997, GENETICS, V145, P453; Liu FX, 2013, MOL PLANT, V6, P757, DOI 10.1093/mp/sss161; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Lv Y, 2016, PLANT CELL ENVIRON, V39, P556, DOI 10.1111/pce.12635; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Ming F, 2001, J PLANT NUTR, V24, P1399, DOI 10.1081/PLN-100106990; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Morsy MR, 2005, GENE, V344, P171, DOI 10.1016/j.gene.2004.09.033; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Murai M, 1991, JPN J BREED, V41, P601; Nakagahra M, 1997, PLANT MOL BIOL, V35, P69, DOI 10.1023/A:1005784431759; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nguyen NV, 2006, PADDY WATER ENVIRON, V4, P1, DOI 10.1007/s10333-005-0031-5; NISHIMURA M, 1993, JPN J CROP SCI, V62, P242, DOI 10.1626/jcs.62.242; Obara M, 2001, J EXP BOT, V52, P1209, DOI 10.1093/jexbot/52.359.1209; Pan YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120590; R Core Team, 2016, R A LANGUAGE AND ENV; Ranawake AL, 2014, BIOTECHNOL BIOTEC EQ, V28, P989, DOI 10.1080/13102818.2014.978539; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Saito K, 2001, THEOR APPL GENET, V103, P862, DOI 10.1007/s001220100661; SAS Institute Inc, 2012, THE SAS SYSTEM FOR W; SAS Institute Inc, 2015, JMP 12 SPECIALIZED M; SATAKE T, 1989, JPN J CROP SCI, V58, P240, DOI 10.1626/jcs.58.240; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Suh JP, 2010, THEOR APPL GENET, V120, P985, DOI 10.1007/s00122-009-1226-8; Takeuchi Y, 2001, BREEDING SCI, V51, P191, DOI 10.1270/jsbbs.51.191; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Vaughan DA, 2008, RICE, V1, P16, DOI 10.1007/s12284-008-9000-0; Venu RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095178; Visioni A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-424; Wang D, 2016, RICE, V9, DOI 10.1186/s12284-016-0133-2; Xiao J., 1996, NATURE, V384, P356; Xing Yong-Zhong, 2001, Acta Genetica Sinica, V28, P439; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917; Yan C, 1998, CHINESE J RICE SCI, V13, P134; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhu YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145704; Zhuang JY, 1997, THEOR APPL GENET, V95, P799, DOI 10.1007/s001220050628	81	74	77	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172133	10.1371/journal.pone.0172133	http://dx.doi.org/10.1371/journal.pone.0172133			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282385	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800008
J	Khatun, M; Al Mamun, A; Scott, J; William, GM; Clavarino, A; Najman, JM				Khatun, Mohsina; Al Mamun, Abdullah; Scott, James; William, Gail M.; Clavarino, Alexandra; Najman, Jake M.			Do children born to teenage parents have lower adult intelligence? A prospective birth cohort study	PLOS ONE			English	Article							ADOLESCENT PREGNANCY; PATERNAL AGE; LIFE-COURSE; OUTCOMES; ASSOCIATION; CHILDHOOD; RISK; MOTHERS; CHILDBEARING; DEPRESSION	Teenage motherhood has been associated with a wide variety of negative offspring outcomes including poorer cognitive development. In the context of limitations of previous research, this paper assesses the contemporary relevance of this finding. In this study we investigate the long-term cognitive status (IQ) among 21 year adult offspring born to teenage parents using the Mater University Study of Pregnancy- a prospective birth cohort study, which recruited all pregnant mothers attending a large obstetrical hospital in Brisbane, Australia, from 1981 to 1983. The analyses were restricted to a sub-sample of 2643 mother-offspring pair. Offspring IQ was measured using the Peabody Picture Vocabulary Test at 21 year. Parental age was reported at first clinic visit. Offspring born to teenage mothers (<20 years) have -3.0 (95% Confidence Interval (CI): -4.3, -1.8) points lower IQ compared to children born to mothers >= 20 years and were more likely to have a low IQ (Odds Ratio (OR) 1.7; 95% CI: 1.3, 2.3). Adjustment for a range of confounding and mediating factors including parental socioeconomic status, maternal IQ, maternal smoking and binge drinking in pregnancy, birthweight, breastfeeding and parenting style attenuates the association, though the effect remains statistically significant (-1.4 IQ points; 95% CI: -2.8,-0.1). Similarly the risk of offspring having low IQ remained marginally significantly higher in those born to teenage mothers (OR 1.3; 95% CI: 1.0, 1.9). In contrast, teenage fatherhood is not associated with adult offspring IQ, when adjusted for maternal age. Although the reduction in IQ is quantitatively small, it is indicative of neurodevelopmental disadvantage experienced by the young adult offspring of teenage mothers. Our results suggest that public policy initiatives should be targeted not only at delaying childbearing in the population but also at supporting early life condition of children born to teenage mothers to minimize the risk for disadvantageous outcomes of the next generation.	[Khatun, Mohsina; Al Mamun, Abdullah; William, Gail M.; Najman, Jake M.] Univ Queensland, Fac Med & Biomed Sci, Sch Publ Hlth, Brisbane, Qld, Australia; [Scott, James] Univ Queensland, Fac Med & Biomed Sci, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Scott, James] Royal Brisbane & Womens Hosp, Metro North Mental Hlth Serv, Queensland, Australia; [Clavarino, Alexandra] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Najman, Jake M.] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland	Khatun, M (corresponding author), Univ Queensland, Fac Med & Biomed Sci, Sch Publ Hlth, Brisbane, Qld, Australia.	m.khatun@uq.edu.au	Scott, James G/D-5900-2012; Mamun, Abdullah/HHM-9898-2022; Najman, Jackob M./B-1527-2008; Mamun, Abdullah A/A-4673-2011; Clavarino, Alexandra/F-1411-2010	Scott, James G/0000-0002-0744-0688; Najman, Jackob M./0000-0001-7079-2080; Mamun, Abdullah A/0000-0002-1535-8086; Clavarino, Alexandra/0000-0002-1145-5946	National Health and Medical Research Council (NHMRC) [1026598]; Australian Research Council (ARC) [DP150100162]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	AAM received a National Health and Medical Research Council (NHMRC) Career Development Fellowship (#1026598). JMN received an Australian Research Council (ARC) Discovery Project (DP150100162). ULRs for NHMRC and ARC https://www.nhmrc.gov.au/grants-funding; http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all women and their offspring who voluntarily participated in the study, the MUSP data collection team, data manger and research team, The University of Queensland. AAM is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (#1026598). JMN is supported by an Australian Research Council (ARC) Discovery Project (DP150100162). The authors thank Greg Shuttlewood of the University of Queensland for help with data management.	AUROUX MR, 1989, HUM REPROD, V4, P794, DOI 10.1093/oxfordjournals.humrep.a136988; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; Bedford A., 1978, DELUSIONS SYMPTOMS S; BEITCHMAN JH, 1986, J SPEECH HEAR DISORD, V51, P98, DOI 10.1044/jshd.5102.98; Bilder DA, 2013, AJIDD-AM J INTELLECT, V118, P156, DOI 10.1352/1944-7558-118.2.156; BROOKSGUNN J, 1986, DEV REV, V6, P224, DOI 10.1016/0273-2297(86)90013-4; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Carlsen KCL, 1997, EUR RESPIR J, V10, P1774, DOI 10.1183/09031936.97.10081774; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Chin HB, 2012, AM J PREV MED, V42, P272, DOI 10.1016/j.amepre.2011.11.006; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; Cornelius MD, 2010, J DEV BEHAV PEDIATR, V31, P405, DOI 10.1097/DBP.0b013e3181e121d2; Cunnington AJ, 2001, J FAM PLAN REPROD H, V27, P36, DOI 10.1783/147118901101194877; Doi SAR, 2015, EPIDEMIOLOGY, V26, pE42, DOI 10.1097/EDE.0000000000000289; Dunn L.M., 2007, PEABODY PICTURE VOCA; Eckenrode J, 2010, ARCH PEDIAT ADOL MED, V164, P9, DOI 10.1001/archpediatrics.2009.240; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; Eriksen HLF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079200; Fall CHD, 2015, LANCET GLOB HEALTH, V3, pE366, DOI 10.1016/S2214-109X(15)00038-8; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Hardy JB, 1998, DEV PSYCHOL, V34, P1220, DOI 10.1037/0012-1649.34.6.1220; Hasan SS, 2013, ASIAN J PSYCHIATR, V6, P460, DOI 10.1016/j.ajp.2013.09.008; Hillis SD, 2004, PEDIATRICS, V113, P320, DOI 10.1542/peds.113.2.320; Hofferth SL, 1987, CHILDREN TEEN CHILDB, VII; Hoffman D. Saul, 2008, KIDS HAVING KIDS EC; Jeha D, 2015, J NEONATAL PERINATAL; KEEPING JD, 1989, BRIT J OBSTET GYNAEC, V96, P289, DOI 10.1111/j.1471-0528.1989.tb02388.x; Kohler U, 2011, STATA J, V11, P420, DOI 10.1177/1536867X1101100306; Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P656, DOI 10.1136/jech.2004.030205; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; McGrath J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077444; Miller LL, 2014, CHEST, V145, P1213, DOI 10.1378/chest.13-1371; MOLLBORN S, 2011, POPULATION RES POLIC, V31, P31; Morinis J, 2013, ARCH DIS CHILD, V98, P959, DOI 10.1136/archdischild-2012-302525; Myrskyla M, 2013, AM J EPIDEMIOL, V177, P649, DOI 10.1093/aje/kws237; NAGLIERI JA, 1983, J CLIN PSYCHOL, V39, P965, DOI 10.1002/1097-4679(198311)39:6<965::AID-JCLP2270390624>3.0.CO;2-9; Najman JM, 2005, INT J EPIDEMIOL, V34, P992, DOI 10.1093/ije/dyi119; Najman JM, 2000, SOC PSYCH PSYCH EPID, V35, P19, DOI 10.1007/s001270050004; Najman JM, 2014, INT J EPIDEMIOLOGY; OLDS DL, 1988, AM J PUBLIC HEALTH, V78, P1436, DOI 10.2105/AJPH.78.11.1436; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Shaw M, 2006, SOC SCI MED, V62, P2526, DOI 10.1016/j.socscimed.2005.10.007; Shearer DL, 2002, PERSPECT SEX REPRO H, V34, P236, DOI 10.2307/3097822; Sipsma H, 2010, AM J PUBLIC HEALTH, V100, P517, DOI 10.2105/AJPH.2009.177600; Stevens-Simon C, 2001, ARCH PEDIAT ADOL MED, V155, P1298, DOI 10.1001/archpedi.155.12.1298; Taylor JL, 2009, J FAM ISSUES, V30, P484, DOI 10.1177/0192513X08329601; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; van der Klis KAM, 2002, AUST NZ J PUBL HEAL, V26, P125, DOI 10.1111/j.1467-842X.2002.tb00904.x; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Woodward L, 2001, J MARRIAGE FAM, V63, P1170, DOI 10.1111/j.1741-3737.2001.01170.x	52	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0167395	10.1371/journal.pone.0167395	http://dx.doi.org/10.1371/journal.pone.0167395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278227	gold, Green Published			2022-12-26	WOS:000396087900104
J	Weiss, O; Dorfman, A; Ram, T; Zadicario, P; Eilam, D				Weiss, Omri; Dorfman, Alex; Ram, Tamar; Zadicario, Pazit; Eilam, David			Rats do not eat alone in public: Food-deprived rats socialize rather than competing for baits	PLOS ONE			English	Article							MALE WISTAR RATS; RECIPROCAL ALTRUISM; PROSOCIAL CHOICE; SUCROSE-PELLETS; BEHAVIOR; DOMINANCE; COOPERATION; EVOLUTION; DEPENDS; BENEFIT	Limited resources result in competition among social animals. Nevertheless, social animals also have innate preferences for cooperative behavior. In the present study, 12 dyads of food-deprived rats were tested in four successive trials, and then re-tested as eight triads of food-deprived rats that were unfamiliar to each other. We found that the food-deprived dyads or triads of rats did not compete for the food available to them at regular spatially-marked locations that they had previously learnt. Rather, these rats traveled together to collect the baits. One rat, or two rats in some triads, lead (ran ahead) to collect most of the baits, but "leaders" differed across trials so that, on average, each rat ultimately collected similar amounts of baits. Regardless of which rat collected the baits, the rats traveled together with no substantial difference among them in terms of their total activity. We suggest that rats, which are a social species that has been found to display reciprocity, have evolved to travel and forage together and to share limited resources. Consequently, they displayed a sort of 'peace economy' that on average resulted in equal access to the baits across trials. For social animals, this type of dynamics is more relaxed, tolerant, and effective in the management of conflicts. Rather than competing for the limited available food, the food-deprived rats socialized and coexisted peacefully.	[Weiss, Omri; Dorfman, Alex; Ram, Tamar; Zadicario, Pazit; Eilam, David] Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel	Tel Aviv University	Eilam, D (corresponding author), Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel.	eilam@post.tau.ac.il	Eilam, David/GOV-6655-2022	Eilam, David/0000-0002-4494-6928	Israel Science Foundation (ISF) grant [230/13]	Israel Science Foundation (ISF) grant	This study was supported by the Israel Science Foundation (ISF) grant # 230/13 to David Eilam.	ADAMS N, 1983, J COMP PSYCHOL, V97, P24, DOI 10.1037/0735-7036.97.1.24; BARNETT SA, 1968, RAT STUDY BEHAV; Barta Z, 2011, P ROY SOC B-BIOL SCI, V278, P843, DOI 10.1098/rspb.2010.1634; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Bednekoff PA, 1998, TRENDS ECOL EVOL, V13, P284, DOI 10.1016/S0169-5347(98)01327-5; BLANCHARD DC, 1990, NEUROSCI BIOBEHAV R, V14, P455, DOI 10.1016/S0149-7634(05)80068-5; Brown MF, 2011, COMP COGN BEHAV REV, V6, P5, DOI 10.3819/ccbr.2011.60003; Bruce RH, 1941, J COMP PSYCHOL, V31, P395, DOI 10.1037/h0056901; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Corman AM, 2016, ECOL EVOL, V6, P974, DOI 10.1002/ece3.1884; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0077; Dolivo V, 2016, LEARN BEHAV, V44, P223, DOI 10.3758/s13420-016-0236-z; Dolivo V, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0959; Dorfman A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146137; Ewer RF, 1971, ANIM BEHAV MONOGR, V4, P125, DOI DOI 10.1016/S0066-1856(71)80002-X; Gavrilets S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1067; GENTSCH C, 1988, BEHAV BRAIN RES, V27, P37, DOI 10.1016/0166-4328(88)90107-6; GENTSCH C, 1988, PROG NEURO-PSYCHOPH, V12, P639, DOI 10.1016/0278-5846(88)90009-7; Hernandez-Lallement J, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00443; Hodge SJ, 2009, BEHAV ECOL, V20, P930, DOI 10.1093/beheco/arp071; Lehner SR, 2011, ETHOLOGY, V117, P949, DOI 10.1111/j.1439-0310.2011.01962.x; Lima SL, 1999, BEHAV ECOL SOCIOBIOL, V46, P110, DOI 10.1007/s002650050599; Marquez C, 2015, CURR BIOL, V25, P1736, DOI 10.1016/j.cub.2015.05.018; Mason P, 2016, HELPING ANOTHER DIST, P177; Palagi E, 2016, BEHAVIOUR IN PRESS, P153; Price ME, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00363; Pronk R, 2010, J EXP BIOL, V213, P1035, DOI 10.1242/jeb.040675; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Sato N, 2015, ANIM COGN, V18, P1039, DOI 10.1007/s10071-015-0872-2; Schneeberger K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-41; Silberberg A, 2014, ANIM COGN, V17, P609, DOI [10.1007/s10071-013-0623-1, 10.1007/s10071-013-0692-1]; Smith JE, 2016, TRENDS ECOL EVOL, V31, P54, DOI 10.1016/j.tree.2015.09.013; SYME GJ, 1974, ANIM BEHAV, V22, P931, DOI 10.1016/0003-3472(74)90016-5; SYME GJ, 1974, ANIM BEHAV, V22, P486, DOI 10.1016/S0003-3472(74)80048-5; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; Vasconcelos M, 2012, BIOL LETTERS, V8, P910, DOI 10.1098/rsbl.2012.0554; Weiss O, 2015, ANIM COGN, V18, P39, DOI 10.1007/s10071-014-0775-7; Zentall TR, 2016, LEARN BEHAV, V44, P7, DOI 10.3758/s13420-015-0201-2	43	13	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173302	10.1371/journal.pone.0173302	http://dx.doi.org/10.1371/journal.pone.0173302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278246	Green Submitted, gold, Green Published			2022-12-26	WOS:000396087900069
J	Li, Z; Mukherjee, T; Bowler, K; Namdari, S; Snow, Z; Prestridge, S; Carlton, A; Bar-Peled, M				Li, Zi; Mukherjee, Thiya; Bowler, Kyle; Namdari, Sholeh; Snow, Zachary; Prestridge, Sarah; Carlton, Alexandra; Bar-Peled, Maor			A four-gene operon in Bacillus cereus produces two rare spore-decorating sugars	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; carbohydrate biosynthesis; glycobiology; glycosylation; sporulation; BclA; cereose; cillose; germination; spores	ANTHRACIS EXOSPORIUM; SPIROTETRONATE ANTIBIOTICS; SURFACE GLYCOPROTEIN; STAINLESS-STEEL; MOLECULAR-BASIS; GENE-CLUSTER; BIOSYNTHESIS; BCLA; IDENTIFICATION; PROTEINS	Bacterial glycan structures on cell surfaces are critical for cell-cell recognition and adhesion and in host-pathogen interactions. Accordingly, unraveling the sugar composition of bacterial cell surfaces can shed light on bacterial growth and pathogenesis. Here, we found that two rare sugars with a 3-C-methyl-6-deoxyhexose structure were linked to spore glycans in Bacillus cereus ATCC 14579 and ATCC 10876. Moreover, we identified a four-gene operon in B. cereus ATCC 14579 that encodes proteins with the following sequential enzyme activities as determined by mass spectrometry and one- and two-dimensional NMR methods: CTP:glucose-1-phosphate cytidylyltransferase, CDP-Glc 4,6-dehydratase, NADH-dependent SAM:C-methyltransferase, and NADPH-dependent CDP-3-C-methyl-6-deoxyhexose 4-reductase. The last enzyme predominantly yielded CDP-3-C-methyl-6-deoxygulose (CDP-cereose) and likely generated a 4-epimer CDP-3-C-methyl-6-deoxyallose (CDP-cillose). Some members of the B. cereus sensu lato group produce CDP-3-C-methyl-6-deoxy sugars for the formation of cereose-containing glycans on spores, whereas others such as Bacillus anthracis do not. Gene knockouts of the Bacillus C-methyltransferase and the 4-reductase confirmed their involvement in the formation of cereose-containing glycan on B. cereus spores. We also found that cereose represented 0.2-1% spore dry weight. Moreover, mutants lacking cereose germinated faster than the wild type, yet the mutants exhibited no changes in sporulation or spore resistance to heat. The findings reported here may provide new insights into the roles of the uncommon 3-C-methyl-6-deoxy sugars in cell-surface recognition and host-pathogen interactions of the genus Bacillus.	[Li, Zi; Mukherjee, Thiya; Bowler, Kyle; Namdari, Sholeh; Snow, Zachary; Prestridge, Sarah; Carlton, Alexandra; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Li, Zi; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu			BioEnergy Science Center, Biological and Environmental Research Program, U. S. Dept. of Energy Office of Science [DE-PS02-06ER64304]	BioEnergy Science Center, Biological and Environmental Research Program, U. S. Dept. of Energy Office of Science	This work was supported by Grant DE-PS02-06ER64304 from the BioEnergy Science Center, Biological and Environmental Research Program, U. S. Dept. of Energy Office of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Abhyankar W, 2013, J PROTEOME RES, V12, P4507, DOI 10.1021/pr4005629; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barlass PJ, 2002, MICROBIOL-SGM, V148, P2089, DOI 10.1099/00221287-148-7-2089; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Bruender NA, 2010, BIOCHEMISTRY-US, V49, P5891, DOI 10.1021/bi100782b; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Daubenspeck JM, 2004, J BIOL CHEM, V279, P30945, DOI 10.1074/jbc.M401613200; Day CJ, 2015, P NATL ACAD SCI USA, V112, pE7266, DOI 10.1073/pnas.1421082112; Du YL, 2015, P NATL ACAD SCI USA, V112, P2717, DOI 10.1073/pnas.1419964112; Faille C, 2010, INT J FOOD MICROBIOL, V143, P125, DOI 10.1016/j.ijfoodmicro.2010.07.038; Fang J, 2008, J BACTERIOL, V190, P6014, DOI 10.1128/JB.00533-08; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Hornstra LM, 2006, APPL ENVIRON MICROB, V72, P3746, DOI 10.1128/AEM.72.5.3746-3749.2006; Hwang S, 2014, J BIOL CHEM, V289, P35620, DOI 10.1074/jbc.M114.614917; Jacques M, 1996, TRENDS MICROBIOL, V4, P408, DOI 10.1016/0966-842X(96)10054-8; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Kohler H, 2002, INFECT IMMUN, V70, P1150, DOI 10.1128/IAI.70.3.1150-1158.2002; Lequette Y, 2011, BIOFOULING, V27, P751, DOI 10.1080/08927014.2011.599842; Lequette Y, 2011, APPL ENVIRON MICROB, V77, P4905, DOI 10.1128/AEM.02872-10; Li Z, 2016, J BIOL CHEM, V291, P19051, DOI 10.1074/jbc.M116.724708; Li Z, 2015, J BIOL CHEM, V290, P691, DOI 10.1074/jbc.M114.612747; Maes E, 2016, J BIOL CHEM, V291, P9666, DOI 10.1074/jbc.M116.718171; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; Oliva C, 2009, P NATL ACAD SCI USA, V106, P13957, DOI 10.1073/pnas.0902392106; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; Thompson BM, 2007, J BACTERIOL, V189, P6704, DOI 10.1128/JB.00762-07; Thompson BM, 2011, MOL MICROBIOL, V79, P799, DOI 10.1111/j.1365-2958.2010.07488.x; THORSON JS, 1993, J AM CHEM SOC, V115, P5827, DOI 10.1021/ja00066a062; Todd SJ, 2003, J BACTERIOL, V185, P3373, DOI 10.1128/JB.185.11.3373-3378.2003; Yang T, 2012, ANAL BIOCHEM, V421, P691, DOI 10.1016/j.ab.2011.12.028; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854	38	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7636	7650		10.1074/jbc.M117.777417	http://dx.doi.org/10.1074/jbc.M117.777417			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28298443	hybrid, Green Published			2022-12-26	WOS:000400761300030
J	Berrached, R; Kadik, L; Mouheb, HA; Prinzing, A				Berrached, Rachda; Kadik, Leila; Mouheb, Hocine Ait; Prinzing, Andreas			Deep roots delay flowering and relax the impact of floral traits and associated pollinators in steppe plants	PLOS ONE			English	Article							PHYLOGENETIC CONSERVATISM; FUNCTIONAL TRAITS; DROUGHT STRESS; PHENOLOGY; COMMUNITY; CLIMATE; VARIABILITY; GRASSLANDS; REGRESSION; DIVERSITY	Strong seasonality in abiotic harshness and pollinator availability shape the reproductive success of plants. Plant species can avoid or can tolerate harsh abiotic conditions and can attract different pollinators, but it remains unknown (i) which of these capacities is most important for flowering phenology, (ii) whether tolerance/avoidance of abiotic harshness reinforces or relaxes the phenological differentiation of species attracting different pollinators. We assembled possibly the first functional trait database for a North African steppe covering 104 species. We inferred avoidance of harshness (drought) from dormancy, i.e. annual life-span and seed size. We inferred tolerance or resistance to harshness from small specific leaf area, small stature, deep roots and high dry matter content. We inferred the type of pollinators attracted from floral colour, shape and depth. We found that avoidance traits did not affect flowering phenology, and among tolerance traits only deep roots had an effect by delaying flowering. Flower colour (red or purple), and occasionally flower depth, delayed flowering. Dish, gullet and flag shape accelerated flowering. Interactive effects however were at least as important, inversing the mentioned relationship between floral characters and flowering phenology. Specifically, among drought-tolerant deep-rooted species, flowering phenologies converged among floral types attracting different pollinators, without becoming less variable overall. Direct and interactive effects of root depth and floral traits explained at least 45% of the variance in flowering phenology. Also, conclusions on interactive effects were highly consistent with and without including information on family identity or outliers. Overall, roots and floral syndromes strongly control flowering phenology, while many other traits do not. Surprisingly, floral syndromes and the related pollinators appear to constrain phenology mainly in shallow-rooted, abiotically little tolerant species. Lack of abiotic tolerance might hence constrain accessible resources and thereby impose a stronger synchronization with biotic partners such as pollinators.	[Berrached, Rachda; Kadik, Leila; Mouheb, Hocine Ait] Univ Sci & Technol Houari Boumediene, Fac Biol Sci, Lab Ecol & Environm, Algiers, Algeria; [Prinzing, Andreas] Univ Rennes 1, CNRS, Res Unit Ecosyst Biodiversite Evolut, Campus Beaulieu,Bat 14 A, Rennes, France	University Science & Technology Houari Boumediene; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Berrached, R (corresponding author), Univ Sci & Technol Houari Boumediene, Fac Biol Sci, Lab Ecol & Environm, Algiers, Algeria.	b_rachda@yahoo.fr						AIDOUD A., 1989, THESIS; Akinci S, 2011, WATER STRESS, P15; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Amghar F, 2012, REV ECOL-TERRE VIE, V67, P257; Barboni D, 2004, J VEG SCI, V15, P635, DOI 10.1111/j.1654-1103.2004.tb02305.x; Bernardello Gabriel, 2007, P19, DOI 10.1007/978-1-4020-5937-7_2; Bosch J, 1997, OECOLOGIA, V109, P583, DOI 10.1007/s004420050120; Catorci A, 2012, PLANT ECOL, V213, P1315, DOI 10.1007/s11258-012-0090-9; Catorci A, 2012, PLANT ECOL EVOL, V145, P165, DOI 10.5091/plecevo.2012.634; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Craine JM, 2012, NEW PHYTOL, V193, P673, DOI 10.1111/j.1469-8137.2011.03953.x; Cruz-Neto O, 2011, BIODIVERS CONSERV, V20, P751, DOI 10.1007/s10531-010-9975-x; Davies TJ, 2013, J ECOL, V101, P1520, DOI 10.1111/1365-2745.12154; Du GZ, 2010, PLANT ECOL, V209, P321, DOI 10.1007/s11258-010-9763-4; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Faegri K., 1979, PRINCIPLES POLLINATI; Fair JM, 2005, J ARID ENVIRON, V62, P235, DOI 10.1016/j.jaridenv.2004.11.010; Gao RR, 2015, PLANT SOIL, V389, P335, DOI 10.1007/s11104-014-2366-4; GARNIER E, 1994, NEW PHYTOL, V128, P725, DOI 10.1111/j.1469-8137.1994.tb04036.x; Gomez JM, 1996, OECOLOGIA, V105, P236, DOI 10.1007/BF00328552; Gomez JM, 2008, P ROY SOC B-BIOL SCI, V275, P2241, DOI 10.1098/rspb.2008.0512; Hallett LM, 2011, PLANT ECOL, V212, P1479, DOI 10.1007/s11258-011-9922-2; Hegland SJ, 2005, OECOLOGIA, V145, P586, DOI 10.1007/s00442-005-0165-6; Jia P, 2011, ARCT ANTARCT ALP RES, V43, P585, DOI 10.1657/1938-4246-43.4.585; Junker RR, 2013, FUNCT ECOL, V27, P329, DOI 10.1111/1365-2435.12005; Kadik-Achoubi L., 2005, THESIS; Kesselring H, 2015, ALPINE BOT, V125, P113, DOI 10.1007/s00035-015-0157-z; Kipling RP, 2014, ECOL RES, V29, P213, DOI 10.1007/s11284-013-1116-z; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; LARSEN WA, 1972, TECHNOMETRICS, V14, P781, DOI 10.2307/1267305; Lima ALA, 2010, J ARID ENVIRON, V74, P1363, DOI 10.1016/j.jaridenv.2010.05.009; Madre JF, 2013, MESURIM POR SOFWARE; Montserrat-Marti G, 2009, TREES-STRUCT FUNCT, V23, P787, DOI 10.1007/s00468-009-0320-5; Ollerton J, 1998, PLANT ECOL, V139, P35, DOI 10.1023/A:1009798320049; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Oosterom EJV, 1993, PLANT SOIL, V148, P223; Ortiz PL, 2015, PERSPECT PLANT ECOL, V17, P142, DOI 10.1016/j.ppees.2015.01.004; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; PETANIDOU T, 1995, AM J BOT, V82, P607, DOI 10.2307/2445419; Pringle EG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001705; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Quezel P, 1962, NOUVELLE FLORE ALGE; Ricklefs RE, 1996, OIKOS, V77, P167, DOI 10.2307/3545598; Sanchez AM, 2012, FLORA, V207, P821, DOI 10.1016/j.flora.2012.09.007; Sanchez-Blanco MJ, 2014, SOIL BIOLOGY, V40, P325; Scaven VL, 2013, CURR ZOOL, V59, P418, DOI 10.1093/czoolo/59.3.418; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Selwyn MA, 2006, BIODIVERS CONSERV, V15, P3207, DOI 10.1007/s10531-005-0035-x; Torres C, 2002, PLANT BIOLOGY, V4, P360, DOI 10.1055/s-2002-32326; VILLARREAL AG, 1990, BOT GAZ, V151, P5, DOI 10.1086/337797; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zaher-Ara T, 2016, TREES-STRUCT FUNCT, V30, P985, DOI 10.1007/s00468-016-1372-y	54	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173921	10.1371/journal.pone.0173921	http://dx.doi.org/10.1371/journal.pone.0173921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301580	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300095
J	Griep, Y; Hanson, LM; Vantilborgh, T; Janssens, L; Jones, SK; Hyde, M				Griep, Yannick; Hanson, Linda Magnusson; Vantilborgh, Tim; Janssens, Laurens; Jones, Samantha K.; Hyde, Martin			Can volunteering in later life reduce the risk of dementia? A 5-year longitudinal study among volunteering and non-volunteering retired seniors	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LEISURE ACTIVITIES; AGING POPULATION; SOCIAL NETWORKS; OLDER-ADULTS; BRAIN; EXERCISE; HEALTH; PERSPECTIVE; PREVALENCE	We propose that voluntary work, characterized by social, physical and cognitive activity in later life is associated with fewer cognitive problems and lower dementia rates. We test these assumptions using 3-wave, self-reported, and registry data from the 2010, 2012, and 2014 Swedish National Prescribed Drug Register. We had three groups of seniors in our data: 1) no volunteering (N = 531), 2) discontinuous volunteering (N = 220), and 3) continuous volunteering (N = 250). We conducted a path analysis in Mplus to investigate the effect of voluntary work (discontinuously and continuously) on self-reported cognitive complaints and the likelihood of being prescribed an anti-dementia treatment after controlling for baseline and relevant background variables. Our results indicated that seniors, who continuously volunteered, reported a decrease in their cognitive complaints over time, whereas no such associations were found for the other groups. In addition, they were 2.44 (95% CI [1.86; 3.21]) and 2.46 (95% CI [1,89; 3.24]) times less likely to be prescribed an anti-dementia treatment in 2012 and 2014, respectively. Our results largely support the assumptions that voluntary work in later life is associated with lower self-reported cognitive complaints and a lower risk for dementia, relative to those who do not engage, or only engage episodically in voluntary work.	[Griep, Yannick; Jones, Samantha K.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Hanson, Linda Magnusson] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Vantilborgh, Tim] Vrije Univ Brussel, Work & Org Psychol WOPs, Brussels, Belgium; [Janssens, Laurens] Katholieke Univ Leuven, Fac Med, Leuven, Belgium; [Hyde, Martin] Swansea Univ, Ctr Innovat Ageing, Swansea, W Glam, Wales	University of Calgary; Stockholm University; Vrije Universiteit Brussel; KU Leuven; Swansea University	Griep, Y (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	yannick.griep@ucalgary.ca	Vantilborgh, Tim/J-4844-2019; Hanson, Linda L Magnusson/D-2435-2017; Griep, Yannick/P-6621-2018	Vantilborgh, Tim/0000-0002-5763-3111; Hanson, Linda L Magnusson/0000-0002-2908-1903; Griep, Yannick/0000-0002-5005-5443; Hyde, Martin/0000-0002-9955-8121				Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Alsnih R, 2003, TRANSPORT RES A-POL, V37, P903, DOI 10.1016/S0965-8564(03)00073-9; Anderson ND, 2014, PSYCHOL BULL, V140, P1505, DOI 10.1037/a0037610; [Anonymous], 2008, J VOLUNTARY SECTOR R; Audirac I, 2008, J PLAN LIT, V23, P4, DOI 10.1177/0885412208318558; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Berr C, 2005, EUR NEUROPSYCHOPHARM, V15, P463, DOI 10.1016/j.euroneuro.2005.04.003; Bohlken J, 2015, EUR NEUROPSYCHOPHARM, V25, P2333, DOI 10.1016/j.euroneuro.2015.09.014; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Burr JA, 2011, J AGING HEALTH, V23, P24, DOI 10.1177/0898264310388272; Carlson MC, 2008, ALZHEIMERS DEMENT, V4, P324, DOI 10.1016/j.jalz.2008.07.002; Carlson MC, 2012, J INT NEUROPSYCH SOC, V18, P286, DOI 10.1017/S135561771100169X; CHAMBRE SM, 1984, GERONTOLOGIST, V24, P292, DOI 10.1093/geront/24.3.292; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Erickson KI, 2007, NEUROBIOL AGING, V28, P272, DOI 10.1016/j.neurobiolaging.2005.12.012; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Fried LP, 2004, J URBAN HEALTH, V81, P64, DOI 10.1093/jurban/jth094; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Griep Y, 2015, J OCCUP HEALTH PSYCH, V20, P190, DOI 10.1037/a0038342; Gunasekara FI, 2012, SOC SCI MED, V74, P1117, DOI 10.1016/j.socscimed.2011.11.038; Hovstadius B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-326; Jahoda M., 1982, EMPLOYMENT UNEMPLOYM; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lleras C, ENCY SOCIAL MEASUREM; Lobo A, 2000, NEUROLOGY, V54, pS4; McMunn A, 2009, AGEING SOC, V29, P765, DOI 10.1017/S0144686X08008350; Middleton LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003124; Monnot M, 2005, J AM BOARD FAM PRACT, V18, P240, DOI 10.3122/jabfm.18.4.240; Muthen L. K., 2012, MPLUS USERS GUIDE; Oesterle S, 2004, SOC FORCES, V82, P1123, DOI 10.1353/sof.2004.0049; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Pilkington PD, 2012, J GERONTOL B-PSYCHOL, V67, P249, DOI 10.1093/geronb/gbr154; Qiu C, 2008, J GERONTOL B-PSYCHOL, V67, P249; Robinson DM, 2006, DRUGS, V66, P1515, DOI 10.2165/00003495-200666110-00015; Scott K., 2003, FUNDING MATTERS IMPA; Small GW, 2009, AM J GERIAT PSYCHIAT, V17, P116, DOI 10.1097/JGP.0b013e3181953a02; Snyder M, 2008, SOC ISS POLICY REV, V2, P1, DOI 10.1111/j.1751-2409.2008.00009.x; Valenzuela MJ, 2007, BRAIN RES REV, V56, P198, DOI 10.1016/j.brainresrev.2007.07.007; Valenzuela MJ, 2008, CURR OPIN PSYCHIATR, V21, P296, DOI 10.1097/YCO.0b013e3282f97b1f; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Windsor TD, 2008, GERONTOLOGIST, V48, P59, DOI 10.1093/geront/48.1.59	49	30	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173885	10.1371/journal.pone.0173885	http://dx.doi.org/10.1371/journal.pone.0173885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301554	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300089
J	Lin, WY; Andersson, KE; Lin, CL; Kao, CH; Wu, HC				Lin, Wei-Yu; Andersson, Karl-Erik; Lin, Cheng-Li; Kao, Chia-Hung; Wu, Hsi-Chin			Association of lower urinary tract syndrome with peripheral arterial occlusive disease	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; CHRONIC BLADDER ISCHEMIA; POPULATION-BASED-COHORT; ERECTILE DYSFUNCTION; NATIONWIDE-COHORT; SYMPTOMS; MEN; PREVALENCE; HEALTH; OBSTRUCTION	Purpose To describe atherosclerosis may lead to chronic bladder ischemia, eventually resulting in lower urinary tract syndrome (LUTS), and peripheral arterial occlusive disease (PAOD). We investigated the association of LUTS with PAOD. Methods This nationwide population-based cohort study was based on data from the Taiwan National Health Insurance Database from 2000 to 2010; follow-up lasted until the end of 2011. We identified patients with newly diagnosed LUTS by using International Classification of Diseases, Ninth Revision, Clinical Modification codes. Results In total, 36,042 and 36,042 patients were enrolled in LUTS and non-LUTS cohorts, respectively. After adjustment for age, sex, and comorbidities, the risk of subsequent PAOD was 1.36-fold higher [95% confidence interval (CI) = 1.26-1.46] in the LUTS cohort than in the non-LUTS cohort. The adjusted risk of PAOD was the highest in patients with LUTS without any comorbidity [adjusted hazard ratio (aHR) = 1.93, 95% CI = 1.54-2.41]. The age-specific relative risk of PAOD was significantly higher in all age groups, particularly in those aged <49 years (aHR = 1.80, 95% CI = 1.39-2.34], in the LUTS cohort than in the non-LUTS cohort. Conclusion LUTS is a risk factor for PAOD. Physicians should consider the possibility of underlying PAOD in patients with LUTS aged <49 years and without cardiovascular comorbidities. Additional studies developing strategies for decreasing the risk of PAOD are warranted.	[Lin, Wei-Yu] Chang Gung Mem Hosp, Div Urol, Dept Surg, Chiayi, Taiwan; [Lin, Wei-Yu] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Lin, Wei-Yu] Chang Gung Univ Sci & Technol, Chiayi, Taiwan; [Lin, Wei-Yu] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Lin, Wei-Yu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Andersson, Karl-Erik] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung; Wu, Hsi-Chin] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung; Wu, Hsi-Chin] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan; [Wu, Hsi-Chin] China Med Univ Beigang Hosp, Dept Urol, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University; Chang Gung University; Wake Forest University; Wake Forest Baptist Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Wu, HC (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Wu, HC (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Wu, HC (corresponding author), China Med Univ Beigang Hosp, Dept Urol, Taichung, Taiwan.	d4746@mail.bh.cmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andersson KE, 2014, THER ADV UROL, V6, P105, DOI 10.1177/1756287214526768; Andersson KE, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.09.030; Azadzoi KM, 2003, ADV EXP MED BIOL, V539, P271; Bouwman II, 2015, WORLD J UROL, V33, P669, DOI 10.1007/s00345-014-1398-y; Bouwman II, 2015, WORLD J UROL, V33, P1911, DOI 10.1007/s00345-015-1560-1; Bschleipfer T, 2015, J UROLOGY, V193, P345, DOI 10.1016/j.juro.2014.08.098; Chen YC, 2014, KIDNEY INT, V85, P1200, DOI 10.1038/ki.2013.455; Chou TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000870; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Hirsch AT, 2013, LANCET, V382, P1312, DOI 10.1016/S0140-6736(13)61576-7; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Kaplan SA, 2006, J UROLOGY, V176, P2351, DOI 10.1016/j.juro.2006.08.125; Karatas OF, 2010, INT J CARDIOL, V144, P452, DOI 10.1016/j.ijcard.2009.03.099; Katz DL, 2004, MED CLIN N AM, V88, P1295, DOI 10.1016/j.mcna.2004.02.003; Kupelian V, 2015, J UROLOGY, V193, P581, DOI 10.1016/j.juro.2014.08.097; Lin CS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001164; Lin HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066403, 10.1371/journal.pone.0066661]; Lin TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002381; Mariappan P, 2006, BJU INT, V98, P1264, DOI 10.1111/j.1464-410X.2006.06525.x; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Ng C. F., 2007, Hong Kong Medical Journal, V13, P421; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P195, DOI 10.1002/nau.21073; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Pinggera GM, 2008, BJU INT, V101, P319, DOI 10.1111/j.1464-410X.2007.07339.x; Pinggera GM, 2008, BJU INT, V102, P470, DOI 10.1111/j.1464-410X.2008.07587.x; Ponholzer A, 2006, EUR UROL, V50, P581, DOI 10.1016/j.eururo.2006.01.031; Russo GI, 2015, INT J UROL, V22, P982, DOI 10.1111/iju.12877; Sandfeldt L, 2003, BJU INT, V92, P64, DOI 10.1046/j.1464-410X.2003.04277.x; Shen CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000911; Signorelli SS, 2015, ANGIOLOGY, V66, P675, DOI 10.1177/0003319714548443; Su TW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001655; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Van den Eeden SK, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-12; Wehrberger C, 2011, UROLOGY, V78, P1063, DOI 10.1016/j.urology.2011.05.065; Wu MP, 2013, UROLOGY, V81, P61, DOI 10.1016/j.urology.2012.08.033; Yamaguchi O, 2014, NEUROUROL URODYNAM, V33, P54, DOI 10.1002/nau.22517; Yeh CC, 2013, MAYO CLIN P, V88, P1901	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0170288	10.1371/journal.pone.0170288	http://dx.doi.org/10.1371/journal.pone.0170288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301517	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300003
J	Lu, SY; Sung, T; Lin, NW; Abraham, RT; Jessen, BA				Lu, Shuyan; Sung, Tae; Lin, Nianwei; Abraham, Robert T.; Jessen, Bart A.			Lysosomal adaptation: How cells respond to lysosomotropic compounds	PLOS ONE			English	Article							REGULATES AUTOPHAGY; THERAPEUTIC TARGET; CELLULAR CLEARANCE; TFEB; BIOGENESIS; HOMEOSTASIS; TOXICITY; DISEASE; MTORC1; DEGRADATION	Lysosomes are acidic organelles essential for degradation and cellular homoeostasis and recently lysosomes have been shown as signaling hub to respond to the intra and extracellular changes (e.g. amino acid availability). Compounds including pharmaceutical drugs that are basic and lipophilic will become sequestered inside lysosomes (lysosomotropic). How cells respond to the lysosomal stress associated with lysosomotropism is not well characterized. Our goal is to assess the lysosomal changes and identify the signaling pathways that involve in the lysosomal changes. Eight chemically diverse lysosomotropic drugs from different therapeutic areas were subjected to the evaluation using the human adult retinal pigmented epithelium cell line, ARPE-19. All lysosomotropic drugs tested triggered lysosomal activation demonstrated by increased lysosotracker red (LTR) and lysosensor green staining, increased cathepsin activity, and increased LAMP2 staining. However, tested lysosomotropic drugs also prompted lysosomal dysfunction exemplified by intracellular and extracellular substrate accumulation including phospholipid, SQSTM1/p62, GAPDH (Glyceraldehyde 3 -phosphate dehydrogenase) and opsin. Lysosomal activation observed was likely attributed to lysosomal dysfunction, leading to compensatory responses including nuclear translocation of transcriptional factors TFEB, TFE3 and MITF. The adaptive changes are protective to the cells under lysosomal stress. Mechanistic studies implicate calcium and mTORC1 modulation involvement in the adaptive changes. These results indicate that lysosomotropic compounds could evoke a compensatory lysosomal biogenic response but with the ultimate consequence of lysosomal functional impairment. This work also highlights a pathway of response to lysosomal stress and evidences the role of TFEB, TFE3 and MITF in the stress response.	[Lu, Shuyan; Sung, Tae; Jessen, Bart A.] Pfizer Inc, Drug Safety Res & Dev, San Diego, CA 92121 USA; [Lin, Nianwei] iXCells Biotechnol, San Diego, CA USA; [Abraham, Robert T.] Pfizer Inc, Oncol Res Unit, San Diego, CA USA	Pfizer; Pfizer	Lu, SY; Jessen, BA (corresponding author), Pfizer Inc, Drug Safety Res & Dev, San Diego, CA 92121 USA.	shuyan.lu@pfizer.com; bart.jessen@pfizer.com	Lin, Nianwei/AAD-9805-2019		Pfizer	Pfizer(Pfizer)	SL, TS, RTA and BAJ are employees of Pfizer Inc. NL was a postdoc in Pfizer Inc. when generating the data. Pfizer provided support in the form of salaries for authors SL, TS, NL, RTA, BAJ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Ashoor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082481; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bowie M, 2015, WORLD J CLIN ONCOL, V6, P299, DOI 10.5306/wjco.v6.i6.299; Cortes CJ, 2014, NAT NEUROSCI, V17, P1180, DOI 10.1038/nn.3787; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Khoh-Reiter S, 2015, TOXICOL SCI, V145, P383, DOI 10.1093/toxsci/kfv059; Kilpatrick BS, 2013, J CELL SCI, V126, P60, DOI 10.1242/jcs.118836; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lee JH, 2015, CELL REP, V12, P1430, DOI 10.1016/j.celrep.2015.07.050; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lemieux B, 2004, ANAL BIOCHEM, V327, P247, DOI 10.1016/j.ab.2004.01.010; Logan R, 2014, J PHARM SCI-US, V103, P1572, DOI 10.1002/jps.23949; Lu SY, 2012, TOXICOL IN VITRO, V26, P613, DOI 10.1016/j.tiv.2012.01.025; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Nadanaciva S, 2011, TOXICOL IN VITRO, V25, P715, DOI 10.1016/j.tiv.2010.12.010; Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shchors K, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.012; Shin SY, 2013, CARCINOGENESIS, V34, P2080, DOI 10.1093/carcin/bgt169; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Steele JW, 2013, MOL PSYCHIATR, V18, P882, DOI 10.1038/mp.2012.115; Steele JW, 2013, AUTOPHAGY, V9, P617, DOI 10.4161/auto.23487; STYRT B, 1988, J CELL PHYSIOL, V135, P309, DOI 10.1002/jcp.1041350219; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Xu M, 2014, J BIOMOL SCREEN, V19, P168, DOI 10.1177/1087057113501197; Yasumoto K, 1998, PIGM CELL RES, V11, P329, DOI 10.1111/j.1600-0749.1998.tb00491.x; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zschocke J, 2011, AUTOPHAGY, V7, P1247, DOI 10.4161/auto.7.10.16520	49	90	89	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173771	10.1371/journal.pone.0173771	http://dx.doi.org/10.1371/journal.pone.0173771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301521	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300070
J	Nagano, K; Hasegawa, Y; Yoshida, Y; Yoshimura, F				Nagano, Keiji; Hasegawa, Yoshiaki; Yoshida, Yasuo; Yoshimura, Fuminobu			Novel fimbrilin PGN_1808 in Porphyromonas gingivalis	PLOS ONE			English	Article							MFA1 FIMBRIAE; GENOME SEQUENCE; PROTEIN; PURIFICATION; COMPONENTS; COMPLEX; MODEL	Porphyromonas gingivalis, a periodontopathic gram-negative anaerobic bacterium, generally expresses two types of fimbriae, FimA and Mfa1. However, a novel potential fimbrilin, PGN_1808, in P. gingivalis strain ATCC 33277 was recently identified by an in silico structural homology search. In this study, we experimentally examined whether the protein formed a fimbrial structure. Anion-exchange chromatography showed that the elution peak of the protein was not identical to those of the major fimbrilins of FimA and Mfa1, indicating that PGN_1808 is not a component of these fimbriae. Electrophoretic analyses showed that PGN_1808 formed a polymer, although it was detergent and heat labile compared to FimA and Mfa1. Transmission electron microscopy showed filamentous structures (2-3 nm x 200-400 nm) on the cell surfaces of a PGN_1808-overexpressing P. gingivalis mutant (deficient in both FimA and Mfa1 fimbriae) and in the PGN_1808 fraction. PGN_1808 was detected in 81 of 84 wild-type strains of P. gingivalis by western blotting, suggesting that the protein is generally present in P. gingivalis.	[Nagano, Keiji; Hasegawa, Yoshiaki; Yoshida, Yasuo; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi, Japan	Aichi Gakuin University	Nagano, K (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi, Japan.	nagano@dpc.agu.ac.jp	Nagano, Keiji/AAS-4912-2020	Nagano, Keiji/0000-0003-3587-7606	JSPS [25462880]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Number 25462880 (K.N.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2010, PERIODONTOL 2000, V52, P12, DOI 10.1111/j.1600-0757.2009.00307.x; Arai M, 2000, FEMS MICROBIOL LETT, V193, P75, DOI 10.1016/S0378-1097(00)00459-6; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DICKINSON DP, 1988, J BACTERIOL, V170, P1658, DOI 10.1128/jb.170.4.1658-1665.1988; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hasegawa Y, 2016, J DENT RES, V95, P1291, DOI 10.1177/0022034516655083; Hasegawa Y, 2013, MOL ORAL MICROBIOL, V28, P467, DOI 10.1111/omi.12040; Hasegawa Y, 2009, MICROBIOL-SGM, V155, P3333, DOI 10.1099/mic.0.028928-0; Hunkapiller MW, 1983, FRONTIERS BIOCH BIOP, P23; Ikai R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139454; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Nagano K, 2015, J DENT RES, V94, P1143, DOI 10.1177/0022034515588275; Nagano K, 2013, MOL ORAL MICROBIOL, V28, P392, DOI 10.1111/omi.12032; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; Socransky SS, 2000, PERIODONTOLOGY, V28, P12, DOI DOI 10.1034/J.1600-0757.2002.280102.X; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; Xu QP, 2016, CELL, V165, P690, DOI 10.1016/j.cell.2016.03.016; YOSHIMURA F, 1984, J BACTERIOL, V160, P949, DOI 10.1128/JB.160.3.949-957.1984	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173541	10.1371/journal.pone.0173541	http://dx.doi.org/10.1371/journal.pone.0173541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296909	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700040
J	Zhao, X; Song, HK; Seifert, AC; Li, C; Wehrli, FW				Zhao, Xia; Song, Hee Kwon; Seifert, Alan C.; Li, Cheng; Wehrli, Felix W.			Feasibility of assessing bone matrix and mineral properties in vivo by combined solid-state H-1 and P-31 MRI	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CORTICAL BONE; MECHANICAL-PROPERTIES; POSTMENOPAUSAL WOMEN; FIELD STRENGTHS; WATER-CONTENT; BOUND WATER; PORE-WATER; DENSITY; POROSITY	Purpose To develop and evaluate an integrated imaging protocol for bone water and phosphorus quantification in vivo by solid-state H-1 and P-31 MRI. Materials and methods All studies were HIPAA-compliant and were performed with institutional review board approval and written informed consent. Proton (H-1) ultra-short echo-time (UTE) and phosphorus (P-31) zero echo-time (ZTE) sequences were designed and implemented on a 3 T clinical MR scanner to quantify bone water and mineral in vivo. The left tibia of ten healthy subjects (including both genders, 49 +/- 15 y/o) was examined with a custom-built H-1/P-31 dual-frequency extremity RF coil. Total bone water (TW), water bound to the collagen matrix (BW) and bone P-31 were quantified from MR images with respect to reference samples of known H-1 or P-31 concentration, and pore water (PW) was subsequently determined from TW and BW. Porosity index (PI) was calculated as the ratio between UTE images acquired at two echo times. MRI parameters were compared with bone density measures obtained by high-resolution peripheral quantitative CT (HR-pQCT). Results The total scan time for the bone water and P-31 quantification protocol was about 50 minutes. Average TW, BW, PW and P-31 concentrations were 13.99 +/- 1.26, 10.39 +/- 0.80, 3.34 +/- 1.41 mol/L and 7.06 +/- 1.53 mol/L for the studied cohort, respectively, in good agreement with previous results conducted ex vivo. Average intra-subject coefficients of variation were 3.47%, 2.60% and 7.50% for TW, BW and PW and 5.60% for P-31. Negative correlations were observed between PW and vBMD (p< 0.05) as well as between PI and P-31 (p< 0.05), while bone mineral content (BMC) estimated from P-31 MRI and HR-pQCT were strongly positively correlated (p< 0.0001). Conclusion This work demonstrates the feasibility of quantifying bone water and mineral phosphorus in human subjects in a single MRI session with a clinically practical imaging protocol.	[Zhao, Xia; Song, Hee Kwon; Seifert, Alan C.; Li, Cheng; Wehrli, Felix W.] Univ Penn, Lab Struct Physiol & Funct Imaging, Dept Radiol, Perelman Sch Med,MRI Educ Ctr, 1 Founders Bldg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Wehrli, FW (corresponding author), Univ Penn, Lab Struct Physiol & Funct Imaging, Dept Radiol, Perelman Sch Med,MRI Educ Ctr, 1 Founders Bldg, Philadelphia, PA 19104 USA.	wehrli@mail.med.upenn.edu		Zhao, Xia/0000-0001-8108-6528	National Institute of Aging, NIH [R01-AG038693]; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH [R01-AR050068]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050068] Funding Source: NIH RePORTER	National Institute of Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Aging, NIH R01-AG038693 (https://www.nia.nih.gov/) to FWW; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH R01-AR050068 (https://www.niams.nih.gov/) to FWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anumula S, 2008, BONE, V42, P405, DOI 10.1016/j.bone.2007.10.011; Anumula S, 2006, MAGN RESON MED, V56, P946, DOI 10.1002/mrm.21050; Anumula S, 2010, BONE, V46, P1391, DOI 10.1016/j.bone.2010.01.372; Biswas R, 2012, BONE, V50, P749, DOI 10.1016/j.bone.2011.11.029; Bousson V, 2000, RADIOLOGY, V217, P179, DOI 10.1148/radiology.217.1.r00se11179; Chen J, 2016, P ISMRM 24 SCI M; Chen J, 2016, NMR BIOMED, V29, P1373, DOI 10.1002/nbm.3579; Fernandez-Seara MA, 2004, J BONE MINER RES, V19, P289, DOI 10.1359/JBMR.0301227; Grodzki DM, 2012, MAGN RESON MED, V67, P510, DOI 10.1002/mrm.23017; GRYNPAS M, 1993, CALCIFIED TISSUE INT, V53, pS57, DOI 10.1007/BF01673403; Horch RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016359; Horch RA, 2010, MAGN RESON MED, V64, P680, DOI 10.1002/mrm.22459; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; LAVALJEANTET AM, 1983, CALCIFIED TISSUE INT, V35, P268, DOI 10.1007/BF02405044; Li C, 2016, MAGN RESON MED; Li C, 2014, IEEE T MED IMAGING, V33, P961, DOI 10.1109/TMI.2014.2300500; Li C, 2012, MAGN RESON MED, V68, P680, DOI 10.1002/mrm.23267; Manhard MK, 2015, RADIOLOGY, V277, P221, DOI 10.1148/radiol.2015140336; Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049; Patsch JM, 2013, J BONE MINER RES, V28, P313, DOI 10.1002/jbmr.1763; Rad HS, 2011, NMR BIOMED, V24, P855, DOI 10.1002/nbm.1631; Rajapakse CS, 2015, RADIOLOGY, V276, P526, DOI 10.1148/radiol.15141850; Robson MD, 2004, MAGNET RESON MED, V51, P888, DOI 10.1002/mrm.20055; Roschger P, 2001, BONE, V29, P185, DOI 10.1016/S8756-3282(01)00485-9; Seeman E, 2013, J GERONTOL A-BIOL, V68, P1218, DOI 10.1093/gerona/glt071; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Seifert AC, 2015, J BONE MINER RES, V30, P2229, DOI 10.1002/jbmr.2580; Seifert AC, 2015, NMR BIOMED, V28, P861, DOI 10.1002/nbm.3305; Seifert AC, 2014, NMR BIOMED, V27, P739, DOI 10.1002/nbm.3107; Seifert AC, 2013, NMR BIOMED, V26, P1158, DOI 10.1002/nbm.2930; Siris ES, 2006, OSTEOPOROSIS INT, V17, P565, DOI 10.1007/s00198-005-0027-4; Techawiboonwong A, 2008, RADIOLOGY, V248, P824, DOI 10.1148/radiol.2482071995; Wehrli FW, 2005, ANN BIOMED ENG, V33, P79, DOI 10.1007/s10439-005-8965-8; Wehrli FW, 2002, J BONE MINER RES, V17, P2265, DOI 10.1359/jbmr.2002.17.12.2265; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Wu YT, 2011, J MAGN RESON IMAGING, V34, P623, DOI 10.1002/jmri.22637; Zarowitz BJ, 2015, J AM MED DIR ASSOC, V16, P341, DOI 10.1016/j.jamda.2015.01.073	37	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173995	10.1371/journal.pone.0173995	http://dx.doi.org/10.1371/journal.pone.0173995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296979	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700086
J	Fukagawa, T; Takafuji, K; Tachibanaki, S; Kawamura, S				Fukagawa, Takashi; Takafuji, Kazuaki; Tachibanaki, Shuji; Kawamura, Satoru			Purification of cone outer segment for proteomic analysis on its membrane proteins in carp retina	PLOS ONE			English	Article							CALCIUM SENSOR PROTEINS; VISUAL PIGMENT; AMELOGENESIS IMPERFECTA; ROD DYSTROPHY; MOUSE RETINA; PHOTORECEPTOR; IDENTIFICATION; ACTIVATION; SEQUENCE; COMPLEX	Rods and cones are both photoreceptors in the retina, but they are different in many aspects including the light response characteristics and, for example, cell morphology and metabolism. These differences would be caused by differences in proteins expressed in rods and cones. To understand the molecular bases of these differences between rods and cones, one of the ways is to compare proteins expressed in rods and cones, and to find those expressed specifically or dominantly. In the present study, we are interested in proteins in the outer segment (OS), the site responsible for generation of rod-or cone-characteristic light responses and also the site showing different morphology between rods and cones. For this, we established a method to purify the OS and the inner segment (IS) of rods and also of cones from purified carp rods and cones, respectively, using sucrose density gradient. In particular, we were interested in proteins tightly bound to the membranes of cone OS. To identify these proteins, we analyzed proteins in some selected regions of an SDS-gel of washed membranes of the OS and the IS obtained from both rods and cones, with Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) using a protein database constructed from carp retina. By comparing the lists of the proteins found in the OS and the IS of both rods and cones, we found some proteins present in cone OS membranes specifically or dominantly, in addition to the proteins already known to be present specifically in cone OS.	[Fukagawa, Takashi; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Takafuji, Kazuaki] Osaka Univ, Grad Sch Med, Ctr Med Innovat & Translat Res, Suita, Osaka, Japan; [Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka, Japan; [Fukagawa, Takashi] Natl Res Inst Police Sci, Kashiwa, Chiba, Japan	Osaka University; Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	banaki@fbs.osaka-u.ac.jp; kawamura@fbs.osaka-u.ac.jp		Kawamura, Satoru/0000-0003-2070-5940	Japan Society for the Promotion of Science KAKENHI grant [16K07438, 24570085, 23227002]	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI grant numbers, 16K07438, 24570085 (to ST) and 23227002 (to SK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Arinobu D, 2010, J NEUROCHEM, V115, P259, DOI 10.1111/j.1471-4159.2010.06925.x; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Fukagawa T, 2016, CARP RETINA TRANSCRI; HAGEMAN GS, 1991, P NATL ACAD SCI USA, V88, P2716, DOI 10.1073/pnas.88.7.2716; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwamoto S, 1998, BIOCHEM BIOPH RES CO, V243, P233, DOI 10.1006/bbrc.1997.8023; Kalies KU, 1996, J BIOL CHEM, V271, P3925; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Koshitani Y, 2014, J BIOL CHEM, V289, P2651, DOI 10.1074/jbc.M113.495325; Krishnan A, 2004, BIOCHEMISTRY-US, V43, P2708, DOI 10.1021/bi035631v; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; Li XF, 2006, J BIOL CHEM, V281; Masuda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22360; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; NAKANO A, 1992, BIOCHEM BIOPH RES CO, V186, P1207, DOI 10.1016/S0006-291X(05)81534-7; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; Rinner O, 2005, NEURON, V47, P231, DOI 10.1016/j.neuron.2005.06.010; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; SCHLUTER K, 1986, P NATL ACAD SCI USA, V83, P6137, DOI 10.1073/pnas.83.16.6137; SCHWAIGER M, 1987, J CELL BIOL, V105, P235, DOI 10.1083/jcb.105.1.235; Shimauchi-Matsukawa Y, 2008, MOL VIS, V14, P358; SISTERMANS EA, 1995, CELL TISSUE RES, V280, P435, DOI 10.1007/s004410050372; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tachibanaki S, 2012, J BIOL CHEM, V287, P41186, DOI 10.1074/jbc.M112.403717; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Tsuji T, 2007, PROTEOMICS, V7, P3500, DOI 10.1002/pmic.200700272; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; Wetzel RK, 1999, J NEUROSCI, V19, P9878; WOODRUFF ML, 1979, J GEN PHYSIOL, V73, P629, DOI 10.1085/jgp.73.5.629; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Yamagata T, 1997, GENOMICS, V45, P535, DOI 10.1006/geno.1997.4966; Yamaoka H, 2015, J BIOL CHEM, V290, P24381, DOI 10.1074/jbc.M115.674101	51	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173908	10.1371/journal.pone.0173908	http://dx.doi.org/10.1371/journal.pone.0173908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291804	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700048
J	Park, D; Cho, KJ				Park, Daegeun; Cho, Kyu-Jin			Development and evaluation of a soft wearable weight support device for reducing muscle fatigue on shoulder	PLOS ONE			English	Article							DESIGN; JOINT; DISORDERS	Compensating the weight of human limbs is important in reducing muscle fatigue experienced by manual laborers. In this study, a compact and lightweight soft wearable weight support device was developed and evaluated. The device supports gravitational force on the shoulder at any arm posture, although there are some limitations in its assistive performance. The device actuator consists of a cam-rod structure, a tendon-driven mechanism, and a rubber band. The desired assistive torque is translated to the shoulder joint along a tendon routing structure. Device performance was evaluated by measuring muscle activation in with-assist and without-assist conditions. Muscle activation on the deltoid was measured by surface electromyography. An experimental protocol consisting of a series of exercises was executed with six healthy subjects. The subjects raised and lowered their arm from 0 to 100 degrees for 30 times under eight conditions, which were combined with-assist and without-assist conditions, and holding the horizontal angle of the arm at 0, 30, 60, or 90 degrees against the sagittal plane. Surface electromyography data were pre-processed and analyzed using a root mean square method. When muscle fatigue occurs, the root mean square of the surface electromyography increases nonlinearly. This was calculated using the standard deviation of the root mean square. Three of six subjects showed decreased variation of the root mean square between the exercises in the with-assist condition. One subject's result was significantly reduced (by about 57.6%) in the with-assist condition. In contrast, two subjects did not show significant difference between measurements taken in the with-assist and without-assist conditions. One subject was dropped from the experiment because the device did not fit the subject's body. In conclusion, the effectiveness of the soft wearable weight support device in supporting shoulder movements was verified through the decreased variation of muscle activation.	[Park, Daegeun; Cho, Kyu-Jin] Seoul Natl Univ, Sch Mech & Aerosp Engn, Inst Adv Machines & Design, Seoul, South Korea	Seoul National University (SNU)	Cho, KJ (corresponding author), Seoul Natl Univ, Sch Mech & Aerosp Engn, Inst Adv Machines & Design, Seoul, South Korea.	kjcho@snu.ac.kr		Park, Daegeun/0000-0001-6586-4238	convergence technology development program for bionic arm through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015M3C1B2052817]; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP) [NRF-2016R1A5A1938472]	convergence technology development program for bionic arm through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP)	This research was supported by the convergence technology development program for bionic arm through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2015M3C1B2052817), and the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP)(No. NRF-2016R1A5A1938472) (http://www.nrf.re.kr/nrf_eng_cms/).	Aaras A, 1996, ERGONOMICS, V39, P171; Asbeck AT, 2015, ROBOT AUTON SYST, V73, P102, DOI 10.1016/j.robot.2014.09.025; Asbeck AT, 2015, INT J ROBOT RES; Ball S., 2007, IEEE ASME INT C ADV, P1, DOI DOI 10.1109/AIM.2007.4412446; Carignan C, 2005, 2005 12TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS, P524; Carpenter JE, 1998, AM J SPORT MED, V26, P262, DOI 10.1177/03635465980260021701; der Heide LAV, 2013, PROSTHET ORTHOT INT; Fernstrom EAC, 1996, ERGONOMICS, V39, P1221, DOI 10.1080/00140139608964541; HAGBERG M, 1981, ERGONOMICS, V24, P543, DOI 10.1080/00140138108924875; Hug F, 2003, CLIN PHYSIOL FUNCT I, V23, P208, DOI 10.1046/j.1475-097X.2003.00497.x; In H, 2015, IEEE ROBOT AUTOM MAG, V22, P97, DOI 10.1109/MRA.2014.2362863; Kawamoto H., 2002, Computers Helping People with Special Needs 8th International Conference, ICCHP 2002. Proceedings (Lecture Notes in Computer Science Vol.2398), P196; Kawamoto H, 2003, IEEE SYS MAN CYBERN, P1648; Kawamoto H, 2009, IEEE ENG MED BIO, P5038, DOI 10.1109/IEMBS.2009.5333698; Koo I, 2014, IEEE INT C INT ROBOT, P542, DOI 10.1109/IROS.2014.6942612; Lin PY, 2013, MECH MACH THEORY, V61, P156, DOI 10.1016/j.mechmachtheory.2012.11.003; Lo HS, 2012, MED ENG PHYS, V34, P261, DOI 10.1016/j.medengphy.2011.10.004; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; Magermans DJ, 2005, CLIN BIOMECH, V20, P591, DOI 10.1016/j.clinbiomech.2005.02.006; Mair SD, 1996, AM J SPORT MED, V24, P137, DOI 10.1177/036354659602400203; Mastenbroek B, 2007, INT C REHAB ROBOT, P1114, DOI 10.1109/ICORR.2007.4428563; Nef Tobias, 2009, Applied Bionics and Biomechanics, V6, P127, DOI 10.1080/11762320902840179; Neumann, 2013, KINESIOLOGY MUSCULOS, P216; OHLSSON K, 1995, AM J IND MED, V27, P731; Panizzolo FA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0150-9; Park D, 2015, INT C REHAB ROBOT, P79, DOI 10.1109/ICORR.2015.7281179; Park D, 2015, IEEE ASME INT C ADV, P647, DOI 10.1109/AIM.2015.7222610; Pascarelli EF, 2001, J OCCUP REHABIL, V11, P1, DOI 10.1023/A:1016647923501; Perry J. C., 2006, 1 IEEE RAS EMBS INT, P805, DOI DOI 10.1109/BIOROB.2006.1639189; Ragonesi D, 2011, IEEE ENG MED BIO, P3515, DOI 10.1109/IEMBS.2011.6090583; RANNEY D, 1995, ERGONOMICS, V38, P1408, DOI 10.1080/00140139508925198; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Strausser KA, 2010, PROCEEDINGS OF THE ASME DYNAMIC SYSTEMS AND CONTROL CONFERENCE 2010, VOL 1, P453; Swift TA, 2010, PROCEEDINGS OF THE ASME DYNAMIC SYSTEMS AND CONTROL CONFERENCE 2010, VOL 1, P405; Tozeren A., 1999, SPRINGER SCI BUSINES; Viteckova S, 2013, BIOCYBERN BIOMED ENG, V33, P96, DOI 10.1016/j.bbe.2013.03.005; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; YOSHIKAWA T, 1994, J EXP BIOL, V188, P217	38	30	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173730	10.1371/journal.pone.0173730	http://dx.doi.org/10.1371/journal.pone.0173730			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291825	gold, Green Published			2022-12-26	WOS:000396094700037
J	Yoo, RE; Yun, TJ; Yoon, BW; Lee, SK; Lee, ST; Kang, KM; Choi, SH; Kim, JH; Sohn, CH; Park, SW; Han, MH				Yoo, Roh-Eul; Yun, Tae Jin; Yoon, Byung-Woo; Lee, Sang Kun; Lee, Soon-Tae; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-hoon; Sohn, Chul-Ho; Park, Sun-Won; Han, Moon Hee			Identification of cerebral perfusion using arterial spin labeling in patients with seizures in acute settings	PLOS ONE			English	Article							BLOOD-FLOW; STATUS EPILEPTICUS; LOBE EPILEPSY; MRI; DIFFUSION; FOCUS; DIAGNOSIS; EEG	This study aimed to explore the utility of arterial spin labeling perfusion-weighted imaging (ASL-PWI) in patients with suspected seizures in acute settings. A total of 164 patients who underwent ASL-PWI for suspected seizures in acute settings (with final diagnoses of seizure [n = 129], poststroke seizure [n = 18], and seizure mimickers [n = 17]), were included in this retrospective study. Perfusion abnormality was analyzed for: (1) pattern, (2) multifocality, and (3) atypical distribution against vascular territories. Perfusion abnormality was detected in 39% (50/129) of the seizure patients, most (94%, 47/50) being the hyperperfusion pattern. Of the patients with perfusion abnormality, multifocality or hemispheric involvement and atypical distribution against vascular territory were revealed in 46% (23/50) and 98% (49/50), respectively. In addition, seizures showed characteristic features including hyperperfusion (with or without non-territorial distribution) on ASL-PWI, thus differentiating them from poststroke seizures or seizure mimickers. In patients in whom seizure focus could be localized on both EEG and ASL-PWI, the concordance rate was 77%. The present study demonstrates that ASL-PWI can provide information regarding cerebral perfusion status in patients with seizures in acute settings and has the potential to be used as a non-invasive imaging tool to identify the cerebral perfusion in patients with seizures.	[Yoo, Roh-Eul; Yun, Tae Jin; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-hoon; Sohn, Chul-Ho; Park, Sun-Won; Han, Moon Hee] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Yoo, Roh-Eul; Yun, Tae Jin; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-hoon; Sohn, Chul-Ho; Han, Moon Hee] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Yoon, Byung-Woo; Lee, Sang Kun; Lee, Soon-Tae] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Park, Sun-Won] Seoul Natl Univ, Dept Radiol, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Yun, TJ (corresponding author), Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea.; Yun, TJ (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	radiologyyun@gmail.com	Sohn, ChulHo/AAV-4565-2021	Yun, Tae Jin/0000-0001-8441-4574; Lee, Soon-Tae/0000-0003-4767-7564	Seoul National University Hospital Research Fund [04-2012-1000]; Seoul National University College of Medicine Research Fund [800-20140025]	Seoul National University Hospital Research Fund; Seoul National University College of Medicine Research Fund	This study was supported by a grant from the Seoul National University Hospital Research Fund [04-2012-1000] and Seoul National University College of Medicine Research Fund [800-20140025]. TJY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Seoul National University Hospital Research Fund [04-2012-1000] and Seoul National University College of Medicine Research Fund [80020140025].	Alsop DC, 2002, EPILEPSIA, V43, P69, DOI 10.1046/j.1528-1157.2002.043s1069.x; Arntz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055498; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Bradley WG, 2000, RADIOLOGY, V214, P651, DOI 10.1148/radiology.214.3.r00mr42651; Calistri V, 2003, AM J NEURORADIOL, V24, P671; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; DUNCAN R, 1992, CEREBROVAS BRAIN MET, V4, P105; Galazzo IB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123975; Guo XQ, 2015, J MAGN RESON IMAGING, V42, P1386, DOI 10.1002/jmri.24920; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Kanazawa Y, 2015, J STROKE CEREBROVASC, V24, P731, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.026; Kim BS, 2016, EUR J RADIOL, V85, P1295, DOI 10.1016/j.ejrad.2016.04.015; Kim Sunhee, 2011, Int J Mol Imaging, V2011, P813028, DOI 10.1155/2011/813028; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leonhardt G, 2005, EPILEPSIA, V46, P1943, DOI 10.1111/j.1528-1167.2005.00336.x; Lim YM, 2008, EPILEPSY RES, V82, P183, DOI 10.1016/j.eplepsyres.2008.08.001; Matsuura K, 2015, J NEUROL SCI, V359, P424, DOI 10.1016/j.jns.2015.10.009; Oishi M, 2012, NEURORADIOLOGY, V54, P653, DOI 10.1007/s00234-012-1027-7; Pendse N, 2010, J NEURORADIOLOGY, V37, P60, DOI 10.1016/j.neurad.2009.05.006; Pizzini F, 2008, EPILEPSY RES, V81, P225, DOI 10.1016/j.eplepsyres.2008.06.009; Pizzini FB, 2013, MAGN RESON IMAGING, V31, P1001, DOI 10.1016/j.mri.2013.03.023; Placidi F, 2002, EPILEPSIA, V43, P1515, DOI 10.1046/j.1528-1157.2002.04702.x; Pollock JM, 2008, J COMPUT ASSIST TOMO, V32, P291, DOI 10.1097/RCT.0b013e31814cf81f; Schwartz Theodore H, 2007, Epilepsy Curr, V7, P91, DOI 10.1111/j.1535-7511.2007.00183.x; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; Stafstrom C.E., 2015, COLD SPRING HARB PER, V5; Sugita K, 2014, SEIZURE-EUR J EPILEP, V23, P318, DOI 10.1016/j.seizure.2014.01.005; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; Toledo M, 2008, EPILEPSIA, V49, P1465, DOI 10.1111/j.1528-1167.2008.01620.x; Toledo M, 2011, EPILEPTIC DISORD, V13, P336, DOI 10.1684/epd.2011.0445; WILDERSMITH E, 1991, NEUROLOGY, V41, P2005, DOI 10.1212/WNL.41.12.2005; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wolf RL, 2001, AM J NEURORADIOL, V22, P1334; Yoo RE, 2013, J MAGN RESON IMAGING, V38, P852, DOI 10.1002/jmri.24026; Yu JT, 2008, BRAIN RES REV, V59, P34, DOI 10.1016/j.brainresrev.2008.04.008	36	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173538	10.1371/journal.pone.0173538	http://dx.doi.org/10.1371/journal.pone.0173538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291816	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700031
J	Eliasson, B; Rawshani, A; Axelsen, M; Hammarstedt, A; Smith, U				Eliasson, Bjorn; Rawshani, Araz; Axelsen, Mette; Hammarstedt, Ann; Smith, Ulf			Cephalic phase of insulin secretion in response to a meal is unrelated to family history of type 2 diabetes	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; RELEASE; HUMANS	The pre-absorptive cephalic phase of insulin secretion is elicited during the first ten min of a meal and before glucose levels rise. Its importance for insulin release during the post-absorptive phase has been well documented in animals but its presence or importance in man has become increasingly controversial. We here examined the presence of an early cephalic phase of insulin release in 31 well matched individuals without (n = 15) or with (n = 16) a known family history of type 2 diabetes (first-degree relatives; FDR). We also examined the potential differences in individuals with or without impaired fasting (IFG) and impaired glucose tolerance (IGT). We here demonstrate that a cephalic phase of insulin secretion was present in all individuals examined and without any differences between control persons and FDR or IFG/IGT. However, the overall importance of the cephalic phase is conjectural since it was unrelated to the subsequent post-absorptive insulin release or glucose tolerance. One of the best predictors of the incremental cephalic phase of insulin release was fasting insulin level and, thus, a relation to degree of insulin sensitivity is likely. In conclusion, an early pre-absorptive and cephalic phase of insulin release is robustly present in man. However, we could not document any relation to family history of Type 2 diabetes nor to the post-absorptive phase and, thus, confirm its importance for subsequent degree of insulin release or glucose tolerance.	[Eliasson, Bjorn; Rawshani, Araz; Hammarstedt, Ann; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Lundberg Lab Diabet Res, Gothenburg, Sweden; [Axelsen, Mette] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Clin Nutr, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Smith, U (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Lundberg Lab Diabet Res, Gothenburg, Sweden.	ulf.smith@medic.gu.se	Rawshani, Araz/AAW-3229-2021; rawshani, araz/HGE-5637-2022; Eliasson, Bjorn/H-5783-2016	Eliasson, Bjorn/0000-0003-2569-4160	Swedish Medical Research Council; Swedish Diabetes Foundation; Novo Nordisk Foundation; Innovative Medicines Initiative Joint Undertaking under EMIF grant [115372]; Novo Nordisk Fonden [NNF14OC0009795, NNF17OC0026712, NNF16OC0021202, NNF15OC0016484] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Diabetes Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Innovative Medicines Initiative Joint Undertaking under EMIF grant; Novo Nordisk Fonden(Novo Nordisk Foundation)	The present study was funded by grants from the Swedish Medical Research Council, the Swedish Diabetes Foundation and the Novo Nordisk Foundation. It also received support from the Innovative Medicines Initiative Joint Undertaking under EMIF grant agreement 115372. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; BERTHOUD HR, 1982, AM J PHYSIOL, V242, pE280, DOI 10.1152/ajpendo.1982.242.4.E280; CALLESESCANDON J, 1987, DIABETES, V36, P1167, DOI 10.2337/diabetes.36.10.1167; LORENTZEN M, 1987, ACTA ENDOCRINOL-COP, V115, P84, DOI 10.1530/acta.0.1150084; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; SIEGEL EG, 1980, GUT, V21, P1002, DOI 10.1136/gut.21.11.1002; TEFF KL, 1993, AM J PHYSIOL, V265, pR1223, DOI 10.1152/ajpregu.1993.265.6.R1223; Teff KL, 1999, AM J PHYSIOL-REG I, V277, pR198, DOI 10.1152/ajpregu.1999.277.1.R198; Thorens B, 2014, DIABETES OBES METAB, V16, P87, DOI 10.1111/dom.12346; Veedfald S, 2016, AM J PHYSIOL-GASTR L, V310, pG43, DOI 10.1152/ajpgi.00222.2015	10	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173654	10.1371/journal.pone.0173654	http://dx.doi.org/10.1371/journal.pone.0173654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288176	gold, Green Published, Green Submitted			2022-12-26	WOS:000396092400023
J	Hatzirodos, N; Glister, C; Hummitzsch, K; Irving-Rodgers, HF; Knight, PG; Rodgers, RJ				Hatzirodos, Nicholas; Glister, Claire; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Knight, Philip G.; Rodgers, Raymond J.			Transcriptomal profiling of bovine ovarian granulosa and theca interna cells in primary culture in comparison with their in vivo counterparts	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ANCHORAGE-INDEPENDENT CULTURE; BONE MORPHOGENETIC PROTEINS; ANDROGEN PRODUCTION; ANTRAL FOLLICLES; INITIATE INFLAMMATION; MOLECULAR-PATTERNS; GENE-EXPRESSION; MENSTRUAL-CYCLE; CORPUS-LUTEUM	In vitro culture of ovarian granulosa cells and theca cells has been very important for our understanding of their function and regulation. One of the most eagerly sought attributes of cell culture is the use of chemically-defined conditions. However, even under such in vitro conditions cell behaviour could differ from the in vivo situation because of differences in oxygen tension, nutrients, adhesion matrix and other factors. To examine this further we compared the transcriptomes of both granulosa cells and cells from the theca interna that were cultured in what are arguably the best in vitro conditions for maintaining the 'follicular' phenotypes of both tissue types, as displayed by their respective freshly-isolated counterparts. The array data analysed are from recently published data and use the same sizes of bovine follicles (small antral 3-6 mm) and the same Affymetrix arrays. We conducted analysis using Partek, Ingenuity Pathway Analysis and GOEAST. Principal Component Analysis (PCA) and hierarchical clustering clearly separated the in vivo from the in vitro groups for both cells types and transcriptomes were more homogeneous upon culture. In both cell cultures behaviours associated with cell adhesion, migration and interaction with matrix or substrate were more abundant. However, the pathways involved generally differed between the two cell types. With the thecal cultures a gene expression signature of an immune response was more abundant, probably by leukocytes amongst the cells cultured from the theca interna. These results indicate differences between in vivo and in vitro that should be considered when interpreting in vitro data.	[Hatzirodos, Nicholas; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Rodgers, Raymond J.] Univ Adelaide, Robinson Res Inst, Sch Med, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Glister, Claire; Knight, Philip G.] Univ Reading, Sch Biol Sci, Hopkins Bldg, Reading, Whiteknights, England; [Irving-Rodgers, Helen F.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia	Robinson Research Institute; University of Adelaide; University of Reading; Griffith University	Rodgers, RJ (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Med, Discipline Obstet & Gynaecol, Adelaide, SA, Australia.	ray.rodgers@adelaide.edu.au	Irving-Rodgers, Helen/E-3660-2010; Hummitzsch, Katja/K-6940-2013; Rodgers, Raymond J/C-3476-2009	Hummitzsch, Katja/0000-0001-5023-2668; knight, philip/0000-0003-0300-1554	United Kingdom Biotechnology and Biological Sciences Research Council [BB/G017174/1]; National Health and Medical Research Council of Australia; Australian Research Council; University of Adelaide; Biotechnology and Biological Sciences Research Council [BB/G017174/1] Funding Source: researchfish; BBSRC [BB/G017174/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Adelaide; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council (grant no. BB/G017174/1 to PGK and CG and Underwood Fellowship award to RJR) and by the National Health and Medical Research Council of Australia and the Australian Research Council and the University of Adelaide.	ALILA HW, 1984, BIOL REPROD, V31, P1015, DOI 10.1095/biolreprod31.5.1015; Best CL, 1996, HUM REPROD, V11, P790; BRANNSTROM M, 1994, FERTIL STERIL, V61, P488; Brannstrom M, 1992, BIOL REPROD S1; Campbell BK, 1998, J REPROD FERTIL, V112, P69, DOI 10.1530/jrf.0.1120069; CHANNING CP, 1981, MOL CELL ENDOCRINOL, V22, P359, DOI 10.1016/0303-7207(81)90044-7; Desai N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-119; EIERMAN DF, 1989, J IMMUNOL, V142, P1970; ERICKSON GF, 1983, MOL CELL ENDOCRINOL, V29, P21, DOI 10.1016/0303-7207(83)90003-5; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Glister C, 2001, BIOL REPROD, V65, P1020, DOI 10.1095/biolreprod65.4.1020; Glister C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-72; Glister C, 2013, P NATL ACAD SCI USA, V110, pE1426, DOI 10.1073/pnas.1222216110; Gutierrez CG, 1997, BIOL REPROD, V56, P608, DOI 10.1095/biolreprod56.3.608; Hatzirodos N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099706; Hatzirodos N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097489; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Havelock JC, 2004, MOL CELL ENDOCRINOL, V228, P67, DOI 10.1016/j.mce.2004.04.018; Irving-Rodgers HF, 2001, REPRODUCTION, V122, P761, DOI 10.1530/rep.0.1220761; KERR JFR, 1995, METHOD CELL BIOL, V46, P1; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LAVRANOS TC, 1994, EXP CELL RES, V211, P245, DOI 10.1006/excr.1994.1084; LISCIA DS, 1988, IN VITRO CELL DEV B, V24, P183, DOI 10.1007/BF02623544; Price JC, 2013, ENDOCRINOLOGY, V154, P3377, DOI 10.1210/en.2013-1102; Price JC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110965; RODGERS HF, 1995, CELL TISSUE RES, V282, P463; Rodgers RJ, 2010, REPRODUCTION, V139, P309, DOI 10.1530/REP-09-0177; Spanel-Borowski K, 1997, J REPROD FERTIL, V111, P197, DOI 10.1530/jrf.0.1110197; Van Wezel IL, 1999, ENDOCRINOLOGY, V140, P2602, DOI 10.1210/en.140.6.2602; vanWezel IL, 1996, BIOL REPROD, V55, P1003, DOI 10.1095/biolreprod55.5.1003; Wickenheisser JK, 2006, TRENDS ENDOCRIN MET, V17, P63, DOI 10.1016/j.tem.2006.01.003; Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818; Yamada S, 1999, MOL HUM REPROD, V5, P607, DOI 10.1093/molehr/5.7.607; ZHOU X, 1992, AM J PHYSIOL, V262, pL600, DOI 10.1152/ajplung.1992.262.5.L600	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e73391	10.1371/journal.pone.0173391	http://dx.doi.org/10.1371/journal.pone.0173391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282394	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000396091800034
J	Huang, H; Liu, Y; Wang, L; Li, W				Huang, Hu; Liu, Ying; Wang, Lei; Li, Wen			Age-related macular degeneration phenotypes are associated with increased tumor necrosis-alpha and subretinal immune cells in aged Cxcr5 knockout mice	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; CHEMOKINE RECEPTOR; OXIDATIVE STRESS; DENDRITIC CELLS; ACCUMULATION; INFLAMMATION; RANIBIZUMAB; EXPRESSION; MICROGLIA; CXCL13	The role of chemokine receptor in age-related macular degeneration (AMD) remains elusive. The objective of this study is to investigate the role of chemokine receptor Cxcr5 in the pathogenesis of AMD. Cxcr5 gene expression levels (mRNA and protein) are higher in the retina and retinal pigment epithelium (RPE) of aged C57BL/6 wild type mice than younger ones. Vascular and glial cells express Cxcr5 and its ligand Cxcl13 in mouse retina. Aged Cxcr5 knockout ((-/-)) mice develop both early and late AMD-like pathological features. White and yellow spots, which look like drusen in humans, were identified with fundscopic examination. Drusen-like sub-RPE deposits with dome-shaped morphology were characterized on the sections. RPE vacuolization, swelling, and sub-RPE basal deposits were illustrated with light and transmission electron microscope (TEM). TEM further illustrated degenerated and disorganized RPE basal infoldings, phagosomes and melanosomes inside RPE, as well as abnormal photoreceptor outer segments. Lipofuscin granules and lipid droplets in the subretinal space, RPE, and choroid were revealed with fluorescence microscope and oil-red-O staining. Increased IgG in RPE/choroid were determined with Western blots (WB). WB and immunofluorescence staining determined RPE zona occuldens (ZO)-1 protein reduction and abnormal subcellular localization. TUNEL staining, outer nuclear layer (ONL) measurement and electroretinogram (ERG) recording indicated that photoreceptors underwent apoptosis, degeneration, and functional impairment. Additionally, spontaneous neovascularization (NV)-like lesions develop in the subretinal space of aged Cxcr5(-/-) mice. The underlying mechanisms are associated with increased subretinal F4/80(+) immune cells, some of which contain RPE marker RPE65, and up-regulation of the multifunctional cytokine tumor necrosis factor-alpha (TNF-alpha) in RPE/choroid and retina. These findings suggest that Cxcr5 itself may be involved in the protection of RPE and retinal cells during aging and its loss may lead to AMD-like pathological changes in aged mice.	[Huang, Hu; Liu, Ying; Wang, Lei; Li, Wen] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Liu, Ying] Aier Eye Hosp, Changsha, Hunan, Peoples R China; [Li, Wen] Cent South Univ, Sch Ophthalmol, Changsha, Hunan, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; Central South University	Huang, H (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21218 USA.	hhuang27@jhmi.edu	Wang, Lei/C-1902-2015	Wang, Lei/0000-0002-7957-1003	Brightfocus Foundation [118211]; Wilmer Pooled Professor Funds; NATIONAL EYE INSTITUTE [P30EY001765] Funding Source: NIH RePORTER	Brightfocus Foundation(BrightFocus Foundation); Wilmer Pooled Professor Funds; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by Brightfocus Foundation (118211; H.H.), Wilmer Pooled Professor Funds (H.H.), and an unrestricted gift from RBP (Wilmer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank Dr. Rhonda Grebe for assistance with TEM, Dr. Sean Hackett for providing the genomic DNA for the controls of rd8 PCR genotyping, and Drs. Long Zhao, Junsong Gong, and Tomohiro Masuda for the help with ERG instrument. We also sincerely thank Drs. James Handa and Debashis Sinha for the critical discussions about the study and Dr. Gerard A. Lutty for reading and editing the manuscript. This work was supported by Brightfocus Foundation (H.H.), Wilmer Pooled Professor Funds (H.H.), and an unrestricted gift from RBP (Wilmer).	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Anand A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/365046; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chan CC, 2003, OPHTHALMOLOGY, V110, P421, DOI 10.1016/S0161-6420(02)01737-2; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Chinnery HR, 2012, NEUROBIOL AGING, V33, P1769, DOI 10.1016/j.neurobiolaging.2011.03.010; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gass J D, 1972, Trans Am Ophthalmol Soc, V70, P409; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hanus J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.478; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Howard OMZ, 2005, BLOOD, V105, P4207, DOI 10.1182/blood-2004-07-2697; Huang H, 2012, INVEST OPHTHALMOL VI, V53; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071808; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Kanda A, 2008, BRIT J OPHTHALMOL, V92, P448, DOI 10.1136/bjo.2007.131581; Kanno M, 2007, NEUROIMMUNOLOGY RES, P193; Kizil C, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-27; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Li YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017106; Luhmann UFO, 2013, EXP EYE RES, V107, P80, DOI 10.1016/j.exer.2012.11.015; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma W, 2014, INVEST OPHTHALMOL VI, V55; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saeki H, 2000, EUR J IMMUNOL, V30, P2808, DOI 10.1002/1521-4141(200010)30:10<2808::AID-IMMU2808>3.0.CO;2-K; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Verbeke G, 2000, LINEAR MIXED MODELS; Vessey KA, 2012, INVEST OPHTH VIS SCI, V53, P7833, DOI 10.1167/iovs.12-10650; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Zanzottera EC, 2015, INVEST OPHTH VIS SCI, V56, P3253, DOI 10.1167/iovs.15-16431	53	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173716	10.1371/journal.pone.0173716	http://dx.doi.org/10.1371/journal.pone.0173716			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282423	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800072
J	Maki, C; Funakoshi-Tago, M; Aoyagi, R; Ueda, F; Kimura, M; Kobata, K; Tago, K; Tamura, H				Maki, Chihiro; Funakoshi-Tago, Megumi; Aoyagi, Ryohei; Ueda, Fumihito; Kimura, Masaki; Kobata, Kenji; Tago, Kenji; Tamura, Hiroomi			Coffee extract inhibits adipogenesis in 3T3-L1 preadipocyes by interrupting insulin signaling through the downregulation of IRS1	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; DIFFERENTIATION-INDUCED GENE; BINDING-PROTEIN; C/EBP-BETA; EARLY PHASE; EXPRESSION; ACID; FAT; FIBROBLASTS; CONSUMPTION	Although epidemiological data have indicated that a strong negative association exists between coffee consumption and the prevalence of obesity-associated diseases, the molecular mechanisms by which coffee intake prevents obesity-associated diseases has not yet been elucidated. In this study, we found that coffee intake significantly suppressed high-fat diet (HFD)-induced metabolic alternations such as increases in body weight and the accumulation of adipose tissue, and up-regulation of glucose, free fatty acid, total cholesterol and insulin levels in the blood. We also found that coffee extract significantly inhibited adipogenesis in 3T3-L1 preadipocytes. In the early phase of adipogenesis, 3T3-L1 cells treated with coffee extract displayed the retardation of cell cycle entry into the G2/M phase called as mitotic clonal expansion (MCE). Coffee extract also inhibited the activation of CCAAT/enhancer-binding protein beta (C/EBP beta) by preventing its phosphorylation by ERK. Furthermore, the coffee extract suppressed the adipogenesis-related events such as MCE and C/EBP beta activation through the down-regulation of insulin receptor substrate 1 (IRS1). The stability of the IRS1 protein was markedly decreased by the treatment with coffee extract due to proteasomal degradation. These results have revealed an anti-adipogenic function for coffee intake and identified IRS1 as a novel target for coffee extract in adipogenesis.	[Maki, Chihiro; Funakoshi-Tago, Megumi; Aoyagi, Ryohei; Ueda, Fumihito; Kimura, Masaki; Tamura, Hiroomi] Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo, Japan; [Kobata, Kenji] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama, Japan; [Tago, Kenji] Jichi Med Univ, Dept Biochem, Div Struct Biochem, Shimotsuke, Japan	Keio University; Josai University; Jichi Medical University	Funakoshi-Tago, M (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo, Japan.	tago-mg@pha.keio.ac.jp		Ueda, Fumihito/0000-0003-1241-1643	MEXT [15K00883]; Mishima Kaiun Memorial Foundation; Informatics, Tobemaki Scholarship Foundation; Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan [25460073]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Informatics, Tobemaki Scholarship Foundation; Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by grants (15K00883) from MEXT, Mishima Kaiun Memorial Foundation and Informatics, Tobemaki Scholarship Foundation, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25460073).	Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378; Aparicio T, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-18; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Berg T, 2005, BIOCHEM BIOPH RES CO, V334, P638, DOI 10.1016/j.bbrc.2005.06.146; Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a; Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; COOK JS, 1988, P NATL ACAD SCI USA, V85, P2949, DOI 10.1073/pnas.85.9.2949; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Krebs DL, 2000, J CELL SCI, V113, P2813; Kwon JY, 2012, NUTR RES, V32, P607, DOI 10.1016/j.nutres.2012.06.014; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Long SD, 1996, J BIOL CHEM, V271, P1138, DOI 10.1074/jbc.271.2.1138; Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/c4fo00042k, 10.1039/C4FO00042K]; Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Myneni R. B., 2012, ENVIRON RES LETT, V7, P1, DOI DOI 10.1074/JBC.M112.405209; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Shimocka II, 2006, BMC COMPLEM ALTERN M, V6, P9, DOI [10.1186/1472-6882-6-9, DOI 10.1186/1472-6882-6-9]; Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	45	36	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173264	10.1371/journal.pone.0173264	http://dx.doi.org/10.1371/journal.pone.0173264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282409	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800025
J	Hair, PS; Sass, LA; Vazifedan, T; Shah, TA; Krishna, NK; Cunnion, KM				Hair, Pamela S.; Sass, Laura A.; Vazifedan, Turaj; Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.			Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity	PLOS ONE			English	Article							IN-VITRO; ACTIVATION; SPUTUM; INFLAMMATION; ELASTASE; RECEPTOR; BLOOD	In cystic fibrosis (CF), lung damage is mediated by a cycle of obstruction, infection, inflammation and tissue destruction. The complement system is a major mediator of inflammation for many diseases with the effectors C5a and C3a often playing important roles. We have previously shown in a small pilot study that CF sputum soluble fraction concentrations of C5a and C3a were associated with clinical measures of CF disease. Here we report a much larger study of 34 CF subjects providing 169 testable sputum samples allowing longitudinal evaluation comparing C5a and C3a with clinical markers. Levels of the strongly pro-inflammatory C5a correlated negatively with FEV1% predicted (P < 0.001), whereas the often anti-inflammatory C3a correlated positively with FEV1% predicted (P = 0.01). C5a concentrations correlated negatively with BMI percentile (P = 0.017), positively with worsening of an acute pulmonary exacerbation score (P = 0.007) and positively with P. aeruginosa growth in sputum (P = 0.002). C5a levels also correlated positively with concentrations of other sputum markers associated with worse CF lung disease including neutrophil elastase (P < 0.001), myeloperoxidase activity (P = 0.006) and DNA concentration (P < 0.001). In contrast to C5a, C3a levels correlated negatively with worse acute pulmonary exacerbation score and correlated negatively with sputum concentrations of neutrophil elastase, myeloperoxidase activity and DNA concentration. In summary, these data suggest that in CF sputum, increased C5a is associated with increased inflammation and poorer clinical measures, whereas increased C3a appears to be associated with less inflammation and improved clinical measures.	[Hair, Pamela S.; Sass, Laura A.; Vazifedan, Turaj; Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Sass, Laura A.; Shah, Tushar A.; Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA 23507 USA; [Sass, Laura A.; Vazifedan, Turaj; Shah, Tushar A.; Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA 23507 USA; [Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.; Cunnion, KM (corresponding author), Childrens Specialty Grp, Norfolk, VA 23507 USA.; Cunnion, KM (corresponding author), Childrens Hosp Kings Daughters, Norfolk, VA 23507 USA.; Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	cunniokm@EVMS.EDU		Vazifedan, Turaj/0000-0002-8319-7499; Cunnion, Kenji/0000-0001-8604-348X; Shah, Tushar/0000-0001-5962-1838	Cystic Fibrosis Foundation [CUNNIO1510]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by a grant from the Cystic Fibrosis Foundation, CUNNIO1510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Cystic Fibrosis Foundation, CUNNIO15I0.	Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Davies JR, 1999, BIOCHEM J, V344, P321, DOI 10.1042/0264-6021:3440321; Dwyer M, 2014, J INNATE IMMUNITY; FICK RB, 1986, PEDIATR RES, V20, P1258, DOI 10.1203/00006450-198612000-00014; Frank MM, 2001, SAMTERS IMMUNOLOGIC, P281; Gharib SA, 2009, J PROTEOME RES, V8, P3020, DOI 10.1021/pr900093j; Gifford AH, 2014, J CYST FIBROS, V13, P311, DOI 10.1016/j.jcf.2013.11.004; Gifford AM, 2014, CURR OPIN HEMATOL, V21, P16, DOI 10.1097/MOH.0000000000000009; HODSON ME, 1995, AM J RESP CRIT CARE, V151, pS70, DOI 10.1164/ajrccm/151.3_Pt_2.S70; LAMBRIS JD, 1998, HUMAN COMPLEMENT SYS, P83; Laursen NS, 2012, CURR MOL MED, V12, P1083; Le Gars M, 2013, AM J RESP CRIT CARE, V187, P170, DOI 10.1164/rccm.201205-0875OC; Mollnes TE, 2002, BLOOD, V100, P1869; Pfeifer PH, 1999, CLIN CHEM, V45, P1190; Pfeifer PH, 2000, IMMUNOPHARMACOLOGY, V46, P163, DOI 10.1016/S0162-3109(99)00167-8; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sass LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144723; SCHIOTZ PO, 1979, ACTA PATH MICRO IM C, V87, P1; Schmudde I, 2013, MUCOSAL IMMUNOL, V6, P807, DOI 10.1038/mi.2012.119; Shinjyo N, 2009, STEM CELLS, V27, P2824, DOI 10.1002/stem.225; Smailhodzic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112682; Tralau T, 2004, EXP DERMATOL, V13, P316, DOI 10.1111/j.0906-6705.2004.00145.x	25	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173257	10.1371/journal.pone.0173257	http://dx.doi.org/10.1371/journal.pone.0173257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278205	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900062
J	Respondek, D; Voss, M; Kuhlewindt, I; Klingel, K; Kruger, E; Beling, A				Respondek, Dorota; Voss, Martin; Kuehlewindt, Ina; Klingel, Karin; Krueger, Elke; Beling, Antje			PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection	PLOS ONE			English	Article							PROTEASOME ACTIVATOR PA28; INTERFERON-GAMMA; HEART-FAILURE; MICE LACKING; REG PA28; 11S REG; IMMUNOPROTEASOME; INHIBITION; REGULATOR; MYOCARDITIS	The function of the proteasome is modulated at the level of subunit expression and by association with its regulatory complexes. During coxsackievirus B3 (CVB3) myocarditis, IFN-induced formation of immunoproteasomes (ip) is known to be critical for regulating immune modulating molecules. The function of the IFN-gamma-inducible proteasome regulator subunits PA28 alpha and beta, however, in this context was unknown. During viral myocarditis, we found an increased abundance of PA28 beta subunits in heart tissue. PA28 alpha/beta exists in PA28-20S-PA28 and PA700-20S-PA28 hybrid proteasome complexes in cells both with either predominant ip and standard proteasome (sp) expression. Being in line with reduced proteasome activity in PA28 alpha/beta-deficient cells, we observed increased levels of oxidized and poly-ubiquitinated proteins upon TLR3-activation in these cells. Moreover, PA28 alpha/beta is capable to interfere directly with viral replication of CVB3 and facilitates the generation of CVB3-derived MHC class I epitopes by the proteasome. In contrast to a distinct function of PA28 alpha/beta in vitro, gene ablation of PA28 alpha/beta in mice being on a genetic background with resistance towards the development of severe infection had no significant impact on disease progression. Other than reported for the ip, in this host PA28 alpha/beta is dispensable to meet the demand of increased peptide hydrolysis capacity by the proteasome during viral myocarditis.	[Respondek, Dorota; Voss, Martin; Kuehlewindt, Ina; Krueger, Elke; Beling, Antje] Charite Univ Med Berlin, Inst Biochem, Berlin, Germany; [Respondek, Dorota; Voss, Martin; Beling, Antje] DZHK German Ctr Cardiovasc Res, Partner Side Berlin, Berlin, Germany; [Klingel, Karin] Univ Klinikum Tubingen, Inst Mol Pathol, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Beling, A (corresponding author), Charite Univ Med Berlin, Inst Biochem, Berlin, Germany.; Beling, A (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Side Berlin, Berlin, Germany.	antje.beling@charite.de	Beling, Antje/AAW-5380-2020; Krueger, Elke/B-1462-2012	Krueger, Elke/0000-0002-2551-242X; Beling, Antje/0000-0002-1826-5248	Foundation for Experimental Biomedicine Zurich, Switzerland; Sonnenfeld foundation Berlin; DFG [VO 1602/2-1, KR 1915/6-1, SFB740]; COST BM1307 Proteostasis	Foundation for Experimental Biomedicine Zurich, Switzerland; Sonnenfeld foundation Berlin; DFG(German Research Foundation (DFG)); COST BM1307 Proteostasis	AB is supported by the Foundation for Experimental Biomedicine Zurich, Switzerland. DR was supported by a PhD scholarship from Sonnenfeld foundation Berlin. This project was granted by DFG VO 1602/2-1 to AB, KR 1915/6-1, SFB740 B3 and COST BM1307 Proteostasis to EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Berkers CR, 2012, MOL PHARMACEUT, V9, P1126, DOI 10.1021/mp2004143; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Cascio P, 2014, BIOMOLECULES, V4, P566, DOI 10.3390/biom4020566; Cornell CT, 2007, J VIROL, V81, P6785, DOI 10.1128/JVI.00198-07; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Dantuma NP, 2010, CARDIOVASC RES, V85, P263, DOI 10.1093/cvr/cvp255; de Graaf N, 2011, EUR J IMMUNOL, V41, P926, DOI 10.1002/eji.201041040; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Ersching J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005698; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Gao G, 2008, AM J PHYSIOL-HEART C, V295, pH401, DOI 10.1152/ajpheart.00292.2008; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hernebring M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01381; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Jakel S, 2009, AM J PATHOL, V175, P510, DOI 10.2353/ajpath.2009.090033; Keller M, 2015, EUR J IMMUNOL, V45, P3257, DOI 10.1002/eji.201445243; Kemball CC, 2008, J VIROL, V82, P4331, DOI 10.1128/JVI.02639-07; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kirschner F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153847; Klingel K, 2003, AM J PATHOL, V162, P1709, DOI 10.1016/S0002-9440(10)64305-2; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kuehn L, 1996, ARCH BIOCHEM BIOPHYS, V329, P87, DOI 10.1006/abbi.1996.0195; Li J, 2001, BIOCHIMIE, V83, P373, DOI 10.1016/S0300-9084(01)01236-6; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Luo HL, 2003, AM J PATHOL, V163, P381, DOI 10.1016/S0002-9440(10)63667-X; MA CP, 1992, J BIOL CHEM, V267, P10515; Macagno A, 2001, EUR J IMMUNOL, V31, P3271, DOI 10.1002/1521-4141(200111)31:11<3271::AID-IMMU3271>3.0.CO;2-2; Mishto M, 2014, EUR J IMMUNOL, V44, P3508, DOI 10.1002/eji.201444902; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Paeschke A, 2016, EUR J IMMUNOL, V46, P619, DOI 10.1002/eji.201545892; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rahnefeld A, 2014, CIRCULATION, V130, P1589, DOI 10.1161/CIRCULATIONAHA.114.009847; Raule M, 2014, CHEM BIOL, V21, P470, DOI 10.1016/j.chembiol.2014.02.006; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Schwarz K, 2000, J IMMUNOL, V165, P768, DOI 10.4049/jimmunol.165.2.768; Seeger M, 1997, J BIOL CHEM, V272, P8145, DOI 10.1074/jbc.272.13.8145; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Spur EM, 2016, TOXICOLOGY, V353, P34, DOI 10.1016/j.tox.2016.04.010; Stohwasser R, 2003, BIOL CHEM, V384, P39, DOI 10.1515/BC.2003.005; Stohwasser R, 2000, EUR J BIOCHEM, V267, P6221, DOI 10.1046/j.1432-1327.2000.01706.x; Strehl B, 2008, J BIOL CHEM, V283, P17891, DOI 10.1074/jbc.M710042200; Sun Y, 2002, CANCER RES, V62, P2875; Szalay G, 2006, AM J PATHOL, V168, P1542, DOI 10.2353/ajpath.2006.050865; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Verdoes M, 2006, CHEM BIOL, V13, P1217, DOI 10.1016/j.chembiol.2006.09.013; Voigt A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00042; Voigt A, 2010, AMINO ACIDS, V39, P243, DOI 10.1007/s00726-009-0434-5; Wessely R, 2001, CIRCULATION, V103, P756; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Zhang ZG, 1999, BIOCHEMISTRY-US, V38, P5651, DOI 10.1021/bi990056+	60	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173259	10.1371/journal.pone.0173259	http://dx.doi.org/10.1371/journal.pone.0173259			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278207	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900063
J	Ito, T; Murai, M; Ninokura, S; Kitazumi, Y; Mezic, KG; Cress, BF; Koffas, MAG; Morgan, JE; Barquera, B; Miyoshi, H				Ito, Takeshi; Murai, Masatoshi; Ninokura, Satoshi; Kitazumi, Yuki; Mezic, Katherine G.; Cress, Brady F.; Koffas, Mattheos A. G.; Morgan, Joel E.; Barquera, Blanca; Miyoshi, Hideto			Identification of the binding sites for ubiquinone and inhibitors in the Na+-pumping NADH-ubiquinone oxidoreductase from Vibrio cholerae by photoaffinity labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; QUINONE OXIDOREDUCTASE; NADHQUINONE OXIDOREDUCTASE; SACCHAROMYCES-CEREVISIAE; BC(1) COMPLEX; NQRC SUBUNITS; ALGINOLYTICUS; REDUCTASE; KORORMICIN; DEHYDROGENASE	The Na+-pumping NADH-quinone oxidoreductase (Na+-NQR) is the first enzyme of the respiratory chain and the main ion transporter in many marine and pathogenic bacteria, including Vibrio cholerae. The V. cholerae Na+-NQR has been extensively studied, but its binding sites for ubiquinone and inhibitors remain controversial. Here, using a photoreactive ubiquinone PUQ-3 as well as two aurachin-type inhibitors [I-125] PAD-1 and [I-125] PAD-2 and photoaffinity labeling experiments on the isolated enzyme, we demonstrate that the ubiquinone ring binds to the NqrA subunit in the regions Leu-32Met- 39 and Phe-131-Lys-138, encompassing the rear wall of a predicted ubiquinone-binding cavity. The quinolone ring and alkyl side chain of aurachin bound to the NqrB subunit in the regions Arg-43-Lys-54 and Trp-23-Gly-89, respectively. These results indicate that the binding sites for ubiquinone and aurachin- type inhibitors are in close proximity but do not overlap one another. Unexpectedly, although the inhibitory effects of PAD-1 and PAD-2 were almost completely abolished by certain mutations in NqrB (i. e. G140A and E144C), the binding reactivities of [I-125] PAD-1 and [I-125] PAD-2 to the mutated enzymes were unchanged compared with those of the wild-type enzyme. We also found that photoaffinity labeling by [I-125] PAD-1 and [I-125] PAD-2, rather than being competitively suppressed in the presence of other inhibitors, is enhanced undersomeexperimental conditions. To explain these apparently paradoxical results, we propose models for the catalytic reaction of Na+-NQR and its interactions with inhibitors on the basis of the biochemical and biophysical results reported here and in previous work.	[Ito, Takeshi; Murai, Masatoshi; Ninokura, Satoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Mezic, Katherine G.; Koffas, Mattheos A. G.; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Cress, Brady F.; Koffas, Mattheos A. G.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Mezic, Katherine G.; Cress, Brady F.; Koffas, Mattheos A. G.; Morgan, Joel E.; Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Kyoto University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Miyoshi, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	miyoshi@kais.kyoto-u.ac.jp	Cress, Brady F/G-9823-2011	Cress, Brady F/0000-0002-2948-2846; Miyoshi, Hideto/0000-0002-1792-554X; Koffas, Mattheos/0000-0002-1405-0565; Murai, Masatoshi/0000-0001-6601-2854; Ito, Takeshi/0000-0001-7739-8705	Japan Society for the Promotion of Science [26292060, 15K07411, 16J02535]; Grants-in-Aid for Scientific Research [15K07411, 16J02535] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 26292060 (to H. M.), 15K07411 (to M. M.), and 16J02535 (to T. I.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Casutt MS, 2012, BBA-BIOENERGETICS, V1817, P1817, DOI 10.1016/j.bbabio.2012.02.012; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Murai M, 2017, BIOCHEMISTRY-US, V56, P570, DOI 10.1021/acs.biochem.6b01011; Murai M, 2014, BIOCHEMISTRY-US, V53, P3995, DOI 10.1021/bi500347s; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Omori A, 2002, ELECTROPHORESIS, V23, P4167, DOI 10.1002/elps.200290034; Sakamoto K, 2002, J PESTIC SCI, V27, P147; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Strickland M, 2014, J BIOL CHEM, V289, P23723, DOI 10.1074/jbc.M114.574640; Tebben J, 2014, MAR DRUGS, V12, P2802, DOI 10.3390/md12052802; Tuz K, 2017, J BIOL CHEM, V292, P3039, DOI [10.1074/jbc.M116.770982, 10.1074/jbc.m116.770982]; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Yoshikawa K, 1997, J ANTIBIOT, V50, P949, DOI 10.7164/antibiotics.50.949; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182	35	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7727	7742		10.1074/jbc.M117.781393	http://dx.doi.org/10.1074/jbc.M117.781393			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28298441	Green Published, hybrid			2022-12-26	WOS:000401154100003
J	Rigoldi, F; Metrangolo, P; Redaelli, A; Gautieri, A				Rigoldi, Federica; Metrangolo, Pierangelo; Redaelli, Alberto; Gautieri, Alfonso			Nanostructure and stability of calcitonin amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; amyloid; molecular dynamics; protein misfolding; protein-protein interaction	MOLECULAR-DYNAMICS SIMULATION; SOLID-STATE NMR; FIBRIL FORMATION; PEPTIDE NANOTUBES; C-13 NMR; OLIGOMERIZATION; SPECTROSCOPY; RESIDUES; SEQUENCE; PARALLEL	Calcitonin is a 32-amino acid thyroid hormone that can form amyloid fibrils. The structural basis of the fibril formation and stabilization is still debated and poorly understood. The reason is that NMR data strongly suggest antiparallel -sheet calcitonin assembly, whereas modeling studies on the short DFNKF peptide (corresponding to the sequence from Asp(15) to Phe(19) of human calcitonin and reported as the minimal amyloidogenic module) show that it assembles with parallel -sheets. In this work, we first predict the structure of human calcitonin through two complementary molecular dynamics (MD) methods, finding that human calcitonin forms an -helix. We use extensive MD simulations to compare previously proposed calcitonin fibril structures. We find that two conformations, the parallel arrangement and one of the possible antiparallel structures (with Asp(15) and Phe(19) aligned), are highly stable and ordered. Nonetheless, fibrils with parallel molecules show bulky loops formed by residues 1 to 7 located on the same side, which could limit or prevent the formation of larger amyloids. We investigate fibrils formed by the DFNKF peptide by simulating different arrangements of this amyloidogenic core sequence. We show that DFNKF fibrils are highly stable when assembled in parallel -sheets, whereas they quickly unfold in antiparallel conformation. Our results indicate that the DFNKF peptide represents only partially the full-length calcitonin behavior. Contrary to the full-length polypeptide, in fact, the DFNKF sequence is not stable in antiparallel conformation, suggesting that the residue flanking the amyloidogenic peptide contributes to the stabilization of the experimentally observed antiparallel -sheet packing.	[Rigoldi, Federica; Redaelli, Alberto; Gautieri, Alfonso] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy; [Metrangolo, Pierangelo] Politecn Milan, Dipartimento Chim Mat & Ingn Chim Giulio Natta, Via L Mancinelli 7, I-20131 Milan, Italy; [Metrangolo, Pierangelo] VTT Tecn Res Ctr Finland, Biologinkuja 7, Espoo 02150, Finland	Polytechnic University of Milan; Polytechnic University of Milan	Gautieri, A (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.	alfonso.gautieri@polimi.it	redaelli, alberto/K-3137-2018	redaelli, alberto/0000-0002-9020-2188; METRANGOLO, PIERANGELO/0000-0002-7945-099X	Fondazione Cariplo [2013-0766, 2016-0481]; European Research Council (ERC) [FOLDHALO 307108]	Fondazione Cariplo(Fondazione Cariplo); European Research Council (ERC)(European Research Council (ERC))	This work was supported by Fondazione Cariplo Grants 2013-0766 and 2016-0481. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Research Council (ERC) starting grant FOLDHALO 307108.	Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Andreotti G, 2011, J BIOL CHEM, V286, P2707, DOI 10.1074/jbc.M110.182014; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; Bertolani A., 2016, CHEMISTRY, V23, P2051; Bertolani A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8574; Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w; Du AW, 2014, BIOMACROMOLECULES, V15, P1097, DOI 10.1021/bm500169p; Fichman G, 2014, NANOMATERIALS-BASEL, V4, P726, DOI 10.3390/nano4030726; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gautieri A, 2014, MATRIX BIOL, V34, P89, DOI 10.1016/j.matbio.2013.09.004; Gautieri A, 2010, J MOL MODEL, V16, P1845, DOI 10.1007/s00894-010-0687-7; Guo CA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13556; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Haspel N, 2005, J MOL BIOL, V345, P1213, DOI 10.1016/j.jmb.2004.11.002; Hauser CAE, 2014, CHEM SOC REV, V43, P5326, DOI 10.1039/c4cs00082j; Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itoh-Watanabe H, 2013, PHYS CHEM CHEM PHYS, V15, P8890, DOI 10.1039/c3cp44544e; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamihira M, 2003, J BIOL CHEM, V278, P2859, DOI 10.1074/jbc.M205285200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Nair AK, 2014, BIOMACROMOLECULES, V15, P2494, DOI 10.1021/bm5003416; Naito A, 2004, MAGN RESON CHEM, V42, P247, DOI 10.1002/mrc.1323; Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Reches M, 2005, ISR J CHEM, V45, P363, DOI 10.1560/5MC0-V3DX-KE0B-YF3J; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tsai HH, 2005, P NATL ACAD SCI USA, V102, P8174, DOI 10.1073/pnas.0408653102; Tsai HH, 2004, BIOPHYS J, V87, P146, DOI 10.1529/biophysj.104.040352; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367	38	14	14	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7348	7357		10.1074/jbc.M116.770271	http://dx.doi.org/10.1074/jbc.M116.770271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28283568	hybrid, Green Published			2022-12-26	WOS:000400761300007
J	Lee, H; Smith, SB; Yoon, Y				Lee, Hakjoo; Smith, Sylvia B.; Yoon, Yisang			The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT OPTIC ATROPHY; M-AAA PROTEASE; INNER-MEMBRANE-FUSION; PROTEOLYTIC CLEAVAGE; OXIDATIVE-PHOSPHORYLATION; INTERMEMBRANE SPACE; CELL-PROLIFERATION; MAMMALIAN-CELLS; OMA1 PROTEASE; FISSION	The protein optic atrophy 1 (OPA1) is a dynamin-related protein associated with the inner mitochondrial membrane and functions in mitochondrial inner membrane fusion and cristae maintenance. Inner membrane-anchored long OPA1 (L-OPA1) undergoes proteolytic cleavage resulting in short OPA1 (S-OPA1). It is often thought that S-OPA1 is a functionally insignificant proteolytic product of L-OPA1 because the accumulation of S-OPA1 due to L-OPA1 cleavage is observed in mitochondrial fragmentation and dysfunction. However, cells contain a mixture of both L-and S-OPA1 in normal conditions, suggesting the functional significance of maintaining both OPA1 forms, but the differential roles of L-and S-OPA1 in mitochondrial fusion and energetics are ill-defined. Here, we examined mitochondrial fusion and energetic activities in cells possessing L-OPA1 alone, S-OPA1 alone, or both L-and S-OPA1. Using a mitochondrial fusion assay, we established that L-OPA1 confers fusion competence, whereas S-OPA1 does not. Remarkably, we found that S-OPA1 alone without L-OPA1 can maintain oxidative phosphorylation function as judged by growth in oxidative phosphorylation-requiring media, respiration measurements, and levels of the respiratory complexes. Most strikingly, S-OPA1 alone maintained normal mitochondrial cristae structure, which has been commonly assumed to be the function of OPA1 oligomers containing both L-and S-OPA1. Furthermore, we found that the GTPase activity of OPA1 is critical for maintaining cristae tightness and thus energetic competency. Our results demonstrate that, contrary to conventional notion, S-OPA1 is fully competent for maintaining mitochondrial energetics and cristae structure.	[Lee, Hakjoo; Yoon, Yisang] Augusta Univ, Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA; [Smith, Sylvia B.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Yoon, Y (corresponding author), Augusta Univ, Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	yyoon@augusta.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	American Heart Association [16GRNT31170032]; National Institutes of Health [R01 EY012830]; NATIONAL EYE INSTITUTE [R01EY012830] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by American Heart Association Grant 16GRNT31170032 (to Y. Y.) and National Institutes of Health Grant R01 EY012830 (to S. B. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; Barrera M, 2016, FEBS LETT, V590, P3309, DOI 10.1002/1873-3468.12384; Bavelloni A, 2015, IUBMB LIFE, V67, P239, DOI 10.1002/iub.1366; Bohovych I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13989; Cabodevilla AG, 2013, J BIOL CHEM, V288, P27777, DOI 10.1074/jbc.M113.466656; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Desmurs M, 2015, MOL CELL BIOL, V35, P1139, DOI 10.1128/MCB.01047-14; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Galloway CA, 2012, J GEN PHYSIOL, V139, P455, DOI 10.1085/jgp.201210771; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Houstek J, 2004, BBA-BIOENERGETICS, V1658, P115, DOI 10.1016/j.bbabio.2004.04.012; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kushnareva YE, 2013, CELL DEATH DIFFER, V20, P353, DOI 10.1038/cdd.2012.128; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; MacVicar TDB, 2014, J CELL SCI, V127, P2313, DOI 10.1242/jcs.144337; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Rainbolt TK, 2013, CELL METAB, V18, P908, DOI 10.1016/j.cmet.2013.11.006; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wang L, 2015, CARDIOVASC RES, V106, P272, DOI 10.1093/cvr/cvv005; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Yoon Yisang, 2005, Sci STKE, V2005, ppe18, DOI 10.1126/stke.2802005pe18; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933	76	103	112	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7115	7130		10.1074/jbc.M116.762567	http://dx.doi.org/10.1074/jbc.M116.762567			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28298442	Green Published, hybrid			2022-12-26	WOS:000400478300022
J	Nelson, SM; Gao, YT; Nogueira, LM; Shen, MC; Wang, BS; Rashid, A; Hsing, AW; Koshiol, J				Nelson, Shakira M.; Gao, Yu-Tang; Nogueira, Leticia M.; Shen, Ming-Chang; Wang, Bingsheng; Rashid, Asif; Hsing, Ann W.; Koshiol, Jill			Diet and biliary tract cancer risk in Shanghai, China	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GALLBLADDER CANCER; GASTRIC-CANCER; INFLAMMATION; GALLSTONES; MARKERS; ASSOCIATION; PATTERNS; METAANALYSIS; BIOMARKERS	Trends in biliary tract cancer incidence rates have increased in Shanghai, China. These trends have coincided with economic and developmental growth, as well as a shift in dietary patterns to a more Westernized diet. To examine the effect of dietary changes on incident disease, we evaluated associations between diet and biliary tract cancers amongst men and women from a population-based case-control study in Shanghai, China. Biliary tract cancer cases were recruited from 42 collaborating hospitals in urban Shanghai, and population -based controls were randomly selected from the Shanghai Household Registry. Food frequency questionnaire data were available for 225 gallbladder, 190 extrahepatic bile duct, and 68 ampulla of Vater cancer cases. A total of 39 food groups were created and examined for associations with biliary tract cancer. Interestingly, only four food groups demonstrated a suggested association with gallbladder, extrahepatic bile duct, or ampulla of Vater cancers. The allium food group, consisting of onions, garlic, and shallots showed an inverse association with gallbladder cancer (OR: 0.81, 95% CI: 0.68-0.97). Similar trends were seen in the food group containing seaweed and kelp (OR: 0.79, 95% CI: 0.67-0.96). In contrast, both preserved vegetables and salted meats food groups showed positive associations with gallbladder cancer (OR:1.27, 95% CI: 1.06-1.52; OR: 1.18, 95% CI: 1.02-1.37, respectively). Each of these four food groups showed similar trends for extrahepatic bile duct and ampulla of Vater cancers. The results of our analysis suggest intake of foods with greater anti-inflammatory properties may play a role in decreasing the risk of biliary tract cancers. Future studies should be done to better understand effects of cultural changes on diet, and to further examine the impact diet and inflammation have on biliary tract cancer incidence.	[Nelson, Shakira M.; Nogueira, Leticia M.] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, Rockville, MD 20892 USA; [Nelson, Shakira M.] NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Nogueira, Leticia M.] Texas Dept State Hlth Serv, Texas Canc Registry, Canc Epidemiol & Surveillance Branch, Austin, TX USA; [Shen, Ming-Chang] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Wang, Bingsheng] Fudan Univ, Sch Med, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Rashid, Asif] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hsing, Ann W.] Stanford Canc Inst, Palo Alto, CA USA; [Hsing, Ann W.] Stanford Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA USA; [Koshiol, Jill] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Shanghai Jiao Tong University; Texas Department of State Health Services; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center; Stanford Cancer Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nelson, SM (corresponding author), NCI, Canc Prevent Fellowship Program, Canc Prevent Div, Rockville, MD 20892 USA.; Nelson, SM (corresponding author), NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA.	shakira.nelson@nih.gov	Stefanadis, Christodoulos/ABH-2232-2020; Nogueira, Leticia/J-2547-2019; gao, yi/HCI-8298-2022; koshiol, Jill/L-8686-2014; Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; koshiol, Jill/0000-0002-3832-6204; 	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG); NATIONAL CANCER INSTITUTE [ZIACP010218] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by general funds from the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; [Anonymous], 1993, IARC MONOGRAPHS EVAL, V56, P83; [Anonymous], 2012, IARC MONOGR EVAL CAR, V100, P1, DOI DOI 10.1016/S1470-2045(09)70096-8; Barbaresko J, 2013, NUTR REV, V71, P511, DOI 10.1111/nure.12035; Bradbury KE, 2014, AM J CLIN NUTR, V100, p394S, DOI 10.3945/ajcn.113.071357; Chiu BCH, 2003, CANCER EPIDEM BIOMAR, V12, P201; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Duan XJ, 2006, FOOD CHEM, V95, P37, DOI 10.1016/j.foodchem.2004.12.015; Eichholzer M, 1998, NUTR REV, V56, P95; Esmaillzadeh A, 2007, J NUTR, V137, P992, DOI 10.1093/jn/137.4.992; Galland L, 2010, NUTR CLIN PRACT, V25, P634, DOI 10.1177/0884533610385703; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Hsing AW, 2008, BRIT J CANCER, V99, P811, DOI 10.1038/sj.bjc.6604616; Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047; Hsing AW, 2008, CANCER RES, V68, P6442, DOI 10.1158/0008-5472.CAN-08-0444; Hsing AW, 2002, J NATL CANCER I, V94, P1648, DOI 10.1093/jnci/94.21.1648; Islami F, 2009, BRIT J CANCER, V101, P1641, DOI 10.1038/sj.bjc.6605372; Jain K, 2013, INT J CANCER, V132, P1660, DOI 10.1002/ijc.27777; Kantor ED, 2012, AM J EPIDEMIOL, V176, P1002, DOI 10.1093/aje/kws186; KATO I, 1990, JPN J CANCER RES, V81, P578, DOI 10.1111/j.1349-7006.1990.tb02612.x; KATO K, 1989, JPN J CANCER RES, V80, P932, DOI 10.1111/j.1349-7006.1989.tb01629.x; Koshiol J, 2016, CYTOKINE, V83, P217, DOI 10.1016/j.cyto.2016.05.003; Kumar R, 2013, DIABET METAB SYND OB, V6, P49, DOI 10.2147/DMSO.S38888; Lim SN, 2002, J AGR FOOD CHEM, V50, P3862, DOI 10.1021/jf020096b; Liu EJ, 2005, CANCER EPIDEM BIOMAR, V14, P1315, DOI 10.1158/1055-9965.EPI-05-0032; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; MOERMAN CJ, 1993, INT J EPIDEMIOL, V22, P207, DOI 10.1093/ije/22.2.207; Nanri A, 2007, ASIAN PAC J CANCER P, V8, P167; Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369, DOI 10.1093/ajcn/83.6.1369; Nicastro HL, 2015, CANCER PREV RES, V8, P181, DOI 10.1158/1940-6207.CAPR-14-0172; Park M, 2014, PREV MED, V65, P13, DOI 10.1016/j.ypmed.2014.03.027; Qin Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-948; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; Ren JS, 2012, CANCER EPIDEM BIOMAR, V21, P905, DOI 10.1158/1055-9965.EPI-12-0202; Scott TE, 1999, DIGEST DIS SCI, V44, P1619, DOI 10.1023/A:1026675329644; Shen J, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/178675; Shukla VK, 2004, EUR J CANCER PREV, V13, P355, DOI 10.1097/01.cej.0000137514.48974.89; Takata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056963; Tamrakar D, 2016, Asian Pac J Cancer Prev, V17, P3447; Tewari M, 2006, J SURG ONCOL, V93, P629, DOI 10.1002/jso.20529; Tsugane S, 2004, BRIT J CANCER, V90, P128, DOI 10.1038/sj.bjc.6601511; Vidyashankar S, 2009, BRIT J NUTR, V101, P1621, DOI 10.1017/S0007114508118748; Wernberg JA, 2014, SURG CLIN N AM, V94, P343, DOI 10.1016/j.suc.2014.01.009; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Zhang XH, 2006, INT J CANCER, V118, P3089, DOI 10.1002/ijc.21748	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173935	10.1371/journal.pone.0173935	http://dx.doi.org/10.1371/journal.pone.0173935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288186	Green Submitted, Green Published, gold			2022-12-26	WOS:000396092400043
J	Hemat, H; Shah, S; Isaakidis, P; Das, M; Kyaw, NTT; Zaheer, S; Qasemy, AQ; Zakir, M; Mahama, G; Van Overloop, C; Dominguez, L				Hemat, Hamayoun; Shah, Safieh; Isaakidis, Petros; Das, Mrinalini; Kyaw, Nang Thu Thu; Zaheer, Sattar; Qasemy, Abdul Qayeum; Zakir, Mutallib; Mahama, Gbane; Van Overloop, Catherine; Dominguez, Lynette			Before the bombing: High burden of traumatic injuries in Kunduz Trauma Center, Kunduz, Afghanistan	PLOS ONE			English	Article								Background Me A decins Sans Frontieres (MSF) has been providing healthcare in Afghanistan since 1981 including specialized health services for trauma patients in Kunduz Trauma Center (KTC) from 2011. On October 3 rd, 2015, a US airstrike hit the KTC, killing 42 people including 14 MSF staff. This study aims to demonstrate the impact on healthcare provision, after hospital destruction, by assessing the extent of care provided for trauma and injuries by the MSF KTC and to report on treatment outcomes from January 2014 to June 2015, three months prior to the bombing. Methods This is a descriptive, retrospective review of hospital records. All patients with traumatic injuries registered in the Emergency Department (ED) or hospitalized in In-Patients Department (IPD) and/ or Intensive Care Unit (ICU) of KTC between January 2014 and June 2015 were included in the study. Results A total of 35647 patients were registered in KTC during the study period. 3199 patients registered in the ED were children aged < 5 years and 310 of them were admitted including 47 to the ICU. 77.5% patients were from Kunduz province and the remaining were from other provinces. The average length of stay was 7.3 days and 3.3 days while the bed occupancy rate was an average 91.1% and 75.8% in IPD and ICU, respectively. Of 4605 IPD patients, 105 (2.3%) developed complications. Among those admitted to the ICU, 12.6% patients died. About one-third surgical interventions were carried out on an urgent basis and the major proportion (45.8%) of surgical procedures was wound surgery followed by orthopedic surgery (27.0%). Conclusions This study highlights the high burden of traumatic injuries in Kunduz province and MSF Trauma Center's contribution to saving lives, preventing disabilities and alleviating suffering among adults and children within the region. The bombing and destruction of KTC has resulted in a specific gap in critical healthcare services for the local communities in the health system of this war-ravaged region. This suggests the urgent need for reconstruction and re-opening of the center.	[Hemat, Hamayoun; Mahama, Gbane] Medecins Sans Frontieres, Operat Ctr Brussels, Kabul, Afghanistan; [Shah, Safieh; Isaakidis, Petros] Medecins Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg; [Kyaw, Nang Thu Thu] Int Union TB & Lung Dis, Mandalay, Myanmar; [Zaheer, Sattar; Qasemy, Abdul Qayeum; Zakir, Mutallib] Medecins Sans Frontieres, Operat Ctr Brussels, Kunduz, Afghanistan; [Van Overloop, Catherine; Dominguez, Lynette] Medecins Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium	Doctors Without Borders; Doctors Without Borders	Hemat, H (corresponding author), Medecins Sans Frontieres, Operat Ctr Brussels, Kabul, Afghanistan.	msf-afghanistan-medcopdep@msf.org	Shah, Safieh/Z-2078-2018; Shah, Safieh/AAK-3257-2020; Shah, Safieh/ABB-4201-2021	Shah, Safieh/0000-0001-5358-9240; Shah, Safieh/0000-0001-5358-9240; Isaakidis, Petros/0000-0002-7881-1554	Department for International Development (DFID), UK	Department for International Development (DFID), UK	The programme was funded by the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, MISS HAITI TAB 2014, P5; [Anonymous], 2004, WOM CHILDR VULN ESC; [Anonymous], 1864, TREATIES STATES PART; [Anonymous], 2010, VIOLANCE INJURIES FA; Esmatia S, 2014, INDICATORS EVALUATIN, P1; Ghaferi AA, 2010, J AM COLL SURGEONS, V211, P325, DOI 10.1016/j.jamcollsurg.2010.04.025; Lucchi E, 2010, DISASTERS, V34, P973, DOI 10.1111/j.1467-7717.2010.01178.x; Meara JG, 2015, SURGERY, V158, P3, DOI [10.1016/j.surg.2015.04.011, 10.1016/S0140-6736(15)60160-X]; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	9	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0165270	10.1371/journal.pone.0165270	http://dx.doi.org/10.1371/journal.pone.0165270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282377	Green Published, gold			2022-12-26	WOS:000396091800001
J	Son, KJ; Choi, KR; Ryu, CK; Lee, SJ; Kim, HJ; Lee, H				Son, Keum-joo; Choi, Ki Ryung; Ryu, Chung-Kyu; Lee, Seog Jae; Kim, Ho Jeong; Lee, Hyunah			Induction of immunogenic cell death of tumors by newly synthesized heterocyclic quinone derivative	PLOS ONE			English	Article							CALRETICULIN EXPOSURE; CANCER; ACTIVATION; COMPLEXES; AGENTS; DRUGS; STAT3	Many cancer types are serious diseases causing mortality, and new therapeutics with improved efficacy and safety are required. Immuno-(cell)-therapy is considered as one of the promising therapeutic strategies for curing intractable cancer. In this study, we tested R2016, a newly developed heterocyclic quinone derivative, for induction of immunogenic tumor cell death and as a possible novel immunochemotherapeutic. We studied the anticancer effects of R2016 against LLC, a lung cancer cell line and B16F10, a melanoma cell line. LLC (non-immunogenic) and B16F10 (immunogenic) cells were killed by R2016 in dose-dependent manner. R2016 reduced the viability of both LLC and B16F10 tumor cells by inducing apoptosis and necrosis, while it demonstrated no cytotoxicity against normal splenocytes. Expression of immunogenic death markers on the cell surface of R2016 treated tumor cells including calreticulin (CRT) and heat shock proteins (HSPs) was increased along with the induction of their genes. Increased CRT expression correlated with dendritic cell (DC) uptake of dying tumor cells: the proportion of CRT(+)CD11c(+)cells was increased in the R2016-treated group. The gene transcription of Calr3, Hspb1, and Tnfaip6, which are related to immunogenicity induction of dead cells, was up-regulated in the R2016 treated tumor cells. On the other hand, ANGPT1, FGF7, and URGCP gene levels were down-regulated by R2016 treatment. This data suggests that R2016 induced immunogenic tumor cell death, and suggests R2016 as an effective anti-tumor immunochemotherapeutic modality.	[Son, Keum-joo; Choi, Ki Ryung; Lee, Hyunah] Pharmicell Co Ltd, R&D Ctr, Seongnam Si, Gyeonggi Do, South Korea; [Ryu, Chung-Kyu; Kim, Ho Jeong] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Ryu, Chung-Kyu; Kim, Ho Jeong] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lee, Seog Jae] Jeju Natl Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Jeju Si, Jeju Do, South Korea	Ewha Womans University; Ewha Womans University; Jeju National University	Lee, H (corresponding author), Pharmicell Co Ltd, R&D Ctr, Seongnam Si, Gyeonggi Do, South Korea.	andyjosh@pharmicell.com			National Research Foundation of Korea [2014R1A1A2055842]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the grant from National Research Foundation of Korea (#2014R1A1A2055842; http://www.nrf.re.kr; funded to HL and the salary of the first author [KS]. Pharmicell Co. Ltd., provided support in the form of salaries for authors [HL & KC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cirone M, 2012, ONCOIMMUNOLOGY, V1, P1218, DOI 10.4161/onci.20428; Cumaraswamy AA, 2012, MEDCHEMCOMM, V3, P22, DOI 10.1039/c1md00175b; Fucikova J, 2011, CANCER RES, V71, P4821, DOI 10.1158/0008-5472.CAN-11-0950; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garuti L, 2007, MINI-REV MED CHEM, V7, P481, DOI 10.2174/138955707780619626; GIORGIRENAULT S, 1985, EUR J MED CHEM, V20, P144; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Ioannis G, 2015, J CANC THER, V6, P709; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kusaba T, 2006, ONCOL REP, V15, P1445; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Martinez R, 2005, CURR MED CHEM, V12, P127, DOI 10.2174/0929867053363414; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oh Su-Jin, 2011, Immune Netw, V11, P383, DOI 10.4110/in.2011.11.6.383; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Pol J, 2015, ONCOIMMUNOL, V4; Rani A, 2016, J INTERF CYTOK RES, V36, P226, DOI 10.1089/jir.2015.0054; Ryu CK, 2011, BIOORG MED CHEM LETT, V21, P427, DOI 10.1016/j.bmcl.2010.10.124; Srinivas G, 2007, MED RES REV, V27, P591, DOI 10.1002/med.20095; Tandon VK, 2005, BIOORG MED CHEM LETT, V15, P3288, DOI 10.1016/j.bmcl.2005.04.066; Wong DYQ, 2015, ANGEW CHEM INT EDIT, V54, P6483, DOI 10.1002/anie.201500934; Yin WH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-15; Yolanda T. P, 1960, J AM CHEM SOC, V82, P1155; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	24	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173121	10.1371/journal.pone.0173121	http://dx.doi.org/10.1371/journal.pone.0173121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282460	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800017
J	Jimenez-Sanchez, C; Olivares-Vicente, M; Rodriguez-Perez, C; Herranz-Lopez, M; Lozano-Sanchez, J; Segura-Carretero, A; Fernandez-Gutierrez, A; Encinar, JA; Micol, V				Jimenez-Sanchez, Cecilia; Olivares-Vicente, Marilo; Rodriguez-Perez, Celia; Herranz-Lopez, Maria; Lozano-Sanchez, Jesus; Segura-Carretero, Antonio; Fernandez-Gutierrez, Alberto; Antonio Encinar, Jose; Micol, Vicente			AMPK modulatory activity of olive-tree leaves phenolic compounds: Bioassay-guided isolation on adipocyte model and in silico approach	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PLANT-DERIVED POLYPHENOLS; SIGNALING PATHWAY; ALTERNATE BEARING; PEEL EXTRACT; ADIPOGENESIS; QUERCETIN; OIL; DIFFERENTIATION; IDENTIFICATION	Scope Olive-tree polyphenols have demonstrated potential for the management of obesity-related pathologies. We aimed to explore the capacity of Olive-tree leaves extract to modulate triglyceride accumulation and AMP-activated protein kinase activity (AMPK) on a hypertrophic adipocyte model. Methods Intracellular triglycerides and AMPK activity were measured on the hypertrophic 3T3-L1 adipocyte model by AdipoRed and immunofluorescence microscopy, respectively. Reverse phase high performance liquid chromatography coupled to time-of-flight mass detection with electrospray ionization (RP-HPLC-ESI-TOF/MS) was used for the fractionation of the extract and the identification of the compounds. In-silico molecular docking of the AMPK alpha-2, beta and gamma subunits with the identified compounds was performed. Results Olive-tree leaves extract decreased the intracellular lipid accumulation through AMPK-dependent mechanisms in hypertrophic adipocytes. Secoiridoids, cinnamic acids, phenylethanoids and phenylpropanoids, flavonoids and lignans were the candidates predicted to account for this effect. Molecular docking revealed that some compounds may be AMPK-gamma modulators. The modulatory effects of compounds over the alpha and beta AMPK subunits appear to be less probable. Conclusions Olive-tree leaves polyphenols modulate AMPK activity, which may become a therapeutic aid in the management of obesity-associated disturbances. The natural occurrence of these compounds may have important nutritional implications for the design of functional ingredients.	[Jimenez-Sanchez, Cecilia; Rodriguez-Perez, Celia; Lozano-Sanchez, Jesus; Segura-Carretero, Antonio; Fernandez-Gutierrez, Alberto] Univ Granada, Dept Analyt Chem, Granada, Spain; [Jimenez-Sanchez, Cecilia; Rodriguez-Perez, Celia; Lozano-Sanchez, Jesus; Segura-Carretero, Antonio; Fernandez-Gutierrez, Alberto] PTS, Res & Dev Funct Food Ctr CIDAF, Granada, Spain; [Olivares-Vicente, Marilo; Herranz-Lopez, Maria; Antonio Encinar, Jose; Micol, Vicente] UMH, IBMC, Alicante, Spain; [Micol, Vicente] Inst Salud Carlos III, CIBER CB12 03 30038, Fisiopatol Obesidad & Nutr, CIBERobn, Palma De Mallorca, Spain	University of Granada; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Micol, V (corresponding author), UMH, IBMC, Alicante, Spain.; Micol, V (corresponding author), Inst Salud Carlos III, CIBER CB12 03 30038, Fisiopatol Obesidad & Nutr, CIBERobn, Palma De Mallorca, Spain.	vmicol@umh.es	Encinar, José A/F-2946-2013; Herranz-Lopez, Maria/AAB-1933-2020; Rodríguez-Pérez, Celia/R-7378-2019; Carretero, Antonio Segura/B-6867-2014; Encinar, José Antonio/AAE-9141-2020; Fernandez-Gutierrez, Alberto/M-8512-2014; Micol, Vicente/K-6841-2014	Encinar, José A/0000-0002-7219-3863; Herranz-Lopez, Maria/0000-0002-1819-7978; Rodríguez-Pérez, Celia/0000-0002-7233-6481; Carretero, Antonio Segura/0000-0002-5564-5338; Encinar, José Antonio/0000-0002-7219-3863; Fernandez-Gutierrez, Alberto/0000-0003-3647-2598; Micol, Vicente/0000-0001-8089-0696	Spanish Ministry of Science and Innovation [BFU2014-52433-C3-2-R, AGL2011-29857-C03-02]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2015-67995-C3-1-R, AGL2015-67995-C3-2-R, PTQ-13-06429, PTQ-14-07243, FPU AP2010-2793]; Andalusian Regional Government Council of Innovation and Science [P09-CTS-4564, P10-FQM-6563, P11-CTS-7625]; Generalitat Valenciana [PROMETEO/2016/006, ACIF/2016/230]; GIBER (Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III) [CB12/03/30038]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Andalusian Regional Government Council of Innovation and Science; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); GIBER (Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III)	This work was supported by the projects BFU2014-52433-C3-2-R, AGL2011-29857-C03-02 (Spanish Ministry of Science and Innovation); projects AGL2015-67995-C3-1-R, AGL2015-67995-C3-2-R, Torres Quevedo grants PTQ-13-06429 and PTQ-14-07243 and scholarship FPU AP2010-2793 from the Spanish Ministry of Economy and Competitiveness (MINECO); P09-CTS-4564, P10-FQM-6563 and P11-CTS-7625 grants from Andalusian Regional Government Council of Innovation and Science; PROMETEO/2016/006, and ACIF/2016/230 from Generalitat Valenciana; GIBER (CB12/03/30038, Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III).	[Anonymous], COLD SPRING HARB PRO; Encinar JA, 2015, DRUG DES DEV THER, V9, P5877, DOI 10.2147/DDDT.S93449; Barbier O, 2003, J BIOL CHEM, V278, P13975, DOI 10.1074/jbc.M300749200; Barrajon-Catalan E, 2014, ADV EXP MED BIOL, V824, P141, DOI 10.1007/978-3-319-07320-0_11; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; BORJA R, 1992, PROCESS BIOCHEM, V27, P231, DOI 10.1016/0032-9592(92)80023-V; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Casado-Diaz A, 2016, J NUTR BIOCHEM, V32, P151, DOI 10.1016/j.jnutbio.2016.03.005; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Corominas-Faja B, 2014, AGING-US, V6, P731, DOI 10.18632/aging.100691; Dundar E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-219; Fu SP, 2010, ANAL BIOANAL CHEM, V397, P643, DOI 10.1007/s00216-010-3604-0; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goodger JQD, 2009, PHYTOCHEMISTRY, V70, P1187, DOI 10.1016/j.phytochem.2009.06.004; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guinda A, 2015, LWT-FOOD SCI TECHNOL, V64, P431, DOI 10.1016/j.lwt.2015.05.001; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Herranz-Lopez M, 2015, PHYTOMEDICINE, V22, P605, DOI 10.1016/j.phymed.2015.03.015; Herranz-Lopez M, 2012, PHYTOMEDICINE, V19, P253, DOI 10.1016/j.phymed.2011.12.001; Hosny M, 2009, PHARMACOGN RES, V1, P91; Joven J, 2012, BBA-GEN SUBJECTS, V1820, P894, DOI 10.1016/j.bbagen.2012.03.020; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kang SI, 2012, BIOL PHARM BULL, V35, P223, DOI 10.1248/bpb.35.223; Kim J, 2010, PHYTOTHER RES, V24, P1543, DOI 10.1002/ptr.3186; Klen TJ, 2015, J AGR FOOD CHEM, V63, P3859, DOI 10.1021/jf506345q; Ko HJ, 2015, J FUNCT FOODS, V17, P271, DOI 10.1016/j.jff.2015.05.033; Kwon B, 2015, BIOCHIMIE, V118, P141, DOI 10.1016/j.biochi.2015.09.006; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lozano-Sanchez J, 2010, J AGR FOOD CHEM, V58, P9942, DOI 10.1021/jf101502q; Ma SZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07633; Gonzalez-Barroso MM, 2012, BBA-BIOENERGETICS, V1817, P1768, DOI 10.1016/j.bbabio.2012.02.019; MEAKINS GD, 1959, J CHEM SOC, P1044, DOI 10.1039/jr9590001044; Melguizo-Melguizo D, 2014, J FUNCT FOODS, V10, P192, DOI 10.1016/j.jff.2014.05.019; Menendez JA, 2013, CELL CYCLE, V12, P555, DOI 10.4161/cc.23756; Michel T, 2015, PHYTOCHEM LETT, V11, P424, DOI 10.1016/j.phytol.2014.12.020; Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006; Novikova DS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P127, DOI 10.1134/S0006297915020017; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Peralbo-Molina A, 2012, J AGR FOOD CHEM, V60, P11542, DOI 10.1021/jf302896m; Perez-Bonilla M, 2011, FOOD CHEM, V124, P36, DOI 10.1016/j.foodchem.2010.05.099; Quirantes-Pine R, 2013, PHYTOCHEM ANALYSIS, V24, P213, DOI 10.1002/pca.2401; Rigacci S, 2015, ONCOTARGET, V6, P35344, DOI 10.18632/oncotarget.6119; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Saimaru H, 2010, J NAT MED-TOKYO, V64, P139, DOI 10.1007/s11418-009-0383-z; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; She GM, 2008, J FOOD SCI, V73, pC476, DOI 10.1111/j.1750-3841.2008.00830.x; Siriwardhana N, 2013, J NUTR BIOCHEM, V24, P613, DOI 10.1016/j.jnutbio.2012.12.013; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; Sung J, 2016, J FUNCT FOODS, V20, P148, DOI 10.1016/j.jff.2015.10.024; Taamalli A, 2012, J AGR FOOD CHEM, V60, P791, DOI 10.1021/jf204233u; Taha MO, 2015, MED CHEM RES, V24, P616, DOI 10.1007/s00044-014-1168-9; Talhaoui N, 2015, J AGR FOOD CHEM, V63, P1722, DOI 10.1021/jf5058205; Talhaoui N, 2014, LWT-FOOD SCI TECHNOL, V58, P28, DOI 10.1016/j.lwt.2014.03.014; Toth G, 2015, IND CROP PROD, V67, P432, DOI 10.1016/j.indcrop.2015.01.077; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xiao N, 2014, PLANTA MED, V80, P993, DOI 10.1055/s-0034-1382864; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Yuan HD, 2011, INT J MOL MED, V27, P531, DOI 10.3892/ijmm.2011.620	64	21	21	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173074	10.1371/journal.pone.0173074	http://dx.doi.org/10.1371/journal.pone.0173074			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278224	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900043
J	Zhang, B; Huang, GY; Wang, YQ; He, HT; Ren, JD				Zhang, Bing; Huang, Guoyan; Wang, Yuqian; He, Haitao; Ren, Jiadong			Mining dynamic noteworthy functions in software execution sequences	PLOS ONE			English	Article							COMPLEX NETWORK; RANKING; NODES	As the quality of crucial entities can directly affect that of software, their identification and protection become an important premise for effective software development, management, maintenance and testing, which thus contribute to improving the software quality and its attack-defending ability. Most analysis and evaluation on important entities like codes-based static structure analysis are on the destruction of the actual software running. In this paper, from the perspective of software execution process, we proposed an approach to mine dynamic noteworthy functions (DNFM) in software execution sequences. First, accord-ing to software decompiling and tracking stack changes, the execution traces composed of a series of function addresses were acquired. Then these traces were modeled as execution sequences and then simplified so as to get simplified sequences (SFS), followed by the extraction of patterns through pattern extraction (PE) algorithm from SFS. After that, evalu-ating indicators inner-importance and inter-importance were designed to measure the note-worthiness of functions in DNFM algorithm. Finally, these functions were sorted by their noteworthiness. Comparison and contrast were conducted on the experiment results from two traditional complex network-based node mining methods, namely PageRank and DegreeRank. The results show that the DNFM method can mine noteworthy functions in software effectively and precisely.	[Zhang, Bing; Huang, Guoyan; Wang, Yuqian; He, Haitao; Ren, Jiadong] Yanshan Univ, Coll Informat Sci & Engn, Qinhuangdao, Hebei, Peoples R China; [Zhang, Bing; Huang, Guoyan; Wang, Yuqian; He, Haitao; Ren, Jiadong] Key Lab Comp Virtual Technol & Syst Integrat Hebe, Qinhuangdao, Hebei, Peoples R China	Yanshan University	Huang, GY (corresponding author), Yanshan Univ, Coll Informat Sci & Engn, Qinhuangdao, Hebei, Peoples R China.; Huang, GY (corresponding author), Key Lab Comp Virtual Technol & Syst Integrat Hebe, Qinhuangdao, Hebei, Peoples R China.	hgy@ysu.edu.cn		Zhang, Bing/0000-0002-9867-8439	National Natural Science Foundation of China [61472341, 61572420]; Natural Science Foundation of Hebei Province [F2014203152, F2016203330]; Graduate innovative Foundation of Hebei Province [2016SJBS010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Graduate innovative Foundation of Hebei Province	This work was supported by National Natural Science Foundation of China Award Number: 61472341, Recipient: Guoyan Huang; National Natural Science Foundation of China Award Number: 61572420, Recipient: Jiadong Ren; Natural Science Foundation of Hebei Province Award Number: F2014203152, Recipient: Jiadong Ren; Natural Science Foundation of Hebei Province Award Number: F2016203330, Recipient: Haitao He; and Graduate innovative Foundation of Hebei Province Award Number: 2016SJBS010, Recipient: Bing Zhang.; This work is supported by the National Natural Science Foundation of China under Grant No. 61472341, No. 61572420, the Natural Science Foundation of Hebei Province P. R. China under Grant No. F2014203152, No. F2016203330 and the Graduate innovative Foundation of Hebei Province under Grant No. 2016SJBS010. The authors are grateful to the valuable comments and suggestions of the reviewers.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alsayed A, 2015, CHAOS SOLITON FRACT, V72, P35, DOI 10.1016/j.chaos.2014.12.009; Bae J, 2014, PHYSICA A, V395, P549, DOI 10.1016/j.physa.2013.10.047; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Basaras P, 2013, COMPUTER, V46, P24, DOI 10.1109/MC.2013.75; Bhattacharya P, 2012, PROC INT CONF SOFTW, P419, DOI 10.1109/ICSE.2012.6227173; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cai KY, 2009, INFORM SCIENCES, V179, P1903, DOI 10.1016/j.ins.2009.01.011; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Du YX, 2015, CHAOS, V25, DOI 10.1063/1.4916215; Gao S, 2014, PHYSICA A, V403, P130, DOI 10.1016/j.physa.2014.02.032; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Hou G, 2012, WOR CONG SOFTW ENG, P9, DOI 10.1109/WCSE.2012.10; Huang GY, 2015, J COMPUTATIONAL INFO, V11, P1109; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Lan W, 2010, RES SOFTWARE CASCADI, P310, DOI [10.1109/MINES.2010.214, DOI 10.1109/MINES.2010.214]; Liu JG, 2013, PHYSICA A, V392, P4154, DOI 10.1016/j.physa.2013.04.037; Liu Y, 2016, CHAOS SOLITON FRACT, V86, P1, DOI 10.1016/j.chaos.2016.01.030; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ren JD, 2015, J COMPUTATIONAL INFO, V11, P3059; Ren JD, 2016, INT J INNOV COMPUT I, V12, P581; Wang B, 2014, ACTA METALL SIN, V50, P685, DOI 10.3724/SP.J.1037.2013.00733; Wang L, 2016, ONCOTARGET, V7, P7, DOI DOI 10.3389/FMICB.2016.00593; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xizhe Zhang, 2012, Information Computing and Applications. Proceedings of the Third International Conference, ICICA 2012, P59, DOI 10.1007/978-3-642-34062-8_8; Zhang XZ, 2011, COMPUTER SCI, V38, P242	32	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173244	10.1371/journal.pone.0173244	http://dx.doi.org/10.1371/journal.pone.0173244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278276	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900059
J	Deng, L; Tang, J; Yang, H; Cheng, C; Lu, S; Jiang, R; Sun, B				Deng, L.; Tang, J.; Yang, H.; Cheng, C.; Lu, S.; Jiang, R.; Sun, B.			MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway	ONCOGENE			English	Article							METASTASIS-ASSOCIATED PROTEIN-1; DOWN-REGULATION; BREAST-CANCER; C-MYC; EXPRESSION; CELLS; BIOMARKERS; EFFECTOR; PROMOTES; GENE	MTA1 is a metastasis-associated protein, which is essential to epithelial-to-mesenchymal transition (EMT). However, information concerning its up-and downstream regulation is rare. We investigated its upstream regulation and downstream effector in human hepatocellular carcinoma ( HCC). In total, 94 paired HCC and adjacent tissue samples were involved in the study, and the results indicated that decreased miR-30e levels were associated with increased MTA1 levels in human HCC. miR-30e exerted its regulation of MTA1 transcription by binding to its 3'-untranslated region, and was negatively associated with EMT. Furthermore, significantly higher expression of MTA1 was associated with overexpression of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ErbB2) in human HCC, and MTA1 can promote transcription of ErbB2 by binding with histone deacetylase 2 (HDAC2) and acting as a promoter. The EMT promotion effect caused by MTA1 largely depended on ErbB2, and reducing the activity of ErbB2 can significantly attenuate EMT promotion by causing overexpression of MTA1 both in vitro and in vivo. In general, downregulation of miR-30e can increase levels of MTA1 in human HCC, and furthermore promote cell invasion and metastasis by promoting ErbB2.	[Deng, L.; Tang, J.; Jiang, R.; Sun, B.] Nanjing Med Univ, Dept Liver Surg, Minist Hlth, Key Lab Living Donor Liver Transplantat,Affiliate, Nanjing, Jiangsu, Peoples R China; [Yang, H.] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China; [Cheng, C.; Lu, S.] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Jiang, R; Sun, B (corresponding author), Nanjing Med Univ, Key Lab Living Donor Liver Transplantat, Minist Hlth, Dept Liver Surg,Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.; Jiang, R; Sun, B (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	Jiangrq@njmu.edu.cn; sunbc@njmu.edu.cn	Jiang, Runqiu/T-8844-2018	Jiang, Runqiu/0000-0003-2720-1366	National Natural Science Foundation [81201880, 81201528, 81572370, 81430062]; Six talent peaks project in Jiangsu Province [2013-wsw-20]; National Key Research and Development Program of China [2016YFC0905900]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Six talent peaks project in Jiangsu Province; National Key Research and Development Program of China	This work was supported by grants from the National Natural Science Foundation (81201880 to LD, 81201528, 81572370 to RJ and 81430062 to BS), Six talent peaks project in Jiangsu Province (2013-wsw-20 to RJ). National Key Research and Development Program of China (2016YFC0905900 to BS).	Ahmad A, 2012, MOL CANCER THER, V11, P2193, DOI 10.1158/1535-7163.MCT-12-0232-T; Bhattacharya S, 2016, AM J PATHOL, V186, P242, DOI 10.1016/j.ajpath.2015.10.003; Bruning A, 2014, CANCER METAST REV, V33, P943, DOI 10.1007/s10555-014-9520-6; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Deng L, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0248-0; Gupta P, 2014, MOL ONCOL, V8, P1532, DOI 10.1016/j.molonc.2014.06.006; Hamatsu T, 2003, ONCOL REP, V10, P599; Hayes CN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030280; He Y, 2014, CANCER LETT, V344, P20, DOI 10.1016/j.canlet.2013.10.021; Jenndahl LE, 2005, INT J ONCOL, V27, P439; Levenson AS, 2014, CANCER METAST REV, V33, P929, DOI 10.1007/s10555-014-9519-z; Li D.S., 2012, INT J DISTRIB SENS N, V2012, P1, DOI DOI 10.1007/S11661-012-1269-3; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Nair SS, 2011, HEPATOLOGY, V54, P1388, DOI 10.1002/hep.24518; Pakala SB, 2011, ONCOGENE, V30, P2230, DOI 10.1038/onc.2010.608; Ryu SH, 2008, HEPATOLOGY, V47, P929, DOI 10.1002/hep.22124; Sen N, 2014, CANCER METAST REV, V33, P879, DOI 10.1007/s10555-014-9515-3; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; TOH Y, 1994, J BIOL CHEM, V269, P22958; van der Burg SH, 2016, NAT REV CANCER, V16, P219, DOI 10.1038/nrc.2016.16; Wang L., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1002/ASL2.454; Wang YR, 2016, HEPATOL RES, V46, P89, DOI 10.1111/hepr.12571; Xia Y, 2013, CELL PHYSIOL BIOCHEM, V32, P476, DOI 10.1159/000354452; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	26	29	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 13	2017	36	28					3976	3985		10.1038/onc.2016.491	http://dx.doi.org/10.1038/onc.2016.491			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FA3YD	28288133				2022-12-26	WOS:000405379900004
J	Fujiki, K; Inamura, H; Miyayama, T; Matsuoka, M				Fujiki, Kota; Inamura, Hisako; Miyayama, Takamitsu; Matsuoka, Masato			Involvement of Notch1 signaling in malignant progression of A549 cells subjected to prolonged cadmium exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-SECRETASE; BREAST-CANCER; PROLIFERATION; RECEPTOR; ACTIVATION; EXPRESSION; APOPTOSIS; INSIGHTS; PATHWAYS	Cadmium exposure is known to increase lung cancer risk, but the underlying molecular mechanisms in cadmium-stimulated progression of malignancy are unclear. Here, we examined the effects of prolonged cadmium exposure on the malignant progression of A549 human lung adenocarcinoma cells and the roles of Notch1, hypoxia-inducible factor 1 alpha (HIF-1 alpha), and insulin-like growth factor 1 receptor (IGF-1R)/Akt/extracellular signal-regulated kinase (ERK)/p70 S6 kinase 1 (S6K1) signaling pathways. Exposing A549 cells to 10 or 20 mu M cadmium chloride (CdCl2) for 9-15 weeks induced a high proliferative potential, the epithelial-mesenchymal transition (EMT), stress fiber formation, high cell motility, and resistance to antitumor drugs. Of note, the CdCl2 exposure increased the levels of the Notch1 intracellular domain and of the downstream Notch1 target genes Snail and Slug. Strikingly, siRNA-mediated Notch1 silencing partially suppressed the CdCl2-induced EMT, stress fiber formation, high cell motility, and antitumor drug resistance. In addition, we found that prolonged CdCl2 exposure induced reduction of E-cadherin in BEAS-2B human bronchial epithelial cells and antitumor drug resistance in H1975 human tumor-derived non-small-cell lung cancer cells depending on Notch1 signaling. Moreover, Notch1, HIF-1 alpha, and IGF-1R/Akt/ERK/S6K1 activated each other to induce EMT in the CdCl2-exposed A549 cells. These results suggest that Notch1, along with HIF-1 alpha and IGF-1R/Akt/ERK/S6K1 signaling pathways, promotes malignant progression stimulated by prolonged cadmium exposure in this lung adenocarcinoma model.	[Fujiki, Kota; Inamura, Hisako; Miyayama, Takamitsu; Matsuoka, Masato] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 1, Tokyo 1628666, Japan	Tokyo Women's Medical University	Fujiki, K (corresponding author), Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 1, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	bunnsidairoku@gmail.com	Miyayama, Takamitsu/N-6175-2017		Japan Society for the Promotion of Science KAKENHI [15K18910, 26460175]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26460175] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 15K18910 and 26460175 and a grant-in-aid for medicine from the Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Beveridge R, 2010, AM J IND MED, V53, P476, DOI 10.1002/ajim.20801; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Ding XB, 2011, INT J BIOL SCI, V7, P269, DOI 10.7150/ijbs.7.269; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Filosto S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023240; Fujiki K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.339; Gao XH, 2015, ENVIRON HEALTH PERSP, V123, P331, DOI 10.1289/ehp.1408234; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Hales EC, 2014, CELL SIGNAL, V26, P149, DOI 10.1016/j.cellsig.2013.09.021; HERNANDEZSANCHEZ C, 1995, J BIOL CHEM, V270, P29176, DOI 10.1074/jbc.270.49.29176; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P202, DOI 10.1179/oeh.2007.13.2.202; IARC, 2012, IARC MONOGR EVAL CAR, V100C, P121; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Kim TH, 2014, J PHARMACOL EXP THER, V349, P268, DOI 10.1124/jpet.113.207563; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Liu JT, 2014, BIOCHEM BIOPH RES CO, V444, P670, DOI 10.1016/j.bbrc.2014.01.164; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; National Toxicology Program (NTP), 2014, 13 NTP DEP HLTH HUM, P1; Person RJ, 2013, TOXICOL APPL PHARM, V273, P281, DOI 10.1016/j.taap.2013.06.013; Satarug S, 2006, TOHOKU J EXP MED, V208, P179, DOI 10.1620/tjem.208.179; Schwanbeck R, 2011, EUR J CELL BIOL, V90, P572, DOI 10.1016/j.ejcb.2010.10.004; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496; Sriuranpong V, 2001, CANCER RES, V61, P3200; Surolia R, 2015, AM J PHYSIOL-LUNG C, V309, pL280, DOI 10.1152/ajplung.00097.2015; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Villa JC, 2014, CELL REP, V8, P1077, DOI 10.1016/j.celrep.2014.07.028; Wael H, 2014, LUNG CANCER, V85, P131, DOI 10.1016/j.lungcan.2014.05.001; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033853; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; WHO INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V58, P119; World Health Organization (WHO), 2008, WHO GUID DRINK WAT Q, V1, P317; Wu WD, 2015, ENVIRON HEALTH PERSP, V123, P231, DOI 10.1289/ehp.1307379; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Yuan X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0087-z; Zhou J, 2004, CANCER RES, V64, P9041, DOI 10.1158/0008-5472.CAN-04-1437	49	31	31	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7942	7953		10.1074/jbc.M116.759134	http://dx.doi.org/10.1074/jbc.M116.759134			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302721	Green Published, hybrid			2022-12-26	WOS:000401154100021
J	Richards, R; Dempski, RE				Richards, Ryan; Dempski, Robert E.			Adjacent channelrhodopsin-2 residues within transmembranes 2 and 7 regulate cation selectivity and distribution of the two open states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydomonas; electrophysiology; gating; ion channel; optogenetics; Chlamydomonas reinhardtii	MOLECULAR-DYNAMICS SIMULATIONS; EMPIRICAL FORCE-FIELD; ION CONDUCTANCE; ALPHA-HELICES; THREONINE RESIDUES; PROTON AFFINITY; EXCITABLE CELLS; OPTICAL CONTROL; NUCLEIC-ACIDS; SCHIFF-BASE	Channelrhodopsin-2 (ChR2) is a light-activated channel that can conduct cations of multiple valencies down the electrochemical gradient. Under continuous light exposure, ChR2 transitions from a high-conducting open state (O1) to a low-conducting open state (O2) with differing ion selectivity. The molecular basis for the O1 O2 transition and how ChR2 modulates selectivity between states is currently unresolved. To this end, we used steered molecular dynamics, electrophysiology, and kinetic modeling to identify residues that contribute to gating and selectivity in discrete open states. Analysis of steered molecular dynamics experiments identified three transmembrane residues (Val-86, Lys-93, and Asn-258) that form a putative barrier to ion translocation. Kinetic modeling of photocurrents generated from ChR2 proteins with conservative mutations at these positions demonstrated that these residues contribute to cation selectivity (Val-86 and Asn-258), the transition between the two open states (Val-86), open channel stability, and the hydrogen-bonding network (K93I and K93N). These results suggest that this approach can be used to identify residues that contribute to the open-state transitions and the discrete ion selectivity within these states. With the rise of ChR2 use in optogenetics, it will be critical to identify residues that contribute to O1 or O2 selectivity and gating to minimize undesirable effects.	[Richards, Ryan; Dempski, Robert E.] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Dempski, RE (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	rdempski@wpi.edu			WPI; Extreme Science and Engineering Discovery Environment (XSEDE); National Science Foundation [1053575]	WPI; Extreme Science and Engineering Discovery Environment (XSEDE); National Science Foundation(National Science Foundation (NSF))	This work was supported by WPI and the Extreme Science and Engineering Discovery Environment (XSEDE) and by National Science Foundation Grant 1053575. The authors declare that they have no conflicts of interest with the contents of this article.	Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cui YB, 2011, BIOCHEM BIOPH RES CO, V412, P654, DOI 10.1016/j.bbrc.2011.08.019; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Gaiko O, 2013, BIOPHYS J, V104, P1230, DOI 10.1016/j.bpj.2013.02.013; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Isralewitz B, 1997, BIOPHYS J, V73, P2972, DOI 10.1016/S0006-3495(97)78326-7; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kruger J, 2011, CONCURR COMP-PRACT E, V23, P279, DOI 10.1002/cpe.1666; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lorenz-Fonfria VA, 2015, P NATL ACAD SCI USA, V112, pE5796, DOI 10.1073/pnas.1511462112; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MARTI T, 1991, J BIOL CHEM, V266, P6919; Nack M, 2012, FEBS LETT, V586, P1344, DOI 10.1016/j.febslet.2012.03.047; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; NINA M, 1995, BIOPHYS J, V68, P25, DOI 10.1016/S0006-3495(95)80184-0; Peralavarez-Marin A, 2004, J BIOL CHEM, V279, P16403, DOI 10.1074/jbc.M313988200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Richards R, 2015, SPRINGER SER BIOPHYS, V18, P361, DOI 10.1007/978-3-319-20149-8_15; Richards R, 2015, BIOCHEMISTRY-US, V54, P5665, DOI 10.1021/acs.biochem.5b00738; Richards R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050018; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Sattig T, 2013, ANGEW CHEM INT EDIT, V52, P9705, DOI 10.1002/anie.201301698; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Stefanescu RA, 2013, B MATH BIOL, V75, P2208, DOI 10.1007/s11538-013-9888-4; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Tajkhorshid E, 1999, J PHYS CHEM B, V103, P5581, DOI 10.1021/jp983742b; Tajkhorshid E, 2000, BIOPHYS J, V78, P683, DOI 10.1016/S0006-3495(00)76626-4; Tajkhorshid E, 1997, J PHYS CHEM B, V101, P8021, DOI 10.1021/jp971283t; Takemoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131094; Talathi SS, 2011, J COMPUT NEUROSCI, V31, P87, DOI 10.1007/s10827-010-0296-6; Volz P, 2016, J BIOL CHEM, V291, P17382, DOI 10.1074/jbc.M115.711200; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Watanabe HC, 2012, J BIOL CHEM, V287, P7456, DOI 10.1074/jbc.M111.320309; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Williams JC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003220; Yu J, 2006, STRUCTURE, V14, P1411, DOI 10.1016/j.str.2006.07.006; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	65	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7314	7326		10.1074/jbc.M116.770321	http://dx.doi.org/10.1074/jbc.M116.770321			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302720	Green Published, hybrid			2022-12-26	WOS:000400761300004
J	Esquerre, M; Bouillette-Marussig, M; Goubier, A; Momot, M; Gonindard, C; Keller, H; Navarro, A; Bissery, MC				Esquerre, Michael; Bouillette-Marussig, Myriam; Goubier, Anne; Momot, Marie; Gonindard, Christophe; Keller, Helene; Navarro, Astrid; Bissery, Marie-Christine			GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8(+) T cell responses leading to tumor regression	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; BORDETELLA-PERTUSSIS; ESTABLISHED TUMORS; CUTTING EDGE; IMIQUIMOD; IMMUNIZATION; ERADICATION; INFECTION; INNATE	Background Prophylactic vaccines are available for women and girls not yet infected with HPV, but women already infected with HPV need a treatment to prevent progression to high-grade cervical lesions and cancer. GTL001 is a bivalent therapeutic vaccine for eradicating HPVinfected cells that contains HPV16 E7 and HPV18 E7 both fused to detoxified adenylate cyclase from Bordetella pertussis, which binds specifically to CD11b(+) antigen-presenting cells. This study examined the ability of therapeutic vaccination with GTL001 adjuvanted with topical imiquimod cream to induce functional HPV16 E7-and HPV18 E7-specific CD8 + T cell responses. Methods Binding of GTL001 to human CD11b was assessed by a cell-based competition binding assay. Cellular immunogenicity of intradermal vaccination with GTL001 was assessed in C57BL/6 mice by enzyme-linked immunospot assay and in vivo killing assays. In vivo efficacy of GTL001 vaccination was investigated in the TC-1 murine HPV16 E7-expressing tumor model. Results GTL001 bound specifically to the human CD11b/CD18 receptor. GTL001 adjuvanted with topical 5% imiquimod cream induced HPV16 E7 and HPV18 E7-specific CD8(+) T cell responses. This CD8(+) T-cell response mediated in vivo killing of HPV E7-expressing cells. In the HPV16 E7-expressing tumor model, GTL001 adjuvanted with imiquimod but not imiquimod alone or a combination of unconjugated HPV16 E7 and HPV18 E7 caused complete tumor regression. Conclusions GTL001 adjuvanted with topical 5% imiquimod is immunogenic and induces HPV16 E7 and HPV18 E7-specific CD8(+) T cell responses that can kill HPV E7-expressing cells and eliminate HPV E7-expressing tumors.	[Esquerre, Michael; Goubier, Anne; Momot, Marie; Gonindard, Christophe; Keller, Helene; Navarro, Astrid] Genticel, Labege, France; [Bouillette-Marussig, Myriam; Bissery, Marie-Christine] Genticel, Paris, France; [Esquerre, Michael; Navarro, Astrid] Evotec, Toulouse, France; [Goubier, Anne] Tusk Therapeut, Meise, Belgium	Evotec	Bissery, MC (corresponding author), Genticel, Paris, France.	mcbissery@orange.fr			Genticel SA; Genticel	Genticel SA; Genticel	This study was funded by Genticel SA. All authors are or were employed by Genticel. Genticel provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adams S, 2008, J IMMUNOL, V181, P776, DOI 10.4049/jimmunol.181.1.776; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Berraondo P, 2007, CANCER RES, V67, P8847, DOI 10.1158/0008-5472.CAN-07-0321; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brun JL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.020; Dadaglio G, 2003, INT IMMUNOL, V15, P1423, DOI 10.1093/intimm/dxg144; Dadaglio G, 2014, J IMMUNOL, V193, P1787, DOI 10.4049/jimmunol.1302974; Fehres CM, 2014, EUR J IMMUNOL, V44, P2415, DOI 10.1002/eji.201344094; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Frazer IH, 2009, VIROLOGY, V384, P410, DOI 10.1016/j.virol.2008.10.004; Gotovtseva EP, 2008, SEX TRANSM DIS, V35, P346, DOI 10.1097/OLQ.0b013e31815ea8d1; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawana Kei, 2012, Open Virol J, V6, P264, DOI 10.2174/1874357901206010264; Khallouf H, 2014, VACCINES-BASEL, V2, P422, DOI 10.3390/vaccines2020422; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lin KY, 1996, CANCER RES, V56, P21; Morrow MP, 2013, EXPERT REV VACCINES, V12, P271, DOI [10.1586/ERV.13.23, 10.1586/erv.13.23]; Tran NP, 2014, RECENT RESULTS CANC, V193, P149, DOI 10.1007/978-3-642-38965-8_9; Preville X, 2005, CANCER RES, V65, P641; Preville X, 2005, INVENTORSRECOMBINANT; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; Schlecht G, 2004, J IMMUNOL, V173, P6089, DOI 10.4049/jimmunol.173.10.6089; Schon MP, 2007, BRIT J DERMATOL, V157, P8, DOI 10.1111/j.1365-2133.2007.08265.x; Simsova M, 2004, INT J MED MICROBIOL, V293, P571, DOI 10.1078/1438-4221-00291; Stanley M, 2012, VACCINE, V30, pF83, DOI 10.1016/j.vaccine.2012.04.106; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; Stern PL, 2012, VACCINE, V30, pF71, DOI 10.1016/j.vaccine.2012.05.091; Van Damme P, CLIN CANC RES OFFICI; van der Burg SH, 2011, CURR OPIN IMMUNOL, V23, P252, DOI 10.1016/j.coi.2010.12.010; Vici P, 2016, EXPERT REV VACCINES, V15, P1327, DOI 10.1080/14760584.2016.1176533; Vrzackova P, 2010, EXPERT REV ANTICANC, V10, P1037, DOI 10.1586/ERA.10.89; Wit EMK, 2014, NAT REV UROL, V11, P110, DOI 10.1038/nrurol.2013.323	35	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174038	10.1371/journal.pone.0174038	http://dx.doi.org/10.1371/journal.pone.0174038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301611	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300116
J	Gros, A; Laharanne, E; Vergier, M; Prochazkova-Carlotti, M; Pham-Ledard, A; Bandres, T; Poglio, S; Berhouet, S; Vergier, B; Vial, JP; Chevret, E; Beylot-Barry, M; Merlio, JP				Gros, Audrey; Laharanne, Elodie; Vergier, Marie; Prochazkova-Carlotti, Martina; Pham-Ledard, Anne; Bandres, Thomas; Poglio, Sandrine; Berhouet, Sabine; Vergier, Beatrice; Vial, Jean-Philippe; Chevret, Edith; Beylot-Barry, Marie; Merlio, Jean-Philippe			TP53 alterations in primary and secondary Se A zary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma	PLOS ONE			English	Article							T-CELL LYMPHOMA; SEZARY-SYNDROME; MYCOSIS-FUNGOIDES; CUTANEOUS-LYMPHOMAS; PERIPHERAL-BLOOD; EUROPEAN-ORGANIZATION; EORTC CLASSIFICATION; MUTATIONS; RECEPTOR; P53	Recent massive parallel sequencing data have evidenced the genetic diversity and complexity of Se A zary syndrome mutational landscape with TP53 alterations being the most prevalent genetic abnormality. We analyzed a cohort of 35 patients with SS and a control group of 8 patients with chronic inflammatory dermatoses. TP53 status was analyzed at different clinical stages especially in 9 patients with a past-history of mycosis fungoides (MF), coined secondary SS. TP53 mutations were only detected in 10 patients with either primary or secondary SS (29%) corresponding to point mutations, small insertions and deletions which were unique in each case. Interestingly, TP53 mutations were both detected in sequential unselected blood mononuclear cells and in skin specimens. Cytogenetic analysis of blood specimens of 32 patients with SS showed a TP53 deletion in 27 cases (84%). Altogether 29 out of 35 cases exhibited TP53 mutation and/or deletion (83%). No difference in prognosis was observed according to TP53 status while patients with secondary SS had a worse prognosis than patients with primary SS. Interestingly, patients with TP53 alterations displayed a younger age and the presence of TP53 alteration at initial diagnosis stage supports a pivotal oncogenic role for TP53 mutation in SS as well as in erythrodermic MF making TP53 assessment an ancillary method for the diagnosis of patients with erythroderma as patients with inflammatory dermatoses did not display TP53 alteration.	[Gros, Audrey; Laharanne, Elodie; Prochazkova-Carlotti, Martina; Pham-Ledard, Anne; Poglio, Sandrine; Vergier, Beatrice; Chevret, Edith; Beylot-Barry, Marie; Merlio, Jean-Philippe] Univ Bordeaux, Bordeaux Res Translat Oncol, INSERM, U1053, Bordeaux, France; [Gros, Audrey; Laharanne, Elodie; Vergier, Marie; Bandres, Thomas; Berhouet, Sabine; Merlio, Jean-Philippe] CHU Bordeaux, Tumor Bank, Pessac, France; [Gros, Audrey; Laharanne, Elodie; Vergier, Marie; Bandres, Thomas; Berhouet, Sabine; Merlio, Jean-Philippe] CHU Bordeaux, Tumor Biol Lab, Pessac, France; [Pham-Ledard, Anne; Beylot-Barry, Marie] CHU Bordeaux, Dept Dermatol, Bordeaux, France; [Vergier, Beatrice] CHU Bordeaux, Dept Pathol, Pessac, France; [Vial, Jean-Philippe] CHU Bordeaux, Hematol Lab, Pessac, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux	Merlio, JP (corresponding author), Univ Bordeaux, Bordeaux Res Translat Oncol, INSERM, U1053, Bordeaux, France.; Merlio, JP (corresponding author), CHU Bordeaux, Tumor Bank, Pessac, France.; Merlio, JP (corresponding author), CHU Bordeaux, Tumor Biol Lab, Pessac, France.	jp.merlio@u-bordeaux.fr	Beylot-Barry, Marie/AHC-3163-2022	Poglio, Sandrine/0000-0001-8783-0709; Beylot-Barry, Marie/0000-0001-6150-1229; vial, jean-philippe/0000-0003-3109-0064; Prochazkova-Carlotti, Martina/0000-0002-7719-7679	MATULILA project; University Hospital of Bordeaux; Ligue contre le Cancer Comite de Gironde grant; Association pour la Recherche Contre le Cancer grant	MATULILA project; University Hospital of Bordeaux; Ligue contre le Cancer Comite de Gironde grant; Association pour la Recherche Contre le Cancer grant	This work is part of the MATULILA project funding to Anne Pham-Ledard supported by the University Hospital of Bordeaux, the Ligue contre le Cancer Comite de Gironde grant to Sandrine Poglio and the Association pour la Recherche Contre le Cancer grant to Edith Chevret. The funders had no role in study design, data	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bagot M, 2001, BLOOD, V97, P1388, DOI 10.1182/blood.V97.5.1388; Beylot-Barry M, 2001, J INVEST DERMATOL, V117, P920, DOI 10.1046/j.0022-202x.2001.01476.x; Boonk SE, 2016, J INVESTIGATIVE DERM; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Chevret E, 2016, J INVEST DERMATOL, V136, P1319, DOI 10.1016/j.jid.2016.04.027; Chevret E, 2014, BLOOD, V123, P1850, DOI 10.1182/blood-2013-05-500686; Choi J, 2015, NAT GENET, V47, P1011, DOI 10.1038/ng.3356; Almeida ACD, 2015, NAT GENET, V47, P1465, DOI 10.1038/ng.3442; Delfau-Larue MH, 2000, BLOOD, V96, P2987; Fraser-Andrews EA, 2000, J INVEST DERMATOL, V114, P117, DOI 10.1046/j.1523-1747.2000.00830.x; Gibson JF, 2016, J AM ACAD DERMATOL, V74, P870, DOI 10.1016/j.jaad.2015.12.018; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Iggo R, 2013, J PATHOL, V231, P441, DOI 10.1002/path.4243; Karenko L, 1999, J INVEST DERMATOL, V112, P392, DOI 10.1038/sj.jid.5600444; Kiel MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9470; Laharanne E, 2010, J INVESTIGATIVE DERM; Laharanne E, 2010, MODERN PATHOL, V23, P547, DOI 10.1038/modpathol.2009.196; Lamprecht B, 2012, BRIT J DERMATOL, V167, P240, DOI 10.1111/j.1365-2133.2012.10918.x; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Mao X, 2003, GENE CHROMOSOME CANC, V36, P250, DOI 10.1002/gcc.10152; Mao X, 2002, BRIT J DERMATOL, V147, P464, DOI 10.1046/j.1365-2133.2002.04966.x; Marks DI, 1996, BRIT J HAEMATOL, V92, P890, DOI 10.1046/j.1365-2141.1996.439978.x; Marty M, 2008, J INVEST DERMATOL, V128, P2458, DOI 10.1038/jid.2008.113; McGirt LY, 2015, BLOOD, V126, P508, DOI 10.1182/blood-2014-11-611194; McGregor JM, 1999, J INVEST DERMATOL, V112, P317, DOI 10.1046/j.1523-1747.1999.00507.x; Muche JM, 1999, BLOOD, V94, P1409, DOI 10.1182/blood.V94.4.1409.416k21_1409_1417; Muche JM, 2004, J INVEST DERMATOL, V122, P574, DOI 10.1111/j.0022-202X.2004.22303.x; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Pham-Ledard A, 2014, MODERN PATHOL, V27, P402, DOI 10.1038/modpathol.2013.156; Prasad A, 2016, J INVESTIGATIVE DERM; Salgado R, 2009, J INVESTIGATIVE DERM; Scarisbrick JJ, 2001, BLOOD, V97, P624, DOI 10.1182/blood.V97.3.624; THEODOROU I, 1995, BLOOD, V86, P305, DOI 10.1182/blood.V86.1.305.bloodjournal861305; van Doorn R, 2016, J INVESTIGATIVE DERM; van Doorn R, 2009, BLOOD, V113, P127, DOI 10.1182/blood-2008-04-153031; Vega F, 2002, BLOOD, V100, P3369, DOI 10.1182/blood.V100.9.3369; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LH, 2015, NAT GENET, V47, P1426, DOI 10.1038/ng.3444; Weed J, 2016, J INVESTIGATIVE DERM; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Willemze R, 1997, BLOOD, V90, P354; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Wong HK, 2016, J INVEST DERMATOL, V136, P1313, DOI 10.1016/j.jid.2016.05.087; Woollard WJ, 2016, BLOOD, V127, P3387, DOI 10.1182/blood-2016-02-699843; Woollard WJ, 2016, J INVESTIGATIVE DERM	49	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173171	10.1371/journal.pone.0173171	http://dx.doi.org/10.1371/journal.pone.0173171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301507	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300026
J	Qi, XJ; Song, WW; Shi, JW				Qi, Xuejun; Song, Wenwu; Shi, Jianwei			Density functional theory study the effects of oxygen-containing functional groups on oxygen molecules and oxygen atoms adsorbed on carbonaceous materials	PLOS ONE			English	Article							SURFACE OXIDES; GRAPHITE; OXIDATION; ADSORPTION; MODEL; O-2; CHEMISORPTION; POTASSIUM	Density functional theory was used to study the effects of different types of oxygen-containing functional groups on the adsorption of oxygen molecules and single active oxygen atoms on carbonaceous materials. During gasification or combustion reactions of carbonaceous materials, oxygen-containing functional groups such as hydroxyl(-OH), carbonyl (-CO), quinone(-O), and carboxyl(-COOH) are often present on the edge of graphite and can affect graphite's chemical properties. When oxygen-containing functional groups appear on a graphite surface, the oxygen molecules are strongly adsorbed onto the surface to form a four-member ring structure. At the same time, the O-O bond is greatly weakened and easily broken. The adsorption energy value indicates that the adsorption of oxygen molecules changes from physisorption to chemisorption for oxygen-containing functional groups on the edge of a graphite surface. In addition, our results indicate that the adsorption energy depends on the type of oxygen-containing functional group. When a single active oxygen atom is adsorbed on the bridge site of graphite, it gives rise to a stable epoxy structure. Epoxy can cause deformation of the graphite lattice due to the transition of graphite from sp(2) to sp(3) after the addition of an oxygen atom. For quinone group on the edge of graphite, oxygen atoms react with carbon atoms to form the precursor of CO2. Similarly, the single active oxygen atoms of carbonyl groups can interact with edge carbon atoms to form the precursor of CO2. The results show that oxygen-containing functional groups on graphite surfaces enhance the activity of graphite, which promotes adsorption on the graphite surface.	[Qi, Xuejun] Xihua Univ, Sch Architecture & Civil Engn, Chengdu, Sichuan, Peoples R China; [Song, Wenwu; Shi, Jianwei] Xihua Univ, Sch Energy & Power Engn, Chengdu, Sichuan, Peoples R China	Xihua University; Xihua University	Qi, XJ (corresponding author), Xihua Univ, Sch Architecture & Civil Engn, Chengdu, Sichuan, Peoples R China.	xuejunqi@foxmail.com			Xihua university key laboratory of green building [szjj2016-056]; key foundation of Xihua university [Z1510612]; ministry of education chunhui plan [Z2016157]; education department of Sichuan province [17ZB0421]; open research fund program provincial key laboratory of fluid machinery of China [szjj2015-037]	Xihua university key laboratory of green building; key foundation of Xihua university; ministry of education chunhui plan; education department of Sichuan province; open research fund program provincial key laboratory of fluid machinery of China	Support was provided by: 1. The open research fund of Xihua university key laboratory of green building(szjj2016-056) [http://jztm.xhu.edu.cn/1282/list.htm]; 2. The key foundation of Xihua university(Z1510612) [http://www.xhu.edu.cn/12/list.htm]; 3. The ministry of education chunhui plan, Z2016157, Dr Xuejun Qi [http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_851/201001/xxgk_77983.html]; 4. Project of education department of Sichuan province, 17ZB0421, Dr Xuejun Qi [http://182.140.219.158:10008/login.aspx]; 5. The open research fund program provincial key laboratory of fluid machinery of China, szjj2015-037, Jianwei Shi [http://klab.xhu.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATAMNY F, 1992, J PHYS CHEM-US, V96, P4522, DOI 10.1021/j100190a072; Boehm HP, 2002, CARBON, V40, P145, DOI 10.1016/S0008-6223(01)00165-8; Chen N, 1998, CARBON, V36, P1061, DOI 10.1016/S0008-6223(98)00078-5; Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; DUBSKY J, 1979, SURF SCI, V79, P53, DOI 10.1016/0039-6028(79)90025-6; Espinal JF, 2004, J PHYS CHEM B, V108, P1003, DOI 10.1021/jp0308211; Espinal JF, 2009, CARBON, V47, P3010, DOI 10.1016/j.carbon.2009.06.048; Ghaderi N, 2010, J PHYS CHEM C, V114, P21625, DOI 10.1021/jp108688m; Gonzalez JD, 2013, FUEL, V114, P199, DOI 10.1016/j.fuel.2012.04.039; Haynes BS, 2001, COMBUST FLAME, V126, P1421, DOI 10.1016/S0010-2180(01)00263-2; He HY, 1998, CHEM PHYS LETT, V287, P53, DOI 10.1016/S0009-2614(98)00144-4; HONTORIALUCAS C, 1995, CARBON, V33, P1585, DOI 10.1016/0008-6223(95)00120-3; JANIAK C, 1993, LANGMUIR, V9, P3427, DOI 10.1021/la00036a017; Krasheninnikov AV, 2004, CARBON, V42, P1021, DOI 10.1016/j.carbon.2003.12.025; Lamoen D, 1998, J CHEM PHYS, V108, P3332, DOI 10.1063/1.475732; Langley LA, 2006, CHEM MATER, V18, P169, DOI 10.1021/cm051462k; Larciprete R, 2009, CARBON, V47, P2579, DOI 10.1016/j.carbon.2009.05.008; Lee SM, 1999, PHYS REV LETT, V82, P217, DOI 10.1103/PhysRevLett.82.217; Orrego JF, 2009, J PHYS CHEM A, V113, P8415, DOI 10.1021/jp903362g; PAN ZJ, 1992, IND ENG CHEM RES, V31, P2675, DOI 10.1021/ie00012a008; Perry ST, 2000, P COMBUST INST, V28, P2313, DOI 10.1016/S0082-0784(00)80642-6; Radovic LR, 2011, CARBON, V49, P4218, DOI 10.1016/j.carbon.2011.05.059; Radovic LR, 2011, CARBON, V49, P4226, DOI 10.1016/j.carbon.2011.05.037; Sendt K, 2005, COMBUST FLAME, V143, P629, DOI 10.1016/j.combustflame.2005.08.026; Sendt K, 2005, P COMBUST INST, V30, P2141, DOI 10.1016/j.proci.2004.08.064; Sendt K, 2005, J PHYS CHEM A, V109, P3438, DOI 10.1021/jp045111p; Sendt K, 2011, P COMBUST INST, V33, P1851, DOI 10.1016/j.proci.2010.06.021; Shaffer MSP, 1998, CARBON, V36, P1603, DOI 10.1016/S0008-6223(98)00130-4; Sorescu DC, 2001, J PHYS CHEM B, V105, P11227, DOI 10.1021/jp0122979; Sun BZ, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3489663; Szabo T, 2006, CHEM MATER, V18, P2740, DOI 10.1021/cm060258+; Zhang GX, 2008, CARBON, V46, P196, DOI 10.1016/j.carbon.2007.11.002	33	22	22	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173864	10.1371/journal.pone.0173864	http://dx.doi.org/10.1371/journal.pone.0173864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301544	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300085
J	Viana, GMR; Okoth, SA; Silva-Flannery, L; Barbosa, DRL; de Oliveira, AM; Goldman, IF; Morton, LC; Huber, C; Anez, A; Machado, RLD; Camargo, LMA; do Valle, SCN; Povoa, MM; Udhayakumar, V; Barnwell, JW				Rachid Viana, Giselle Maria; Okoth, Sheila Akinyi; Silva-Flannery, Luciana; Lima Barbosa, Danielle Regina; de Oliveira, Alexandre Macedo; Goldman, Ira F.; Morton, Lindsay C.; Huber, Curtis; Anez, Arletta; Dantas Machado, Ricardo Luiz; Aranha Camargo, Luis Marcelo; Negreiros do Valle, Suiane Costa; Povoa, Marinete Marins; Udhayakumar, Venkatachalam; Barnwell, John W.			Histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in Plasmodium falciparum isolates from select sites in Brazil and Bolivia	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; MALARIA; ANTIBODIES; SECRETION; PARASITES	More than 80% of available malaria rapid diagnostic tests (RDTs) are based on the detection of histidine-rich protein-2 (PfHRP2) for diagnosis of Plasmodium falciparum malaria. Recent studies have shown the genes that code for this protein and its paralog, histidine-rich protein-3 (PfHRP3), are absent in parasites from the Peruvian Amazon Basin. Lack of PfHRP2 protein through deletion of the pfhrp2 gene leads to false-negative RDT results for P. falciparum. We have evaluated the extent of pfhrp2 and pfhrp3 gene deletions in a convenience sample of 198 isolates from six sites in three states across the Brazilian Amazon Basin (Acre, Rondonia and Para) and 25 isolates from two sites in Bolivia collected at different times between 2010 and 2012. Pfhrp2 and pfhrp3 gene and their flanking genes on chromosomes 7 and 13, respectively, were amplified from 198 blood specimens collected in Brazil. In Brazil, the isolates collected in Acre state, located in the western part of the Brazilian Amazon, had the highest percentage of deletions for pfhrp2 25 (31.2%) of 79, while among those collected in Rondonia, the prevalence of pfhrp2 gene deletion was only 3.3% (2 out of 60 patients). In isolates from Para state, all parasites were pfhrp2-positive. In contrast, we detected high proportions of isolates from all 3 states that were pfhrp3-negative ranging from 18.3% (11 out of 60 samples) to 50.9% (30 out of 59 samples). In Bolivia, only one of 25 samples (4%) tested had deleted pfhrp2 gene, while 68% (17 out of 25 samples) were pfhrp3-negative. Among the isolates tested, P. falciparum pfhrp2 gene deletions were present mainly in those from Acre State in the Brazilian Amazon. These results indicate it is important to reconsider the use of PfHRP2-based RDTs in the western region of the Brazilian Amazon and to implement appropriate surveillance systems to monitor pfhrp2 gene deletions in this and other parts of the Amazon region.	[Rachid Viana, Giselle Maria; Lima Barbosa, Danielle Regina; Dantas Machado, Ricardo Luiz; Povoa, Marinete Marins] Inst Evandro Chagas IEC SVS MS, Ananindeua, Para, Brazil; [Okoth, Sheila Akinyi; Silva-Flannery, Luciana; de Oliveira, Alexandre Macedo; Goldman, Ira F.; Morton, Lindsay C.; Huber, Curtis; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA; [Okoth, Sheila Akinyi; Silva-Flannery, Luciana] Atlanta Res & Educ Fdn, Decatur, GA USA; [Anez, Arletta] Pan Amer Hlth Org, La Paz, Bolivia; [Aranha Camargo, Luis Marcelo] ICB5 USP, Porto Velho, Rondonia, Brazil; [Aranha Camargo, Luis Marcelo] Fac Sao Lucas, Porto Velho, Rondonia, Brazil; [Negreiros do Valle, Suiane Costa] Secretaria Estadual Saude Acre, Hemonucleo Cruzeiro do Sul, Cruzeiro Do Sul, Acre, Brazil	Instituto Evandro Chagas; Centers for Disease Control & Prevention - USA; Pan American Health Organization	Udhayakumar, V (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA.	vxu0@cdc.gov	CAMARGO, LMA/B-4156-2009; Povoa, Marinete Marins/C-7039-2017; Viana, Giselle/ABF-2920-2020; Machado, Ricardo Luiz Dantas Dantas/P-1288-2014; Machado, Ricardo/GXM-8198-2022	CAMARGO, LMA/0000-0001-9486-6195; Povoa, Marinete Marins/0000-0003-3517-2227; Viana, Giselle/0000-0003-1771-7211; Machado, Ricardo Luiz Dantas Dantas/0000-0002-8955-3204; Lima Barbosa, Danielle Regina/0000-0001-5054-2033; Morton, Lindsay/0000-0002-7295-8475; Anez, Arletta/0000-0001-8355-4073	Amazon Malaria Initiative - United States Agency for International Development (USAID); Atlanta Research and Education Foundation; CDC Emerging Infectious Disease Fellowship; Oak Ridge Institute for Science and Education (ORISE)	Amazon Malaria Initiative - United States Agency for International Development (USAID)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Atlanta Research and Education Foundation; CDC Emerging Infectious Disease Fellowship; Oak Ridge Institute for Science and Education (ORISE)	This study was supported by the Amazon Malaria Initiative, which is funded by the United States Agency for International Development (USAID). SAO and LS-F were also supported by the Atlanta Research and Education Foundation. LM was supported by a CDC Emerging Infectious Disease Fellowship administered through the Association of Public Health Laboratories (APHL), and subsequently by a fellowship with the Oak Ridge Institute for Science and Education (ORISE).	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Brazil MoH, 2009, MAN DIAGN LAB MAL; Brazilian Ministry of Health, SIST INF VIG EP MAL; de Oliveira MRF, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-390; Desakorn V, 2005, T ROY SOC TROP MED H, V99, P517, DOI 10.1016/j.trstmh.2004.11.014; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Ho MF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-480; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Lee N, 2012, J CLIN MICROBIOL, V50, P1397, DOI 10.1128/JCM.06533-11; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152; Manning L, 2011, CLIN INFECT DIS, V52, P440, DOI 10.1093/cid/ciq105; Solano CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131576; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Noedl H, 2002, EXP PARASITOL, V102, P157, DOI 10.1016/S0014-4894(03)00051-1; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Rubach MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035985; Saude Md, 2006, GUIA VIGILANCIA EPID; SCHERF A, 1992, NUCLEIC ACIDS RES, V20, P1491, DOI 10.1093/nar/20.7.1491; Taylor SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01165; Trouvay M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074269; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	30	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171150	10.1371/journal.pone.0171150	http://dx.doi.org/10.1371/journal.pone.0171150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301474	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300010
J	Sandhu, HS; Bhanwer, AJS; Puri, S				Sandhu, Harkirat Singh; Bhanwer, A. J. S.; Puri, Sanjeev			Retinoic acid exacerbates chlorpyrifos action in ensuing adipogenic differentiation of C3H10T1/2 cells in a GSK3 beta dependent pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PRENATAL DEXAMETHASONE AUGMENTS; WNT SIGNALING PATHWAY; MARROW STROMAL CELLS; BONE-MINERAL DENSITY; ADIPOSE-TISSUE; DEVELOPMENTAL NEUROTOXICITY; GENE-EXPRESSION; PRETERM LABOR; FATTY-ACIDS	The cell differentiation can be exploited as a paradigm to evaluate the effects of noxious chemicals, on human health, either alone or in combinations. In this regard, the effect of a known cell differentiation agent, retinoic acid (RA) was analyzed in the presence of a noxious chemical chlorpyrifos (CPF), an organophosphate (OP), the receptors of which have recently been localized to mesenchymal stem cells (MSCs). The observed imbalance of adipogenic to skeletal differentiation by CPF together with conundrum about adipogenic potential of RA prompted us to delineate their combinatorial effects on C(3)H(10)T1/2MSC-like undifferentiated cells. Based on MTT assay, the cellular viability was retained by CPF at concentrations ranging from 0.01-50 mu M, beyond which it caused cytotoxicity. These nontoxic concentrations also mildly interfered with adipogenesis of C(3)H(10)T1/2 cells following exposure to adipogenic cocktail. However, upon exposure to RA alone, these MSCs adopted elongated morphology and accumulated lipid vesicles, by day 20, as discerned by phase-contrast and transmission electron microscopy (TEM), in concert with enhanced Oil Red O stained cells. This effect got strongly augmented upon exposure to combination of CPF and RA in a dose-dependent manner. Simultaneous up-regulation in perilipin-1 (PLIN1) and adipsin (ADN) genes, additionally reiterated the adipogenic differentiation. Mechanistically, GSK3 beta pathway was found to be a major player, whereby inhibiting it with lithium chloride (LiCl) resulted in complete blockage of lipid accumulation, accompanied by complete down regulation of PLIN1 and ADN gene expression. In conclusion, these observations for the first time, lend evidence that exposure of CPF accompanied by RA directs commitment of C(3)H(10)T1/2 cells to adipogenic differentiation through a process involving a crosstalk at GSK3 beta signaling.	[Sandhu, Harkirat Singh; Bhanwer, A. J. S.] Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India; [Sandhu, Harkirat Singh; Puri, Sanjeev] Panjab Univ, Ctr Stem Cell Tissue Engn & Biomed Excellence, Chandigarh, India; [Puri, Sanjeev] Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh, India	Guru Nanak Dev University; Panjab University; Panjab University	Puri, S (corresponding author), Panjab Univ, Ctr Stem Cell Tissue Engn & Biomed Excellence, Chandigarh, India.	spuri_1111@yahoo.com		Puri, Sanjeev/0000-0002-3967-987X; Puri, Sanjeev/0000-0002-4314-9871; Bhanwer, AJS/0000-0001-5181-9268	PURSE Grant (DST, New Delhi); Maulana Azad National Fellowship	PURSE Grant (DST, New Delhi); Maulana Azad National Fellowship	PURSE Grant (DST, New Delhi) to Centre for Stem Cell Tissue Engineering and Biomedical Excellence and Maulana Azad National Fellowship for Minority Students to H.S.S. at Department of Human Genetics, GNDU, Amritsar, are thankfully acknowledged.	Anjali Choudhary, 2014, Asian Journal of Biomedical and Pharmaceutical Sciences, V4, P30; [Anonymous], 1999, NUTR REV, V57, P192; Arana Miriam, 2013, Methods Mol Biol, V1036, P47, DOI 10.1007/978-1-62703-511-8_4; Astudillo P, 2008, J CELL BIOCHEM, V103, P1054, DOI 10.1002/jcb.21516; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BERESFORD JN, 1992, J CELL SCI, V102, P341; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Christensen K., 2009, CHLORPYRIFOS TECHNIC; Compston JE, 1999, LANCET, V354, P1791, DOI 10.1016/S0140-6736(99)04466-9; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Culbreth ME, 2012, NEUROTOXICOLOGY, V33, P1499, DOI 10.1016/j.neuro.2012.05.012; Dani C, 1997, J CELL SCI, V110, P1279; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Eimar H, 2013, J MUSCULOSKEL NEURON, V13, P124; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032; Galli C, 2013, CLIN ORAL IMPLAN RES, V24, P921, DOI 10.1111/j.1600-0501.2012.02488.x; Garcia-Rojas P, 2010, J ANIM SCI, V88, P1801, DOI 10.2527/jas.2009-2579; Genever PG, 1999, BONE, V24, P297, DOI 10.1016/S8756-3282(98)00187-2; Gupta RC, TOXICOLOGY ORGANOPHO, P1; Henning P, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00031; Hoogduijn MJ, 2006, TOXICOL SCI, V94, P342, DOI 10.1093/toxsci/kfl101; Hoogduijn MJ, 2009, STEM CELLS DEV, V18, P103, DOI 10.1089/scd.2008.0032; Hoshiba T, 2012, BIOMATERIALS, V33, P2025, DOI 10.1016/j.biomaterials.2011.11.061; Inkson CA, 2004, BONE, V35, P819, DOI 10.1016/j.bone.2004.05.026; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Kapka-Skrzypczak L, 2011, ANN AGR ENV MED, V18, P294; Karami-Mohajeri S, 2011, HUM EXP TOXICOL, V30, P1119, DOI 10.1177/0960327110388959; Kaur M., 2014, INT J SCI ENV TECHNO, V3, P473; Kim DM, 2013, BIOCHEM BIOPH RES CO, V434, P455, DOI 10.1016/j.bbrc.2013.03.095; Kojima T, 2013, BIOSCI BIOTECH BIOCH, V77, P1035, DOI 10.1271/bbb.121017; Levin ED, 2014, NEUROTOXICOL TERATOL, V41, P35, DOI 10.1016/j.ntt.2013.10.004; Liu HY, 2011, BIOMATERIALS, V32, P6773, DOI 10.1016/j.biomaterials.2011.05.080; MacIntosh DL, 2001, ENVIRON HEALTH PERSP, V109, P145, DOI 10.2307/3434767; Marasinghe J, 2014, TOXICS, V2, P92, DOI 10.3390/toxics2020092; Pino AM, 2012, BIOL RES, V45, P279, DOI 10.4067/S0716-97602012000300009; Mathur HB, CSE PML PR 21 2005; McGown C, 2014, CLIN LIVER DIS, V18, P41, DOI 10.1016/j.cld.2013.09.012; Meggs WJ, 2007, J MED TOXICOL, V3, P89, DOI 10.1007/BF03160916; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Morikawa K, 2013, CELL BIOL INT, V37, P36, DOI 10.1002/cbin.10005; MOUSTAID N, 1990, J CELL BIOCHEM, V42, P243, DOI 10.1002/jcb.240420407; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Osei-Sarfo K, 2014, STEM CELLS, V32, P2061, DOI 10.1002/stem.1706; Pamies D, 2014, INT J MOL SCI, V15, P905, DOI 10.3390/ijms15010905; Pei LM, 2004, J CLIN INVEST, V113, P805, DOI 10.1172/JCI200421311; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiao D, 2003, DEV BRAIN RES, V147, P183, DOI 10.1016/S0165-3806(03)00222-0; RACKE KD, 1993, REV ENVIRON CONTAM T, V131, P1; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rinker TE, 2014, INTEGR BIOL-UK, V6, P324, DOI [10.1039/c3ib40194d, 10.1039/c3b40194d]; ROMERO P, 1989, ENVIRON RES, V50, P256, DOI 10.1016/S0013-9351(89)80006-4; SAFONOVA I, 1994, BIOCHEM BIOPH RES CO, V204, P498, DOI 10.1006/bbrc.1994.2487; Saunders M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S5; Slotkin TA, 2013, NEUROTOXICOL TERATOL, V37, P1, DOI [10.1016/j.ntt.2013.02.002, 10.1016/j.ntt2013.02.002]; Slotkin TA, 2012, NEUROTOXICOL TERATOL, V34, P505, DOI 10.1016/j.ntt.2012.07.002; Solomon KR, 2014, REV ENVIRON CONTAM T, V231, P13, DOI 10.1007/978-3-319-03865-0_2; Takahashi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064605; Tsimbiri PF., 2015, ODEM, V3, P24, DOI [10.4236/odem.2015.32004, DOI 10.4236/ODEM.2015.32004]; United States Environmental Protection Agency, 2011, CHLORP PREL HUM HLTH; Wang AX, 2008, BIOCHEM BIOPH RES CO, V375, P435, DOI 10.1016/j.bbrc.2008.08.036; Wang YJ, 2014, ENVIRON TOXICOL CHEM, V33, P431, DOI 10.1002/etc.2453; Wu B., 1996, Yaoxue Xuebao, V31, P241; YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205; Zamani A, 2009, BONE, V44, P331, DOI 10.1016/j.bone.2008.10.001; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11	74	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173031	10.1371/journal.pone.0173031	http://dx.doi.org/10.1371/journal.pone.0173031			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291828	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700009
J	Chang, WT; Liu, YW; Liu, PY; Hsu, CH; Tsai, WC				Chang, Wei-Ting; Liu, Yen-Wen; Liu, Ping-Yen; Hsu, Chih-Hsin; Tsai, Wei-Chuan			The association between right ventricular free wall strain and exercise capacity for health check-up subjects	PLOS ONE			English	Article							FUNCTIONAL-CAPACITY; DIASTOLIC FUNCTION; PARAMETERS; DISEASE; GENDER; RISK	Background Right ventricular ( RV) function has been found to be a major factor of exercise capacity in patients with heart failure. However, the role of RV function in exercise capacity in healthy subjects has not been well studied. This study aims to validate the role of RV strain derived from speckle tracking echocardiography for exercise capacity for health check-up subjects. Methods This study prospectively recruited subjects from a routine health examination. All of them were symptom free. RV function represented by RV strain was derived from speckle tracking echocardiography in addition to traditional echocardiography parameters. Functional capacity was determined by a symptom limited treadmill exercise test with the Bruce protocol. Results Among 164 recruited subjects (age 52.2-9.2 years, 66.4% male), 32 subjects represented impaired functional capacity (MET< 8), which was significantly correlated with age, left ventricular mass index, left ventricular filling pressure (E/e'), global longitudinal strain of the left ventricle (LVGLS) (-16.0-2.5% vs. -18.9-3.8%, p < 0.001) and RV free wall strain (RVLS_FW) (-17.0-4.9% vs. -21.9-3.2%, p < 0.001). After multivariate logistic regression, RVS_FW was an independent predictor for impaired functional capacity (OR 1.62, CI 1.32-1.98; p < 0.001). Conclusions In conclusion, RV strain is independently associated with exercise capacity for health check-up subjects. RV function is an important factor for functional capacity.	[Chang, Wei-Ting] Chi Mei Med Ctr, Dept Internal Med, Div Cardiol, Tainan, Taiwan; [Chang, Wei-Ting; Liu, Yen-Wen; Liu, Ping-Yen; Tsai, Wei-Chuan] Natl Cheng Kung Univ Hosp, Div Cardiol, Tainan, Taiwan; [Chang, Wei-Ting] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Hsu, Chih-Hsin] Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Southern Taiwan University of Science & Technology	Chang, WT (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Div Cardiol, Tainan, Taiwan.; Chang, WT (corresponding author), Natl Cheng Kung Univ Hosp, Div Cardiol, Tainan, Taiwan.; Chang, WT (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	wctsai@seed.net.tw			Chi-Mei Medical Center; National Cheng Kung University, Taiwan	Chi-Mei Medical Center; National Cheng Kung University, Taiwan	This work was supported by the collaborative grant of Chi-Mei Medical Center and National Cheng Kung University, Taiwan.	Castro ML, 2013, INT J CARDIOL, V168, P2927, DOI 10.1016/j.ijcard.2013.03.181; Chia EM, 2015, J AM SOC ECHOCARDIOG, V28, P1441, DOI 10.1016/j.echo.2015.08.006; Chia EM, 2014, J AM SOC ECHOCARDIOG, V27, P1079, DOI 10.1016/j.echo.2014.06.007; DEBAKKER JMT, 1988, CIRCULATION, V77, P589, DOI 10.1161/01.CIR.77.3.589; Dulgheru R, 2016, EUR HEART J-CARD IMG, V17, P217, DOI 10.1093/ehjci/jev147; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Friedberg MK, 2013, AM HEART J, V165, P551, DOI 10.1016/j.ahj.2012.06.029; Gokdeniz T, 2014, RESPIRATION, V88, P223, DOI 10.1159/000365222; Guendouz S, 2012, CIRC J, V76, P127, DOI 10.1253/circj.CJ-11-0778; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Hasselberg NE, 2015, EUR HEART J-CARD IMG, V16, P217, DOI 10.1093/ehjci/jeu277; Iacoviello M, 2011, EUR J ECHOCARDIOGR, V12, P773, DOI 10.1093/ejechocard/jer139; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lindqvist P, 2005, ECHOCARDIOGR-J CARD, V22, P305, DOI 10.1111/j.1540-8175.2005.04023.x; Lund O, 1997, EUR HEART J, V18, P1977; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Noordegraaf AV, 2011, EUR RESPIR REV, V20, P243, DOI 10.1183/09059180.00006511; Park Jae-Hyeong, 2015, J Cardiovasc Ultrasound, V23, P91, DOI 10.4250/jcu.2015.23.2.91; Petersen JW, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-20; Quintana Miguel, 2005, Cardiovasc Ultrasound, V3, P4, DOI 10.1186/1476-7120-3-4; Shah SJ, 2009, CIRC-HEART FAIL, V2, P278, DOI 10.1161/CIRCHEARTFAILURE.108.807826; Simsek Z, 2013, INT J CARDIOVAS IMAG, V29, P1265, DOI 10.1007/s10554-013-0204-z; Smiseth OA, 2016, EUR HEART J, V37, P1196, DOI 10.1093/eurheartj/ehv529; Stefani L, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-17; SZLACHCIC J, 1985, AM J CARDIOL, V55, P1037, DOI 10.1016/0002-9149(85)90742-8; Tsai WC, 2010, J AM SOC ECHOCARDIOG, V23, P1183, DOI 10.1016/j.echo.2010.08.011; Van De Bruaene A, 2011, EUR J ECHOCARDIOGR, V12, P206, DOI 10.1093/ejechocard/jeq169; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Walker LA, 2013, CURR CARDIOL REV, V9, P73, DOI 10.2174/1573403X11309010009	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173307	10.1371/journal.pone.0173307	http://dx.doi.org/10.1371/journal.pone.0173307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288177	gold, Green Submitted, Green Published			2022-12-26	WOS:000396092400012
J	Castano, AG; de Nanclares, GP; Madariaga, L; Aguirre, M; Madrid, A; Chocron, S; Nadal, I; Navarro, M; Lucas, E; Fijo, J; Espino, M; Espitaletta, Z; Nieto, VG; de Frutos, DB; Loza, R; Pintos, G; Castano, L; Ariceta, G				Garcia Castano, Alejandro; Perez de Nanclares, Gustavo; Madariaga, Leire; Aguirre, Mireia; Madrid, Alvaro; Chocron, Sara; Nadal, Inmaculada; Navarro, Mercedes; Lucas, Elena; Fijo, Julia; Espino, Mar; Espitaletta, Zilac; Garcia Nieto, Victor; Barajas de Frutos, David; Loza, Reyner; Pintos, Guillem; Castano, Luis; Ariceta, Gema		RenalTube Grp	Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome	PLOS ONE			English	Article							CHLORIDE CHANNEL GENE; SALT-LOSING TUBULOPATHIES; MOLECULAR ANALYSIS; CLCNKB; MUTATIONS; NEPHROCALCINOSIS; GITELMAN	Introduction Type III Bartter syndrome (BS) is an autosomal recessive renal tubule disorder caused by loss-of-function mutations in the CLCNKB gene, which encodes the chloride channel protein ClC-Kb. In this study, we carried out a complete clinical and genetic characterization in a cohort of 30 patients, one of the largest series described. By comparing with other published populations, and considering that 80% of our patients presented the p. Ala204Thr Spanish founder mutation presumably associated with a common phenotype, we aimed to test the hypothesis that allelic differences could explain the wide phenotypic variability observed in patients with type III BS. Methods Clinical data were retrieved from the referral centers. The exon regions and flanking intronic sequences of the CLCNKB gene were screened for mutations by polymerase chain reaction (PCR) followed by direct Sanger sequencing. Presence of gross deletions or duplications in the region was checked for by MLPA and QMPSF analyses. Results Polyuria, polydipsia and dehydration were the main common symptoms. Metabolic alkalosis and hypokalemia of renal origin were detected in all patients at diagnosis. Calciuria levels were variable: hypercalciuria was detected in 31% of patients, while 23% had hypocalciuria. Nephrocalcinosis was diagnosed in 20% of the cohort. Two novel CLCNKB mutations were identified: a small homozygous deletion (c.753delG) in one patient and a small deletion (c.1026delC) in another. The latter was present in compound heterozygosis with the already previously described p.Glu442Gly mutation. No phenotypic association was obtained regarding the genotype. Conclusion A poor correlation was found between a specific type of mutation in the CLCNKB gene and type III BS phenotype. Importantly, two CLCNKB mutations not previously described were found in our cohort.	[Garcia Castano, Alejandro; Perez de Nanclares, Gustavo; Castano, Luis] Cruces Univ Hosp, Ciberer, BioCruces Hlth Res Inst, Bizkaia, Spain; [Madariaga, Leire; Aguirre, Mireia] Cruces Univ Hosp, Pediat Nephrol, Bizkaia, Spain; [Madariaga, Leire; Castano, Luis] Univ Basque Country, UPV EHU, Dept Pediat, Sch Med & Odontol, Bizkaia, Spain; [Madrid, Alvaro; Chocron, Sara; Ariceta, Gema] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Pediat Nephrol, Barcelona, Spain; [Nadal, Inmaculada] Virgen del Camino Hosp, Pediat Nephrol, Pamplona, Spain; [Navarro, Mercedes] La Paz Univ Hosp, Pediat Nephrol, Madrid, Spain; [Lucas, Elena] Manises Hosp, Pediat, Valencia, Spain; [Fijo, Julia] Virgen del Rocio Hosp, Pediat Nephrol, Seville, Spain; [Espino, Mar] Fdn Alcorcon Univ Hosp, Pediat Nephrol, Madrid, Spain; [Espitaletta, Zilac] San Ignacio Univ Hosp, Bogota, Colombia; [Garcia Nieto, Victor] Nuestra Senora de Candelaria Univ Hosp, Pediat Nephrol, Tenerife, Canarias, Spain; [Barajas de Frutos, David] Virgen de las Nieves Hosp, Pediat Nephrol, Granada, Spain; [Loza, Reyner] Cayetano Heredia Univ, Cayetano Heredia Hosp, Nephrol Unit, Lima, Peru; [Pintos, Guillem] Germans Trias & Pujol Univ Hosp, Badalona, Spain; [Castano, Luis] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [RenalTube Grp] Asturias Cent Univ Hosp, Pediat Nephrol, Oviedo, Asturias, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Cruces; Hospital Universitario Cruces; University of Basque Country; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario La Paz; Virgen del Rocio University Hospital; Alcorcon Foundation University Hospital; Hospital Universitario San Ignacio; Hospital Universitario Virgen de las Nieves; Universidad Peruana Cayetano Heredia; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Central University Hospital Asturias	Ariceta, G (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Pediat Nephrol, Barcelona, Spain.	gariceta@vhebron.net	alvarez, victoria/GXV-1088-2022; Madariaga, Leire/B-5220-2019; García, Alejandro/AAA-6023-2020; alvarez, victoria/ABC-7891-2021; Blanco, Leire/O-5114-2017	alvarez, victoria/0000-0002-1916-2523; Madariaga, Leire/0000-0002-4032-9842; alvarez, victoria/0000-0002-1916-2523; ESPITALETA, ZILAC/0000-0003-4710-386X; Castano, Luis/0000-0003-0437-9401; Madrid, Alvaro/0000-0002-5942-8488; Perez de Nanclares, Gustavo/0000-0002-1692-8976; Loza, Reyner/0000-0003-1769-9527	FIS of the Institute de Salud Carlos III, Madrid, Spain [PI09/90888, PI11/01412]; Department of Health of the Basque Government [2014111064]; Department of Education of the Basque Government [IT795-13]	FIS of the Institute de Salud Carlos III, Madrid, Spain; Department of Health of the Basque Government; Department of Education of the Basque Government	This study was supported by two grants (PI09/90888 and PI11/01412) from the FIS of the Institute de Salud Carlos III, Madrid, Spain, the Department of Health of the Basque Government (2014111064), and the Department of Education of the Basque Government (IT795-13).	BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; Bettinelli A, 2000, PEDIATR NEPHROL, V14, P940, DOI 10.1007/PL00013418; Bettinelli A, 2007, AM J KIDNEY DIS, V49, P91, DOI 10.1053/j.ajkd.2006.10.001; Bilbao JR, 2005, PEDIATR NEPHROL, V20, P891; Brochard K, 2009, NEPHROL DIAL TRANSPL, V24, P1455, DOI 10.1093/ndt/gfn689; Colussi G, 2002, NEPHROL DIAL TRANSPL, V17, P521, DOI 10.1093/ndt/17.3.521; Ellison DH, 2000, AM J PHYSIOL-RENAL, V279, pF616, DOI 10.1152/ajprenal.2000.279.4.F616; Castano AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074673; Gorgojo JJ, 2006, HORM RES, V65, P62, DOI 10.1159/000090601; Jeck N, 2000, PEDIATR RES, V48, P754, DOI 10.1203/00006450-200012000-00009; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Lee BH, 2012, NEPHROL DIAL TRANSPL, V27, P1516, DOI 10.1093/ndt/gfr475; Nozu K, 2007, PEDIATR RES, V62, P364, DOI 10.1203/PDR.0b013e318123fb90; Nozu K, 2010, J CLIN ENDOCR METAB, V95, pE511, DOI 10.1210/jc.2010-0392; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; Peters M, 2002, AM J MED, V112, P183, DOI 10.1016/S0002-9343(01)01086-5; SaitoOhara F, 1996, GENOMICS, V36, P372, DOI 10.1006/geno.1996.0479; Schurman SJ, 2001, J PEDIATR-US, V139, P105, DOI 10.1067/mpd.2001.115020; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Tajima T, 2006, ENDOCR J, V53, P647, DOI 10.1507/endocrj.K06-034; TAKEUCHI Y, 1995, KIDNEY INT, V48, P1497, DOI 10.1038/ki.1995.439; Watanabe T, 2005, PEDIATR NEPHROL, V20, P676, DOI 10.1007/s00467-004-1732-5; Zelikovic I, 2003, NEPHROL DIAL TRANSPL, V18, P1696, DOI 10.1093/ndt/gfg249; Zelikovic I, 2003, KIDNEY INT, V63, P24, DOI 10.1046/j.1523-1755.2003.00730.x	24	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173581	10.1371/journal.pone.0173581	http://dx.doi.org/10.1371/journal.pone.0173581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288174	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400019
J	Shen, W; Liang, XH; Sun, H; De Hoyos, CL; Crooke, ST				Shen, Wen; Liang, Xue-hai; Sun, Hong; De Hoyos, Cheryl L.; Crooke, Stanley T.			Depletion of NEAT1 lncRNA attenuates nucleolar stress by releasing sequestered P54nrb and PSF to facilitate c-Myc translation	PLOS ONE			English	Article							RNA-POLYMERASE-I; NONCODING RNA; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; NUCLEAR-BODIES; MESSENGER-RNAS; CELLS; TRANSCRIPTION; PARASPECKLES; EXPRESSION; PROTEINS	Altered expression of NEAT1, the architectural long non-coding RNA (lncRNA) of nuclear paraspeckles, has been reported during tumorigenesis, as well as under various cellular stress conditions. Here we report that the depletion of NEAT1 lncRNA alleviates nucleolar stress during RNAP I inhibition through releasing sequestered P54nrb and PSF to facilitate the IRES-dependent translation of c-Myc. RNAP I inhibitor CX5461 disrupts the SL1-rDNA interaction and induces nucleolar disruption, demonstrated by the accumulation of fibrillarin-containing nucleoplasmic foci and nucleolar clearance of ribosomal proteins in HeLa cells. Antisense oligonucleotide-mediated depletion of NEAT1 lncRNA significantly attenuated the RNAP I inhibition and its related nucleolar disruption. Interestingly, induction in the levels of c-Myc protein was observed in NEAT1-depeleted cells under RNAP I inhibition. NEAT1associated paraspeckle proteins P54nrb and PSF have been reported as positive regulators of c-Myc translation through interaction with c-Myc IRES. Indeed, an increased association of P54nrb and PSF with c-Myc mRNA was observed in NEAT1-depleted cells. Moreover, apoptosis was observed in HeLa cells depleted of P54nrb and PSF, further confirming the positive involvement of P54nrb and PSF in cell proliferation. Together, our results suggest that NEAT1 depletion rescues CX5461-induced nucleolar stress through facilitating c-Myc translation by relocating P54nrb/PSF from nuclear paraspeckles to c-Myc mRNAs.	[Shen, Wen; Liang, Xue-hai; Sun, Hong; De Hoyos, Cheryl L.; Crooke, Stanley T.] IONIS Pharmaceut Inc, Dept Core Antisense Res, 2855 Gazelle Court, Carlsbad, CA 92010 USA	Ionis Pharmaceuticals, Inc.	Liang, XH (corresponding author), IONIS Pharmaceut Inc, Dept Core Antisense Res, 2855 Gazelle Court, Carlsbad, CA 92010 USA.	Lliang@ionisph.com			Ionis Pharmaceuticals, Inc.	Ionis Pharmaceuticals, Inc.	The work is supported by the internal research funding from Ionis Pharmaceuticals, Inc. The funder provided support in the form of salaries for authors WS, XL, HS, CLD, and STC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blume CJ, 2015, LEUKEMIA, V29, P2015, DOI 10.1038/leu.2015.119; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen M, 2004, ACTA PHARMACOL SIN, V25, P902; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Heyd F, 2011, BIOCHEM BIOPH RES CO, V414, P743, DOI 10.1016/j.bbrc.2011.09.149; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Li L, 2009, P NATL ACAD SCI USA, V106, P12956, DOI 10.1073/pnas.0906005106; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Liang XH, 2016, NAT BIOTECHNOL, V34, P875, DOI 10.1038/nbt.3589; Liang XH, 2014, NUCLEIC ACIDS RES, V42, P7819, DOI 10.1093/nar/gku484; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Mircsof D, 2015, NAT NEUROSCI, V18, P1731, DOI 10.1038/nn.4169; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Shen W, 2015, NUCLEIC ACIDS RES, V43, P4569, DOI 10.1093/nar/gkv298; Shen W, 2014, NUCLEIC ACIDS RES, V42, P8648, DOI 10.1093/nar/gku579; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Zhang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.139; Zhu Z, 2015, ONCOGENE	30	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173494	10.1371/journal.pone.0173494	http://dx.doi.org/10.1371/journal.pone.0173494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288210	Green Submitted, gold, Green Published			2022-12-26	WOS:000396092400016
J	Wang, SD; Sung, KJ; Lin, XXNN; Burns, MA				Wang, Sida; Sung, Ki-Joo; Lin, Xiaoxia Nina; Burns, Mark A.			Bead mediated separation of microparticles in droplets	PLOS ONE			English	Article							STREPTAVIDIN-BIOTIN INTERACTION; DNA COPY NUMBER; INTERFACE; BIOSENSOR; SYSTEM; GROWTH; ARRAYS	Exchange of components such as particles and cells in droplets is important and highly desired in droplet microfluidic assays, and many current technologies use electrical or magnetic fields to accomplish this process. Bead-based microfluidic techniques offer an alternative approach that uses the bead's solid surface to immobilize targets like particles or biological material. In this paper, we demonstrate a bead-based technique for exchanging droplet content by separating fluorescent microparticles in a microfluidic device. The device uses posts to filter surface-functionalized beads from a droplet and re-capture the filtered beads in a new droplet. With post spacing of 7 mu m, beads above 10 mu m had 100% capture efficiency. We demonstrate the efficacy of this system using targeted particles that bind onto the functionalized beads and are, therefore, transferred from one solution to another in the device. Binding capacity tests performed in the bulk phase showed an average binding capacity of 5 particles to each bead. The microfluidic device successfully separated the targeted particles from the non-targeted particles with up to 98% purity and 100% yield.	[Wang, Sida; Lin, Xiaoxia Nina; Burns, Mark A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Sung, Ki-Joo] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Lin, Xiaoxia Nina; Burns, Mark A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Burns, MA (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Burns, MA (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	maburns@umich.edu			 [T32GM008353 1-R21-HG-005077-01-A1 3-R21-HG-005007-02-S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by T32GM008353 1-R21-HG-005077-01-A1 3-R21-HG-005007-02-S1 https://www.nih.gov/. T.C. Chang Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2010, P NATL ACAD SCI; Ali MF, 2003, ANAL CHEM, V75, P4732, DOI 10.1021/ac034106z; Baret JC, 2012, LAB CHIP, V12, P422, DOI 10.1039/c1lc20582j; Brosseau Q, 2014, SOFT MATTER, V10, P3066, DOI 10.1039/c3sm52543k; Brouzes E, 2015, LAB CHIP, V15, P908, DOI 10.1039/c4lc01327a; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Cho SK, 2007, LAB CHIP, V7, P490, DOI 10.1039/b615665g; Choi JW, 2002, LAB CHIP, V2, P27, DOI 10.1039/b107540n; Dewan A, 2012, BIOTECHNOL BIOENG, V109, P2987, DOI 10.1002/bit.24568; Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028; Fornell A, 2015, ANAL CHEM, V87, P10521, DOI 10.1021/acs.analchem.5b02746; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Hein M, 2015, LAB CHIP, V15, P2879, DOI 10.1039/c5lc00420a; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jung JH, 2016, LAB CHIP, V16, P3235, DOI 10.1039/c6lc00648e; Kim JA, 2015, BIOSENS BIOELECTRON, V67, P724, DOI 10.1016/j.bios.2014.10.042; Kurup GK, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3700120; Lee H, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4892495; Lee J, 2002, SENSOR ACTUAT A-PHYS, V95, P259, DOI 10.1016/S0924-4247(01)00734-8; Lim CT, 2007, BIOSENS BIOELECTRON, V22, P1197, DOI 10.1016/j.bios.2006.06.005; Mazutis L, 2009, LAB CHIP, V9, P2665, DOI 10.1039/b903608c; Moon H, 2002, J APPL PHYS, V92, P4080, DOI 10.1063/1.1504171; Ng JK, 2008, BIOSENS BIOELECTRON, V23, P803, DOI 10.1016/j.bios.2007.08.026; OKU Y, 1988, MICROBIOL IMMUNOL, V32, P807, DOI 10.1111/j.1348-0421.1988.tb01442.x; Pan XY, 2011, ELECTROPHORESIS, V32, P3399, DOI 10.1002/elps.201100078; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017019; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Shah GJ, 2009, LAB CHIP, V9, P1732, DOI 10.1039/b821508a; Sinn I, 2011, LAB CHIP, V11, P2604, DOI 10.1039/c0lc00734j; Teste B, 2013, LAB CHIP, V13, P2344, DOI 10.1039/c3lc50353d; Wang C, 2000, RAPID COMMUN MASS SP, V14, P1377, DOI 10.1002/1097-0231(20000815)14:15<1377::AID-RCM31>3.0.CO;2-2; Wang JJ, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816943; Wong J, 1999, BIOMOL ENG, V16, P45, DOI 10.1016/S1050-3862(99)00035-2; Zhao Y, 2010, SYNCHRONIZATION WASH, P635, DOI DOI 10.1039/C3LC50353D	35	7	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173479	10.1371/journal.pone.0173479	http://dx.doi.org/10.1371/journal.pone.0173479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282412	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800044
J	Bilardi, JE; Walker, SM; Temple-Smith, MJ; McNair, RP; Mooney-Somers, J; Vodstrcil, LA; Bellhouse, CE; Fairley, CK; Bradshaw, CS				Bilardi, Jade E.; Walker, Sandra M.; Temple-Smith, Meredith J.; McNair, Ruth P.; Mooney-Somers, Julie; Vodstrcil, Lenka A.; Bellhouse, Clare E.; Fairley, Christopher K.; Bradshaw, Catriona S.			Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; RISK-FACTORS; ORAL METRONIDAZOLE; PRETERM DELIVERY; COLONIZATION; CIRCUMCISION; ASSOCIATION; EXPERIENCES; PREVALENCE; PREVENTION	Background Bacterial vaginosis (BV) affects a third of women of reproductive age in the US and there is increasing evidence to suggest it may be sexually transmitted. This study aimed to extend and validate the findings of our earlier smaller qualitative study by exploring in detail women's views and experiences of the triggering factors associated with BV onset and recurrence. Methods Women aged 20-49, who had experienced one or more symptomatic episode of BV within 6 months, were opportunistically recruited to complete a 38-item questionnaire on their experience of BV. Results 103 women completed the questionnaire. Women were significantly more likely to report sexual than lifestyle factors triggered BV onset and recurrence (p< 0.001). The top 3 factors women attributed to both BV onset and recurrence were identical-and all sexual. They included, in order: 1) unprotected sex; 2) sex with a new male partner; and 3) sex in general. The main lifestyle factors nominated included stress, diet, menstruation and the use of feminine hygiene products. While many women felt their BV had been transmitted through sexual contact (54%) and developed as a result of sexual activity (59%), few considered BV a sexually transmitted infection (STI) (10%). Despite this 57% felt partners should also be treated for BV. Conclusion These data concur with our earlier qualitative findings that women believe BV is triggered by sexual activity. While many women felt BV was sexually transmitted and supported partner treatment, they did not consider BV an STI. This contradiction is likely due to information conveyed to women based on current guidelines. In the absence of highly effective BV treatments, this study highlights the need for guidelines to indicate there is scientific uncertainty around the pathogenesis of BV and to contain clear health messages regarding the evidence for practices shown to be associated with a reduced risk of BV ( i.e. consistent condom use.	[Bilardi, Jade E.; Walker, Sandra M.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Bradshaw, Catriona S.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Bilardi, Jade E.; Walker, Sandra M.; Vodstrcil, Lenka A.; Bellhouse, Clare E.; Fairley, Christopher K.; Bradshaw, Catriona S.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bilardi, Jade E.; Temple-Smith, Meredith J.; McNair, Ruth P.] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Mooney-Somers, Julie] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW, Australia; [Bellhouse, Clare E.] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; Monash University; University of Melbourne	Bilardi, JE (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.; Bilardi, JE (corresponding author), Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Bilardi, JE (corresponding author), Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia.	jbilardi@mshc.org.au	Vodstrcil, Lenka/AAF-8722-2020; McNair, Ruth P/B-3027-2012; Vodstrcil, Lenka/AAC-1896-2019	Vodstrcil, Lenka/0000-0003-3679-9195; Christopher, Fairley/0000-0001-9081-1664; Bilardi, Jade/0000-0003-0461-2605; bradshaw, catriona/0000-0002-6643-5678; McNair, Ruth/0000-0002-4738-8781	NHMRC Early Career Fellowship [1013135]	NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Dr Jade Bilardi is in receipt of an NHMRC Early Career Fellowship no 1013135.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Amaya-Guio J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011701.pub2; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Bilardi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151794; Bilardi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150272; Bilardi JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074378; Boskey ER, 2005, ALTERN THER HEALTH M, V11, P38; Bradshaw CS, 2016, J INFECT DIS, V214, pS14, DOI 10.1093/infdis/jiw159; Bradshaw CS, 2014, J INFECT DIS, V209, P1562, DOI 10.1093/infdis/jit664; Bradshaw CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057688; Bradshaw CS, 2013, CLIN INFECT DIS, V56, P777, DOI 10.1093/cid/cis1030; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Calzolari E, 2000, INT J GYNECOL OBSTET, V70, P341, DOI 10.1016/S0020-7292(00)00217-4; Chapple A, 2000, J REPROD INFANT PSYC, V18, P309, DOI 10.1080/713683045; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Culhane Jennifer F, 2006, Curr Infect Dis Rep, V8, P459, DOI 10.1007/s11908-006-0020-x; EASMON CSF, 1992, GENITOURIN MED, V68, P134; Eschenbach DA, 2007, CLIN INFECT DIS, V44, P220, DOI 10.1086/509584; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fethers KA, 2009, J INFECT DIS, V200, P1662, DOI 10.1086/648092; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Gray RH, 2009, J INFECT DIS, V199, P1, DOI 10.1086/595568; Guedou FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Hood JE, 2011, SEX HEALTH, V8, P159, DOI 10.1071/SH10070; Hutchinson KB, 2007, SEX TRANSM DIS, V34, P671, DOI 10.1097/01.olq.0000258435.34879.da; Irving G, 1998, SEX TRANSM INFECT, V74, P334, DOI 10.1136/sti.74.5.334; Johnson SR, 2010, J LOW GENIT TRACT DI, V14, P287, DOI 10.1097/LGT.0b013e3181d85bb7; Karasz A, 2003, SOC SCI MED, V56, P1013, DOI 10.1016/S0277-9536(02)00092-8; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Liu CM, 2015, MBIO, V6, DOI 10.1128/mBio.00589-15; Liu CM, 2013, MBIO, V4, DOI 10.1128/mBio.00076-13; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P335, DOI 10.1097/OLQ.0b013e3181ca3cac; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; Mehta SD, 2012, SEX TRANSM DIS, V39, P822, DOI 10.1097/OLQ.0b013e3182631d89; Melbourne Sexual Health Centre, 2016, BACT VAG BV FACTSH; Miller K, 2003, AM J HEALTH BEHAV, V27, pS264; Mitchell C, 2011, SEX TRANSM DIS, V38, P1137, DOI 10.1097/OLQ.0b013e31822e6121; Nansel TR, 2006, AM J OBSTET GYNECOL, V194, P381, DOI 10.1016/j.ajog.2005.07.047; Ness RB, 2002, OBSTET GYNECOL, V100, P765, DOI 10.1016/S0029-7844(02)02184-1; Newton Danielle C, 2005, Sex Health, V2, P63, DOI 10.1071/SH04015; Nyirjesy P, 1997, OBSTET GYNECOL, V90, P50, DOI 10.1016/S0029-7844(97)00242-1; ODowd T, 1996, BRIT J GEN PRACT, V46, P415; Parma M, 2014, ALTERN THER HEALTH M, V20, P52; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Royce RA, 1999, SEX TRANSM DIS, V26, P96, DOI 10.1097/00007435-199902000-00007; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Smart S, 2004, SEX TRANSM INFECT, V80, P58, DOI 10.1136/sti.2003.004978; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; SOBEL JD, 1993, J INFECT DIS, V167, P783, DOI 10.1093/infdis/167.3.783; Spark MJ, 2014, RES SOC ADMIN PHARM, V10, P469, DOI 10.1016/j.sapharm.2013.06.007; Verstraelen H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-148; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Vodstrcil LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073055; Willis GB, 1999 M AM STAT ASS; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	63	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173637	10.1371/journal.pone.0173637	http://dx.doi.org/10.1371/journal.pone.0173637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278277	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900023
J	Masuda, H; Shimochi, E; Hamada, T; Senoura, T; Kobayashi, T; Aung, MS; Ishimaru, Y; Ogo, Y; Nakanishi, H; Nishizawa, NK				Masuda, Hiroshi; Shimochi, Erika; Hamada, Tatsuro; Senoura, Takeshi; Kobayashi, Takanori; Aung, May Sann; Ishimaru, Yasuhiro; Ogo, Yuko; Nakanishi, Hiromi; Nishizawa, Naoko K.			A new transgenic rice line exhibiting enhanced ferric iron reduction and phytosiderophore production confers tolerance to low iron availability in calcareous soil	PLOS ONE			English	Article							ORYZA-SATIVA L.; REGULATED METAL TRANSPORTER; GRAMINEOUS PLANTS; HORDEUM-VULGARE; MUGINEIC ACID; BARLEY GENES; NICOTIANAMINE AMINOTRANSFERASE; 2'-DEOXYMUGINEIC ACID; CHELATE REDUCTASE; SYNTHASE GENES	Iron (Fe) deficiency is a critical agricultural problem, especially in calcareous soil, which is distributed worldwide. Rice plants take up Fe(II) from soil through a OsIRT1 transporter (Strategy I-related system) and also take up Fe(III) via a phytosiderophore-based system (Strategy II system). However, rice plants are susceptible to low-Fe conditions because they have low Fe(III) reduction activity and low-level phytosiderophore secretion. Previously, we produced transgenic rice plants expressing a mutationally reconstructed yeast ferric chelate reductase, refre1/372, under the control of the OsIRT1 promoter. This transgenic rice line exhibited higher Fe(III) chelate reductase activity and tolerance to Fe deficiency. In addition, we produced transgenic rice overexpressing the Fe deficiency-inducible transcription factor, OsIRO2, which regulates the expression of various genes involved in the strategy II Fe(III) uptake system, including OsNAS1, OsNAAT1, OsDMAS1, OsYSL15, and TOM1. This transgenic rice exhibited improved phytosiderophore secretion ability and tolerance to Fe deficiency. In the present research, transgenic rice plants that possess both the OsIRT1 promoter-refre1/372 and the 35S promoter-OsIRO2 (RI lines) were produced to enhance both Strategy I Fe(II) reductase ability and Strategy II phytosiderophore productivity. RI lines exhibited enhanced tolerance to Fe-deficient conditions at the early and middle-late stages of growth in calcareous soil, compared to both the non-transgenic line and lines harboring either OsIRT1 promoter-refre1/372 or 35S promoter-OsIRO2 alone. RI lines also exhibited a 9-fold higher yield than the non-transgenic line. Moreover, we successfully produced Fe-deficiency-tolerant Tachisugata rice, which is a high-biomass variety used as fodder. Collectively, our results demonstrate that combined enhancement of two Fe uptake systems in rice is highly effective in conferring tolerance to low Fe availability in calcareous soil.	[Masuda, Hiroshi; Shimochi, Erika; Hamada, Tatsuro; Senoura, Takeshi; Kobayashi, Takanori; Aung, May Sann; Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan; [Ishimaru, Yasuhiro] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi, Japan; [Ogo, Yuko] Natl Inst Agrobiol Sci, Funct Plant Res Unit, Tsukuba, Ibaraki, Japan; [Nakanishi, Hiromi] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Ishikawa Prefecture University; Tohoku University; National Institute of Agrobiological Sciences - Japan; University of Tokyo	Nishizawa, NK (corresponding author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan.	kz-naoko@ishikawa-pu.ac.jp	ISHIMARU, Yasuhiro/AAS-5947-2020	ISHIMARU, Yasuhiro/0000-0003-4723-8844	Advanced Low Carbon Technology Research and Development Program (ALGA) of the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Sciences (JSPS)	Advanced Low Carbon Technology Research and Development Program (ALGA) of the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Sciences (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALGA) of the Japan Science and Technology Agency (JST) to NK Nishizawa and a Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Sciences (JSPS) to NK Nishizawa.	Araki R, 2015, PLANT J, V81, P233, DOI 10.1111/tpj.12722; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Briat JF, 2015, TRENDS PLANT SCI, V20, P33, DOI 10.1016/j.tplants.2014.07.005; Bughio N, 2002, J EXP BOT, V53, P1677, DOI 10.1093/jxb/erf004; Connolly EL, 2003, PLANT PHYSIOL, V133, P1102, DOI 10.1104/pp.103.025122; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Horita M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-014-0192-9; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Ishimaru Y, 2011, J BIOL CHEM, V286, P24649, DOI 10.1074/jbc.M111.221168; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2001, PLANTA, V212, P864, DOI 10.1007/s004250000453; Kobayashi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3792; Kobayashi T, 2009, PLANT J, V60, P948, DOI 10.1111/j.1365-313X.2009.04015.x; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Ma JF, 1999, PLANTA, V207, P590, DOI 10.1007/s004250050522; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Masuda H, 2013, RICE, V6, DOI 10.1186/1939-8433-6-40; Masuda H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00132; Masuda H, 2009, RICE, V2, P155, DOI 10.1007/s12284-009-9031-1; Masuda H, 2008, RICE, V1, P100, DOI 10.1007/s12284-008-9007-6; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Nakanishi H, 2000, PLANT MOL BIOL, V44, P199, DOI 10.1023/A:1006491521586; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Nozoye T, 2014, PLANT J, V77, P246, DOI 10.1111/tpj.12383; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Ogo Y, 2011, PLANT MOL BIOL, V75, P593, DOI 10.1007/s11103-011-9752-6; Ohta H., 2010, B NATL I CROP SCI, V11, P67; Oki H, 2004, SOIL SCI PLANT NUTR, V50, P1159, DOI 10.1080/00380768.2004.10408589; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; Suzuki M, 2008, SOIL SCI PLANT NUTR, V54, P77, DOI 10.1111/j.1747-0765.2007.00205.x; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; Terada R, 2004, PLANT CELL REP, V22, P653, DOI 10.1007/s00299-003-0752-0; THOMSON D, 1995, BIOTECHNIQUES, V19, P394	50	18	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173441	10.1371/journal.pone.0173441	http://dx.doi.org/10.1371/journal.pone.0173441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278216	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900093
J	Chang, GJ; Mouillet, JF; Mishima, T; Chu, TJ; Sadovsky, E; Coyne, CB; Parks, WT; Surti, U; Sadovsky, Y				Chang, Guojing; Mouillet, Jean-Francois; Mishima, Takuya; Chu, Tianjiao; Sadovsky, Elena; Coyne, Carolyn B.; Parks, W. Tony; Surti, Urvashi; Sadovsky, Yoel			Expression and trafficking of placental microRNAs at the feto-maternal interface	FASEB JOURNAL			English	Article						pregnancy; placenta; trophoblasts; C19MC	GENE-EXPRESSION; IN-VIVO; INTERCELLULAR COMMUNICATION; CIRCULATING MICRORNAS; RNA INTERFERENCE; MATERNAL PLASMA; C19MC MICRORNAS; CLUSTER C19MC; LENTIVIRUS; CELLS	During pregnancy, placental trophoblasts at the feto-maternal interface produce a broad repertoire of microRNA (miRNA) species. These species include miRNA from the primate-specific chromosome 19 miRNA cluster (C19MC), which is expressed nearly exclusively in the placenta. Trafficking of these miRNAs among the maternal, placental, and fetal compartments is unknown. To determine miRNA expression and trafficking patterns during pregnancy, we sequenced miRNAs in triads of human placenta and of maternal and fetal blood and found large subject-to-subject variability, with C19MC exhibiting compartment-specific expression. We therefore created humanized mice that transgenically express the entire 160-kb human C19MC locus or lentivirally express C19MC miRNAmembers selectively in the placenta. C19MC transgenic mice expressed a low level of C19MC miRNAs in diverse organs. When pregnant, female C19MC mice exhibited a strikingly elevated(>40-fold) expression of C19MC miRNA in the placenta, compared with other organs, that resembled C19MC miRNAs patterns in humans. Our mouse models showed that placental miRNA traffic primarily to the maternal circulation and that maternal miRNA can traffic to the placenta and even into the fetal compartment. These findings define an extraordinary means of nonhormonal, miRNA-based communication between the placenta and feto-maternal compartments.-Chang, G., Mouillet, J.-F., Mishima, T., Chu, T., Sadovsky, E., Coyne, C.B., Parks, W.T., Surti, U., Sadovsky, Y. Expression and trafficking of placental microRNAs at the feto-maternal interface.	[Chang, Guojing; Mouillet, Jean-Francois; Mishima, Takuya; Chu, Tianjiao; Sadovsky, Elena; Coyne, Carolyn B.; Parks, W. Tony; Surti, Urvashi; Sadovsky, Yoel] Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA; [Mouillet, Jean-Francois; Mishima, Takuya; Chu, Tianjiao; Sadovsky, Elena; Coyne, Carolyn B.; Parks, W. Tony; Surti, Urvashi; Sadovsky, Yoel] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Coyne, Carolyn B.; Sadovsky, Yoel] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Surti, Urvashi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Parks, W. Tony] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Surti, Urvashi] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Pittsburgh Cytogenet Lab,Ctr Med Genet & Genom, Pittsburgh, PA USA; [Chang, Guojing] Tsinghua Univ, Sch Med, Beijing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University	Sadovsky, Y (corresponding author), Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA.	ysadovsky@mwri.magee.edu		Sadovsky, Yoel/0000-0003-2969-6737	University of Pittsburgh-Tsinghua University Education Program; Pennsylvania Department of Health Research Formula Funds; U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD075665, R01-HD065893, R21-HD071707]; 25 Club of Magee Womens Hospital; NIH National Institute of General Medical Sciences [UL1-RR024153]; NIH [UL1-TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD071707, R01HD065893, R01HD075665] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	University of Pittsburgh-Tsinghua University Education Program; Pennsylvania Department of Health Research Formula Funds; U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; 25 Club of Magee Womens Hospital; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank Judy Ziegler for technical assistance, Lori Rideout for assistance in manuscript preparation, and Bruce Campbell for editing (all from Magee Womens Research Institute). This project was supported by the University of Pittsburgh-Tsinghua University Education Program (to G.C.), Pennsylvania Department of Health Research Formula Funds (to J.-F.M and T.C.), U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant R01-HD075665 to C.B.C. and Y.S., and Grants R01-HD065893 and R21-HD071707 to Y.S.), and the 25 Club of Magee Womens Hospital (to Y.S.). Generation of C19MC BAC was made possible by NIH National Institute of General Medical Sciences Grant UL1-RR024153 and NIH Cooperative Agreement Grant UL1-TR000005. C.C. and Y.S. are named inventors on a pending patent application that describes the use of C19MC microRNAs as therapeutics.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentwich I, 2005, FASEB J, V19, P875, DOI 10.1096/fj.04-3609hyp; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Blaydes SM, 1999, MAMM GENOME, V10, P549, DOI 10.1007/s003359901042; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chu TJ, 2015, BIOINFORMATICS, V31, P1780, DOI 10.1093/bioinformatics/btv038; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Gabriel JM, 1998, P NATL ACAD SCI USA, V95, P14857, DOI 10.1073/pnas.95.25.14857; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hartigan J., 1975, CLUSTERING ALGORITHM; HOLM S, 1979, SCAND J STAT, V6, P65; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; John RM, 1999, HUM MOL GENET, V8, P2211, DOI 10.1093/hmg/8.12.2211; Jones BK, 2002, HUM MOL GENET, V11, P411, DOI 10.1093/hmg/11.4.411; KINGDOM J, 2000, PLACENTA BASIC SCI C; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li X, 2011, BIOTECHNOL LETT, V33, P1723, DOI 10.1007/s10529-011-0633-5; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Malashicheva A, 2007, GENESIS, V45, P456, DOI 10.1002/dvg.20313; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mishima T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33345; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Oh SY, 2011, PLACENTA, V32, P1004, DOI 10.1016/j.placenta.2011.09.010; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; R Core Team, 2018, R LANG ENV STAT COMP; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Sadovsky Y., 2015, PLACENTA PLACENTAL T, DOI [10.1016/B978-0-12-397175-3.00039-9, DOI 10.1016/B978-0-12-397175-3.00039-9]; Sadovsky Y, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023036; Vaira V, 2012, J MOL ENDOCRINOL, V49, P115, DOI 10.1530/JME-11-0189; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003; Zhang XY, 2004, J VIROL, V78, P1219, DOI 10.1128/JVI.78.3.1219-1229.2004	56	54	55	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2760	2770		10.1096/fj.201601146R	http://dx.doi.org/10.1096/fj.201601146R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28289056	Green Published			2022-12-26	WOS:000405931000005
J	Bhave, S; Gade, A; Kang, M; Hauser, KF; Dewey, WL; Akbarali, HI				Bhave, Sukhada; Gade, Aravind; Kang, Minho; Hauser, Kurt F.; Dewey, William L.; Akbarali, Hamid I.			Connexin-purinergic signaling in enteric glia mediates the prolonged effect of morphine on constipation	FASEB JOURNAL			English	Article						ATP; lipopolysaccharide; inflammation; electrophysiology	MU-OPIOID RECEPTOR; GUINEA-PIG ILEUM; EXPERIMENTAL COLITIS; NERVOUS-SYSTEM; TOLERANCE; RAT; ROLES; CELLS; P2X7; MICE	Morphine is one of the most widely used drugs for the treatment of pain. However, side effects, including persistent constipation and antinociceptive tolerance, limit its clinical efficacy. Prolonged morphine treatment results in a "leaky" gut, predisposing to colonic inflammation that is facilitated by microbial dysbiosis and associated bacterial translocation. In this study, we examined the role of enteric glia in mediating this secondary inflammatory response to prolonged treatment with morphine. We found that purinergic P2X receptor activity was significantly enhanced in enteric glia that were isolated from mice with long-term morphine treatment (in vivo) but not upon direct exposure of glia to morphine (in vitro). LPS, a major bacterial product, also increased ATP-induced currents, as well as expression of P2X4, P2X7, IL6, IL-1 beta mRNA in enteric glia. LPS increased connexin43 (Cx43) expression and enhanced ATP release from enteric glia cells. LPS-induced P2X currents and proinflammatory cytokine mRNA expression were blocked by the Cx43 blockers Gap26 and carbenoxolone. Likewise, colonic inflammation related to prolonged exposure to morphine was significantly attenuated by carbenoxolone (25mg/kg). Carbenoxolone also prevented gut wall disruption and significantly reduced morphine-induced constipation. These findings imply that enteric glia activation is a significant modulator of morphine-related inflammation and constipation.	[Bhave, Sukhada; Gade, Aravind; Kang, Minho; Hauser, Kurt F.; Dewey, William L.; Akbarali, Hamid I.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, 1112 E Clay St,McGuire Hall 100D, Richmond, VA 23298 USA	Virginia Commonwealth University	Akbarali, HI (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, 1112 E Clay St,McGuire Hall 100D, Richmond, VA 23298 USA.	hamid.akbarali@vcuhealth.org	Bhave, Sukhada/ABC-4954-2020; BHAVE, SUKHADA/AAM-3518-2020; Hauser, Kurt/AAX-8361-2020; Akbarali, Hamid/Q-9344-2019	Hauser, Kurt/0000-0001-7886-0332	U S. National Institutes of Health (NIH) National Institute on Drug Abuse [DA024009, DA036975]; NIH [P30033934]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024009, K02DA027374, R01DA036975, P30DA033934] Funding Source: NIH RePORTER	U S. National Institutes of Health (NIH) National Institute on Drug Abuse; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank David Stevens for technical assistance and Ryan Mischel, Charity Huang, and Aliyeen Khan (all from the Virginia Commonwealth University) for support with the double-blind studies. This study was supported by the U S. National Institutes of Health (NIH) National Institute on Drug Abuse Grants DA024009 (to H.I.A. and W.L.D.) and DA036975 (to H.I.A. and W.L.D.), and NIH Research Programs and Projects/Centers Grant P30033934 (to W.L.D.). The authors declare no conflicts of interest.	Antonioli L, 2013, PHARMACOL THERAPEUT, V139, P157, DOI 10.1016/j.pharmthera.2013.04.002; Aube AC, 2006, GUT, V55, P630, DOI 10.1136/gut.2005.067595; Bassotti G, 2006, HUM PATHOL, V37, P1252, DOI 10.1016/j.humpath.2006.04.027; Boesmans W, 2013, NEUROGASTROENT MOTIL, V25, pE151, DOI 10.1111/nmo.12065; Brookes SJH, 2001, ANAT RECORD, V262, P58; BROUSSARD DL, 1993, J NEUROSCI RES, V34, P24, DOI 10.1002/jnr.490340104; Brown IAM, 2016, CELL MOL GASTROENTER, V2, P77, DOI 10.1016/j.jcmgh.2015.08.007; Connors BW, 2012, EPILEPSY CURR, V12, P66, DOI 10.5698/1535-7511-12.2.66; Corder G, 2017, NAT MED, V23, P164, DOI 10.1038/nm.4262; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; Diezmos EF, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00311; Guedia J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31203; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Gulbransen BD, 2009, GASTROENTEROLOGY, V136, P1349, DOI 10.1053/j.gastro.2008.12.058; Guzman J, 2006, INFLAMM BOWEL DIS, V12, P766, DOI 10.1097/00054725-200608000-00014; Hanani M, 2000, AM J PHYSIOL-GASTR L, V278, pG644, DOI 10.1152/ajpgi.2000.278.4.G644; Hilburger ME, 1997, J INFECT DIS, V176, P183, DOI 10.1086/514021; Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98; Kang M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42658; Kumar L, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/141737; Maguma HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103894; Marques CC, 2014, BBA-MOL BASIS DIS, V1842, P65, DOI 10.1016/j.bbadis.2013.10.012; McClain JL, 2014, GASTROENTEROLOGY, V146, P497, DOI 10.1053/j.gastro.2013.10.061; Meng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054040; NORTH RA, 1977, BRIT J PHARMACOL, V61, P541, DOI 10.1111/j.1476-5381.1977.tb07546.x; Pappagallo M, 2001, AM J SURG, V182, p11S, DOI 10.1016/S0002-9610(01)00782-6; PATON WDM, 1957, BRIT J PHARM CHEMOTH, V12, P119, DOI 10.1111/j.1476-5381.1957.tb01373.x; PATRICK GA, 1978, J PHARMACOL EXP THER, V205, P556; Roberts JA, 2012, CURR OPIN PHARMACOL, V12, P659, DOI 10.1016/j.coph.2012.09.011; Rosenbaum C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151335; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Roy S, 1998, MOL BRAIN RES, V61, P190, DOI 10.1016/S0169-328X(98)00212-5; Ruhl A, 2001, NEUROGASTROENT MOTIL, V13, P95, DOI 10.1046/j.1365-2982.2001.00246.x; RUNKEL NSF, 1993, DIGEST DIS SCI, V38, P1530, DOI 10.1007/BF01308616; Ruzicka BB, 1995, MOL BRAIN RES, V34, P209, DOI 10.1016/0169-328X(95)00165-O; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Smith TH., 2013, J VIS EXP, V78, P50688; Turchan-Cholewo J, 2008, J NEUROSCI RES, V86, P2100, DOI 10.1002/jnr.21653; Van Crombruggen K, 2007, NEUROPHARMACOLOGY, V53, P257, DOI 10.1016/j.neuropharm.2007.05.010; Vanderwinden JM, 2003, CELL TISSUE RES, V312, P149, DOI 10.1007/s00441-003-0716-2; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109	42	30	30	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2649	2660		10.1096/fj.201601068R	http://dx.doi.org/10.1096/fj.201601068R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28280004	Green Published			2022-12-26	WOS:000401553400035
J	Hoffer, ED; Miles, SJ; Dunham, CM				Hoffer, Eric D.; Miles, Stacey J.; Dunham, Christine M.			The structure and function of Mycobacterium tuberculosis MazF-mt6 toxin provide insights into conserved features of MazF endonucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIBOSOMAL-RNA; BACTERIAL PERSISTENCE; ANTITOXIN SYSTEMS; CLEAVAGE; PROTEIN; ENDORIBONUCLEASE; RECOGNITION; TRANSLATION; COMPLEX	Toxin-antitoxin systems are ubiquitous in prokaryotic and archaeal genomes and regulate growth in response to stress. Escherichia coli contains at least 36 putative toxin-antitoxin gene pairs, and some pathogens such as Mycobacterium tuberculosis have over 90 toxin-antitoxin operons. E. coli MazF cleaves free mRNA after encountering stress, and nine M. tuberculosis MazF family members cleave mRNA, tRNA, or rRNA. Moreover, M. tuberculosis MazF-mt6 cleaves 23S rRNA Helix 70 to inhibit protein synthesis. The overall tertiary folds of these MazFs are predicted to be similar, and therefore, it is unclear how they recognize structurally distinct RNAs. Here we report the 2.7-angstrom X-ray crystal structure of MazF-mt6. MazF-mt6 adopts a PemK-like fold but lacks an elongated beta 1-beta 2 linker, a region that typically acts as a gate to direct RNA or antitoxin binding. In the absence of an elongated beta 1-beta 2 linker, MazF-mt6 is unable to transition between open and closed states, suggesting that the regulation of RNA or antitoxin selection may be distinct from other canonical MazFs. Additionally, a shortened beta 1-beta 2 linker allows for the formation of a deep, solvent- accessible, active-site pocket, which may allow recognition of specific, structured RNAs like Helix 70. Structure-based mutagenesis and bacterial growth assays demonstrate that MazF-mt6 residues Asp-10, Arg-13, and Thr-36 are critical for RNase activity and likely catalyze the proton-relay mechanism for RNA cleavage. These results provide further critical insights into how MazF secondary structural elements adapt to recognize diverse RNA substrates.	[Hoffer, Eric D.] Emory Univ, Sch Med, Grad Div Biol & Biomed Sci, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA; [Hoffer, Eric D.; Miles, Stacey J.; Dunham, Christine M.] Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA	Emory University; Emory University	Dunham, CM (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	christine.m.dunham@emory.edu		Hoffer, Eric/0000-0002-2273-6743	National Institute of General Medical Sciences; National Institutes of Health [P41 GM103403]; Southeast Regional Collaborative Access Team beamline; National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation [S10 RR029205]; United States DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southeast Regional Collaborative Access Team beamline; National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation; United States DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dunham laboratory members Drs. T. Maehigashi, J. Meisner, and M. A. Schureck for helpful discussions throughout the project; Dr. M. Witek for providing purified E. coli 50S; and Dr. G. L. Conn for critical reading of the manuscript. We thank Dr. Woychik for reagents and Woychik laboratory member Dr. J. M. Schifano for technical guidance. This work is based upon research conducted at the Northeastern Collaborative Access Team beamline, which is funded by the National Institute of General Medical Sciences, National Institutes of Health Grant P41 GM103403, and at the Southeast Regional Collaborative Access Team beamline. The Pilatus 6M detector on the 24-ID-C beamline is funded by a National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation Grant S10 RR029205. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357.	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Bertini I, 2009, J AM CHEM SOC, V131, P5134, DOI 10.1021/ja8080764; Cook GM, 2013, BBA-GENE REGUL MECH, V1829, P523, DOI 10.1016/j.bbagrm.2013.02.007; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2004, ACTA CRYSTALLOGR D, V60, P1132, DOI 10.1107/S0907444904007814; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Gomis-Ruth FX, 1998, EMBO J, V17, P7404, DOI 10.1093/emboj/17.24.7404; Han JS, 2010, BIOCHEM BIOPH RES CO, V400, P293, DOI 10.1016/j.bbrc.2010.08.023; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Jackman JE, 2006, P NATL ACAD SCI USA, V103, P8640, DOI 10.1073/pnas.0603068103; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Lobato-Marquez D, 2016, FEMS MICROBIOL REV, V40, P592, DOI 10.1093/femsre/fuw022; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Park JH, 2011, FEBS LETT, V585, P2526, DOI 10.1016/j.febslet.2011.07.008; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schifano JM, 2016, NUCLEIC ACIDS RES, V44, P1256, DOI 10.1093/nar/gkv1370; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Schreiter ER, 2006, P NATL ACAD SCI USA, V103, P13676, DOI 10.1073/pnas.0606247103; Simanshu DK, 2013, MOL CELL, V52, P447, DOI 10.1016/j.molcel.2013.09.006; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Witek MA, 2016, NUCLEIC ACIDS RES, V44, P342, DOI 10.1093/nar/gkv1306; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; Zorzini V, 2016, J BIOL CHEM, V291, P10950, DOI 10.1074/jbc.M116.715912; Zorzini V, 2014, NUCLEIC ACIDS RES, V42, P6709, DOI 10.1093/nar/gku266	46	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7718	7726		10.1074/jbc.M117.779306	http://dx.doi.org/10.1074/jbc.M117.779306			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28298445	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000401154100002
J	de Weerd, NA; Matthews, AY; Pattie, PR; Bourke, NM; Lim, SS; Vivian, JP; Rossjohn, J; Hertzog, PJ				de Weerd, Nicole A.; Matthews, Antony Y.; Pattie, Phillip R.; Bourke, Nollaig M.; Lim, San S.; Vivian, Julian P.; Rossjohn, Jamie; Hertzog, Paul J.			A hot spot on interferon alpha/beta receptor subunit 1 (IFNAR1) underpins its interaction with interferon-beta and dictates signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; mutagenesis; receptor; signal transduction; structure-function	I-INTERFERON; INFECTION; CELLS; MICE; ACTIVATION; EXPRESSION; RESPONSES; BLOCKADE; PROTEINS; IMMUNITY	The interaction of IFN- with its receptor IFNAR1 (interferon / receptor subunit 1) is vital for host-protective anti-viral and anti-proliferative responses, but signaling via this interaction can be detrimental if dysregulated. Whereas it is established that IFNAR1 is an essential component of the IFNAR signaling complex, the key residues underpinning the IFN--IFNAR1 interaction are unknown. Guided by the crystal structure of the IFN--IFNAR1 complex, we used truncation variants and site-directed mutagenesis to investigate domains and residues enabling complexation of IFN- to IFNAR1. We have identified an interface on IFNAR1-subdomain-3 that is differentially utilized by IFN- and IFN- for signal transduction. We used surface plasmon resonance and cell-based assays to investigate this important IFN- binding interface that is centered on IFNAR1 residues Tyr(240) and Tyr(274) binding the C and N termini of the B and C helices of IFN-, respectively. Using IFNAR1 and IFN- variants, we show that this interface contributes significantly to the affinity of IFN- for IFNAR1, its ability to activate STAT1, the expression of interferon stimulated genes, and ultimately to the anti-viral and anti-proliferative properties of IFN-. These results identify a key interface created by IFNAR1 residues Tyr(240) and Tyr(274) interacting with IFN- residues Phe(63), Leu(64), Glu(77), Thr(78), Val(81), and Arg(82) that underlie IFN--IFNAR1-mediated signaling and biological processes.	[de Weerd, Nicole A.; Matthews, Antony Y.; Pattie, Phillip R.; Bourke, Nollaig M.; Lim, San S.; Hertzog, Paul J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia; [de Weerd, Nicole A.; Matthews, Antony Y.; Bourke, Nollaig M.; Lim, San S.; Hertzog, Paul J.] Monash Univ, Monash Hlth, Sch Clin Sci, Dept Mol & Translat Sci, 27-31 Wright St, Clayton, Vic 3168, Australia; [Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Hudson Institute of Medical Research; Monash University; Monash University; Monash University; Monash University; Cardiff University	de Weerd, NA; Hertzog, PJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	nicole.deweerd@hudson.org.au; paul.hertzog@hudson.org.au	Bourke, Nollaig/AAE-7279-2019; Rossjohn, Jamie/F-9032-2013; de Weerd, Nicole/X-5886-2019; Bourke, Nollaig M/A-9840-2017; Hertzog, Paul/I-7053-2013	Bourke, Nollaig/0000-0003-4313-6859; Rossjohn, Jamie/0000-0002-2020-7522; de Weerd, Nicole/0000-0002-7985-189X; Bourke, Nollaig M/0000-0003-4313-6859; Hertzog, Paul/0000-0002-1373-8472; Vivian, Julian/0000-0002-9400-4437	National Health and Medical Research Council (NHMRC) [APP1070782]; NHMRC [APP1126524, APP1117527]; Victorian Government's Operational Infrastructure Support Program; Australian Research Council (ARC)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian Research Council (ARC)(Australian Research Council)	Supported by a National Health and Medical Research Council (NHMRC) New Investigator grant (2014-2016, APP1070782) and NHMRC Project Grant APP1126524 and the Victorian Government's Operational Infrastructure Support Program.; Supported by an Australian Research Council (ARC) Laureate Fellowship.; Supported by NHMRC SPRF (Senior Principal Research Fellow) Fellowship APP1117527 and Project Grant APP1126524 and the Victorian Government's Operational Infrastructure Support Program.	Annibali V, 2015, CYTOKINE GROWTH F R, V26, P221, DOI 10.1016/j.cytogfr.2014.10.010; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Dejager L, 2014, J INFECT DIS, V209, P960, DOI 10.1093/infdis/jit600; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jaitin DA, 2007, J INTERF CYTOK RES, V27, P653, DOI 10.1089/jir.2006.0162; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Lebrun C, 2011, Int MS J, V17, P88; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lehmann MH, 2016, J LEUKOCYTE BIOL, V99, P1057, DOI 10.1189/jlb.4MA0815-376RR; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Lin S., 2014, PETROLEUM PROJECT CO, V2, P1, DOI DOI 10.1186/S12929-014-0099-6; Mahieu T, 2006, P NATL ACAD SCI USA, V103, P2292, DOI 10.1073/pnas.0510874103; Mahieu T, 2007, INFECT IMMUN, V75, P22, DOI 10.1128/IAI.00829-06; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Sharma N, 2016, J BIOL CHEM, V291, P3371, DOI 10.1074/jbc.M115.686071; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; Stifter SA, 2014, PROTEIN EXPRES PURIF, V94, P7, DOI 10.1016/j.pep.2013.10.019; Stokes JA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-148; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao WL, 2008, J IMMUNOL, V180, P5483, DOI 10.4049/jimmunol.180.8.5483	37	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7554	7565		10.1074/jbc.M116.773788	http://dx.doi.org/10.1074/jbc.M116.773788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28289093	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000400761300023
J	Mugabo, Y; Zhao, S; Lamontagne, J; Al-Mass, A; Peyot, ML; Corkey, BE; Joly, E; Madiraju, SRM; Prentki, M				Mugabo, Yves; Zhao, Shangang; Lamontagne, Julien; Al-Mass, Anfal; Peyot, Marie-Line; Corkey, Barbara E.; Joly, Erik; Madiraju, S. R. Murthy; Prentki, Marc			Metabolic fate of glucose and candidate signaling and excess-fuel detoxification pathways in pancreatic -cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose metabolism; insulin secretion; lipid metabolism; metabolomics; mitochondrial metabolism; glucodetoxification; pancreatic cells	STIMULATED INSULIN-SECRETION; BETA-CELL; MALONYL-COA; ISLET CELLS; REGULATED ANAPLEROSIS; OBESE MICE; ACID CYCLE; RESISTANCE; ACCUMULATION; CHOLESTEROL	Glucose metabolism promotes insulin secretion in -cells via metabolic coupling factors that are incompletely defined. Moreover, chronically elevated glucose causes -cell dysfunction, but little is known about how cells handle excess fuels to avoid toxicity. Here we sought to determine which among the candidate pathways and coupling factors best correlates with glucose-stimulated insulin secretion (GSIS), define the fate of glucose in the -cell, and identify pathways possibly involved in excess-fuel detoxification. We exposed isolated rat islets for 1 h to increasing glucose concentrations and measured various pathways and metabolites. Glucose oxidation, oxygen consumption, and ATP production correlated well with GSIS and saturated at 16 mm glucose. However, glucose utilization, glycerol release, triglyceride and glycogen contents, free fatty acid (FFA) content and release, and cholesterol and cholesterol esters increased linearly up to 25 mm glucose. Besides being oxidized, glucose was mainly metabolized via glycerol production and release and lipid synthesis (particularly FFA, triglycerides, and cholesterol), whereas glycogen production was comparatively low. Using targeted metabolomics in INS-1(832/13) cells, we found that several metabolites correlated well with GSIS, in particular some Krebs cycle intermediates, malonyl-CoA, and lower ADP levels. Glucose dose-dependently increased the dihydroxyacetone phosphate/glycerol 3-phosphate ratio in INS-1(832/13) cells, indicating a more oxidized state of NAD in the cytosol upon glucose stimulation. Overall, the data support a role for accelerated oxidative mitochondrial metabolism, anaplerosis, and malonyl-CoA/lipid signaling in -cell metabolic signaling and suggest that a decrease in ADP levels is important in GSIS. The results also suggest that excess-fuel detoxification pathways in -cells possibly comprise glycerol and FFA formation and release extracellularly and the diversion of glucose carbons to triglycerides and cholesterol esters.	[Mugabo, Yves; Zhao, Shangang; Lamontagne, Julien; Al-Mass, Anfal; Peyot, Marie-Line; Joly, Erik; Madiraju, S. R. Murthy; Prentki, Marc] Ctr Hosp Univ Montreal, Montreal Diabet Res Ctr, Montreal, PQ H2X 0A9, Canada; [Mugabo, Yves; Zhao, Shangang; Lamontagne, Julien; Al-Mass, Anfal; Peyot, Marie-Line; Joly, Erik; Madiraju, S. R. Murthy; Prentki, Marc] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Zhao, Shangang; Al-Mass, Anfal] McGill Univ, Dept Med, Montreal, PQ H3A 1B1, Canada; [Zhao, Shangang; Al-Mass, Anfal] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Mugabo, Yves; Prentki, Marc] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Mugabo, Yves; Prentki, Marc] Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Mugabo, Yves; Prentki, Marc] Univ Montreal, Fac Med, Dept Mol Med, Montreal, PQ H3C 3J7, Canada; [Corkey, Barbara E.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA; [Zhao, Shangang] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Prentki, M (corresponding author), CRCHUM, Montreal Diabet Res Ctr, 900 St Denis,Viger Tower,Rm R08-412, Montreal, PQ H2X 0A9, Canada.	marc.prentki@umontreal.ca	ZHao, Shangang/H-5730-2019	Zhao, Shangang/0000-0002-9209-8206	Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Sante; department of Nutrition of Universite de Montreal; Diabete Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); department of Nutrition of Universite de Montreal; Diabete Quebec	This work was supported in part by grants from the Canadian Institutes of Health Research (to M. P. and S. R. M. M.) and fellowships from Fonds de Recherche du Quebec-Sante, the department of Nutrition of Universite de Montreal, and Diabete Quebec (to Y. M.). The authors declare that they have no conflicts of interest with the contents of this article.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT F M, 1991, Current Opinion in Cell Biology, V3, P671, DOI 10.1016/0955-0674(91)90040-6; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; BRADLEY DC, 1989, ANAL BIOCHEM, V180, P11, DOI 10.1016/0003-2697(89)90081-X; Brereton MF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13496; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Brunham LR, 2008, J CLIN INVEST, V118, P403, DOI 10.1172/JCI33296; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Ferdaoussi M, 2017, TRENDS CELL BIOL, V27, P163, DOI 10.1016/j.tcb.2016.10.003; Ferdaoussi M, 2015, J CLIN INVEST, V125, P3847, DOI 10.1172/JCI82498; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Gehrmann W, 2010, DIABETES OBES METAB, V12, P149, DOI 10.1111/j.1463-1326.2010.01265.x; Gooding JR, 2016, ARCH BIOCHEM BIOPHYS, V589, P120, DOI 10.1016/j.abb.2015.06.013; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang M, 2012, ISLETS, V4, P210, DOI 10.4161/isl.20141; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS189, DOI 10.1055/s-2001-18581; Krebs M, 2004, CURR MED CHEM, V11, P901, DOI 10.2174/0929867043455620; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 2014, J BIOL CHEM, V289, P12189, DOI 10.1074/jbc.R114.557314; Llanos P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129238; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Lu XL, 2011, CELL STRESS CHAPERON, V16, P539, DOI 10.1007/s12192-011-0265-7; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maechler P, 2010, ADV EXP MED BIOL, V654, P193, DOI 10.1007/978-90-481-3271-3_9; Martins EF, 2004, DIABETES METAB, V30, P21, DOI 10.1016/S1262-3636(07)70085-X; Massa ML, 2001, J ENDOCRINOL, V171, P551, DOI 10.1677/joe.0.1710551; MATSCHINSKY FM, 1986, J BIOL CHEM, V261, P14057; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Nolan CJ, 2015, DIABETES, V64, P673, DOI 10.2337/db14-0694; Nolan CJ, 2013, LANCET DIABETES ENDO, V1, P9, DOI 10.1016/S2213-8587(13)70027-5; Pearson GL, 2016, MOL METAB, V5, P404, DOI 10.1016/j.molmet.2016.04.003; Pepin E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153017; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Proks P, 2010, J GEN PHYSIOL, V136, P389, DOI 10.1085/jgp.201010475; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Rancoule C, 2013, DIABETOLOGIA, V56, P1394, DOI 10.1007/s00125-013-2891-3; Reinbothe TM, 2009, MOL ENDOCRINOL, V23, P893, DOI 10.1210/me.2008-0306; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Sandberg MB, 2005, MOL CELL ENDOCRINOL, V240, P94, DOI 10.1016/j.mce.2005.05.005; Sarre A, 2012, FREE RADICAL BIO MED, V52, P142, DOI 10.1016/j.freeradbiomed.2011.10.437; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Xue JH, 2010, CARDIOVASC RES, V86, P141, DOI 10.1093/cvr/cvp388; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9; Zhao S, 2015, MOL METAB, V4, P940, DOI 10.1016/j.molmet.2015.09.012; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003; Zhou YP, 1996, METABOLISM, V45, P981, DOI 10.1016/S0026-0495(96)90267-X	93	34	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7407	7422		10.1074/jbc.M116.763060	http://dx.doi.org/10.1074/jbc.M116.763060			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28280244	Green Published, hybrid			2022-12-26	WOS:000400761300012
J	Weems, JC; Slaughter, BD; Unruh, JR; Boeing, S; Hall, SM; McLaird, MB; Yasukawa, T; Aso, T; Svejstrup, JQ; Conaway, JW; Conaway, RC				Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Boeing, Stefan; Hall, Shawn M.; McLaird, Merry B.; Yasukawa, Takashi; Aso, Teijiro; Svejstrup, Jesper Q.; Conaway, Joan W.; Conaway, Ronald C.			Cockayne syndrome B protein regulates recruitment of the Elongin A ubiquitin ligase to sites of DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR-SIII; NUCLEOTIDE EXCISION-REPAIR; MAMMALIAN ELONGIN; CUL5-RBX2 MODULES; COUPLED REPAIR; CSB PROTEIN; ELONGATION; ACTIVATION; POLYUBIQUITYLATION	Elongin A performs dual functions as the transcriptionally active subunit of RNA polymerase II (Pol II) elongation factor Elongin and as the substrate recognition subunit of a Cullin-RING E3 ubiquitin ligase that ubiquitylates Pol II in response to DNA damage. Assembly of the ElonginAubiquitin ligase and its recruitment to sites ofDNAdamage is a tightly regulated process induced by DNA-damaging agents and alpha-amanitin, a drug that induces Pol II stalling. In this study, we demonstrate (i) that Elongin A and the ubiquitin ligase subunit CUL5 associate in cells with the Cockayne syndrome B (CSB) protein and (ii) that this interaction is also inducedbyDNA-damagingagentsand alpha-amanitin. Inaddition, we presentevidencethattheCSBproteinpromotesstablerecruitment of the ElonginAubiquitin ligase to sites ofDNAdamage. Our findings are consistent with the model that the Elongin A ubiquitin ligase and theCSBprotein function together in acommonpathway in response to Pol II stalling and DNA damage.	[Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Hall, Shawn M.; McLaird, Merry B.; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA; [Boeing, Stefan; Svejstrup, Jesper Q.] Clare Hall Labs, Francis Crick Inst, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Yasukawa, Takashi; Aso, Teijiro] Kochi Med Sch, Dept Funct Genom, Nanko Ku, Oko Cho, Kochi 7838505, Japan	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Kochi University	Conaway, JW; Conaway, RC (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org; rcc@stowers.org		Svejstrup, Jesper/0000-0003-4964-6147; Unruh, Jay/0000-0003-3077-4990; Conaway, Joan/0000-0002-2786-0663	Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; Francis Crick Institute from Cancer Research UK [FC001166]; UK Medical Research Council [FC001166]; Wellcome Trust [FC001166]; European Research Council [693327, 268797]; Cancer Research UK [11567] Funding Source: researchfish; The Francis Crick Institute [10168, 10166, 10490, 10002] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K08177] Funding Source: KAKEN	Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); The Francis Crick Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation. This work was also supported by the Francis Crick Institute (which receives its core funding from Cancer Research UK (FC001166), the UK Medical Research Council (FC001166), and the Wellcome Trust (FC001166)) and by grants from the European Research Council, Agreements 693327 (TRANSDAM) and 268797 (TRANSINTEG). The authors declare that they have no conflicts of interest with the contents of this article.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Batenburg NL, 2015, EMBO J, V34, P1399, DOI 10.15252/embj.201490041; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; GARRETT KP, 1994, P NATL ACAD SCI USA, V91, P5237, DOI 10.1073/pnas.91.12.5237; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Iyama T, 2016, J MOL BIOL, V428, P62, DOI 10.1016/j.jmb.2015.11.020; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Menoni H, 2012, J CELL BIOL, V199, P1037, DOI 10.1083/jcb.201205149; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Stevnsner T, 2008, MECH AGEING DEV, V129, P441, DOI 10.1016/j.mad.2008.04.009; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; Wang YM, 2014, P NATL ACAD SCI USA, V111, P14454, DOI 10.1073/pnas.1412569111; Weems JC, 2015, J BIOL CHEM, V290, P15030, DOI 10.1074/jbc.M114.632794; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249	44	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 21	2017	292	16					6431	6437		10.1074/jbc.C117.777946	http://dx.doi.org/10.1074/jbc.C117.777946			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8NI	28292928	Green Published, hybrid			2022-12-26	WOS:000399813400001
J	Deng, YS; Cai, CF; Xia, D; Ding, SW; Chen, JZ				Deng, Yusong; Cai, Chongfa; Xia, Dong; Ding, Shuwen; Chen, Jiazhou			Fractal features of soil particle size distribution under different land-use patterns in the alluvial fans of collapsing gullies in the hilly granitic region of southern China	PLOS ONE			English	Article							MULTIFRACTAL ANALYSIS; PHYSICAL-PROPERTIES; LASER DIFFRACTION; LOESS PLATEAU; EROSION; FRAGMENTATION; PROFILES; MODELS	Collapsing gullies are among the most severe soil erosion problems in the tropical and subtropical areas of southern China. However, few studies have examined the relationship of soil particle size distribution (PSD) changes with land-use patterns in the alluvial fans of collapsing gullies. Recently, the fractal method has been applied to estimate soil structure and has proven to be an effective tool in analyzing soil properties and their relationships with other eco-environmental factors. In this study, the soil fractal dimension (D), physico-chemical properties and their relationship with different land-use patterns in alluvial fans were investigated in an experiment that involved seven collapsing gully areas in seven counties of southern China. Our results demonstrated that different land-use patterns of alluvial fans had a significant effect on soil physico-chemical properties. Compared to grasslands and woodlands, farmlands and orchards generally contained more fine soil particles (silt and clay) and fewer coarse particles, whereas significant differences were found in the fractal dimension of soil PSD in different land-use patterns. Specifically, the soil fractal dimension was lower in grasslands and higher in orchards relative to that of other land-use patterns. The average soil fractal dimension of grasslands had a value that was 0.08 lower than that of orchards. Bulk density was lower but porosity was higher in farmlands and orchards. Saturated moisture content was lower in woodlands and grasslands, but saturated hydraulic conductivity was higher in all four land-use patterns. Additionally, the fractal dimension had significant linear relationships with the silt, clay and sand contents and soil properties and exhibited a positive correlation with the clay (R-2 = 0.976, P< 0.001), silt (R-2 = 0.578, P< 0.01), organic carbon (R-2 = 0.777, P< 0.001) and saturated water (R-2 = 0.639, P< 0.01) contents but a negative correlation with gravel content (R-2 = 0.494, P< 0.01), coarse sand content (R-2 = 0.623, P< 0.01) and saturated hydraulic conductivity (R-2 = 0.788, P< 0.001). However, the fractal dimension exhibited no significant correlation with pH, bulk density or total porosity. Furthermore, the second-degree polynomial equation was found to be more adequate for describing the correlations between soil fractal dimension and particle size distribution. The results of this study demonstrate that a fractal dimension analysis of soil particle size distribution is a useful method for the quantitative description of different land-use patterns in the alluvial fans of collapsing gullies in southern China.	[Deng, Yusong; Cai, Chongfa; Ding, Shuwen; Chen, Jiazhou] Huazhong Agr Univ, Minist Agr, Coll Resources & Environm, Key Lab Arable & Consevat Middle & Lower Reaches, Wuhan, Peoples R China; [Xia, Dong] China Three Gorges Univ, Coll Hydraul & Environm Engn, Yichang, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; China Three Gorges University	Cai, CF (corresponding author), Huazhong Agr Univ, Minist Agr, Coll Resources & Environm, Key Lab Arable & Consevat Middle & Lower Reaches, Wuhan, Peoples R China.	chongfacai@126.com		Chen, Jiazhou/0000-0002-6660-6676	National Natural Science Foundation of China [41630858, 41601287, 41571258]; National Science and Technology basic work project [2014 FY110200A16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology basic work project	Financial support for this research was provided by the National Natural Science Foundation of China (No. 41630858, 41601287 and 41571258) and the National Science and Technology basic work project (No. 2014 FY110200A16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arya LM, 2010, SOIL SCI SOC AM J, V74, P33, DOI 10.2136/sssaj2009.0022; Barnes RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108340; Bird N, 2006, J HYDROL, V322, P211, DOI 10.1016/j.jhydrol.2005.02.039; Birkhofer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043292; Bittelli M, 1999, SOIL SCI SOC AM J, V63, P782, DOI 10.2136/sssaj1999.634782x; BUCHAN GD, 1993, SOIL SCI SOC AM J, V57, P901, DOI 10.2136/sssaj1993.03615995005700040004x; Cai LiPing, 2012, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V41, P524; Chen Z., 2007, SOIL WATER CONSERV C, V3, P15; Cheng XianFu, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P76; CLAPP RB, 1978, WATER RESOUR RES, V14, P601, DOI 10.1029/WR014i004p00601; Deng YS, 2015, PROVINCE SCI SOIL WA, V1, P47; Deng YS, 2015, CHINA J INTEGR AGR, V15, P1863; [邓羽松 Deng Yusong], 2015, [水土保持研究, Research of Soil and Water Conservation], V22, P56; [邓羽松 Deng Yusong], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P4850; Ding F, 2014, PLOS ONE, V9, P4703; Fan HC, 2006, SOIL WATER CONSERVE, V1, P27; Feng M.H., 2009, YANGTZE RIVER, V40, P66; Filgueira RR, 1999, SOIL TILL RES, V52, P217, DOI 10.1016/S0167-1987(99)00082-3; Gao GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088559; Grout H, 1998, ENVIRON SCI TECHNOL, V32, P1176, DOI 10.1021/es9704343; Haregeweyn N, 2008, LAND DEGRAD DEV, V19, P136, DOI 10.1002/ldr.830; Hillel D, 1980, FUNDAMENTALS SOIL PH; Huang GuanHua, 2002, Acta Pedologica Sinica, V39, P490; Institute of Soil Science the Chinese Academy of Science (ISSCAS), 1981, SOIL CHEM PHYS AN; Islam KR, 2000, AGR ECOSYST ENVIRON, V79, P9, DOI 10.1016/S0167-8809(99)00145-0; Jiang FS, 2014, SOIL SCI SOC AM J, V78, P1741, DOI 10.2136/sssaj2014.04.0132; Lan HX, 2003, J ASIAN EARTH SCI, V21, P353, DOI 10.1016/S1367-9120(02)00020-2; Liang Y., 2009, SWCC, V1, P31; Liang Y, 2008, SOIL WATER CONSERVE, V12, P50; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087600; Liu X, 2014, CHINA ENV EARTH SCI, V73, P6091, DOI DOI 10.1007/S12665-014-3833-1; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; Luk SH, 1997, CATENA, V29, P97, DOI 10.1016/S0341-8162(96)00049-5; Luk SH, 1997, CATENA, V29, P177, DOI 10.1016/S0341-8162(96)00054-9; Luo BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122842; Lyu XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121368; MANDELBORT B. B., 1982, FRACTAL GEOMETRY NAT, P45; Mandelort BB, 1977, FRACTALS FORM CHANCE; Martin MA, 2002, SOIL TILL RES, V64, P113, DOI 10.1016/S0167-1987(01)00249-5; Martinez-Casanovas JA, 2000, SOIL TILL RES, V57, P101, DOI 10.1016/S0167-1987(00)00142-2; Nie XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105927; Perfect E, 1997, ENG GEOL, V48, P185, DOI 10.1016/S0013-7952(97)00040-9; Pinheiro EFM, 2004, SOIL TILL RES, V77, P79, DOI 10.1016/j.still.2003.11.005; Poesen J, 2003, CATENA, V50, P91, DOI 10.1016/S0341-8162(02)00143-1; Posadas AND, 2003, SOIL SCI SOC AM J, V67, P1361, DOI 10.2136/sssaj2003.1361; Prosperini N, 2008, GEODERMA, V145, P185, DOI 10.1016/j.geoderma.2008.03.004; Sarkar S., 2015, PLOS ONE, V10; Schrumpf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089364; Segal E, 2009, SOIL SCI, V174, P639, DOI 10.1097/SS.0b013e3181c2a928; Sheng JA, 1997, CATENA, V29, P211, DOI 10.1016/S0341-8162(96)00057-4; Skaggs TH, 2001, SOIL SCI SOC AM J, V65, P1038, DOI 10.2136/sssaj2001.6541038x; Song Z, 2015, PLOS ONE, V10, P361; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang D, 2008, CATENA, V72, P29, DOI 10.1016/j.catena.2007.03.019; Wang XD, 2006, GEODERMA, V134, P56, DOI 10.1016/j.geoderma.2005.08.014; Wei YJ, 2015, CATENA, V135, P254, DOI 10.1016/j.catena.2015.08.003; Woo MK, 1997, CATENA, V29, P145, DOI 10.1016/S0341-8162(96)00052-5; Xia D, 2015, NAT HAZARDS, V79, P455, DOI 10.1007/s11069-015-1852-1; Xiao L, 2014, J ARID LAND, V6, P550, DOI 10.1007/s40333-014-0023-7; Xu GC, 2013, CATENA, V101, P17, DOI 10.1016/j.catena.2012.09.013; Xu J., 1992, IAHS PUBL, V209, P455; Xu JX, 1996, CATENA, V27, P249, DOI 10.1016/0341-8162(96)00014-8; YANG PL, 1993, CHINESE SCI BULL, V38, P1896; Zeng Z. X., 1980, ROCK TOPOGRAPHY; Zhang JC, 2015, PLOS ONE, V10; Zhang X.J., 2010, CHINA WATER RESOUR, V4, P17; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zhong BL, 2013, LAND USE POLICY, V32, P119, DOI 10.1016/j.landusepol.2012.10.005; Zou XY, 2002, J ARID ENVIRON, V51, P183, DOI 10.1006/jare.2001.0943	72	25	28	7	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173555	10.1371/journal.pone.0173555	http://dx.doi.org/10.1371/journal.pone.0173555			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301524	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300050
J	Kim, HW; Lee, JC; Lee, J; Kim, JW; Kim, J; Hwang, JH				Kim, Hyoung Woo; Lee, Jong-Chan; Lee, Jongchan; Kim, Jin Won; Kim, Jaihwan; Hwang, Jin-Hyeok			Early versus delayed initiation of adjuvant treatment for pancreatic cancer	PLOS ONE			English	Article							LONG-TERM SURVIVAL; PLUS FOLINIC ACID; SURGICAL COMPLICATIONS; CHEMOTHERAPY; GEMCITABINE; SURGERY; ADENOCARCINOMA; RESECTION; CLASSIFICATION; METASTASIS	Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor showing a tendency for early recurrence, even after curative resection. Although adjuvant treatment improves survival, it is unclear whether early adjuvant treatment initiation yields better outcomes in patients with PDAC. Methods We retrospectively enrolled 113 patients who underwent chemotherapy or chemoradiotherapy after curative resection of PDAC: Fifty-six and 57 patients were in the early and delayed groups, respectively based on the median time of treatment initiation (35 days [range, 20 +/- 83 days]). Results Patient baseline characteristics were comparable in both groups, except for grade III or IV postoperative complications (5.4% in the early group vs. 22.8% in the delayed group). With a median 20.3-month follow-up, the overall survival (OS) and disease-free survival (DFS) times were 29.5 and 14.7 months, respectively. The early group had significantly prolonged OS (39.1 vs. 21.1 months, p = 0.018) and DFS (18.8 vs. 10.0 months, p = 0.034), compared to the delayed group. Among 71 patients who completed planned adjuvant treatment, patients in the early group tended to have longer, though not statistically significant, OS and DFS times than those in the delayed group. In 67 patients without postoperative complications, patients in the early group had longer OS (42.8 vs. 20.5 months, p = 0.002) and DFS (19.6 vs. 9.1 months, p = 0.005) than those in the delayed group. By multivariate analysis, incompletion of treatment (hazard ratio [HR]: 4.039, 95% confidence interval [CI]: 2.334 +/- 6.992), delayed treatment initiation (HR: 1.822, 95% CI: 1.081 +/- 3.070), and positive angiolymphatic invasion (HR: 2.116, 95% CI: 1.160 +/- 3.862) were significantly associated with shorter OS. Conclusions Adjuvant treatment should be delivered earlier and completed for better outcomes in resected PDAC patients, especially without postoperative complications.	[Kim, Hyoung Woo; Lee, Jong-Chan; Lee, Jongchan; Kim, Jin Won; Kim, Jaihwan; Hwang, Jin-Hyeok] Seoul Natl Univ, Dept Internal Med, Coll Med, Bundang Hosp, Seongnam, South Korea; [Kim, Hyoung Woo] Chungbuk Natl Univ, Dept Internal Med, Chungbuk Natl Univ Hosp, Coll Med, Cheongju, South Korea	Seoul National University (SNU); Chungbuk National University; Chungbuk National University Hospital	Hwang, JH (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Bundang Hosp, Seongnam, South Korea.	woltoong@snu.ac.kr		Hwang, Jin-Hyeok/0000-0002-5643-8461				Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Bos ACRK, 2015, EUR J CANCER, V51, P2553, DOI 10.1016/j.ejca.2015.08.016; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Dias-Santos D, 2015, SURGERY, V157, P881, DOI 10.1016/j.surg.2014.12.006; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Farolfi A, 2015, EUR J CANCER, V51, P1874, DOI 10.1016/j.ejca.2015.07.003; FISHER B, 1989, CANCER RES, V49, P1996; Gagliato DD, 2014, J CLIN ONCOL, V32, P735, DOI 10.1200/JCO.2013.49.7693; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hensler T, 1997, INFECT IMMUN, V65, P2283, DOI 10.1128/IAI.65.6.2283-2291.1997; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; Katz MHG, 2009, ANN SURG ONCOL, V16, P836, DOI 10.1245/s10434-008-0295-2; Murakami Y, 2013, CANCER CHEMOTH PHARM, V71, P419, DOI 10.1007/s00280-012-2029-1; Neoptolemos JP, 2012, JAMA-J AM MED ASSOC, V308, P147, DOI 10.1001/jama.2012.7352; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Seth R, 2013, ANN SURG, V258, P158, DOI 10.1097/SLA.0b013e31826fcbdb; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stalder M, 2005, TRANSPL INT, V18, P1158, DOI 10.1111/j.1432-2277.2005.00119.x; Tempero MA, 2014, J NATL COMPR CANC NE, V12, P1083, DOI 10.6004/jnccn.2014.0106; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Ziprin P, 2003, CELL COMMUN ADHES, V10, P141, DOI 10.1080/15419060390262561	29	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173960	10.1371/journal.pone.0173960	http://dx.doi.org/10.1371/journal.pone.0173960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301556	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300102
J	Kierdorf, U; Miller, KV; Flohr, S; Gomez, S; Kierdorf, H				Kierdorf, Uwe; Miller, Karl V.; Flohr, Stefan; Gomez, Santiago; Kierdorf, Horst			Multiple osteochondromas of the antlers and cranium in a free-ranging white-tailed deer (Odocoileus virginianus)	PLOS ONE			English	Article							OF-THE-LITERATURE; FALLOW DEER; MANDIBULAR CONDYLE; HEPARAN-SULFATE; DAMA-DAMA; BONE; EXOSTOSES; OSSIFICATION; GROWTH; TUMOR	This paper reports a case of multiple osteochondromas affecting the antlers and the left zygomatic bone of a free-ranging adult white-tailed buck (Odocoileus virginianus) from Georgia, USA. Along with a few postcranial bones, the antlered cranium of the individual was found in a severely weathered condition and devoid of any soft tissue. The antlers exhibited five pedunculated exostoses that were composed of cancellous bone and, in their peripheral portions, also mineralized cartilage. The largest of the exostoses, located on the right antler, had a maximum circumference of 55 cm. The exostosis arising from the zygomatic bone was broad -based and much smaller than the exophytic outgrowths on the antlers. Diagnosis of the exostoses as osteochondromas was based on their overall morphology, the normal bone structure in their stalk regions, and the continuity of their spongiosa and cortex with the respective components of the parent bones. Antleromas, i.e., pathological outgrowths developing on antlers as a result of insufficient androgen production, were excluded in the differential diagnosis, based on (1) the apparent maturity and, except for the tumors, normal shape of the antlers and (2) the fact that exostosis formation had also affected the zygomatic bone. Previously only a single case of solitary osteochondroma of an antler has been described in the scientific literature. The case presented here is the first report of multiple osteochondromas in a deer. As antlers are regularly collected as trophies, and huge numbers of them are critically inspected each year, the fact that thus far only two cases of antler osteochondromas have been reported suggests that these tumors are very rare.	[Kierdorf, Uwe; Flohr, Stefan; Kierdorf, Horst] Univ Hildesheim, Dept Biol, Hildesheim, Germany; [Miller, Karl V.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Gomez, Santiago] Univ Cadiz, Dept Pathol Anat, Cadiz, Spain	University of Hildesheim; University System of Georgia; University of Georgia; Universidad de Cadiz	Kierdorf, U (corresponding author), Univ Hildesheim, Dept Biol, Hildesheim, Germany.	uwe.kierdorf@uni-hildesheim.de	Kierdorf, Uwe/F-2539-2012	Kierdorf, Uwe/0000-0003-0531-2460; Kierdorf, Horst/0000-0001-6411-9631; Flohr, Stefan/0000-0001-8205-849X				BANKS WJ, 1974, CALC TISS RES, V14, P257, DOI 10.1007/BF02060300; Bovee JVMG, 2002, J CLIN PATHOL, V55, P226, DOI 10.1136/jcp.55.3.226; Craig, 2016, JUBB KENNEDY PALMERS, P16, DOI DOI 10.1016/B978-0-7020-5317-7.00002-3; Czerniak B, 2016, DORFMAN CZERNIAKS BO, Vsecond; de Brot S, 2013, J VET DIAGN INVEST, V25, P599, DOI 10.1177/1040638713495545; Douville M, 1907, B SOC GEN MED VET, V61, P148; Ealla Kranti Kiran Reddy, 2014, J Oral Maxillofac Pathol, V18, P303, DOI 10.4103/0973-029X.140912; FORSSELL H, 1985, BRIT J ORAL MAX SURG, V23, P183, DOI 10.1016/0266-4356(85)90088-9; GESCHICKTER C.G., 1949, TUMORS OF BONE, V3; Gomez S, 2013, BONE, V52, P506, DOI 10.1016/j.bone.2012.09.015; Goss R.J., 1983, DEER ANTLERS REGENER; GOSS RJ, 1995, ANAT REC, V241, P291, DOI 10.1002/ar.1092410302; GOSS RJ, 1990, SCANNING MICROSCOPY, V4, P715; Gruber G. B., 1937, Nachr Ges Wiss Gottingen (Biol), V3, P9; Herzog G., 1944, SPEZIELLE PATHOLOGIE; Hongo H, 2015, J NEUROL SURG REP, V76, P13, DOI 10.1055/s-0034-1387189; Huegel J, 2013, DEV DYNAM, V242, P1021, DOI 10.1002/dvdy.24010; Jochmann K, 2014, MATRIX BIOL, V34, P55, DOI 10.1016/j.matbio.2013.11.003; KERSCHER A, 1993, ORAL SURG ORAL MED O, V75, P559, DOI 10.1016/0030-4220(93)90224-R; KIERDORF H, 1985, Z JAGDWISS, V31, P52, DOI 10.1007/BF02241565; Kierdorf H, 1995, ANN ANAT, V177, P525, DOI 10.1016/S0940-9602(11)80085-3; Kierdorf U, 2004, ANAT REC PART A, V281A, P1352, DOI 10.1002/ar.a.20127; Kierdorf U, 2013, J ANAT, V223, P364, DOI 10.1111/joa.12091; Kierdorf U, 2011, GERONTOLOGY, V57, P53, DOI 10.1159/000300565; Kim SM, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0777-9; Kitsoulis P, 2008, IN VIVO, V22, P633; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; La Sala LF, 2012, DIS AQUAT ORGAN, V102, P149, DOI 10.3354/dao02538; Landete-Castillejos T, 2012, BONE, V50, P245, DOI 10.1016/j.bone.2011.10.026; LEONE NC, 1987, J HERED, V78, P171, DOI 10.1093/oxfordjournals.jhered.a110351; Matthews KA, 2012, COMPARATIVE MED, V62, P149; Munk BA, 2015, VET PATHOL, V52, P213, DOI 10.1177/0300985814528216; POOL RR, 1990, TUMORS DOMESTIC ANIM, P157; Resnick D, 1995, DIAGNOSIS BONE JOINT, P3628; Roschger P, 1998, BONE, V23, P319, DOI 10.1016/S8756-3282(98)00112-4; Unni K. K., 2010, DAHLINS BONE TUMORS; von Korff K., 1914, ANAT HEFTE, V51, P691; Wang XM, 1992, J VERTEBR PALEONTOL, V12, P387, DOI 10.1080/02724634.1992.10011467; WILLIAMS ES, 1989, J WILDLIFE DIS, V25, P258, DOI 10.7589/0090-3558-25.2.258; WISLOCKI GB, 1947, ENDOCRINOLOGY, V40, P202, DOI 10.1210/endo-40-3-202	40	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173775	10.1371/journal.pone.0173775	http://dx.doi.org/10.1371/journal.pone.0173775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296944	Green Published, gold			2022-12-26	WOS:000396311700062
J	Peled, M; Nishi, H; Weinstock, A; Barrett, TJ; Zhou, F; Quezada, A; Fisher, EA				Peled, Michael; Nishi, Hitoo; Weinstock, Ada; Barrett, Tessa J.; Zhou, Felix; Quezada, Alexandra; Fisher, Edward A.			A wild-type mouse-based model for the regression of inflammation in atherosclerosis	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PCSK9 GENE; KNOCKOUT MICE; PROGRESSION; INHIBITION; MUTATIONS; INDUCTION; THERAPY; DIET	Atherosclerosis can be induced by the injection of a gain-of-function mutant of proprotein convertase subtilisin/kexin type 9 (PCSK9)-encoding adeno-associated viral vector (AAVmPCSK9), avoiding the need for knockout mice models, such as low-density lipoprotein receptor deficient mice. As regression of atherosclerosis is a crucial therapeutic goal, we aimed to establish a regression model based on AAVmPCSK9, which will eliminate the need for germ-line genetic modifications. C57BL6/J mice were injected with AAVmPCSK9 and were fed with Western diet for 16 weeks, followed by reversal of hyperlipidemia by a diet switch to chow and treatment with a microsomal triglyceride transfer protein inhibitor (MTPi). Sixteen weeks following AAVmPCSK9 injection, mice had advanced atherosclerotic lesions in the aortic root. Surprisingly, diet switch to chow alone reversed hyperlipidemia to near normal levels, and the addition of MTPi completely normalized hyperlipidemia. A six week reversal of hyperlipidemia, either by diet switch alone or by diet switch and MTPi treatment, was accompanied by regression of atherosclerosis as defined by a significant decrease of macrophages in the atherosclerotic plaques, compared to baseline. Thus, we have established an atherosclerosis regression model that is independent of the genetic background.	[Fisher, Edward A.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10003 USA; NYU, Sch Med, Dept Med, Marc & Ruti Bell Program Vasc Biol, New York, NY USA	New York University; New York University	Fisher, EA (corresponding author), NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10003 USA.	Edward.fisher@nyumc.org	Fisher, Edward/ABE-7469-2020	Zhou, Felix/0000-0002-8619-7160; Fisher, Edward/0000-0001-9802-143X; Weinstock, Ada/0000-0003-3619-3388; Barrett, Tessa/0000-0003-0751-1578	NIH [HL084312, HL117226, DK095684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16H06901] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	These studies were supported by NIH grants HL084312, HL117226, DK095684 (EAF). The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.	Abboud S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001043; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Bjorklund MM, 2014, CIRC RES, V114, P1684, DOI 10.1161/CIRCRESAHA.114.302937; Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Hewing B, 2013, ATHEROSCLEROSIS, V227, P125, DOI 10.1016/j.atherosclerosis.2012.12.026; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Josekutty J, 2013, J BIOL CHEM, V288, P14372, DOI 10.1074/jbc.M113.459602; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Lytle KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146942; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Peled M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00579; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Roche-Molina M, 2015, ARTERIOSCL THROM VAS, V35, P50, DOI 10.1161/ATVBAHA.114.303617; Sands MS, 2011, METHODS MOL BIOL, V807, P141, DOI 10.1007/978-1-61779-370-7_6; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Tolani S, 2013, ATHEROSCLEROSIS, V229, P79, DOI 10.1016/j.atherosclerosis.2013.03.031; Ueshima K, 2005, BIOL PHARM BULL, V28, P247, DOI 10.1248/bpb.28.247	25	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173975	10.1371/journal.pone.0173975	http://dx.doi.org/10.1371/journal.pone.0173975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291840	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700052
J	Carella, F; De Vico, G; Landini, G				Carella, Francesca; De Vico, Gionata; Landini, Gabriel			Nuclear morphometry and ploidy of normal and neoplastic haemocytes in mussels	PLOS ONE			English	Article							COCKLES CERASTODERMA-EDULE; DNA IMAGE-ANALYSIS; FLOW-CYTOMETRY; MYTILUS-GALLOPROVINCIALIS; MYA-ARENARIA; HEMIC NEOPLASIA; SOFTSHELL CLAMS; GENETIC INSTABILITY; MARINE BIVALVES; CELL CARCINOMA	Haemic neoplasia (HN) in bivalves has been reported in association with mass mortality events in various species of molluscs. The aim of this work was to quantify the nuclear morphometry and DNA content of neoplastic cells of mussels Mytilus galloprovincialis affected by HN using nuclear densitometry in Feulgen-stained preparations. The results were also compared with a population of normal mussel haemocytes. We captured 256 images of 3 different neoplasia stages and 120 images of normal haemocytes; thus, a total of 120,166 nuclei were analysed. We extracted 21 morphological parameters from normal and neoplastic nuclei. Eighteen of these parameters were different (P<0.05). Among those (expressed in pixel units-inter-pixel distance of 0.45 micrometres-as: normal vs. neoplastic) nuclear area (117.1 +/- 94.1 vs. 423.1 +/- 226.9), perimeter (44.9 +/- 14.0 vs. 79.0 +/- 21.3) and (IOD) integrated optical density (13.47 +/- 34.5 vs. 177.1 +/- 150.8) were relevant features to discriminate between normal and neoplastic cells. Those differences allowed identifying two distinctive populations of neoplastic nuclei, occasionally in the same individuals at a given phase of the disease. Moreover, neoplastic haemocytes in less extended lesions showed a ploidy value of 6.2 n along with the presence of a second population of circulating cells with a DNA content of 10.7n. In samples with moderate disease only one peak at 7n was observed. Finally, in more severe conditions, a further ploidy peak of 7.8n was recorded, accompanied by a shallow but broad peak of 31n. This latter extreme value is thought to be due to the presence of giant multinucleated cells where individual nuclei overlap in space and cannot be discerned individually. Computer-based imaging allowed the direct visualization of the cell populations and simultaneous collection of ploidy data as well as morphological features of nuclei.	[Carella, Francesca; De Vico, Gionata] Univ Naples Federico II, Dept Biol, Naples, Italy; [Landini, Gabriel] Univ Birmingham, Sch Dent, Coll Med & Dent Sci, Birmingham B5 7EG, W Midlands, England	University of Naples Federico II; University of Birmingham	Carella, F (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	francesca.carella@unina.it	; DE VICO, Gionata/N-7268-2016	Landini, Gabriel/0000-0002-9689-0989; CARELLA, Francesca/0000-0003-1780-1990; DE VICO, Gionata/0000-0001-5953-4160	Progetto MODO-Animal Model; Engineering and Physical Sciences Research Council (UK) [EP/M023869/1]; Engineering and Physical Sciences Research Council [EP/M023869/1] Funding Source: researchfish; EPSRC [EP/M023869/1] Funding Source: UKRI	Progetto MODO-Animal Model; Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by the following: Progetto MODO-Animal Model 2014; the Engineering and Physical Sciences Research Council (UK) (Grant No. EP/M023869/1, Novel context-based segmentation algorithms for intelligent microscopy).	Agarwal N, 2014, 2014 IEEE HEALTHCARE INNOVATION CONFERENCE (HIC), P6, DOI 10.1109/HIC.2014.7038861; Alanen KA, 1998, ANAL QUANT CYTOL, V20, P178; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; AUFFRET M, 1986, AQUACULTURE, V58, P9, DOI 10.1016/0044-8486(86)90152-3; Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; BERTINO B, 1994, ANAL CELL PATHOL, V6, P377; Bierhoff E, 2003, ANTICANCER RES, V23, P2697; Bignold LP, 2006, EXP SUPPL, V96, P1; Bihari N, 1999, PERIOD BIOL, V101, P151; BOCKING A, 1995, ANAL CELL PATHOL, V8, P67; Borgiani L., 1994, Pathologica (Genoa), V86, P356; BRUNETTI R, 1988, MAR ECOL PROG SER, V44, P65, DOI 10.3354/meps044065; Carella F, 2013, DIS AQUAT ORGAN, V105, P81, DOI 10.3354/dao02612; Ciocan C, 2005, MAR POLLUT BULL, V50, P1335, DOI 10.1016/j.marpolbul.2005.04.042; De Vico G, 2015, ISJ-INVERT SURVIV J, V12, P19; De Vico G, 2012, ARGOMENTI PATOLOGIA, DOI [10.13140/2.1.3560.5440, DOI 10.13140/2.1.3560.5440]; Delaporte M, 2008, J INVERTEBR PATHOL, V98, P190, DOI 10.1016/j.jip.2007.12.005; DeVico G, 1997, J COMP PATHOL, V117, P99, DOI 10.1016/S0021-9975(97)80026-6; Dimitriadis VK, 2003, MAR BIOL, V142, P915, DOI 10.1007/s00227-002-1008-1; DIXON DR, 1985, SCI TOTAL ENVIRON, V46, P1, DOI 10.1016/0048-9697(85)90278-5; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; ELSTON RA, 1992, REV AQUAT SCI, V6, P405; FARLEY CA, 1991, ENVIRON HEALTH PERSP, V90, P35, DOI 10.2307/3430843; FARLEY CA, 1969, NATL CANCER I MONOGR, P541; Fickert P, 2014, J HEPATOL, V60, P1290, DOI 10.1016/j.jhep.2014.02.006; Figueras A.J., 1991, J SHELLFISH RES, V10, P84; FIGUERAS AJ, 1991, AQUACULTURE, V99, P17, DOI 10.1016/0044-8486(91)90285-F; FISCHLER DF, 1994, ANAL QUANT CYTOL, V16, P167; Galimany E, 2008, J SHELLFISH RES, V27, P1201, DOI 10.2983/0730-8000-27.5.1201; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GARDNER GR, 1991, ENVIRON HEALTH PERSP, V90, P43, DOI 10.2307/3430844; Giam M, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0009-7; GREEN M, 1983, AQUACULTURE, V30, P1, DOI 10.1016/0044-8486(83)90146-1; Gregory TR, 2003, GENOME, V46, P841, DOI [10.1139/g03-069, 10.1139/G03-069]; Hardie DC, 2002, J HISTOCHEM CYTOCHEM, V50, P735, DOI 10.1177/002215540205000601; Hillman RE, 1990, INCIDENCE NEOPLASIA; INSUA A, 1992, Aquatic Living Resources, V5, P1, DOI 10.1051/alr:1992001; Kontak JA, 2003, UROL CLIN N AM, V30, P467, DOI 10.1016/S0094-0143(03)00020-X; Kullman B., 2006, FOLIA CRYPTOG, V42, P43; Landini G, 2004, CYTOM PART A, V61A, P45, DOI 10.1002/cyto.a.20082; Landini G., 2006, CORRECT BACKGROUND I; Landini G., 2008, P 2 IMAGEJ US DEV C, P116; Li LXL, 2003, AM J DERMATOPATH, V25, P190, DOI 10.1097/00000372-200306000-00002; Lobo J, 2015, J TISSUE ENG REGEN M; LOWE DM, 1978, JNCI-J NATL CANCER I, V60, P1455, DOI 10.1093/jnci/60.6.1455; Maiolino P, 2004, VET PATHOL, V41, P608, DOI 10.1354/vp.41-6-608; Maiolino P, 2002, J COMP PATHOL, V127, P114, DOI 10.1053/jcpa.2002.0568; Marcos Beatriz, 1998, Sangre (Saragossa), V43, P25; McLaughlin SM., 1994, INVERTEBRATE NEOPLAS, P21; Metzger MJ, 2016, NATURE, V534, P705, DOI 10.1038/nature18599; Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Micic M, 2001, AQUAT TOXICOL, V55, P61, DOI 10.1016/S0166-445X(01)00156-4; MOORE JD, 1991, J INVERTEBR PATHOL, V58, P231, DOI 10.1016/0022-2011(91)90067-Z; NACCI D, 1992, MAR ENVIRON RES, V33, P83, DOI 10.1016/0141-1136(92)90134-8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; OPRANDY JJ, 1981, J INVERTEBR PATHOL, V38, P45, DOI 10.1016/0022-2011(81)90033-1; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Peters E.C., 1988, American Fisheries Society Special Publication, P74; PINDUR A, 1994, PROSTATE, V25, P189, DOI 10.1002/pros.2990250404; Puech M, 1999, CYTOMETRY, V36, P11, DOI 10.1002/(SICI)1097-0320(19990501)36:1<11::AID-CYTO2>3.3.CO;2-K; Raghavan S.C., 2010, J NUCL ACIDS, V2010, P2010, DOI DOI 10.1109/INFC0M.2010.5462024; Rasband W., 2006, IMAGEJ; Reeder JE, 1997, CYTOMETRY, V28, P176, DOI 10.1002/(SICI)1097-0320(19970601)28:2<176::AID-CYTO12>3.0.CO;2-N; RENO PW, 1994, J INVERTEBR PATHOL, V64, P163, DOI 10.1016/S0022-2011(94)90025-6; Roels SLMF, 2000, AM J VET RES, V61, P1074, DOI 10.2460/ajvr.2000.61.1074; Romalde JL, 2007, J INVERTEBR PATHOL, V94, P95, DOI 10.1016/j.jip.2006.09.007; Russell JA, 1999, PSYCHOL BULL, V125, P3, DOI 10.1037/0033-2909.125.1.3; Serra J, 1983, IMAGE ANAL MATH MORP; SORENSEN FB, 1992, LAB INVEST, V66, P4; Strefezzi RD, 2003, VET PATHOL, V40, P268, DOI 10.1354/vp.40-3-268; Sunila I., 1994, INVERTEBRATE NEOPLAS, P11; Thunnissen FBJM, 1996, ANAL CELL PATHOL, V12, P13; Thunnissen FBJM, 1997, CYTOMETRY, V27, P21, DOI 10.1002/(SICI)1097-0320(19970101)27:1<21::AID-CYTO3>3.0.CO;2-O; Tiscar PG, 1990, ATTI SOC ITAL SCI VE, V44, P709; VANBENEDEN RJ, 1993, CANCER RES, V53, P2976; Vassilenko E, 2014, J INVERTEBR PATHOL, V117, P68, DOI 10.1016/j.jip.2014.02.002; Villalba A, 2001, DIS AQUAT ORGAN, V46, P213, DOI 10.3354/dao046213; VUKMIROVIC M, 1994, MAR ECOL PROG SER, V109, P165, DOI 10.3354/meps109165; WRISBERG MN, 1992, ECOTOX ENVIRON SAFE, V23, P191, DOI 10.1016/0147-6513(92)90058-B; YAMAMOTO T, 1994, JPN J CANCER RES, V85, P1171, DOI 10.1111/j.1349-7006.1994.tb02924.x; Zizzo N., 1991, B SOC ITAL PATOL ITT, V7, P19	85	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173219	10.1371/journal.pone.0173219	http://dx.doi.org/10.1371/journal.pone.0173219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282459	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800022
J	Misterska, E; Kaminiarczyk-Pyzalka, D; Adamczak, K; Adamczyk, KA; Niedziela, M; Glowacki, M; Glowacki, J				Misterska, Ewa; Kaminiarczyk-Pyzalka, Dominika; Adamczak, Karolina; Adamczyk, Katarzyna A.; Niedziela, Marek; Glowacki, Maciej; Glowacki, Jakub			Mental health and adjustment to juvenile idiopathic arthritis: Level of agreement between parent and adolescent reports according to Strengths and Difficulties Questionnaire and Adolescent Outcomes Questionnaire	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; RECENT ONSET; CHILDREN; DISEASE; ASSOCIATIONS; ADAPTATION; VALIDITY; MOTHERS; LIFE	The aims of this study were threefold. Firstly, to analyze the psychometric properties of the Polish-language Pediatric Outcomes Data Collection Instrument (PODCI) questionnaire in the self-report Adolescent Outcomes Questionnaire (adolescents, 11 - 18 years of age) and in the parent-report Adolescent Outcomes Questionnaire (completed by a parent or guardian of an adolescent aged 11 - 18 years). Secondly, to determine the level of agreement between parents and adolescents in rating dysfunction in juvenile idiopathic arthritis (JIA) and thirdly, to examine associations between psychological adjustments of patients to JIA and disease as well as their socio-demographic characteristics. The study sample consisted of 52 participants. 26 adolescents between the ages of 11 and 18 years with a diagnosis of JIA and 26 parents were considered for inclusion. Disease course was classified as pauciarticular (n = 12, 46.2%) and polyarticular (n = 14, 53.8%). Participants completed the PODCI (self-and parent-report) twice and the Strengths and Difficulties Questionnaire-25 (SDQ25). Considering the distribution of results regarding PODCI normative scores, 73.1% of parents and 69.2% of patients scored below 50 on the Global Functioning Scale; that is lower than the average for the general healthy population. Regarding the parent report, the total score of the SDQ-25 equaled 11.86 (SD 2.66), whereas the patient report equaled 11.23 (SD 2.78). The study groups do not differ significantly in regards to either the PODCI or the SDQ-25 results. Parents and adolescents with JIA appear to hold very similar perceptions of patients' health. Greater differences emerge as disease severity and age of patients increase. Excellent internal consistency, intrarater and test-retest reliability of the Global Functioning Scale have been confirmed in the Polish version of the PODCI, the questionnaire may therefore aid identification of patients reporting significant problems in this group.	[Misterska, Ewa] Univ Secur, Dept Pedag & Psychol, Poznan, Poland; [Kaminiarczyk-Pyzalka, Dominika; Adamczak, Karolina; Niedziela, Marek] Poznan Univ Med Sci, Dept Paediat Endocrinol & Rheumatol, Chair Paediat 2, Poznan, Poland; [Glowacki, Maciej] Adam Mickiewicz Univ, Inst Psychol, Poznan, Poland; [Glowacki, Maciej] Poznan Univ Med Sci, Dept Pediat Orthopaed & Traumatol, Poznan, Poland; [Glowacki, Jakub] HCP Med Ctr, Poznan, Poland	Poznan University of Medical Sciences; Adam Mickiewicz University; Poznan University of Medical Sciences	Misterska, E (corresponding author), Univ Secur, Dept Pedag & Psychol, Poznan, Poland.	emisterska1@wp.pl	Niedziela, Marek/A-1155-2011	Niedziela, Marek/0000-0001-8862-6937; Adamczyk, Katarzyna/0000-0002-7612-8380; Glowacki, Jakub/0000-0002-8200-742X				Abramowicz S, 2016, INT J ORAL MAXILLOFA; BAILDAM EM, 1995, BRIT J RHEUMATOL, V34, P470; Barlow J, 1995, CLIN CHILD PSYCHOL P, V57, P445; Barth S, 2016, PLOS ONE, V26; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BILLINGS AG, 1987, HEALTH PSYCHOL, V6, P343, DOI 10.1037/0278-6133.6.4.343; Consolaro A, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0085-5; Daltroy LH, 1998, J PEDIATR ORTHOPED, V18, P561, DOI 10.1097/00004694-199809000-00001; Damiano DL, 2005, J PEDIATR ORTHOPED, V25, P641, DOI 10.1097/01.bpo.0000167079.83835.22; Degotardi PJ, 1999, ARTHRIT CARE RES, V12, P314, DOI 10.1002/1529-0131(199910)12:5<314::AID-ART2>3.0.CO;2-V; Ding T, 2008, RHEUMATOLOGY, V47, P660, DOI 10.1093/rheumatology/ken095; DUFFY CM, 1993, J RHEUMATOL, V20, P2134; ENNETT ST, 1991, J PEDIATR PSYCHOL, V16, P557, DOI 10.1093/jpepsy/16.5.557; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; GORTMAKER SL, 1990, PEDIATRICS, V85, P267; Hersh AO, 2016, RHEUM DIS CLIN N AM, V42, P333, DOI 10.1016/j.rdc.2016.01.004; JESSOP DJ, 1988, J DEV BEHAV PEDIATR, V9, P147; Kazak AE, 2006, J PEDIATR PSYCHOL, V31, P343, DOI 10.1093/jpepsy/jsj054; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Klepper SE, 2011, ARTHRIT CARE RES, V63, pS371, DOI 10.1002/acr.20635; Kwon DG, 2011, J PEDIATR ORTHOPED, V31, P102, DOI 10.1097/BPO.0b013e318202c6fb; LAVIGNE JV, 1993, J DEV BEHAV PEDIATR, V14, P117; LeBovidge JS, 2003, J PEDIATR PSYCHOL, V28, P29, DOI 10.1093/jpepsy/28.1.29; Mazur J, 2007, DEV PERIOD MED, V11, P13; Noll RB, 1995, FAMILY SYSTEMS MED, V13, P11, DOI DOI 10.1037/H0089103; Quittner AL, 1998, HEALTH PSYCHOL, V17, P112, DOI 10.1037//0278-6133.17.2.112; Rapoff MA, 2005, HDB PEDIAT PSYCHOL; Rosenbaum PL, 1995, QUALITY LIFE PHARMAC, P785; Salter K, 2000, EVIDENCE BASED REV S, P1; Sawyer MG, 2004, RHEUMATOLOGY, V43, P325, DOI 10.1093/rheumatology/keh030; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; THOMPSON R, 1996, ADAPTATION CHRONIC C; VANDVIK IH, 1991, J DEV BEHAV PEDIATR, V12, P84; VANDVIK IH, 1989, J RHEUMATOL, V16, P1088; Wren TAL, 2008, J PEDIATR ORTHOPED, V28, P199, DOI 10.1097/BPO.0b013e318165216d	36	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173768	10.1371/journal.pone.0173768	http://dx.doi.org/10.1371/journal.pone.0173768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282424	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800079
J	Ares, MA; Fernandez-Vazquez, JL; Pacheco, S; Martinez-Santos, VI; Jarillo-Quijada, MD; Torres, J; Alcantar-Curiel, MD; Gonzalez-y-Merchand, JA; De la Cruz, MA				Ares, Miguel A.; Fernandez-Vazquez, Jose L.; Pacheco, Sabino; Martinez-Santos, Veronica I.; Dolores Jarillo-Quijada, Ma.; Torres, Javier; Alcantar-Curiel, Maria D.; Gonzalez-y-Merchand, Jorge A.; De la Cruz, Miguel A.			Additional regulatory activities of MrkH for the transcriptional expression of the Klebsiella pneumoniae mrk genes: Antagonist of H-NS and repressor	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; BIOFILM FORMATION; TYPE-3 FIMBRIAE; DEPENDENT REPRESSION; VIBRIO-CHOLERAE; LIVER-ABSCESS; FOREIGN DNA; IDENTIFICATION; BACTERIA; GENOME	Klebsiella pneumoniae is a common opportunistic pathogen causing nosocomial infections. One of the main virulence determinants of K. pneumoniae is the type 3 pilus (T3P). T3P helps the bacterial interaction to both abiotic and biotic surfaces and it is crucial for the biofilm formation. T3P is genetically organized in three transcriptional units: the mrkABCDF polycistronic operon, the mrkHI bicistronic operon and the mrkJ gene. MrkH is a regulatory protein encoded in the mrkHI operon, which positively regulates the mrkA pilin gene and its own expression. In contrast, the H-NS nucleoid protein represses the transcriptional expression of T3P. Here we reported that MrkH and H-NS positively and negatively regulate mrkJ expression, respectively, by binding to the promoter of mrkJ. MrkH protein recognized a sequence located at position -63.5 relative to the transcriptional start site of mrkJ gene. Interestingly, our results show that, in addition to its known function as classic transcriptional activator, MrkH also positively controls the expression of mrk genes by acting as an anti-repressor of H-NS; moreover, our results support the notion that high levels of MrkH repress T3P expression. Our data provide new insights about the complex regulatory role of the MrkH protein on the transcriptional control of T3P in K. pneumoniae.	[Ares, Miguel A.; Torres, Javier; De la Cruz, Miguel A.] Ctr Med Nacl Siglo XXI IMSS, Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Ciudad De Mexico, Mexico; [Ares, Miguel A.; Gonzalez-y-Merchand, Jorge A.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Ciudad De Mexico, Mexico; [Fernandez-Vazquez, Jose L.; Dolores Jarillo-Quijada, Ma.; Alcantar-Curiel, Maria D.] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Ciudad De Mexico, Mexico; [Pacheco, Sabino] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca, Morelos, Mexico; [Martinez-Santos, Veronica I.] Univ Autonoma Guerrero, Unidad Acad Ciencias Quim Biol, Chilpancingo, Guerrero, Mexico	Instituto Mexicano del Seguro Social; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	De la Cruz, MA (corresponding author), Ctr Med Nacl Siglo XXI IMSS, Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Ciudad De Mexico, Mexico.	miguel_angel_81@live.com	Pacheco, Sabino/AFJ-9017-2022	Martinez-Santos, Veronica/0000-0002-0157-5696; Ares, Miguel/0000-0003-2574-958X; De la Cruz, Miguel A./0000-0001-6909-2941; Pacheco, Sabino/0000-0002-0208-0046; Jarillo-Quijada, Ma Dolores/0000-0003-4510-9707				Alcantar-Curiel MD, 2013, VIRULENCE, V4, P129, DOI 10.4161/viru.22974; ALLEN BL, 1991, J BACTERIOL, V173, P916, DOI 10.1128/jb.173.2.916-920.1991; Ares MA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00013; Ayala JC, 2015, MOL MICROBIOL, V97, P630, DOI 10.1111/mmi.13058; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Chang CM, 2008, INFECTION, V36, P328, DOI 10.1007/s15010-008-7272-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; De la Cruz MA, 2007, MOL MICROBIOL, V66, P727, DOI 10.1111/j.1365-2958.2007.05958.x; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Gallego-Hernandez AL, 2012, J BACTERIOL, V194, P2254, DOI 10.1128/JB.06164-11; GERLACH GF, 1989, J BACTERIOL, V171, P1262, DOI 10.1128/jb.171.3.1262-1270.1989; HAN SHB, 1995, WESTERN J MED, V162, P220; HORNICK DB, 1995, INFECT IMMUN, V63, P2026, DOI 10.1128/IAI.63.5.2026-2032.1995; Huang YJ, 2009, RES MICROBIOL, V160, P71, DOI 10.1016/j.resmic.2008.10.009; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Johnson JG, 2011, J BACTERIOL, V193, P3453, DOI 10.1128/JB.00286-11; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Lithgow JK, 2007, MOL MICROBIOL, V66, P685, DOI 10.1111/j.1365-2958.2007.05950.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Schelenz S, 2007, JOINT BONE SPINE, V74, P275, DOI 10.1016/j.jbspin.2006.08.007; Schroll C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-179; SCHURTZ TA, 1994, INFECT IMMUN, V62, P4186, DOI 10.1128/IAI.62.10.4186-4191.1994; Sebghati TAS, 1998, INFECT IMMUN, V66, P2887, DOI 10.1128/IAI.66.6.2887-2894.1998; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Struve C, 2009, INFECT IMMUN, V77, P5016, DOI 10.1128/IAI.00585-09; Tan JWH, 2015, J BACTERIOL, V197, P1659, DOI 10.1128/JB.02615-14; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Yang JJ, 2013, J GERIATR CARDIOL, V10, P10, DOI [10.3969/j.issn.1671-5411.2013.01.003, 10.3724/SP.J.1263.2012.12191]; Zamorano-Sanchez D, 2015, J BACTERIOL, V197, P1221, DOI 10.1128/JB.02439-14	45	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173285	10.1371/journal.pone.0173285	http://dx.doi.org/10.1371/journal.pone.0173285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278272	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900067
J	Hanemaaijer, M; Olivier, BG; Roling, WFM; Bruggeman, FJ; Teusink, B				Hanemaaijer, Mark; Olivier, Brett G.; Roling, Wilfred F. M.; Bruggeman, Frank J.; Teusink, Bas			Model-based quantification of metabolic interactions from dynamic microbial-community data	PLOS ONE			English	Article							CLOSTRIDIUM-ACETOBUTYLICUM; GENE-EXPRESSION; MIXED-CULTURE; NITRATE; GROWTH; FERMENTATION; NITROGEN; GLUCOSE; BIOLOGY; NITRITE	An important challenge in microbial ecology is to infer metabolic-exchange fluxes between growing microbial species from community-level data, concerning species abundances and metabolite concentrations. Here we apply a model-based approach to integrate such experi-mental data and thereby infer metabolic-exchange fluxes. We designed a synthetic anaero-bic co-culture of Clostridium acetobutylicum and Wolinella succinogenes that interact via interspecies hydrogen transfer and applied different environmental conditions for which we expected the metabolic-exchange rates to change. We used stoichiometric models of the metabolism of the two microorganisms that represents our current physiological under-standing and found that this understanding -the model -is sufficient to infer the identity and magnitude of the metabolic-exchange fluxes and it suggested unexpected interactions. Where the model could not fit all experimental data, it indicates specific requirement for fur-ther physiological studies. We show that the nitrogen source influences the rate of interspe-cies hydrogen transfer in the co-culture. Additionally, the model can predict the intracellular fluxes and optimal metabolic exchange rates, which can point to engineering strategies. This study therefore offers a realistic illustration of the strengths and weaknesses of model-based integration of heterogenous data that makes inference of metabolic-exchange fluxes possible from community-level experimental data.	[Hanemaaijer, Mark; Olivier, Brett G.; Bruggeman, Frank J.; Teusink, Bas] Vrije Univ Amsterdam, Amsterdam Insititute Mol Med & Syst, Syst Bioinformat, Amsterdam, Netherlands; [Hanemaaijer, Mark; Roling, Wilfred F. M.] Vrije Univ Amsterdam, Amsterdam Insititute Mol Med & Syst, Mol Cell Physiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Teusink, B (corresponding author), Vrije Univ Amsterdam, Amsterdam Insititute Mol Med & Syst, Syst Bioinformat, Amsterdam, Netherlands.	b.teusink@vu.nl	Bruggeman, Frank/AAS-8371-2020; Olivier, Brett G/A-2800-2008	Bruggeman, Frank/0000-0002-0255-4766; Olivier, Brett G/0000-0002-5293-5321; Teusink, Bas/0000-0003-3929-0423	ZonMW; Netherlands Genomics Initiative via a Zenith Horizon grant [40-41009-98-10038]; BE-Basic Foundation grant [F08.005.001]	ZonMW(Netherlands Organization for Health Research and Development); Netherlands Genomics Initiative via a Zenith Horizon grant; BE-Basic Foundation grant	This work is financially supported by ZonMW and the Netherlands Genomics Initiative via a Zenith Horizon grant 40-41009-98-10038. BGO is supported by a BE-Basic Foundation grant F08.005.001.	Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Avila M, 2014, INT J FOOD MICROBIOL, V172, P70, DOI 10.1016/j.ijfoodmicro.2013.12.002; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; BOKRANZ M, 1983, ARCH MICROBIOL, V135, P36, DOI 10.1007/BF00419479; Chen JS, 2001, J IND MICROBIOL BIOT, V27, P281, DOI 10.1038/sj.jim.7000083; CHUNG KT, 1976, APPL ENVIRON MICROB, V31, P342, DOI 10.1128/AEM.31.3.342-348.1976; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; De Vuyst L, 2005, TRENDS FOOD SCI TECH, V16, P43, DOI 10.1016/j.tifs.2004.02.012; Embree M, 2015, P NATL ACAD SCI USA, V112, P15450, DOI 10.1073/pnas.1506034112; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Hanemaaijer M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00213; Hanly TJ, 2011, BIOTECHNOL BIOENG, V108, P376, DOI 10.1002/bit.22954; Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370; Jones E., 2001, SCIPY OPEN SOURCE SC; Kelk SM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00580; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Klitgord N, 2011, CURR OPIN BIOTECH, V22, P541, DOI 10.1016/j.copbio.2011.04.018; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Kraft B, 2014, SCIENCE, V345, P676, DOI 10.1126/science.1254070; Lee J, 2008, APPL MICROBIOL BIOT, V80, P849, DOI 10.1007/s00253-008-1654-4; Lee SM, 2010, APPL BIOCHEM BIOTECH, V161, P75, DOI 10.1007/s12010-009-8788-4; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Maarleveld TR, 2014, PLANT PHYSIOL, P113; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Moller S, 1998, APPL ENVIRON MICROB, V64, P721; Olivier BG, 2015, J INTEGR BIOINFORMAT, V12, DOI 10.2390/biecoll-jib-2015-269; Patle S, 2007, BIOTECHNOL LETT, V29, P1839, DOI 10.1007/s10529-007-9493-4; Pawelczyk S, 2008, J MICROBIOL METH, V75, P117, DOI 10.1016/j.mimet.2008.05.018; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; Roling WFM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00125; ROSENBLUM ED, 1949, J BACTERIOL, V57, P413, DOI 10.1128/JB.57.4.413-414.1949; Salimi F, 2010, BIOTECHNOL J, V5, P726, DOI 10.1002/biot.201000159; SCHUMACHER W, 1992, ARCH MICROBIOL, V158, P287, DOI 10.1007/BF00245247; Senger RS, 2008, BIOTECHNOL BIOENG, V101, P1036, DOI 10.1002/bit.22010; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; VANANDEL JG, 1985, APPL MICROBIOL BIOT, V23, P21, DOI 10.1007/BF02660113; Wilson PW, 1930, J BACTERIOL, V19, P231, DOI 10.1128/JB.19.4.231-260.1930; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yang JE, 1998, SOIL SCI SOC AM J, V62, P1108, DOI 10.2136/sssaj1998.03615995006200040036x; Yizhak K, 2010, BIOINFORMATICS, V26, pi255, DOI 10.1093/bioinformatics/btq183; Zengler K, 2012, NAT REV MICROBIOL, V10, P366, DOI 10.1038/nrmicro2763; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11; Zhuang K, 2011, ISME J, V5, P305, DOI 10.1038/ismej.2010.117	47	30	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173183	10.1371/journal.pone.0173183	http://dx.doi.org/10.1371/journal.pone.0173183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278266	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900053
J	Libert, X; Packeu, A; Bureau, F; Roosens, NH; De Keersmaecker, SCJ				Libert, Xavier; Packeu, Ann; Bureau, Fabrice; Roosens, Nancy H.; De Keersmaecker, Sigrid C. J.			Development and performance assessment of a luminex xMAP (R) direct hybridization assay for the detection and identification of indoor air fungal contamination	PLOS ONE			English	Article							REAL-TIME PCR; INTERNAL TRANSCRIBED SPACER; ASPERGILLUS-FUMIGATUS; AIRBORNE FUNGI; DNA; TECHNOLOGY; VALIDATION; BUILDINGS; PATHOGENS; ASTHMA	Considered as a public health problem, indoor fungal contamination is generally monitored using classical protocols based on culturing. However, this culture dependency could influence the representativeness of the fungal population detected in an analyzed sample as this includes the dead and uncultivable fraction. Moreover, culture-based protocols are often time-consuming. In this context, molecular tools are a powerful alternative, especially those allowing multiplexing. In this study a Luminex xMAP (R) assay was developed for the simultaneous detection of 10 fungal species which are most frequently in indoor air and that may cause health problems. This xMAP (R) assay was found to be sensitive, i.e. its limit of detection is ranging between 0.05 and 0.01 ng of gDNA. The assay was subsequently tested with environmental air samples which were also analyzed with a classical protocol. All the species identified with the classical method were also detected with the xMAP (R) assay, however in a shorter time frame. These results demonstrate that the Luminex xMAP (R) fungal assay developed in this study could contribute to the improvement of public health and specifically to the indoor fungal contamination treatment.	[Libert, Xavier; Roosens, Nancy H.; De Keersmaecker, Sigrid C. J.] Sci Inst Publ Hlth WIV ISP, Platform Biotechnol & Mol Biol, Brussels, Belgium; [Libert, Xavier; Bureau, Fabrice] Univ Liege ULg, GIGA, Cellular & Mol Immunol, Sart Tilman Par Liege, Belgium; [Packeu, Ann] Sci Inst Publ Hlth WIV ISP, Mycol & Aerobiol, Brussels, Belgium		De Keersmaecker, SCJ (corresponding author), Sci Inst Publ Hlth WIV ISP, Platform Biotechnol & Mol Biol, Brussels, Belgium.	sigrid.dekeersmaecker@wiv-isp.be	De Keersmaecker, Sigrid/ABB-5332-2021	De Keersmaecker, Sigrid/0000-0003-4198-4133; Roosens, Nancy H C J/0000-0001-9218-078X	RP/PJ WIV-ISP (rechtspersoonlijkheid / personnalite juridique Wetenschappelijk Instituut Volksgezondheid - Institut Scientifique de Sante Publique) (mycoMOLAIR)	RP/PJ WIV-ISP (rechtspersoonlijkheid / personnalite juridique Wetenschappelijk Instituut Volksgezondheid - Institut Scientifique de Sante Publique) (mycoMOLAIR)	This work was supported by RP/PJ WIV-ISP (rechtspersoonlijkheid / personnalite juridique Wetenschappelijk Instituut Volksgezondheid - Institut Scientifique de Sante Publique) (mycoMOLAIR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni S., 2014, XMAP COOKBOOK, V2nd; Barbau-Piednoir E, 2013, APPL MICROBIOL BIOT, V97, P4021, DOI [10.1007/s00253-012-4477-2, 10.1007/s00253-013-5234-x]; Beguin H, 1994, AEROBIOLOGIA, V10, P157, DOI DOI 10.1007/BF02459231; Bellanger AP, 2009, LETT APPL MICROBIOL, V49, P260, DOI 10.1111/j.1472-765X.2009.02653.x; Betancourt DA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01114-15; Black Jonathan, 2013, J Biomol Tech, V24, P32, DOI 10.7171/jbt.13-2401-004; Christopher-Hennings J, 2013, J VET DIAGN INVEST, V25, P671, DOI 10.1177/1040638713507256; Costa C, 2001, J MICROBIOL METH, V44, P263, DOI 10.1016/S0167-7012(01)00212-3; Crameri R, 2011, CLIN EXP ALLERGY, V41, P302, DOI 10.1111/j.1365-2222.2011.03703.x; Dean TR, 2004, J MICROBIOL METH, V56, P431, DOI 10.1016/j.mimet.2003.11.015; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; DUNBAR SA, 2007, CLIN MICROBIOLOGY NE, V29, P79; Etienne KA, 2009, J CLIN MICROBIOL, V47, P1096, DOI 10.1128/JCM.01899-08; European Aviation Safety Agency, 2015, DEC 2015 027 R, P1, DOI DOI 10.1002/9783527678679.DG02483; Gurvich OL, 2011, METHODS MOL BIOL, V784, P1, DOI 10.1007/978-1-61779-289-2_1; Haugland RA, 2004, SYST APPL MICROBIOL, V27, P198, DOI 10.1078/072320204322881826; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Heseltine E., 2009, WHO GUID IND AIR QUA; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Iwen PC, 2002, MED MYCOL, V40, P87, DOI 10.1080/mmy.40.1.87.109; Johnson GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040022; Knutsen A.P., 2011, CLIN REV ALLERG IMMU, V129, P280; Landlinger C, 2009, J CLIN MICROBIOL, V47, P1063, DOI 10.1128/JCM.01558-08; Lezar S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-87; Libert X, 2016, APPL MICROBIOL BIOT, V100, P1377, DOI 10.1007/s00253-015-7175-z; Libert X, 2015, APPL MICROBIOL BIOT, V99, P7267, DOI 10.1007/s00253-015-6785-9; Libert X, DISCRIMINATION 3 CLO; Lin A, 2011, J MICROBIOL METH, V87, P105, DOI 10.1016/j.mimet.2011.07.019; Meheust D, 2014, CRIT REV MICROBIOL, V40, P248, DOI 10.3109/1040841X.2013.777687; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Mohanta TK, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0020-z; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nolard N, 2004, VALIDATION METHODES; Pieckova E, 2004, ANN AGR ENV MED, V11, P67; Pitkaranta M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-235; Prevost-Boure NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024166; Puckeu A, 2012, B-ENT, V8, P73; Reboux G, 2010, REV MAL RESPIR, V27, P169, DOI 10.1016/j.rmr.2009.09.003; Rosenbaum PF, 2010, J EXPO SCI ENV EPID, V20, P503, DOI 10.1038/jes.2009.27; Roussel S, 2013, ENVIRON INT, V55, P20, DOI 10.1016/j.envint.2013.02.002; Schell WA, 2012, EUR J CLIN MICROBIOL, V31, P2237, DOI 10.1007/s10096-012-1561-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; United States Environmental Protection Agency, EPA TECHNOLOGY FOR M; Van den Bulcke M, 2010, ANAL BIOANAL CHEM, V396, P2113, DOI 10.1007/s00216-009-3286-7; Vesper S, 2011, CRIT REV MICROBIOL, V37, P15, DOI 10.3109/1040841X.2010.506177; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Wuyst V, 2015, BIOMED RES INT	49	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173390	10.1371/journal.pone.0173390	http://dx.doi.org/10.1371/journal.pone.0173390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278219	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900085
J	Zufferey, M; Montandon, C; Douet, V; Demarsy, E; Agne, B; Baginsky, S; Kessler, F				Zufferey, Monica; Montandon, Cyrille; Douet, Veronique; Demarsy, Emilie; Agne, Birgit; Baginsky, Sacha; Kessler, Felix			The novel chloroplast outer membrane kinase KOC1 is a required component of the plastid protein import machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ENVELOPE MEMBRANE; PREPROTEIN RECEPTOR; ARABIDOPSIS CHLOROPLASTS; DISTINCT PATHWAYS; GTP-BINDING; IN-VIVO; TOC159; BIOGENESIS; TRANSLOCATION; COMPLEX	The biogenesis and maintenance of cell organelles such as mitochondria and chloroplasts require the import of many proteins from the cytosol, a process that is controlled by phosphorylation. In the case of chloroplasts, the import of hundreds of different proteins depends on translocons at the outer and inner chloroplast membrane (TOC and TIC, respectively) complexes. The essential protein TOC159 functions thereby as an import receptor. It has an N-terminal acidic (A-) domain that extends into the cytosol, controls receptor specificity, and is highly phosphorylated in vivo. However, kinases that phosphorylate the TOC159 A-domain to enable protein import have remained elusive. Here, using co-purification with TOC159 from Arabidopsis, we discovered a novel component of the chloroplast import machinery, the regulatory kinase at the outer chloroplast membrane 1 (KOC1). We found that KOC1 is an integral membrane protein facing the cytosol and stably associates with TOC. Moreover, KOC1 phosphorylated the A-domain of TOC159 in vitro, and in mutant koc1 chloroplasts, preprotein import efficiency was diminished. koc1 Arabidopsis seedlings had reduced survival rates after transfer from the dark to the light in which protein import into plastids is required to rapidly complete chloroplast biogenesis. In summary, our data indicate that KOC1 is a functional component of the TOC machinery that phosphorylates import receptors, supports preprotein import, and contributes to efficient chloroplast biogenesis.	[Zufferey, Monica; Douet, Veronique; Kessler, Felix] Univ Neuchatel, Lab Plant Physiol, CH-2000 Neuchatel, Switzerland; [Montandon, Cyrille] Cornell Univ, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Demarsy, Emilie] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland; [Agne, Birgit; Baginsky, Sacha] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Saale, Germany	University of Neuchatel; Cornell University; University of Geneva; Martin Luther University Halle Wittenberg	Kessler, F (corresponding author), Univ Neuchatel, Lab Plant Physiol, CH-2000 Neuchatel, Switzerland.	felix.kessler@unine.ch	Kessler, Felix Henrique/AAO-1722-2020	Kessler, Felix/0000-0001-6409-5043; Baginsky, Sacha/0000-0002-5440-3898	University of Neuchatel; Swiss National Science Foundation [31003A_156998, IZEBZ0_143169]	University of Neuchatel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	lThis work was supported by the University of Neuchatel and Swiss National Science Foundation Grants 31003A_156998 and IZEBZ0_143169. The authors declare that they have no conflicts of interest with the contents of this article.	Agne B, 2010, PLANT PHYSIOL, V153, P1016, DOI 10.1104/pp.110.158048; Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andres C, 2010, BBA-MOL CELL RES, V1803, P715, DOI 10.1016/j.bbamcr.2010.03.004; Aronsson H, 2006, FEBS LETT, V580, P649, DOI 10.1016/j.febslet.2005.12.055; Aronsson H, 2010, PLANT J, V63, P297, DOI 10.1111/j.1365-313X.2010.04242.x; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Demarsy E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00483; Dhanoa PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010098; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Flores-Perez U, 2013, BBA-MOL CELL RES, V1833, P332, DOI 10.1016/j.bbamcr.2012.03.019; Fulgosi H, 2002, J BIOL CHEM, V277, P8934, DOI 10.1074/jbc.M110679200; Gerbeth C, 2013, CELL METAB, V18, P578, DOI 10.1016/j.cmet.2013.09.006; Helm S, 2014, J PROTEOMICS, V98, P79, DOI 10.1016/j.jprot.2013.12.007; Hiltbrunner A, 2001, BIOCHEM CELL BIOL, V79, P629, DOI 10.1139/bcb-79-5-629; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Inoue H, 2010, PLANT CELL, V22, P1947, DOI 10.1105/tpc.110.074328; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Jelic M, 2002, BIOL CHEM, V383, P1875, DOI 10.1515/BC.2002.211; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kessler F, 2004, TRENDS CELL BIOL, V14, P334, DOI 10.1016/j.tcb.2004.05.004; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kessler F, 2012, SCIENCE, V338, P622, DOI 10.1126/science.1230658; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kim DH, 2013, TRAFFIC, V14, P613, DOI 10.1111/tra.12043; Kohler D, 2015, PLANT PHYSIOL, V167, P972, DOI 10.1104/pp.114.255562; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Lee KH, 2003, J BIOL CHEM, V278, P36794, DOI 10.1074/jbc.M304457200; Ling QH, 2015, CURR BIOL, V25, P2527, DOI 10.1016/j.cub.2015.08.015; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Ma YK, 1996, J CELL BIOL, V134, P315, DOI 10.1083/jcb.134.2.315; Nakai M, 2015, BBA-BIOENERGETICS, V1847, P957, DOI 10.1016/j.bbabio.2015.02.011; Paila YD, 2016, ELIFE, V5, DOI 10.7554/eLife.12631; Paila YD, 2015, J MOL BIOL, V427, P1038, DOI 10.1016/j.jmb.2014.08.016; Richardson LGL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00269; Richardson LGL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-35; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Schnell DJ, 1997, TRENDS CELL BIOL, V7, P303, DOI 10.1016/S0962-8924(97)01111-2; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Smith Matthew D, 2003, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1116s17; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Sveshnikova N, 2000, P NATL ACAD SCI USA, V97, P4973, DOI 10.1073/pnas.080491597; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Wang F, 2008, J CELL BIOL, V183, P87, DOI 10.1083/jcb.200803034; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	56	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6952	6964		10.1074/jbc.M117.776468	http://dx.doi.org/10.1074/jbc.M117.776468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28283569	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000400478300008
J	Abe, D; Fukuoka, Y; Horiuchi, M				Abe, Daijiro; Fukuoka, Yoshiyuki; Horiuchi, Masahiro			Muscle activities during walking and running at energetically optimal transition speed under normobaric hypoxia on gradient slopes	PLOS ONE			English	Article							TO-RUN-TRANSITION; M.-TIBIALIS-ANTERIOR; MECHANICAL DETERMINANTS; ENERGY-COST; ECONOMICAL WALKING; SUPPORT; LOCOMOTION; PROPULSION; EFFICIENCY; EXERCISE	Energy cost of transport per unit distance (CoT; J.kg(-1).km(-1)) displays a U-shaped fashion in walking and a linear fashion in running as a function of gait speed (v; km.h(-1)). There exists an intersection between U-shaped and linear CoT-v relationships, being termed energetically optimal transition speed (EOTS; km.h(-1)). Combined effects of gradient and moderate normobaric hypoxia (15.0% O-2) were investigated when walking and running at the EOTS in fifteen young males. The CoT values were determined at eight walking speeds (2.4.7.3 km.h(-1)) and four running speeds (7.39.4 km.h(-1)) on level and gradient slopes (+/- 5%) at normoxia and hypoxia. Since an alteration of tibialis anterior (TA) activity has been known as a trigger for gait transition, electromyogram was recorded from TA and its antagonists (gastrocnemius medialis (GM) and gastrocnemius lateralis (GL)) for about 30 steps during walking and running corresponding to the individual EOTS in each experimental condition. Mean power frequency (MPF; Hz) of each muscle was quantified to evaluate alterations of muscle fiber recruitment pattern. The EOTS was not significantly different between normoxia and hypoxia on any slopes (ranging from 7.412 to 7.679 km.h(-1) at normoxia and 7.516 to 7.678 km.h(-1) at hypoxia) due to upward shifts (enhanced metabolic rate) of both U-shaped and linear CoT-v relationships at hypoxia. GM, but not GL, activated more when switching from walking to running on level and gentle downhill slopes. Significant decreases in the muscular activity and/or MPF were observed only in the TA when switching the gait pattern. Taken together, the EOTS was not slowed by moderate hypoxia in the population of this study. Muscular activities of lower leg extremities and those muscle fiber recruitment patterns are dependent on the gradient when walking and running at the EOTS.	[Abe, Daijiro] Kyushu Sangyo Univ, Ctr Hlth & Sports Sci, Fukuoka, Japan; [Fukuoka, Yoshiyuki] Doshisha Univ, Fac Hlth & Sports Sci, Kyotanabe, Japan; [Horiuchi, Masahiro] Mt Fuji Res Inst, Div Human Environm Sci, Fujiyoshida, Yamanashi, Japan	Doshisha University	Abe, D (corresponding author), Kyushu Sangyo Univ, Ctr Hlth & Sports Sci, Fukuoka, Japan.	abed@ip.kyusan-u.ac.jp		Fukuoka, Yoshiyuki/0000-0001-6409-2694	Japan Society for the Promotion of Science [26440266JP, 26650175JP, 26440268JP]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (26440266JP to DA, 26650175JP to YF, and 26440268JP to MH).	Abe D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138154; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Ardigo LP, 2003, EUR J APPL PHYSIOL, V90, P365, DOI 10.1007/s00421-003-0882-7; AURA O, 1986, EUR J APPL PHYSIOL, V55, P37, DOI 10.1007/BF00422890; Bartlett JL, 2008, J EXP BIOL, V211, P1281, DOI 10.1242/jeb.011932; Billaut F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077297; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P467, DOI 10.1113/jphysiol.1977.sp011866; Dahmane R, 2005, J BIOMECH, V38, P2451, DOI 10.1016/j.jbiomech.2004.10.020; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Faulhaber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049953; Francis CA, 2013, GAIT POSTURE, V38, P993, DOI 10.1016/j.gaitpost.2013.05.009; Ganley KJ, 2011, METABOLISM, V60, P609, DOI 10.1016/j.metabol.2010.06.007; Gazendam MGJ, 2007, GAIT POSTURE, V25, P604, DOI 10.1016/j.gaitpost.2006.06.013; GERDLE B, 1991, ACTA PHYSIOL SCAND, V142, P457, DOI 10.1111/j.1748-1716.1991.tb09180.x; Girard O, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00260; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Horiuchi M, 2016, BIOL OPEN, V5, P1408, DOI 10.1242/bio.019810; Horiuchi M, 2015, J EXERC SCI FIT, V13, P79, DOI 10.1016/j.jesf.2015.06.001; Horiuchi M, 2014, INT J IND ERGONOM, V44, P442, DOI 10.1016/j.ergon.2013.11.014; HRELJAC A, 1993, MED SCI SPORT EXER, V25, P1158; Hreljac A, 2007, GAIT POSTURE, V25, P419, DOI 10.1016/j.gaitpost.2006.05.005; Huddleston B, 2003, 10 UN FAO; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Long LL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0980; MacLeod TD, 2014, J APPL BIOMECH, V30, P95, DOI 10.1123/jab.2013-0041; Malcolm P, 2009, GAIT POSTURE, V30, P322, DOI 10.1016/j.gaitpost.2009.06.002; Malcolm P, 2009, GAIT POSTURE, V29, P6, DOI 10.1016/j.gaitpost.2008.05.016; MARTIN PE, 1992, J APPL PHYSIOL, V73, P200; Masschelein E, 2012, J APPL PHYSIOL, V113, P736, DOI 10.1152/japplphysiol.01253.2011; McGowan CP, 2009, J BIOMECH, V42, P850, DOI 10.1016/j.jbiomech.2009.01.025; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; MINETTI AE, 1993, J PHYSIOL-LONDON, V472, P725, DOI 10.1113/jphysiol.1993.sp019969; MINETTI AE, 1994, J EXP BIOL, V195, P211; Motoi M, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0094-6; Neptune RR, 2005, J EXP BIOL, V208, P799, DOI 10.1242/jeb.01435; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; Rooney BD, 2013, J BIOMECH, V46, P2201, DOI 10.1016/j.jbiomech.2013.06.022; Rotstein A, 2005, MED SCI SPORT EXER, V37, P1864, DOI 10.1249/01.mss.0000177217.12977.2f; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; Segers V, 2007, GAIT POSTURE, V25, P639, DOI 10.1016/j.gaitpost.2006.07.008; Segers V, 2013, J EXP BIOL, V216, P3047, DOI 10.1242/jeb.087015; Shih Y, 2016, GAIT POSTURE, V46, P5, DOI 10.1016/j.gaitpost.2016.01.003; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Torres-Peralta R, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00414; Tseh W, 2002, EUR J APPL PHYSIOL, V88, P117, DOI 10.1007/s00421-002-0698-x; Vernillo G, SPORTS MED IN PRESS; Wall-Scheffler CM, 2015, INTEGR COMP BIOL, V55, P1155, DOI 10.1093/icb/icv072; Wall-Scheffler CM, 2013, J HUM EVOL, V64, P448, DOI 10.1016/j.jhevol.2013.01.014; Watson RR, 2011, P ROY SOC B-BIOL SCI, V278, P2040, DOI 10.1098/rspb.2010.2022; Wezenberg D, 2013, ARCH PHYS MED REHAB, V94, P1714, DOI 10.1016/j.apmr.2013.02.016; Willcockson MA, 2012, MED SCI SPORT EXER, V44, P1344, DOI 10.1249/MSS.0b013e318248d907; Yong JR, 2014, J BIOMECH, V47, P3593, DOI 10.1016/j.jbiomech.2014.10.015; Ziv G, 2009, MED SCI SPORT EXER, V41, P797, DOI 10.1249/MSS.0b013e31818ff715	63	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173816	10.1371/journal.pone.0173816	http://dx.doi.org/10.1371/journal.pone.0173816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301525	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300077
J	Hu, ZL; Chen, J; Wang, J; Xiong, QF; Zhong, YD; Yang, YF; Xu, CJ; Wei, HX				Hu, Zhiliang; Chen, Jun; Wang, Juan; Xiong, Qingfang; Zhong, Yandan; Yang, Yongfeng; Xu, Chuanjun; Wei, Hongxia			Radiological characteristics of pulmonary cryptococcosis in HIV-infected patients	PLOS ONE			English	Article							IMMUNOCOMPETENT; NODULES; DISEASE; UPDATE; AIDS	Background Current understanding of human immunodeficiency virus (HIV)-associated pulmonary cryptococcosis (PC) is largely based on studies performed about 2 decades ago which reported that the most common findings on chest radiograph were diffuse interstitial infiltrates. Few studies are available regarding the computed tomography (CT) findings. The aim of this study was to characterize chest CT features of HIV-associated PC. Methods HIV patients with cryptococccal infection and pulmonary abnormalities on Chest CT between September 2010 and May 2016 in the Second Affiliated Hospital of the Southeast University were retrospectively analyzed. Confirmed cases of tumors, mycobacterial infections and other fungal infections were excluded from the analysis. Results 60 cases were identified. The median CD4 T-cell counts were 20 cells/mu L (range, 0-205 cells/mu L). Chest CT scans demonstrated nodular lesions in 93.3% of the studied patients. Those nodular lesions were usually cavitated and solitary nodule was the most common form. Pleural effusions and pneumonic infiltrates occurred in 11.6% and 31.7% of the cases respectively. Those lesions were usually had co-existing nodular lesions. Etiological analysis suggested that 76.8% of the nodular lesions could have a relationship with PC that 12.5% of the nodular lesions were "laboratory-confirmed" cases, 48.2% were "clinically confirmed cases and 16.1% were "clinically probable" cases. 85.7% of the pleural effusions could be "clinically confirmed" cases of PC. At least, 38.5% of the diffuse pneumonic infiltrates may be clinically attributed to pneumocystis pneumonia. Conclusions This study suggested that pulmonary nodules but not diffuse pneumonia are the most common radiological characteristics of HIV-associated PC. HIV-infected patients with pulmonary nodules on Chest CT should particularly be screened for cryptococcal infection.	[Hu, Zhiliang; Xiong, Qingfang; Zhong, Yandan; Yang, Yongfeng; Wei, Hongxia] Southeast Univ, Second Affiliated Hosp, Sch Med, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Jun] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200433, Peoples R China; [Wang, Juan] Nanjing Med Univ, Nanjing Brain Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Xu, Chuanjun] Southeast Univ, Second Affiliated Hosp, Sch Med, Dept Radiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Fudan University; Nanjing Medical University; Southeast University - China	Wei, HX (corresponding author), Southeast Univ, Second Affiliated Hosp, Sch Med, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China.; Xu, CJ (corresponding author), Southeast Univ, Second Affiliated Hosp, Sch Med, Dept Radiol, Nanjing, Jiangsu, Peoples R China.	xchuanjun@163.com; wghongxia@163.com	Hu, Zhiliang/AAS-3469-2020	Hu, Zhiliang/0000-0001-8543-821X	Department of Science and Technique, Jiangsu [BL-2013003]; project of Jiangsu Province Medical Youth Talent	Department of Science and Technique, Jiangsu; project of Jiangsu Province Medical Youth Talent	This work is supported by clinical special grant BL-2013003 from Department of Science and Technique, Jiangsu (http://www.jstd.gov.cn/), and the project of Jiangsu Province Medical Youth Talent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATUNGWANAYO J, 1994, AIDS, V8, P1271, DOI 10.1097/00002030-199409000-00008; Benito N, 2012, EUR RESPIR J, V39, P730, DOI 10.1183/09031936.00200210; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; Chang WC, 2006, CHEST, V129, P333, DOI 10.1378/chest.129.2.333; Chitasombat M, 2013, CURR FUNGAL INFECT R, V7, P44, DOI 10.1007/s12281-012-0119-5; Hare SS, 2012, BRIT J RADIOL, V85, P848, DOI 10.1259/bjr/16420165; Hu ZL, 2013, SCAND J INFECT DIS, V45, P378, DOI 10.3109/00365548.2012.749422; Iribarren JA, 2016, PREVENTION TREATMENT; Kisembo HN, 2012, BRIT J RADIOL, V85, pE130, DOI 10.1259/bjr/70704099; Kohno S, 2015, J INFECT CHEMOTHER, V21, P23, DOI 10.1016/j.jiac.2014.08.025; La Ferla L, 2013, EUR REV MED PHARMACO, V17, P2354; Lin CY, 2009, HIV MED, V10, P191, DOI 10.1111/j.1468-1293.2008.00674.x; MEYOHAS MC, 1995, CLIN INFECT DIS, V21, P628, DOI 10.1093/clinids/21.3.628; Miller KD, 1996, CLIN INFECT DIS, V23, P810, DOI 10.1093/clinids/23.4.810; Muldoon EG, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0276-3; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Restrepo CS, 2006, RADIOGRAPHICS, V26, P1169, DOI 10.1148/rg.264055129; Steininger C, 2006, J CLIN VIROL, V37, P1, DOI 10.1016/j.jcv.2006.03.005; Visnegarwala F, 1998, CLIN INFECT DIS, V27, P1231, DOI 10.1086/514984; Ye C, 2015, NIGER J CLIN PRACT, V18, P304, DOI 10.4103/1119-3077.151075; Ye F, 2012, LUNG, V190, P339, DOI 10.1007/s00408-011-9362-8; Zhang Y, 2012, EUR RESPIR J, V40, P1191, DOI 10.1183/09031936.00168011	22	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173858	10.1371/journal.pone.0173858	http://dx.doi.org/10.1371/journal.pone.0173858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301552	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300082
J	Muls, N; Nasr, Z; Dang, HA; Sindic, C; van Pesch, V				Muls, Nathalie; Nasr, Zakia; Dang, Hong Anh; Sindic, Christian; van Pesch, Vincent			IL-22, GM-CSF and IL-17 in peripheral CD4(+) T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOOD-BRAIN-BARRIER; HELPER 17 CELLS; TH17 CELLS; MESSENGER-RNA; AUTOIMMUNE ENCEPHALOMYELITIS; INTERLEUKIN-22 PROTECTS; MONONUCLEAR-CELLS; T(H)17 CELLS; EXPRESSION	Multiple sclerosis (MS) is thought to be a Th17-mediated dysimmune disease of the central nervous system. However, recent publications have questioned the pathogenicity of IL-17 per se and rather suggest the implication of other Th17-related inflammatory mediators. Therefore, we studied the expression of GM-CSF, IL-22, IL-24, IL-26 and CD39 in peripheral blood mononuclear cells (PBMCs) from MS patients during relapses, remission and following corticosteroid treatment. We performed qPCR to measure mRNA levels from ex vivo or in vitro-stimulated PBMCs. Cytokine levels were determined by ELISA. We used flow cytometry to assess GM-CSF+, IL-22(+) and CD39(+) cells in relationship to IL-17(+) CD4(+) T cells. Our results showed that IL-22 mRNA and IL-22(+) CD4(+) lymphocytes are increased in circulating cells of relapsing MS patients compared to remitting patients while GM-CSF was unchanged. We have further shown that 12.9, 39 and 12.4% of Th17 cells from MS patients during relapses expressed IL-22, GM-CSF and CD39 respectively. No changes in these proportions were found in stable MS patients. However, the majority of GM-CSF+ or IL-22(+) T cells did not co-express IL-17. GM-CSF mRNA, but not IL-22 mRNA, was dramatically decreased ex vivo by ivMP. Our results contribute to a better characterisation of Th17, Th22 and ThGM-CSF cells in the setting of MS and according to disease activity.	[Muls, Nathalie; Nasr, Zakia; Dang, Hong Anh; Sindic, Christian; van Pesch, Vincent] Catholic Univ Louvain, Inst Neurosci, Unite Neurochim, Ave Mounier,53 BP B1 53 03, Brussels, Belgium; [van Pesch, Vincent] Clin Univ St Luc, Dept Neurol, Ave Hippocrate 10, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	van Pesch, V (corresponding author), Catholic Univ Louvain, Inst Neurosci, Unite Neurochim, Ave Mounier,53 BP B1 53 03, Brussels, Belgium.; van Pesch, V (corresponding author), Clin Univ St Luc, Dept Neurol, Ave Hippocrate 10, Brussels, Belgium.	vincent.vanpesch@uclouvain.be	van Pesch, Vincent/AAK-9506-2020	van Pesch, Vincent/0000-0003-2885-9004	Fonds National de la Recherche Scientifique; Bayer educational grants; Belgian Charcot Foundation	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Bayer educational grants; Belgian Charcot Foundation	This work was supported by the Fonds National de la Recherche Scientifique (www.fnrs.be), Bayer educational grants and the Belgian Charcot Foundation (www.fondation-charcot.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almolda B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027473; Andoh A, 2009, J IMMUNOL, V183, P687, DOI 10.4049/jimmunol.0804169; Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Constantinescu CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000117; Cortez-Espinosa N, 2015, HUM IMMUNOL, V76, P622, DOI 10.1016/j.humimm.2015.09.007; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; De Iudicibus S, 2011, WORLD J GASTROENTERO, V17, P1095, DOI 10.3748/wjg.v17.i9.1095; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Esendagli G, 2013, J NEUROIMMUNOL, V255, P81, DOI 10.1016/j.jneuroim.2012.10.009; Gayo A, 1998, J NEUROIMMUNOL, V85, P122, DOI 10.1016/S0165-5728(97)00262-2; Gross CC, 2016, MULT SCLER; He M, 2010, J IMMUNOL, V184, P1793, DOI 10.4049/jimmunol.0901829; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ingwersen J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0512-z; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li S, 2012, MEDIAT INFLAMM, V2012, DOI DOI 10.1155/2012/260473; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; Liu Y, 2009, EUR J IMMUNOL, V39, P1472, DOI 10.1002/eji.200838811; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Longhi MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087956; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Muls N, 2012, J NEUROIMMUNOL, V243, P73, DOI 10.1016/j.jneuroim.2011.12.010; Muls NG, 2015, MULT SCLER; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Ossege LM, 1998, J NEUROIMMUNOL, V84, P1, DOI 10.1016/S0165-5728(97)00211-7; Pan HF, 2013, CYTOKINE GROWTH F R, V24, P51, DOI 10.1016/j.cytogfr.2012.07.002; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Perriard G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0335-3; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Rolla S, 2014, J LEUKOCYTE BIOL, V96, P1155, DOI 10.1189/jlb.5A0813-463RR; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Vogel DYS, 2015, EUR J IMMUNOL, V45, P1808, DOI 10.1002/eji.201444960; Wang LL, 2013, MOL MED REP, V8, P1432, DOI 10.3892/mmr.2013.1692; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	51	29	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173780	10.1371/journal.pone.0173780	http://dx.doi.org/10.1371/journal.pone.0173780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301515	gold, Green Submitted, Green Published			2022-12-26	WOS:000396318300071
J	Chen, VCH; Yang, YH; Liao, YT; Kuo, TY; Liang, HY; Huang, KY; Huang, YC; Lee, Y; McIntyre, RS; Lin, TC				Chen, Vincent Chin-Hung; Yang, Yao-Hsu; Liao, Yin-To; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You; Huang, Yin-Cheng; Lee, Yena; McIntyre, Roger S.; Lin, Tzu-Chin			The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; MEDICATION ADHERENCE; CHILDREN; INJURY; ASTHMA; PREVALENCE; ADULTS; PHARMACOTHERAPY; OSTEOPOROSIS	Attention-deficit hyperactivity disorder (ADHD) is associated with higher risk for fracture. Whether the medical treatment for ADHD would mitigate the risk remains unclear. In this study, we sought to investigate the effect of methylphenidate treatment on risk for fracture, as well the moderational role of treatment duration on the risk of fracture, in a large national sample. Cases less than 18 years old were identified from Taiwan's National Health Insurance Research Database with a new primary diagnosis of ADHD (ICD-9: 314) between 1996 and 2013. A total of 6201 cases with ADHD were included as the study cohort. The cases were divided into 3 groups according to the duration of methylphenidate treatment (0, 1-180, and more than 180 days). All groups were followed until the end of 2013 for first diagnoses of fracture (ICD-9 codes 800 to 829). Cox proportional hazards models were applied. Compared to the group without methylphenidate treatment, the risk for fracture was lower among the group treated for more than 180 days. The adjusted hazard ratio was 0.77 (95% Confidence interval: 0.63-0.94). The groups treated for 180 days or fewer had no significant difference in the risk for fracture. In conclusion, methylphenidate treatment was associated with lower risk for fracture among ADHD patients. The association was evident only in the cohort treated for more than 180 days.	[Lin, Tzu-Chin] Chiayi Chang Gung Mem Hosp, Chang Gung Med Fdn, Chiayi, Taiwan; [Chen, Vincent Chin-Hung; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You] Chang Gung Univ, Sch Med, Dept Med, Taoyuan, Taiwan; [Liao, Yin-To; Kuo, Ting-Yu; Liang, Hsin-Yi; Lee, Yena] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Chen, Vincent Chin-Hung; Liang, Hsin-Yi; Huang, Yin-Cheng; Lee, Yena] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You] Natl Taiwan Univ Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Chen, Vincent Chin-Hung; Kuo, Ting-Yu; Lin, Tzu-Chin] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan; [Liao, Yin-To; Liang, Hsin-Yi; McIntyre, Roger S.] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Liao, Yin-To; Huang, Yin-Cheng; McIntyre, Roger S.] Chung Shan Med Univ, Sch Med, Dept Psychiat, Taichung, Taiwan; [Liang, Hsin-Yi; Huang, Yin-Cheng; Lee, Yena; McIntyre, Roger S.] Linkou Chang Gung Mem Hosp, Dept Child Psychiat, Taoyuan, Taiwan; [Yang, Yao-Hsu; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You] Chung Shan Med Univ, Dept Speech, Language Pathol & Audiol, Taichung, Taiwan; [Chen, Vincent Chin-Hung; Liao, Yin-To; Huang, Yin-Cheng] Chung Shan Med Univ, Dept Speech, Language Pathol & Audiol, Taichung, Taiwan; [Yang, Yao-Hsu; Liao, Yin-To; Huang, Yin-Cheng] Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; [Chen, Vincent Chin-Hung; Kuo, Ting-Yu] Univ Toronto, Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada; [Liao, Yin-To; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You; Huang, Yin-Cheng] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Taiwan University; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chang Gung Memorial Hospital; Chung Shan Medical University; Chung Shan Medical University; Chang Gung Memorial Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Lin, TC (corresponding author), Chiayi Chang Gung Mem Hosp, Chang Gung Med Fdn, Chiayi, Taiwan.	jamaalbest@gmail.com	Lee, Yena/D-9016-2019; Lee, Yena/L-5505-2019; 楊, 曜旭/A-3450-2019; McIntyre, Roger/AAU-1000-2020; Students, MDPU/ABE-8402-2020	Lee, Yena/0000-0003-0629-9456; Lee, Yena/0000-0003-0629-9456; 楊, 曜旭/0000-0002-8080-0504; McIntyre, Roger/0000-0003-4733-2523; 	Ministry of Science and Technology, R.O.C. [MOST 102-2314-B-040-004-MY3]; Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital [CMRPG6E0261, CORPG6D0162]	Ministry of Science and Technology, R.O.C.; Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital	The present study is supported in part by the Ministry of Science and Technology, R.O.C. (MOST 102-2314-B-040-004-MY3) and Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital (CMRPG6E0261, CORPG6D0162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study is based on the National Health Insurance Research Database provided by the Central Bureau of National Health Insurance, the Department of Health, and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of Bureau of National Health Insurance, Department of Health, or National Health Research Institutes.	Adler LD, 2010, POSTGRAD MED, V122, P184, DOI 10.3810/pgm.2010.01.2112; Altun C, 2012, SPEC CARE DENT, V32, P184, DOI 10.1111/j.1754-4505.2012.00270.x; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Blondis TA, 1999, PEDIATR CLIN N AM, V46, P899, DOI 10.1016/S0031-3955(05)70162-0; Buehring B, 2013, J ALLERGY CLIN IMMUN, V132, P1019, DOI 10.1016/j.jaci.2013.08.040; Cairney J, 2014, DEV MED CHILD NEUROL, V56, P1040, DOI 10.1111/dmcn.12509; Center J, 1998, AM J MENT RETARD, V103, P19, DOI 10.1352/0895-8017(1998)103<0019:PWMRHA>2.0.CO;2; Charach A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0371-6; Chee Carolyn, 2014, Open Respir Med J, V8, P85, DOI 10.2174/1874306401408010085; Chen CY, 2011, J CHILD ADOL PSYCHOP, V21, P265, DOI 10.1089/cap.2010.0107; Chen MH, 2013, J CHILD PSYCHOL PSYC, V54, P1208, DOI 10.1111/jcpp.12087; Childress AC, 2014, CNS DRUGS, V28, P121, DOI 10.1007/s40263-013-0130-6; Chou IC, 2014, DEV MED CHILD NEUROL, V56, P1111, DOI 10.1111/dmcn.12501; Durand-Rivera A, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/207801; Erdogan M, 2014, ACTA CHIR ORTHOP TR, V81, P221; Ertan C, 2012, EMERG MED J, V29, P911, DOI 10.1136/emermed-2011-200298; Fernandez-Jaen A, 2006, Rev Neurol, V42 Suppl 2, pS25; Garbe E, 2012, J CHILD ADOL PSYCHOP, V22, P452, DOI 10.1089/cap.2012.0022; Gatti D, 2011, ANN ALLERG ASTHMA IM, V107, P202, DOI 10.1016/j.anai.2011.03.018; Gau SSF, 2008, J CLIN PSYCHIAT, V69, P131, DOI 10.4088/JCP.v69n0118; Gazer-Snitovsky M., 2015, J ATTENTION DISORDER; Guo NW, 2015, J PEDIAT ORTHOPEDI B; Hong M, 2016, J KOREAN MED SCI, V31, P611, DOI 10.3346/jkms.2016.31.4.611; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Lange H, 2016, J ATTEN DISORD, V20, P501, DOI 10.1177/1087054713518237; Liang WB, 2011, J ASTHMA, V48, P311, DOI 10.3109/02770903.2011.554945; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; LODER RT, 1995, J PEDIATR ORTHOPED, V15, P41, DOI 10.1097/01241398-199501000-00010; Marcus SC, 2008, J ATTEN DISORD, V12, P64, DOI 10.1177/1087054707305168; Melton LJ, 2005, J BONE MINER RES, V20, P564, DOI 10.1359/JBMR.041218; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Nakaniida A, 2014, J ORTHOP TRAUMA, V28, P167, DOI 10.1097/BOT.0b013e318299cd20; National Health Research Institutes, 2013, INTR NAT HLTH INS RE; Neumeyer AM, 2015, J AUTISM DEV DISORD, V45, P881, DOI 10.1007/s10803-014-2228-1; Nijmeijer JS, 2008, CLIN PSYCHOL REV, V28, P692, DOI 10.1016/j.cpr.2007.10.003; Ozer K, 2010, J PEDIATR ORTHOPED, V30, P324, DOI 10.1097/BPO.0b013e3181d8fa8c; Perry BA, 2016, OSTEOPOROSIS INT, V27, P2223, DOI 10.1007/s00198-016-3547-1; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Punja S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002312; Reiersen Angela M, 2008, Expert Rev Neurother, V8, P657, DOI 10.1586/14737175.8.4.657; Rheims S, 2016, EPILEPSIA; Rogers M, 2011, CHILD NEUROPSYCHOL, V17, P444, DOI 10.1080/09297049.2010.544648; Sadock B.J., 2015, KAPLAN SADOCKS SYNOP, P509; Seidenberg M, 2009, FUTUR NEUROL, V4, P663, DOI 10.2217/FNL.09.32; Sobanski E, 2006, EUR ARCH PSY CLIN N, V256, P26, DOI 10.1007/s00406-006-1004-4; Spady DW, 2004, PEDIATRICS, V113, P522, DOI 10.1542/peds.113.3.522; Strom MA, 2016, BRIT J DERMATOLOGY; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Tsai CJ, 2014, ANN CLIN PSYCHIATRY, V26, P254; Uslu MM, 2008, ARCH ORTHOP TRAUM SU, V128, P417, DOI 10.1007/s00402-007-0393-9; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; van den Ban E, 2014, EUR CHILD ADOLES PSY, V23, P95, DOI 10.1007/s00787-013-0432-8; Vaughan B, 2012, CHILD ADOL PSYCH CL, V21, P941, DOI 10.1016/j.chc.2012.07.005; Vestergaard P, 2008, CALCIFIED TISSUE INT, V82, P34, DOI 10.1007/s00223-007-9095-0; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; Yeh FJ, 2006, OSTEOPOROSIS INT, V17, P267, DOI 10.1007/s00198-005-2009-y	57	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173762	10.1371/journal.pone.0173762	http://dx.doi.org/10.1371/journal.pone.0173762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296941	gold, Green Published			2022-12-26	WOS:000396311700058
J	Lehner, MS; de Paula, TJ; Del Ponte, EM; Mizubuti, ESG; Pethybridge, SJ				Lehner, Miller S.; de Paula Junior, Trazilbo J.; Del Ponte, Emerson M.; Mizubuti, Eduardo S. G.; Pethybridge, Sarah J.			Independently founded populations of Sclerotinia sclerotiorum from a tropical and a temperate region have similar genetic structure	PLOS ONE			English	Article							DIVERSITY; RAREFACTION; EXTRAPOLATION; RECOMBINATION; PATHOGEN; PROGRAMS; SAMPLES; CANOLA; IMPACT; FUNGUS	Sclerotinia sclerotiorum populations from tropical agricultural zones have been suggested to be more variable compared to those from temperate zones. However, no data were available comparing populations from both zones using the same set of markers. In this study, we compared S. sclerotiorum populations from the United States of America (USA, temperate) and southeast Brazil (tropical) using the frequency of mycelial compatibility groups (MCGs) and 13 microsatellite (SSR) markers. Populations were sourced from diseased plants within leguminous crops in New York, USA (NY; n = 78 isolates), and Minas Gerais State, Brazil (MG; n = 109). Twenty MCGs were identified in NY and 14 were previously reported in MG. The effective number of genotypes based on Hill's number of order 0, which corresponded to the number of multilocus genotypes (MLGs) were 22 (95% CI = 15.6-28.4) and 24 (95% CI = 18.9-29.1) in NY and MG, respectively. Clonal fractions of MLGs were 71.8% (NY) and 78.0% (MG). The effective number of genotypes based on Hill's number of orders 1 and 2 in NY were 8.9 (95% CI = 5.2-12.6) and 4.4 (95% CI = 2.6-6.1), respectively. For MG these indices were 11.4 (95% CI = 8.7-14.1) and 7.1 (95% CI = 5.1-9.0), respectively. There were no significant differences of allelic richness, private allelic richness, gene diversity, effective number of alleles and genotype evenness between the NY and MG populations. The populations were differentiated, with 29% of total variance attributed to differences between them and G"(ST) and Jost's D indices higher than 0.50. Cluster analysis revealed dissimilarity higher than 80% among most MLGs from both populations. Different alleles segregated in the populations but both had similar levels of genotypic variability.	[Lehner, Miller S.; Pethybridge, Sarah J.] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA; [de Paula Junior, Trazilbo J.] Empresa Pesquisa Agr Minas Gerais EPAMIG, Vicosa, MG, Brazil; [Del Ponte, Emerson M.; Mizubuti, Eduardo S. G.] Univ Fed Vicosa, Dept Fitopatol, Vicosa, MG, Brazil	Cornell University; Universidade Federal de Vicosa	Pethybridge, SJ (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA.	sjp277@cornell.edu	Del Ponte, Emerson M/D-2464-2012; Del Ponte, Emerson Medeiros/AAC-1369-2021	Del Ponte, Emerson M/0000-0003-4398-409X; Del Ponte, Emerson Medeiros/0000-0003-4398-409X	United States Department of Agriculture, National Institute of Food and Agriculture (USDA - NIFA) Hatch project [NYG-625424]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq	United States Department of Agriculture, National Institute of Food and Agriculture (USDA - NIFA) Hatch project; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for the involvement of MSL and SJP in this study was provided by the United States Department of Agriculture, National Institute of Food and Agriculture (USDA - NIFA) Hatch project NYG-625424, managed by the New York Agricultural Experiment Station, Cornell University, Geneva, New York, USA. TJPJ, EMDP, and ESGM were supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aldrich-Wolfe L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139188; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Zancan WLA, 2015, BIOSCI J, V31, P1143, DOI 10.14393/BJ-v31n4a2015-26247; Atallah ZK, 2004, PHYTOPATHOLOGY, V94, P737, DOI 10.1094/PHYTO.2004.94.7.737; Attanayake RN, 2014, HEREDITY, V113, P353, DOI 10.1038/hdy.2014.37; Attanayake RN, 2013, PHYTOPATHOLOGY, V103, P750, DOI 10.1094/PHYTO-07-12-0159-R; Baturo-Ciesniewska A, 2016, PLANT DIS; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Carbone I, 2001, MOL ECOL, V10, P947, DOI 10.1046/j.1365-294X.2001.01244.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Clarkson JP, 2013, PLANT PATHOL, V62, P309, DOI 10.1111/j.1365-3059.2012.02635.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cubeta MA, 1997, PHYTOPATHOLOGY, V87, P1000, DOI 10.1094/PHYTO.1997.87.10.1000; del Rio LE, 2007, PLANT DIS, V91, P191, DOI 10.1094/PDIS-91-2-0191; del Rio LE, 2004, PLANT DIS, V88, P1352, DOI 10.1094/PDIS.2004.88.12.1352; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Hambleton S, 2002, CAN J PLANT PATHOL, V24, P309; Hemmati R, 2009, EUR J PLANT PATHOL, V125, P617, DOI 10.1007/s10658-009-9510-7; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hsieh TC, 2016, METHODS ECOL EVOL; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KOHLI Y, 1995, MOL ECOL, V4, P69, DOI 10.1111/j.1365-294X.1995.tb00193.x; KOHLI Y, 1992, PHYTOPATHOLOGY, V82, P875, DOI 10.1094/Phyto-82-875; Kohli Y, 1998, FUNGAL GENET BIOL, V23, P139, DOI 10.1006/fgbi.1997.1026; Lehner MS, 2015, PLANT PATHOL, V64, P921, DOI 10.1111/ppa.12322; Lehner MS, 2017, TROP PLANT PATHOL; Lehner MS, 2016, PLANT PATHOL; Ludwig JA, 1988, STAT ECOLOGY; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; NEI M, 1978, GENETICS, V89, P583; Njambere EN, 2014, PLANT PATHOL, V63, P994, DOI 10.1111/ppa.12176; Schafer MR, 2006, MYCOLOGIA, V98, P593, DOI 10.3852/mycologia.98.4.593; Sexton AC, 2004, CURR GENET, V46, P357, DOI 10.1007/s00294-004-0543-3; Sirjusingh C, 2001, MOL ECOL NOTES, V1, P267, DOI 10.1046/j.1471-8278.2001.00102.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Winton LM, 2006, CAN J PLANT PATHOL, V28, P426, DOI 10.1080/07060660609507316; Zhan J, 2003, FUNGAL GENET BIOL, V38, P286, DOI 10.1016/S1087-1845(02)00538-8	46	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173915	10.1371/journal.pone.0173915	http://dx.doi.org/10.1371/journal.pone.0173915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296968	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700077
J	Ziegler, D; Winter, K; Strom, A; Zhivov, A; Allgeier, S; Papanas, N; Ziegler, I; Bruggemann, J; Ringel, B; Peschel, S; Kohler, B; Stachs, O; Guthoff, RF; Roden, M				Ziegler, Dan; Winter, Karsten; Strom, Alexander; Zhivov, Andrey; Allgeier, Stephan; Papanas, Nikolaos; Ziegler, Iris; Brueggemann, Jutta; Ringel, Bernd; Peschel, Sabine; Koehler, Bernd; Stachs, Oliver; Guthoff, Rudolf F.; Roden, Michael		German Diabet Study GDS Grp	Spatial analysis improves the detection of early corneal nerve fiber loss in patients with recently diagnosed type 2 diabetes	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; PERIPHERAL NEUROPATHY; IMAGE-RECONSTRUCTION; PLEXUS; RISK; MULTICENTER; WHORL	Corneal confocal microscopy (CCM) has revealed reduced corneal nerve fiber (CNF) length and density (CNFL, CNFD) in patients with diabetes, but the spatial pattern of CNF loss has not been studied. We aimed to determine whether spatial analysis of the distribution of corneal nerve branching points (CNBPs) may contribute to improving the detection of early CNF loss. We hypothesized that early CNF decline follows a clustered rather than random distribution pattern of CNBPs. CCM, nerve conduction studies (NCS), and quantitative sensory testing (QST) were performed in a cross-sectional study including 86 patients recently diagnosed with type 2 diabetes and 47 control subjects. In addition to CNFL, CNFD, and branch density (CNBD), CNBPs were analyzed using spatial point pattern analysis (SPPA) including 10 indices and functional statistics. Compared to controls, patients with diabetes showed lower CNBP density and higher nearest neighbor distances, and all SPPA parameters indicated increased clustering of CNBPs (all P<0.05). SPPA parameters were abnormally increased >97.5th percentile of controls in up to 23.5% of patients. When combining an individual SPPA parameter with CNFL, >= 1 of 2 indices were > 99 th or < 1st percentile of controls in 28.6% of patients compared to 2.1% of controls, while for the conventional CNFL/CNFD/CNBD combination the corresponding rates were 16.3% vs 2.1%. SPPA parameters correlated with CNFL and several NCS and QST indices in the controls (all P < 0.001), whereas in patients with diabetes these correlations were markedly weaker or lost. In conclusion, SPPA reveals increased clustering of early CNF loss and substantially improves its detection when combined with a conventional CCM measure in patients with recently diagnosed type 2 diabetes.	[Ziegler, Dan; Strom, Alexander; Papanas, Nikolaos; Ziegler, Iris; Brueggemann, Jutta; Ringel, Bernd; Roden, Michael] Heinrich Heine Univ, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Ziegler, Dan; Roden, Michael] Heinrich Heine Univ, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Ziegler, Dan; Strom, Alexander; Roden, Michael] German Ctr Diabet Res DZD, Munich, Germany; [Winter, Karsten] Univ Leipzig, Inst Anat, Leipzig, Germany; [Zhivov, Andrey; Peschel, Sabine; Stachs, Oliver; Guthoff, Rudolf F.] Univ Rostock, Dept Ophthalmol, Rostock, Germany; [Allgeier, Stephan; Koehler, Bernd] Karlsruhe Inst Technol, Inst Appl Comp Sci, Karlsruhe, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leipzig University; University of Rostock; Helmholtz Association; Karlsruhe Institute of Technology	Ziegler, D (corresponding author), Heinrich Heine Univ, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany.; Ziegler, D (corresponding author), Heinrich Heine Univ, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany.; Ziegler, D (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	dan.ziegler@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019; Allgeier, Stephan/AAU-8698-2020	Allgeier, Stephan/0000-0002-1218-448X	German Diabetes Center; German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF); Ministry of Science, Research and the Arts of Baden-Wurttemberg [AZ 33-7533-7-11.6-9/3/1]	German Diabetes Center; German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Science, Research and the Arts of Baden-Wurttemberg	The German Diabetes Study (GDS) was initiated and financed by the German Diabetes Center, which is funded by the German Federal Ministry of Health (Berlin, Germany), the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany), and grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). Parts of this work were supported by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (AZ 33-7533-7-11.6-9/3/1).r The authors wish to thank the staff of the GDS at the German Diabetes Center, Dusseldorf, Germany, especially M. Behler and M. Schroers-Teuber, for their excellent technical support. The German Diabetes Study (GDS) was initiated and financed by the German Diabetes Center, which is funded by the German Federal Ministry of Health (Berlin, Germany), the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany), and grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). Parts of this work were supported by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (AZ 33-7533-7-11.6-9/3/1).	Abbott CA, 1998, DIABETES CARE, V21, P1071, DOI 10.2337/diacare.21.7.1071; Allgeier S, 2013, BIOMED TECH BERL S1, V58; Allgeier S, 2012, BIOMED TECH BERL S1, V57, P793; Allgeier S, 2014, INVEST OPHTH VIS SCI, V55, P6082, DOI 10.1167/iovs.14-14698; Allgeier S, 2011, INVEST OPHTH VIS SCI, V52, P5022, DOI 10.1167/iovs.10-6065; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; BORGEFORS G, 1986, COMPUT VISION GRAPH, V34, P344, DOI 10.1016/S0734-189X(86)80047-0; Brownrigg JRW, 2014, HEART, V100, P1837, DOI 10.1136/heartjnl-2014-305657; Calles-Escandon J, 2010, DIABETES CARE, V33, P721, DOI 10.2337/dc09-1471; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; DYCK PJ, 1986, ANN NEUROL, V19, P440, DOI 10.1002/ana.410190504; Edwards K, 2014, DIABETIC MED, V31, P1205, DOI 10.1111/dme.12466; Edwards K, 2012, CORNEA, V31, P1078, DOI 10.1097/ICO.0b013e318245c012; Hahn U, 2012, J AM STAT ASSOC, V107, P754, DOI 10.1080/01621459.2012.688463; Kennedy WR, 1999, MUSCLE NERVE, V22, P360, DOI 10.1002/(SICI)1097-4598(199903)22:3<360::AID-MUS9>3.0.CO;2-J; Kohler B, 2014, KLIN MONATSBL AUGENH, V231, P1170, DOI 10.1055/s-0034-1383331; Kohler B, 2011, KLIN MONATSBL AUGENH, V228, P1060, DOI 10.1055/s-0031-1281959; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Papanas N, 2013, CURR DIABETES REP, V13, P488, DOI 10.1007/s11892-013-0390-z; Papanas N, 2015, J DIABETES INVEST, V6, P381, DOI 10.1111/jdi.12335; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Petropoulos IN, 2015, INVEST OPHTH VIS SCI, V56, P2498, DOI 10.1167/iovs.14-15919; Petropoulos IN, 2013, DIABETES CARE, V36, P3646, DOI 10.2337/dc13-0193; Pritchard N, 2015, CORNEA, V34, P756, DOI 10.1097/ICO.0000000000000447; Pritchard N, 2015, DIABETES CARE, V38, P671, DOI 10.2337/dc14-2114; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; SINCLAIR DF, 1985, ECOLOGY, V66, P1084, DOI 10.2307/1940568; Stoyan D., 1994, FRACTALS RANDOM SHAP; Szmyt J, 2014, SILVA FENN, V48, DOI 10.14214/sf.1008; Tavakoli M, 2015, DIABETES CARE, V38, P838, DOI 10.2337/dc14-2311; Voronoi G., 1907, J REINE ANGEW MATH, V133, P97, DOI DOI 10.1515/CRLL.1908.133.97; Waller LA, 2011, STAT MED, V30, P2827, DOI 10.1002/sim.4315; Winter K, 2016, CURR EYE RES, V41, P186, DOI 10.3109/02713683.2015.1010686; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Ziegler D, 2011, DIABETIC MED, V28, P1412, DOI 10.1111/j.1464-5491.2011.03345.x; Ziegler Dan, 2014, Handb Clin Neurol, V126, P3, DOI 10.1016/B978-0-444-53480-4.00001-1; Ziegler D, 2014, DIABETES, V63, P2454, DOI 10.2337/db13-1819	39	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173832	10.1371/journal.pone.0173832	http://dx.doi.org/10.1371/journal.pone.0173832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296936	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700071
J	Jacob, CE; Tozzi, E; Willenborg, CJ				Jacob, Cory. E.; Tozzi, Eric; Willenborg, Christian J.			Neighbour presence, not identity, influences root and shoot allocation in pea	PLOS ONE			English	Article							SELF/NON-SELF DISCRIMINATION; BELOW-GROUND COMPETITION; KIN RECOGNITION; PLANTS; TRAGEDY; YIELD; PERCEPTION; AVOIDANCE; RESPONSES; COMMONS	Competition is a key feature that structures the composition of plant communities. A growing body of evidence is showing that the presence of neighbours, especially belowground neighbours, induces varied morphological responses in plants. However, in many species, it is not known whether neighbour identity also influences plant morphological responses such as biomass allocation patterns. To assess plant response to above- and belowground neighbour presence and identity, we conducted a greenhouse experiment consisting of conspecific (pea; Pisum sativum L.) and heterospecific (oat; Avena sativa L.) neighbours growing with a P. sativum focal plant. Four interaction regimes were constructed including shoot, root, or 'full' interaction (root & shoot) treatments, as well as a control with no interactions permitted. Our results showed that pea plants responded negatively to the presence of neighbours, and in particular, the presence of belowground neighbours. Treatments where belowground interactions were permitted (full and root interactions) had lower root and shoot mass fractions (R:S ratios) than where shoot interactions were permitted. Shoot and root allocation and R:S ratios of focal pea plants were not affected by neighbour identity, suggesting that neighbour presence, but not identity, influenced allocation patterns. The impact on P. sativum of a neighbouring competitor was more prominent than neighbour identity, showing that some plants may not discriminate between the identity of neighbours even though they are capable of responding to their presence.	[Jacob, Cory. E.; Tozzi, Eric; Willenborg, Christian J.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada	University of Saskatchewan	Willenborg, CJ (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.	chris.willenborg@usask.ca	Willenborg, Christian/AAH-9360-2021	Willenborg, Christian/0000-0001-9733-2252	Alberta Pulse Growers; Canadian Agricultural Adaptation Program; Natural Sciences and Engineering Research Council of Canada	Alberta Pulse Growers; Canadian Agricultural Adaptation Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors gratefully acknowledge funding for the study provided by the Alberta Pulse Growers, the Canadian Agricultural Adaptation Program, and the Natural Sciences and Engineering Research Council of Canada. NSERC provided a partial salary for postdoc Eric Tozzi, and the Alberta Pulse Growers provided a graduate student stipend for lead author Cory Jacob. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge funding for the study provided by the Alberta Pulse Growers, the Canadian Agricultural Adaptation Program, and the Natural Sciences and Engineering Research Council of Canada.	Afifi M, 2011, WEED RES, V51, P442, DOI 10.1111/j.1365-3180.2011.00865.x; Armas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027791; Asaduzzaman M, 2012, SCI HORTIC-AMSTERDAM, V134, P26, DOI 10.1016/j.scienta.2011.11.035; Bazzaz F. A., 1996, PLANTS CHANGING ENV; Bennett JA, 2016, J ECOL, V104, P1410, DOI 10.1111/1365-2745.12614; Bhatt MV, 2011, NEW PHYTOL, V189, P1135, DOI 10.1111/j.1469-8137.2010.03548.x; Booth BD, 2002, WEED SCI, V50, P2, DOI 10.1614/0043-1745(2002)050[0002:AIATAT]2.0.CO;2; Brown D. A., 1984, Roots, nutrient and water influx, and plant growth . ASA Special PublicationNo. 49., P101; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; Cahill JF, 2011, ANNU REV ECOL EVOL S, V42, P289, DOI 10.1146/annurev-ecolsys-102710-145006; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Cahill JF, 2005, J ECOL, V93, P958, DOI 10.1111/j.1365-2745.2005.01013.x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chen BJW, 2015, FUNCT ECOL, V29, P1383, DOI 10.1111/1365-2435.12450; Chen BJW, 2012, PLANT SCI, V195, P157, DOI 10.1016/j.plantsci.2012.07.006; CHESSON P, 1991, TRENDS ECOL EVOL, V6, P26, DOI 10.1016/0169-5347(91)90144-M; COTE R, 1992, CAN J BOT, V70, P571, DOI 10.1139/b92-073; Dener E, 2016, CURR BIOL, V26, P1763, DOI 10.1016/j.cub.2016.05.008; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Dudley SA, 2013, FUNCT ECOL, V27, P898, DOI 10.1111/1365-2435.12121; Dunbabin V, 2007, FIELD CROP RES, V104, P44, DOI 10.1016/j.fcr.2007.03.014; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; FONTEYN PJ, 1978, NATURE, V275, P544, DOI 10.1038/275544a0; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; Gal J, 2015, WEED SCI, V63, P888, DOI 10.1614/WS-D-15-00039.1; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Gersani M, 1998, EVOL ECOL, V12, P223, DOI 10.1023/A:1006587813950; Green-Tracewicz E, 2011, WEED SCI, V59, P43, DOI 10.1614/WS-D-10-00081.1; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; Gundel PE, 2014, OECOLOGIA, V176, P1, DOI 10.1007/s00442-014-2983-x; Harper J.L., 1977, PLANT POPULATION BIO; Hess L, 2007, J ECOL, V95, P241, DOI 10.1111/j.1365-2745.2006.01204.x; Horvath DP, 2007, WEED SCI, V55, P546, DOI 10.1614/WS-07-008.1; Jacob CE, 2016, WEED SCI, V64, P137, DOI 10.1614/WS-D-15-00113.1; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Koscielny CB, 2012, CAN J PLANT SCI, V92, P1229, DOI 10.4141/CJPS2012-070; Lamb EG, 2009, J ECOL, V97, P155, DOI 10.1111/j.1365-2745.2008.01454.x; Lankau RA, 2001, J ECOL, V99, P176; MACKAY AD, 1986, AGRON J, V78, P699, DOI 10.2134/agronj1986.00021962007800040028x; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; Maina GG, 2002, PLANT ECOL, V160, P235, DOI 10.1023/A:1015822003011; Mckenzie-Gopsill AG, 2016, WEED RES, V56, P267, DOI 10.1111/wre.12207; McNickle GG, 2014, J ECOL, V102, P963, DOI 10.1111/1365-2745.12259; Meier IC, 2013, PLANTA, V238, P577, DOI 10.1007/s00425-013-1910-4; Milla R, 2009, P ROY SOC B-BIOL SCI, V276, P2531, DOI 10.1098/rspb.2009.0369; Murphy GP, 2007, J ECOL, V95, P261, DOI 10.1111/j.1365-2745.2007.01217.x; Murphy KM, 2008, FIELD CROP RES, V105, P107, DOI 10.1016/j.fcr.2007.08.004; O'Brien EE, 2005, NEW PHYTOL, V168, P401, DOI 10.1111/j.1469-8137.2005.01520.x; O'Donovan JT, 2000, WEED TECHNOL, V14, P624, DOI 10.1614/0890-037X(2000)014[0624:WOAFII]2.0.CO;2; Pierik R, 2013, FUNCT ECOL, V27, P841, DOI 10.1111/1365-2435.12010; Radosevich SR, 2007, ECOLOGY OF WEEDS AND INVASIVE PLANTS: RELATIONSHIP TO AGRICULTURE AND NATURAL RESOURCE MANAGEMENT, 3RD EDITION, P183; SAS Institute, 2011, SAS US GUID VERS 9 3; Schmid C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00296; Semchenko M, 2007, J ECOL, V95, P252, DOI 10.1111/j.1365-2745.2007.01210.x; Semchenko M, 2014, NEW PHYTOL, V204, P631, DOI 10.1111/nph.12930; Walker JA, 2009, CAN J PLANT SCI, V89, P21, DOI 10.4141/CJPS08010; Wardle DA, 2003, OIKOS, V100, P497, DOI 10.1034/j.1600-0706.2003.12030.x; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Willenborg CJ, 2005, CROP SCI, V45, P1410, DOI 10.2135/cropsci2004.0638; WILSON JB, 1988, J APPL ECOL, V25, P279, DOI 10.2307/2403626; Zerner MC, 2008, AGRON J, V100, P1729, DOI 10.2134/agronj2008.0068	62	17	17	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173758	10.1371/journal.pone.0173758	http://dx.doi.org/10.1371/journal.pone.0173758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291827	Green Submitted, gold, Green Published			2022-12-26	WOS:000396094700038
J	Chen, SR; Liu, W; Wang, K; Fan, YZ; Chen, JQ; Ma, JB; Wang, XY; He, DL; Zeng, J; Li, L				Chen, Shurui; Liu, Wei; Wang, Ke; Fan, Yizeng; Chen, Jiaqi; Ma, Jianbin; Wang, Xinyang; He, Dalin; Zeng, Jin; Li, Lei			Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-kappa B/MMP-9 signaling	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; KAPPA-B; METASTASIS; MMP-9; ACTIVATION; EXPRESSION; PATHWAY; PROLIFERATION; APOPTOSIS; THERAPY	Renal cell carcinoma (RCC) is known as one of the most lethal malignancies in the urological system because of its high incidence of metastasis. Tetrandrine (Tet), a traditional Chinese herbal medicine, exerts a potent anti-cancer effect in a variety of cancer cells. However, the anti-metastatic effect of Tet and its possible mechanism in RCC is still unclear. The present study revealed that Tet significantly suppressed the migration and invasion of RCC 786-O and 769-P cells in vitro. Mechanistically, the protein levels of matrix metalloproteinases 9 (MMP-9), phosphorylated PI3K, PDK1, Akt and NF-kappa B were markedly reduced after Tet treatment. Moreover, co-treatment with LY294002 (PI3K inhibitor) could further enhance the Tet-inhibited migration and invasion, and the NF-kappa B and MMP-9 protein levels were further decreased. Similar results were observed after PDTC (NF-kappa B inhibitor) co-treatment. Conversely, SC79, an Akt activator, could partially reverse the anti-metastatic effects of Tet, accompanied by the restoration of NF-kappa B and MMP-9 protein levels. In conclusion, the current results indicated that Tet inhibited migration and invasion of RCC partially by regulating Akt/NF-kappa B/MMP-9 signaling pathway, suggesting that Tet may be a potential therapeutic candidate against metastatic RCC.	[Chen, Shurui; Liu, Wei; Wang, Ke; Fan, Yizeng; Chen, Jiaqi; Ma, Jianbin; Wang, Xinyang; He, Dalin; Zeng, Jin; Li, Lei] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Xian, Peoples R China; [Chen, Shurui] Jinzhou Med Univ, Dept Sci & Technol, Jinzhou, Peoples R China	Xi'an Jiaotong University; Jinzhou Medical University	Zeng, J; Li, L (corresponding author), Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Xian, Peoples R China.	zengjin1984@gmail.com; lilydr@hotmail.com	Wang, Xin/GYU-1129-2022	Zeng, Jin/0000-0002-0872-587X	National High Technology Research and Development Program of China (863 Program) [SS2014AA020607]; National Natural Science Foundation of China [81072107, 81472679, 81302227, 81130041, 81101936]; National Key Research and Development Program [2016YFC0902603]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This work was supported by The National High Technology Research and Development Program of China (863 Program, NO SS2014AA020607) and National Natural Science Foundation of China grant (NO.81072107, 81472679, 81302227, 81130041, 81101936), and the National Key Research and Development Program (2016YFC0902603). The funders had no role in study design, data collection and analysis, decision to publish, role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The National High Technology Research and Development Program of China (863 Program, NO SS2014AA020607) and National Natural Science Foundation of China grant (NO.81072107, 81472679, 81130041, 81101936, 81672538), and the National Key Research and Development Program (2016YFC0902603).	Chang XJ, 2016, PATHOL ONCOL RES, V22, P789, DOI 10.1007/s12253-016-0071-8; Chen SQ, 2016, INT J ONCOL, V48, P1391, DOI 10.3892/ijo.2016.3368; Chiu CT, 2015, NUTRIENTS, V7, P5065, DOI 10.3390/nu7075065; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Comperat E, 2012, Diagn Interv Imaging, V93, P221, DOI 10.1016/j.diii.2012.01.015; Dolle L, 2006, CURR CANCER DRUG TAR, V6, P729, DOI 10.2174/156800906779010263; Duensing S, 2016, LANCET, V387, P1973, DOI 10.1016/S0140-6736(16)00653-X; Fan DM, 2016, GYNECOL ONCOL, V141, P166, DOI 10.1016/j.ygyno.2016.02.006; Gao JL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/265061; Gao LN, 2016, J ORTHOP RES, V34, P1557, DOI 10.1002/jor.23155; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hainaut P, 2013, CURR OPIN ONCOL, V25, P50, DOI 10.1097/CCO.0b013e32835b651e; Kang H, 2012, J CELL BIOCHEM, V113, P2845, DOI 10.1002/jcb.24159; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kou B, 2016, ONCOL REP, V35, P2880, DOI 10.3892/or.2016.4649; Li CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091332; Li XD, 2011, J SURG RES, V166, pE45, DOI 10.1016/j.jss.2010.10.034; Lien JC, 2016, ENV TOXICOLOGY; Liu T, 2016, ONCOTARGET, DOI 10.18632/oncotarget.1346527888803; Liu W, 2015, ASIAN J ANDROL, V17, P850, DOI 10.4103/1008-682X.142134; Park SY, 2013, INT J ONCOL, V42, P287, DOI 10.3892/ijo.2012.1695; Shen DF, 2010, BRIT J PHARMACOL, V159, P970, DOI 10.1111/j.1476-5381.2009.00605.x; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Thangapazham RL, 2007, CANCER BIOL THER, V6, P1938, DOI 10.4161/cbt.6.12.4974; Wang J, 2015, CLIN EXP METASTAS, V32, P605, DOI 10.1007/s10585-015-9731-4; Wang X, 2015, J SPECTROSC, V2015, P1, DOI 10.1155/2015/285891; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Zhang YR, 2016, J STAT MECH-THEORY E, P1, DOI 10.1088/1742-5468/2016/11/113207; Zhou F, 2016, BIOCHEM BIOPH RES CO, V472, P451, DOI 10.1016/j.bbrc.2016.01.065	30	28	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173725	10.1371/journal.pone.0173725	http://dx.doi.org/10.1371/journal.pone.0173725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288190	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400032
J	El-Sharnouby, S; Fischer, B; Magbanua, JP; Umans, B; Flower, R; Choo, SW; Russell, S; White, R				El-Sharnouby, Sherif; Fischer, Bettina; Magbanua, Jose Paolo; Umans, Benjamin; Flower, Rosalyn; Choo, Siew Woh; Russell, Steven; White, Robert			Regions of very low H3K27me3 partition the Drosophila genome into topological domains	PLOS ONE			English	Article							CHROMATIN IMMUNOPRECIPITATION ASSAY; BINDING-SITES; CHROMODOMAIN PROTEIN; JIL-1 KINASE; HISTONE H4; CTCF SITES; ORGANIZATION; ACETYLATION; PRINCIPLES; REVEALS	It is now well established that eukaryote genomes have a common architectural organization into topologically associated domains (TADs) and evidence is accumulating that this organization plays an important role in gene regulation. However, the mechanisms that partition the genome into TADs and the nature of domain boundaries are still poorly understood. We have investigated boundary regions in the Drosophila genome and find that they can be identified as domains of very low H3K27me3. The genome-wide H3K27me3 profile partitions into two states; very low H3K27me3 identifies Depleted (D) domains that contain housekeeping genes and their regulators such as the histone acetyltransferase-containing NSL complex, whereas domains containing moderate-to-high levels of H3K27me3 (Enriched or E domains) are associated with regulated genes, irrespective of whether they are active or inactive. The D domains correlate with the boundaries of TADs and are enriched in a subset of architectural proteins, particularly Chromator, BEAF-32, and Z4/Putzig. However, rather than being clustered at the borders of these domains, these proteins bind throughout the H3K27me3-depleted regions and are much more strongly associated with the transcription start sites of housekeeping genes than with the H3K27me3 domain boundaries. While we have not demonstrated causality, we suggest that the D domain chromatin state, characterised by very low or absent H3K27me3 and established by housekeeping gene regulators, acts to separate topological domains thereby setting up the domain architecture of the genome.	[El-Sharnouby, Sherif; Magbanua, Jose Paolo; Umans, Benjamin; Flower, Rosalyn; White, Robert] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Fischer, Bettina; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Fischer, Bettina; Russell, Steven] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Choo, Siew Woh] Univ Malaya, Dept Oral & Craniofacial Sci, Fac Dent, Kuala Lumpur, Malaysia	University of Cambridge; University of Cambridge; University of Cambridge; Universiti Malaya	White, R (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England.	rw108@cam.ac.uk		White, Robert/0000-0002-0019-8227; Umans, Benjamin/0000-0002-8209-9731; Russell, Steven/0000-0003-0546-3031	Wellcome Trust [089834/Z/09/Z]; University of Malaya High Impact Research from the Ministry of Higher Education Malaysia [UM.C/625/HIR/MOHE/CHAN-08]; BBSRC [BB/M007081/1]; Cambridge Marshall Scholarship; Biotechnology and Biological Sciences Research Council [BB/M007081/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); University of Malaya High Impact Research from the Ministry of Higher Education Malaysia; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Marshall Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (https://wellcome.ac.uk/, grant 089834/Z/09/Z to RW, SR), by the University of Malaya High Impact Research (hir.um.edu.my, grant UM.C/625/HIR/MOHE/CHAN-08 to SWC) from the Ministry of Higher Education Malaysia, and by the BBSRC (www.bbsrc.ac.uk, grant BB/M007081/1 to RW, SR). BU was funded by a Cambridge Marshall Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Bowman SK, 2014, ELIFE, V3, DOI 10.7554/eLife.02833; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen X, 2011, DEVELOPMENT, V138, P2441, DOI 10.1242/dev.056572; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dahl JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1158; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gan M, 2011, J BIOSCIENCES, V36, P425, DOI 10.1007/s12038-011-9089-y; Gomez-Marin C, 2015, P NATL ACAD SCI USA, V112, P7542, DOI 10.1073/pnas.1505463112; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hoffman M. M., 2012, NUCLEIC ACIDS RES; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Lee HG, 2015, GENOME RES, V25, P1170, DOI 10.1101/gr.188920.114; Levy-Leduc C, 2014, BIOINFORMATICS, V30, pI386, DOI 10.1093/bioinformatics/btu443; Li L, 2015, MOL CELL, V58, P216, DOI 10.1016/j.molcel.2015.02.023; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lowe N, 2014, DEVELOPMENT, V141, P3994, DOI 10.1242/dev.111054; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lv WW, 2012, J CELL SCI, V125, P5369, DOI 10.1242/jcs.106336; Majumder P, 2014, J IMMUNOL, V192, P3925, DOI 10.4049/jimmunol.1303205; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mifsud B, 2013, GOTHIC BINOMIAL TEST; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Patel B, 2014, LEUKEMIA, V28, P349, DOI 10.1038/leu.2013.158; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sidiropoulos N, 2015, 028191V1 BIORXIV; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Stampfel G, 2015, NATURE, V528, P147, DOI 10.1038/nature15545; Taramasco O, 2013, RHMM HIDDEN MARKOV M; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; van Berkum NL, 2010, J VIS EXP JOVE; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	71	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172725	10.1371/journal.pone.0172725	http://dx.doi.org/10.1371/journal.pone.0172725			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282436	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800011
J	Gleason, JA; Fagliano, JA				Gleason, Jessie A.; Fagliano, Jerald A.			Effect of drinking water source on associations between gastrointestinal illness and heavy rainfall in New Jersey	PLOS ONE			English	Article							UNITED-STATES; TIME-SERIES; DISEASE; PHILADELPHIA; TURBIDITY; GASTROENTERITIS; PRECIPITATION; OUTBREAKS; QUALITY; WEATHER	Gastrointestinal illness (GI) has been associated with heavy rainfall. Storm events and periods of heavy rainfall and runoff can result in increased microbiological contaminants in raw water. Surface water supplies are open to the environment and runoff can directly influence the presence of contaminants. A time-stratified bi-directional case-crossover study design was used to estimate associations of heavy rainfall and hospitalizations for GI. Cases of GI were identified as in-patient hospitalization with a primary diagnosis of infectious disease associated diarrhea [ ICD-9 codes: specified gastrointestinal infections 001 - 009.9 or diarrhea 787.91] among the residents of New Jersey from 2009 to 2013 resulting in a final sample size of 47,527 cases. Two control days were selected on the same days of the week as the case day, within fixed 21-day strata. Conditional logistic regression was used to estimate odds ratios controlling for temperature and humidity. To determine potential effect modification estimates were stratified by season (warm or cold) and drinking water source (groundwater, surface water, or 'other' category). Stratified analyses by drinking water source and season identified positive associations of rainfall and GI hospitalizations in surface water systems during the warm season with no lag (OR = 1.12, 95% CI 1.05 - 1.19) and a 2-day lag (OR = 1.09, 95% CI 1.03 - 1.16). Positive associations in 'Other' water source areas (served by very small community water systems, private wells, or unknown) during the warm season with a 4-day lag were also found. However, there were no statistically significant positive associations in groundwater systems during the warm season. The results suggest that water systems with surface water sources can play an important role in preventing GI hospitalizations during and immediately following heavy rainfall. Regulators should work with water system providers to develop system specific prevention techniques to limit the impact of heavy rainfall on public health.	[Gleason, Jessie A.; Fagliano, Jerald A.] New Jersey Dept Hlth, Environm & Occupat Hlth Surveillance Program, Trenton, NJ 08625 USA	New Jersey Department of Health & Senior Services	Gleason, JA (corresponding author), New Jersey Dept Hlth, Environm & Occupat Hlth Surveillance Program, Trenton, NJ 08625 USA.	jessie.gleason@doh.state.nj.us						Aramini J, 2000, Can Commun Dis Rep, V26, P211; Beaudeau P, 2014, WATER RES, V52, P188, DOI 10.1016/j.watres.2014.01.005; Beaudeau P, 2014, J EXPO SCI ENV EPID, V24, P192, DOI 10.1038/jes.2013.5; Borchardt MA, 2012, ENVIRON HEALTH PERSP, V120, P1272, DOI 10.1289/ehp.1104499; Colford John M. Jr., 2006, Journal of Water and Health, V4, P71, DOI 10.2166/wh.2006.018; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; ELDER D., 2011, WATER QUALITY TREATM, V6a; Febriani Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-48; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Fung KY, 2003, INT J EPIDEMIOL, V32, P1064, DOI 10.1093/ije/dyg246; Harper SL, 2011, ECOHEALTH, V8, P93, DOI 10.1007/s10393-011-0690-1; Herrador BRG, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0014-y; Hilborn ED, 2013, MMWR-MORBID MORTAL W, V62, P714; Hsieh JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125071; LeChevallier M, 2011, WATER QUALITY TREATM; Li S, 2011, ENV RES; Mann AG, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-256; Messner Michael, 2006, Journal of Water and Health, V4, P201, DOI 10.2166/wh.2006.024; Murphy HM, 2014, J WATER HEALTH, V12, P634, DOI 10.2166/wh.2014.049; Navidi W, 1998, BIOMETRICS, V54, P596, DOI 10.2307/3109766; NAVIDI W, 1999, RES REP HLTH EFF I, V86, P1; [NCEI National Centers for Environmental Information], 2014, GLOB SURF SUMM DAY G; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; NJDEP, 2015, WAT PURV SERV AR 199; NJDEP, 2015, NEW JERS DRINK WAT W; Office of the New Jersey State Climatologist, 2015, CLIM NEW JERS; PHASE, 2007, TECHN BACKGR REP CAS; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Teschke K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-767; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Tornevi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128487; Uejio CK, 2014, AM J PUBLIC HLTH; US Census Bureau, 2015, AM FACTFINDER; USEPA, 2015, MON UNR DRINK WAT CO; Wallender EK, 2014, GROUNDWATER, V52, P886, DOI 10.1111/gwat.12121; WENIGER BG, 1983, AM J PUBLIC HEALTH, V73, P868, DOI 10.2105/AJPH.73.8.868; White ANJ, 2009, ECOHEALTH, V6, P200, DOI 10.1007/s10393-009-0246-9	42	14	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173794	10.1371/journal.pone.0173794	http://dx.doi.org/10.1371/journal.pone.0173794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282467	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800080
J	Clink, DJ; Dillis, C; Feilen, KL; Beaudrot, L; Marshall, AJ				Clink, Dena J.; Dillis, Christopher; Feilen, Katie L.; Beaudrot, Lydia; Marshall, Andrew J.			Dietary diversity, feeding selectivity, and responses to fruit scarcity of two sympatric Bornean primates (Hylobates albibarbis and Presbytis rubicunda rubida)	PLOS ONE			English	Article							PALUNG-NATIONAL-PARK; FALLBACK FOODS; REPRODUCTIVE-BEHAVIOR; TAXONOMIC SUFFICIENCY; SEASONAL-VARIATION; LEAF MONKEYS; RAIN-FORESTS; GIBBONS; CHIMPANZEES; AVAILABILITY	Effectively characterizing primate diets is fundamental to understanding primate behavior, ecology and morphology. Examining temporal variation in a species' diet, as well as comparing the responses of different species to variation in resource availability, can enhance understanding of the evolution of morphology and socioecology. In this study, we use feeding data collected over five years to describe the diets of two sympatric Southeast Asian primate species of similar body size: white-bearded gibbons (Hylobates albibarbis) and red leaf monkeys (Presbytis rubicunda rubida), in Gunung Palung National Park, West Kalimantan, Indonesia. Long-term data sets are especially important for characterizing primate diets in Southeast Asia, where the forests exhibit supra-annual mast fruiting events. We found that gibbons were mainly frugivorous, with fruit and figs comprising 70% of their 145 independent feeding observations, whereas leaf monkeys ate a substantial amount of seeds (26%), fruits and figs (26.5%) and leaves (30%, n = 219 independent feeding observations). Leaf monkeys consumed a higher number of plant genera, and this was due mostly to the non-frugivorous portion of their diet. To investigate resource selection by these primates we utilized two different approaches: the Manly Selectivity Ratio, which did not take into account temporal variation of resource availability, and a model selection framework which did incorporate temporal variation. Both species selected figs (Ficus) more than predicted based on their availability under the Manly Selectivity Ratio. Model selection allowed us to determine how these primates alter the proportion of leaves, flowers, seeds, figs and fruit in their diets in response to variation in fruit availability. When fruits were scarce, both gibbons and leaf monkeys incorporated more leaves and figs into their diets, indicating that these two food classes are fallback foods for these primates. We discuss how different measures of resource selection can provide seemingly contradictory results, and emphasize the importance of long term studies that combine independent feeding observations with rigorous assessment of temporal variation in resource availability when modelling feeding selectivity.	[Clink, Dena J.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Dillis, Christopher] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Feilen, Katie L.] Disneys Anim Sci & Environm, Conservat Dept, Lake Buena Vista, FL USA; [Beaudrot, Lydia] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Beaudrot, Lydia] Univ Michigan, Michigan Soc Fellows, Ann Arbor, MI 48109 USA; [Marshall, Andrew J.] Univ Michigan, Dept Anthropol, Program Environm, Ann Arbor, MI 48109 USA; [Marshall, Andrew J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Clink, DJ (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	djclink@ucdavis.edu	Beaudrot, L./M-6936-2017	Beaudrot, L./0000-0001-8135-7519	UC Davis Hellman Fellowship; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates; Seneca Park Zoo; Mohamed bin Zayed Species Conservation Fund, Promoting gibbon conservation in Gunung Palung National Park, West Kalimantan through training and participatory monitoring activities with Indonesian university students and citizen scientists; Victoria University, Wellington, New Zealand; Orangutan Conservancy Grant; Leakey Foundation Research Grant; UC Davis New Research Initiatives, From individuals to landscapes: testing fundamental hypotheses about the reproduction of Bornean rainforest plants across a complex tropical landscape; Leakey Foundation Research Grant, Causes and consequences of habitat quality variation for Bornean primates; UC Davis Principal Investigator Bridge Program, Continued research on the population ecology of Bornean rainforest primates; Orangutan Conservancy, Infrastructure completion of the Cabang Panti Research Station and reestablishment of research at Gunung Palung; Disney's Animals, Science and Environment	UC Davis Hellman Fellowship; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates; Seneca Park Zoo; Mohamed bin Zayed Species Conservation Fund, Promoting gibbon conservation in Gunung Palung National Park, West Kalimantan through training and participatory monitoring activities with Indonesian university students and citizen scientists; Victoria University, Wellington, New Zealand; Orangutan Conservancy Grant; Leakey Foundation Research Grant; UC Davis New Research Initiatives, From individuals to landscapes: testing fundamental hypotheses about the reproduction of Bornean rainforest plants across a complex tropical landscape; Leakey Foundation Research Grant, Causes and consequences of habitat quality variation for Bornean primates; UC Davis Principal Investigator Bridge Program, Continued research on the population ecology of Bornean rainforest primates; Orangutan Conservancy, Infrastructure completion of the Cabang Panti Research Station and reestablishment of research at Gunung Palung; Disney's Animals, Science and Environment	This work was supported by: UC Davis Hellman Fellowship, 2009-2010, $25,500; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2013, $2,000; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2012, $2,000; Seneca Park Zoo, Grant for orangutan gibbon field research and habitat conservation, 2012, $750; Mohamed bin Zayed Species Conservation Fund, Promoting gibbon conservation in Gunung Palung National Park, West Kalimantan through training and participatory monitoring activities with Indonesian university students and citizen scientists, 2012, $10,000 (URL: http://www.speciesconservation.org/); Victoria University, Wellington, New Zealand, The importance of mast seeding for vertebrate community structure and dynamics, 2012, with Heiko U. Wittmer, $40,000 NZD; Victoria University, Wellington, New Zealand, The importance of mast seeding for community dynamics, 2011, with Heiko U. Wittmer, $4,000 NZD; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2011, $2,000; Orangutan Conservancy Grant, Emergency funding for Gunung Palung, 2011, $9,000; Leakey Foundation Research Grant, Emergency funding for Gunung Palung, 2011, $6,000 (URL: http://leakeyfoundation.rg/grants/research-grants/); UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2010, $1,800; UC Davis New Research Initiatives, From individuals to landscapes: testing fundamental hypotheses about the reproduction of Bornean rainforest plants across a complex tropical landscape, 2009, $12,000; Leakey Foundation Research Grant, Causes and consequences of habitat quality variation for Bornean primates, 2009, $15,000 (URL: https://leakeyfoundation.org/ grants/research-grants/); UC Davis Principal Investigator Bridge Program, Continued research on the population ecology of Bornean rainforest primates, 2008, $12,000; UC Davis Small Grant in Aid of Research, Continued research on the population ecology of Bornean rainforest primates, 2008, $2,000; Orangutan Conservancy, Infrastructure completion of the Cabang Panti Research Station and reestablishment of research at Gunung Palung (with C. Knott), 2007, $10,000; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2007, $2,000. Disney's Animals, Science and Environment provided support in the form of salaries for author KLF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bacci T, 2009, MAR ECOL-EVOL PERSP, V30, P13, DOI 10.1111/j.1439-0485.2009.00324.x; Beaudrot L, 2013, ECOGRAPHY, V36, P984, DOI 10.1111/j.1600-0587.2013.00122.x; Calenge C., 2006, ECOLOGICAL MODELLING; Cannon CH, 2007, CURR SCI INDIA, V93, P1558; Cannon CH, 2007, ECOL LETT, V10, P956, DOI 10.1111/j.1461-0248.2007.01089.x; CANT J G H, 1980, Primates, V21, P538, DOI 10.1007/BF02373842; Chainho P, 2007, HYDROBIOLOGIA, V587, P63, DOI 10.1007/s10750-007-0694-6; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHAPMAN CA, 1991, FOLIA PRIMATOL, V56, P162, DOI 10.1159/000156542; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Chivers DJ, 1994, FUNCTIONAL ANATOMY G; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P971, DOI 10.1023/A:1020370119096; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; Davies A. Glyn, 1994, P285; DAVIES AG, 1988, BIOL J LINN SOC, V34, P33, DOI 10.1111/j.1095-8312.1988.tb01947.x; De Vleeschouwer KM, 2013, MULTILEVEL TRANSDISC; Dillis C, 2015, BIOTROPICA, V47, P85, DOI 10.1111/btp.12176; Fossey D, 1977, P415; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Garcia LC, 2014, BIOTROPICA, V46, P114, DOI 10.1111/btp.12080; Hanya G, 2012, INT J PRIMATOL, V33, P322, DOI 10.1007/s10764-012-9580-9; Harris TR, 2010, BEHAV ECOL, V21, P46, DOI 10.1093/beheco/arp150; Harrison ME, 2011, INT J PRIMATOL, V32, P531, DOI 10.1007/s10764-010-9487-2; HARRISON MJS, 1983, ANIM BEHAV, V31, P969, DOI 10.1016/S0003-3472(83)80001-3; Hawes JE, 2014, OIKOS, V123, P365, DOI 10.1111/j.1600-0706.2013.00745.x; Hawes JE, 2013, INT J PRIMATOL, V34, P1081, DOI 10.1007/s10764-013-9738-0; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Isbell LA, 2002, BEHAVIOUR, V139, P177, DOI 10.1163/156853902760102645; Kay Robin N. B., 1994, P229; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kim S, 2012, AM J PRIMATOL, V74, P1154, DOI 10.1002/ajp.22074; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Koch F, 2016, AM J PRIMATOL; LAMBERT FR, 1991, J ECOL, V79, P793, DOI 10.2307/2260668; Lambert J.E., 2007, PRIMATES PERSPECTIVE, P482, DOI DOI 10.1146/ANNUREV-ANTHRO-102313-025928; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Lambert JE, 2015, ANNU REV ANTHROPOL, V44, P493, DOI 10.1146/annurev-anthro-102313-025928; LEIGHTON M, 1993, INT J PRIMATOL, V14, P257, DOI 10.1007/BF02192635; LEIGHTON M, 1983, P181; Liu XC, 2016, PRIMATES, V57, P479, DOI 10.1007/s10329-016-0535-1; Lucas Peter W., 1994, P173; Manly BF, 2002, RESOURCE SELECTION A, P1, DOI [10.1007/0-306-48151-0_1, DOI 10.1007/0-306-48151-0_1]; Marshall AJ, 2014, INT J PRIMATOL, V35, P1; Marshall AJ, 2004, THESIS; Marshall Andrew J., 2006, P313; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Marshall AJ, 2013, TECH ECOL CONSERVAT, P103; Marshall AJ, 2010, DEV PRIMATOL-PROG PR, P157, DOI 10.1007/978-1-4419-1560-3_9; Marshall Andrew J., 2009, P97; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; Marshall Andrew J., 2009, P161, DOI 10.1007/978-0-387-88604-6_9; McConkey Kim R., 2009, P189, DOI 10.1007/978-0-387-88604-6_10; McConkey KR, 2003, INT J PRIMATOL, V24, P19, DOI 10.1023/A:1021490327385; McConkey KR, 2002, INT J PRIMATOL, V23, P123, DOI 10.1023/A:1013253909046; McElreath R., 2012, RETHINKING STAT RETH; MCKEY D, 1978, SCIENCE, V202, P61; MOLE S, 1985, J CHEM ECOL, V11, P1323, DOI 10.1007/BF01024119; Oksanen J., 2007, COMMUN ECOL PACK, P631; Porter LM, 2001, INT J PRIMATOL, V22, P961, DOI 10.1023/A:1012013621258; R Core Team, 2021, R LANGUAGE ENV STAT; RAEMAEKERS J, 1978, FOLIA PRIMATOL, V30, P194, DOI 10.1159/000155863; ROSENBERGER AL, 1992, AM J PHYS ANTHROPOL, V88, P525, DOI 10.1002/ajpa.1330880408; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sato H, 2016, INT J PRIMATOL, V37, P109, DOI 10.1007/s10764-015-9877-6; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Smith DAE, 2013, AM J PRIMATOL, V75, P848, DOI 10.1002/ajp.22148; Snaith TV, 2007, EVOL ANTHROPOL, V16, P94, DOI 10.1002/evan.20132; SUPRIATNA J, 1986, PRIMATES, V27, P185, DOI 10.1007/BF02382597; Terborgh J., 1983, 5 NEW WORLD PRIMATES; Timms LL, 2013, INSECT CONSERV DIVER, V6, P453, DOI 10.1111/icad.12004; TUTIN CEG, 1993, AM J PRIMATOL, V30, P195, DOI 10.1002/ajp.1350300305; UNGAR PS, 1995, INT J PRIMATOL, V16, P221, DOI 10.1007/BF02735479; VANSCHAIK CP, 1988, BEHAVIOUR, V105, P77, DOI 10.1163/156853988X00458; Vogel ER, 2009, AM J PHYS ANTHROPOL, V140, P716, DOI 10.1002/ajpa.21119; WATERMAN PG, 1992, CIBA F SYMP, V171, P255; Watts DP, 2012, AM J PRIMATOL, V74, P130, DOI 10.1002/ajp.21015; Wich SA, 2000, J TROP ECOL, V16, P563, DOI 10.1017/S0266467400001577; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	81	12	13	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173369	10.1371/journal.pone.0173369	http://dx.doi.org/10.1371/journal.pone.0173369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278215	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900078
J	Liu, TF; Luo, CL; Wang, J; Ma, J; Shu, DM; Lund, MS; Su, GS; Qu, H				Liu, Tianfei; Luo, Chenglong; Wang, Jie; Ma, Jie; Shu, Dingming; Lund, Mogens Sando; Su, Guosheng; Qu, Hao			Assessment of the genomic prediction accuracy for feed efficiency traits in meat-type chickens	PLOS ONE			English	Article							ESTIMATED BREEDING VALUES; GENETIC-PARAMETERS; CONVERSION RATIO; SELECTION; GROWTH; ASSOCIATION; RELIABILITY; PEDIGREE	Feed represents the major cost of chicken production. Selection for improving feed utilization is a feasible way to reduce feed cost and greenhouse gas emissions. The objectives of this study were to investigate the efficiency of genomic prediction for feed conversion ratio (FCR), residual feed intake (RFI), average daily gain (ADG) and average daily feed intake (ADFI) and to assess the impact of selection for feed efficiency traits FCR and RFI on eviscerating percentage (EP), breast muscle percentage (BMP) and leg muscle percentage (LMP) in meat-type chickens. Genomic prediction was assessed using a 4-fold cross-validation for two validation scenarios. The first scenario was a random family sampling validation (CVF), and the second scenario was a random individual sampling validation (CVR). Variance components were estimated based on the genomic relationship built with single nucleotide polymorphism markers. Genomic estimated breeding values (GEBV) were predicted using a genomic best linear unbiased prediction model. The accuracies of GEBV were evaluated in two ways: the correlation between GEBV and corrected phenotypic value divided by the square root of heritability, i.e., the correlation-based accuracy, and model-based theoretical accuracy. Breeding values were also predicted using a conventional pedigree-based best linear unbiased prediction model in order to compare accuracies of genomic and conventional predictions. The heritability estimates of FCR and RFI were 0.29 and 0.50, respectively. The heritability estimates of ADG, ADFI, EP, BMP and LMP ranged from 0.34 to 0.53. In the CVF scenario, the correlation-based accuracy and the theoretical accuracy of genomic prediction for FCR were slightly higher than those for RFI. The correlation-based accuracies for FCR, RFI, ADG and ADFI were 0.360, 0.284, 0.574 and 0.520, respectively, and the model-based theoretical accuracies were 0.420, 0.414, 0.401 and 0.382, respectively. In the CVR scenario, the correlation-based accuracy and the theoretical accuracy of genomic prediction for FCR was lower than RFI, which was different from the CVF scenario. The correlation-based accuracies for FCR, RFI, ADG and ADFI were 0.449, 0.593, 0.581 and 0.627, respectively, and the model-based theoretical accuracies were 0.577, 0.629, 0.631 and 0.638, respectively. The accuracies of genomic predictions were 0.371 and 0.322 higher than the conventional pedigree-based predictions for the CVF and CVR scenarios, respectively. The genetic correlations of FCR with EP, BMP and LMP were -0.427, -0.156 and -0.338, respectively. The correlations between RFI and the three carcass traits were -0.320, -0.404 and -0.353, respectively. These results indicate that RFI and FCR have a moderate accuracy of genomic prediction. Improving RFI and FCR could be favourable for EP, BMP and LMP. Compared with FCR, which can be improved by selection for ADG in typical meat-type chicken breeding programs, selection for RFI could lead to extra improvement in feed efficiency.	[Liu, Tianfei; Luo, Chenglong; Wang, Jie; Ma, Jie; Shu, Dingming; Qu, Hao] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China; [Liu, Tianfei; Luo, Chenglong; Wang, Jie; Shu, Dingming; Qu, Hao] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China; [Ma, Jie] Guangdong Key Lab Anim Breeding & Nutr, Guangzhou, Guangdong, Peoples R China; [Lund, Mogens Sando; Su, Guosheng] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Aarhus, Denmark	Guangdong Academy of Agricultural Sciences; Aarhus University	Qu, H (corresponding author), Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China.	qhw03@163.com	Liu, Tianfei/X-9848-2019; Lund, Mogens S/I-4321-2016	Liu, Tianfei/0000-0003-1835-9807; 	Earmarked Fund for Modern Agro-Industry Technology Research System [nycytx-42]; Science and Technology Program of Guangzhou [201504010017]; Dean Fund of Guangdong Academy of Agricultural Science [201618]	Earmarked Fund for Modern Agro-Industry Technology Research System; Science and Technology Program of Guangzhou; Dean Fund of Guangdong Academy of Agricultural Science	This work was supported by the Earmarked Fund for Modern Agro-Industry Technology Research System (nycytx-42, http://www.moa.gov.cn/), the Science and Technology Program of Guangzhou (201504010017, http://www.gzsi.gov.cn/) and the Dean Fund of Guangdong Academy of Agricultural Science (201618,http://www.gdaas.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggrey SE, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-25; Berenos C, 2014, MOL ECOL, V23, P3434, DOI 10.1111/mec.12827; Cai W, 2008, J ANIM SCI, V86, P287, DOI 10.2527/jas.2007-0396; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; Ding X, 2013, J DAIRY SCI, V96, P5315, DOI 10.3168/jds.2012-6194; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; GUNSETT FC, 1984, J ANIM SCI, V59, P1185, DOI 10.2527/jas1984.5951185x; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hoque MA, 2009, J ANIM SCI, V87, P3069, DOI 10.2527/jas.2008-1268; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Liu TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112685; Liu TF, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0110-y; LUITING P, 1990, WORLD POULTRY SCI J, V46, P133, DOI 10.1079/WPS19900017; Luo C, 2015, ANIM GENET, V46, P265, DOI 10.1111/age.12284; Madsen P, 2010, 9 WORLD C GEN APPL L; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2013, ANNU REV ANIM BIOSCI, V1, P221, DOI 10.1146/annurev-animal-031412-103705; N'Dri AL, 2006, BRIT POULTRY SCI, V47, P273, DOI 10.1080/00071660600753664; Santana MHA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-21; Sheng ZY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-151; Su G, 2010, J DAIRY SCI, V93, P1175, DOI 10.3168/jds.2009-2192; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Varkoohi S, 2010, POULTRY SCI, V89, P1590, DOI 10.3382/ps.2010-00744; Wang JL, 2016, THEOR POPUL BIOL, V107, P4, DOI 10.1016/j.tpb.2015.08.006; Willems OW, 2013, WORLD POULTRY SCI J, V69, P77, DOI 10.1017/S004393391300007X; Williams YJ, 2011, J DAIRY SCI, V94, P4715, DOI 10.3168/jds.2010-4015; Wolc A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0133-5; Wolc A, 2013, POULTRY SCI, V92, P2270, DOI 10.3382/ps.2013-03085; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-23; Yeaman JC, 2013, J ANIM SCI, V91, P4628, DOI 10.2527/jas.2012-6226; Yuan JW, 2015, POULTRY SCI, V94, P1470, DOI 10.3382/ps/pev122	37	10	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173620	10.1371/journal.pone.0173620	http://dx.doi.org/10.1371/journal.pone.0173620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278209	Green Published, gold			2022-12-26	WOS:000396087900017
J	Maloney, JP; Branchford, BR; Brodsky, GL; Cosmic, MS; Calabrese, DW; Aquilante, CL; Maloney, KW; Gonzalez, JR; Zhang, WM; Moreau, KL; Wiggins, KL; Smith, NL; Broeckel, U; Di Paola, J				Maloney, James P.; Branchford, Brian R.; Brodsky, Gary L.; Cosmic, Maxwell S.; Calabrese, David W.; Aquilante, Christina L.; Maloney, Kelly W.; Gonzalez, Joseph R.; Zhang, Weiming; Moreau, Kerrie L.; Wiggins, Kerri L.; Smith, Nicholas L.; Broeckel, Ulrich; Di Paola, Jorge			The ENTPD1 promoter polymorphism-860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk	FASEB JOURNAL			English	Article						CD39 Denver; P2Y1; platelet aggregation; purinergic signaling	GENOME-WIDE ASSOCIATION; VENOUS THROMBOEMBOLISM; PULMONARY-HYPERTENSION; MOLECULAR-CLONING; P2Y(1) RECEPTOR; CD39; DIPHOSPHOHYDROLASE; ASPIRIN; DISEASE; THROMBOREGULATION	Ectonudeoside triphosphate diphosphohydrolase 1 (NTPDase1) degrades the purines ATP and ADP that are key regulators of inflammation and clotting. We hypothesized that NTPDase1 polymorphisms exist and that they regulate this pathway. We sequenced the ENTPDI gene (encoding NTPDase1) in 216 subjects then assessed genotypes in 2 cohorts comprising 2213 humans to identify ENTPDI polymorphisms associated with venous thromboembolism (VTE). The G allele of the intron 1 polymorphism rs3176891 was more common in VTE vs. controls (odds ratio 1.26-1.9); it did not affect RNA splicing, but it was in strong linkage disequilibrium with the G allele of the promoter polymorphism rs3814159, which increased transcriptional activity by 8-fold. Oligonucleotides containing the G allele of this promoter region bound nuclear extracts more avidly. Carriers of rs3176891 G had endothelial cells with increased NTPDase1 activity and protein expression, and had platelets with enhanced aggregation. Thus, the G allele of rs3176891 marks a haplotype associated with increased dotting and platelet aggregation attributable to a promoter variant associated with increased transcription, expression, and activity of NTPDase1. We term this gain-of-function phenotype observed with rs3814159 G "CD39 Denver." Maloney, J. P., Branchford, B. R., Brodsky, G. L., Cosmic, M. S., Calabrese, D. W., Aquilante, C. L, Maloney, K. W., Gonzalez, J. R., Zhang, W., Moreau, K. L., Wiggins, K. L., Smith, N. L., Broeckel, U., Di Paola, J. The ENTPDI promoter polymorphism 860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk	[Maloney, James P.; Calabrese, David W.] Univ Colorado Denver, Div Pulm & Crit Care Med, 12700 East 19th Ave,C-272, Aurora, CO 80045 USA; [Branchford, Brian R.; Brodsky, Gary L.; Maloney, Kelly W.; Di Paola, Jorge] Univ Colorado Denver, Ctr Canc & Blood Disorders, Aurora, CO USA; [Aquilante, Christina L.] Univ Colorado Denver, Sch Pharm, Pharmaceut Sci, Aurora, CO USA; [Gonzalez, Joseph R.] Univ Colorado Denver, Otolaryngol Head & Neck Surg, Aurora, CO USA; [Zhang, Weiming] Univ Colorado Denver, Colorado Sch Publ Hlth, Biostat & Informat, Aurora, CO USA; [Moreau, Kerrie L.] Univ Colorado Denver, Div Geriatr Med, Aurora, CO USA; [Maloney, James P.; Calabrese, David W.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Cosmic, Maxwell S.] Chest Infect Dis & Crit Care Associates, Des Moines, IA USA; [Wiggins, Kerri L.] Univ Washington, Dept Med, Seattle, WA USA; [Smith, Nicholas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Smith, Nicholas L.] Vet Affairs Off Res & Dev, Seattle, WA USA; [Smith, Nicholas L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Broeckel, Ulrich] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Broeckel, Ulrich] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Broeckel, Ulrich] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Maloney, JP (corresponding author), Univ Colorado Denver, Div Pulm & Crit Care Med, 12700 East 19th Ave,C-272, Aurora, CO 80045 USA.	james.maloney@ucdenver.edu	Branchford, Brian/H-7581-2019	Branchford, Brian/0000-0002-4076-270X; Wiggins, Kerri L/0000-0003-2749-1279	U.S. National Institutes of Health (NIH)/Heart, Lung, and Blood Institute (NHLBI) [RO1 HL071618]; NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development Child Health Research [K12 HD068372]; Hemostasis and Thrombosis Research Society (HTRS) Mentored Research Award; CSL Behring/Prof. Heim burger Award; American Society of Hematology (ASH) Scholar Award; NIH National Institute on Aging Grant [AG027678]; NIH/NHLBI [R01 HL084086, HL43201, HL60739, HL68986, HL73410, HL74745, HL85251, HL95080]; Postle Family Chair of Pediatric Cancer and Blood Disorders; NIH/National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute (CTSA) [UL1 TR001082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068372] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068986, R01HL071618, R01HL074745, R01HL095080, R01HL084086, R01HL043201, R01HL085251, R01HL073410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027678] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/Heart, Lung, and Blood Institute (NHLBI); NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development Child Health Research; Hemostasis and Thrombosis Research Society (HTRS) Mentored Research Award; CSL Behring/Prof. Heim burger Award; American Society of Hematology (ASH) Scholar Award; NIH National Institute on Aging Grant; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Postle Family Chair of Pediatric Cancer and Blood Disorders; NIH/National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute (CTSA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the patients and volunteers who agreed to participate in this study. The authors also thank W. Kohrt and S. Colgan (both from the University of Colorado at Denver) for their contributions of resources and helpful advice. This work was supported, in part, by the following: U.S. National Institutes of Health (NIH)/Heart, Lung, and Blood Institute (NHLBI) Grant RO1 HL071618 (to J.M.); NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development Child Health Research Career Development Award (K12 HD068372), Hemostasis and Thrombosis Research Society (HTRS) Mentored Research Award, CSL Behring/Prof. Heim burger Award, American Society of Hematology (ASH) Scholar Award (to B.B.); NIH National Institute on Aging Grant AG027678 (to K.L.M.); NIH/NHLBI Grant R01 HL084086 and Postle Family Chair of Pediatric Cancer and Blood Disorders (to J.D.); and NIH/National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute (CTSA; Grant UL1 TR001082). The Heart and Vascular Health Study is supported by the NIH/NHLBI (Grants HL43201, HL60739, HL68986, HL73410, HL74745, HL85251, and HL95080).	Alvarado-Castillo C, 2005, MOL PHARMACOL, V67, P114, DOI 10.1124/mol.104.006908; Anderson DR, 2013, ANN INTERN MED, V158, P800, DOI 10.7326/0003-4819-158-11-201306040-00004; Antoni G, 2010, J THROMB HAEMOST, V8, P2671, DOI 10.1111/j.1538-7836.2010.04092.x; Aquilante CL, 2013, PHARMACOTHERAPY, V33, P1000, DOI 10.1002/phar.1292; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer KA, 2011, JAMA-J AM MED ASSOC, V305, P1336, DOI 10.1001/jama.2011.361; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Colombo PC, 2002, J APPL PHYSIOL, V92, P1331, DOI 10.1152/japplphysiol.00680.2001; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Friedman DJ, 2009, DIABETES, V58, P999, DOI 10.2337/db08-1214; ?GAYLEIII RB, 1998, J CLIN INVEST, V101, P1851; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Heit JA, 2012, J THROMB HAEMOST, V10, P1521, DOI 10.1111/j.1538-7836.2012.04810.x; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Maloney JP, 2012, AM J PHYSIOL-LUNG C, V302, pL541, DOI 10.1152/ajplung.00282.2011; Maloney JP, 1998, AM J PHYSIOL-HEART C, V275, pH1054, DOI 10.1152/ajpheart.1998.275.3.H1054; MARCUS AJ, 1991, J CLIN INVEST, V88, P1690, DOI 10.1172/JCI115485; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Reitsma PH, 2012, ARTERIOSCL THROM VAS, V32, P563, DOI 10.1161/ATVBAHA.111.242818; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Simone B, 2013, EUR J EPIDEMIOL, V28, P621, DOI 10.1007/s10654-013-9825-8; Takasaki J, 2001, MOL PHARMACOL, V60, P432; Tang WH, 2013, GENET EPIDEMIOL, V37, P512, DOI 10.1002/gepi.21731; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389	39	6	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2771	2784		10.1096/fj.201600344R	http://dx.doi.org/10.1096/fj.201600344R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28302652	Green Published			2022-12-26	WOS:000405931000006
J	Yoshida, K; Tsunoda, SP; Brown, LS; Kandori, H				Yoshida, Kazuho; Tsunoda, Satoshi P.; Brown, Leonid S.; Kandori, Hideki			A unique choanoflagellate enzyme rhodopsin exhibits light-dependent cyclic nucleotide phosphodiesterase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; cyclic nucleotide; enzyme mechanism; membrane enzyme; optogenetics; phosphodiesterases; photoreceptor; rhodopsin	SENSORY-RHODOPSIN; PHARAONIS PHOBORHODOPSIN; GUANYLYL-CYCLASE; ADENYLYL-CYCLASE; OPTICAL CONTROL; CELLULAR CAMP; HAMP DOMAIN; MANIPULATION; MECHANISM; SIGNAL	Photoactivated adenylyl cyclase (PAC) and guanylyl cyclase rhodopsin increase the concentrations of intracellular cyclic nucleotides upon illumination, serving as promising second-generation tools in optogenetics. To broaden the arsenal of such tools, it is desirable to have light-activatable enzymes that can decrease cyclic nucleotide concentrations in cells. Here, we report on an unusual microbial rhodopsin that may be able to meet the demand. It is found in the choanoflagellate Salpingoeca rosetta and contains a C-terminal cyclic nucleotide phosphodiesterase (PDE) domain. We examined the enzymatic activity of the protein (named Rh-PDE) both in HEK293 membranes and whole cells. Although Rh-PDE was constitutively active in the dark, illumination increased its hydrolytic activity 1.4-fold toward cGMP and 1.6-fold toward cAMP, as measured in isolated crude membranes. Purified full-length Rh-PDE displayed maximal light absorption at 492 nm and formed the M intermediate with the deprotonated Schiff base upon illumination. The M state decayed to the parent spectral state in 7 s, producing long-lasting activation of the enzyme domain with increased activity. We discuss a possible mechanism of the Rh-PDE activation by light. Furthermore, Rh-PDE decreased cAMP concentration in HEK293 cells in a light-dependent manner and could do so repeatedly without losing activity. Thus, Rh-PDE may hold promise as a potential optogenetic tool for light control of intracellular cyclic nucleotides (e.g. to study cyclic nucleotide-associated signal transduction cascades).	[Yoshida, Kazuho; Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tsunoda, Satoshi P.] JST PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Brown, Leonid S.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada	Nagoya Institute of Technology; Nagoya Institute of Technology; Japan Science & Technology Agency (JST); University of Guelph	Tsunoda, SP; Kandori, H (corresponding author), Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan.	tsunoda.satoshi@nitech.ac.jp; kandori@nitech.ac.jp	Brown, Leonid/X-7445-2019; Brown, Leonid/A-1050-2008; Tsunoda, Satoshi/AAN-7023-2021	Brown, Leonid/0000-0002-5614-8317; Brown, Leonid/0000-0002-5614-8317; Tsunoda, Satoshi/0000-0003-3636-1521	Japanese Ministry of Education, Culture, Sports, Science, and Technology [25104009, 15H02391]; PRESTO, Japan Science and Technology Agency [JPMJPR1688]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2013-250202]; Grants-in-Aid for Scientific Research [15J06657] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, 25104009 and 15H02391 (to H. K.), by PRESTO, Japan Science and Technology Agency Grant JPMJPR1688 (to S. P. T.), and by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN-2013-250202 (to L. S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown LS, 2014, BBA-BIOENERGETICS, V1837, P553, DOI 10.1016/j.bbabio.2013.05.006; Costa WS, 2014, METHODS MOL BIOL, V1148, P161, DOI 10.1007/978-1-4939-0470-9_11; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dugue GP, 2012, PROG BRAIN RES, V196, P1, DOI 10.1016/B978-0-444-59426-6.00001-X; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Katayama K, 2012, BIOCHEMISTRY-US, V51, P1126, DOI 10.1021/bi201676y; Katayama K, 2010, ANGEW CHEM INT EDIT, V49, P891, DOI 10.1002/anie.200903837; Klare JP, 2004, PHOTOCH PHOTOBIO SCI, V3, P543, DOI 10.1039/b402656j; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Miesenbock G, 2011, ANNU REV CELL DEV BI, V27, P731, DOI 10.1146/annurev-cellbio-100109-104051; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Page RD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0602S01; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; SCHARF B, 1992, EUR J BIOCHEM, V206, P359, DOI 10.1111/j.1432-1033.1992.tb16935.x; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shichida Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P70, DOI 10.1562/2006-03-22-IR-854; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	46	54	54	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7531	7541		10.1074/jbc.M117.775569	http://dx.doi.org/10.1074/jbc.M117.775569			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302718	Green Published, hybrid			2022-12-26	WOS:000400761300021
J	Gorelik, A; Liu, FY; Illes, K; Nagar, B				Gorelik, Alexei; Liu, Fangyu; Illes, Katalin; Nagar, Bhushan			Crystal structure of the human alkaline sphingomyelinase provides insights into substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-SALTS; IDENTIFICATION; BINDING; LIPASE; ENZYME; PHOSPHATIDYLCHOLINE; PURIFICATION; HYDROLYSIS; ACTIVATION; AUTOTAXIN	Absorption of dietary sphingomyelin (SM) requires its initial degradation into ceramide, a process catalyzed by the intestinal enzyme alkaline sphingomyelinase (alk-SMase, NPP7, ENPP7). alk-SMase belongs to the nucleotide pyrophosphatase/phosphodiesterase (NPP) family, the members of which hydrolyze nucleoside phosphates, phospholipids, and other related molecules. NPP7 is the only paralog that can cleave SM, and its activity requires the presence of bile salts, a class of physiological anionic detergents. To elucidate the mechanism of substrate recognition, we determined the crystal structure of human alk-SMase in complex with phosphocholine, a reaction product. Although the overall fold and catalytic center are conserved relative to other NPPs, alk-SMase recognizes the choline moiety of its substrates via an NPP7-specific aromatic box composed of tyrosine residues. Mutational analysis and enzymatic activity assays identified features on the surface of the protein-a cationic patch and a unique hydrophobic loop-that are essential for accessing SM in bile salt micelles. These results shed new light on substrate specificity determinants within the NPP enzyme family.	McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Nagar, B (corresponding author), Rm 464,3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	bhushan.nagar@mcgill.ca		Gorelik, Alexei/0000-0001-6236-4633	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology; CREATE Training Program in Bionanomachines (Natural Sciences and Engineering Research Council of Canada); Canada Research Chair; Canadian Institutes of Health Research Operating Grant [MOP-133535]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR)); CREATE Training Program in Bionanomachines (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research (to the Canadian Light Source). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology and the CREATE Training Program in Bionanomachines (Natural Sciences and Engineering Research Council of Canada).; Supported by a Canada Research Chair and Canadian Institutes of Health Research Operating Grant MOP-133535. To whom correspondence should be addressed: Rm. 464, 3649 Promenade Sir-William-Osler, Montreal, PQ H3G 0B1, Canada. Tel.: 514-398-7272; Fax: 514-398-3387; E-mail: bhushan.nagar@mcgill.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Airola MV, 2015, STRUCTURE, V23, P1482, DOI 10.1016/j.str.2015.06.013; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Albright RA, 2014, J BIOL CHEM, V289, P3294, DOI 10.1074/jbc.M113.505867; CAREY MC, 1972, ARCH INTERN MED, V130, P506, DOI 10.1001/archinte.130.4.506; Chen Y, 2015, MOL CANCER THER, V14, P259, DOI 10.1158/1535-7163.MCT-14-0468-T; Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; Duan JX, 2010, BIOCHEMISTRY-US, V49, P9096, DOI 10.1021/bi101069u; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Duan RD, 2003, J LIPID RES, V44, P1241, DOI 10.1194/jlr.M300037-JLR200; Duan RD, 1997, HEPATOLOGY, V26, P823, DOI 10.1053/jhep.1997.v26.pm0009328299; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freie AB, 2006, J BIOL CHEM, V281, P7793, DOI 10.1074/jbc.M512984200; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hertervig E, 1997, CANCER, V79, P448, DOI 10.1002/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E; Hertervig E, 1999, BRIT J CANCER, V81, P232, DOI 10.1038/sj.bjc.6690682; Jansen S, 2012, STRUCTURE, V20, P1948, DOI 10.1016/j.str.2012.09.001; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Keune WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11248; Kornhuber J, 2015, BIOL CHEM, V396, P707, DOI 10.1515/hsz-2015-0109; Liu JJ, 2000, J NUTR BIOCHEM, V11, P192, DOI 10.1016/S0955-2863(00)00064-4; Maldonado-Valderrama J, 2011, ADV COLLOID INTERFAC, V165, P36, DOI 10.1016/j.cis.2010.12.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morita J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20995; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Nyberg L, 1996, BBA-LIPID LIPID MET, V1300, P42, DOI 10.1016/0005-2760(95)00245-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrill AL, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-65; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tsai SH, 2015, IMMUNITY, V42, P279, DOI 10.1016/j.immuni.2015.01.015; Wang XQ, 1997, STRUCTURE, V5, P1209, DOI 10.1016/S0969-2126(97)00271-2; Wu J, 2006, BIOCHEM J, V394, P299, DOI 10.1042/BJ20051121; Wu J, 2005, BIOCHEM J, V386, P153, DOI 10.1042/BJ20041455; Wu J, 2004, AM J PHYSIOL-GASTR L, V287, pG967, DOI 10.1152/ajpgi.00190.2004; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	39	23	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7087	7094		10.1074/jbc.M116.769273	http://dx.doi.org/10.1074/jbc.M116.769273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28292932	Green Published, hybrid			2022-12-26	WOS:000400478300019
J	Aguera, Z; Brewin, N; Chen, J; Granero, R; Kang, Q; Fernandez-Aranda, F; Arcelus, J				Agueera, Zaida; Brewin, Nicola; Chen, Jue; Granero, Roser; Kang, Qing; Fernandez-Aranda, Fernando; Arcelus, Jon			Eating symptomatology and general psychopathology in patients with anorexia nervosa from China, UK and Spain: A cross-cultural study examining the role of social attitudes	PLOS ONE			English	Article							RATING INSTRUMENT CEDRI; MENTAL-HEALTH; RISK-FACTORS; BODY-IMAGE; SELF-ESTEEM; DISORDERS; DEPRESSION; PATHOLOGY; WOMEN; DISSATISFACTION	Cultural studies exploring differences in the manifestation of anorexia nervosa (AN) have primarily focus on Western and non-Western cultures. However, no study so far has considered the role that social attitudes (i.e. Collectivist vs. Individualist cultural values) have in the clinical manifestations of eating disorders, including AN patients. With this in mind, the aim of this study is to compare eating and general psychopathology in a large sample of individuals diagnosed with AN from China, Spain, and United Kingdom (UK), in order to study the differences according to belonging to Western or non-Western country, or the country's Individualist Index (IDV). The total sample comprised on 544 adults with a diagnosis of AN recruited from People As Republic of China (n = 72), UK (n = 117), and Spain (n = 355). Assessment measures included the Eating Disorders Inventory and the Symptom Check-list-90-Revised. Our results show significant differences in most of the eating and psychopathological indices between the three countries. Patients from Western societies (Spain and UK) share more similarities regarding psychopathological expression of AN than the non-Western country (China). While Western countries show higher levels of body dissatisfaction, somatization and overall psychopathology, Chinese patients tend to deny or minimize depression, anxiety and other psychopathological symptoms. Besides, the IDV shows cultural differences in the interpersonal sensitivity scale, being AN patients from UK (the more individualistic society) who presented with higher levels of interpersonal sensitivity (i.e. discomfort during interpersonal interactions and more negative expectations concerning interpersonal behavior). In conclusion, our findings suggest that psychopathological expression of AN is better explained by Western/Eastern influence than by individualist/collectivist values. Although the diagnosis for the eating disorder may be the same, differences in the psychopathology comorbid to the eating disorders may suggest the need for treatments to be modified according to the culture.	[Agueera, Zaida; Granero, Roser; Fernandez-Aranda, Fernando] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Inst Salud Carlos 3, Barcelona, Spain; [Agueera, Zaida; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [Brewin, Nicola; Arcelus, Jon] Leicester Glenfield Hosp, Benn Ctr, Leicestershire Eating Disorder Serv, Leicester, Leics, England; [Chen, Jue; Kang, Qing] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Dept Clin Psychol, Shanghai 200030, Peoples R China; [Granero, Roser] Univ Autonoma Barcelona, Dept Psicobiol & Metodol, E-08193 Barcelona, Spain; [Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Arcelus, Jon] Univ Nottingham, Fac Med & Hlth Sci, Inst Mental Hlth, Nottingham, England	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Shanghai Jiao Tong University; Autonomous University of Barcelona; University of Barcelona; University of Nottingham	Aguera, Z (corresponding author), CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Inst Salud Carlos 3, Barcelona, Spain.; Aguera, Z (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain.; Chen, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Dept Clin Psychol, Shanghai 200030, Peoples R China.	zaguera@bellvitgehospital.cat; chenjue2088@163.com	Granero, Roser/F-9492-2016; AGÜERA, ZAIDA/K-9771-2014; Granero, Roser/S-3529-2019; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Fernandez-Aranda, Fernando/L-9762-2014	Granero, Roser/0000-0001-6308-3198; AGÜERA, ZAIDA/0000-0003-4453-4939; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Arcelus, Jon/0000-0002-3805-0180	Institute Salud Carlos III [FIS PI14/00290]; Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe; Natural Science Foundation of Shanghai [16ZR1430400]; Scientific Technology Committee Foundation of Shanghai [16411965200]; Key Characteristic Specialist Department of Shanghai Mental Health Center [2013-YJTSZK-02]	Institute Salud Carlos III(Instituto de Salud Carlos III); Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Scientific Technology Committee Foundation of Shanghai; Key Characteristic Specialist Department of Shanghai Mental Health Center	This work was supported by the following sources: Institute Salud Carlos III (FIS PI14/00290 and CIBERobn), to FFA; Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe, to FFA; Natural Science Foundation of Shanghai (16ZR1430400 to JC); Scientific Technology Committee Foundation of Shanghai (16411965200 to JC); and the Key Characteristic Specialist Department of Shanghai Mental Health Center (No.2013-YJTSZK-02), to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Arrindell WA, 2004, PERS INDIV DIFFER, V37, P627, DOI 10.1016/j.paid.2003.11.002; Chen SX, 2008, J COUNS PSYCHOL, V55, P442, DOI 10.1037/a0012898; Chiao JY, 2015, EMOT REV, V7, P280, DOI 10.1177/1754073914546389; Claudat K, 2016, J CLIN PSYCHOL, V72, P88, DOI 10.1002/jclp.22234; Derogatis LR., 1977, SCL 90 ADM SCORING P; DiBartolo PM, 2012, CLIN PSYCHOL REV, V32, P139, DOI 10.1016/j.cpr.2011.09.007; Draguns JG, 2003, BEHAV RES THER, V41, P755, DOI 10.1016/S0005-7967(02)00190-0; Eddy KT, 2007, J NERV MENT DIS, V195, P196, DOI 10.1097/01.nmd.0000243922.49394.7d; Essau CA, 2013, SOC PSYCH PSYCH EPID, V48, P2017, DOI 10.1007/s00127-013-0673-3; Feng Z, 2001, ACTA ACAD MED MILITA, V23, P481; Garner D.M., 1998, INVENTARIO TRASTORNO; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Gartstein MA, 2006, CHILD PSYCHIAT HUM D, V37, P145, DOI 10.1007/s10578-006-0025-6; Gonzalez de Rivera JL, 2002, CUESTIONARIO 90 SINT; Gunnard K, 2012, EUR EAT DISORD REV, V20, P271, DOI 10.1002/erv.1148; Heinrichs N, 2006, BEHAV RES THER, V44, P1187, DOI 10.1016/j.brat.2005.09.006; Hofstede G., 2010, CULTURES ORG SOFTWAR, V3rd; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd, DOI DOI 10.1016/S0005-7967(02)00184-5; Humphry TA, 2004, INT J EAT DISORDER, V35, P579, DOI 10.1002/eat.10269; Huwae S, 2018, INT J PSYCHOL, V53, P176, DOI 10.1002/ijop.12283; Hwang WC, 2008, CLIN PSYCHOL REV, V28, P211, DOI 10.1016/j.cpr.2007.05.001; Jaeger B, 2002, PSYCHOTHER PSYCHOSOM, V71, P54, DOI 10.1159/000049344; Katzman MA, 1997, INT J EAT DISORDER, V22, P385, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;385::AID-EAT3&gt;3.0.CO;2-I; Keel PK, 2003, PSYCHOL BULL, V129, P747, DOI 10.1037/0033-2909.129.5.747; Kleinman A., 2004, NEW ENGL J MED, P35110; Lai KYC, 2000, J ADOLESCENCE, V23, P561, DOI 10.1006/jado.2000.0343; Lapid MI, 2010, INT PSYCHOGERIATR, V22, P523, DOI 10.1017/S1041610210000104; Lee HY, 2007, INT J EAT DISORDER, V40, P227, DOI 10.1002/eat.20364; Lee S, 2000, INT J EAT DISORDER, V27, P317, DOI 10.1002/(SICI)1098-108X(200004)27:3&lt;317::AID-EAT9&gt;3.0.CO;2-2; LEE S, 1993, PSYCHOL MED, V23, P999, DOI 10.1017/S0033291700026465; Lee S, 1997, INT J EAT DISORDER, V21, P187, DOI 10.1002/(SICI)1098-108X(199703)21:2&lt;187::AID-EAT10&gt;3.0.CO;2-#; Lee S, 2010, INT J EAT DISORDER, V43, P307, DOI 10.1002/eat.20686; Mak WWS., 2012, OXFORD HDB CHINESE P, DOI DOI 10.1093/0XFORDHB/9780199541850.013.0026; Makino M., 2004, MEDSCAPE GEN MED, V6, P49; Mangweth-Matzek B, 2014, CURR OPIN PSYCHIATR, V27, P431, DOI 10.1097/YCO.0000000000000102; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mazzeo SE, 2009, CHILD ADOL PSYCH CL, V18, P67, DOI 10.1016/j.chc.2008.07.003; MCCOURT J, 1995, INT J EAT DISORDER, V17, P277, DOI 10.1002/1098-108X(199504)17:3<277::AID-EAT2260170308>3.0.CO;2-D; Midlarsky E, 2008, J GEN PSYCHOL, V135, P393, DOI 10.3200/GENP.135.4.393-408; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; PALMER R, 1987, INT J EAT DISORDER, V6, P9, DOI 10.1002/1098-108X(198701)6:1<9::AID-EAT2260060103>3.0.CO;2-Z; Palmer R, 1996, EUR EAT DISORD REV, V4, P149; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Russell ST, 2008, J YOUTH ADOLESCENCE, V37, P50, DOI 10.1007/s10964-007-9231-1; Ryder AG, 2008, J ABNORM PSYCHOL, V117, P300, DOI 10.1037/0021-843X.117.2.300; Schreier SS, 2010, DEPRESS ANXIETY, V27, P1128, DOI 10.1002/da.20746; Soh NLW, 2008, EUR EAT DISORD REV, V16, P287, DOI 10.1002/erv.836; Soh NLW, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-4; Soh NL, 2006, EUR EAT DISORD REV, V14, P54, DOI 10.1002/erv.678; Soto JA, 2011, EMOTION, V11, P1450, DOI 10.1037/a0023340; Spector PE, 2004, PERS PSYCHOL, V57, P119, DOI 10.1111/j.1744-6570.2004.tb02486.x; Striegel-Moore RH, 2007, AM PSYCHOL, V62, P181, DOI 10.1037/0003-066X.62.3.181; Tareen A, 2005, INT J EAT DISORDER, V37, P161, DOI 10.1002/eat.20080; Triandis HC, 2001, J PERS, V69, P907, DOI 10.1111/1467-6494.696169; Triandis HC, 1995, INDIVIDUALISM COLLEC; Wang Z., 1984, SYMPTOM CHECKLIST SC, V2, P68, DOI DOI 10.32388/SG7B5L]; Watson HJ, 2015, EUR EAT DISORD REV, V23, P68, DOI 10.1002/erv.2334; Witcomb Gemma L, 2013, Shanghai Arch Psychiatry, V25, P332, DOI 10.3969/j.issn.1002-0829.2013.06.002; Wynaden D, 2005, INT J MENT HEALTH NU, V14, P88, DOI 10.1111/j.1440-0979.2005.00364.x	61	16	16	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173781	10.1371/journal.pone.0173781	http://dx.doi.org/10.1371/journal.pone.0173781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301566	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300072
J	Dewes, CF; Rangwala, I; Barsugli, JJ; Hobbins, MT; Kumar, S				Dewes, Candida F.; Rangwala, Imtiaz; Barsugli, Joseph J.; Hobbins, Michael T.; Kumar, Sanjiv			Drought risk assessment under climate change is sensitive to methodological choices for the estimation of evaporative demand	PLOS ONE			English	Article							CALCULATING POTENTIAL EVAPORATION; EVAPOTRANSPIRATION ESTIMATION; TERRESTRIAL ARIDITY; WATER-RESOURCES; VARIABILITY; MODEL; 21ST-CENTURY; HYDROLOGY; RESPONSES; SCALE	Several studies have projected increases in drought severity, extent and duration in many parts of the world under climate change. We examine sources of uncertainty arising from the methodological choices for the assessment of future drought risk in the continental US (CONUS). One such uncertainty is in the climate models' expression of evaporative demand (E-0), which is not a direct climate model output but has been traditionally estimated using several different formulations. Here we analyze daily output from two CMIP5 GCMs to evaluate how differences in E-0 formulation, treatment of meteorological driving data, choice of GCM, and standardization of time series influence the estimation of E-0. These methodological choices yield different assessments of spatio-temporal variability in E-0 and different trends in 21st century drought risk. First, we estimate E-0 using three widely used E-0 formulations: Penman-Monteith; Hargreaves-Samani; and Priestley-Taylor. Our analysis, which primarily focuses on the May-September warm-season period, shows that E-0 climatology and its spatial pattern differ substantially between these three formulations. Overall, we find higher magnitudes of E-0 and its interannual variability using Penman-Monteith, in particular for regions like the Great Plains and southwestern US where E-0 is strongly influenced by variations in wind and relative humidity. When examining projected changes in E-0 during the 21st century, there are also large differences among the three formulations, particularly the Penman-Monteith relative to the other two formulations. The 21st century E-0 trends, particularly in percent change and standardized anomalies of E-0, are found to be sensitive to the long-term mean value and the amplitude of interannual variability, i.e. if the magnitude of E-0 and its interannual variability are relatively low for a particular E-0 formulation, then the normalized or standardized 21 st century trend based on that formulation is amplified relative to other formulations. This is the case for the use of Hargreaves-Samani and Priestley-Taylor, where future E-0 trends are comparatively much larger than for Penman-Monteith. When comparing Penman-Monteith E-0 responses between different choices of input variables related to wind speed, surface roughness, and net radiation, we found differences in E-0 trends, although these choices had a much smaller influence on E-0 trends than did the E-0 formulation choices. These methodological choices and specific climate model selection, also have a large influence on the estimation of trends in standardized drought indices used for drought assessment operationally. We find that standardization tends to amplify divergences between the E-0 trends calculated using different E-0 formulations, because standardization is sensitive to both the climatology and amplitude of interannual variability of E-0. For different methodological choices and GCM output considered in estimating E-0, we examine potential sources of uncertainty in 21st century trends in the Standardized Precipitation Evapotranspiration Index (SPEI) and Evaporative Demand Drought Index (EDDI) over selected regions of the CONUS to demonstrate the practical implications of these methodological choices for the quantification of drought risk under climate change.	[Dewes, Candida F.; Rangwala, Imtiaz; Barsugli, Joseph J.; Hobbins, Michael T.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Dewes, Candida F.; Rangwala, Imtiaz; Barsugli, Joseph J.; Hobbins, Michael T.; Kumar, Sanjiv] NOAA, Div Phys Sci, ESRL, Boulder, CO USA; [Dewes, Candida F.; Rangwala, Imtiaz; Barsugli, Joseph J.] North Cent Climate Sci Ctr, Dept Interior, Ft Collins, CO USA	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior	Dewes, CF (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.; Dewes, CF (corresponding author), NOAA, Div Phys Sci, ESRL, Boulder, CO USA.; Dewes, CF (corresponding author), North Cent Climate Sci Ctr, Dept Interior, Ft Collins, CO USA.	candida.dewes@noaa.gov	Hobbins, Mike/N-4630-2014	Hobbins, Mike/0000-0001-5540-8466; DEWES, CANDIDA/0000-0003-1882-3710	United States Geological Survey's North Central Climate Science Center [G13AC00392, G14AP00182]; National Research Council Research Associateship Award at NOAA ESRL Physical Science Division	United States Geological Survey's North Central Climate Science Center; National Research Council Research Associateship Award at NOAA ESRL Physical Science Division	This study is supported by the United States Geological Survey's North Central Climate Science Center (award # G13AC00392 and G14AP00182). SKs contribution was supported by the National Research Council Research Associateship Award at NOAA ESRL Physical Science Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allen R. G., 2005, ASCE STANDARDIZED RE; Almorox J, 2015, J HYDROL, V528, P514, DOI 10.1016/j.jhydrol.2015.06.057; Begueria S, 2014, INT J CLIMATOL, V34, P3001, DOI 10.1002/joc.3887; Bonan G., 2015, ECOLOGICAL CLIMATOLO; BOUCHET R. J., 1963, Publ. Int. Ass. sci. Hydrol. 62 gen. Assembly Berkeley, P134; Brazhnik K, 2016, ECOL MODEL, V320, P182, DOI 10.1016/j.ecolmodel.2015.09.016; Budyko M. I., 1974, CLIMATE LIFE; Cayan DR, 2010, P NATL ACAD SCI USA, V107, P21271, DOI 10.1073/pnas.0912391107; Chadwick R, 2016, NAT CLIM CHANGE, V6, P177, DOI [10.1038/NCLIMATE2805, 10.1038/nclimate2805]; Chow V.T., 1988, APPL HYDROLOGY; Christensen NS, 2004, CLIMATIC CHANGE, V62, P337, DOI 10.1023/B:CLIM.0000013684.13621.1f; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; de Noblet-Ducoudre N, 2012, J CLIMATE, V25, P3261, DOI 10.1175/JCLI-D-11-00338.1; Deser C, 2012, CLIM DYNAM, V38, P527, DOI 10.1007/s00382-010-0977-x; Farahmand A, 2015, ADV WATER RESOUR, V76, P140, DOI 10.1016/j.advwatres.2014.11.012; Federer CA, 1996, WATER RESOUR RES, V32, P2315, DOI 10.1029/96WR00801; Ficklin DL, 2016, J CLIMATE, V29, P1269, DOI 10.1175/JCLI-D-15-0439.1; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Forster PM, 2013, J GEOPHYS RES-ATMOS, V118, P1139, DOI 10.1002/jgrd.50174; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Fu Q, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD021608; Girvetz EH, 2014, CLIMATIC CHANGE, V126, P469, DOI 10.1007/s10584-014-1218-9; GREGORY S, 1986, GEOGRAPHY, V71, P97; Greve P, 2015, GEOPHYS RES LETT, V42, P5493, DOI 10.1002/2015GL064127; Guttman NB, 1998, J AM WATER RESOUR AS, V34, P113, DOI 10.1111/j.1752-1688.1998.tb05964.x; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Harmon ME, 2002, CAN J FOREST RES, V32, P863, DOI [10.1139/x01-216, 10.1139/X01-216]; Hobbins M, 2016, J HYDROMETEOROL; Hobbins MT, 2016, T ASABE, V59, P561; Hobbins M, 2012, J HYDROMETEOROL, V13, P1195, DOI 10.1175/JHM-D-11-0101.1; Hobbins MT, 2004, REGIONAL EVAPOTRANSP; Hobbins MT, 2004, GEOPHYS RES LETT, P31; Hounam CE, 1975, 138 WHO; Hufkens K, 2016, NAT CLIM CHANGE, V6; Kay AL, 2008, J HYDROL, V358, P221, DOI 10.1016/j.jhydrol.2008.06.005; Kingston DG, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040267; Klos PZ, 2014, GEOPHYS RES LETT, V41, P4560, DOI 10.1002/2014GL060500; Kumar S, 2016, J GEOPHYS RES ATMOS; Kumar S, 2016, WATER RESOUR RES, V52, P3127, DOI 10.1002/2016WR018607; Kumar S, 2013, J GEOPHYS RES-ATMOS, V118, P6337, DOI 10.1002/jgrd.50463; McEvoy DJ, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000447.1; McEvoy DJ, 2016, J HYDROMETEOROL; MCKENNEY MS, 1993, AGR FOREST METEOROL, V64, P81, DOI 10.1016/0168-1923(93)90095-Y; Melesse A., 2013, EVAPORATION EVAPOTRA, DOI 10.1007/978-94-007-4737-1; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Milly PCD, 2016, NAT CLIM CHANGE; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; NCCSC, 2015, COMM NEWSL N CENTR C; Oliver TH, 2015, NAT CLIM CHANGE, V5, P941, DOI [10.1038/NCLIMATE2746, 10.1038/nclimate2746]; Oppenheimer M, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1039; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Pierce DW, 2013, J CLIMATE, V26, P4148, DOI 10.1175/JCLI-D-12-00534.1; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Prudhomme C, 2014, P NATL ACAD SCI USA, V111, P3262, DOI 10.1073/pnas.1222473110; Ramirez JA, 2005, GEOPHYS RES LETT, P32; RIND D, 1990, J GEOPHYS RES-ATMOS, V95, P9983, DOI 10.1029/JD095iD07p09983; Roderick ML, 2015, WATER RESOUR RES, V51, P5450, DOI 10.1002/2015WR017031; Roderick ML, 2007, GEOPHYS RES LETT, P34; Rotstayn LD, 2006, GEOPHYS RES LETT, P33; Roy J, 2016, P NATL ACAD SCI USA, V113, P6224, DOI 10.1073/pnas.1524527113; Ruffault J, 2013, CLIMATIC CHANGE, V117, P103, DOI 10.1007/s10584-012-0559-5; Scheff J, 2015, J CLIMATE, V28, P5583, DOI 10.1175/JCLI-D-14-00480.1; Seager R, 2015, J APPL METEOROL CLIM, V54, P1121, DOI 10.1175/JAMC-D-14-0321.1; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Shuttleworth WJ, 1992, HDB HYDROLOGY; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Spinoni J, 2015, INT J CLIMATOL, V35, P2210, DOI 10.1002/joc.4124; Teuling AJ, 2013, GEOPHYS RES LETT, V40, P2071, DOI 10.1002/grl.50495; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Van Loon AF, 2016, NAT GEOSCI, V9, P89, DOI 10.1038/ngeo2646; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wilhite D. A., 1985, Water International, V10, P111, DOI 10.1080/02508068508686328; Wilhite DA, 2014, WEATHER CLIM EXTREME, V3, P4, DOI 10.1016/j.wace.2014.01.002; Wilks DS, 2011, STAT METHODS ATMOSPH, P23, DOI DOI 10.1016/B978-0-12-385022-5.00003-8; Williams AP, 2015, GEOPHYS RES LETT, V42, P6819, DOI 10.1002/2015GL064924; WMO, 1986, REP DROUGHT COUNTR A; Xu CY, 2002, WATER RESOUR MANAG, V16, P197, DOI 10.1023/A:1020282515975	88	39	39	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174045	10.1371/journal.pone.0174045	http://dx.doi.org/10.1371/journal.pone.0174045			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301603	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300118
J	Kendzerska, T; Sadatsafavi, M; Aaron, SD; To, TM; Lougheed, MD; FitzGerald, JM; Gershon, AS				Kendzerska, Tetyana; Sadatsafavi, Mohsen; Aaron, Shawn D.; To, Teresa M.; Lougheed, M. Diane; FitzGerald, J. Mark; Gershon, Andrea S.		Canadian Resp Res Network	Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality	PLOS ONE			English	Article							COPD OVERLAP SYNDROME; TRENDS; FEATURES; HEALTH; CANADA; RISK; CHILDHOOD; SMOKING; ONTARIO; BURDEN	Objective We conducted a population-based cohort study to estimate trends in prevalence, incidence, and mortality of concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease (COPD). Study design and setting Two validated health administrative case definitions were used to identify asthma and COPD among all individuals aged 35 years and older living in Ontario, Canada. Annual asthma, COPD, and concurrent asthma and COPD prevalence, incidence, and mortality, standardized for age and sex, were estimated, and compared from 2002 to 2012, using generalized linear models. Results Standardized prevalence of concurrent asthma and COPD increased by 10.5%, from 2.9% in 2002 to 3.2% in 2012 overall, but more prominently in women compared to men. Overall, standardized incidence decreased by16%, from 2.5 to 2.1 per 1000 individuals, but increased significantly in young adults. All-cause mortality among patients with concurrent asthma and COPD decreased by 11.2%, from 2.6% to 2.2%. Being diagnosed with both diseases was significantly associated with higher all-cause mortality compared to asthma (OR = 1.56, 95% CI: 1.50 +/- 1.58), but not compared to COPD (OR = 0.97, 0.96 +/- 0.98), except in young adults aged 35 to 49 years where people with asthma and COPD had higher mortality (OR = 1.21, 1.15 +/- 1.27). Conclusions In a large North American population, the burden of concurrent physician-diagnosed asthma and COPD is increasing, particularly in women and young adults.	[Kendzerska, Tetyana; Aaron, Shawn D.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Kendzerska, Tetyana; To, Teresa M.; Gershon, Andrea S.] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Kendzerska, Tetyana; To, Teresa M.; Gershon, Andrea S.] Sunnybrook Res Inst, Toronto, ON, Canada; [Sadatsafavi, Mohsen; FitzGerald, J. Mark] Univ British Columbia, Vancouver, BC, Canada; [To, Teresa M.; Gershon, Andrea S.] Univ Toronto, Toronto, ON, Canada; [To, Teresa M.; Gershon, Andrea S.] Hosp Sick Children, Toronto, ON, Canada; [To, Teresa M.; Gershon, Andrea S.] Queens Univ, Kingston, ON, Canada; [Gershon, Andrea S.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Queens University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Kendzerska, T (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Kendzerska, T (corresponding author), Inst Clin Evaluat Sci, Ottawa, ON, Canada.; Kendzerska, T (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	tkendzerska@toh.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Kendzerska, Tetyana/I-7274-2019	Sadatsafayi, Mohsen/0000-0002-0419-7862; Kendzerska, Tetyana/0000-0002-5301-1796; Martin, James/0000-0001-7574-5363; Halayko, Andrew/0000-0002-7865-4552	Canadian Respiratory Research Network (CRRN); Canadian Institutes of Health Research (CIHR); CIHR Institute of Circulatory and Respiratory Health; Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; Boehringer-Ingelheim Canada Ltd; AstraZeneca Canada Inc.; Novartis Canada Ltd.; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); CRRN Fellowship Training Award; GlaxoSmithKline Inc.	Canadian Respiratory Research Network (CRRN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; Boehringer-Ingelheim Canada Ltd(Boehringer Ingelheim); AstraZeneca Canada Inc.(AstraZeneca); Novartis Canada Ltd.; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); CRRN Fellowship Training Award; GlaxoSmithKline Inc.(GlaxoSmithKline)	This project is supported by the Canadian Respiratory Research Network (CRRN) and the Canadian Institutes of Health Research (CIHR). The CRRN is supported by grants from the CIHR Institute of Circulatory and Respiratory Health; Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; and Industry Partners Boehringer-Ingelheim Canada Ltd, AstraZeneca Canada Inc., and Novartis Canada Ltd. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Dr. Kendzerska is supported by the CRRN Fellowship Training Award. Funding for training of graduate students and new investigators within the Network was supported by the above funding Sponsors and as well by GlaxoSmithKline Inc. The funding Sponsors had no role in the study design, data collection and analysis, or preparation of the manuscript. Dr. FitrGerald is a member of the Global Initiative for Asthma (GINA) Science Committee. Dr. Lougheed has received research funding not related to this study paid directly to Queen's University from GlaxoSmithKline, Janssen and Hoffmann LaRoche.	Akinbami Lara J, 2012, NCHS Data Brief, P1; Alshabanat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136065; Andersen H, 2013, CLIN RESPIR J, V7, P342, DOI 10.1111/crj.12013; Anderson R N, 1998, Natl Vital Stat Rep, V47, P1; [Anonymous], 2014, DIAGN DIS CHRON AIRF; [Anonymous], 2013, TRENDS COPD CHRON BR; Barnes PJ, 2016, CHEST, V149, P7, DOI 10.1016/j.chest.2015.08.017; Beavers S. F., 2014, AM J RESP CRITICAL C; CAMILLI AE, 1991, AM J EPIDEMIOL, V133, P795, DOI 10.1093/oxfordjournals.aje.a115958; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Cazzola M, 2016, J ALLERGY CLIN IMMUN, V138, P977, DOI 10.1016/j.jaci.2016.04.028; Chung JW, 2014, INT J CHRONIC OBSTR, V9, P795, DOI 10.2147/COPD.S61093; Cosio BG, 2016, CHEST, V149, P45, DOI 10.1378/chest.15-1055; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Diaz-Guzman E, 2011, COPD, V8, P400, DOI 10.3109/15412555.2011.611200; Evans J, 2014, HEALTH REP, V25, P3; Fay MP, 1997, STAT MED, V16, P791; Fransoo Randall R, 2013, Healthc Policy, V8, P27; Fu JJ, 2014, RESPIRATION, V87, P63, DOI 10.1159/000352053; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon A, 2012, J ALLERGY CLIN IMMUN, V129, P679, DOI 10.1016/j.jaci.2011.11.014; Gershon AS, 2008, CAN MED ASSOC J, V178, P871, DOI 10.1503/cmaj.061353; Gershon AS, 2014, JAMA-J AM MED ASSOC, V312, P1114, DOI 10.1001/jama.2014.11432; Gershon AS, 2014, CHEST, V145, P272, DOI 10.1378/chest.13-0790; Gershon AS, 2012, CHEST, V141, P1190, DOI 10.1378/chest.11-0831; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Gershon AS, 2010, ARCH INTERN MED, V170, P560, DOI 10.1001/archinternmed.2010.17; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Global Initiative for Asthma, 2015, 2015 ASTHM COPD ASTH; Hansell AL, 2003, EUR RESPIR J, V22, P809, DOI 10.1183/09031936.03.00031403; Harada T, 2015, INT J CHRONIC OBSTR, V10, P595, DOI 10.2147/COPD.S77491; Hardin M, 2014, EUR RESPIR J, V44, P341, DOI 10.1183/09031936.00216013; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Hitchman SC, 2011, B WORLD HEALTH ORGAN, V89, P195, DOI 10.2471/BLT.10.079905; ICES, 2015, DAT DICT 2015; Janz T., 2011, CURRENT SMOKING TREN; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; Kostikas K, 2016, INT J CHRONIC OBSTR, V11, P1297, DOI 10.2147/COPD.S107307; Kumbhare S, 2016, ANN AM THORAC SOC, V13, P803, DOI 10.1513/AnnalsATS.201508-554OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Mohsen Kendzerska TS, 2015, AM J RESP CRIT CARE, V191, pA6165; Morogan A. PLM, 2014, AM J RESP CRIT CARE, pA5937; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Postma DS, 2015, EUR RESPIR J, V46, P587, DOI 10.1183/13993003.00810-2015; Sieminska A, 2014, MED SCI MONITOR, V20, DOI 10.12659/MSM.889796; Simpson CR, 2010, J ROY SOC MED, V103, P98, DOI 10.1258/jrsm.2009.090348; Sin DD, 2016, EUR RESPIR J, V48, P664, DOI 10.1183/13993003.00436-2016; Soriano JB, 2000, THORAX, V55, P789, DOI 10.1136/thorax.55.9.789; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Sorino C, 2016, EUR J INTERN MED; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; To T, 2014, ANN AM THORACIC SOC; To T, 2010, AM J RESP CRIT CARE, V181, P337, DOI 10.1164/rccm.200907-1035OC; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; van Boven JFM, 2016, CHEST, V149, P1011, DOI 10.1016/j.chest.2015.12.002	60	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173830	10.1371/journal.pone.0173830	http://dx.doi.org/10.1371/journal.pone.0173830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301574	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300078
J	Needell, JC; Dinarello, CA; Ir, D; Robertson, CE; Ryan, SM; Kroehl, ME; Frank, DN; Zipris, D				Needell, James C.; Dinarello, Charles A.; Ir, Diana; Robertson, Charles E.; Ryan, Sarah M.; Kroehl, Miranda E.; Frank, Daniel N.; Zipris, Danny			Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes	PLOS ONE			English	Article							INNATE IMMUNITY; TYPE-1; INFLAMMATION; TRIAL; INTERLEUKIN-1; INTERPLAY; ALIGNMENT; BLOCKADE; DISEASES; SYSTEM	Type 1 diabetes (T1D) is an autoimmune proinflammatory disease with no effective intervention. A major obstacle in developing new immunotherapies for T1D is the lack of means for monitoring immune responsiveness to experimental therapies. The LEW1. WR1 rat develops autoimmunity following infection with the parvovirus Kilham rat virus (KRV) via mechanisms linked with activation of proinflammatory pathways and alterations in the gut bacterial composition. We used this animal to test the hypothesis that intervention with agents that block innate immunity and diabetes is associated with a shift in the gut microbiota. We observed that infection with KRV results in the induction of proinflammatory gene activation in both the spleen and pancreatic lymph nodes. Furthermore, administering animals the histone deacetylase inhibitor ITF-2357 and IL-1 receptor antagonist (Anakinra) induced differential STAT-1 and the p40 unit of IL-12/IL-23 gene expression. Sequencing of bacterial 16S rRNA genes demonstrated that both ITF-2357 and Anakinra alter microbial diversity. ITF-2357 and Anakinra modulated the abundance of 23 and 8 bacterial taxa in KRV-infected animals, respectively, of which 5 overlapped between the two agents. Lastly, principal component analysis implied that ITF-2357 and Anakinra induce distinct gut microbiomes compared with those from untreated animals or rats provided KRV only. Together, the data suggest that ITF-2357 and Anakinra differentially influence the innate immune system and the intestinal microbiota and highlight the potential use of the gut microbiome as a surrogate means of assessing anti-inflammatory immune effects in type 1 diabetes.	[Needell, James C.; Zipris, Danny] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Dinarello, Charles A.; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO USA; [Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Microbiome Res Consortium MiRC, Aurora, CO USA; [Ryan, Sarah M.; Kroehl, Miranda E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Ryan, Sarah M.; Kroehl, Miranda E.] Univ Colorado Denver, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Zipris, D (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA.	danny.zipris@ucdenver.edu	Dinarello, Charles/C-8524-2013; Ryan, Sarah/ABF-1514-2020	ROBERTSON, CHARLES/0000-0002-4136-4121; Ryan, Sarah/0000-0002-4395-1696	NIH/NCATS Colorado CCTSI Grant [UL1 TR001082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NIH/NCATS Colorado CCTSI Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NCATS Colorado CCTSI Grant Number UL1 TR001082. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Alkanani AK, 2015, ALTERATIONS INTESTIN; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Chervonsky AV, 2012, CURR OPIN IMMUNOL, V24, P255, DOI 10.1016/j.coi.2012.03.002; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dinarello CA, 2006, E SCHERING RES FDN W, V56, P45; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2011, MOL MED, V17, P333, DOI 10.2119/molmed.2011.00116; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Furlan A, 2011, MOL MED, V17, P353, DOI 10.2119/molmed.2011.00020; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gianani R, 2005, IMMUNOL REV, V204, P232, DOI 10.1111/j.0105-2896.2005.00248.x; Hara N, 2013, J MOL MED, P1; Hara N, 2014, INNATE IMMUN-LONDON, V20, P574, DOI 10.1177/1753425913502242; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Londono P, 2010, CLIN IMMUNOL, V135, P401, DOI 10.1016/j.clim.2010.01.007; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Michail S, 2012, INFLAMM BOWEL DIS, V18, P1799, DOI 10.1002/ibd.22860; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qaisar N, 2017, DIABETES, V66, P145, DOI 10.2337/db16-0462; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Thaiss CA, 2014, CURR OPIN IMMUNOL, V26, P41, DOI 10.1016/j.coi.2013.10.016; Tooley JE, 2014, CURR OPIN ENDOCRINOL, V21, P287, DOI 10.1097/MED.0000000000000076; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Wolter TR, 2009, CLIN IMMUNOL, V132, P103, DOI 10.1016/j.clim.2009.02.007; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zipris D, 2005, J IMMUNOL, V174, P131, DOI 10.4049/jimmunol.174.1.131	41	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173968	10.1371/journal.pone.0173968	http://dx.doi.org/10.1371/journal.pone.0173968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301545	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300103
J	Lomaev, D; Mikhailova, A; Erokhin, M; Shaposhnikov, AV; Moresco, JJ; Blokhina, T; Wolle, D; Aoki, T; Ryabykh, V; Yates, JR; Shidlovskii, YV; Georgiev, P; Schedl, P; Chetverina, D				Lomaev, Dmitry; Mikhailova, Anna; Erokhin, Maksim; Shaposhnikov, Alexander V.; Moresco, James J.; Blokhina, Tatiana; Wolle, Daniel; Aoki, Tsutomu; Ryabykh, Vladimir; Yates, John R., III; Shidlovskii, Yulii V.; Georgiev, Pavel; Schedl, Paul; Chetverina, Darya			The GAGA factor regulatory network: Identification of GAGA factor associated proteins	PLOS ONE			English	Article							POLYCOMB RESPONSE ELEMENTS; CHROMATIN REMODELING COMPLEX; DROSOPHILA BITHORAX COMPLEX; ENHANCER-BLOCKING ACTIVITY; FAB-7 BOUNDARY ACTIVITY; TRITHORAX GROUP GENES; MESSENGER-RNA EXPORT; TRANSCRIPTION FACTOR; DNA-BINDING; INSULATOR FUNCTION	The Drosophila GAGA factor (GAF) has an extraordinarily diverse set of functions that include the activation and silencing of gene expression, nucleosome organization and remodeling, higher order chromosome architecture and mitosis. One hypothesis that could account for these diverse activities is that GAF is able to interact with partners that have specific and dedicated functions. To test this possibility we used affinity purification coupled with high throughput mass spectrometry to identify GAF associated partners. Consistent with this hypothesis the GAF interacting network includes a large collection of factors and complexes that have been implicated in many different aspects of gene activity, chromosome structure and function. Moreover, we show that GAF interactions with a small subset of partners is direct; however for many others the interactions could be indirect, and depend upon intermediates that serve to diversify the functional capabilities of the GAF protein.	[Lomaev, Dmitry; Mikhailova, Anna; Erokhin, Maksim; Shaposhnikov, Alexander V.; Blokhina, Tatiana; Shidlovskii, Yulii V.; Georgiev, Pavel; Schedl, Paul; Chetverina, Darya] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, SR302B, La Jolla, CA 92037 USA; [Wolle, Daniel; Aoki, Tsutomu; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Ryabykh, Vladimir] Inst Anim Physiol Biochem & Nutr, Borovsk, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Scripps Research Institute; Princeton University; L.K. Ernst Federal Science Center for Animal Husbandry; All-Russia Research Institute of Animal Physiology, Biochemistry & Nutrition	Georgiev, P; Schedl, P; Chetverina, D (corresponding author), Russian Acad Sci, Inst Gene Biol, Moscow, Russia.; Schedl, P (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	georgiev_p@mail.ru; pschedl@Princeton.EDU; daria.chetverina@gmail.com	Shidlovskii, Yulii V/P-7687-2017	Shidlovskii, Yulii V/0000-0002-3643-9889; Erokhin, Maksim/0000-0002-2467-868X; Shaposhnikov, Alexander/0000-0003-4851-4775; Chetverina, Darya/0000-0003-0008-3814	Russian Science Foundation [14-24-00166]; Russian Federation Ministry of Education and Science grant [14.B25.31.0022]; NIH [GM043432]; Russian Foundation for Basic Research [16-34-60214]; National Institute of General Medical Sciences [8 P41GM103533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043432] Funding Source: NIH RePORTER; Russian Science Foundation [17-24-00019] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Federation Ministry of Education and Science grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (14-24-00166) to PG; Russian Federation Ministry of Education and Science grant to the Gene Biology Institute (14.B25.31.0022); NIH (GM043432) to PS; Russian Foundation for Basic Research (16-34-60214) to YS; National Institute of General Medical Sciences (8 P41GM103533) to JJM and JRY.	Aoki T, 2008, MOL CELL BIOL, V28, P1047, DOI 10.1128/MCB.01622-07; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bauer M, 2016, CHROMOSOMA, V125, P471, DOI 10.1007/s00412-015-0539-4; Belozerov VE, 2003, EMBO J, V22, P3113, DOI 10.1093/emboj/cdg297; Bhat KM, 1996, DEVELOPMENT, V122, P1113; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Bonchuk A, 2011, J MOL BIOL, V412, P423, DOI 10.1016/j.jmb.2011.07.052; Chalkley GE, 2008, MOL CELL BIOL, V28, P2920, DOI 10.1128/MCB.02217-07; Chang YL, 2007, MOL CELL BIOL, V27, P5486, DOI 10.1128/MCB.00692-07; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; Cuartero S, 2014, EMBO J, V33, P637, DOI 10.1002/embj.201386001; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; Emelyanov AV, 2012, GENE DEV, V26, P603, DOI 10.1101/gad.180604.111; Erokhin M, 2015, P NATL ACAD SCI USA, V112, P14930, DOI 10.1073/pnas.1515276112; Espinas ML, 2000, EMBO REP, V1, P253, DOI 10.1093/embo-reports/kvd046; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Fereres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113255; Fuda NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005108; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gause M, 2001, MOL CELL BIOL, V21, P4807, DOI 10.1128/MCB.21.14.4807-4817.2001; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Gildea JJ, 2000, GENETICS, V156, P645; Grossniklaus U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019331; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hagstrom K, 1997, GENETICS, V146, P1365; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Kellner WA, 2013, NUCLEIC ACIDS RES, V41, P9274, DOI 10.1093/nar/gkt722; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kopytova DV, 2010, GENE DEV, V24, P86, DOI 10.1101/gad.550010; Kugler SJ, 2010, MOL BIOL CELL, V21, P3443, DOI 10.1091/mbc.E10-03-0212; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Li J, 2013, MOL CELL, V50, P711, DOI 10.1016/j.molcel.2013.05.016; Maksimenko O, 2015, GENOME RES, V25, P89, DOI 10.1101/gr.174169.114; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McElroy KA, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140006; Melnikova L, 2004, P NATL ACAD SCI USA, V101, P14806, DOI 10.1073/pnas.0403959101; Mishra K, 2003, MECH DEVELOP, V120, P681, DOI 10.1016/S0925-4773(03)00046-7; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Murawsky CM, 2001, EMBO REP, V2, P1089, DOI 10.1093/embo-reports/kve252; Nakayama T, 2012, DEVELOPMENT, V139, P4582, DOI 10.1242/dev.083246; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Ohtsuki S, 1998, GENE DEV, V12, P3325, DOI 10.1101/gad.12.21.3325; Okada M, 1998, MOL CELL BIOL, V18, P2455, DOI 10.1128/MCB.18.5.2455; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orsi GA, 2014, GENOME RES, V24, P809, DOI 10.1101/gr.163642.113; Pagans S, 2002, NUCLEIC ACIDS RES, V30, P4406, DOI 10.1093/nar/gkf570; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Ray P, 2016, P NATL ACAD SCI USA, V113, P3826, DOI 10.1073/pnas.1520926113; Reddy BA, 2010, MOL CELL BIOL, V30, P5234, DOI 10.1128/MCB.00266-10; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Schweinsberg S, 2004, GENETICS, V168, P1371, DOI 10.1534/genetics.104.029561; Schweinsberg SE, 2004, DEVELOPMENT, V131, P4743, DOI 10.1242/dev.01343; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Shaposhnikov AV, 2016, BIOORG KHIM, V42, P712; SHEARN A, 1989, GENETICS, V121, P517; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; Weber JA, 1997, MOL CELL BIOL, V17, P3799, DOI 10.1128/MCB.17.7.3799; Wolle D, 2015, MOL CELL BIOL, V35, P3739, DOI 10.1128/MCB.00456-15; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wright K., 1989, BIOCHEM EDUC, V17, P220, DOI [10.1016/0307-4412(89)90165-9, DOI 10.1016/0307-4412(89)90165-9.]; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yanez-Cuna JO, 2014, GENOME RES, V24, P1147, DOI 10.1101/gr.169243.113; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	88	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173602	10.1371/journal.pone.0173602	http://dx.doi.org/10.1371/journal.pone.0173602			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296955	Green Submitted, gold, Green Published			2022-12-26	WOS:000396311700045
J	Hoy, AR; Ly, M; Carlsson, CM; Okonkwo, OC; Zetterberg, H; Blennow, K; Sager, MA; Asthana, S; Johnson, SC; Alexander, AL; Bendlin, BB				Hoy, Andrew R.; Ly, Martina; Carlsson, Cynthia M.; Okonkwo, Ozioma C.; Zetterberg, Henrik; Blennow, Kaj; Sager, Mark A.; Asthana, Sanjay; Johnson, Sterling C.; Alexander, Andrew L.; Bendlin, Barbara B.			Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging	PLOS ONE			English	Article							FIBER TRACTOGRAPHY; CORPUS-CALLOSUM; CSF; BRAIN; BETA; DEGENERATION; DEMENTIA; VOLUME; TRACTS; APOE	Brain changes associated with Alzheimer's disease (AD) begin decades before disease diagnosis. While beta-amyloid plaques and neurofibrillary tangles are defining features of AD, neuronal loss and synaptic pathology are closely related to the cognitive dysfunction. Brain imaging methods that are tuned to assess degeneration of myelinated nerve fibers in the brain (collectively called white matter) include diffusion tensor imaging (DTI) and related techniques, and are expected to shed light on disease-related loss of structural connectivity. Participants (N = 70, ages 47-76 years) from the Wisconsin Registry for Alzheimer's Prevention study underwent DTI and hybrid diffusion imaging to determine a free-water elimination (FWE-DTI) model. The study assessed the extent to which preclinical AD pathology affects brain white matter. Preclinical AD pathology was determined using cerebrospinal fluid (CSF) biomarkers. The sample was enriched for AD risk (APOE epsilon 4 and parental history of AD). AD pathology assessed by CSF analyses was significantly associated with altered microstructure on both DTI and FWE-DTI. Affected regions included frontal, parietal, and especially temporal white matter. The f-value derived from the FWE-DTI model appeared to be the most sensitive to the relationship between the CSF AD biomarkers and microstructural alterations in white matter. These findings suggest that white matter degeneration is an early pathological feature of AD that may have utility both for early disease detection and as outcome measures for clinical trials. More complex models of microstructural diffusion properties including FWE-DTI may provide increased sensitivity to early brain changes associated with AD over standard DTI.	[Hoy, Andrew R.] US Navy, Med Serv Corp, Falls Church, VA 22042 USA; [Hoy, Andrew R.; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Hoy, Andrew R.; Alexander, Andrew L.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA; [Hoy, Andrew R.] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA; [Ly, Martina; Carlsson, Cynthia M.; Okonkwo, Ozioma C.; Asthana, Sanjay; Johnson, Sterling C.; Bendlin, Barbara B.] William S Middleton Mem Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Madison, WI USA; [Ly, Martina; Carlsson, Cynthia M.; Okonkwo, Ozioma C.; Sager, Mark A.; Asthana, Sanjay; Johnson, Sterling C.; Bendlin, Barbara B.] Univ Wisconsin, Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA; [Ly, Martina] Univ Wisconsin, Neurosci Training Program, Madison, WI USA; [Carlsson, Cynthia M.; Okonkwo, Ozioma C.; Sager, Mark A.; Asthana, Sanjay; Johnson, Sterling C.; Bendlin, Barbara B.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Inst, Madison, WI USA; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Dept Psychiat & Neurochem, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Queen Sq, London WC1N 3BG, England; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Uniformed Services University of the Health Sciences - USA; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Gothenburg; University of London; University College London; University of Wisconsin System; University of Wisconsin Madison	Hoy, AR (corresponding author), US Navy, Med Serv Corp, Falls Church, VA 22042 USA.; Hoy, AR (corresponding author), Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA.; Hoy, AR (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA.; Hoy, AR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA.	Andrew.Hoy@usuhs.edu	Alexander, Andrew/ABA-2806-2020		National Institutes of Health [P50AG033514, R01AG027161, P30HD003352, P50MH100031, R01AG037639]; Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG037639, R01AG021155, P50AG033514, R01AG037639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported in part by the National Institutes of Health under Grant Award Numbers P50AG033514, R01AG027161, P30HD003352, P50MH100031, and R01AG037639. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Biomarker analyses in this project was supported by the Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences.	Adluru N, 2014, NEUROIMAGE-CLIN, V4, P730, DOI 10.1016/j.nicl.2014.04.008; Alexander AL, 2001, ANAL PARTIAL VOLUME, V780, P770; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Alobuia WM, 2013, NEUROCHEM INT, V63, P782, DOI 10.1016/j.neuint.2013.08.013; Andrade-Moraes CH, 2013, BRAIN, V136, P3738, DOI 10.1093/brain/awt273; [Anonymous], 1988, COGN REHABIL; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; Bendlin BB, 2010, ALZHEIMERS DEMENT, V6, P394, DOI 10.1016/j.jalz.2009.11.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berlot R, 2014, NEUROIMAGE, P1; Brinkmalm G, 2013, BRAIN RES, V1513, P117, DOI 10.1016/j.brainres.2013.03.019; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Canu E, 2010, J ALZHEIMERS DIS, V19, P963, DOI 10.3233/JAD-2010-1295; Christensen DZ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00139; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Cox SG, 2005, BRIT J CLIN PSYCHOL, V44, P454, DOI 10.1348/014466505X105850; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Gold BT, 2014, NEUROBIOL AGING, V35, P2263, DOI 10.1016/j.neurobiolaging.2014.04.030; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hanyu H, 1999, J NEUROL SCI, V167, P37, DOI 10.1016/S0022-510X(99)00135-5; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hoy AR, 2014, NEUROIMAGE, V103, P323, DOI 10.1016/j.neuroimage.2014.09.053; Hoy AR, 2015, J MAGN RESON IMAGING, P1; Huang H, 2012, NEUROBIOL AGING, V33, P2029, DOI 10.1016/j.neurobiolaging.2011.06.027; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Koopman K, 2009, NEUROCHEM INT, V55, P214, DOI 10.1016/j.neuint.2009.02.017; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Larsson EM, 2004, DEMENT GERIATR COGN, V17, P316, DOI 10.1159/000077162; LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x; Lautner R, 2015, JAMA NEUROL, V72, P125, DOI 10.1001/jamaneurol.2014.3552; Lewczuk P, 2004, J MOL NEUROSCI, V23, P115, DOI 10.1385/JMN:23:1-2:115; Li X, 2015, J INTERN MED; Ly M, 2014, HUM BRAIN MAPP, V35, P2044, DOI 10.1002/hbm.22311; Lyall DM, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.006; Maier-Hein KH, 2015, ALZHEIMERS DEMENT, V11, P485, DOI 10.1016/j.jalz.2014.04.518; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Mattsson N, 2011, NEUROMOL MED, V13, P151, DOI 10.1007/s12017-011-8147-9; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Metzler-Baddeley C, 2012, J NEUROSCI, V32, P17612, DOI 10.1523/JNEUROSCI.3299-12.2012; Metzler-Baddeley C, 2012, NEUROLOGY, V79, P2233, DOI 10.1212/WNL.0b013e31827689e8; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Okada T, 2006, RADIOLOGY, V238, P668, DOI 10.1148/radiol.2382042192; Pajevic S, 2000, MAGNET RESON MED, V43, P921, DOI 10.1002/1522-2594(200006)43:6<921::AID-MRM23>3.0.CO;2-I; Pasternak O, 2012, J NEUROSCI, V32, P17365, DOI 10.1523/JNEUROSCI.2904-12.2012; Pasternak O, 2012, LECT NOTES COMPUT SC, V7511, P305, DOI 10.1007/978-3-642-33418-4_38; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Perneczky R, 2011, NEUROLOGY, V77, P35, DOI 10.1212/WNL.0b013e318221ad47; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pierpaoli C, 2004, P 12 ANN M ISMRM KYO, V21, P1215; Rathi Y, 2013, HUM BRAIN MAPP; Ray NJ, 2015, J NEUROSCI, V35, P739, DOI 10.1523/JNEUROSCI.3617-14.2015; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Roher Alex E, 2013, Am J Neurodegener Dis, V2, P187; Roses Allen D., 1994, Current Opinion in Biotechnology, V5, P663, DOI 10.1016/0958-1669(94)90091-4; Ryan NS, 2013, BRAIN, V136, P1399, DOI 10.1093/brain/awt065; Sager MA, 2005, J GERIATR PSYCH NEUR, V18, P245, DOI 10.1177/0891988705281882; Samgard K, 2010, INT J GERIATR PSYCH, V25, P403, DOI 10.1002/gps.2353; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Strauss E, 1998, CLIN ORTHOP RELAT R, P2; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Tosto G, 2014, JAMA NEUROL, V71, P872, DOI 10.1001/jamaneurol.2014.667; van Bruggen T, INT SOC MAGN RES MED, P790; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang Y, 2011, NEUROIMAGE, V55, P1577, DOI 10.1016/j.neuroimage.2011.01.038; Westlye LT, 2012, NEUROLOGY, V79, P1961, DOI 10.1212/WNL.0b013e3182735c9c; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	88	67	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173982	10.1371/journal.pone.0173982	http://dx.doi.org/10.1371/journal.pone.0173982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291839	gold, Green Published, Green Submitted			2022-12-26	WOS:000396094700053
J	Snedeker, J; Schock, EN; Struve, JN; Chang, CF; Cionni, M; Tran, PV; Brugmann, SA; Stottmann, RW				Snedeker, John; Schock, Elizabeth N.; Struve, Jamie N.; Chang, Ching-Fang; Cionni, Megan; Tran, Pamela V.; Brugmann, Samantha A.; Stottmann, Rolf W.			Unique spatiotemporal requirements for intraflagellar transport genes during forebrain development	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIA; SONIC HEDGEHOG; NEURAL CREST; KINESIN-II; MOUSE; MORPHOGENESIS; PROTEINS; KIF3A; MANIPULATION	Primary cilia are organelles extended from virtually all cells and are required for the proper regulation of a number of canonical developmental pathways. The role in cortical development of proteins important for ciliary form and function is a relatively understudied area. Here we have taken a genetic approach to define the role in forebrain development of three intraflagellar transport proteins known to be important for primary cilia function. We have genetically ablated Kif3a, Ift88, and Ttc21b in a series of specific spatiotemporal domains. The resulting phenotypes allow us to draw several conclusions. First, we conclude that the Ttc21b cortical phenotype is not due to the activity of Ttc21b within the brain itself. Secondly, some of the most striking phenotypes are from ablations in the neural crest cells and the adjacent surface ectoderm indicating that cilia transduce critical tissue-tissue interactions in the developing embryonic head. Finally, we note striking differences in phenotypes from ablations only one embryonic day apart, indicating very discrete spatiotemporal requirements for these three genes in cortical development.	[Snedeker, John; Cionni, Megan; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA; [Schock, Elizabeth N.; Struve, Jamie N.; Chang, Ching-Fang; Brugmann, Samantha A.; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Dept Pediat, Cincinnati, OH 45229 USA; [Schock, Elizabeth N.; Struve, Jamie N.; Chang, Ching-Fang; Brugmann, Samantha A.] Cincinnati Childrens Hosp Med Ctr, Div Plast Surg, Dept Surg, Cincinnati, OH 45229 USA; [Tran, Pamela V.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Kansas; University of Kansas Medical Center	Stottmann, RW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA.	rolf.stottmann@cchmc.org	Stottmann, Rolf/GRO-3453-2022; Stottmann, Rolf/U-6589-2019	Stottmann, Rolf/0000-0003-4512-6806; Schock, Elizabeth/0000-0002-3970-799X; Tran, Pamela/0000-0003-4619-4376; Chang, Ching-Fang/0000-0001-6754-2769	Cincinnati Children's Research Foundation; March of Dimes Foundation Basil O'Connor Starter Scholar Research Award [5-FY13-194]; NIH [R01DE023804, R01NS085023, R01GM112744]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007453] Funding Source: NIH RePORTER	Cincinnati Children's Research Foundation; March of Dimes Foundation Basil O'Connor Starter Scholar Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work comes from the Cincinnati Children's Research Foundation (R.W.S., S.A.B.), a March of Dimes Foundation Basil O'Connor Starter Scholar Research Award (Grant No. 5-FY13-194 to R.W.S.) and the NIH (R01DE023804 to S.A.B., and R01NS085023, R01GM112744 to R.W.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Beccari L, 2013, MECH DEVELOP, V130, P95, DOI 10.1016/j.mod.2012.10.004; Behringer R, 2014, MANIPULATING MOUSE E, P814; Berbari NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106576; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Fossat N, 2012, CELL CYCLE, V11, P26, DOI 10.4161/cc.11.1.18700; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Hou YQ, 2015, EXP CELL RES, V334, P26, DOI 10.1016/j.yexcr.2015.02.017; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Jiang XB, 2002, MECH DEVELOP, V117, P115, DOI 10.1016/S0925-4773(02)00206-X; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Lorentzen E, 2016, COLD SPRING HARB PER, V8; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Stottmann RW, 2009, DEV BIOL, V335, P166, DOI 10.1016/j.ydbio.2009.08.023; Stottmann RW, 2011, DEV DYNAM, V240, P755, DOI 10.1002/dvdy.22579; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tran PV, 2014, J AM SOC NEPHROL, V25, P2201, DOI 10.1681/ASN.2013070735; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wilson SL, 2012, DEV NEUROBIOL, V72, P1196, DOI 10.1002/dneu.20985; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	55	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173258	10.1371/journal.pone.0173258	http://dx.doi.org/10.1371/journal.pone.0173258			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291836	gold, Green Submitted, Green Published			2022-12-26	WOS:000396094700018
J	Ahn, AC; Meier-Kolthoff, JP; Overmars, L; Richter, M; Woyke, T; Sorokin, DY; Muyzer, G				Ahn, Anne-Catherine; Meier-Kolthoff, Jan P.; Overmars, Lex; Richter, Michael; Woyke, Tanja; Sorokin, Dimitry Y.; Muyzer, Gerard			Genomic diversity within the haloalkaliphilic genus Thioalkalivibrio	PLOS ONE			English	Article							SULFUR-OXIDIZING BACTERIA; MULTILOCUS SEQUENCE-ANALYSIS; DNA-DNA HYBRIDIZATION; LIVING TREE PROJECT; AD-HOC-COMMITTEE; SP-NOV.; MICROBIAL DIVERSITY; PROKARYOTIC DIVERSITY; HORIZONTAL TRANSFER; ESCHERICHIA-COLI	Thioalkalivibrio is a genus of obligate chemolithoautotrophic haloalkaliphilic sulfur-oxidizing bacteria. Their habitat are soda lakes which are dual extreme environments with a pH range from 9.5 to 11 and salt concentrations up to saturation. More than 100 strains of this genus have been isolated from various soda lakes all over the world, but only ten species have been effectively described yet. Therefore, the assignment of the remaining strains to either existing or novel species is important and will further elucidate their genomic diversity as well as give a better general understanding of this genus. Recently, the genomes of 76 Thioalkalivibrio strains were sequenced. On these, we applied different methods including (i) 16S rRNA gene sequence analysis, (ii) Multilocus Sequence Analysis (MLSA) based on eight housekeeping genes, (iii) Average Nucleotide Identity based on BLAST (ANI(b)) and MUMmer (ANI(m)), (iv) Tetranucleotide frequency correlation coefficients (TETRA), (v) digital DNA: DNA hybridization (dDDH) as well as (vi) nucleotide-and amino acid-based Genome BLAST Distance Phylogeny (GBDP) analyses. We detected a high genomic diversity by revealing 15 new "genomic" species and 16 new "genomic" subspecies in addition to the ten already described species. Phylogenetic and phylogenomic analyses showed that the genus is not monophyletic, because four strains were clearly separated from the other Thioalkalivibrio by type strains from other genera. Therefore, it is recommended to classify the latter group as a novel genus. The biogeographic distribution of Thioalkalivibrio suggested that the different "genomic" species can be classified as candidate disjunct or candidate endemic species. This study is a detailed genome-based classification and identification of members within the genus Thioalkalivibrio. However, future phenotypical and chemotaxonomical studies will be needed for a full species description of this genus.	[Ahn, Anne-Catherine; Overmars, Lex; Muyzer, Gerard] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Microbial Syst Ecol, Amsterdam, Netherlands; [Meier-Kolthoff, Jan P.] Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany; [Richter, Michael] Ribocon, Bremen, Germany; [Woyke, Tanja] DOE Joint Genome Inst, Walnut Creek, CA USA; [Sorokin, Dimitry Y.] Russian Acad Sci, Biotechnol Res Ctr, Winogradsky Inst Microbiol, Moscow, Russia; [Sorokin, Dimitry Y.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	University of Amsterdam; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); United States Department of Energy (DOE); Research Center of Biotechnology RAS; Russian Academy of Sciences; Delft University of Technology	Muyzer, G (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Microbial Syst Ecol, Amsterdam, Netherlands.	g.muijzer@uva.nl	Muyzer, Gerard/ABE-5834-2020; Meier-Kolthoff, Jan Philipp/AAX-6799-2021; Meier-Kolthoff, Jan P./GOP-1205-2022	Muyzer, Gerard/0000-0002-2422-0732; Meier-Kolthoff, Jan Philipp/0000-0001-9105-9814; 	ERC Advanced Grant PARASOL [322551]; European Union Seventh Framework Programme (FP7) [311975]; RFBR grant [16-04-00035]; U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility; DOE Office of Science User Facility [DE-AC02-05CH11231]	ERC Advanced Grant PARASOL; European Union Seventh Framework Programme (FP7); RFBR grant(Russian Foundation for Basic Research (RFBR)); U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility(United States Department of Energy (DOE)); DOE Office of Science User Facility(United States Department of Energy (DOE))	Financial support for Anne-Catherine Ahn, Lex Overmars and Gerard Muyzer was provided by the ERC Advanced Grant PARASOL (No322551). Michael Richter has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 311975 (MaCuMBA). Dimitry Sorokin was supported by the RFBR grant 16-04-00035; Tanja Woyke was funded by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, and was supported under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cherel Balkema for her help in the laboratory, Judith Umbach for her assistance with the ANI analysis and Emily D. Melton for proofreading and helpful comments. The work conducted by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, is supported under Contract No. DE-AC02-05CH11231.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; ASH C, 1991, INT J SYST BACTERIOL, V41, P343, DOI 10.1099/00207713-41-3-343; ASHLOCK PD, 1971, SYST ZOOL, V20, P63, DOI 10.2307/2412223; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Banciu H, 2005, FEMS MICROBIOL LETT, V243, P181, DOI 10.1016/j.femsle.2004.12.004; Banciu H, 2004, EXTREMOPHILES, V8, P325, DOI 10.1007/s00792-004-0391-6; Banciu H, 2004, EXTREMOPHILES, V8, P185, DOI 10.1007/s00792-004-0376-5; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Bryantseva I, 1999, INT J SYST BACTERIOL, V49, P697, DOI 10.1099/00207713-49-2-697; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0; COLWELL RR, 1970, J BACTERIOL, V104, P410, DOI 10.1128/JB.104.1.410-433.1970; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feil EJ, 2000, GENETICS, V154, P1439; Foti M, 2006, FEMS MICROBIOL ECOL, V56, P95, DOI 10.1111/j.1574-6941.2006.00068.x; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Fulthorpe RR, 1998, APPL ENVIRON MICROB, V64, P1620; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Garrido-Sanz D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150183; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Glaeser SP, 2015, SYST APPL MICROBIOL, V38, P237, DOI 10.1016/j.syapm.2015.03.007; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Habib C, 2014, APPL ENVIRON MICROB, V80, P5503, DOI 10.1128/AEM.01177-14; Hahnke RL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02003; Henz SR, 2005, BIOINFORMATICS, V21, P2329, DOI 10.1093/bioinformatics/bth324; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Imhoff JF, 1996, ARCH MICROBIOL, V165, P106, DOI 10.1007/s002030050304; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jones B, 2000, MICROBIAL BIOSYSTEMS, P681; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; JONES BF, 1977, GEOCHIM COSMOCHIM AC, V41, P53, DOI 10.1016/0016-7037(77)90186-7; Kompantseva EI, 2009, MIKROBIOLOGIYA, V78, P709; Lai QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106353; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101394; Liu YW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08263; Loiko N. G., 2003, Mikrobiologiya, V72, P328; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ma YH, 2004, EXTREMOPHILES, V8, P45, DOI 10.1007/s00792-003-0358-z; Delamuta JRM, 2012, BRAZ J MICROBIOL, V43, P698, DOI 10.1590/S1517-83822012000200035; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Meier-Kolthoff JP, 2014, CONCURR COMP-PRACT E, V26, P1715, DOI 10.1002/cpe.3112; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MELACK JM, 1974, LIMNOL OCEANOGR, V19, P743, DOI 10.4319/lo.1974.19.5.0743; Mesbah NM, 2007, MICROB ECOL, V54, P598, DOI 10.1007/s00248-006-9193-y; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Mu TZ, 2016, J BIOTECHNOL, V227, P21, DOI 10.1016/j.jbiotec.2016.04.019; Muyzer G, 2011, STAND GENOMIC SCI, V5, P341, DOI 10.4056/sigs.2315092; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roesler CS, 2002, LIMNOL OCEANOGR, V47, P440, DOI 10.4319/lo.2002.47.2.0440; Siddall ME, 2010, CLADISTICS, V26, P444, DOI 10.1111/j.1096-0031.2009.00295.x; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sorokin DY, 2015, CURR OPIN MICROBIOL, V25, P88, DOI 10.1016/j.mib.2015.05.004; Sorokin DY, 2014, EXTREMOPHILES, V18, P791, DOI 10.1007/s00792-014-0670-9; Sorokin DY, 2012, INT J SYST EVOL MICR, V62, P1884, DOI 10.1099/ijs.0.034504-0; Sorokin DY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00044; Sorokin DY, 2008, INT J SYST EVOL MICR, V58, P1685, DOI 10.1099/ijs.0.65654-0; Sorokin DY, 2005, FEMS MICROBIOL REV, V29, P685, DOI 10.1016/j.femsre.2004.10.005; Sorokin DY, 2005, FEMS MICROBIOL ECOL, V52, P287, DOI 10.1016/j.femsec.2005.02.012; Sorokin DY, 2004, MICROBIOL-SGM, V150, P2435, DOI 10.1099/mic.0.27015-0; Sorokin DY, 2003, INT J SYST EVOL MICR, V53, P1779, DOI 10.1099/ijs.0.02615-0; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P657, DOI 10.1099/00207713-52-2-657; Sorokin DY, 2001, APPL ENVIRON MICROB, V67, P528, DOI 10.1128/AEM.67.2.528-538.2001; Sorokin DY, 2001, ARCH MICROBIOL, V175, P94, DOI 10.1007/s002030000210; Sorokin DY, 2001, INT J SYST EVOL MICR, V51, P565, DOI 10.1099/00207713-51-2-565; Sorokin DY, 2013, PROKARYOTES PROKARYO, P530; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Stackebrandt E, 2003, FOOD TECHNOL BIOTECH, V41, P17; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Takaichi S, 2004, TETRAHEDRON LETT, V45, P8303, DOI 10.1016/j.tetlet.2004.09.073; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Tian RM, 2015, GENOME BIOL EVOL, V7, P2310, DOI 10.1093/gbe/evv143; Vandamme P, 2014, ANTON LEEUW INT J G, V106, P57, DOI 10.1007/s10482-014-0148-x; Ventura M, 2006, INT J SYST EVOL MICR, V56, P2783, DOI 10.1099/ijs.0.64233-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; WOOD SW, 1994, CLADISTICS, V10, P339, DOI 10.1006/clad.1994.1024; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001	97	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173517	10.1371/journal.pone.0173517	http://dx.doi.org/10.1371/journal.pone.0173517			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282461	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800048
J	Jamnadass, ESL; Keelan, JA; Russell-Smith, SN; Hickey, M; Maybery, MT; Whitehouse, AJO				Jamnadass, Esha S. L.; Keelan, Jeffrey A.; Russell-Smith, Suzanna N.; Hickey, Martha; Maybery, Murray T.; Whitehouse, Andrew J. O.			Umbilical cord androgens and estrogens in relation to verbal and nonverbal abilities at age 10 in the general population	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; PRENATAL TESTOSTERONE LEVELS; SEX-DIFFERENCES; MENTAL ROTATION; FETAL TESTOSTERONE; SOCIOECONOMIC-STATUS; LANGUAGE-DEVELOPMENT; COGNITIVE-ABILITIES; SPATIAL ABILITY; YOUNG-ADULTS	Sex differences in verbal and nonverbal abilities are a contentious area of research. Prenatal steroids have been shown to have masculinizing effects on the brain that may affect the development of nonverbal and verbal abilities in later life. The current study examined a wide range of biologically active sex steroids (both androgens and estrogens) in umbilical cord blood at birth in a large pregnancy cohort in relation to performance on nonverbal (Raven's Coloured Progressive Matrices) and verbal (Clinical Evaluation of Language Fundamentals-3 and the Peabody Picture Vocabulary Test-III) measures at age 10 years. Overall, Androgen and Estrogen composites in cord blood were not found to be predictive of performance on verbal and nonverbal measures at age 10. These data suggest that late gestation sex steroids do not exert a major effect on nonverbal and verbal abilities in middle childhood.	[Jamnadass, Esha S. L.; Russell-Smith, Suzanna N.; Maybery, Murray T.] Univ Western Australia, Sch Psychol, Perth, WA, Australia; [Jamnadass, Esha S. L.; Whitehouse, Andrew J. O.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Keelan, Jeffrey A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Hickey, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Hickey, Martha] Royal Womens Hosp, Melbourne, Vic, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Melbourne	Jamnadass, ESL (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA, Australia.	esha.jamnadass@research.uwa.edu.au	Whitehouse, Andrew J.O./AGJ-2519-2022; Keelan, Jeffrey/G-2170-2011	Whitehouse, Andrew J.O./0000-0001-8722-1575; Keelan, Jeffrey/0000-0002-5403-6266; Maybery, Murray/0000-0002-3760-1382	University of Western Australia (UWA); Curtin University; Edith Cowan University; UWA Faculty of Medicine, Dentistry and Health Sciences; Raine Medical Research Foundation; Telethon Kids Institute; Women's and Infants Research Foundation; NHMRC [403968, 1003424, 1004065]; Australian Rotary Health; Women and Infants' Research Foundation	University of Western Australia (UWA); Curtin University; Edith Cowan University; UWA Faculty of Medicine, Dentistry and Health Sciences; Raine Medical Research Foundation; Telethon Kids Institute; Women's and Infants Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Rotary Health; Women and Infants' Research Foundation	The authors would like to acknowledge the National Health and Medical Research Council (NHMRC) and the Telethon Kids Institute for their long term contribution to funding the Raine study over the last 20 years. Core Management of the Raine study has been funded by the University of Western Australia (UWA), Curtin University, Edith Cowan University, the UWA Faculty of Medicine, Dentistry and Health Sciences, the Raine Medical Research Foundation, the Telethon Kids Institute, and the Women's and Infants Research Foundation. The two-year follow-up was funded by the NHMRC and the Raine Medical Research Foundation, and funding from the NHMRC (#403968) and Australian Rotary Health was used for the androgen analysis. AJOW (#1004065) and MH are funded by Career Development Fellowships from the NHMRC; JAK is funded by the Women and Infants' Research Foundation. This study was partly funded by NHMRC Project Grant # 1003424. The authors are extremely grateful to the study participants and their families, as well as the whole Raine Study Team which includes the Cohort Manager, Data Manager and data collection researchers.	ABRAMOVICH DR, 1974, J OBSTET GYN BR COMM, V81, P448; Alwin DF, 2001, J GERONTOL B-PSYCHOL, V56, pS151, DOI 10.1093/geronb/56.3.S151; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Auyeung B, 2012, PRIMATE MIND BUILT C, P194; Auyeung B, 2013, PFLUG ARCH EUR J PHY, V465, P557, DOI 10.1007/s00424-013-1268-2; Auyeung B, 2012, ARCH SEX BEHAV, V41, P571, DOI 10.1007/s10508-011-9864-8; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Berenbaum SA, 2012, BEHAV NEUROSCI, V126, P86, DOI 10.1037/a0026652; Blair Eve M, 2005, BMC Pediatr, V5, P13, DOI 10.1186/1471-2431-5-13; BOCHNER S, 1978, PSYCHOL SCHOOLS, V15, P320, DOI 10.1002/1520-6807(197807)15:3<320::AID-PITS2310150302>3.0.CO;2-B; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; Dart D., 2014, J ENDOCR DISORD, V1, P1005; Dunn L.M., 1981, PEABODY PICTURE VOCA; FAIRWEATHER H, 1976, COGNITION, V4, P231, DOI 10.1016/0010-0277(76)90019-6; FINEGAN JAK, 1992, DEV PSYCHOL, V28, P1075, DOI 10.1037/0012-1649.28.6.1075; Galsworthy MJ, 2000, DEVELOPMENTAL SCI, V3, P206, DOI 10.1111/1467-7687.00114; GRIMSHAW GM, 1995, BRAIN COGNITION, V29, P85, DOI 10.1006/brcg.1995.1269; Halpern D.F., 2013, SEX DIFFERENCES COGN, V4; HAMPSON E, 1995, J PSYCHIATR NEUROSCI, V20, P397; Hampson E, 1998, DEV NEUROPSYCHOL, V14, P299, DOI 10.1080/87565649809540713; Hampson E, 2015, PSYCHONEUROENDOCRINO, V54, P60, DOI 10.1016/j.psyneuen.2015.01.022; Hampson E, 2014, HORM BEHAV, V65, P238, DOI 10.1016/j.yhbeh.2013.12.016; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Hegarty M., 2005, CAM BRIDGE HDB VISUO, P121, DOI DOI 10.1017/CBO9780511610448.005; Hines M, 2003, BRAIN GENDER; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Hines M, 2010, TRENDS COGN SCI, V14, P448, DOI 10.1016/j.tics.2010.07.005; Hoff-Ginsberg E, 1998, APPL PSYCHOLINGUIST, V19, P603, DOI 10.1017/S0142716400010389; Hollier LP, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00064; Hollier LP, 2013, BIOL PSYCHOL, V92, P212, DOI 10.1016/j.biopsycho.2012.10.016; Hollier LP, 2014, ADULT DIGIT RATIO 2D; Hutson JM., 2012, DISOERDERS SEX DEV, P23; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; JACKLIN CN, 1988, DEV PSYCHOBIOL, V21, P567, DOI 10.1002/dev.420210607; Jamnadass ESL, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9114-9; Keelan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042827; Kimura D, 2003, SEX DIFFERENCES IN C; Knickmeyer R, 2014, FRONTIERS ENDOCRINOL, P5; Knickmeyer RC, 2006, EARLY HUM DEV, V82, P755, DOI 10.1016/j.earlhumdev.2006.09.014; Kraus C, 2008, M PLANCK I DEMOGRAPH, V1, P2008; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P319, DOI 10.1016/S0163-6383(02)00095-4; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Lynn R, 2004, INTELLIGENCE, V32, P481, DOI 10.1016/j.intell.2004.06.008; Mazer NA, 2009, STEROIDS, V74, P512, DOI 10.1016/j.steroids.2009.01.008; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Pungello EP, 2009, DEV PSYCHOL, V45, P544, DOI 10.1037/a0013917; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; Quinn PC, 2008, PSYCHOL SCI, V19, P1067, DOI 10.1111/j.1467-9280.2008.02201.x; Raven J, 2003, HANDBOOK OF NONVERBAL ASSESSMENT, P223; Raven J.C., 1938, PROGR MATRICES PERCE; RESKO JA, 1975, ENDOCRINOLOGY, V97, P425, DOI 10.1210/endo-97-2-425; RESNICK SM, 1986, DEV PSYCHOL, V22, P191, DOI 10.1037/0012-1649.22.2.191; Reynolds CR, 2007, ENCY SPECIAL ED; Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171; Semel E, 1997, CELF 3 CLIN EVALUATI; SERONFERRE M, 1993, ENDOCR REV, V14, P594, DOI 10.1210/er.14.5.594; SLOB AK, 1980, J ENDOCRINOL, V87, P81, DOI 10.1677/joe.0.0870081; TAN U, 1990, INT J NEUROSCI, V54, P283, DOI 10.3109/00207459008986645; TAN U, 1992, INT J NEUROSCI, V64, P213, DOI 10.3109/00207459209000548; Valla JM, 2011, PERSPECT PSYCHOL SCI, V6, P134, DOI 10.1177/1745691611400236; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Voyer D, 2011, PSYCHON B REV, V18, P267, DOI 10.3758/s13423-010-0042-0; WABER DP, 1976, SCIENCE, V192, P572, DOI 10.1126/science.1257795; Wallen K., 2002, HORMONES BRAIN BEHAV, P385, DOI DOI 10.1016/B978-012532104-4/50071-8; Wallentin M, 2009, BRAIN LANG, V108, P175, DOI 10.1016/j.bandl.2008.07.001; Whitehouse AJO, 2012, J CHILD PSYCHOL PSYC, V53, P726, DOI 10.1111/j.1469-7610.2011.02523.x; Whitehouse AJO, 2010, PSYCHONEUROENDOCRINO, V35, P1259, DOI 10.1016/j.psyneuen.2010.02.007; WILLIAMS CL, 1991, PSYCHONEUROENDOCRINO, V16, P155, DOI 10.1016/0306-4530(91)90076-6; ZLOTKIN SH, 1987, CLIN CHEM, V33, P411	74	1	1	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173493	10.1371/journal.pone.0173493	http://dx.doi.org/10.1371/journal.pone.0173493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278304	Green Published, gold			2022-12-26	WOS:000396087900002
J	Kamthan, A; Kamthan, M; Datta, A				Kamthan, Ayushi; Kamthan, Mohan; Datta, Asis			Expression of C-5 sterol desaturase from an edible mushroom in fisson yeast enhances its ethanol and thermotolerance	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SIMULTANEOUS SACCHARIFICATION; OXALATE DECARBOXYLASE; GENE; TOLERANCE; CLONING; IDENTIFICATION; BIOSYNTHESIS; ERGOSTEROL; GROWTH	Bioethanol is an environment friendly and renewable source of energy produced by the fermentation of agricultural raw material by a variety of microorganisms including yeast. Obtaining yeast strains that are tolerant to stresses like high levels of ethanol and high temperature is highly desirable as it reduces cost and increases yield during bioethanol production. Here, we report that heterologous expression of C-5 Sterol desaturase (FvC5SD)-an ergosterol biosynthesis enzyme from an edible mushroom Flammulina velutipes in fission yeast, not only imparts increased thermotolerance but also tolerance towards high ethanol concentration and low pH. This tolerance could be attributed to an increase of approximate to 1.5 fold in the level of ergosterol and oleic acid (C-18 unsaturated fatty acid) as analysed by gas chromatography-mass spectrometry. FvC5SD is a membrane localized iron binding enzyme that introduces double bond at C-5 position into the Delta 7-sterol substrates to yield Delta 5,7-sterols as products. In F.velutipes, FvC5SD transcript was observed to be upregulated by approximate to 5 fold under low pH condition and by approximate to 9 folds and approximate to 5 fold at 40 degrees C and 4 degrees C respectively when compared to normal growth temperature of 23 degrees C. Besides, susceptibility to cell wall inhibiting drugs like Congo red and Calcoflour white was also found to increase in FvC5SD expressing S. pombe strain. Alteration in membrane sterol and fatty acid composition could also lead to increase in susceptibility to cell wall inhibiting drugs. Thus, this study has immense industrial application and can be employed to ensure competitiveness of fermentation process.	[Kamthan, Ayushi; Kamthan, Mohan; Datta, Asis] Natl Inst Plant Genome Res, New Delhi, India; [Kamthan, Mohan] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Datta, A (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	asis_datta@rediffmail.com		Kamthan, Mohan/0000-0001-8859-4699	Council of Scientific and Industrial Research; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/CEIB/12/11/01]; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	AK thanks Council of Scientific and Industrial Research for fellowship. AD thanks Department of Biotechnology, Ministry of Science and Technology, Government of India. (BT/01/CEIB/12/11/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank confocal facility, NIPGR for immunoflourescence microscopy. AK thanks Council of Scientific and Industrial Research for fellowship. AD thanks Department of Biotechnology, Government of India, for funding the project. This article does not contain any studies with human participants or animals performed by any of the authors.	Abubaker H.O., 2012, J MICROBIOL RES, V2, P36, DOI 10.5923/j.microbiology.20120202.06; Alcazar-Fuoli L, 2006, ANTIMICROB AGENTS CH, V50, P453, DOI 10.1128/AAC.50.2.453-460.2006; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; ArthingtonSkaggs BA, 1996, FEBS LETT, V392, P161, DOI 10.1016/0014-5793(96)00807-1; Azam M, 2002, BIOCHEM J, V367, P67, DOI 10.1042/BJ20011573; BANAT IM, 1992, WORLD J MICROB BIOT, V8, P259, DOI 10.1007/BF01201874; Banat IM, 1998, WORLD J MICROB BIOT, V14, P809, DOI 10.1023/A:1008802704374; BREIVIK ON, 1957, J AGR FOOD CHEM, V5, P360, DOI 10.1021/jf60075a005; Brumfield KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008659; CASEY GP, 1986, CRC CR REV MICROBIOL, V13, P219, DOI 10.3109/10408418609108739; Dahiya P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27967; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Fiedurek J, 2011, POL J MICROBIOL, V60, P51, DOI 10.33073/pjm-2011-007; Forsburg Susan L, 2005, Gravit Space Biol Bull, V18, P3; Gachotte D, 1996, PLANT J, V9, P391, DOI 10.1046/j.1365-313X.1996.09030391.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; Guan WJ, 2016, BIORESOURCE TECHNOL, V200, P713, DOI 10.1016/j.biortech.2015.10.102; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; Husselstein T, 1999, PLANT MOL BIOL, V39, P891, DOI 10.1023/A:1006113919172; Imai K, 2005, J BIOL CHEM, V280, P8275, DOI 10.1074/jbc.M409428200; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; Inoue T, 2000, BIOSCI BIOTECH BIOCH, V64, P229, DOI 10.1271/bbb.64.229; Waki T, 2008, MICROBIOL-SGM, V154, P830, DOI 10.1099/mic.0.2007/011155-0; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kadar Z, 2004, IND CROP PROD, V20, P103, DOI 10.1016/j.indcrop.2003.12.015; Kamthan A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00951; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Kawahata M, 2006, FEMS YEAST RES, V6, P924, DOI 10.1111/j.1567-1364.2006.00089.x; KAWATA S, 1985, J BIOL CHEM, V260, P6609; Kim J, 1996, APPL ENVIRON MICROB, V62, P1563, DOI 10.1128/AEM.62.5.1563-1569.1996; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Limtong S, 2007, BIORESOURCE TECHNOL, V98, P3367, DOI 10.1016/j.biortech.2006.10.044; Linde M, 2008, BIOMASS BIOENERG, V32, P326, DOI 10.1016/j.biombioe.2007.09.013; LLOYD D, 1993, YEAST, V9, P825, DOI 10.1002/yea.320090803; Ly HV, 2002, LANGMUIR, V18, P8988, DOI 10.1021/la026010q; Matsushima M, 1996, CYTOGENET CELL GENET, V74, P252, DOI 10.1159/000134427; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MEHTA A, 1991, J BIOL CHEM, V266, P23548; Miyazaki Y, 1999, GENE, V236, P43, DOI 10.1016/S0378-1119(99)00263-2; Munn AL, 1999, MOL BIOL CELL, V10, P3943, DOI 10.1091/mbc.10.11.3943; NES WR, 1988, J BIOL CHEM, V263, P11844; NOVOTNY C, 1992, FOLIA MICROBIOL, V37, P43, DOI 10.1007/BF02814578; Nusblat AD, 2009, EUKARYOT CELL, V8, P1287, DOI 10.1128/EC.00057-09; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; OSUMI T, 1979, J BIOCHEM-TOKYO, V85, P819; PARKS LW, 1982, LIPIDS, V17, P187, DOI 10.1007/BF02535102; PESTI M, 1981, CURR MICROBIOL, V5, P187, DOI 10.1007/BF01578527; SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; SUUTARI M, 1990, J GEN MICROBIOL, V136, P1469, DOI 10.1099/00221287-136-8-1469; Takagi H, 2005, APPL ENVIRON MICROB, V71, P8656, DOI 10.1128/AEM.71.12.8656-8662.2005; Taton M, 1996, ARCH BIOCHEM BIOPHYS, V325, P279, DOI 10.1006/abbi.1996.0035; Teixeira MC, 2009, APPL ENVIRON MICROB, V75, P5761, DOI 10.1128/AEM.00845-09; THOMAS DS, 1978, ARCH MICROBIOL, V117, P239, DOI 10.1007/BF00738541; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Vogl C, 2008, J BIOL CHEM, V283, P7379, DOI 10.1074/jbc.M708275200; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; WATSON K, 1982, BIOTECHNOL LETT, V4, P397, DOI 10.1007/BF00135429; West AG, 1999, J MOL BIOL, V286, P1311, DOI 10.1006/jmbi.1999.2576; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x; You KM, 2003, APPL ENVIRON MICROB, V69, P1499, DOI 10.1128/AEM.69.3.1499-1503.2003	64	17	19	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173381	10.1371/journal.pone.0173381	http://dx.doi.org/10.1371/journal.pone.0173381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278249	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900081
J	Park, JW; Park, KH; Jung, EY				Park, Jeong Woo; Park, Kyo Hoon; Jung, Eun Young			Clinical significance of histologic chorioamnionitis with a negative amniotic fluid culture in patients with preterm labor and premature membrane rupture	PLOS ONE			English	Article							ACUTE INFLAMMATORY LESIONS; INTRAAMNIOTIC INFECTION; GESTATIONAL-AGE; PREDICTIVE-VALUE; RISK-FACTOR; PLACENTA; DELIVERY; CYTOKINES; MORBIDITY; INVASION	Objective To evaluate the effect of histological chorioamnionitis (HCA) with a negative amniotic fluid (AF) culture on adverse pregnancy and neonatal outcomes and inflammatory status in the AF compartment in women with preterm labor or preterm premature rupture of membranes (PPROM). Methods This is a retrospective cohort study of 153 women diagnosed as having a preterm labor or PPROM (20-34 weeks) who delivered singleton gestations within 48 hours of amniocentesis. AF obtained through amniocentesis was cultured, and interleukin (IL)-6, IL-8, and metalloproteinase-9 (MMP-9) levels were determined. The placentas were examined histologically. Results The prevalence of HCA with negative AF culture was 23.5% (36/153). The women with HCA but with a negative AF culture (group 2) and those with a positive AF culture (group 3) had a significantly lower mean gestational age at amniocentesis and delivery than those with a negative AF culture and without HCA (group 1). Women in group 3 had the highest levels of AF IL-6, IL-8, and MMP-9, followed by those in group 2, and those in group 1. Composite neonatal morbidity was significantly higher in groups 2 and 3 than in group 1, but this was no longer significant after adjusting for confounders caused mainly by the impact of gestational age. Discussion In the women who delivered preterm neonates, HCA with a negative AF culture was associated with increased risks of preterm birth, intense intra-amniotic inflammatory response, and prematurity-associated composite neonatal morbidity, and its risks are similar to the risk posed by positive AF culture.	[Park, Jeong Woo; Park, Kyo Hoon] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Park, Jeong Woo] Inje Univ, Coll Med, Dept Obstet & Gynecol, Ilsan Paik Hosp, Gyeonggi, South Korea; [Park, Kyo Hoon; Jung, Eun Young] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea	Seoul National University (SNU); Inje University; Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.; Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea.	pkh0419@snubh.org		Park, Jeong Woo/0000-0001-6499-0814	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI 14C1798]	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. HI 14C1798).	Bersani I, 2012, J MATERN-FETAL NEO M, V25, P12, DOI 10.3109/14767058.2012.663161; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; GYR TN, 1994, AM J OBSTET GYNECOL, V170, P223; HILLIER SL, 1993, OBSTET GYNECOL, V81, P941; Holst RM, 2006, ULTRASOUND OBST GYN, V28, P768, DOI 10.1002/uog.3837; Jacobsson B, 2009, ACTA OBSTET GYN SCAN, V88, P63, DOI 10.1080/00016340802572646; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Lau J, 2005, AM J OBSTET GYNECOL, V193, P708, DOI 10.1016/j.ajog.2005.01.017; Lee SY, 2013, J KOREAN MED SCI, V28, P1226, DOI 10.3346/jkms.2013.28.8.1226; Lee Y, 2015, J PERINAT MED, V43, P259, DOI 10.1515/jpm-2014-0035; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Odibo A O, 1999, J Perinatol, V19, P407, DOI 10.1038/sj.jp.7200210; Oh KJ, 2011, PLACENTA, V32, P732, DOI 10.1016/j.placenta.2011.07.080; Park KH, 2012, REPROD SCI, V19, P658, DOI 10.1177/1933719111432869; Pettker CM, 2007, OBSTET GYNECOL, V109, P739, DOI 10.1097/01.AOG.0000255663.47512.23; Rodriguez-Trujillo A, 2016, ACTA OBSTET GYN SCAN, V95, P926, DOI 10.1111/aogs.12905; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1382, DOI 10.1016/0002-9378(92)91609-E; Ryu A, 2013, ACTA OBSTET GYN SCAN, V92, P517, DOI 10.1111/aogs.12073; Thomas W, 2011, NEONATOLOGY, V99, P177, DOI 10.1159/000320170; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	23	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173312	10.1371/journal.pone.0173312	http://dx.doi.org/10.1371/journal.pone.0173312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278303	Green Submitted, gold, Green Published			2022-12-26	WOS:000396087900072
J	Sousa, GR; Gomes, JAS; Damasio, MPS; Nunes, MCP; Costa, HS; Medeiros, NI; Fares, RCG; Chaves, AT; Correa-Oliveira, R; Rocha, MOC				Sousa, Giovane R.; Gomes, Juliana A. S.; Damasio, Marcos Paulo S.; Nunes, Maria Carmo P.; Costa, Henrique S.; Medeiros, Nayara I.; Fares, Rafaelle C. G.; Chaves, Ana Thereza; Correa-Oliveira, Rodrigo; Rocha, Manoel Otavio C.			The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function	PLOS ONE			English	Article							T-CELLS; IL-17; CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ASSOCIATION; MANAGEMENT; CAPACITY	Interleukin 17A (IL-17A) has been associated with protective rather than pathogenic response in Chagas disease (ChD). However, it is not established whether or not IL-17Amediated immune response is correlated with patient's left ventricular (LV) function in ChD. To address this question we have gathered cardiac functional parameters from ChD patients and analysed the possible relationship between their plasma IL-17A levels and LV function. Plasma IL-17A levels were measured by BD Cytometric Bead Array (CBA) in 240 patients with positive specific serology for Trypanosoma cruzi (T. cruzi) grouped as indeterminate (IND) and Chagas cardiomyopathy (CARD) forms. The levels of IL-17A in ChD patients were compared with 32 healthy individuals, mean age of 39 years, 50% male, that were also included as a control group (non-infected [NI]). The overall mean age of ChD patients was 46 years and 52% were male. The IND group included 95 asymptomatic patients, with ages ranging from 27 to 69 years (mean of 43 years), and 42.1% of them were male. The CARD group included 145 patients, which 58.6% were male, with ages ranging from 23 to 67 years (mean of 49). The IND group presented substantially higher levels of IL17A, median of 26.16 (3.66-48.33) as compared to both the CARD group, median of 13.89 (3.87-34.54) (P < 0.0001), and the NI group, median of 10.78 (6.23-22.26) (P < 0.0001). The data analysis demonstrated that the IND group comprises a significantly greater proportion (P < 0.001) of high IL-17A producers (52.6%, 50 of 95 subjects) than do the other groups. A significant direct correlation was verified between IL-17A levels and cardiac function expressed by LV ejection fraction (LVEF), LV diastolic diameter (LVDd), and body surface area (BSA)-indexed LVDd as well as ratio of the early diastolic transmitral flow velocity to early diastolic mitral annular velocity (E/e') in both groups. We demonstrated that plasma IL17A levels has an accurate sensitivity and specificity to predict heart failure in serology-positive patients and might be a useful parameter to distinguish patients with or without cardiac impairment. This study indicates a consistent relationship between high expression of IL17A and better LV in human chronic ChD. Our data raise the possibility that IL-17A plays an important immunomodulatory role in the chronic phase of ChD and might be involved in protection against myocardial damage.	[Sousa, Giovane R.; Gomes, Juliana A. S.; Nunes, Maria Carmo P.; Costa, Henrique S.; Chaves, Ana Thereza; Rocha, Manoel Otavio C.] Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Gomes, Juliana A. S.; Damasio, Marcos Paulo S.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Lab Cell Cell Interact, Belo Horizonte, MG, Brazil; [Medeiros, Nayara I.; Fares, Rafaelle C. G.; Correa-Oliveira, Rodrigo] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Cellular & Mol Immunol, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo] Natl Inst Sci & Technol Trop Dis INCT DT, Belo Horizonte, MG, Brazil; [Sousa, Giovane R.] Harvard Med Sch, Joslin Diabet Ctr, Immunobiol Sect, Boston, MA 02115 USA; [Damasio, Marcos Paulo S.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland; [Fares, Rafaelle C. G.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Dundee; US Food & Drug Administration (FDA)	Sousa, GR (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil.; Sousa, GR (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Immunobiol Sect, Boston, MA 02115 USA.	giovane.sousa@gmail.com	Gomes, Juliana A. S./M-4083-2017; Medeiros, Nayara I/F-3273-2018; Nunes, Maria Carmo/AAV-5185-2020; Rocha, Manoel Otávio C/H-4776-2013; Costa, Henrique Silveira/H-8286-2014; Sousa, Giovane R./H-6102-2016; Damasio, Marcos/AAJ-7196-2021	Gomes, Juliana A. S./0000-0002-8332-2907; Medeiros, Nayara I/0000-0002-5791-4802; Costa, Henrique Silveira/0000-0002-1426-7246; Sousa, Giovane R./0000-0003-0085-3882; Correa-Oliveira, Rodrigo/0000-0001-6419-9459; Fares Gusmao, Rafaelle/0000-0002-2186-4145	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [407692/2012-6, 478846/2009-6, 404151/2012-4, 475497/2007-4, 403592/2008-9, 308219/2012-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-02601-10, APQ-04129-10, PPM-00501-13]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http//www.cripq.br, [407692/2012-6, 478846/2009-6, 404151/2012-4 (RCO), 475497/2007-4, 403592/2008-9, 308219/2012-0 (JASG)] and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, http://www.fapermg.br, [APQ-02601-10, APQ-04129-10, PPM-00501-13 (JASG)]. JASG, MCPN, RCO and MOCR are CNPq Research Fellows. GRS was supported by a Ph.D. Studentship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the colleagues of the Division of Echocardiography and of the Referral Outpatient Center for Chagas Disease at the Clinical Hospital, UFMG as well as of the Laboratory of Cellular and Molecular Immunology and of the Flow Cytometry facility at the Centro de Pesquisas Rene Rachou, FIOCRUZ for their technical assistance. The authors also thank the Program for Technological Development in Tools for Health PDTIS FIOCRUZ for the use of its facilities. We acknowledge Professor Paul Crocker at the Division of Cell Signalling and Immunology, University of Dundee, UK for helpful discussions. We are very grateful to all patients and control volunteers who participated in this study. This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil. JASG, MCPN, RCO and MOCR are CNPq Research Fellows. GRS was supported by a Ph.D. Studentship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Altman D.G., 1991, PRACTICAL STATISTIC; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dutra WO, 2014, PARASITE IMMUNOL, V36, P377, DOI 10.1111/pim.12107; Gaffen S, 2016, NAT REV IMMUNOL, V16, P4, DOI 10.1038/nri.2015.2; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leon B, 2013, NAT IMMUNOL, V14, P419, DOI 10.1038/ni.2593; Lima MMO, 2013, INT J CARDIOL, V167, P2363, DOI 10.1016/j.ijcard.2012.11.055; Magalhaes LMD, 2013, J INFECT DIS, V207, P661, DOI 10.1093/infdis/jis724; Guedes PMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001630; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Nogueira LG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/914326; Nunes MCP, 2011, INT J CARDIOL, V147, P294, DOI 10.1016/j.ijcard.2010.12.044; Nunes MCP, 2009, J AM SOC ECHOCARDIOG, V22, P82, DOI 10.1016/j.echo.2008.11.015; Nunes MP, 2012, J HEART LUNG TRANSPL, V31, P634, DOI 10.1016/j.healun.2012.01.865; Lima MMO, 2010, ECHOCARDIOGR-J CARD, V27, P519, DOI 10.1111/j.1540-8175.2009.01081.x; Pereira J B, 1992, Rev Soc Bras Med Trop, V25, P101, DOI 10.1590/S0037-86821992000200003; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Perez AR, 2011, J NEUROIMMUNOL, V235, P84, DOI 10.1016/j.jneuroim.2011.03.010; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Rocha MOC, 2009, MEM I OSWALDO CRUZ, V104, P159, DOI 10.1590/S0074-02762009000900022; Rocha MOC, 2003, FRONT BIOSCI-LANDMRK, V8, pE44, DOI 10.2741/926; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Snedecor GW, 1980, STAT METHODS, V7th; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Song XY, 2013, CYTOKINE, V62, P175, DOI 10.1016/j.cyto.2013.03.014; Sousa GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087082; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; Wu L, 2014, J EXP MED, V211, P1441, DOI 10.1084/jem.20132126; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	38	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172833	10.1371/journal.pone.0172833	http://dx.doi.org/10.1371/journal.pone.0172833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278264	Green Submitted, gold, Green Published			2022-12-26	WOS:000396087900130
J	Thaper, D; Vahid, S; Nip, KM; Moskalev, I; Shan, X; Frees, S; Roberts, ME; Ketola, K; Harder, KW; Gregory-Evans, C; Bishop, JL; Zoubeidi, A				Thaper, D.; Vahid, S.; Nip, K. M.; Moskalev, I.; Shan, X.; Frees, S.; Roberts, M. E.; Ketola, K.; Harder, K. W.; Gregory-Evans, C.; Bishop, J. L.; Zoubeidi, A.			Targeting Lyn regulates Snail family shuttling and inhibits metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RESISTANT PROSTATE-CANCER; BREAST-CANCER; GENE-EXPRESSION; TYROSINE KINASE; GSK-3-BETA-MEDIATED PHOSPHORYLATION; SIGNAL-TRANSDUCTION; TUMOR-SUPPRESSOR; LEUKEMIA-CELLS; IN-VIVO	The acquisition of an invasive phenotype by epithelial cells occurs through a loss of cellular adhesion and polarity, heralding a multistep process that leads to metastatic dissemination. Since its characterization in 1995, epithelial-mesenchymal transition (EMT) has been closely linked to the metastatic process. As a defining aspect of EMT, loss of cell adhesion through downregulation of E-cadherin is carried out by several transcriptional repressors; key among them the SNAI family of transcription factors. Here we identify for the first time that Lyn kinase functions as a key modulator of SNAI family protein localization and stability through control of the Vav-Rac1-PAK1 (Vav-Rac1-p21-activated kinase) pathway. Accordingly, targeting Lyn in vitro reduces EMT and in vivo reduces metastasis of primary tumors. We also demonstrate the clinical relevance of targeting Lyn as a key player controlling EMT; patient samples across many cancers revealed a strong negative correlation between Lyn and E-cadherin, and high Lyn expression in metastatic tumors as well as metastasis-prone primary tumors. This work reveals a novel pancancer mechanism of Lyndependent control of EMT and further underscores the role of this kinase in tumor progression.	[Thaper, D.; Vahid, S.; Nip, K. M.; Moskalev, I.; Frees, S.; Ketola, K.; Bishop, J. L.; Zoubeidi, A.] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada; [Thaper, D.; Vahid, S.; Nip, K. M.; Zoubeidi, A.] Univ British Columbia, Dept Urol Sci, Fac Med, Vancouver, BC, Canada; [Shan, X.; Gregory-Evans, C.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Fac Med, Vancouver, BC, Canada; [Roberts, M. E.; Harder, K. W.] Univ British Columbia, Dept Microbiol & Immunol, Fac Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Zoubeidi, A (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Dept Urol, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	azoubeidi@prostatecentre.com	Gregory-Evans, Cheryl Y/G-9550-2011; Ketola, Kirsi/O-1071-2016	Ketola, Kirsi/0000-0001-6484-9861; Roberts, Morgan/0000-0002-5850-7985	Terry Fox Research Institute; Prostate Cancer Canada; Canadian Institutes of Health Research; Michael Smith Foundation	Terry Fox Research Institute; Prostate Cancer Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research)	This work was supported by the Terry Fox Research Institute, Michael Smith Foundation, Prostate Cancer Canada and Canadian Institutes of Health Research. We would like to thank Dr Peter Black for the UC13 and UC13-luciferase cells, and Dr Yuzhou Wang for Oncomine access. We also appreciate the assistance of Eliana Beraldi and Shannon Awery for experimental support.	Bates RC, 2001, CANCER RES, V61, P5275; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bougeret C, 2001, J BIOL CHEM, V276, P33711, DOI 10.1074/jbc.M104209200; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Cordonnier T, 2015, INT J CANCER, V136, pE496, DOI 10.1002/ijc.29122; De Mesquita DD, 2001, FEBS LETT, V502, P84, DOI 10.1016/S0014-5793(01)02669-2; Delaney MK, 2012, ARTERIOSCL THROM VAS, V32, P2761, DOI 10.1161/ATVBAHA.112.254920; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gelman IH, 2014, MOL CANCER RES, V12, P1470, DOI 10.1158/1541-7786.MCR-13-0490-T; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guan H, 2008, MOL CANCER THER, V7, P1807, DOI 10.1158/1535-7163.MCT-08-0058; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; HIBBS ML, 1995, GENE, V156, P175, DOI 10.1016/0378-1119(95)00022-X; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Jager W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059536; Kantarjian H, 2010, CANCER-AM CANCER SOC, V116, P2665, DOI 10.1002/cncr.25079; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kim JY, 2012, FEBS J, V279, P2929, DOI 10.1111/j.1742-4658.2012.08674.x; Kim J, 2014, EMBO REP, V15, P1062, DOI 10.15252/embr.201438587; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Maness PF, 1996, PERSPECT DEV NEUROBI, V4, P169; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Modlich O, 2004, CLIN CANCER RES, V10, P3410, DOI 10.1158/1078-0432.CCR-03-0134; OPPERMANN H, 1979, P NATL ACAD SCI USA, V76, P1804, DOI 10.1073/pnas.76.4.1804; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pecina-Slaus N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-17; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rahaman SO, 2011, J BIOL CHEM, V286, P7010, DOI 10.1074/jbc.M110.192450; Ren XP, 2002, CANCER BIOL THER, V1, P703, DOI 10.4161/cbt.323; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Stettner AR, 2005, CANCER RES, V65, P5535, DOI 10.1158/0008-5472.CAN-04-3688; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Tabaries S, 2015, ONCOTARGET, V6, P9476, DOI 10.18632/oncotarget.3269; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Teng Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-453; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yazawa N, 2003, BLOOD, V102, P1374, DOI 10.1182/blood-2002-11-3573; Yokota A, 2007, BLOOD, V109, P306, DOI 10.1182/blood-2006-03-013250; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zardan A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.30; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	66	25	26	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 13	2017	36	28					3964	3975		10.1038/onc.2017.5	http://dx.doi.org/10.1038/onc.2017.5			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FA3YD	28288135				2022-12-26	WOS:000405379900003
J	Chauhan, AS; Kumar, M; Chaudhary, S; Patidar, A; Dhiman, A; Sheokand, N; Malhotra, H; Raje, CI; Raje, M				Chauhan, Anoop Singh; Kumar, Manoj; Chaudhary, Surbhi; Patidar, Anil; Dhiman, Asmita; Sheokand, Navdeep; Malhotra, Himanshu; Raje, Chaaya Iyengar; Raje, Manoj			Moonlighting glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH): an evolutionarily conserved plasminogen receptor on mammalian cells	FASEB JOURNAL			English	Article						cell migration; inflammation; multifunctional protein; plasmin; urokinase activator receptor	EXTRACELLULAR-MATRIX; MACROPHAGE-MIGRATION; TRANSFERRIN RECEPTOR; SURFACE; IRON; BINDING; S100A10; LACTOFERRIN; ACTIVATION; MECHANISMS	Prokaryotic pathogens establish infection in mammals by capturing the proteolytic enzyme plasminogen (Plg) onto their surface to digest host extracellular matrix (ECM). One of the bacterial surface Plg receptors is the multifunctional glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In a defensive response, the host mounts an inflammatory response, which involves infiltration of leukocytes to sites of inflammation. This requires macrophage exit from the blood and migration across basement membranes, a phenomenon dependent on proteolytic remodeling of the ECM utilizing Plg. The ability of Plg to facilitate inflammatory cell recruitment critically depends on receptors on the surface of phagocyte cells. Utilizing a combination of biochemical, cellular, knockdown, and in vivo approaches, we demonstrated that upon inflammation, macrophages recruit GAPDH onto their surface to carry out the same task of capturing Plg to digest ECM to aid rapid phagocyte migration and combat the invading pathogens. We propose that GAPDH is an ancient, evolutionarily conserved receptor that plays a key role in the Plg-dependent regulation of macrophage recruitment in the inflammatory response to microbial aggression, thus pitting prokaryotic GAPDH against mammalian GAPDH, with both involved in a conserved role of Plg activation on the surface of their respective cells, to conflicting ends.	[Chauhan, Anoop Singh; Kumar, Manoj; Chaudhary, Surbhi; Patidar, Anil; Dhiman, Asmita; Sheokand, Navdeep; Malhotra, Himanshu; Raje, Manoj] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India; [Raje, Chaaya Iyengar] Natl Inst Pharmaceut Educ & Res, Sahibzada Ajit Singh Nag, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Raje, M (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	manoj@imtech.res.in	Chauhan, Anoop/GYD-7325-2022; Raje, Chaaya Iyengar/AAU-2651-2021; Malik, Navdeep/AAU-3303-2020; Malik, Navdeep/V-9125-2019	Chauhan, Anoop/0000-0001-8722-2404; Malik, Navdeep/0000-0003-1113-2562; KUMAR, MANOJ/0000-0001-6934-2103; Chaudhary, Surbhi/0000-0002-7457-7166; , Asmita/0000-0002-6415-6819; Iyengar, Chaaya/0000-0003-4434-0536	Department of Biotechnology (DBT; Ministry of Science and Technology of India); Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC; New Delhi, India); CSIR; Department of Science and Technology of India (DST)	Department of Biotechnology (DBT; Ministry of Science and Technology of India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC; New Delhi, India)(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology of India (DST)(Department of Science & Technology (India))	A. Theophilus and R. Sharma (Institute of Microbial Technology) are acknowledged for technical assistance. A.S.C. and A.P. received fellowships from the Department of Biotechnology (DBT; Ministry of Science and Technology of India). N.S. and M.K. received financial support from the Council of Scientific and Industrial Research (CSIR), and H.M. and S.C. received fellowships from the University Grants Commission (UGC; New Delhi, India). The financial support of CSIR and the Department of Science and Technology of India (DST) is acknowledged. This article is Institute of Microbial Technology (IMTECH) communication 060/2016.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Boradia VM, 2014, BIOCHEM SOC T, V42, P1796, DOI 10.1042/BST20140220; Boradia VM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5730; Bugge TH, 1997, BLOOD, V90, P4522; Chauhan AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep18465; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Didiasova M, 2014, INT J MOL SCI, V15, P21229, DOI 10.3390/ijms151121229; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; HALL SW, 1991, J BIOL CHEM, V266, P12329; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones AL, 2004, J BIOL CHEM, V279, P38267, DOI 10.1074/jbc.M406027200; Kumar S, 2012, INT J BIOCHEM CELL B, V44, P189, DOI 10.1016/j.biocel.2011.10.016; Lighvani S, 2011, BLOOD, V118, P5622, DOI 10.1182/blood-2011-03-344242; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Miles LA, 2013, SEMIN THROMB HEMOST, V39, P329, DOI 10.1055/s-0033-1334483; Modun B, 2000, TRENDS MICROBIOL, V8, P231, DOI 10.1016/S0966-842X(00)01728-5; O'Connell PA, 2010, BLOOD, V116, P1136, DOI 10.1182/blood-2010-01-264754; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Phipps KD, 2011, CANCER RES, V71, P6676, DOI 10.1158/0008-5472.CAN-11-1748; Ploplis VA, 1998, BLOOD, V91, P2005, DOI 10.1182/blood.V91.6.2005.2005_2005_2009; Plow E. F., 2012, J BIOMED BIOTECHNOL, V2012, P1, DOI DOI 10.1155/2012/141806.141806; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; Ranson M, 1998, BRIT J CANCER, V77, P1586, DOI 10.1038/bjc.1998.261; Rawat P, 2012, BIOCHEM CELL BIOL, V90, P329, DOI [10.1139/O11-058, 10.1139/o11-058]; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Seidler NW, 2012, GAPDH BIOL PROPERTIE; Sheokand N, 2014, J CELL SCI, V127, P4279, DOI 10.1242/jcs.154005; Sheokand N, 2013, BBA-GEN SUBJECTS, V1830, P3816, DOI 10.1016/j.bbagen.2013.03.019; Shibuya A, 2002, HEPATOL RES, V22, P174, DOI 10.1016/S1386-6346(01)00134-6; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; WUN TC, 1988, CRIT REV BIOTECHNOL, V8, P131, DOI 10.3109/07388558809150542; Zhang LB, 2004, J BIOL CHEM, V279, P2053, DOI 10.1074/jbc.M310357200	47	23	23	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2638	2648		10.1096/fj.201600982R	http://dx.doi.org/10.1096/fj.201600982R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28298336				2022-12-26	WOS:000401553400034
J	Ahmed, S; Shrivastava, T; Kumar, N; Ozorowski, G; Ward, AB; Chakrabarti, BK				Ahmed, Shubbir; Shrivastava, Tripti; Kumar, Naresh; Ozorowski, Gabriel; Ward, Andrew B.; Chakrabarti, Bimal K.			Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; ENV TRIMERS; DEPENDENT EPITOPE; DESIGN; VACCINE; GP120; RECOGNITION; STRATEGIES	Designing an effective HIV-1 envelope glycoprotein (Env) immunogen for elicitation of broadly neutralizing antibodies (bNAbs) is a challenging task because of the high sequence diversity, heavy glycosylation, and inherent meta-stability of Env. Based on the antigenic profile of recently isolated bNAbs, the rational approach to immunogen design is to make a stable version of the Env trimer, which mimics the native trimeric Env present on the viral surface. The SOSIP. 664 form of a clade A Env, BG505, yields a homogeneous and well ordered prefusion trimeric form, which maintains structural integrity and desired antigenicity. Following the same approach, we attempted to stabilize a naturally occurring efficiently cleaved clade C Env, namely 4-2.J41, isolated from an Indian patient. Although the SOSIP form of 4-2.J41 failed to produce reasonably well ordered trimers, the 4-2.J41. SOSIP. 664 Env could be stabilized in a native-like trimeric form by swapping a domain from BG505 Env to 4-2.J41 Env. Using various biochemical and biophysical means we confirmed that this engineered Env is cleaved, trimeric, and it retains its native-like quaternary conformation exposing mostly broadly neutralizing epitopes. Moreover, introduction of a disulfide bond in the bridging sheet region further stabilized the closed conformation of the Env. Thus, our 4-2.J41. SOSIP. 664 Env adds to the increasing pool of potential immunogens for a HIV-1 vaccine, particularly for clade C, which is the most prevalent in India and many other countries. Besides, the approach used to stabilize the 4-2.J41 Env may be used successfully with Envs from other HIV-1 strains as well. Additionally, a soluble native trimeric form of an efficiently cleaved membrane-bound Env, 4-2.J41, may be beneficial for immunization studies using various prime-boost strategies.	[Ahmed, Shubbir; Shrivastava, Tripti; Kumar, Naresh; Chakrabarti, Bimal K.] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, HIV Vaccine Translat Res Lab, Faridabad 121001, Haryana, India; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Int AIDS Vaccine Initiat, Neutralizing Antibody Ctr, Dept Integrat Struct & Computat Biol,Ctr HIV AIDS, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Chakrabarti, Bimal K.] Int AIDS Vaccine Initiat, New York, NY 10004 USA	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative	Ahmed, S; Chakrabarti, BK (corresponding author), NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, HIV Vaccine Translat Res Lab, Faridabad 121001, Haryana, India.	sahmed@thsti.res.in; bchakrabarti@iavi.org	Ahmed, Shubbir/AAC-4289-2019; Ward, Andrew B/F-9203-2014; Ozorowski, Gabriel/HCH-0634-2022; Ward, Andrew/ABD-7728-2021	Ahmed, Shubbir/0000-0003-1655-6735; Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769	Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation CAVD Grants [OPP1115782, OPP1084519]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation CAVD Grants	The work at IAVI was made possible by generous support from many donors including the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid; the Ministry of Finance of Japan, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. The electron microscopy studies were supported by the International AIDS Vaccine Initiative, and Bill and Melinda Gates Foundation CAVD Grants OPP1115782 and OPP1084519. We thank the Neutralizing Antibody Consortium and the NIH AIDS Research and Reference Reagent Program for providing monoclonal antibodies and sCD4. We also thank Dr. Jayanta Bhattacharya, Dr. Supratik Das, and Dr. Rajesh Kumar for helpful discussions.	Benjelloun F, 2012, J VIROL, V86, P13152, DOI 10.1128/JVI.01110-12; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Boliar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122443; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Center RJ, 2004, J VIROL, V78, P2265, DOI 10.1128/JVI.78.5.2265-2276.2004; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Dey AK, 2007, VIROLOGY, V360, P199, DOI 10.1016/j.virol.2006.09.046; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005767; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klasse PJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005864; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mann JK, 2015, VIROL J, V12, DOI 10.1186/s12985-014-0221-0; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41	39	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8236	8243		10.1074/jbc.M117.776419	http://dx.doi.org/10.1074/jbc.M117.776419			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28283570	hybrid, Green Published			2022-12-26	WOS:000401788600010
J	Zuo, RJ; Liu, XH; Wang, WS; Li, WJ; Ying, H; Sun, K				Zuo, Rujuan; Liu, Xiaohui; Wang, Wangsheng; Li, Wenjiao; Ying, Hao; Sun, Kang			A repressive role of enhancer of zeste homolog 2 in 11 beta-hydroxysteroid dehydrogenase type 2 expression in the human placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E2F transcription factor; glucocorticoid; histone methylation; histone modification; placenta; trophoblast; 11-hydroxysteroid dehydrogenase 2; EZH2; fetal development	11-BETA-HSD2 EXPRESSION; EPIGENETIC REGULATION; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; METHYLATION; TROPHOBLAST; INHIBITION; EZH2; GLUCOCORTICOIDS; ACETYLATION	The expression of 11-hydroxysteroid dehydrogenase type 2 (11-HSD2), which acts as a placental glucocorticoid barrier, is silenced in cytotrophoblasts but substantially up-regulated during syncytialization. However, the repressive mechanism of 11-HSD2 expression before syncytialization and how this repression is lifted during syncytialization remain mostly unresolved. Here we found that enhancer of zeste homolog 2 (EZH2) accounts for the silence of 11-HSD2 expression via trimethylation of histone H3 lysine 27 at the promoter of the 11-HSD2 gene. Further studies revealed that, upon syncytialization, human chorionic gonadotropin reduced the phosphorylation of retinoblastoma protein (pRB) via activation of the cAMP/PKA pathway, which sequesters E2F transcription factor 1 (E2F1), the transcription factor for EZH2 expression. As a result of inactivation of the pRB-E2F1-EZH2 pathway, the repressive marker trimethylation of histone H3 lysine 27 at the 11-HSD2 promoter is removed, which leads to the robust expression of 11-HSD2 during syncytialization.	[Zuo, Rujuan; Wang, Wangsheng; Li, Wenjiao; Sun, Kang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China; [Zuo, Rujuan; Wang, Wangsheng; Li, Wenjiao; Sun, Kang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China; [Liu, Xiaohui; Ying, Hao] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Shanghai 200135, Peoples R China	Shanghai Jiao Tong University; Tongji University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China.; Sun, K (corresponding author), Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China.	sungangrenji@hotmail.com	Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Zuo, Rujuan/0000-0003-3060-2179	National Natural Science Foundation of China [31671566, 81330018, 81601286]; National Key Basic Research Program of China [2014CB943302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31671566, 81330018, and 81601286 and National Key Basic Research Program of China Grant 2014CB943302. The authors declare that they have no conflicts of interest with the contents of this article.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Conradt E, 2013, EPIGENETICS-US, V8, P1321, DOI 10.4161/epi.26634; Costa MA, 2016, MOL CELL ENDOCRINOL, V420, P180, DOI 10.1016/j.mce.2015.11.010; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fogarty NME, 2015, PLACENTA, V36, P796, DOI 10.1016/j.placenta.2015.05.006; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gundisch S, 2012, ANTICANCER RES, V32, P4251; Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Hunkapiller J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002576; Huppertz Berthold, 2008, V475, P135, DOI 10.1007/978-1-59745-250-2_8; Jensen Pena Catherine, 2012, PLoS One, V7, pe39791, DOI 10.1371/journal.pone.0039791; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Li JN, 2011, J CLIN ENDOCR METAB, V96, pE899, DOI 10.1210/jc.2010-2852; Li JN, 2013, J CLIN ENDOCR METAB, V98, pE1189, DOI 10.1210/jc.2012-4291; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Naderi S, 2005, MOL BIOL CELL, V16, P1527, DOI 10.1091/mbc.E04-06-0501; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; Ni XT, 2009, PLACENTA, V30, P1023, DOI 10.1016/j.placenta.2009.10.005; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Rugg-Gunn PJ, 2012, REPROD BIOMED ONLINE, V25, P21, DOI 10.1016/j.rbmo.2012.01.012; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Sun K, 1997, J CLIN ENDOCR METAB, V82, P300, DOI 10.1210/jc.82.1.300; Togher KL, 2014, EPIGENETICS-US, V9, P816, DOI 10.4161/epi.28703; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang WS, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6151; Ward AC, 1996, BIOCHEM BIOPH RES CO, V224, P10, DOI 10.1006/bbrc.1996.0976; Weedon-Fekjraer MS, 2012, PLACENTA, V33, pS87, DOI 10.1016/j.placenta.2011.11.003; Williamson EA, 1997, LEUKEMIA, V11, P73, DOI 10.1038/sj.leu.2400551; Zhang N, 2015, J CLIN ENDOCR METAB, V100, pE542, DOI 10.1210/jc.2014-4376; Zhao Y, 2014, EUR J HUM GENET, V22, P734, DOI 10.1038/ejhg.2013.226; Zuo RJ, 2015, J BIOL CHEM, V290, P21280, DOI 10.1074/jbc.M115.656629	39	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7578	7587		10.1074/jbc.M116.765800	http://dx.doi.org/10.1074/jbc.M116.765800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28302719	hybrid, Green Published			2022-12-26	WOS:000400761300025
J	McMahon, LA; Rachlow, JL; Shipley, LA; Forbey, JS; Johnson, TR; Olsoy, PJ				McMahon, Laura A.; Rachlow, Janet L.; Shipley, Lisa A.; Forbey, Jennifer S.; Johnson, Timothy R.; Olsoy, Peter J.			Evaluation of micro-GPS receivers for tracking small-bodied mammals	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; ACTIVITY PATTERNS; HABITAT USE; THERMAL ENVIRONMENT; COLLAR PERFORMANCE; HOME-RANGE; 3 BRANDS; TELEMETRY; MOVEMENT; TEMPERATURE	GPS telemetry markedly enhances the temporal and spatial resolution of animal location data, and recent advances in micro-GPS receivers permit their deployment on small mammals. One such technological advance, snapshot technology, allows for improved battery life by reducing the time to first fix via postponing recovery of satellite ephemeris (satellite location) data and processing of locations. However, no previous work has employed snapshot technology for small, terrestrial mammals. We evaluated performance of two types of micro-GPS (< 20 g) receivers (traditional and snapshot) on a small, semi-fossorial lagomorph, the pygmy rabbit (Brachylagus idahoensis), to understand how GPS errors might influence fine-scale assessments of space use and habitat selection. During stationary tests, microtopography (i. e., burrows) and satellite geometry had the largest influence on GPS fix success rate (FSR) and location error (LE). There was no difference between FSR while animals wore the GPS collars above ground (determined via light sensors) and FSR generated during stationary, above-ground trials, suggesting that animal behavior other than burrowing did not markedly influence micro-GPS errors. In our study, traditional micro-GPS receivers demonstrated similar FSR and LE to snapshot receivers, however, snapshot receivers operated inconsistently due to battery and software failures. In contrast, the initial traditional receivers deployed on animals experienced some breakages, but a modified collar design consistently functioned as expected. If such problems were resolved, snapshot technology could reduce the tradeoff between fix interval and battery life that occurs with traditional micro-GPS receivers. Our results suggest that micro-GPS receivers are capable of addressing questions about space use and resource selection by small mammals, but that additional techniques might be needed to identify use of habitat structures (e. g., burrows, tree cavities, rock crevices) that could affect micro-GPS performance and bias study results.	[McMahon, Laura A.; Rachlow, Janet L.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Shipley, Lisa A.; Olsoy, Peter J.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Forbey, Jennifer S.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Johnson, Timothy R.] Univ Idaho, Dept Stat Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; Washington State University; Idaho; Boise State University; Idaho; University of Idaho	McMahon, LA (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	mcma2967@vandals.uidaho.edu		Sorensen Forbey, Jennifer/0000-0001-6069-4049; Olsoy, Peter/0000-0002-8785-0459	National Science Foundation [DEB-1146166, DEB-1146368, DEB-1146194]; Berklund Graduate Assistantship; University of Idaho; Bureau of Land Management; US Forest Service; Division Of Environmental Biology [1146194, 1146166] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Berklund Graduate Assistantship; University of Idaho; Bureau of Land Management; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding and other support was provided by the National Science Foundation (DEB-1146166 to JLR, DEB-1146368 to LAS, DEB-1146194 to JSF), Berklund Graduate Assistantship, University of Idaho, Bureau of Land Management, and US Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065763; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BLACKBURN TM, 1994, OIKOS, V70, P127, DOI 10.2307/3545707; Blackie HM, 2010, J WILDLIFE MANAGE, V74, P1911, DOI 10.2193/2009-412; Booth DT, 2006, ENVIRON MONIT ASSESS, V123, P97, DOI 10.1007/s10661-005-9164-7; Bowman JL, 2000, WILDLIFE SOC B, V28, P141; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Brown DD, 2012, WILDLIFE SOC B, V36, P139, DOI 10.1002/wsb.111; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; CEDERLUND GN, 1988, J WILDLIFE MANAGE, V52, P336, DOI 10.2307/3801246; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Dussault C, 2001, WILDLIFE SOC B, V29, P171; Feierabend D, 2014, J MAMMAL, V95, P525, DOI 10.1644/13-MAMM-A-199; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Glasby L, 2013, EUR J WILDLIFE RES, V59, P915, DOI 10.1007/s10344-013-0770-3; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; GREEN J S, 1980, Mammalian Species, P1, DOI 10.2307/3503856; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Long RA, 2005, J MAMMAL, V86, P314, DOI 10.1644/BRG-224.1; Moen R, 1997, J WILDLIFE MANAGE, V61, P530, DOI 10.2307/3802612; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Moriarty KM, 2015, WILDLIFE SOC B, V39, P349, DOI 10.1002/wsb.524; Murray IW, 2012, CAN J ZOOL, V90, P1171, DOI 10.1139/Z2012-084; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Parsons MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1334; R Development Core Team, 2015, R LANG ENV STAT COMP; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Recio MR, 2010, NEW ZEAL J ECOL, V34, P288; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Sanchez DM, 2008, J WILDLIFE MANAGE, V72, P1304, DOI 10.2193/2007-225; Sanchez DM, 2007, PROQUEST; Sharpe PB, 1999, J THERM BIOL, V24, P265, DOI 10.1016/S0306-4565(99)00021-2; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Stevenson CD, 2013, ECOL EVOL, V3, P2350, DOI 10.1002/ece3.638; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Tobler MW, 2009, J TROP ECOL, V25, P217, DOI 10.1017/S0266467409005811; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Tsoar Asaf, 2011, Proc Natl Acad Sci U S A, V108, pE718, DOI 10.1073/pnas.1107365108; Visscher DR, 2006, ECOGRAPHY, V29, P458; WILSON D. E., 1996, MEASURING MONITORING	51	12	13	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173185	10.1371/journal.pone.0173185	http://dx.doi.org/10.1371/journal.pone.0173185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301495	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300027
J	Qu, XZ; Sheng, JY; Shen, LY; Su, J; Xu, YJ; Xie, Q; Wu, Y; Zhang, XW; Sun, LK				Qu, Xianzhi; Sheng, Jiyao; Shen, Luyan; Su, Jing; Xu, Yunjie; Xie, Qi; Wu, Yao; Zhang, Xuewen; Sun, Liankun			Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; LUNG-CANCER CELLS; OXIDATIVE STRESS; GLUCOSE-METABOLISM; RESISTANCE; ACTIVATION; GROWTH; DEATH; DEGRADATION; INDUCTION	The tumor cells have some metabolic characteristics of the original tissues, and the metabolism of the tumor cells is closely related to autophagy. However, the mechanism of autophagy and metabolism in chemotherapeutic drug resistance is still poorly understood. In this study, we investigated the role and mechanism of autophagy and glucose metabolism in chemotherapeutic drug resistance by using cholangiocarcinoma QBC939 cells with primary cisplatin resistance and hepatocellular carcinoma HepG2 cells. We found that QBC939 cells with cisplatin resistance had a higher capacity for glucose uptake, consumption, and lactic acid generation, and higher activity of the pentose phosphate pathway compared with HepG2 cells, and the activity of PPP was further increased after cisplatin treatment in QBC939 cells. It is suggested that there are some differences in the metabolism of glucose in hepatocellular carcinoma and cholangiocarcinoma cells, and the activation of PPP pathway may be related to the drug resistance. Through the detection of autophagy substrates p62 and LC3, found that QBC939 cells have a higher flow of autophagy, autophagy inhibitor chloroquine can significantly increase the sensitivity of cisplatin in cholangiocarcinoma cells compared with hepatocellular carcinoma HepG2 cells. The mechanism may be related to the inhibition of QBC939 cells with higher activity of the PPP, the key enzyme G6PDH, which reduces the antioxidant capacity of cells and increases intracellular ROS, especially mitochondrial ROS. Therefore, we hypothesized that autophagy and the oxidative stress resistance mediated by glucose metabolism may be one of the causes of cisplatin resistance in cholangiocarcinoma cells. It is suggested that according to the metabolism characteristics of tumor cells, inhibition of autophagy lysosome pathway with chloroquine may be a new route for therapeutic agents against cholangiocarcinoma.	[Qu, Xianzhi; Sheng, Jiyao; Zhang, Xuewen] Jilin Univ, Hosp 2, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China; [Shen, Luyan; Su, Jing; Xu, Yunjie; Xie, Qi; Wu, Yao; Sun, Liankun] Jilin Univ, Sch Basic Med Sci, Dept Pathophysiol, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Zhang, XW (corresponding author), Jilin Univ, Hosp 2, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China.; Sun, LK (corresponding author), Jilin Univ, Sch Basic Med Sci, Dept Pathophysiol, Changchun, Jilin, Peoples R China.	zxw515@sohu.com; sunlk@jlu.edu.cn			National Natural Science Foundation of China [81202552, 81472419, 81272876]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	J. Su (National Natural Science Foundation of China, Grant number: 81202552, http://www.nsfc.gov.cn/) took part in making decision to publish; L. Sun (National Natural Science Foundation of China, Grant number: 81472419, 81272876, http://www.nsfc.gov.cn/) took part in making decision to publish, preparing the manuscript and study design.	Catanzaro D, 2015, ONCOTARGET; Chen JL, 2015, CANCER CHEMOTH PHARM, V75, P1217, DOI 10.1007/s00280-015-2739-2; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09925; Chen Y, 2015, J MOL NEUROSCI, V55, P126, DOI 10.1007/s12031-014-0385-5; Desideri E, 2014, AUTOPHAGY, V10, P1652, DOI 10.4161/auto.29456; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Fan CD, 2006, BIOORGAN MED CHEM, V14, P3218, DOI 10.1016/j.bmc.2005.12.035; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Ganguli A, 2014, BIOCHIMIE, V107, P338, DOI 10.1016/j.biochi.2014.10.001; Glasauer A, 2014, BIOCHEM PHARMACOL, V92, P90, DOI 10.1016/j.bcp.2014.07.017; GORDON G, 1995, ARCH BIOCHEM BIOPHYS, V318, P25, DOI 10.1006/abbi.1995.1199; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hou YJ, 2011, LAB INVEST, V91, P1146, DOI 10.1038/labinvest.2011.97; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Lee SW, 2015, CANCER LETT, V360, P195, DOI 10.1016/j.canlet.2015.02.012; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y; Likhitrattanapisal S, 2016, TUMOR BIOL, V37, P12755, DOI 10.1007/s13277-016-5186-8; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Sinthupibulyakit C, 2010, INT J ONCOL, V37, P1575, DOI 10.3892/ijo_00000811; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tai DJ, 2012, EXP THER MED, V4, P291, DOI 10.3892/etm.2012.591; Venmar KT, 2015, BBA-MOL CELL RES, V1853, P1219, DOI 10.1016/j.bbamcr.2015.02.020; Wu YC, 2010, NEUROCHEM INT, V57, P198, DOI 10.1016/j.neuint.2010.05.008; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Xiong N, 2011, NEUROSCIENCE, V199, P292, DOI 10.1016/j.neuroscience.2011.10.031; YEH GC, 1987, CANCER RES, V47, P5994; Yoon H, 2012, CANCER LETT, V316, P70, DOI 10.1016/j.canlet.2011.10.024; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101	39	49	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173712	10.1371/journal.pone.0173712	http://dx.doi.org/10.1371/journal.pone.0173712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301876	gold, Green Submitted, Green Published			2022-12-26	WOS:000396318300065
J	Gan, S; Zakaria, S; Chia, CH; Chen, RS; Ellis, AV; Kaco, H				Gan, Sinyee; Zakaria, Sarani; Chia, Chin Hua; Chen, Ruey Shan; Ellis, Amanda V.; Kaco, Hatika			Highly porous regenerated cellulose hydrogel and aerogel prepared from hydrothermal synthesized cellulose carbamate	PLOS ONE			English	Article								Here, a stable derivative of cellulose, called cellulose carbamate (CC), was produced from Kenaf (Hibiscus cannabinus) core pulp (KCP) and urea with the aid of a hydrothermal method. Further investigation was carried out for the amount of nitrogen yielded in CC as different urea concentrations were applied to react with cellulose. The effect of nitrogen concentration of CC on its solubility in a urea-alkaline system was also studied. Regenerated cellulose products (hydrogels and aerogels) were fabricated through the rapid dissolution of CC in a urea-alkaline system. The morphology of the regenerated cellulose products was viewed under Field emission scanning electron microscope (FESEM). The transformation of allomorphs in regenerated cellulose products was examined by X-ray diffraction (XRD). The transparency of regenerated cellulose products was determined by Ultraviolet-visible (UV-Vis) spectrophotometer. The degree of swelling (DS) of regenerated cellulose products was also evaluated. This investigation provides a simple and efficient procedure of CC determination which is useful in producing regenerated CC products.	[Gan, Sinyee; Zakaria, Sarani; Chia, Chin Hua; Chen, Ruey Shan; Kaco, Hatika] Univ Kebangsaan Malaysia, Sch Appl Phys, Fac Sci & Technol, Bangi, Selangor, Malaysia; [Ellis, Amanda V.] Univ Melbourne, Dept Chem Engn, Parkville, Vic, Australia	Universiti Kebangsaan Malaysia; University of Melbourne	Gan, S; Zakaria, S (corresponding author), Univ Kebangsaan Malaysia, Sch Appl Phys, Fac Sci & Technol, Bangi, Selangor, Malaysia.	gansinyee@ukm.edu.my; szakaria@ukm.edu.my	zakaria, sarani/D-6099-2018; Chen, Ruey Shan/C-7376-2017; Chia, Chin-hua/I-7261-2013; YEE, GAN SIN/Q-6347-2018; Ellis, Amanda V/AAD-3450-2019	Chen, Ruey Shan/0000-0002-2713-942X; Chia, Chin-hua/0000-0002-5269-4070; YEE, GAN SIN/0000-0003-2411-4611; Ellis, Amanda V/0000-0002-0053-5641; Zakaria, Sarani/0000-0002-5981-0986	Universiti Kebangsaan Malaysia (UKM) [AP-2015-005, DIP-2016-004, LRGS/TD/2012/USM-UKM/PT/04]; Ministry of Higher Education Malaysia	Universiti Kebangsaan Malaysia (UKM); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	The authors thank Universiti Kebangsaan Malaysia (UKM) for the financial support via the research Project Grants AP-2015-005, DIP-2016-004, LRGS/TD/2012/USM-UKM/PT/04 and the Ministry of Higher Education Malaysia for MyBrain15-MyMaster Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Universiti Kebangsaan Malaysia (UKM) for the financial support via the research Project Grants AP-2015-005, DIP-2016-004, LRGS/TD/2012/USM-UKM/PT/04 and the Ministry of Higher Education Malaysia for MyBrainl5-MyMaster Scholarship. The authors are also thankful to the Centre for Research and Instrumentation Management (CRIM) at UKM for providing the XRD and FESEM testing.	Ahmed EM., 2013, J ADV RES, P17; Cai J, 2008, CHEMSUSCHEM, V1, P149, DOI 10.1002/cssc.200700039; Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023; Chang CY, 2009, POLYMER, V50, P5467, DOI 10.1016/j.polymer.2009.06.001; Ding ZD, 2012, CARBOHYD POLYM, V89, P7, DOI 10.1016/j.carbpol.2012.01.080; Dong H, 2013, CARBOHYD POLYM, V95, P760, DOI 10.1016/j.carbpol.2013.03.041; Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696; Fu FY, 2015, ACS SUSTAIN CHEM ENG, V3, P1510, DOI 10.1021/acssuschemeng.5b00219; Fu YJ, 2017, BIORESOURCES, V12, P992, DOI 10.15376/biores.12.1.992-1006; Gan S, 2016, BIORESOURCES, V11, P126; Gan S, 2015, CELLULOSE, V22, P3851, DOI 10.1007/s10570-015-0749-1; Gan S, 2015, BIORESOURCES, V10, P2244, DOI 10.15376/biores.10.2.2244-2255; Gan S, 2014, CARBOHYD POLYM, V106, P160, DOI 10.1016/j.carbpol.2014.01.076; Ganji F, 2010, IRAN POLYM J, V19, P375; Glasser W. G., 2008, TOP CURR CHEM, V1473; Guo Y, 2010, CELLULOSE, V17, P1115, DOI 10.1007/s10570-010-9446-2; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Klemm D., 2005, CELLULOSE BIOPOLYMER; Kotek R., 2006, HDB FIBER CHEM, P668; Ma AAMA, 2000, POLYM DEGRAD STABIL, V70, P347; OLSSON C, 2013, CELLULOSE FUNDAMENTA; Padzil FNM, 2015, CARBOHYD POLYM, V124, P164, DOI 10.1016/j.carbpol.2015.02.013; Paunonen S., 2013, STRENGTH BARRIER ENH; Pinnow M, 2008, MACROMOL SYMP, V262, P129, DOI 10.1002/masy.200850213; Qiu XY, 2013, MATERIALS, V6, P738, DOI 10.3390/ma6030738; Shen XD, 2005, POLYM BULL, V55, P317, DOI 10.1007/s00289-005-0442-x; Vo LTT, 2010, CARBOHYD POLYM, V82, P1191, DOI 10.1016/j.carbpol.2010.06.052; Wang Y, 2008, CELLULOSE FIBER DISS; Wong SS, 2009, CARBOHYD POLYM, V77, P280, DOI 10.1016/j.carbpol.2008.12.038; Yin CY, 2007, EUR POLYM J, V43, P2111, DOI 10.1016/j.eurpolymj.2007.01.041; Yin CY, 2007, CARBOHYD POLYM, V67, P147, DOI 10.1016/j.carbpol.2006.05.010; Zhang JX, 2010, CARBOHYD POLYM, V79, P164, DOI 10.1016/j.carbpol.2009.07.038	32	32	33	7	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173743	10.1371/journal.pone.0173743	http://dx.doi.org/10.1371/journal.pone.0173743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296977	gold, Green Published			2022-12-26	WOS:000396311700054
J	Lashkari, BS; Anumba, DOC				Lashkari, Behnia S.; Anumba, Dilly O. C.			Estradiol alters the immune-responsiveness of cervical epithelial cells stimulated with ligands of Toll-like receptors 2 and 4	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; ESTROGEN-RECEPTORS; EXPRESSION; INNATE; LIPOPOLYSACCHARIDE; RECOGNITION; DEFENSINS; INFECTION; CYTOKINES; RESPONSES	The mucosa of the female reproductive tract plays a pivotal role in host defence. Pregnancy must alter immunological mechanisms at this interface to protect the conceptus. We sought to determine how estradiol (E-2) alters the immune-responsiveness of cervical epithelial cells to ligand stimulation of Toll-like receptor (TLR)-2 and -4. Human ectocervical epithelial cells (HECECs) were cultured and co-incubated with two concentrations of E-2 and peptidoglycan (PGN) or lipopolysaccharide (LPS) over durations that ranged between 10 minutes and 18 hours. Cytometric Bead Array was performed to quantify eight cytokines in the supernatant fluid. In response to PGN, HECECs co-incubated with E-2 released lesser quantities of IL-1 beta and IFN gamma, higher levels of RANTES, and variable levels of IL-6 and IL-8 than those not exposed to E-2. In contrast, HECECs co-incubated with LPS and E-2 secreted increased levels of IL-1 beta, IL-6, IL-8, and IFN gamma at 2 and 18 hours than HECECs not exposed to E-2, and reduced levels of RANTES at same study time-points. Estradiol alters the immune-responsiveness of cultured HECECs to TLR2 and TLR4 ligands in a complex fashion that appears to vary with bacterial ligand, TLR subtype, and duration of exposure. Our observations are consistent with the functional complexity that this mucosal interface requires for its immunological roles.	[Lashkari, Behnia S.; Anumba, Dilly O. C.] Univ Sheffield, Dept Human Metab, Acad Unit Reprod & Dev Med, Jessop Wing, Sheffield, S Yorkshire, England; [Lashkari, Behnia S.] Univ British Columbia, Dept Pathol & Lab Med, Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada	University of Sheffield; University of British Columbia	Anumba, DOC (corresponding author), Univ Sheffield, Dept Human Metab, Acad Unit Reprod & Dev Med, Jessop Wing, Sheffield, S Yorkshire, England.	d.o.c.anumba@sheffield.ac.uk	Professor Dilly Anumba MBBS, FWACS/A-6358-2011	Professor Dilly Anumba MBBS, FWACS/0000-0003-2502-3033				Abrahams VM, 2013, AM J REPROD IMMUNOL, V69, P33, DOI 10.1111/aji.12016; Aflatoonian R, 2007, HUM REPROD, V22, P586, DOI 10.1093/humrep/del388; Agrawal T, 2013, BRIT J BIOMED SCI, V70, P51, DOI 10.1080/09674845.2013.11669935; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; [Anonymous], 2014, IMMUNOHISTOCHEMICAL; Arslan SY, 2015, ENDOCRINOLOGY, V156, P1602, DOI 10.1210/en.2014-1840; Boesch AW, 2013, J IMMUNOL METHODS, V397, P71, DOI 10.1016/j.jim.2013.09.001; Chen C, 2014, DEV COMP IMMUNOL, V46, P341, DOI 10.1016/j.dci.2014.05.008; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; Dasu MR, 2009, ATHEROSCLEROSIS, V202, P76, DOI 10.1016/j.atherosclerosis.2008.04.010; Dosiou C, 2008, J ENDOCRINOL, V196, P67, DOI 10.1677/JOE-07-0317; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Estrogen K. S., 2005, CURR MED CHEM IMMUNO, V5, P85; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Giannoni E, 2011, INFECT IMMUN, V79, P2690, DOI 10.1128/IAI.00076-11; GILBERT SF, 1975, CELL, V5, P11, DOI 10.1016/0092-8674(75)90086-0; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hirata T, 2007, J REPROD IMMUNOL, V74, P53, DOI 10.1016/j.jri.2006.11.004; Kalinka J, 2005, AM J REPROD IMMUNOL, V54, P70, DOI 10.1111/j.1600-0897.2005.00289.x; Kamine J, 1985, J TISSUE CULTURE MET, V9, P33; Katzenellenbogen BS, 2002, SCIENCE, V295, P2380, DOI 10.1126/science.1070442; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Lashkari BS, 2015, J REPROD IMMUNOL, V107, P43, DOI 10.1016/j.jri.2014.10.001; Li X, 2014, REPROD SCI, V21, P898, DOI 10.1177/1933719113518982; Locklear TD, 2010, MATURITAS, V66, P315, DOI 10.1016/j.maturitas.2010.04.001; Lorenz E, 2002, PEDIATR RES, V52, P373, DOI 10.1203/01.PDR.0000025342.83436.53; Lyon D, 2010, BIOL RES NURS, V11, P371, DOI 10.1177/1099800409344620; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Nalbandian G, 2005, IMMUNOL RES, V31, P91, DOI 10.1385/IR:31:2:091; Nasu K, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/976024; Noguchi T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/490406; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; Papoutsi Z, 2009, J MOL ENDOCRINOL, V43, P65, DOI 10.1677/JME-08-0177; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Solar Paula, 2013, J Mol Signal, V8, P1, DOI 10.1186/1750-2187-8-1; Sriskandan S, 2011, J ROY COLL PHYS EDIN, V41, P339, DOI 10.4997/JRCPE.2011.411; Stanley MA, 2002, CULTURE HUMAN CERVIC; Thaxton JE, 2010, INFECT DIS OBSTET GY, V2010, P430; VESTERINEN E, 1976, ACTA PATH MICRO IM B, V84, P29; Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620; Young BC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.037; Young SH, 2008, J IMMUNOL METHODS, V331, P59, DOI 10.1016/j.jim.2007.11.004; Youssef RE, 2009, REPROD SCI, V16, P843, DOI 10.1177/1933719109336621; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhao Li-Qin, 2013, Shengli Xuebao, V65, P623	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173646	10.1371/journal.pone.0173646	http://dx.doi.org/10.1371/journal.pone.0173646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296959	gold, Green Published, Green Accepted			2022-12-26	WOS:000396311700048
J	Rohde, JF; Handel, MN; Stougaard, M; Olsen, NJ; Traerup, M; Mortensen, EL; Heitmann, BL				Rohde, Jeanett Friis; Handel, Mina Nicole; Stougaard, Maria; Olsen, Nanna Julie; Traerup, Maria; Mortensen, Erik Lykke; Heitmann, Berit Lilienthal			Relationship between pickiness and subsequent development in body mass index and diet intake in obesity prone normal weight preschool children	PLOS ONE			English	Article							YOUNG-CHILDREN; EATING BEHAVIOR; PICKY EATERS; FAMILY; FOOD; PATTERNS; ASSOCIATION; PREVALENCE; VALIDATION; FREQUENCY	Background Most children have periods in their life where they reject familiar as well as non-familiar food items and this is often referred to as pickiness. The consequences of pickiness may be malnutrition and, if prolonged, potentially lower body weight. However, studies investigating the consequence of pickiness on subsequent changes in diet intake and weight are limited. Objectives To examine whether pickiness influences body mass index as well as diet intake over subsequent 15 months among obesity prone normal weight children aged 2-6 years. Methods Data was obtained from the "Healthy Start" intervention study which included 271 children aged 2-6 years susceptible to overweight later in life. Information on pickiness was obtained from a parental questionnaire. Dietary habits were collected by 4-day dietary records filled in by the parents and height and weight were measured by trained health professionals and both measured twice over a 15 month period. Linear regression models were performed to assess the influence of pickiness on body mass index and diet with adjustments for possible confounders. Results No differences in mean BMI Z-score were seen between picky/non-picky (P = 0.68) and little picky/non-picky (P = 0.68) children at 15 month follow-up. Picky children had a lower intake of protein (P = 0.01) than non-picky children despite no differences in total energy intake (P = 0.74), or in the other macronutrients, or the intake of fruit and vegetables, though children being a little picky had a lower intake of starch compared to non-picky children (P = 0.05). Results were essentially similar before and after adjustment for key covariates. Conclusion Our study showed that BMI Z-score after 15 months follow-up was similar for picky and non-picky children. Picky children seemed to develop a lower protein intake despite similar total energy intake and diet composition.	[Rohde, Jeanett Friis; Handel, Mina Nicole; Stougaard, Maria; Olsen, Nanna Julie; Traerup, Maria; Heitmann, Berit Lilienthal] Bispebjerg & Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark; [Rohde, Jeanett Friis; Heitmann, Berit Lilienthal] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Handel, Mina Nicole] Univ Southern Denmark, Dept Clin Res, Odense Patient Data Explorat Network OPEN, Odense Univ Hosp, Odense, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Heitmann, Berit Lilienthal] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia; [Heitmann, Berit Lilienthal] Univ Copenhagen, Dept Publ Hlth, Sect Gen Med, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Copenhagen; University of Sydney; University of Copenhagen	Rohde, JF (corresponding author), Bispebjerg & Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark.; Rohde, JF (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	Jeanett.friis.rohde@regionh.dk	Olsen, Nanna Julie/G-6723-2016; Handel, Mina Nicole/G-4591-2016	Rohde, Jeanett Friis/0000-0002-9300-9009; Stougaard, Maria/0000-0002-5573-4971; Olsen, Nanna Julie/0000-0001-5765-3000; Handel, Mina Nicole/0000-0001-8256-8756; Heitmann, Berit Lilienthal/0000-0002-6809-4504	Danish Heart Foundation [12-04-R91-A3790-22689, 12-04-R91-A3775-22683]; Tryg Foundation [7984-07, 7106-09, 7-10-0330]; Danish Medical Research Council [271-07-0281]; Health Foundation [2008B101]; TrygFonden	Danish Heart Foundation; Tryg Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Foundation; TrygFonden	This study was funded by The Danish Heart Foundation (grant: 12-04-R91-A3790-22689; 12-04-R91-A3775-22683) (JFR). The Healthy Start study was funded by the Tryg Foundation (grant: 7984-07, 7106-09, and 7-10-0330) (BLH), the Danish Medical Research Council (grant: 271-07-0281) (BLH), and the Health Foundation (grant: 2008B101) (BLH).; The authors would like to acknowledge The Danish Heart Foundation, TrygFonden, The Danish Medical Council and The Health Foundation for providing financial support for this study. The source of funding had no influence on the manuscript. We would also like to thank all of the participating families in the "Healthy Start" project.	Birch LL, 2014, AM J CLIN NUTR, V99, p723S, DOI 10.3945/ajcn.113.069047; Burnier D, 2011, J NUTR EDUC BEHAV, V43, P473, DOI 10.1016/j.jneb.2011.01.005; Carruth BR, 2004, J AM DIET ASSOC, V104, pS57, DOI 10.1016/j.jada.2003.10.024; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; de Barse LM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0313-2; Dovey TM, 2008, APPETITE, V50, P181, DOI 10.1016/j.appet.2007.09.009; Ekstein S, 2010, CLIN PEDIATR, V49, P217, DOI 10.1177/0009922809337331; Equit M, 2013, ACTA PAEDIATR, V102, P149, DOI 10.1111/apa.12078; Farrow CV, 2009, APPETITE, V52, P307, DOI 10.1016/j.appet.2008.10.009; Fulkerson JA, 2014, J NUTR EDUC BEHAV, V46, P2, DOI 10.1016/j.jneb.2013.07.012; Galloway AT, 2005, J AM DIET ASSOC, V105, P541, DOI 10.1016/j.jada.2005.01.029; Gondolf UH, 2012, EUR J CLIN NUTR, V66, P91, DOI 10.1038/ejcn.2011.133; Lafraire J, 2016, APPETITE, V96, P347, DOI 10.1016/j.appet.2015.09.008; Mascola AJ, 2010, EAT BEHAV, V11, P253, DOI 10.1016/j.eatbeh.2010.05.006; Nicholls D, 2002, EUR J CLIN NUTR, V56, P857, DOI 10.1038/sj.ejcn.1601403; Nicklas TA, 2001, NUTR REV, V59, P224, DOI 10.1111/j.1753-4887.2001.tb07014.x; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Olsen NJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-590; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; Rodenburg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050642; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Svensson V, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-134; Taylor CM, 2015, APPETITE, V95, P349, DOI 10.1016/j.appet.2015.07.026; Tharner A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-14; Utter J, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-50; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219	26	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172772	10.1371/journal.pone.0172772	http://dx.doi.org/10.1371/journal.pone.0172772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296896	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700014
J	Shrestha, NK; Lim, SH; Wilson, DA; SalasVargas, AV; Churi, YS; Rhodes, PA; Mazzone, PJ; Procop, GW				Shrestha, Nabin K.; Lim, Sung H.; Wilson, Deborah A.; SalasVargas, Ana Victoria; Churi, Yair S.; Rhodes, Paul A.; Mazzone, Peter J.; Procop, Gary W.			The combined rapid detection and species-level identification of yeasts in simulated blood culture using a colorimetric sensor array	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; OPTOELECTRONIC NOSE; STREAM PATHOGENS; BACTERIA; PCR	Background A colorimetric sensor array (CSA) has been demonstrated to rapidly detect and identify bacteria growing in blood cultures by obtaining a species-specific "fingerprint" of the volatile organic compounds (VOCs) produced during growth. This capability has been demonstrated in prokaryotes, but has not been reported for eukaryotic cells growing in culture. The purpose of this study was to explore if a disposable CSA could differentially identify 7 species of pathogenic yeasts growing in blood culture. Methods Culture trials of whole blood inoculated with a panel of clinically important pathogenic yeasts at four different microorganism loads were performed. Cultures were done in both standard BacT/Alert and CSA-embedded bottles, after adding 10 mL of spiked blood to each bottle. Color changes in the CSA were captured as images by an optical scanner at defined time intervals. The captured images were analyzed to identify the yeast species. Time to detection by the CSA was compared to that in the BacT/Alert system. Results One hundred sixty-two yeast culture trials were performed, including strains of several species of Candida (Ca. albicans, Ca. glabrata, Ca. parapsilosis, and Ca. tropicalis), Clavispora (synonym Candida) lusitaniae, Pichia kudriavzevii (synonym Candida krusei) and Cryptococcus neoformans, at loads of 8.2 x 10(5), 8.3 x 10(3), 8.5 x 10(1), and 1.7 CFU/mL. In addition, 8 negative trials (no yeast) were conducted. All negative trials were correctly identified as negative, and all positive trials were detected. Colorimetric responses were species-specific and did not vary by inoculum load over the 500000-fold range of loads tested, allowing for accurate species-level identification. The mean sensitivity for species-level identification by CSA was 74% at detection, and increased with time, reaching almost 95% at 4 hours after detection. At an inoculum load of 1.7 CFU/mL, mean time to detection with the CSA was 6.8 hours (17%) less than with the BacT/Alert platform. Conclusion The CSA combined rapid detection of pathogenic yeasts in blood culture with accurate species- level identification.	[Shrestha, Nabin K.; SalasVargas, Ana Victoria] Cleveland Clin, Inst Med, Dept Infect Dis, Cleveland, OH 44106 USA; [Shrestha, Nabin K.; Wilson, Deborah A.; Procop, Gary W.] Cleveland Clin, Pathol & Lab Med Inst, Dept Clin Pathol, Cleveland, OH 44106 USA; [Lim, Sung H.; Churi, Yair S.; Rhodes, Paul A.] Specif Technol, Mountain View, CA USA; [Mazzone, Peter J.] Cleveland Clin, Resp Inst, Dept Pulm & Crit Care Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Shrestha, NK (corresponding author), Cleveland Clin, Inst Med, Dept Infect Dis, Cleveland, OH 44106 USA.; Shrestha, NK (corresponding author), Cleveland Clin, Pathol & Lab Med Inst, Dept Clin Pathol, Cleveland, OH 44106 USA.	shrestn@ccf.org	Mazzone, Peter/AAW-5401-2021; Shrestha, Nabin/B-3600-2015	Mazzone, Peter/0000-0003-2121-0595; Shrestha, Nabin/0000-0001-6766-9874	Cleveland Clinic Research Programs Committees [RPC: 2012-1057]; Specific Technologies	Cleveland Clinic Research Programs Committees; Specific Technologies	This study was partially supported by an internal grant from the Cleveland Clinic Research Programs Committees (NKS, AVSV; grant no. RPC: 2012-1057), and with material support from Specific Technologies, Mountain View, CA. Specific Technologies provided support in the form of salaries for authors SHL, YSC, PAR, and assisted with data analysis, the decision to publish, and in the preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Carey JR, 2011, J AM CHEM SOC, V133, P7571, DOI 10.1021/ja201634d; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Feng LA, 2010, ANAL CHEM, V82, P9433, DOI 10.1021/ac1020886; Fuglsang-Damgaard D, 2011, APMIS, V119, P681, DOI 10.1111/j.1600-0463.2011.02756.x; Horvath A, 2010, ACTA MICROBIOL IMM H, V57, P225, DOI 10.1556/AMicr.57.2010.3.7; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; Kroumova V, 2011, RAPID COMMUN MASS SP, V25, P2247, DOI 10.1002/rcm.5113; Lim SH, 2016, ANALYST, V141, P918, DOI 10.1039/c5an01990g; Lim SH, 2014, J CLIN MICROBIOL, V52, P592, DOI 10.1128/JCM.02377-13; Lim SH, 2009, NAT CHEM, V1, P562, DOI [10.1038/NCHEM.360, 10.1038/nchem.360]; Lonsdale CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062726; Moens M, 2006, LETT APPL MICROBIOL, V42, P121, DOI 10.1111/j.1472-765X.2005.01822.x; Moussaoui W, 2010, CLIN MICROBIOL INFEC, V16, P1631, DOI 10.1111/j.1469-0691.2010.03356.x; Pfeiffer CD, 2011, J CLIN MICROBIOL, V49, P2879, DOI 10.1128/JCM.00609-11; Quiles-Melero I, 2011, EUR J CLIN MICROBIOL, V30, P21, DOI 10.1007/s10096-010-1045-5; Rowther FB, 2009, J CLIN MICROBIOL, V47, P2964, DOI 10.1128/JCM.00418-07; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Suslick KS, 2012, CURR OPIN CHEM BIOL, V16, P557, DOI 10.1016/j.cbpa.2012.10.030; Suslick KS, 2004, MRS BULL, V29, P720, DOI 10.1557/mrs2004.209; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Wilson AD, 2011, SENSORS-BASEL, V11, P1105, DOI 10.3390/s110101105; Won H, 2011, J CLIN MICROBIOL, V49, P1705, DOI 10.1128/JCM.00217-11; Yan YJ, 2011, J CLIN MICROBIOL, V49, P2528, DOI 10.1128/JCM.00339-11; ZECHMAN JM, 1986, J CHROMATOGR, V377, P49, DOI 10.1016/S0378-4347(00)80760-4	24	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173130	10.1371/journal.pone.0173130	http://dx.doi.org/10.1371/journal.pone.0173130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296967	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700026
J	Yonow, T; Kriticos, DJ; Ota, N				Yonow, Tania; Kriticos, Darren J.; Ota, Noboru			The potential distribution of cassava mealybug (Phenacoccus manihoti), a threat to food security for the poor	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; MATILE-FERRERO; CLIMATE-CHANGE; HOMOPTERA; PSEUDOCOCCIDAE; PEST; TEMPERATURE; SPREAD; CONGO; HOM	The cassava mealybug is a clear and present threat to the food security and livelihoods of some of the world's most impoverished citizens. Niche models, such as CLIMEX, are useful tools to indicate where and when such threats may extend, and can assist with planning for biosecurity and the management of pest invasions. They can also contribute to bioeconomic analyses that underpin the allocation of resources to alleviate poverty. Because species can invade and establish in areas with climates that are different from those that are found in their native range, it is essential to define robust range-limiting mechanisms in niche models. To avoid spurious results when applied to novel climates, it is necessary to employ cross-validation techniques spanning different knowledge domains (e.g., distribution data, experimental results, phenological observations). We build upon and update a CLIMEX niche model by Parsa et al. (PloS ONE 7: e47675), correcting inconsistent parameters and re-fitting it based on a careful examination of geographical distribution data and relevant literature. Further, we consider the role of irrigation, the known distribution of cassava production and a targeted review of satellite imagery to refine, validate and interpret our model and results. In so doing, we bring new insights into the potential spread of this invasive insect, enabling us to identify potential bio-security threats and biological control opportunities. The fit of the revised model is improved, particularly in relation to the wet and dry limits to establishment, and the parameter values are biologically plausible and accord with published scientific literature.	[Yonow, Tania; Kriticos, Darren J.] Univ Minnesota, InSTePP, HarvestChoice, St Paul, MN 55108 USA; [Yonow, Tania; Kriticos, Darren J.] CSIRO, Canberra, ACT, Australia; [Kriticos, Darren J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Ota, Noboru] CSIRO, Wembley, WA, Australia	University of Minnesota System; University of Minnesota Twin Cities; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kriticos, DJ (corresponding author), Univ Minnesota, InSTePP, HarvestChoice, St Paul, MN 55108 USA.; Kriticos, DJ (corresponding author), CSIRO, Canberra, ACT, Australia.; Kriticos, DJ (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	Darren.kriticos@csiro.au	Kriticos, Darren J/A-4170-2008; Ota, Noboru/ABE-4698-2020	Kriticos, Darren J/0000-0003-2599-8105; , Noboru/0000-0002-8759-9030	Bill and Melinda Gates Foundation [2010X446]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was partly supported by the Bill and Melinda Gates Foundation under the HarvestCHoice project "HarvestChoice: Supporting Strategic Investment Choices in Agricultural Technology Development and Adoption", grant number 2010X446. UMN to support TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DK and NO received no specific funding for this work.	Baker RHA, 2000, AGR ECOSYST ENVIRON, V82, P57, DOI 10.1016/S0167-8809(00)00216-4; Bellotti AC, 1999, ANNU REV ENTOMOL, V44, P343, DOI 10.1146/annurev.ento.44.1.343; Bellotti A, 2012, TROP PLANT BIOL, V5, P39, DOI 10.1007/s12042-011-9091-4; Bennett F, 1978, P CASS PROT WORKSH 7; Berry SD, 2004, ANN ENTOMOL SOC AM, V97, P852, DOI 10.1603/0013-8746(2004)097[0852:MEFFDB]2.0.CO;2; CHAMBERLIN TC, 1965, SCIENCE, V148, P754, DOI 10.1126/science.148.3671.754; Colvin J, 2004, PLANT PATHOL, V53, P577, DOI 10.1111/j.0032-0862.2004.01062.x; Ezumah H, 1978, P INT WORKSH CASS ME; FABRES G, 1981, AGRON TROP, V36, P82; FABRES G, 1981, AGRONOMIE, V1, P483, DOI 10.1051/agro:19810608; Fabres G, 1981, TROPICAL ROOT CROPS, P84; HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1; HAMMOND WNO, 1990, ENTOMOPHAGA, V35, P515, DOI 10.1007/BF02375086; HENNESSEY RD, 1990, TROP PEST MANAGE, V36, P103, DOI 10.1080/09670879009371451; HERREN HR, 1991, ANNU REV ENTOMOL, V36, P257, DOI 10.1146/annurev.en.36.010191.001353; IHEAGWAM EU, 1983, DEUT ENTOMOL Z, V30, P17; JAMES BD, 1992, TROP PEST MANAGE, V38, P89; KLEIJNEN JPC, 1995, EUR J OPER RES, V82, P145, DOI 10.1016/0377-2217(94)00016-6; Kriticos DJ, 2003, BIOL INVASIONS, V5, P147, DOI 10.1023/A:1026193424587; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos D. J., 2015, CLIMEX VERSION 4 EXP; Kriticos DJ, 2007, J APPL ECOL, V44, P853, DOI 10.1111/j.1365-2664.2007.01331.x; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Legese Hidoto, 2013, African Journal of Agricultural Research, V8, P2559; Legg JP, 2014, VIRUS RES, V186, P61, DOI 10.1016/j.virusres.2013.11.018; LOHR B, 1990, B ENTOMOL RES, V80, P417, DOI 10.1017/S0007485300050677; Matile-Ferrero D., 1978, Proceedings of the International Workshop on the cassava mealybug Phenacoccus manihoti Mat.-Ferr. (Pseudococcidae) held at INERA-M'vuazi, Bas-Zaire, Zaire, June 26-29, 1977., P29; Minko D. Obame, 2009, Tropicultura, V27, P21; Montle B. P., 2014, Journal of Development and Agricultural Economics, V6, P443; Mulualem T., 2012, J NAT SCI RES, V2, P122; Muniappan R, 2009, J AGR URBAN ENTOMOL, V26, P167, DOI 10.3954/1523-5475-26.4.167; Neuenschwander P, 2001, BIOL CONTROL, V21, P214, DOI 10.1006/bcon.2001.0937; Neuenschwander Peter, 2003, P45, DOI 10.1079/9780851996394.0045; Nweke F. I., 2005, P VAL FOR GLOB CASS, V2; Okigbo B. N., 1980, Food and Nutrition Bulletin, V2, P1; Parsa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047675; Sartiami D, 2015, ZOOTAXA, V3957, P235, DOI 10.11646/zootaxa.3957.2.8; SCHULTHESS F, 1987, INSECT SCI APPL, V8, P851, DOI 10.1017/S1742758400023055; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Singh T, 1982, ROOT CROPS E AFR P W; Soon LG, 2013, TCPRAS3311 FAO; Spencer D, 2005, P VAL FOR GLOB CASS, P27; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Wyckhuys KAG, 2014, BIOCONTROL NEWS INFO, V35, p35N; Yonow T., 2016, J PEST SCI, P1; Yonow T, 2013, CROP PROT, V44, P18, DOI 10.1016/j.cropro.2012.10.006; You L., 2012, MAPSPAM HOME SPATIAL; You L, 2014, SPATIAL PRODUCTION A	52	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173265	10.1371/journal.pone.0173265	http://dx.doi.org/10.1371/journal.pone.0173265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296903	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700030
J	Chen, JH; Borges, M				Chen, Jey-Hsin; Borges, Melissa			Histopathology and enhanced detection of tumor invasion of peritoneal membranes	PLOS ONE			English	Article							ELASTIC LAMINAL INVASION; II COLON-CANCER; COLORECTAL-CANCER; SEROSAL INVASION; STAGE-II; RECTAL-CANCER; INVOLVEMENT; SURVIVAL; PROGNOSIS; STAIN	Tumor invasion of the peritoneal membrane may have an adverse prognostic significance, but its histopathologic features can be diagnostically difficult to recognize. We observed that local peritoneal injury associated with tumor invasion is characterized by activation and proliferation of serosal stromal cells that express cytokeratin, a characteristic property of injured serosal membranes that may have diagnostic utility. To explore this, we examined 120 primary tumors of the gastrointestinal tract and pancreaticobiliary system using cytokeratin and elastic stains to assess for tumor invasion of peritoneal membranes. Peritoneal invasion by tumor was associated with retraction, splaying, and destruction of the elastic lamina and proliferation of keratin-expressing stromal cells of serosal membranes. All 82 peritoneal invasive tumors were characterized by neoplastic cells that invaded the elastic lamina and the serosal connective tissue with neoplastic cells that abutted or were surrounded by keratin-positive stromal cells, whereas all 38 tumors limited to the subserosa showed none of these features. The diagnosis of tumor invasion of peritoneal membranes is enhanced by the combined use of cytokeratin and elastic stains, which in turn would enable better histopathologic correlation with patient treatment and outcome.	[Chen, Jey-Hsin; Borges, Melissa] CellNetix Pathol & Labs, Seattle, WA 98104 USA; [Chen, Jey-Hsin] Swedish Med Ctr, Seattle, WA 98122 USA	Swedish Medical Center	Chen, JH (corresponding author), CellNetix Pathol & Labs, Seattle, WA 98104 USA.; Chen, JH (corresponding author), Swedish Med Ctr, Seattle, WA 98122 USA.	jchen@cellnetix.com			CellNetix Pathology and Laboratories	CellNetix Pathology and Laboratories	Both authors are employed by CellNetix Pathology and Laboratories, which provided support in the form of salaries for the authors (JHC and MB), research materials, and publication fees, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BOKU T, 1990, BRIT J SURG, V77, P436, DOI 10.1002/bjs.1800770425; BOLEN JW, 1986, AM J SURG PATHOL, V10, P34, DOI 10.1097/00000478-198601000-00005; Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T; Edge S, 2010, AJCC CANC STAGING MA, V7th; ELLIS H, 1965, BRIT J SURG, V52, P471, DOI 10.1002/bjs.1800520616; EPSTEIN JI, 1986, HUM PATHOL, V17, P514, DOI 10.1016/S0046-8177(86)80042-9; Erlichman C, 1999, J CLIN ONCOL, V17, P1356, DOI 10.1200/JCO.1999.17.5.1356; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; GALLAGHER B, 1990, HUM PATHOL, V21, P512, DOI 10.1016/0046-8177(90)90007-R; Grin A, 2013, HUM PATHOL, V44, P2696, DOI 10.1016/j.humpath.2013.07.013; KAIBARA N, 1987, CANCER, V60, P136, DOI 10.1002/1097-0142(19870701)60:1<136::AID-CNCR2820600125>3.0.CO;2-X; Katsumata D, 2008, SURG TODAY, V38, P115, DOI 10.1007/s00595-007-3608-3; Kazlouskaya V, 2013, J CUTAN PATHOL, V40, P211, DOI 10.1111/cup.12036; Keshava A, 2007, COLORECTAL DIS, V9, P609, DOI 10.1111/j.1463-1318.2006.01136.x; KNUDSEN PJT, 1991, J ANAT, V177, P41; Kojima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088018; Kojima M, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00179; Kojima M, 2010, AM J SURG PATHOL, V34, P1351, DOI 10.1097/PAS.0b013e3181ecfe98; Lennon AM, 2003, AM J CLIN PATHOL, V119, P108, DOI 10.1309/J6BDTWM2M792TN2V; Liang WY, 2013, AM J SURG PATHOL, V37, P1565, DOI 10.1097/PAS.0b013e31828ea2de; Ludeman L, 2005, HISTOPATHOLOGY, V47, P123, DOI 10.1111/j.1365-2559.2005.02189.x; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Nakanishi Y, 2016, ARCH PATHOL LAB MED, V140, P81, DOI 10.5858/arpa.2014-0647-OA; NEWLAND RC, 1994, CANCER, V73, P2076, DOI 10.1002/1097-0142(19940415)73:8<2076::AID-CNCR2820730811>3.0.CO;2-6; PITT MA, 1995, J CLIN PATHOL, V48, P226, DOI 10.1136/jcp.48.3.226; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; RAFTERY AT, 1973, BRIT J SURG, V60, P293, DOI 10.1002/bjs.1800600412; Shepherd NA, 1997, GASTROENTEROLOGY, V112, P1096, DOI 10.1016/S0016-5085(97)70119-7; Shinto E, 2004, DIS COLON RECTUM, V47, P467, DOI 10.1007/s10350-003-0083-9; Snaebjornsson P, 2014, INT J CANCER, V135, P467, DOI 10.1002/ijc.28676; Sobin LH., 2003, INT UNION CANC UICC, V7, DOI [10.1002/0471463752, DOI 10.1002/0471463752]; Stewart CJR, 2007, HISTOPATHOLOGY, V51, P372, DOI 10.1111/j.1365-2559.2007.02787.x; Stewart Colin J R, 2011, Cancers (Basel), V3, P164, DOI 10.3390/cancers3010164; Travis WD, 2008, J THORAC ONCOL, V3, P1384, DOI 10.1097/JTO.0b013e31818e0d9f; Yokota M, 2014, DIS COLON RECTUM, V57, P830, DOI 10.1097/DCR.0000000000000124	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173833	10.1371/journal.pone.0173833	http://dx.doi.org/10.1371/journal.pone.0173833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282462	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800082
J	Drew, ML; Weiser, GC				Drew, Mark L.; Weiser, Glen C.			Potential disease agents in domestic goats and relevance to bighorn sheep (Ovis canadensis) management	PLOS ONE			English	Article							PASTEURELLA-HAEMOLYTICA; RESPIRATORY-DISEASE; MYCOPLASMA-OVIPNEUMONIAE; TRANSMISSION; PNEUMONIA; TREHALOSI; CONTACT; HERDS; COMB; SPP.	Domestic goats are raised for meat, milk and hair production, in herds for rangeland weed control, and as pack animals. Domestic sheep, goats and wild bighorn sheep are all susceptible to a multifactorial pneumonia. We sampled 43 herd goats from 7 herds and 48 pack goats from 11 herds for viral and bacterial serology, parasitology, and Pasteurellaceae microbiology. The goats in this study were in generally good health, although most goats did harbor various pathogens and parasites including several bacteria, specifically Pasteurellaceae, which have been associated with pneumonia in free-ranging bighorn sheep. It is not known if domestic goats can transmit the Pasteurellaceae or other pathogens found in this study readily to wild bighorn sheep. However, due the possibility of transmission, domestic goats in areas in or near bighorn sheep habitat should be managed to minimize the risk of spreading disease agents to bighorn sheep.	[Drew, Mark L.] Idaho Dept Fish & Game, Wildlife Hlth Lab, Eagle, ID 83616 USA; [Weiser, Glen C.] Univ Idaho, Caine Vet Teaching Ctr, Caldwell, ID USA	Idaho; University of Idaho	Drew, ML (corresponding author), Idaho Dept Fish & Game, Wildlife Hlth Lab, Eagle, ID 83616 USA.	Mark.drew@idfg.idaho.gov		Drew, Mark/0000-0002-1277-3284	Idaho Department of Fish and Game	Idaho Department of Fish and Game	Funding was provided by Idaho Department of Fish and Game. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angen O, 2002, VET MICROBIOL, V84, P103, DOI 10.1016/S0378-1135(01)00439-4; Angen O, 1999, INT J SYST BACTERIOL, V49, P67, DOI 10.1099/00207713-49-1-67; Angen O, 1999, VET MICROBIOL, V65, P253, DOI 10.1016/S0378-1135(98)00304-6; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; BISGAARD M, 1995, HAEMOPHILUS, ACTINOBACILLUS, AND PASTEURELLA, P1; Blackall PJ, 2007, INT J SYST EVOL MICR, V57, P666, DOI 10.1099/ijs.0.64521-0; Brogden KA, 1998, VET RES, V29, P233; COGGINS VL, 1988, P BIENN S NO SHEEP G, V6, P57; CZUPRYNSKI CJ, 1995, HAEMOPHILUS, ACTINOBACILLUS, AND PASTEURELLA, P143; Drew ML, 2014, WILDLIFE SOC B, V38, P332, DOI 10.1002/wsb.393; Fisher MA, 1999, AM J VET RES, V60, P1402; Foreyt W.J., 1994, P BIENN S NO WILD SH, V9, P7; Foreyt WJ, 2009, J WILDLIFE DIS, V45, P272, DOI 10.7589/0090-3558-45.2.272; FOREYT WJ, 1989, AM J VET RES, V50, P341; Foreyt WJ, 1994, VET PARASITOLOGY REF, V3rd; Heinse LM, 2016, WILDLIFE SOC B, P625; Jansen BD, 2006, J WILDLIFE DIS, V42, P407, DOI 10.7589/0090-3558-42.2.407; Jaworski MD, 1998, J VET DIAGN INVEST, V10, P49, DOI 10.1177/104063879801000109; JAWORSKI MD, 1993, J CLIN MICROBIOL, V31, P831, DOI 10.1128/JCM.31.4.831-835.1993; MARTIN KD, 1996, P BIENN S NO WILD SH, V10, P72; McAuliffe L, 2003, VET REC, V153, P687, DOI 10.1136/vr.153.22.687; Miller David S., 2012, Veterinary Medicine International, V2011, DOI 10.4061/2011/162520; Miller DS, 2011, VET MICROBIOL, V150, P284, DOI 10.1016/j.vetmic.2011.01.024; Miller MW, 2013, J WILDLIFE DIS, V49, P653, DOI 10.7589/2012-11-274; Miller Michael W., 2001, P330, DOI 10.1002/9780470344880.ch20; Miller MW, 2008, PASTEURELLOSIS TRANS; Monello RJ, 2001, CAN J ZOOL, V79, P1423, DOI 10.1139/cjz-79-8-1423; ONDERKA DK, 1988, J WILDLIFE DIS, V24, P663, DOI 10.7589/0090-3558-24.4.663; ROBINSON RA, 1983, VET CLIN N AM-LARGE, V5, P539; Rudolph KM, 2007, J ZOO WILDLIFE MED, V38, P548, DOI 10.1638/2006-0027R.1; Rudolph KM, 2003, J WILDLIFE DIS, V39, P897, DOI 10.7589/0090-3558-39.4.897; Smith MC, 1983, VET CLIN N AM LARGE, V5; Toweill D. D. E., 1999, RETURN ROYALTY WILD; United States Department of Agriculture, 2011, SMALL SCAL US GOAT O; United States Department of Agriculture, 2016, SHEEP AND GOATS; United States Department of Agriculture, 2004, GOAT IND STRUCT CONC; Ward ACS, 2002, AM J VET RES, V63, P119, DOI 10.2460/AJVR.2002.63.119; Ward ACS, 1997, J WILDLIFE DIS, V33, P544, DOI 10.7589/0090-3558-33.3.544; Western Association of Fish and Wildlife Agencies, 2010, REC DOM SHEEP GOAT M; Western Association of Fish and Wildlife Agencies, 2015, WAFWA WILDL HLTH COM; Wood ME, 2017, J WILDLIFE DIS, V53, P126, DOI 10.7589/2016-05-097	41	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e73396	10.1371/journal.pone.0173396	http://dx.doi.org/10.1371/journal.pone.0173396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282407	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800036
J	Mao, YM; Kuo, SW; Chen, L; Heckman, CJ; Jiang, MC				Mao, Yimin; Kuo, Su-Wei; Chen, Le; Heckman, C. J.; Jiang, M. C.			The essential and downstream common proteins of amyotrophic lateral sclerosis: A protein-protein interaction network analysis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; VALOSIN-CONTAINING PROTEIN; LARGE GENE LISTS; MESSENGER-RNA; HEXANUCLEOTIDE REPEAT; POLYUBIQUITIN GENE; SQSTM1 MUTATIONS; VCP MUTATIONS; PAGET-DISEASE; SPORADIC ALS	Amyotrophic Lateral Sclerosis (ALS) is a devastative neurodegenerative disease characterized by selective loss of motoneurons. While several breakthroughs have been made in identifying ALS genetic defects, the detailed molecular mechanisms are still unclear. These genetic defects involve in numerous biological processes, which converge to a common destiny: motoneuron degeneration. In addition, the common comorbid Frontotemporal Dementia (FTD) further complicates the investigation of ALS etiology. In this study, we aimed to explore the protein-protein interaction network built on known ALS-causative genes to identify essential proteins and common downstream proteins between classical ALS and ALS+FTD (classical ALS + ALS/FTD) groups. The results suggest that classical ALS and ALS+FTD share similar essential protein set (VCP, FUS, TDP-43 and hnRNPA1) but have distinctive functional enrichment profiles. Thus, disruptions to these essential proteins might cause motoneuron susceptible to cellular stresses and eventually vulnerable to proteinopathies. Moreover, we identified a common downstream protein, ubiquitin-C, extensively interconnected with ALS-causative proteins (22 out of 24) which was not linked to ALS previously. Our in silico approach provides the computational background for identifying ALS therapeutic targets, and points out the potential downstream common ground of ALS-causative mutations.	[Mao, Yimin; Chen, Le] Jiangxi Univ Sci & Technol, Inst Appl Sci, Ganzhou, Jiangxi, Peoples R China; [Mao, Yimin; Kuo, Su-Wei; Heckman, C. J.; Jiang, M. C.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Heckman, C. J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Heckman, C. J.] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	Jiangxi University of Science & Technology; Northwestern University; Northwestern University; Northwestern University	Jiang, MC (corresponding author), Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA.	m-jiang@northwestern.edu		Heckman, CJ/0000-0002-1324-7278; Kuo, Su-Wei/0000-0002-7951-3970	Northwestern University [T32]; National Institute of Neurological Disorders and Stroke [NS07786303]; ALS Association [277]	Northwestern University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association	This work was supported Northwestern University, Grant #T32 (http://www.nuin.northwestern.edu/inside-nuin/training-grants/training-in-the-neurobiology-of-movement-and-rehabilitation-sciences/) to SWK; the National Institute of Neurological Disorders and Stroke, Grant #NS07786303 (http://www.ninds.nih.gov/) to CJH and the ALS Association, Grant #277 (http://www.alsa.org/) to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Batada NN, 2006, EVOLUTIONARY AND PHY; Bianchi M, 2015, GENE, V573, P100, DOI 10.1016/j.gene.2015.07.030; Brown K.J., 2007, ELECTRON J DIFFER EQ, V69, P1; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chua HN, 2008, TOOLS ART INT 2008 I; Crinelli R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136882; de Pril R, 2010, MOL CELL NEUROSCI, V43, P281, DOI 10.1016/j.mcn.2009.12.001; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fecto F, 2011, J MOL NEUROSCI, V45, P663, DOI 10.1007/s12031-011-9637-9; Ferrari R, 2011, CURR ALZHEIMER RES, V8, P273, DOI 10.2174/156720511795563700; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Genc E B, 2015, CEREB CORTEX; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hallengren J, 2013, CELL BIOCHEM BIOPHYS, V67, P67, DOI 10.1007/s12013-013-9634-4; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kondrashov FA, 2004, NUCLEIC ACIDS RES, V32, P1731, DOI 10.1093/nar/gkh330; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lage K, 2014, BBA-MOL BASIS DIS, V1842, P1971, DOI 10.1016/j.bbadis.2014.05.028; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Li M, 2010, LECT N BIOINFORMAT, V6053, P89; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Malaspina A, 2000, J NEUROCHEM, V75, P2511, DOI 10.1046/j.1471-4159.2000.0752511.x; Manavalan A, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.76; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; Marinovic AC, 2007, AM J PHYSIOL-RENAL, V292, pF660, DOI 10.1152/ajprenal.00178.2006; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; da Silva JPM, 2008, PHYSICA A, V387, P1049, DOI 10.1016/j.physa.2007.10.044; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Toole O, 2008, J NEUROL NEUROSUR PS, V79, P30, DOI 10.1136/jnnp.2007.117788; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Radici L, 2013, ADV BIOSCIENCE BIOTE, V2013; Ren J, 2011, LECT N BIOINFORMAT, V6674, P12, DOI 10.1007/978-3-642-21260-4_6; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Ryu HW, 2011, BIOCHEM BIOPH RES CO, V404, P470, DOI 10.1016/j.bbrc.2010.12.004; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Ryu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032956; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Song CC, 2015, BBA-MOL CELL RES, V1853, P222, DOI 10.1016/j.bbamcr.2014.10.019; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sundaramoorthy V, 2014, HUM MOL GENET; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wang T, 2015, NEUROBIOL AGING, V36, P527, DOI 10.1016/j.neurobiolaging.2014.07.044; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Webster CP, 2016, EMBO J; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang SH, 2006, COMPUT BIOL CHEM, V30, P445, DOI 10.1016/j.compbiolchem.2006.10.001; Zhang T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004693; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	86	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172246	10.1371/journal.pone.0172246	http://dx.doi.org/10.1371/journal.pone.0172246			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282387	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800009
J	Betekhtin, A; Rojek, M; Jaskowiak, J; Milewska-Hendel, A; Kwasniewska, J; Kostyukova, Y; Kurczynska, E; Rumyantseva, N; Hasterok, R				Betekhtin, Alexander; Rojek, Magdalena; Jaskowiak, Joanna; Milewska-Hendel, Anna; Kwasniewska, Jolanta; Kostyukova, Yulia; Kurczynska, Ewa; Rumyantseva, Natalya; Hasterok, Robert			Nuclear genome stability in long-term cultivated callus lines of Fagopyrum tataricum (L.) Gaertn	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; TISSUE-CULTURE; ARABIDOPSIS-THALIANA; PHENOLIC-COMPOUNDS; TETRAPLOID PLANTS; CELLS; REGENERATION; PLURIPOTENT; PROTOPLASTS; INSTABILITY	Long-term cultivated Fagopyrum tataricum (L.) Gaertn. (Tartary buckwheat) morphogenic and non-morphogenic callus lines are interesting systems for gaining a better understanding of the mechanisms that are responsible for the genetic stability and instability of a plant tissue culture. In this work, we used histological sections and transmission electron microscopy to identify and describe the morphology of the nuclei of all of the analysed callus lines. We demonstrated that the embryogenic callus cells had prominent round nuclei that did not contain heterochromatin clumps in contrast to the non-morphogenic callus lines, in which we found nuclei that had multiple lobes. Flow cytometry analysis revealed significant differences in the relative DNA content between the analysed calli. All of the analysed morphogenic callus lines had peaks from 2C to 8C as compared to the non-morphogenic callus lines, whose peaks did not reflect any regular DNA content and exceeded 8C and 16C for the line 6p1 and 16C and 32C for the callus line 10p(2)A. The results showed that non-morphogenic calli are of an aneuploid nature. The TUNEL test enabled us to visualise the nuclei that had DNA fragmentation in both the morphogenic and non-morphogenic lines. We revealed significantly higher frequencies of positively labelled nuclei in the non-morphogenic lines than in the morphogenic lines. In the case of the morphogenic lines, the highest observed frequency of TUNEL-positive nuclei was 7.7% for lines 2-3. In the non-morphogenic calli, the highest level of DNA damage (68.5%) was revealed in line 6p1. These results clearly indicate greater genome stability in the morphogenic lines.	[Betekhtin, Alexander; Rojek, Magdalena; Jaskowiak, Joanna; Kwasniewska, Jolanta; Hasterok, Robert] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland; [Milewska-Hendel, Anna; Kurczynska, Ewa] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Cell Biol, Katowice, Poland; [Kostyukova, Yulia; Rumyantseva, Natalya] Russian Acad Sci, Kazan Inst Biochem & Biophys, Lab Physiol & Genet Plant Cell Cultures, Kazan Sci Ctr, Kazan, Russia; [Rumyantseva, Natalya] Kazan Fed Univ, Inst Fundamental Med & Biol, Dept Bot & Plant Physiol, Kazan, Russia	University of Silesia in Katowice; University of Silesia in Katowice; Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; Kazan Federal University	Betekhtin, A (corresponding author), Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	alexander.betekhtin@us.edu.pl	Rumyantseva, Natalya I./K-1350-2018; Kwasniewska, Jolanta/ABF-1547-2020; Hasterok, Robert/A-1629-2008; Костюкова, Юлия/ABE-8066-2021; Betekhtin, Alexander/O-4619-2018	Betekhtin, Alexander/0000-0001-6146-1669; Kostukova, Ulia/0000-0001-5313-3542; Kurczynska, Ewa/0000-0003-0772-8961; Milewska-Hendel, Anna/0000-0002-9066-477X; Kwasniewska, Jolanta/0000-0002-8965-8727; Hasterok, Robert/0000-0001-6667-2721				Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Baranek M, 2010, PLANT CELL TISS ORG, V101, P11, DOI 10.1007/s11240-009-9656-1; Bourdon M, 2012, DEVELOPMENT, V139, P3817, DOI 10.1242/dev.084053; BRAR DS, 1998, SOMACLONAL VARIATION, P15, DOI DOI 10.1007/978-94-015-9125-6_2; Brian J, 2004, STUDY NEW HLTH FOODS; CHEN CC, 1980, CAN J GENET CYTOL, V22, P607, DOI 10.1139/g80-066; Combrinck S, 2007, ANN BOT-LONDON, V99, P1111, DOI 10.1093/aob/mcm064; Danilova MF, 1980, RHIZODERMIS; de Almeida M, 2012, PLANT CELL REP, V31, P1495, DOI 10.1007/s00299-012-1264-6; Fabjan N, 2003, J AGR FOOD CHEM, V51, P6452, DOI 10.1021/jf034543e; Filipecki M, 2006, J APPL GENET, V47, P17, DOI 10.1007/BF03194594; FISHER DB, 1968, HISTOCHEMISTRY, V16, P92, DOI 10.1007/BF00306214; FRANKLIN CI, 1989, PLANT CELL REP, V8, P101, DOI 10.1007/BF00716849; Fras A, 2007, PLANT CELL REP, V26, P1933, DOI 10.1007/s00299-007-0415-7; Fras A, 2004, GENETICA, V121, P145, DOI 10.1023/B:GENE.0000040375.18684.82; Fras A, 2003, ACTA BIOL CRACOV BOT, V45, P145; GALBRAITH DW, 1991, PLANT PHYSIOL, V96, P985, DOI 10.1104/pp.96.3.985; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; GILISSEN LJW, 1993, PLANT SCI, V91, P171, DOI 10.1016/0168-9452(93)90140-U; Gregory T. Ryan, 2005, P3; Gumerova EA, 2015, RUSS J PLANT PHYSL+, V62, P195, DOI 10.1134/S1021443715020077; Hasler J, 2003, BIOL CELL, V95, P357, DOI 10.1016/S0248-4900(03)00077-7; HIROCHIKA H, 1993, EMBO J, V12, P2521, DOI 10.1002/j.1460-2075.1993.tb05907.x; Jain SM, 2001, EUPHYTICA, V118, P153, DOI 10.1023/A:1004124519479; Jaligot E, 2004, GENOME, V47, P224, DOI 10.1139/G03-085; Prado MJ, 2010, PLANT CELL TISS ORG, V103, P49, DOI 10.1007/s11240-010-9753-1; JHA S, 1989, CYTOLOGIA, V54, P687, DOI 10.1508/cytologia.54.687; Joachimiak A, 2003, ACTA SOC BOT POL, V72, P11, DOI 10.5586/asbp.2003.002; Johnston JW, 2009, PLANT PHYSIOL BIOCH, V47, P123, DOI 10.1016/j.plaphy.2008.10.008; Kamalova GV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P686, DOI 10.1134/S0006297909060145; KARP A, 1995, EUPHYTICA, V85, P295, DOI 10.1007/BF00023959; Karp A, 1994, PLANT CELL TISSUE CU, P139; Kreft M, 2016, NUTR RES REV, V29, P30, DOI 10.1017/S0954422415000190; Kubalakova M, 1996, BIOL PLANTARUM, V38, P475, DOI 10.1007/BF02896685; Kwasniewska J, 2012, ACTA BIOL CRACOV BOT, V54, P93, DOI 10.2478/v10182-012-0028-5; LAVANIA UC, 1988, PROTOPLASMA, V145, P55, DOI 10.1007/BF01323256; LEDILY F, 1993, IN VITRO CELL DEV-PL, V29P, P149, DOI 10.1007/BF02632027; Li XQ, 2002, J PLANT PHYSIOL, V159, P1229, DOI 10.1078/0176-1617-00899; LINGLEE M, 1977, NEW PHYTOL, V78, P313, DOI 10.1111/j.1469-8137.1977.tb04835.x; LoSchiavo F, 2000, EUR J CELL BIOL, V79, P294, DOI 10.1078/S0171-9335(04)70032-1; Makowczynska J, 2000, ACTA SOC BOT POL, V69, P245, DOI 10.5586/asbp.2000.031; Nakano M, 2003, PLANT CELL TISS ORG, V72, P63, DOI 10.1023/A:1021290106221; NOVAK FJ, 1980, Z PFLANZENZUCHT, V84, P250; Ochatt SJ, 2000, PLANT SCI, V156, P177, DOI 10.1016/S0168-9452(00)00250-8; PHILLIPS GC, 1979, CROP SCI, V19, P59, DOI 10.2135/cropsci1979.0011183X001900010014x; PHILLIPS RL, 1994, P NATL ACAD SCI USA, V91, P5222, DOI 10.1073/pnas.91.12.5222; PIJNACKER LP, 1990, PLANT CELL TISS ORG, V21, P153, DOI 10.1007/BF00033435; Potocka I, 2012, PLANT CELL REP, V31, P2031, DOI 10.1007/s00299-012-1314-0; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roux NS, 2004, DETECTING PLOIDY LEV; ROY SC, 1980, PROTOPLASMA, V102, P171, DOI 10.1007/BF01276957; Rumiantseva N I, 2004, Prikl Biokhim Mikrobiol, V40, P571; Rumyantseva N I, 2003, Dokl Biol Sci, V391, P375, DOI 10.1023/A:1025127323165; RUMYANTSEVA N I, 1989, Fiziologiya Rastenii (Moscow), V36, P187; SENGUPTA J, 1988, BIOL PLANTARUM, V30, P247, DOI 10.1007/BF02878202; Soukupova J, 2000, NEW PHYTOL, V146, P403, DOI 10.1046/j.1469-8137.2000.00666.x; Steadman KJ, 2001, J SCI FOOD AGR, V81, P1094, DOI 10.1002/jsfa.914; Tomiczak K, 2016, PLANT CELL TISS ORG, V126, P319, DOI 10.1007/s11240-016-1000-y; TRUMP BF, 1961, J ULTRA MOL STRUCT R, V5, P343, DOI 10.1016/S0022-5320(61)80011-7; Vasilyev AE., 1980, SECRETORY STRUCTURES; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; Wood M, 1998, PLANT SCI, V131, P149, DOI 10.1016/S0168-9452(97)00253-7; WYMAN J, 1992, PLANT SCI, V85, P189, DOI 10.1016/0168-9452(92)90115-3; Zidorn C., 2008, Scientia Pharmaceutica, V76, P743, DOI 10.3797/scipharm.0810-25	64	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173537	10.1371/journal.pone.0173537	http://dx.doi.org/10.1371/journal.pone.0173537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278222	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900009
J	Bullock, B; Murray, G; Meyer, D				Bullock, Ben; Murray, Greg; Meyer, Denny			Highs and lows, ups and downs: Meteorology and mood in bipolar disorder	PLOS ONE			English	Article							SEASONAL-VARIATION; CIRCADIAN-RHYTHMS; LIFE EVENTS; SYMPTOMS; WEATHER; SLEEP; CHRONORECORD	Seasonal variation of manic and depressive symptoms is a controversial topic in bipolar disorder research. Several studies report seasonal patterns of hospital admissions for depression and mania and variation in symptoms that appear to follow a seasonal pattern, whereas others fail to report such patterns. Differences in research methodologies, data analysis strategies, and temporal resolution of data may partly explain the variation in findings between studies. The current study adds a novel perspective to the literature by investigating specific meteorological factors such as atmospheric pressure, hours of sunshine, relative humidity, and daily maximum and minimum temperatures as more proximal predictors of self-reported daily mood change in people diagnosed with bipolar disorder. The results showed that daily maximum temperature was the only meteorological variable to predict clinically-relevant mood change, with increases in temperature associated with greater odds of a transition into manic mood states. The mediating effects of sleep and activity were also investigated and suggest at least partial influence on the prospective relationship between maximum temperature and mood. Limitations include the small sample size and the fact that the number and valence of social interactions and exposure to natural light were not investigated as potentially important mediators of relationships between meteorological factors and mood. The current data make an important contribution to the literature, serving to clarify the specific meteorological factors that influence mood change in bipolar disorder. From a clinical perspective, greater understanding of seasonal patterns of symptoms in bipolar disorder will help mood episode prophylaxis in vulnerable individuals.	[Bullock, Ben; Murray, Greg] Swinburne Univ Technol, Dept Psychol Sci, Melbourne, Vic, Australia; [Meyer, Denny] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Melbourne, Vic, Australia	Swinburne University of Technology; Swinburne University of Technology	Bullock, B (corresponding author), Swinburne Univ Technol, Dept Psychol Sci, Melbourne, Vic, Australia.	bbullock@swin.edu.au	Murray, Greg/N-8933-2017	Murray, Greg/0000-0001-7208-5603; Bullock, Ben/0000-0003-1459-9061				Akhter A, 2013, BIPOLAR DISORD, V15, P377, DOI 10.1111/bdi.12072; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2013, HLM 7 01 FOR WINDOWS; Bauer M, 2004, BIPOLAR DISORD, V6, P67, DOI 10.1046/j.1399-5618.2003.00085.x; Bauer M, 2008, PSYCHIAT RES, V159, P359, DOI 10.1016/j.psychres.2007.04.013; Bauer M, 2009, J AFFECT DISORDERS, V116, P170, DOI 10.1016/j.jad.2008.11.014; Boland EM, 2012, J AFFECT DISORDERS, V139, P264, DOI 10.1016/j.jad.2012.01.038; Christensen EM, 2008, NORD J PSYCHIAT, V62, P55, DOI 10.1080/08039480801970049; Faurholt-Jepsen M, 2016, PSYCHIAT RES, V237, P166, DOI 10.1016/j.psychres.2016.01.047; Friedman E, 2006, ACTA PSYCHIAT SCAND, V113, P510, DOI 10.1111/j.1600-0447.2005.00701.x; Geoffroy PA, 2014, J AFFECT DISORDERS, V168, P210, DOI 10.1016/j.jad.2014.07.002; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; Harvey AG, 2012, PSYCHOL BULL, V138, P77, DOI 10.1037/a0025730; Huibers MJH, 2010, PSYCHIAT RES, V180, P143, DOI 10.1016/j.psychres.2009.09.016; Johnson SL, 2016, PSYCHIAT CLIN N AM, V39, P87, DOI 10.1016/j.psc.2015.09.003; Judd LL, 2003, INT J NEUROPSYCHOPH, V6, P127, DOI 10.1017/S1461145703003341; Klimstra TA, 2011, EMOTION, V11, P1495, DOI 10.1037/a0024649; Koots L, 2011, J INDIVID DIFFER, V32, P74, DOI 10.1027/1614-0001/a000037; Kripke DF, 2015, F1000 RES, V4; Maj M, 2002, AM J PSYCHIAT, V159, P1711, DOI 10.1176/appi.ajp.159.10.1711; Malhi GS, 2015, AUST NZ J PSYCHIAT, V49, P1087, DOI 10.1177/0004867415617657; Murray G, 2011, BIPOLAR DISORD, V13, P687, DOI 10.1111/j.1399-5618.2011.00959.x; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Traffanstedt MK, 2016, CLINICAL PSYCHOLOGIC; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; Watson D., 2000, MOOD TEMPERAMENT; Yen CF, 2007, BIPOLAR DISORD, V9, P238, DOI 10.1111/j.1399-5618.2007.00407.x	30	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173431	10.1371/journal.pone.0173431	http://dx.doi.org/10.1371/journal.pone.0173431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278268	gold, Green Published			2022-12-26	WOS:000396087900092
J	Jiang, F; Meng, D; Weng, MQ; Zhu, WS; Wu, WX; Kasper, D; Walker, WA				Jiang, Fei; Meng, Di; Weng, Meiqian; Zhu, Weishu; Wu, Wenxue; Kasper, Dennis; Walker, W. Allan			The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1 beta-induced inflammation in human fetal enterocytes via toll receptors 2 and 4	PLOS ONE			English	Article							DEVELOPING HUMAN INTESTINE; NECROTIZING ENTEROCOLITIS; CAPSULAR POLYSACCHARIDE; BIOSYNTHESIS LOCUS; COLONIZATION; RECOGNITION; MATURATION; EPITHELIUM; MUCOSAL	Colonizing bacteria interacting with the immature, unlike the mature, human intestine favors inflammation over immune homeostasis. As a result, ten percent of premature infants under 1500 grams weight develop an inflammatory necrosis of the intestine after birth, e.g., necrotizing enterocolitis (NEC). NEC is a major health problem in this population causing extensive morbidity and mortality and an enormous expenditure of health care dollars. NEC can be prevented by giving preterm infants their mother's expressed breast milk or ingesting selective probiotic organisms. Vaginally delivered, breast fed newborns develop health promoting bacteria "pioneer" bacteria) which preferentially stimulate intestinal host defense andanti-inflammation. One such "pioneer" organism is Bacteroides fragilis with a polysaccharide (PSA) on its capsule. B. fragilis has been shown developmentally in intestinal lymphocytes and dendritic cells to produce a balanced T-helper cell (TH1/TH2) response and to reduce intestinal inflammation by activity through the TLR2 receptor stimulating IL-10 which inhibits IL-17 causing inflammation. No studies have been done on the role of B. fragilis PSA on fetal enterocytes and its increased inflammation. Accordingly, using human and mouse fetal intestinal models, we have shown that B. fragilis with PSA and PSA alone inhibits IL1a-induced IL-8 inflammation in fetal and NEC intestine. We have also begun to define the mechanism for this unique inflammation noted in fetal intestine. We have shown that B. fragilis PSA anti-inflammation requires both the TLR2 and TLR4 receptor and is in part mediated by the AP1 transcription factor (TLR2) which is developmentally regulated. These observations may help to devise future preventative treatments of premature infants against NEC.	[Jiang, Fei; Wu, Wenxue] China Agr Univ, Coll Vet Med, Lab Rapid Diagnost Technol Anim Dis, Beijing, Peoples R China; [Jiang, Fei; Meng, Di; Weng, Meiqian; Zhu, Weishu; Walker, W. Allan] Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Jiang, Fei; Meng, Di; Weng, Meiqian; Zhu, Weishu; Walker, W. Allan] Harvard Med Sch, Charlestown, MA 02129 USA; [Kasper, Dennis] Harvard Med Sch, Dept Microbiol & Mol Genet, Boston, MA USA	China Agricultural University; Harvard University; Harvard Medical School	Walker, WA (corresponding author), Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.; Walker, WA (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	wwalker@partners.org			National Institutes of Child Health and Human Development [R01-HD01237, R01-HD059126]; National Institutes of Digestive Disease and Kidney Disease [P01-DK033506, P30-DK040561]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Digestive Disease and Kidney Disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Child Health and Human Development - R01-HD01237; R01-HD059126- WAW; National Institutes of Digestive Disease and Kidney Disease - P01-DK033506; P30-DK040561 -WAW.	AlFaleh Khalid, 2014, Evid Based Child Health, V9, P584, DOI 10.1002/ebch.1976; AlFaleh K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005496.pub4; Baumann H, 1999, BIOCHEMISTRY-US, V31, P4081; Cahill CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145184; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Comstock LE, 1999, INFECT IMMUN, V67, P3525, DOI 10.1128/IAI.67.7.3525-3532.1999; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012; Grave GD, 2007, PEDIATR RES, V62, P510, DOI 10.1203/PDR.0b013e318142580a; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Houghteling PD, 2015, J PEDIATR GASTR NUTR, V60, P294, DOI 10.1097/MPG.0000000000000597; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Meng D, 2016, AM J PHYSL GASTROINT; Meng D, 2007, AM J PHYSIOL-GASTR L, V293, pG780, DOI 10.1152/ajpgi.00010.2007; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; Underwood MA, 2014, PEDIATR RES, V76, P326, DOI 10.1038/pr.2014.102; Van Haver ER, 2009, J PEDIATR GASTR NUTR, V49, P90, DOI 10.1097/MPG.0b013e31818de393; Viscardi RM, 1997, PEDIATR PATHOL LAB M, V17, P547, DOI 10.1080/107710497174516	35	30	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172738	10.1371/journal.pone.0172738	http://dx.doi.org/10.1371/journal.pone.0172738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278201	gold, Green Submitted, Green Published			2022-12-26	WOS:000396087900127
J	Trabado, S; Al-Salameh, A; Croixmarie, V; Masson, P; Corruble, E; Feve, B; Colle, R; Ripoll, L; Walther, B; Boursier-Neyret, C; Werner, E; Becquemont, L; Chanson, P				Trabado, Severine; Al-Salameh, Abdallah; Croixmarie, Vincent; Masson, Perrine; Corruble, Emmanuelle; Feve, Bruno; Colle, Romain; Ripoll, Laurent; Walther, Bernard; Boursier-Neyret, Claire; Werner, Erwan; Becquemont, Laurent; Chanson, Philippe			The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age	PLOS ONE			English	Article							PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; OXIDATIVE STRESS; PPAR-ALPHA; ATHEROSCLEROSIS; SPHINGOMYELIN; DISEASE; ADULTS; LONGEVITY; INSIGHTS; LIGAND	Metabolomic approaches are increasingly used to identify new disease biomarkers, yet normal values of many plasma metabolites remain poorly defined. The aim of this study was to define the "normal" metabolome in healthy volunteers. We included 800 French volunteers aged between 18 and 86, equally distributed according to sex, free of any medication and considered healthy on the basis of their medical history, clinical examination and standard laboratory tests. We quantified 185 plasma metabolites, including amino acids, biogenic amines, acylcarnitines, phosphatidylcholines, sphingomyelins and hexose, using tandem mass spectrometry with the Biocrates AbsoluteIDQ p180 kit. Principal components analysis was applied to identify the main factors responsible for metabolome variability and orthogonal projection to latent structures analysis was employed to confirm the observed patterns and identify pattern- related metabolites. We established a plasma metabolite reference dataset for 144/185 metabolites. Total blood cholesterol, gender and age were identified as the principal factors explaining metabolome variability. High total blood cholesterol levels were associated with higher plasma sphingomyelins and phosphatidylcholines concentrations. Compared to women, men had higher concentrations of creatinine, branched-chain amino acids and lyso-phosphatidylcholines, and lower concentrations of sphingomyelins and phosphatidylcholines. Elderly healthy subjects had higher sphingomyelins and phosphatidylcholines plasma levels than young subjects. We established reference human metabolome values in a large and well-defined population of French healthy volunteers. This study provides an essential baseline for defining the "normal" metabolome and its main sources of variation.	[Trabado, Severine] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Trabado, Severine; Chanson, Philippe] Univ Paris Saclay, Fac Med Paris Sud, Inserm U1185, Le Kremlin Bicetre, France; [Al-Salameh, Abdallah; Chanson, Philippe] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Croixmarie, Vincent; Ripoll, Laurent] Inst Rech Int Servier, Suresnes, France; [Masson, Perrine; Walther, Bernard; Boursier-Neyret, Claire; Werner, Erwan] Technol Servier, Orleans, France; [Corruble, Emmanuelle; Colle, Romain] Univ Paris Sud, INSERM UMR 1178, Equipe Depress & Antidepresseurs, Hop Bicetre,AP HP,Serv Psychiat, Le Kremlin Bicetre, France; [Feve, Bruno] UPMC Univ Paris 06, INSERM UMR S938, Ctr Rech St Antoine, Hop St Antoine,AP HP, Paris, France; [Becquemont, Laurent] Univ Paris Sud, Hop Bicetre,CEA,DSV IMETI,IDMIT,Div Immunovirol, AP HP,Fac Med Paris Sud,Dept Pharmacol,UMR 1184, INSERM Ctr Immunol Infect Virales & Malad Autoim, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Servier; Institut de Recherches Internationales Servier; Servier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; CEA; UDICE-French Research Universities; Universite Paris Saclay	Trabado, S (corresponding author), Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France.	severine.trabado@aphp.fr	Colle, romain/D-9144-2017; Al-Salameh, Abdallah/S-7043-2016; Chanson, Philippe/F-8511-2013	Al-Salameh, Abdallah/0000-0002-7951-9926; Chanson, Philippe/0000-0001-5096-5722; Feve, Bruno/0000-0001-6577-9009; Trabado, Severine/0000-0002-1925-1999; Colle, Romain/0000-0002-2549-4495	national grant (PHRC) [AOM09122]; Assistance Publique-Hopitaux de Paris (APHP, Paris, France)	national grant (PHRC); Assistance Publique-Hopitaux de Paris (APHP, Paris, France)	The VARIETE study was financed by a national grant (PHRC, AOM09122) and sponsored by Assistance Publique-Hopitaux de Paris (APHP, Paris, France). Metabolomic analyses were performed at Technologie Servier (Orleans, France). One or more of the authors are employed by a commercial company: "Technologie Servier, [VC, PM, LR, BW, CBN, EW]. These authors performed metabolomic analyses, statistical analyses, data collection and analyses and preparation of the manuscript.	ARMSTRONG MD, 1973, METABOLISM, V22, P561, DOI 10.1016/0026-0495(73)90069-3; Bouchard-Mercier A, 2013, NUTR J, V12; Breier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089728; Bub A, 2016, JMIR RES PROTOC, V5, P225, DOI 10.2196/resprot.5792; Carayol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135437; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chanson P, 2016, J CLIN ENDOCR METAB; Clement AB, 2009, J NEUROCHEM, V111, P669, DOI 10.1111/j.1471-4159.2009.06360.x; Correl Niaudet C, 2010, MUTAT RES-REV MUTAT, V704, P61; de Brouwer APM, 2002, EXP CELL RES, V274, P100, DOI 10.1006/excr.2001.5460; Draisma HHM, 2015, NAT COMMUN, P6; Dunn WB, 2015, METABOLOMICS, V11, P9, DOI 10.1007/s11306-014-0707-1; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Ersoy BA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004111; Everett JR, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00297; Floegel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021103; Furse S, 2015, MOL MEMBR BIOL, V32, P117, DOI 10.3109/09687688.2015.1066894; Gonzalez-Covarrubias V, 2013, AGING CELL, V12, P426, DOI 10.1111/acel.12064; Guertin KA, 2014, AM J CLIN NUTR, V100, P208, DOI 10.3945/ajcn.113.078758; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Ichi I, 2009, TOXICOLOGY, V261, P33, DOI 10.1016/j.tox.2009.04.040; Ishikawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091806; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Krumsiek J, 2015, METABOLOMICS, V11, P1815, DOI 10.1007/s11306-015-0829-0; Matsumoto T, 2007, CURR MED CHEM, V14, P3209, DOI 10.2174/092986707782793899; Mecocci P, 1996, NEUROSCI LETT, V207, P129, DOI 10.1016/0304-3940(96)12509-X; MERRILL AH, 1985, LIPIDS, V20, P252, DOI 10.1007/BF02534197; Mielke MM, 2015, AGING CELL, V14, P112, DOI 10.1111/acel.12275; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Nicholson JK, 2012, EXPERT OPIN DRUG MET, V8, P135, DOI 10.1517/17425255.2012.646987; Nikkila Janne, 2008, Mol Syst Biol, V4, P197, DOI 10.1038/msb.2008.34; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Piccinini M, 2010, MOL NEUROBIOL, V41, P314, DOI 10.1007/s12035-009-8096-6; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Reuter SE, 2008, ANN CLIN BIOCHEM, V45, P585, DOI 10.1258/acb.2008.008045; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Sakai H, 2014, J BIOL CHEM, V289, P26607, DOI 10.1074/jbc.M114.590950; Shin SY, 2014, GENOME MED, V6, DOI 10.1186/gm542; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smith AR, 2006, AGING CELL, V5, P391, DOI 10.1111/j.1474-9726.2006.00232.x; Souberbielle JC, 2016, ENDOCRINE, V53, P543, DOI 10.1007/s12020-016-0960-3; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Vaarhorst AAM, 2011, AGE, V33, P219, DOI 10.1007/s11357-010-9172-6; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Yeboah J, 2010, ARTERIOSCL THROM VAS, V30, P628, DOI 10.1161/ATVBAHA.109.199281; Yet I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153672; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x	51	83	84	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173615	10.1371/journal.pone.0173615	http://dx.doi.org/10.1371/journal.pone.0173615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278231	gold, Green Submitted, Green Published			2022-12-26	WOS:000396087900016
J	Verhagen, JH; Lexmond, P; Vuong, O; Schutten, M; Guldemeester, J; Osterhaus, ADME; Elbers, ARW; Slaterus, R; Hornman, M; Koch, G; Fouchier, RAM				Verhagen, Josanne H.; Lexmond, Pascal; Vuong, Oanh; Schutten, Martin; Guldemeester, Judith; Osterhaus, Albert D. M. E.; Elbers, Armin R. W.; Slaterus, Roy; Hornman, Menno; Koch, Guus; Fouchier, Ron A. M.			Discordant detection of avian influenza virus subtypes in time and space between poultry and wild birds; Towards improvement of surveillance programs	PLOS ONE			English	Article							A VIRUSES; HUMAN INFECTION; NETHERLANDS; PATTERNS; DUCKS; PERFORMANCE; AUSTRALIA; EVOLUTION; CHICKENS; OUTBREAK	Avian influenza viruses from wild birds can cause outbreaks in poultry, and occasionally infect humans upon exposure to infected poultry. Identification and characterization of viral reservoirs and transmission routes is important to develop strategies that prevent infection of poultry, and subsequently virus transmission between poultry holdings and to humans. Based on spatial, temporal and phylogenetic analyses of data generated as part of intense and large-scale influenza surveillance programs in wild birds and poultry in the Netherlands from 2006 to 2011, we demonstrate that LPAIV subtype distribution differed between wild birds and poultry, suggestive of host-range restrictions. LPAIV isolated from Dutch poultry were genetically most closely related to LPAIV isolated from wild birds in the Netherlands or occasionally elsewhere in Western Europe. However, a relatively long time interval was observed between the isolations of related viruses from wild birds and poultry. Spatial analyses provided evidence for mallards (Anas platyrhynchos) being more abundant near primary infected poultry farms. Detailed year-round investigation of virus prevalence and wild bird species distribution and behavior near poultry farms should be used to improve risk assessment in relation to avian influenza virus introduction and retarget avian influenza surveillance programs.	[Verhagen, Josanne H.; Lexmond, Pascal; Vuong, Oanh; Schutten, Martin; Guldemeester, Judith; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Elbers, Armin R. W.; Koch, Guus] Cent Vet Inst part Wageningen UR, Lelystad, Netherlands; [Slaterus, Roy; Hornman, Menno] Sovon, Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [Verhagen, Josanne H.] Linnaeus Univ, Dept Biol & Environm Sci, Kalmar, Sweden; [Osterhaus, Albert D. M. E.] Vet Univ Hannover, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Linnaeus University; University of Veterinary Medicine Hannover, Foundation	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Verhagen, Josanne/0000-0003-3133-5228	Dutch Ministry of Economic Affairs [TRCDR/2006/7406]; European Research Council project FLUPLAN [250136]; European Union's Horizon [643476]; NIAID/NIH [HHSN272201400008C]; Ministry of Infrastructure and the Environment	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); European Research Council project FLUPLAN; European Union's Horizon; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Infrastructure and the Environment	This study was sponsored by grants from the Dutch Ministry of Economic Affairs contract no. TRCDR/2006/7406, European Research Council project FLUPLAN (250136), European Union's Horizon 2020 grant no. 643476 "COMPARE" and NIAID/NIH contract no. HHSN272201400008C.; The authors thank Ger van der Water and Dries Oomen for logistical and technical assistance. We thank Teun de Vaal, Bert Pellegrom, Hans Zantinge, Arie Keijzer, Jan Berkhouwer, Jan Slijkerman, Dick Jonkers, Engbert van Oort, Gerard Miiskens, David Kleijn, Frank Majoor, Kees Oosterbeek for sampling wild birds, and veterinarians of various practices for sampling poultry, and Sjaak de Wit of the Animal Health Service (GD Deventer) for providing farm data. The Dutch waterbird census scheme is part of a governmental ecological surveillance (NEM), carried out in association with Dutch Statistics and supported by Dutch Ministry of Economic Affairs and the Ministry of Infrastructure and the Environment.	Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Berhane Y, 2009, EMERG INFECT DIS, V15, P1492, DOI 10.3201/eid1509.080231; Brown J, 2012, AVIAN DIS, V56, P969, DOI 10.1637/10158-040912-Reg.1; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Daoust PY, 2013, VET PATHOL, V50, P548, DOI 10.1177/0300985812469633; de Wit JJ, 2004, AVIAN PATHOL, V33, P565, DOI 10.1080/03079450400013196; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Elbers ARW, 2005, AVIAN PATHOL, V34, P181, DOI 10.1080/03079450500096497; Fereidouni SR, 2014, INFLUENZA OTHER RESP, V8, P613, DOI 10.1111/irv.12275; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Gonzales J., 2012, THESIS; Gonzales JL, 2010, INFLUENZA OTHER RESP, V4, P91, DOI 10.1111/j.1750-2659.2009.00126.x; Gonzales JL, 2013, INFLUENZA OTHER RESP, V7, P6, DOI 10.1111/j.1750-2659.2012.00348.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hornman M, 2012, WATERVOGELS NEDERLAN; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Jourdain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024155; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0098; Lebarbenchon C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-328; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Post J, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-23; Ramey AM, 2014, J WILDLIFE DIS, V50, P916, DOI 10.7589/2013-09-232; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Si YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053362; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tonnessen R, 2011, AVIAN DIS, V55, P680, DOI 10.1637/9701-030411-ResNote.1; Velkers FC, 2006, VET REC, V159, P403, DOI 10.1136/vr.159.13.403; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Welby S, 2010, AVIAN DIS, V54, P597, DOI 10.1637/8749-033009-Reg.1; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010	47	32	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173470	10.1371/journal.pone.0173470	http://dx.doi.org/10.1371/journal.pone.0173470			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278281	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900097
J	Dias, LD; Macoris, MDD; Andrighetti, MTM; Otrera, VCG; Dias, AD; Bauzer, LGSD; Rodovalho, CD; Martins, AJ; Lima, JBP				Dias, Luciana dos Santos; da Graca Macoris, Maria de Lourdes; Macoris Andrighetti, Maria Teresa; Garbeloto Otrera, Vanessa Camargo; Dias, Adriana dos Santos; Soares da Rocha Bauzer, Luiz Guilherme; Rodovalho, Cynara de Melo; Martins, Ademir Jesus; Pereira Lima, Jose Bento			Toxicity of spinosad to temephos-resistant Aedes aegypti populations in Brazil	PLOS ONE			English	Article							NATURALLY DERIVED INSECTICIDE; RIO-DE-JANEIRO; ALTERNATIVE INSECTICIDES; BIOINSECTICIDE SPINOSAD; FIELD POPULATIONS; IN-FIELD; DIPTERA; CULICIDAE; EFFICACY; SUSCEPTIBILITY	The mosquito Aedes aegypti is the primary vector of different arboviruses and represents a major public health problem. Several Brazilian populations of Ae. aegypti have developed resistance to temephos, the most used organophosphate larvicide. New tools which are less harmful to the environment and safer for humans are becoming increasingly important to control this insect vector. Spinosad, an aerobic fermentation product of a soil actinobacteria, has a favorable environmental profile. It presents selective insecticide properties, a mechanism of action that differs from those of many synthetic chemical insecticides. The toxicity of spinosad and temephos to Aedes aegypti populations from Brazil, which were previously exposed to temephos, were investigated in this study. Larval susceptibility (LC50) to temephos varied from 3pg/L for Rockefeller up to 260 pg/L for Santana do Ipanema field derived population. Larval susceptibility (LC50) to spinosad varied from 23pg/L for Rockefeller up to 93pg/L for Marilia field derived population. In addition, a semi-field trial was performed to evaluate spinosad (NatularTM DT) initial efficacy and persistence toward four field-derived lineages and the Rockefeller lineage, used as an internal control. Spinosad was tested at 0.5mg active ingredient/L in 200L capacity water tanks. Mortality was recorded each 24 hours after exposition and tanks were further recolonized once per week with mortality being recorded daily for eight weeks. Spinosad provided a level equal or superior to 80% mortality during a seven to eight week evaluation period. The assessed populations did not present cross-resistance between spinosad and temephos in laboratory conditions. It demonstrates that spinosad may be a promising larvicide for the control of Ae. aegypti, especially for populations in which resistance to temephos has been detected.	[Dias, Luciana dos Santos; Dias, Adriana dos Santos; Soares da Rocha Bauzer, Luiz Guilherme; Rodovalho, Cynara de Melo; Martins, Ademir Jesus; Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, RJ, Brazil; [Dias, Luciana dos Santos; Dias, Adriana dos Santos; Soares da Rocha Bauzer, Luiz Guilherme; Rodovalho, Cynara de Melo; Martins, Ademir Jesus; Pereira Lima, Jose Bento] Inst Biol Exercito, Lab Entomol, Rio De Janeiro, RJ, Brazil; [da Graca Macoris, Maria de Lourdes; Macoris Andrighetti, Maria Teresa; Garbeloto Otrera, Vanessa Camargo] Superintendencia Controle Endemias, Marilia, SP, Brazil	Fundacao Oswaldo Cruz	Lima, JBP (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, RJ, Brazil.; Lima, JBP (corresponding author), Inst Biol Exercito, Lab Entomol, Rio De Janeiro, RJ, Brazil.	jbento@ioc.fiocruz.br	Martins, Ademir J./B-4117-2009; Bauzer, Luiz G S R/I-4664-2014; Martins, Ademir/W-3251-2019	Martins, Ademir/0000-0001-5739-1215; dos Santos Dias, Luciana/0000-0002-4824-9062; Rodovalho, Cynara/0000-0002-4927-0672; Bauzer, Luiz/0000-0003-0900-860X	Fundacao Oswaldo Cruz; Fundacao coordenacao de aperfeicoamento de pessoal de nivel superior	Fundacao Oswaldo Cruz; Fundacao coordenacao de aperfeicoamento de pessoal de nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao Oswaldo Cruz (http://portal.fiocruz.br/pt-br) and Fundacao coordenacao de aperfeicoamento de pessoal de nivel superior (http://www.capes.gov.br/).	Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297; Diniz DFA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1276-5; Attaran A, 2000, NAT MED, V6, P729, DOI 10.1038/77438; Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064; Bisset Juan A., 2002, Rev Cubana Med Trop, V54, P202; Bond JG, 2004, MED VET ENTOMOL, V18, P50, DOI 10.1111/j.0269-283X.2004.0480.x; Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015; Braga Ima Aparecida, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P347, DOI 10.1590/S0037-86822000000400003; Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de Vigilancia Epidemiologica, 2009, DIR NAC PREV CONTR E; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; BROWN A W, 1958, Bull World Health Organ, V18, P309; Centers for Disease Control and Prevention-CDC, 2016, INS RES; CEPAGRI, 2012, CLIM MUN PIOS PAUL; Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409; Cleveland CB, 2002, J AGR FOOD CHEM, V50, P3244, DOI 10.1021/jf011663i; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; Darriet F, 2005, J AM MOSQUITO CONTR, V21, P495, DOI 10.2987/8756-971X(2006)21[495:SANLAI]2.0.CO;2; Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3; Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6; Environmental Protection Agency, 2005, FED REGISTER, V70, P41730; Ferreira BJ, 2009, CIENC SAUDE COLETIVA, V14, P961, DOI 10.1590/S1413-81232009000300032; Fontoura NG, 2012, MEM I OSWALDO CRUZ, V107, P387, DOI 10.1590/S0074-02762012000300014; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515; Kirst HA, 1992, SYNTHESIS CHEM AGROC, P214; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329; Lima José Bento Pereira, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P125, DOI 10.1590/S0036-46652005000300002; Macoris MDG, 1999, REV SAUDE PUBL, V33, P521, DOI 10.1590/S0034-89101999000500013; Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335; MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315; Medronho Roberto de Andrade, 2008, Cad. Saúde Pública, V24, P948, DOI 10.1590/S0102-311X2008000500001; Miles M, 2000, INT S CROP, V65, P393; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Pan American Health Organization, 1994, PAHO PUBLICATION, V548; Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2; Pereira BB, 2016, J TOXICOL ENV HEAL A, V79, P477, DOI 10.1080/15287394.2016.1176974; Perez CM, 2007, J MED ENTOMOL, V44, P631, DOI 10.1603/0022-2585(2007)44[631:SANDIF]2.0.CO;2; Prabhu K, 2011, ASIAN PAC J TROP MED, V4, P610, DOI 10.1016/S1995-7645(11)60157-0; Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117; Romi R, 2006, J AM MOSQUITO CONTR, V22, P93, DOI 10.2987/8756-971X(2006)22[93:LEOTBS]2.0.CO;2; Sadanandane C, 2009, J AM MOSQUITO CONTR, V25, P66, DOI 10.2987/08-5807.1; Salgado VL, 1998, PESTIC BIOCHEM PHYS, V60, P91, DOI 10.1006/pest.1998.2332; Sparks T. C., 1995, P BELTW COTT C NAT C, P903; Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018; Thavara U, 2009, SE ASIAN J TROP MED, V40, P235; Thompson G., 1995, BELTW COTT C, P1039; Walker K, 2000, MED VET ENTOMOL, V14, P345, DOI 10.1046/j.1365-2915.2000.00262.x; Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1; Watson GB, 2001, PESTIC BIOCHEM PHYS, V71, P20, DOI 10.1006/pest.2001.2559; WHO, 2005, GUID LAB FIELD TEST; WHO, 2016, WHOPES REC COMP FORM; WHO, 2000, SCI WORK GROUP DENG, P10; WHO, 2010, DRINK WAT US VECT CO; WHO (World Health Organization), 1981, INSTR DET SUSC RES A; Williams T, 2003, BIOCONTROL SCI TECHN, V13, P459, DOI 10.1080/0958315031000140956; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	65	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173689	10.1371/journal.pone.0173689	http://dx.doi.org/10.1371/journal.pone.0173689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301568	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300061
J	Li, JH; Qian, LY; Dowling, JP; Curcione, C; Kurup, D; Zhang, JK				Li, Jinghe; Qian, Liangyue; Dowling, John P.; Curcione, Christine; Kurup, Drishya; Zhang, Jianke			Daxx plays a novel role in T cell survival but is dispensable in Fas-induced apoptosis	PLOS ONE			English	Article							DEATH DOMAIN PROTEIN; KINASE ACTIVATION; SIGNALING COMPLEX; RECEPTOR SIGNALS; JNK ACTIVATION; FADD; MICE; PROLIFERATION; INTERACTS; ANTIBODY	Daxx was originally isolated as a Fas-binding protein. However, the in vivo function of Daxx in Fas-induced apoptosis has remained enigmatic. Fas plays an important role in homeostasis in the immune system. Fas gene mutations lead to autoimmune-lymphoproliferation (lpr) diseases characterized by hyperplasia of secondary lymphoid organs. It is well established that the FADD adaptor binds to Fas, and recruits/activates caspase 8. However, additional proteins including Daxx have also been indicated to associate with Fas. It was proposed that Daxx mediates a parallel apoptotic pathway that is independent of FADD and caspase 8, but signals through ASK1-mediated apoptotic pathway. However, because the deletion of Daxx leads to embryonic lethality, the in vivo function of Daxx has not been properly analyzed. In the current study, analysis was performed using a conditional mutant mouse in which Daxx was deleted specifically in T cells. The data show that Daxx(-/-) T cells were able to undergo normal Fas-induced apoptosis. While containing normal thymocyte populations, the T cell-specific Daxx(-/-) mice have a reduced peripheral T cell pool. Importantly, Daxx-deficient T cells displayed increased death responses upon activation through TCR stimulation. These results unequivocally demonstrated that Daxx does not mediate Fas-induced apoptosis, but rather that it plays a critical role in survival responses in primary mature T cells.	[Li, Jinghe; Qian, Liangyue; Dowling, John P.; Curcione, Christine; Kurup, Drishya; Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Zhang, Jianke] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Zhang, JK (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.; Zhang, JK (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	jianke.zhang@jefferson.edu	KURUP, DRISHYA/GMW-6326-2022	Kurup, Drishya/0000-0002-3959-7700; Dowling, John/0000-0001-7414-5606	NIH [R21 AI105794, R01 AI119069]; NCI Cancer Center support grant [P30CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105794, R01AI119069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported in part by NIH grants R21 AI105794 and R01 AI119069 to J.Z. The Flow Cytometry Facility and Research Animal Facility of the Sidney Kimmel Cancer Center, where some of the analysis was performed, is supported in part by NCI Cancer Center support grant P30CA56036.	Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Budd RC, 2001, CURR OPIN IMMUNOL, V13, P356, DOI 10.1016/S0952-7915(00)00227-2; Chang HY, 1999, P NATL ACAD SCI USA, V96, P1252, DOI 10.1073/pnas.96.4.1252; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Feng B, 2004, CELL IMMUNOL, V232, P9, DOI 10.1016/j.cellimm.2005.01.006; Fukuyama H, 1998, J IMMUNOL, V160, P3805; Hueber AO, 2000, J BIOL CHEM, V275, P10453, DOI 10.1074/jbc.275.14.10453; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Imtiyaz HZ, 2005, J BIOL CHEM, V280, P31360, DOI 10.1074/jbc.M504138200; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kim YY, 2003, BIOCHEM BIOPH RES CO, V312, P426, DOI 10.1016/j.bbrc.2003.10.144; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Leal-Sanchez J, 2007, CELL DEATH DIFFER, V14, P795, DOI 10.1038/sj.cdd.4402056; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lu JV, 2011, P NATL ACAD SCI US; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Villunger A, 2000, J IMMUNOL, V165, P1337, DOI 10.4049/jimmunol.165.3.1337; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yun HJ, 2011, EMBO J, V30, P2465, DOI 10.1038/emboj.2011.152; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	46	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174011	10.1371/journal.pone.0174011	http://dx.doi.org/10.1371/journal.pone.0174011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301594	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300110
J	Kolasa-Trela, R; Konieczynska, M; Bazanek, M; Undas, A				Kolasa-Trela, Renata; Konieczynska, Malgorzata; Bazanek, Marta; Undas, Anetta			Specific changes in circulating cytokines and growth factors induced by exercise stress testing in asymptomatic aortic valve stenosis	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEPATOCYTE GROWTH; SHEAR-STRESS; MECHANISMS; EXPRESSION; CELLS; CALCIFICATION; INTERLEUKIN-6; INFLAMMATION; ASSOCIATION	Background We evaluated exercise-induced changes in the profile of circulating cytokines and growth factors in patients with AS. Methods We studied 32 consecutive asymptomatic moderate-to-severe AS patients and 32 age and sex-matched controls. Plasma levels of interleukin (IL)-6, IL-10, hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and transforming growth factor (TGF)-beta were measured at 4 time points, i.e. at rest, at peak bicycle exercise, one hour and 24 hours after a symptom-limited exercise. Results Exercise increased all the 5 markers in both groups (all p<0.0001). The maximum levels of all tested cytokines were higher in the AS group (all p<0.05) compared with controls. In AS patients the highest levels of VEGF, IL-6, and IL-10 were observed one hour after exercise, while in the control group at peak exercise. In both groups maximum TGF-beta levels were observed one hour after exercise. HGF levels were higher at peak and one hour after test in the AS group (p = 0.0001), however the maximum value in AS was observed at peak while in controls after test. In both groups TGF-beta was the only marker that remained increased 24 hours after exercise compared with the value at rest (p = 0.0001). The cytokines and growth factors showed no association with heart rate and the workload. Conclusion In asymptomatic patients with moderate-to-severe AS, exercise produces a different pattern of changes in circulating cytokines and growth factors, and maximum levels of all tested cytokines were significantly higher in AS patients compared with the control group.	[Kolasa-Trela, Renata; Konieczynska, Malgorzata; Bazanek, Marta] John Paul 2 Hosp, Dept Diagnost Med, Krakow, Poland; [Undas, Anetta] Jagiellonian Univ, Inst Cardiol, Coll Med, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Undas, A (corresponding author), Jagiellonian Univ, Inst Cardiol, Coll Med, Krakow, Poland.	mmundas@cyf-kr.edu.pl			Jagiellonian University Medical College [N40238338, K/ZDS/002936]	Jagiellonian University Medical College	This work was supported by funds from Jagiellonian University Medical College N40238338 to AU and Jagiellonian University Medical College K/ZDS/002936 to AU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128965; Blaha V, 2014, PHYSIOL RES, V63, pS351, DOI 10.33549/physiolres.932857; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Charest A, 2006, HEART, V92, P1844, DOI 10.1136/hrt.2005.086595; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Dasu D, 2013, J HEART VALVE DIS, V22, P621; Davies PF, 2013, CARDIOVASC RES, V99, P315, DOI 10.1093/cvr/cvt101; Dimitrow PP, 2016, POL ARCH MED WEWN, V126, P121, DOI 10.20452/pamw.3335; Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093; El Husseini D, 2014, J MOL CELL CARDIOL, V72, P146, DOI 10.1016/j.yjmcc.2014.02.014; Fernandez-Pisonero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109081; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gaudreault N, 2011, AM J CARDIOL, V108, P1305, DOI 10.1016/j.amjcard.2011.06.050; Gould ST, 2013, CIRC RES, V113, P186, DOI 10.1161/CIRCRESAHA.112.300154; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Helske S, 2007, CURR OPIN LIPIDOL, V18, P483, DOI 10.1097/MOL.0b013e3282a66099; Henaut L, 2016, EXPERT OPIN THER TAR, V20, P89, DOI 10.1517/14728222.2015.1081685; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kastellanos SS, 2009, HELL J CARDIOL, V50, P26; Kobayashi J, 2013, GEN THORAC CARDIOVAS, V61, P663, DOI 10.1007/s11748-013-0242-4; Kolasa-Trela R, 2015, J CARDIOL, V65, P501, DOI 10.1016/j.jjcc.2014.07.019; Konya H, 2014, WORLD J DIABETES, V5, P678, DOI 10.4239/wjd.v5.i5.678; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Larrouy D, 2002, J PHYSL, V543, P373; Maejima Y, 2003, ATHEROSCLEROSIS, V167, P89, DOI 10.1016/S0021-9150(02)00384-2; Mathieu P, 2014, CAN J CARDIOL, V30, P982, DOI 10.1016/j.cjca.2014.03.029; Niebauer J, 1999, J AM COLL CARDIOL, V34, P1201, DOI 10.1016/S0735-1097(99)00304-6; OLSSON M, 1994, J AM COLL CARDIOL, V23, P1162, DOI 10.1016/0735-1097(94)90606-8; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Rodriguez-Nunez I, 2016, ARCH CARDIOL MEX, V21; Sim M, 2013, INT J SPORT NUTR EXE, V23, P178, DOI 10.1123/ijsnem.23.2.178; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Steiner I, 2007, VIRCHOWS ARCH, V450, P653, DOI 10.1007/s00428-007-0430-7; Swierszcz J, 2012, J HEART VALVE DIS, V21, P599; Syvaranta S, 2012, ATHEROSCLEROSIS, V221, P366, DOI 10.1016/j.atherosclerosis.2011.12.034; Syvaranta S, 2010, ARTERIOSCL THROM VAS, V30, P1220, DOI 10.1161/ATVBAHA.109.198267; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Van Craenenbroeck A. H., 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/216534; Volaklis KA, 2015, J SPORT SCI MED, V14, P91; Wahl P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096024; Wang NF, 2009, INT HEART J, V50, P291, DOI 10.1536/ihj.50.291; Wang W, 2014, ARTERIOSCL THROM VAS, V34, P1924, DOI 10.1161/ATVBAHA.114.303852	45	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173787	10.1371/journal.pone.0173787	http://dx.doi.org/10.1371/journal.pone.0173787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291817	Green Submitted, gold, Green Published			2022-12-26	WOS:000396094700039
J	Obot, MS; Li, CC; Fang, T; Chen, JQ				Obot, Mfrekemfon Samuel; Li, Changcheng; Fang, Ting; Chen, Jinquan			Measurement of thermal properties of white radish (R-raphanistrum) using easily constructed probes	PLOS ONE			English	Article							THERMOPHYSICAL PROPERTIES; MOISTURE-CONTENT; CONDUCTIVITY; DIFFUSIVITY; L.; TEMPERATURE; POTATO; HEAT	Thermal properties are necessary for the design and control of processes and storage facilities of food materials. This study proposes the measurement of thermal properties using easily constructed probes with specific heat capacity calculated, as opposed to the use of Differential Scanning Calorimeter (DSC) or other. These probes were constructed and used to measure thermal properties of white radish in the temperature range of 80-20 degrees C and moisture content of 91-6.1% wb. Results showed thermal properties were within the range of 0.71-0.111 Wm(-1) C-1 for thermal conductivity, 1.869x10(-7)-0.72x10(-8) m(2) s-(1) for thermal diffusivity and 4.316-1.977 kJ kg(-1) C-1 for specific heat capacity. These results agree with reports for similar products studied using DSC and commercially available line heat source probes. Empirical models were developed for each property through linear multiple regressions. The data generated would be useful in modeling and control of its processing and equipment design.	[Obot, Mfrekemfon Samuel; Li, Changcheng; Fang, Ting; Chen, Jinquan] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou, Fujian, Peoples R China; [Obot, Mfrekemfon Samuel] Univ Uyo, Fac Engn, Dept Agr & Food Engn, Uyo, Akwa Ibom State, Nigeria	Fujian Agriculture & Forestry University; University of Uyo	Chen, JQ (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou, Fujian, Peoples R China.	chenjq6613@163.com			National Natural Science Foundation of China [31401597]; High Level University Construction Funds: Research on the innovation of the Sub Tropical Special Agricultural Products processing and Safety Control Technology [612014042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Level University Construction Funds: Research on the innovation of the Sub Tropical Special Agricultural Products processing and Safety Control Technology	This research was funded by National Natural Science Foundation of China, http://www.nsfc.gov.cn/ (grant number 31401597; funding received by TF); and High Level University Construction Funds: Research on the innovation of the Sub Tropical Special Agricultural Products processing and Safety Control Technology (grant number 612014042; funding received by The Dean, College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairi A, 2007, J FOOD ENG, V78, P669, DOI 10.1016/j.jfoodeng.2005.11.004; Gutierrez Rosa Martha Perez, 2004, ScientificWorldJournal, V4, P811; HALLIDAY PJ, 1995, J FOOD ENG, V26, P273, DOI 10.1016/0260-8774(94)00047-D; Jaramillo-Flores ME, 2000, J FOOD ENG, V46, P139, DOI 10.1016/S0260-8774(00)00074-1; Kim YH, 2011, KOREAN J CHEM ENG, V28, P1924, DOI 10.1007/s11814-011-0048-y; MAGEE TRA, 1995, J FOOD ENG, V25, P223, DOI 10.1016/0260-8774(94)00025-5; Modi SK, 2014, INT J HEAT MASS TRAN, V78, P354, DOI 10.1016/j.ijheatmasstransfer.2014.06.076; Mohsenin N. N., 1980, THERMAL PROPERTIES F; NESVADBA P, 2005, ENG PROPERTIES FOODS, P149; Njie DN, 1998, J FOOD ENG, V37, P63, DOI 10.1016/S0260-8774(98)00068-5; Quirion SB, 2012, J FOOD ENG, V113, P27, DOI 10.1016/j.jfoodeng.2012.05.032; Shrivastava M, 1999, J FOOD ENG, V39, P255, DOI 10.1016/S0260-8774(98)00145-9; Sirisomboon P, 2012, BIOSYST ENG, V113, P402, DOI 10.1016/j.biosystemseng.2012.09.013; SWEAT VE, 1974, T ASAE, V17, P56; Tansakul A, 2006, J FOOD ENG, V73, P276, DOI 10.1016/j.jfoodeng.2005.01.035; Tansakul A, 2008, J FOOD ENG, V87, P91, DOI 10.1016/j.jfoodeng.2007.11.016; Vagenas Gk, 1990, ENG FOOD, P399; Yu DU, 2015, J FOOD ENG, V165, P156, DOI [10.1016/f.foodeng.2015.05.012, 10.1016/j.jfoodeng.2015.05.012]	18	2	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0171016	10.1371/journal.pone.0171016	http://dx.doi.org/10.1371/journal.pone.0171016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288175	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400005
J	Valbusa, F; Bonapace, S; Agnoletti, D; Scala, L; Grillo, C; Arduini, P; Turcato, E; Mantovani, A; Zoppini, G; Arcaro, G; Byrne, C; Targher, G				Valbusa, Filippo; Bonapace, Stefano; Agnoletti, Davide; Scala, Luca; Grillo, Cristina; Arduini, Pietro; Turcato, Emanuela; Mantovani, Alessandro; Zoppini, Giacomo; Arcaro, Guido; Byrne, Christopher; Targher, Giovanni			Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; PREVALENCE; REHOSPITALIZATION; METAANALYSIS; ASSOCIATION; DYSFUNCTION; DIAGNOSIS; REGISTRY	Nonalcoholic fatty liver disease (NAFLD) is an emerging risk factor for heart failure (HF). Although some progress has been made in improving survival among patients admitted for HF, the rates of hospital readmissions and the related costs continue to rise dramatically. We sought to examine whether NAFLD and its severity (diagnosed at hospital admission) was independently associated with a higher risk of 1-year all-cause and cardiac re-hospitalization in patients admitted for acute HF. We studied 212 elderly patients who were consecutively admitted with acute HF to the Hospital of Negrar (Verona) over a 1-year period. Diagnosis of NAFLD was based on ultrasonography, whereas the severity of advanced NAFLD fibrosis was based on the fibrosis (FIB)-4 score and other non-invasive fibrosis scores. Patients with acute myocardial infarction, severe valvular heart diseases, endstage renal disease, cancer, known liver diseases or decompensated cirrhosis were excluded. Cox regression was used to estimate hazard ratios (HR) for the associations between NAFLD and the outcome(s) of interest. The cumulative rate of 1-year all-cause re-hospitalizations was 46.7% (n = 99, mainly due to cardiac causes). Patients with NAFLD (n = 109; 51.4%) had remarkably higher 1-year all-cause and cardiac re-hospitalization rates compared with their counterparts without NAFLD. Both event rates were particularly increased in those with advanced NAFLD fibrosis. NAFLD was associated with a 5-fold increased risk of 1-year all-cause re-hospitalization (adjusted-hazard ratio 5.05, 95% confidence intervals 2.78-9.10, p<0.0001) after adjustment for established risk factors and potential confounders. Similar results were found for 1-year cardiac re-hospitalization (adjusted-hazard ratio 8.05, 95% confidence intervals 3.77-15.8, p<0.0001). In conclusion, NAFLD and its severity were strongly and independently associated with an increased risk of 1-year all-cause and cardiac re-hospitalization in elderly patients admitted with acute HF.	[Valbusa, Filippo; Agnoletti, Davide; Scala, Luca; Grillo, Cristina; Arcaro, Guido] Sacro Cuore Hosp, Div Gen Med, Verona, Italy; [Bonapace, Stefano] Sacro Cuore Hosp, Div Cardiol, Verona, Italy; [Arduini, Pietro; Turcato, Emanuela] Sacro Cuore Hosp, Div Geriatr, Verona, Italy; [Mantovani, Alessandro; Zoppini, Giacomo; Targher, Giovanni] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy; [Mantovani, Alessandro; Zoppini, Giacomo; Targher, Giovanni] Azienda Osped Univ Integrata Verona, Verona, Italy; [Byrne, Christopher] Univ Southampton, Nutr & Metab, Fac Med, Southampton, Hants, England; [Byrne, Christopher] Southampton Univ Hosp, Southampton NIHR Biomed Res Ctr, Southampton, Hants, England	IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Southampton; University of Southampton	Targher, G (corresponding author), Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy.; Targher, G (corresponding author), Azienda Osped Univ Integrata Verona, Verona, Italy.	giovanni.targher@univr.it	Mantovani, Alessandro/AAB-9015-2019; Targher, Giovanni/AAB-9008-2019; zoppini, giacomo/AAA-9000-2022; Agnoletti, Davide/K-1441-2016	Mantovani, Alessandro/0000-0002-7271-6329; Targher, Giovanni/0000-0002-4325-3900; zoppini, giacomo/0000-0003-1085-554X; Agnoletti, Davide/0000-0001-8108-7133; Byrne, Christopher D/0000-0001-6322-7753; Bonapace, Stefano/0000-0001-9122-2642	Southampton National Institute for Health Research Biomedical Research Centre; University School of Medicine of Verona, Verona, Italy	Southampton National Institute for Health Research Biomedical Research Centre; University School of Medicine of Verona, Verona, Italy	The authors received no specific funding for this work. However, CDB is supported in part by the Southampton National Institute for Health Research Biomedical Research Centre. GT is supported in part by grants from the University School of Medicine of Verona, Verona, Italy.	Alonso A, 2014, HEART, V100, P1511, DOI 10.1136/heartjnl-2014-305756; Alvarez AM, 2011, INT J ANGIOL, V20, P135, DOI 10.1055/s-0031-1284434; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Byrne CD, 2016, GASTROENTEROLOGY, V150, P7, DOI 10.1053/j.gastro.2015.11.016; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Dhingra R, 2010, ARTERIOSCL THROM VAS, V30, P1855, DOI 10.1161/ATVBAHA.110.207340; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Graner M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001979; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Karajamaki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937; Kociol RD, 2011, CIRC-HEART FAIL, V4, P628, DOI 10.1161/CIRCHEARTFAILURE.111.962290; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lonardo A, 2016, WORLD J GASTROENTERO, V22, P9674, DOI 10.3748/wjg.v22.i44.9674; Lonardo A, 2015, DIGEST LIVER DIS, V47, P997, DOI 10.1016/j.dld.2015.08.004; Mantovani A, 2016, DIGEST DIS SCI, V61, P1246, DOI 10.1007/s10620-016-4040-6; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; McPherson S., 2016, AM J GASTROENTEROL; Park CC, 2017, GASTROENTEROLOGY, V152, P598, DOI 10.1053/j.gastro.2016.10.026; Poelzl G, 2009, CIRC-HEART FAIL, V2, P294, DOI 10.1161/CIRCHEARTFAILURE.108.826735; Santaguida PL, 2014, HEART FAIL REV, V19, P453, DOI 10.1007/s10741-014-9442-y; Siegelman ES, 2001, SEMIN LIVER DIS, V21, P71, DOI 10.1055/s-2001-12930; Targher G, 2017, EUR J HEART FAIL, V19, P54, DOI 10.1002/ejhf.679; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Targher G, 2016, INT J CARDIOL, V203, P587, DOI 10.1016/j.ijcard.2015.10.207; Targher G, 2013, CLIN SCI, V125, P301, DOI 10.1042/CS20130036; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Valbusa F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002760; van Riet EES, 2016, EUR J HEART FAIL, V18, P242, DOI 10.1002/ejhf.483; VanWagner LB, 2015, HEPATOLOGY, V62, P773, DOI 10.1002/hep.27869; Wang YJ, 2013, HEART, V99, P163, DOI 10.1136/heartjnl-2012-302972; Wannamethee SG, 2012, ARTERIOSCL THROM VAS, V32, P830, DOI 10.1161/ATVBAHA.111.240457	34	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173398	10.1371/journal.pone.0173398	http://dx.doi.org/10.1371/journal.pone.0173398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288193	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396092400015
J	Lee, AL; Ung, HM; Sands, LP; Kikis, EA				Lee, Amy L.; Ung, Hailey M.; Sands, L. Paul; Kikis, Elise A.			A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles	PLOS ONE			English	Article							CAG REPEAT LENGTH; MOLECULAR CHAPERONES; MUTANT HUNTINGTIN; TRINUCLEOTIDE REPEAT; POLYGLUTAMINE DISEASE; PROTEIN AGGREGATION; CASPASE CLEAVAGE; DYSFUNCTION; NEURODEGENERATION; EXPANSION	Expanded polyglutamine repeats in different proteins are the known determinants of at least nine progressive neurodegenerative disorders whose symptoms include cognitive and motor impairment that worsen as patients age. One such disorder is Huntington's Disease (HD) that is caused by a polyglutamine expansion in the human huntingtin protein (htt). The polyglutamine expansion destabilizes htt leading to protein misfolding, which in turn triggers neurodegeneration and the disruption of energy metabolism in muscle cells. However, the molecular mechanisms that underlie htt proteotoxicity have been somewhat elusive, and the muscle phenotypes have not been well studied. To generate tools to elucidate the basis for muscle dysfunction, we engineered Caenorhabditis elegans to express a disease-associated 513 amino acid fragment of human htt in body wall muscle cells. We show that this htt fragment aggregates in C. elegans in a polyglutamine length-dependent manner and is toxic. Toxicity manifests as motor impairment and a shortened lifespan. Compared to previous models, the data suggest that the protein context in which a polyglutamine tract is embedded alters aggregation propensity and toxicity, likely by affecting interactions with the muscle cell environment.	[Lee, Amy L.; Ung, Hailey M.; Sands, L. Paul; Kikis, Elise A.] Univ South Sewanee, Dept Biol, Sewanee, TN 37383 USA; [Lee, Amy L.] deCODE Genet, Reykjavik, Iceland	Sewanee: University of the South	Kikis, EA (corresponding author), Univ South Sewanee, Dept Biol, Sewanee, TN 37383 USA.	eakikis@sewanee.edu			University of the South; Emory University Integrated Cellular Imaging Microscopy Core	University of the South; Emory University Integrated Cellular Imaging Microscopy Core	There were no external sources of funding for this work. All funding was provided by internal support from the University of the South including Faculty Development Grants and a Kennedy Endowed Faculty Fellowship to EK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to the laboratory of Richard Morimoto at Northwestern University for the equipment used to generate transgenic animals, as well as for fruitful conversations. The laboratory of Janine Kirstein at the Leibniz Institute for Molecular Pharmacology provided assistance with transgene integration. Matthew Rudd of the University of the South provided assistance with statistical analyses. Last but not least, this research project was supported in part by the Emory University Integrated Cellular Imaging Microscopy Core.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bhat KP, 2014, P NATL ACAD SCI USA, V111, P5706, DOI 10.1073/pnas.1402215111; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Butterworth NJ, 1998, NEUROSCIENCE, V87, P49, DOI 10.1016/S0306-4522(98)00129-8; CAI Yanhui, 2006, ENG SURVERYING MAPPI, V15, P41, DOI DOI 10.1093/HMG/DDL017; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chai YH, 1999, J NEUROSCI, V19, P10338; Christie NTM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096835; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-100; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Huntington G, 2003, J NEUROPSYCH CLIN N, V15, P109, DOI 10.1176/appi.neuropsych.15.1.109; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kikis EA, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0161-2; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lejeune FX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-91; Lodi R, 2000, ANN NEUROL, V48, P72; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Parker JA, 2012, J NEUROSCI, V32, P12630, DOI 10.1523/JNEUROSCI.0277-12.2012; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020; Sahl SJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00895; Sahoo B, 2014, BIOCHEMISTRY-US, V53, P3897, DOI 10.1021/bi500300c; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Tourette C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001895; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang HJ, 2009, ACTA GEOLOGICA SICHU, V29, p11 , DOI DOI 10.1093/HMG/DDN404; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Zhang X, 2005, PHYS PLASMAS, V12, P1; Zielonka D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00380	51	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173644	10.1371/journal.pone.0173644	http://dx.doi.org/10.1371/journal.pone.0173644			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282438	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800061
J	Li, HL; Gu, XH; Li, BJ; Chen, X; Lin, HR; Xia, JH				Li, Hong Lian; Gu, Xiao Hui; Li, Bi Jun; Chen, Xiao; Lin, Hao Ran; Xia, Jun Hong			Characterization and functional analysis of hypoxia-inducible factor HIF1 alpha and its inhibitor HIF1 alpha n in tilapia	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HIF-ALPHA ISOFORMS; AQUATIC HYPOXIA; GENE-EXPRESSION; FACTOR-I; TRANSCRIPTIONAL REGULATION; CARDIORESPIRATORY FUNCTION; BLOOD PARAMETERS; FISH; OXYGEN	Hypoxia is a major cause of fish morbidity and mortality in the aquatic environment. Hypoxia-inducible factors are very important modulators in the transcriptional response to hypoxic stress. In this study, we characterized and conducted functional analysis of hypoxia-inducible factor HIF1 alpha and its inhibitor HIF1 alpha n in Nile tilapia (Oreochromis niloticus). By cloning and Sanger sequencing, we obtained the full length cDNA sequences for HIF1 alpha (2686bp) and HIF1 alpha n (1308bp), respectively. The CDS of HIF1 alpha includes 15 exons encoding 768 amino acid residues and the CDS of HIF1 alpha n contains 8 exons encoding 354 amino acid residues. The complete CDS sequences of HIF1 alpha and HIF1 alpha n cloned from tilapia shared very high homology with known genes from other fishes. HIF1 alpha show differentiated expression in different tissues (brain, heart, gill, spleen, liver) and at different hypoxia exposure times (6h, 12h, 24h). HIF1 alpha n expression level under hypoxia is generally increased (6h, 12h, 24h) and shows extremely highly upregulation in brain tissue under hypoxia. A functional determination site analysis in the protein sequences between fish and land animals identified 21 amino acid sites in HIF1 alpha and 2 sites in HIF1 alpha n as significantly associated sites (alpha = 0.05). Phylogenetic tree-based positive selection analysis suggested 22 sites in HIF1 alpha as positively selected sites with a p-value of at least 95% for fish lineages compared to the land animals. Our study could be important for clarifying the mechanism of fish adaptation to aquatic hypoxia environment.	[Xia, Jun Hong] Sun Yat Sen Univ, Coll Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; Sun Yat Sen Univ, Coll Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xia, JH (corresponding author), Sun Yat Sen Univ, Coll Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	xiajunh3@mail.sysu.edu.cn	LI, HONGLIAN/Q-9905-2019; lin, haoran/GXH-3030-2022; li, bijun/AAP-8969-2020	Bijun, Li/0000-0003-4435-4364	National Natural Science Foundation of China [31572612]; Natural Science Foundation of Guangdong Province, China [2015A030313150]; Special Fund for Marine Fisheries-Scientific Research of Guangdong Province [A201501A04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Special Fund for Marine Fisheries-Scientific Research of Guangdong Province	This work was supported by the National Natural Science Foundation of China (No.31572612), Natural Science Foundation of Guangdong Province, China (No. 2015A030313150), Special Fund for Marine Fisheries-Scientific Research of Guangdong Province (A201501A04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affonso EG, 2002, COMP BIOCHEM PHYS C, V133, P375, DOI 10.1016/S1532-0456(02)00127-8; Baptista RB, 2016, FISH PHYSL BIOCH; Belao TC, 2015, COMP BIOCHEM PHYS A, V187, P130, DOI 10.1016/j.cbpa.2015.05.010; Belao TC, 2011, J COMP PHYSIOL B, V181, P905, DOI 10.1007/s00360-011-0577-z; Bernier NJ, 2012, J EXP BIOL, V215, P2273, DOI 10.1242/jeb.066183; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Cheung CHY, 2014, ECOTOXICOLOGY, V23, P1260, DOI 10.1007/s10646-014-1269-8; Chi W, 2013, FEBS OPEN BIO, V3, P479, DOI 10.1016/j.fob.2013.09.004; Choi K, 2007, J AQUAT ANIM HEALTH, V19, P128, DOI 10.1577/H06-010.1; Del Rizzo PA, 2012, MOL CELL BIOL, V32, P4044, DOI 10.1128/MCB.00513-12; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farcy E, 2007, COMP BIOCHEM PHYS B, V146, P540, DOI 10.1016/j.cbpb.2006.12.006; Froehlich HE, 2015, COMP BIOCHEM PHYS A, V189, P58, DOI 10.1016/j.cbpa.2015.07.016; Gallage S, 2016, FISH SHELLFISH IMMUN, V51, P271, DOI 10.1016/j.fsi.2016.02.024; Geng X, 2014, COMP BIOCHEM PHYS B, V169, P38, DOI 10.1016/j.cbpb.2013.12.007; Gil M, 2013, MOL BIOL EVOL, V30, P1270, DOI 10.1093/molbev/mst034; Guzy RD, 2007, ANTIOXID REDOX SIGN, V9, P1317, DOI 10.1089/ars.2007.1708; Heise K, 2006, COMP BIOCHEM PHYS A, V143, P494, DOI 10.1016/j.cbpa.2006.01.014; Jessen LE, 2013, NUCLEIC ACIDS RES, V41, pW286, DOI 10.1093/nar/gkt497; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kietzmann T, 2003, BLOOD, V101, P907, DOI 10.1182/blood-2002-06-1693; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Landry CA, 2007, COMP BIOCHEM PHYS A, V148, P317, DOI 10.1016/j.cbpa.2007.04.023; Law SHW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-15; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mandic M, 2009, P ROY SOC B-BIOL SCI, V276, P735, DOI 10.1098/rspb.2008.1235; Mu WJ, 2015, MAR ENVIRON RES, V110, P142, DOI 10.1016/j.marenvres.2015.04.008; Neilan RM, 2014, J THEOR BIOL, V343, P54, DOI 10.1016/j.jtbi.2013.11.004; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; Rahman MS, 2007, GENE, V396, P273, DOI 10.1016/j.gene.2007.03.009; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Ravenna L, 2016, FEBS J, V283, P993, DOI 10.1111/febs.13572; Rimoldi S, 2012, MOL BIOL REP, V39, P4009, DOI 10.1007/s11033-011-1181-8; Rissanen E, 2006, J EXP BIOL, V209, P994, DOI 10.1242/jeb.02103; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Shang EHH, 2004, ENVIRON SCI TECHNOL, V38, P4763, DOI 10.1021/es0496423; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Shen RJ, 2010, COMP BIOCHEM PHYS B, V157, P273, DOI 10.1016/j.cbpb.2010.06.013; So JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109517; Soitamo AJ, 2001, J BIOL CHEM, V276, P19699, DOI 10.1074/jbc.M009057200; Speers-Roesch B, 2013, J COMP PHYSIOL B, V183, P773, DOI 10.1007/s00360-013-0750-7; Speers-Roesch B, 2010, AM J PHYSIOL-REG I, V298, pR104, DOI 10.1152/ajpregu.00418.2009; Sun SM, 2016, COMP BIOCHEM PHYS B, V196, P48, DOI 10.1016/j.cbpb.2016.02.002; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Urbina MA, 2012, J COMP PHYSIOL B, V182, P1057, DOI 10.1007/s00360-012-0678-3; Val AL, 2015, COMP BIOCHEM PHYS A, V184, P125, DOI 10.1016/j.cbpa.2015.02.020; van Rooijen E, 2011, METHOD CELL BIOL, V105, P163, DOI 10.1016/B978-0-12-381320-6.00007-2; Vianen GJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE318, DOI 10.1152/ajpendo.00187.2001; Wang Y, 2015, GENOME BIOL EVOL, V7, P2970, DOI 10.1093/gbe/evv192; Wang Y, 2015, GENE, V565, P211, DOI 10.1016/j.gene.2015.04.023; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Xiao WH, 2015, SCI CHINA LIFE SCI, V58, P148, DOI 10.1007/s11427-015-4801-z; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zeraik VM, 2013, COMP BIOCHEM PHYS A, V166, P17, DOI 10.1016/j.cbpa.2013.04.024; Zhao Y, 2014, BIOCHEM BIOPH RES CO, V454, P183, DOI 10.1016/j.bbrc.2014.10.068; Zhu CD, 2013, J COMP PHYSIOL B, V183, P1005, DOI 10.1007/s00360-013-0762-3	61	23	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173478	10.1371/journal.pone.0173478	http://dx.doi.org/10.1371/journal.pone.0173478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278251	gold, Green Published, Green Submitted			2022-12-26	WOS:000396087900100
J	Lyu, L; Wang, BL; Xiong, CY; Zhang, XT; Zhang, XY; Zhang, JJ				Lyu, Lin; Wang, Baolu; Xiong, Chaoyang; Zhang, Xiaotian; Zhang, Xiaoyan; Zhang, Junjie			Selective export of autotaxin from the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY SECRETORY PATHWAY; LYSOPHOSPHOLIPASE-D; PI3K/AKT/MTOR PATHWAY; ANCHORED PROTEINS; CELL-MIGRATION; P24 PROTEINS; CANCER; LPA; ER; EXPRESSION	Autotaxin (ATX) or ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2) is a secretory glycoprotein and functions as the key enzyme for lysophosphatidic acid generation. The mechanism of ATX protein trafficking is largely unknown. Here, we demonstrated that p23, a member of the p24 protein family, was the protein-sorting receptor required for endoplasmic reticulum (ER) export of ATX. A di-phenylalanine (Phe-838/Phe-839) motif in the human ATX C-terminal region was identified as a transport signal essential for the ATX-p23 interaction. Knockdown of individual Sec24 isoforms by siRNA revealed that ER export of ATX was impaired only if Sec24C was down-regulated. These results suggest that ATX is selectively exported from the ER through a p23, Sec24C-dependent pathway. In addition, it was found that AKT signaling played a role in ATX secretion regulation to facilitate ATX ER export by enhancing the nuclear factor of activated T cell-mediated p23 expression. Furthermore, the di-hydrophobic amino acid motifs (FY) also existed in the C-terminal regions of human ENPP1 and ENPP3. Such a p23, Sec24C-dependent selective ER export mechanism is conserved among these ENPP family members.	[Lyu, Lin; Wang, Baolu; Xiong, Chaoyang; Zhang, Xiaotian; Zhang, Xiaoyan; Zhang, Junjie] Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Inst Cell Biol, Beijing 100875, Peoples R China; [Wang, Baolu] Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Xian 710062, Shanxi, Peoples R China; [Xiong, Chaoyang] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Beijing Normal University; Shaanxi Normal University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, JJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat Biol, Minist Educ,Inst Cell Biol, Beijing 100875, Peoples R China.	jjzhang@bnu.edu.cn		Zhang, Junjie/0000-0001-8809-1485	National Natural Science Foundation of China [31470765, 31500619]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 31470765 and 31500619 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Contreras I, 2004, PLANT CELL PHYSIOL, V45, P1779, DOI 10.1093/pcp/pch200; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Im DS, 2010, ACTA PHARMACOL SIN, V31, P1213, DOI 10.1038/aps.2010.135; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Jansen S, 2007, J BIOL CHEM, V282, P11084, DOI 10.1074/jbc.M611503200; Jansen S, 2009, J BIOL CHEM, V284, P14296, DOI 10.1074/jbc.M900790200; Kim MS, 2014, J BIOL CHEM, V289, P31349, DOI 10.1074/jbc.M114.587188; Kinoshita T, 2013, BBA-MOL CELL RES, V1833, P2473, DOI 10.1016/j.bbamcr.2013.01.027; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Li S, 2009, BIOCHEM BIOPH RES CO, V378, P264, DOI 10.1016/j.bbrc.2008.11.047; Li X, 2015, BIOCHEM BIOPH RES CO, V463, P483, DOI 10.1016/j.bbrc.2015.04.151; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Liu SC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-21; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Nishimasu H, 2012, TRENDS PHARMACOL SCI, V33, P138, DOI 10.1016/j.tips.2011.12.004; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nufer O, 2002, J CELL SCI, V115, P619; Pradere JP, 2007, BBA-MOL CELL BIOL L, V1771, P93, DOI 10.1016/j.bbalip.2006.11.010; Pua TL, 2009, FUTURE ONCOL, V5, P1659, DOI 10.2217/FON.09.120; Rancoule C, 2014, BIOCHIMIE, V96, P140, DOI 10.1016/j.biochi.2013.04.010; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Tabchy A, 2011, NAT STRUCT MOL BIOL, V18, P117, DOI 10.1038/nsmb0211-117; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Willier S, 2013, BIOL CELL, V105, P317, DOI 10.1111/boc.201300011; Wu Guangyu, 2012, Subcell Biochem, V63, P83, DOI 10.1007/978-94-007-4765-4_5; Wu T, 2014, FASEB J, V28, P861, DOI 10.1096/fj.13-232868; Yuelling LM, 2008, BBA-MOL CELL BIOL L, V1781, P525, DOI 10.1016/j.bbalip.2008.04.009; Zaslavsky A, 2006, BBA-MOL CELL BIOL L, V1761, P1200, DOI 10.1016/j.bbalip.2006.08.011	48	11	11	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7011	7022		10.1074/jbc.M116.774356	http://dx.doi.org/10.1074/jbc.M116.774356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28298439	Green Published, hybrid			2022-12-26	WOS:000400478300013
J	Shukla, S; Abel, B; Chufan, EE; Ambudkar, SV				Shukla, Suneet; Abel, Biebele; Chufan, Eduardo E.; Ambudkar, Suresh V.			Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG TRANSPORTER; ATP-BINDING; ELECTRON-MICROSCOPY; CATALYTIC CYCLE; DRUG-BINDING; RESISTANCE; ABCB1; INHIBITION; MECHANISM	P-glycoprotein (P-gp) is a multidrug transporter that uses energy from ATP hydrolysis to export many structurally dissimilar hydrophobic and amphipathic compounds, including anticancer drugs from cells. Several structural studies on purified P-gp have been reported, but only limited and sometimes conflicting information is available on ligand interactions with the isolated transporter in a dodecyl-maltoside detergent environment. In this report we compared the biochemical properties of P-gp in native membranes, detergent micelles, and when reconstituted in artificial membranes. We found that the modulators zosuquidar, tariquidar, and elacridar stimulated the ATPase activity of purified human or mouse P-gp in a detergent micelle environment. In contrast, these drugs inhibited ATPase activity in native membranes or in proteoliposomes, with IC50 values in the 10-40 nM range. Similarly, a 30-150-fold decrease in the apparent affinity for verapamil and cyclic peptide inhibitor QZ59-SSS was observed in detergent micelles compared with native or artificial membranes. Together, these findings demonstrate that the high-affinity site is inaccessible because of either a conformational change or binding of detergent at the binding site in a detergent micelle environment. The ligands bind to a low-affinity site, resulting in altered modulation of P-gp ATPase activity. We, therefore, recommend studying structural and functional aspects of ligand interactions with purified P-gp and other ATP-binding cassette transporters that transport amphipathic or hydrophobic substrates in a detergent-free native or artificial membrane environment.	[Shukla, Suneet; Abel, Biebele; Chufan, Eduardo E.; Ambudkar, Suresh V.] NCI, Lab Cell Biol, Ctr Canc Res, NIH, 37 Convent Dr,Rm 2120, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambudkar, SV (corresponding author), NCI, Lab Cell Biol, Ctr Canc Res, NIH, 37 Convent Dr,Rm 2120, Bethesda, MD 20892 USA.	ambudkar@helix.nih.gov	Ambudkar, Suresh V/L-1317-2016		Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Beck A, 2013, BIOCHEMISTRY-US, V52, P3297, DOI 10.1021/bi400203d; Blatter XL, 2010, BIOPHYS J, V99, P3589, DOI 10.1016/j.bpj.2010.10.033; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Chufan EE, 2016, BIOCHEM PHARMACOL, V101, P40, DOI 10.1016/j.bcp.2015.12.007; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; Denisov IG, 2016, NAT STRUCT MOL BIOL, V23, P481, DOI 10.1038/nsmb.3195; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kapoor K., 2013, MOL MECH TUMOR CELL, P1; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2016, BIOCHEM BIOPH RES CO, V472, P379, DOI 10.1016/j.bbrc.2016.02.124; Loo TW, 2015, J BIOL CHEM, V290, P29389, DOI 10.1074/jbc.M115.695171; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; Maki N, 2003, J BIOL CHEM, V278, P18132, DOI 10.1074/jbc.M210413200; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Orlowski S, 1998, Cancer Biochem Biophys, V16, P85; Pluchino KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136396; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Rybczynska M, 2001, BRIT J CANCER, V84, P1405, DOI 10.1054/bjoc.2001.1776; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Singh S, 2014, CHEMBIOCHEM, V15, P157, DOI 10.1002/cbic.201300565; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Zoghbi ME, 2016, J BIOL CHEM, V291, P4453, DOI 10.1074/jbc.M115.698498	43	32	32	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7066	7076		10.1074/jbc.M116.771634	http://dx.doi.org/10.1074/jbc.M116.771634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28283574	Green Published, hybrid			2022-12-26	WOS:000400478300017
J	Amoozgar, B; Wei, XL; Lee, JH; Bloomer, M; Zhao, ZT; Coh, P; He, F; Luan, L; Xie, C; Han, Y				Amoozgar, Behzad; Wei, Xiaoling; Lee, Jun Hui; Bloomer, Michele; Zhao, Zhengtuo; Coh, Paul; He, Fei; Luan, Lan; Xie, Chong; Han, Ying			A novel flexible microfluidic meshwork to reduce fibrosis in glaucoma surgery	PLOS ONE			English	Article							ADJUNCTIVE MITOMYCIN-C; MACROPOROUS NANOELECTRONIC NETWORKS; OPEN-ANGLE GLAUCOMA; AHMED GLAUCOMA; VALVE IMPLANTATION; DIFFERENT BIOMATERIALS; HYPERTENSIVE PHASE; TREATMENT OUTCOMES; AMNIOTIC MEMBRANE; TISSUE-RESPONSE	Purpose/Relevance Fibrosis and hence capsule formation around the glaucoma implants are the main reasons for glaucoma implant failure. To address these issues, we designed a microfluidic meshwork and tested its biocompatibility in a rabbit eye model. The amount of fibrosis elicited by the microfluidic meshwork was compared to the amount elicited by the plate of conventional glaucoma drainage device. Methods Six eyes from 3 New Zealand albino rabbits were randomized to receive either the novel microfluidic meshwork or a plate of Ahmed glaucoma valve model PF7 (AGV PF7). The flex-ible microfluidic implant was made from negative photoresist SU-8 by using micro-fabrica-tion techniques. The overall size of the meshwork was 7 mm x 7 mm with a grid period of 100 mu m Both implants were placed in the subtenon space at the supratemporal quadrant in a standard fashion. There was no communication between the implants and the anterior chamber via a tube. All animal eyes were examined for signs of infection and implant erosion on days 1, 3, 7, and 14 and then monthly. Exenterations were performed in which the entire orbital contents were removed at 3 months. Histology slides of the implant and the surrounding tissues were prepared and stained with hematoxylin-eosin. Thickness of the fibrous capsules beneath the implants were measured and compared with paired student's t-test between the two groups. Results The gross histological sections showed that nearly no capsule formed around the microflui-dic meshwork in contrast to the thick capsule formed around the plate of AGV PF7. Thick-ness of the fibrotic capsules beneath the AGV PF7 plate from the 3 rabbit eyes was 90 mu m, 82 mu m, and 95 mu m, respectively. The thickness at the bottom of fibrotic capsules around the new microfluidic implant were 1 mu m, 2 mu m, and 1 mu m, respectively. The difference in thickness of capsule between the two groups was significant (P = 0.002). No complications were noticed in the 6 eyes, and both implants were tolerated well by all rabbits. Conclusion The microfluidic meshwork elicited minimal fibrosis and capsule formation after 3-months implantation in a rabbit model. This provides promising evidence to aid in future development of a new glaucoma drainage implant that will elicit minimal scar formation and provide better long-term surgical outcomes.	[Amoozgar, Behzad; Lee, Jun Hui; Bloomer, Michele; Coh, Paul; Han, Ying] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Wei, Xiaoling; Zhao, Zhengtuo; He, Fei; Xie, Chong] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Luan, Lan] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Han, Y (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.; Xie, C (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	Chongxie@utexas.edu; Ying.Han@ucsf.edu	Wei, Xiaoling/K-4552-2012	Wei, Xiaoling/0000-0002-0099-2260; Luan, Lan/0000-0002-5327-2240	UT Austin Cockrell School of Engineering and Department of Biomedical Engineering start-up fund; Office of the Assistant Secretary of Defense for Health Affairs through the Clinical and Rehabilitative Medicine Research Program [W81XWH-16-1-0580]; Man May Seen Seed Grant; UCSF Catalyst Award; Core Grant [EY00216]; Research to Prevent Blindness unrestricted funding; NATIONAL EYE INSTITUTE [P30EY002162] Funding Source: NIH RePORTER	UT Austin Cockrell School of Engineering and Department of Biomedical Engineering start-up fund; Office of the Assistant Secretary of Defense for Health Affairs through the Clinical and Rehabilitative Medicine Research Program; Man May Seen Seed Grant; UCSF Catalyst Award; Core Grant; Research to Prevent Blindness unrestricted funding(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by UT Austin Cockrell School of Engineering and Department of Biomedical Engineering start-up fund (CX), by the Office of the Assistant Secretary of Defense for Health Affairs through the Clinical and Rehabilitative Medicine Research Program under Award No. W81XWH-16-1-0580 (CX), by The Man May Seen Seed Grant (YH and CX), by UCSF Catalyst Award (YH and CX), by EY00216- Core Grant (YH) and by Research to Prevent Blindness unrestricted funding (YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JA, 2008, AM J OPHTHALMOL, V146, P276, DOI 10.1016/j.ajo.2008.04.008; [Anonymous], 2008, SEMINARS IMMUNOLOGY; Ayyala RS, 2000, ARCH OPHTHALMOL-CHIC, V118, P1081, DOI 10.1001/archopht.118.8.1081; Ayyala RS, 1999, ARCH OPHTHALMOL-CHIC, V117, P233; Brandao LM, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/705915; Budenz DL, 2015, OPHTHALMOLOGY, V122, P308, DOI 10.1016/j.ophtha.2014.08.043; Caprioli J, 2011, AM J OPHTHALMOL, V152, P340, DOI 10.1016/j.ajo.2011.05.029; Costa VP, 2004, OPHTHALMOLOGY, V111, P1071, DOI 10.1016/j.ophtha.2003.09.037; Danesh-Meyer HV, 2002, ARCH OPHTHALMOL-CHIC, V120, P846; DeCroos FC, 2009, CURR EYE RES, V34, P562, DOI 10.1080/02713680902963167; Gedde SJ, 2013, CURR OPIN OPHTHALMOL, V24, P87, DOI 10.1097/ICU.0b013e32835cf0f5; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; GRESSEL MG, 1984, OPHTHALMOLOGY, V91, P1242; Hinkle DM, 2007, EUR J OPHTHALMOL, V17, P696, DOI 10.1177/112067210701700502; Ishida K, 2006, OPHTHALMOLOGY, V113, P1320, DOI 10.1016/j.ophtha.2006.04.020; Iwao K, 2014, J GLAUCOMA, V23, P88, DOI 10.1097/IJG.0b013e3182685167; Kim YG, 2009, J GLAUCOMA, V18, P443, DOI 10.1097/IJG.0b013e3181895e5c; Kurnaz E, 2005, EUR J OPHTHALMOL, V15, P27, DOI 10.1177/112067210501500105; Lama PJ, 2003, SURV OPHTHALMOL, V48, P314, DOI 10.1016/S0039-6257(03)00038-9; Law SK, 2005, OPHTHALMOLOGY, V112, P1514, DOI 10.1016/j.ophtha.2005.04.012; Lee JW, 2014, OPHTHALMIC RES, V51, P129, DOI 10.1159/000357097; Liu J, 2015, NAT NANOTECHNOL, V10, P629, DOI [10.1038/NNANO.2015.115, 10.1038/nnano.2015.115]; Liu J, 2013, P NATL ACAD SCI USA, V110, P6694, DOI 10.1073/pnas.1305209110; Nouri-Mahdavi K, 2003, AM J OPHTHALMOL, V136, P1001, DOI 10.1016/S0002-9394(03)00630-5; Pakravan M, 2014, OPHTHALMOLOGY, V121, P1693, DOI 10.1016/j.ophtha.2014.03.014; Paschalis EI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067404; Sahiner N, 2009, ARCH OPHTHALMOL-CHIC, V127, P448, DOI 10.1001/archophthalmol.2009.19; Susanna R, 2003, INVEST OPHTH VIS SCI, V44, pU313; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; Tanimoto SA, 2006, CURR OPIN OPHTHALMOL, V17, P132, DOI 10.1097/01.icu.0000193091.60185.27; Teixeira SH, 2012, J GLAUCOMA, V21, P342, DOI 10.1097/IJG.0b013e31820d7e4e; Thieme H, 2011, J GLAUCOMA, V20, P246, DOI 10.1097/IJG.0b013e3181e080ef; Turalba AV, 2014, CLIN OPHTHALMOL, V8, P1311, DOI 10.2147/OPTH.S64257; Vajaranant TS, 2012, AM J OPHTHALMOL, V154, P303, DOI 10.1016/j.ajo.2012.02.024; Van de Velde S, 2015, PROG BRAIN RES, V221, P319, DOI 10.1016/bs.pbr.2015.05.002; Wei X, ULTRAFLEXIBLE MICROF; Xie C, 2015, NAT MATER, V14, P1286, DOI [10.1038/NMAT4427, 10.1038/nmat4427]; Yamanaka O, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0134-8; Yazdani S, 2016, J GLAUCOMA, V25, P415, DOI 10.1097/IJG.0000000000000256	39	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172556	10.1371/journal.pone.0172556	http://dx.doi.org/10.1371/journal.pone.0172556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301490	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300016
J	Claessens, LC; Zonnenberg, IA; van den Dungen, FAM; Vermeulen, RJ; van Weissenbruch, MM				Claessens, L. C.; Zonnenberg, I. A.; van den Dungen, F. A. M.; Vermeulen, R. J.; van Weissenbruch, M. M.			Cerebral ultrasound abnormalities in preterm infants caused by late-onset sepsis	PLOS ONE			English	Article							WHITE-MATTER INJURY; INTRAVENTRICULAR HEMORRHAGE; NEONATAL INFECTION; CHILDREN; RISK	Introduction This study describes cerebral ultrasound abnormalities caused by late-onset sepsis (LOS) in very preterm infants with a gestational age of < 32 weeks and/or birthweight < 1500 grams. Methods The prospective study ("INFANT study") included 117 preterm infants with suspected LOS. Proven LOS was defined as a positive blood culture after 72 hours of life. In case of coagulase-negative staphylococci an elevated C-reactive protein was additionally required to establish proven LOS. Patients were identified as proven LOS and patients with only clinical symptoms of LOS. Cerebral ultrasound images were obtained in the first week after birth, during/after LOS and before discharge. Cerebral findings were divided in no/minor and major abnormalities. Results Eighty-six preterm infants had proven LOS and 31 preterm infants had only clinical signs of LOS. Four infants were excluded because pre-existing major brain abnormalities. No significant differences (p = 0.624) for incidence of major brain abnormalities on cerebral ultrasound were found. Conclusion No differences were revealed in prevalence of major brain abnormalities between the groups with proven LOS and with clinical signs of LOS. Both infants with a gram negative sepsis developed major brain abnormalities, whereas only two of 66 preterm infants coagulase- negative staphylococci sepsis developed major brain abnormalities.	[Claessens, L. C.; Zonnenberg, I. A.; van den Dungen, F. A. M.; van Weissenbruch, M. M.] Vrije Univ Amsterdam, Med Ctr, Dept Neonatol, Amsterdam, Netherlands; [Vermeulen, R. J.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Vermeulen, R. J.] MUMC, Dept Child Neurol, Maastricht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Zonnenberg, IA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Neonatol, Amsterdam, Netherlands.	i.zonnenberg@vumc.nl		Zonnenberg, Inge/0000-0002-9919-7696; van Weissenbruch, Mirjam M/0000-0002-8086-9552; Vermeulen, R. Jeroen/0000-0002-3503-3625	Fonds Nuts Ohra [0901-042, 1101-093]	Fonds Nuts Ohra	This work was supported by grants from Fonds Nuts Ohra (grant numbers 0901-042 and 1101-093), http://www.fondsnutsohra.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Bartels DB, 2007, ARCH DIS CHILD-FETAL, V92, P449; Benjamin Daniel K, 2004, J Perinatol, V24, P175, DOI 10.1038/sj.jp.7211068; Brouwer A, 2008, J PEDIATR-US, V152, P648, DOI 10.1016/j.jpeds.2007.10.005; Brunner B, 2013, J PEDIATR-US, V163, P23, DOI 10.1016/j.jpeds.2012.12.035; Chau V, 2012, PEDIATR RES, V71, P274, DOI 10.1038/pr.2011.40; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; DYKES FD, 1980, PEDIATRICS, V66, P42; Evans N, 1996, ARCH DIS CHILD-FETAL, V75, pF183, DOI 10.1136/fn.75.3.F183; Futagi Y, 2006, PEDIATR NEUROL, V34, P219, DOI 10.1016/j.pediatrneurol.2005.08.011; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Glass HC, 2008, PEDIATRICS, V122, P299, DOI 10.1542/peds.2007-2184; Graham EM, 2004, AM J OBSTET GYNECOL, V191, P1305, DOI 10.1016/j.ajog.2004.06.058; Kliegman R M, 1987, Curr Probl Pediatr, V17, P213; Leijser LM, 2009, EARLY HUM DEV, V85, P101, DOI 10.1016/j.earlhumdev.2008.11.010; Lucignano B, 2011, J CLIN MICROBIOL, V49, P2252, DOI 10.1128/JCM.02460-10; Paolucci M, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/120139; Rand KM, 2016, J PEDIATR-US, V170, P97, DOI 10.1016/j.jpeds.2015.11.017; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Sarvikivi E, 2010, J HOSP INFECT, V76, P156, DOI 10.1016/j.jhin.2010.03.020; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; VOLPE JJ, 1989, ANN NEUROL, V25, P109, DOI 10.1002/ana.410250202	26	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173227	10.1371/journal.pone.0173227	http://dx.doi.org/10.1371/journal.pone.0173227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301503	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300028
J	Harms, TM; Murphy, KT; Lyu, XD; Patterson, SS; Kinkead, KE; Dinsmore, SJ; Frese, PW				Harms, Tyler M.; Murphy, Kevin T.; Lyu, Xiaodan; Patterson, Shane S.; Kinkead, Karen E.; Dinsmore, Stephen J.; Frese, Paul W.			Using landscape habitat associations to prioritize areas of conservation action for terrestrial birds	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTIONS; ESTIMATING SITE OCCUPANCY; CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; COLONIZATION; MODELS; EXTINCTION; POPULATIONS; HOTSPOTS	Predicting species distributions has long been a valuable tool to plan and focus efforts for biodiversity conservation, particularly because such an approach allows researchers and managers to evaluate species distribution changes in response to various threats. Utilizing data from a long-term monitoring program and land cover data sets, we modeled the probability of occupancy and colonization for 38 bird Species of Greatest Conservation Need (SGCN) in the robust design occupancy modeling framework, and used results from the best models to predict occupancy and colonization on the Iowa landscape. Bird surveys were conducted at 292 properties from April to October, 2006-2014. We calculated landscape habitat characteristics at multiple spatial scales surrounding each of our surveyed properties to be used in our models and then used kriging in ArcGIS to create predictive maps of species distributions. We validated models with data from 2013 using the area under the receiver operating characteristic curve (AUC). Probability of occupancy ranged from 0.001 (SE < 0.001) to 0.995 (SE = 0.004) for all species and probability of colonization ranged from 0.001 (SE < 0.001) to 0.999 (SE < 0.001) for all species. AUC values for predictive models ranged from 0.525 - 0.924 for all species, with 17 species having predictive models considered useful (AUC > 0.70). The most important predictor for occupancy of grassland birds was percentage of the landscape in grassland habitat, and the most important predictor for woodland birds was percentage of the landscape in woodland habitat. This emphasizes the need for managers to restore specific habitats on the landscape. In an era during which funding continues to decrease for conservation agencies, our approach aids in determining where to focus limited resources to best conserve bird species of conservation concern.	[Harms, Tyler M.; Lyu, Xiaodan] Iowa State Univ, Ctr Survey Stat & Methodol, 208 Off & Lab Bldg,2401 Osborn Dr, Ames, IA 50011 USA; [Murphy, Kevin T.; Patterson, Shane S.; Dinsmore, Stephen J.] Iowa State Univ, Dept Nat Resource Ecol & Management, 339 Sci Hall 2,2310 Pammel Dr, Ames, IA USA; [Lyu, Xiaodan] Iowa State Univ, Dept Stat, 1121 Snedecor Hall,2438 Osborn Dr, Ames, IA USA; [Kinkead, Karen E.; Frese, Paul W.] Iowa Dept Nat Resources, Wildlife Div Program, Boone, IA USA	Iowa State University; Iowa State University; Iowa State University	Harms, TM (corresponding author), Iowa State Univ, Ctr Survey Stat & Methodol, 208 Off & Lab Bldg,2401 Osborn Dr, Ames, IA 50011 USA.	harmsy@iastate.edu		Lyu, Xiaodan/0000-0003-3715-7215	State Wildlife Grant Enhancement [S15AP00040]; State Wildlife Grants, a Landowner Incentive Program Grant under the U.S. Fish and Wildlife Service Wildlife and Sport Fish [T-6-R-1, T-6-R-2, T-6-R-3, T-6-R-4, T-6-R-5]; Restoration Program	State Wildlife Grant Enhancement; State Wildlife Grants, a Landowner Incentive Program Grant under the U.S. Fish and Wildlife Service Wildlife and Sport Fish; Restoration Program	The analysis portion of this project was funded by a State Wildlife Grant Enhancement (S15AP00040). Data collection for the project was funded by various State Wildlife Grants (T-6-R-1, T-6-R-2, T-6-R-3, T-6-R-4, T-6-R-5), a Landowner Incentive Program Grant under the U.S. Fish and Wildlife Service Wildlife and Sport Fish and Restoration Program. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2011, DIVERS DISTRIB, V17, P191, DOI 10.1111/j.1472-4642.2010.00737.x; Azerrad JM, 2006, LANDSCAPE URBAN PLAN, V77, P255, DOI 10.1016/j.landurbplan.2005.03.001; Bakker KK, 2002, CONSERV BIOL, V16, P1638, DOI 10.1046/j.1523-1739.2002.01328.x; Beyer H. L, 2012, GEOSPATIAL MODELLING; BirdLife International, 2000, THREAT BIRDS WORLD; BLONDEL J, 1981, STUDIES AVIAN BIOL, V6, P414; Bosso L, 2016, BIOL INVASIONS, V18, P1759, DOI 10.1007/s10530-016-1118-1; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Brotons L, 2007, DIVERS DISTRIB, V13, P276, DOI 10.1111/j.1472-4642.2007.00339.x; Buckland S.T., 2001, pi; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Comte L, 2013, DIVERS DISTRIB, V19, P996, DOI 10.1111/ddi.12078; Crooks KR, 2001, CONSERV BIOL, V15, P159, DOI 10.1046/j.1523-1739.2001.99379.x; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Davis M.B., 1992, GLOBAL WARMING BIOL, P297; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; DUNNING JB, 1995, CONSERV BIOL, V9, P542, DOI 10.1046/j.1523-1739.1995.09030542.x; ESRI, 2012, ARCGIS VER 10 1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferreira MT, 2016, CLIMATIC CHANGE, V138, P603, DOI 10.1007/s10584-016-1754-6; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fleishman E, 2001, CONSERV BIOL, V15, P1674, DOI 10.1046/j.1523-1739.2001.00053.x; Fletcher RJ, 2002, J WILDLIFE MANAGE, V66, P1011, DOI 10.2307/3802933; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hamer TL, 2006, LANDSCAPE ECOL, V21, P569, DOI 10.1007/s10980-005-2167-5; Iowa Department of Natural Resources, 2013, HIGH RES LANDC IOW 2; Jackson LS, 1996, IOWA BREEDING BIRD A; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kent TH, 1996, BIRDS IN IOWA; Kery M, 2013, J BIOGEOGR, V40, P1463, DOI 10.1111/jbi.12087; Kery M, 2011, J BIOGEOGR, V38, P617, DOI 10.1111/j.1365-2699.2011.02487.x; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Miles L, 2004, GLOBAL ECOL BIOGEOGR, V13, P553, DOI 10.1111/j.1466-822X.2004.00105.x; Miller JR, 2009, CONSERV BIOL, V23, P53, DOI 10.1111/j.1523-1739.2008.01110.x; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Prior JC, 1991, LANDFORM REGIONS IOW; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Reeder K., 2015, IOWAS WILDLIFE ACTIO; Renfrew RB, 2008, LANDSCAPE ECOL, V23, P181, DOI 10.1007/s10980-007-9179-2; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; Ruiz-Navarro A, 2016, BIOL CONSERV, V203, P33, DOI 10.1016/j.biocon.2016.08.021; Russo D, 2015, J ZOOL, V297, P165, DOI 10.1111/jzo.12271; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Teaming with Wildlife, 2015, STAT WILDL ACT PLANS; Thogmartin WE, 2006, CONDOR, V108, P25, DOI 10.1650/0010-5422(2006)108[0025:PRAORG]2.0.CO;2; Titeux N, 2007, BIOL CONSERV, V138, P207, DOI 10.1016/j.biocon.2007.04.019; U. S. Fish and Wildlife Service, 2015, MIDW BIRDS CONC; VILLARD MA, 1994, OECOLOGIA, V98, P393, DOI 10.1007/BF00324229; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Yarrow G, 2009, HABITAT REQUIREMENTS	62	8	8	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173041	10.1371/journal.pone.0173041	http://dx.doi.org/10.1371/journal.pone.0173041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301877	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300024
J	Kim, JE; Lee, H; Lee, CH; Lee, S				Kim, Jung Eun; Lee, Hyojung; Lee, Chang Hyeong; Lee, Sunmi			Assessment of optimal strategies in a two-patch dengue transmission model with seasonality	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; VECTOR-BORNE DISEASE; REPRODUCTION NUMBER; VIRUS TRANSMISSION; HUMAN MOVEMENT; DYNAMICS; IMPACT; FEVER; DETERMINANTS; CLIMATE	Emerging and re-emerging dengue fever has posed serious problems to public health officials in many tropical and subtropical countries. Continuous traveling in seasonally varying areas makes it more difficult to control the spread of dengue fever. In this work, we consider a two-patch dengue model that can capture the movement of host individuals between and within patches using a residence-time matrix. A previous two-patch dengue model without seasonality is extended by adding host demographics and seasonal forcing in the transmission rates. We investigate the effects of human movement and seasonality on the two-patch dengue transmission dynamics. Motivated by the recent Peruvian dengue data in jungle/rural areas and coast/urban areas, our model mimics the seasonal patterns of dengue outbreaks in two patches. The roles of seasonality and residence-time configurations are highlighted in terms of the seasonal reproduction number and cumulative incidence. Moreover, optimal control theory is employed to identify and evaluate patch-specific control measures aimed at reducing dengue prevalence in the presence of seasonality. Our findings demonstrate that optimal patch-specific control strategies are sensitive to seasonality and residence-time scenarios. Targeting only the jungle (or endemic) is as effective as controlling both patches under weak coupling or symmetric mobility. However, focusing on intervention for the city (or high density areas) turns out to be optimal when two patches are strongly coupled with asymmetric mobility.	[Kim, Jung Eun; Lee, Hyojung; Lee, Chang Hyeong] Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea; [Lee, Sunmi] Kyung Hee Univ, Dept Appl Math, Yongin, South Korea; [Lee, Sunmi] Kyung Hee Univ, Inst Nat Sci, Yongin, South Korea	Ulsan National Institute of Science & Technology (UNIST); Kyung Hee University; Kyung Hee University	Lee, CH (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea.; Lee, S (corresponding author), Kyung Hee Univ, Dept Appl Math, Yongin, South Korea.; Lee, S (corresponding author), Kyung Hee Univ, Inst Nat Sci, Yongin, South Korea.	chlee@unist.ac.kr; sunmilee@khu.ac.kr	Lee, Chang Hyeong/F-4142-2010	Lee, Chang Hyeong/0000-0003-3247-5791	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2054976]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [20152194]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Research Foundation of Korea (NRF) - Korean government (MSIP)	Chang Hyeong Lee was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2054976). Sunmi Lee was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No.20152194).	Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Agusto F, 2013, J BIOL SYST, V21, DOI 10.1142/S0218339013400020; ANDERSON R M, 1991; Andraud M, 2013, MATH BIOSCI, V244, P22, DOI 10.1016/j.mbs.2013.04.001; Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; Blayneh KW, 2010, B MATH BIOL, V72, P1006, DOI 10.1007/s11538-009-9480-0; Brauer F., 2001, MATH MODELS POPULATI, V40; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Castillo-Chavez C, 2003, FRONT APP M, V28, P173; Centers for Disease Control and Prevention, 2016, DENGUE; Chamchod F, 2014, B MATH BIOL, V76, P2052, DOI 10.1007/s11538-014-9998-7; Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290; Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016; Diekmann O., 2000, MATH EPIDEMIOLOGY IN, V5; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Favier C, 2005, P ROY SOC B-BIOL SCI, V272, P1171, DOI 10.1098/rspb.2004.3020; Fleming WH, 2012, DETERMINISTIC STOCHA, V1; Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Halstead SB, 2002, LANCET, V360, P1243, DOI 10.1016/S0140-6736(02)11276-1; Halstead SB, 2004, INFECT DIS, V360; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Hayes CG, 1996, AM J TROP MED HYG, V55, P459, DOI 10.4269/ajtmh.1996.55.459; Helmersson J., 2012, MATH MODELING DENGUE; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lee S, 2015, J THEOR BIOL, V374, P152, DOI 10.1016/j.jtbi.2015.03.005; Lee S, 2012, B MATH BIOL, V74, P958, DOI 10.1007/s11538-011-9704-y; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Lenhart S., 2007, OPTIMAL CONTROL APPL; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Luz PM, 2011, MEM I OSWALDO CRUZ, V106, P755, DOI 10.1590/S0074-02762011000600017; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001; Mattar S, 2013, INT J INFECT DIS, V17, pE358, DOI 10.1016/j.ijid.2012.11.021; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; Mpolya EA, 2014, J THEOR BIOL, V343, P120, DOI 10.1016/j.jtbi.2013.11.024; Nevai AL, 2014, MATH MED BIOL, V31, P150, DOI 10.1093/imammb/dqt002; Nishiura H., 2006, DENGUE B; Oki M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001367; Polwiang S, 2015, PEERJ, V3, DOI 10.7717/peerj.1069; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Reiskind MH, 2001, TROP MED INT HEALTH, V6, P212, DOI 10.1046/j.1365-3156.2001.00703.x; Rodrigues HS, 2014, MATH METHODS APPL SC; Rodriguez DJ, 2001, B MATH BIOL, V63, P547, DOI 10.1006/bulm.2001.0231; Aznar VR, 2013, ECOL MODEL, V253, P44, DOI 10.1016/j.ecolmodel.2012.12.004; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; ten Bosch QA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004680; Torre CA, 2009, THESIS; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Uziel A, 2012, J THEOR BIOL, V305, P88, DOI 10.1016/j.jtbi.2012.02.031; Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO, 2013, DENG CONTR D CONTR S; WHO, 2015, DENG VACC RES	61	31	32	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173673	10.1371/journal.pone.0173673	http://dx.doi.org/10.1371/journal.pone.0173673			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301523	Green Submitted, gold, Green Published			2022-12-26	WOS:000396318300059
J	Monneret, G; Jaffrezic, F; Rau, A; Zerjal, T; Nuel, G				Monneret, Gilles; Jaffrezic, Florence; Rau, Andrea; Zerjal, Tatiana; Nuel, Gregory			Identification of marginal causal relationships in gene networks from observational and interventional expression data	PLOS ONE			English	Article							DIRECTED ACYCLIC GRAPHS; REGULATORY NETWORKS; INFERENCE	Causal network inference is an important methodological challenge in biology as well as other areas of application. Although several causal network inference methods have been proposed in recent years, they are typically applicable for only a small number of genes, due to the large number of parameters to be estimated and the limited number of biological replicates available. In this work, we consider the specific case of transcriptomic studies made up of both observational and interventional data in which a single gene of biological interest is knocked out. We focus on a marginal causal estimation approach, based on the framework of Gaussian directed acyclic graphs, to infer causal relationships between the knocked-out gene and a large set of other genes. In a simulation study, we found that our proposed method accurately differentiates between downstream causal relationships and those that are upstream or simply associative. It also enables an estimation of the total causal effects between the gene of interest and the remaining genes. Our method performed very similarly to a classical differential analysis for experiments with a relatively large number of biological replicates, but has the advantage of providing a formal causal interpretation. Our proposed marginal causal approach is computationally efficient and may be applied to several thousands of genes simultaneously. In addition, it may help highlight subsets of genes of interest for a more thorough subsequent causal network inference. The method is implemented in an R package called Marginalcausality (available on GitHub).	[Monneret, Gilles; Jaffrezic, Florence; Rau, Andrea; Zerjal, Tatiana] Univ Paris Saclay, INRA, AgroParisTech, UMR GABI, Jouy En Josas, France; [Monneret, Gilles; Nuel, Gregory] Sorbonne Univ, UPMC, UMR CNRS 7599, LPMA, 4 Pl Jussieu, F-75005 Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Monneret, G (corresponding author), Univ Paris Saclay, INRA, AgroParisTech, UMR GABI, Jouy En Josas, France.; Monneret, G (corresponding author), Sorbonne Univ, UPMC, UMR CNRS 7599, LPMA, 4 Pl Jussieu, F-75005 Paris, France.	gilles.monneret@upmc.fr	zerjal, tatiana/AAO-9473-2020		National de la Recherche Agronomique Jouy-en-Josas	National de la Recherche Agronomique Jouy-en-Josas	The authors received 18500(sic) from Institut National de la Recherche Agronomique Jouy-en-Josas for this work (http://www.jouy.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bonissone P., 1991, P 6 C UNC ART INT, P255; Buhlmann P, 2014, ANNU REV STAT APPL, V1, P255, DOI 10.1146/annurev-statistics-022513-115545; Chickering D. M., 2003, Journal of Machine Learning Research, V3, P507, DOI 10.1162/153244303321897717; Chickering David Maxwell, 1997, P 13 C UNC ART INT P, P80; de Matos Simoes Ricardo, 2012, PLoS One, V7, pe33624, DOI 10.1371/journal.pone.0033624; DURIEZ B, 1993, MOL ENDOCRINOL, V7, P806, DOI 10.1210/me.7.6.806; Emmert-Streib F, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00038; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Hauser A, 2012, J MACH LEARN RES, V13, P2409; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Pearl J., 2000, CAUSALITY MODELS REA, V29; Pinna A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-73; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Rau A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-111; Simoes RD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-324; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spirtes P., 2000, CAUSATION PREDICTION, V81; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171142	10.1371/journal.pone.0171142	http://dx.doi.org/10.1371/journal.pone.0171142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301504	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300009
J	Bhattacharya, R; Rose, PW; Burley, SK; Prlic, A				Bhattacharya, Roshni; Rose, Peter W.; Burley, Stephen K.; Prlic, Andreas			Impact of genetic variation on three dimensional structure and function of proteins	PLOS ONE			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; NON-SYNONYMOUS SNPS; NUCLEOTIDE POLYMORPHISMS; MENDELIAN DISEASE; STABILITY CHANGES; COMMON DISEASE; MUTATIONS; DATABASE; PREDICTION; SEQUENCE	The Protein Data Bank (PDB; http://wwpdb.org) was established in 1971 as the first open access digital data resource in biology with seven protein structures as its initial holdings. The global PDB archive now contains more than 126,000 experimentally determined atomic level three-dimensional (3D) structures of biological macromolecules (proteins, DNA, RNA), all of which are freely accessible via the Internet. Knowledge of the 3D structure of the gene product can help in understanding its function and role in disease. Of particular interest in the PDB archive are proteins for which 3D structures of genetic variant proteins have been determined, thus revealing atomic-level structural differences caused by the variation at the DNA level. Herein, we present a systematic and qualitative analysis of such cases. We observe a wide range of structural and functional changes caused by single amino acid differences, including changes in enzyme activity, aggregation propensity, structural stability, binding, and dissociation, some in the context of large assemblies. Structural comparison of wild type and mutated proteins, when both are available, provide insights into atomic-level structural differences caused by the genetic variation.	[Bhattacharya, Roshni] San Diego State Univ, Bioinformat & Med Informat, San Diego, CA 92182 USA; [Rose, Peter W.; Burley, Stephen K.; Prlic, Andreas] Univ Calif San Diego, RCSB Prot Data Bank, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Burley, Stephen K.] Rutgers State Univ, RCSB Prot Data Bank, Dept Chem & Chem Biol, Ctr Integrat Prote Res,Inst Quantitat Biomed, Piscataway, NJ USA; [Burley, Stephen K.] Rutgers State Univ, Canc Inst New Jersey, Piscataway, NJ USA; [Burley, Stephen K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of California System; University of California San Diego	Prlic, A (corresponding author), Univ Calif San Diego, RCSB Prot Data Bank, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.	andreas.prlic@gmail.com	Prlić, Andreas/A-6134-2012	Prlić, Andreas/0000-0001-6346-6391; Rose, Peter/0000-0001-9981-9750; Burley, Stephen K./0000-0002-2487-9713	National Science Foundation [DBI-1338415]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation grant to the RCSB PDB (DBI-1338415; PI: Stephen K. Burley). The Protein Data Bank archive is managed by the Worldwide Protein Data Bank organization, which consists of the RCSB Protein Data Bank, Protein Data Bank in Europe, Protein Data Bank Japan, and BioMagResBank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei I, 2013, CURRENT PROTOCOL S76; Al-Numair NS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S4; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Arodz T, 2012, PROTEINS, V80, P1780, DOI 10.1002/prot.24073; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Borgstahl GEO, 1996, BIOCHEMISTRY-US, V35, P4287, DOI 10.1021/bi951892w; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Burke DF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-301; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, BIOINFORMATICS, V21, P54, DOI 10.1093/bioinformatics/bti1109; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Dantzer J, 2005, NUCL ACIDS RES S2, V33; De Baets G, 2012, NUCL ACIDS RES, V40; Denayer E, 2008, HUM MUTAT, V29, P232, DOI 10.1002/humu.20616; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Jegga AG, 2007, NUCL ACIDS RES S1, V35; KIMURA M, 1983, P NATL ACAD SCI-BIOL, V80, P1048, DOI 10.1073/pnas.80.4.1048; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lakshminarasimhan M, 2008, BIOCHEMISTRY-US, V47, P1381, DOI 10.1021/bi701189c; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; Mi H., 2013, NUCL ACIDS RES, V41; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pirmohamed M, 2001, TRENDS PHARMACOL SCI, V22, P298, DOI 10.1016/S0165-6147(00)01717-X; Prlic A, 2016, BIOINFORMATICS; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Rutherford K, 2008, BIOCHEMISTRY-US, V47, P893, DOI 10.1021/bi701737f; Ryan M, 2009, BIOINFORMATICS, V25, P1431, DOI 10.1093/bioinformatics/btp242; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; von Bulow R, 2002, J BIOL CHEM, V277, P9455, DOI 10.1074/jbc.M111993200; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	69	36	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0171355	10.1371/journal.pone.0171355	http://dx.doi.org/10.1371/journal.pone.0171355			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296894	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700002
J	Rimnacova, J; Mikes, L; Turjanicova, L; Bulantova, J; Horak, P				Rimnacova, Jana; Mikes, Libor; Turjanicova, Libuse; Bulantova, Jana; Horak, Petr			Changes in surface glycosylation and glycocalyx shedding in Trichobilharzia regenti (Schistosomatidae) during the transformation of cercaria to schistosomulum	PLOS ONE			English	Article							MANSONI CERCARIAE; LECTIN-BINDING; LEWIS-X; CARBOHYDRATE EPITOPES; EXPRESSION PATTERNS; PROTEOMIC ANALYSIS; GLAND SECRETION; MAMMALIAN SKIN; O-GLYCANS; HOST	The invasive larvae (cercariae) of schistosomes penetrate the skin of their definitive hosts. During the invasion, they undergo dramatic ultrastructural and physiological transitions. These changes result in the development of the subsequent stage, schistosomulum, which migrates through host tissues in close contact with host's immune system. One of the striking changes in the transforming cercariae is the shedding of their thick tegumental glycocalyx, which represents an immunoattractive structure; therefore its removal helps cercariae to avoid immune attack. A set of commercial fluorescently labeled lectin probes, their saccharide inhibitors and monoclonal antibodies against the trisaccharide Lewis-X antigen (Le(X), CD15) were used to characterize changes in the surface saccharide composition of the neuropathogenic avian schistosome Trichobilharzia regenti during the transformation of cercariae to schistosomula, both in vitro and in vivo. The effect of various lectins on glycocalyx shedding was evaluated microscopically. The involvement of peptidases and their inhibitors on the shedding of glycocalyx was investigated using T. regenti recombinant cathepsin B2 and a set of peptidase inhibitors. The surface glycocalyx of T. regenti cercariae was rich in fucose and mannose/glucose residues. After the transformation of cercariae in vitro or in vivo within their specific duck host, reduction and vanishing of these epitopes was observed, and galactose/N-acetylgalactosamine emerged. The presence of Le(X) was not observed on the cercariae, but the antigen was gradually expressed from the anterior part of the body in the developing schistosomula. Some lectins which bind to the cercarial surface also induced secretion from the acetabular penetration glands. Seven lectins induced the shedding of glycocalyx by cercariae, among which five bound strongly to cercarial surface; the effect could be blocked by saccharide inhibitors. Mannose-binding protein, part of the lectin pathway of the complement system, also bound to cercariae and schistosomula, but had little effect on glycocalyx shedding. Our study did not confirm the involvement of proteolysis in glycocalyx shedding.	[Rimnacova, Jana; Mikes, Libor; Turjanicova, Libuse; Bulantova, Jana; Horak, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Vinicna 7, Prague 2, Czech Republic	Charles University Prague	Mikes, L (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Vinicna 7, Prague 2, Czech Republic.	mikes@natur.cuni.cz	Mikes, Libor/J-8551-2017; Bulantová, Jana/M-5239-2017; Horák, Petr/C-6482-2009; Turjanicová, Libuše/M-5292-2017; Horák, Petr/AGF-2029-2022	Mikes, Libor/0000-0002-2440-6641; Horák, Petr/0000-0001-9820-5044; Turjanicová, Libuše/0000-0002-8228-1031; Horák, Petr/0000-0001-9820-5044; Bulantova, Jana/0000-0001-9769-4640	Czech Science Foundation [13-29577S]; Charles University [220214/2014]; UNCE [204017]; PRVOUK [P41]; SVV [260202/2015]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; UNCE; PRVOUK; SVV	Funded by Czech Science Foundation (Grant No. 13-29577S), www.gacr.cz - (PH, LM, JR, JB, LT), Charles University grant support, www.cuni.cz/UKEN-65.html - GAUK No. 220214/2014 (LT, LM), UNCE No. 204017 (JB), PRVOUK No. P41 (PH, LM, JB, LT), SVV No. 260202/2015 (PH, LM, JB, LT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxt LA, 2008, GENE DEV, V22, P1636, DOI 10.1101/gad.1667708; BEISLER GK, 1984, JPN J EXP MED, V54, P263; Blazova K, 2005, PARASITOL INT, V54, P167, DOI 10.1016/j.parint.2005.03.003; CAULFIELD JP, 1987, J PARASITOL, V73, P514, DOI 10.2307/3282129; Chanova M, 2009, PARASITOL RES, V104, P1445, DOI 10.1007/s00436-009-1343-y; COLES GC, 1988, J CHEM ECOL, V14, P691, DOI 10.1007/BF01013916; COUSIN CE, 1981, EXP PARASITOL, V51, P341, DOI 10.1016/0014-4894(81)90122-3; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Curwen RS, 2004, MOL BIOCHEM PARASIT, V138, P57, DOI 10.1016/j.molbiopara.2004.06.016; D'Costa S, 1999, INT J DEV BIOL, V43, P349; DANIEL BE, 1992, PARASITOLOGY, V104, P41, DOI 10.1017/S0031182000060789; Doleckova K, 2009, INT J PARASITOL, V39, P201, DOI 10.1016/j.ijpara.2008.06.010; DRESDEN MH, 1975, J PARASITOL, V61, P398, DOI 10.2307/3279310; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; FISHELSON Z, 1992, EXP PARASITOL, V75, P87, DOI 10.1016/0014-4894(92)90124-S; Haas W, 1997, J PARASITOL, V83, P1079, DOI 10.2307/3284366; Haas W, 2003, ZOOLOGY, V106, P349, DOI 10.1078/0944-2006-00125; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; HAYUNGA EG, 1986, J PARASITOL, V72, P913, DOI 10.2307/3281844; HOCKLEY D J, 1973, International Journal for Parasitology, V3, P13, DOI 10.1016/0020-7519(73)90004-0; Horak P, 2008, PARASITE, V15, P299, DOI 10.1051/parasite/2008153299; HORAK P, 1995, PARASITE, V2, P419; Horak P, 1998, PARASITOLOGY, V116, P139, DOI 10.1017/S0031182097002059; Horak P, 1995, FOLIA PARASIT, V42, P255; Horak P, 2001, TRENDS PARASITOL, V17, P66, DOI 10.1016/S1471-4922(00)01770-0; Horak P, 2015, CLIN MICROBIOL REV, V28, P165, DOI 10.1128/CMR.00043-14; Horak P, 2011, FRESHWATER BIOL, V56, P779, DOI 10.1111/j.1365-2427.2010.02545.x; Huang HH, 2001, GLYCOBIOLOGY, V11, P395, DOI 10.1093/glycob/11.5.395; Jang-Lee J, 2007, MOL CELL PROTEOMICS, V6, P1485, DOI 10.1074/mcp.M700004-MCP200; KERR MA, 1992, HISTOCHEM J, V24, P811, DOI 10.1007/BF01046353; Khoo KH, 2001, GLYCOBIOLOGY, V11, P149, DOI 10.1093/glycob/11.2.149; KHOO KH, 1995, J BIOL CHEM, V270, P17114, DOI 10.1074/jbc.270.29.17114; Klabunde J, 2000, EXP PARASITOL, V95, P231, DOI 10.1006/expr.2000.4539; Knudsen GM, 2005, MOL CELL PROTEOMICS, V4, P1862, DOI 10.1074/mcp.M500097-MCP200; KOSTER B, 1994, PARASITOLOGY, V108, P433, DOI 10.1017/S0031182000075995; Lee KP, 1996, J BIOL CHEM, V271, P32960, DOI 10.1074/jbc.271.51.32960; Ligasova A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-162; LINDER E, 1985, EXP PARASITOL, V59, P307, DOI 10.1016/0014-4894(85)90085-2; Liu M, 2015, J PROTEOME RES, V14, P4623, DOI 10.1021/acs.jproteome.5b00465; MARIKOVSKY M, 1988, MOL BIOCHEM PARASIT, V30, P45, DOI 10.1016/0166-6851(88)90131-4; MARIKOVSKY M, 1990, PARASITE IMMUNOL, V12, P389, DOI 10.1111/j.1365-3024.1990.tb00976.x; MATSUMURA K, 1990, J PARASITOL, V76, P436, DOI 10.2307/3282684; Meevissen MHJ, 2012, EXP PARASITOL, V132, P14, DOI 10.1016/j.exppara.2011.05.005; Mikes L, 2005, PARASITOL RES, V96, P230, DOI 10.1007/s00436-005-1347-1; Modha J, 1998, PARASITOL TODAY, V14, P396, DOI 10.1016/S0169-4758(98)01321-0; NANDURI J, 1991, J BIOL CHEM, V266, P1341; Nyame AK, 2003, EXP PARASITOL, V104, P1, DOI 10.1016/S0014-4894(03)00110-3; Nyame AK, 1998, GLYCOBIOLOGY, V8, P615, DOI 10.1093/glycob/8.6.615; Page AP, 2014, INT J PARASITOL-DRUG, V4, P133, DOI 10.1016/j.ijpddr.2014.05.003; Parker-Manuel SJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001274; Paveley RA, 2011, INT J PARASITOL, V41, P1335, DOI 10.1016/j.ijpara.2011.08.005; Podhorsky M, 2009, ACTA PARASITOL, V54, P28, DOI 10.2478/s11686-009-0011-9; Rhodes JM, 1998, METHODS MOL MED; SAMUELSON JC, 1982, J CELL BIOL, V94, P363, DOI 10.1083/jcb.94.2.363; SAMUELSON JC, 1985, J CELL BIOL, V100, P1423, DOI 10.1083/jcb.100.5.1423; Smit CH, 2015, GLYCOBIOLOGY, V25, P1465, DOI 10.1093/glycob/cwv066; Smit CH, 2015, MOL CELL PROTEOMICS, V14, P1750, DOI 10.1074/mcp.M115.048280; STIREWALT M, 1961, EXP PARASITOL, V11, P191, DOI 10.1016/0014-4894(61)90026-1; van Die I, 2010, GLYCOBIOLOGY, V20, P2, DOI 10.1093/glycob/cwp140; van Remoortere A, 2000, GLYCOBIOLOGY, V10, P601, DOI 10.1093/glycob/10.6.601; WIEST PM, 1989, AM J TROP MED HYG, V41, P70, DOI 10.4269/ajtmh.1989.41.70; Wuhrer M, 2000, GLYCOBIOLOGY, V10, P89, DOI 10.1093/glycob/10.1.89; XU XF, 1994, EXP PARASITOL, V79, P399, DOI 10.1006/expr.1994.1102	63	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173217	10.1371/journal.pone.0173217	http://dx.doi.org/10.1371/journal.pone.0173217			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296924	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700028
J	Stephen, J; Yokoyama, T; Tolman, NJ; O'Brien, KJ; Nicoli, ER; Brooks, BP; Huryn, L; Titus, SA; Adams, DR; Chen, D; Gahl, WA; Gochuico, BR; Malicdan, MCV				Stephen, Joshi; Yokoyama, Tadafumi; Tolman, Nathanial J.; O'Brien, Kevin J.; Nicoli, Elena-Raluca; Brooks, Brian P.; Huryn, Laryssa; Titus, Steven A.; Adams, David R.; Chen, Dong; Gahl, William A.; Gochuico, Bernadette R.; Malicdan, May Christine V.			Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5	PLOS ONE			English	Article							LYSOSOME-RELATED ORGANELLES; PROTEIN TRAFFICKING; COMPLEX; BLOC-2; BIOGENESIS; DISEASE; CELLS; HPS5; AP-3	Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organelle Complexes (BLOCs), which are groups of proteins that function together in the formation and/or trafficking of lysosomal-related endosomal compartments. BLOC-2, for example, consists of the proteins HPS3, HPS5, and HPS6. Here we present an HPS patient with defective BLOC-2 due to a novel intronic mutation in HPS5 that activates a cryptic acceptor splice site. This mutation leads to the insertion of nine nucleotides in-frame and results in a reduced amount of HPS5 at the transcript and protein level. In studies using skin fibroblasts derived from the proband and two other individuals with HPS-5, we found a perinuclear distribution of acidified organelles in patient cells compared to controls. Our results suggest the role of HPS5 in the endo-lysosomal dynamics of skin fibroblasts.	[Stephen, Joshi; O'Brien, Kevin J.; Huryn, Laryssa; Gochuico, Bernadette R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Tolman, Nathanial J.; Titus, Steven A.; Adams, David R.; Chen, Dong] NIH, Undiagnosed Dis Program, Bldg 10, Bethesda, MD 20892 USA; [Tolman, Nathanial J.; Brooks, Brian P.; Chen, Dong; Gahl, William A.] NIH, Bldg 10, Bethesda, MD 20892 USA; [O'Brien, Kevin J.; Huryn, Laryssa; Chen, Dong] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD USA; [O'Brien, Kevin J.; Titus, Steven A.; Adams, David R.] Natl Inst Hlth, Div Pre clin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Tolman, Nathanial J.; Brooks, Brian P.; Huryn, Laryssa; Titus, Steven A.] Natl Human Genome Res Inst, Natl Inst Hlth, Bethesda, MD USA; [Yokoyama, Tadafumi; Brooks, Brian P.; Huryn, Laryssa] Mayo Clin, Div Hematopathol, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic	Gochuico, BR (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	gochuicb@mail.nih.gov	Nicoli, Elena-Raluca/F-3968-2011; Stephen, Joshi/ABB-8045-2020; Malicdan, May Christine/AAK-7422-2021	Nicoli, Elena-Raluca/0000-0002-5545-630X; 	Intramural Research Programs of the National Human Genome Research Institute; National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA; NATIONAL EYE INSTITUTE [ZIEEY000477] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215, ZIDHG200352] Funding Source: NIH RePORTER	Intramural Research Programs of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Programs of the National Human Genome Research Institute and the National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.	Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Carmona-Rivera C, 2011, J INVEST DERMATOL, V131, P2394, DOI 10.1038/jid.2011.228; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; Dennis MK, 2015, J CELL BIOL, V209, P563, DOI 10.1083/jcb.201410026; Di Pietro SM, 2004, TRAFFIC, V5, P276, DOI 10.1111/j.1600-0854.2004.0171.x; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Huizing M, 2004, TRAFFIC, V5, P711, DOI 10.1111/j.1600-0854.2004.00208.x; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Khan AO, 2016, CLIN GENETICS; Korswagen LA, 2008, EUR J HAEMATOL, V80, P356, DOI 10.1111/j.1600-0609.2007.01024.x; Livak K., 1997, COMP CT METHOD; Nazarian R, 2003, P NATL ACAD SCI USA, V100, P8770, DOI 10.1073/pnas.1532040100; Ringeisen AL, 2013, J AAPOS, V17, P334, DOI 10.1016/j.jaapos.2013.02.002; Rouhani FN, 2009, AM J RESP CRIT CARE, V180, P1114, DOI 10.1164/rccm.200901-0023OC; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Yu DZ, 2014, J BIOMOL SCREEN, V19, P1164, DOI 10.1177/1087057114537378; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087	19	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173682	10.1371/journal.pone.0173682	http://dx.doi.org/10.1371/journal.pone.0173682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296950	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700052
J	Zong, YB; Yao, SK; Lang, JF; Chen, XX; Fan, JD; Sun, ZB; Duan, XL; Li, NN; Fang, H; Zhou, GZ; Xiao, TQ; Li, AG; Jiang, HD				Zong, Yunbing; Yao, Shengkun; Lang, Jianfeng; Chen, Xuexiang; Fan, Jiadong; Sun, Zhibin; Duan, Xiulan; Li, Nannan; Fang, Hui; Zhou, Guangzhao; Xiao, Tiqiao; Li, Aiguo; Jiang, Huaidong			Structural and compositional analysis of a casting mold sherd from ancient China	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; RAY	Casting had symbolic significance and was strictly controlled in the Shang dynasty of ancient China. Vessel casting was mainly distributed around the Shang capital, Yin Ruins, which indicates a rigorous centralization of authority. Thus, for a casting mold to be excavated far from the capital region is rare. In addition to some bronze vessel molds excavated at the Buyao Village site, another key discovery of a bronze vessel mold occurred at Daxinzhuang. The Daxinzhuang site was a core area in the east of Shang state and is an important site to study the eastward expansion of the Shang. Here, combining synchrotron X-rays and other physicochemical analysis methods, nondestructive three-dimensional structure imaging and different elemental analyses were conducted on this mold sherd. Through high penetration X-ray tomography, we obtained insights on the internal structure and discovered some pores. We infer that the generation of pores inside the casting mold sherd was used to enhance air permeability during casting. Furthermore, we suppose that the decorative patterns on the surface were carved and not pasted onto it. Considering the previous compositional studies of bronze vessels, the copper and iron elements were analyzed by different methods. Unexpectedly, a larger amount of iron than of copper was detected on the surface. According to the data analysis and archaeological context, the source of iron on the casting mold sherd could be attributed to local soil contamination. A refined compositional analysis confirms that this casting mold was fabricated locally and used for bronze casting.	[Zong, Yunbing; Yao, Shengkun; Fan, Jiadong; Sun, Zhibin; Duan, Xiulan; Li, Nannan; Jiang, Huaidong] Shandong Univ, State Key Lab Crystal Mat, Jinan, Shandong, Peoples R China; [Yao, Shengkun; Fan, Jiadong; Jiang, Huaidong] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China; [Lang, Jianfeng; Chen, Xuexiang; Fang, Hui] Shandong Univ, Dept Archaeol, Jinan, Shandong, Peoples R China; [Zhou, Guangzhao; Xiao, Tiqiao; Li, Aiguo] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai, Peoples R China	Shandong University; ShanghaiTech University; Shandong University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Jiang, HD (corresponding author), Shandong Univ, State Key Lab Crystal Mat, Jinan, Shandong, Peoples R China.; Jiang, HD (corresponding author), ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China.	jianghd@shanghaitech.edu.cn			National Natural Science Foundation of China [31430031, U1332118]; National Social Science Foundation of China [146KG009]; Humanities and Social Science Youth Team Project, SDU [IFYT1505]; Fundamental Research Funds of Shandong University [2014JC007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China; Humanities and Social Science Youth Team Project, SDU; Fundamental Research Funds of Shandong University	This work was supported by the National Natural Science Foundation of China (31430031, U1332118), the National Social Science Foundation of China (146KG009), Humanities and Social Science Youth Team Project, SDU (IFYT1505) and the Fundamental Research Funds of Shandong University (2014JC007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley R, 2009, ARTIBUS ASIAE, V69, P39; BARNARD N., 1961, BRONZE CASTING BRONZ; Brodowski S, 2005, GEODERMA, V128, P116, DOI 10.1016/j.geoderma.2004.12.019; Chen L, 2014, NATURE, V516, P238, DOI 10.1038/nature13766; Chen X, 2008, DONGFANG KAOGU, V4, P47; de Villiers S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000169; Dik J, 2008, ANAL CHEM, V80, P6436, DOI 10.1021/ac800965g; Fang H., 2004, J SHANDONG U PHILOS, V1; Fang H., 2006, J SHANDONG U PHILOS, V5, P006; Frisia S, 2012, CLIM PAST, V8, P2039, DOI 10.5194/cp-8-2039-2012; Higham C., 2009, ENCY ANCIENT ASIAN C; Karlbeck O., 1935, ANYANG MOULDS; Kearns Th., 2010, HIST METALLURGY, V44, P48; Keightley D., 1978, HIST RELIGIONS, V17, P211; Kwang-Chih C, 1986, INT C SHANG CIV, P63; Lamassu Design, 2009, MAP SHANG DYN BAMB A; Lamberg-Karlovsky CC., 1989, ARCHAEOLOGICAL THOUG, P155, DOI 10.1017/CBO9780511558221.011; LI XD, 1995, CHEM GEOL, V124, P109, DOI 10.1016/0009-2541(95)00029-L; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Liu L., 2003, STATE FORMATION EARL; Liu SR, 2013, J ARCHAEOL SCI, V40, P2402, DOI 10.1016/j.jas.2012.11.010; Liu Y., 2009, HUAXIA ARCHAEOLOGY, V1, P007; Luan F., 2006, J SHANDONG U PHILOS, V5, P005; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Maire E, 2014, INT MATER REV, V59, P1, DOI 10.1179/1743280413Y.0000000023; Martini I. Peter, 2010, LANDSCAPES SOC SELEC; Mocella V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6895; Nickel L, 2006, ARTIBUS ASIAE, V66, P5, DOI 10.2307/25261842; Okpalugo TIT, 2005, CARBON, V43, P153, DOI 10.1016/j.carbon.2004.08.033; Ortega R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000925; Saleh IM, 2003, J ENDODONT, V29, P595, DOI 10.1097/00004770-200309000-00013; Scruggd B., 2000, ADV XRAY ANAL, V42, P19; Song Z, 2004, ARCHAEOLOGY, V2, P007; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tan D., 1999, ACTA ARCHAEOLOGICA S, V2; Wang XD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-3; Xu J., 2000, CULTURAL RELICS CENT, V3, P004; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; ZHAO F, 1994, COMMUN SOIL SCI PLAN, V25, P407, DOI 10.1080/00103629409369047	39	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0174057	10.1371/journal.pone.0174057	http://dx.doi.org/10.1371/journal.pone.0174057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN9HQ	28296963	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700090
J	Ledesma, JC; Aguilar, MA; Gimenez-Gomez, P; Minarro, J; Rodriguez-Arias, M				Carlos Ledesma, Juan; Aguilar, Maria A.; Gimenez-Gomez, Pablo; Minarro, Jose; Rodriguez-Arias, Marta			Adolescent but not adult ethanol binge drinking modulates cocaine withdrawal symptoms in mice	PLOS ONE			English	Article							PREPULSE INHIBITION; RECOGNITION MEMORY; GENE-EXPRESSION; ANXIETY-LIKE; EXPOSURE; RECEPTOR; DEPRESSION; STARTLE; ABUSE; RATS	Background Ethanol (EtOH) binge drinking is an increasingly common behavior among teenagers that induces long-lasting neurobehavioral alterations in adulthood. An early history of EtOH abuse during adolescence is highly correlated with cocaine addiction in adulthood. Abstinence of cocaine abuse can cause psychiatric symptoms, such as anxiety, psychosis, depression, and cognitive impairments. This study assessed the consequences of adolescent exposure to EtOH on the behavioral alterations promoted by cocaine withdrawal in adulthood. Methods We pretreated juvenile (34-47 days old) or adult (68-81 days old) mice with EtOH (1.25 g/ kg) following a binge-drinking pattern. Then, after a three-week period without drug delivery, they were subjected to a chronic cocaine treatment in adulthood and tested under cocaine withdrawal by the ensuing paradigms: open field, elevated plus maze, prepulse inhibition, tail suspension test, and object recognition. Another set of mice were treated with the same EtOH binge-drinking procedure during adolescence and were tested immediately afterwards under the same behavioral paradigms. Results Adolescent EtOH pretreatment undermined the anxiogenic effects observed after cocaine abstinence, reduced prepulse inhibition, and increased immobility scores in the tail suspension test following cocaine withdrawal. Moreover, the memory deficits evoked by these substances when given separately were enhanced in cocaine-withdrawn mice exposed to EtOH during adolescence. EtOH binge drinking during adolescence also induced anxiety, depressive symptoms, and memory impairments when measured immediately afterwards. In contrast, neither EtOH nor cocaine alone or in combination altered any of these behaviors when given in adulthood. Conclusions EtOH binge drinking induces short- and long-term behavioral alterations and modulates cocaine withdrawal symptoms when given in adolescent mice.	[Carlos Ledesma, Juan; Aguilar, Maria A.; Gimenez-Gomez, Pablo; Minarro, Jose; Rodriguez-Arias, Marta] Univ Valencia, Dept Psicobiol, Valencia, Spain	University of Valencia	Ledesma, JC (corresponding author), Univ Valencia, Dept Psicobiol, Avda Blasco Ibanez 21, Valencia, Spain.	juan.ledesma@uv.es	Aguilar, Maria A/D-3416-2011; Ledesma, Juan Carlos/AAA-2722-2019; Gimenez Gomez, Pablo/AFV-9002-2022; Ledesma, Juan/AAC-1058-2019; Minarro, Jose/B-4414-2011; Rodriguez-Arias, Marta/B-5163-2011	Aguilar, Maria A/0000-0002-1935-6619; Ledesma, Juan/0000-0001-6372-2842; Minarro, Jose/0000-0002-5731-7821; Gimenez Gomez, Pablo/0000-0002-9404-4615	Ministerio de Economia y Competitividad (MINECO); Direccion General de Investigacion [PSI2014-51847-R]; Institute de Salud Carlos III; Red de Trastornos Adictivos (RTA) [RD12/0028/ 0005]; RD12/0028/ 0005; Union Europea; Fondos FEDER "una manera de hacer Europa"; Generalitat Valenciana; Conselleria de Educacion [PROMETE011/2014/063]; European Foundation for Alcohol Research (ERAB) [EA1308]; Conselleria d'Educacio, Investigacio, Cultura i Esport [APOSTD/2016/147]; Generalitat Valenciana, Spain	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Direccion General de Investigacion(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); Red de Trastornos Adictivos (RTA); RD12/0028/ 0005; Union Europea; Fondos FEDER "una manera de hacer Europa"; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Conselleria de Educacion; European Foundation for Alcohol Research (ERAB); Conselleria d'Educacio, Investigacio, Cultura i Esport; Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This work was supported by grants from Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion, PSI2014-51847-R, Institute de Salud Carlos III, Red de Trastornos Adictivos (RTA) RD12/0028/ 0005; Union Europea, Fondos FEDER "una manera de hacer Europa"; Generalitat Valenciana, Conselleria de Educacion, PROMETE011/2014/063; and The European Foundation for Alcohol Research (ERAB), EA1308. Juan Carlos Ledesma was supported by a postdoctoral fellowship from the Conselleria d'Educacio, Investigacio, Cultura i Esport (APOSTD/2016/147), Generalitat Valenciana, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion, PSI2014-51847-R, Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA) RD12/0028/0005; Union Europea, Fondos FEDER "una manera de hacer Europa"; Generalitat Valenciana, Conselleria de Educacion, PROME-TEOII/2014/063; and The European Foundation for Alcohol Research (ERAB), EA1308. Juan Carlos Ledesma was supported by a postdoctoral fellowship from the Conselleria d'Educacio, Investigacio, Cultura i Esport (APOSTD/2016/147), Generalitat Valenciana, Spain. We wish to thank Mark Andrews for his English language editing of the manuscript. The author(s) are entirely responsible for the scientific content of the paper.	Adams JU, 2001, PHARMACOL BIOCHEM BE, V68, P753, DOI 10.1016/S0091-3057(01)00478-6; Alves CJ, 2014, NEUROSCIENCE, V277, P343, DOI 10.1016/j.neuroscience.2014.07.008; [Anonymous], 2015, EUR DRUG REP TRENDS; Arias F, 2013, REV PSIQUIATR SALUD, V6, P121, DOI 10.1016/j.rpsm.2012.09.002; Arias F, 2013, ACTAS ESP PSIQUIATRI, V41, P122; Black YD, 2006, J NEUROSCI, V26, P9656, DOI 10.1523/JNEUROSCI.2391-06.2006; Briand LA, 2008, NEUROSCIENCE, V155, P1, DOI 10.1016/j.neuroscience.2008.06.004; Briones TL, 2013, NEUROSCIENCE, V254, P324, DOI 10.1016/j.neuroscience.2013.09.031; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Ledesma JC, 2013, PSYCHOPHARMACOLOGY, V226, P673, DOI 10.1007/s00213-012-2831-9; Chartoff E, 2012, NEUROPHARMACOLOGY, V62, P167, DOI 10.1016/j.neuropharm.2011.06.014; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Craige CP, 2015, NEUROPHARMACOLOGY, V93, P41, DOI 10.1016/j.neuropharm.2015.01.021; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dalley JW, 2005, PSYCHOPHARMACOLOGY, V182, P579, DOI 10.1007/s00213-005-0107-3; Cito MDD, 2012, BEHAV BRAIN RES, V231, P116, DOI 10.1016/j.bbr.2012.01.056; Degenhardt L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003015; Deroche-Gamonet V, 2014, NEUROPHARMACOLOGY, V76, P437, DOI 10.1016/j.neuropharm.2013.07.014; El Hage C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043535; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Escarabajal MD, 2003, PSYCHOPHARMACOLOGY, V167, P130, DOI 10.1007/s00213-003-1427-9; ESTUDES, 2013, INF ENC EST US DROG; Fendt M, 2013, CELL TISSUE RES, V354, P287, DOI 10.1007/s00441-013-1599-5; Filip M, 2013, PHARMACOL REP, V65, P1529, DOI 10.1016/S1734-1140(13)71514-7; Forbes A, 2013, ALCOHOL, V47, P95, DOI 10.1016/j.alcohol.2012.12.007; Garcia-Moreno LM, 2012, ALCOHOL, V46, P757, DOI 10.1016/j.alcohol.2012.08.001; Georgiou P, 2016, EUR J NEUROSCI, V44, P2446, DOI 10.1111/ejn.13348; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Gobira PH, 2013, REV PSIQUIATR SALUD, P35; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Guizzetti M, 2016, ALCOHOL CLIN EXP RES, V40, P1182, DOI 10.1111/acer.13072; Hage CE, 2012, PLOS ONE, V7; Hall BJ, 2010, NEUROSCI LETT, V474, P84, DOI 10.1016/j.neulet.2010.03.011; Kandel DB, 2006, ADDICTION, V101, P470, DOI 10.1111/j.1360-0443.2006.01426.x; Kandel D, 2015, ACTA PAEDIATR, V104, P130, DOI 10.1111/apa.12851; Kupferschmidt DA, 2012, NEUROSCIENCE, V204, P125, DOI 10.1016/j.neuroscience.2011.07.022; Kyzar EJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00222; Labouvie E, 1997, J STUD ALCOHOL, V58, P638, DOI 10.15288/jsa.1997.58.638; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lejuez CW, 2008, BEHAV RES THER, V46, P811, DOI 10.1016/j.brat.2008.03.010; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Lynskey MT, 2003, JAMA-J AM MED ASSOC, V289, P427, DOI 10.1001/jama.289.4.427; Martinez ZA, 1999, PSYCHOPHARMACOLOGY, V142, P253, DOI 10.1007/s002130050887; Mateos-Garcia A, 2015, PSYCHOPHARMACOLOGY, V232, P101, DOI 10.1007/s00213-014-3642-y; Montagud-Romero S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092576; Montesinos J, 2016, BRAIN BEHAV IMMUN, V53, P159, DOI 10.1016/j.bbi.2015.12.006; Montesinos J, 2015, BRAIN BEHAV IMMUN, V45, P233, DOI 10.1016/j.bbi.2014.11.015; Morisot N, 2014, INT J NEUROPSYCHOPH, V17, P1969, DOI 10.1017/S1461145714000625; Murphy CA, 2001, PSYCHOPHARMACOLOGY, V156, P155, DOI 10.1007/s002130100759; Pandey SC, 2015, NEUROBIOL DIS, V82, P607, DOI 10.1016/j.nbd.2015.03.019; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Perrine SA, 2008, NEUROPHARMACOLOGY, V54, P355, DOI 10.1016/j.neuropharm.2007.10.007; Pollak DD, 2010, ANN MED, V42, P252, DOI 10.3109/07853891003769957; Powell Susan B, 2012, Curr Top Behav Neurosci, V12, P251, DOI 10.1007/7854_2011_195; Realini N, 2009, PHARMACOL RES, V60, P132, DOI 10.1016/j.phrs.2009.03.006; Rodriguez-Arias M, 2011, PSYCHOPHARMACOLOGY, V218, P429, DOI 10.1007/s00213-011-2329-x; Roger-Sanchez C, 2012, NEUROTOXICOL TERATOL, V34, P108, DOI 10.1016/j.ntt.2011.07.011; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; Schaaffhausen Nicole Tatit von, 2009, Psychol. Neurosci., V2, P75, DOI 10.3922/j.psns.2009.1.11; Schoenbaum G, 2004, EUR J NEUROSCI, V19, P1997, DOI 10.1111/j.1460-9568.2004.03274.x; Skuza G, 2013, PHARMACOL REP, V65, P1681, DOI 10.1016/S1734-1140(13)71530-5; Sweeney FE, 2014, NEUROPHARMACOLOGY, V81, P303, DOI 10.1016/j.neuropharm.2013.08.039; Tang YL, 2014, J DUAL DIAGN, V10, P98, DOI 10.1080/15504263.2014.906133; Valsamis B, 2011, JOVE-J VIS EXP, DOI 10.3791/3446; Valzachi MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078317; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; Vaugeois JM, 1997, PSYCHOPHARMACOLOGY, V134, P387, DOI 10.1007/s002130050475; Vidal-Infer A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-32; WILCOX RR, 1987, ANNU REV PSYCHOL, V38, P29, DOI 10.1146/annurev.psych.38.1.29; Zilkha N, 2014, J NEUROCHEM, V130, P575, DOI 10.1111/jnc.12753	71	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0172956	10.1371/journal.pone.0172956	http://dx.doi.org/10.1371/journal.pone.0172956			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291777	gold, Green Published, Green Submitted			2022-12-26	WOS:000396094700008
J	Huseinovic, A; van Leeuwen, JS; van Welsem, T; Stulemeijer, I; van Leeuwen, F; Vermeulen, NPE; Kooter, JM; Vos, JC				Huseinovic, Angelina; van Leeuwen, Jolanda S.; van Welsem, Tibor; Stulemeijer, Iris; van Leeuwen, Fred; Vermeulen, Nico P. E.; Kooter, Jan M.; Vos, J. Chris			The effect of acetaminophen on ubiquitin homeostasis in Saccharomyces cerevisiae	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; TRANSLESION DNA-SYNTHESIS; LONG-TERM USE; POSTREPLICATION REPAIR; PROSPECTIVE VITAMINS; YEAST; RESISTANCE; TOXICITY; INJURY; RAD5	Acetaminophen (APAP), although considered a safe drug, is one of the major causes of acute liver failure by overdose, and therapeutic chronic use can cause serious health problems. Although the reactive APAP metabolite N-acetyl-p-benzoquinoneimine (NAPQI) is clearly linked to liver toxicity, toxicity of APAP is also found without drug metabolism of APAP to NAPQI. To get more insight into mechanisms of APAP toxicity, a genome-wide screen in Saccharomyces cerevisiae for APAP-resistant deletion strains was performed. In this screen we identified genes related to the DNA damage response. Next, we investigated the link between genotype and APAP-induced toxicity or resistance by performing a more detailed screen with a library containing mutants of 1522 genes related to nuclear processes, like DNA repair and chromatin remodelling. We identified 233 strains that had an altered growth rate relative to wild type, of which 107 showed increased resistance to APAP and 126 showed increased sensitivity. Gene Ontology analysis identified ubiquitin homeostasis, regulation of transcription of RNA polymerase II genes, and the mitochondria-to-nucleus signalling pathway to be associated with APAP resistance, while histone exchange and modification, and vesicular transport were connected to APAP sensitivity. Indeed, we observed a link between ubiquitin levels and APAP resistance, whereby ubiquitin deficiency conferred resistance to APAP toxicity while ubiquitin overexpression resulted in sensitivity. The toxicity profile of various chemicals, APAP, and its positional isomer AMAP on a series of deletion strains with ubiquitin deficiency showed a unique resistance pattern for APAP. Furthermore, exposure to APAP increased the level of free ubiquitin and influenced the ubiquitination of proteins. Together, these results uncover a role for ubiquitin homeostasis in APAP-induced toxicity.	[Huseinovic, Angelina; Vermeulen, Nico P. E.; Vos, J. Chris] Vrije Univ Amsterdam, AIMMS Div Mol Toxicol, Dept Chem & Pharmaceut Sci, Amsterdam, Netherlands; [van Leeuwen, Jolanda S.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [van Welsem, Tibor; Stulemeijer, Iris; van Leeuwen, Fred] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Kooter, Jan M.] Vrije Univ Amsterdam, Genet Sect, AIMMS Dept Mol Cell Biol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Toronto; Netherlands Cancer Institute; Vrije Universiteit Amsterdam	Vos, JC (corresponding author), Vrije Univ Amsterdam, AIMMS Div Mol Toxicol, Dept Chem & Pharmaceut Sci, Amsterdam, Netherlands.	j.c.vos@vu.nl	van Leeuwen, Fred/A-7698-2010	van Leeuwen, Fred/0000-0002-7267-7251; van Leeuwen, Jolanda/0000-0003-3991-518X; Vermeulen, Nico P.E./0000-0003-4194-6401; Vos, J. Chris/0000-0003-3737-9942	AIM MS, the Amsterdam Institute for Molecules, Medicines and Systems, Bridging PhD project [10-001-204]	AIM MS, the Amsterdam Institute for Molecules, Medicines and Systems, Bridging PhD project	This research was supported by AIM MS, the Amsterdam Institute for Molecules, Medicines and Systems, Bridging PhD project 10-001-204.	Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen JJ, 2011, CELL BIOCHEM BIOPHYS, V60, P47, DOI 10.1007/s12013-011-9187-3; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chun LJ, 2009, J CLIN GASTROENTEROL, V43, P342, DOI 10.1097/MCG.0b013e31818a3854; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Dargan PI, 2001, EMERG MED J, V18, P178, DOI 10.1136/emj.18.3.178; dos Santos Sandra C., 2012, Frontiers in Genetics, V3, P63, DOI 10.3389/fgene.2012.00063; dos Santos SC, 2011, MOL GENET GENOMICS, V286, P333, DOI 10.1007/s00438-011-0649-5; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Groothuis TAM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-21; Halas A, 2011, MOL MICROBIOL, V80, P786, DOI 10.1111/j.1365-2958.2011.07610.x; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Henderson AJ, 2013, PAEDIATR RESPIR REV, V14, P9, DOI 10.1016/j.prrv.2012.04.004; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Jensen KG, 1996, PHARMACOL TOXICOL, V78, P224, DOI 10.1111/j.1600-0773.1996.tb00209.x; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kato H, 2014, INTERNAL MED, V53, P1531, DOI 10.2169/internalmedicine.53.1502; Khawaja A, 2012, J PAK MED ASSOC, V62, P524; Kim EJ, 2014, ASIA PAC ALLERGY, V4, P68, DOI 10.5415/apallergy.2014.4.1.68; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Laine JE, 2009, XENOBIOTICA, V39, P11, DOI [10.1080/00498250802512830, 10.1080/00498250802512830 ]; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Liew Z, 2014, JAMA PEDIATR, V168, P313, DOI 10.1001/jamapediatrics.2013.4914; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; McConkey SE, 2009, J VET PHARMACOL THER, V32, P585, DOI 10.1111/j.1365-2885.2009.01080.x; Michaut A, 2014, LIVER INT, V34, pE171, DOI 10.1111/liv.12514; Miettinen TP, 2014, MOL PHARMACEUT, V11, P4395, DOI 10.1021/mp5004866; Miyakawa K, 2015, J PHARMACOL EXP THER, V354, P230, DOI 10.1124/jpet.115.223537; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Srikanth CV, 2005, MICROBIOL-SGM, V151, P99, DOI 10.1099/mic.0.27374-0; Srivas R, 2013, CELL REP, V5, P1714, DOI 10.1016/j.celrep.2013.11.035; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; van Leeuwen JS, 2012, CURR DRUG METAB, V13, P1464; van Leeuwen JS, 2011, MICROBIOL-SGM, V157, P685, DOI 10.1099/mic.0.044578-0; Walter RB, 2011, CANCER EPIDEM BIOMAR, V20, P2637, DOI 10.1158/1055-9965.EPI-11-0709; Walter RB, 2011, J CLIN ONCOL, V29, P2424, DOI 10.1200/JCO.2011.34.6346; Wright AP, YEAST, V5, P51; Xie YC, 2015, TOXICOL APPL PHARM, V289, P213, DOI 10.1016/j.taap.2015.09.022; Zhou X, 2009, GENOMICS, V94, P294, DOI 10.1016/j.ygeno.2009.07.003	55	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173573	10.1371/journal.pone.0173573	http://dx.doi.org/10.1371/journal.pone.0173573			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291796	Green Published, gold, Green Submitted			2022-12-26	WOS:000396094700032
J	Ju, SM; Yin, NN; Wang, LP; Zhang, CY; Wang, YK				Ju, Shuming; Yin, Ningning; Wang, Liping; Zhang, Cuiying; Wang, Yukun			Effects of silicon on Oryza sativa L. seedling roots under simulated acid rain stress	PLOS ONE			English	Article							ZEA-MAYS L.; CHLOROPHYLL FLUORESCENCE; LIPID-PEROXIDATION; OXIDATIVE STRESS; HEAVY-METALS; GROWTH; RICE; ACCUMULATION; GERMINATION; RESPONSES	Silicon (Si) has an important function in reducing the damage of environmental stress on plants. Acid rain is a serious abiotic stress factor, and Si can alleviate the stress induced by acid rain on plants. Based on these assumptions, we investigated the effects of silicon on the growth, root phenotype, mineral element contents, hydrogen peroxide (H2O2) and antioxidative enzymes of rice (Oryza sativa L.) seedling roots under simulated acid rain (SAR) stress. The results showed that the combined or single effects of Si and/or SAR on rice roots depend on the concentration of Si and the pH of the SAR. The combined or single effects of a low or moderate concentration of Si (1.0 or 2.0 mM) and light SAR (pH 4.0) enhanced the growth of rice roots, and the combined effects were stronger than those of the single treatment. A high concentration of Si (4.0 mM) or severe SAR (pH 2.0) exerted deleterious effects. The incorporation of Si (1.0, 2.0 or 4.0 mM) into SAR with pH 3.0 or 2.0 promoted the rice root growth, decreased the H2O2 content, increased the Si concentration and the superoxide dismutase (SOD), catalase (CAT), peroxidase (POD) and ascorbate peroxidase (APX) activities, maintained the balance of mineral element (K, Ca, Mg, Fe, Zn, and Cu) concentrations in the roots of rice seedlings compared with SAR alone. The alleviatory effects observed with a moderate concentration of Si (2.0 mM) were better than the effects obtained with a low or high concentration of Si (1.0 or 4.0 mM). The observed effects were due to disruptions in the absorption and utilization of mineral nutrients and impacts on the activity of antioxidant enzymes in roots, and this conclusion suggests that the degree of rice root damage caused by acid rain might be attributed to not only acid rain but also the level of Si in the soil.	[Ju, Shuming; Yin, Ningning; Wang, Liping; Zhang, Cuiying] China Univ Min & Technol, Sch Environm & Spatial Informat, Xuzhou, Jiangsu, Peoples R China; [Ju, Shuming; Zhang, Cuiying; Wang, Yukun] Xuzhou Inst Technol, Xuzhou, Jiangsu, Peoples R China	China University of Mining & Technology; Xuzhou University of Technology	Wang, LP (corresponding author), China Univ Min & Technol, Sch Environm & Spatial Informat, Xuzhou, Jiangsu, Peoples R China.	qusm2010@163.com	Wang, Yukun/GRJ-5930-2022		National spark plan project [S2013C100537, 2015GA690089]; Program of Environmental Science and Technology of Jiangsu Province [2007024]	National spark plan project; Program of Environmental Science and Technology of Jiangsu Province	This work was supported by National spark plan project (S2013C100537, 2015GA690089) and The Program of Environmental Science and Technology of Jiangsu Province (No.2007024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Spark Plan Project (Nos. S2013C100537 and 2015GA690089) and the Programme of Environmental Science and Technology of Jiangsu Province (No. 2007024).	Abbasi Tasneem, 2013, International Journal of Environmental Engineering, V5, P229, DOI 10.1504/IJEE.2013.054703; Azevedo MM, 2007, SCI TOTAL ENVIRON, V377, P233, DOI 10.1016/j.scitotenv.2007.02.027; Bai LP, 2006, PEDOSPHERE, V16, P326, DOI 10.1016/S1002-0160(06)60059-3; Bashkin V. N., 2003, J ENV STUD, V60, P205, DOI [10.1080/00207230290015711, DOI 10.1080/00207230290015711]; Datnoff LE, 1997, CROP PROT, V16, P525, DOI 10.1016/S0261-2194(97)00033-1; Detmann KC, 2012, NEW PHYTOL, V196, P752, DOI 10.1111/j.1469-8137.2012.04299.x; Dias APL, 2011, ENVIRON POLLUT, V159, P458, DOI 10.1016/j.envpol.2010.10.020; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fageria NK, 2011, ADV AGRON, V110, P251, DOI 10.1016/B978-0-12-385531-2.00004-9; Fallah A., 2012, International Journal of AgriScience, V2, P630; Fan HB, 2000, FOREST ECOL MANAG, V126, P321, DOI 10.1016/S0378-1127(99)00103-6; Forino LMC, 2012, J HAZARD MATER, V235, P271, DOI 10.1016/j.jhazmat.2012.07.051; Foy C.D., 1992, ADV SOIL SCI, P97, DOI DOI 10.1007/978-1-4612-2894-3_5; Garg N, 2009, PLANT BIOSYST, V143, P81, DOI 10.1080/11263500802633626; Gauci V, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000501; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gunes A, 2007, PLANT SOIL, V290, P103, DOI 10.1007/s11104-006-9137-9; Guntzer F, 2012, AGRON SUSTAIN DEV, V32, P201, DOI 10.1007/s13593-011-0039-8; Guo W, 2005, PLANT SOIL, V272, P173, DOI 10.1007/s11104-004-4732-0; HARTE J, 1983, ATMOS ENVIRON, V17, P403, DOI 10.1016/0004-6981(83)90058-6; Hermans C, 2005, J EXP BOT, V56, P2153, DOI 10.1093/jxb/eri215; Hong FS, 2003, BIOL TRACE ELEM RES, V94, P273, DOI 10.1385/BTER:94:3:273; Hosono Tatsuo, 1994, Journal of Agricultural Meteorology, V50, P121, DOI 10.2480/agrmet.50.121; [金鑫 Jin Xin], 2015, [环境监测管理与技术, The Administration and Technique of Environmental Monitoring], V27, P65; Koricheva J, 1997, ENVIRON POLLUT, V95, P249, DOI 10.1016/S0269-7491(96)00071-1; Kuzniak E, 1999, PLANT SCI, V148, P69, DOI 10.1016/S0168-9452(99)00121-1; Lamppu J, 2003, ENVIRON POLLUT, V122, P119, DOI 10.1016/S0269-7491(02)00274-9; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Li TQ, 2009, J HAZARD MATER, V169, P734, DOI 10.1016/j.jhazmat.2009.04.004; Liang J, 2008, THESIS; Liang YC, 2005, CHEMOSPHERE, V58, P475, DOI 10.1016/j.chemosphere.2004.09.034; Liang YC, 1999, PLANT SOIL, V209, P217, DOI 10.1023/A:1004526604913; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Liu MH, 2015, PHOTOSYNTHETICA, V53, P23, DOI 10.1007/s11099-015-0071-z; Liu TW, 2011, TREE PHYSIOL, V31, P402, DOI 10.1093/treephys/tpr019; [罗璇 Luo Xuan], 2013, [地球与环境, Earth and Environment], V41, P566; Ma J.F., 2002, SOIL FERTILIZER PLAN; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Menz FC, 2004, ENVIRON SCI POLICY, V7, P253, DOI 10.1016/j.envsci.2004.05.005; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Esposito JBN, 2015, ENVIRON SCI POLLUT R, V22, P5315, DOI 10.1007/s11356-014-3951-z; Odiyi B. O., 2014, Journal of Agricultural Science (Toronto), V6, P96; Peng Q, 2009, BIOL TRACE ELEM RES, V127, P69, DOI 10.1007/s12011-008-8218-4; Perry CC, 2003, REV MINERAL GEOCHEM, V54, P291, DOI 10.2113/0540291; Rebitanim NA., 2015, INT J AGRON AGR RES, V6, P71; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Richmond KE, 2003, CURR OPIN PLANT BIOL, V6, P268, DOI 10.1016/S1369-5266(03)00041-4; Rodrigues F. A., 2005, Fitopatologia Brasileira, V30, P457, DOI 10.1590/S0100-41582005000500001; Sahebi M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/396010; Sajedi Nour Ali, 2011, Physiology and Molecular Biology of Plants, V17, P215, DOI 10.1007/s12298-011-0067-5; Shi GR, 2010, PLANT GROWTH REGUL, V61, P45, DOI 10.1007/s10725-010-9447-z; Singh A, 2008, J ENVIRON BIOL, V29, P15; Sivanesan I, 2014, SCI WORLD J, DOI 10.1155/2014/521703; Song AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24640; State Environmental Protection Administration of China, 2005, ENV PROT, V6, P11; Sun ZG, 2013, CHEMOSPHERE, V93, P344, DOI 10.1016/j.chemosphere.2013.04.089; Taiz L., 2018, FUNDAMENTALS PLANT P; TAKAHASHI MA, 1983, ARCH BIOCHEM BIOPHYS, V226, P558, DOI 10.1016/0003-9861(83)90325-9; Vaculik M, 2012, ANN BOT-LONDON, V110, P433, DOI 10.1093/aob/mcs039; Vaculik M, 2012, ENVIRON POLLUT, V163, P117, DOI 10.1016/j.envpol.2011.12.031; Wailes EJ, 2010, ARKANSAS GLOBAL RICE, P1; Wang CY, 2010, SCI TOTAL ENVIRON, V408, P2706, DOI 10.1016/j.scitotenv.2010.03.023; Wang LH, 2010, SEED SCI TECHNOL, V38, P26, DOI 10.15258/sst.2010.38.1.03; Wang LH, 2008, CHEMOSPHERE, V73, P314, DOI 10.1016/j.chemosphere.2008.06.004; Wattanapayapkul W., 2011, INDIAN J PLANT PATHO, V5, P134; WELCH RM, 1995, CRIT REV PLANT SCI, V14, P49, DOI 10.1080/713608066; Wen KJ, 2011, CHEMOSPHERE, V84, P601, DOI 10.1016/j.chemosphere.2011.03.054; Winslow MD, 1997, PLANT SOIL, V188, P239, DOI 10.1023/A:1004298817861; Wu C, 2016, CHEMOSPHERE, V165, P478, DOI 10.1016/j.chemosphere.2016.09.061; Wu C, 2016, ENVIRON POLLUT, V212, P27, DOI 10.1016/j.envpol.2016.01.004; Wu C, 2015, CHEMOSPHERE, V138, P447, DOI 10.1016/j.chemosphere.2015.06.081; Wyrwicka A, 2006, ENVIRON EXP BOT, V56, P198, DOI 10.1016/j.envexpbot.2005.02.003; Wyrwicka A, 2014, ACTA PHYSIOL PLANT, V36, P837, DOI 10.1007/s11738-013-1462-z; Ye J, 2012, ENVIRON POLLUT, V162, P369, DOI 10.1016/j.envpol.2011.12.002; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu JQ, 2002, PHOTOSYNTHETICA, V40, P331, DOI 10.1023/A:1022658504882; Zabawi AGM, 2008, J TROP AGR FOOD SCI, V36; Zhang XY, 2010, J PLANT PHYSIOL, V167, P88, DOI 10.1016/j.jplph.2009.07.006; Zhang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138820; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020	84	30	31	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173378	10.1371/journal.pone.0173378	http://dx.doi.org/10.1371/journal.pone.0173378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291806	gold, Green Submitted, Green Published			2022-12-26	WOS:000396094700022
J	Alford, A; Krupke, CH				Alford, Adam; Krupke, Christian H.			Translocation of the neonicotinoid seed treatment clothianidin in maize	PLOS ONE			English	Article							MAGGOT DIPTERA; CORN GROWTH; COLEOPTERA; PESTICIDE; RESIDUES; THIAMETHOXAM; INSECTICIDES; DETECTIONS; EXPOSURE; ADJACENT	Neonicotinoid seed treatments, typically clothianidin or thiamethoxam, are routinely applied to >80% of maize (corn) seed grown in North America where they are marketed as a targeted pesticide delivery system. Despite this widespread use, the amount of compound translocated into plant tissue from the initial seed treatment to provide protection has not been reported. Our two year field study compared concentrations of clothianidin seed treatments in maize to that of maize without neonicotinoid seed treatments and found neonicotinoids present in root tissues up to 34 days post planting. Plant-bound clothianidin concentrations followed an exponential decay pattern with initially high values followed by a rapid decrease within the first similar to 20 days post planting. A maximum of 1.34% of the initial seed treatment was successfully recovered from plant tissues in both study years and a maximum of 0.26% was recovered from root tissue. Our findings show neonicotinoid seed treatments may provide protection from some early season secondary maize pests. However, the proportion of the neonicotinoid seed treatment clothianidin translocated into plant tissues throughout the growing season is low overall and this observation may provide a mechanism to explain reports of inconsistent efficacy of this pest management approach and increasing detections of environmental neonicotinoids.	[Alford, Adam; Krupke, Christian H.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Alford, A (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	AdamMAlford@gmail.com		Alford, Adam/0000-0002-4035-1396	Purdue Research Foundation	Purdue Research Foundation	This research was funded by the Purdue Research Foundation.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiades M, 2003, J AOAC INT, V86, P412; Anderson TA, 2013, CHEMOSPHERE, V92, P84, DOI 10.1016/j.chemosphere.2013.02.054; [Anonymous], 2015, VERSION 9 4 M3; Bledsoe L, 2010, EXTENSION PUBLICATIO, VE-49-W; BONMATIN JM, 2005, ENV CHEM PP, P00483; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Brunson AM, 1959, EXTENSION CIRCULAR N, P1; Cook K, 2004, PROCEEDINGS ILLINOIS; Cox WJ, 2007, CROP SCI, V47, P2482, DOI 10.2135/cropsci2006.12.0810; DeLorenzo ME, 2012, ENVIRON MONIT ASSESS, V184, P343, DOI 10.1007/s10661-011-1972-3; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Elzhov TV, PACKAGE MINPACK LM V; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gotelli NJ, 2013, ECOSIMR 1 00; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; GUSTAFSON DI, 1989, ENVIRON TOXICOL CHEM, V8, P339, DOI 10.1897/1552-8618(1989)8[339:GUSASM]2.0.CO;2; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; HAMMOND R B, 1990, Environmental Entomology, V19, P510; HIGLEY LG, 1984, ENVIRON ENTOMOL, V13, P1436; Hilton MJ, 2016, PEST MANAG SCI, V72, P388, DOI 10.1002/ps.4024; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; HOKKANEN HMT, 1991, ANNU REV ENTOMOL, V36, P119, DOI 10.1146/annurev.en.36.010191.001003; Huseth AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097081; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Jordan TA, 2012, CROP PROT, V39, P57, DOI 10.1016/j.cropro.2012.04.006; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Long EY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11629; Ma BL, 2009, FIELD CROP RES, V111, P189, DOI 10.1016/j.fcr.2008.12.006; Main AR, 2015, ENVIRON SCI TECHNOL, V49, P8367, DOI 10.1021/acs.est.5b01287; Metcalf RL, 1993, DESTRUCTIVE AND USEF; Mogren CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29608; Myers C, 2014, BENEFITS OF NEONICOT; Myresiotis CK, 2015, PEST MANAG SCI, V71, P1258, DOI 10.1002/ps.3919; NOSE K, 1987, J PESTIC SCI, V12, P505; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Pedigo LP., 2009, ENTOMOLOGY PEST MANA; Pollack P., 2011, FINE CHEMICALS THE I; Purdue University Agricultural Communication, 2015, EXTENSION PUBLICATIO; R Core Team, 2016, R A LANGUAGE AND ENV; RILEY TJ, 1979, ANN ENTOMOL SOC AM, V72, P408, DOI 10.1093/aesa/72.3.408; ROUCHAUD J, 1994, B ENVIRON CONTAM TOX, V53, P344, DOI 10.1007/BF00197224; SANBORN SM, 1982, ANN ENTOMOL SOC AM, V75, P103, DOI 10.1093/aesa/75.1.103; Sanchez-Bayo F, 2014, CHEMOSPHERE, V99, P143, DOI 10.1016/j.chemosphere.2013.10.051; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Storer NP, 2006, J ECON ENTOMOL, V99, P1381, DOI 10.1603/0022-0493-99.4.1381; Studebaker G., 2007, ECHNICAL REPORT FOR, P11; Sur R, 2002, B INSECTOL, V56, P35; United States Environmental Protection Agency, 2010, ENVIRONMENTAL FATE A; USDA (US Department of Agriculture), 2014, USITC PUBL, VAC-12-A-51; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Vijver MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089837; Wilde G, 2007, J AGR URBAN ENTOMOL, V24, P177, DOI 10.3954/1523-5475-24.4.177; Xue YG, 2015, ENVIRON SCI TECHNOL, V49, P13003, DOI 10.1021/acs.est.5b03753; YOUNGMAN RR, 1993, ENVIRON ENTOMOL, V22, P1251, DOI 10.1093/ee/22.6.1251; [No title captured]	58	63	65	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173836	10.1371/journal.pone.0173836	http://dx.doi.org/10.1371/journal.pone.0173836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282441	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800083
J	Domino, M; Pawlinski, B; Gajewski, Z				Domino, Malgorzata; Pawlinski, Bartosz; Gajewski, Zdzislaw			Biomathematical pattern of EMG signal propagation in smooth muscle of the nonpregnant porcine uterus	PLOS ONE			English	Article							CAJAL-LIKE CELLS; UTERINE CONTRACTILITY; ELECTRICAL-ACTIVITY; HUMAN MYOMETRIUM; ELECTROMYOGRAPHY; LABOR; PREGNANCY; VELOCITY; SOWS; RAT	Uterine contractions are generated by myometrial smooth muscle cells (SMCs) that comprise most of the myometrial layer of the uterine wall. Aberrant uterine motility (i.e., hypo-or hyper-contractility or asynchronous contractions) has been implicated in the pathogenesis of infertility due to the failure of implantation, endometriosis and abnormal estrous cycles. The mechanism whereby the non-pregnant uterus initiates spontaneous contractions remains poorly understood. The aim of the present study was to employ linear synchronization measures for analyzing the pattern of EMG signal propagation (direction and speed) in smooth muscles of the non-pregnant porcine uterus in vivo using telemetry recording system. It has been revealed that the EMG signal conduction in the uterine wall of the non-pregnant sow does not occur at random but it rather exhibits specific directions and speed. All detectable EMG signals moved along the uterine horn in both cervico-tubal and tubo-cervical directions. The signal migration speed could be divided into the three main types or categories: i. slow basic migration rhythm (SBMR); ii. rapid basic migration rhythm (RBMR); and iii. rapid accessory migration rhythm (RAMR). In conclusion, the EMG signal propagation in smooth muscles of the porcine uterus in vivo can be assessed using a linear synchronization model. Physiological pattern of the uterine contractile activity determined in this study provides a basis for future investigations of normal and pathologicall myogenic function of the uterus.	[Gajewski, Zdzislaw] Warsaw Univ Life Sci WULS SGGW, Fac Vet Med, Vet Res Ctr, Dept Large Anim Dis Clin, Warsaw, Poland; Warsaw Univ Life Sci WULS SGGW, Fac Vet Med, Ctr Biomed Res, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences	Gajewski, Z (corresponding author), Warsaw Univ Life Sci WULS SGGW, Fac Vet Med, Vet Res Ctr, Dept Large Anim Dis Clin, Warsaw, Poland.	zgajewski@supermedia.pl	Domino, Malgorzata/Y-9574-2018; Pawlinski, Bartosz/O-3852-2018; Gajewski, Zdzislaw/N-1481-2016	Domino, Malgorzata/0000-0001-9436-1074; Pawlinski, Bartosz/0000-0002-2307-8922; Gajewski, Zdzislaw/0000-0001-8779-5050	State Committee for Research Investigation [NN308 077439]; EFRR RPO WM	State Committee for Research Investigation; EFRR RPO WM	This work was supported by the State Committee for Research Investigation grant NN308 077439, Narodowe Centrum Nauki, https://www.ncn.gov.pl/. This work was conducted in the Veterinary Research Centre WULS (WCB) and the Center for Biomedical Research (CBB) supported by EFRR RPO WM 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was conducted in the Veterinary Research Centre WULS (WCB) and the Center for Biomedical Research (CBB) supported by EFRR RPO WM 2007-2013.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Alkan A, 2012, EXPERT SYST APPL, V39, P44, DOI 10.1016/j.eswa.2011.06.043; Bower RE., 1974, THESIS, P117; Bozler E, 1938, AM J PHYSIOL, V124, P502, DOI 10.1152/ajplegacy.1938.124.2.502; Bursztyn L, 2007, AM J PHYSIOL-CELL PH, V292, pC1816, DOI 10.1152/ajpcell.00478.2006; Ciontea SM, 2005, J CELL MOL MED, V9, P407, DOI 10.1111/j.1582-4934.2005.tb00366.x; Cochran AL, 2015, MATH MECH SOLIDS, V20, P540, DOI 10.1177/1081286513507940; Cretoiu D, 2006, J CELL MOL MED, V10, P789, DOI 10.1111/j.1582-4934.2006.tb00438.x; DEVEDEUX D, 1993, AM J OBSTET GYNECOL, V169, P1636, DOI 10.1016/0002-9378(93)90456-S; Dodds KN, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.129809; Domino M, 2016, THERIOGENOLOGY; GAJEWSKI Z, 2004, REPROD DOMEST ANIM, V1, P41; GAJEWSKI Z, 2001, NEWSLETTER 5 ESDAR V, V1, P36; Gajewski Z, 2003, P 6 C ESDAR DUBL, V1, P4; GARFIELD RE, 1977, SCIENCE, V198, P958, DOI 10.1126/science.929182; Garfield RE, 2002, J SOC GYNECOL INVEST, V9, P265, DOI 10.1016/S1071-5576(02)00173-9; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Govindan RB, 2015, REPROD SCI, V22, P595, DOI 10.1177/1933719114556484; Hassan M, 2013, IEEE T BIO-MED ENG, V60, P1160, DOI 10.1109/TBME.2012.2229279; Kilianczyk R, 2015, REPROD DOMEST ANIM, V50, P43; LAMMERS WJEP, 1994, AM J PHYSIOL-CELL PH, V267, pC1210, DOI 10.1152/ajpcell.1994.267.5.C1210; Lammers WJEP, 2011, AM J PHYSIOL-REG I, V294, pR919; Lange L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086775; Langendijk P, 2005, THERIOGENOLOGY, V63, P500, DOI 10.1016/j.theriogenology.2004.09.027; Langendijk P, 2002, THERIOGENOLOGY, V57, P1563, DOI 10.1016/S0093-691X(02)00657-X; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Maggio CD, 2012, B MATH BIOL, V74, P143, DOI 10.1007/s11538-011-9681-1; Mikkelsen E, 2013, ACTA OBSTET GYN SCAN, V92, P1070, DOI 10.1111/aogs.12190; MILLER SM, 1989, AM J PHYSIOL, V256, pC130, DOI 10.1152/ajpcell.1989.256.1.C130; Muthuswamy J, 1998, J NEUROSCI METH, V83, P1, DOI 10.1016/S0165-0270(98)00065-X; Oczeretko E, 2007, ANN NY ACAD SCI, V1101, P49, DOI 10.1196/annals.1389.007; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Popescu LM, 2007, ANN NY ACAD SCI, V1101, P139, DOI 10.1196/annals.1389.022; Rabotti C, 2015, ACTA PHYSIOL, V213, P406, DOI 10.1111/apha.12424; Rabotti C, 2010, IEEE ENG MED BIO, P4262, DOI 10.1109/IEMBS.2010.5627172; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P2178, DOI 10.1109/TBME.2010.2049111; Sharifimajd B, 2016, BIOMECH MODEL MECHAN, V15, P497, DOI 10.1007/s10237-015-0703-z; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Wray S, 2003, J SOC GYNECOL INVEST, V10, P252, DOI 10.1016/S1071-5576(03)00089-3; Young RC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003850; Young RC, 2011, REPROD SCI, V18, P64, DOI 10.1177/1933719110379637; Zerobin K, 1972, Adv Vet Sci Comp Med, V16, P303	42	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173452	10.1371/journal.pone.0173452	http://dx.doi.org/10.1371/journal.pone.0173452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282410	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800041
J	Goudey, B; Abraham, G; Kikianty, E; Wang, Q; Rawlinson, D; Shi, F; Haviv, I; Stern, L; Kowalczyk, A; Inouye, M				Goudey, Benjamin; Abraham, Gad; Kikianty, Eder; Wang, Qiao; Rawlinson, Dave; Shi, Fan; Haviv, Izhak; Stern, Linda; Kowalczyk, Adam; Inouye, Michael			Interactions within the MHC contribute to the genetic architecture of celiac disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; EPISTATIC INTERACTIONS; GYNECOLOGICAL HISTORY; SUSCEPTIBILITY LOCI; FEMALE FERTILITY; COMPLEX DISEASES; MULTIPLE COMMON; RISK VARIANTS; MUTATION	Interaction analysis of GWAS can detect signal that would be ignored by single variant analysis, yet few robust interactions in humans have been detected. Recent work has highlighted interactions in the MHC region between known HLA risk haplotypes for various autoimmune diseases. To better understand the genetic interactions underlying celiac disease (CD), we have conducted exhaustive genome-wide scans for pairwise interactions in five independent CD case-control studies, using a rapid model-free approach to examine over 500 billion SNP pairs in total. We found 14 independent interaction signals within the MHC region that achieved stringent replication criteria across multiple studies and were independent of known CD risk HLA haplotypes. The strongest independent CD interaction signal corresponded to genes in the HLA class III region, in particular PRRC2A and GPANK1/C6orf47, which are known to contain variants for non-Hodgkin's lymphoma and early menopause, co-morbidities of celiac disease. Replicable evidence for statistical interaction outside the MHC was not observed. Both within and between European populations, we observed striking consistency of two-locus models and model distribution. Within the UK population, models of CD based on both interactions and additive single-SNP effects increased explained CD variance by approximately 1% over those of single SNPs. The interactions signal detected across the five cohorts indicates the presence of novel associations in the MHC region that cannot be detected using additive models. Our findings have implications for the determination of genetic architecture and, by extension, the use of human genetics for validation of therapeutic targets.	[Goudey, Benjamin; Wang, Qiao; Rawlinson, Dave; Shi, Fan; Kowalczyk, Adam] Univ Melbourne, NICTA Victoria Res Lab, Parkville, Vic, Australia; [Goudey, Benjamin; Wang, Qiao; Rawlinson, Dave; Shi, Fan; Stern, Linda; Kowalczyk, Adam] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Goudey, Benjamin] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic, Australia; [Goudey, Benjamin] IBM Res, Level 5, Carlton, Vic, Australia; [Abraham, Gad; Inouye, Michael] Univ Melbourne, Ctr Syst Genom, Parkville, Vic, Australia; [Abraham, Gad; Inouye, Michael] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Abraham, Gad; Inouye, Michael] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia; [Kikianty, Eder] Univ Johannesburg, Dept Math, Auckland Pk, South Africa; [Haviv, Izhak] Bar Ilan Univ, Fac Med, Safed, Israel; [Kowalczyk, Adam] Univ Melbourne, Ctr Neural Engn, Parkville, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Johannesburg; Bar Ilan University; University of Melbourne	Inouye, M (corresponding author), Univ Melbourne, Ctr Syst Genom, Parkville, Vic, Australia.; Inouye, M (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.; Inouye, M (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic, Australia.	minouye@unimelb.edu.au	Haviv, Izhak/E-3782-2015; Goudey, Benjamin/AAA-8492-2022	Haviv, Izhak/0000-0002-0837-5005; Goudey, Benjamin/0000-0002-2318-985X; Abraham, Gad/0000-0003-4853-0118; Inouye, Michael/0000-0001-9413-6520; Kikianty, Eder/0000-0003-4355-0339	Career Development Fellowship; Australian NHMRC and Heart Foundation [1061435]; NHMRC Peter Doherty Early Career Fellowship [1090462]; University of Melbourne; IBM Research Australia; National ICT Australia (NICTA)	Career Development Fellowship; Australian NHMRC and Heart Foundation(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); IBM Research Australia(International Business Machines (IBM)); National ICT Australia (NICTA)(NICTA)	MI was supported by a Career Development Fellowship co-funded by the Australian NHMRC and Heart Foundation (#1061435). GA was supported by an NHMRC Peter Doherty Early Career Fellowship (#1090462). MI and GA were also supported by University of Melbourne funding. BG was supported by IBM Research Australia. BG, EK, QW, DR, FS, IH and AK were supported by National ICT Australia (NICTA). The funders provided support in the form of salaries for authors BG, EK, QW, DR, FS, IH and AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004137; Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; Abraham G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-88; Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Garner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101428; Goudey B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S10; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Hemani G, 2011, BIOINFORMATICS, V27, P1462, DOI 10.1093/bioinformatics/btr172; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu XH, 2010, CELL RES, V20, P854, DOI 10.1038/cr.2010.68; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mero IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058352; Mitchison NA, 2011, EUR J IMMUNOL, V41, P2152, DOI 10.1002/eji.201141811; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; Nieters A, 2012, BLOOD, V120, P4645, DOI 10.1182/blood-2012-05-427989; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ostensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070174; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Prabhu S, 2012, GENOME RES, V22, P2230, DOI 10.1101/gr.137885.112; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; SHER KS, 1994, DIGESTION, V55, P243, DOI 10.1159/000201155; Sher KS, 1996, ACTA PAEDIATR, V85, P76, DOI 10.1111/j.1651-2227.1996.tb14258.x; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Heel DA, 2005, BEST PRACT RES CL GA, V19, P323, DOI 10.1016/j.bpg.2005.01.001; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wei WH, 2014, HUM MOL GENET, V23, P5061, DOI 10.1093/hmg/ddu227; Wei WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071203; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109; [No title captured]	66	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172826	10.1371/journal.pone.0172826	http://dx.doi.org/10.1371/journal.pone.0172826			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282431	Green Published, gold			2022-12-26	WOS:000396091800013
J	Celis, JS; Edgell, DR; Stelbrink, B; Wibberg, D; Hauffe, T; Blom, J; Kalinowski, J; Wilke, T				Celis, Juan Sebastian; Edgell, David R.; Stelbrink, Bjoern; Wibberg, Daniel; Hauffe, Torsten; Blom, Jochen; Kalinowski, Joern; Wilke, Thomas			Evolutionary and biogeographical implications of degraded LAGLIDADG endonuclease functionality and group I intron occurrence in stony corals (Scleractinia) and mushroom corals (Corallimorpharia)	PLOS ONE			English	Article							MITOCHONDRIAL COX1 GENE; HOMING ENDONUCLEASE; HORIZONTAL TRANSFER; GENOME; DNA; SEQUENCES; PROTEIN; REEF; METAZOAN; RNA	Group I introns and homing endonuclease genes (HEGs) are mobile genetic elements, capable of invading target sequences in intron-less genomes. LAGLIDADG HEGs are the largest family of endonucleases, playing a key role in the mobility of group I introns in a process known as 'homing'. Group I introns and HEGs are rare in metazoans, and can be mainly found inserted in the COXI gene of some sponges and cnidarians, including stony corals (Scleractinia) and mushroom corals (Corallimorpharia). Vertical and horizontal intron transfer mechanisms have been proposed as explanations for intron occurrence in cnidarians. However, the central role of LAGLIDADG motifs in intron mobility mechanisms remains poorly understood. To resolve questions regarding the evolutionary origin and distribution of group I introns and HEGs in Scleractinia and Corallimorpharia, we examined intron/HEGs sequences within a comprehensive phylogenetic framework. Analyses of LAGLIDADG motif conservation showed a high degree of degradation in complex Scleractinia and Corallimorpharia. Moreover, the two motifs lack the respective acidic residues necessary for metal-ion binding and catalysis, potentially impairing horizontal intron mobility. In contrast, both motifs are highly conserved within robust Scleractinia, indicating a fully functional endonuclease capable of promoting horizontal intron transference. A higher rate of non-synonymous substitutions (K-a) detected in the HEGs of complex Scleractinia and Corallimorpharia suggests degradation of the HEG, whereas lower K-a rates in robust Scleractinia are consistent with a scenario of purifying selection. Molecular-clock analyses and ancestral inference of intron type indicated an earlier intron insertion in complex Scleractinia and Corallimorpharia in comparison to robust Scleractinia. These findings suggest that the lack of horizontal intron transfers in the former two groups is related to an age-dependent degradation of the endonuclease activity. Moreover, they also explain the peculiar geographical patterns of introns in stony and mushroom corals.	[Celis, Juan Sebastian; Stelbrink, Bjoern; Hauffe, Torsten; Wilke, Thomas] Justus Liebig Univ, Anim Ecol & Systemat, Giessen, Hessen, Germany; [Celis, Juan Sebastian; Wilke, Thomas] Corp Ctr Excellence Marine Sci CEMarin, Bogota, Colombia; [Edgell, David R.] Western Univ, Sch Med & Dent, Dept Biochem, London, ON, Canada; [Wibberg, Daniel; Kalinowski, Joern] Univ Bielefeld, Inst Genome Res & Syst Biol CeBiTec, Dept Biochem, Bielefeld, Germany; [Blom, Jochen] Justus Liebig Univ, Bioinformat & Syst Biol, Giessen, Germany	Justus Liebig University Giessen; Western University (University of Western Ontario); University of Bielefeld; Justus Liebig University Giessen	Celis, JS (corresponding author), Justus Liebig Univ, Anim Ecol & Systemat, Giessen, Hessen, Germany.; Celis, JS (corresponding author), Corp Ctr Excellence Marine Sci CEMarin, Bogota, Colombia.	Juan.S.Celis-Melo@bio.uni-giessen.de	Wilke, Thomas/G-1517-2012; Edgell, David/AAJ-1971-2020; Stelbrink, Björn/Y-5023-2019	Wilke, Thomas/0000-0001-8263-7758; Stelbrink, Björn/0000-0002-7471-4992; Hauffe, Torsten/0000-0001-5711-9457	German Academic Exchange Service [A1372429]; Corporation Center of Excellence in Marine Sciences [80221287]	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Corporation Center of Excellence in Marine Sciences	JSC was funded jointly by the German Academic Exchange Service (Grant number A1372429. https://www.daad.de/en/) and the Corporation Center of Excellence in Marine Sciences (Grant Number 80221287. http://cemarin.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-161; Beagley CT, 1996, P NATL ACAD SCI USA, V93, P5619, DOI 10.1073/pnas.93.11.5619; Belfort Marlene, 2002, P761; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2006, GENES CONFLICT BIOL; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; Celis JS, 2016, MITOCHONDRIAL DNA A, V27, P3695, DOI 10.3109/19401736.2015.1079860; Chevalier B, 2005, NUCL ACID M, V16, P33; Cho YR, 1999, MOL BIOL EVOL, V16, P1155, DOI 10.1093/oxfordjournals.molbev.a026206; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgell DR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-22; Edgell DR, 2009, CURR BIOL, V19, pR115, DOI 10.1016/j.cub.2008.12.019; Edgell DR, 2003, CURR BIOL, V13, P973, DOI 10.1016/S0960-9822(03)00340-3; Emblem A, 2014, MOL PHYLOGENET EVOL, V75, P184, DOI 10.1016/j.ympev.2014.02.016; Fluegel Erik, 2002, P391; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fukami H, 2005, CORAL REEFS, V24, P410, DOI 10.1007/s00338-005-0023-3; Fukami H, 2007, J MOL EVOL, V64, P591, DOI 10.1007/s00239-006-0279-4; Goddard MR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000003; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, NUCLEIC ACIDS RES, V32, P2049, DOI 10.1093/nar/gkh520; Hausner G, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-8; Huchon D, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0556-1; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiessling W, 2011, GLOBAL CHANGE BIOL, V17, P56, DOI 10.1111/j.1365-2486.2010.02204.x; Kiessling W, 2009, PALAIOS, V24, P657, DOI 10.2110/palo.2009.p09-030r; Kitahara MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094774; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leprieur F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11461; Lin MF, 2014, GENOME BIOL EVOL, V6, P1086, DOI 10.1093/gbe/evu084; LOIZOS N, 1994, P NATL ACAD SCI USA, V91, P11983, DOI 10.1073/pnas.91.25.11983; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miller M.A., 2010, P GAT COMP ENV WORKS; NEI M, 1986, MOL BIOL EVOL, V3, P418; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2013, R LANG ENV STAT COMP; Rambaut A., TRACER V 1 5; Renema W, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500850; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roman J, 1998, P NATL ACAD SCI USA, V95, P2134, DOI 10.1073/pnas.95.5.2134; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Roy AC, 2016, NUCLEIC ACIDS RES, V44, P7350, DOI 10.1093/nar/gkw614; Sandegren L, 2005, NUCLEIC ACIDS RES, V33, P6203, DOI 10.1093/nar/gki932; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Simpson C, 2011, EVOLUTION, V65, P3274, DOI 10.1111/j.1558-5646.2011.01365.x; Stoddard BL, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-7; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Swithers KS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-303; Szitenberg A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-288; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723	69	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173734	10.1371/journal.pone.0173734	http://dx.doi.org/10.1371/journal.pone.0173734			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278261	Green Submitted, gold, Green Published			2022-12-26	WOS:000396087900035
J	Takahara, I; Akazawa, Y; Tabuchi, M; Matsuda, K; Miyaaki, H; Kido, Y; Kanda, Y; Taura, N; Ohnita, K; Takeshima, F; Sakai, Y; Eguchi, S; Nakashima, M; Nakao, K				Takahara, Ikuko; Akazawa, Yuko; Tabuchi, Maiko; Matsuda, Katsuya; Miyaaki, Hisamitsu; Kido, Youko; Kanda, Yasuko; Taura, Naota; Ohnita, Ken; Takeshima, Fuminao; Sakai, Yusuke; Eguchi, Susumu; Nakashima, Masahiro; Nakao, Kazuhiko			Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR XBP1; ER STRESS; SIGNALING PATHWAY; MESSENGER-RNA; STEATOHEPATITIS; LIPOAPOPTOSIS; CELLS; LIPOGENESIS; OBESITY; BIM	Background and aims A high serum level of saturated free fatty acids (FFAs) is associated with the development of nonalcoholic fatty liver disease (NAFLD). X-box binding protein-1 (XBP-1) is activated by FFA treatment upon splicing. XBP-1 is a transcription factor induced by the endoplasmic reticulum (ER) stress sensor endoribonuclease inositol-requiring enzyme 1 alpha (IRE1 alpha). However, the role of XBP-1 in NAFLD remains relatively unexplored. Toyocamycin was recently reported to attenuate the activation of XBP-1, possibly by inducing a conformational change in IRE1 alpha. In this study, we examined the effect of toyocamycin on hepatocyte lipoapoptosis and steatosis. We also explored the effects of toyocamycin in a mouse model of NAFLD. Methods Huh-7 cells and isolated rat primary hepatocytes were treated with palmitic acid (PA), which is a saturated FFA, in the presence or absence of toyocamycin. In addition, male C57BL/6J mice were fed a diet rich in saturated fat, fructose, and cholesterol (FFC) for 4 months, after which the effect of toyocamycin was assessed. Results Toyocamycin attenuated FFA-induced steatosis. It also significantly reduced PA-induced hepatocyte lipoapoptosis. In addition, toyocamycin reduced the expression of cytosine-cytosine-adenosine-adenosine-thymidine enhancer-binding protein homologous protein (CHOP), which is a key player in ER stress-mediated apoptosis, as well as its downstream cell death modulator, death receptor 5. In the in vivo study, toyocamycin ameliorated the liver injury caused by FFC-induced NAFLD. It also reduced hepatic steatosis and the expression of lipogenic genes. Conclusions The data we obtained suggest that toyocamycin attenuates hepatocyte lipogenesis and ameliorates NAFLD in vivo and may therefore be beneficial in the treatment of NAFLD in humans.	[Takahara, Ikuko; Akazawa, Yuko; Tabuchi, Maiko; Miyaaki, Hisamitsu; Kido, Youko; Kanda, Yasuko; Taura, Naota; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ, Sch Med, Div Gastroenterol & Hepatol, Nagasaki, Japan; [Matsuda, Katsuya; Nakashima, Masahiro] Nagasaki Univ, Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki, Japan; [Sakai, Yusuke; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Akazawa, Y (corresponding author), Nagasaki Univ, Sch Med, Div Gastroenterol & Hepatol, Nagasaki, Japan.	akazaway@nagasaki-u.ac.jp		Eguchi, Susumu/0000-0002-7876-0152; Sakai, Yusuke/0000-0001-7999-9731	Japan Society for the Promotion of Science (JSPS) Kakenhi [24790709]	Japan Society for the Promotion of Science (JSPS) Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (JSPS) Kakenhi [grant numbers 24790709 YA] https://www.jsps.go.jp/english/index.html.r We thank Mr. Tsutomu Kanda for his excellent support during the study. This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI [grant number 24790709 YA].	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Cazanave SC, 2011, J BIOL CHEM, V286, P39336, DOI 10.1074/jbc.M111.280420; Cazanave SC, 2009, HEPATOLOGY, V50, P1009, DOI 10.1002/hep.23188; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Franca LM, 2014, BIOCHEM BIOPH RES CO, V443, P725, DOI 10.1016/j.bbrc.2013.12.042; Glimcher LH, 2009, ANN NY ACAD SCI, V1173, pE2, DOI 10.1111/j.1749-6632.2009.04956.x; Hirsova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070599; Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831; Ibrahim SH, 2014, LIVER INT, V34, P427, DOI 10.1111/liv.12353; Ibrahim SH, 2011, J HEPATOL, V54, P765, DOI 10.1016/j.jhep.2010.09.039; Kakazu E, 2015, J LIPID RES; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Liu XY, 2015, AM J PHYSIOL-GASTR L, V309, pG965, DOI 10.1152/ajpgi.00132.2015; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Mhaidat NM, 2015, J CHEMOTHER; Ning J, 2011, ENDOCRINOLOGY, V152, P2247, DOI 10.1210/en.2010-1036; Olivares S, 2015, J BIOL CHEM; OSADA H, 1989, J ANTIBIOT, V42, P102, DOI 10.7164/antibiotics.42.102; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rajapaksa G., 2014, ONCOGENE; Reimold AM, 2000, GENE DEV, V14, P152; Ri M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.26; Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Sharma M, 2012, J HEPATOL, V56, P192, DOI 10.1016/j.jhep.2011.03.019; Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	39	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0170591	10.1371/journal.pone.0170591	http://dx.doi.org/10.1371/journal.pone.0170591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278289	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900107
J	Phan, K; Ng, CA; David, E; Shishmarev, D; Kuchel, PW; Vandenberg, JI; Perry, MD				Phan, Kevin; Ng, Chai Ann; David, Erikka; Shishmarev, Dmitry; Kuchel, Philip W.; Vandenberg, Jamie I.; Perry, Matthew D.			The S1 helix critically regulates the finely tuned gating of Kv11.1 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; cardiovascular disease; channel activation; electrophysiology; hERG; ion channel; mutagenesis in vitro; nuclear magnetic resonance (NMR); oocyte; potassium channel	LONG-QT-SYNDROME; HERG K+ CHANNELS; CRYOELECTRON MICROSCOPY STRUCTURE; VOLTAGE-SENSING DOMAIN; SWISS-MODEL WORKSPACE; POTASSIUM CHANNEL; ION-CHANNEL; CARDIAC-ARRHYTHMIA; TRAFFICKING DEFECT; STRUCTURAL BASIS	Congenital mutations in the cardiac Kv11.1 channel can cause long QT syndrome type 2 (LQTS2), a heart rhythm disorder associated with sudden cardiac death. Mutations act either by reducing protein expression at the membrane and/or by perturbing the intricate gating properties of Kv11.1 channels. A number of clinical LQTS2-associated mutations have been reported in the first transmembrane segment (S1) of Kv11.1 channels, but the role of this region of the channel is largely unexplored. In part, this is due to problems defining the extent of the S1 helix, as a consequence of its low sequence homology with other Kv family members. Here, we used NMR spectroscopy and electrophysiological characterization to show that the S1 of Kv11.1 channels extends seven helical turns, from Pro-405 to Phe-431, and is flanked by unstructured loops. Functional analysis suggests that pre-S1 loop residues His-402 and Tyr-403 play an important role in regulating the kinetics and voltage dependence of channel activation and deactivation. Multiple residues within the S1 helix also play an important role in fine-tuning the voltage dependence of activation, regulating slow deactivation, and modulating C-type inactivation of Kv11.1 channels. Analyses of LQTS2-associated mutations in the pre-S1 loop or S1 helix of Kv11.1 channels demonstrate perturbations to both protein expression and most gating transitions. Thus, S1 region mutations would reduce both the action potential repolarizing current passed by Kv11.1 channels in cardiac myocytes, as well as the current passed in response to premature depolarizations that normally helps protect against the formation of ectopic beats.	[Phan, Kevin; Ng, Chai Ann; David, Erikka; Vandenberg, Jamie I.; Perry, Matthew D.] Victor Chang Cardiac Res Inst, 405 Liverpool St, Darlinghurst, NSW 2010, Australia; [Phan, Kevin; Ng, Chai Ann; Vandenberg, Jamie I.; Perry, Matthew D.] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Shishmarev, Dmitry; Kuchel, Philip W.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Sydney	Perry, MD (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Programme Cardiac Electro, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	m.perry@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013; Shishmarev, Dmitry/A-6468-2018	Vandenberg, Jamie I/0000-0002-3859-3716; Shishmarev, Dmitry/0000-0002-0724-0002; Kuchel, Philip/0000-0003-4100-7332; Ng, Chai Ann/0000-0002-3120-5450	Australian Research Council Discovery Grant [DP150101929]; National Health and Medical Research Council [App1074386]; National Health and Medical Research Council Fellowship [App1116948]	Australian Research Council Discovery Grant(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in whole or part by Australian Research Council Discovery Grant DP150101929, National Health and Medical Research Council Program Grant App1074386, and National Health and Medical Research Council Fellowship App1116948 (to J. I. V). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Anderson CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6535; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balijepalli SY, 2012, CIRCULATION, V126, P2809, DOI 10.1161/CIRCULATIONAHA.112.118018; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; Bocksteins E, 2011, EUR BIOPHYS J BIOPHY, V40, P783, DOI 10.1007/s00249-011-0694-3; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Cheng YM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00083; Colenso CK, 2013, J CHEM INF MODEL, V53, P1358, DOI 10.1021/ci4000739; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Dhillon MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04201; Es-Salah-Lamoureux Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010876; Garcia-Elias A, 2015, STRUCTURE, V23, P1404, DOI 10.1016/j.str.2015.05.018; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Gong QM, 2007, CIRCULATION, V116, P17, DOI 10.1161/CIRCULATIONAHA.107.708818; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Haitin Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001935; Hite RK, 2017, NATURE, V541, P52, DOI 10.1038/nature20775; Hite RK, 2015, NATURE, V527, P198, DOI 10.1038/nature14958; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Kanters JK, 2015, SCAND J CLIN LAB INV, V75, P699, DOI 10.3109/00365513.2015.1091090; Ke Y, 2013, BIOCHEM J, V454, P69, DOI 10.1042/BJ20130328; Koval OM, 2007, J GEN PHYSIOL, V129, P209, DOI 10.1085/jgp.200609662; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lacroix JJ, 2012, J GEN PHYSIOL, V140, P635, DOI 10.1085/jgp.201210827; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Liu QN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123951; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; Ng CA, 2014, J BIOL CHEM, V289, P25822, DOI 10.1074/jbc.M114.558379; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Perry MD, 2016, J PHYSIOL-LONDON, V594, P4031, DOI 10.1113/JP271805; Perry MD, 2013, J BIOL CHEM, V288, P11482, DOI 10.1074/jbc.M113.461442; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Piper DR, 2008, CELL PHYSIOL BIOCHEM, V21, P37, DOI 10.1159/000113745; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; Shimizu W, 2009, J AM COLL CARDIOL, V54, P2052, DOI 10.1016/j.jacc.2009.08.028; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Tao X, 2017, NATURE, V541, P46, DOI 10.1038/nature20608; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Zhang M, 2005, J MEMBRANE BIOL, V207, P169, DOI 10.1007/s00232-005-0812-1; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhang T, 2010, HUM MUTAT, V31, pE1801, DOI 10.1002/humu.21341; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	71	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7688	7705		10.1074/jbc.M117.779298	http://dx.doi.org/10.1074/jbc.M117.779298			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28280240	hybrid, Green Published			2022-12-26	WOS:000400761300034
J	Acuna, SM; Bastias, JM; Toledo, PG				Acuna, Sergio M.; Bastias, Jose M.; Toledo, Pedro G.			Direct measurement of interaction forces between bovine serum albumin and poly (ethylene oxide) in water and electrolyte solutions	PLOS ONE			English	Article							POLYSTYRENE SURFACES; AQUEOUS-ELECTROLYTE; PROTEIN ADSORPTION; GLASS SURFACES; ADHESION; BRUSHES; STRATEGIES; STABILITY; BACTERIA; FILMS	The net interaction between a probe tip coated with bovine serum albumin (BSA) protein and a flat substrate coated with poly(ethylene oxide) (PEO) polymer was measured directly on approach in water and electrolyte solutions using AFM. The approach force curve between the two surfaces was monotonically repulsive in water and in electrolyte solutions. At pH similar to 5, slightly above the isoelectric point (pI) of BSA, and at large distances, the force was dominated by electrostatic repulsion between the oxygen atoms of the incoming protein with those belonging to the ether groups of PEO. Such repulsive force and range decreased in NaCl. Under physiological conditions, pH 6, BSA is definitely charged and the electrostatic repulsion with ether groups in PEO appears at larger separation distances. Interestingly, at pH 4, below the pI of BSA, the repulsion decreased because of an attractive, although weak, electrostatic force that appeared between the ether groups in PEO and the positively charged amino groups of BSA. However, for all solution conditions, once compression of PEO begun, the net repulsion was always dominated by short-range polymeric steric repulsion and repulsive enthalpy penalties for breaking PEO-water bonds. Results suggest that PEO in mushroom conformation may also be effective in reducing biofouling.	[Acuna, Sergio M.; Bastias, Jose M.] Univ Bio Bio, Dept Food Engn, Chillan, Chile; [Toledo, Pedro G.] Univ Concepcion, Dept Chem Engn, Correo 3, Concepcion, Chile; [Toledo, Pedro G.] Univ Concepcion, Lab Surface Anal, Correo 3, Concepcion, Chile	Universidad del Bio-Bio; Universidad de Concepcion; Universidad de Concepcion	Acuna, SM (corresponding author), Univ Bio Bio, Dept Food Engn, Chillan, Chile.	sacuna@ubiobio.cl	Acuña, Sergio M./N-3875-2019; Acuña, Sergio M./D-4071-2016; Toledo, Pedro/R-6094-2017; Bastias, Jose/AGI-3305-2022	Acuña, Sergio M./0000-0003-1365-9851; Acuña, Sergio M./0000-0003-1365-9851; Toledo, Pedro/0000-0003-2863-7997; 	Universidad del Bio-Bio [GI 152322/EF]; Fondecyt-CONICYT [1090781]; Center CRHIAM-FONDAP-CONICYT [15130015]	Universidad del Bio-Bio; Fondecyt-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center CRHIAM-FONDAP-CONICYT	We gratefully acknowledge the support from the Universidad del Bio-Bio through Project GI 152322/EF, Fondecyt-CONICYT through Project 1090781 and Center CRHIAM-FONDAP-CONICYT through Project 15130015.; We gratefully acknowledge the support from the Universidad del Bio-Bio through Project GI 152322/EF, Fondecyt-CONICYT through Project 1090781 and Center CRHIAM-FONDAP-CONICYT through Project 15130015. We thank Paula Toledo for the graphical abstract"	Acuna SM, 2008, LANGMUIR, V24, P4881, DOI 10.1021/la703866g; Barbosa LRS, 2010, BIOPHYS J, V98, P147, DOI 10.1016/j.bpj.2009.09.056; Bosker WTE, 2005, J COLLOID INTERF SCI, V286, P496, DOI 10.1016/j.jcis.2005.01.091; Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437; Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006; Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488; Considine RF, 1999, LANGMUIR, V15, P1657, DOI 10.1021/la980900h; Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225; DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0; DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024; Efremova NV, 2001, LANGMUIR, V17, P7628, DOI 10.1021/la010405c; Fernandez ICS, 2007, BIOMATERIALS, V28, P4105, DOI 10.1016/j.biomaterials.2007.05.023; Follstaedt SC, 2000, TECH REP; Ge SR, 1998, J BIOMAT SCI-POLYM E, V9, P131; GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211; Gon S, 2012, MACROMOLECULES, V45, P8373, DOI 10.1021/ma300981r; Hamilton-Brown P, 2009, LANGMUIR, V25, P9149, DOI 10.1021/la900703e; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0; Kang S, 2007, J MEMBRANE SCI, V296, P42, DOI 10.1016/j.memsci.2007.03.012; Kaper HJ, 2003, J BIOMAT SCI-POLYM E, V14, P313, DOI 10.1163/156856203321478847; Kim KS, 2016, ACS APPL MATER INTER, V8, P20342, DOI 10.1021/acsami.6b04629; Krishnamoorthy M, 2014, CHEM REV, V114, P10976, DOI 10.1021/cr500252u; Louguet S, 2001, J COLLOID INTERF SCI, V359, P413; Maas JH, 2003, THIN SOLID FILMS, V426, P135, DOI 10.1016/S0040-6090(03)00033-6; MARON SH, 1972, J MACROMOL SCI PHYS, VB  6, P79, DOI 10.1080/00222347208224790; Michnik A, 2005, J THERM ANAL CALORIM, V80, P399, DOI 10.1007/s10973-005-0667-9; Miquel S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00592; Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014; Ngadi N, 2009, INT J BIOL LIFE SCI, V1, P145; Ngadi N., 2009, WORLD ACAD SCI ENG T, V49, P144; Pinheiro JP, 2004, ANAL BIOANAL CHEM, V380, P964, DOI 10.1007/s00216-004-2843-3; Rana D, 2010, CHEM REV, V110, P2448, DOI 10.1021/cr800208y; Rixman MA, 2003, LANGMUIR, V19, P9357, DOI 10.1021/la034057l; Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227; Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0; Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0; Saavedra JH, 2013, J COLLOID INTERF SCI, V410, P188, DOI 10.1016/j.jcis.2013.08.001; Sadekuzzaman M, 2015, COMPR REV FOOD SCI F, V14, P491, DOI 10.1111/1541-4337.12144; Sanchez-Gonzalez J, 2003, J COLLOID INTERF SCI, V267, P286, DOI 10.1016/S0021-9797(03)00754-9; Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399; Vinogradova OI, 2001, J CHEM PHYS, V114, P8124, DOI 10.1063/1.1365954	42	5	5	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173910	10.1371/journal.pone.0173910	http://dx.doi.org/10.1371/journal.pone.0173910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296940	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700076
J	Kommerein, N; Stumpp, SN; Musken, M; Ehlert, N; Winkel, A; Haussler, S; Behrens, P; Buettner, FFR; Stiesch, M				Kommerein, Nadine; Stumpp, Sascha N.; Muesken, Mathias; Ehlert, Nina; Winkel, Andreas; Haeussler, Susanne; Behrens, Peter; Buettner, Falk F. R.; Stiesch, Meike			An oral multispecies biofilm model for high content screening applications	PLOS ONE			English	Article							IN-VITRO; PERI-IMPLANT; IDENTIFICATION; COLONIZATION; VEILLONELLA; PREVALENCE; COMMUNITY; BACTERIA; MUTANS; GROWTH	Peri-implantitis caused by multispecies biofilms is a major complication in dental implant treatment. The bacterial infection surrounding dental implants can lead to bone loss and, in turn, to implant failure. A promising strategy to prevent these common complications is the development of implant surfaces that inhibit biofilm development. A reproducible and easy-to-use biofilm model as a test system for large scale screening of new implant surfaces with putative antibacterial potency is therefore of major importance. In the present study, we developed a highly reproducible in vitro four-species biofilm model consisting of the highly relevant oral bacterial species Streptococcus oralis, Actinomyces naeslundii, Veillonella dispar and Porphyromonas gingivalis. The application of live/dead staining, quantitative real time PCR (qRT-PCR), scanning electron microscopy (SEM) and urea-NaCl fluorescence in situ hybridization (urea-NaCl-FISH) revealed that the four-species biofilm community is robust in terms of biovolume, live/dead distribution and individual species distribution over time. The biofilm community is dominated by S. oralis, followed by V. dispar, A. naeslundii and P. gingivalis. The percentage distribution in this model closely reflects the situation in early native plaques and is therefore well suited as an in vitro model test system. Furthermore, despite its nearly native composition, the multispecies model does not depend on nutrient additives, such as native human saliva or serum, and is an inexpensive, easy to handle and highly reproducible alternative to the available model systems. The 96-well plate format enables high content screening for optimized implant surfaces impeding biofilm formation or the testing of multiple antimicrobial treatment strategies to fight multispecies biofilm infections, both exemplary proven in the manuscript.	[Kommerein, Nadine; Stumpp, Sascha N.; Winkel, Andreas; Stiesch, Meike] Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany; [Muesken, Mathias; Haeussler, Susanne] TWINCORE, Inst Mol Bacteriol, Ctr Expt & Clin Infect Res, Hannover, Germany; [Muesken, Mathias; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany; [Ehlert, Nina; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, Hannover, Germany; [Buettner, Falk F. R.] Hannover Med Sch, Inst Clin Biochem, Hannover, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Leibniz University Hannover; Hannover Medical School	Kommerein, N (corresponding author), Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany.	kommerein.nadine@mh-hannover.de	Pohl, Sarah/B-3102-2016; Häussler, Susanne/I-2605-2014; Kommerein, Nadine/AAT-5392-2020	Pohl, Sarah/0000-0003-2655-7037; Häussler, Susanne/0000-0001-6141-9102; Kommerein, Nadine/0000-0001-5978-2965; Musken, Mathias/0000-0002-5624-1378	Ministry of Lower Saxony; VolkswagenStiftung [VWZN2860]; Deutsche Forschungsgemeinschaft (DFG, German to Reconstructive Therapy) [EXC 62/2]	Ministry of Lower Saxony; VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft (DFG, German to Reconstructive Therapy)	This work was supported by funding from the Ministry of Lower Saxony and VolkswagenStiftung (both BIOFABRICATION FOR NIFE: VWZN2860). F.F.R. Buettner was supported by funding from the Deutsche Forschungsgemeinschaft (DFG, German to Reconstructive Therapy, EXC 62/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x; Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Ammann TW, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-227; Andric N, 2016, BIONANOMATERIALS, V17; Baqain ZH, 2012, BRIT J ORAL MAX SURG, V50, P239, DOI 10.1016/j.bjoms.2011.04.074; Bornstein MM, 2009, INT J ORAL MAX IMPL, V24, P12; Canullo L, 2015, CLIN ORAL IMPLANTS R; Casado PL, 2011, IMPLANT DENT, V20, P226, DOI 10.1097/ID.0b013e3182199348; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; de Soet JJ, 2000, CARIES RES, V34, P486, DOI 10.1159/000016628; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Edlund A, MICROBIOME, P25; Egland PG, 2004, INTERSPECIES COMMUNI; Ehlert N, 2011, J MATER CHEM, V21, P752, DOI 10.1039/c0jm01487g; Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; GIBBONS R J, 1970, Archives of Oral Biology, V15, P1397, DOI 10.1016/0003-9969(70)90031-2; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Henry PJ, 2005, CLIN EXP PHARMACOL P, V32, P123, DOI 10.1111/j.1440-1681.2005.04140.x; Huynh-Ba G, 2008, J PERIODONTOL, V79, P2256, DOI [10.1902/jop.2008.070602, 10.1902/jop.2008.070602 ]; Hwang G, SCI REP, P62016; Koldsland OC, 2009, J PERIODONTOL, V80, P1069, DOI 10.1902/jop.2009.080594; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; KOLENBRANDER PE, 1992, ADV MICROB ECOL, V12, P183; Lawson TS, 2012, LETT APPL MICROBIOL, V54, P263, DOI 10.1111/j.1472-765X.2011.03197.x; Levignac J, 1965, Rev Fr Odontostomatol, V12, P1251; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Maruyama N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06602; Mashima I, J BACTERIOL, P2104; MIKX FHM, 1975, ARCH ORAL BIOL, V20, P407, DOI 10.1016/0003-9969(75)90224-1; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Olate S, 2010, J ORAL MAXIL SURG, V68, P414, DOI 10.1016/j.joms.2009.10.002; Periasamy S, INFECT IMMUN, P3542; Periasamy S, 2009, APPL ENVIRON MICROB, V75, P3250, DOI 10.1128/AEM.02901-08; Persson GR, 2014, CLIN IMPLANT DENT R, V16, P783, DOI 10.1111/cid.12052; Peyyala R, 2011, APPL ENVIRON MICROB, V77, P3413, DOI 10.1128/AEM.00039-11; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; ROGOSA M, 1964, J BACTERIOL, V88, P37, DOI 10.1128/JB.88.1.37-41.1964; Sanchez MC, 2011, J PERIODONTAL RES, V46, P252, DOI 10.1111/j.1600-0765.2010.01341.x; Schaumann S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-157; Sennerby L, 2000, PERIODONTOL 2000, V4, P58; Tabanella G, 2009, CLIN IMPLANT DENT R, V11, P24, DOI 10.1111/j.1708-8208.2008.00088.x; TAKAHASHI N, 1990, J DENT RES, V69, P1266, DOI 10.1177/00220345900690060801; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P43, DOI 10.1034/j.1399-302X.1999.140105.x; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P60, DOI 10.1034/j.1399-302X.1999.140108.x; Thurnheer T, 2004, J MICROBIOL METH, V56, P37, DOI 10.1016/j.mimet.2003.09.003; VANWINKELHOFF AJ, 1989, J CLIN PERIODONTOL, V16, P128; Washio J, APPL ENV MICROBIOL, P4184; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x; Zobell CE, 1936, OBSERVATIONS MULTIPL	55	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173973	10.1371/journal.pone.0173973	http://dx.doi.org/10.1371/journal.pone.0173973			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296966	gold, Green Published			2022-12-26	WOS:000396311700084
J	Bai, L; Wang, H; Wang, AH; Zhang, LY; Bai, J				Bai, Lin; Wang, Hui; Wang, Ai-Hua; Zhang, Luo-Ying; Bai, Jie			MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; TARGETING TELOMERASE; HTERT; EXPRESSION; GROWTH; METASTASIS; SLUG; RNA; EMT	Human telomerase reverse transcriptase (hTERT) plays a crucial role in ovarian cancer (OC) progression. However, the mechanisms underlying hTERT upregulation in OC, and the specific microRNAs (miRNAs) involved in the regulation of hTERT in OC cells, remains unclear. We performed a bioinformatics search to identify potential miRNAs that bind to the 3'-untranslated region (3'-UTR) region of the hTERT mRNA. We examined the expression levels of miR-532/miR-3064 in OC tissues and normal ovarian tissues, and analyzed the correlation between miRNA expression and OC patient outcomes. The impacts of miR-532/miR-3064 on hTERT expression were evaluated by western blot analysis and hTERT 3'-UTR reporter assays. We investigated the effects of miR-532/miR-3064 on proliferation and invasion in OC cells. We found that miR-532 and miR-3064 are down-regulated in OC specimens. We observed a significant association between reduced miR-532/miR-3064 expression and poorer survival of patients with OC. We confirmed that in OC cells, these two miRNAs downregulate hTERT levels by directly targeting its 3'-UTR region, and inhibited proliferation, EMT and invasion of OC cells. In addition, the overexpression of the hTERT cDNA lacking the 3'-UTR partially restored miR-532/miR-3064-inhibited OC cell proliferation and invasion. The silencing of hTERT by siRNA oligonucleotides abolished these malignant features, and phenocopied the effects of miR-532/miR-3064 overexpression. Furthermore, overexpression of miR-532/miR-3064 inhibits the growth of OC cells in vivo. Our findings demonstrate a miR-532/miR-3064-mediated mechanism responsible for hTERT upregulation in OC cells, and reveal a possibility of targeting miR-532/miR-3064 for future treatment of OC.	[Bai, Lin; Wang, Hui; Wang, Ai-Hua; Zhang, Luo-Ying; Bai, Jie] First Peoples Hosp Shangqiu, Dept Obstet & Gynecol, Shangqiu, Peoples R China		Bai, L (corresponding author), First Peoples Hosp Shangqiu, Dept Obstet & Gynecol, Shangqiu, Peoples R China.	drlinbai2013@sina.com			First People's Hospital of Shangqiu (Shangqiu, China) [2010-104]	First People's Hospital of Shangqiu (Shangqiu, China)	This study was supported by a grant from the First People's Hospital of Shangqiu (2010-104, Shangqiu, China). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.553; Choi MJ, 2015, ONCOGENE, V34, P3402, DOI 10.1038/onc.2014.270; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Dong PX, 2016, ONCOTARGET, V7, P20260, DOI 10.18632/oncotarget.7754; Ell B, 2013, TRENDS CELL BIOL, V23, P603, DOI 10.1016/j.tcb.2013.06.001; He B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21955; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Kasiappan R, 2012, J BIOL CHEM, V287, P41297, DOI 10.1074/jbc.M112.407189; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kim SH, 2016, ARCH PHARM RES, V39, P240, DOI 10.1007/s12272-015-0666-8; Kong WM, 2015, J CANCER, V6, P1337, DOI 10.7150/jca.13054; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Li J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135265; Li M, 2015, MOL MED REP, V11, P4645, DOI 10.3892/mmr.2015.3287; Liu N, 2016, NUCLEIC ACIDS RES, V44, P8693, DOI 10.1093/nar/gkw549; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Meng E, 2012, GYNECOL ONCOL, V124, P598, DOI 10.1016/j.ygyno.2011.11.018; Qi Z, 2016, CANCER GENE THER, V23, P36, DOI 10.1038/cgt.2015.64; Qin Y, 2016, ONCOTARGET, V7, P351, DOI 10.18632/oncotarget.5968; Ruden M, 2013, CANCER TREAT REV, V39, P444, DOI 10.1016/j.ctrv.2012.06.007; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Slattery ML, 2016, CARCINOGENESIS, V37, P245, DOI 10.1093/carcin/bgv249; Tang B, 2016, ONCOTARGET, V7, P11364, DOI 10.18632/oncotarget.6575; Wang F, 2016, MOL CANCER THER, V15, P1123, DOI 10.1158/1535-7163.MCT-15-0943; Wang T, 2012, ONCOL REP, V28, P1153, DOI 10.3892/or.2012.1952; Zhao Q, 2015, ONCOL REP, V34, P979, DOI 10.3892/or.2015.4013	27	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173912	10.1371/journal.pone.0173912	http://dx.doi.org/10.1371/journal.pone.0173912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291810	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700049
J	Chang, T; Moniz, MH; Plegue, MA; Sen, A; Davis, MM; Villamor, E; Richardson, CR				Chang, Tammy; Moniz, Michelle H.; Plegue, Melissa A.; Sen, Ananda; Davis, Matthew M.; Villamor, Eduardo; Richardson, Caroline R.			Characteristics of women age 15-24 at risk for excess weight gain during pregnancy	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY INTERVENTIONS; PHYSICAL-ACTIVITY; UNITED-STATES; OBESITY; ADOLESCENTS; PREVALENCE; RETENTION; CHILDREN	Purpose Excess weight gain during pregnancy is a serious health concern among young pregnant women in the US. This study aimed to characterize young women at highest risk for gaining over the recommended amount of weight during pregnancy. Methods Using a database that is representative of births in large U.S. cities, The Fragile Families and Child Wellbeing Study, we identified mothers of singleton term-infants age 15-24 years at the time of delivery. Institute of Medicine guidelines were used to categorize each mother's weight gain as less than, within, or more than recommended during pregnancy. Multinomial logistic regression models for weight gain category were performed, controlling for age, race/ethnicity, federal poverty level (FPL), health status, and prepregnancy BMI. Results Among the weighted sample (n = 1,034, N = 181,375), the mean (SD) age was 21 (3) years, 32% were black, 39% were Hispanic, 44% reported income under the Federal Poverty Level, 45% were overweight or obese before pregnancy, and 55% gained more weight than recommended during pregnancy. Women who were overweight or obese before pregnancy were at increased risk for gaining more pregnancy weight than recommended, compared to normal-weight women (adjusted Relative Risk Ratio (RRR) = 3.82, p = 0.01; RRR = 3.27, p = 0.03, respectively). Hispanics were less likely than non-Hispanics to gain more weight than recommended (RRR = 0.39, p = 0.03). Conclusions The majority of mothers ages 15-24 gained excess weight during pregnancy, a strong risk factor for later obesity. Prepregnancy overweight or obesity and non-Hispanic ethnicity predicted excess pregnancy weight gain. Interventions and policies should target these high-risk young women to prevent excess weight gain.	[Chang, Tammy; Richardson, Caroline R.] Univ Michigan, Sch Med, Dept Family Med, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Moniz, Michelle H.] Univ Michigan, Dept Obstet & Gynecol, Sch Med, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Plegue, Melissa A.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Sen, Ananda] Univ Michigan, Dept Family Med & Biostat, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Villamor, Eduardo] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chang, T (corresponding author), Univ Michigan, Sch Med, Dept Family Med, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.	tachang@med.umich.edu		Richardson, Caroline/0000-0002-1945-6046	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health [R01HD36916, R01HD39135, R01HD40421]; National Institutes of Health [5 K23 HD083527-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD074544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, P30DK020572] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health under award numbers R01HD36916, R01HD39135, and R01HD40421, as well as a consortium of private foundations. Additionally, Tammy Chang received funding from the National Institutes of Health grant number 5 K23 HD083527-05. The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication.	[Anonymous], FRAG FAM CHILD WELLB; Brown MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039503; Bucchianeri MM, 2013, BODY IMAGE, V10, P1, DOI 10.1016/j.bodyim.2012.09.001; Centers for Disease Control and Prevention, OV OB DEF CHILDH OB; Centers for Disease Control and Prevention, REPR HLTH TEEN PREGN; Centers for Disease Control and Prevention, OV OB DEF AD OV OB; Centers for Disease Control and Prevention, PREGN COMPL; Chang T, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-47; Deputy NP, 2015, MMWR-MORBID MORTAL W, V64, P1215, DOI 10.15585/mmwr.mm6443a3; Deputy NP, 2015, OBSTET GYNECOL, V125, P773, DOI 10.1097/AOG.0000000000000739; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Fraser A, 2011, AM J CLIN NUTR, V93, P1285, DOI 10.3945/ajcn.110.008326; Groth SW, 2013, JOGNN-J OBST GYN NEO, V42, P541, DOI 10.1111/1552-6909.12230; Haakstad LAH, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/193170; Harper LM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.053; Headen IE, 2012, ADV NUTR, V3, P83, DOI 10.3945/an.111.000984; Herring Sharon J, 2008, BMC Pregnancy Childbirth, V8, P54, DOI 10.1186/1471-2393-8-54; Jekielek S., 2005, TRANSITION ADULTHOOD; Joseph NP, 2008, J PEDIATR ADOL GYNEC, V21, P195, DOI 10.1016/j.jpag.2007.08.006; Kominiarek MA, 2015, MATERN CHILD HLTH J, V19, P1698, DOI 10.1007/s10995-015-1684-3; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Muktabhant B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub2; National Research Council, 2010, WEIGHT GAIN PREGNANC; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; Ostbye T, 2013, INT J OBESITY, V37, P1314, DOI 10.1038/ijo.2013.76; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010; Quinlivan JA, 2011, OBSTET GYNECOL, V118, P1395, DOI 10.1097/AOG.0b013e3182396bc6; Reichman NE, 2001, CHILD YOUTH SERV REV, V23, P303, DOI 10.1016/S0190-7409(01)00141-4; Rong K, 2015, PUBLIC HEALTH NUTR, V18, P2172, DOI 10.1017/S1368980014002523; Rothberg BEG, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.028; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Sridhar SB, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.030; Tanentsapf I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-81; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; Weisman CS, 2010, WOMEN HEALTH ISS, V20, P126, DOI 10.1016/j.whi.2009.12.002; Whitaker KM, 2016, WOMEN HEALTH ISS, V26, P116, DOI 10.1016/j.whi.2015.10.007	40	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173790	10.1371/journal.pone.0173790	http://dx.doi.org/10.1371/journal.pone.0173790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291802	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700040
J	Hsu, FG; Hsieh, YW; Sheu, MJ; Lin, CC; Lin, CL; Hsu, CY; Lee, CY; Chang, MY; Chang, KH				Hsu, Fan-Gen; Hsieh, Yow-Wen; Sheu, Ming-Jyh; Lin, Che-Chen; Lin, Cheng-Li; Hsu, Chung Y.; Lee, Chang-Yin; Chang, Mei-Yin; Chang, Kuang-Hsi			Tamoxifen use and acute pancreatitis: A population-based cohort study	PLOS ONE			English	Article							INDUCED HYPERTRIGLYCERIDEMIA; BREAST-CANCER; PHASE-II; RISK; DRUGS	Background Several case reports have indicated that tamoxifen induced acute pancreatitis (AP); but no pharmacoepidemiological data support the claim. Therefore, we investigated whether tamoxifen use is correlated with the risk of AP in patients with breast cancer. Methods This population-based cohort study used the Taiwan National Health Insurance Research Database. A cohort of 22 005 patients aged >= 20 years with breast cancer from January 1, 2000 to December 31, 2009 was identified and the date of cancer diagnosis was set as the index date. The end point was developing AP during the follow-up. Hazard ratios (HRs) and 95% confidence intervals (CIs) were evaluated to determine the correlation between the risk of AP and tamoxifen use. Because the drug use varied over time, it was measured as a time-dependent covariate in the Cox proportional hazard model. The same approaches were applied in PS-matched cohorts. Results After adjustment for covariates and medication use including fluorouracil and doxorubicin, the risk of AP was not significant between tamoxifen users and tamoxifen nonusers (adjusted HR = 0.94, 95% CI = 0.74-1.19) in the non-matching cohorts. The results revealed no dose-response trend between tamoxifen use and the risk of AP (adjusted HR = 0.98, 95% CI = 0.96-1.00). The comorbidities DM and gallstones were associated with a significantly increased risk of AP. Similar trends were observed in PS-matched cohorts. Conclusions No significant correlation was observed between tamoxifen use and the risk of AP in patients with breast cancer.	[Hsu, Fan-Gen; Hsieh, Yow-Wen; Sheu, Ming-Jyh] China Med Univ, Sch Pharm, Taichung, Taiwan; [Hsu, Fan-Gen; Hsieh, Yow-Wen] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan; [Lin, Che-Chen] Taichung Vet Gen Hosp, Healthcare Serv Res Ctr, Taichung, Taiwan; [Lin, Che-Chen; Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lee, Chang-Yin] I Shou Univ, Sch Chinese Med Post Baccalaureate, Coll Med, Yancho Campus, Kaohsiung, Taiwan; [Lee, Chang-Yin] E DA Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Chang, Mei-Yin] Fooyin Univ, Sch Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Chang, Kuang-Hsi] China Med Univ, Inst Biomed Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; I Shou University; E-Da Hospital; Fooyin University; China Medical University Taiwan	Chang, KH (corresponding author), China Med Univ, Inst Biomed Sci, Taichung, Taiwan.	s76881072@yahoo.com.tw		Hsu, Chung Y./0000-0002-5632-2733	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002, MOHW105-TDUB-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006, MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Ministry of Science and Technology [MOST103-2314-6-715-001-MY2, MOST104-2314-6-715-003-MY3]; Mackay Medical College [RD1040109]; Mackay Memorial Hospital [MMH-MM-10304, MMH-MM-10405]; Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW105-TDU-B-212-133019]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Mackay Medical College; Mackay Memorial Hospital; Taiwan Ministry of Health and Welfare Clinical Trial Center	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002, MOHW105-TDUB-212-133019); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006, MOST 104-2325-B-039-005); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. We appreciate the financial support by grants from the Ministry of Science and Technology (MOST103-2314-6-715-001-MY2, and MOST104-2314-6-715-003-MY3), Mackay Medical College (RD1040109), and Mackay Memorial Hospital (MMH-MM-10304, MMH-MM-10405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.r This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW105-TDU-B-212-133019).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Andren-Sandberg A, 1999, ANN ONCOL, V10, P131, DOI 10.1023/A:1008377928466; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Bertilsson S, 2015, PANCREAS, V44, P1096, DOI 10.1097/MPA.0000000000000406; Bi Yan, 2015, Curr Treat Options Gastroenterol, V13, P354, DOI 10.1007/s11938-015-0058-7; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Eckel F, 2000, J EXP CLIN CANC RES, V19, P295; Elisaf M, 2000, BREAST, V9, P238, DOI 10.1054/brst.1999.0129; Elisaf MS, 2000, ANN ONCOL, V11, P1067, DOI 10.1023/A:1008309613082; Filippatos TD, 2009, CANCER TREAT REV, V35, P175, DOI 10.1016/j.ctrv.2008.09.007; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Hung SC, 2015, AM J GASTROENTEROL, V110, P1490, DOI 10.1038/ajg.2015.259; Kim YA, 2014, CHINESE J CANCER RES, V26, P341, DOI 10.3978/j.issn.1000-9604.2014.05.01; Lai SW, 2011, AM J GASTROENTEROL, V106, P1697, DOI 10.1038/ajg.2011.155; Lancashire RJ, 2003, ALIMENT PHARM THER, V17, P887, DOI 10.1046/j.1365-2036.2003.01485.x; Lankisch PG, 2015, LANCET; Lim YP, 2015, CLIN BREAST CANCER, V15, P294, DOI 10.1016/j.clbc.2015.03.005; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Scherer J, 2014, J CLIN GASTROENTEROL, V48, P195, DOI 10.1097/01.mcg.0000436438.60145.5a; Singh HK, 2016, J PHARMACOL PHARMACO, V7, P38, DOI 10.4103/0976-500X.179365; Tenner S, 2014, WORLD J GASTROENTERO, V20, P16529, DOI 10.3748/wjg.v20.i44.16529; Tomao S, 2002, ANTICANCER RES, V22, P2361; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wadood Ali, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-214837; Xie X, 2015, ONCOL LETT, V9, P837, DOI 10.3892/ol.2014.2711	26	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173089	10.1371/journal.pone.0173089	http://dx.doi.org/10.1371/journal.pone.0173089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291833	gold, Green Published, Green Submitted			2022-12-26	WOS:000396094700011
J	Luck, AN; Slatko, BE; Foster, JM				Luck, Ashley N.; Slatko, Barton E.; Foster, Jeremy M.			Removing the needle from the haystack: Enrichment of Wolbachia endosymbiont transcripts from host nematode RNA by Cappable-seq (TM)	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; BRUGIA-MALAYI; ANTIFILARIAL THERAPY; DIROFILARIA-IMMITIS; FILARIAL NEMATODES; DOXYCYCLINE; GENOME; ENDOBACTERIA; EXPRESSION; DEPLETION	Efficient transcriptomic sequencing of microbial mRNA derived from host-microbe associations is often compromised by the much lower relative abundance of microbial RNA in the mixed total RNA sample. One solution to this problem is to perform extensive sequencing until an acceptable level of transcriptome coverage is obtained. More cost-effective methods include use of prokaryotic and/or eukaryotic rRNA depletion strategies, sometimes in conjunction with depletion of polyadenylated eukaryotic mRNA. Here, we report use of Cappable-seq (TM) to specifically enrich, in a single step, Wolbachia endobacterial mRNA transcripts from total RNA prepared from the parasitic filarial nematode, Brugia malayi. The obligate Wolbachia endosymbiont is a proven drug target for many human filarial infections, yet the precise nature of its symbiosis with the nematode host is poorly understood. Insightful analysis of the expression levels of Wolbachia genes predicted to underpin the mutualistic association and of known drug target genes at different life cycle stages or in response to drug treatments is typically challenged by low transcriptomic coverage. Cappable-seq resulted in up to similar to 5-fold increase in the number of reads mapping to Wolbachia. On average, coverage of Wolbachia transcripts from B. malayi microfilariae was enriched similar to 40-fold by Cappable-seq. Additionally, this method has an additional benefit of selectively removing abundant prokaryotic ribosomal RNAs. The deeper microbial transcriptome sequencing afforded by Cappable-seq facilitates more detailed characterization of gene expression levels of pathogens and symbionts present in animal tissues.	[Luck, Ashley N.; Slatko, Barton E.; Foster, Jeremy M.] New England Biolabs Inc, Genome Biol Div, Ipswich, MA 01938 USA	New England Biolabs	Foster, JM (corresponding author), New England Biolabs Inc, Genome Biol Div, Ipswich, MA 01938 USA.	foster@neb.com			New England Biolabs, Ipswich, MA	New England Biolabs, Ipswich, MA	This work was funded internally by New England Biolabs, Ipswich, MA, of which all authors are employees. The specific roles of the authors are articulated in the 'author contributions' section. Employees and owners of New England Biolabs not on the author list did not contribute to the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Critical feedback and proofreading of the manuscript was provided by additional members of the NEB.	Andrews S., 2010, FASTQC QUALITY CONTR; Bandi C, 2001, VET PARASITOL, V98, P215, DOI 10.1016/S0304-4017(01)00432-0; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brownlie JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-68; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Ettwiller L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2539-z; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Foster JM, 2013, PARASITIC NEMATODES: MOLECULAR BIOLOGY, BIOCHEMISTRY AND IMMUNOLOGY, 2ND EDITION, P308, DOI 10.1079/9781845937591.0308; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Godel C, 2012, FASEB J, V26, P4650, DOI 10.1096/fj.12-205096; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Ioannidis P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-639; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kumar N, 2016, SCI REP-UK, V6, DOI 10.1038/srep34850; Kumar Nikhil, 2012, BMC Res Notes, V5, P230, DOI 10.1186/1756-0500-5-230; Landmann F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000758; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Luck AN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2083-2; Luck AN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1041; Raverdy S, 2008, MOL BIOCHEM PARASIT, V160, P163, DOI 10.1016/j.molbiopara.2008.04.014; Supali T, 2008, CLIN INFECT DIS, V46, P1385, DOI 10.1086/586753; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	29	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173186	10.1371/journal.pone.0173186	http://dx.doi.org/10.1371/journal.pone.0173186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291780	gold, Green Published, Green Submitted			2022-12-26	WOS:000396094700015
J	Renwick, AR; Robinson, CJ; Garnett, ST; Leiper, I; Possingham, HP; Carwardine, J				Renwick, Anna R.; Robinson, Catherine J.; Garnett, Stephen T.; Leiper, Ian; Possingham, Hugh P.; Carwardine, Josie			Mapping Indigenous land management for threatened species conservation: An Australian case-study	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; ECOLOGICAL KNOWLEDGE; BIOLOGICAL DIVERSITY	Much biodiversity lives on lands to which Indigenous people retain strong legal and management rights. However this is rarely quantified. Here we provide the first quantitative overview of the importance of Indigenous land for a critical and vulnerable part of biodiversity, threatened species, using the continent of Australia as a case study. We find that three quarters of Australia's 272 terrestrial or freshwater vertebrate species listed as threatened under national legislation have projected ranges that overlap Indigenous lands. On average this overlap represents 45% of the range of each threatened species while Indigenous land is 52% of the country. Hotspots where multiple threatened species ranges overlap occur predominantly in coastal Northern Australia. Our analysis quantifies the vast potential of Indigenous land in Australia for contributing to national level conservation goals, and identifies the main land management arrangements available to Indigenous people which may enable them to deliver those goals should they choose to do so.	[Renwick, Anna R.; Possingham, Hugh P.] Univ Queensland, ARC Ctr Excellence Environm Decis, NERP Environm Decis Hub, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Robinson, Catherine J.; Carwardine, Josie] CSIRO Ecosyst Sci, Ecosci Precinct, Brisbane, Qld, Australia; [Robinson, Catherine J.] Charles Darwin Univ, Northern Inst, Darwin, NT, Australia; [Garnett, Stephen T.; Leiper, Ian] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Darwin University; Charles Darwin University	Renwick, AR (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, NERP Environm Decis Hub, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia.	a.renwick@uq.edu.au	Leiper, Ian/P-8140-2019; Carwardine, Josie/A-5801-2011; POSSINGHAM, HUGH/R-8310-2019; Robinson, Cathy/D-3349-2011; Possingham, Hugh/B-1337-2008	POSSINGHAM, HUGH/0000-0001-7755-996X; Robinson, Cathy/0000-0002-3453-572X; Possingham, Hugh/0000-0001-7755-996X; Leiper, Ian/0000-0001-6491-9145	ARC Centre of Excellence for Environmental Decisions; NERP Research Hub for Environmental Decisions; National Environment Science Program Threatened Species Research Hub	ARC Centre of Excellence for Environmental Decisions(Australian Research Council); NERP Research Hub for Environmental Decisions; National Environment Science Program Threatened Species Research Hub	This work received support from ARC Centre of Excellence for Environmental Decisions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NERP Research Hub for Environmental Decisions also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Environment Science Program Threatened Species Research Hub supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the ARC Centre of Excellence for Environmental Decisions, the NERP Research Hub for Environmental Decisions and the National Environment Science Program Threatened Species Research Hub.	[Anonymous], 2005, EC HUM WELL BEING SY; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; CBD Secretariat, 2010, 20 M C PART CONV BIO; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Convention on Biological Diversity, 2011, AICH BIOD TARG; Department of Environment, 2016, NAT THREAT SPEC STRA; Department of the Environment and Energy, 2012, INT BIOG REG AUSTR R; Ens EJ, 2015, BIOL CONSERV, V181, P133, DOI 10.1016/j.biocon.2014.11.008; Environment Do, 2009, USTR STRAT NAT RES S; Ferrari Maurizio Farhan, 2015, BIODIVERSITY-OTTAWA, V16, P57, DOI 10.1080/14888386.2015.1074111; Fleming PA., 2016, MAMMAL REV; Gorenflo LJ, 2012, P NATL ACAD SCI USA, V109, P8032, DOI 10.1073/pnas.1117511109; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Hill R, 2015, ENVIRON SCI POLICY, V51, P267, DOI 10.1016/j.envsci.2015.04.014; Hill R., 2012, ECOLOGY SOC, V17, P23, DOI DOI 10.5751/ES-04587-170123; Hill R., 2013, INDIGENOUS LAND MANA; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jones Gareth R., 2014, CENGAGE LEARNING; Mauro F, 2000, ECOL APPL, V10, P1263, DOI 10.1890/1051-0761(2000)010[1263:TKOIAL]2.0.CO;2; McDermott M, 2013, ENVIRON SCI POLICY, V33, P416, DOI 10.1016/j.envsci.2012.10.006; McDonald JA, 2015, BIOL CONSERV, V182, P102, DOI 10.1016/j.biocon.2014.11.030; Poe MR, 2014, CONSERV LETT, V7, P166, DOI 10.1111/conl.12068; Reed P, 2011, FORESTS, V2, P525, DOI 10.3390/f2020525; Renwick AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091281; Robinson CJ, 2016, ENVIRON SCI POLICY, V56, P129, DOI 10.1016/j.envsci.2015.11.007; Smyth D., 2015, PARKS, DOI [10.2305/IUCN.CH.2014.PARKS-21-2DS.en, DOI 10.2305/IUCN.CH.2014.PARKS-21-2DS.EN]; Sobrevila C, 2008, ROLE INDIENOUS PEOPL; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; UNDP, 2006, GEF SMALL GRANTS PRO; UNDP, 2014, SOC ENV STAND; Walker R., 2013, RECLAIMING INDIGENOU; Walsh FJ, 2013, ECOL SOC, V18, DOI 10.5751/ES-05501-180318; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x; Zander KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023154	36	27	28	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173876	10.1371/journal.pone.0173876	http://dx.doi.org/10.1371/journal.pone.0173876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291797	gold, Green Submitted, Green Published			2022-12-26	WOS:000396094700047
J	Habets, MN; van Selm, S; van der Gaast-de Jongh, CE; Diavatopoulos, DA; de Jonge, MI				Habets, Marrit N.; van Selm, Saskia; van der Gaast-de Jongh, Christa E.; Diavatopoulos, Dimitri A.; de Jonge, Marien I.			A novel flow cytometry-based assay for the quantification of antibody-dependent pneumococcal agglutination	PLOS ONE			English	Article							PHARYNGEAL EPITHELIAL-CELLS; STREPTOCOCCUS-PNEUMONIAE; CAPSULAR POLYSACCHARIDE; VACCINE; COLONIZATION; PROTECTION; IMMUNITY; IMMUNIZATION; ACQUISITION; INFECTION	The respiratory pathogen Streptococcus pneumoniae is a major cause of diseases such as otitis media, pneumonia, sepsis and meningitis. The first step towards infection is colonization of the nasopharynx. Recently, it was shown that agglutinating antibodies play an important role in the prevention of mucosal colonization with S. pneumoniae. Here, we present a novel method to quantify antibody-dependent pneumococcal agglutination in a high-throughput manner using flow cytometry. We found that the concentration of agglutinating antibodies against pneumococcal capsule are directly correlated with changes in the size and complexity of bacterial aggregates, as measured by flow cytometry and confirmed by light microscopy. Using the increase in size, we determined the agglutination index. The cutoff value was set by measuring a series of non-agglutinating antibodies. With this method, we show that not only anti-polysaccharide capsule antibodies are able to induce agglutination but that also anti-PspA protein antibodies have agglutinating capabilities. In conclusion, we have described and validated a novel method to quantify pneumococcal agglutination, which can be used to screen sera from murine or human vaccination studies, in a high-throughput manner.	[Habets, Marrit N.; van Selm, Saskia; van der Gaast-de Jongh, Christa E.; Diavatopoulos, Dimitri A.; de Jonge, Marien I.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat,Radboud Inst Mol Life Sci, Nijmegen, Netherlands	Radboud University Nijmegen	van Selm, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat,Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	Saskia.vanSelm@radboudumc.nl	de Jonge, Marien I./P-5869-2015; Diavatopoulos, Dimitri A/L-4269-2015	de Jonge, Marien I./0000-0003-2812-5895; Diavatopoulos, Dimitri A/0000-0001-7065-7807	EU (Eurostars, Pneumonav project) [9285]	EU (Eurostars, Pneumonav project)	This study was funded by the EU (Eurostars, Pneumonav project, grant number: 9285, https://www.eurostars-eureka.eu/project/id/9285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Cremers AJH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14952; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; DEVELASCO EA, 1995, J INFECT DIS, V172, P562, DOI 10.1093/infdis/172.2.562; Dochez AR, 1913, J AMER MED ASSOC, V61, P727, DOI 10.1001/jama.1913.04350100005003; Goldblatt D, 2011, CLIN VACCINE IMMUNOL, V18, P1728, DOI 10.1128/CVI.05252-11; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hanniffy SB, 2007, J INFECT DIS, V195, P185, DOI 10.1086/509807; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Klugman K P, 2001, Lancet Infect Dis, V1, P85, DOI 10.1016/S1473-3099(01)00063-9; Klugman KP, 2014, LANCET GLOB HEALTH, V2, pE365, DOI 10.1016/S2214-109X(14)70241-4; Kuipers K, 2015, VACCINE, V33, P2022, DOI 10.1016/j.vaccine.2015.03.010; Laine C, 2004, INFECT IMMUN, V72, P3331, DOI 10.1128/IAI.72.6.3331-3335.2004; Lebon A, 2011, INFECT IMMUN, V79, P1680, DOI 10.1128/IAI.01379-10; Lister FS, 1913, PUBL S AFR I MED RES, V1, P103; LUND E, 1960, Bull World Health Organ, V23, P5; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Malley R, 2012, P NATL ACAD SCI USA, V109, P3623, DOI 10.1073/pnas.1121383109; Mitsi E, 2016, MUCOSAL IMMUNOL; Mudany MA, 2003, J MED MICROBIOL, V52, P975, DOI 10.1099/jmm.0.05306-0; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Oma K, 2009, VACCINE, V27, P3181, DOI 10.1016/j.vaccine.2009.03.055; Pearce BJ, 2002, RES MICROBIOL, V153, P243, DOI 10.1016/S0923-2508(02)01312-8; Roche AM, 2015, MUCOSAL IMMUNOL, V8, P176, DOI 10.1038/mi.2014.55; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Slotved HC, 2004, J CLIN MICROBIOL, V42, P2518, DOI 10.1128/JCM.42.6.2518-2522.2004; Song JY, 2013, J INFECT CHEMOTHER, V19, P412, DOI 10.1007/s10156-013-0601-1; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Weil-Olivier C, 2014, VACCINE, V32, P2022, DOI 10.1016/j.vaccine.2014.02.008; Williams CA, 1977, METHODS IMMUNOLOGY I, P84	35	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0170884	10.1371/journal.pone.0170884	http://dx.doi.org/10.1371/journal.pone.0170884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288168	gold, Green Published, Green Submitted			2022-12-26	WOS:000396092400003
J	Hall, RN; Capucci, L; Matthaei, M; Esposito, S; Kerr, PJ; Frese, M; Strive, T				Hall, Robyn N.; Capucci, Lorenzo; Matthaei, Markus; Esposito, Simona; Kerr, Peter J.; Frese, Michael; Strive, Tanja			An in vivo system for directed experimental evolution of rabbit haemorrhagic disease virus	PLOS ONE			English	Article							ORYCTOLAGUS-CUNICULUS; BENEFICIAL MUTATIONS; SILENT MUTATIONS; SEQUENCE DATA; CALICIVIRUS; IDENTIFICATION; RESISTANCE; RNA; AUSTRALIA; LAGOVIRUS	The calicivirus Rabbit haemorrhagic disease virus (RHDV) is widely used in Australia as a biocontrol agent to manage wild European rabbit (Oryctolagus cuniculus) populations. However, widespread herd immunity limits the effectiveness of the currently used strain, CAPM V-351. To overcome this, we developed an experimental platform for the selection and characterisation of novel RHDV strains. As RHDV does not replicate in cell culture, variant viruses were selected by serially passaging a highly virulent RHDV field isolate in immunologically naive laboratory rabbits that were passively immunised 18-24 hours post-challenge with a neutralising monoclonal antibody. After seven passages, two amino acid substitutions in the P2 domain of the capsid protein became fixed within the virus population. Furthermore, a synonymous substitution within the coding sequence of the viral polymerase appeared and was also maintained in all subsequent passages. These findings demonstrate proof-of-concept that RHDV evolution can be experimentally manipulated to select for virus variants with altered phenotypes, in this case partial immune escape.	[Hall, Robyn N.; Matthaei, Markus; Kerr, Peter J.; Frese, Michael; Strive, Tanja] Commonwealth Sci & Ind Res Org, Hlth & Biosecur, Canberra, ACT, Australia; [Hall, Robyn N.; Frese, Michael; Strive, Tanja] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT, Australia; [Capucci, Lorenzo; Esposito, Simona] Ist Zooprofilatt Sperimentale Lombardia & Emilia, IZSLER, Brescia, Italy; [Kerr, Peter J.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Frese, Michael] Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia; [Frese, Michael; Strive, Tanja] Univ Canberra, Inst Appl Ecol, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Canberra; IZS Lombardia e Emilia; University of Sydney; University of Canberra; University of Canberra	Strive, T (corresponding author), Commonwealth Sci & Ind Res Org, Hlth & Biosecur, Canberra, ACT, Australia.; Strive, T (corresponding author), Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT, Australia.; Strive, T (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT, Australia.	Tanja.Strive@csiro.au	Hall, Robyn N/E-3121-2017; Capucci, Lorenzo/E-5919-2011; Strive, Tanja/C-1486-2008; esposito, simona/AAC-4963-2020	Hall, Robyn N/0000-0002-5836-2990; Capucci, Lorenzo/0000-0002-1830-3929; 	Invasive Animals Cooperative Research Centre (IA CRC) [IACRC 3.L.4]	Invasive Animals Cooperative Research Centre (IA CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding for this work was obtained from the Invasive Animals Cooperative Research Centre (IA CRC), grant #IACRC 3.L.4.	Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; CAPUCCI L, 1995, VIRUS RES, V37, P221, DOI 10.1016/0168-1702(95)00033-M; Capucci L, 1998, VIRUS RES, V58, P115, DOI 10.1016/S0168-1702(98)00106-3; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cuevas JM, 2002, GENETICS, V162, P533; Eden JS, 2015, J VIROL, V89, P12217, DOI 10.1128/JVI.01937-15; Eden JS, 2015, J VIROL, V89, P9548, DOI 10.1128/JVI.01100-15; Elsworth PG, 2012, EPIDEMIOL INFECT, V140, P1972, DOI 10.1017/S0950268811002743; Elsworth P, 2014, VIROLOGY, V464, P415, DOI 10.1016/j.virol.2014.06.037; Jimenez JI, 2013, P NATL ACAD SCI USA, V110, P14984, DOI 10.1073/pnas.1307604110; Kashiwagi A, 2014, J VIROL, V88, P11459, DOI 10.1128/JVI.01127-14; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14; Lauring AS, 2012, CELL HOST MICROBE, V12, P623, DOI 10.1016/j.chom.2012.10.008; Le Gall-Recule G, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-81; Leuthold MM, 2015, J VIROL, V89, P2378, DOI 10.1128/JVI.02832-14; Liu JE, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-182; Liu JN, 2012, VET MICROBIOL, V157, P345, DOI 10.1016/j.vetmic.2012.01.018; Lochridge VP, 2007, J VIROL, V81, P12316, DOI 10.1128/JVI.01254-07; Long JS, 2013, J VIROL, V87, P9983, DOI 10.1128/JVI.01399-13; MacLachlan NJ, 2011, FENNER'S VETERINARY VIROLOGY, 4TH EDITION, P443, DOI 10.1016/B978-0-12-375158-4.00027-4; MacLean RC, 2013, NAT REV GENET, V14, P221, DOI 10.1038/nrg3415; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matthaei M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-109; McColl KA, 2002, EPIDEMIOL INFECT, V129, P655, DOI 10.1017/S0950268802007756; McIntosh MT, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-96; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Mutze G, 2014, WILDLIFE RES, V41, P552, DOI 10.1071/WR14107; Mutze G, 1998, J WILDLIFE DIS, V34, P221, DOI 10.7589/0090-3558-34.2.221; NEILL JD, 1992, VIRUS RES, V24, P211, DOI 10.1016/0168-1702(92)90008-W; OHLINGER VF, 1990, J VIROL, V64, P3331, DOI 10.1128/JVI.64.7.3331-3336.1990; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; Sironen T, 2008, J GEN VIROL, V89, P1309, DOI 10.1099/vir.0.83662-0; Strengell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025848; Strive T, 2009, VIROLOGY, V384, P97, DOI 10.1016/j.virol.2008.11.004; Strive T, 2010, VIROLOGY, V398, P125, DOI 10.1016/j.virol.2009.11.045; STUDDERT MJ, 1994, AUST VET J, V71, P264, DOI 10.1111/j.1751-0813.1994.tb03428.x; Taube S, 2010, J VIROL, V84, P5695, DOI 10.1128/JVI.00316-10; Telwatte S, 2015, NUCLEIC ACIDS RES, V43, P3256, DOI 10.1093/nar/gkv128; Thorne L, 2012, J VIROL, V86, P11441, DOI 10.1128/JVI.00439-12; Wang X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003132; Yoo DW, 2001, CLIN DIAGN LAB IMMUN, V8, P297, DOI 10.1128/CDLI.8.2.297-302.2001; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173727	10.1371/journal.pone.0173727	http://dx.doi.org/10.1371/journal.pone.0173727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288206	gold, Green Published, Green Submitted			2022-12-26	WOS:000396092400033
J	Carlson, GE; Martin, EW; Shirure, VS; Malgor, R; Resto, VA; Goetz, DJ; Burdick, MM				Carlson, Grady E.; Martin, Eric W.; Shirure, Venktesh S.; Malgor, Ramiro; Resto, Vicente A.; Goetz, Douglas J.; Burdick, Monica M.			Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues	PLOS ONE			English	Article							PHYSIOLOGICAL FLOW CONDITIONS; HUMAN ATHEROSCLEROTIC LESIONS; CUTANEOUS LYMPHOCYTE ANTIGEN; CELL-ADHESION MOLECULE-1; SIALYL-LEWIS-X; P-SELECTIN; LEUKOCYTE ADHESION; CARCINOMA-CELLS; SHEAR-FLOW; GLYCOPROTEIN LIGAND-1	A growing body of evidence suggests that L-selectin ligands presented on circulating tumor cells facilitate metastasis by binding L-selectin presented on leukocytes. Commonly used methods for detecting L-selectin ligands on tissues, e.g., immunostaining, are performed under static, no-flow conditions. However, such analysis does not assay for functional L-selectin ligands, specifically those ligands that promote adhesion under shear flow conditions. Recently our lab developed a method, termed dynamic biochemical tissue analysis (DBTA), to detect functional selectin ligands in situ by probing tissues with L-selectin-coated microspheres under hemodynamic flow conditions. In this investigation, DBTA was used to probe human colon tissues for L-selectin ligand activity. The detection of L-selectin ligands using DBTA was highly specific. Furthermore, DBTA reproducibly detected functional Lselectin ligands on diseased, e.g., cancerous or inflamed, tissues but not on noncancerous tissues. In addition, DBTA revealed a heterogeneous distribution of functional L-selectin ligands on colon cancer tissues. Most notably, detection of L-selectin ligands by immunostaining using HECA-452 antibody only partially correlated with functional L-selectin ligands detected by DBTA. In summation, the results of this study demonstrate that DBTA detects functional selectin ligands to provide a unique characterization of pathological tissue.	[Carlson, Grady E.; Martin, Eric W.; Shirure, Venktesh S.; Goetz, Douglas J.; Burdick, Monica M.] Ohio Univ, Russ Coll Engn & Technol, Dept Chem & Biomol Engn, Athens, OH 45701 USA; [Carlson, Grady E.; Martin, Eric W.; Malgor, Ramiro; Goetz, Douglas J.; Burdick, Monica M.] Ohio Univ, Russ Coll Engn & Technol, Biomed Engn Program, Athens, OH 45701 USA; [Malgor, Ramiro] Ohio Univ, Heritage Coll Osteopath Med, Biomed Sci, Athens, OH 45701 USA; [Resto, Vicente A.] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Burdick, Monica M.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University of Texas System; University of Texas Medical Branch Galveston; University System of Ohio; Ohio University	Burdick, MM (corresponding author), Ohio Univ, Russ Coll Engn & Technol, Dept Chem & Biomol Engn, Athens, OH 45701 USA.; Burdick, MM (corresponding author), Ohio Univ, Russ Coll Engn & Technol, Biomed Engn Program, Athens, OH 45701 USA.; Burdick, MM (corresponding author), Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA.	burdick@ohio.edu	Shirure, Venktesh/M-8806-2015	Shirure, Venktesh/0000-0002-4430-2612; Burdick, Monica/0000-0003-3168-0072	National Institutes of Health [R15CA161830-01]; National Science Foundation [1039869]; Ohio University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ohio University	This work was supported by the National Institutes of Health (R15CA161830-01; to M.M.B.), National Science Foundation (MRI Award 1039869; to D.J.G. and M.M.B.), Ohio University (Student Enhancement Award to G.E.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 1996, J CELL BIOL, V135, P849, DOI 10.1083/jcb.135.3.849; Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, J IMMUNOL, V154, P5356; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Beste MT, 2008, P NATL ACAD SCI USA, V105, P20716, DOI 10.1073/pnas.0808213105; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Borsig L, 2007, J BIOL CHEM, V282, P14984, DOI 10.1074/jbc.M610560200; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; Burdick MM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00103; Caputo KE, 2007, BIOPHYS J, V92, P787, DOI 10.1529/biophysj.106.082321; Cheung LSL, 2011, BIOPHYS J, V100, P2338, DOI 10.1016/j.bpj.2011.04.013; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; De Marzo AM, 2002, HUM PATHOL, V33, P756, DOI 10.1053/hupa.2002.126187; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dimitroff CJ, 2001, J BIOL CHEM, V276, P47623, DOI 10.1074/jbc.M105997200; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Fuhlbrigge RC, 1996, J CELL BIOL, V135, P837, DOI 10.1083/jcb.135.3.837; Goetz DJ, 1996, AM J PATHOL, V149, P1661; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; Greenberg AW, 2000, BIOPHYS J, V79, P2391, DOI 10.1016/S0006-3495(00)76484-8; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Huang X, 1997, HISTOCHEM CELL BIOL, V107, P57, DOI 10.1007/s004180050089; Jeong S, 2001, BIOCHEM BIOPH RES CO, V281, P237, DOI 10.1006/bbrc.2001.4327; JONES RJ, 1991, BLOOD, V77, P649; Kim YJ, 1999, AM J PATHOL, V155, P461, DOI 10.1016/S0002-9440(10)65142-5; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Lafferriere J, 2004, CLIN EXP METASTAS, V21, P257, DOI 10.1023/B:CLIN.0000037708.09420.9a; Lafkas D, 2015, NATURE, V528, P127, DOI 10.1038/nature15715; Laubli H, 2006, CANCER RES, V66, P1536, DOI 10.1158/0008-5472.CAN-05-3121; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Lawrence MB, 1999, CURR OPIN CHEM BIOL, V3, P659, DOI 10.1016/S1367-5931(99)00023-X; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; Malgor R, 2014, INFLAMM RES, V63, P277, DOI 10.1007/s00011-013-0697-x; MANNORI G, 1995, CANCER RES, V55, P4425; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; MUNN LL, 1994, BIOPHYS J, V67, P889, DOI 10.1016/S0006-3495(94)80550-8; Nakamori S, 1997, DIS COLON RECTUM, V40, P420, DOI 10.1007/BF02258386; NEEDHAM LK, 1993, P NATL ACAD SCI USA, V90, P1359, DOI 10.1073/pnas.90.4.1359; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; Otali D, 2009, BIOTECH HISTOCHEM, V84, P223, DOI 10.1080/10520290903039094; Renkonen R, 1997, GLYCOCONJUGATE J, V14, P593, DOI 10.1023/A:1018536509950; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Sackstein R, 1997, BLOOD, V89, P2773, DOI 10.1182/blood.V89.8.2773; Shea DJ, 2015, ONCOTARGET, V6, P24842, DOI 10.18632/oncotarget.4704; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Sundd P, 2011, BIORHEOLOGY, V48, P1, DOI 10.3233/BIR-2011-0579; SUZUKI Y, 1993, BIOCHEM BIOPH RES CO, V190, P426, DOI 10.1006/bbrc.1993.1065; Tao L, 1997, ELECTROPHORESIS, V18, P112, DOI 10.1002/elps.1150180121; Tees DFJ, 2003, NEWS PHYSIOL SCI, V18, P186, DOI 10.1152/nips.01444.2003; Tu L, 1999, J EXP MED, V189, P241, DOI 10.1084/jem.189.2.241; Tu LL, 1999, J IMMUNOL, V163, P5070; Xie R, 2011, J HISTOCHEM CYTOCHEM, V59, P356, DOI 10.1369/0022155411398488; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Zhu Cheng, 2005, Molecular & Cellular Biomechanics, V2, P91	66	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173747	10.1371/journal.pone.0173747	http://dx.doi.org/10.1371/journal.pone.0173747			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282455	Green Submitted, gold, Green Published			2022-12-26	WOS:000396091800077
J	Kreusser, MM; Lehmann, LH; Haass, M; Buss, SJ; Katus, HA; Lossnitzer, D				Kreusser, Michael M.; Lehmann, Lorenz H.; Haass, Markus; Buss, Sebastian J.; Katus, Hugo A.; Lossnitzer, Dirk			Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; HEART-FAILURE; SYMPATHETIC ACTIVATION; INDUCED REDUCTION; NEURONAL UPTAKE; RECEPTORS; PLASMA; ABNORMALITIES; ENDOTHELIN; SPILLOVER	In heart failure (HF), a disturbed cardiac norepinephrine (NE) homeostasis is characterized by depleted cardiac NE stores, impairment of the cardiac NE re-uptake by the neuronal norepinephrine transporter (NET) and enhanced cardiac NE net release. Reduced cardiac NE content appears to be caused by enhanced cardiac NE net release from sympathetic neurons in HF, triggered by neurohumoral activation. However, it remains unclear whether reduced NE itself has an impact on cardiac NE re-uptake, independent of neurohumoral activation. Here, we evaluated whether depletion of cardiac NE stores alone can regulate cardiac NE re-uptake. Treatment of Wistar rats with reserpine (5 mg/kg/d) for one (1d) or five days (5d) resulted in markedly reduced cardiac NE content, comparable to NE stores in experimental HF due to pressure overload. In order to assess cardiac NE re-uptake, the specific cardiac [H-3]-NE uptake via the NET in a Langendorff preparation was measured. Reserpine treatment led to decreased NE re-uptake at 1d and 5d compared to saline treatment. Expression of tyrosine hydroxylase (TH), the rate-limiting enzyme of the NE synthesis, was elevated in left stellate ganglia after reserpine. Mechanistically, measurement of NET mRNA expression in left stellate ganglia and myocardial NET density revealed a posttranscriptional downregulation of the NET by reserpine. In summary, present data demonstrate that depletion of cardiac NE stores alone is sufficient to impair cardiac NE re-uptake via downregulation of the NET, independent of systemic neurohumoral activation. Knowledge about the regulation of the cardiac NE homeostasis may offer novel therapeutic strategies in HF.	[Kreusser, Michael M.; Lehmann, Lorenz H.; Buss, Sebastian J.; Katus, Hugo A.] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Kreusser, Michael M.; Lehmann, Lorenz H.; Buss, Sebastian J.; Katus, Hugo A.; Lossnitzer, Dirk] German Ctr Cardiovasc Res, DZHK, Heidelberg, Germany; [Haass, Markus] Theresienkrankenhaus, Dept Cardiol, Mannheim, Germany; [Lossnitzer, Dirk] Univ Hosp Mannheim, Dept Cardiol, Mannheim, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg	Kreusser, MM (corresponding author), Heidelberg Univ, Dept Cardiol, Heidelberg, Germany.; Kreusser, MM (corresponding author), German Ctr Cardiovasc Res, DZHK, Heidelberg, Germany.	michael.kreusser@med.uni-heidelberg.de	Lehmann, Lorenz/AAP-9161-2021	Lehmann, Lorenz/0000-0001-5077-8580	German Society of Cardiology (DGK); DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)	German Society of Cardiology (DGK); DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	M.M.K. was supported by a scholarship from the German Society of Cardiology (DGK). H.A. K. was supported by the DZHK (Deutsches Zentrum fOr Herz-Kreislauf-Forschung - German Center for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The expert technical assistance of Silvia Harrack, Jutta Krebs, and Michaela Oestringer is gratefully acknowledged. M.M.K. was supported by a scholarship from the German Society of Cardiology (DGK). H.A.K. was supported by the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung German Center for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research).	Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; Backs J, 2001, J MOL CELL CARDIOL, V33, P461, DOI 10.1006/jmcc.2000.1319; Backs J, 2005, CARDIOVASC RES, V67, P283, DOI 10.1016/j.cardiores.2005.03.018; BANERJEE A, 1993, CIRC RES, V73, P656, DOI 10.1161/01.RES.73.4.656; BOHM M, 1995, J AM COLL CARDIOL, V25, P146, DOI 10.1016/0735-1097(94)00353-R; Buss SJ, 2006, ENDOCRINOLOGY, V147, P2526, DOI 10.1210/en.2005-1167; CHIDSEY CA, 1966, PHARMACOL REV, V18, P685; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; DELEHANTY JM, 1994, AM J PHYSIOL, V266, pH930, DOI 10.1152/ajpheart.1994.266.3.H930; Deng MX, 2016, J NEUROCHEM, V139, P197, DOI 10.1111/jnc.13761; Eisenhofer G, 1996, CIRCULATION, V93, P1667, DOI 10.1161/01.CIR.93.9.1667; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; HALARIS AE, 1975, EUR J PHARMACOL, V32, P93, DOI 10.1016/0014-2999(75)90327-1; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; IKEDA J, 1991, J AUTONOM NERV SYST, V34, P231, DOI 10.1016/0165-1838(91)90089-L; Kaludercic N, 2010, CIRC RES, V106, P193, DOI 10.1161/CIRCRESAHA.109.198366; Kawai H, 1999, AM J PHYSIOL-HEART C, V277, pH1609, DOI 10.1152/ajpheart.1999.277.4.H1609; Kaye DM, 2000, CIRC RES, V86, pE80, DOI 10.1161/01.RES.86.7.e80; Kolettis TM, 2014, LIFE SCI, V118, P281, DOI 10.1016/j.lfs.2014.01.069; Kopin IJ, 1998, AM J PHYSIOL-REG I, V275, pR165, DOI 10.1152/ajpregu.1998.275.1.R165; Kreusser MM, 2008, J MOL CELL CARDIOL, V44, P380, DOI 10.1016/j.yjmcc.2007.10.019; Kreusser MM, 2014, AM J PHYSIOL-HEART C, V307, pH1169, DOI 10.1152/ajpheart.00193.2014; Kreusser MM, 2006, HYPERTENSION, V47, P209, DOI 10.1161/01.HYP.0000200157.25792.26; Kristen AV, 2006, J CARD FAIL, V12, P577, DOI 10.1016/j.cardfail.2006.05.006; La Rocca HPB, 2001, EUR HEART J, V22, P1136, DOI 10.1053/euhj.2000.2407; LEE CM, 1983, SCIENCE, V220, P626, DOI 10.1126/science.6301013; Lehmann LH, 2014, LIFE SCI, V118, P165, DOI 10.1016/j.lfs.2014.03.005; Lehmann LH, 2014, P NATL ACAD SCI USA, V111, P13499, DOI 10.1073/pnas.1409026111; LEIMBACH WN, 1986, CIRCULATION, V73, P913, DOI 10.1161/01.CIR.73.5.913; Liang CS, 2007, ACTA PHARMACOL SIN, V28, P921, DOI 10.1111/j.1745-7254.2007.00585.x; LIANG CS, 1989, J CLIN INVEST, V84, P1267, DOI 10.1172/JCI114294; Lymperopoulos A, 2007, NAT MED, V13, P315, DOI 10.1038/nm1553; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Mandela P, 2006, J NEUROCHEM, V97, P310, DOI 10.1111/j.1471-4159.2006.03717.x; Mandela P, 2010, NEUROCHEM INT, V56, P760, DOI 10.1016/j.neuint.2010.02.011; Mao WK, 2005, AM J PHYSIOL-HEART C, V288, pH2381, DOI 10.1152/ajpheart.00904.2004; Mao WK, 2004, AM J PHYSIOL-HEART C, V287, pH29, DOI 10.1152/ajpheart.01168.2003; Martinez-Olivares R, 2006, AUTON NEUROSCI-BASIC, V128, P64, DOI 10.1016/j.autneu.2006.04.004; MELIKIAN HE, 1994, J BIOL CHEM, V269, P12290; MERLET P, 1992, J NUCL MED, V33, P471; Ogita H, 2001, HEART, V86, P656, DOI 10.1136/heart.86.6.656; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Qin FZ, 2002, AM J PHYSIOL-HEART C, V282, pH363, DOI 10.1152/ajpheart.00319.2001; Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169; SCHOMIG A, 1988, CIRC RES, V63, P214, DOI 10.1161/01.RES.63.1.214; SNYDER S H, 1970, Biological Psychiatry, V2, P367; SOLE MJ, 1977, CIRC RES, V41, P814, DOI 10.1161/01.RES.41.6.814; World Medical A. & American Physiological, 2002, AM J PHYSIOL-REG I, V283, pR281	51	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172070	10.1371/journal.pone.0172070	http://dx.doi.org/10.1371/journal.pone.0172070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282374	Green Submitted, Green Published, gold			2022-12-26	WOS:000396091800006
J	Zennaro, C; Tonon, F; Zarattini, P; Clai, M; Corbelli, A; Carraro, M; Marchetti, M; Ronda, L; Paredi, G; Rastaldi, MP; Percudani, R				Zennaro, Cristina; Tonon, Federica; Zarattini, Paola; Clai, Milan; Corbelli, Alessandro; Carraro, Michele; Marchetti, Marialaura; Ronda, Luca; Paredi, Gianluca; Rastaldi, Maria Pia; Percudani, Riccardo			The renal phenotype of allopurinol-treated HPRT-deficient mouse	PLOS ONE			English	Article							LESCH-NYHAN-SYNDROME; PURINE NUCLEOSIDE PHOSPHORYLASE; URATE-OXIDASE; XANTHINE OXIDOREDUCTASE; CLASSICAL XANTHINURIA; MESENCHYMAL TRANSITION; URIC-ACID; DISEASE; NEPHROPATHY; GENE	Excess of uric acid is mainly treated with xanthine oxidase (XO) inhibitors, also called uricostatics because they block the conversion of hypoxanthine and xanthine into urate. Normally, accumulation of upstream metabolites is prevented by the hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme. The recycling pathway, however, is impaired in the presence of HPRT deficiency, as observed in Lesch-Nyhan disease. To gain insights into the consequences of purine accumulation with HPRT deficiency, we investigated the effects of the XO inhibitor allopurinol in Hprt-lacking (HPRT-/-) mice. Allopurinol was administered in the drinking water of E12-E14 pregnant mothers at dosages of 150 or 75 mu g/ml, and mice sacrificed after weaning. The drug was well tolerated by wild-type animals and heterozygous HPRT+/- mice. Instead, a profound alteration of the renal function was observed in the HPRT-/- model. Increased hypoxanthine and xanthine concentrations were found in the blood. The kidneys showed a yellowish appearance, diffuse interstitial nephritis, with dilated tubules, inflammatory and fibrotic changes of the interstitium. There were numerous xanthine tubular crystals, as determined by HPLC analysis. Oil red O staining demonstrated lipid accumulation in the same location of xanthine deposits. mRNA analysis showed increased expression of adipogenesis-related molecules as well as profibrotic and proinflammatory pathways. Immunostaining showed numerous monocyte-macrophages and overexpression of alpha-smooth muscle actin in the tubulointerstitium. In vitro, addition of xanthine to tubular cells caused diffuse oil red O positivity and modification of the cell phenotype, with loss of epithelial features and appearance of mesenchymal characteristics, similarly to what was observed in vivo. Our results indicate that in the absence of HPRT, blockade of XO by allopurinol causes rapidly developing renal failure due to xanthine deposition within the mouse kidney. Xanthine seems to be directly involved in promoting lipid accumulation and subsequent phenotype changes of tubular cells, with activation of inflammation and fibrosis.	[Zennaro, Cristina; Tonon, Federica; Carraro, Michele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Zarattini, Paola] Univ Trieste, Dept Life Sci, Trieste, Italy; [Clai, Milan] Azienda Sanit Univ Integrata Trieste, Dept Pathol & Legal Med, Trieste, Italy; [Corbelli, Alessandro] IRCCS Mario Negri Inst Pharmacol Res, Dept Cardiovasc Res, Unit Bioimaging, Milan, Italy; [Marchetti, Marialaura; Percudani, Riccardo] Univ Parma, Dept Life Sci, Parma, Italy; [Ronda, Luca] Univ Parma, Dept Neurosci, Parma, Italy; [Paredi, Gianluca] Univ Parma, PARMA Interdept Ctr, Dept Pharm, Parma, Italy; [Paredi, Gianluca] Univ Parma, PARMA Interdept Ctr, SITEIA, Parma, Italy; [Rastaldi, Maria Pia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy	University of Trieste; University of Trieste; University of Trieste; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Parma; University of Parma; University of Parma; University of Parma; IRCCS Ca Granda Ospedale Maggiore Policlinico	Zennaro, C (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	czennaro@units.it	Paredi, Gianluca/N-9977-2019; Marchetti, Marialaura/U-3644-2017; Corbelli, Alessandro/ABG-3900-2020; Tonon, Federica/AAC-7343-2022	Marchetti, Marialaura/0000-0002-4615-6786; Corbelli, Alessandro/0000-0001-8545-8050; 	Telethon grant, "Development of an uricolytic treatment for HPRT-deficiency in animal models" [GGP13149]; FRA University of Trieste, "Application of in vitro and Zebrafish models to uncover the potential involvement of the urostatic drug allopurinol in renal and neuronal damage of Lesch-Nyhan disease"	Telethon grant, "Development of an uricolytic treatment for HPRT-deficiency in animal models"(Fondazione Telethon); FRA University of Trieste, "Application of in vitro and Zebrafish models to uncover the potential involvement of the urostatic drug allopurinol in renal and neuronal damage of Lesch-Nyhan disease"	This work was supported by a Telethon grant GGP13149, "Development of an uricolytic treatment for HPRT-deficiency in animal models", providing also salaries for CZ, FT, MM, and AC. Funding was received also from FRA 2015 University of Trieste, "Application of in vitro and Zebrafish models to uncover the potential involvement of the urostatic drug allopurinol in renal and neuronal damage of Lesch-Nyhan disease".	Arikyants N, 2007, PEDIATR NEPHROL, V22, P310, DOI 10.1007/s00467-006-0267-3; BRADBURY MG, 1995, PEDIATR NEPHROL, V9, P476, DOI 10.1007/BF00866732; Burdett TC, 2013, BIOMED CHROMATOGR, V27, P122, DOI 10.1002/bmc.2760; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Constantinescu R, 2011, DRUG TODAY, V47, P369, DOI 10.1358/dot.2011.47.5.1591834; Crook ED, 2003, AM J MED SCI, V325, P340, DOI 10.1097/00000441-200306000-00005; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; GOMEZ GA, 1978, ARCH INTERN MED, V138, P1017, DOI 10.1001/archinte.138.6.1017; Harris JC, 1998, ARCH NEUROL-CHICAGO, V55, P547, DOI 10.1001/archneur.55.4.547; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hershfield MS, 2010, P NATL ACAD SCI USA, V107, P14351, DOI 10.1073/pnas.1001072107; Ho MC, 2010, P NATL ACAD SCI USA, V107, P4805, DOI 10.1073/pnas.0913439107; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; Ichida K, 1998, INTERNAL MED, V37, P77, DOI 10.2169/internalmedicine.37.77; Javor ED, 2004, J CLIN ENDOCR METAB, V89, P3199, DOI 10.1210/jc.2003-032140; Jinnah HA, 2009, DIS MODEL MECH, V2, P116, DOI 10.1242/dmm.002543; Kang TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016572; Kiss A, 1999, UROL INT, V63, P242, DOI 10.1159/000030458; Kucera J, 1997, J SMALL ANIM PRACT, V38, P302, DOI 10.1111/j.1748-5827.1997.tb03471.x; Levartovsky D, 2000, KIDNEY INT, V57, P2215, DOI 10.1046/j.1523-1755.2000.00082.x; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Miranda M, 2010, J VET MED SCI, V72, P921, DOI 10.1292/jvms.09-0494; MIZUNO T, 1976, NEUROPADIATRIE, V7, P351, DOI 10.1055/s-0028-1091635; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; OGAWA A, 1985, UROLOGY, V26, P56, DOI 10.1016/0090-4295(85)90256-0; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Roche A, 2009, AM J KIDNEY DIS, V53, P677, DOI 10.1053/j.ajkd.2008.09.011; Ryu ES, 2013, AM J PHYSIOL-RENAL, V304, pF471, DOI 10.1152/ajprenal.00560.2012; Saeedi R, 2015, CLIN BIOCHEM, V48, P472, DOI 10.1016/j.clinbiochem.2014.08.014; Scriver C.R., 1995, METABOLIC MOL BASES; Shimo T, 2005, TOXICOL SCI, V87, P267, DOI 10.1093/toxsci/kfi210; Sikora P, 2006, PEDIATR NEPHROL, V21, P1045, DOI 10.1007/s00467-006-0149-8; Simmonds H.A., 1995, METABOLIC MOL BASIS; STOECKLER JD, 1980, BIOCHEMISTRY-US, V19, P102, DOI 10.1021/bi00542a016; Thomas N, 1996, J Assoc Physicians India, V44, P203; Torres RJ, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-48; Torres RJ, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-011-0231-5; Tsuchida S, 2007, J FELINE MED SURG, V9, P503, DOI 10.1016/j.jfms.2007.03.012; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; Waldek S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-72; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Xu P, 2000, J BIOL CHEM, V275, P5918, DOI 10.1074/jbc.275.8.5918	46	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173512	10.1371/journal.pone.0173512	http://dx.doi.org/10.1371/journal.pone.0173512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282408	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800047
J	Gordya, N; Yakovlev, A; Kruglikova, A; Tulin, D; Potolitsina, E; Suborova, T; Bordo, D; Rosano, C; Chernysh, S				Gordya, Natalia; Yakovlev, Andrey; Kruglikova, Anastasia; Tulin, Dmitry; Potolitsina, Evdokia; Suborova, Tatyana; Bordo, Domenico; Rosano, Camillo; Chernysh, Sergey			Natural antimicrobial peptide complexes in the fighting of antibiotic resistant biofilms: Calliphora vicina medicinal maggots	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; INSECT	Biofilms, sedimented microbial communities embedded in a biopolymer matrix cause vast majority of human bacterial infections and many severe complications such as chronic inflammatory diseases and cancer. Biofilms' resistance to the host immunity and antibiotics makes this kind of infection particularly intractable. Antimicrobial peptides (AMPs) are a ubiquitous facet of innate immunity in animals. However, AMPs activity was studied mainly on planktonic bacteria and little is known about their effects on biofilms. We studied structure and anti-biofilm activity of AMP complex produced by the maggots of blowfly Calliphora vicina living in environments extremely contaminated by biofilm-forming germs. The complex exhibits strong cell killing and matrix destroying activity against human pathogenic antibiotic resistant Escherichia coli, Staphylococcus aureus and Acinetobacter baumannii biofilms as well as non-toxicity to human immune cells. The complex was found to contain AMPs from defensin, cecropin, diptericin and proline-rich peptide families simultaneously expressed in response to bacterial infection and encoded by hundreds mRNA isoforms. All the families combine cell killing and matrix destruction mechanisms, but the ratio of these effects and antibacterial activity spectrum are specific to each family. These molecules dramatically extend the list of known anti-biofilm AMPs. However, pharmacological development of the complex as a whole can provide significant advantages compared with a conventional one-component approach. In particular, a similar level of activity against biofilm and planktonic bacteria (MBEC/MIC ratio) provides the complex advantage over conventional antibiotics. Available methods of the complex in situ and in vitro biosynthesis make this idea practicable.	[Gordya, Natalia; Yakovlev, Andrey; Kruglikova, Anastasia; Tulin, Dmitry; Potolitsina, Evdokia; Chernysh, Sergey] St Petersburg State Univ, Lab Insect Biopharmacol & Immunol, Fac Biol, St Petersburg, Russia; [Suborova, Tatyana] Kirov Mil Med Acad, Res Ctr, St Petersburg, Russia; [Bordo, Domenico; Rosano, Camillo] IRCCS AOU San Martino IST, Natl Inst Canc Res, Genoa, Italy	Saint Petersburg State University; University of Genoa; IRCCS AOU San Martino IST	Chernysh, S (corresponding author), St Petersburg State Univ, Lab Insect Biopharmacol & Immunol, Fac Biol, St Petersburg, Russia.	sichernysh1951@gmail.com	Andrey, Yakovlev Yu/G-1002-2015; Rosano, Camillo/D-5386-2011; Rosano, Camillo/AAA-9954-2021; Kruglikova, Anastasia/E-7127-2016	Rosano, Camillo/0000-0003-2949-9215; Rosano, Camillo/0000-0003-2949-9215; Yakovlev, Andrey/0000-0003-2985-3907; Kruglikova, Anastasia/0000-0002-3809-7229	Russian Science Foundation [16-14-00048]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by a grant from the Russian Science Foundation (URL http://rscf.ru/), grant No 16-14-00048 (SC, NG, AY, DT, EP, AK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Batoni G, 2016, BBA-BIOMEMBRANES, V1858, P1044, DOI 10.1016/j.bbamem.2015.10.013; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Cerovsky V, 2010, CELL MOL LIFE SCI, V67, P455, DOI 10.1007/s00018-009-0194-0; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; Chernysh SI, 2011, J EVOL BIOCHEM PHYS+, V47, P524, DOI 10.1134/S0022093011060032; Chernysh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130788; Chernysh Sergey I., 2000, Entomological Science, V3, P139; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Di Luca M, 2014, PATHOG DIS, V70, P257, DOI 10.1111/2049-632X.12151; Dufour D., 2010, ENDODONTIC TOPICS, V22, P2, DOI [10.1111/j.1601-1546.2012.00277.x|, DOI 10.1111/J.1601-1546.2012.00277.X, DOI 10.1111/J.1601-1546.2012.00277.X|]; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Gupta P, 2016, ARCH MICROBIOL, V198, P1, DOI 10.1007/s00203-015-1148-6; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; KEPPI E, 1989, ARCH INSECT BIOCHEM, V10, P229, DOI 10.1002/arch.940100306; Knezevic P, 2008, J MICROBIOL METH, V74, P114, DOI 10.1016/j.mimet.2008.03.005; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Leid JG, 2009, MICROBE, V4, P66; McCafferty DG, 1999, CURR OPIN CHEM BIOL, V3, P672, DOI 10.1016/S1367-5931(99)00025-3; Mylonakis E, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0290; Napier BA, 2013, MBIO, V4, DOI 10.1128/mBio.00021-13; NESIN AP, 1995, APPL ENTOMOL ZOOL, V30, P351; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Palm-Apergi C, 2008, J CONTROL RELEASE, V132, P49, DOI 10.1016/j.jconrel.2008.08.011; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Pinto-Santini D, 2005, CANCER EPIDEM BIOMAR, V14, P1853, DOI 10.1158/1055-9965.EPI-04-0784; Pletzer D, 2016, CURR OPIN MICROBIOL, V33, P35, DOI 10.1016/j.mib.2016.05.016; Poppel AK, 2015, ANTIMICROB AGENTS CH, V59, P2508, DOI 10.1128/AAC.05180-14; Rahnamaeian M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0293; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Ratcliffe N, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/904958; Riddell CE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1031; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Sherman RA, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/592419; Strempel N, 2015, CURR PHARM DESIGN, V21, P67, DOI 10.2174/1381612820666140905124312; Tonk M, 2016, APPL MICROBIOL BIOT, V100, P7397, DOI 10.1007/s00253-016-7718-y; Wiesner J, 2011, BIOL INSPIR SYST, V2, P29, DOI 10.1007/978-90-481-9641-8_3; Yakovlev AY, 2016, IN VITRO CELL DEV; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001; Yu GZ, 2016, ANTIMICROB AGENTS CH, V60, P1717, DOI 10.1128/AAC.02434-15; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhan P, 2011, EUR J CANCER, V47, P742, DOI 10.1016/j.ejca.2010.11.003	49	46	51	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173559	10.1371/journal.pone.0173559	http://dx.doi.org/10.1371/journal.pone.0173559			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278280	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900012
J	Souza, HR; de Azevedo, LR; Possebon, L; Costa, SD; Iyomasa-Pilon, MM; Oliani, SM; Girol, AP				Souza, Helena Ribeiro; de Azevedo, Lucas Ribeiro; Possebon, Lucas; Costa, Sara de Souza; Iyomasa-Pilon, Melina Mizusaki; Oliani, Sonia Maria; Girol, Ana Paula			Heterogeneity of mast cells and expression of Annexin A1 protein in a second degree burn model with silver sulfadiazine treatment	PLOS ONE			English	Article							LEVEL LASER THERAPY; CHYMASE; SKIN; INFLAMMATION; ACTIVATION; PROTEASES; TRYPTASE; PEPTIDE; SCAR; CYTOKINES	Mast cells (MCs) participate in all stages of skin healing and one of their mediators is the Annexin A1 protein (AnxA1), linked to inflammation, proliferation, migration and apoptosis processes, but not studied in thermal burns yet. Therefore, our objectives were to evaluate the behavior of MCs and AnxA1 in a second degree burn model, treated or not with silver sulfadiazine 1% (SDP 1%) and associated to macrophages quantification and cytokines dosages. MCs counts showed few cells in the early stages of repair but increased MCs in the final phases in the untreated group. The normal skin presented numerous tryptase-positive MCs that were reduced after burning in all analyzed periods. Differently, few chymasepositive MCs were observed in the early stages of healing, however, increased chymasepositive MCs were found at the final phase in the untreated group. MCs also showed high immunoreactivity for AnxA1 on day 3 in both groups. In the tissue there was a strong protein expression in the early stages of healing, but in the final phases only in the SDP treated animals. TNF-alpha, IL-1 beta, IL-6, IL-10 and MCP-1 levels and macrophages quantification were increased in inflammation and reepithelialization phases. Reduced IL-1 beta, IL-6 and IL-10 levels and numerous macrophages occurred in the treated animals during tissue repair. Our results indicate modulation in the profile of MCs and AnxA1expression during healing by the treatment with SDP 1%, pointing them as targets for therapeutic interventions on skin burns.	[Souza, Helena Ribeiro; Iyomasa-Pilon, Melina Mizusaki; Girol, Ana Paula] Integrated Coll Padre Albino Fdn FIPA, Sao Paulo, Brazil; [Souza, Helena Ribeiro; de Azevedo, Lucas Ribeiro; Possebon, Lucas; Costa, Sara de Souza; Oliani, Sonia Maria; Girol, Ana Paula] Sao Paulo State Univ UNESP, Lab Immunomorphol, Dept Biol, Sao Paulo, Brazil	Universidade Estadual Paulista	Girol, AP (corresponding author), Integrated Coll Padre Albino Fdn FIPA, Sao Paulo, Brazil.; Girol, AP (corresponding author), Sao Paulo State Univ UNESP, Lab Immunomorphol, Dept Biol, Sao Paulo, Brazil.	anapaulagirol@hotmail.com	Girol, Ana P/O-1716-2013; Possebon, Lucas P/G-1132-2015; Oliani, Sonia Maria/E-3476-2012; Costa, Sara Souza/X-7128-2018	Girol, Ana P/0000-0002-8760-8945; Possebon, Lucas P/0000-0002-7065-526X; Oliani, Sonia Maria/0000-0003-0918-2130; Costa, Sara Souza/0000-0002-9359-5482	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/en/); APG. The funding agency was instrumental in the acquisition of equipment and supplies for laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	amazo AS, 2011, BMC IMMUNOL, V12, P1; Artuc M, 2002, J INVEST DERMATOL, V119, P411, DOI 10.1046/j.1523-1747.2002.01838.x; Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; Babcock GF, 2012, INFLAMMATION, V35, P259, DOI 10.1007/s10753-011-9313-9; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bastian Boris C., 1993, Journal of Dermatological Science, V6, P225, DOI 10.1016/0923-1811(93)90043-O; Bayat M, 2005, J PHOTOCH PHOTOBIO B, V78, P171, DOI 10.1016/j.jphotobiol.2004.08.012; Bayat M, 2008, J REHABIL RES DEV, V45, P931, DOI 10.1682/JRRD.2007.07.0110; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Bizzarro V., 2012, PLOS ONE, V7, P1; Boudhraa Z, 2014, CLIN EXP METASTAS, V31, P749, DOI 10.1007/s10585-014-9665-2; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; Del Gaudio P, 2015, CARBOHYD POLYM, V115, P629, DOI 10.1016/j.carbpol.2014.09.040; Dong XL, 2015, EXP THER MED, V9, P955, DOI 10.3892/etm.2015.2216; Dong XL, 2014, INT J CLIN EXP PATHO, V7, P3596; Dong XL, 2013, EXP THER MED, V5, P643, DOI 10.3892/etm.2012.836; Dong XL, 2012, MOL MED REP, V5, P1487, DOI 10.3892/mmr.2012.851; Douaiher J, 2014, ADV IMMUNOL, V122, P211, DOI 10.1016/B978-0-12-800267-4.00006-7; Ehrlich HP, 2013, ADV WOUND CARE, V2, P113, DOI 10.1089/wound.2012.0414; Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; GAMELLI RL, 1993, SURG GYNECOL OBSTET, V177, P115; Gauglitz GG, 2008, SHOCK, V30, P503, DOI 10.1097/SHK.0b013e31816e3373; Gavins FNE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00354; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Guo CM, 2013, FUTURE ONCOL, V9, P1773, DOI [10.2217/FON.13.114, 10.2217/fon.13.114]; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harunari N, 2006, BURNS, V32, P669, DOI 10.1016/j.burns.2006.03.015; Hermes B, 2000, J INVEST DERMATOL, V114, P51, DOI 10.1046/j.1523-1747.2000.00837.x; Huttunen M, 2000, EXP DERMATOL, V9, P258, DOI 10.1034/j.1600-0625.2000.009004258.x; Jia Y, 2013, J CELL PHYSIOL, V228, P476, DOI 10.1002/jcp.24156; Kamal AM, 2005, MEM I OSWALDO CRUZ, V100, P39, DOI 10.1590/S0074-02762005000900008; Kubo H, 2014, LEGAL MED-TOKYO, V16, P8, DOI 10.1016/j.legalmed.2013.10.002; da Silva HAL, 2015, REV SOC BRAS MED TRO, V48, P560, DOI 10.1590/0037-8682-0183-2015; Leoni G, 2015, MUCOSAL IMMUNOL, V8, P959, DOI 10.1038/mi.2015.63; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; LEVISCHAFFER F, 1995, J INVEST DERMATOL, V104, P999, DOI 10.1111/1523-1747.ep12606237; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Ma F, 2008, STEM CELLS, V26, P706, DOI 10.1634/stemcells.2007-0348; Marx David E, 2014, Burns, V40 Suppl 1, pS9, DOI 10.1016/j.burns.2014.09.010; Meng Z, 2014, LUPUS, V23, P183, DOI 10.1177/0961203313513820; Meyerholz DK, 2009, INT J EXP PATHOL, V90, P26, DOI 10.1111/j.1365-2613.2008.00617.x; Nakazawa S, 2014, EUR J IMMUNOL, V44, P204, DOI 10.1002/eji.201343838; Neymeyer H, 2015, ACTA PHYSIOL, V215, P144, DOI 10.1111/apha.12586; Nishikori Y, 1998, ARCH DERMATOL RES, V290, P553, DOI 10.1007/s004030050351; Oliani SM, 2008, INFLAMM RES, V57, P450, DOI 10.1007/s00011-008-7222-7; Oliani SM, 2000, LAB INVEST, V80, P1429, DOI 10.1038/labinvest.3780150; Oppeltz RF, 2012, CYTOKINE, V60, P528, DOI 10.1016/j.cyto.2012.07.003; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Patel N, 2008, AESTHET PLAST SURG, V32, P470, DOI 10.1007/s00266-008-9120-3; Paula R, 2015, J MOL HISTOL, V46, P33, DOI 10.1007/s10735-014-9595-y; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Richardson P, 2009, BURNS, V35, P921, DOI 10.1016/j.burns.2009.03.003; SAARINEN J, 1994, J BIOL CHEM, V269, P18134; Saito N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008227; Sato-Matsumura KC, 2000, ARCH DERMATOL RES, V292, P496, DOI 10.1007/s004030000172; SatoMatsumura KC, 1996, ARCH DERMATOL RES, V288, P565, DOI 10.1007/BF02505257; Stroncek John D., 2008, P3; Summer GJ, 2007, J PAIN, V8, P533, DOI 10.1016/j.jpain.2007.02.426; Takeo M, 2015, COLD SPRING HARB PER, P51; Teixeira RAP, 2013, J TISSUE ENG REGEN M, V10, P524; Trentin PG, 2015, BRIT J PHARMACOL, V172, P3058, DOI 10.1111/bph.13109; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Yeh FL, 2009, BURNS, V35, P348, DOI 10.1016/j.burns.2008.06.018	70	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173417	10.1371/journal.pone.0173417	http://dx.doi.org/10.1371/journal.pone.0173417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278234	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900089
J	Cha, BY; Yang, JB; Singh, V; Zachos, NC; Sarker, RI; Chen, TE; Chakraborty, M; Tse, CM; Donowitz, M				Cha, Boyoung; Yang, Jianbo; Singh, Varsha; Zachos, Nicholas C.; Sarker, Rafiquel I.; Chen, Tian-e; Chakraborty, Molee; Tse, Chung-Ming; Donowitz, Mark			PDZ domain-dependent regulation of NHE3 protein by both internal Class II and C-terminal Class I PDZ-binding motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER NHE3; BRUSH-BORDER; INHIBITION; MEMBRANE; KINASE; NHERF2; TRAFFICKING; BASAL; STIMULATION; SPECIFICITY	NHE3 directly binds Na+/H+ exchanger regulatory factor (NHERF) family scaffolding proteins that are required for many aspects of NHE3 regulation. The NHERFs bind both to an internal region (amino acids 586-660) of the NHE3 C terminus and to the NHE3 C-terminal four amino acids. The internal NHERF-binding region contains both putative Class I (-(592)SAV-) and Class II (-(CLDM)-C-595-) PDZ-binding motifs (PBMs). Point mutagenesis showed that only the Class II motif contributes to NHERF binding. In this study, the roles in regulation of NHE3 activity of these two PBMs were investigated, revealing the following findings. 1) Interaction occurred between these binding sites because mutation of either removed nearly all NHERF binding. 2) Mutations in either significantly reduced basal NHE3 activity. Total and percent plasma membrane (PM) NHE3 protein expression was reduced in the C-terminal but not in the internal PBD mutation. 3) cGMP- and Ca2+-mediated inhibition of NHE3 was impaired in both the internal and the C-terminal PBM mutations. 4) There was a significant reduction in half-life of the PM pool of NHE3 in only the internal PBM mutation but no change in total NHE3 half-life in either. 5) There were some differences in NHE3-associating proteins in the two PBM mutations. In conclusion, NHE3 binds to NHERF proteins via both an internal Class II PBM and C-terminal Class I PBM, which interact. The former determines NHE3 stability in the PM, and the latter determines total expression and percent PM expression.	Johns Hopkins Univ, Sch Med, Gastroenterol Div, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Gastroenterol Div, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GI Div, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Zachos, Nicholas/GWC-7914-2022; yang, jian/HIK-0188-2022		NIDDK; National Institutes of Health [R01-DK26523, R01-DK61765, P01-DK072084, P30-DK89502]; The Hopkins Digestive Diseases Basic and Translational Research Core Center; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061765, R01DK026523, P01DK072084, P30DK089502] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hopkins Digestive Diseases Basic and Translational Research Core Center; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants R01-DK26523, R01-DK61765, P01-DK072084, and P30-DK89502; The Hopkins Digestive Diseases Basic and Translational Research Core Center; and The Hopkins Center for Epithelial Disorders. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Boisguerin P, 2004, CHEM BIOL, V11, P449, DOI 10.1016/j.chembiol.2004.03.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley P, 2005, PROTEINS, V61, P128, DOI 10.1002/prot.20729; Cavet ME, 2001, AM J PHYSIOL-CELL PH, V281, pC2039, DOI 10.1152/ajpcell.2001.281.6.C2039; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Cha BY, 2014, AM J PHYSIOL-CELL PH, V307, pC55, DOI 10.1152/ajpcell.00045.2014; Cha BY, 2010, J CELL SCI, V123, P2434, DOI 10.1242/jcs.056713; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Chen T, 2015, J BIOL CHEM, V290, P1952, DOI 10.1074/jbc.M114.590174; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Paasche JD, 2005, MOL PHARMACOL, V67, P1581, DOI 10.1124/mol.104.007013; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Singh V, 2015, MOL BIOL CELL, V26, P2030, DOI 10.1091/mbc.E14-12-1597; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SRINIVASAN R, 1995, PROTEINS, V22, P81, DOI 10.1002/prot.340220202; Srinivasan R, 2002, PROTEINS, V47, P489, DOI 10.1002/prot.10103; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; Vaccaro P, 2002, FEBS LETT, V512, P345, DOI 10.1016/S0014-5793(02)02220-2; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zencir S, 2013, BIOCHEM BIOPH RES CO, V432, P10, DOI 10.1016/j.bbrc.2013.01.098; Zhu XJ, 2011, J BIOL CHEM, V286, P34486, DOI 10.1074/jbc.M111.230219; Zizak M, 2012, J BIOL CHEM, V287, P13442, DOI 10.1074/jbc.M111.307256	42	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8279	8290		10.1074/jbc.M116.774489	http://dx.doi.org/10.1074/jbc.M116.774489			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28283572	Green Published, hybrid			2022-12-26	WOS:000401788600014
J	Taschner, M; Mourao, A; Awasthi, M; Basquin, J; Lorentzen, E				Taschner, Michael; Mourao, Andre; Awasthi, Mayanka; Basquin, Jerome; Lorentzen, Esben			Structural basis of outer dynein arm intraflagellar transport by the transport adaptor protein ODA16 and the intraflagellar transport protein IFT46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; crystal structure; dynein; intracellular trafficking; primary cilium; IFT; cilium; flagellum; intraflagellar transport; outer dynein arms	B CORE COMPLEX; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; TUBULIN TRANSPORT; CRYSTAL-STRUCTURE; ARCHITECTURE; CILIUM; PURIFICATION; RESOLUTION; MOTILITY	Motile cilia are found on unicellular organisms such as the green alga Chlamydomonas reinhardtii, on sperm cells, and on cells that line the trachea and fallopian tubes in mammals. The motility of cilia relies on a number of large protein complexes including the force-generating outer dynein arms (ODAs). The transport of ODAs into cilia has been previously shown to require the transport adaptor ODA16, as well as the intraflagellar transport (IFT) protein IFT46, but the molecular mechanism by which ODAs are recognized and transported into motile cilia is still unclear. Here, we determined the high-resolution crystal structure of C. reinhardtii ODA16 (CrODA16) and mapped the binding to IFT46 and ODAs. The CrODA16 structure revealed a small 80-residue N-terminal domain and a C-terminal 8-bladed -propeller domain that are both required for the association with the N-terminal 147 residues of IFT46. The dissociation constant of the IFT46-ODA16 complex was 200 nm, demonstrating that CrODA16 associates with the IFT complex with an affinity comparable with that of the individual IFT subunits. Furthermore, we show, using ODAs extracted from the axonemes of C. reinhardtii, that the C-terminal -propeller but not the N-terminal domain of CrODA16 is required for the interaction with ODAs. These data allowed us to present an architectural model for ODA16-mediated IFT of ODAs.	[Taschner, Michael; Lorentzen, Esben] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Mourao, Andre] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Awasthi, Mayanka] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Basquin, Jerome] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Aarhus University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Maryland; University of Maryland College Park; Max Planck Society	Lorentzen, E (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark.	el@mbg.au.dk	AWASTHI, MAYANKA/J-1219-2019; Lorentzen, Esben/AAX-8077-2020	AWASTHI, MAYANKA/0000-0002-4395-0589; Taschner, Michael/0000-0002-8881-3705; Lorentzen, Esben/0000-0001-6493-7220	Novo Nordisk Foundation [NNF15OC0014164]; European Research Council [310343]; Novo Nordisk Fonden [NNF15OC0016050] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Novo Nordisk Foundation Grant NNF15OC0014164 and European Research Council Grant 310343. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Bassler J, 2014, J CELL BIOL, V207, P481, DOI 10.1083/jcb.201408111; Bhogaraju S, 2014, BIOESSAYS, V36, P463, DOI 10.1002/bies.201400007; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Bieniossek C., 2008, CURR PROTOC PROTEIN; Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Brennich ME, 2017, JOVE-J VIS EXP, DOI 10.3791/54861; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Dobell C., 1932, A LEEUWENHOEK HIS LI; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Ishikawa H, 2014, ELIFE, V3, DOI 10.7554/eLife.01566; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; Jiang X, 2017, J CELL SCI, V130, P879, DOI 10.1242/jcs.199117; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh Y, 2016, J BIOL CHEM, V291, P10962, DOI 10.1074/jbc.M116.713883; King SM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028100; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kubo T, 2016, J CELL SCI, V129, P2106, DOI 10.1242/jcs.187120; Lechtreck KF, 2015, TRENDS BIOCHEM SCI, V40, P765, DOI 10.1016/j.tibs.2015.09.003; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; Moon TM, 2013, J MOL BIOL, V425, P1245, DOI 10.1016/j.jmb.2013.01.031; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Richey EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043118; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Taschner M, 2016, METHODS MOL BIOL, V1454, P69, DOI 10.1007/978-1-4939-3789-9_5; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Taschner M, 2011, J BIOL CHEM, V286, P26344, DOI 10.1074/jbc.M111.254920; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala Maimoona A, 2011, Proc Am Thorac Soc, V8, P430, DOI 10.1513/pats.201103-023SD	65	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	2017	292	18					7462	7473		10.1074/jbc.M117.780155	http://dx.doi.org/10.1074/jbc.M117.780155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU1FY	28298440	Green Published, hybrid			2022-12-26	WOS:000400761300016
J	Fong, G; Backman, LJ; Alfredson, H; Scott, A; Danielson, P				Fong, Gloria; Backman, Ludvig J.; Alfredson, Hakan; Scott, Alex; Danielson, Patrik			The effects of substance P and acetylcholine on human tenocyte proliferation converge mechanistically via TGF-beta 1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACHILLES-TENDON; NEUROKININ-1 RECEPTOR; PATELLAR TENDON; UP-REGULATION; EXPRESSION; TENDINOPATHY; TENDINOSIS; MATRIX; CELLS	Previous in vitro studies on human tendon cells (tenocytes) have demonstrated that the exogenous administration of substance P (SP) and acetylcholine (ACh) independently result in tenocyte proliferation, which is a prominent feature of tendinosis. Interestingly, the possible link between SP and ACh has not yet been explored in human tenocytes. Recent studies in other cell types demonstrate that both SP and ACh independently upregulate TGF-beta 1 expression via their respective receptors, the neurokinin 1 receptor (NK-1R) and muscarinic ACh receptors (mAChRs). Furthermore, TGF-beta 1 has been shown to downregulate NK-1R expression in human keratocytes. The aim of this study was to examine if TGF-beta 1 is the intermediary player involved in mediating the proliferative pathway shared by SP and ACh in human tenocytes. The results showed that exogenous administration of SP and ACh both caused significant upregulation of TGF-beta 1 at the mRNA and protein levels. Exposing cells to TGF-beta 1 resulted in increased cell viability of tenocytes, which was blocked in the presence of the TGF beta RI/II kinase inhibitor. In addition, the proliferative effects of SP and ACh on tenocytes were reduced by the TGF beta RI/II kinase inhibitor; this supports the hypothesis that the proliferative effects of these signal substances are mediated via the TGF-beta axis. Furthermore, exogenous TGF-beta 1 downregulated NK-1R and mAChRs expression at both the mRNA and protein levels, and these effects were negated by simultaneous exposure to the TGF beta RI/II kinase inhibitor, suggesting a negative feedback loop. In conclusion, the results indicate that TGF-beta 1 is the intermediary player through which the proliferative actions of both SP and ACh converge mechanistically.	[Fong, Gloria; Backman, Ludvig J.; Danielson, Patrik] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Fong, Gloria; Scott, Alex] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Alfredson, Hakan] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Danielson, Patrik] Umea Univ, Dept Clin Sci, Ophthalmol, Umea, Sweden	Umea University; Vancouver Coastal Health Research Institute; Umea University; Umea University	Danielson, P (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.; Danielson, P (corresponding author), Umea Univ, Dept Clin Sci, Ophthalmol, Umea, Sweden.	patrik.danielson@umu.se		Scott, Alex/0000-0003-0366-8404	National Swedish Research Council [397 521-2013-2612, 521-2013-2612]; Swedish Society of Medicine [SLS-410021, 504541]; Vasterbotten County Council (VLL 'Spjutspetsmedel') [VLL-363161]; Umea University [VLL-549761]; Vasterbotten County Council [VLL-549761]	National Swedish Research Council(Swedish Research Council); Swedish Society of Medicine; Vasterbotten County Council (VLL 'Spjutspetsmedel'); Umea University; Vasterbotten County Council	Financial support was obtained by P.D. from the National Swedish Research Council (grant no.397 521-2013-2612, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), the Swedish Society of Medicine (SLS-410021 and 504541, http://www.sls.se/Om-SLS/In-English/), and Vasterbotten County Council (VLL 'Spjutspetsmedel') (VLL-363161). Financial support was furthermore provided to P.D. through a regional agreement (ALF) between Umea University and Vasterbotten County Council (VLL-549761, http://www.medfak.umu.se/om-fakulteten/aktuellt/nyhetsvisning/alf-investeringsmedel-2016.cid265286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr Sandrine LeRoux for technical assistance and scientific advice. Financial support was obtained by P.D. from the National Swedish Research Council (grant no. 521-2013-2612), the Swedish Society of Medicine (SLS-410021 and 504541), and Vasterbotten County Council (VLL 'Spjutspetsmedel') (VLL-363161). Financial support was furthermore provided to P.D. through a regional agreement (ALF) between Umea University and Vasterbotten County Council (VLL-549761).	Andersson G, 2008, REGUL PEPTIDES, V150, P81, DOI 10.1016/j.regpep.2008.02.005; Backman LJ, 2011, J MUSCULOSKEL NEURON, V11, P133; Backman LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027209; Bjur D, 2008, CELL TISSUE RES, V331, P385, DOI 10.1007/s00441-007-0524-1; Chung YT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084980, 10.1371/journal.pone.0070128]; Danielson P, 2007, LIFE SCI, V80, P2235, DOI 10.1016/j.lfs.2007.01.005; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Fong G, 2013, CELL TISSUE RES, V351, P465, DOI 10.1007/s00441-012-1530-5; Fong G, 2013, J ORTHOP RES, V31, P91, DOI 10.1002/jor.22191; Fu SC, 2005, CLIN ORTHOP RELAT R, P226, DOI 10.1097/01.blo.0000145887.48534.6f; Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067; Gingery A, 2014, J ORTHOP RES, V32, P1444, DOI 10.1002/jor.22694; Goodier HCJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0947-8; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; Le Roux S, 2016, CURR EYE RES, V41, P1035, DOI 10.3109/02713683.2015.1088954; Lian O, 2006, AM J SPORT MED, V34, P1801, DOI 10.1177/0363546506289169; Matthiesen S, 2006, AM J RESP CELL MOL, V35, P621, DOI 10.1165/rcmb.2005-0343RC; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Pingel J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-53; Schubert TEO, 2005, ANN RHEUM DIS, V64, P1083, DOI 10.1136/ard.2004.029876; Spindler KP, 1996, J ORTHOP RES, V14, P542, DOI 10.1002/jor.1100140407; Steyaert A, 2010, ACTA ORTHOP BELG, V76, P387; Tsubone T, 2006, J ORTHOP RES, V24, P569, DOI 10.1002/jor.20101; Visser LC, 2010, VET SURG, V39, P811, DOI 10.1111/j.1532-950X.2010.00739.x; Xu YY, 2008, BRIT J HAEMATOL, V142, P192, DOI 10.1111/j.1365-2141.2008.07130.x; Yang H, 2015, CONNECT TISSUE RES, V56, P461, DOI 10.3109/03008207.2015.1054030; Yang K, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-53; Yaraee R, 2009, IRAN J ALLERGY ASTHM, V8, P19, DOI 08.01/ijaai.1924	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174101	10.1371/journal.pone.0174101	http://dx.doi.org/10.1371/journal.pone.0174101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301610	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300126
J	Streubel, J; Baum, H; Grau, J; Stuttman, J; Boch, J				Streubel, Jana; Baum, Heidi; Grau, Jan; Stuttman, Johannes; Boch, Jens			Dissection of TALE-dependent gene activation reveals that they induce transcription cooperatively and in both orientations	PLOS ONE			English	Article							BACTERIAL-BLIGHT RESISTANCE; RICE ORYZA-SATIVA; AGROBACTERIUM-TUMEFACIENS; BIDIRECTIONAL PROMOTERS; RECESSIVE RESISTANCE; INTERGENIC REGION; CRYSTAL-STRUCTURE; DNA RECOGNITION; PROTEIN AVRBS3; EFFECTOR	Plant-pathogenic Xanthomonas bacteria inject transcription activator-like effector proteins (TALEs) into host cells to specifically induce transcription of plant genes and enhance susceptibility. Although the DNA-binding mode is well-understood it is still ambiguous how TALEs initiate transcription and whether additional promoter elements are needed to support this. To systematically dissect prerequisites for transcriptional initiation the activity of one TALE was compared on different synthetic Bs4 promoter fragments. In addition, a large collection of artificial TALEs spanning the OsSWEET14 promoter was compared. We show that the presence of a TALE alone is not sufficient to initiate transcription suggesting the requirement of additional supporting promoter elements. At the OsSWEET14 promoter TALEs can initiate transcription from various positions, in a synergistic manner of multiple TALEs binding in parallel to the promoter, and even by binding in reverse orientation. TALEs are known to shift the transcriptional start site, but our data show that this shift depends on the individual position of a TALE within a promoter context. Our results implicate that TALEs function like classical enhancer-binding proteins and initiate transcription in both orientations which has consequences for in planta target gene prediction and design of artificial activators.	[Streubel, Jana; Boch, Jens] Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany; [Streubel, Jana; Baum, Heidi; Stuttman, Johannes; Boch, Jens] Martin Luther Univ Halle Wittenberg, Dept Plant Genet, Halle, Germany; [Grau, Jan] Martin Luther Univ Halle Wittenberg, Inst Comp Sci, Halle, Germany	Leibniz University Hannover; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Streubel, J (corresponding author), Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany.	jana.streubel@genetik.uni-hannover.de	Grau, Jan/H-5465-2019	Grau, Jan/0000-0003-2081-6405; Stuttmann, Johannes/0000-0002-6207-094X; Streubel, Jana/0000-0001-8155-511X	Deutsche Forschungsgemeinschaft [BO 1496/7-1, BO 1496/8-1, GR 4587/1-1]; COST action "SUSTAIN" [FM208]; Leibniz Universitat Hannover	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); COST action "SUSTAIN"(European Cooperation in Science and Technology (COST)); Leibniz Universitat Hannover	This project was supported by grants from the Deutsche Forschungsgemeinschaft (BO 1496/7-1 and BO 1496/8-1 to JB, and GR 4587/1-1 to JG) and by the COST action FM208 "SUSTAIN". The publication of this article was funded by the Open Access Fund of the Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Anthony K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095790; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Banerjee J, 2013, PLOS ONE, V8; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blanvillain-Baufume S, 2017, PLANT BIOTECHNOL J, V15, P306, DOI 10.1111/pbi.12613; Boch J, 2014, NEW PHYTOL, V204, P823, DOI 10.1111/nph.13015; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bruckner K, 2015, PLANT J, V82, P707, DOI 10.1111/tpj.12843; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; Cohn M, 2014, MOL PLANT MICROBE IN, V27, P1186, DOI 10.1094/MPMI-06-14-0161-R; Cuculis L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8277; de Souza TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032305; Dehury B, 2015, J MOL GRAPH MODEL, V57, P49, DOI 10.1016/j.jmgm.2015.01.005; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Dion V, 2003, J BIOL CHEM, V278, P11495, DOI 10.1074/jbc.M211938200; Domingues MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041553; Domingues MN, 2010, MOL PLANT PATHOL, V11, P663, DOI [10.1111/J.1364-3703.2010.00636.X, 10.1111/j.1364-3703.2010.00636.x]; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; GELVIN SB, 1983, NUCLEIC ACIDS RES, V11, P159; Gonzalez C, 2007, MOL PLANT MICROBE IN, V20, P534, DOI 10.1094/MPMI-20-5-0534; Grau J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002962; Gross P, 2006, BIOCHEM SOC SYMP, V73, P225; Gurlebeck D, 2005, PLANT J, V42, P175, DOI 10.1111/j.1365-313X.2005.02370.x; Huang S, 2016, PLANT J, V86, P186, DOI 10.1111/tpj.13164; Hummel AW, 2012, NEW PHYTOL, V195, P883, DOI 10.1111/j.1469-8137.2012.04216.x; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kay S, 2005, MOL PLANT MICROBE IN, V18, P838, DOI 10.1094/MPMI-18-0838; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kourmpetli S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-187; Kulaeva OI, 2012, MOL CELL BIOL, V32, P4892, DOI 10.1128/MCB.01127-12; Kumari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079011; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; LEUNG J, 1991, MOL GEN GENET, V230, P463, DOI 10.1007/BF00280304; Lis M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2630-5; Liu XQ, 2016, J EXP BOT, V67, P4403, DOI 10.1093/jxb/erw226; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Meyer P, 2000, PLANT MOL BIOL, V43, P221, DOI 10.1023/A:1006483428789; Mitra A, 2009, PLANTA, V229, P1015, DOI 10.1007/s00425-008-0859-1; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakagawa T, 2007, PGWB VECTORS TRANSFO; Ordon J, 2016, PLANT J; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; Pereira ALA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-157; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Perez-Quintero A, 2013, PLOS ONE, V8; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; REIMERS PJ, 1991, PHYSIOL MOL PLANT P, V38, P39, DOI 10.1016/S0885-5765(05)80141-9; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Russo MT, 2015, MAR GENOM, V24, P69, DOI 10.1016/j.margen.2015.06.010; Schornack S, 2005, MOL PLANT MICROBE IN, V18, P1215, DOI 10.1094/MPMI-18-1215; Schornack S, 2008, NEW PHYTOL, V179, P546, DOI 10.1111/j.1469-8137.2008.02487.x; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; Shahmuradov IA, 2003, NUCLEIC ACIDS RES, V31, P114, DOI 10.1093/nar/gkg041; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Soprano AS, 2013, PLANT PHYSIOL, V163, P232, DOI 10.1104/pp.113.224642; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; Streubel J, 2013, NEW PHYTOL, V200, P808, DOI 10.1111/nph.12411; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Uhde-Stone C, 2014, BIOCHEM BIOPH RES CO, V443, P1189, DOI 10.1016/j.bbrc.2013.12.111; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Wan Q, 2016, NEW PHYTOL; Wang CL, 2014, MOL PLANT PATHOL, V15, P333, DOI 10.1111/mpp.12092; Wang CL, 2015, MOL PLANT, V8, P290, DOI 10.1016/j.molp.2014.10.010; Wang L, 2017, MOL PLANT, V10, P285, DOI 10.1016/j.molp.2016.12.002; Wang Q, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S29; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254; Yuan M, 2016, ELIFE, V5, DOI 10.7554/eLife.19605; Yuan M, 2014, J INTEGR PLANT BIOL, V56, P559, DOI 10.1111/jipb.12173; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang HS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku535; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824	97	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173580	10.1371/journal.pone.0173580	http://dx.doi.org/10.1371/journal.pone.0173580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301511	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300052
J	Astrom, E; Stal, P; Zenlander, R; Edenvik, P; Alexandersson, C; Haglund, M; Ryden, I; Pahlsson, P				Astrom, Eva; Stal, Per; Zenlander, Robin; Edenvik, Pia; Alexandersson, Catharina; Haglund, Mats; Ryden, Ingvar; Pahlsson, Peter			Reverse lectin ELISA for detecting fucosylated forms of alpha 1-acid glycoprotein associated with hepatocellular carcinoma	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; ALPHA-FETOPROTEIN; SERUM; HAPTOGLOBIN; BIOMARKERS; CIRRHOSIS; PLASMA	Altered fucosylation of glycoproteins is associated with development of hepatocellular carcinoma (HCC). Lectins have been commonly used to assay changes in fucosylation of plasma glycoproteins. In the present study a recombinantly engineered form of the fucose binding lectin Aleuria aurantia (AAL) consisting of a single binding site for fucose (S2), was used to construct a reverse lectin ELISA method. Microtiter plates coated with the S2 lectin were used to capture glycoproteins from plasma samples followed by antibody detection of S2-bound fucosylated alpha 1-acid glycoprotein (S2-bound AGP). The method was used to compare the level of S2-bound AGP in serum samples from a small cohort of patients with hepatitis, cirrhosis or HCC. Using the reverse S2 lectin ELISA it was shown that the levels of S2-bound AGP was significantly higher in HCC patients compared to non-cancer patients and that there was also a significant elevation of S2-bound AGP in HCC patients compared to cirrhosis patients. There was no correlation between the level of S2-bound AGP and total AGP concentration. The performance of S2-bound AGP in differentiating HCC from cirrhosis samples or hepatitis samples were compared to other markers. A combination of S2-bound AGP, alpha-fetoprotein and AGP concentration showed performances giving area under receiver operating curves of 0.87 and 0.95 respectively.	[Astrom, Eva; Pahlsson, Peter] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Stal, Per; Zenlander, Robin; Edenvik, Pia] Karolinska Univ Hosp, Karolinska Inst, Div Gastroenterol & Hepatol, Dept Med, Stockholm, Sweden; [Alexandersson, Catharina; Haglund, Mats] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden; [Ryden, Ingvar] Kalmar Cty Hosp, Dept Clin Chem, Kalmar, Sweden	Linkoping University; Karolinska Institutet; Karolinska University Hospital	Astrom, E (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	eva.i.astrom@liu.se	Stål, Per/J-2154-2019	Stål, Per/0000-0003-2915-1964; Astrom, Eva/0000-0002-3258-4042	Stockholm County Council [20140329, 20150403]; Swedish Society of Medicine, Gastroenterology Fund [SLS 505601]; Ruth and Richard Julins Foundation [40661, 45300]; Uppsala Bio, Bio-X; Health Research Council of Southeast of Sweden [FORSS-389021]	Stockholm County Council(Stockholm County Council); Swedish Society of Medicine, Gastroenterology Fund; Ruth and Richard Julins Foundation; Uppsala Bio, Bio-X; Health Research Council of Southeast of Sweden	PE and PS obtained funding from Stockholm County Council ALF projects 20140329 and 20150403 (http://forskningsstod.vmi.se/Ansokan/start.asp), the Swedish Society of Medicine, Gastroenterology Fund SLS 505601 (http://www.sls.se/) and Ruth and Richard Julins Foundation 40661 and 45300, (https://www.wallenberg.com/rrj/) PP obtained funding from Uppsala Bio, Bio-X (http://www.bio.x.nu/ and the Health Research Council of Southeast of Sweden, FORSS-389021 (https://www.fou.nu/is/forss/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM R, 1991, J IMMUNOL METHODS, V144, P77, DOI 10.1016/0022-1759(91)90233-6; Ahn YH, 2013, ANALYST, V138, P6454, DOI 10.1039/c3an01126g; Ahn YH, 2012, ANAL BIOANAL CHEM, V402, P2101, DOI 10.1007/s00216-011-5646-3; Asao T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/834790; Asazawa H, 2015, CLIN CHEM LAB MED, V53, P95, DOI 10.1515/cclm-2014-0427; Bachtiar Indra, 2010, BMC Res Notes, V3, P319, DOI 10.1186/1756-0500-3-319; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Comunale MA, 2013, PROTEOM CLIN APPL, V7, P690, DOI 10.1002/prca.201200125; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c; DEGRAAF TW, 1993, J EXP MED, V177, P657, DOI 10.1084/jem.177.3.657; Ertle JM, 2013, DIGESTION, V87, P121, DOI 10.1159/000346080; Kuzmanov U, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-31; Marrero JA, 2006, CURR OPIN GASTROEN, V22, P248, DOI 10.1097/01.mog.0000218961.86182.8c; Mehta A, 2008, DIS MARKERS, V25, P259, DOI 10.1155/2008/264594; Naitoh A, 1999, J GASTROEN HEPATOL, V14, P436, DOI 10.1046/j.1440-1746.1999.01882.x; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; Olausson J, 2011, GLYCOBIOLOGY, V21, P34, DOI 10.1093/glycob/cwq129; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Sarbah SA, 2004, DIGEST DIS SCI, V49, P850, DOI 10.1023/B:DDAS.0000030098.75759.32; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Tanabe K, 2008, BIOCHEM BIOPH RES CO, V374, P219, DOI 10.1016/j.bbrc.2008.06.124; Tanabe K, 2016, J PROTEOME RES, V15, P2935, DOI 10.1021/acs.jproteome.5b01145; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Wu J, 2014, J PROTEOME RES, V13, P2197, DOI 10.1021/pr401061c; Zhu JH, 2014, J PROTEOME RES, V13, P2986, DOI 10.1021/pr500128t	27	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173897	10.1371/journal.pone.0173897	http://dx.doi.org/10.1371/journal.pone.0173897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296934	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700075
J	Goede, SL; Rabeneck, L; van Ballegooijen, M; Zauber, AG; Paszat, LF; Hoch, JS; Yong, JHE; Kroep, S; Tinmouth, J; Lansdorp-Vogelaar, I				Goede, S. Lucas; Rabeneck, Linda; van Ballegooijen, Marjolein; Zauber, Ann G.; Paszat, Lawrence F.; Hoch, Jeffrey S.; Yong, Jean H. E.; Kroep, Sonja; Tinmouth, Jill; Lansdorp-Vogelaar, Iris			Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening	PLOS ONE			English	Article							COLONOSCOPY; POPULATION; GUIDELINES; POLYP; COLON; PREVENTION; MORTALITY; US	Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50-74 years to the more sensitive, but also less specific fecal immunochemical test (FIT). The aim of this study is to estimate whether the additional benefits of FIT screening compared to gFOBT outweigh the additional costs and harms. Methods We used microsimulation modeling to estimate quality adjusted life years (QALYs) gained and costs of gFOBT and FIT, compared to no screening, in a cohort of screening participants. We compared strategies with various age ranges, screening intervals, and cut-off levels for FIT. Cost-efficient strategies were determined for various levels of available colonoscopy capacity. Results Compared to no screening, biennial gFOBT screening between age 50-74 years provided 20 QALYs at a cost of CAN$200,900 per 1,000 participants, and required 17 colonoscopies per 1,000 participants per year. FIT screening was more effective and less costly. For the same level of colonoscopy requirement, biennial FIT (with a high cut-off level of 200 ng Hb/ml) between age 50-74 years provided 11 extra QALYs gained while saving CAN$ 333,300 per 1000 participants, compared to gFOBT. Without restrictions in colonoscopy capacity, FIT (with a low cut-off level of 50 ng Hb/ml) every year between age 45-80 years was the most cost-effective strategy providing 27 extra QALYs gained per 1000 participants, while saving CAN$448,300. Interpretation Compared to gFOBT screening, switching to FIT at a high cut-off level could increase the health benefits of a CRC screening program without considerably increasing colonoscopy demand.	[Goede, S. Lucas; van Ballegooijen, Marjolein; Kroep, Sonja; Lansdorp-Vogelaar, Iris] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Rabeneck, Linda] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Rabeneck, Linda; Paszat, Lawrence F.; Hoch, Jeffrey S.; Tinmouth, Jill] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Rabeneck, Linda] Univ Toronto, Dept Med, Toronto, ON, Canada; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Hoch, Jeffrey S.; Yong, Jean H. E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Excellence Econ Anal Res, Toronto, ON, Canada; [Tinmouth, Jill] Sunnybrook Hlth Sci Ctr, Div Gastroenterol, Dept Med, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; Cancer Care Ontario; University of Toronto; University of Toronto; Memorial Sloan Kettering Cancer Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Lansdorp-Vogelaar, I (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl	Hoch, Jeffrey/O-3406-2017	Hoch, Jeffrey/0000-0002-4880-4281; Tinmouth, Jill/0000-0002-0264-2176	Canadian Institutes of Health Research [CST-85478]; National Cancer Institute at the National Institutes of Health [U01-CA-097426, U01-CA-115953, U01-CA-152959]; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); NATIONAL CANCER INSTITUTE [U01CA199335, P30CA008748] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This publication is supported by a grant from the Canadian Institutes of Health Research (grant number CST-85478). In addition, this publication was made possible by the National Cancer Institute at the National Institutes of Health, which supported part of the development of the MISCAN-Colon model through the Cancer Intervention and Surveillance Modeling Network (grant numbers U01-CA-097426, U01-CA-115953, and U01-CA-152959). This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC).	Altobelli E, 2014, PREV MED, V62, P132, DOI 10.1016/j.ypmed.2014.02.010; [Anonymous], 2013, LIF TABL CAN PROV TE; [Anonymous], 2003, STAT SOFTW VERS 5 3; Benson VS, 2008, INT J CANCER, V122, P1357, DOI 10.1002/ijc.23273; Cancer Care Ontario, 2012, COL CANC CHECK 2010; Colorectal Cancer Screening, 2001, CMAJ, V165, P206; Djalalov S, 2014, MED DECIS MAKING, V34, P809, DOI 10.1177/0272989X14536779; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Halloran SP, 2012, ENDOSCOPY, V44, pSE65, DOI 10.1055/s-0032-1309791; Hassan C, 2011, ENDOSCOPY, V43, P780, DOI 10.1055/s-0030-1256409; Heitman SJ, 2005, CAN MED ASSOC J, V173, P877, DOI 10.1503/cmaj.050553; Heitman SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000370; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Ho C, 2008, 114 CAN AG DRUGS TEC; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Hol L, 2009, BRIT J CANCER, V100, P1103, DOI 10.1038/sj.bjc.6604961; Holme O, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009259.pub2; Jeong KE, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-20; Lansdorp-Vogelaar I, 2010, ANN INTERN MED, V153, P368, DOI 10.7326/0003-4819-153-6-201009210-00004; Lansdorp-Vogelaar I, 2009, CANCER-AM CANCER SOC, V115, P2410, DOI 10.1002/cncr.24256; Lejeune C, 2014, DIGEST LIVER DIS, V46, P76, DOI 10.1016/j.dld.2013.07.018; Lejeune C, 2010, INT J TECHNOL ASSESS, V26, P40, DOI 10.1017/S026646230999078X; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Loeve F, 2004, INT J CANCER, V111, P633, DOI 10.1002/ijc.20277; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Loeve F, 1998, NO1CN55186 ER U DEP; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; MORSON BC, 1962, JAMA-J AM MED ASSOC, V179, P316, DOI 10.1001/jama.1962.03050050006002; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; Orpana Heather M, 2009, Health Rep, V20, P29; Rabeneck L, 2014, CANCER EPIDEM BIOMAR, V23, P508, DOI 10.1158/1055-9965.EPI-13-0956; Rabeneck L, 2012, CAN J GASTROENTEROL, V26, P131, DOI 10.1155/2012/486328; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Sharp L, 2012, BRIT J CANCER, V106, P805, DOI 10.1038/bjc.2011.580; Siegel JE, 1997, PHARMACOECONOMICS, V11, P159, DOI 10.2165/00019053-199711020-00005; Statistics Canada, 2011, TABL 103 0550 NEW CA; Telford JJ, 2010, CAN MED ASSOC J, V182, P1307, DOI 10.1503/cmaj.090845; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; van Roon AH, 2010, GASTROENTEROLOGY, V138, pS189; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Ventura L, 2014, DIGEST LIVER DIS, V46, P82, DOI 10.1016/j.dld.2013.07.017; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Wilschut JA, 2011, JNCI-J NATL CANCER I, V103, P1741, DOI 10.1093/jnci/djr385; Zauber AG, 2007, COST EFFECTIVENESS D; Zorzi M, 2007, EPIDEMIOL PREV, V31, P49; Zorzi M, 2015, GUT, V64, P1007, DOI 10.1136/gutjnl-2014-308970	47	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172864	10.1371/journal.pone.0172864	http://dx.doi.org/10.1371/journal.pone.0172864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296927	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700016
J	King, M; Lodwick, R; Jones, R; Whitaker, H; Petersen, I				King, Michael; Lodwick, Rebecca; Jones, Rebecca; Whitaker, Heather; Petersen, Irene			Death following partner bereavement: A self-controlled case series analysis	PLOS ONE			English	Article							MORTALITY; HEALTH; ADULT	Background There is mixed evidence that older people bereaved of a spouse or partner are at risk of adverse outcomes. The main difficulty is to take account of other explanatory factors. We tested for an association between a patient's death and the timing of any bereavement of a cohabitee. Method Self-controlled case series study in which each case serves as his or her own control and which thereby accounts for all fixed measurable and unmeasurable confounders. We used the Health Improvement Network (THIN) primary care database to identify patients who died aged 50-99 years during the period 2003 to 2014. We used the household identifier in the database to determine whether they had an opposite sex cohabitee at the start of the observation period. Results 38,773 men and 23,396 women who had died and who had a cohabitee at the start of the observation period, were identified and included in male and female cohorts respectively. A higher risk of death was found in the 24 months after the death of the cohabitee than in the time classified as unexposed. The greatest risk was during the first 3 months after the death of the cohabitee (age-adjusted incidence rate ratio [IRR] 1.63, 95% CI 1.45-1.83 in the male cohort, and IRR 1.70, 95% CI 1.52-1.90 in the female cohort). Conclusion Risk of death in men or women was significantly higher after the death of a cohabitee and this was greatest in the first three months of bereavement. We need more evidence on the effectiveness of interventions to reduce this increased mortality.	[King, Michael; Jones, Rebecca] UCL, Div Psychiat, London, England; [Lodwick, Rebecca; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England; [Whitaker, Heather] Open Univ, Dept Math & Stat, Milton Keynes, Bucks, England	University of London; University College London; University of London; University College London; Open University - UK	King, M (corresponding author), UCL, Div Psychiat, London, England.	michael.king@ucl.ac.uk	Whitaker, Heather Joy/O-4995-2017	Whitaker, Heather Joy/0000-0001-5833-1863				Booth N, 1994, Health Libr Rev, V11, P177; CHARLTON R, 1995, BRIT J GEN PRACT, V45, P427; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Farrington CP, 2006, J R STAT SOC C-APPL, V55, P553, DOI 10.1111/j.1467-9876.2006.00554.x; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; King M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052561; PARKES CM, 1969, BMJ-BRIT MED J, V1, P740, DOI 10.1136/bmj.1.5646.740; Parkes CM, 1998, BRIT MED J, V316, P856, DOI 10.1136/bmj.316.7134.856; Petersen I, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4515; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schorr L, 2016, ANN EPIDEMIOL, V26, P115, DOI 10.1016/j.annepidem.2015.12.008; Shah SM, 2013, CIRCULATION; Shah SM, 2013, AM J PUBLIC HEALTH, V103, P1140, DOI 10.2105/AJPH.2012.301050; Shah SM, 2012, AM J EPIDEMIOL, V176, P689, DOI 10.1093/aje/kws162; Shor E, 2012, DEMOGRAPHY, V49, P575, DOI 10.1007/s13524-012-0096-x; Simeonova E, 2013, J HEALTH ECON, V32, P33, DOI 10.1016/j.jhealeco.2012.10.010; Stahl ST, 2016, PSYCHOSOM MED, V78, P697, DOI 10.1097/PSY.0000000000000317; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Waller A, 2015, PALLIATIVE MED; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Woof WR, 1997, BRIT J GEN PRACT, V47, P443; Ytterstad E, 2015, EPIDEMIOLOGY, V26, P289, DOI 10.1097/EDE.0000000000000266	23	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173870	10.1371/journal.pone.0173870	http://dx.doi.org/10.1371/journal.pone.0173870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296949	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000396311700073
J	Lau, CI; Lin, CC; Chen, HJ; Wang, HC; Chen, WH; Liang, JA				Lau, Chi-Ieong; Lin, Che-Chen; Chen, Hsuan-Ju; Wang, Han-Cheng; Chen, Wei-Hung; Liang, Ji-An			Increased risk of essential tremor in migraine: A population-based retrospective cohort study	PLOS ONE			English	Article							PARKINSONISM; IMPAIRMENT; PREVALENCE	Purpose To examine the long-term risk of essential tremor (ET) in migraine. Methods Using population-based administrative data from a subset of the National Health Insurance Research Database (NHIRD) of Taiwan, we identified 22,696 newly diagnosed migraineurs (mean age 44.5 years) and a matched migraine-free cohort of 90,784 individuals in the period 2000-2008. Multivariable Cox proportional hazards regression analysis was conducted for assessing the ET risk for the migraine cohort compared to the migraine-free cohort. Results After adjusting for covariates, the migraine cohort had a 1.83-fold increased risk (95% CI 1.50-2.23) of subsequent ET in comparison to the migraine-free cohort (8.97 vs. 4.81 per 10,000 person-years). In the subgroup analysis, patients with migraine were associated with higher risks of ET, regardless of gender, age or the existence of comorbidities. Conclusion Our findings demonstrated an association between migraine and ET, suggesting a possible shared pathophysiology underpinning both disorders.	[Lau, Chi-Ieong; Wang, Han-Cheng; Chen, Wei-Hung] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan; [Lau, Chi-Ieong] Univ Oxford, Div Clin Neurol, Nuffield Dept Clin Neurosci, Oxford, England; [Lau, Chi-Ieong] UCL, Inst Cognit Neurosci, Queen Sq, London, England; [Lau, Chi-Ieong] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan; [Lin, Che-Chen; Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Che-Chen] Taichung Vet Gen Hosp, Healthcare Serv Res Ctr, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Wang, Han-Cheng; Chen, Wei-Hung] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Wang, Han-Cheng] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Liang, Ji-An] China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; University of Oxford; University of London; University College London; Fu Jen Catholic University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; Taipei Medical University; National Taiwan University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liang, JA (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan.; Liang, JA (corresponding author), China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan.	d4615@mail.cmuh.org.tw		Liang, Ji-An/0000-0002-4170-7155	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Barbanti P, 2002, CEPHALALGIA, V22, P2, DOI 10.1046/j.1468-2982.2002.00313.x; Barbanti P, 2010, CEPHALALGIA, V30, P686, DOI 10.1177/0333102409352253; Bermejo-Pareja F, 2011, NAT REV NEUROL, V7, P273, DOI 10.1038/nrneurol.2011.44; BIARY N, 1990, J NEUROL NEUROSUR PS, V53, P1060, DOI 10.1136/jnnp.53.12.1060; CAPELLA D, 1988, BRIT MED J, V297, P722, DOI 10.1136/bmj.297.6650.722; Deuschl G, 2000, NEUROLOGY, V54, pS14; Duval C, 2006, HEADACHE, V46, P1005, DOI 10.1111/j.1526-4610.2006.00471.x; Fekete R, 2011, MOVEMENT DISORD, V26, P391, DOI 10.1002/mds.23512; Fenstermacher N, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d583; Gamboa J, 1998, J VOICE, V12, P444, DOI 10.1016/S0892-1997(98)80053-2; Hu YQ, 2014, CEPHALALGIA, V34, P1142, DOI 10.1177/0333102414531153; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jimenez-Jimenez FJ, 2013, ACTA NEUROL SCAND, V128, P359, DOI 10.1111/ane.12148; Jimenez-Jimenez FJ, 2010, EUR J NEUROL, V17, P152, DOI 10.1111/j.1468-1331.2009.02784.x; JIMENEZJIMENEZ FJ, 1995, PRESSE MED, V24, P1152; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Kuiper M, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D8P55MKX; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Louis ED, 2016, PARKINSONISM RELAT D, V22, pS115, DOI 10.1016/j.parkreldis.2015.08.034; Louis ED, 2014, CURR OPIN NEUROL, V27, P461, DOI 10.1097/WCO.0000000000000115; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Morgan JC, 2005, LANCET NEUROL, V4, P866, DOI 10.1016/S1474-4422(05)70250-7; Mulleners WM, 2015, CEPHALALGIA, V35, P51, DOI 10.1177/0333102414534325; Raethjen J, 2001, J NEUROL NEUROSUR PS, V70, P78, DOI 10.1136/jnnp.70.1.78; Sandor PS, 2001, ANN NEUROL, V49, P668, DOI 10.1002/ana.1019; Scher AI, 2014, NEUROLOGY, V83, P1246, DOI 10.1212/WNL.0000000000000840; Silberstein SD, 2008, NAT CLIN PRACT NEURO, V4, P482, DOI 10.1038/ncpneuro0861; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Troster AI, 2002, EUR J NEUROL, V9, P143; Welch KMA, 1998, NEUROLOGY, V51, P1465, DOI 10.1212/WNL.51.5.1465	33	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173586	10.1371/journal.pone.0173586	http://dx.doi.org/10.1371/journal.pone.0173586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288163	Green Published, gold, Green Submitted			2022-12-26	WOS:000396092400020
J	Huang, SC; Zhang, LH; Rehman, MU; Iqbal, MK; Lan, YF; Mehmood, K; Zhang, H; Qiu, G; Nabi, F; Yao, WY; Wang, M; Li, JK				Huang, Shucheng; Zhang, Lihong; Rehman, Mujeeb Ur; Iqbal, Muhammad Kashif; Lan, Yanfang; Mehmood, Khalid; Zhang, Hui; Qiu, Gang; Nabi, Fazul; Yao, Wangyuan; Wang, Meng; Li, Jiakui			High altitude hypoxia as a factor that promotes tibial growth plate development in broiler chickens	PLOS ONE			English	Article							TIBETAN CHICKENS; BONE-DEVELOPMENT; DYSCHONDROPLASIA; EXPRESSION; ANGIOGENESIS; ADAPTATIONS; HEMOGLOBIN; CARTILAGE; EMBRYOS; OXYGEN	Tibial dyschondroplasia (TD) is one of the most common problems in the poultry industry and leads to lameness by affecting the proximal growth plate of the tibia. However, due to the unique environmental and geographical conditions of Tibet, no case of TD has been reported in Tibetan chickens (TBCs). The present study was designed to investigate the effect of high altitude hypoxia on blood parameters and tibial growth plate development in chickens using the complete blood count, morphology, and histological examination. The results of this study showed an undesirable impact on the overall performance, body weight, and mortality of Arbor Acres chickens (AACs) exposed to a high altitude hypoxic environment. However, AACs raised under hypoxic conditions showed an elevated number of red blood cells (RBCs) and an increase in hemoglobin and hematocrit values on day 14 compared to the hypobaric normoxia group. Notably, the morphology and histology analyses showed that the size of tibial growth plates in AACs was enlarged and that the blood vessel density was also higher after exposure to the hypoxic environment for 14 days, while no such change was observed in TBCs. Altogether, our results revealed that the hypoxic environment has a potentially new role in increasing the blood vessel density of proximal tibial growth plates to strengthen and enhance the size of the growth plates, which may provide new insights for the therapeutic manipulation of hypoxia in poultry TD.	[Huang, Shucheng; Zhang, Lihong; Rehman, Mujeeb Ur; Iqbal, Muhammad Kashif; Lan, Yanfang; Mehmood, Khalid; Zhang, Hui; Qiu, Gang; Nabi, Fazul; Yao, Wangyuan; Wang, Meng; Li, Jiakui] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Qiu, Gang; Li, Jiakui] Tibet Agr & Anim Husb Coll, Lab Detect & Monitoring Highland Anim Dis, Linzhi Tibet, Peoples R China; [Nabi, Fazul] Lasbela Univ Agr Water & Marine Sci Uthal, Fac Vet & Anim Sci, Balochistan, Pakistan	Huazhong Agricultural University; Tibet Agriculture & Animal Husbandry University	Li, JK (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.; Li, JK (corresponding author), Tibet Agr & Anim Husb Coll, Lab Detect & Monitoring Highland Anim Dis, Linzhi Tibet, Peoples R China.	lijk210@sina.com	黄, 淑成/GPX-4389-2022; Mehmood, Khalid/Y-5882-2019; Huang 黄淑成, Shu-cheng/GOV-6692-2022; Nabi, Fazul/A-7871-2017; Rehman, Mujeeb/L-3379-2019; Li, Jiakui/HDN-1674-2022; Qiu, Gang/F-5587-2015	黄, 淑成/0000-0003-3163-8616; Mehmood, Khalid/0000-0003-4720-8792; Huang 黄淑成, Shu-cheng/0000-0003-3163-8616; Nabi, Fazul/0000-0002-3219-4124; Rehman, Mujeeb/0000-0002-5078-5657; Qiu, Gang/0000-0002-5336-5404; Li, Jiakui/0000-0002-6065-6648; Yao, Wangyuan/0000-0001-9428-9973	National Natural Science Foundation of China [31460682, C180802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by The National Natural Science Foundation of China (No. 31460682). Funds received by Jiakui Li.; The study was supported by the National Natural Science Foundation of China (No. C180802).	Ahmadipour B, 2015, J ETHNOPHARMACOL, V159, P49, DOI 10.1016/j.jep.2014.10.043; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Befani CD, 2013, J MOL MED, V91, P771, DOI 10.1007/s00109-013-1030-4; Bentovim L, 2012, DEVELOPMENT, V139, P4473, DOI 10.1242/dev.083881; Brown EA, 2012, BIOL REV, V87, P838, DOI 10.1111/j.1469-185X.2012.00227.x; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; CAREY C, 1993, RESP PHYSIOL, V93, P151, DOI 10.1016/0034-5687(93)90002-R; Chen JC, 2015, INT J ONCOL, V46, P2629, DOI 10.3892/ijo.2015.2946; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; DEGRAUW TJ, 1986, BIOL NEONATE, V49, P85, DOI 10.1159/000242515; Gao JF, 2013, AVIAN PATHOL, V42, P416, DOI 10.1080/03079457.2013.821568; Geng X, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12965; Giatromanolaki A, 2010, ANTICANCER RES, V30, P2831; Gonzalez-Alonso J, 2002, CIRC RES, V91, P1046, DOI 10.1161/01.RES.0000044939.73286.E2; Gou X, 2007, COMP BIOCHEM PHYS B, V147, P147, DOI 10.1016/j.cbpb.2006.11.031; Hao R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098868; Herzog A, 2011, AM J PHYSIOL-REG I, V301, pR140, DOI 10.1152/ajpregu.00134.2011; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Jia CL, 2016, POULTRY SCI, V95, P1660, DOI 10.3382/ps/pew048; Khajali F, 2016, J ANIM PHYSIOL AN N, V100, P3, DOI 10.1111/jpn.12315; Kohl ZF, 2015, COMP BIOCHEM PHYS A, V190, P1, DOI 10.1016/j.cbpa.2015.07.023; Lee S, 2016, TISSUE ENG; Li L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07166; Li M, 2009, SCI CHINA SER C, V52, P284, DOI 10.1007/s11427-009-0005-8; Liu C, 2009, POULTRY SCI, V88, P2689, DOI 10.3382/ps.2009-00311; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Nabi F, 2016, AVIAN PATHOL, V45, P187, DOI 10.1080/03079457.2016.1141170; Ozkan S, 2010, POULTRY SCI, V89, P974, DOI 10.3382/ps.2009-00293; Pines M, 2005, WORLD POULTRY SCI J, V61, P285, DOI 10.1079/WPS200454; PINES M, 1991, POULTRY SCI, V70, P1806, DOI 10.3382/ps.0701806; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rath NC, 2007, POULTRY SCI, V86, P2390, DOI 10.3382/ps.2007-00219; Rath NC, 2005, J COMP PATHOL, V133, P41, DOI 10.1016/j.jcpa.2005.01.005; Rath NC, 2004, POULTRY SCI, V83, P266, DOI 10.1093/ps/83.2.266; Rostami A, 2016, J ANIM PHYSL AN N, V30, P127; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shahzad M, 2014, AVIAN DIS, V58, P468, DOI 10.1637/10781-012614-ResNote.1; Shim MY, 2012, POULTRY SCI, V91, P62, DOI 10.3382/ps.2011-01599; Su Y, 2016, J GENET, V95, P675, DOI 10.1007/s12041-016-0684-4; Sun HL, 2012, J BIOL CHEM; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P572, DOI 10.1302/0301-620X.45B3.572; VISSCHEDIJK AHJ, 1985, J APPL PHYSIOL, V58, P416, DOI 10.1152/jappl.1985.58.2.416; WALSER MM, 1982, AVIAN DIS, V26, P265, DOI 10.2307/1590095; Wang Y, 2007, ANN NY ACAD SCI, V1117, P1, DOI 10.1196/annals.1402.049; Westerterp KR, 2006, EUR J GASTROEN HEPAT, V18, P1, DOI 10.1097/00042737-200601000-00001; Woods AL, 2016, INT J SPORT NUTR EXE, V24, P1; Yang YZ, 2011, J ANIM VET ADV, V10, P2172, DOI 10.3923/javaa.2011.2172.2175; Yang YZ, 2011, CHINA ANIMAL HUSBAND, V38, P84; Zhang H, 2007, POULTRY SCI, V86, P1384, DOI 10.1093/ps/86.7.1384; Zhang Hao, 2006, Journal of China Agricultural University, V11, P35; Zhang LF, 2007, ANIMAL, V1, P1467, DOI 10.1017/S1751731107000687; Zhang Q, 2016, GENOME BIOL EVOL, V8, P765, DOI 10.1093/gbe/evw032; Zhao J, 2011, INT ORTHOP, V35, P925, DOI 10.1007/s00264-010-1157-7	54	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173698	10.1371/journal.pone.0173698	http://dx.doi.org/10.1371/journal.pone.0173698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282429	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800070
J	Lee, IH; Jung, YJ; Cho, YG; Nou, IS; Huq, MA; Nogoy, FM; Kang, KK				Lee, In Hye; Jung, Yu-Jin; Cho, Yong Gu; Nou, Ill Sup; Huq, Md. Amdadul; Nogoy, Franz Marielle; Kang, Kwon-Kyoo			SP-LL-37, human antimicrobial peptide, enhances disease resistance in transgenic rice	PLOS ONE			English	Article							CECROPIN-B; EXPRESSION; GENE; IDENTIFICATION; TOBACCO	Human LL-37 is a multifunctional antimicrobial peptide of cathelicidin family. It has been shown in recent studies that it can serve as a host's defense against influenza A virus. We now demonstrate in this study how signal peptide LL-37 (SP-LL-37) can be used in rice resistance against bacterial leaf blight and blast. We synthesized LL-37 peptide and sub-cloned in a recombinant pPZP vector with pGD1 as promoter. SP-LL-37 was introduced into rice plants by Agrobacterium mediated transformation. Stable expression of SP-LL-37 in transgenic rice plants was confirmed by RT-PCR and ELISA analyses. Subcellular localization of SP-LL-37-GFP fusion protein showed evidently in intercellular space. Our data on testing for resistance to bacterial leaf blight and blast revealed that the transgenic lines are highly resistant compared to its wildtype. Our results suggest that LL-37 can be further explored to improve wide-spectrum resistance to biotic stress in rice.	[Lee, In Hye; Jung, Yu-Jin; Huq, Md. Amdadul; Kang, Kwon-Kyoo] Hankyong Natl Univ, Dept Hort Life Sci, Ansung, South Korea; [Jung, Yu-Jin; Huq, Md. Amdadul; Kang, Kwon-Kyoo] Hankyong Natl Univ, Inst Genet Engn, Ansung, South Korea; [Cho, Yong Gu; Nogoy, Franz Marielle] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea; [Nou, Ill Sup] Sunchon Natl Univ, Dept Hort, Sunchon, South Korea	Hankyong National University; Hankyong National University; Chungbuk National University; Sunchon National University	Kang, KK (corresponding author), Hankyong Natl Univ, Dept Hort Life Sci, Ansung, South Korea.; Kang, KK (corresponding author), Hankyong Natl Univ, Inst Genet Engn, Ansung, South Korea.	kykang@hknu.ac.kr	Cho, Yong-Gu/AAV-1904-2021		"Next-Generation BioGreen 21 Program" Rural Development Administration, Republic of Korea [PJ01124501]	"Next-Generation BioGreen 21 Program" Rural Development Administration, Republic of Korea	This work was carried out with the support of "the Next-Generation BioGreen 21 Program (Project No. PJ01124501)" Rural Development Administration, Republic of Korea.	Abdula S. E., 2013, Plant Breeding and Biotechnology, V1, P33, DOI 10.9787/PBB.2013.1.1.033; Alan AR, 2004, PLANT CELL REP, V22, P388, DOI 10.1007/s00299-003-0702-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho YG, 2007, CROP SCI, V47, P2403, DOI 10.2135/cropsci2006.08.0509; Coca M, 2006, PLANTA, V223, P392, DOI 10.1007/s00425-005-0069-z; Colinas J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003670; Daoubi M, 2005, J AGR FOOD CHEM, V53, P6035, DOI 10.1021/jf050600n; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; FLORACK D, 1995, TRANSGENIC RES, V4, P132, DOI 10.1007/BF01969415; HIGHTOWER R, 1994, PLANT CELL REP, V13, P295, DOI 10.1007/BF00233324; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Jung YJ, 2013, BIOTECHNOL BIOPROC E, V18, P615, DOI 10.1007/s12257-013-0392-3; Jung YJ, 2012, PLANT BIOTECHNOL REP, V6, P39, DOI 10.1007/s11816-011-0193-0; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Mee Park Jeong, 2005, The Plant Pathology Journal, V21, P99; MILLS D, 1994, PLANT SCI, V104, P17, DOI 10.1016/0168-9452(94)90186-4; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Okamoto M, 1998, PLANT CELL PHYSIOL, V39, P57, DOI 10.1093/oxfordjournals.pcp.a029289; Owens LD, 1997, MOL PLANT MICROBE IN, V10, P525, DOI 10.1094/MPMI.1997.10.4.525; Pan QH, 1996, PHYTOPATHOLOGY, V86, P1071, DOI 10.1094/Phyto-86-1071; Park S, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-36; Rahnamaeian M, 2011, PLANT SIGNAL BEHAV, V6, P1325, DOI 10.4161/psb.6.9.16319; Wang XH, 2015, APPL BIOCHEM BIOTECH, V175, P996, DOI 10.1007/s12010-014-1322-3; Wu TQ, 2013, EUR J PLANT PATHOL, V137, P93, DOI 10.1007/s10658-013-0219-2	24	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172936	10.1371/journal.pone.0172936	http://dx.doi.org/10.1371/journal.pone.0172936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282452	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800014
J	Pathmanathan, I; Dokubo, EK; Shiraishi, RW; Agolory, SG; Auld, AF; Onotu, D; Odafe, S; Dalhatu, I; Abiri, O; Debem, HC; Bashorun, A; Ellerbrock, T				Pathmanathan, Ishani; Dokubo, E. Kainne; Shiraishi, Ray W.; Agolory, Simon G.; Auld, Andrew F.; Onotu, Dennis; Odafe, Solomon; Dalhatu, Ibrahim; Abiri, Oseni; Debem, Henry C.; Bashorun, Adebobola; Ellerbrock, Tedd			Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012	PLOS ONE			English	Article							SOUTH-AFRICA; IMMUNE RECONSTITUTION; TREATMENT OUTCOMES; RISK-FACTORS; PREVENTION; COHORT	Background Nigeria had the most AIDS-related deaths worldwide in 2014 (170,000), and 46% were associated with tuberculosis (TB). Although treatment of people living with HIV (PLHIV) with antiretroviral therapy (ART) reduces TB-associated morbidity and mortality, incident TB can occur while on ART. We estimated incidence and characterized factors associated with TB after ART initiation in Nigeria. Methods We analyzed retrospective cohort data from a nationally representative sample of adult patients on ART. Data were abstracted from 3,496 patient records, and analyses were weighted and controlled for a complex survey design. We performed domain analyses on patients without documented TB disease and used a Cox proportional hazard model to assess factors associated with TB incidence after ART. Results At ART initiation, 3,350 patients (95.8%) were not receiving TB treatment. TB incidence after ART initiation was 0.57 per 100 person-years, and significantly higher for patients with CD4<50/mu L (adjusted hazard ratio [AHR]: 4.2, 95% confidence interval [CI]: 1.4-12.7) compared with CD4 >= 200/mu L. Patients with suspected but untreated TB at ART initiation and those with a history of prior TB were more likely to develop incident TB (AHR: 12.2, 95% CI: 4.5-33.5 and AHR: 17.6, 95% CI: 3.5-87.9, respectively). Conclusion Incidence of TB among PLHIV after ART initiation was low, and predicted by advanced HIV, prior TB, and suspected but untreated TB. Study results suggest a need for improved TB screening and diagnosis, particularly among high-risk PLHIV initiating ART, and reinforce the benefit of early ART and other TB prevention efforts.	[Pathmanathan, Ishani; Dokubo, E. Kainne; Shiraishi, Ray W.; Agolory, Simon G.; Auld, Andrew F.; Ellerbrock, Tedd] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA; [Pathmanathan, Ishani] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Onotu, Dennis; Odafe, Solomon; Dalhatu, Ibrahim; Debem, Henry C.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Abiri, Oseni] Univ S Alabama, Dept Nursing, Mobile, AL USA; [Bashorun, Adebobola] Fed Minist Hlth, Div HIV AIDS, Abuja, Nigeria	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of South Alabama	Pathmanathan, I (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA.; Pathmanathan, I (corresponding author), US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	ydi6@cdc.gov	Odafe, Solomon/AAJ-2390-2020; Agolory, Simon/AIF-4664-2022	Agolory, Simon/0000-0001-5023-5754; Dokubo, Emily Kainne/0000-0002-1499-0151; Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	The study and writing of this report has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC).	Akanbi MO, 2013, AIDS RES HUM RETROV, V29, P931, DOI [10.1089/aid.2012.0231, 10.1089/AID.2012.0231]; [Anonymous], 2015, AIDS CHANG EV; Auld AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054665; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dalhatu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165528; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Dokubo KE, 2014, MMWR-MORBID MORTAL W, V63, P1172; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Federal Republic of Nigeria, 2012, 1 NAT TB PREV SURV 2; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Howard AA, 2012, JAIDS-J ACQ IMM DEF, V60, pS136, DOI 10.1097/QAI.0b013e31825cfe8e; Kufa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111209; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Liu EJ, 2015, AIDS, V29, P1391, DOI 10.1097/QAD.0000000000000705; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Naidoo K, 2013, CURR OPIN INFECT DIS, V26, P35, DOI 10.1097/QCO.0b013e32835ba8f9; National Agency for the Control of AIDS, 2015, FED REP NIG GLOB AID; Nglazi MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-21; Nigeria Federal Ministry of Health, 2008, NAT TUB LEPR CONTR P; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2015, AIDS CHANG EV MDG 6; UNAIDS, 2014, THE GAP REP; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; World Health Organization, 2011, WHO GUID INT TUB CAS; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, GLOB TUB REP 2014; World Health Organization, 2010, WHO PRIOR RES QUEST; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	33	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173309	10.1371/journal.pone.0173309	http://dx.doi.org/10.1371/journal.pone.0173309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282390	Green Published, gold, Green Submitted			2022-12-26	WOS:000396091800028
J	Shinkins, B; Nicholson, BD; Primrose, J; Perera, R; James, T; Pugh, S; Mant, D				Shinkins, Bethany; Nicholson, Brian D.; Primrose, John; Perera, Rafael; James, Timothy; Pugh, Sian; Mant, David			The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; COLON-CANCER; ROC CURVES; FOLLOW-UP; SURVIVAL	Objective To evaluate the diagnostic accuracy of a single CEA (carcinoembryonic antigen) blood test in detecting colorectal cancer recurrence. Background Patients who have undergone curative resection for primary colorectal cancer are typically followed up with scheduled CEA testing for 5 years. Decisions to investigate further (usually by CT imaging) are based on single test results, reflecting international guidelines. Methods A secondary analysis was undertaken of data from the FACS trial (two arms included CEA testing). The composite reference standard applied included CT-CAP imaging, clinical assessment and colonoscopy. Accuracy in detecting recurrence was evaluated in terms of sensitivity, specificity, likelihood ratios, predictive values, time-dependent area under the ROC curves, and operational performance when used prospectively in clinical practice are reported. Results Of 582 patients, 104 (17.9%) developed recurrence during the 5 year follow-up period. Applying the recommended threshold of 5 mu g/L achieves at best 50.0% sensitivity (95% CI: 40.1-59.9%); in prospective use in clinical practice it would lead to 56 missed recurrences (53.8%; 95% CI: 44.2-64.4%) and 89 false alarms (56.7% of 157 patients referred for investigation). Applying a lower threshold of 2.5 mu g/L would reduce the number of missed recurrences to 36.5% (95% CI: 26.5-46.5%) but would increase the false alarms to 84.2% (924/mu 1097 referred). Some patients are more prone to false alarms than others-at the 5 mu g/L threshold, the 89 episodes of unnecessary investigation were clustered in 29 individuals. Conclusion Our results demonstrated very low sensitivity for CEA, bringing to question whether it could ever be used as an independent triage test. It is not feasible to improve the diagnostic performance of a single test result by reducing the recommended action threshold because of the workload and false alarms generated. Current national and international guidelines merit reevaluation and options to improve performance, such as making clinical decisions on the basis of CEA trend, should be further assessed.	[Shinkins, Bethany] Univ Leeds, Acad Unit Hlth Econ, Test Evaluat Grp, Leeds LS2 9JT, W Yorkshire, England; [Nicholson, Brian D.; Perera, Rafael; Mant, David] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX1 2JD, England; [Primrose, John; Pugh, Sian] Univ Southampton, Acad Unit Canc Sci, Southampton SO9 5NH, Hants, England; [James, Timothy] Oxford Univ Hosp NHS Fdn Trust, Oxford, England	University of Leeds; University of Oxford; University of Southampton; Oxford University Hospitals NHS Foundation Trust	Shinkins, B (corresponding author), Univ Leeds, Acad Unit Hlth Econ, Test Evaluat Grp, Leeds LS2 9JT, W Yorkshire, England.	b.shinkins@leeds.ac.uk	Shinkins, Bethany/AAX-4045-2020	Primrose, John/0000-0002-2069-7605; Perera, Rafael/0000-0003-2418-2091; Shinkins, Bethany/0000-0001-5350-1018	UK National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme [99/10/99, 11/136/81]; NIHR Leeds Diagnostic Evidence Co-operative; UK NIHR HTA; MRC [MR/M018423/1] Funding Source: UKRI; Medical Research Council [MR/M018423/1] Funding Source: researchfish; National Institute for Health Research [99/10/99, SPCR-047, 11/136/81] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme; NIHR Leeds Diagnostic Evidence Co-operative; UK NIHR HTA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Both the main FAGS project and this sub study on CEA were funded by the UK National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project numbers 99/10/99 and 11/136/81). Bethany Shinkins is currently supported by the NIHR Leeds Diagnostic Evidence Co-operative. The funding agency (UK NIHR HTA) had no role in: the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; nor decision to submit the manuscript for publication.	CARL J, 1993, SCAND J CLIN LAB INV, V53, P751, DOI 10.3109/00365519309092581; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P778, DOI 10.6004/jnccn.2009.0056; Guthrie JA, 2002, ABDOM IMAGING, V27, P570, DOI 10.1007/s00261-001-0081-0; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hellinger Michael D, 2006, Clin Colon Rectal Surg, V19, P228, DOI 10.1055/s-2006-956445; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Litvak A, 2014, J NATL COMPR CANC NE, V12, P907, DOI 10.6004/jnccn.2014.0085; MINTON JP, 1978, CANCER, V42, P1422, DOI 10.1002/1097-0142(197809)42:3+<1422::AID-CNCR2820420807>3.0.CO;2-1; NICE, 2011, NICE CLIN GUID CG131; Nicholson BD, 2016, JAMA-J AM MED ASSOC, V316, P1310, DOI 10.1001/jama.2016.11212; Nicholson BD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011134.pub2; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shinkins B, 2014, CLIN CHEM, V60, P1572, DOI 10.1373/clinchem.2014.228601; STAAB HJ, 1985, AM J SURG, V149, P198, DOI 10.1016/S0002-9610(85)80064-7; Tan E, 2009, SURG ONCOL, V18, P15, DOI 10.1016/j.suronc.2008.05.008	16	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0171810	10.1371/journal.pone.0171810	http://dx.doi.org/10.1371/journal.pone.0171810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282381	Green Published, gold, Green Accepted			2022-12-26	WOS:000396091800003
J	Xu, F; Xiang, N; Higano, Y				Xu, Feng; Xiang, Nan; Higano, Yoshiro			How to reach haze control targets by air pollutants emission reduction in the Beijing-Tianjin-Hebei region of China?	PLOS ONE			English	Article							POLLUTION; IMPACT; PM2.5	Currently, Haze is one of the greatest environmental problems with serious impacts on human health in China, especially in capital region (Beijing-Tianjin-Hebei region). To alleviate this problem, the Chinese government introduced a National Air Pollution Control Action Plan (NAPCAP) with air pollutants reduction targets by 2017. However, there is doubt whether these targets can be achieved once the plan is implemented. In this work, the effectiveness of NAPCAP is analyzed by developing models of the statistical relationship between PM2.5 concentrations and air pollutant emissions (SO2, NOx, smoke and dust), while taking into account wind and neighboring transfer impacts. The model can also identify ways of calculating the intended emission levels in the Beijing-Tianjin-Hebei area. The results indicate that haze concentration control targets will not be attained by following the NAPCAP, and that the amount of progress needed to meet the targets is unrealistic. A more appropriate approach to reducing air emissions is proposed, which addresses joint regional efforts.	[Xu, Feng] Beijing Univ Chem Technol, Sch Econ & Management, Beijing, Peoples R China; [Xu, Feng] State Adm Cultural Heritage, Key Res Base Cultural Rel Protect Technol & Evalu, Beijing, Peoples R China; [Xiang, Nan] Beijing Univ Technol, Coll Econ & Management, Beijing, Peoples R China; [Xiang, Nan] Beijing Univ Technol, Coll Econ & Management, Res Base Beijing Modern Mfg Dev, Beijing, Peoples R China; [Higano, Yoshiro] Univ Tsukuba, Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Beijing University of Chemical Technology; Beijing University of Technology; Beijing University of Technology; University of Tsukuba	Xiang, N (corresponding author), Beijing Univ Technol, Coll Econ & Management, Beijing, Peoples R China.; Xiang, N (corresponding author), Beijing Univ Technol, Coll Econ & Management, Res Base Beijing Modern Mfg Dev, Beijing, Peoples R China.	xiangnan@bjut.edu.cn	Higano, Yoshiro/C-5136-2017; Higano, Yoshiro/U-2785-2019	Higano, Yoshiro/0000-0003-0886-5685; Higano, Yoshiro/0000-0003-0886-5685	"International Promotion Program for Young Researchers" of Beijing University of Chemical Technology; Beijing University of Technology; Research Base of Beijing Modern Manufacturing Development from Beijing University of Technology	"International Promotion Program for Young Researchers" of Beijing University of Chemical Technology; Beijing University of Technology; Research Base of Beijing Modern Manufacturing Development from Beijing University of Technology	This study is supported by grants from the "International Promotion Program for Young Researchers" of Beijing University of Chemical Technology and Beijing University of Technology distinctly, and the Research Base of Beijing Modern Manufacturing Development from Beijing University of Technology. The corresponding author gratefully acknowledges data support from the Greenpeace-East Asia (Beijing Office). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SM, 2006, SCI TOTAL ENVIRON, V368, P663, DOI 10.1016/j.scitotenv.2006.03.031; [Anonymous], 2013, B CHINESE ACAD SCI; [Anonymous], 2010, REGION, V9; Clean Air Alliance of China, 2013, CHIN TACKL AIR POLL; Cobourn WG, 2010, ATMOS ENVIRON, V44, P3015, DOI 10.1016/j.atmosenv.2010.05.009; Dong C, 2012, ENERGY, V37, P673, DOI 10.1016/j.energy.2011.10.030; Guan DB, 2014, HAZE TRUTH PM2 5 POL, P121; Ministry of Environmental Protection of China (MEP), 2013, EX PROGR ACT PLAN BE; O'Keefe B., 2013, RECENT TRENDS AIR QU; Pan XC, 2012, DANGER OUT BREATHING; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; USEP A Integrated science assessment for particulate matter, 2009, EPA600R08, V139; Vallius M, 2005, SCI TOTAL ENVIRON, V337, P147, DOI 10.1016/j.scitotenv.2004.06.018; Wang G., 2015, ENVIRON MONIT ASSESS, V187; Wang YJ, 2011, ENERG POLICY, V39, P6745, DOI 10.1016/j.enpol.2010.07.002; Xue Wen-bo, 2014, China Environmental Science, V34, P2490; Zhao B, 2013, ATMOS ENVIRON, V77, P453, DOI 10.1016/j.atmosenv.2013.05.012; Zheng GJ, 2015, ATMOS CHEM PHYS, V15, P2969, DOI 10.5194/acp-15-2969-2015; Zhou Y., 2012, THESIS STANFORD U	20	7	7	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173612	10.1371/journal.pone.0173612	http://dx.doi.org/10.1371/journal.pone.0173612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282464	gold, Green Published, Green Submitted			2022-12-26	WOS:000396091800054
J	Naz, S; Page, A; Agho, KE				Naz, Sabrina; Page, Andrew; Agho, Kingsley Emwinyore			Household air pollution from use of cooking fuel and under-five mortality: The role of breastfeeding status and kitchen location in Pakistan	PLOS ONE			English	Article							BIOMASS FUEL; RESPIRATORY ILLNESS; CHILD-MORTALITY; SOLID-FUEL; HEALTH; BANGLADESH; INDIA; EXPOSURE; RISK; INFANTS	Household air pollution (HAP) mainly from cooking fuel is one of the major causes of respiratory illness and deaths among young children in low and middle-income countries like Pakistan. This study investigates for the first time the association between HAP from cooking fuel and under-five mortality using the 2013 Pakistan Demographic and Health Survey (PDHS) data. Multi-level logistic regression models were used to examine the association between HAP and under-five mortality in a total of 11,507 living children across four age-groups (neonatal aged 0-28 days, post-neonatal aged 1-11 months, child aged 12-59 months and under-five aged 0-59 months). Use of cooking fuel was weakly associated with total under-five mortality (OR = 1.22, 95% CI = 0.92-1.64, P = 0.170), with stronger associations evident for sub-group analyses of children aged 12-59 months (OR = 1.98, 95% CI = 0.75-5.25, P = 0.169). Strong associations between use of cooking fuel and mortality were evident (ORs >5) in those aged 12-59 months for households without a separate kitchen using polluting fuels, and in children whose mother never breastfed. The results of this study suggest that HAP from cooking fuel is associated with a modest increase in the risk of death among children under five years of age in Pakistan, but particularly in those aged 12-59 months, and those living in poorer socioeconomic conditions. To reduce exposure to cooking fuel which is a preventable determinant of under-five mortality in Pakistan, the challenge remains to promote behavioural interventions such as breastfeeding in infancy period, keeping young children away from the cooking area, and improvements in housing and kitchen design.	[Naz, Sabrina; Page, Andrew] Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus, Penrith, NSW, Australia; [Agho, Kingsley Emwinyore] Univ Western Sydney, Sch Sci & Hlth, Campbelltown Campus, Penrith, NSW, Australia	Western Sydney University; Western Sydney University	Naz, S (corresponding author), Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus, Penrith, NSW, Australia.	sabrinanaz@gmail.com	Agho, Kingsley/AAW-5622-2021; Agho, Kingsley/AAE-9971-2020	Agho, Kingsley/0000-0003-4111-3207; Naz, Sabrina/0000-0002-0338-1203				Ahmed Z, 2015, INT J HLTH SYSTEM DI, V3, P19, DOI DOI 10.4103/2347-9019.168569; [Anonymous], 2014, BURD DIS JOINT EFF H; [Anonymous], 2011, ENCY ENV HLTH; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Bassani DG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-491; Bates MN, 2013, ENVIRON HEALTH PERSP, V121, P637, DOI 10.1289/ehp.1205491; Bhutto AW, 2011, RENEW SUST ENERG REV, V15, P3207, DOI 10.1016/j.rser.2011.04.015; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Choi JY, 2015, OCCUP ENVIRON MED, V72, P114, DOI 10.1136/oemed-2014-102472; Cushing AH, 1998, AM J EPIDEMIOL, V147, P863, DOI 10.1093/oxfordjournals.aje.a009540; Dasgupta S, 2006, INDOOR AIR, V16, P426, DOI 10.1111/j.1600-0668.2006.00436.x; DSouza RM, 1997, J BIOSOC SCI, V29, P271, DOI 10.1017/S002193209700271X; Epstein MB, 2013, INT J HYG ENVIR HEAL, V216, P523, DOI 10.1016/j.ijheh.2012.12.006; Ezeh OK, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-113; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Gurley ES, 2013, INDOOR AIR, V23, P379, DOI 10.1111/ina.12038; Heinig MJ, 2001, PEDIATR CLIN N AM, V48, P105, DOI 10.1016/S0031-3955(05)70288-1; IGME U, 2015, LEV TRENDS CHILD MOR; IHME, 2010, GLOB BURD DIS GBD PR; Jan I, 2012, RENEW SUST ENERG REV, V16, P3200, DOI 10.1016/j.rser.2012.02.038; Janjua NZ, 2012, PUBLIC HEALTH, V126, P855, DOI 10.1016/j.puhe.2012.06.012; Kashima S, 2010, J OCCUP ENVIRON MED, V52, P340, DOI 10.1097/JOM.0b013e3181d44e3f; Khalequzzaman M, 2007, INDOOR AIR, V17, P297, DOI 10.1111/j.1600-0668.2007.00477.x; Khalequzzaman Md, 2011, Environmental Health and Preventive Medicine, V16, P375, DOI 10.1007/s12199-011-0208-z; Khalequzzaman Md., 2010, Environmental Health and Preventive Medicine, V15, P236, DOI 10.1007/s12199-009-0133-6; Khushk WA, 2005, INDOOR AIR, V15, P311, DOI 10.1111/j.1600-0668.2005.00367.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ministry of Planning DaR, 2013, PAK MILL DEV GOALS R; Mir AA, 2012, BIRTH, V1; Munroe RL, 2012, INT J ENVIRON HEAL R, V22, P156, DOI 10.1080/09603123.2011.628642; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Nasir ZA, 2015, J INTEGR ENVIRON SCI, V12, P107, DOI 10.1080/1943815X.2015.1005105; Nasir ZA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024002; National Institute of Population Studies II, 2013, PAK DEM HLTH SURV 20; Naz S, 2016, ENV HLTH, V15, DOI [10.1111/f.1600-0668.2007.00477.x, DOI 10.1111/F.1600-0668.2007.00477.X]; Naz S, 2015, INT J ENV RES PUB HE, V12, P12847, DOI 10.3390/ijerph121012847; Pandey S, 2013, MATERN CHILD HLTH J, V17, P1499, DOI 10.1007/s10995-012-1163-z; Prasad R, 2012, DRUG DISCOVERIES THE, V6; Pronczuk-Garbino J., 2005, CHILDRENS HLTH ENV G; Rehfuess EA, 2009, J EPIDEMIOL COMMUN H, V63, P887, DOI 10.1136/jech.2008.082685; Rinne ST, 2007, AM J TROP MED HYG, V76, P585, DOI 10.4269/ajtmh.2007.76.585; Rutstein SO, 2006, GUIDE DHS STAT; Tielsch JM, 2009, INT J EPIDEMIOL, V38, P1351, DOI 10.1093/ije/dyp286; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WHO, 2009, DEATHS DALYS ATTR SE; WHO, 2006, EXPOSURE ASSESSMENT; Wichmann J, 2006, MATERN CHILD HLTH J, V10, P553, DOI 10.1007/s10995-006-0121-z	48	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173256	10.1371/journal.pone.0173256	http://dx.doi.org/10.1371/journal.pone.0173256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278260	Green Published, gold			2022-12-26	WOS:000396087900061
J	Tettelbach, ST; Europe, JR; Tettelbach, CRH; Havelin, J; Rodgers, BS; Furman, BT; Velasquez, M				Tettelbach, Stephen T.; Europe, James R.; Tettelbach, Christian R. H.; Havelin, Jason; Rodgers, Brooke S.; Furman, Bradley T.; Velasquez, Marissa			Hard clam walking: Active horizontal locomotion of adult Mercenaria mercenaria at the sediment surface and behavioral suppression after extensive sampling	PLOS ONE			English	Article							ELLIPTIO-COMPLANATA MOLLUSCA; CRAWLING BEHAVIOR; FERTILIZATION SUCCESS; SPATIAL-DISTRIBUTION; BURROWING BEHAVIOR; MACOMA-BALTHICA; BODY-SIZE; BIVALVIA; MUSSELS; AGGREGATION	Locomotion of infaunal bivalve mollusks primarily consists of vertical movements related to burrowing; horizontal movements have only been reported for a few species. Here, we characterize hard clam walking: active horizontal locomotion of adults (up to 118 mm shell length, SL) of the commercially important species, Mercenaria mercenaria, at the sediment surface-a behavior only briefly noted in the literature. We opportunistically observed walking over a 10-yr period, at 9 different sites in the Peconic Bays, New York, USA, and tested several hypotheses for the underlying cause of this behavior through quantitative field sampling and reproductive analyses. Hard clam walking was exhibited by males and females at equal frequency, predominantly during June/July and October, when clams were in peak spawning condition. Extensive walking behavior appears to be cued by a minimum population density; we suggest it may be mediated by unidentified pheromone(s), infaunal pressure waves and/or other unidentified factors. There was no directionality exhibited by walking clams, but individuals in an area of extensive walking were highly aggregated and walking clams were significantly more likely to move toward a member of the opposite sex. Thus, we conclude that hard clam walking serves to aggregate mature individuals prior to spawning, thereby facilitating greater fertilization success. In the process of investigating this behavior, however, we apparently oversampled one population and reduced clam densities below the estimated minimum threshold density and, in so doing, suppressed extensive walking for a period of > 3 years running. This not only reinforces the importance of detailed field investigations of species biology and ecology, even for those that are considered to be well studied, but also highlights the need for greater awareness of the potential for research activities to affect focal species behavior.	[Tettelbach, Stephen T.] LIU Post, Dept Biol, Brookville, NY 11548 USA; [Europe, James R.] NOAA, Southeast Fisheries Sci Ctr, Miami, FL USA; [Tettelbach, Christian R. H.] Univ Calif Berkeley, Coll Nat Resources, Berkeley, CA USA; [Havelin, Jason] Cornell Cooperat Extens Suffolk Cty, Marine Program, Southold, NY USA; [Rodgers, Brooke S.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY USA; [Furman, Bradley T.] Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA; [Velasquez, Marissa] Cornell Univ, Dept Biol, Ithaca, NY USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Berkeley; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Virginia; Cornell University	Tettelbach, ST (corresponding author), LIU Post, Dept Biol, Brookville, NY 11548 USA.	Stephen.Tettelbach@liu.edu		Tettelbach, Stephen/0000-0003-3715-1235; Furman, Bradley/0000-0002-9284-8388	Suffolk County Water Quality Protection and Restoration Program [HSN1]; Long Island University; Suffolk County (NY) Water Quality Protection and Restoration Program	Suffolk County Water Quality Protection and Restoration Program; Long Island University; Suffolk County (NY) Water Quality Protection and Restoration Program	Funding which helped support the project activities was obtained from the Suffolk County Water Quality Protection and Restoration Program (http://www.suffolkcountyny.gov/Departments/ EnconomicDevelopmentandPlanning/PlanningandEnvironment/WaterOualityImprovement aspx), under contract # HSN1 to Cornell Cooperative Extension of Suffolk County (Christopher F. Smith) and Long Island University (STT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for funding from the Suffolk County (NY) Water Quality Protection and Restoration Program. We thank the following individuals for their assistance: Scott Hughes, Brigid Maloney, Matthew Schwartz, Michael Cotrone, Justin Ecret and Hailey Brosnan (field work); Bassem Allam (histological analyses); Matthew Harke and Christopher Gobler (chlorophyll analyses). We also appreciate the thoughtful and constructive comments of the Academic Editor and two reviewers.	AHN IY, 1993, MAR ECOL PROG SER, V99, P61; Alcock J., 1989, ANIMAL BEHAV EVOLUTI; Amyot JP, 1998, FRESHWATER BIOL, V39, P351, DOI 10.1046/j.1365-2427.1998.00289.x; Amyot JP, 1997, FRESHWATER BIOL, V37, P345, DOI 10.1046/j.1365-2427.1997.00158.x; ANSELL A. D., 1967, PROC MALACOL SOC LONDON, V37, P395; Ansell A. D., 1969, Proceedings of the Malacological Society of London, V38, P387; ANSELL AD, 1967, J EXP BIOL, V46, P105; BALFOUR DL, 1995, J FRESHWATER ECOL, V10, P255, DOI 10.1080/02705060.1995.9663445; Barnes RD, 1974, INVERTEBRATE ZOOLOGY; BELDING DL, 1912, REPORT QUAHOG OYSTER; BOTTON M L, 1988, Journal of Shellfish Research, V7, P407; Carriker MR, 2001, DEV AQUAC FISH SCI, V31, P283; Catton CA, 2013, J SHELLFISH RES, V32, P181, DOI 10.2983/035.032.0124; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Clements JC, 2015, J SHELLFISH RES, V34, P619; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Cote IM, 1999, J EXP MAR BIOL ECOL, V235, P201, DOI 10.1016/S0022-0981(98)00155-5; Cyr H, 2009, J N AM BENTHOL SOC, V28, P319, DOI 10.1899/08-133.1; Candido LTD, 2007, BELG J ZOOL, V137, P11; DOW RL, 1955, SCIENCE, V122, P641, DOI 10.1126/science.122.3171.641; DOWNING JA, 1993, J N AM BENTHOL SOC, V12, P148, DOI 10.2307/1467344; Fegley Sr, 2001, DEV AQUAC FISH SCI, V31, P383; Ferguson C. D., 2009, THESIS; Folk RL, 1974, PETROGRAPHY SEDIMENT; Fraenkel G S, 1927, Z VERGL PHYSIOL, V6, P167, DOI 10.1007/BF00333682; HARGER J R E, 1970, Veliger, V12, P401; Huang DW, 2007, J EXP MAR BIOL ECOL, V342, P269, DOI 10.1016/j.jembe.2006.10.051; HURLBERT SH, 1990, OIKOS, V58, P257, DOI 10.2307/3545216; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kappes H, 2012, AQUAT SCI, V74, P1, DOI 10.1007/s00027-011-0187-6; Kim Y, 2004, J SHELLFISH RES, V23, P429; Knights AM, 2010, MAR ECOL PROG SER, V404, P79, DOI 10.3354/meps08480; Kraeuter JN, 2001, DEV AQUAC FISH SCI, V31, P441; Kraeuter JN, 2005, J SHELLFISH RES, V24, P1043; Levinton J. S., 2014, MARINE BIOL FUNCTION; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; Liermann M, 2001, FISH FISH, V2, P33, DOI 10.1046/j.1467-2979.2001.00029.x; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Malinowski SR, 1985, THESIS; Minteer BA, 2014, SCIENCE, V344, P260, DOI 10.1126/science.1250953; Morisita M., 1959, MEMOIRS FS KYUSHU U, V2, P215; Mouritsen KN, 1997, OIKOS, V79, P513, DOI 10.2307/3546895; Nelson TC, 1940, J EXP ZOOL, V85, P299, DOI 10.1002/jez.1400850207; New York State Department of Environmental Conservation, 2015, SHELLF HARV LIM; Newell RIE, 2009, MAR ECOL PROG SER, V387, P179, DOI 10.3354/meps08083; PADILLA DK, 2011, J SHELLFISH RES, V30, P540; Prezant RS, 2010, GEOARCHAEOLOGY ST CA, P237; QUAYLE D. B., 1949, PROC MALACOL SOC LONDON, V28, P31; ROBERTS D, 1989, J EXP MAR BIOL ECOL, V126, P271, DOI 10.1016/0022-0981(89)90192-5; Saarinen M, 2003, J MOLLUS STUD, V69, P81, DOI 10.1093/mollus/69.1.81; Schwalb AN, 2007, J N AM BENTHOL SOC, V26, P261, DOI 10.1899/0887-3593(2007)26[261:HAVMOU]2.0.CO;2; SEED R, 1969, OECOLOGIA, V3, P277, DOI 10.1007/BF00390380; Seuront L, 2014, P NATL ACAD SCI USA, V111, P2206, DOI 10.1073/pnas.1322363111; STANLEY SM, 1975, ANNU REV EARTH PL SC, V3, P361, DOI 10.1146/annurev.ea.03.050175.002045; STOKESBURY KDE, 1993, MAR ECOL PROG SER, V96, P159, DOI 10.3354/meps096159; Stoner AW, 2000, MAR ECOL PROG SER, V202, P297, DOI 10.3354/meps202297; SWENNEN C, 1974, Netherlands Journal of Sea Research, V8, P108, DOI 10.1016/0077-7579(74)90029-5; Tallqvist M, 2001, MAR ECOL PROG SER, V212, P183, DOI 10.3354/meps212183; TAN WH, 1975, AQUACULTURE, V6, P357, DOI 10.1016/0044-8486(75)90114-3; Tettelbach ST, 2015, MAR ECOL PROG SER, V529, P121, DOI 10.3354/meps11263; Tettelbach ST, 2013, MAR ECOL PROG SER, V478, P153, DOI 10.3354/meps10111; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Trueman E. R., 1966, Proceedings of the Malacological Society of London, V37, P97; TRUEMAN ER, 1966, J EXP BIOL, V44, P469; Veness C., CALCULATE DISTANCE B; WELLS HW, 1957, ECOLOGY, V38, P123, DOI 10.2307/1932134; Wethey DS, 2005, BIOL BULL-US, V209, P139, DOI 10.2307/3593131; WILKENS LA, 2006, SCALLOPS BIOL ECOLOG, P317; Yenni G, 2012, ECOLOGY, V93, P456, DOI 10.1890/11-1087.1; Yonge C. M., 1976, LIVING MARINE MOLLUS; Yund PO, 2003, LIMNOL OCEANOGR, V48, P795, DOI 10.4319/lo.2003.48.2.0795; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	73	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173626	10.1371/journal.pone.0173626	http://dx.doi.org/10.1371/journal.pone.0173626			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278288	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900021
J	Junk, DJ; Bryson, BL; Smigiel, JM; Parameswaran, N; Bartel, CA; Jackson, MW				Junk, D. J.; Bryson, B. L.; Smigiel, J. M.; Parameswaran, N.; Bartel, C. A.; Jackson, M. W.			Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-TUMOR CELLS; TGF-BETA; STEM-CELL; INTERLEUKIN-6 EXPRESSION; MALIGNANT-TRANSFORMATION; STAT3; ACTIVATION; IL-6; CHEMOTHERAPY	Increasing evidence supports the idea that cancer cell plasticity promotes metastasis and tumor recurrence, resulting in patient mortality. While it is clear that the tumor microenvironment (TME) contributes to cancer cell plasticity, the specific TME factors most actively controlling plasticity remain largely unknown. Here, we performed a screen to identify TME cytokines and growth factors that promote epithelial-mesenchymal plasticity, and acquisition of cancer stem cell (CSC) properties. Of 28 TME cytokines and growth factors tested, we identified Oncostatin M (OSM) as the most potent inducer of mesenchymal/CSC properties. OSM-induced plasticity was Signal Transducer and Activator of Transcription 3 (STAT3)-dependent, and also required a novel intersection with transforming growth factor-alpha (TGF-alpha)/SMAD signaling. OSM/STAT3 activation promoted SMAD3 nuclear accumulation, DNA binding and induced SMAD3-dependent transcriptional activity. Suppression of TGF-alpha receptor activity or ablation of SMAD3 or SMAD4, but not SMAD2, strongly suppressed OSM/ STAT3-mediated plasticity. Moreover, removal of OSM or inhibition of STAT3 or SMAD3 resulted in a marked reversion to a non-invasive, epithelial phenotype. We propose that targeted blockade of the STAT3/SMAD3 axis in tumor cells may represent a novel therapeutic approach to prevent the plasticity required for metastatic progression and tumor recurrence.	[Junk, D. J.; Bryson, B. L.; Smigiel, J. M.; Parameswaran, N.; Bartel, C. A.; Jackson, M. W.] Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,WRB 3134, Cleveland, OH 44106 USA; [Jackson, M. W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Jackson, MW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,WRB 3134, Cleveland, OH 44106 USA.	mark.w.jackson@case.edu	Bryson, Benjamin L/D-1070-2014	Bryson, Benjamin L/0000-0003-4131-0200	NIH [T32 CA059366]; US National Institutes of Health [R01CA138421]; American Cancer Society [RSG CCG-122517]; Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [R21CA178327, T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DJJ was supported by NIH T32 CA059366. MWJ is supported by the US National Institutes of Health (R01CA138421) and the American Cancer Society (Research Scholar Award # RSG CCG-122517). Additional support was provided by the Case Comprehensive Cancer Center (P30 CA43703; Cytometry & Imaging Microscopy).	Adorno-Cruz V, 2015, CANCER RES, V75, P924, DOI 10.1158/0008-5472.CAN-14-3225; Akizu N, 2010, DEVELOPMENT, V137, P2915, DOI 10.1242/dev.049395; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bastid J, 2012, CANCER METAST REV, V31, P277, DOI 10.1007/s10555-011-9344-6; Baulida J, 2015, BBA-REV CANCER, V1856, P55, DOI 10.1016/j.bbcan.2015.05.005; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Boero Ferdinando, 2015, F1000Prime Rep, V7, P49, DOI 10.12703/P7-49; Brooks MD, 2015, CELL STEM CELL, V17, P260, DOI 10.1016/j.stem.2015.08.014; Buijs JT, 2012, ONCOGENE, V31, P2164, DOI 10.1038/onc.2011.400; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Doherty MR, 2016, CANCERS, V8, DOI 10.3390/cancers8010008; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; ELIAS JA, 1991, J IMMUNOL, V146, P3437; Fang YY, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/478641; Farrell J, 2014, J PROTEOME RES, V13, P2874, DOI 10.1021/pr5000285; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Goldman A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7139; Gough DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083395; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hart JR, 2011, P NATL ACAD SCI USA, V108, P13247, DOI 10.1073/pnas.1110486108; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Heldin P, 2014, ADV CANCER RES, V123, P211, DOI 10.1016/B978-0-12-800092-2.00008-3; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hermanns HM, 2000, J BIOL CHEM, V275, P40742, DOI 10.1074/jbc.M005408200; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Junk DJ, 2014, CANCERS, V6, P741, DOI 10.3390/cancers6020741; Junk DJ, 2013, NEOPLASIA, V15, P1086, DOI 10.1593/neo.131114; Junk DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053776; Kan CE, 2011, CANCER RES, V71, P6930, DOI 10.1158/0008-5472.CAN-10-3860; Khoo BL, 2015, ONCOTARGET, V6, P15578; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li YZ, 2015, P NATL ACAD SCI USA, V112, P1839, DOI 10.1073/pnas.1424171112; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Luo LY, 2014, TUMOR BIOL, V35, P8379, DOI 10.1007/s13277-014-2203-7; Luwor RB, 2013, ONCOGENE, V32, P2433, DOI 10.1038/onc.2012.260; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Moon SU, 2015, ONCOL REP, V33, P185, DOI 10.3892/or.2014.3582; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morrison CD, 2013, CANCER LETT, V341, P30, DOI 10.1016/j.canlet.2013.02.048; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Reilly S, 2014, J BIOL CHEM, V289, P9952, DOI 10.1074/jbc.M113.545822; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Plater-Zyberk C, 2001, ARTHRITIS RHEUM, V44, P2697, DOI 10.1002/1529-0131(200111)44:11<2697::AID-ART450>3.0.CO;2-#; Poling J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0396-3; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103; Rycaj K, 2015, CANCER RES, V75, P4003, DOI 10.1158/0008-5472.CAN-15-0798; Saitoh M, 2016, ONCOGENE, V35, P1049, DOI 10.1038/onc.2015.161; Seong GJ, 2009, MOL VIS, V15, P2123; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Singh RAK, 1998, IMMUNOL LETT, V62, P159, DOI 10.1016/S0165-2478(98)00040-6; Smith DA, 2013, MOL CANCER RES, V11, P1159, DOI 10.1158/1541-7786.MCR-13-0238; Sodhi A, 1997, IMMUNOL CELL BIOL, V75, P492, DOI 10.1038/icb.1997.76; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Tang BW, 1999, CANCER RES, V59, P4834; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; TURNER M, 1990, Cytokine, V2, P211, DOI 10.1016/1043-4666(90)90018-O; Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Unternaehrer JJ, 2014, STEM CELL REP, V3, P691, DOI 10.1016/j.stemcr.2014.09.008; Vlaicu P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-197; Walia B, 2003, FASEB J, V17, P2130, DOI 10.1096/fj.02-1211fje; Wang G, 2016, ONCOGENE, V35, P4388, DOI 10.1038/onc.2015.446; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Wendt MK, 2013, ONCOGENE, V32, P2005, DOI 10.1038/onc.2012.230; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; West NR, 2014, ONCOGENE, V33, P1485, DOI 10.1038/onc.2013.105; West NR, 2012, ENDOCR-RELAT CANCER, V19, P181, DOI 10.1530/ERC-11-0326; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu MY, 2014, BBA-MOL BASIS DIS, V1842, P2237, DOI 10.1016/j.bbadis.2014.07.025; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Ye L, 2010, CANCER SCI, V101, P2137, DOI 10.1111/j.1349-7006.2010.01648.x; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123; Zhu MJ, 2015, ONCOL REP, V34, P129, DOI 10.3892/or.2015.3951	98	66	66	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 13	2017	36	28					4001	4013		10.1038/onc.2017.33	http://dx.doi.org/10.1038/onc.2017.33			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FA3YD	28288136	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000405379900006
J	Azouaoui, H; Montigny, C; Dieudonne, T; Champeil, P; Jacquot, A; Vazquez-Ibar, JL; Le Marechal, P; Ulstrup, J; Ash, MR; Lyons, JA; Nissen, P; Lenoir, G				Azouaoui, Hassina; Montigny, Cedric; Dieudonne, Thibaud; Champeil, Philippe; Jacquot, Aurore; Vazquez-Ibar, Jose Luis; Le Marechal, Pierre; Ulstrup, Jakob; Ash, Miriam-Rose; Lyons, Joseph A.; Nissen, Poul; Lenoir, Guillaume			High phosphatidylinositol 4-phosphate (PI4P)-dependent ATPase activity for the Drs2p-Cdc50p flippase after removal of its N- and C-terminal extensions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; SARCOPLASMIC-RETICULUM CA2+-ATPASE; MEMBRANE CALCIUM-PUMP; AMINOPHOSPHOLIPID TRANSPORT; PHOSPHOLIPID FLIPPASE; TRANSLOCASE ACTIVITY; BETA-SUBUNIT; GOLGI; PROTEIN; YEAST	P4-ATPases, also known as phospholipid flippases, are responsible for creating and maintaining transbilayer lipid asymmetry in eukaryotic cell membranes. Here, we use limited proteolysis to investigate the role of theNand C termini in ATP hydrolysis and auto-inhibition of the yeast flippase Drs2p-Cdc50p. We show that limited proteolysis of the detergent-solubilized and purified yeast flippase may result in more than 1 order of magnitude increase of its ATPase activity, which remains dependent on phosphatidylinositol 4-phosphate (PI4P), a regulator of this lipid flippase, and specific to a phosphatidyl-serine substrate. Using thrombin as the protease, Cdc50p remains intact and in complex with Drs2p, which is cleaved at two positions, namely after Arg(104) and after Arg(1290), resulting in a homogeneous sample lacking 104 and 65 residues from its N and C termini, respectively. Removal of the 1291-1302-amino acid region of the C-terminal extension is critical for relieving the auto-inhibition of full-length Drs2p, whereas the 1-104 N-terminal residues have an additional but more modest significance for activity. The present results therefore reveal that trimming off appropriate regions of the terminal extensions of Drs2p can greatly increase its ATPase activity in the presence of PI4P and demonstrate that relief of such auto-inhibition remains compatible with subsequent regulation by PI4P. These experiments suggest that activation of the Drs2p-Cdc50p flippase follows a multistep mechanism, with preliminary release of a number of constraints, possibly through the binding of regulatory proteins in the trans-Golgi network, followed by full activation by PI4P.	[Azouaoui, Hassina; Montigny, Cedric; Dieudonne, Thibaud; Champeil, Philippe; Jacquot, Aurore; Vazquez-Ibar, Jose Luis; Lenoir, Guillaume] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, F-91198 Gif Sur Yvette, France; [Le Marechal, Pierre] Univ Paris Saclay, Univ Paris Sud, CNRS, NeuroPSI,UMR 9197, Batiment 430, F-91405 Orsay, France; [Ulstrup, Jakob; Ash, Miriam-Rose; Lyons, Joseph A.; Nissen, Poul] Aarhus Univ, Danish Natl Res Fdn, DANDRITE, Nord EMBL Partnership Mol Med, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Ulstrup, Jakob; Ash, Miriam-Rose; Lyons, Joseph A.; Nissen, Poul] Aarhus Univ, Danish Natl Res Fdn, Dept Mol Biol & Genet, PUMPkin, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Danmarks Grundforskningsfond	Lenoir, G (corresponding author), CEA Saclay, Inst Integrat Biol Cell, Batiment 528,PC 103, F-91191 Gif Sur Yvette, France.	guillaume.lenoir@i2bc.paris-saclay.fr	Lyons, Joseph/AAA-2528-2020; Lenoir, Guillaume/I-4002-2019; Vazquez-Ibar, Jose-Luis/AAD-8827-2021; MONTIGNY, Cédric/AAH-4216-2021	Lenoir, Guillaume/0000-0002-8759-5179; Vazquez-Ibar, Jose-Luis/0000-0002-8314-3378; Dieudonne, Thibaud/0000-0001-6988-4121; Lyons, Joseph/0000-0003-0218-4862; Nissen, Poul/0000-0003-0948-6628	CNRS; Agence Nationale de la Recherche (ANR) [ANR-14-CE09-0022]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05]; Lundbeck Foundation [R171-2014-663]; Lundbeck Foundation [R155-2015-2666, R209-2015-2704] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the CNRS, by Agence Nationale de la Recherche (ANR) Grant ANR-14-CE09-0022 (to G. L.) (AsymLip), by French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05, and by Postdoctoral Fellowship R171-2014-663 from the Lundbeck Foundation (to J. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Azouaoui H, 2016, METHODS MOL BIOL, V1377, P37, DOI 10.1007/978-1-4939-3179-8_6; Azouaoui H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112176; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; FADOK VA, 1992, J IMMUNOL, V148, P2207; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lopez-Marques RL, 2015, BBA-GEN SUBJECTS, V1850, P461, DOI 10.1016/j.bbagen.2014.04.008; Lopreiato R, 2014, J BIOL CHEM, V289, P10261, DOI 10.1074/jbc.O114.555565; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Montigny C, 2014, J BIOL CHEM, V289, P33850, DOI 10.1074/jbc.M114.590307; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Tsai PC, 2013, P NATL ACAD SCI USA, V110, pE668, DOI 10.1073/pnas.1221484110; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619	47	17	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7954	7970		10.1074/jbc.M116.751487	http://dx.doi.org/10.1074/jbc.M116.751487			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302728	Green Published, hybrid			2022-12-26	WOS:000401154100022
J	Sato, Y; Katoh, Y; Matsumoto, M; Sato, M; Ebina, M; Itoh-Nakadai, A; Funayama, R; Nakayama, K; Unno, M; Igarashi, K				Sato, Yoshihiro; Katoh, Yasutake; Matsumoto, Mitsuyo; Sato, Masaki; Ebina, Masayuki; Itoh-Nakadai, Ari; Funayama, Ryo; Nakayama, Keiko; Unno, Michiaki; Igarashi, Kazuhiko			Regulatory signatures of liver regeneration distilled by integrative analysis of mRNA, histone methylation, and proteomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE GENE LISTS; METHIONINE ADENOSYLTRANSFERASE; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; IDENTIFICATION; HEPATECTOMY; EXPRESSION; FOXM1; EMBOLIZATION	The capacity of the liver to regenerate is likely to be encoded as a plasticity of molecular networks within the liver. By applying a combination of comprehensive analyses of the epigenome, transcriptome, and proteome, we herein depict the molecular landscape of liver regeneration. We demonstrated that histone H3 Lys-4 was trimethylated at the promoter regions of many loci, among which only a fraction, including cell-cycle-related genes, were transcriptionally up-regulated. A cistrome analysis guided by the histone methylation patterns and the transcriptome identified FOXM1 as the key transcription factor promoting liver regeneration, which was confirmed in vitro using a hepatocarcinoma cell line. The promoter regions of cell-cycle-related genes and Foxm1 acquired higher levels of trimethylated histone H3 Lys-4, suggesting that epigenetic regulations of these key regulatory genes define quiescence and regeneration of the liver cells. A quantitative proteome analysis of the regenerating liver revealed that conditional protein degradation also mediated regeneration-specific protein expression. These sets of informational resources should be useful for further investigations of liver regeneration.	[Sato, Yoshihiro; Katoh, Yasutake; Matsumoto, Mitsuyo; Sato, Masaki; Ebina, Masayuki; Itoh-Nakadai, Ari; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan; [Sato, Yoshihiro; Sato, Masaki; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan; [Katoh, Yasutake; Funayama, Ryo; Nakayama, Keiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan; [Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Dept Cell Proliferat, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan; [Ebina, Masayuki; Igarashi, Kazuhiko] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Matsumoto, Mitsuyo/AAC-3065-2019; Unno, Michiaki/A-8633-2010; Unno, Michiaki/AAX-5246-2020	Unno, Michiaki/0000-0002-2145-6416; Unno, Michiaki/0000-0002-2145-6416; Igarashi, Kazuhiko/0000-0002-2470-2475; Sato, Yoshihiro/0000-0003-3722-6815	Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan; AMED-CREST from the Japan Agency for Medical Research and Development;  [15H02506];  [25670156];  [24390066];  [23116003]; Grants-in-Aid for Scientific Research [15H02506] Funding Source: KAKEN	Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan; AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid 15H02506, 25670156, 24390066, and 23116003 and the Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan and AMED-CREST from the Japan Agency for Medical Research and Development. Additional initiative supports were from the Uehara Foundation, Takeda Foundation, and Astellas Foundation for Research on Metabolic Disorders. Restoration of the laboratory from the damage due to the 2011 Tohoku earthquake was provided in part by the Astellas Foundation for Research on Metabolic Disorders, the Banyu Foundation, the Naito Foundation, A. Miyazaki, and A. Iida. The authors declare that they have no conflicts of interest with the contents of this article.	Azimifar SB, 2014, CELL METAB, V20, P1076, DOI 10.1016/j.cmet.2014.11.002; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen H, 2014, BBA-GENE REGUL MECH, V1839, P415, DOI 10.1016/j.bbagrm.2014.03.010; Chen T, 2014, CANCER GENE THER, V21, P133, DOI 10.1038/cgt.2014.8; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Chen XG, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-59; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Gehart H, 2015, TRENDS GENET, V31, P344, DOI 10.1016/j.tig.2015.04.005; Gilgenkrantz H, 2011, CLIN RES HEPATOL GAS, V35, P623, DOI 10.1016/j.clinre.2011.04.002; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hosogane M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003698; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JS, 2014, EPIGENETICS-US, V9, P1521, DOI 10.4161/15592294.2014.983371; Huang ZZ, 1998, AM J PHYSIOL-GASTR L, V275, pG14, DOI 10.1152/ajpgi.1998.275.1.G14; Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Jin S, 2013, WORLD J GASTROENTERO, V19, P7983, DOI 10.3748/wjg.v19.i44.7983; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kera Y, 2013, J BIOL CHEM, V288, P13592, DOI 10.1074/jbc.M112.429738; Kowalik MA, 2011, HEPATOLOGY, V53, P2086, DOI 10.1002/hep.24289; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuttippurathu L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2492-x; Li C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.468; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Low TY, 2013, CELL REP, V5, P1469, DOI 10.1016/j.celrep.2013.10.041; MAKUUCHI M, 1990, SURGERY, V107, P521; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Mencalha AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048160; Muller GA, 2014, NUCLEIC ACIDS RES, V42, P10331, DOI 10.1093/nar/gku696; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Obata F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9332; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shirasaki K, 2014, HEPATOLOGY, V59, P2371, DOI 10.1002/hep.27020; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Sun HC, 2011, ONCOL REP, V25, P1533, DOI 10.3892/or.2011.1230; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Tashiro S, 2009, J HEPATO-BILIARY-PAN, V16, P292, DOI 10.1007/s00534-009-0058-x; van Lienden KP, 2013, CARDIOVASC INTER RAD, V36, P25, DOI 10.1007/s00270-012-0440-y; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200	49	12	12	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8019	8037		10.1074/jbc.M116.774547	http://dx.doi.org/10.1074/jbc.M116.774547			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302717	hybrid, Green Published			2022-12-26	WOS:000401154100027
J	Herbei, R; Paul, R; Berliner, LM				Herbei, Radu; Paul, Rajib; Berliner, L. Mark			Applying diffusion-based Markov chain Monte Carlo	PLOS ONE			English	Article							CONVERGENCE	We examine the performance of a strategy for Markov chain Monte Carlo (MCMC) developed by simulating a discrete approximation to a stochastic differential equation (SDE). We refer to the approach as diffusion MCMC. A variety of motivations for the approach are reviewed in the context of Bayesian analysis. In particular, implementation of diffusion MCMC is very simple to set-up, even in the presence of nonlinear models and non-conjugate priors. Also, it requires comparatively little problem-specific tuning. We implement the algorithm and assess its performance for both a test case and a glaciological application. Our results demonstrate that in some settings, diffusion MCMC is a faster alternative to a general Metropolis-Hastings algorithm.	[Herbei, Radu; Berliner, L. Mark] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Paul, Rajib] Western Michigan Univ, Dept Stat, Kalamazoo, MI USA	Ohio State University; Western Michigan University	Herbei, R (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	herbei@stat.osu.edu			National Science Foundation [DMS-1209142, NSF-CMMI-1537379, ATM-07-3024403, DMS-10-49064]	National Science Foundation(National Science Foundation (NSF))	RH has been supported in part by the National Science Foundation (www.nsf.gov) grant number DMS-1209142. RP has been supported in part by the National Science Foundation (www.nsf.gov) grant NSF-CMMI-1537379. LMB was supported in part by the National Science Foundation (www.nsf.gov) grants ATM-07-3024403 and DMS-10-49064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Berliner LM, 2008, J GLACIOL, V54, P705, DOI 10.3189/002214308786570917; Bernardo JM, 1994, BAYESIAN THEORY; Bou-Rabee N, 2013, IMA J NUMER ANAL, V33, P80, DOI 10.1093/imanum/drs003; Bruce A., 1996, APPL WAVELET ANAL S; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Gilks WR, 1998, J AM STAT ASSOC, V93, P1045, DOI 10.1080/01621459.1998.10473766; Girolami M, 2011, J R STAT SOC B, V73, P123, DOI 10.1111/j.1467-9868.2010.00765.x; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Karatzas I., 2012, BROWNIAN MOTION STOC; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; Lamba H, 2007, IMA J NUMER ANAL, V27, P479, DOI [10.1093/imanum/drl032, 10.1093/imanum/dr1032]; Mattingly JC, 2010, SIAM J NUMER ANAL, V48, P552, DOI 10.1137/090770527; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Roberts G., 2002, METHODOL COMPUT APPL, V4, P337, DOI DOI 10.1023/A:1023562417138; Roberts G.O., 1996, BERNOULLI, V2, P341, DOI DOI 10.2307/3318418; Roberts GO, 2009, J COMPUT GRAPH STAT, V18, P349, DOI 10.1198/jcgs.2009.06134; Talay D., 1990, Stochastics and Stochastics Reports, V29, P13, DOI 10.1080/17442509008833606; Vidakovic B., 1999, STAT MODELING WAVELE	18	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173453	10.1371/journal.pone.0173453	http://dx.doi.org/10.1371/journal.pone.0173453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301529	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300042
J	Lindstrom, S; Loomis, S; Turman, C; Huang, HY; Huang, JY; Aschard, H; Chan, AT; Choi, H; Cornelis, M; Curhan, G; De Vivo, I; Eliassen, AH; Fuchs, C; Gaziano, M; Hankinson, SE; Hu, F; Jensen, M; Kang, JH; Kabrhel, C; Liang, LM; Pasquale, LR; Rimm, E; Stampfer, MJ; Tamimi, RM; Tworoger, SS; Wiggs, JL; Hunter, DJ; Kraft, P				Lindstrom, Sara; Loomis, Stephanie; Turman, Constance; Huang, Hongyan; Huang, Jinyan; Aschard, Hugues; Chan, Andrew T.; Choi, Hyon; Cornelis, Marilyn; Curhan, Gary; De Vivo, Immaculata; Eliassen, A. Heather; Fuchs, Charles; Gaziano, Michael; Hankinson, Susan E.; Hu, Frank; Jensen, Majken; Kang, Jae H.; Kabrhel, Christopher; Liang, Liming; Pasquale, Louis R.; Rimm, Eric; Stampfer, Meir J.; Tamimi, Rulla M.; Tworoger, Shelley S.; Wiggs, Janey L.; Hunter, David J.; Kraft, Peter			A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; BREAST-CANCER RISK; BODY-MASS INDEX; COMMON VARIANTS; MAMMOGRAPHIC DENSITY; SUSCEPTIBILITY LOCI; METAANALYSIS; HEALTH; WOMEN	The Nurses' Health Study (NHS), Nurses' Health Study II (NHSII), Health Professionals Follow Up Study (HPFS) and the Physicians Health Study (PHS) have collected detailed longitudinal data on multiple exposures and traits for approximately 310,000 study participants over the last 35 years. Over 160,000 study participants across the cohorts have donated a DNA sample and to date, 20,691 subjects have been genotyped as part of genome-wide association studies (GWAS) of twelve primary outcomes. However, these studies utilized six different GWAS arrays making it difficult to conduct analyses of secondary phenotypes or share controls across studies. To allow for secondary analyses of these data, we have created three new datasets merged by platform family and performed imputation using a common reference panel, the 1,000 Genomes Phase I release. Here, we describe the methodology behind the data merging and imputation and present imputation quality statistics and association results from two GWAS of secondary phenotypes (body mass index (BMI) and venous thromboembolism (VTE)). We observed the strongest BMI association for the FTO SNP rs55872725 (beta = 0.45, p = 3.48x10(-22)), and using a significance level of p = 0.05, we replicated 19 out of 32 known BMI SNPs. For VTE, we observed the strongest association for the rs2040445 SNP (OR = 2.17, 95% CI: 1.79.2.63, p = 2.70x10(-15)), located downstream of F5 and also observed significant associations for the known ABO and F11 regions. This pooled resource can be used to maximize power in GWAS of phenotypes collected across the cohorts and for studying gene-environment interactions as well as rare phenotypes and genotypes.	[Lindstrom, Sara; Turman, Constance; Huang, Hongyan; Huang, Jinyan; Aschard, Hugues; De Vivo, Immaculata; Liang, Liming; Hunter, David J.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Lindstrom, Sara; Turman, Constance; Huang, Hongyan; Huang, Jinyan; Aschard, Hugues; De Vivo, Immaculata; Eliassen, A. Heather; Hankinson, Susan E.; Hu, Frank; Liang, Liming; Rimm, Eric; Stampfer, Meir J.; Tamimi, Rulla M.; Tworoger, Shelley S.; Hunter, David J.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lindstrom, Sara] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Loomis, Stephanie; Pasquale, Louis R.; Wiggs, Janey L.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Choi, Hyon] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA; [Choi, Hyon] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA; [Cornelis, Marilyn] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Curhan, Gary; De Vivo, Immaculata; Eliassen, A. Heather; Fuchs, Charles; Hankinson, Susan E.; Jensen, Majken; Kang, Jae H.; Kabrhel, Christopher; Pasquale, Louis R.; Rimm, Eric; Stampfer, Meir J.; Tamimi, Rulla M.; Tworoger, Shelley S.; Hunter, David J.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Curhan, Gary; De Vivo, Immaculata; Eliassen, A. Heather; Fuchs, Charles; Hankinson, Susan E.; Jensen, Majken; Kang, Jae H.; Kabrhel, Christopher; Pasquale, Louis R.; Rimm, Eric; Stampfer, Meir J.; Tamimi, Rulla M.; Tworoger, Shelley S.; Hunter, David J.] Harvard Med Sch, Boston, MA USA; [Curhan, Gary] Brigham & Womens Hosp, Dept Med, Div Renal, 75 Francis St, Boston, MA 02115 USA; [Fuchs, Charles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gaziano, Michael] Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA; [Hankinson, Susan E.] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Hu, Frank; Jensen, Majken; Rimm, Eric; Stampfer, Meir J.; Hunter, David J.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Kabrhel, Christopher] Harvard Med Sch, Dept Emergency Med, Ctr Vasc Emergencies, Massachusetts Gen Hosp, Boston, MA USA; [Liang, Liming; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Boston University; Boston University; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Lindstrom, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA.; Lindstrom, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Lindstrom, S (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	saralind@uw.edu	Kraft, Peter/GQH-8448-2022	Kraft, Peter/0000-0002-4472-8103; De Vivo, Immaculata/0000-0002-7185-7402; Jensen, Majken Karoline/0000-0003-4729-7545; Eliassen, A Heather/0000-0002-3961-6609	National Institute of Health [P01CA87969, P01CA055075, P01DK070756, U01HG004728, UM1CA186107, UM1CA176726, R01CA49449, R01CA50385, R01CA67262, R01CA131332, R01HL034594, R01HL088521, R01HL35464, R01HL116854, R01EY015473, R01EY022305, P30EY014104, R03DC013373, R03CA165131]; Harvard Medical School Distinguished Ophthalmology Scholar award; NATIONAL CANCER INSTITUTE [U01CA210171, R35CA197449] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022305, R01EY020928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013373] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School Distinguished Ophthalmology Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute of Health (P01CA87969 (MJS), P01CA055075, P01DK070756 (GC), U01HG004728 (LRP), UM1CA186107 (MJS), UM1CA176726, R01CA49449 (SJH), R01CA50385, R01CA67262 (SJH), R01CA131332 (RMT), R01HL034594, R01HL088521, R01HL35464 (ER), R01HL116854 (CK), R01EY015473 (LRP), R01EY022305 (JLW), P30EY014104 (JLW), R03DC013373 (MC) and R03CA165131 (SL)). Dr. Pasquale is also supported by a Harvard Medical School Distinguished Ophthalmology Scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Cornelis MC, 2014, MOL PSYCHIAT; De Vivo I, 2014, HUM GENET, V133, P211, DOI 10.1007/s00439-013-1369-1; Doll R, 2004, BMJ-BRIT MED J, V328, P1529, DOI 10.1136/bmj.328.7455.1529; DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071; Doll R, 1954, BMJ-BRIT MED J, V328, P33; Germain M, 2015, AM J HUM GENET, V96, P532, DOI 10.1016/j.ajhg.2015.01.019; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Johnson EO, 2013, HUM GENET, V132, P509, DOI 10.1007/s00439-013-1266-7; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindstrom S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6303; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Mondul AM, 2011, HUM MOL GENET, V20, P4724, DOI 10.1093/hmg/ddr387; Monsees GM, 2009, GENET EPIDEMIOL, V33, P717, DOI 10.1002/gepi.20424; Nan HM, 2011, HUM MOL GENET, V20, P2673, DOI 10.1093/hmg/ddr154; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Prescott J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037815; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Qi Q, 2014, HUMAN MOL GENETICS; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rajaraman P, 2012, HUM GENET, V131, P1877, DOI 10.1007/s00439-012-1212-0; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Sesso HD, 2002, CONTROL CLIN TRIALS, V23, P686, DOI 10.1016/S0197-2456(02)00235-0; Sinnott JA, 2012, HUM GENET, V131, P111, DOI 10.1007/s00439-011-1054-1; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stevens KN, 2012, HUM MOL GENET, V21, P3299, DOI 10.1093/hmg/dds158; Tworoger SS, 2006, CANCER RES, V66, P2476, DOI 10.1158/0008-5472.CAN-05-3369; Uh HW, 2012, EUR J HUM GENET, V20, P572, DOI 10.1038/ejhg.2011.231; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhang XH, 2013, BREAST CANCER RES TR, V137, P883, DOI 10.1007/s10549-012-2391-z	60	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173997	10.1371/journal.pone.0173997	http://dx.doi.org/10.1371/journal.pone.0173997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301549	Green Submitted, gold, Green Published			2022-12-26	WOS:000396318300108
J	Ngowi, BV; Tonnang, HEZ; Mwangi, EM; Johansson, T; Ambale, J; Ndegwa, PN; Subramanian, S				Ngowi, Benignus V.; Tonnang, Henri E. Z.; Mwangi, Evans M.; Johansson, Tino; Ambale, Janet; Ndegwa, Paul N.; Subramanian, Sevgan			Temperature-dependent phenology of Plutella xylostella (Lepidoptera: Plutellidae): Simulation and visualization of current and future distributions along the Eastern Afromontane	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; CLIMATE-CHANGE; LIFE-TABLE; SEASONAL ABUNDANCE; IMPACT; YPONOMEUTIDAE; POPULATION; COLEOPTERA; DYNAMICS; SURVIVAL	There is a scarcity of laboratory and field-based results showing the movement of the diamondback moth (DBM) Plutella xylostella (L.) across a spatial scale. We studied the population growth of the diamondback moth (DBM) Plutella xylostella (L.) under six constant temperatures, to understand and predict population changes along altitudinal gradients and under climate change scenarios. Non-linear functions were fitted to continuously model DBM development, mortality, longevity and oviposition. We compiled the best-fitted functions for each life stage to yield a phenology model, which we stochastically simulated to estimate the life table parameters. Three temperature-dependent indices (establishment, generation and activity) were derived from a logistic population growth model and then coupled to collected current (2013) and downscaled temperature data from AFRICLIM (2055) for geospatial mapping. To measure and predict the impacts of temperature change on the pest's biology, we mapped the indices along the altitudinal gradients of Mt. Kilimanjaro (Tanzania) and Taita Hills (Kenya) and assessed the differences between 2013 and 2055 climate scenarios. The optimal temperatures for development of DBM were 32.5, 33.5 and 33 degrees C for eggs, larvae and pupae, respectively. Mortality rates increased due to extreme temperatures to 53.3, 70.0 and 52.4% for egg, larvae and pupae, respectively. The net reproduction rate reached a peak of 87.4 female offspring/female/generation at 20 degrees C. Spatial simulations indicated that survival and establishment of DBM increased with a decrease in temperature, from low to high altitude. However, we observed a higher number of DBM generations at low altitude. The model predicted DBM population growth reduction in the low and medium altitudes by 2055. At higher altitude, it predicted an increase in the level of suitability for establishment with a decrease in the number of generations per year. If climate change occurs as per the selected scenario, DBM infestation may reduce in the selected region. The study highlights the need to validate these predictions with other interacting factors such as cropping practices, host plants and natural enemies.	[Ngowi, Benignus V.; Tonnang, Henri E. Z.; Johansson, Tino; Ambale, Janet; Subramanian, Sevgan] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Ngowi, Benignus V.; Mwangi, Evans M.; Ndegwa, Paul N.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya; [Ngowi, Benignus V.] Natl Plant Quarantine Stn, Trop Pesticides Res Inst, Arusha, Tanzania; [Tonnang, Henri E. Z.] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya; [Johansson, Tino] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland	International Centre of Insect Physiology & Ecology (ICIPE); University of Nairobi; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Helsinki	Subramanian, S (corresponding author), Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.	ssubramania@icipe.org	TONNANG, Henri/AAQ-2206-2021; , Subramanian/H-8531-2014	TONNANG, Henri/0000-0002-9424-9186; , Subramanian/0000-0003-4447-0744; Johansson, Tino Petri/0000-0002-2381-5144	Ministry of Foreign Affairs of Finland through the Climate Change Impacts on Ecosystem Services and Food Security in the Eastern Africa (CHIESA) Project; UK Aid from the UK Government; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	Ministry of Foreign Affairs of Finland through the Climate Change Impacts on Ecosystem Services and Food Security in the Eastern Africa (CHIESA) Project; UK Aid from the UK Government(CGIAR); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	We gratefully acknowledge the financial support for this research from the Ministry of Foreign Affairs of Finland through the Climate Change Impacts on Ecosystem Services and Food Security in the Eastern Africa (CHIESA) Project and icipe core funding provided by UK Aid from the UK Government, Swedish International Development Cooperation Agency (Sida), the Swiss Agency for Development and Cooperation (SDC), Federal Ministry for Economic Cooperation and Development (BMZ), Germany, and the Kenyan Government.	AHLRICHS R, 1981, J CHIM PHYS PCB, V78, P315, DOI 10.1051/jcp/1981780315; Ahmad S. K., 2008, Asian Journal of Agricultural Research, V2, P25; Ahmad Tufail, 2010, Journal of Plant Protection Research, V50, P280, DOI 10.2478/v10045-010-0049-6; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; American National Standards Institute, 2007, 41986 ANSI INCITS; Aminu-Kano A, 1992, WORKING DOCUMENT SER, V21; Andrew Nigel R., 2013, P311; ANNAMALAI S, 1988, RES POPUL ECOL, V30, P329, DOI 10.1007/BF02513253; [Anonymous], 2013, SOFTWARE PACKAGE DEV; Bahar MH, 2012, ENVIRON ENTOMOL, V41, P1653, DOI 10.1603/EN12156; Bahar MH, 2014, ENVIRON ENTOMOL, V43, P1443, DOI 10.1603/EN14055; Barton BT, 2014, ECOLOGY, V95, P1479, DOI 10.1890/13-1977.1; Bergant K, 2005, ENVIRON ENTOMOL, V34, P755, DOI 10.1603/0046-225X-34.4.755; Bonnar JD, 2010, GAMMA FUNCTION; BUTTS RA, 1981, CAN ENTOMOL, V113, P127, DOI 10.4039/Ent113127-2; Chelliah S., 1986, P63; Nguyen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087535; Collier RH, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P163; Craparo ACW, 2015, AGR FOREST METEOROL, V207, P1, DOI 10.1016/j.agrformet.2015.03.005; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Fernandes E. C. M., 1984, Agroforestry Systems, V2, P73; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gergonne J. D., 1974, HIST MATH, V1, P439, DOI [DOI 10.1016/0315-0860(74)90034-2, https://doi.org/10.1016/0315-0860(74)90034-2]; Golizadeh A, 2009, J AGR SCI TECH-IRAN, V11, P115; Golizadeh A, 2007, INSECT SCI, V14, P309, DOI 10.1111/j.1744-7917.2007.00157.x; Guilloux T, 2003, J APPL ENTOMOL, V127, P288, DOI 10.1046/j.1439-0418.2003.00746.x; Guo SF, 2010, J ECON ENTOMOL, V103, P2028, DOI 10.1603/EC09251; Harcourt D.G., 1986, P3; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Hemp A, 2006, BIODIVERS CONSERV, V15, P1193, DOI 10.1007/s10531-004-8230-8; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; HONDA K, 1992, DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P43; IMURA O, 1987, APPL ENTOMOL ZOOL, V22, P449, DOI 10.1303/aez.22.449; Kahuthia-Gathu R., 2008, International Journal of Tropical Insect Science, V28, P19, DOI 10.1017/S1742758408901375; Kahuthia-Gathu R., 2013, Journal of Plant Breeding and Crop Science, V5, P73; Khadioli N, 2014, ANN APPL BIOL, V165, P373, DOI 10.1111/aab.12157; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Kobori Y, 2003, APPL ENTOMOL ZOOL, V38, P249, DOI 10.1303/aez.2003.249; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Li Z, 2016, B ENTOMOL RES, V106, P197, DOI 10.1017/S0007485315001017; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; Liu TX, 1997, ANN ENTOMOL SOC AM, V90, P776, DOI 10.1093/aesa/90.6.776; Liu WeiWei, 2014, Journal of Resources and Ecology, V5, P306; Loehr B, 2007, B ENTOMOL RES, V97, P337, DOI 10.1017/S0007485307005068; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lott JE, 2009, AGR FOREST METEOROL, V149, P1140, DOI 10.1016/j.agrformet.2009.02.002; Macharia I, 2005, CROP PROT, V24, P981, DOI 10.1016/j.cropro.2005.02.005; Marchioro CA, 2012, B ENTOMOL RES, V102, P489, DOI 10.1017/S0007485312000119; Marchioro CA, 2011, NEOTROP ENTOMOL, V40, P533, DOI 10.1590/S1519-566X2011000500003; Maywald GF, 2007, DYMEX MODEL BUILDER, P172; Miranda F, 2011, ENVIRON ENTOMOL, V40, P333, DOI 10.1603/EN10277; Mohandass S, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P117; Mwalusepo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130427; Nyambo B., 2005, Second International Symposium on Biological Control of Arthropods, Davos, Switzerland, 12-16 September, 2005, P290; Pellikka PKE, 2009, INT J APPL EARTH OBS, V11, P221, DOI 10.1016/j.jag.2009.02.002; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; Petavy G, 2004, EVOL ECOL RES, V6, P873; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Core Team, 2012, R LANG ENV STAT COMP; Rangwala I, 2012, CLIMATIC CHANGE, V114, P527, DOI 10.1007/s10584-012-0419-3; Rebaudo F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00139; Shelton AM, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P3; Shirai Y, 2000, B ENTOMOL RES, V90, P357, DOI 10.1017/S0007485300000481; Smith TJ, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P249; Soini, 2000, CHANGING LANDSCAPES; Southwood T.R.E., 1966, ECOLOGICAL METHODS P; Sow Gallo, 2013, Folia Horticulturae, V25, P3, DOI 10.2478/fhort-2013-0001; Sporleder M, 2012, ILCYM D INSECT LIFE, P124; Sporleder M, 2008, ADV CROP RES, V10, P15; STIGTER CJ, 1984, ARCH METEOR GEOPHY B, V34, P203, DOI 10.1007/BF02275684; Stigter K, 1987, ILEIA NEWSLETTER, V3, P5; Swann ALS, 2012, P NATL ACAD SCI USA, V109, P712, DOI 10.1073/pnas.1116706108; TANIGOSHI LK, 1978, ANN ENTOMOL SOC AM, V71, P313, DOI 10.1093/aesa/71.3.313; Tonnang HEZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135283; Tonnang HEZ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-12; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; UMEYA K, 1973, Japanese Journal of Applied Entomology and Zoology, V17, P19, DOI 10.1303/jjaez.17.19; Vannette RL, 2011, GLOBAL CHANGE BIOL, V17, P1277, DOI 10.1111/j.1365-2486.2010.02316.x; Verkerk RHJ, 1996, B ENTOMOL RES, V86, P205, DOI 10.1017/S0007485300052482; Vickers RA, 2004, ENTOMOL EXP APPL, V111, P7, DOI 10.1111/j.0013-8703.2004.00140.x; Wakisaka S., 1992, P 2 INT WORKSH MAN D, P15; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Xing K, 2015, FLA ENTOMOL, V98, P651, DOI 10.1653/024.098.0240; Xing Kun, 2013, Yingyong Shengtai Xuebao, V24, P1769; YAMADA H, 1983, JPN J APPL ENTOMOL Z, V27, P17, DOI 10.1303/jjaez.27.17; Zalucki M.P., 2011, MANAGEMENT DIAMONDBA, P8; Zhang W, 2015, OECOLOGIA, V179, P947, DOI 10.1007/s00442-015-3409-0; Zhang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10436; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075923	91	12	12	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173590	10.1371/journal.pone.0173590	http://dx.doi.org/10.1371/journal.pone.0173590			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301564	Green Published, gold			2022-12-26	WOS:000396318300053
J	Chu, YW; Wu, WS; Hsu, CF; Wang, JJ; Weng, SF; Chien, CC				Chu, Yeh-Wen; Wu, Wen-Shiann; Hsu, Chen-Fang; Wang, Jhi-Joung; Weng, Shih-Feng; Chien, Chih-Chiang			Bidirectional association between ESRD dialysis and diabetes: National cohort study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; MORTALITY; TAIWAN; HEMODIALYSIS; MELLITUS; IMPACT	Background Diabetes is associated with development of end-stage renal disease (ESRD) dialysis, but it is not clear whether ESRD dialysis is a risk factor for new-onset diabetes (NODM). Methods Using the Taiwan National Health Insurance Research Database, we designed two cohort studies to determine the association between dialysis and diabetes. Analysis 1 estimated the hazard ratios (HR) of ESRD dialysis in 20,585 patients with type 2 diabetes (T2DM) and 82,340 gender- and age-matched controls without diabetes. Analysis 2 estimated the HRs of NODM in 18,489 ESRD patients undergoing dialysis and 73,956 gender- and age matched controls without ESRD dialysis. The follow-up period was from 2000 to date of endpoint, the date of death, or December 31, 2008. Cox proportional models were used to estimate the relative hazards. Results In analysis 1, the incidence of ESRD dialysis was higher in the T2DM cohort than in the non diabetes cohort (6.78 vs. 0.61 per 1,000 person-years; HR: 7.97; 95%X1: 7.05-8.00). In analysis 2, the incidence of NODM was higher in the ESRD dialysis cohort than in the without-ESRD dialysis cohort (22.84 vs. 13.99 per 1,000 person-years; HR: 1.40; 95% CI: 1.34-1.47). Conclusions ESRD dialysis and diabetes were bidirectionally associated. The relationship between T2DM and incident ESRD dialysis was much stronger than between ESRD dialysis and NODM. Further studies are needed to determine the mechanism of ESRD dialysis-related NODM.	[Chu, Yeh-Wen; Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Wu, Wen-Shiann] Chi Mei Med Ctr, Dept Cardiol, Tainan, Taiwan; [Wu, Wen-Shiann] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan; [Hsu, Chen-Fang] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Weng, Shih-Feng] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital; Kaohsiung Medical University	Chien, CC (corresponding author), Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan.	ccchien58@yahoo.com.tw		Weng, Shih-Feng/0000-0001-8684-3487	Chi-Mei Medical Center [CMFHR10242]; National Health Research Institutes in Taiwan [NHRI-NHIRD-99182, NHRI-NHIRD-100057]	Chi-Mei Medical Center; National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	The study was supported by grant CMFHR10242 from Chi-Mei Medical Center and grant NHRI-NHIRD-99182 and NHRI-NHIRD-100057 from the National Health Research Institutes in Taiwan. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13; Chien CC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-43; Chou MT, 2013, INT J CARDIOL, V167, P2719, DOI 10.1016/j.ijcard.2012.06.108; DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493; DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095; Hoffmann F, 2011, NEPHROL DIAL TRANSPL, V26, P1634, DOI 10.1093/ndt/gfq609; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Jiang Y., 2009, Plant Biology (Rockville), V2009, P111; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kan WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068748; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Lin-Tan DT, 2007, J AM SOC NEPHROL, V18, P2385, DOI 10.1681/ASN.2006121409; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; Pavkov ME, 2006, JAMA-J AM MED ASSOC, V296, P421, DOI 10.1001/jama.296.4.421; Pecoits R, 2003, KIDNEY INT, V63, pS162, DOI 10.1046/j.1523-1755.63.s84.39.x; PERRY HM, 1995, HYPERTENSION, V25, P587, DOI 10.1161/01.HYP.25.4.587; Pupim LB, 2004, KIDNEY INT, V66, P2054, DOI 10.1111/j.1523-1755.2004.00978.x; Sabe MA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002850; Salifu MO, 2010, AM J NEPHROL, V31, P239, DOI 10.1159/000276542; Szeto CC, 2007, AM J KIDNEY DIS, V49, P524, DOI 10.1053/j.ajkd.2007.01.018; Tien KJ, 2013, DIABETES CARE, V36, P3027, DOI 10.2337/dc12-2148; United States Renal Data System, 2011, EXC USRDS 2009 ANN R; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x; Wu CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158533; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173785	10.1371/journal.pone.0173785	http://dx.doi.org/10.1371/journal.pone.0173785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296932	Green Published, Green Submitted, gold			2022-12-26	WOS:000396311700064
J	Sakchaisri, K; Kim, SO; Hwang, J; Soung, NK; Lee, KH; Choi, TW; Lee, Y; Park, CM; Thimmegowda, NR; Lee, PY; Shwetha, B; Srinivasrao, G; Pham, TTH; Jang, JH; Yum, HW; Surh, YJ; Lee, KS; Park, H; Kim, SJ; Kwon, YT; Ahn, JS; Kim, BY				Sakchaisri, Krisada; Kim, Sun-Ok; Hwang, Joonsung; Soung, Nak Kyun; Lee, Kyung Ho; Choi, Tae Woong; Lee, Yongjun; Park, Chan-Mi; Thimmegowda, Naraganahalli R.; Lee, Phil Young; Shwetha, Bettaswamigowda; Srinivasrao, Ganipisetti; Pham, Thi Thu Huong; Jang, Jae-Hyuk; Yum, Hye-Won; Surh, Young-Joon; Lee, Kyung S.; Park, Hwangseo; Kim, Seung Jun; Kwon, Yong Tae; Ahn, Jong Seog; Kim, Bo Yeon			Anticancer activity of a novel small molecule tubulin inhibitor STK899704	PLOS ONE			English	Article							MICROTUBULE DYNAMICS; DUAL INHIBITORS; ACYLHYDRAZONE DERIVATIVES; CHROMOSOME CONDENSATION; MULTIDRUG-RESISTANCE; MAMMALIAN-CELLS; GENE-EXPRESSION; BINDING AGENTS; P-GLYCOPROTEIN; HISTONE H3	We have identified the small molecule STK899704 as a structurally novel tubulin inhibitor. STK899704 suppressed the proliferation of cancer cell lines from various origins with IC50 values ranging from 0.2 to 1.0 mu M. STK899704 prevented the polymerization of purified tubulin in vitro and also depolymerized microtubule in cultured cells leading to mitotic arrest, associated with increased Cdc25C phosphorylation and the accumulation of both cyclin B1 and polo-like kinase 1 (Plk1), and apoptosis. Unlike many anticancer drugs such as Taxol and doxorubicin, STK899704 effectively displayed antiproliferative activity against multi-drug-resistant cancer cell lines. The proposed binding mode of STK899704 is at the interface between alpha beta-tubulin heterodimer overlapping with the colchicine-binding site. Our in vivo carcinogenesis model further showed that STK 899704 is potent in both the prevention and regression of tumors, remarkably reducing the number and volume of skin tumor by STK899704 treatment. Moreover, it was significant to note that the efficacy of STK899704 was surprisingly comparable to 5-fluorouracil, a widely used anticancer therapeutic. Thus, our results demonstrate the potential of STK899704 to be developed as an anticancer chemotherapeutic and an alternative candidate for existing therapies.	[Sakchaisri, Krisada; Kim, Sun-Ok; Hwang, Joonsung; Soung, Nak Kyun; Lee, Kyung Ho; Choi, Tae Woong; Lee, Yongjun; Park, Chan-Mi; Thimmegowda, Naraganahalli R.; Lee, Phil Young; Shwetha, Bettaswamigowda; Srinivasrao, Ganipisetti; Pham, Thi Thu Huong; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] KRIBB, Anticanc Agents Res Ctr, Ochang, Cheongwon, South Korea; [Sakchaisri, Krisada] Mahidol Univ, Dept Pharmacol, Fac Pharm, Bangkok, Thailand; [Pham, Thi Thu Huong] Vietnam Natl Univ, VNU Univ Sci, KLEPT, Hanoi, Vietnam; [Yum, Hye-Won; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Kyung S.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Park, Hwangseo] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Mahidol University; Vietnam National University Hanoi; Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sejong University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Ahn, JS; Kim, BY (corresponding author), KRIBB, Anticanc Agents Res Ctr, Ochang, Cheongwon, South Korea.; Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea.	yok5@snu.ac.kr; jsahn@kribb.re.kr; bykim@kribb.re.kr	GANIPISETTI, SRINIVASRAO/AAA-6802-2022; Kim, Seung Jun/N-5248-2019; GANIPISETTI, SRINIVASRAO/AAP-6825-2020	Kim, Seung Jun/0000-0002-6913-6358; GANIPISETTI, SRINIVASRAO/0000-0001-9803-8813	Bio and Medical Technology Development Program [NRF-2014M3A9B5073938]; National Research Council of Science & Technology grant [CAP-16-03-KRIBB]; Global R&D Center program [NRF-2010-00719]; World Class Institute Program of the Ministry of Science, ICT and Future Planning of Korea [WCI2009-002]; KRIBB Research Initiative Program [KGS531162]; International Cooperation Research Program of National Research Council of Science & Technology (NST) of Republic of Korea; R&D Convergence Program of National Research Council of Science & Technology (NST) of Republic of Korea [CAP-16-03-KRIBB]; Basic Science Research Program of the Ministry of Science, ICT and Future Planning (MSIP) of Korea [NRF-2016R1A2B3011389]	Bio and Medical Technology Development Program; National Research Council of Science & Technology grant; Global R&D Center program; World Class Institute Program of the Ministry of Science, ICT and Future Planning of Korea; KRIBB Research Initiative Program; International Cooperation Research Program of National Research Council of Science & Technology (NST) of Republic of Korea; R&D Convergence Program of National Research Council of Science & Technology (NST) of Republic of Korea; Basic Science Research Program of the Ministry of Science, ICT and Future Planning (MSIP) of Korea	This work was supported by the Bio and Medical Technology Development Program (NRF-2014M3A9B5073938), the National Research Council of Science & Technology grant (CAP-16-03-KRIBB), Global R&D Center (NRF-2010-00719) program and the World Class Institute Program (WCI2009-002) of the Ministry of Science, ICT and Future Planning of Korea and KRIBB Research Initiative Program (KGS531162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the R&D Convergence Program (CAP-16-03-KRIBB) and the International Cooperation Research Program of National Research Council of Science & Technology (NST) of Republic of Korea. This work was also supported the Bio and Medical Technology Development Program (NRF-2014M3A9B5073938), the Basic Science Research Program (NRF-2016R1A2B3011389) of the Ministry of Science, ICT and Future Planning (MSIP) of Korea and KRIBB Research Initiative Program.	Bahner JD, 2013, CLIN DERMATOL, V31, P792, DOI 10.1016/j.clindermatol.2013.08.020; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Dalton WB, 2009, FUTURE ONCOL, V5, P1363, DOI 10.2217/FON.09.118; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; do Amaral DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085380; Duan YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25387; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gilchrest Barbara A, 2013, J Invest Dermatol, V133, pE2, DOI 10.1038/skinbio.2013.176; Gloster HM, 2006, J AM ACAD DERMATOL, V55, P741, DOI 10.1016/j.jaad.2005.08.063; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; HENNINGS H, 1993, CARCINOGENESIS, V14, P2353, DOI 10.1093/carcin/14.11.2353; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Huzil JT, 2007, CANCER INFORM, V3, P159; HWANG A, 1995, J BIOL CHEM, V270, P28419; Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; JORDAN MA, 1992, J CELL SCI, V102, P401; Kang MR, 2010, ONCOL REP, V23, P801, DOI 10.3892/or_00000701; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kim HM, 1997, FEBS LETT, V412, P201, DOI 10.1016/S0014-5793(97)00777-1; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Liu HD, 2014, CANCER PREV RES, V7, P74, DOI 10.1158/1940-6207.CAPR-13-0133; Maia RD, 2014, EXPERT OPIN THER PAT, V24, P1161, DOI 10.1517/13543776.2014.959491; Nashan D, 2013, EUR J DERMATOL, V23, P14, DOI 10.1684/ejd.2013.1923; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Park H, 2016, J MED CHEM, V59, P9018, DOI 10.1021/acs.jmedchem.6b00944; Park H, 2016, J NAT PROD, V79, P293, DOI 10.1021/acs.jnatprod.5b00851; Park H, 2015, J AM CHEM SOC, V137, P337, DOI 10.1021/ja510636t; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rodrigues DA, 2016, J MED CHEM, V59, P655, DOI 10.1021/acs.jmedchem.5b01525; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Salum LB, 2015, EUR J MED CHEM, V96, P504, DOI 10.1016/j.ejmech.2015.02.041; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shin S, 2016, J CHEM INF MODEL, V56, P802, DOI 10.1021/acs.jcim.6b00026; Society AC, 2014, CANC FACTS FIG 2015; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Windebank AJ, 1999, CURR OPIN NEUROL, V12, P565, DOI 10.1097/00019052-199910000-00010; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219	49	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173311	10.1371/journal.pone.0173311	http://dx.doi.org/10.1371/journal.pone.0173311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296906	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700033
J	Goetz, SC; Bangs, F; Barrington, CL; Katsanis, N; Anderson, KV				Goetz, Sarah C.; Bangs, Fiona; Barrington, Chloe L.; Katsanis, Nicholas; Anderson, Kathryn V.			The Meckel syndrome-associated protein MKS1 functionally interacts with components of the BBSome and IFT complexes to mediate ciliary trafficking and hedgehog signaling	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; INTRAFLAGELLAR TRANSPORT PROTEIN; PRIMARY CILIUM; CORE COMPLEX; DEFECTS; CILIOPATHIES; MUTATIONS; KINESIN; INPP5E; CILIOGENESIS	The importance of primary cilia in human health is underscored by the link between ciliary dysfunction and a group of primarily recessive genetic disorders with overlapping clinical features, now known as ciliopathies. Many of the proteins encoded by ciliopathy-associated genes are components of a handful of multi-protein complexes important for the transport of cargo to the basal body and/or into the cilium. A key question is whether different complexes cooperate in cilia formation, and whether they participate in cilium assembly in conjunction with intraflagellar transport (IFT) proteins. To examine how ciliopathy protein complexes might function together, we have analyzed double mutants of an allele of the Meckel syndrome (MKS) complex protein MKS1 and the BBSome protein BBS4. We find that Mks1; Bbs4 double mutant mouse embryos exhibit exacerbated defects in Hedgehog (Hh) dependent patterning compared to either single mutant, and die by E14.5. Cells from double mutant embryos exhibit a defect in the trafficking of ARL13B, a ciliary membrane protein, resulting in disrupted ciliary structure and signaling. We also examined the relationship between the MKS complex and IFT proteins by analyzing double mutant between Mks1 and a hypomorphic allele of the IFTB component Ift172. Despite each single mutant surviving until around birth, Mks1; Ift172(avc1) double mutants die at mid-gestation, and exhibit a dramatic failure of cilia formation. We also find that Mks1 interacts genetically with an allele of Dync2h1, the IFT retrograde motor. Thus, we have demonstrated that the MKS transition zone complex cooperates with the BBSome to mediate trafficking of specific trans-membrane receptors to the cilium. Moreover, the genetic interaction of Mks1 with components of IFT machinery suggests that the transition zone complex facilitates IFT to promote cilium assembly and structure.	[Goetz, Sarah C.; Bangs, Fiona; Anderson, Kathryn V.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, New York, NY 10021 USA; [Goetz, Sarah C.; Barrington, Chloe L.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27708 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA	Memorial Sloan Kettering Cancer Center; Duke University; Duke University; Duke University	Goetz, SC (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, 1275 York Ave, New York, NY 10021 USA.	sarah.c.goetz@duke.edu		Barrington, Chloe/0000-0002-3884-102X	United States National Institutes of Health [R00 HD076444, R01 HD042601, R01 NS044385, R01 DK072301]; Memorial Sloan Kettering Cancer Center's National Institute of Health Cancer Center Support Grant [P30 CA008748]; NIH Pathway to Independence Award [R00 HD076444]; NIH [R01 HD042601, R01 NS044385, DK072301]; MSKCC Cancer Center Support Grant [P30 CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601, R00HD076444] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center's National Institute of Health Cancer Center Support Grant; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the following grants made by the United States National Institutes of Health (www.nih.gov): To SCG: R00 HD076444 (from the National Institute of Child Health and Human Development); To KVA: R01 NS044385 (From the National Institute of Neurological Disorders and Stroke); To NK: R01 HD042601 (from the National Institute of Child Health and Human Development), R01 DK072301 (from the National Institute of Diabetes and Digestive and Kidney Disorders). Funding was also received through Memorial Sloan Kettering Cancer Center's National Institute of Health Cancer Center Support Grant (P30 CA008748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ift172<SUP>avc1</SUP> mice were kindly provided by Ivan Moskowitz. The GLI2 antibody was a gift from Jonathan Eggenschwiler. Antibodies against ISL1 and NKX2.2 were obtained from the Developmental Studies Hybridoma Bank created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology. Imaging was performed using the Molecular Cytology and Electron Microscopy core facilities at Sloan Kettering Institute and the Light Microscopy core facility at Duke University. This work was supported by an NIH Pathway to Independence Award to SCG (R00 HD076444), and NIH grants to KVA (R01 NS044385), and NK (R01 HD042601 and DK072301), and the MSKCC Cancer Center Support Grant (P30 CA008748).	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Castro-Sanchez S, 2015, J MED GENET, V52, P503, DOI 10.1136/jmedgenet-2015-103099; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cui C, 2010, DIS MODEL MECH, P1; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Friedland-Little JM, 2011, HUM MOL GENET, V20, P3725, DOI 10.1093/hmg/ddr241; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Masyukova SV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005841; Migliavacca E, 2015, AM J HUM GENET, V96, P784, DOI 10.1016/j.ajhg.2015.04.002; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Perrault I, 2015, J MED GENET, V52, P657, DOI 10.1136/jmedgenet-2014-102838; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Yee LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005627; Zhang QH, 2013, J CELL SCI, V126, P2372, DOI 10.1242/jcs.111740; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004	67	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173399	10.1371/journal.pone.0173399	http://dx.doi.org/10.1371/journal.pone.0173399			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291807	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700023
J	Lan, L; Tian, FR; Zhuge, DL; Zhuge, QC; Shen, BX; Jin, BH; Huang, JP; Wu, MZ; Fan, LX; Zhao, YZ; Xu, HL				Lan, Li; Tian, Fu-Rong; ZhuGe, De-Li; ZhuGe, Qi-Chuan; Shen, Bi-Xin; Jin, Bing-Hui; Huang, Jian-Ping; Wu, Ming-Ze; Fan, Lu-Xin; Zhao, Ying-Zheng; Xu, He-Lin			Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; IN-VITRO; MODEL; DELIVERY; REGENERATION; RECOVERY; NANOPARTICLES; INHIBITION; SCAFFOLDS; THERAPY	In this study, porous gelatin microspheres (GMSs) were constructed to improve the neuroprotective effect of basic fibroblast growth factor (bFGF) on spinal cord injury. GMSs were prepared by a W/O emulsion template, followed by cross-linking, washing and drying. The particle sizes and surface porosity of the blank GMSs were carefully characterized by scan electronic microscopy. The blank GMSs have a mean particle size of 35 mu m and theirs surface was coarse and porous. bFGF was easily encapsulated inside the bulk GMSs through diffusion along the porous channel. 200 mu g of bFGF was completely encapsulated in 100mg of GMSs. The bFGF-loaded GMSs displayed a continuous drug release pattern without an obvious burst release over two weeks in vitro. Moreover, the therapeutic effects of bFGF-loaded GMSs were also evaluated in spinal cord injury rat model. After implantation of bFGF-loaded GMSs, the recovery of the motor function of SCI rats were evaluated by behavioral score and foot print experiment. The motor function of SCI rats treated with bFGF-loaded GMSs was more obvious than that treated with free bFGF solution (P<0.05). At the 28 th days after treatment, rats were sacrificed and the injured spinal were removed for histopathological and apoptosis examination. Compared with treatment with free bFGF solution, treatment with bFGF-loaded GMSs resulted in a less necrosis, less infiltration of leukocytes, and a reduced the cavity ratio and less apoptotic cells in injured spinal(P<0.01), indicating its better therapeutic effect. Implantable porous GMSs may be a potential carrier to deliver bFGF for therapy of spinal cord injury.	[Lan, Li; ZhuGe, Qi-Chuan; Xu, He-Lin] Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou, Peoples R China; [Tian, Fu-Rong; ZhuGe, De-Li; Shen, Bi-Xin; Jin, Bing-Hui; Wu, Ming-Ze; Fan, Lu-Xin; Zhao, Ying-Zheng; Xu, He-Lin] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou City, Zhejiang, Peoples R China; [Huang, Jian-Ping] WenZhou Chinese Med Hosp, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Xu, HL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou, Peoples R China.; Zhao, YZ; Xu, HL (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou City, Zhejiang, Peoples R China.	pharmtds@163.com; xhlpharm1214@126.com	Tian, Furong/AAA-6037-2020	Tian, Furong/0000-0002-4953-1131	National Natural Science Foundation of China [81603036, 81360195, 81301982, 81571392, 81272160]; research fund for the doctoral program of high education by ministry of education of China [20133321120005]; Zhejiang provincial program for the cultivation of high-level innovative health talents; 151 talent project of Zhejiang province; 551 talent project of Wenzhou; key support of high level talent innovation and technology project of Wenzhou; Zhejiang Provincial Foundation for Health Department [2015ZDA023, 2016KYA136]; Zhejiang Provincial Natural Science Foundation [LY14H280002]; Wenzhou Bureau of Science and Technology [Y20160086]; School Talent Start Fund of Wenzhou Medical University [QTJ15020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); research fund for the doctoral program of high education by ministry of education of China; Zhejiang provincial program for the cultivation of high-level innovative health talents; 151 talent project of Zhejiang province; 551 talent project of Wenzhou; key support of high level talent innovation and technology project of Wenzhou; Zhejiang Provincial Foundation for Health Department; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Wenzhou Bureau of Science and Technology; School Talent Start Fund of Wenzhou Medical University	This research was supported by National Natural Science Foundation of China (Grant No. 81603036, 81360195, 81301982,81571392 and 81272160), research fund for the doctoral program of high education by ministry of education of China (Grant No.20133321120005, Cui-Tao Lu), Zhejiang provincial program for the cultivation of high-level innovative health talents (Ying-Zheng Zhao), 151 talent project of Zhejiang province and 551 talent project of Wenzhou (Ying-Zheng Zhao), key support of high level talent innovation and technology project of Wenzhou (Zhao Ying-Zheng), Zhejiang Provincial Foundation for Health Department (Grant No.2015ZDA023 and 2016KYA136), Zhejiang Provincial Natural Science Foundation (Grant No. LY14H280002), Medicine Grant from Wenzhou Bureau of Science and Technology (Grant No. Y20160086), School Talent Start Fund of Wenzhou Medical University (Grant No.QTJ15020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Natural Science Foundation of China (Grant No. 81603036, 81360195, 81301982,81571392 and 81272160), research fund for the doctoral program of high education by ministry of education of China (Grant No.20133321120005, Cui-Tao Lu), Zhejiang provincial program for the cultivation of high-level innovative health talents (Ying-Zheng Zhao), 151 talent project of Zhejiang province and 551 talent project of Wenzhou (Ying-Zheng Zhao), key support of high level talent innovation and technology project of Wenzhou (Zhao Ying-Zheng), Zhejiang Provincial Foundation for Health Department (Grant No.2015ZDA023 and 2016KYA136), Zhejiang Provincial Natural Science Foundation (Grant No. LY14H280002), Medicine Grant from Wenzhou Bureau of Science and Technology (Grant No. Y20160086), School Talent Start Fund of Wenzhou Medical University (Grant No. QTJ15020).	Cai PT, 2016, AGING DIS, V7, P336, DOI 10.14336/AD.2016.0117; Chang SS, 2014, SURG TODAY, V44, P1536, DOI 10.1007/s00595-014-0864-x; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Fraher JP, 2000, J ANAT, V196, P137; FRAHER JP, 1992, PROG NEUROBIOL, V38, P261, DOI 10.1016/0301-0082(92)90022-7; Fujimaki H, 2016, J BIOMED MAT RES A; Han YS, 2009, GERONTOLOGY, V55, P592, DOI 10.1159/000235547; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Housley WJ, 2015, CLIN IMMUNOL, V161, P51, DOI 10.1016/j.clim.2015.06.015; Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853; Igai H, 2007, J THORAC CARDIOV SUR, V134, P170, DOI 10.1016/j.jtcvs.2007.02.022; Jin Y, 2014, ACTA BIOMATER, V10, P3126, DOI 10.1016/j.actbio.2014.02.045; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031; Leszczynska AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143602; Makarevich PI, 2015, KARDIOLOGIYA, V55, P59; Minardi S, 2015, ACS APPL MATER INTER, V7, P16364, DOI 10.1021/acsami.5b03464; Nakamichi M, 2016, AM J PATHOL; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Ren H, 2014, BIOMATERIALS, V35, P6585, DOI 10.1016/j.biomaterials.2014.04.042; Shi Q, 2014, SCI CHINA LIFE SCI, V57, P232, DOI 10.1007/s11427-014-4612-7; Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7; Tan Z, 2009, CYTOTHERAPY, V11, P317, DOI 10.1080/14653240902824757; Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002; Xu HL, 2011, PHARMAZIE, V66, P654, DOI 10.1691/ph.2011.1042; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhang YP, 2004, J NEUROSURG, V100, P343, DOI 10.3171/spi.2004.100.4.0343; Zhao YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148848; Zhao YZ, 2016, J CONTROL RELEASE, V224, P165, DOI 10.1016/j.jconrel.2016.01.017; Zhao YZ, 2014, J CONTROL RELEASE, V186, P22, DOI 10.1016/j.jconrel.2014.04.054	33	24	24	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173814	10.1371/journal.pone.0173814	http://dx.doi.org/10.1371/journal.pone.0173814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291798	Green Published, gold, Green Submitted			2022-12-26	WOS:000396094700042
J	Ravindran, D; Ridiandries, A; Vanags, LZ; Henriquez, R; Cartland, S; Tan, JTM; Bursill, CA				Ravindran, Dhanya; Ridiandries, Anisyah; Vanags, Laura Z.; Henriquez, Rodney; Cartland, Sian; Tan, Joanne T. M.; Bursill, Christina A.			Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice	PLOS ONE			English	Article							E-KNOCKOUT MICE; NF-KAPPA-B; FRACTALKINE CX3CL1; PLAQUE-FORMATION; LESION FORMATION; GENE-TRANSFER; INFLAMMATION; INHIBITION; DISEASE; RECRUITMENT	Chemokines are important in macrophage recruitment and the progression of atherosclerosis. The 'M3' chemokine binding protein inactivates key chemokines involved in atherosclerosis (e.g. CCL2, CCL5 and CX(3)CL1). We aimed to determine the effect of M3 on plaque development and composition. In vitro chemotaxis studies confirmed that M3 protein inhibited the activity of chemokines CCL2, CCL5 and CX(3)CL1 as primary human monocyte migration as well as CCR2-, CCR5- and CX(3)CR1-directed migration was attenuated by M3. In vivo, adenoviruses encoding M3 (AdM3) or green fluorescence protein (AdGFP; control) were infused systemically into apolipoprotein (apo)-E-/- mice. Two models of atherosclerosis development were used in which the rate of plaque progression was varied by diet including: (1) a 'rapid promotion' model (6-week high-fat-fed) and (2) a 'slow progression' model (12-week chow-fed). Plasma chemokine activity was suppressed in AdM3-infused mice as indicated by significantly less monocyte migration towards AdM3 mouse plasma ex vivo (29.56%, p = 0.014). In the 'slow progression' model AdM3 mice had reduced lesion area (45.3%, p = 0.035) and increased aortic smooth muscle cell a-actin expression (60.3%, p = 0.014). The reduction in lesion size could not be explained by changes in circulating inflammatory monocytes as they were higher in the AdM3 group. In the 'rapid promotion' model AdM3 mice had no changes in plaque size but reduced plaque macrophage content (46.8%, p = 0.006) and suppressed lipid deposition in thoracic aortas (66.9%, p<0.05). There was also a reduction in phosphorylated p65, the active subunit of NF-kappa b, in the aortas of AdM3 mice (37.3%, p<0.0001). M3 inhibited liver CCL2 concentrations in both models with no change in CCL5 or systemic chemokine levels. These findings show M3 causes varying effects on atherosclerosis progression and plaque composition depending on the rate of lesion progression. Overall, our studies support a promising role for chemokine inhibition with M3 for the treatment of atherosclerosis.	[Ravindran, Dhanya; Ridiandries, Anisyah; Vanags, Laura Z.; Henriquez, Rodney; Cartland, Sian; Tan, Joanne T. M.; Bursill, Christina A.] Heart Res Inst, Sydney, NSW, Australia; [Ravindran, Dhanya; Ridiandries, Anisyah; Vanags, Laura Z.; Cartland, Sian; Tan, Joanne T. M.; Bursill, Christina A.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	University of Sydney; Heart Research Institute; University of Sydney	Bursill, CA (corresponding author), Heart Res Inst, Sydney, NSW, Australia.; Bursill, CA (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	bursillc@hri.org.au	Ridiandries, Anisyah/I-4360-2017; Tan, Joanne Tsui Ming/Y-4423-2019; Tan, Ming-Jen/A-3862-2011	Ridiandries, Anisyah/0000-0001-8996-6896; Tan, Joanne Tsui Ming/0000-0003-1875-4882; Bursill, Christina/0000-0002-0682-8760; Tan, Ming-Jen/0000-0002-3583-1723; Cartland, Sian/0000-0003-1723-2679; Henriquez, Rodney/0000-0002-2959-2260	Heart Research Institute, Sydney, Australia	Heart Research Institute, Sydney, Australia	This work was funded by the Heart Research Institute, Sydney, Australia (www.hri.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Belvoncikova P, 2008, ACTA VIROL, V52, P91; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bursi CA, 2004, CURR OPIN LIPIDOL, V15, P145, DOI [10.1097/00041433-200404000-00007, 10.1097/01.mol.0000124526.75650.13]; Bursill CA, 2009, GENE THER, V16, P93, DOI 10.1038/gt.2008.141; Bursill CA, 2004, CIRCULATION, V110, P2460, DOI 10.1161/01.CIR.0000145122.58420.CO; Bursill CA, 2003, IMMUNOBIOLOGY, V207, P187, DOI 10.1078/0171-2985-00228; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Langenfeld MR, 2001, CLIN SCI, V101, P731, DOI 10.1042/CS20010110; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Mach F, 2001, Curr Atheroscler Rep, V3, P243, DOI 10.1007/s11883-001-0067-y; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Ni WH, 2001, CIRCULATION, V103, P2096; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Prosser HCG, 2014, CARDIOVASC RES, V101, P145, DOI 10.1093/cvr/cvt234; Pyo R, 2004, AM J PATHOL, V164, P2289, DOI 10.1016/S0002-9440(10)63785-6; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Shang LM, 2009, GASTROENTEROLOGY, V137, P1006, DOI 10.1053/j.gastro.2009.05.055; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4	33	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173224	10.1371/journal.pone.0173224	http://dx.doi.org/10.1371/journal.pone.0173224			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282403	Green Published, Green Submitted, gold			2022-12-26	WOS:000396091800023
J	Ikhlef, S; Berrougui, H; Simo, OK; Zerif, E; Khalil, A				Ikhlef, Souade; Berrougui, Hicham; Simo, Olivier Kamtchueng; Zerif, Echarki; Khalil, Abdelouahed			Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; ABCA1 MESSENGER-RNA; HEART-DISEASE RISK; SERUM PARAOXONASE; PON1 ACTIVITY; MACROPHAGES; ATHEROSCLEROSIS; BINDING; PATHWAY; ASSOCIATION	This study was aimed to investigate the effect of human PON1 overexpression in mice on cholesterol efflux and reverse cholesterol transport. PON1 overexpression in PON1-Tg mice induced a significant 3-fold (p<0.0001) increase in plasma paraoxonase activity and a significant similar to 30% (p<0.0001) increase in the capacity of HDL to mediate cholesterol efflux from J774 macrophages compared to wild-type mice. It also caused a significant 4fold increase (p<0.0001) in the capacity of macrophages to transfer cholesterol to apoA-1, a significant 2-fold (p<0.0003) increase in ABCA1 mRNA and protein expression, and a significant increase in the expression of PPAR. (p<0.0003 and p<0.04, respectively) and LXR alpha (p<0.0001 and p<0.01, respectively) mRNA and protein compared to macrophages from wild-type mice. Moreover, transfection of J774 macrophages with human PON1 also increased ABCA1, PPAR. and LXRa protein expression and stimulates macrophages cholesterol efflux to apo A1. In vivo measurements showed that the overexpression of PON1 significantly increases the fecal elimination of macrophage-derived cholesterol in PON1-Tg mice. Overall, our results suggested that the overexpression of PON1 in mice may contribute to the regulation of the cholesterol homeostasis by improving the capacity of HDL to mediate cholesterol efflux and by stimulating reverse cholesterol transport.	[Ikhlef, Souade; Berrougui, Hicham; Simo, Olivier Kamtchueng; Khalil, Abdelouahed] Res Ctr Aging, Sherbrooke, PQ, Canada; [Berrougui, Hicham] Univ Sultan Moulay Slimane, Polydisciplinary Fac, Dept Biol, Beni Mellal, Morocco; [Zerif, Echarki] Univ Sherbrooke, Ctr Rech Clin CHUS, Div Immunol, Dept Pediat, Sherbrooke, PQ, Canada; [Khalil, Abdelouahed] Univ Sherbrooke, Fac Med & Hlth Sci, Geriatr Serv, Dept Med, Sherbrooke, PQ, Canada	Sultan Moulay Slimane University of Beni Mellal; University of Sherbrooke; University of Sherbrooke	Khalil, A (corresponding author), Res Ctr Aging, Sherbrooke, PQ, Canada.; Khalil, A (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Geriatr Serv, Dept Med, Sherbrooke, PQ, Canada.	a.khalil@usherbrooke.ca		berrougui, hicham/0000-0002-0546-6534; Khalil, Abdelouahed/0000-0003-0817-3160	Canadian Institutes of Health Research [MOP-89912, IAO-134212]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by Canadian Institutes of Health Research (MOP-89912 and IAO-134212).	Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berrougui H, 2012, FREE RADICAL BIOL ME; Berrougui H, 2012, J CLIN LIPIDOL, V6, P524, DOI 10.1016/j.jacl.2012.04.004; Berrougui H, 2012, FREE RADICAL BIO MED, V52, P1372, DOI 10.1016/j.freeradbiomed.2012.01.019; Berti JA, 2005, BRAZ J MED BIOL RES, V38, P391, DOI 10.1590/S0100-879X2005000300010; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; BLATTER MC, 1993, EUR J BIOCHEM, V211, P871, DOI 10.1111/j.1432-1033.1993.tb17620.x; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Field FJ, 2010, J LIPID RES, V51, P1407, DOI 10.1194/jlr.M002410; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Helal O, 2013, BRIT J NUTR, V109, P1844, DOI 10.1017/S0007114512003856; Hou M, 2007, CELL BIOCHEM FUNCT, V25, P33, DOI 10.1002/cbf.1374; Ikhlef S, 2016, FEBS LETT, V590, P1614, DOI 10.1002/1873-3468.12198; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joy T, 2009, CURR OPIN CARDIOL, V24, P364, DOI 10.1097/HCO.0b013e32832ac166; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kielar D, 2001, CLIN CHEM, V47, P2089; Linton S, 2001, EXP GERONTOL, V36, P1503, DOI 10.1016/S0531-5565(01)00136-X; Loued S, 2012, LIFE SCI, V90, P82, DOI 10.1016/j.lfs.2011.10.018; Mukhamedova N, 2008, J LIPID RES, V49, P2312, DOI 10.1194/jlr.M800095-JLR200; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200; Rosenblat M, 2005, ATHEROSCLEROSIS, V179, P69, DOI 10.1016/j.atherosclerosis.2004.10.028; Rosenblat M, 2006, ATHEROSCLEROSIS, V187, P74, DOI 10.1016/j.athersclerosis.2005.08.026; Seres I, 2004, EXP GERONTOL, V39, P59, DOI 10.1016/j.exger.2003.08.001; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Wang MS, 2012, DNA CELL BIOL, V31, P975, DOI 10.1089/dna.2011.1478; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Xia M, 2005, J BIOL CHEM, V280, P36792, DOI 10.1074/jbc.M505047200; Zhang B, 2003, CLIN NEPHROL, V60, P257; Zhao Y, 2012, MOL GENET METAB, V105, P141, DOI 10.1016/j.ymgme.2011.09.018; Zhu Y, 2005, CARDIOVASC RES, V68, P425, DOI 10.1016/j.cardiores.2005.07.003	44	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173385	10.1371/journal.pone.0173385	http://dx.doi.org/10.1371/journal.pone.0173385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278274	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900084
J	Reynolds, JD; Case, LK; Krementsov, DN; Raza, A; Bartiss, R; Teuscher, C				Reynolds, Jacob D.; Case, Laure K.; Krementsov, Dimitry N.; Raza, Abbas; Bartiss, Rose; Teuscher, Cory			Modeling month-season of birth as a risk factor in mouse models of chronic disease: from multiple sclerosis to autoimmune encephalomyelitis	FASEB JOURNAL			English	Article						autoimmunity; cytokines; EAE; month of birth; seasonal variation	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REPRODUCTIVE-PERFORMANCE; ENVIRONMENTAL-FACTORS; SEX-RATIO; VITAMIN-D; ULTRAVIOLET-RADIATION; CIRCANNUAL RHYTHM; ATOPIC-DERMATITIS; GUT MICROBIOME; LITTER SIZE	Month-season of birth (M-SOB) is a risk factor in multiple chronic diseases, including multiple sclerosis (MS), where the lowest and greatest risk of developing MS coincide with the lowest and highest birth rates, respectively. To determine whether M-SOB effects in such chronic diseases as MS can be experimentally modeled, we examined the effect of M-SOB on susceptibility of C57BL/6J mice to experimental autoimmune encephalomyelitis (EAE). As in MS, mice that were born during the M-SOB with the lowest birth rate were less susceptible to EAE than mice born during the M-SOB with the highest birth rate. We also show that the M-SOB effect on EAE susceptibility is associated with differential production of multiple cytokines/chemokines by neuroantigen-specific T cells that are known to play a role in EAE pathogenesis. Taken together, these results support the existence of an M-SOB effect that may reflect seasonally dependent developmental differences in adaptive immune responses to self-antigens independent of external stimuli, including exposure to sunlight and vitamin D. Moreover, our documentation of an M-SOB effect on EAE susceptibility in mice allows for modeling and detailed analysis of mechanisms that underlie the M-SOB effect in not only MS but in numerous other diseases in which M-SOB impacts susceptibility.	[Reynolds, Jacob D.; Case, Laure K.; Krementsov, Dimitry N.; Raza, Abbas; Teuscher, Cory] Univ Vermont, Dept Med, Burlington, VT USA; [Teuscher, Cory] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Bartiss, Rose] Trudeau Inst, Saranac Lake, NY USA	University of Vermont; University of Vermont; Trudeau Institute	Teuscher, C (corresponding author), Univ Vermont, C331 Given Bldg,89 Beaumont Ave, Burlington, VT 05405 USA.	c.teuscher@uvm.edu	Raza, Abbas/AAF-2541-2021; Krementsov, Dimitry/Y-8288-2019	Krementsov, Dimitry/0000-0003-2709-7466; Raza, Abbas/0000-0003-0359-5647	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS061014, NS060901, AI041747, NS036526, NS069628]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118228, P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060901, R01NS069628, R01NS036526, R01NS061014] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS061014, AI041747, NS060901, NS036526, and NS069628 (all to C.T.).	Aggarwal R, 2013, J RHEUMATOL, V40, P430, DOI 10.3899/jrheum.120643; Alizadeh A, 2016, TOXINS, V8, DOI 10.3390/toxins8110334; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Barnard DE, 2009, J AM ASSOC LAB ANIM, V48, P709; Bartiss R., 2015, AT JACKSON LAB, V1, P1; Baschat A A, 2003, J Matern Fetal Neonatal Med, V13, P381, DOI 10.1080/jmf.13.6.381.384; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P2, DOI 10.1111/j.1751-0813.1946.tb15473.x; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; BIGGERS JD, 1954, BIOCHEM J, V58, P278, DOI 10.1042/bj0580278; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Blay M, 2010, J PHARMACEUT BIOMED, V51, P382, DOI 10.1016/j.jpba.2009.03.028; Boland Mary Regina, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P189; Boland MR, 2015, J AM MED INFORM ASSN, V22, P1042, DOI 10.1093/jamia/ocv046; Bondy GS, 2000, J TOXICOL ENV HEAL B, V3, P109, DOI 10.1080/109374000281113; BRADEN AWH, 1967, AUST J AGR RES, V18, P335, DOI 10.1071/AR9670355; Brewerton TD, 2012, INT J EAT DISORDER, V45, P131, DOI 10.1002/eat.20898; BROCK MA, 1983, J IMMUNOL, V130, P2586; Burrell AM, 2011, DISCOV MED, V11, P187; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Cano PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053647; Case LK, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0591-7; Castro SBR, 2012, INT IMMUNOPHARMACOL, V12, P465, DOI 10.1016/j.intimp.2011.12.025; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; CORRIER DE, 1991, VET IMMUNOL IMMUNOP, V30, P73, DOI 10.1016/0165-2427(91)90010-A; Cruz PMR, 2016, JAMA NEUROL, V73, P954, DOI 10.1001/jamaneurol.2016.1463; De Paula ML, 2008, INT IMMUNOPHARMACOL, V8, P1291, DOI 10.1016/j.intimp.2008.05.002; Delgado LF, 2012, SCI TOTAL ENVIRON, V435, P509, DOI 10.1016/j.scitotenv.2012.07.046; Disanto G, 2013, JAMA NEUROL, V70, P527, DOI 10.1001/jamaneurol.2013.2116; Disanto G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-69; Disanto G, 2012, CNS NEUROL DISORD-DR, V11, P545, DOI 10.2174/187152712801661266; Disanto G, 2011, BRIT J PSYCHIAT, V198, P404, DOI 10.1192/bjp.bp.110.085944; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Donald DB, 2007, ENVIRON HEALTH PERSP, V115, P1183, DOI 10.1289/ehp.9435; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; DRICKAMER L C, 1977, Laboratory Animals (London), V11, P159, DOI 10.1258/002367777780936639; DRICKAMER LC, 1990, LAB ANIM SCI, V40, P284; Fiddes B, 2014, J NEUROL, V261, P1851, DOI 10.1007/s00415-014-7241-y; Fiddes B, 2013, ANN NEUROL, V73, P714, DOI 10.1002/ana.23925; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gardener H, 2010, MOVEMENT DISORD, V25, P1560, DOI 10.1002/mds.23339; Goldinger A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126995; Grytten N, 2013, MULT SCLER J, V19, P1028, DOI 10.1177/1352458512471094; Gwinner E., 1986, CIRCANNUAL RHYTHMS, Vfirst; Halldner L, 2014, J CHILD PSYCHOL PSYC, V55, P897, DOI 10.1111/jcpp.12229; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Hanson FB, 1924, GENETICS, V9, P363; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Helm B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0016; Hintzen R, 2013, NAT REV NEUROL, V9, P489, DOI 10.1038/nrneurol.2013.156; Huber S, 2008, HUM REPROD, V23, P1187, DOI 10.1093/humrep/den079; Huber S, 2004, HUM REPROD, V19, P1081, DOI 10.1093/humrep/deh247; Huber S, 2009, AM J HUM BIOL, V21, P25, DOI 10.1002/ajhb.20799; Huber S, 2011, AM J HUM BIOL, V23, P546, DOI 10.1002/ajhb.21184; Hueza IM, 2014, TOXINS, V6, P1080, DOI 10.3390/toxins6031080; Jahromi SR, 2014, IRAN J ALLERGY ASTHM, V13, P256; Javaras KN, 2011, INT J EAT DISORDER, V44, P630, DOI 10.1002/eat.20864; Jorg S, 2016, CELL MOL LIFE SCI, V73, P4611, DOI 10.1007/s00018-016-2311-1; Kahn HS, 2009, DIABETES CARE, V32, P2010, DOI 10.2337/dc09-0891; Kemkes A, 2010, J BIOSOC SCI, V42, P177, DOI 10.1017/S002193200999054X; KORSGAARD J, 1983, CLIN ALLERGY, V13, P529, DOI 10.1111/j.1365-2222.1983.tb02634.x; Krementsov DN, 2013, MULT SCLER J, V19, P1684, DOI 10.1177/1352458513506954; Kuo CL, 2016, ALLERGY, V71, P1626, DOI 10.1111/all.12954; Kusunoki T, 1999, J ALLERGY CLIN IMMUN, V103, P1148, DOI 10.1016/S0091-6749(99)70191-0; Langgartner D, 2017, STRESS, V20, P10, DOI 10.1080/10253890.2016.1254186; Levitan RD, 2010, NEUROPSYCHOPHARMACOL, V35, P1729, DOI 10.1038/npp.2010.38; LIGHTFOOT RJ, 1967, AUST J AGR RES, V18, P755, DOI 10.1071/AR9670755; Lu CM, 2010, P NATL ACAD SCI USA, V107, P18967, DOI 10.1073/pnas.1008816107; Martinez-Bakker M, 2015, TRENDS ECOL EVOL, V30, P314, DOI 10.1016/j.tree.2015.03.012; McDowell TY, 2010, NEUROEPIDEMIOLOGY, V34, P238, DOI 10.1159/000297749; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Messias E, 2006, J NERV MENT DIS, V194, P870, DOI 10.1097/01.nmd.0000243762.63694.e6; Mika KM, 2016, AM J HUM GENET, V99, P1059, DOI 10.1016/j.ajhg.2016.09.002; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; MOCK EJ, 1980, BIOL REPROD, V22, P119, DOI 10.1095/biolreprod22.2.119; MOCK EJ, 1978, BIOL REPROD, V18, P772, DOI 10.1095/biolreprod18.5.772; MOCK EJ, 1975, NATURE, V256, P61, DOI 10.1038/256061a0; MOCK EJ, 1978, BIOL REPROD, V19, P927, DOI 10.1095/biolreprod19.4.927; Mohammad-Shahi M, 2011, BIOIMPACTS, V1, P161, DOI 10.5681/bi.2011.022; Moorthy LN, 2008, LUPUS, V17, P128, DOI 10.1177/0961203307085111; Nagamine Satomi, 2011, Open Orthop J, V5, P134, DOI 10.2174/1874325001105010134; Nakaya N, 2003, IN VITRO CELL DEV-AN, V39, P383, DOI 10.1290/1543-706X(2003)039<0383:ECSIPI>2.0.CO;2; Nelson RJ, 1996, Q REV BIOL, V71, P511, DOI 10.1086/419555; Norval M, 2008, PHOTOCHEM PHOTOBIOL, V84, P19, DOI 10.1111/j.1751-1097.2007.00239.x; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Ober C, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.1.33; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; OBER C, 1992, AM J HUM GENET, V50, P6; OBER CL, 1983, AM J HUM GENET, V35, P994; Ohzu E., 1963, ZOOL MAG TOKYO, V72, P139; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Parkes AS, 1926, BR J EXP BIOL, V4, P93; PATI AK, 1987, CELL IMMUNOL, V108, P227, DOI 10.1016/0008-8749(87)90207-3; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; PAYNE CM, 1986, DIAGN MICR INFEC DIS, V5, P39, DOI 10.1016/0732-8893(86)90090-8; Paynter S, 2015, J INFECTION, V70, P1, DOI 10.1016/j.jinf.2014.09.006; Pelikan J., 1981, Symposia of the Zoological Society of London, P205; PENNYCUIK PR, 1972, AUST J BIOL SCI, V25, P627; PLANELLES D, 1994, CELL PROLIFERAT, V27, P333, DOI 10.1111/j.1365-2184.1994.tb01430.x; Plytycz Barbara, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P157; Poltavskiy Eduard, 2016, Online J Public Health Inform, V8, pe186; POPE GS, 1954, DAIRY SCI ABSTR, V16, P334; Prasad M, 2010, PUBLIC HEALTH NUTR, V13, P939, DOI 10.1017/S1368980010001138; Rafii F, 2015, METABOLITES, V5, P56, DOI 10.3390/metabo5010056; Reddersen K, 2002, CHEMOSPHERE, V49, P539, DOI 10.1016/S0045-6535(02)00387-9; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P195, DOI 10.1177/074873049000500303; Roenneberg T, 2004, J BIOL RHYTHM, V19, P193, DOI 10.1177/0748730404264863; Salib E, 2006, BRIT J PSYCHIAT, V188, P416, DOI 10.1192/bjp.bp.105.009118; Saligrama N, 2014, FASEB J, V28, P1898, DOI 10.1096/fj.13-239939; SCHLAGER G, 1968, J HERED, V59, P363, DOI 10.1093/oxfordjournals.jhered.a107747; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Simmons SB, 2013, TRENDS IMMUNOL, V34, P410, DOI 10.1016/j.it.2013.04.006; Sofi MH, 2014, DIABETES, V63, P632, DOI 10.2337/db13-0981; Spach KM, 2009, J IMMUNOL, V182, P7776, DOI 10.4049/jimmunol.0900142; Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015; Staples J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1640; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P398, DOI 10.1016/j.jaci.2008.10.043; Stevenson TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1453; Teuschert C, 2006, P NATL ACAD SCI USA, V103, P8024, DOI 10.1073/pnas.0600536103; Thigpen JE, 2007, ENVIRON HEALTH PERSP, V115, P1717, DOI 10.1289/ehp.10165; Thigpen JE, 2013, J AM ASSOC LAB ANIM, V52, P130; Thysen AH, 2016, J ALLERGY CLIN IMMUN, V137, P1238, DOI 10.1016/j.jaci.2015.08.041; Torkildsen O, 2012, ACTA NEUROL SCAND, V126, P58, DOI 10.1111/ane.12040; Torkildsen O, 2014, ANN CLIN TRANSL NEUR, V1, P141, DOI 10.1002/acn3.37; Tyagi AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021216; van der Mei IAF, 2016, MULT SCLER J, V22, P461, DOI 10.1177/1352458515594040; Vassallo MF, 2010, ANN ALLERG ASTHMA IM, V104, P307, DOI 10.1016/j.anai.2010.01.019; Visser ME, 2010, PHILOS T R SOC B, V365, P3113, DOI 10.1098/rstb.2010.0111; Watson PE, 2007, EUR J CLIN NUTR, V61, P1271, DOI 10.1038/sj.ejcn.1602644; Wedekind C, 1996, HEREDITY, V77, P400, DOI 10.1038/hdy.1996.160; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Wolf KJ, 2014, J HISTOCHEM CYTOCHEM, V62, P237, DOI 10.1369/0022155413519650; WONG CC, 1983, J ENDOCRINOL, V97, P179, DOI 10.1677/joe.0.0970179	136	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2709	2719		10.1096/fj.201700062	http://dx.doi.org/10.1096/fj.201700062			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28292961	Green Published			2022-12-26	WOS:000401553400040
J	Robinson, PJ; Pringle, MA; Woolhead, CA; Bulleid, NJ				Robinson, Philip J.; Pringle, Marie Anne; Woolhead, Cheryl A.; Bulleid, Neil J.			Folding of a single domain protein entering the endoplasmic reticulum precedes disulfide formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PROTEINS; BOND FORMATION; IN-VITRO; ISOMERASE; MEMBRANE; RIBOSOME; TRANSLOCATION; CELLS; BETA(2)-MICROGLOBULIN; COMPLEX	The relationship between protein synthesis, folding, and disulfide formation within the endoplasmic reticulum (ER) is poorly understood. Previous studies have suggested that preexisting disulfide links are absolutely required to allow protein folding and, conversely, that protein folding occurs prior to disulfide formation. To address the question of what happens first within the ER, that is, protein folding or disulfide formation, we studied folding events at the early stages of polypeptide chain translocation into the mammalian ER using stalled translation intermediates. Our results demonstrate that polypeptide folding can occur without complete domain translocation. Protein disulfide isomerase (PDI) interacts with these early intermediates, but disulfide formation does not occur unless the entire sequence of the protein domain is translocated. This is the first evidence that folding of the polypeptide chain precedes disulfide formation within a cellular context and highlights key differences between protein folding in the ER and refolding of purified proteins.	[Robinson, Philip J.; Pringle, Marie Anne; Woolhead, Cheryl A.; Bulleid, Neil J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Bulleid, NJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk		Robinson, Philip/0000-0003-2576-5010; Bulleid, Neil/0000-0002-9839-5279; PRINGLE, MARIE ANNE/0000-0002-1358-4610	Wellcome Trust [103720]; BBSRC [BB/M017656/1, BB/D00764X/1, BB/L00593X/1, BB/P017665/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Wellcome Trust Grant 103720. The authors declare that they have no conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Ellgaard L, 2004, BIOCHEM SOC T, V32, P663, DOI 10.1042/BST0320663; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Frisch C, 1996, FOLD DES, V1, P431, DOI 10.1016/S1359-0278(96)00059-4; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; Irvine AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082511; ISENMAN DE, 1975, P NATL ACAD SCI USA, V72, P548, DOI 10.1073/pnas.72.2.548; Jackson SE, 2013, TOP CURR CHEM, V328, P1, DOI 10.1007/128_2011_171; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; KADERBHAI MA, 1985, EUR J BIOCHEM, V153, P167, DOI 10.1111/j.1432-1033.1985.tb09283.x; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; KLAPPA P, 1995, EUR J BIOCHEM, V232, P755, DOI 10.1111/j.1432-1033.1995.tb20870.x; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nilsson OB, 2015, CELL REP, V12, P1533, DOI 10.1016/j.celrep.2015.07.065; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeffer S, 2016, BBA-GEN SUBJECTS, V1860, P2122, DOI 10.1016/j.bbagen.2016.06.024; Qin M, 2015, P NATL ACAD SCI USA, V112, P11241, DOI 10.1073/pnas.1503909112; RUDIKOFF S, 1986, P NATL ACAD SCI USA, V83, P7875, DOI 10.1073/pnas.83.20.7875; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008	39	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					6978	6986		10.1074/jbc.M117.780742	http://dx.doi.org/10.1074/jbc.M117.780742			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28298446	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000400478300010
J	Bellucci, A; Tondelli, A; Fangel, JU; Torp, AM; Xu, X; Willats, WGT; Flavell, A; Cattivelli, L; Rasmussen, SK				Bellucci, Andrea; Tondelli, Alessandro; Fangel, Jonatan U.; Torp, Anna Maria; Xu, Xin; Willats, William G. T.; Flavell, Andrew; Cattivelli, Luigi; Rasmussen, Soren K.			Genome-wide association mapping in winter barley for grain yield and culm cell wall polymer content using the high-throughput CoMPP technique	PLOS ONE			English	Article							BYMOVIRUS RESISTANCE; BIOFUEL TRAITS; BIOMASS; GENE; PREDICTION; MARKER; IDENTIFICATION; ARABIDOPSIS; SOFTWARE; PROTEINS	A collection of 112 winter barley varieties (Hordeum vulgare L.) was grown in the field for two years (2008/09 and 2009/10) in northern Italy and grain and straw yields recorded. In the first year of the trial, a severe attack of barley yellow mosaic virus (BaYMV) strongly influenced final performances with an average reduction of similar to 50% for grain and straw harvested in comparison to the second year. The genetic determination (GD) for grain yield was 0.49 and 0.70, for the two years respectively, and for straw yield GD was low in 2009 (0.09) and higher in 2010 (0.29). Cell wall polymers in culms were quantified by means of the monoclonal antibodies LM6, LM11, JIM13 and BS-400-3 and the carbohydrate-binding module CBM3a using the high-throughput CoMPP technique. Of these, LM6, which detects arabinan components, showed a relatively high GD in both years and a significantly negative correlation with grain yield (GYLD). Overall, heritability (H-2) was calculated for GYLD, LM6 and JIM and resulted to be 0.42, 0.32 and 0.20, respectively. A total of 4,976 SNPs from the 9K iSelect array were used in the study for the analysis of population structure, linkage disequilibrium (LD) and genome-wide association study (GWAS). Marker-trait associations (MTA) were analyzed for grain yield and cell wall determination by LM6 and JIM13 as these were the traits showing significant correlations between the years. A single QTL for GYLD containing three MTAs was found on chromosome 3H located close to the Hv-eIF4E gene, which is known to regulate resistance to BaYMV. Subsequently the QTL was shown to be tightly linked to rym4, a locus for resistance to the virus. GWAs on arabinans quantified by LM6 resulted in the identification of major QTLs closely located on 3H and hypotheses regarding putative candidate genes were formulated through the study of gene expression levels based on bioinformatics tools.	[Bellucci, Andrea; Fangel, Jonatan U.; Torp, Anna Maria; Willats, William G. T.; Rasmussen, Soren K.] Univ Copenhagen, Dept Plant & Environm Sci, Fac Sci, Frederiksberg, Denmark; [Tondelli, Alessandro; Cattivelli, Luigi] Consiglio Ric & Sperimentaz Agr & Anal Econ Agr, Ctr Ric Genom Vegetale, Fiorenzuola Darda, Italy; [Xu, Xin; Flavell, Andrew] Univ Dundee, Sch Life Sci, Dundee, Scotland	University of Copenhagen; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Dundee	Rasmussen, SK (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Fac Sci, Frederiksberg, Denmark.	skr@plen.ku.dk	Tondelli, Alessandro/I-7433-2015; Torp, Anna Maria/I-8189-2014; cattivelli, luigi/AAE-7046-2020; Tondelli, Alessandro/AAJ-1720-2020; Rasmussen, Soren K./F-6728-2014	Tondelli, Alessandro/0000-0001-9299-7773; Torp, Anna Maria/0000-0001-8199-1480; cattivelli, luigi/0000-0002-6067-4600; Tondelli, Alessandro/0000-0001-9299-7773; Rasmussen, Soren K./0000-0001-6169-2504	Innovation Fund Denmark [001-2011-4]; Danish Council for Strategic Research, Biotechnology for Bioenergy, Bio4Bio [2104080039]; ERA-PG, grant Genomics-Assisted Analysis and Exploitation of Barley Diversity	Innovation Fund Denmark; Danish Council for Strategic Research, Biotechnology for Bioenergy, Bio4Bio; ERA-PG, grant Genomics-Assisted Analysis and Exploitation of Barley Diversity	This work was supported by the Innovation Fund Denmark B21st (http://innovationsfonden.dk/en), grant no. 001-2011-4 to SKR, the Danish Council for Strategic Research, Biotechnology for Bioenergy, Bio4Bio, grant no. 2104080039 to SKR, and the ERA-PG, grant Genomics-Assisted Analysis and Exploitation of Barley Diversity to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar T, 2009, PLANT BREEDING, V128, P381, DOI 10.1111/j.1439-0523.2008.01553.x; Alexandersson E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00286; Alonso-Simon A, 2010, BIOTECHNOL BIOENG, V105, P509, DOI 10.1002/bit.22546; Bailoni L, 2003, VET RES COMMUN, V27, P249, DOI 10.1023/B:VERC.0000014152.80334.86; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bellucci A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01046; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown TB, 2014, CURR OPIN PLANT BIOL, V18, P73, DOI 10.1016/j.pbi.2014.02.002; Burton RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00130; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Digel B, 2016, PLANT PHYSIOL, V172, P405, DOI 10.1104/pp.16.00977; Dwivedi SL, 2007, ADV AGRON, V95, P163, DOI 10.1016/S0065-2113(07)95003-8; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Granier C, 2014, CURR OPIN PLANT BIOL, V18, P96, DOI 10.1016/j.pbi.2014.02.009; Houston K, 2015, PLOS ONE, V10; Houston K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-907; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kai H, 2012, THEOR APPL GENET, V124, P577, DOI 10.1007/s00122-011-1730-5; Kuczynska A, 2013, J APPL GENET, V54, P381, DOI 10.1007/s13353-013-0165-x; Kumlehn J, BIOTECHNOLOGICAL APP; Lado B, 2013, G3-GENES GENOM GENET, V3, P2105, DOI 10.1534/g3.113.007807; Leplat F, 2016, BMC GENOMICS, V17, P15; Leplat F, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.09.0085; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lopes MS, 2015, THEOR APPL GENET, V128, P453, DOI 10.1007/s00122-014-2444-2; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Malosetti M, 2011, THEOR APPL GENET, V122, P1605, DOI 10.1007/s00122-011-1558-z; Marcotuli I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132787; Marzec M, 2015, J EXP BOT, V66, P1245, DOI 10.1093/jxb/eru475; Matthies IE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110046; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McCann MC, 2015, J EXP BOT, V66, P4109, DOI 10.1093/jxb/erv267; Mikkelsen D, 2015, BIOMACROMOLECULES, V16, P1232, DOI 10.1021/acs.biomac.5b00009; Mikkelsen MD, 2014, ANN BOT-LONDON, V114, P1217, DOI 10.1093/aob/mcu171; Mocoeur A, 2015, THEOR APPL GENET, V128, P1685, DOI 10.1007/s00122-015-2538-5; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Nakano Y, 2015, FRONT PLANT SCI, V6, P18; Nielsen NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094000; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Peltonen-Sainio P, 2009, FIELD CROP RES, V110, P85, DOI 10.1016/j.fcr.2008.07.007; Penning BW, 2014, PLANT PHYSIOL, V165, P1475, DOI 10.1104/pp.114.242446; Perovic D, 2014, THEOR APPL GENET, V127, P1061, DOI 10.1007/s00122-014-2279-x; Pritchard JK, 2000, GENETICS, V155, P945; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Ramstein GP, 2015, G3-GENES GENOM GENET, V5, P891, DOI 10.1534/g3.115.017533; Sang J, OS01G0883800 RICE WI; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Schwender H, 2012, J TOXICOL ENV HEAL A, V75, P438, DOI 10.1080/15287394.2012.674910; Schwerdt JG, 2015, PLANT PHYSIOL, V168, P968, DOI 10.1104/pp.15.00140; Sedlacek T, 2010, CZECH J GENET PLANT, V46, P159, DOI 10.17221/7/2010-CJGPB; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Slavov GT, 2014, NEW PHYTOL, V201, P1227, DOI 10.1111/nph.12621; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Technow F., 2014, R PACKAGE MOVING GRI; Tyler L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-25; Tyrka M, 2008, J APPL GENET, V49, P127, DOI 10.1007/BF03195605; Uma B, 2011, J PLANT PHYSIOL, V168, P2141, DOI 10.1016/j.jplph.2011.09.005; Visioni A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-424; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Yang F, 2013, PLANT BIOTECHNOL J, V11, P325, DOI 10.1111/pbi.12016; Yang P, 2014, THEOR APPL GENET, V127, P1625, DOI 10.1007/s00122-014-2324-9; Zhang ZY, 2015, FUNCT INTEGR GENOMIC, V15, P17, DOI 10.1007/s10142-014-0395-y	69	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173313	10.1371/journal.pone.0173313	http://dx.doi.org/10.1371/journal.pone.0173313			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301509	Green Submitted, Green Published, gold			2022-12-26	WOS:000396318300032
J	Paredes, OSL; Norris, D; de Oliveira, TG; Michalski, F				Landazuri Paredes, Omar Stalin; Norris, Darren; de Oliveira, Tadeu Gomes; Michalski, Fernanda			Water availability not fruitfall modulates the dry season distribution of frugivorous terrestrial vertebrates in a lowland Amazon forest	PLOS ONE			English	Article							WHITE-LIPPED PECCARIES; CAMERA-TRAP; TAYASSU-PECARI; LOCAL EXTINCTIONS; RAIN-FOREST; PATCH SIZE; HOME-RANGE; AREA; POPULATIONS; TOPOGRAPHY	Terrestrial vertebrate frugivores constitute one of the major guilds in tropical forests. Previous studies show that the meso-scale distribution of this group is only weakly explained by variables such as altitude and tree basal area in lowland Amazon forests. For the first time we test whether seasonally limiting resources (water and fallen fruit) affect the dry season distribution in 25 species of terrestrial vertebrates. To examine the effects of the spatial availability of fruit and water on terrestrial vertebrates we used a standardized, regularly spaced arrangement of camera-traps within 25km(2) of lowland Amazon forest. Generalized linear models (GLMs) were then used to examine the influence of four variables (altitude, distance to large rivers, distance to nearest water, and presence vs absence of fruits) on the number of photos on five functional groups (all frugivores, small, medium, large and very large frugivores) and on seven of the most abundant frugivore species (Cuniculus paca, Dasyprocta leporina, Mazama americana, Mazama nemorivaga, Myoprocta acouchy, Pecari tajacu and Psophia crepitans). A total of 279 independent photos of 25 species were obtained from 900 camera-trap days. For most species and three functional groups, the variation in the number of photos per camera was significantly but weakly explained by the GLMs (deviance explained ranging from 6.2 to 48.8%). Generally, we found that the presence of water availability was more important than the presence of fallen fruit for the groups and species studied. Medium frugivores, large-bodied frugivores, and two of the more abundant species (C. paca and P. crepitans) were recorded more frequently closer to water bodies; while none of the functional groups nor the most abundant species showed any significant relationship with the presence of fallen fruit. Two functional groups and two of the seven most common frugivore species assessed in the GLMs showed significant results with species-specific responses to altitude. Our findings provide a more detailed understanding of how frugivorous vertebrates cope with periods of water and fruit scarcity in lowland Amazon forests.	[Landazuri Paredes, Omar Stalin; Norris, Darren; Michalski, Fernanda] Univ Fed Amapa, Lab Ecol & Conservacao Vertebrados, Macapa, Amapa, Brazil; [Landazuri Paredes, Omar Stalin; Norris, Darren; Michalski, Fernanda] Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil; [de Oliveira, Tadeu Gomes] Univ Estadual Maranhao, Dept Biol, Ctr Ciencias Exatas & Nat, Sao Luis, Maranhao, Brazil; [de Oliveira, Tadeu Gomes; Michalski, Fernanda] Inst Procarnivoros, Sao Paulo, Brazil	Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa; Universidade Estadual do Maranhao	Michalski, F (corresponding author), Univ Fed Amapa, Lab Ecol & Conservacao Vertebrados, Macapa, Amapa, Brazil.; Michalski, F (corresponding author), Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil.; Michalski, F (corresponding author), Inst Procarnivoros, Sao Paulo, Brazil.	fmichalski@gmail.com	Michalski, Fernanda/J-4691-2012; Norris, Darren/J-5182-2012; Oliveira, Tadeu/M-6095-2016	Michalski, Fernanda/0000-0002-8074-9964; Norris, Darren/0000-0003-0015-8214; Oliveira, Tadeu/0000-0002-8760-3159	Brazilian National Counsel of Technological and Scientific Development ("Conselho Nacional de Desenvolvimento Cientifico e Tecnologico"CNPq) [MCTI/CNPQ/Universal 14/2014: 446926/2014-0]; Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"-CAPES); CNPq [301562/2015-6]	Brazilian National Counsel of Technological and Scientific Development ("Conselho Nacional de Desenvolvimento Cientifico e Tecnologico"CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"-CAPES); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian National Counsel of Technological and Scientific Development (Conselho Nacional de Desenvolvimento Cientifico e TecnologicoCNPq) [grant number MCTI/CNPQ/Universal 14/2014: 446926/2014-0]. OSLP received a MSc scholarship from the Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"-CAPES). FM receives a productivity scholarship from CNPq (Process 301562/2015-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler GH, 1997, J ZOOL, V241, P43, DOI 10.1111/j.1469-7998.1997.tb05498.x; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Aliaga-Rossel E, 2008, J TROP ECOL, V24, P367, DOI 10.1017/S0266467408005129; ANA, SIST MON HIDR HYDR M; Anile S, 2016, ANIM CONSERV, V19, P35, DOI 10.1111/acv.12214; Barroso GM, 1999, FRUTOS SEMENTES MORF, DOI DOI 10.17801/0101-3122/RBS.V21N2P64-69; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Benchimol M, 2014, AM J PRIMATOL, V76, P289, DOI 10.1002/ajp.22233; Bicknell J, 2010, FOREST ECOL MANAG, V259, P2267, DOI 10.1016/j.foreco.2010.02.027; BODMER RE, 1991, OECOLOGIA, V85, P361, DOI 10.1007/BF00320611; BODMER RE, 1990, OIKOS, V57, P319, DOI 10.2307/3565960; BODMER RE, 1990, J ZOOL, V222, P121, DOI 10.1111/j.1469-7998.1990.tb04034.x; Bodmer Richard, 2006, Conservation Biology Series (Cambridge), V11, P232; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Carrillo E, 2002, BIOL CONSERV, V108, P317, DOI 10.1016/S0006-3207(02)00118-0; Chatterjee Soumik, 2015, Proceedings of the Zoological Society (Calcutta), V68, P147, DOI 10.1007/s12595-014-0112-9; Cornejo F., 2010, SEEDS AMAZONIAN PLAN; da Rocha DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154624; de Oliveira TG, 2014, J MAMM EVOL, V21, P427, DOI 10.1007/s10914-013-9251-4; Dubost G, 2006, J TROP ECOL, V22, P641, DOI 10.1017/S0266467406003440; Dunn PK, 2014, VEGAN COMMUNITY ECOL; Eisenberg JF., 1999, MAMMALS NEOTROPICS C; ERARD C, 1991, Gibier Faune Sauvage, V8, P183; Erard C, 2007, REV ECOL-TERRE VIE, V62, P323; ESRI, 2015, ARCGIS DESKT REL 10; Feer F, 1997, NEOTROPICAL RAINFORE; Fleming TH, 2011, ACTA OECOL, V37, P521, DOI 10.1016/j.actao.2011.01.016; Garrote G, 2011, EUR J WILDLIFE RES, V57, P355, DOI 10.1007/s10344-010-0440-7; Gayot M, 2004, J TROP ECOL, V20, P31, DOI 10.1017/S0266467404006157; Gentry A. H, 1996, FIELD GUIDE FAMILIES; Hanya G, 2010, ECOL RES, V25, P1081, DOI 10.1007/s11284-010-0733-z; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hawes JE, 2014, OIKOS, V123, P365, DOI 10.1111/j.1600-0706.2013.00745.x; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; ICMBio, 2014, PLAN MAN NAC AM I CH; Jiménez Carlos F., 2010, Rev. peru biol., V17, P191; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Keuroghlian A, 2004, BIOL CONSERV, V120, P411, DOI 10.1016/j.biocon.2004.03.016; Kitamura S, 2002, OECOLOGIA, V133, P559, DOI 10.1007/s00442-002-1073-7; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Laurance SGW, 2010, J VEG SCI, V21, P96, DOI 10.1111/j.1654-1103.2009.01122.x; Magnusson W.E., 2013, BIODIVERSIDADE MONIT; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Pontes ARM, 2012, BIOTROPICA, V44, P834, DOI 10.1111/j.1744-7429.2012.00873.x; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Michalski LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126114; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Negroes N, 2011, BIODIVERS CONSERV, V20, P505, DOI 10.1007/s10531-010-9961-3; Nogueira-Filho S. L. G., 2004, PEOPLE NATURE WILDLI, P464; Norris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106150; Norris D, 2010, J MAMMAL, V91, P551, DOI 10.1644/09-MAMM-A-199.1; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Farrill G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095049; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliveira TG, 2016, ORYX; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2000, J TROP ECOL, V16, P287, DOI 10.1017/S0266467400001413; PERES CA, 1999, MAMMALS NEOTROPICS C, P564; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Peres CA, 2016, P NATL ACAD SCI USA, V113, P892, DOI 10.1073/pnas.1516525113; Pickles RSA, 2011, BIOTA NEOTROP, V11, P237, DOI 10.1590/S1676-06032011000300021; R Development Core Team, 2015, LANG ENV STAT COMP; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Reis NR, 2006, MAMIFEROS DO BRASIL; Reyna-Hurtado R, 2015, BIODIVERSITY AND CONSERVATION OF THE YUCATAN PENINSULA, P227, DOI 10.1007/978-3-319-06529-8_10; Reyna-Hurtado R, 2012, J MAMMAL, V93, P124, DOI 10.1644/10-MAMM-A-384.1; Reyna-Hurtado R, 2010, ORYX, V44, P89, DOI 10.1017/S0030605309990664; Reyna-Hurtado R, 2009, J MAMMAL, V90, P1199, DOI 10.1644/08-MAMM-A-246.1; Rich LN, 2016, J APPL ECOL, V53, P1225, DOI 10.1111/1365-2664.12650; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Schleuning M, 2011, ECOLOGY, V92, P26, DOI 10.1890/09-1842.1; Sick H., 1997, ORNITOLOGIA BRASILEI; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; SMYTHE N, 1970, American Naturalist, V104, P25, DOI 10.1086/282638; SMYTHE N, 1986, ANNU REV ECOL SYST, V17, P169; TEAM Network, 2011, TERRESTRIAL VERTEBRA; Terborgh J., 1986, Tasks for Vegetation Science, V15, P371; Terborgh JW, 1984, NEW SERIES, V21, P1; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wilting A, 2012, ORYX, V46, P423, DOI 10.1017/S0030605311001694	84	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174049	10.1371/journal.pone.0174049	http://dx.doi.org/10.1371/journal.pone.0174049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301589	gold, Green Published, Green Submitted			2022-12-26	WOS:000396318300120
J	Zhou, LF; Zhang, MX; Kong, LQ; Liu, JJ; Feng, QM; Lu, W; Wei, B; Zhao, LP				Zhou, Li-fang; Zhang, Mao-xin; Kong, Ling-qian; Liu, Jun-jun; Feng, Qi-ming; Lu, Wei; Wei, Bo; Zhao, Lue Ping			Assessment of potential factors associating with costs of hospitalizing cardiovascular diseases in 141 hospitals in Guangxi, China	PLOS ONE			English	Article							HEALTH-INSURANCE; HEART-FAILURE; TRENDS	Background The rising cost of healthcare is of great concern in China, as evidenced by the media features negative reports almost daily. However there are only a few studies from well-developed cities, like Beijing or Shanghai, and little is known about healthcare costs in rest of the country. In this study, we use hospitalization summary reports (HSRs) from admitted cardiovascular diseases patients in Guangxi hospitals during 2013 - 2016, and we investigate temporal trends of healthcare costs and associated factors. Methods By generalized additive model, we compute temporal trends of cost per stay (CPS), cost per day (CPD) and others. We then use generalized linear models to assess which factors associate with CPS and CPD. Findings Using a total of 760,000 HSRs, we find that CPS appears to be stabilized around $ 1040 until the middle of year 2015, before exhibiting a downward trend. Similarly, CPD exhibits similar stable pattern. Meanwhile, surgery-specific CPS showed an increase in year 2013 - 2014, and then stabilized. Drug costs account for over 1/3 of CPS, but they are gradually declining. Costs associated with physicians' and nurses' services represent less than 5% of CPS. We found that age, sex, marital status, occupation and payment methods are significantly associated with CPS or CPD. Interestingly, we found no association between patient ethnicity and these costs. However, we did find that minority patients use more secondary hospitals than Han patients. Interpretations Healthcare costs in Guangxi are stable, contrary to the rise portrayed by Chinese mass media. Several factors can be associated with healthcare costs, and these may be useful for developing evidence-based policies. In particular, there is a need to encourage more Han patients to seek care in primary and secondary hospitals.	[Zhou, Li-fang; Zhang, Mao-xin; Liu, Jun-jun; Feng, Qi-ming; Wei, Bo] Guangxi Med Univ, Nanning, Peoples R China; [Zhou, Li-fang] Guangxi Med Univ, Fourth Affiliated Hosp, Liuzhou, Peoples R China; [Zhou, Li-fang; Zhao, Lue Ping] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Kong, Ling-qian; Lu, Wei] Hlth & Family Planning Commiss Guangxi, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Wei, B (corresponding author), Guangxi Med Univ, Nanning, Peoples R China.; Zhao, LP (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA.	weibogx@163.com; lzhao@fredhutch.org			Guangxi Education Department [YCBZ2015034]	Guangxi Education Department	This work is supported by Guangxi Education Department Grant (YCBZ2015034) entitled "Innovation Project of Guangxi Graduate Education" (LFZ). Other investigators are supported by their respective institutional supports.	Berry C, 2001, EUR J HEART FAIL, V3, P283, DOI 10.1016/S1388-9842(01)00123-4; Burner S T, 1992, Health Care Financ Rev, V14, P1; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; CHEN WWG, 2014, CHINESE CIRCULATION, V30, P617; Gao Sulan LW, 2013, CHINA MED ENG, V21, P133; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hongyu YGLSZ, 2013, J CHONGQING MED U, V38, P1378; Jia GS, 2013, J PEIKING U, V45, P382; Klenk J, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0089-x; Li C, 2011, SOC SCI MED, V73, P359, DOI 10.1016/j.socscimed.2011.06.002; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; McCullagh P, 1989, GEN LINEAR MODEL; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Sekhri N, 2005, B WORLD HEALTH ORGAN, V83, P127; Sun Xinxin YZ, 2013, MODERN BUSINESS TRAD, P132; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033; Wu ZS, 2001, CIRCULATION, V103, P462; Xu Ling MQ, 2014, CHINESE J HLTH INFOR, P193; Xu Lixin LD, 2015, MOD HOSP, V15, P121; Yang Yuting, 2015, SHANGHAI CHIN J HOSP, V31, P271; Yao X, 2015, CHINESE HLTH EC, V34, P31; Zhang Qian ZD, 2016, J CARDIOVASCULAR PUL, V35, P75; Zhao LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072166; Zhengjie LBZZF, 2006, CHINA TROPICAL MED, V6, P1513; 辛然, 2014, [中国老年学杂志, Chinese Journal of Gerontology], V34, P4308	27	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173451	10.1371/journal.pone.0173451	http://dx.doi.org/10.1371/journal.pone.0173451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301501	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300041
J	Garcia-Hermoso, A; Carrillo, HA; Gonzalez-Ruiz, K; Vivas, A; Triana-Reina, HR; Martinez-Torres, J; Prieto-Benavidez, DH; Correa-Bautista, JE; Ramos-Sepulveda, JA; Villa-Gonzalez, E; Peterson, MD; Ramirez-Velez, R				Garcia-Hermoso, Antonio; Alejandro Carrillo, Hugo; Gonzalez-Ruiz, Katherine; Vivas, Andres; Reynaldo Triana-Reina, Hector; Martinez-Torres, Javier; Humberto Prieto-Benavidez, Daniel; Enrique Correa-Bautista, Jorge; Alexander Ramos-Sepulveda, Jeison; Villa-Gonzalez, Emilio; Peterson, Mark D.; Ramirez-Velez, Robinson			Fatness mediates the influence of muscular fitness on metabolic syndrome in Colombian collegiate students	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; MUSCLE STRENGTH; HANDGRIP STRENGTH; AEROBIC FITNESS; GRIP STRENGTH; DISEASE; ASSOCIATIONS; DEFINITION; STATEMENT; EXERCISE	The purpose of this study was two-fold: to analyze the association between muscular fitness (MF) and clustering of metabolic syndrome (MetS) components, and to determine if fatness parameters mediate the association between MF and MetS clustering in Colombian collegiate students. This cross-sectional study included a total of 886 (51.9% women) healthy collegiate students (21.4 +/- 3.3 years old). Standing broad jump and isometric handgrip dynamometry were used as indicators of lower and upper body MF, respectively. Also, a MF score was computed by summing the standardized values of both tests, and used to classify adults as fit or unfit. We also assessed fat mass, body mass index, waist-to-height ratio, and abdominal visceral fat, and categorized individuals as low and high fat using international cut-offs. A MetS cluster score was derived by calculating the sum of the sample-specific z-scores from the triglycerides, HDL cholesterol, fasting glucose, waist circumference, and arterial blood pressure. Linear regression models were used to examine whether the association between MF and MetS cluster was mediated by the fatness parameters. Data were collected from 2013 to 2016 and the analysis was done in 2016. Findings revealed that the best profiles (fit + low fat) were associated with lower levels of the MetS clustering (p < 0.001 in the four fatness parameters), compared with unfit and fat (unfit + high fat) counterparts. Linear regression models indicated a partial mediating effect for fatness parameters in the association of MF with MetS clustering. Our findings indicate that efforts to improve MF in young adults may decrease MetS risk partially through an indirect effect on improvements to adiposity levels. Thus, weight reduction should be taken into account as a complementary goal to improvements in MF within exercise programs.	[Garcia-Hermoso, Antonio] Univ Santiago Chile, USACH, Fac Ciencias Med, Lab Ciencias Actividad Fis Deporte & Salud, Santiago, Chile; [Alejandro Carrillo, Hugo] Univ Valle, Programa Educ Fis & Deportes, Grp GRINDER, Santiago De Cali, Colombia; [Gonzalez-Ruiz, Katherine; Vivas, Andres] Univ Manuela Beltran, Grp Ejercicio Fis & Deportes, Vicerrectoria Invest, Bogota, Colombia; [Reynaldo Triana-Reina, Hector; Martinez-Torres, Javier] Univ Santo Tomas, Fac Cultura Fis Deporte & Recreac, Grp GICAEDS, Bogota, Colombia; [Humberto Prieto-Benavidez, Daniel; Enrique Correa-Bautista, Jorge; Ramirez-Velez, Robinson] Univ Rosario, Escuela Med & Ciencias Salud, Ctr Estudios Med Actividad Fis CEMA, Bogota, Colombia; [Alexander Ramos-Sepulveda, Jeison] Inst Univ Antonio Jose Camacho, Fac Educ Distancia & Virtual, Santiago De Cali, Colombia; [Villa-Gonzalez, Emilio] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sport, PROFITH PROmoting FITness & Hlth Phys Act Res Grp, Granada, Spain; [Peterson, Mark D.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Peterson, Mark D.] Univ Michigan, Sch Med, Global REACH, Ann Arbor, MI USA	Universidad de Santiago de Chile; Universidad del Valle; Universidad Manuela Beltran - UMB; Universidad Santo Tomas USTA; Universidad del Rosario; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Garcia-Hermoso, A (corresponding author), Univ Santiago Chile, USACH, Fac Ciencias Med, Lab Ciencias Actividad Fis Deporte & Salud, Santiago, Chile.	antonio.garcia.h@usach.cl	García-Hermoso, Antonio/P-1857-2017; Garcia-Hermoso, Antonio/AGK-7815-2022; /AGR-8343-2022; Villa-González, Emilio/G-6421-2015; Ramírez-Vélez, Robinson/D-5311-2016; García-Hermoso, Antonio/ADU-2591-2022; Peterson, Mark/ABD-3853-2020; González-Ruíz, Katherine/AGI-4611-2022; Correa-Bautista, Jorge Enrique/N-2741-2015	García-Hermoso, Antonio/0000-0002-1397-7182; Garcia-Hermoso, Antonio/0000-0002-1397-7182; /0000-0001-8991-5079; Villa-González, Emilio/0000-0002-2815-2060; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Peterson, Mark/0000-0002-9861-4275; González-Ruíz, Katherine/0000-0001-7518-0761; Vivas, Andres/0000-0001-8169-1664; Ramos-Sepulveda, Jeison Alexander/0000-0003-2734-7912; TRIANA R, HECTOR REYNALDO/0000-0002-6334-7082; Correa-Bautista, Jorge Enrique/0000-0002-0646-2316	Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario [FIUR DN-BG001]; Proyectos Basales y Vicerrectoria de Investigacion, Desarrollo e Innovacion" (Universidad de Santiago de Chile, USACH); Institucion Universitaria Antonio Jose Camacho [PI-0516]	Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario; Proyectos Basales y Vicerrectoria de Investigacion, Desarrollo e Innovacion" (Universidad de Santiago de Chile, USACH)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Institucion Universitaria Antonio Jose Camacho	This work was supported by the Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario FIUR DN-BG001. AGH is funded by Proyectos Basales y Vicerrectoria de Investigacion, Desarrollo e Innovacion" (Universidad de Santiago de Chile, USACH). RR-V and JEC-B are funded by Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario (Code No FIUR DN-BG001), JAR-S funded by Institucion Universitaria Antonio Jose Camacho (Code No PI-0516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amato MC, 2013, J ENDOCRINOL INVEST, V36, P537, DOI 10.3275/8943; Vivas-Diaz JA, 2016, NUTR HOSP, V33, P330; [Anonymous], 2000, WHO TECHN REP SER; Aoyama T, 2011, J PHYSIOL ANTHROPOL, V30, P133, DOI 10.2114/jpa2.30.133; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Diez-Fernandez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116506; dong-il Kim, 2012, Journal of Obesity & Metabolic Syndrome, V21, P99, DOI 10.7570/kjo.2012.21.2.99; Eisenmann JC, 2005, AM HEART J, V149, P46, DOI 10.1016/j.ahj.2004.07.016; Eisenmann JC, 2007, MED SCI SPORT EXER, V39, P1251, DOI 10.1249/MSS.0b013e318064c8b0; Fraser BJ, 2016, MED SCI SPORT EXER, V48, P1715, DOI 10.1249/MSS.0000000000000955; Gaster M, 2002, APMIS, V110, P611, DOI 10.1034/j.1600-0463.2002.1100903.x; Han TS, 2002, OBES RES, V10, P923, DOI 10.1038/oby.2002.126; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hulens M, 2001, INT J OBESITY, V25, P676, DOI 10.1038/sj.ijo.0801560; Jakicic JM, 2011, CURR CARDIOVASC RISK, V5, P113, DOI 10.1007/s12170-011-0158-4; Jekal Y, 2009, INT J SPORTS MED, V30, P733, DOI 10.1055/s-0029-1224173; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Macias N, 2014, BMC PUBLIC HEALTH, V14, P1; MacKinnon D.P., 2012, INTRO STAT MEDIATION; McAuley PA, 2011, J SPORT SCI, V29, P773, DOI 10.1080/02640414.2011.553965; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; Moliner-Urdiales D, 2011, BRIT J SPORT MED, V45, P101, DOI 10.1136/bjsm.2009.062430; Myers R, 2000, CLASSICAL MODERN REG, V2nd, P488; ORTEGA FB, 2012, BMJ, V345; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ramirez-Velez R, 2016, J PEDIATR-US, V179, P82, DOI 10.1016/j.jpeds.2016.08.099; Ramirez-Velez R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3678-5; Ramirez-Velez R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1043-2; Ramirez-Velez R, 2015, NUTR HOSP, V31, P793, DOI [10.3305/nh.2015.31.2.7910, 10.3305/nh.2014.30.4.7684]; Ramírez-Vélez Robinson, 2012, Rev. salud pública, V14, P226, DOI 10.1590/S0124-00642012000200004; Roberts CK, 2015, MED SCI SPORT EXER, V47, P1211, DOI 10.1249/MSS.0000000000000526; Sacheck JM, 2010, MED SCI SPORT EXER, V42, P1039, DOI 10.1249/MSS.0b013e3181c9216b; Sayer AA, 2007, QJM-INT J MED, V100, P707, DOI 10.1093/qjmed/hcm095; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stenholm S, 2010, REJUV RES, V13, P3, DOI 10.1089/rej.2009.0891; Stewart KJ, 2005, AM J PREV MED, V28, P9, DOI 10.1016/j.amepre.2004.09.006; Strand B. H., 2016, J EPIDEMIOL COMMUNIT; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Wijndaele K, 2007, MED SCI SPORT EXER, V39, P233, DOI 10.1249/01.mss.0000247003.32589.a6; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; Wing RR, 2007, MED SCI SPORT EXER, V39, P2107, DOI 10.1249/mss.0b013e31815614cb	44	20	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173932	10.1371/journal.pone.0173932	http://dx.doi.org/10.1371/journal.pone.0173932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296952	Green Published, gold			2022-12-26	WOS:000396311700079
J	Novinrooz, A; Salehi, TZ; Firouzi, R; Arabshahi, S; Derakhshandeh, A				Novinrooz, Aytak; Salehi, Taghi Zahraei; Firouzi, Roya; Arabshahi, Sina; Derakhshandeh, Abdollah			In-silico design, expression, and purification of novel chimeric Escherichia coli O157: H7 OmpA fused to LTB protein in Escherichia coli	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; HEAT-LABILE ENTEROTOXIN; HEMOLYTIC-UREMIC-SYNDROME; B-SUBUNIT; INFECTION; VACCINE; EHEC; VIRULENCE; OUTBREAK; ANTIBODY	E. coli O157: H7, one of the major EHEC serotypes, is capable of developing bloody diarrhea, hemorrhagic colitis (HC), and fatal hemolytic uremic syndrome (HUS) and is accompanied by high annual economic loss worldwide. Due to the increased risk of HC and HUS development following antibiotic therapy, the prevention of infections caused by this pathogen is considered to be one of the most effective ways of avoiding the consequences of this infection. The main aim of the present study was to design, express, and purify a novel chimeric protein to develope human vaccine candidate against E. coli O157: H7 containing loop 2-4 of E. coli O157: H7, outer membrane protein A (OmpA), and B subunit of E. coli heat labile enterotoxin (LTB) which are connected by a flexible peptide linker. Several online databases and bioinformatics software were utilized to choose the peptide linker among 537 analyzed linkers, design the chimeric protein, and optimize the codon of the relative gene encoding this protein. Subsequently, the recombinant gene encoding OmpA-LTB was synthesized and cloned into pET-24a (+) expression vector and transferred to E. coli BL21 (DE3) cells. The expression of OmpA-LTB chimeric protein was then carried out by induction of cultured E. coli Bl21 (DE3) cells with 1mM isopropyl-beta-D-thiogalactopyranoside (IPTG). The purification of OmpA-LTB was then performed by nickel affinity chromatography. Expression and purification were analyzed by sodium dodecyl sulphate poly acrylamide gel electrophoresis. Moreover, the identity of the expressed protein was analyzed by western blotting. SDS-PAGE and western immunoblotting confirmed the successful expression of a 27 KDa recombinant protein after 24 hours at 37 degrees C post-IPTG induction. OmpA-LTB was then successfully purified, using nickel affinity chromatography under denaturing conditions. The yield of purification was 12 mg per liter of culture media. Ultimately, we constructed the successful design and efficient expression and purification of OmpA-LTB divalent under the above-mentioned conditions.	[Novinrooz, Aytak; Firouzi, Roya; Arabshahi, Sina; Derakhshandeh, Abdollah] Shiraz Univ, Sch Vet Med, Dept Pathobiol, Shiraz, Iran; [Salehi, Taghi Zahraei] Univ Tehran, Fac Vet Med, Dept Microbiol & Immunol, Tehran, Iran	Shiraz University; University of Tehran	Salehi, TZ (corresponding author), Univ Tehran, Fac Vet Med, Dept Microbiol & Immunol, Tehran, Iran.	tsalehi@ut.ac.ir	Derakhshandeh, abdollah/X-1124-2018; Derakhshandeh, Abdollah/B-5387-2015	Derakhshandeh, abdollah/0000-0002-1878-1103; Derakhshandeh, Abdollah/0000-0002-1878-1103; Novinrooz, Aytak/0000-0001-8615-7065; Zahraei Salehi, Taghi/0000-0002-5665-5757; Arabshahi, Sina/0000-0003-0048-3068				Abe Yoshihiro, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P32, DOI 10.1089/mab.2012.0069; Amani J, 2010, VACCINE, V28, P6923, DOI 10.1016/j.vaccine.2010.07.061; Bardiau M, 2010, J APPL MICROBIOL, V109, P2214, DOI 10.1111/j.1365-2672.2010.04855.x; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Carson M, 2007, ACTA CRYSTALLOGR D, V63, P295, DOI 10.1107/S0907444906052024; Chung WY, 2006, J BIOL CHEM, V281, P39465, DOI 10.1074/jbc.M606038200; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Deng GC, 2013, J BIOSCI BIOENG, V115, P147, DOI 10.1016/j.jbiosc.2012.09.009; Farsani Hassan Heydari, 2015, World J Methodol, V5, P230, DOI 10.5662/wjm.v5.i4.230; Farshadpour F, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.11261; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Goldwater PN, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-12; Hsieh WS, 2016, J MICROBIOL IMMUNOL, V49, P329, DOI 10.1016/j.jmii.2014.07.012; Hu R, 2013, ISR J VET MED, V68, P48; Janeway C., 2001, IMMUNOBIOLOGY 5 IMMU, Vfifth; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kawai K, 2004, VACCINE, V22, P3411, DOI 10.1016/j.vaccine.2004.02.026; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Kuhne SA, 2004, J CLIN MICROBIOL, V42, P2966, DOI 10.1128/JCM.42.7.2966-2976.2004; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Matkovic-Calogovic D, 1999, J BIOL CHEM, V274, P8764; Mehr Kowsar Shariati, 2012, Iranian Biomedical Journal, V16, P133, DOI 10.6091/ibj.1059.2012; Missiakas D, 2016, J EXP MED, V213, P1645, DOI 10.1084/jem.20160569; Mohawk KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/258185; Mudrak B, 2010, TOXINS, V2, P1445, DOI 10.3390/toxins2061445; Nazarian S, 2012, J MICROBIOL METH, V90, P36, DOI 10.1016/j.mimet.2012.04.001; Nguyen Y, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00090; Orth D, 2008, EXPERT REV ANTI-INFE, V6, P101, DOI 10.1586/14787210.6.1.101; Page AV, 2013, MED CLIN N AM, V97, P681, DOI 10.1016/j.mcna.2013.04.001; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Rad HS, 2013, IRAN J MICROBIOL, V5, P244; Ran XQ, 2008, VET MICROBIOL, V127, P209, DOI 10.1016/j.vetmic.2007.08.021; Salimian J, 2010, IRAN J MICROBIOL, V2, P120; Sartz L, 2008, EPIDEMIOL INFECT, V136, P370, DOI 10.1017/S0950268807008473; Schets FM, 2005, WATER RES, V39, P4485, DOI 10.1016/j.watres.2005.08.025; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Soulas C, 2000, J IMMUNOL, V165, P2335, DOI 10.4049/jimmunol.165.5.2335; Torres AG, 2006, INFECT IMMUN, V74, P2676, DOI 10.1128/IAI.74.5.2676-2685.2006; Torres AG, 2003, INFECT IMMUN, V71, P4985, DOI 10.1128/IAI.71.9.4985-4995.2003; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Wu HH, 2009, J NEUROPATH EXP NEUR, V68, P677, DOI 10.1097/NEN.0b013e3181a77d1e; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou WY, 2009, VACCINE, V27, P5013, DOI 10.1016/j.vaccine.2009.05.009	45	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173761	10.1371/journal.pone.0173761	http://dx.doi.org/10.1371/journal.pone.0173761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296951	Green Submitted, gold, Green Published			2022-12-26	WOS:000396311700057
J	Vertucci, S; Pepper, M; Edwards, DL; Roberts, JD; Mitchell, N; Keogh, JS				Vertucci, Samantha; Pepper, Mitzy; Edwards, Danielle L.; Roberts, J. Dale; Mitchell, Nicola; Keogh, J. Scott			Evolutionary and natural history of the turtle frog, Myobatrachus gouldii, a bizarre myobatrachid frog in the southwestern Australian biodiversity hotspot	PLOS ONE			English	Article							ARENOPHRYNE-ROTUNDA TYLER; PHYLOGENETIC-RELATIONSHIPS; NEOBATRACHUS ANURA; POPULATION HISTORY; GENETIC-STRUCTURE; MITOCHONDRIAL; SPECIATION; NUCLEAR; PHYLOGEOGRAPHY; REFUGIA	Southwest Australia (SWA) is a global biodiversity hotspot and a centre of diversity and endemism for the Australo-Papuan myobatrachid frogs. Myobatrachus gouldii (the turtle frog) has a highly derived morphology associated with its forward burrowing behaviour, largely subterranean habit, and unusual mode of reproduction. Its sister genera Metacrinia and Arenophryne have restricted distributions in Western Australia with significant phylogeographic structure, leading to the recent description of a new species in the latter. In contrast, Myobatrachus is distributed widely throughout SWA over multiple climatic zones, but little is known of its population structure, geographic variation in morphology, or reproduction. We generated molecular and morphological data to test for genetic and morphological variation, and to assess whether substrate specialisation in this species may have led to phylogeographic structuring similar to that of other plant and animal taxa in SWA. We assembled sequence data for one mitochondrial and four nuclear DNA loci (3628 base pairs) for 42 turtle frogs sampled throughout their range. Likelihood phylogenetic analyses revealed shallow phylogeographic structure in the mtDNA locus (up to 3.3% genetic distance) and little variation in three of the four nDNA loci. The mtDNA haplotype network suggests five geographically allopatric groups, with no shared haplotypes between regions. These geographic patterns are congruent with several other SWA species, with genetic groups restricted to major hydrological divisions, the Swan Coastal Plain, and the Darling Scarp. The geographically structured genetic groups showed no evidence of significant morphological differentiation (242 individuals), and there was little sexual size dimorphism, but subtle differences in reproductive traits suggest more opportunistic breeding in lower rainfall zones. Call data were compared to sister genera Metacrinia and Arenophryne and found to be highly conservative across the three genera. Like many taxa in SWA, topographic variation and Plio-Pleistocene arid fluctuations likely were historic drivers of diversification in M. gouldii.	[Vertucci, Samantha; Pepper, Mitzy; Keogh, J. Scott] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Edwards, Danielle L.] Univ Calif, Sch Nat Sci, Merced, CA USA; [Roberts, J. Dale] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia; [Mitchell, Nicola] Univ Western Australia, Sch Anim Biol, Crawley, Australia	Australian National University; University of California System; University of California Merced; University of Western Australia; University of Western Australia	Keogh, JS (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	Scott.Keogh@anu.edu.au	Mitchell, Nicola/AAE-4132-2020; Keogh, Scott/C-8441-2009; Mitchell, Nicola/K-5277-2012	Keogh, Scott/0000-0002-1373-6186; Edwards, Danielle/0000-0002-1165-4427; Pepper, Mitzy/0000-0003-4828-9977; Mitchell, Nicola/0000-0003-0744-984X	Australian Research Council [DP0662772]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (http://www.arc.gov.au/), grant number DP0662772, awarded to JSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RR, 2002, AUST J EARTH SCI, V49, P3, DOI 10.1046/j.1440-0952.2002.00912.x; Anstis Marion, 2007, Records of the Western Australian Museum, V23, P259; Beard JS, 2000, J BIOGEOGR, V27, P1257, DOI 10.1046/j.1365-2699.2000.00509.x; Berry O, 2001, J HERPETOL, V35, P136, DOI 10.2307/1566037; BULL CM, 1978, AUST J ZOOL, V26, P305, DOI 10.1071/ZO9780305; Burton TC, 2001, AUST J ZOOL, V49, P539, DOI 10.1071/ZO01045; Byrne M, 2002, J EVOLUTION BIOL, V15, P576, DOI 10.1046/j.1420-9101.2002.00429.x; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; CALABY J. H., 1956, WESTERN AUSTRALIAN NAT, V5, P93; Camargo A, 2006, BIOL J LINN SOC, V87, P325, DOI 10.1111/j.1095-8312.2006.00581.x; Catullo Renee A., 2011, Zootaxa, V2902, P1; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; COGGER HG, 1992, REPTILES AMPHIBIANS; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; DAVIES M, 1984, AUST J ZOOL, V32, P789, DOI 10.1071/ZO9840789; Davis RA, 2005, AUST J ZOOL, V53, P167, DOI 10.1071/ZO04021; Dodson JR, 2004, GLOBAL PLANET CHANGE, V41, P285, DOI 10.1016/j.gloplacha.2004.01.013; Doughty Paul, 2008, Records of the Western Australian Museum, V24, P121, DOI 10.18195/issn.0312-3162.24(2).2008.121-131; Driscoll DA, 1998, EVOLUTION, V52, P1147, DOI 10.1111/j.1558-5646.1998.tb01841.x; Edwards DL, 2008, J BIOGEOGR, V35, P1803, DOI 10.1111/j.1365-2699.2008.01927.x; Edwards DL, 2007, MOL PHYLOGENET EVOL, V45, P494, DOI 10.1016/j.ympev.2007.05.023; Edwards DL, 2007, MOL ECOL, V16, P2782, DOI 10.1111/j.1365-294X.2007.03374.x; FRAKES LA, 1999, FLORA AUSTR, V0001, P00163; Gamble T, 2008, MOL PHYLOGENET EVOL, V48, P112, DOI 10.1016/j.ympev.2008.03.015; Gray J.E., 1841, ANN MAG NAT HIST, V7, P86, DOI [DOI 10.1080/03745484109442670, 10.1080/03745484109442670]; Guayasamin JM, 2008, MOL PHYLOGENET EVOL, V48, P574, DOI 10.1016/j.ympev.2008.04.012; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; HOPPER SD, 1979, ANNU REV ECOL SYST, V10, P399, DOI 10.1146/annurev.es.10.110179.002151; Hopper Stephen D., 1996, P1; Hoskin CJ, 2009, J ZOOL, V278, P36, DOI 10.1111/j.1469-7998.2009.00550.x; Hoskin Conrad J., 2011, Zootaxa, V3027, P39; Kay GM, 2012, ZOOTAXA, P1; KEMP EM, 1978, PALAEOGEOGR PALAEOCL, V24, P169, DOI 10.1016/0031-0182(78)90042-1; KENDRICK GW, 1991, QUATERNARY SCI REV, V10, P419, DOI 10.1016/0277-3791(91)90005-F; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; Lynch JD, 1971, MUSEUM NATURAL HIST, V53, P238; Mable BK, 1997, COPEIA, P680, DOI 10.2307/1447286; Mahony M, 1996, AUST J ZOOL, V44, P639, DOI 10.1071/ZO9960639; MAXSON LR, 1985, J ZOOL, V207, P289; Melville J, 2008, AUST J ZOOL, V56, P159, DOI 10.1071/ZO07069; Mitchell NJ, 2011, PERTHS BANKSIA WOODL, P47; Morgan MJ, 2007, MOL PHYLOGENET EVOL, V44, P371, DOI 10.1016/j.ympev.2006.12.009; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nokhbatolfoghahai M, 2010, HERPETOL J, V20, P59; Noonan BP, 2005, MOL ECOL, V14, P3017, DOI 10.1111/j.1365-294X.2005.02624.x; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P750, DOI 10.1016/j.ympev.2011.08.009; Pinho C, 2009, CONSERV GENET, P121; Read K, 2001, MOL PHYLOGENET EVOL, V21, P294, DOI 10.1006/mpev.2001.1014; Rix MG, 2015, BIOL REV, V90, P762, DOI 10.1111/brv.12132; ROBERTS JD, 1984, AUST WILDLIFE RES, V11, P191, DOI 10.1071/WR9840191; ROBERTS JD, 1981, AUST WILDLIFE RES, V8, P451; ROBERTS JD, 1985, EVOLUTION, V39, P325, DOI 10.1111/j.1558-5646.1985.tb05670.x; Slatyer C, 2007, J BIOGEOGR, V34, P583, DOI 10.1111/j.1365-2699.2006.01647.x; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TEMPLETON AR, 1995, GENETICS, V140, P767; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Wang IJ, 2008, MOL PHYLOGENET EVOL, V47, P992, DOI 10.1016/j.ympev.2008.02.021; WATSON J. A. L., 1959, WESTERN AUSTRALIAN NAT, V7, P1; Wheeler MA, 2006, AUST J BOT, V54, P17, DOI 10.1071/BT05086; Withers P. C., 1993, Journal of the Royal Society of Western Australia, V76, P49; Wyrwoll KH, 2003, AUSTR GEOMECHANICS, V38, P17	65	3	3	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173348	10.1371/journal.pone.0173348	http://dx.doi.org/10.1371/journal.pone.0173348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296914	Green Published, gold			2022-12-26	WOS:000396311700034
J	Carroll, SH; Zhang, E; Wang, BF; LeClair, KB; Rahman, A; Cohen, DE; Plutzky, J; Patwari, P; Lee, RT				Carroll, Shannon H.; Zhang, Ellen; Wang, Bing F.; LeClair, Katherine B.; Rahman, Arifeen; Cohen, David E.; Plutzky, Jorge; Patwari, Parth; Lee, Richard T.			Adipocyte arrestin domain-containing 3 protein (Arrdc3) regulates uncoupling protein 1 (Ucp1) expression in white adipose independently of canonical changes in beta-adrenergic receptor signaling	PLOS ONE			English	Article							BETA-2-ADRENERGIC RECEPTOR; BROWN; FAT; THERMOGENESIS; BINDING; TARGET; MUSCLE; LIGASE; MICE	Adaptive thermogenesis and cold-induced activation of uncoupling protein 1 (Ucp1) in brown adipose tissue in rodents is well-described and attributed to sympathetic activation of beta-adrenergic signaling. The arrestin domain containing protein Arrdc3 is a regulator of obesity in mice and also appears linked to obesity in humans. We generated a mouse with conditional deletion of Arrdc3, and here we present evidence that genetic ablation of Arrdc3 specifically in adipocytes results in increased Ucp1 expression in subcutaneous and parametrial adipose tissue. Although this increase in expression did not correspond with significant changes in body weight or energy expenditure, adipocyte-specific Arrdc3-null mice had improved glucose tolerance. It was previously hypothesized that Arrdc3 ablation leads to increased beta-adrenergic receptor sensitivity; however, in vitro experiments show that Arrdc3-null adipocytes responded to beta-adrenergic receptor agonist with decreased Ucp1 levels. Additionally, canonical beta-adrenergic receptor signaling was not different in Arrdc3-null adipocytes. These data reveal a role for Arrdc3 in the regulation of Ucp1 expression in adipocytes. However, this adipocyte effect is insufficient to generate the obesity-resistant phenotype of mice with ubiquitous deletion of Arrdc3, indicating a likely role for Arrdc3 in cells other than adipocytes.	[Carroll, Shannon H.; Zhang, Ellen; Wang, Bing F.; Rahman, Arifeen; Lee, Richard T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Carroll, Shannon H.; Zhang, Ellen; Wang, Bing F.; Rahman, Arifeen; Lee, Richard T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [LeClair, Katherine B.; Cohen, David E.] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, 75 Francis St, Boston, MA 02115 USA; [LeClair, Katherine B.; Cohen, David E.] Harvard Med Sch, Boston, MA USA; [Plutzky, Jorge; Patwari, Parth; Lee, Richard T.] Brigham & Womens Hosp, Cardiovasc Div, Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lee, RT (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Lee, RT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Lee, RT (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA.	Richard_Lee@harvard.edu	Plutzky, Jorge/V-3410-2019	Lee, Richard/0000-0003-4687-1381	National Institutes of Health [R01DK107396, F32DK105682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01DK107396 to RTL, F32DK105682 to SHC). SHC and RTL planned the experiments and wrote the paper. S.H. C performed the majority of experiments.	Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Cohen P, 2015, DIABETES, V64, P2346, DOI 10.2337/db15-0318; Collins GP, 2001, SCI AM, V284, p24B; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Forest C, 2016, ADIPOCYTE, V5, P136, DOI 10.1080/21623945.2016.1187345; Giordano A, 2016, NAT REV DRUG DISCOV, V15, P405, DOI 10.1038/nrd.2016.31; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kang HW, 2013, J BIOL CHEM, V288, P33376, DOI 10.1074/jbc.M113.481408; Keipert S, 2014, BBA-BIOENERGETICS, V1837, P1075, DOI 10.1016/j.bbabio.2014.02.008; Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Qi SQ, 2014, PROTEIN SCI, V23, P1708, DOI 10.1002/pro.2549; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Ramseyer VD, 2016, ADIPOCYTE, V5, P119, DOI 10.1080/21623945.2016.1145846; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173823	10.1371/journal.pone.0173823	http://dx.doi.org/10.1371/journal.pone.0173823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291835	gold, Green Published, Green Submitted			2022-12-26	WOS:000396094700043
J	Dussan, A; Bertel, SD; Melo, SF; Mesa, F				Dussan, A.; Bertel, S. D.; Melo, S. F.; Mesa, F.			Synthesis and characterization of porous silicon as hydroxyapatite host matrix of biomedical applications	PLOS ONE			English	Article							FABRICATION; ACID	In this work, porous-silicon samples were prepared by electrochemical etching on p-type (B-doped) Silicon (Si) wafers. Hydrofluoric acid (HF)-ethanol (C2H5OH) [HF:Et] and Hydrofluoric acid (HF)-dimethylformamide (DMF-C3H7NO) [HF:DMF] solution concentrations were varied between [1:2]-[1:3] and [1:7]-[1:9], respectively. Effects of synthesis parameters, like current density, solution concentrations, reaction time, on morphological properties were studied by scanning electron microscopy (SEM) and atomic force microscopy (AFM) measurements. Pore sizes varying from 20 nm to micrometers were obtained for long reaction times and [HF:Et] [1:2] concentrations; while pore sizes in the same order were observed for [HF:DMF] [1:7], but for shorter reaction time. Greater surface uniformity and pore distribution was obtained for a current density of around 8 mA/cm(2) using solutions with DMF. A correlation between reflectance measurements and pore size is presented. The porous-silicon samples were used as substrate for hydroxyapatite growth by sol-gel method. X-ray diffraction (XRD) and SEM were used to characterize the layers grown. It was found that the layer topography obtained on PS samples was characterized by the evidence of Hydroxyapatite in the inter-pore regions and over the surface.	[Dussan, A.; Bertel, S. D.; Melo, S. F.] Univ Nacl Colombia, Fac Ciencias, Dept Fis, Grp Mat Nanoestruct & Sus Aplicac, Ciudad Univ, Bogota, Colombia; [Mesa, F.] Univ Rosario, Fac Ciencias Nat & Matemat, Grp NanoTech, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Mesa, F (corresponding author), Univ Rosario, Fac Ciencias Nat & Matemat, Grp NanoTech, Bogota, Colombia.	fredy.mesa@urosario.edu.co	Mesa, Fredy/E-8730-2016	Mesa, Fredy/0000-0003-0920-7748	Universidad Nacional de Colombia; COLCIENCIAS; Universidad del Rosario	Universidad Nacional de Colombia; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad del Rosario	This work was supported by Universidad Nacional de Colombia, COLCIENCIAS and Universidad del Rosario.; This work was supported by Universidad Nacional de Colombia, COLCIENCIAS and Universidad del Rosario. We thank to the professor Dr. Alvaro Angel Arrieta for laboratory support in sample preparation and characterization.	Abd HR, 2013, INT J ELECTROCHEM SC, V8, P11461; BEALE MIJ, 1985, J CRYST GROWTH, V73, P622, DOI 10.1016/0022-0248(85)90029-6; Ben-Arfa BAE, 2017, MAT SCI ENG C-MATER, V70, P796, DOI 10.1016/j.msec.2016.09.054; Bhattacharyy D, 2015, RSC ADV, V5, P70361, DOI 10.1039/c5ra12191d; Chen SQ, 2004, APPL SURF SCI, V230, P418, DOI 10.1016/j.apsusc.2004.03.203; Collart-Dutilleul PY, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-564; Dhanekar S, 2013, BIOSENS BIOELECTRON, V41, P54, DOI 10.1016/j.bios.2012.09.045; Dzhafarov T., 2014, HDB POROUS SILICON P, P945; Foll H, 2002, MAT SCI ENG R, V39, P93, DOI 10.1016/S0927-796X(02)00090-6; Hamammu IM, 2011, AIP CONF PROC, V1341, P332, DOI 10.1063/1.3587013; Harraz FA, 2014, SENSOR ACTUAT B-CHEM, V202, P897, DOI 10.1016/j.snb.2014.06.048; Hernandez-Montelongo J, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00060; Jane A, 2009, TRENDS BIOTECHNOL, V27, P230, DOI 10.1016/j.tibtech.2008.12.004; Jenie SNA, 2015, BIOSENS BIOELECTRON, V74, P637, DOI 10.1016/j.bios.2015.07.025; Katti DR, 2015, MAT SCI ENG C-MATER, V46, P207, DOI 10.1016/j.msec.2014.07.057; Kholostov K, 2015, MATER SCI ENG B-ADV, V194, P78, DOI 10.1016/j.mseb.2015.01.002; Kim H-S, 2014, BIOMED RES INT, V2014, P7, DOI DOI 10.3947/IC.2014.46.2.94; LEHMANN V, 1991, APPL PHYS LETT, V58, P856, DOI 10.1063/1.104512; Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840; Liu H, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158021; Milani SHD, 2006, J OPTOELECTRON ADV M, V8, P1216; Naglieri V, 2013, ACTA MATER, V61, P6948, DOI 10.1016/j.actamat.2013.08.006; Nayef U.M., 2013, INT J BASIC APPL SCI, V13, P15; Ohji H, 2000, SENSOR ACTUAT A-PHYS, V82, P254, DOI 10.1016/S0924-4247(99)00341-6; Premnath P, 2012, BIORESEARCH OPEN ACC, V1, P231, DOI 10.1089/biores.2012.0254; Qu YQ, 2010, J MATER CHEM, V20, P3590, DOI 10.1039/c0jm00493f; Sanosh KP, 2009, B MATER SCI, V32, P465, DOI 10.1007/s12034-009-0069-x; Sygnatowicz M, 2010, JOM-US, V62, P65, DOI 10.1007/s11837-010-0111-x; Sygnatowicz M, 2009, MAT SCI ENG C-BIO S, V29, P1071, DOI 10.1016/j.msec.2008.08.036; Thakur M, 2012, J POWER SOURCES, V205, P426, DOI 10.1016/j.jpowsour.2012.01.058; TURNER DR, 1958, J ELECTROCHEM SOC, V105, P402, DOI 10.1149/1.2428873; UHLIR A, 1956, AT&T TECH J, V35, P333, DOI 10.1002/j.1538-7305.1956.tb02385.x; Vendamani VS, 2015, NUCL INSTRUM METH B, V358, P105, DOI 10.1016/j.nimb.2015.05.040; Wei YL, 2015, APPL SURF SCI, V353, P79, DOI 10.1016/j.apsusc.2015.06.064; Yaakob S., 2012, J PHYS SCI, V23, P17; Zhang YB, 2016, OPTIK, V127, P3009, DOI 10.1016/j.ijleo.2015.12.020	36	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173118	10.1371/journal.pone.0173118	http://dx.doi.org/10.1371/journal.pone.0173118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291792	Green Published, Green Submitted, gold			2022-12-26	WOS:000396094700013
J	Hua, ZL; Zheng, XZ; Xue, HC; Wang, JM; Yao, J				Hua, Zhaolai; Zheng, Xianzhi; Xue, Hengchuan; Wang, Jianming; Yao, Jun			Long-term trends and survival analysis of esophageal and gastric cancer in Yangzhong, 1991-2013	PLOS ONE			English	Article							RISK; CARCINOMA; SHANGHAI; STOMACH; COHORT; DIET	Objective To describe the long-term trends of the incidence, mortality and survival of upper digestive tract cancers in a high-risk area of China. Methods We extracted esophageal and gastric cancer cases diagnosed from 1991 to 2013 through the Yangzhong Cancer Registry and calculated the crude and age-standardized incidence and mortality rates. Cancer trends were calculated using the Joinpoint Regression Program and were reported using the annual percentage change (APC). The cancer-specific survival rates were evaluated and compared between groups using the Kaplan-Meier method and log-rank test. Results The age-standardized incidence rate of esophageal cancer declined from 107.06 per 100,000 person-years (male: 118.05 per 100,000 person-years; female: 97.42 per 100,000 person-years) in 1991 to 37.04 per 100,000 person-years (male: 46.43 per 100,000 person-years; female: 27.26 per 100,000 person-years) in 2013, with an APC of -2.5% (95% confidence interval (CI): -3.4%, -1.5%) for males and -4.9% (95% CI:-5.8%, -3.9%) for females. The age-standardized incidence rate of gastric cancer was 165.11 per 100,000 person-years (male: 225.39 per 100,000 person-years; female: 113.34 per 100,000 person-years) in 1991 and 53.46 per 100,000 person-years (male: 76.51 per 100,000 person-years; female: 32.43 per 100,000 person-years) in 2013, with the APC of -3.6% (95% CI: -4.5%, -2.7%) for males and -4.8% (95% CI: -5.7%, -3.9%) for females. The median survival time was 3.0 years for patients with esophageal or gastric cancer. Cancer cases detected after 2004 had a better prognosis. Conclusions The age-standardized incidence rates of both esophageal and gastric cancer continuously decreased since 1991 through 2013, whereas the mortality rate remained stable before 2004 and significantly declined following the massive endoscopic screening program initiated in 2004. The survival probability of patients with esophageal and gastric cancer has improved obviously in recent decades.	[Hua, Zhaolai] Yangzhong Canc Res Inst, Dept Epidemiol, Yangzhong, Peoples R China; [Hua, Zhaolai; Zheng, Xianzhi; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China; [Xue, Hengchuan] Peoples Hosp Yangzhong, Dept Thorac Surg, Yangzhong, Peoples R China; [Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Innovat Ctr Social Risk Governance Hlth, Nanjing, Jiangsu, Peoples R China; [Yao, Jun] Zhenjiang First Peoples Hosp, Dept Gastroenterol, Zhenjiang, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China.; Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Innovat Ctr Social Risk Governance Hlth, Nanjing, Jiangsu, Peoples R China.; Yao, J (corresponding author), Zhenjiang First Peoples Hosp, Dept Gastroenterol, Zhenjiang, Peoples R China.	jmwang@njmu.edu.cn; 13952943749@163.com		Wang, Jianming/0000-0002-9151-284X	National Natural Science Foundation of China [81673249]; Qing Lan Project; Social Development Project of Zhenjiang [SH2016048]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Medical Science and Technology Development Foundation; Jiangsu Province Department of Health [Y201313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qing Lan Project(Jiangsu Polytech Institute); Social Development Project of Zhenjiang; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Medical Science and Technology Development Foundation; Jiangsu Province Department of Health	This study was supported by the National Natural Science Foundation of China (81673249), Qing Lan Project (2014), Social Development Project of Zhenjiang (SH2016048), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Medical Science and Technology Development Foundation, Jiangsu Province Department of Health (Y201313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2015, GASTROENTEROLOGY, V148, P1234, DOI 10.1053/j.gastro.2015.02.007; Bao PP, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2313-2; Chen V., 1994, COMPARABILITY QUALIT; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen XZ, 2016, LANCET S1, V388, pS40; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; di Pietro M, 2015, GASTROENTEROLOGY, V148, P912, DOI 10.1053/j.gastro.2015.02.012; Ferlay J, 2005, IARC IACR TOOLS CANC; Gallagher LG, 2015, AM J IND MED, V58, P267, DOI 10.1002/ajim.22412; Ilbawi AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3008853; Kato M, 2013, GUT, V62, P1425, DOI 10.1136/gutjnl-2011-301647; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Lansdorp-Vogelaar I, 2016, GUT, V65, P543, DOI 10.1136/gutjnl-2015-310356; Maruthappu M, 2016, LANCET, V388, P684, DOI 10.1016/S0140-6736(16)00577-8; Murphy G, 2011, GUT, V60, P618, DOI 10.1136/gut.2010.225854; Organization WH, 1992, ICD 10 INT STAT CLAS, V1; Pasechnikov V, 2014, WORLD J GASTROENTERO, V20, P13842, DOI 10.3748/wjg.v20.i38.13842; Peeters A, 2011, EUR J EPIDEMIOL, V26, P369, DOI 10.1007/s10654-011-9546-9; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Sun P, 2016, ONCOTARGET, V7, P42650, DOI 10.18632/oncotarget.9516; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Veitch AM, 2015, NAT REV GASTRO HEPAT, V12, P660, DOI 10.1038/nrgastro.2015.128; Wang JM, 2007, EUR J GASTROEN HEPAT, V19, P171, DOI 10.1097/MEG.0b013e32800ff77a; Wang JM, 2005, EUR J GASTROEN HEPAT, V17, P1339, DOI 10.1097/00042737-200512000-00012; Ward ST, 2016, GUT; Yu HJ, 2011, BIOMED ENVIRON SCI, V24, P268, DOI 10.3967/0895-3988.2011.03.010; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187; Zheng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117773; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	31	7	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173896	10.1371/journal.pone.0173896	http://dx.doi.org/10.1371/journal.pone.0173896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288195	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400040
J	Blundell, KLIM; Pal, M; Roe, SM; Pearl, LH; Prodromou, C				Blundell, Katie L. I. M.; Pal, Mohinder; Roe, S. Mark; Pearl, Laurence H.; Prodromou, Chrisostomos			The structure of FKBP38 in complex with the MEEVD tetratricopeptide binding-motif of Hsp90	PLOS ONE			English	Article							ATPASE ACTIVITY; PROTEIN; BCL-2; DIMERIZATION; RECOGNITION; INHIBITOR; APOPTOSIS; INTERACTS; DOMAIN; NS5A	Tetratricopeptide (TPR) domains are known protein interaction domains. We show that the TPR domain of FKBP8 selectively binds Hsp90, and interactions upstream of the conserved MEEVD motif are critical for tight binding. In contrast FKBP8 failed to bind intact Hsp70. The PPIase domain was not essential for the interaction with Hsp90 and binding was completely encompassed by the TPR domain alone. The conformation adopted by Hsp90 peptides, containing the conserved MEEVD motif, in the crystal structure were similar to that seen for the TPR domains of CHIP, AIP and Tah1. The carboxylate clamp interactions with bound Hsp90 peptide were a critical component of the interaction and mutation of Lys 307, involved in the carboxylate clamp, completely disrupted the interaction with Hsp90. FKBP8 binding to Hsp90 did not substantially influence its ATPase activity.	[Blundell, Katie L. I. M.; Pal, Mohinder; Roe, S. Mark; Pearl, Laurence H.; Prodromou, Chrisostomos] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Prodromou, C (corresponding author), Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	chris.prodromou@sussex.ac.uk	Prodromou, Chrisostomos/ABA-9133-2021	Prodromou, Chrisostomos/0000-0003-4320-1147; Pal, Mohinder/0000-0002-8025-0119; Roe, Mark/0000-0002-7371-9855	Wellcome Trust [095605/Z11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, 095605/Z11/Z (https://wellcome.ac.uk).; We thank the Wellcome Trust for their financial support (095605/Z11/Z) and Diamond Light Source for access to beamline 104_1 (MX10088) that contributed to the results presented here.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Bricogne G, BUSTER TNT 2 10 2; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, DOI [10.1038/sj.emboj.7600739, DOI 10.1038/SJ.EMBOJ.7600739]; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erdmann F, 2007, FEBS LETT, V581, P5709, DOI 10.1016/j.febslet.2007.11.037; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liang J, 1999, ACTA CRYSTALLOGR D, V55, P736, DOI 10.1107/S0907444998014747; Maestre-Martinez M, 2006, J BIOMOL NMR, V34, P197, DOI 10.1007/s10858-006-0018-6; Maestre-Martinez M, 2010, BIOL CHEM, V391, P1157, DOI 10.1515/BC.2010.122; Morgan RML, 2015, ACTA CRYSTALLOGR D, V71, P1197, DOI 10.1107/S1399004715004551; Morgan RML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053339; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Schrodinger L., PYMOL MOL GRAPHICS S; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; Taguwa S, 2008, J VIROL, V82, P2631, DOI 10.1128/JVI.02153-07; Taguwa S, 2009, J VIROL, V83, P10427, DOI 10.1128/JVI.01035-09; Tong MM, 2016, CURR MOL PHARMACOL, V9, P48, DOI 10.2174/1874467208666150519113541; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wallace AC, 1996, BIOCHEM SOC T, V24, P280, DOI 10.1042/bst0240280; Wang JD, 2006, FEBS LETT, V580, P4392, DOI 10.1016/j.febslet.2006.07.002; WILSON KP, 1995, ACTA CRYSTALLOGR D, V51, P511, DOI 10.1107/S0907444994014514; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	46	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173543	10.1371/journal.pone.0173543	http://dx.doi.org/10.1371/journal.pone.0173543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278223	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396087900010
J	Cockrell, DC; Long, CM; Robertson, SJ; Shannon, JG; Miller, HE; Myers, L; Larson, CL; Starr, T; Beare, PA; Heinzen, RA				Cockrell, Diane C.; Long, Carrie M.; Robertson, Shelly J.; Shannon, Jeffrey G.; Miller, Heather E.; Myers, Lara; Larson, Charles L.; Starr, Tregei; Beare, Paul A.; Heinzen, Robert A.			Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages	PLOS ONE			English	Article							PARASITOPHOROUS VACUOLE MATURATION; Q-FEVER; IN-VITRO; ALVEOLAR MACROPHAGES; NATURAL-RESISTANCE; EFFECTOR PROTEINS; MOUSE MACROPHAGES; HOST-CELL; INFECTION; LIPOPOLYSACCHARIDE	Published data show that murine bone marrow-derived macrophages (BMDM) restrict growth of avirulent phase II, but not virulent phase I, Coxiella burnetii. Growth restriction of phase II bacteria is thought to result from potentiated recognition of pathogen-associated molecular patterns, which leads to production of inhibitory effector molecules. Past studies have used conditioned medium from L-929 murine fibroblasts as a source of macrophagecolony stimulating factor (M-CSF) to promote differentiation of bone marrow-derived myeloid precursors into macrophages. However, uncharacterized components of conditioned medium, such as variable amounts of type I interferons, can affect macrophage activation status and their permissiveness for infection. In the current study, we show that the C. burnetii Nine Mile phase II (NMII) strain grows robustly in primary macrophages from C57BL/6J mice when bone marrow cells are differentiated with recombinant murine M-CSF (rmMCSF). Bacteria were readily internalized by BMDM, and replicated within degradative, LAMP1-positive vacuoles to achieve roughly 3 logs of growth over 6 days. Uninfected BMDM did not appreciably express CD38 or Egr2, markers of classically (M1) and alternatively (M2) activated macrophages, respectively, nor did infection change the lack of polarization. In accordance with an M0 phenotype, infected BMDM produced moderate amounts of TNF and nitric oxide. Similar NMII growth results were obtained using C57BL/6J myeloid progenitors immortalized with an estrogen-regulated Hoxb8 (ER-Hoxb8) oncogene. To demonstrate the utility of the ER-Hoxb8 system, myeloid progenitors from natural resistance-associated macrophage protein 1 (Nramp1) C57BL/6J knock-in mice were transduced with ER-Hoxb8, and macrophages were derived from immortalized progenitors using rmM-CSF and infected with NMII. No difference in growth was observed when compared to macrophages from wild type mice, indicating depletion of metal ions by the Nramp1 transporter does not negatively impact NMII growth. Results with NMII were recapitulated in primary macrophages where C57BL/6J Nramp1+ BMDM efficiently killed Salmonella enterica serovar Typhimurium. M-CSF differentiated murine macrophages from bone marrow and conditional ER-Hoxb8 myeloid progenitors will be useful ex vivo models for studying Coxiella-macrophage interactions.	[Cockrell, Diane C.; Long, Carrie M.; Miller, Heather E.; Larson, Charles L.; Beare, Paul A.; Heinzen, Robert A.] NIAID, Coxiella Pathogenesis Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Robertson, Shelly J.] NIAID, Innate Immun & Pathogenesis Unit, Virol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Shannon, Jeffrey G.] NIAID, Plague Sect, Lab Zoonot Pathogens, Rocky Mt Labs,NIH, Hamilton, MT USA; [Myers, Lara] NIAID, Retroviral Immunol Sect, Persistent Viral Dis Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Starr, Tregei] NIAID, Salmonella Host Cell Interact Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Heinzen, RA (corresponding author), NIAID, Coxiella Pathogenesis Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA.	rheinzen@niaid.nih.gov	Long, Carrie Mae/U-2169-2019	Long, Carrie Mae/0000-0001-5030-975X	National Institute of Allergy and Infectious Diseases, National Institutes of Health [1 Z1A A100931]; Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000931] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grant number 1 Z1A A100931).; This work was supported by funding from the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (RAH)	Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Battisti JM, 2011, MICROBIOL-SGM, V157, P966, DOI 10.1099/mic.0.046649-0; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2014, J BACTERIOL, V196, P1925, DOI 10.1128/JB.01532-14; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bradley WP, 2016, INFECT IMMUN, V84, P998, DOI 10.1128/IAI.01536-15; Briggs HL, 2008, INFECT IMMUN, V76, P2189, DOI 10.1128/IAI.01609-07; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Chow SH, 2016, CELL MICROBIOL, V18, P466, DOI 10.1111/cmi.12573; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Crane DD, 2013, CLIN VACCINE IMMUNOL, V20, P1531, DOI 10.1128/CVI.00319-13; Cunha LD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10205; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Fernandes TD, 2016, INFECT IMMUN, V84, P2439, DOI 10.1128/IAI.00411-16; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Ghigo E, 2012, ADV EXP MED BIOL, V984, P141, DOI 10.1007/978-94-007-4315-1_8; Goncalves R, 2015, CURR PROTOC IMMUN, V111; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Graham JG, 2013, CELL MICROBIOL, V15, P1012, DOI 10.1111/cmi.12096; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; HACKSTADT T, 1981, P NATL ACAD SCI-BIOL, V78, P3240, DOI 10.1073/pnas.78.5.3240; HACKSTADT T, 1988, INFECT IMMUN, V56, P802, DOI 10.1128/IAI.56.4.802-807.1988; Helbig KJ, 2003, GENES IMMUN, V4, P82, DOI 10.1038/sj.gene.6363912; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Klingenbeck L, 2013, CELL MICROBIOL, V15, P675, DOI 10.1111/cmi.12066; Larson CL, 2016, FUTURE MICROBIOL, V11, P919, DOI 10.2217/fmb-2016-0044; Larson CL, 2015, INFECT IMMUN, V83, P661, DOI 10.1128/IAI.02763-14; Lathrop SK, 2015, INFECT IMMUN, V83, P2661, DOI 10.1128/IAI.00033-15; Lee CM, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-30; Loomis WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111763; Luhrmann A, 2010, P NATL ACAD SCI USA, V107, P18997, DOI 10.1073/pnas.1004380107; Martinez E, 2016, P NATL ACAD SCI USA, V113, pE3260, DOI 10.1073/pnas.1522811113; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Newton HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004286; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Ochoa-Reparaz J, 2007, INFECT IMMUN, V75, P5845, DOI 10.1128/IAI.00901-07; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Rosas M, 2011, EUR J IMMUNOL, V41, P356, DOI 10.1002/eji.201040962; Sauer JD, 2005, INFECT IMMUN, V73, P4494, DOI 10.1128/IAI.73.8.4494-4504.2005; SCOTT GH, 1987, J GEN MICROBIOL, V133, P691; Shannon JG, 2005, ANN NY ACAD SCI, V1063, P154, DOI 10.1196/annals.1355.024; Shannon JG, 2009, IMMUNOL RES, V43, P138, DOI 10.1007/s12026-008-8059-4; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Stein A, 2005, INFECT IMMUN, V73, P2469, DOI 10.1128/IAI.73.4.2469-2477.2005; Swanson MS, 2006, J IMMUNOL, V177, P4945, DOI 10.4049/jimmunol.177.8.4945; TIGERTT WD, 1961, BACTERIOL REV, V25, P285, DOI 10.1128/MMBR.25.3.285-293.1961; Toman R, 1996, CARBOHYD RES, V283, P175, DOI 10.1016/0008-6215(96)87610-5; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; WARREN MK, 1985, J IMMUNOL, V134, P982; Wessling-Resnick M, 2015, J BIOL CHEM, V290, P18984, DOI 10.1074/jbc.R115.643973; Winchell CG, 2014, INFECT IMMUN, V82, P2229, DOI 10.1128/IAI.01236-13; Zamboni DS, 2004, J BIOL CHEM, V279, P54405, DOI 10.1074/jbc.M410340200; Zamboni DS, 2004, INFECT IMMUN, V72, P2395, DOI 10.1128/IAI.72.4.2395-2399.2004; Zamboni DS, 2004, INFECT IMMUN, V72, P2075, DOI 10.1128/IAI.72.4.2075-2080.2004; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003	67	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173528	10.1371/journal.pone.0173528	http://dx.doi.org/10.1371/journal.pone.0173528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278296	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900007
J	Fagbamila, IO; Barco, L; Mancin, M; Kwaga, J; Ngulukun, SS; Zavagnin, P; Lettini, AA; Lorenzetto, M; Abdu, PA; Kabir, J; Umoh, J; Ricci, A; Muhammad, M				Fagbamila, Idowu Oluwabunmi; Barco, Lisa; Mancin, Marzia; Kwaga, Jacob; Ngulukun, Sati Samuel; Zavagnin, Paola; Lettini, Antonia Anna; Lorenzetto, Monica; Abdu, Paul Ayuba; Kabir, Junaidu; Umoh, Jarlath; Ricci, Antonia; Muhammad, Maryam			Salmonella serovars and their distribution in Nigerian commercial chicken layer farms	PLOS ONE			English	Article							FOOD-PRODUCING ANIMALS; POULTRY; ENTERICA; RESISTANT; SURVEILLANCE; ENVIRONMENT; INFECTIONS	Commercial poultry farms (n degrees 523), located in all the six regions of Nigeria were sampled with a view to generate baseline information about the distribution of Salmonella serovars in this country. Five different matrices (litter, dust, faeces, feed and water) were collected from each visited farm. Salmonella was isolated from at least one of the five matrices in 228 farms, with a farm prevalence of 43.6% (CI95[39.7-48.3%]). Altogether, 370 of 2615 samples collected (14.1%, CI95[12.8; 15.5%]) contained Salmonella. Considering the number of positive farms and the number of positive samples, it was evident that for the majority of the sampled farms, few samples were positive for Salmonella. With regard to the matrices, there was no difference in Salmonella prevalence among the five matrices considered. Of the 370 isolates serotyped, eighty-two different serotypes were identified and Salmonella Kentucky was identified as having the highest isolation rate in all the matrices sampled (16.2%), followed by S. Poona and S. Elisabethville. S. Kentucky was distributed across the country, whereas the other less frequent serovars had a more circumscribed diffusion. This is one of few comprehensive studies on the occurrence and distribution of Salmonella in commercial chicken layer farms from all the six regions of Nigeria. The relatively high prevalence rate documented in this study may be attributed to the generally poor infrastructure and low biosecurity measures in controlling stray animals, rodents and humans. Data collected could be valuable for instituting effective intervention strategies for Salmonella control in Nigeria and also in other developing countries with a similar poultry industry structure, with the final aim of reducing Salmonella spread in animals and ultimately in humans.	[Fagbamila, Idowu Oluwabunmi; Ngulukun, Sati Samuel; Muhammad, Maryam] Natl Inst Vet Res, Bacterial Res Div, Vom, Plateau State, Nigeria; [Barco, Lisa; Mancin, Marzia; Zavagnin, Paola; Lettini, Antonia Anna; Lorenzetto, Monica; Ricci, Antonia] Inst Zooprofilatt Sperimentale Venezie, Reference Lab Salmonella, Padua, Italy; [Kwaga, Jacob; Kabir, Junaidu; Umoh, Jarlath] Ahmadu Bello Univ, Dept Vet Publ Hlth & Prevent Med, Zaria, Nigeria; [Abdu, Paul Ayuba] Ahmadu Bello Univ, Fac Vet Med, Dept Med, Zaria, Nigeria	IZS delle Venezie; Ahmadu Bello University; Ahmadu Bello University	Barco, L (corresponding author), Inst Zooprofilatt Sperimentale Venezie, Reference Lab Salmonella, Padua, Italy.	lbarco@izsvenezie.it	Fagbamila, Idowu Oluwabunmi/GWZ-9428-2022; Ricci, Antonia/AAA-9473-2019; Barco, Lisa/K-2284-2016	Ricci, Antonia/0000-0002-4774-9655; mancin, marzia/0000-0002-7260-6031; Barco, Lisa/0000-0002-6247-248X; Lettini, Antonia Anna/0000-0001-9644-5992; Fagbamila, Idowu Oluwabunmi/0000-0002-7483-5284; , Monica/0000-0003-4729-0300	Federal Government of Nigeria through the Competitive Agriculture Research Grant Scheme (CARGS) [24]; International Centre for Genetic Engineering and Biotechnology (ICGEB) SMART fellowship [S/NIG 14-02]	Federal Government of Nigeria through the Competitive Agriculture Research Grant Scheme (CARGS); International Centre for Genetic Engineering and Biotechnology (ICGEB) SMART fellowship	The Federal Government of Nigeria through the Competitive Agriculture Research Grant Scheme (CARGS) funded the investigation (Sampling, Culture and isolation) (Grant Number: CARGS/RFA 2 No. 24). International Centre for Genetic Engineering and Biotechnology (ICGEB) SMART fellowship (Fellowship Reference Number: S/NIG 14-02).	AHO M, 1992, INT J FOOD MICROBIOL, V15, P225, DOI 10.1016/0168-1605(92)90053-6; Andoh LA, 2016, EPIDEMIOL INFECT, P1; Antunes P, 2011, J ANTIMICROB CHEMOTH, V66, P2028, DOI 10.1093/jac/dkr228; Ao TT, 2015, EMERG INFECT DIS; Barbour EK, 2015, J INFECT DEV COUNTR, V9, P1, DOI 10.3855/jidc.5065; Barua H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035914; Bettridge JM, 2014, PREV VET MED, V117, P358, DOI 10.1016/j.prevetmed.2014.07.002; Carrique-Mas JJ, 2008, LETT APPL MICROBIOL, V47, P514, DOI 10.1111/j.1472-765X.2008.02450.x; Carrique-Mas JJ, 2009, EPIDEMIOL INFECT, V137, P837, DOI 10.1017/S0950268808001568; Castillo A, 2004, J FOOD PROTECT, V67, P713, DOI 10.4315/0362-028X-67.4.713; Davies RH, 1996, VET MICROBIOL, V50, P117, DOI 10.1016/0378-1135(96)00031-4; Dione MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001148; EFSA, 2007, EFSA J, V97; EFSA, EFSA J; European Centre for Disease Prevention and Control, 2013, ANS, P103; Folorunso O R, 2014, Pak J Biol Sci, V17, P74, DOI 10.3923/pjbs.2014.74.79; Food and Agricultural Organization (FAO), 2008, ASSESSMENT OF THE NI; Food and Agricultural Organization (FAO), 2006, THE STRUCTURE AND IM; Food and Agricultural Organization (FAO), 2015, DATA SOURCE 2015 FAO; Freitas N.O.C., 2010, J POULT SCI, V12, P1; Gast RK, 2007, AVIAN DIS, V51, P817, DOI 10.1637/8090-081807.1; Grimont PAD, 2007, ANTIGENIC FORMULAE O; Humphrey T, 2006, BRIT POULTRY SCI, V47, P379, DOI 10.1080/00071660600829084; Idowu F., 2010, International Journal of Poultry Science, V9, P959; International Organization for Standardization (ISO), ISO 6579 2002 FDAMD; Ishihara K, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-35; Issenhuth-Jeanjean S, 2014, RES MICROBIOL, V165, P526, DOI DOI 10.1018/L/533552014/07.004; Jones FT, 2004, POULTRY SCI, V83, P384, DOI 10.1093/ps/83.3.384; Kagambega A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-253; Kuroki T, 2015, JPN J INFECT DIS, V68, P333, DOI 10.7883/yoken.JJID.2014.490; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Lettini AA, 2015, ZOONOSES AND PUBLIC; Magwedere K, 2015, CLIN INFECT DIS, V61, pS283, DOI 10.1093/cid/civ663; Mamman P.H., 2014, INT J PUBLIC HLTH EP, V3, P82; MBUKO IJ, 2009, J BACTERIOLOGY RES, V1, P1; Molbak K, 2015, FOODBORNE INFECTIONS, P57; Muhammad M., 2009, International Journal of Poultry Science, V8, P656; Muhammad M, 2010, VET MICROBIOL, V140, P131, DOI 10.1016/j.vetmic.2009.07.009; Ogunleye AO, 2012, J INFECT DEV COUNTR, V6, P483, DOI 10.3855/jidc.1988; Onunkwo O., 1978, Kenya Veterinarian, V2, P33; Orji MU, 2005, INT J INFECT DIS, V9, P86, DOI 10.1016/j.ijid.2004.04.016; Osiyemi T I, 1976, Bull Anim Health Prod Afr, V24, P261; Raufu I, 2013, J APPL MICROBIOL, V115, P1059, DOI 10.1111/jam.12304; Sanchez S, 2002, J AM VET MED ASSOC, V221, P492, DOI 10.2460/javma.2002.221.492; Smith S, 2016, EUR J CLIN MICROBIOL, V35, P1913, DOI 10.1007/s10096-016-2760-3; Tabo JA, 2013, VET MICROBIOL, V166, P293, DOI 10.1016/j.vetmic.2013.05.010; Thrusfield M, 2007, VETERINARY EPIDEMIOL; Useh NM, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00315-16; Wales A, 2007, AVIAN PATHOL, V36, P187, DOI 10.1080/03079450701338755; Walters MS, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1735	51	37	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173097	10.1371/journal.pone.0173097	http://dx.doi.org/10.1371/journal.pone.0173097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278292	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900046
J	Fajardo, VA; Gamu, D; Mitchell, A; Bloemberg, D; Bombardier, E; Chambers, PJ; Bellissimo, C; Quadrilatero, J; Tupling, AR				Fajardo, Val A.; Gamu, Daniel; Mitchell, Andrew; Bloemberg, Darin; Bombardier, Eric; Chambers, Paige J.; Bellissimo, Catherine; Quadrilatero, Joe; Tupling, A. Russell			Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice	PLOS ONE			English	Article							CALCINEURIN-A-ALPHA; HEAVY-CHAIN GENE; SARCO(ENDO)PLASMIC RETICULUM CA2+-ATPASES; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CENTRONUCLEAR MYOPATHY; IN-VIVO; NFATC2-DEPENDENT PATHWAY; CONTRACTILE FUNCTION; CRUCIAL REGULATOR	Sarcolipin (SLN) and phospholamban (PLN) are two small proteins that regulate the sarco (endo)plasmic reticulum Ca2+-ATPase pumps. In a recent study, we discovered that Pln overexpression (Pln(OE)) in slow-twitch type I skeletal muscle fibers drastically impaired SERCA function and caused a centronuclear myopathy-like phenotype, severe muscle atrophy and weakness, and an 8 to 9-fold upregulation of SLN protein in the soleus muscles. Here, we sought to determine the physiological role of SLN upregulation, and based on its role as a SERCA inhibitor, we hypothesized that it would represent a maladaptive response that contributes to the SERCA dysfunction and the overall myopathy observed in the Pln(OE) mice. To this end, we crossed Sln-null (Sln(KO) mice with Pln(OE) mice to generate a Pln(OE)/Sln(KO) mouse colony and assessed SERCA function, CNM pathology, in vitro contractility, muscle mass, calcineurin signaling, daily activity and food intake, and proteolytic enzyme activity. Our results indicate that genetic deletion of Sin did not improve SERCA function nor rescue the CNM phenotype, but did result in exacerbated muscle atrophy and weakness, due to a failure to induce type II fiber compensatory hypertrophy and a reduction in total myofiber count. Mechanistically, our findings suggest that impaired calcineurin activation and resultant decreased expression of stabilin-2, and/or impaired autophagic signaling could be involved. Future studies should examine these possibilities. In conclusion, our study demonstrates the importance of SLN upregulation in combating muscle myopathy in the Pln(OE) mice, and since SLN is upregulated across several myopathies, our findings may reveal SLN as a novel and universal therapeutic target.	[Fajardo, Val A.; Gamu, Daniel; Mitchell, Andrew; Bloemberg, Darin; Bombardier, Eric; Chambers, Paige J.; Bellissimo, Catherine; Quadrilatero, Joe; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Tupling, AR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	rtupling@uwaterloo.ca			Canadian Institutes of Health Research [MOP 86618, MOP 47296]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by research grants from the Canadian Institutes of Health Research (MOP 86618 and MOP 47296 to A.R.T). A doctoral award from the Canadian Institutes of Health Research supported V.A.F. and doctoral awards from the Natural Sciences and Engineering Research Council supported A.M. and D.B.	Al-Qusairi L, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-26; Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Altamirano F, 2012, J BIOL CHEM, V287, P20876, DOI 10.1074/jbc.M112.344929; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; Calvo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032632; Campanaro S, 2002, HUM MOL GENET, V11, P3283, DOI 10.1093/hmg/11.26.3283; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Dowling J, 2014, NEUROTHERAPEUTICS, V11, P773, DOI 10.1007/s13311-014-0300-3; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Duhamel TA, 2007, J APPL PHYSIOL, V103, P1986, DOI 10.1152/japplphysiol.01440.2006; Dunn SE, 2000, J CELL BIOL, V151, P663, DOI 10.1083/jcb.151.3.663; Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908; Fajardo VA, 2015, DIS MODEL MECH, V8, P999, DOI 10.1242/dmm.020859; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gamu D, 2014, EXERC SPORT SCI REV, V42, P136, DOI 10.1249/JES.0000000000000016; Gayan-Ramirez G, 2000, J PHYSIOL-LONDON, V524, P387, DOI 10.1111/j.1469-7793.2000.t01-2-00387.x; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Horsley V, 2003, J CELL BIOL, V161, P111, DOI 10.1083/jcb.200208085; Ito N, 2013, NAT MED, V19, P101, DOI 10.1038/nm.3019; Jungbluth H, 2007, NEUROMUSCULAR DISORD, V17, P338, DOI 10.1016/j.nmd.2007.01.016; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; KNOTTS S, 1994, J BIOL CHEM, V269, P31275; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; Michel RN, 2004, P NUTR SOC, V63, P341, DOI 10.1079/PNS2004362; Michel RN, 2007, APPL PHYSIOL NUTR ME, V32, P921, DOI 10.1139/H07-093; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nakagawa O, 2005, GENE DEV, V19, P2066, DOI 10.1101/gad.1338705; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Ottenheijm CAC, 2008, FASEB J, V22, P2912, DOI 10.1096/fj.07-104372; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004; Radley-Crabb Hannah G, 2011, PLoS Curr, V3, pRRN1276, DOI 10.1371/currents.RRN1276; RINDT H, 1993, J BIOL CHEM, V268, P5332; RINDT H, 1995, P NATL ACAD SCI USA, V92, P1540, DOI 10.1073/pnas.92.5.1540; Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Schneider JS, 2013, J MUSCLE RES CELL M, V34, P349, DOI 10.1007/s10974-013-9350-0; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Serrano AL, 2001, P NATL ACAD SCI USA, V98, P13108, DOI 10.1073/pnas.231148598; Shaikh SA, 2016, J MOL CELL CARDIOL, V91, P81, DOI 10.1016/j.yjmcc.2015.12.030; Song QJ, 2004, FASEB J, V18, P974, DOI 10.1096/fj.03-1058fje; Sopariwala DH, 2015, J APPL PHYSIOL, V118, P1050, DOI 10.1152/japplphysiol.01066.2014; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; Stupka N, 2008, AM J PHYSIOL-REG I, V294, pR983, DOI 10.1152/ajpregu.00375.2007; Stupka N, 2007, AM J PHYSIOL-REG I, V293, pR686, DOI 10.1152/ajpregu.00612.2006; Stupka N, 2006, NEUROMUSCULAR DISORD, V16, P337, DOI 10.1016/j.nmd.2006.03.003; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Tupling AR, 2002, J BIOL CHEM, V277, P44740, DOI 10.1074/jbc.M206171200; Tupling R, 2002, J APPL PHYSIOL, V92, P1603, DOI 10.1152/japplphysiol.00756.2001; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; ZUBRZYCKAGAARN E, 1984, J BIOENERG BIOMEMBR, V16, P441, DOI 10.1007/BF00743238	74	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173708	10.1371/journal.pone.0173708	http://dx.doi.org/10.1371/journal.pone.0173708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278204	Green Submitted, Green Published, gold			2022-12-26	WOS:000396087900031
J	Snell, J; Meeter, M; Grainger, J				Snell, Joshua; Meeter, Martijn; Grainger, Jonathan			Evidence for simultaneous syntactic processing of multiple words during reading	PLOS ONE			English	Article							PARAFOVEAL PREVIEW BENEFIT; EYE-MOVEMENTS; PERCEPTUAL SPAN; MODEL; ATTENTION; FIXATION; CONTEXT; SWIFT	A hotly debated issue in reading research concerns the extent to which readers process parafoveal words, and how parafoveal information might influence foveal word recognition. We investigated syntactic word processing both in sentence reading and in reading isolated foveal words when these were flanked by parafoveal words. In Experiment 1 we found a syntactic parafoveal preview benefit in sentence reading, meaning that fixation durations on target words were decreased when there was a syntactically congruent preview word at the target location (n) during the fixation on the pre-target (n-1). In Experiment 2 we used a flanker paradigm in which participants had to classify foveal target words as either noun or verb, when those targets were flanked by syntactically congruent or incongruent words (stimulus on-time 170 ms). Lower response times and error rates in the congruent condition suggested that higher-order (syntactic) information can be integrated across foveal and parafoveal words. Although higher-order parafoveal-on-foveal effects have been elusive in sentence reading, results from our flanker paradigm show that the reading system can extract higher-order information from multiple words in a single glance. We propose a model of reading to account for the present findings.	[Snell, Joshua; Grainger, Jonathan] Aix Marseille Univ, Marseille, France; [Snell, Joshua] Brain & Language Res Inst, Aix En Provence, France; [Meeter, Martijn] Vrije Univ, Amsterdam, Netherlands; [Grainger, Jonathan] Ctr Natl Rech Sci, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS)	Snell, J (corresponding author), Aix Marseille Univ, Marseille, France.; Snell, J (corresponding author), Brain & Language Res Inst, Aix En Provence, France.	Joshua.snell@hotmail.com	Grainger, Jonathan/C-9299-2009; Meeter, Martijn/A-2926-2009	Meeter, Martijn/0000-0002-5112-6717	French National Research Agency (ANR) [ANR-11-LABX-0036, ANR-15-CE33-0002-01]; personal research fund of Martijn Meeter	French National Research Agency (ANR)(French National Research Agency (ANR)); personal research fund of Martijn Meeter	This research was supported by grants ANR-11-LABX-0036 and ANR-15-CE33-0002-01 from the French National Research Agency (ANR) and the personal research fund of Martijn Meeter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele B, 2013, J EXP PSYCHOL HUMAN, V39, P526, DOI 10.1037/a0029492; Baayen R. H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertram Raymond, 2007, P391, DOI 10.1016/B978-008044980-7/50019-7; Boston MF, 2011, LANG COGNITIVE PROC, V26, P301, DOI 10.1080/01690965.2010.492228; Brothers T., 2016, J EXPT PSYC IN PRESS; Dalmaijer ES, 2014, BEHAV RES METHODS, V46, P913, DOI 10.3758/s13428-013-0422-2; Dare N, 2013, Q J EXP PSYCHOL, V66, P487, DOI 10.1080/17470218.2012.703212; Deutsch A, 2005, LANG COGNITIVE PROC, V20, P341, DOI 10.1080/01690960444000115; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; FLOWERS JH, 1982, PERCEPT PSYCHOPHYS, V32, P581, DOI 10.3758/BF03204214; Grabbe JW, 2013, EXP AGING RES, V39, P419, DOI 10.1080/0361073X.2013.808110; Grainger J, 2014, ACTA PSYCHOL, V146, P35, DOI 10.1016/j.actpsy.2013.11.014; Hohenstein S, 2014, J EXP PSYCHOL LEARN, V40, P166, DOI 10.1037/a0033670; Hohenstein S, 2010, J EXP PSYCHOL LEARN, V36, P1150, DOI 10.1037/a0020233; HYONA J, 1995, J EXP PSYCHOL HUMAN, V21, P68, DOI 10.1037/0096-1523.21.1.68; Inhoff A., 2000, READING PERCEPTUAL P; Jordan TR, 2014, PSYCHON B REV, V21, P505, DOI 10.3758/s13423-013-0510-4; Jordan TR, 2002, J EXP PSYCHOL LEARN, V28, P34, DOI 10.1037//0278-7393.28.1.34; Juhasz BJ, 2009, Q J EXP PSYCHOL, V62, P1356, DOI 10.1080/17470210802400010; Keuleers E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00174; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Paterson KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088358; Radach R, 2004, EUR J COGN PSYCHOL, V16, P3, DOI 10.1080/09541440340000295; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; Rayner K, 2014, PSYCHON B REV, V21, P1067, DOI 10.3758/s13423-014-0582-9; Reichle ED, 2006, COGN SYST RES, V7, P4, DOI 10.1016/j.cogsys.2005.07.002; Reingold EM, 2004, J EXP PSYCHOL HUMAN, V30, P194, DOI 10.1037/0096-1523.30.1.194; Risse S, 2014, VIS COGN, V22, P283, DOI 10.1080/13506285.2014.881444; Schotter ER, 2015, J MEM LANG, V83, P118, DOI 10.1016/j.jml.2015.04.005; Schotter ER, 2013, J MEM LANG, V69, P619, DOI 10.1016/j.jml.2013.09.002; Schotter ER, 2012, ATTEN PERCEPT PSYCHO, V74, P5, DOI 10.3758/s13414-011-0219-2; Snell J., 2017, Q J EXPT PSYCHOL; Snell J., LANGUAGE CO IN PRESS; Veldre A, 2015, J EXP PSYCHOL HUMAN, V41, P219, DOI 10.1037/xhp0000017; Vitu F, 2004, EUR J COGN PSYCHOL, V16, P154, DOI 10.1080/09541440340000178; Yan M, 2012, J EXP PSYCHOL LEARN, V38, P1069, DOI 10.1037/a0026935; Yen MH, 2008, MEM COGNITION, V36, P1033, DOI 10.3758/MC.36.5.1033	42	53	54	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173720	10.1371/journal.pone.0173720	http://dx.doi.org/10.1371/journal.pone.0173720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278305	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900033
J	Starke, SD; Baber, C				Starke, Sandra Dorothee; Baber, Chris			Movement consistency during repetitive tool use action	PLOS ONE			English	Article							STEP FREQUENCY; BOUNCING TASK; WALKING SPEED; RESONANCE; MUSCLE; CONSTRAINTS; AFFORDANCES; PERFORMANCE; LOCOMOTION; SELECTION	The consistency and repeatability of movement patterns has been of long-standing interest in locomotor biomechanics, but less well explored in other domains. Tool use is one of such a domain; while the complex dynamics of the human-tool-environment system have been approached from various angles, to date it remains unknown how the rhythmicity of repetitive tool-using action emerges. To examine whether the spontaneously adopted movement frequency is a variable susceptible to individual execution approaches or emerges as constant behaviour, we recorded sawing motion across a range of 14 experimental conditions using various manipulations. This was compared to free and pantomimed arm movements. We found that a mean (SD) sawing frequency of 2.0 (0.4) Hz was employed across experimental conditions. Most experimental conditions did not significantly affect the sawing frequency, signifying the robustness of this spontaneously emerging movement. Free horizontal arm translation and miming of sawing was performed at half the movement frequency with more than double the excursion distance, showing that not all arm movements spontaneously emerge at the observed sawing parameters. Observed movement frequencies across all conditions could be closely predicted from movement time reference data for generic arm movements found in the Methods Time Measurement literature, highlighting a generic biomechanical relationship between the time taken for a given distance travelled underlying the observed behaviour. We conclude that our findings lend support to the hypothesis that repetitive movements during tool use are executed according to generic and predictable musculoskeletal mechanics and constraints, albeit in the context of the general task (sawing) and environmental constraints such as friction, rather than being subject to task-specific control or individual cognitive schemata.	[Starke, Sandra Dorothee; Baber, Chris] Univ Birmingham, Sch Engn, Coll Engn & Phys Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Starke, SD (corresponding author), Univ Birmingham, Sch Engn, Coll Engn & Phys Sci, Birmingham B15 2TT, W Midlands, England.	SandraDStarke@gmail.com	Baber, Chris/A-7412-2014	Baber, Chris/0000-0002-1830-2272; Starke, Sandra/0000-0002-1434-7094				[Anonymous], 2003, COGNITION TOOL USE F; Baber C, 2015, APPL ERGON, V51, P211, DOI 10.1016/j.apergo.2015.05.002; Bach P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00254; Barnes R. M., 1980, MOTION TIME STUDY DE; Bernstein N, 1967, COORDINATION REGULAT; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Bril B, 2010, J EXP PSYCHOL HUMAN, V36, P825, DOI 10.1037/a0018171; Brisswalter J, 2000, INT J SPORTS MED, V21, P60; Bullock D, 1992, P INT JOINT C NEUR N, P91; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Connick MJ, 2014, GAIT POSTURE, V39, P634, DOI 10.1016/j.gaitpost.2013.07.112; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Dean JC, 2011, J APPL PHYSIOL, V110, P873, DOI 10.1152/japplphysiol.00505.2010; DRILLIS R, 1963, HUM FACTORS, V5, P467, DOI 10.1177/001872086300500505; DRILLIS RJ, 1963, HUM FACTORS, V5, P427, DOI 10.1177/001872086300500502; Habes Daniel J., 1993, INT J IND ERGONOM, V12, P199; HAMMARSKJOLD E, 1990, CLIN BIOMECH, V5, P81, DOI 10.1016/0268-0033(90)90042-5; HOLT KG, 1990, HUM MOVEMENT SCI, V9, P55, DOI 10.1016/0167-9457(90)90035-C; HOLT KG, 1995, J MOTOR BEHAV, V27, P164, DOI 10.1080/00222895.1995.9941708; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Ishibashi H, 2000, CAN J PHYSIOL PHARM, V78, P958, DOI 10.1139/cjpp-78-11-958; Jagacinski R.J., 2003, CONTROL THEORY HUMAN; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; JONES GM, 1971, J PHYSIOL-LONDON, V219, P709, DOI 10.1113/jphysiol.1971.sp009684; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; KUNESCH E, 1989, EXP BRAIN RES, V78, P539; LEIST A, 1987, HUM NEUROBIOL, V6, P19; Lutz K, 2005, NEUROSCI LETT, V373, P61, DOI 10.1016/j.neulet.2004.09.058; Mayr M, 2003, TECHNISCHE MECH; Mayville JM, 1999, EXP BRAIN RES, V127, P371, DOI 10.1007/s002210050805; Medler S, 2009, COMP BIOCHEM PHYS A, V152, P407, DOI 10.1016/j.cbpa.2008.11.021; Merritt KJ, 2012, J NEUROPHYSIOL, V107, P2244, DOI 10.1152/jn.00984.2011; NEILSON PD, 1972, MED BIOL ENG, V10, P450, DOI 10.1007/BF02474193; Osiurak F, 2010, PSYCHOL REV, V117, P517, DOI 10.1037/a0019004; Pagliara R, 2014, J EXP BIOL, V217, P2939, DOI 10.1242/jeb.105270; PEW RW, 1967, IEEE TRANS HUM FACT, VHFE8, P130, DOI 10.1109/THFE.1967.233630; Raburn CE, 2011, J EXP BIOL, V214, P3768, DOI 10.1242/jeb.058743; RALSTON H J, 1958, Int Z Angew Physiol, V17, P277; Rein R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113567; Sardroodian M, 2015, GAIT POSTURE, V42, P60, DOI 10.1016/j.gaitpost.2015.04.003; Schmidt RA, 2003, RES Q EXERCISE SPORT, V74, P366, DOI 10.1080/02701367.2003.10609106; Snaterse M, 2011, J APPL PHYSIOL, V110, P1682, DOI 10.1152/japplphysiol.00536.2010; Takeshita D, 2006, J APPL PHYSIOL, V101, P111, DOI 10.1152/japplphysiol.01084.2005; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TURVEY MT, 1988, J THEOR BIOL, V130, P285, DOI 10.1016/S0022-5193(88)80031-6; Vaesen K, 2012, BEHAV BRAIN SCI, V35, P203, DOI 10.1017/S0140525X11001452; van Noorden L, 1999, J NEW MUSIC RES, V28, P43, DOI 10.1076/jnmr.28.1.43.3122; Wagman JB, 2001, ECOL PSYCHOL, V13, P173, DOI 10.1207/S15326969ECO1303_1; Will U, 2007, NEUROSCI LETT, V424, P55, DOI 10.1016/j.neulet.2007.07.036; ZARRUGH MY, 1978, EUR J APPL PHYSIOL O, V38, P215, DOI 10.1007/BF00430080	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173281	10.1371/journal.pone.0173281	http://dx.doi.org/10.1371/journal.pone.0173281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278273	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000396087900066
J	Yu, X; Zhang, Q; Zhao, Y; Schwarz, BJ; Stallone, JN; Heaps, CL; Han, GC				Yu, Xuan; Zhang, Qiao; Zhao, Yan; Schwarz, Benjamin J.; Stallone, John N.; Heaps, Cristine L.; Han, Guichun			Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; CA2+ SENSITIZATION; BLOOD-PRESSURE; K+ CHANNELS; EPAC; CAMP; ENDOTHELIUM; PHOSPHORYLATION; CELLS; GPER	Previously, we reported that cAMP/PKA signaling is involved in GPER-mediated coronary relaxation by activating MLCP via inhibition of RhoA pathway. In the current study, we tested the hypothesis that activation of GPER induces coronary artery relaxation via inhibition of RhoA/Rho kinase pathway by cAMP downstream targets, exchange proteins directly activated by cAMP (Epac) as well as PKA. Our results show that Epac inhibitors, brefeldin A (BFA, 50 mu M), or ESI-09 (20 mu M), or CE3F4 (100 mu M), all partially inhibited porcine coronary artery relaxation response to the selective GPER agonist, G-1 (0.3-3 mu M); while concurrent administration of BFA and PKI (5 mu M), a PKA inhibitor, almost completely blocked the relaxation effect of G-1. The Epac specific agonist, 8-CPT-2Me-cAMP (007, 1-100 mu M), induced a concentration-dependent relaxation response. Furthermore, the activity of Ras-related protein 1 (Rap1) was up regulated by G-1 (1 mu M) treatment of porcine coronary artery smooth muscle cells (CASMCs). Phosphorylation of vasodilator-stimulated phosphoprotein (p-VASP) was elevated by G-1 (1 mu M) treatment, but not by 007 (50 mu M); and the effect of G-1 on p-VASP was blocked by PKI, but not by ESI-09, an Epac antagonist. RhoA activity was similarly down regulated by G-1 and 007, whereas ESI-09 restored most of the reduced RhoA activity by G-1 treatment. Furthermore, G-1 decreased PGF2 alpha-induced p-MYPT1, which was partially reversed with either ESI-09 or PKI; whereas, concurrent administration of ESI-09 and PKI totally prevented the inhibitory effect of G-1. The inhibitory effects of G-1 on p-MLC levels in CASMCs were mostly restored by either ESI-09 or PKI. These results demonstrate that activation of GPER induces coronary artery relaxation via concurrent inhibition of RhoA/Rho kinase by Epac/Rap1 and PKA. GPER could be a potential drug target for preventing and treating cardiovascular diseases.	[Yu, Xuan; Zhang, Qiao; Zhao, Yan; Schwarz, Benjamin J.; Stallone, John N.; Heaps, Cristine L.; Han, Guichun] Texas A&M Univ, Dept Physiol & Pharmacol, College Stn, TX 77843 USA; [Zhang, Qiao] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan, Peoples R China; [Zhao, Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Xian, Peoples R China; [Stallone, John N.; Han, Guichun] Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Huazhong University of Science & Technology; Xi'an Jiaotong University; Texas A&M University System; Texas A&M University College Station	Han, GC (corresponding author), Texas A&M Univ, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.; Han, GC (corresponding author), Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA.	ghan@cvm.tamu.edu		Yu, Xuan/0000-0003-3343-7105	American Heart Association [15BGIA25060013]	American Heart Association(American Heart Association)	The funder is American Heart Association. Grant number is: 15BGIA25060013. http://www.heart.org/HEARTORG/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calderon-Sanchez E, 2009, CARDIOVASC RES, V83, P717, DOI 10.1093/cvr/cvp161; Chrzanowska-Wodnicka M, 2013, EXP CELL RES, V319, P2350, DOI 10.1016/j.yexcr.2013.07.022; Courilleau D, 2012, J BIOL CHEM, V287, P44192, DOI 10.1074/jbc.M112.422956; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Han GC, 2013, PHARMACOL RES, V71, P53, DOI 10.1016/j.phrs.2013.02.008; Han GC, 2009, J PHARMACOL EXP THER, V329, P850, DOI 10.1124/jpet.108.149112; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Jeyaraj SC, 2011, LIFE SCI, V88, P645, DOI 10.1016/j.lfs.2011.01.023; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306; Lakshmikanthan S, 2015, EMBO REP, V16, P628, DOI 10.15252/embr.201439846; Lakshmikanthan S, 2014, ARTERIOSCL THROM VAS, V34, P1486, DOI 10.1161/ATVBAHA.114.303678; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064771; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; METRICH M, 2009, PFLUGERS ARCH, V459, P535, DOI DOI 10.1007/S00424-009-0747-Y; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009; Nini L, 2010, ANAL BIOCHEM, V398, P135, DOI 10.1016/j.ab.2009.11.011; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Purves GI, 2009, J PHYSIOL-LONDON, V587, P3639, DOI 10.1113/jphysiol.2009.173534; Rajagopal S, 2013, AM J PHYSIOL-GASTR L, V304, pG527, DOI 10.1152/ajpgi.00388.2012; Roberts OL, 2014, BIOCHEM SOC T, V42, P89, DOI 10.1042/BST20130253; Roberts OL, 2013, J PHYSIOL-LONDON, V591, P5107, DOI 10.1113/jphysiol.2013.262006; Sukhanova I F, 2006, Dokl Biol Sci, V411, P441, DOI 10.1134/S0012496606060044; White RE, 2005, AM J PHYSIOL-HEART C, V289, pH1468, DOI 10.1152/ajpheart.01173.2004; White RE, 2002, CARDIOVASC RES, V53, P650, DOI 10.1016/S0008-6363(01)00428-X; Yu X, 2014, AM J PHYSIOL-ENDOC M, V307, pE398, DOI 10.1152/ajpendo.00534.2013; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhu YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09344; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	36	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173085	10.1371/journal.pone.0173085	http://dx.doi.org/10.1371/journal.pone.0173085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278256	Green Submitted, gold, Green Published			2022-12-26	WOS:000396087900045
J	Reyes-Reveles, J; Dhingra, A; Alexander, D; Bragin, A; Philp, NJ; Boesze-Battaglia, K				Reyes-Reveles, Juan; Dhingra, Anuradha; Alexander, Desiree; Bragin, Alvina; Philp, Nancy J.; Boesze-Battaglia, Kathleen			Phagocytosis-dependent ketogenesis in retinal pigment epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BETA-OXIDATION; 3-HYDROXYACYL-COA DEHYDROGENASE-DEFICIENCY; OUTER SEGMENT MEMBRANES; PHOTORECEPTOR CELLS; FATTY-ACIDS; DOCOSAHEXAENOIC ACID; ARACHIDONIC ACIDS; RPE CELLS; ROD; METABOLISM	Daily, the retinal pigment epithelium (RPE) ingests a bolus of lipid and protein in the form of phagocytized photoreceptor outer segments (OS). The RPE, like the liver, expresses enzymes required for fatty acid oxidation and ketogenesis. This suggests that these pathways play a role in the disposal of lipids from ingested OS, as well as providing a mechanism for recycling metabolic intermediates back to the outer retina. In this study, we examined whether OS phagocytosis was linked to ketogenesis. We found increased levels of beta-hydroxybutyrate (beta-HB) in the apical medium following ingestion of OS by human fetal RPE and ARPE19 cells cultured on Transwell inserts. No increase in ketogenesis was observed following ingestion of oxidized OS or latex beads. Our studies further defined the connection between OS phagocytosis and ketogenesis in wild-type mice and mice with defects in phagosome maturation using a mouse RPE explant model. In explant studies, the levels of beta-HB released were temporally correlated with OS phagocytic burst after light onset. In the Mreg(-/-) mouse where phagosome maturation is delayed, there was a temporal shift in the release of beta-HB. An even more pronounced shift in maximal beta-HB production was observed in the Abca4(-/-) RPE, in which loss of the ATP-binding cassette A4 transporter results in defective phagosome processing and accumulation of lipid debris. These studies suggest that FAO and ketogenesis are key to supporting the metabolism of the RPE and preventing the accumulation of lipids that lead to oxidative stress and mitochondrial dysfunction.	[Reyes-Reveles, Juan; Dhingra, Anuradha; Alexander, Desiree; Bragin, Alvina; Boesze-Battaglia, Kathleen] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Philp, Nancy J.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19146 USA	University of Pennsylvania; Jefferson University	Boesze-Battaglia, K (corresponding author), Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA.; Philp, NJ (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19146 USA.	nancy.philp@jefferson.edu; battagli@upenn.edu		Philp, Nancy/0000-0001-7028-0448	National Institutes of Health [EY010420, EY 012042, EY026525]; NATIONAL EYE INSTITUTE [R29EY010420, R56EY012042, R01EY012042, R01EY010420, P30EY001583, R01EY026525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in whole or in part by National Institutes of Health Grants EY010420 (to K. B.-B.), EY 012042 (to N. J. P.), and EY026525 (to K. B.-B. and N. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adijanto J, 2014, EXP EYE RES, V126, P77, DOI 10.1016/j.exer.2014.01.015; Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; Ahmado A, 2011, INVEST OPHTH VIS SCI, V52, P7148, DOI 10.1167/iovs.10-6374; Bazan N G, 1989, Prog Clin Biol Res, V312, P95; BAZAN NG, 1994, J OCUL PHARMACOL, V10, P591, DOI 10.1089/jop.1994.10.591; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2007, BIOCHEMISTRY-US, V46, P1256, DOI 10.1021/bi061466i; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1992, BIOCHIM BIOPHYS ACTA, V1111, P256, DOI 10.1016/0005-2736(92)90318-G; Burke JM, 2005, MOL INTERV, V5, P241, DOI 10.1124/mi.5.4.7; CHEN HM, 1993, EXP EYE RES, V57, P369, DOI 10.1006/exer.1993.1136; CHEN HM, 1993, J LIPID RES, V34, P1943; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; Damek-Poprawa M, 2009, J BIOL CHEM, V284, P10877, DOI 10.1074/jbc.M808857200; De Rosa MC, 2015, J CELL PHYSIOL, V230, P2059, DOI 10.1002/jcp.24932; DETURCO EBR, 1990, J NEUROSCI RES, V27, P522, DOI 10.1002/jnr.490270413; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Frost LS, 2015, MOL NEUROBIOL, V52, P1135, DOI 10.1007/s12035-014-8920-5; Frost LS, 2013, VISUAL NEUROSCI, V30, P55, DOI 10.1017/S0952523813000096; GORDON WC, 1992, CURR EYE RES, V11, P73, DOI 10.3109/02713689209069169; Handa JT, 2017, BBA-MOL CELL BIOL L, V1862, P430, DOI 10.1016/j.bbalip.2016.07.013; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Jiang M, 2015, J CELL BIOL, V210, P595, DOI 10.1083/jcb.201410112; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LAVAIL MM, 1976, EXP EYE RES, V23, P277, DOI 10.1016/0014-4835(76)90209-8; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; Nelson CP, 2015, ARTERIOSCL THROM VAS, V35, P1456, DOI 10.1161/ATVBAHA.114.304925; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Polinati PP, 2015, INVEST OPHTH VIS SCI, V56, P3371, DOI 10.1167/iovs.14-14007; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Shenker BJ, 2015, INFECT IMMUN, V83, P1487, DOI 10.1128/IAI.03132-14; SINGH I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P44, DOI 10.1016/0005-2760(93)90174-8; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; Tyni T, 2002, PEDIATR RES, V52, P595, DOI 10.1203/01.PDR.0000030874.20888.2D; VANKUIJK FJGM, 1987, FREE RADICAL BIO MED, V3, P349, DOI 10.1016/S0891-5849(87)80046-1; Volland S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125631; Wang W, 2016, CELL REP, V15, P372, DOI 10.1016/j.celrep.2016.03.022; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wihlmark U, 1996, APMIS, V104, P272, DOI 10.1111/j.1699-0463.1996.tb00717.x; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	48	55	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8038	8047		10.1074/jbc.M116.770784	http://dx.doi.org/10.1074/jbc.M116.770784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28302729	Green Published, hybrid			2022-12-26	WOS:000401154100028
J	Li, Z; Du, L; Zhang, W; Zhang, XW; Jiang, YY; Liu, K; Men, P; Xu, HF; Fortman, JL; Sherman, DH; Yu, B; Gao, S; Li, SY				Li, Zhong; Du, Lei; Zhang, Wei; Zhang, Xingwang; Jiang, Yuanyuan; Liu, Kun; Men, Ping; Xu, Huifang; Fortman, Jeffrey L.; Sherman, David H.; Yu, Bing; Gao, Song; Li, Shengying			Complete elucidation of the late steps of bafilomycin biosynthesis in Streptomyces lohii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-SYNTHETASE; GENE-CLUSTER; MACROLIDE ANTIBIOTICS; SP CS; ACID; A(1); INHIBITORS; MICROORGANISMS; FERMENTATION; PURIFICATION	Bafilomycins are an important subgroup of polyketides with diverse biological activities and possible applications as specific inhibitors of vacuolar H+-ATPase. However, the general toxicity and structural complexity of bafilomycins present formidable challenges to drug design via chemical modification, prompting interests in improving bafilomycin activities via biosynthetic approaches. Two bafilomycin biosynthetic gene clusters have been identified, but their post-polyketide synthase (PKS) tailoring steps for structural diversification and bioactivity improvement remain largely unknown. In this study, the post-PKS tailoring pathway from bafilomycin A(1) (1)-> C-1 (2)-> B-1 (3) in the marine microorganism Streptomyces lohii was elucidated for the first time by in vivo gene inactivation and in vitro biochemical characterization. We found that fumarate is first adenylated by a novel fumarate adenylyltransferase Orf3. Then, the fumaryl transferase Orf2 is responsible for transferring the fumarate moiety from fumaryl-AMP to the 21-hydroxyl group of 1 to generate 2. Last, the ATP-dependent amide synthetase BafY catalyzes the condensation of 2 and 2-amino-3-hydroxycyclopent-2-enone (C5N) produced by the 5-aminolevulinic acid synthase BafZ and the acyl-CoA ligase BafX, giving rise to the final product 3. The elucidation of fumarate incorporation mechanism represents the first paradigm for biosynthesis of natural products containing the fumarate moiety. Moreover, the bafilomycin post-PKS tailoring pathway features an interesting cross-talk between primary and secondary metabolisms for natural product biosynthesis. Taken together, this work provides significant insights into bafilomycin biosynthesis to inform future pharmacological development of these compounds.	[Li, Zhong; Du, Lei; Zhang, Wei; Zhang, Xingwang; Jiang, Yuanyuan; Liu, Kun; Men, Ping; Xu, Huifang; Li, Shengying] Chinese Acad Sci, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China; [Li, Zhong; Du, Lei; Zhang, Wei; Zhang, Xingwang; Jiang, Yuanyuan; Liu, Kun; Men, Ping; Xu, Huifang; Li, Shengying] Chinese Acad Sci, CAS Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China; [Li, Zhong; Du, Lei; Jiang, Yuanyuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Fortman, Jeffrey L.; Sherman, David H.] Univ Michigan, Life Sci Inst, Dept Med Chem, Ann Arbor, MI 48109 USA; [Fortman, Jeffrey L.; Sherman, David H.] Univ Michigan, Life Sci Inst, Dept Chem, Ann Arbor, MI 48109 USA; [Fortman, Jeffrey L.; Sherman, David H.] Univ Michigan, Life Sci Inst, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Yu, Bing; Gao, Song] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State Key Lab Oncology South China; Sun Yat Sen University	Li, SY (corresponding author), Chinese Acad Sci, Shandong Prov Key Lab Synthet Biol, Qingdao 266101, Shandong, Peoples R China.; Li, SY (corresponding author), Chinese Acad Sci, CAS Key Lab Biofuels, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China.	lishengying@qibebt.ac.cn	jiang, anyi/GPT-0379-2022	Gao, Song/0000-0001-7427-6681; Zhang, Wei/0000-0001-9459-680X	National Natural Science Foundation of China [NSFC 21472204]; Shandong Provincial Natural Science Foundation [JQ201407]; Primary Research & Development Plan of Shandong Province [2016GSF121001]; Applied Basic Research Program of Qingdao [15-9-1-93-jch]; China Postdoctoral Science Foundation [2016M590669]; Youth Innovation Promotion Association of CAS [2015166]; National Institutes of Health [R35GM118101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118101] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Primary Research & Development Plan of Shandong Province; Applied Basic Research Program of Qingdao; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Promotion Association of CAS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grant NSFC 21472204, Shandong Provincial Natural Science Foundation Grant JQ201407, Primary Research & Development Plan of Shandong Province Grant 2016GSF121001, Applied Basic Research Program of Qingdao Grant 15-9-1-93-jch, China Postdoctoral Science Foundation Grant 2016M590669, and the Youth Innovation Promotion Association of CAS Grant 2015166. This work was also supported by National Institutes of Health Grant R35GM118101 (to D. H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bera AK, 2010, ACTA CRYSTALLOGR D, V66, P664, DOI 10.1107/S0907444910008425; BEWLEY CA, 1994, J AM CHEM SOC, V116, P7631, DOI 10.1021/ja00096a020; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Carr G, 2010, J NAT PROD, V73, P422, DOI 10.1021/np900632r; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Dai WM, 2005, CURR MED CHEM, V12, P1947, DOI 10.2174/0929867054546591; Drose S, 1997, J EXP BIOL, V200, P1; Elix JA, 1999, AUST J CHEM, V52, P713, DOI 10.1071/CH99056; FISHER SH, 1989, J BACTERIOL, V171, P2378, DOI 10.1128/jb.171.5.2378-2383.1989; Fremlin L, 2011, ORG BIOMOL CHEM, V9, P1201, DOI 10.1039/c0ob00654h; Gagliardi S, 1998, J MED CHEM, V41, P1883, DOI 10.1021/jm9707838; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; GOETZ MA, 1985, J ANTIBIOT, V38, P161, DOI 10.7164/antibiotics.38.161; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HUANG L, 1984, J ANTIBIOT, V37, P970, DOI 10.7164/antibiotics.37.970; Hwang JY, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-24; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KINASHI H, 1984, J ANTIBIOT, V37, P1333, DOI 10.7164/antibiotics.37.1333; Kleinbeck F, 2009, ANGEW CHEM INT EDIT, V48, P578, DOI 10.1002/anie.200804645; KOWALSKY A, 1956, J BIOL CHEM, V219, P719; KRETSCHMER A, 1985, AGR BIOL CHEM TOKYO, V49, P2509, DOI 10.1080/00021369.1985.10867119; KRISHNASWAMY PR, 1962, J BIOL CHEM, V237, P2932; Li JA, 2010, J ANTIBIOT, V63, P595, DOI 10.1038/ja.2010.95; Li PW, 2015, APPL MICROBIOL BIOT, V99, P1923, DOI 10.1007/s00253-014-6369-0; Lu CH, 2004, J ANTIBIOT, V57, P597, DOI 10.7164/antibiotics.57.597; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McQuade TJ, 2009, ANAL BIOCHEM, V386, P244, DOI 10.1016/j.ab.2008.12.014; Moon SS, 2003, J ANTIBIOT, V56, P856, DOI 10.7164/antibiotics.56.856; Nara A, 2017, J ANTIBIOT, V70, P616, DOI 10.1038/ja.2017.33; Ostash B, 2013, MOL MICROBIOL, V90, P1324, DOI 10.1111/mmi.12437; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Rui Z, 2010, J BIOL CHEM, V285, P24915, DOI 10.1074/jbc.M110.128850; RUSNAK F, 1989, BIOCHEMISTRY-US, V28, P6827, DOI 10.1021/bi00443a008; Scheidt KA, 2002, J AM CHEM SOC, V124, P6981, DOI 10.1021/ja017885e; Suzuki H, 2007, J ANTIBIOT, V60, P380, DOI 10.1038/ja.2007.52; Toshima K, 1997, J ORG CHEM, V62, P3271, DOI 10.1021/jo970314d; TOYOTA M, 1990, PHYTOCHEMISTRY, V29, P1485, DOI 10.1016/0031-9422(90)80106-Q; UYEDA M, 1995, J ANTIBIOT, V48, P1234, DOI 10.7164/antibiotics.48.1234; Wang P, 2015, TETRAHEDRON, V71, P5362, DOI 10.1016/j.tet.2015.05.112; WERNER G, 1984, J ANTIBIOT, V37, P110, DOI 10.7164/antibiotics.37.110; WERNER G, 1983, TETRAHEDRON LETT, V24, P5193, DOI 10.1016/S0040-4039(00)88394-X; WILTON JH, 1985, J ANTIBIOT, V38, P1449, DOI 10.7164/antibiotics.38.1449; WRAY LV, 1988, GENE, V71, P247, DOI 10.1016/0378-1119(88)90041-8; Wu CS, 2016, ACS CHEM BIOL, V11, P478, DOI 10.1021/acschembio.5b00801; Yu ZG, 2011, J ANTIBIOT, V64, P159, DOI 10.1038/ja.2010.147; Zhang DJ, 2011, J ANTIBIOT, V64, P391, DOI 10.1038/ja.2011.12; Zhang W, 2013, CHEMBIOCHEM, V14, P301, DOI 10.1002/cbic.201200743; Zhang WJ, 2010, J AM CHEM SOC, V132, P6402, DOI 10.1021/ja1002845; Zhao F, 2016, FITOTERAPIA, V109, P113, DOI 10.1016/j.fitote.2015.12.015; Zhuang YB, 2011, ORG LETT, V13, P1130, DOI 10.1021/ol103164n	51	12	15	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 28	2017	292	17					7095	7104		10.1074/jbc.M116.751255	http://dx.doi.org/10.1074/jbc.M116.751255			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET7LP	28292933	Green Published, hybrid			2022-12-26	WOS:000400478300020
J	Austin, AW; Pelletier, R; Pilote, L; Rabi, DM				Austin, Anthony W.; Pelletier, Roxanne; Pilote, Louise; Rabi, Doreen M.		GENESIS-PRAXY Investigators	Factors associated with study completion in patients with premature acute coronary syndrome	PLOS ONE			English	Article							SOCIAL-STATUS; ATTRITION; PARTICIPATION; DEPRESSION; PREDICTORS; RETENTION; SMOKING; HEALTH	Background Factors associated with study completion in younger adults are not well understood. This study sought to describe psychosocial, clinical, and demographic features associated with completion of a study of men and women with premature acute coronary syndrome. Methods As part of the GENdEr and Sex determInantS of cardiovascular disease: From bench to beyond-Premature Acute Coronary Syndrome (GENESIS-PRAXY) study, demographic, psychosocial, and clinical variables were assessed in 1213 patients hospitalized for acute coronary syndrome (<= 55 years; 30% women). Patients were followed for 12 months. Dropouts withdrew from the study or were lost to follow-up after 12 months; completers were still enrolled after 12 months. Results Of 1213 patients initially enrolled, 777 (64.1%) completed 12-month follow-up. Fully adjusted models suggested that being older (OR = 1.04, 95% CI [1.01, 1.06]), higher subjective social status within one's country (OR = 1.11, 95% CI [1.01, 1.22]), being free of type II diabetes, (OR = 0.66, 95% CI [0.45, 0.97]), non-smoking status (OR = 0.70, 95% CI [0.51, 0.95]) and being free of depression (OR = 1.52, 95% CI [1.11, 2.07]) were independently associated with study completion. Conclusions Recruitment/retention strategies targeting individuals who smoke, are younger, have low subjective social status within one's country, have diabetes, or have depression may improve participant follow-up in cardiovascular cohort studies.	[Austin, Anthony W.] Univ Arkansas Pine Bluff, Dept Social & Behav Sci, Pine Bluff, AR USA; [Pelletier, Roxanne] Ctr Psychol Fil Maux, Montreal, PQ, Canada; [Pilote, Louise] McGill Univ Hlth Ctr, Div Gen Internal Med & Clin Epidemiol, Montreal, PQ, Canada; [Rabi, Doreen M.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Rabi, Doreen M.] Univ Calgary, Dept Community Hlth, Calgary, AB, Canada; [Rabi, Doreen M.] Univ Calgary, Dept Cardiol Sci, Calgary, AB, Canada	University of Arkansas System; University Arkansas Pine Bluff; McGill University; University of Calgary; University of Calgary; University of Calgary	Rabi, DM (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.; Rabi, DM (corresponding author), Univ Calgary, Dept Community Hlth, Calgary, AB, Canada.; Rabi, DM (corresponding author), Univ Calgary, Dept Cardiol Sci, Calgary, AB, Canada.	Doreen.Rabi@albertahealthservices.ca	Stark, Ken D/I-1347-2016; Austin, Anthony/U-7709-2019; Bacon, Simon/B-2637-2012	Stark, Ken D/0000-0001-7828-4072; Austin, Anthony/0000-0002-3275-5948; Norris, Colleen/0000-0002-6793-9333; Bacon, Simon/0000-0001-7075-0358; Cox, Jafna/0000-0001-7908-5323; Pilote, Louise/0000-0002-6159-0628; Lavoie, Kim/0000-0003-2606-1357; Engert, James/0000-0001-8411-4790	Canadian Institutes of Health Research [200804MOP-190260-GSH-CFAC-40513, OR-201303, CFE-113622]; Heart and Stroke Foundation of Quebec, Canada; Heart and Stroke Foundation of Nova Scotia, Canada; Heart and Stroke Foundation of Alberta, Canada; Heart and Stroke Foundation of Ontario, Canada; Heart and Stroke Foundation of Yukon, Canada; Heart and Stroke Foundation of British Columbia, Canada; Fonds de recherche du Quebec - Sante (FRQS) award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec, Canada; Heart and Stroke Foundation of Nova Scotia, Canada; Heart and Stroke Foundation of Alberta, Canada; Heart and Stroke Foundation of Ontario, Canada(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Yukon, Canada; Heart and Stroke Foundation of British Columbia, Canada; Fonds de recherche du Quebec - Sante (FRQS) award	This work was supported by the Canadian Institutes of Health Research [grant number 200804MOP-190260-GSH-CFAC-40513; http://www.cihr-irsc.gc.ca/e/193.html] and Heart and Stroke Foundations of Quebec, Nova Scotia, Alberta, Ontario, Yukon, and British Columbia, Canada (http://www.heartandstroke.com). Dr. Austin and Dr. Pelletier were supported by the Canadian Institutes of Health Research [grant number OR-201303 to A.W.A. and grant number CFE-113622 to R.P.; http://www.cihr-irsc.gc.ca/e/193.html]. Dr. Pilote was supported by the Fonds de recherche du Quebec - Sante (FRQS) award (http://www.frqs.gouv.qc.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N, 2008, SOC SCI MED, V66, P1034, DOI 10.1016/j.socscimed.2007.11.031; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson B, 2007, AM J MANAG CARE, V13, pS103; Bambs CE, 2013, ANN EPIDEMIOL, V23, P328, DOI 10.1016/j.annepidem.2013.02.007; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; Bhamra S, 2008, QUAL AGEING OLDER AD, V9, P27, DOI 10.1108/14717794200800025; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Clark MM, 1996, ADDICT BEHAV, V21, P509, DOI 10.1016/0306-4603(95)00081-X; Damen NL, 2015, EUR J PREV CARDIOL, V22, P196, DOI 10.1177/2047487313506548; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Hartge P, 2006, EPIDEMIOLOGY, V17, P252, DOI 10.1097/01.ede.0000209441.24307.92; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Lee CS, 2010, HEALTH EDUC RES, V25, P687, DOI 10.1093/her/cyq010; Marcellus Lenora, 2004, Can J Nurs Res, V36, P82; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Naderi S, 2013, J COMMUN HEALTH, V38, P458, DOI 10.1007/s10900-012-9644-y; Organization for Economic Co-Operation and Development, 2012, OECD STATEXTRACTS 20; Pilote L, 2012, AM HEART J, V163, P741, DOI 10.1016/j.ahj.2012.01.022; Statistics Canada, 2013, LOW INC CUT OFFS 199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	22	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173594	10.1371/journal.pone.0173594	http://dx.doi.org/10.1371/journal.pone.0173594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301532	Green Published, Green Submitted, gold			2022-12-26	WOS:000396318300054
J	Li, J; Jin, ZH; Gao, YY; Zhou, L; Ge, XN; Guo, X; Han, J; Yang, HC				Li, Jie; Jin, Zhonghui; Gao, Yueyi; Zhou, Lei; Ge, Xinna; Guo, Xin; Han, Jun; Yang, Hanchun			Development of the full-length cDNA clones of two porcine epidemic diarrhea disease virus isolates with different virulence	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; INFECTIOUS CDNA; TRANSMISSIBLE GASTROENTERITIS; UNITED-STATES; CORONAVIRUS; PIGS; STRAIN; CHINA; MANIPULATION; PATHOGENESIS	The recently emerged highly virulent variants of porcine epidemic and diarrhea virus (PEDV) remain a huge threat to the worldwide swine industry. Here, we describe the development of a bacterial artificial chromosome (BAC) reverse genetics system for PEDV based on two recent Chinese field isolates, namely CHM2013 and BJ2011C. Phylogenetically, CHM2013 is closely related to the vaccine strain SM98 whereas the isolate BJ2011C belongs to the GIIb group, a cluster that contains many recent pandemic strains. The full-length cDNA clones of the two isolates were constructed into BAC under the control of CMV promoter. The rescued viruses rBJ2011C and rCHM2013 were found to replicate at the kinetics similar to their respective parental viruses in cell culture. When tested in the 2-day-old pig model, rBJ2011C caused severe diarrhea of piglets with extensive damages to the intestinal epithelium, leading to 100% fatality within 48 hours. In contrast, the rCHM2013-inoculated piglets all survived with only very minor tissue damage observed. Thus, we have successfully established a convenient platform for PEDV genome manipulation. This study also represents the first description of a DNA-launched reverse genetics system for the highly virulent PEDV.	[Han, Jun; Yang, Hanchun] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Minist Agr, Beijing, Peoples R China; China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Han, J; Yang, HC (corresponding author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Minist Agr, Beijing, Peoples R China.	hanx0158@cau.edu.cn; yanghanchun1@cau.edu.cn		Han, Jun/0000-0002-7104-7223; Zhou, Lei/0000-0002-8837-3965	National Key Research and Development Program [2016YFD0500101]; earmarked fund for Modern Agro-industry Technology Research System of China from the Chinese Ministry of Agriculture [CARS-36]	National Key Research and Development Program; earmarked fund for Modern Agro-industry Technology Research System of China from the Chinese Ministry of Agriculture	This work was supported by the National Key Research and Development Program (2016YFD0500101) (http://program.most.gov.cn/) and the earmarked fund for Modern Agro-industry Technology Research System of China (CARS-36) from the Chinese Ministry of Agriculture (http://www.moa.gov.cn/).	Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516; Beall A, 2016, MBIO, V7, DOI 10.1128/mBio.01451-15; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Chae C, 2000, VET REC, V147, P606, DOI 10.1136/vr.147.21.606; Cheun-Arom T, 2015, GENOME ANNOUNC, V3; Cima Greg, 2013, J Am Vet Med Assoc, V243, P469; de Arriba ML, 2002, VET IMMUNOL IMMUNOP, V85, P85, DOI 10.1016/S0165-2427(01)00417-2; Donaldson EF, 2008, J VIROL, V82, P11948, DOI 10.1128/JVI.01804-08; Fan BC, 2017, VIROLOGY, V500, P50, DOI 10.1016/j.virol.2016.10.011; Gao H, 2016, FRONT MED, P1; Gao YY, 2013, ARCH VIROL, V158, P711, DOI 10.1007/s00705-012-1541-2; Huang J.J., 1980, AGR SCI TECHNOL SHAN, V2, P42; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Jengarn J, 2015, J GEN VIROL, V96, P2206, DOI 10.1099/vir.0.000184; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Jung K, 2015, VET MICROBIOL, V178, P31, DOI 10.1016/j.vetmic.2015.04.022; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Kweon CH, 1993, KOREAN J VET RES, V33, P249; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069997; Li L, 2013, MBIO, V4; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Li ZL, 2012, VIRUS GENES, V45, P181, DOI 10.1007/s11262-012-0735-8; Masuda T, 2015, ARCH VIROL, V160, P2565, DOI 10.1007/s00705-015-2522-z; Oldham J, 1972, PIG FARMING, V10, P72; Paarlberg PL, 2014, WORKING PAPERS, V14, P1; Park SJ, 2007, VIRUS GENES, V35, P321, DOI 10.1007/s11262-007-0096-x; Park S, 2014, EMERG INFECT DIS, V20, P2089, DOI 10.3201/eid2012.131642; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Pritchard GC, 1999, VET REC, V144, P616; Shibata I, 2000, VET MICROBIOL, V72, P173, DOI 10.1016/S0378-1135(99)00199-6; Song DS, 2007, RES VET SCI, V82, P134, DOI 10.1016/j.rvsc.2006.03.007; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; St-Jean JR, 2006, J VIROL, V80, P3670, DOI 10.1128/JVI.80.7.3670-3674.2006; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; SUEYOSHI M, 1995, J COMP PATHOL, V113, P59, DOI 10.1016/S0021-9975(05)80069-6; Sun M, 2015, J CLIN MICROBIOL, V53, P1484, DOI 10.1128/JCM.02898-14; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Suzuki T., 2016, J GEN VIROL; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang D, 2016, VIRUS RES; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Xuan H, 1984, CHIN J VET SCI, V4, P202, DOI DOI 10.1292/JVMS.13-0539; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100	49	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173998	10.1371/journal.pone.0173998	http://dx.doi.org/10.1371/journal.pone.0173998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301551	gold, Green Submitted, Green Published			2022-12-26	WOS:000396318300109
J	Lotufo, FA; Parpinelli, MA; Osis, MJ; Surita, FG; Costa, ML; Cecatti, JG				Lotufo, Fatima Aparecida; Parpinelli, Mary Angela; Osis, Maria Jose; Surita, Fernanda Garanhani; Costa, Maria Laura; Cecatti, Jose Guilherme			Obstetrician's risk perception on the prescription of magnesium sulfate in severe preeclampsia and eclampsia: A qualitative study in Brazil	PLOS ONE			English	Article							HEALTH; AVAILABILITY; MANAGEMENT; REGIMENS; BARRIERS; CARE	Introduction Magnesium sulfate (MgSO4) is the drug of choice for the prevention and control of seizures in the management of severe preeclampsia/eclampsia. Several barriers have been iden-tified in the use of MgSO4, especially in low and middle-income settings. Objective To describe the obstetrician's perception on possible reasons for underutilizing magnesium sulfate to treat preeclampsia/eclampsia. Method A qualitative clinical study, based on phenomenological reference by semi-structured inter-views and open-ended discussions with obstetricians of the public healthcare system in pri-mary care units (PCU) and referral maternity hospitals (RMH), in a southeastern Brazilian city. Results Fear of drug toxicity was the major cause for not prescribing the medication in PCU. Fear was justified by insufficient technical, structural and organizational resources of healthcare facilities and by a shortage of physicians properly trained for adequate drug use. Conclusion Fear of toxicity of magnesium sulfate was the main barrier towards timely and proper drug use. Periodic skill development and training of obstetricians, along with integration of the medical team in the work environment may contribute to decrease fear, ensuring safety of drug prescription and thus possibly reducing adverse outcomes related to PE.	[Lotufo, Fatima Aparecida; Parpinelli, Mary Angela; Surita, Fernanda Garanhani; Costa, Maria Laura; Cecatti, Jose Guilherme] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil; [Osis, Maria Jose] Univ Estadual Campinas, Sch Med Sci, Postgrad Program Obstet & Gynecol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Parpinelli, MA (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.	parpinelli@caism.unicamp.br	Lotufo, Fátima/AFK-9571-2022; Cecatti, Jose Guilherme/M-5945-2013; Costa, Maria Laura/I-4980-2019; Surita, Fernanda Garanhani/H-9575-2012	Cecatti, Jose Guilherme/0000-0003-1285-8445; Costa, Maria Laura/0000-0001-8280-3234; Surita, Fernanda Garanhani/0000-0003-4335-0337				Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Austin A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0493-4; Bardin L., 1977, ANAL OF CONTENT, V70; Bigdeli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059158; Brasil. Brazilian Institute of Geography and Statistics, 2010 CENS; Brazil. Ministry of Health. Department of Informatics. Health information, HLTH INF VIT STAT MO; Bruyne P, 1982, DINAMICA PESQUISA CI; Campinas. Municipal Department of Health (Campinas), STRUCT UN HLTH SYST; Chaturvedi S, 2013, J HEALTH POPUL NUTR, V31, P86; DULEY L, 1995, LANCET, V345, P1455; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; Ekele B A, 2005, Afr J Reprod Health, V9, P128; Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401; Campos CJG, 2009, REV LAT-AM ENFERM, V17, P259, DOI 10.1590/S0104-11692009000200019; Gordon R, 2014, J OBSTET GYNAECOL CA, V36, P154, DOI 10.1016/S1701-2163(15)30662-9; Long Q, 2016, BJOG; Lotufo FA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1055-0; Merigue MA, 2003, ABORDAGENS TEORICOME, P1; Minossi José Guilherme, 2013, Rev. Col. Bras. Cir., V40, P494; Minossi José Guilherme, 2009, Rev. Col. Bras. Cir., V36, P90; Municipal Department of Halth (Campinas), HLTH INF HLTH NUMB; Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Pratt JJ, 2016, ACTA OBSTET GYN SCAN, V95, P144, DOI 10.1111/aogs.12807; PRITCHARD JA, 1955, SURG GYNECOL OBSTET, V100, P131; Salinger DH, 2013, BJOG-INT J OBSTET GY, V120, P894, DOI 10.1111/1471-0528.12222; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Shamsuddin L, 2005, Bangladesh Med Res Counc Bull, V31, P75; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; TRAN DN, 2015, J GLOB HLTH, V5; Turato E.R, 2011, TRATADO METODOLOGIA; Turato ER, 2005, REV SAUDE PUBL, V39, P507, DOI 10.1590/S0034-89102005000300025; WHO, PRIOR MED MOTN CHILD; World Health Organization, GLOB HLTH OBS GHO DA; Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4; Zuspan F P, 1966, Clin Obstet Gynecol, V9, P954, DOI 10.1097/00003081-196612000-00010	38	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172602	10.1371/journal.pone.0172602	http://dx.doi.org/10.1371/journal.pone.0172602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301493	Green Submitted, gold, Green Published			2022-12-26	WOS:000396318300017
J	Menghini, P; Di Martino, L; Lopetuso, LR; Corridoni, D; Webster, JC; Xin, W; Arseneau, KO; Lam, M; Pizarro, TT; Cominelli, F				Menghini, Paola; Di Martino, Luca; Lopetuso, Loris R.; Corridoni, Daniele; Webster, Joshua C.; Xin, Wei; Arseneau, Kristen O.; Lam, Minh; Pizarro, Theresa T.; Cominelli, Fabio			A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis	PLOS ONE			English	Article							BETA-CATENIN; INFLAMMATION; ROLES	Patients with inflammatory bowel disease (IBD) are at increased risk for developing colorectal cancer. Evidence suggests that colonic dysplasia and colitis-associated cancer (CAC) are often linked to repeated cycles of epithelial cell injury and repair in the context of chronic production of inflammatory cytokines. Several mouse models of CAC have been proposed, including chemical induction through exposure to dextran sulfate sodium (DSS) with the genotoxic agents azoxymethane (AOM), 1,2-dymethylhydrazine (DHM) or targeted genetic mutations. However, such models are usually performed on healthy animals that usually lack the underlying genetic predisposition, immunological dysfunction and dysbiosis characteristic of IBD. We have previously shown that inbred SAMP1/YitFc (SAMP) mice develop a progressive Crohn's disease (CD)-like ileitis in the absence of spontaneous colitis. We hypothesize that SAMP mice may be more susceptible to colonic tumorigenesis due to their predisposition to IBD. To test this hypothesis, we administered AOM/DSS to IBD-prone SAMP and their non-inflamed parental control strain, AKR mice. Our results showed that AOM/DSS treatment enhanced the susceptibility of colitis in SAMP compared to AKR mice, as assessed by endoscopic and histologic inflammatory scores, daily weight loss and disease activity index (DAI), during and after DSS administration. SAMP mice also showed increased colonic tumorigenesis, resulting in the occurrence of intramucosal carcinoma and a higher incidence of high-grade dysplasia and tumor burden. These phenomena occurred even in the absence of AOM and only upon repeated cycles of DSS. Taken together, our data demonstrate a heightened susceptibility to colonic inflammation and tumorigenesis in AOM/DSS-treated SAMP mice with CD-like ileitis. This novel model represents a useful tool to investigate relevant mechanisms of CAC, as well as for pre-clinical testing of potential IBD and colon cancer therapeutics.	[Menghini, Paola; Di Martino, Luca; Corridoni, Daniele; Webster, Joshua C.; Arseneau, Kristen O.; Lam, Minh; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Menghini, Paola; Di Martino, Luca; Lopetuso, Loris R.; Corridoni, Daniele; Webster, Joshua C.; Xin, Wei; Arseneau, Kristen O.; Lam, Minh; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Digest Hlth Res Inst, Cleveland, OH 44106 USA; [Lopetuso, Loris R.; Xin, Wei; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Cominelli, F (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.; Cominelli, F (corresponding author), Case Western Reserve Univ, Digest Hlth Res Inst, Cleveland, OH 44106 USA.; Cominelli, F (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	fabio.cominelli@case.edu	Lopetuso, Loris Riccardo/AAC-9065-2019	Corridoni, Daniele/0000-0003-0251-2248; Menghini, Paola/0000-0002-8779-088X; Cominelli, Fabio/0000-0002-1571-1548	National Institute of Health [DK042191, DK055812, DK091222, DK097948]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, R01DK042191, P30DK097948] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by National Institute of Health grants DK042191, DK055812, DK091222, and DK097948.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Aust DE, 2001, MODERN PATHOL, V14, P29, DOI 10.1038/modpathol.3880253; Bonomi M, 2014, ADV EXP MED BIOL, V816, P107, DOI 10.1007/978-3-0348-0837-8_5; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Catana CS, 2015, WORLD J GASTROENTERO, V21, P5823, DOI 10.3748/wjg.v21.i19.5823; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; COOPER HS, 1993, LAB INVEST, V69, P238; Dang CV, 1999, MOL CELL BIOL, V19, P1; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Di Martino L, 2016, CANC RES; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Jia LG, 2016, J IMMUNOL, V197, P377, DOI 10.4049/jimmunol.1502466; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kodani T, 2013, JOVE-J VIS EXP, DOI 10.3791/50843; Koskensalo S, 2011, TUMOR BIOL, V32, P259, DOI 10.1007/s13277-010-0080-2; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Low D, 2014, INFLAMM BOWEL DIS, V20, P2115, DOI 10.1097/MIB.0000000000000094; Mager LF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00096; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Olson TS, 2006, J EXP MED, V203, P541, DOI 10.1084/jem.20050407; Oshima H, 2015, CANCER RES, V75, P766, DOI 10.1158/0008-5472.CAN-14-2036; Pizarro TT, 2011, INFLAMM BOWEL DIS, V17, P2566, DOI 10.1002/ibd.21638; Shenoy AK, 2012, CANCER RES, V72, P5091, DOI 10.1158/0008-5472.CAN-12-1806; Subramaniam Renuka, 2016, Cancer Res Front, V2, P1; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thaker AI, 2012, JOVE-J VIS EXP, DOI 10.3791/4100; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Wang K, 2015, CLIN EXP RHEUMATOL, V33, pS87; WATTENBERG LW, 1977, CANCER, V40, P2432, DOI 10.1002/1097-0142(197711)40:5+<2432::AID-CNCR2820400907>3.0.CO;2-8; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174121	10.1371/journal.pone.0174121	http://dx.doi.org/10.1371/journal.pone.0174121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301579	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300129
J	Sui, X; Du, QN; Xu, KF; Tian, XL; Song, L; Wang, X; Xu, XL; Wang, ZX; Wang, YY; Gu, J; Song, W; Jin, ZY				Sui, Xin; Du, Qianni; Xu, Kai-Feng; Tian, Xinlun; Song, Lan; Wang, Xiao; Xu, Xiaoli; Wang, Zixing; Wang, Yuyan; Gu, Jun; Song, Wei; Jin, Zhengyu			Quantitative assessment of Pulmonary Alveolar Proteinosis (PAP) with ultra-dose CT and correlation with Pulmonary Function Tests (PFTs)	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CHEST; EMPHYSEMA; DENSITOMETRY; QUALITY	Background The purpose of this study was to investigate whether ultra-low-dose chest computed tomog-raphy (CT) can be used for visual assessment of CT features in patients with pulmonary alveolar proteinosis (PAP) and to evaluate the relationship between the quantitative analysis of the ultra low dose CT scans and the pulmonary function tests (PFTs). Methods Thirty eight patients (mean [SD] age, 44.47 [12.28] years; 29 males, 9 females) with PAP were enrolled and subjected to two scans each with low dose CT (reference parameters: 120 kV and 50 mAs) and ultra low dose CT (reference parameters, 80 kV, 25 mAs). Images were reconstructed via filtered back projection (FBP) for low dose CT and iterative recon-struction (IR) for ultra low dose CT. All patients underwent PFT. The Visual analysis for ground glass opacity (GGO) is performed. The quantitative CT and PFT results were analyzed by canonical correlations. Results The mean body mass index (BMI) was 25.37 +/- 3.26 kg/m (2). The effective radiation doses were 2.30 +/- 0.46 and 0.24 +/- 0.05 mSv for low dose and ultra low dose CT, respectively. The size specific dose estimates were 5.81 +/- 0.81 and 0.62 +/- 0.09 mSv for low dose and ultra-low-dose CT. GGOs and interlobular septal thickening were observed bilaterally in all patients. The average visual GGO score was lower in the upper field (2.67 +/- 1.24) but higher in the middle and lower fields (3.08 +/- 1.32 and 3.08 +/- 0.97, respectively). The average score for the whole lung was 2.94 +/- 1.19. There is a significant correlation between PFTs and quantitative of ultra low dose CT (canonical loading = 0.78). Conclusions Ultra-low-dose CT has the potential to quantify the lung parenchyma changes of PAP. This technique could provide a sensitive and objective assessment of PAP and has good relation with PFTs. In addition, the radiation dose of ultra-low-dose CT was very low.	[Sui, Xin; Du, Qianni; Song, Lan; Wang, Xiao; Xu, Xiaoli; Song, Wei; Jin, Zhengyu] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China; [Xu, Kai-Feng; Tian, Xinlun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing, Peoples R China; [Wang, Zixing; Wang, Yuyan] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Wang, Zixing; Wang, Yuyan] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China; [Gu, Jun] Siemens Healthineers, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Siemens AG	Song, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China.	cjr.songwei@vip.163.com	Xu, Kai-Feng/AAO-2445-2020; Wang, Yuyan/GQZ-8255-2022; Tian, Xinlun/AAF-5444-2019	Tian, Xinlun/0000-0003-4307-6665; Jin, Zhengyu/0000-0002-6179-9632; Wang, Yuyan/0000-0003-3747-0762	National Health and Family Planning Commission the People's Republic of China [201402013]	National Health and Family Planning Commission the People's Republic of China	National Health and Family Planning Commission the People's Republic of China funded this study (201402013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Akira M, 2000, THORAX, V55, P854, DOI 10.1136/thorax.55.10.854; [Anonymous], 2011, 204 AAPM; Bacher K, 2003, AM J ROENTGENOL, V181, P923, DOI 10.2214/ajr.181.4.1810923; Bankier AA, 2007, RADIOLOGY, V242, P898, DOI 10.1148/radiol.2423060196; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; Diederich S, 1999, RADIOLOGY, V213, P289, DOI 10.1148/radiology.213.1.r99oc29289; Frazier AA, 2008, RADIOGRAPHICS, V28, P883, DOI 10.1148/rg.283075219; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Guan YB, 2012, EUR J RADIOL, V81, P2430, DOI 10.1016/j.ejrad.2011.05.005; Hardoon DR, 2004, NEURAL COMPUT, V16, P2639, DOI 10.1162/0899766042321814; KEMERINK GJ, 1995, RADIOLOGY, V197, P749, DOI 10.1148/radiology.197.3.7480750; Kim WJ, 2009, CHEST, V136, P396, DOI 10.1378/chest.08-2858; Lee SW, 2014, EUR RADIOL, V24, P817, DOI 10.1007/s00330-013-3090-9; Lucaya J, 2000, AM J ROENTGENOL, V175, P985, DOI 10.2214/ajr.175.4.1750985; Madani A, 2007, RADIOLOGY, V243, P250, DOI 10.1148/radiol.2431060194; McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Perez A, 2005, CHEST, V128, P2471, DOI 10.1378/chest.128.4.2471; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Pourjabbar S, 2015, ACTA RADIOL, V56, P688, DOI 10.1177/0284185114537256; Quaia E, 2012, EUR RADIOL, V22, P1912, DOI 10.1007/s00330-012-2440-3; Robinson TE, 2009, CHEST, V135, P842, DOI 10.1378/chest.08-1317; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Task Group on Control of Radiation Dose in Computed Tomography, 2000, Ann ICRP, V30, P7; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Wang R, 2015, AM J ROENTGENOL, V204, P743, DOI 10.2214/AJR.14.13101; Yang WJ, 2013, J COMPUT ASSIST TOMO, V37, P301, DOI 10.1097/RCT.0b013e31827b8c66	31	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172958	10.1371/journal.pone.0172958	http://dx.doi.org/10.1371/journal.pone.0172958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301535	Green Published, gold, Green Submitted			2022-12-26	WOS:000396318300020
J	Costa, LC; Nalin, RS; Ramalho, MAP; de Souza, EA				Costa, Larissa Carvalho; Nalin, Rafael Storto; Patto Ramalho, Magno Antonio; de Souza, Elaine Aparecida			Are duplicated genes responsible for anthracnose resistance in common bean?	PLOS ONE			English	Article							ANGULAR LEAF-SPOT; COLLETOTRICHUM-LINDEMUTHIANUM; PHASEOLUS-VULGARIS; MOLECULAR DIVERSITY; RACE 65; CULTIVAR; VIRULENCE; GENOME; VARIABILITY; INHERITANCE	The race 65 of Colletotrichum lindemuthianum, etiologic agent of anthracnose in common bean, is distributed worldwide, having great importance in breeding programs for anthracnose resistance. Several resistance alleles have been identified promoting resistance to this race. However, the variability that has been detected within race has made it difficult to obtain cultivars with durable resistance, because cultivars may have different reactions to each strain of race 65. Thus, this work aimed at studying the resistance inheritance of common bean lines to different strains of C. lindemuthianum, race 65. We used six C. lindemuthianum strains previously characterized as belonging to the race 65 through the international set of differential cultivars of anthracnose and nine commercial cultivars, adapted to the Brazilian growing conditions and with potential ability to discriminate the variability within this race. To obtain information on the resistance inheritance related to nine commercial cultivars to six strains of race 65, these cultivars were crossed two by two in all possible combinations, resulting in 36 hybrids. Segregation in the F2 generations revealed that the resistance to each strain is conditioned by two independent genes with the same function, suggesting that they are duplicated genes, where the dominant allele promotes resistance. These results indicate that the specificity between host resistance genes and pathogen avirulence genes is not limited to races, it also occurs within strains of the same race. Further research may be carried out in order to establish if the alleles identified in these cultivars are different from those described in the literature.	[Costa, Larissa Carvalho; Patto Ramalho, Magno Antonio; de Souza, Elaine Aparecida] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Nalin, Rafael Storto] Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Dept Genet, Piracicaba, SP, Brazil	Universidade Federal de Lavras; Universidade de Sao Paulo	de Souza, EA (corresponding author), Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil.	easouza@dbi.ufla.br	costa, larissa/GRX-4740-2022		Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [134246/2013-6]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants and scholarships from the following Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (134246/2013-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, P NATL ACAD SCI USA, V100, P10836, DOI 10.1073/pnas.1934431100; Alzate-Marin A.L., 1999, ANN REPORT BEAN IMPR, V42, P15; Alzate-Marin A. L, 2003, ANN REPT BEAN IMPROV, V46, P177; Alzate-Marin AL, 2003, EUPHYTICA, V133, P165, DOI 10.1023/A:1025551006444; Alzate-marin AL, 2004, CROP BREED APPL BIOT, V4, P446; Alzate-Marin AL, 2007, EUPHYTICA, V154, P1, DOI 10.1007/s10681-006-9253-x; AlzateMarin AL, 1997, PLANT DIS, V81, P996, DOI 10.1094/PDIS.1997.81.9.996; Arantes LD, 2010, CROP BREED APPL BIOT, V10, P232; Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; BANNEROT H, 1971, ANN AMELIOR PLANT, V21, P83; Barcelos L, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100438; Bennetzen JL, 2007, CURR OPIN PLANT BIOL, V10, P176, DOI 10.1016/j.pbi.2007.01.010; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Carbonell Sergio A.M., 1999, Fitopatologia Brasileira, V24, P60; Castro SAL, 2014, ANN REP BEAN IMPROV, V57, P163; Davide LMC, 2009, CROP BREED APPL BIOT, V9, P23, DOI 10.12702/1984-7033.v09n01a04; Coelho RT., 2013, ANN REP BEAN IMPROV, V56, P43; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; de Abreu AFB, 2004, CROP BREED APPL BIOT, V4, P372, DOI DOI 10.12702/1984-7033.v04n03a21; DESOUZA TLP, 2005, CROP BREED APPL BIOT, V5, P247; Devos KM, 2010, CURR OPIN PLANT BIOL, V13, P139, DOI 10.1016/j.pbi.2009.12.005; Ferreira J.J., 2013, TRANSLATIONAL GENOMI, VI, P151, DOI DOI 10.1002/9781118728475.CH9; Ferreira JJ, 2000, EUPHYTICA, V113, P259, DOI 10.1023/A:1003907130234; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fouilloux G, 1979, NEW RACES BEAN ANTHR, P221; Fouilloux G., 1976, ANN REP BEAN IMPROV, V19, P36; Gao D, 2014, FRONT PLANT SCI, V5, P9; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Gon?alves AMO., 2010, ANN REP BEAN IMPROV, V53, P220; Gonalves-Vidigal M. C., 2001, Crop Breeding and Applied Biotechnology, V1, P99; Goncalves-Vidigal MC, 2013, THEOR APPL GENET, V126, P2245, DOI 10.1007/s00122-013-2131-8; Goncalves-Vidigal MC, 2009, CROP SCI, V49, P133, DOI 10.2135/cropsci2008.01.0004; Goncalves-Vidigal MC, 2008, PLANT BREEDING, V127, P592, DOI 10.1111/j.1439-0523.2008.01530.x; Goncalves-Vidigal MC, 2006, EUPHYTICA, V151, P411, DOI 10.1007/s10681-006-9164-x; Goncalves-Vidigal MC, 2012, PLANT BREEDING, V131, P423, DOI 10.1111/j.1439-0523.2011.01939.x; Goncalves-Vidigal MC, 2011, THEOR APPL GENET, V122, P893, DOI 10.1007/s00122-010-1496-1; Gonqalves-Vidigal MC, 2007, GENET MOL BIOL, V30, P589, DOI 10.1590/S1415-47572007000400015; Gonzalez AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00141; Guttman DS, 2014, NAT REV GENET, V15, P797, DOI 10.1038/nrg3748; Hagiwara W. E., 2001, Crop Breeding and Applied Biotechnology, V1, P355; Ishikawa FH, 2011, J PLANT PATHOL, V93, P461; Ishikawa F.H., 2012, ANN REP BEAN IMPROV, V55, P141; Ishikawa FH, 2008, BIOLOGIA, V63, P156, DOI 10.2478/s11756-008-0039-6; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Ferreira JJ, 2008, PLANT DIS, V92, P705, DOI 10.1094/PDIS-92-5-0705; Marcondes EHK, 2010, CIENC AGROTEC, V34, P975, DOI 10.1590/S1413-70542010000400025; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Kim KD, 2015, PLANT PHYSIOL, V168, P1433, DOI 10.1104/pp.15.00408; Lima IA, 2008, ANN REP BEAN IMPROV, V51, P188; Mahuku GS, 2004, EUR J PLANT PATHOL, V110, P253, DOI 10.1023/B:EJPP.0000019795.18984.74; MASTENBROEK C., 1960, EUPHYTICA, V9, P177, DOI 10.1007/BF00022219; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; McRostie GP, 1919, PHYTOPATHOLOGY, V9, P141; Melotto M, 2000, COLLETOTRICHUM, P346; Melotto M, 2000, ALLELIC SERIES CO 1, V73, P143; Mendez-Vigo B, 2005, EUPHYTICA, V141, P237, DOI 10.1007/s10681-005-7075-x; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Oblessuc PR, 2015, THEOR APPL GENET, V128, P1193, DOI 10.1007/s00122-015-2500-6; Parker IM, 2004, ANNU REV ECOL EVOL S, V35, P675, DOI 10.1146/annurev.ecolsys.34.011802.132339; PASTOR-CORRALES M A, 1991, Phytopathology, V81, P694; Pereira H. S., 2004, Crop Breeding and Applied Biotechnology, V4, P422; Pereira R, 2015, GENET MOL RES, V14, P5044, DOI 10.4238/2015.May.12.7; Pinto JMA, 2012, PHYTOPATHOLOGY, V102, P490, DOI 10.1094/PHYTO-06-11-0179; Ramalho MAP, 1986, CIENCIA PRATICA LAVR, V10, P343; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Royer MR, 1984, NATURAL OUTCROSSING, P194; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Santos J., 2008, REV BRASILEIRA AGROC, V14, P115, DOI [10.18539/cast.v14i3.1940, DOI 10.18539/CAST.V14I3.1940]; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schwartz H.F., 1989, BEAN PRODUCTION PROB; Botelho FBS, 2011, J PHYTOPATHOL, V159, P175, DOI 10.1111/j.1439-0434.2010.01743.x; Silvurio L., 2002, ANN REPORT BEAN IMPR, V45, P74; Singh SP, 2010, CROP SCI, V50, P2199, DOI 10.2135/cropsci2009.03.0163; Souza EA, 2010, GENET MOL RES, V9, P1759, DOI 10.4238/vol9-3gmr863; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; TU JC, 1985, MICROBIOS, V44, P87; Vallejo V., 2009, Open Horticulture Journal, V2, P29; van Schoonhoven A, 1987, STANDARD SYSTEM EVAL, P54; Young RA, 1998, THEOR APPL GENET, V96, P87, DOI 10.1007/s001220050713	83	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e017378	10.1371/journal.pone.0173789	http://dx.doi.org/10.1371/journal.pone.0173789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296933	gold, Green Published, Green Submitted			2022-12-26	WOS:000396311700065
J	Kuo, CH; Chen, SC; Fang, CT; Nien, FJ; Wu, ET; Lin, SY; Chuang, LM; Lee, CN; Li, HY				Kuo, Chun-Heng; Chen, Szu-Chi; Fang, Chi-Tai; Nien, Feng-Jung; Wu, En-Tzu; Lin, Shin-Yu; Chuang, Lee-Ming; Lee, Chien-Nan; Li, Hung-Yuan			Screening gestational diabetes mellitus: The role of maternal age	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; FASTING PLASMA-GLUCOSE; BETA-CELL DYSFUNCTION; INTERNATIONAL ASSOCIATION; PREGNANCY OUTCOMES; INSULIN-RESISTANCE; HYPERGLYCEMIA; DIAGNOSIS; CRITERIA; RISK	Objective Using a specific cutoff of fasting plasma glucose (FPG) to screen gestational diabetes mellitus (GDM) can reduce the use of oral glucose tolerance tests (OGTT). Since the prevalence of GDM increases with age, this screening method may not be appropriate in healthcare systems where women become pregnant at older ages. Therefore, we aimed to develop a screening algorithm for GDM that takes maternal age into consideration. Methods We included 945 pregnant women without history of GDM who received 75g OGTT to diagnose GDM in 2011. Screening algorithms using FPG with or without age were developed. Another 362 pregnant women were recruited in 2013-2015 as the validation cohort. Results Using FPG criteria alone, more GDM diagnoses were missed in women >= 35 years than in women <35 years (13.2% vs. 5.8%, p < 0.001). Among GDM women >= 35 years, 63.6% had FPG <92 mg/dL (5.1 mmol/L). Use of the algorithm with an "age plus FPG" cutoff could reduce the use of OGTT (OGTT%) from 77.6% to 62.9%, while maintaining good sensitivity (from 91.9% to 90.2%) and specificity (from 100% to 100%). Similar reduction in OGTT% was found in the validation cohort (from 86.4% to 76.8%). In the simulation, if the percentage of women >= 35 years were 40% or more, the screening algorithm with an "age plus FPG" cutoff could further reduce OGTT% by 11.0%-18.8%. Conclusions A screening algorithm for GDM that takes maternal age into consideration can reduce the use of OGTT when women become pregnant at older ages.	[Kuo, Chun-Heng; Chen, Szu-Chi] New Taipei City Hosp, Dept Internal Med, New Taipei, Taiwan; [Fang, Chi-Tai; Chuang, Lee-Ming; Li, Hung-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Fang, Chi-Tai; Chuang, Lee-Ming] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Nien, Feng-Jung] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Wu, En-Tzu] Dianthus MFM Clin, Dept Obstet & Gynecol, Taipei, Taiwan; [Lin, Shin-Yu; Lee, Chien-Nan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Li, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Lee, CN (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	leecn@ntu.edu.tw; larsli@ntuh.gov.tw	Chuang, Lee-Ming/AAF-3324-2019; Fang, Chi-Tai/P-2908-2016	Fang, Chi-Tai/0000-0002-7380-1699; Lee, Chien-Nan/0000-0002-1725-0407; Kuo, Chun Heng/0000-0001-7673-3567; CHUANG, LEE-MING/0000-0003-0978-2662; Li, Hung-Yuan/0000-0001-9644-2855; LIN, SHIN-YU/0000-0002-0753-2793	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-002-157-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported in part by a grant (MOST 103-2314-B-002-157-MY2) from the Ministry of Science and Technology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Agarwal MM, 2010, DIABETES CARE, V33, P2018, DOI 10.2337/dc10-0572; ANDRES R, 1971, MED CLIN N AM, V55, P835, DOI 10.1016/S0025-7125(16)32479-8; Astolfi P, 2002, PAEDIATR PERINAT EP, V16, P67, DOI 10.1046/j.1365-3016.2002.00375.x; Baan CA, 1999, AM J EPIDEMIOL, V149, P219; Bando Y, 2001, DIABETES CARE, V24, P1156, DOI 10.2337/diacare.24.7.1156; Committee on Practice Bulletins-Obstetrics, 2013, OBSTET GYNECOL 1, V122, P406; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6; de Pablos-Velasco PL, 2001, DIABETIC MED, V18, P235, DOI 10.1046/j.1464-5491.2001.00451.x; HARRIS M, 1979, DIABETES, V28, P1039; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hosseinpanah F, 2006, DIABETIC MED, V23, P982, DOI 10.1111/j.1464-5491.2006.01939.x; JACKSON RA, 1982, J CLIN ENDOCR METAB, V55, P840, DOI 10.1210/jcem-55-5-840; Lai YC, 2013, DIABETIC MED, V30, P318, DOI 10.1111/dme.12008; Laopaiboon M, 2014, BJOG-INT J OBSTET GY, V121, P49, DOI 10.1111/1471-0528.12659; Li CL, 2003, DIABETES RES CLIN PR, V59, P225, DOI 10.1016/S0168-8227(02)00249-8; McIntyre HD, 2015, BEST PRACT RES CL OB, V29, P194, DOI 10.1016/j.bpobgyn.2014.04.022; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; National Institutes of Health consensus development conference statement, 2013, OBSTET GYNECOLOGY 1, V122, P358; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Savona-Ventura C, 2013, INT J GYNECOL OBSTET, V120, P240, DOI 10.1016/j.ijgo.2012.10.016; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Wei JN, 2007, OBESITY, V15, P1609, DOI 10.1038/oby.2007.190; Wu ET, 2016, J DIABETES INVEST, V7, P121, DOI 10.1111/jdi.12378; Xu L, 2010, METABOLISM, V59, P367, DOI 10.1016/j.metabol.2009.08.004; Xu X, 2016, INTERNATIONAL JOURNA, V13; Zhu WW, 2013, DIABETES CARE, V36, P2038, DOI 10.2337/dc12-2465	29	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173049	10.1371/journal.pone.0173049	http://dx.doi.org/10.1371/journal.pone.0173049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296923	Green Submitted, Green Published, gold			2022-12-26	WOS:000396311700024
J	Peixoto, LD; Laviola, BG; Alves, AA; Rosado, TB; Bhering, LL				Peixoto, Leonardo de Azevedo; Laviola, Bruno Galveas; Alves, Alexandre Alonso; Rosado, Tatiana Barbosa; Bhering, Leonardo Lopes			Breeding Jatropha curcas by genomic selection: A pilot assessment of the accuracy of predictive models	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; GENOMEWIDE SELECTION; QUANTITATIVE TRAITS; PLANT; OIL; BIOFUELS; QUALITY; GROWTH; VALUES; SETS	Genomic wide selection is a promising approach for improving the selection accuracy in plant breeding, particularly in species with long life cycles, such as Jatropha. Therefore, the objectives of this study were to estimate the genetic parameters for grain yield (GY) and the weight of 100 seeds (W100S) using restricted maximum likelihood (REML); to compare the performance of GWS methods to predict GY and W100S; and to estimate how many markers are needed to train the GWS model to obtain the maximum accuracy. Eight GWS models were compared in terms of predictive ability. The impact that the marker density had on the predictive ability was investigated using a varying number of markers, from 2 to 1,248. Because the genetic variance between evaluated genotypes was significant, it was possible to obtain selection gain. All of the GWS methods tested in this study can be used to predict GY and W100S in Jatropha. A training model fitted using 1,000 and 800 markers is sufficient to capture the maximum genetic variance and, consequently, maximum prediction ability of GY and W100S, respectively. This study demonstrated the applicability of genome-wide prediction to identify useful genetic sources of GY and W100S for Jatropha breeding. Further research is needed to confirm the applicability of the proposed approach to other complex traits.	[Peixoto, Leonardo de Azevedo; Bhering, Leonardo Lopes] Univ Fed Vicosa, Dept Biol, Vicosa, MG, Brazil; [Laviola, Bruno Galveas; Alves, Alexandre Alonso; Rosado, Tatiana Barbosa] Embrapa Agroenergia, Empresa Brasileira Pesquisa Agr, Parque Estacao Biol PqEB S-N, Brasilia, DF, Brazil	Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Peixoto, LD (corresponding author), Univ Fed Vicosa, Dept Biol, Vicosa, MG, Brazil.	leoazevedop@gmail.com	Bhering, Leonardo/AAK-9548-2020; Laviola, Bruno G/F-5855-2010; Laviola, Bruno Galvêas/AAK-8551-2020	Laviola, Bruno/0000-0002-6360-1204; Bhering, Leonardo/0000-0002-6072-0996	CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior); Cnpq (National Counsel of Technological and Scientific Development); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais); Funarbe (Fundacao Arthur Bernardes); Federal University of Vicosa	CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Cnpq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Funarbe (Fundacao Arthur Bernardes); Federal University of Vicosa	We are thankful to CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior), Cnpq (National Counsel of Technological and Scientific Development), FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais), Funarbe (Fundacao Arthur Bernardes) and Federal University of Vicosa for financial support. We also thank the Biometric Lab (Federal University of Vicosa, Brazil) where all analyses were performed by remote access.	Akanno EC, 2013, LIVEST SCI, V152, P101, DOI 10.1016/j.livsci.2012.07.021; Akintayo ET, 2004, BIORESOURCE TECHNOL, V92, P307, DOI 10.1016/S0960-8524(03)00197-4; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Azevedo CF, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0264-2; Bahadur B., 2012, JATROPHA CHALLENGES; Bailis R, 2011, GCB BIOENERGY, V3, P449, DOI 10.1111/j.1757-1707.2011.01100.x; Bailis R, 2011, ANN ASSOC AM GEOGR, V101, P827, DOI 10.1080/00045608.2011.568867; Becker K., 2008, LIPID TECHNOL, V20, P104, DOI [DOI 10.1002/LITE.200800023, 10.1002/lite.200800023]; Berchmans HJ, 2008, BIORESOURCE TECHNOL, V99, P1716, DOI 10.1016/j.biortech.2007.03.051; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Butler JB, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0987-x; Carels N, 2013, CHALLENGES NEW ENERG; Clark SA, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-4; Cleveland MA, 2012, G3-GENES GENOM GENET, V2, P429, DOI 10.1534/g3.111.001453; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Dias LAdS, 2007, CULTIVO MANSO JATROP, V1, P1; Falconer D. S., 1996, Introduction to quantitative genetics.; FERNANDO RL, 1986, THEOR APPL GENET, V72, P822, DOI 10.1007/BF00266552; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2011, CROP SCI, V51, P2597, DOI 10.2135/cropsci2011.05.0253; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; IWATA H, 2011, TREE GENET GENOMES, V7, DOI DOI 10.1007/s11295-011-0371-9; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Junqueira VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157038; KUMAR S, 2012, TREE GENET GENOMES, V8, P1, DOI DOI 10.1007/s11295-011-0425-z; Laviola BG, 2010, PESQUI AGROPECU BRAS, V45, P1117, DOI 10.1590/S0100-204X2010001000010; Lorenz AJ, 2012, CROP SCI, V52, P1609, DOI 10.2135/cropsci2011.09.0503; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Meuwissen THE, 2001, GENETICS, V157, P1819; Mohammadi SA, 2003, CROP SCI, V43, P1235, DOI 10.2135/cropsci2003.1235; Naylor RL, 2007, ENVIRONMENT, V49, P30, DOI 10.3200/ENVT.49.9.30-43; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Nithiyanantham S, 2012, J AM OIL CHEM SOC, V89, P961, DOI 10.1007/s11746-012-2012-3; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Peixoto L, 2016, GENETICS MOL RES GMR, V15; Peixoto LD, 2016, IND CROP PROD, V80, P70, DOI 10.1016/j.indcrop.2015.10.034; Pszczola M, 2012, J DAIRY SCI, V95, P389, DOI 10.3168/jds.2011-4338; Pu Y, 2011, BIORESOURCES, V6, P4856; R Core Team, 2013, R LANG ENV STAT COMP; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Resende MDV, 2000, ANALISE ESTATISTICA; Resende MDVd, 2002, SOFTW SELEGEN REML B; Rutkoski J, 2012, PLANT GENOME-US, V5, P51, DOI 10.3835/plantgenome2012.02.0001; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Technow F, 2013, G3-GENES GENOM GENET, V3, P197, DOI 10.1534/g3.112.004630; Terakami S, 2016, BREEDING SCI, V66, P271, DOI 10.1270/jsbbs.66.271; Vencovsky R., 1987, MELHORAMENTO PRODUCA, P137; Wong CK, 2008, THEOR APPL GENET, V116, P815, DOI 10.1007/s00122-008-0715-5	59	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173368	10.1371/journal.pone.0173368	http://dx.doi.org/10.1371/journal.pone.0173368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296913	gold, Green Submitted, Green Published			2022-12-26	WOS:000396311700036
J	Shu, JP; Shang, H; Jin, DM; Wei, HJ; Zhou, XL; Liu, HM; Gu, YF; Wang, Y; Wang, FG; Shen, H; Zhang, R; Adjie, B; Yan, YH				Shu, Jiang-Ping; Shang, Hui; Jin, Dongmei; Wei, Hong-Jin; Zhou, Xi-Le; Liu, Hong-Mei; Gu, Yu-Feng; Wang, Ying; Wang, Fa-Guo; Shen, Hui; Zhang, Rui; Adjie, Bayu; Yan, Yue-Hong			Re-establishment of species from synonymies based on DNA barcoding and phylogenetic analysis using Diplopterygium simulans (Gleicheniaceae) as an example	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; DELIMITATION; COMPLEX; PLANTS; MODEL	Because synonymy treatment traditionally relies on morphological judgments, it usually causes many problems in species delimitation and in the biodiversity catalogue. For example, Diplopterygium simulans, which belongs to the Gleicheniaceae family, has been considered to be synonymous with D. glaucum or D. giganteum based mainly on the morphology of its pinna rachis and blade. In the absence of molecular evidence, these revisions remain doubtful. DNA barcoding, which is considered to be a powerful method for species-level identification, was employed to assess the genetic distance among 9 members of the Diplopterygium genus. The results indicate that D. simulans is an independent species rather than a synonymy of D. glaucum or D. giganteum. Moreover, phylogenetic analysis uncovered the sisterhood of D. simulans and D. cantonense, which is supported by their geographical distributions and morphological traits. Incorrect synonymy treatment is prevalent in the characterization of biological diversity, and our study proposes a convenient and effective method for validating synonym treatments and discovering cryptic species.	[Shu, Jiang-Ping; Shang, Hui; Jin, Dongmei; Wei, Hong-Jin; Zhou, Xi-Le; Gu, Yu-Feng; Wang, Ying; Shen, Hui; Zhang, Rui; Yan, Yue-Hong] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Shu, Jiang-Ping; Gu, Yu-Feng; Wang, Ying] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Liu, Hong-Mei] Chinese Acad Sci, Shenzhen Fairylake Bot Garden, Shenzhen, Peoples R China; [Wang, Fa-Guo] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Adjie, Bayu] Indonesian Inst Sci, Bali Bot Garden, Bali, Indonesia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Normal University; Chinese Academy of Sciences; Chinese Academy of Sciences; South China Botanical Garden, CAS; Indonesian Institute of Sciences	Yan, YH (corresponding author), Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China.	yhyan@sibs.ac.cn	Gu, Yu-Feng/AAM-2150-2021	Shu, Jiang-Ping/0000-0001-9714-3064; Jin, Dongmei/0000-0001-7133-4460	National Natural Science Foundation of China [31370234]; Shanghai Municipal Administration of Forestation & City Appearances [G142433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Administration of Forestation & City Appearances	Support was provided by the National Natural Science Foundation of China, 31370234, [http://www.nsfc.gov.cn/publish/portal1/] and the Shanghai Municipal Administration of Forestation & City Appearances, G142433, [http://lhsr.sh.gov.cn/]. The funders had main role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Blair C, 2015, MOL PHYLOGENET EVOL, V84, P254, DOI 10.1016/j.ympev.2015.01.003; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chantarasuwan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128289; Chao Z, 2014, PHYTOMEDICINE, V21, P1767, DOI 10.1016/j.phymed.2014.09.001; Chen H, 1997, FLORA OF HAINAN; Ching R, 1959, ACTA PHYTOTAXONOMICA, V8, P125; Ching R-C, 1959, FLORA REIPUBLICAE PO, V2, P116; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dong W, 2012, PLOS ONE, P1932; Du JA, 2010, FLORA, V205, P399, DOI 10.1016/j.flora.2009.12.018; Federici S, 2013, BOT J LINN SOC, V171, P687, DOI 10.1111/boj.12034; Gao T, 2011, PLANTA MED, V77, P92, DOI 10.1055/s-0030-1250050; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067818; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogendoorn K, 2015, ZOOKEYS, P41, DOI 10.3897/zookeys.520.6185; Jin XF, 2013, FLORA CHINA, V2-3, P110; [金孝锋 JIN XiaoFeng], 2008, [云南植物研究, Acta Botanica Yunnanica], V30, P9; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; [李春香 LI Chun-xiang], 2010, [古生物学报, Acta Palaeontologica Sinica], V49, P64; Li YQ, 2015, PHYTOTAXA, V226, P295; Liu HM, 2013, TAXON, V62, P688, DOI 10.12705/624.26; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Lu JM, 2012, J PLANT RES, V125, P237, DOI 10.1007/s10265-011-0441-y; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; McNeill J, 2012, INT CODE NOMENCLATUR; Nakai T, 1950, B NATL SCI MUSEUM, V31, P1; Paton AJ, 2008, TAXON, V57, P602, DOI 10.2307/25066027; Pimm SL, 2001, WORLD ACCORDING PIMM; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; Su X, 2015, ANN BOT; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Wu T, 2000, FLORA OF GUANGDONG; Ya ZDJYX, 1999, ACTA PHYTOECOLOGICA, V6; Zhang XC, 2004, NOVON, V14, P149	52	6	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0164604	10.1371/journal.pone.0164604	http://dx.doi.org/10.1371/journal.pone.0164604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296890	Green Published, gold, Green Submitted			2022-12-26	WOS:000396311700001
J	Hammock, BG; Slater, SB; Baxter, RD; Fangue, NA; Cocherell, D; Hennessy, A; Kurobe, T; Tai, CY; Teh, SJ				Hammock, Bruce G.; Slater, Steven B.; Baxter, Randall D.; Fangue, Nann A.; Cocherell, Dennis; Hennessy, April; Kurobe, Tomofumi; Tai, Christopher Y.; Teh, Swee J.			Foraging and metabolic consequences of semi-anadromy for an endangered estuarine fish	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; PARTIAL MIGRATION; DELTA SMELT; PHYTOPLANKTON BIOMASS; PRIMARY PRODUCTIVITY; LIFE-HISTORY; SALINITY; SACRAMENTO; CALIFORNIA; PATTERNS	Diadromy affords fish access to productive ecosystems, increasing growth and ultimately fitness, but it is unclear whether these advantages persist for species migrating within highly altered habitat. Here, we compared the foraging success of wild Delta Smelt(_)an endangered, zooplanktivorous, annual, semi-anadromous fish that is endemic to the highly altered San Francisco Estuary (SFE)(_)collected from freshwater (<0.55 psu) and brackish habitat (>= 0.55 psu). Stomach fullness, averaged across three generations of wild Delta Smelt sampled from juvenile through adult life stages (n = 1,318), was 1.5-fold higher in brackish than in freshwater habitat. However, salinity and season interacted, with higher fullness (1.7-fold) in freshwater than in brackish habitat in summer, but far higher fullness in brackish than freshwater habitat during fall/winter and winter/spring (1.8 and 2.0-fold, respectively). To examine potential causes of this interaction we compared mesozooplankton abundance, collected concurrently with the Delta Smelt, in freshwater and brackish habitat during summer and fall/winter, and the metabolic rate of sub-adult Delta Smelt acclimated to salinities of 0.4, 2.0, and 12.0 psu in a laboratory experiment. A seasonal peak in mesozooplankton density coincided with the summer peak in Delta Smelt foraging success in freshwater, and a pronounced decline in freshwater mesozooplankton abundance in the fall coincided with declining stomach fullness, which persisted for the remainder of the year (fall, winter and spring). In brackish habitat, greater foraging 'efficiency' (prey items in stomachs/mesozooplankton abundance) led to more prey items per fish and generally higher stomach fullness (i.e., a higher proportion of mesozooplankton detected in concurrent trawls were eaten by fish in brackish habitat). Delta Smelt exhibited no difference in metabolic rate across the three salinities, indicating that metabolic responses to salinity are unlikely to have caused the stomach fullness results. Adult migration and freshwater spawning therefore places young fish in a position to exploit higher densities of prey in freshwater in the late spring/summer, and subsequent movement downstream provides older fish more accessible prey in brackish habitat. Thus, despite endemism to a highly-altered estuary, semi-anadromy provided substantial foraging benefits to Delta Smelt, consistent with other temperate migratory fish.	[Hammock, Bruce G.; Kurobe, Tomofumi; Tai, Christopher Y.; Teh, Swee J.] Univ Calif Davis, Aquat Hlth Program, Sch Vet Med, Dept Anat Physiol & Cell Biol,VetMed 3B, Davis, CA 95616 USA; [Slater, Steven B.; Baxter, Randall D.; Hennessy, April] Calif Dept Fish & Wildlife, Stockton, CA USA; [Fangue, Nann A.; Cocherell, Dennis] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hammock, BG (corresponding author), Univ Calif Davis, Aquat Hlth Program, Sch Vet Med, Dept Anat Physiol & Cell Biol,VetMed 3B, Davis, CA 95616 USA.	brucehammock@gmail.com		Kurobe, Tomofumi/0000-0003-3906-1989	California Department of Fish and Wildlife (CDFW) Ecosystem Restoration Program [E1183004]; U.S. Geological Survey [G12AC20079, G15AS00018]; California Department of Water Resources [4600011155]; University of California Davis Agricultural Experiment Station [2098-H]; Interagency Ecological Program; Department of Water Resources [4600010609]; U.S. Bureau of Reclamation [R15AC00094]	California Department of Fish and Wildlife (CDFW) Ecosystem Restoration Program; U.S. Geological Survey(United States Geological Survey); California Department of Water Resources; University of California Davis Agricultural Experiment Station(University of California System); Interagency Ecological Program; Department of Water Resources; U.S. Bureau of Reclamation	Funding for this study was provided by grants to SJT from the California Department of Fish and Wildlife (CDFW) Ecosystem Restoration Program E1183004 and U.S. Geological Survey G12AC20079 and G15AS00018 (Erwin Van Nieuwenhuyse program manager). Partial support was provided by California Department of Water Resources Contract 4600011155 to SJT (Louise Conrad program manager) and the University of California Davis Agricultural Experiment Station (grant 2098-H to NAF). Participation of Steven B. Slater, Randall D. Baxter, and April Hennessy was supported by the Interagency Ecological Program through contracts with Department of Water Resources 4600010609 (Karen Gehrts contract manager) and U.S. Bureau of Reclamation R15AC00094 (Erwin Van Nieuwenhuyse contract manager).	Alerstam T, LONG DISTANCE MIGRAT; ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; [Anonymous], STAT FED LIST END TH; [Anonymous], 2004, IEP LONG TERM FISH M; [Anonymous], 2011, SAN FRANCISCO ESTUAR; [Anonymous], [No title captured]; Avgar T, 2014, CAN J ZOOL, V92, P481, DOI 10.1139/cjz-2013-0076; Baskerville-Bridges B, 2004, AM FISHERIES SOC S; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bennett WA, 2015, ESTUAR COAST, V38, P826, DOI 10.1007/s12237-014-9877-3; Bennett W.A., 2005, SAN FRANCISCO ESTUAR, V3, P2, DOI [DOI 10.15447/SFEWS.2005V3ISS2ART1, 10.15447/sfews.2005v3iss2art1]; Bever A., 2016, SAN FRANCISCO ESTUAR, V14; BLACKETT RF, 1973, J FISH RES BOARD CAN, V30, P543, DOI 10.1139/f73-091; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Brooks ML, 2012, ESTUAR COAST, V35, P603, DOI 10.1007/s12237-011-9459-6; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown Larry R., 2016, San Francisco Estuary & Watershed Science, V14, P4; Cairns DK, 2009, J FISH BIOL, V74, P2094, DOI 10.1111/j.1095-8649.2009.02290.x; Cech J.J., 2004, FISHES INTRO ICHTHYO, V5th; Cech J.J. Jr, 1990, P335; Chabot D, 2016, J FISH BIOL, V88, P81, DOI 10.1111/jfb.12845; CHADWICK HAROLD K., 1964, CALIFORNIA FISH AND GAME, V50, P69; Chapman BB, 2012, J FISH BIOL, V81, P456, DOI 10.1111/j.1095-8649.2012.03342.x; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; CLOERN JE, 1987, CONT SHELF RES, V7, P1367, DOI 10.1016/0278-4343(87)90042-2; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Dege M, 2003, AM FISHERIES SOC S; DESILVA SS, 1976, AQUACULTURE, V7, P327, DOI 10.1016/0044-8486(76)90129-0; Dingle H, 2006, J ORNITHOL, V147, P212, DOI 10.1007/s10336-005-0052-2; Duijns S, 2015, J ANIM ECOL, V84, P565, DOI 10.1111/1365-2656.12309; Elliott J. M., 1972, FRESHWATER BIOL, V2, P1, DOI DOI 10.1111/J.1365-2427.1972.TB01575.X; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Feyrer F, 2003, ENVIRON BIOL FISH, V67, P277, DOI 10.1023/A:1025839132274; Feyrer F, 2007, T AM FISH SOC, V136, P469, DOI 10.1577/T06-044.1; Feyrer F, 2011, ESTUAR COAST, V34, P120, DOI 10.1007/s12237-010-9343-9; Finstad AG, 2012, GLOBAL CHANGE BIOL, V18, P2487, DOI 10.1111/j.1365-2486.2012.02717.x; Fisch KM, 2013, J HERED, V104, P92, DOI 10.1093/jhered/ess084; Glibert PM, 2010, REV FISH SCI, V18, P211, DOI 10.1080/10641262.2010.492059; Greene VE, 2011, MAR ECOL PROG SER, V431, P183, DOI 10.3354/meps09099; GROSS MR, 1988, SCIENCE, V239, P1291, DOI 10.1126/science.239.4845.1291; Gross MR, 1987, AM FISHERIES SOC S; Hammock BG, 2015, SCI TOTAL ENVIRON, V532, P316, DOI 10.1016/j.scitotenv.2015.06.018; Hasenbein M, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow004; Hasenbein M, 2013, INTEGR COMP BIOL, V53, P620, DOI 10.1093/icb/ict082; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; HUTCHINGS JA, 1985, OIKOS, V45, P118, DOI 10.2307/3565229; Hutton PH, 2015, J WATER RESOURCES PL; JASSBY AD, 1994, ESTUAR COAST SHELF S, V39, P595, DOI 10.1016/S0272-7714(06)80012-0; Jassby AD, 2002, LIMNOL OCEANOGR, V47, P698, DOI 10.4319/lo.2002.47.3.0698; Kammerer BD, 2016, FISH PHYSIOL BIOCHEM, V42, P219, DOI 10.1007/s10695-015-0131-0; Kedney G, 1987, AM FISHERIES SOC S; Kerr LA, 2009, FISHERIES, V34, P114, DOI 10.1577/1548-8446-34.3.114; Kimmerer W, 1996, CAUSES LONG TERM DEC, P403; Kimmerer W.J., 2008, SAN FRANC ESTUARY WA, V6, DOI [10.15447/sfews.2008v6iss2art2, DOI 10.15447/SFEWS.2008V6ISS2ART2]; KIMMERER WJ, 1994, MAR ECOL PROG SER, V113, P81, DOI 10.3354/meps113081; Kimmerer WJ, 1998, LIMNOL OCEANOGR, V43, P1697, DOI 10.4319/lo.1998.43.7.1697; KOMOROSKE L, 2014, CONSERV PHYSIOL, V2, P1, DOI DOI 10.1093/C0NPHYS/C0U008; Komoroske L. M., 2016, EVOLUTIONARY APPL; LAMBERT Y, 1994, CAN J FISH AQUAT SCI, V51, P1569, DOI 10.1139/f94-155; Lehman PW, 2000, ESTUARIES, V23, P216, DOI 10.2307/1352829; McMahon R.F., 1983, P505; Moore JW, 2014, J ANIM ECOL, V83, P1035, DOI 10.1111/1365-2656.12212; Morgan JD, 1999, AM J PHYSIOL-REG I, V277, pR631, DOI 10.1152/ajpregu.1999.277.3.R631; Morita K, 1998, J FISH BIOL, V53, P1140, DOI 10.1111/j.1095-8649.1998.tb00471.x; MOYLE PB, 1992, T AM FISH SOC, V121, P67, DOI 10.1577/1548-8659(1992)121<0067:LHASOD>2.3.CO;2; NICHOLS FH, 1986, SCIENCE, V231, P567, DOI 10.1126/science.231.4738.567; Nicolini Mary Helen, 2000, Pacific Science, V54, P377; Northcote T.G., 1978, P326; Parker AE, 2012, MAR POLLUT BULL, V64, P574, DOI 10.1016/j.marpolbul.2011.12.016; Rose KA, 2013, T AM FISH SOC, V142, P1260, DOI 10.1080/00028487.2013.799519; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Skov C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1178; Slater S. B., 2014, SAN FRANCISCO ESTUAR, V12; SMITH DW, 1988, HYDROBIOLOGIA, V159, P259, DOI 10.1007/BF00008239; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Stevens DE, 1977, P C ASS EFF POW PLAN; Sullivan LJ, 2016, ENVIRON BIOL FISH, P1; Swanson C, 1996, T AM FISH SOC, V125, P326, DOI 10.1577/1548-8659(1996)125&lt;0326:UOSAAP&gt;2.3.CO;2; Teh SJ, 2016, AQUAT TOXICOL, V170, P152, DOI 10.1016/j.aquatox.2015.11.009; U.S. Fish and Wildlife Service, 1993, FED REGISTER, V58, P12854; Van Nieuwenhuyse EE, 2007, CAN J FISH AQUAT SCI, V64, P1529, DOI 10.1139/F07-121; Vinagre C, 2007, J APPL ICHTHYOL, V23, P240, DOI 10.1111/j.1439-0426.2007.00852.x; Walton LR, 2001, J MAMMAL, V82, P867, DOI 10.1644/1545-1542(2001)082<0867:MPOBGW>2.0.CO;2; Winder M, 2011, ESTUAR COAST, V34, P675, DOI 10.1007/s12237-010-9342-x; Wood CC, 1996, EVOLUTION, V50, P1265, DOI [10.1111/j.1558-5646.1996.tb02367.x, 10.2307/2410667]; Wysujack K, 2009, ECOL FRESHW FISH, V18, P52, DOI 10.1111/j.1600-0633.2008.00322.x	88	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173497	10.1371/journal.pone.0173497	http://dx.doi.org/10.1371/journal.pone.0173497			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291808	Green Submitted, Green Published, gold			2022-12-26	WOS:000396094700030
J	Sung, S; Son, SH; Park, EY; Kay, CS				Sung, SooYoon; Son, Seok Hyun; Park, Eun Young; Kay, Chul Seung			Prognosis of locally advanced rectal cancer can be predicted more accurately using pre-and post-chemoradiotherapy neutrophillymphocyte ratios in patients who received preoperative chemoradiotherapy	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; HEPATOCELLULAR-CARCINOMA; NEOADJUVANT CHEMORADIATION; CURATIVE RESECTION; INFLAMMATION; RADIOTHERAPY; CHEMOTHERAPY; SURVIVAL; FLUOROURACIL; HEPATECTOMY	Purpose The neutrophil-lymphocyte ratio (NLR) has been suggested as an inflammation-related factor, but also as an indicator of systemic anti-tumor immunity. We aimed to evaluate the prognostic value of the NLR and to propose a proper cut-off value in patients with locally advanced rectal cancer who received preoperative chemoradiation (CRT) followed by curative total mesorectal excision (TME). Methods A total of 110 rectal cancer patients with clinical T3-4 or node-positive disease were retrospectively analyzed. The NLR value before preoperative CRT (pre-CRT NLR) and the NLR value between preoperative CRT and surgery (post-CRT NLR) were obtained. Using a maximally selected log-rank test, cut-off values were determined as 1.75 for the pre-CRT NLR and 5.14 for the post-CRT NLR. Results Patients were grouped as follows: group A, pre-CRT NLR <= 1.75 and post-CRT NLR <= 5.14 (n = 29); group B, pre-CRT NLR > 1.75 and post-CRT NLR <= 5.14, or pre-CRT NLR <= 1.75 and post-CRT NLR > 5.14 (n = 61); group C, pre-CRT NLR > 1.75 and post-CRT NLR > 5.14 (n = 20). The median follow-up time was 31.1 months. The 3-year disease-free survival (DFS) and overall survival (OS) rates showed significant differences between the NLR groups (3-year DFS rate: 92.7% vs. 73.0% vs. 47.3%, for group A, B, and C, respectively, p = 0.018; 3-year OS rate: 96.0% vs. 85.5% vs. 59.8%, p = 0.034). Multivariate analysis revealed that the NLR was an independent prognostic factor for DFS (p = 0.028). Conclusion Both the pre-CRT NLR and the post-CRT NLR have a predictive value for the prognosis of patients with locally advanced rectal cancer treated with preoperative CRT followed by curative TME and adjuvant chemotherapy. A persistently elevated post-CRT NLR may be an indicator of an increased risk of distant metastasis.	[Sung, SooYoon] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiat Oncol, Seoul, South Korea; [Son, Seok Hyun; Park, Eun Young; Kay, Chul Seung] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Son, SH (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	sonshyun@catholic.ac.kr		Son, Seok Hyun/0000-0002-2577-1915				Adamsson Eryd S, 2012, ARTERIOSCL THROM VAS, V32, P533, DOI 10.1161/ATVBAHA.111.240416; Balta S, 2013, CLIN APPL THROMB-HEM, V19, P579, DOI 10.1177/1076029612475023; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Carruthers R, 2012, COLORECTAL DIS, V14, pE701, DOI 10.1111/j.1463-1318.2012.03147.x; Chen Q, 2015, TUMOR BIOL, V36, P5283, DOI 10.1007/s13277-015-3188-6; Collette L, 2007, J CLIN ONCOL, V25, P4379, DOI 10.1200/JCO.2007.11.9685; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Govindarajan A, 2011, ANN SURG ONCOL, V18, P3666, DOI 10.1245/s10434-011-1788-y; Hothorn T, 2008, BIOMETRICS, V64, P1263, DOI 10.1111/j.1541-0420.2008.00995.x; Hung HY, 2011, INT J COLORECTAL DIS, V26, P1059, DOI 10.1007/s00384-011-1192-x; Kayadibi H, 2014, WORLD J GASTROENTERO, V20, P9631, DOI 10.3748/wjg.v20.i28.9631; Kim IY, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-94; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lee DY, 2013, J GASTRIC CANCER, V13, P111, DOI 10.5230/jgc.2013.13.2.111; Liu Huanran, 2010, J Gastrointest Cancer, V41, P116, DOI 10.1007/s12029-009-9125-4; Maas M, 2015, INT J CANCER, V137, P212, DOI 10.1002/ijc.29355; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mercan R, 2016, J CLIN LAB ANAL, V30, P597, DOI 10.1002/jcla.21908; Nagasaki T, 2015, DIGEST SURG, V32, P496, DOI 10.1159/000441396; Neal CP, 2009, EUR J CANCER, V45, P56, DOI 10.1016/j.ejca.2008.08.019; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Qi X, 2016, ONCOTARGET; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shen LJ, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0295-2; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Tan TP, 2015, ANZ J SURG, V85, P414, DOI 10.1111/ans.13036; Xu XS, 2014, CHINESE MED J-PEKING, V127, P4204, DOI 10.3760/cma.j.issn.0366-6999.20141234; Yamamura K, 2014, J HEPATO-BIL-PAN SCI, V21, P682, DOI 10.1002/jhbp.114; Yang HJ, 2016, WORLD J GASTROENTERO, V22, P5088, DOI 10.3748/wjg.v22.i21.5088; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	34	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173955	10.1371/journal.pone.0173955	http://dx.doi.org/10.1371/journal.pone.0173955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291841	gold, Green Published, Green Submitted			2022-12-26	WOS:000396094700051
J	Thompson, DS; Younger-Coleman, N; Lyew-Ayee, P; Greene, LG; Boyne, MS; Forrester, TE				Thompson, Debbie S.; Younger-Coleman, Novie; Lyew-Ayee, Parris; Greene, Lisa-Gaye; Boyne, Michael S.; Forrester, Terrence E.			Socioeconomic factors associated with severe acute malnutrition in Jamaica	PLOS ONE			English	Article							5 YEARS OLD; NUTRITIONAL-STATUS; CHILDREN; HEALTH; LEAD; UNDERNUTRITION; MOTHERS	Objectives Severe acute malnutrition (SAM) is an important risk factor for illness and death globally, contributing to more than half of deaths in children worldwide. We hypothesized that SAM is positively correlated to poverty, low educational attainment, major crime and higher mean soil concentrations of lead, cadmium and arsenic. Methods We reviewed admission records of infants admitted with a diagnosis of SAM over 14 years (2000-2013) in Jamaica. Poverty index, educational attainment, major crime and environmental heavy metal exposure were represented in a Geographic Information System (GIS). Cases of SAM were grouped by community and the number of cases per community/year correlated to socioeconomic variables and geochemistry data for the relevant year. Results 375 cases of SAM were mapped across 204 urban and rural communities in Jamaica. The mean age at admission was 9 months (range 1-45 months) and 57% were male. SAM had a positive correlation with major crime (r = 0.53; P < 0.001), but not with educational attainment or the poverty index. For every one unit increase in the number of crimes reported, the rate of occurrence of SAM cases increased by 1.01% [Incidence rate ratio (IRR) = 1.01 (95% CI = 1.006-1.014); P P < 0.001]. The geochemistry data yielded no correlation between levels of heavy metals and the prevalence of malnutrition. Conclusion Major crime has an independent positive association with severe acute malnutrition in Jamaican infants. This could suggest that SAM and major crime might have similar sociological origins or that criminality at the community level may be indicative of reduced income opportunities with the attendant increase in poor nutrition in the home.	[Thompson, Debbie S.; Younger-Coleman, Novie; Boyne, Michael S.] Univ W Indies, Res Inst Trop Med, Mona, Jamaica; [Lyew-Ayee, Parris; Greene, Lisa-Gaye] Univ W Indies, Mona GeoInformat Inst, Mona, Jamaica; [Forrester, Terrence E.] Univ W Indies, UWI Solut Developing Countries, Mona, Jamaica	University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Mona Jamaica	Thompson, DS (corresponding author), Univ W Indies, Res Inst Trop Med, Mona, Jamaica.	debbie.thompson@uwimona.edu.jm	Boyne, Michael/AAC-3675-2020; Boyne, Michael S/I-2242-2013; Thompson, Debbie S/AAE-8408-2022	Boyne, Michael/0000-0002-5227-2492; Boyne, Michael S/0000-0002-5227-2492; Thompson, Debbie S/0000-0001-6781-7646				Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; Ackerson LK, 2008, AM J EPIDEMIOL, V167, P1188, DOI 10.1093/aje/kwn049; Amaya E, 2012, ENVIRON RES, V120, P63; [Anonymous], 2013, GLOB DAT CHILD GROWT; Bellinger DC, 2005, BIRTH DEFECTS RES A, V73, P409, DOI 10.1002/bdra.20127; BITHONEY WG, 1986, PEDIATRICS, V78, P891; Bourne P, 2013, MAJOR CRIMES KINGSTO; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Chatman LM, 2004, BIRTH-ISS PERINAT C, V31, P265, DOI 10.1111/j.0730-7659.2004.00318.x; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fergusson D, 2004, J CHILD PSYCHOL PSYC, V45, P956, DOI 10.1111/j.1469-7610.2004.t01-1-00288.x; Ghazi HF, 2013, J HEALTH POPUL NUTR, V31, P350; Harriott Anthony, 2001, SOULS CRITICAL J BLA, V3, P56; HENDRICKS KM, 1995, ARCH PEDIAT ADOL MED, V149, P1118, DOI 10.1001/archpedi.1995.02170230072010; Hopenhayn C, 2003, EPIDEMIOLOGY, V14, P593, DOI 10.1097/01.ede.0000072104.65240.69; Justice EIfCPaCISoCa, 2011, COUNTRIES COMPARED C; Kumar Dinesh, 2006, Indian Journal of Pediatrics, V73, P417, DOI 10.1007/BF02758565; Kurzewski K, 2005, W INDIAN MED J, V54, P28; Lalor G., 1996, GEOCHEMICAL ATLAS JA; Lalor GC, 1996, ENVIRON GEOCHEM HLTH, V18, P89, DOI 10.1007/BF01771284; Lalor GC, 2008, SCI TOTAL ENVIRON, V400, P162, DOI 10.1016/j.scitotenv.2008.07.011; Liu JH, 2004, AM J PSYCHIAT, V161, P2005, DOI 10.1176/appi.ajp.161.11.2005; Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758; Mullany LC, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.055087; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; PIOJ, 2008, MAPP POV IND CONS BA; Ruiz-Grosso Paulo, 2014, Rev. perú. med. exp. salud publica, V31, P16; Silveira KBR, 2010, J PEDIAT-BRAZIL, V86, P215, DOI 10.2223/JPED.1991; Tian LL, 2009, BIOL TRACE ELEM RES, V132, P51, DOI 10.1007/s12011-009-8391-0; United Kingdom FCO, 2009, N CENTR AM CAR JAM; UNPFA, 2008, UNFPA THE CAR; Waterlow J C, 1976, Monogr Ser World Health Organ, P530; World Bank GPWG, 2014, WORLD DEV IND; World Health Organization (WHO), 2014, CHILDR RED MORT	34	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173101	10.1371/journal.pone.0173101	http://dx.doi.org/10.1371/journal.pone.0173101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291805	gold, Green Submitted, Green Published			2022-12-26	WOS:000396094700012
J	Asor, E; Stav, MY; Simon, E; Fahoum, I; Sabo, E; Ben-Izhak, O; Hershkovitz, D				Asor, Eyal; Stav, Michael Y.; Simon, Einav; Fahoum, Ibrahim; Sabo, Edmond; Ben-Izhak, Ofer; Hershkovitz, Dov			Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; SURGICAL PATHOLOGY; LUNG-CANCER; HUMAN-PAPILLOMAVIRUS; CROSS-CONTAMINATION; COLORECTAL-CANCER; EXTRANEOUS TISSUE; EGFR; CARCINOMA; EXPRESSION	With the increasing usage of sensitive PCR technology for pharmacogenetics, cross contamination becomes a significant concern. Researchers employed techniques which basically include replacing laboratory equipment after each sample preparation; however, there are no recommended guidelines. In the present work we wanted to evaluate the risk of cross contamination during tissue processing using the routine precaution measures. Twenty-one surgical samples of lung adenocarcinoma were used, of which 7 contained EGFR exon 19 mutation, 7 contained EGFR exon 21 mutation (p.L858R) and 7 were EGFR wild-type. The samples were ordered by alternating the mutation group to maximize the potential for cross contamination and underwent tissue sectioning and de-paraffinization. The entire process was performed using the same tools. Following DNA extraction all samples underwent PCR amplification and were scrutinized for small fractions of EGFR mutation using deep sequencing with the Ion torrent PGM technology. Twenty samples yielded results. The fraction of mutated copies was 41 +/- 23% (range 11-66) for the cases with known exon 19 mutation and 48 +/- 24% (range 0-65) for the cases with known exon 21 mutations. No in-frame exon 19 deletion mutations were identified in the wild-type (WT) and exon 21 groups. The fraction of EGFR exon 21 (codon 858) mutations was 0.018 +/- 0.014% (range 0-0.05%) in the WT and exon 19 groups, which was not statistically different than the background sequencing artifact noise for the same base-pair alteration (p = 0.21). Our results suggest that standard precautions are sufficient for molecular pathology diagnosis of surgical samples and are not associated with increased risk of cross contamination.	[Asor, Eyal; Simon, Einav; Sabo, Edmond; Ben-Izhak, Ofer] Technion Israel Inst Technol, B Rappaport Fac Med, Haifa, Israel; [Asor, Eyal; Stav, Michael Y.; Sabo, Edmond; Ben-Izhak, Ofer] Rambam Hlth Care Campus, Inst Pathol, Haifa, Israel; [Fahoum, Ibrahim; Hershkovitz, Dov] Tel Aviv Sourasky Med Ctr, Inst Pathol, Tel Aviv, Israel; [Hershkovitz, Dov] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Hershkovitz, D (corresponding author), Tel Aviv Sourasky Med Ctr, Inst Pathol, Tel Aviv, Israel.; Hershkovitz, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	dovh@tlvmc.gov.il		Hershkovitz, Dov/0000-0002-7954-4486				Bluth MJ, 2013, CLIN LAB MED, V33, P753, DOI 10.1016/j.cll.2013.09.004; Chong IY, 2013, J PATHOL, V231, P301, DOI 10.1002/path.4247; de Leng WWJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149405; Dubbink HJ, 2014, MOL ONCOL, V8, P830, DOI 10.1016/j.molonc.2014.03.004; Gephardt GN, 1996, ARCH PATHOL LAB MED, V120, P1009; Gheit T, 2014, J MED VIROL, V86, P642, DOI 10.1002/jmv.23866; Gokhale S, 2002, APPL IMMUNOHISTO M M, V10, P282, DOI 10.1097/01.PAI.0000024388.65085.D4; Hunt JL, 2008, ADV ANAT PATHOL, V15, P211, DOI 10.1097/PAP.0b013e31817bf596; Hunt JL, 2003, ARCH PATHOL LAB MED, V127, P213; Jager W, 2013, J UROLOGY, V190, P1404, DOI 10.1016/j.juro.2013.03.009; Lamy A, 2011, MODERN PATHOL, V24, P1090, DOI 10.1038/modpathol.2011.60; Layfield LJ, 2011, AM J CLIN PATHOL, V136, P767, DOI 10.1309/AJCP4FFSBPHAU8IU; Messersmith WA, 2008, NEW ENGL J MED, V359, P1834, DOI 10.1056/NEJMe0806778; Netto George J, 2003, Proc (Bayl Univ Med Cent), V16, P379; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Platt E, 2009, ARCH PATHOL LAB MED, V133, P973, DOI 10.1043/1543-2165-133.6.973; Ritchey JW, 2006, J AM ASSOC LAB ANIM, V45, P7; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Carunchio L, 2015, BJOG-INT J OBSTET GY, V122, P119, DOI 10.1111/1471-0528.13071; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sarchianaki E, 2014, TUMOR BIOL, V35, P3203, DOI 10.1007/s13277-013-1419-2; Sequist LV, 2008, ANNU REV MED, V59, P429, DOI 10.1146/annurev.med.59.090506.202405; Sholl LM, 2009, CANCER RES, V69, P8341, DOI 10.1158/0008-5472.CAN-09-2477; Tezal M, 2012, ARCH OTOLARYNGOL, V138, P669, DOI 10.1001/archoto.2012.873; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Varanat M, 2009, VET PATHOL, V46, P940, DOI 10.1354/vp.08-VP-0259-B-BC; Warth A, 2016, VIRCHOWS ARCH, V468, P101, DOI 10.1007/s00428-015-1869-6; Yatabe Y, 2008, CANCER RES, V68, P2106, DOI 10.1158/0008-5472.CAN-07-5211	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173760	10.1371/journal.pone.0173760	http://dx.doi.org/10.1371/journal.pone.0173760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288198	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400035
J	Ikuno, T; Masumoto, H; Yamamizu, K; Yoshioka, M; Minakata, K; Ikeda, T; Sakata, R; Yamashita, JK				Ikuno, Takeshi; Masumoto, Hidetoshi; Yamamizu, Kohei; Yoshioka, Miki; Minakata, Kenji; Ikeda, Tadashi; Sakata, Ryuzo; Yamashita, Jun K.			Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP	PLOS ONE			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; FUNCTIONAL HUMAN LIVER; ORGAN BUD TRANSPLANT; PROGENITOR CELLS; RAT HEARTS; NOTCH; ARTERIAL; SHEETS; INDUCTION; BLOOD	Blood vessels are essential components for many tissues and organs. Thus, efficient induction of endothelial cells (ECs) from human pluripotent stem cells is a key method for generating higher tissue structures entirely from stem cells. We previously established an EC differentiation system with mouse pluripotent stem cells to show that vascular endothelial growth factor (VEGF) is essential to induce ECs and that cyclic adenosine monophosphate (cAMP) synergistically enhances VEGF effects. Here we report an efficient and robust EC differentiation method from human pluripotent stem cell lines based on a 2D monolayer, serum-free culture. We controlled the direction of differentiation from mesoderm to ECs using stage-specific stimulation with VEGF and cAMP combined with the elimination of non-responder cells at early EC stage. This "stimulation-elimination" method robustly achieved very high efficiency (> 99%) and yield (> 10 ECs from 1 hiPSC input) of EC differentiation, with no purification of ECs after differentiation. We believe this method will be a valuable technological basis broadly for regenerative medicine and 3D tissue engineering.	[Ikuno, Takeshi; Masumoto, Hidetoshi; Yamamizu, Kohei; Yoshioka, Miki; Yamashita, Jun K.] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Ikuno, Takeshi; Masumoto, Hidetoshi; Minakata, Kenji; Ikeda, Tadashi; Sakata, Ryuzo] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto, Japan	Kyoto University; Kyoto University	Yamashita, JK (corresponding author), Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan.	juny@cira.kyoto-u.ac.jp			MEXT/JSPS KAKENHI Grant [24390197]; Japan Agency for Medical Research and Development, AMED; Health Labour Sciences Research Grant	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	Support was provided by MEXT/JSPS KAKENHI Grant, #24390197; Core Center for iPS Cell Research, Research Center Network for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development, AMED.; This study was funded by Core Center for iPS Cell Research, Research Center Network for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development, AMED, MEXT/JSPS KAKENHI Grant, and Health Labour Sciences Research Grant. We thank Dr. Peter Karagiannis (Kyoto University) for critical reading of the manuscript.	Arita Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5552; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105; Bao XP, 2016, METHODS MOL BIOL, V1481, P183, DOI 10.1007/978-1-4939-6393-5_17; Carpenter L, 2012, STEM CELLS DEV, V21, P977, DOI 10.1089/scd.2011.0075; Carreira CM, 2001, CANCER RES, V61, P8079; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Du C, 2014, BIOMATERIALS, V35, P6006, DOI 10.1016/j.biomaterials.2014.04.011; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dunne LW, 2014, ACTA BIOMATER, V10, P3630, DOI 10.1016/j.actbio.2014.05.005; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Gloor SM, 2001, BRAIN RES REV, V36, P258, DOI 10.1016/S0165-0173(01)00102-3; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liu YW, 2014, BIOMACROMOLECULES, V15, P1044, DOI 10.1021/bm401926k; Masumoto H, 2012, STEM CELLS, V30, P1196, DOI 10.1002/stem.1089; Nagamori E, 2013, BIOMATERIALS, V34, P662, DOI 10.1016/j.biomaterials.2012.08.055; Ngo TX, 2013, BIOTECHNOL LETT, V35, P1001, DOI 10.1007/s10529-013-1174-x; Nishiguchi A, 2014, BIOMATERIALS, V35, P4739, DOI 10.1016/j.biomaterials.2014.01.079; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pirraco RP, 2014, LAB INVEST, V94, P663, DOI 10.1038/labinvest.2014.55; Prasain N, 2014, NAT BIOTECHNOL, V32, P1151, DOI 10.1038/nbt.3048; Ricono JM, 2003, J HISTOCHEM CYTOCHEM, V51, P141, DOI 10.1177/002215540305100202; Rufaihah AJ, 2013, AM J TRANSL RES, V5, P21; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Sriram G, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0260-5; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yamamizu K, 2013, STEM CELL REP, V1, P545, DOI 10.1016/j.stemcr.2013.10.006; Yamamizu K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03213; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41	50	49	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173271	10.1371/journal.pone.0173271	http://dx.doi.org/10.1371/journal.pone.0173271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288160	Green Published, Green Submitted, gold			2022-12-26	WOS:000396092400011
J	Tadesse, SE; Seid, O; Mariam, YG; Fekadu, A; Wasihun, Y; Endris, K; Bitew, A				Tadesse, Sisay Eshete; Seid, Omer; Mariam, Yemane G.; Fekadu, Abel; Wasihun, Yitbarek; Endris, Kedir; Bitew, Abebayehu			Determinants of anemia among pregnant mothers attending antenatal care in Dessie town health facilities, northern central Ethiopia, unmatched case -control study	PLOS ONE			English	Article							RISK-FACTORS; WOMEN	Introduction Anemia affects around 38.2% and 22% of pregnant women at a global and national level respectively. In developing countries, women start pregnancy with already depleted body stores of iron and other vitamins with significant variation of anemia within and between regions. Objective To identify the determinants of anemia among pregnant mothers attending antenatal care in Dessie town health facilities, northern central Ethiopia. Methods A health facility based unmatched case control study was conducted among 112 cases and 336 controls from January to March 2016 G.C. The sample size was determined by using Epi Info version 7.1.5.2. Study subjects were selected using consecutive sampling technique. Data were collected using a structured questionnaire, entered using Epi Data version 3.1 and analyzed using SPSS version 20. Bivariable and multivariable logistic regression model was used to see the determinants of anemia. Adjusted odds ratio (AOR) with 95% confidence interval (CI) and p-value< 0.05 were used to see the significant association. Results Failure to take dark green leafy vegetables per two weeks (AOR = 5.02, 95% CI: 2.16, 11.71), didn't take chicken per two weeks (AOR = 2.68, 95% CI: 1.22, 5.86), 1 st trimester (AOR = 2.07, 95% CI: 1.12, 3.84), 3rd trimester (AOR = 2.96, 95% CI: 1.53, 5.72), HIV infection (AOR = 6.78, 95% CI: 2.28, 20.18) and medication (AOR = 3.57 95% CI: 1.60, 7.98) were positively associated with anemia. Conclusions Inadequate intake of dark green leafy vegetables, inadequate consumption of chicken, trimester of the current pregnancy, HIV infection and medication were the determinants of anemia among pregnant women. Therefore, anemia prevention strategy should include promotion of adequate intake of dark green leafy vegetables and chicken, increase meal pattern during the entire pregnancy and strengthen the prevention of mother to child HIV transmission/antenatal care programs.	[Tadesse, Sisay Eshete] Wollo Univ, Dept Nutr, Coll Med & Hlth Sci, Dessie, Ethiopia; [Seid, Omer] Mekelle Univ, Dept Nutr & Dietet, Coll Hlth Sci, Mekelle, Ethiopia; [Mariam, Yemane G.] Mekelle Univ, Coll Hlth Sci, Hlth Care Management, Mekelle, Ethiopia; [Fekadu, Abel] Univ Gondar, Dept Biostat & Epidemiol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Wasihun, Yitbarek] Wollo Univ, Dept Hlth Educ, Coll Med & Hlth Sci, Dessie, Ethiopia; [Endris, Kedir] Mekelle Univ, Dept Nursing, Coll Hlth Sci, Mekelle, Ethiopia; [Bitew, Abebayehu] Debre Markos Univ, Dept Biostat & Epidemiol, Coll Med & Hlth Sci, Debre Markos, Ethiopia	Mekelle University; Mekelle University; University of Gondar; Mekelle University	Tadesse, SE (corresponding author), Wollo Univ, Dept Nutr, Coll Med & Hlth Sci, Dessie, Ethiopia.	sisay.eshete@wu.edu.et	Dadi, Abel Fekadu/AAU-3433-2020; Tadesse, Sisay/AAD-7107-2019	Dadi, Abel Fekadu/0000-0001-9967-7713; 	Wollo University; Mekelle University	Wollo University; Mekelle University	Wollo University funded this research project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Wollo University and Mekelle University for their support during conducting this research. We would also like to thank study participants, data collectors, friends and supervisors for their full cooperation during the data collection period.	Adesina O, 2011, Afr J Med Med Sci, V40, P67; Alene KA, 2014, ANEMIA, V2014, DOI 10.1155/2014/561567; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Belachew Tefera, 2006, Ethiop Med J, V44, P211; DAINIAK N, 1988, BRIT J HAEMATOL, V69, P299, DOI 10.1111/j.1365-2141.1988.tb02366.x; DeBenoist B, 2008, WHO GLOBAL DATABASE, P1993; Dim Cyril C, 2007, MedGenMed, V9, P11; Geneva W., 2011, HAEMOGLOBIN CONCENTR; Jufar AH., 2014, J HEMATOLOGY THROMBO; Karaoglu L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-329; Kefiyalew Filagot, 2014, BMC Res Notes, V7, P771, DOI 10.1186/1756-0500-7-771; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Melku M, 2014, ANEMIA, V2014, DOI 10.1155/2014/108593; MONSEN ER, 1982, J AM DIET ASSOC, V80, P307; Obse N, 2013, ETHIOP J HEALTH SCI, V23, P165; Osungbade K. O., 2012, ANAEMIA DEVELOPING C, V3, P116, DOI DOI 10.5772/29148; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320; Shrivastava D, 2014, GLOBAL J MED RES, V13; Uneke CJ, 2007, J HEALTH POPUL NUTR, V25, P328; [WHO UNICEF], 2004, FOC AN INT APPR EFF; Witz M, 2000, AM J HEMATOL, V64, P137; World Health Organization, 2015, GLOB PREV AN 2011	23	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173173	10.1371/journal.pone.0173173	http://dx.doi.org/10.1371/journal.pone.0173173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288159	gold, Green Submitted, Green Published			2022-12-26	WOS:000396092400010
J	Diwadkar, VA; Asemi, A; Burgess, A; Chowdury, A; Bressler, SL				Diwadkar, Vaibhav A.; Asemi, Avisa; Burgess, Ashley; Chowdury, Asadur; Bressler, Steven L.			Potentiation of motor sub-networks for motor control but not working memory: Interaction of dACC and SMA revealed by resting- state directed functional connectivity	PLOS ONE			English	Article							DORSAL ANTERIOR CINGULATE; HUMAN BRAIN; FMRI DATA; CORTEX; SCHIZOPHRENIA; TASK; FLUCTUATIONS; ACTIVATION; COGNITION; MRI	The dorsal Anterior Cingulate Cortex (dACC) and the Supplementary Motor Area (SMA) are known to interact during motor coordination behavior. We previously discovered that the directional influences underlying this interaction in a visuo-motor coordination task are asymmetric, with the dACC! SMA influence being significantly greater than that in the reverse direction. To assess the specificity of this effect, here we undertook an analysis of the interaction between dACC and SMA in two distinct contexts. In addition to the motor coordination task, we also assessed these effects during a (n-back) working memory task. We applied directed functional connectivity analysis to these two task paradigms, and also to the rest condition of each paradigm, in which rest blocks were interspersed with task blocks. We report here that the previously known asymmetric interaction between dACC and SMA, with dACC! SMA dominating, was significantly larger in the motor coordination task than the memory task. Moreover the asymmetry between dACC and SMA was reversed during the rest condition of the motor coordination task, but not of the working memory task. In sum, the dACC! SMA influence was significantly greater in the motor task than the memory task condition, and the SMA! dACC influence was significantly greater in the motor rest than the memory rest condition. We interpret these results as suggesting that the potentiation of motor sub-networks during the motor rest condition supports the motor control of SMA by dACC during the active motor task condition.	[Diwadkar, Vaibhav A.; Burgess, Ashley; Chowdury, Asadur] Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48207 USA; [Asemi, Avisa; Bressler, Steven L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Bressler, Steven L.] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA	Wayne State University; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Diwadkar, VA (corresponding author), Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48207 USA.	vdiwadka@med.wayne.edu		Chowdury, Asadur/0000-0002-5653-9721	Career Development Chair from Wayne State University; Charles H. Gershenson Distinguished Faculty Fellowship from Wayne State University; Lyckaki-Young Fund from the State of Michigan; Prechter Family Bipolar Foundation; Children's Hospital of Michigan Foundation; Children's Research Center of Michigan; Cohen Neuroscience Endowment; National Institute of Mental Health [MH 59299, MH111177]	Career Development Chair from Wayne State University; Charles H. Gershenson Distinguished Faculty Fellowship from Wayne State University; Lyckaki-Young Fund from the State of Michigan; Prechter Family Bipolar Foundation; Children's Hospital of Michigan Foundation; Children's Research Center of Michigan; Cohen Neuroscience Endowment; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Preparation of this work was supported by a Career Development Chair from Wayne State University, the Charles H. Gershenson Distinguished Faculty Fellowship from Wayne State University, the Lyckaki-Young Fund from the State of Michigan, the Prechter Family Bipolar Foundation, the Childrens Hospital of Michigan Foundation, the Childrens Research Center of Michigan, the Cohen Neuroscience Endowment, and the National Institute of Mental Health (MH 59299, MH111177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asemi A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00309; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Bakshi N, 2011, J PSYCHIATR RES, V45, P1067, DOI 10.1016/j.jpsychires.2011.01.002; Banyai M, 2011, NEUROIMAGE, V58, P870, DOI 10.1016/j.neuroimage.2011.06.046; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Bazan PR, 2015, BRAIN CONNECT, V5, P631, DOI 10.1089/brain.2014.0332; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Breukelaar IA, 2016, HUMAN BRAIN MAPPING; Cummiford CM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0934-0; De Pasquale F., 2015, CEREB CORTEX; de Zwart JA, 2013, BRAIN TOPOGR, V26, P525, DOI 10.1007/s10548-013-0290-1; Deco G, 2014, J NEUROSCI, V34, P7886, DOI 10.1523/JNEUROSCI.5068-13.2014; Deco G, 2013, TRENDS NEUROSCI, V36, P268, DOI 10.1016/j.tins.2013.03.001; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Diwadkar VA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00149; Diwadkar VA, 2011, PSYCHIAT RES-NEUROIM, V192, P91, DOI 10.1016/j.pscychresns.2010.12.005; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Driver ID, 2016, J NEUROSCI, V36, P8541, DOI 10.1523/JNEUROSCI.4263-15.2016; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Gopinath K, 2011, NEUROIMAGE, V54, P380, DOI 10.1016/j.neuroimage.2010.07.021; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Hoffstaedter F., 2014, BRAIN STRUCT FUNCT; Hoffstaedter F, 2013, HUMAN BRAIN MAPPING; Kellermann TS, 2013, NEUROIMAGE, V72, P69, DOI 10.1016/j.neuroimage.2013.01.046; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2009, NEUROIMAGE, V45, P1080, DOI 10.1016/j.neuroimage.2009.01.010; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Ponce-Alvarez A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004445; Price CJ, 2005, COGN NEUROPSYCHOL, V22, P262, DOI 10.1080/02643290442000095; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Silverstein BH, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00132; Singh KD, 2012, NEUROIMAGE, V62, P1121, DOI 10.1016/j.neuroimage.2012.01.028; Tang W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002513; van den Bosch GE, 2014, HUM BRAIN MAPP, V35, P698, DOI 10.1002/hbm.22193; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Wickens T.D., 2001, ELEMENTARY SIGNAL DE	46	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172531	10.1371/journal.pone.0172531	http://dx.doi.org/10.1371/journal.pone.0172531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278267	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900122
J	Kala, P; Novotny, T; Andrsova, I; Benesova, K; Holicka, M; Jarkovsky, J; Hnatkova, K; Koc, L; Mikolaskova, M; Novakova, T; Ondrus, T; Privarova, L; Spinar, J; Malik, M				Kala, Petr; Novotny, Tomas; Andrsova, Irena; Benesova, Klara; Holicka, Maria; Jarkovsky, Jiri; Hnatkova, Katerina; Koc, Lumir; Mikolaskova, Monika; Novakova, Tereza; Ondrus, Tomas; Privarova, Lenka; Spinar, Jindrich; Malik, Marek			Higher incidence of hypotension episodes in women during the sub-acute phase of ST elevation myocardial infarction and relationship to covariates	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TROPONIN-T ASSAY; PRIMARY ANGIOPLASTY; EJECTION FRACTION; HEART-ASSOCIATION; FAILURE; SEX; GUIDELINE; TRIAL	Objective The introduction of primary percutaneous coronary intervention (PPCI) has modified the profile of ST elevation myocardial infarction (STEMI) patients. Occurrence and prognostic significance of hypotension episodes are not known in PPCI treated STEMI patients. It is also not known whether and/or how the hypotension episodes correlate with the degree of myocardial damage and whether there are any sex differences. Methods Data of 293 consecutive STEMI patients (189 males) treated by PPCI and without cardiogenic shock were analyzed. Blood pressure was measured noninvasively. A hypotensive episode was defined as a systolic blood pressure below 90 mmHg over a period of at least 30 minutes. Results A hypotensive episode was observed in 92 patients (31.4%). Female sex was the strongest independent predictor of hypotension episodes (p < 0.0001), while there was no relationship to electrocardiographic STEMI localization. Hypotensive patients had significantly higher levels of troponin T and brain natriuretic peptide; hypotensive episodes were particularly frequent in women with increased troponin T. Treatment with angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB) and betablockers was less frequent in hypotensive patients. After a mean 20-month follow-up, all-cause mortality did not differ between hypotensive patients and others. However, mortality in hypotensive patients who did not tolerate ACEI/ARB therapy was significantly higher compared to other hypotensive patients (p = 0.016). Conclusion Hypotension episodes are not uncommon in the sub-acute phase of contemporarily treated STEMI patients with a striking difference between sexes-female sex was the strongest independent predictor of hypotension episodes. Hypotensive episodes may lead to a delay in pharmacotherapy which influences prognosis. Higher incidence of hypotension in women could at least partially explain the sex-related differences in the use of cardiovascular pharmacotherapy which was repeatedly observed in various studies.	[Kala, Petr; Novotny, Tomas; Andrsova, Irena; Holicka, Maria; Koc, Lumir; Mikolaskova, Monika; Novakova, Tereza; Ondrus, Tomas; Privarova, Lenka; Spinar, Jindrich] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [Kala, Petr; Novotny, Tomas; Andrsova, Irena; Holicka, Maria; Koc, Lumir; Mikolaskova, Monika; Novakova, Tereza; Ondrus, Tomas; Privarova, Lenka; Spinar, Jindrich] Masaryk Univ, Fac Med, Brno, Czech Republic; [Benesova, Klara; Jarkovsky, Jiri] Masaryk Univ, Inst Biostat & Anal, Fac Med, Brno, Czech Republic; [Hnatkova, Katerina; Malik, Marek] Imperial Coll, Natl Heart & Lung Inst, London, England	University Hospital Brno; Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno; Imperial College London	Novotny, T (corresponding author), Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic.; Novotny, T (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.	novotny-t@seznam.cz	Novotny, Tomas/ABD-5968-2020; Ondrus, Tomas/AAV-2604-2021; Jarkovsky, Jiri/G-5494-2017	Ondrus, Tomas/0000-0002-6621-0364; Novotny, Tomas/0000-0002-0292-4034; Malik, Marek/0000-0002-3792-1407	Ministry of Health of the Czech Republic [NT/13767-4]; British Heart Foundation [NH/16/2/32499] Funding Source: researchfish	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); British Heart Foundation(British Heart Foundation)	The research was supported by the grant NT/13767-4 of the Ministry of Health of the Czech Republic (http://www.macr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, J WOMENS HEALTH, V24, P859, DOI 10.1089/jwh.2015.5412; [Anonymous], 2016, LANCET, V387, P506, DOI 10.1016/S0140-6736(16)00267-1; Borlaug BA, 2011, CIRCULATION, V123, P2006, DOI 10.1161/CIRCULATIONAHA.110.954388; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Collinson PO, 2011, HEART, V97, P169, DOI 10.1136/hrt.2010.212175; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gore MO, 2014, J AM COLL CARDIOL, V63, P1441, DOI 10.1016/j.jacc.2013.12.032; Hsich EM, 2013, AM HEART J, V166, P1063, DOI 10.1016/j.ahj.2013.08.029; HUME R, 1966, J CLIN PATHOL, V19, P389, DOI 10.1136/jcp.19.4.389; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Koopman C, 2013, EUR HEART J, V34, P3198, DOI 10.1093/eurheartj/eht368; LEW AS, 1985, CIRCULATION, V72, P1321, DOI 10.1161/01.CIR.72.6.1321; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Rao ACR, 2003, HEART, V89, P559, DOI 10.1136/heart.89.5.559; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Villa C, CLIN PHYSL FUNCT IMA; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2	20	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173699	10.1371/journal.pone.0173699	http://dx.doi.org/10.1371/journal.pone.0173699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278275	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900030
J	Mullin, JM; Diguilio, KM; Valenzano, MC; Deis, R; Thomas, S; Zurbach, EP; Abdulhaqq, S; Montaner, LJ				Mullin, James M.; Diguilio, Katherine M.; Valenzano, Mary C.; Deis, Rachael; Thomas, Sunil; Zurbach, E. Peter; Abdulhaqq, Shaheed; Montaner, Luis J.			Zinc reduces epithelial barrier compromise induced by human seminal plasma	PLOS ONE			English	Article							SEMEN-DERIVED ENHANCER; TIGHT JUNCTION DISRUPTION; GROWTH-FACTOR-BETA; ADENOCARCINOMA CELLS; VIRUS-INFECTION; HIV-1; TRANSMISSION; PATHOGENESIS; INHIBITION; MECHANISMS	Human semen has the potential to modulate the epithelial mucosal tissues it contacts, as seminal plasma (SP) is recognized to contain both pro-and anti-barrier components, yet its effects on epithelial barrier function are largely unknown. We addressed the role of human SP when exposed to the basal-lateral epithelial surface, a situation that would occur clinically with prior mechanical or disease-related injury of the human epithelial mucosal cell layers in contact with semen. The action of SP on claudins-2, -4, -5, and -7 expression, as well as on a target epithelium whose basolateral surface has been made accessible to SP, showed upregulation of claudins-4 and -5 in CACO-2 human epithelial cell layers, despite broad variance in SP-induced modulation of transepithelial electrical resistance and mannitol permeability. Upregulation of claudin-2 by SP also exhibited such variance by SP sample. We characterize individual effects on CACO-2 barrier function of nine factors known to be present abundantly in seminal plasma (zinc, EGF, citrate, spermine, fructose, urea, TGF, histone, inflammatory cytokines) to establish that zinc, spermine and fructose had significant potential to raise CACO-2 transepithelial resistance, whereas inflammatory cytokines and EGF decreased this measure of barrier function. The role of zinc as a dominant factor in determining higher levels of transepithelial resistance and lower levels of paracellular leak were confirmed by zinc chelation and exogenous zinc addition. As expected, SP presentation to the basolateral cell surface also caused a very dramatic yet transient elevation of pErk levels. Results suggest that increased zinc content in SP can compete against the barrier-compromising effect of negative modulators in SP when SP gains access to that epithelium's basolateral surface. Prophylactic elevation of zinc in an epithelial cell layer prior to contact by SP may help to protect an epithelial barrier from invasion by SP-containing STD microbial pathogens such as HPV or HIV.	[Mullin, James M.; Diguilio, Katherine M.; Valenzano, Mary C.; Thomas, Sunil] Lankenau Inst Med Res, Wynnewood, PA USA; [Deis, Rachael] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Zurbach, E. Peter] St Josephs Univ, Dept Chem, Philadelphia, PA 19131 USA; [Abdulhaqq, Shaheed; Montaner, Luis J.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Drexel University; Saint Joseph's University; The Wistar Institute	Mullin, JM (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	mullinj@mlhs.org	Mullin, James M./AAD-9348-2020	Mullin, James/0000-0001-5285-7530; Thomas, Sunil/0000-0003-4780-8851	National Institutes of Health [R01 AI094603, T32 AI070099]; Philadelphia Foundation (Robert I. Jacobs Fund); Penn Center for AIDS Research [P30 AI 045008]; Cancer Center Grant [P30 CA10815]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, T32AI070099, R01AI094603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia Foundation (Robert I. Jacobs Fund); Penn Center for AIDS Research; Cancer Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grants R01 AI094603 to LJM and T32 AI070099 to SA. Additional support was provided to LJM by The Philadelphia Foundation (Robert I. Jacobs Fund), Henry S. Miller, Jr. and J. Kenneth Nimblett, the Penn Center for AIDS Research (P30 AI 045008), and Cancer Center Grant (P30 CA10815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhaqq SA, MUCOSAL IMMUNOL; Allen SA, 2015, J VIROL, V89, P5569, DOI 10.1128/JVI.00309-15; Arens M, 2000, J CLIN MICROBIOL, V38, P1758, DOI 10.1128/JCM.38.5.1758-1762.2000; Bai L, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-77; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Battersby S, 2007, HUM REPROD, V22, P36, DOI 10.1093/humrep/del328; Baum MK, 2000, J NUTR, V130, p1421S, DOI 10.1093/jn/130.5.1421S; Bourne N, 2005, ANTIMICROB AGENTS CH, V49, P1181, DOI 10.1128/AAC.49.3.1181-1183.2005; Burgener A, 2015, CURR OPIN IMMUNOL, V36, P22, DOI 10.1016/j.coi.2015.06.004; Bzik VA, 2012, J PHARM PHARMACOL, V64, P644, DOI 10.1111/j.2042-7158.2011.01441.x; Cavarelli M, 2014, AM J REPROD IMMUNOL, V71, P537, DOI 10.1111/aji.12245; Cohen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.262; COLLEEN S, 1975, SCAND J UROL NEPHROL, V9, P198, DOI 10.3109/00365597509134211; Delorme-Axford E, 2012, VIRUSES, V3, P2462, DOI [10.3390/43122462, DOI 10.3390/43122462]; Doncel GF, 2011, AM J REPROD IMMUNOL, V65, P292, DOI 10.1111/j.1600-0897.2010.00931.x; Gorodeski GI, 2007, ENDOCRINOLOGY, V148, P218, DOI 10.1210/en.2006-1120; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Grant PM, 2012, J INFECT DIS, V206, P1715, DOI 10.1093/infdis/jis604; Grant-Tschudy KS, 2005, J REPROD IMMUNOL, V67, P1, DOI 10.1016/j.jri.2005.06.001; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hartjen P, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-2; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Ho Y, 2008, MOL PHARMACOL, V74, P1141, DOI 10.1124/mol.108.049064; Howe KL, 2005, AM J PATHOL, V167, P1587, DOI 10.1016/S0002-9440(10)61243-6; Joseph T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.101956; Kranjec C, 2011, J VIROL, V85, P1757, DOI 10.1128/JVI.01756-10; Lawrence P, 2012, AIDS, V26, P785, DOI 10.1097/QAD.0b013e328351426e; Ma JF, 2009, J MAGN RESON IMAGING, V29, P1154, DOI 10.1002/jmri.21746; Marconi M, 2009, INT BRAZ J UROL, V35, P299, DOI 10.1590/S1677-55382009000300006; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Mori K, 2015, J DENT RES, V94, P1149, DOI 10.1177/0022034515589289; Muller M, 2006, ENDOCRINOLOGY, V147, P3356, DOI 10.1210/en.2005-1429; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Olsen JS, 2012, J BIOL CHEM, V287, P11842, DOI 10.1074/jbc.M111.314336; Preshaw PM, 2013, ENDOCRIN METAB CLIN, V42, P849, DOI 10.1016/j.ecl.2013.05.012; ROUSSET M, 1979, CANCER RES, V39, P531; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Samet JM, 2003, TOXICOL APPL PHARM, V191, P86, DOI 10.1016/S0041-008X(03)00219-9; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Scaldaferri F, 2012, J CLIN GASTROENTEROL, V46, pS12, DOI 10.1097/MCG.0b013e31826ae849; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Sheftic SR, 2012, EUR BIOPHYS J BIOPHY, V41, P695, DOI 10.1007/s00249-012-0846-0; Talukder P, 2011, INT IMMUNOPHARMACOL, V11, P141, DOI 10.1016/j.intimp.2010.10.010; Tan SY, 2014, LAB INVEST, V94, P777, DOI 10.1038/labinvest.2014.72; Tawar RG, 2015, SEMIN CELL DEV BIOL, V42, P39, DOI 10.1016/j.semcdb.2015.04.011; Tugizov SM, 2013, VIROLOGY, V446, P378, DOI 10.1016/j.virol.2013.08.018; Valenzano MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133926; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Wang XL, 2013, MAR GENOM, V10, P1, DOI 10.1016/j.margen.2012.12.002; Wang XX, 2013, DIGEST DIS SCI, V58, P77, DOI 10.1007/s10620-012-2328-8; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; Yang RK, 2005, INTENS CARE MED, V31, P709, DOI 10.1007/s00134-005-2601-9; Yarbrough VL, 2015, HUM REPROD UPDATE, V21, P353, DOI 10.1093/humupd/dmu065; Yin Y, 2015, MUCOSAL IMMUNOL, V8, P799, DOI 10.1038/mi.2014.110; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, P18	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0170306	10.1371/journal.pone.0170306	http://dx.doi.org/10.1371/journal.pone.0170306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278250	Green Published, gold, Green Submitted			2022-12-26	WOS:000396087900106
J	Tolppanen, AM; Voutilainen, A; Taipale, H; Tanskanen, A; Lavikainen, P; Koponen, M; Tiihonen, J; Hartikainen, S				Tolppanen, Anna-Maija; Voutilainen, Ari; Taipale, Heidi; Tanskanen, Antti; Lavikainen, Piia; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa			Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011	PLOS ONE			English	Article							DRUG-USE; PRESCRIPTION; DEMENTIA; WARNINGS	Objectives To describe and compare temporal changes in prevalence and incidence of psychotropic use (antipsychotics, antidepressants and benzodiazepines and related drugs; BZDRs) in persons with newly diagnosed Alzheimer's disease (AD) between university hospital districts of Finland during 2005-2011. Methods The MEDALZ study includes all community-dwellers of Finland who received a clinically verified AD diagnosis in 2005-2011 (N = 70,718). Prevalent and incident use of psychotropics among those who had received AD diagnosis less than one year ago were compared in 2005-2011. Results Regional differences in psychotropic use between university hospital districts were more evident in 2005 than 2011 for prevalent use of any psychotropic, antipsychotic and BZDRs and incident use of any psychotropic and antipsychotics. Regional differences in prevalent antidepressant use and incident BZDR use remained similar during the follow-up, while differences in incident antidepressant use increased during the follow-up. The prevalence of any psychotropic use in 2005 varied between 44.7-50.7% and between 45.0-47.9% in 2011. Incidence of any psychotropic use in 2005 was between 8.6-12.1% and 6.2-8.2% in 2011. In 2005, the distribution of incident psychotropic use followed a large scale spatial variation that, however, did not correspond to university hospital districts. During the study period from 2005 to 2011 the cyclic spatial variation disappeared. No sign of adjacent hospital districts being more or less closely related to each other compared to hospital districts in general was detected. Conclusions Except for antidepressants, regional differences in psychotropic use have mainly diminished between 2005 and 2011. Our findings highlight the importance of acknowledging regional differences in a country with relatively homogeneous healthcare system and conducting future studies assessing the reasons behind these differences.	[Tolppanen, Anna-Maija; Taipale, Heidi; Lavikainen, Piia; Koponen, Marjaana; Hartikainen, Sirpa] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Tolppanen, Anna-Maija] Univ Eastern Finland, Res Ctr Comparat Effectiveness & Patient Safety R, Kuopio, Finland; [Voutilainen, Ari] Univ Eastern Finland, Dept Nursing Sci, Kuopio, Finland; [Taipale, Heidi; Koponen, Marjaana; Hartikainen, Sirpa] Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari] Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Tanskanen, Antti] Natl Inst Hlth & Welf, Helsinki, Finland; [Hartikainen, Sirpa] Kuopio Univ Hosp, Dept Psychiat, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Karolinska Institutet; Finland National Institute for Health & Welfare; Kuopio University Hospital; University of Eastern Finland	Tolppanen, AM (corresponding author), Univ Eastern Finland, Sch Pharm, Kuopio, Finland.; Tolppanen, AM (corresponding author), Univ Eastern Finland, Res Ctr Comparat Effectiveness & Patient Safety R, Kuopio, Finland.	anna-maija.tolppanen@uef.fi	Voutilainen, Ari/H-3406-2019; Tiihonen, Jari/G-3078-2012	Tiihonen, Jari/0000-0002-0400-6798; Lavikainen, Piia/0000-0003-3560-8860; Taipale, Heidi/0000-0002-3281-934X	University of Eastern Finland; Academy of Finland [295334, 307232]	University of Eastern Finland; Academy of Finland(Academy of Finland)	This study was funded by strategic funding from the University of Eastern Finland (http://www.uef.fi/en/etusivu), AMT and HT; Academy of Finland (grants 295334 and 307232, http://www.aka.fi/en), AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Franchi C, 2012, EUR NEUROPSYCHOPHARM, V22, P569, DOI 10.1016/j.euroneuro.2011.12.009; Koponen M, 2015, BRIT J PSYCHIAT, V207, P444, DOI 10.1192/bjp.bp.114.162834; Martinez C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002080; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Norgaard A, 2016, J ALZHEIMERS DIS, V49, P211, DOI 10.3233/JAD-150481; Oksanen J., **DATA OBJECT**; Puranen A, INT J GERIA IN PRESS; Rikala M, 2010, DRUG AGING, V27, P337, DOI 10.2165/11315960-000000000-00000; Saarelainen L, 2016, J ALZHEIMERS DIS, V49, P809, DOI 10.3233/JAD-150630; Schulze J, 2013, PHARMACOEPIDEM DR S, V22, P1308, DOI 10.1002/pds.3527; Schulze J, 2013, EUR NEUROPSYCHOPHARM, V23, P1034, DOI 10.1016/j.euroneuro.2013.02.001; Suhonen Jaana, 2010, Duodecim, V126, P2167; Taipale H, 2016, LAAKARILEHTI, V71; Taipale H, 2014, EUR NEUROPSYCHOPHARM, V24, P1729, DOI 10.1016/j.euroneuro.2014.10.004; Tanskanen A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0140-z; Tolppanen AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012100; Tolppanen Anna-Maija, 2013, Clin Epidemiol, V5, P277, DOI 10.2147/CLEP.S46622; Voutilainen A, 2015, SCAND J PUBLIC HLTH; Voutilainen A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-11; Working group appointed by the Finnish Medical Society Duodecim Societas Gerontologica Fennica the Finnish Neurological Society Finnish Psychogeriatric Association and the Finnish Association for General Practice, 2010, FINN CURR CAR REC ME; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173450	10.1371/journal.pone.0173450	http://dx.doi.org/10.1371/journal.pone.0173450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278245	Green Published, Green Submitted, gold			2022-12-26	WOS:000396087900094
